PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bahng, S; Mossessova, E; Nurse, P; Marians, KJ				Bahng, S; Mossessova, E; Nurse, P; Marians, KJ			Mutational analysis of Escherichia coli topoisomerase IV. Identification of a region of ParE involved in covalent catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL FRAGMENT; DNA GYRASE; CRYSTAL-STRUCTURE; MECHANISM; PURIFICATION; DOMAIN; ENZYME	The products of three dominant-negative alleles of parE, encoding the ATP-binding subunit of topoisomerase TV (Topo TV), were purified and their activities characterized when reconstituted with ParC to form Topo IV. The ability of the ParE E418K, ParE G419D, and ParE G442D mutant Topo IVs to bind DNA, hydrolyze ATP, and close their ATP-dependent clamp was relatively unaffected. However, their ability to relax negatively supercoiled DNA was compromised significantly. This could be attributed to severe defects in covalent complex formation between ParC and DNA. Thus, these residues, which are far from the active site Tyr of ParC, contribute to covalent catalysis, This indicates that a dramatic conformational rearrangement of the protein likely occurs subsequent to the binding of the G: segment at the DNA gate and prior to its opening.	Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Mol Biol Grad Program, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Bahng, S (corresponding author), Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34558] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Caron PR, 1999, METH MOL B, V94, P279; KATO J, 1992, J BIOL CHEM, V267, P25676; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; Marians KJ, 1997, J BIOL CHEM, V272, P9401; Mossessova E, 2000, J BIOL CHEM, V275, P4099, DOI 10.1074/jbc.275.6.4099; Nurse P, 2000, J BIOL CHEM, V275, P4104, DOI 10.1074/jbc.275.6.4104; PENG H, 1995, J BIOL CHEM, V270, P25286, DOI 10.1074/jbc.270.42.25286; PENG H, 1993, J BIOL CHEM, V268, P24481; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WASSERMAN RA, 1994, J BIOL CHEM, V269, P20943; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; YONG YQ, 1995, J BIOL CHEM, V270, P24509, DOI 10.1074/jbc.270.41.24509	20	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4112	4117		10.1074/jbc.275.6.4112	http://dx.doi.org/10.1074/jbc.275.6.4112			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660571	hybrid			2022-12-27	WOS:000085288800055
J	Hinke, SA; Pospisilik, JA; Demuth, HU; Mannhart, S; Kuhn-Wache, K; Hoffmannn, T; Nishimura, E; Pederson, RA; McIntosh, CHS				Hinke, SA; Pospisilik, JA; Demuth, HU; Mannhart, S; Kuhn-Wache, K; Hoffmannn, T; Nishimura, E; Pederson, RA; McIntosh, CHS			Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon - Characterization of glucagon degradation products and DPIV-resistant analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; IN-VITRO; BIOLOGICAL-ACTIVITIES; MASS-SPECTROMETRY; RECEPTOR; BINDING; ANTAGONISTS; SPECIFICITY; POSITION-12; METABOLISM	Over the past decade, numerous studies have been targeted at defining structure-activity relationships of glucagon. Recently, we have found that glucagon(1-29) is hydrolyzed by dipeptidyl peptidase IV (DPIV) to produce glucagon(3-29) and glucagon(5-29); in human serum, [pyroglutamyl (pGlu)(3)]glucagon(3-29) is formed from glucagon(3-29) and this prevents further hydrolysis of glucagon by DPIV (H.-U. Demuth, K. Glund, U. Heiser, J. Pospisilik, S. Hinke, T. Hoffmann, F. Rosche, D. Schlenzig, M. Wermann, C. McIntosh, and R. Pederson, manuscript in preparation). In the current study, the biological activity of these peptides was examined in vitro. The amino-terminally truncated peptides all behaved as partial agonists in cyclic AMP stimulation assays, with Chinese hamster ovary K1 cells overexpressing the human glucagon receptor (potency: glucagon(1-29) > [pGlu(3)]glucagon(3-29) > glucagon(3-29) > glucagon(5-29) > [Glu(9)]glucagon(2-29)). In competition binding experiments, [pGlu(3)]glucagon(3-29) and glucagon(5-29) both demonstrated 5-fold lower affinity for the receptor than glucagon(1-29), whereas glucagon(3-29) exhibited 18-fold lower affinity. Of the peptides tested, only glucagon(5-29) showed antagonist activity, and this was weak compared with the classical glucagon antagonist, [Glu(9)]glucagon(2-29). Hence, DPIV hydrolysis of glucagon yields low affinity agonists of the glucagon receptor. As a corollary to evidence indicating that DPIV degrades glucagon (Demuth, ct at, manuscript in preparation), DPIV-resistant analogs were synthesized. Matrix-assisted laser desorption/ionization-time of flight mass spectrometry was used to assess DPIV resistance, and it allowed kinetic analysis of degradation. Of several analogs generated, only [D-Ser(2)] and [Gly(2)]glucagon retained high affinity binding and biological potency, similar to native glucagon in vitro. [D-Ser(2)]Glucagon exhibited enhanced hyperglycemic activity in a bioassay, whereas [Gly(2)]glucagon was not completely resistant to DPIV degradation.	Univ British Columbia, Fac Med, Dept Physiol, Vancouver, BC V6T 1Z3, Canada; Bioctr, D-06120 Halle, Saale, Germany; Novo Nordisk AS, Dept Diabet Biochem & Metab, DK-2760 Malov, Denmark	University of British Columbia; Novo Nordisk	McIntosh, CHS (corresponding author), Univ British Columbia, Fac Med, Dept Physiol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.		Hinke, Simon/R-7120-2019	Nishimura, Erica/0000-0001-5741-3648				ALFORD FP, 1976, J CLIN ENDOCR METAB, V42, P830, DOI 10.1210/jcem-42-5-830; Azizeh BY, 1997, PEPTIDES, V18, P633, DOI 10.1016/S0196-9781(97)00131-9; BUGGY JJ, 1995, J BIOL CHEM, V270, P7474, DOI 10.1074/jbc.270.13.7474; CHIASSON JL, 1983, HDB EXPT PHARM, V66, P361; Dalle S, 1999, J BIOL CHEM, V274, P10869, DOI 10.1074/jbc.274.16.10869; Deacon CF, 1998, DIABETES, V47, P764, DOI 10.2337/diabetes.47.5.764; DEMUTH HU, 1998, 12 INT S REG PEPT AB; DEMUTH HU, 1995, DIPEPTIDYL PEPTIDASE, V4, P1; FRANDSEN EK, 1981, H-S Z PHYSIOL CHEM, V362, P665, DOI 10.1515/bchm2.1981.362.1.665; Gelling RW, 1997, REGUL PEPTIDES, V69, P151, DOI 10.1016/S0167-0115(97)00009-8; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Grondin G, 1999, J HISTOCHEM CYTOCHEM, V47, P489, DOI 10.1177/002215549904700407; Hansen LH, 1996, DIABETES, V45, P725, DOI 10.2337/diabetes.45.6.725; HENDRIKS T, 1981, DIABETOLOGIA, V20, P553; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; Hoist JJ, 1994, GUT PEPTIDES BIOCH P, P305; Holst JJ, 1991, DEGRADATION BIOACTIV, P167; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; HRUBY VJ, 1982, MOL CELL BIOCHEM, V44, P49, DOI 10.1007/BF00573846; JASPAN JB, 1981, AM J PHYSIOL, V240, pE233, DOI 10.1152/ajpendo.1981.240.3.E233; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; LEFEBVRE P, 1983, HDB EXPT PHARM, V66, P389; Li J, 1997, BBA-MOL CELL RES, V1356, P229, DOI 10.1016/S0167-4889(96)00170-X; MARKI F, 1983, HORM METAB RES, V15, P307, DOI 10.1055/s-2007-1018703; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; NIH, 1985, NIH PUBL; Pauly RP, 1999, METABOLISM, V48, P385, DOI 10.1016/S0026-0495(99)90090-2; Pauly RP, 1996, J BIOL CHEM, V271, P23222, DOI 10.1074/jbc.271.38.23222; PAVOINE C, 1991, AM J PHYSIOL, V260, pC993, DOI 10.1152/ajpcell.1991.260.5.C993; Pederson RA, 1998, DIABETES, V47, P1253, DOI 10.2337/diabetes.47.8.1253; Proost P, 1999, J BIOL CHEM, V274, P3988, DOI 10.1074/jbc.274.7.3988; ROBBINS SB, 1988, MEAS EVAL COUNS DEV, V21, P117, DOI 10.1080/07481756.1988.12022893; ROSCHE F, 2000, PROTEIN PEPTIDE ANAL; Schmidt J, 1996, PROTEIN PEPTIDE LETT, V3, P385; SMITH RA, 1993, MOL PHARMACOL, V43, P741; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; UNSON CG, 1994, P NATL ACAD SCI USA, V91, P454, DOI 10.1073/pnas.91.2.454; Unson CG, 1998, J BIOL CHEM, V273, P10308, DOI 10.1074/jbc.273.17.10308; UNSON CG, 1989, J BIOL CHEM, V264, P789; WHEELER MB, 1995, ENDOCRINOLOGY, V136, P4629, DOI 10.1210/en.136.10.4629; WOLF B, 1978, ACTA BIOL MED GER, V37, P409; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572	42	106	127	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3827	3834		10.1074/jbc.275.6.3827	http://dx.doi.org/10.1074/jbc.275.6.3827			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660533	Green Submitted, hybrid			2022-12-27	WOS:000085288800017
J	Petersen, C; Orem, N; Trueheart, J; Thorner, JW; Macara, IG				Petersen, C; Orem, N; Trueheart, J; Thorner, JW; Macara, IG			Random mutagenesis and functional analysis of the Ran-binding protein, RanBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEAR EXPORT SIGNAL; IMPORT FACTOR P97; RAN/TC4 GTPASE; KARYOPHERIN-BETA; TRANSPORT FACTORS; PORE COMPLEX; YEAST; RCC1; LOCALIZATION	Ran GTPase is required for nucleocytoplasmic transport of many types of cargo. Several proteins that recognize Ran in its GTP-bound state (Ran GTP) possess a conserved Ran-binding domain (RanBD), Ran-binding protein-1 (RanBP1) has a single RanBD and is required for RanGAP-mediated GTP hydrolysis and release of Ran from nuclear transport receptors (karyopherins), In budding yeast (Saccharomyces cerevisiae), RanBP1 is encoded by the essential YRB1 gene; expression of mouse RanBP1 cDNA rescues the lethality of Yrb1-deficient cells. We generated libraries of mouse RanBP1 mutants and examined 11 mutants in vitro and for their ability to complement a temperature-sensitive yrb1 mutant (yrb1-51(ts)) in vivo, In 9 of the mutants, the alteration was a change in a residue (or 2 residues) that is conserved in all known RanBDs, However, 4 of these 9 mutants displayed biochemical properties indistinguishable from that of wild-type RanBP1. These mutants bound to Ran GTP, stimulated RanGAP, inhibited the exchange activity of RCC1, and rescued growth of the yrb1-51(ts) yeast cells. Two of the 9 mutants altered in residues thought to be essential for interaction with Ran were unable to rescue growth of the yrb1(ts) mutant and did not bind detectably to Ran in vitro. However, one of these 2 mutants (and 2 others that were crippled in other RanBP1 functions) retained some ability to coactivate RanGAP, A truncated form of RanBP1 (lacking its nuclear export signal) was able to complement the yrb1(ts) mutation. When driven from the YRB1 promoter, 4 of the 5 mutants most impaired for Ran binding were unable to rescue growth of the yrb1(ts) cells; remarkably, these mutants could nevertheless form ternary complexes with importin-5 or importin-beta and Ran-GTP, The same mutants stimulated only inefficiently RanGAP-mediated GTP hydrolysis of the Ran GTP-importin-5 complex. Thus, the essential biological activity of RanBP1 in budding yeast correlates not with Ran GTP binding per se or with the ability to form ternary complexes with karyopherins, but with the capacity to potentiate Ran-GAP activity toward GTP-bound Ran in these complexes.	Univ Virginia, Markey Ctr Cell Signalling, Charlottesville, VA 22908 USA; Dartmouth Coll, Hanover, NH 03755 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Virginia; Dartmouth College; University of California System; University of California Berkeley	Macara, IG (corresponding author), Univ Virginia, Markey Ctr Cell Signalling, 7191 Hosp W, Charlottesville, VA 22908 USA.	igm9c@virginia.edu	THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021841, R01GM021841, R01GM050526] Funding Source: NIH RePORTER; NCI NIH HHS [CA09041] Funding Source: Medline; NIGMS NIH HHS [GM50526, GM21841] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; BEDDOW AL, 1995, P NATL ACAD SCI USA, V92, P3328, DOI 10.1073/pnas.92.8.3328; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chi NC, 1997, MOL BIOL CELL, V8, P945, DOI 10.1091/mbc.8.6.945; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; CORBETT AH, 1995, J CELL BIOL, V130, P1017, DOI 10.1083/jcb.130.5.1017; COUTAVAS E, 1993, NATURE, V366, P585, DOI 10.1038/366585a0; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Floer M, 1996, J BIOL CHEM, V271, P5313, DOI 10.1074/jbc.271.10.5313; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Hieda M, 1999, J CELL BIOL, V144, P645, DOI 10.1083/jcb.144.4.645; HOPPER AK, 1990, J CELL BIOL, V111, P309, DOI 10.1083/jcb.111.2.309; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; LOUNSBURY KM, 1994, J BIOL CHEM, V269, P11285; Lounsbury KM, 1997, J BIOL CHEM, V272, P551; Lounsbury KM, 1996, J BIOL CHEM, V271, P2357, DOI 10.1074/jbc.271.5.2357; Macara LG, 1999, CURR BIOL, V9, pR436, DOI 10.1016/S0960-9822(99)80275-9; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; OUSPENSKI II, 1995, J BIOL CHEM, V270, P1975, DOI 10.1074/jbc.270.5.1975; Ouspenski II, 1998, EXP CELL RES, V244, P171, DOI 10.1006/excr.1998.4174; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Sazer S, 1996, TRENDS CELL BIOL, V6, P81, DOI 10.1016/0962-8924(96)80992-5; SCHLENSTEDT G, 1995, EMBO J, V14, P5367, DOI 10.1002/j.1460-2075.1995.tb00221.x; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seki T, 1996, J BIOCHEM, V120, P207; Solsbacher J, 1998, MOL CELL BIOL, V18, P6805, DOI 10.1128/MCB.18.11.6805; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Talcott B, 1999, TRENDS CELL BIOL, V9, P312, DOI 10.1016/S0962-8924(99)01608-6; Turi TG, 1996, J BIOL CHEM, V271, P9166, DOI 10.1074/jbc.271.15.9166; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wozniak RW, 1998, TRENDS CELL BIOL, V8, P184, DOI 10.1016/S0962-8924(98)01248-3; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang CM, 1999, J CELL SCI, V112, P2453; ZHOU YH, 1991, NUCLEIC ACIDS RES, V19, P6052, DOI 10.1093/nar/19.21.6052	57	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4081	4091		10.1074/jbc.275.6.4081	http://dx.doi.org/10.1074/jbc.275.6.4081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660567	hybrid			2022-12-27	WOS:000085288800051
J	Eckhardt, M; Barth, H; Blocker, D; Aktories, K				Eckhardt, M; Barth, H; Blocker, D; Aktories, K			Binding of Clostridium botulinum C2 toxin to asparagine-linked complex and hybrid carbohydrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFRINGENS-IOTA-TOXIN; GOLGI VESICLE MEMBRANES; HAMSTER OVARY CELLS; BINARY TOXIN; ADP-RIBOSYLTRANSFERASE; GLYCOSYLATION MUTANTS; ESCHERICHIA-COLI; SPIROFORME TOXIN; RHO-PROTEINS; ACTIN	Clostridium botulinum C2 toxin is a binary toxin composed of an enzymatic subunit (C2I) capable of ADP-ribosylating actin and a binding subunit (C2II) that is responsible for interaction with receptors on eukaryotic cells. Here we show that binding of C2 toxin depends on the presence of asparagine-linked carbohydrates. A recently identified Chinese hamster ovary cell mutant (Fritz G., Schroeder, P., and Aktories, K. (1995) Infect. Immun. 63, 2334-2340) was found to be deficient in N-acetylglucosaminyltransferase I. C2 sensitivity of this mutant was restored by transfection of an N-acetylglucosaminyltransferase I cDNA C2 toxin sensitivity was reduced after inhibition of alpha-mannosidase II. In contrast, Chinese hamster ovary cell mutants deficient in sialylated (Lec2) or galactosylated (Lec8) glycoconjugates showed an increase in toxin sensitivity compared with wild-type cells. Our results show that the GlcNAc residue linked beta-1,2 to the alpha-1,3-mannose of the asparagine-linked core structure is essential for C2II binding to Chinese hamster ovary cells.	Univ Freiburg, Inst Pharmakol & Toxikol, D-79104 Freiburg, Germany	University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Pharmakol & Toxikol, Hermann Herder Str 5, D-79104 Freiburg, Germany.	aktories@uni-freiburg.de	Barth, Holger/E-7920-2013; Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436				AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 1998, J BIOL CHEM, V273, P29506, DOI 10.1074/jbc.273.45.29506; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; Boquet P, 1998, CURR OPIN MICROBIOL, V1, P66, DOI 10.1016/S1369-5274(98)80144-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; CUMMINGS RD, 1994, METHOD ENZYMOL, V230, P66; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FRITZ G, 1995, INFECT IMMUN, V63, P2334, DOI 10.1128/IAI.63.6.2334-2340.1995; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; GOTTLIEB C, 1975, J BIOL CHEM, V250, P3303; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kimura K, 1998, VET MICROBIOL, V62, P27, DOI 10.1016/S0378-1135(98)00195-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAUSS S, 1990, EUR J BIOCHEM, V194, P237, DOI 10.1111/j.1432-1033.1990.tb19448.x; OHISHI I, 1987, INFECT IMMUN, V55, P1461, DOI 10.1128/IAI.55.6.1461-1465.1987; OHISHI I, 1992, INFECT IMMUN, V60, P4648, DOI 10.1128/IAI.60.11.4648-4655.1992; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; PERELLE S, 1993, INFECT IMMUN, V61, P5147, DOI 10.1128/IAI.61.12.5147-5156.1993; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; Sandvig K, 1997, ADV EXP MED BIOL, V412, P225; SIMPSON LI, 1989, J PHARMACOL EXP THER, V251, P1223; SINGH Y, 1991, J BIOL CHEM, V266, P15493; STANLEY P, 1977, SOMAT CELL GENET, V3, P391, DOI 10.1007/BF01542968; STANLEY P, 1992, GLYCOBIOLOGY, V2, P99, DOI 10.1093/glycob/2.2.99; STANLEY P, 1984, ANNU REV GENET, V18, P525, DOI 10.1146/annurev.ge.18.120184.002521; SUGII S, 1990, BIOCHIM BIOPHYS ACTA, V1034, P176, DOI 10.1016/0304-4165(90)90073-6; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; WEGNER A, 1988, J BIOL CHEM, V263, P13739; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	36	100	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2328	2334		10.1074/jbc.275.4.2328	http://dx.doi.org/10.1074/jbc.275.4.2328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644682	hybrid			2022-12-27	WOS:000085128000014
J	Olson, MW; Bernardo, MM; Pietila, M; Gervasi, DC; Toth, M; Kotra, LP; Massova, I; Mobashery, S; Fridman, R				Olson, MW; Bernardo, MM; Pietila, M; Gervasi, DC; Toth, M; Kotra, LP; Massova, I; Mobashery, S; Fridman, R			Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9 - Differential rates for activation by stromelysin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOPEXIN-LIKE DOMAIN; COOH-TERMINAL DOMAIN; HUMAN GELATINASE-A; TISSUE INHIBITOR; IV COLLAGENASE; INTERSTITIAL COLLAGENASE; PROTEOLYTIC ACTIVITY; CRYSTAL-STRUCTURE; EXPRESSION; BINDING	Matrix metalloproteinase-9 (MMP-9) is a member of the MMP family that has been associated with degradation of the extracellular matrix in normal and pathological conditions. A unique characteristic of MMP-9 is its ability to exist in a monomeric and a disulfide-bonded dimeric form. However, there exists a paucity of information on the properties of the latent (pro-MMP-9) and active MMP-9 dimer. Here we report the purification to homogeneity of the monomer and dimer forms of pro-MMP-9 and the characterization of their biochemical properties and interactions with tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. Gel filtration and surface plasmon resonance analyses demonstrated that the pro-MMP-9 monomeric and dimeric forms bind TIMP-1 with similar affinities. In contrast, TIMP-2 binds only to the active forms. After activation, the two enzyme forms exhibited equal catalytic competence in the turnover of a synthetic peptide substrate with comparable kinetic parameters for the onset of inhibition with TIMPs and for dissociation of the inhibited complexes. Kinetic analyses of the activation of monomeric and dimeric pro-MMP-9 by stromelysin 1 revealed K-m values in the nanomolar range and relative low k(cat) values (1.9 x 10(-3) and 4.1 x 10(-4) s(-1), for the monomer and dimer, respectively) consistent with a faster rate (1 order of magnitude) of activation of the monomeric form by stromelysin 1, This suggests that the rate-limiting event in the activation of pro-MMP-9 may be a requisite slow unfolding of pro-MMP-9 near the site of the hydrolytic cleavage by stromelysin 1.	Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA; Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; Wayne State Univ, Dept Chem, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Fridman, R (corresponding author), Wayne State Univ, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.				NCI NIH HHS [CA-61986] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061986] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agren MS, 1998, BRIT J SURG, V85, P68; Ahrens D, 1996, ARTHRITIS RHEUM, V39, P1576, DOI 10.1002/art.1780390919; BECKER JW, 1995, PROTEIN SCI, V4, P1966, DOI 10.1002/pro.5560041002; Bigg HF, 1997, J BIOL CHEM, V272, P15496, DOI 10.1074/jbc.272.24.15496; BROOKS CL, 1988, THEORETICAL PERSPECT; BROWN PD, 1990, CANCER RES, V50, P6184; CANETESOLER R, 1995, DEV DYNAM, V204, P30, DOI 10.1002/aja.1002040105; Esser CK, 1997, J MED CHEM, V40, P1026, DOI 10.1021/jm960465t; Finzel BC, 1998, PROTEIN SCI, V7, P2118, DOI 10.1002/pro.5560071008; FRIDMAN R, 1992, J BIOL CHEM, V267, P15398; FRIDMAN R, 1995, CANCER RES, V55, P2548; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLICK BR, 1978, CAN J BIOCHEM CELL B, V56, P1055, DOI 10.1139/o78-166; Gohlke U, 1996, FEBS LETT, V378, P126, DOI 10.1016/0014-5793(95)01435-7; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Gonzalez-Avila G, 1998, PATHOBIOLOGY, V66, P196, DOI 10.1159/000028023; HIMELSTEIN BP, 1994, INVAS METAST, V14, P246; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KNIGHT CG, 1995, METHOD ENZYMOL, V248, P18; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YY, 1998, CIRCULATION, V98, P1728, DOI 10.1161/01.CIR.98.17.1728; LIBSON AM, 1995, NAT STRUCT BIOL, V2, P938, DOI 10.1038/nsb1195-938; MANN KG, 1990, BLOOD, V76, P1; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Mautino G, 1997, AM J RESP CELL MOL, V17, P583, DOI 10.1165/ajrcmb.17.5.2562; MOLL UM, 1990, CANCER RES, V50, P6162; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.0.CO;2-T; MURPHY G, 1995, METHOD ENZYMOL, V248, P470; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; NAGASE H, 1994, J BIOL CHEM, V269, P20952; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Ohno I, 1997, AM J RESP CELL MOL, V16, P212, DOI 10.1165/ajrcmb.16.3.9070604; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Pickford AR, 1997, STRUCTURE, V5, P359, DOI 10.1016/S0969-2126(97)00193-7; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Sehgal G, 1998, AM J PATHOL, V152, P591; STRONGIN AY, 1993, KIDNEY INT, V43, P158, DOI 10.1038/ki.1993.26; Tamarina NA, 1997, SURGERY, V122, P264, DOI 10.1016/S0039-6060(97)90017-9; Toth M, 1997, CANCER RES, V57, P3159; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Upadhya AG, 1997, HEPATOLOGY, V26, P922, DOI 10.1002/hep.510260418; VARTIO T, 1989, FEBS LETT, V255, P285, DOI 10.1016/0014-5793(89)81107-X; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; VU TH, 1998, GELATINASE B, P115; WILHELM SM, 1989, J BIOL CHEM, V264, P17213	51	131	138	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2661	2668		10.1074/jbc.275.4.2661	http://dx.doi.org/10.1074/jbc.275.4.2661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644727	hybrid			2022-12-27	WOS:000085128000059
J	Marin, EP; Krishna, KG; Zvyaga, TA; Isele, J; Siebert, F; Sakmar, TP				Marin, EP; Krishna, KG; Zvyaga, TA; Isele, J; Siebert, F; Sakmar, TP			The amino terminus of the fourth cytoplasmic loop of rhodopsin modulates rhodopsin-transducin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-2-ADRENERGIC RECEPTOR; PROTEIN-COUPLED RECEPTORS; BOVINE RHODOPSIN; ACTIVATION; PALMITOYLATION; MUTANT; FLUORESCENCE; MUTAGENESIS; INFORMATION; RECOGNITION	Rhodopsin is a seven-transmembrane helix receptor that binds and catalytically activates the heterotrimeric G protein transducin (G(t)). This interaction involves the cytoplasmic surface of rhodopsin, which comprises four putative loops and the carboxyl-terminal tail. The fourth loop connects the carboxyl end of transmembrane helix 7 with Cys(322) and Cys(323), which are both modified by membrane-inserted palmitoyl groups. Published data on the roles of the fourth loop in the binding and activation of G(t) are contradictory. Here, we attempt to reconcile these conflicts and define a role for the fourth loop in rhodopsin-G(t) interactions. Fluorescence experiments demonstrated that a synthetic peptide corresponding to the fourth loop of rhodopsin inhibited the activation of G(t) by rhodopsin and interacted directly with the alpha subunit of G(t). A series of rhodopsin mutants was prepared in which portions of the fourth loop were replaced with analogous sequences from the beta(2)-adrenergic receptor or the mi muscarinic receptor. Chimeric receptors in which residues 310-312 were replaced could not efficiently activate G(t). The defect in G(t) interaction in the fourth loop mutants was not affected by preventing palmitoylation of Cys(322) and CyS323. We suggest that the amino terminus of the fourth loop interacts directly with G(t), particularly with G alpha(t), and with other regions of the intracellular surface of rhodopsin to support G(t) binding.	Rockefeller Univ, Howard Hughes Med Inst, Biochem & Mol Biol Lab, New York, NY 10021 USA; Univ Freiburg, Inst Biophys & Strahlenbiol, D-79104 Freiburg, Germany	Howard Hughes Medical Institute; Rockefeller University; University of Freiburg	Sakmar, TP (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Biochem & Mol Biol Lab, Box 284,1230 York Ave, New York, NY 10021 USA.	sakmar@rockvax.rockefeller.edu	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; Aradhyam, Gopala Krishna/0000-0001-8232-3935	NEI NIH HHS [EY07138] Funding Source: Medline; NIGMS NIH HHS [GM07982, GM07739] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007138] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abdulaev NG, 1998, P NATL ACAD SCI USA, V95, P12854, DOI 10.1073/pnas.95.22.12854; Altenbach C, 1999, BIOCHEMISTRY-US, V38, P7931, DOI 10.1021/bi9900121; Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; BenTal N, 1996, BIOPHYS J, V70, P1803, DOI 10.1016/S0006-3495(96)79744-8; BORJIGIN J, 1994, J BIOL CHEM, V269, P14715; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; FUNG BKK, 1983, J BIOL CHEM, V258, P495; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; HAN M, 2000, IN PRESS METHODS ENZ; Helmreich EJM, 1996, BBA-REV BIOMEMBRANES, V1286, P285, DOI 10.1016/S0304-4157(96)00013-5; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; LIGGETT SB, 1991, J BIOL CHEM, V266, P4816; LO KM, 1984, P NATL ACAD SCI-BIOL, V81, P2285, DOI 10.1073/pnas.81.8.2285; MIN KC, 1993, J BIOL CHEM, V268, P9400; MOENCH SJ, 1994, BIOCHEMISTRY-US, V33, P5791, DOI 10.1021/bi00185a017; MORRISON DF, 1991, J BIOL CHEM, V266, P20118; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OSAWA S, 1994, MOL PHARMACOL, V46, P1036; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PAPAC DI, 1992, J BIOL CHEM, V267, P16889; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17032; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SHICHI H, 1984, VISION RES, V24, P1523, DOI 10.1016/S0042-6989(84)80001-2; TAKEMOTO DJ, 1986, BIOCHEM J, V235, P309, DOI 10.1042/bj2350309; WEISS ER, 1994, BIOCHEMISTRY-US, V33, P7587, DOI 10.1021/bi00190a011; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Yang K, 1996, BIOCHEMISTRY-US, V35, P14040, DOI 10.1021/bi962113u; Yeagle P L, 1996, Mol Vis, V2, P12	45	131	163	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1930	1936		10.1074/jbc.275.3.1930	http://dx.doi.org/10.1074/jbc.275.3.1930			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636894	hybrid			2022-12-27	WOS:000084940000057
J	Mezghrani, A; Courageot, J; Mani, JC; Pugniere, M; Bastiani, P; Miquelis, R				Mezghrani, A; Courageot, J; Mani, JC; Pugniere, M; Bastiani, P; Miquelis, R			Protein-disulfide isomerase (PDI) in FRTL5 cells - pH-dependent thyroglobulin/PDI interactions determine a novel PDI function in the post-endoplasmic reticulum of thyrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGLUCOSAMINE-SPECIFIC RECEPTOR; MOLECULAR CHAPERONES; PLASMA-MEMBRANE; PROTEINDISULFIDE ISOMERASE; MULTIFUNCTIONAL PROTEIN; SURFACE EXPRESSION; IODINE CONTENT; GOLGI-COMPLEX; SECRETION; LOCALIZATION	Thyroglobulin (TG)) is secreted by the thyrocytes into the follicular lumen of the thyroid. After maturation and hormone formation, TG is endocytosed and delivered to lysosomes, Quality control mechanisms may occur during this bidirectional traffic since 1) several molecular chaperones are cosecreted with TG in vivo, and 2) lysosomal targeting of immature TG is thought to be prevented via the interaction, in acidic conditions, between the Ser(789)-Met(1172) TG hormonogenic domain (BD) and an unidentified membrane receptor. We investigated the secretion and cell surface expression of PDI and other chaperones in the FRTL5 thyroid cell line, and then studied the characteristics of the interaction between TG and PDI. We demonstrated that PDI, but also other chaperones such as calnexin and KDEL-containing proteins are exposed at the cell surface. We observed on living cells or membrane preparations that PDI specifically binds TG in acidic conditions, and that only ED is involved in binding. Surface plasmon resonance analysis of TG/PDI interactions indicated: 1) that PDI bound TG but only in acidic conditions, and that it preferentially recognized immature molecules, and 2) ED is involved in binding even if cysteine-rich modules are deleted. The notion that PDI acts as an "escort" for immature TG in acidic post-endoplasmic reticulum compartments is discussed.	CNRS, UMR 9921, Fac Pharm, F-34060 Montpellier 2, France; Univ Aix Marseille 2, Lab Biochim Ingn Prot, UMR 6560, Inst Federat Jean Roche,Fac Med Nord, F-13916 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite	Miquelis, R (corresponding author), CNRS, UMR 9921, Fac Pharm, 15 Ave Charles Flahault, F-34060 Montpellier 2, France.		Pugniere, Martine/T-1355-2017; PUGNIERE, Martine/AAD-4315-2020	Pugniere, Martine/0000-0002-2049-2909; PUGNIERE, Martine/0000-0002-2049-2909				ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; ARVAN P, 1991, J CELL BIOL, V112, P365, DOI 10.1083/jcb.112.3.365; BASTIANI P, 1980, ACTA ENDOCRINOL-COP, V94, P71, DOI 10.1530/acta.0.0940071; BASTIANI P, 1995, ENDOCRINOLOGY, V136, P4204, DOI 10.1210/en.136.10.4204; Berndorfer U, 1996, J CLIN ENDOCR METAB, V81, P1918, DOI 10.1210/jc.81.5.1918; BJORKMAN U, 1980, BIOCH THYROID HORMON, P88; BLANCK I, 1995, GENOMICS, V27, P561; BLANCK O, 1994, GENOMICS, V21, P18, DOI 10.1006/geno.1994.1219; Bruneau N, 1998, J CELL SCI, V111, P2665; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; CHEN K, 1992, BLOOD, V79, P2226; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONSIGLIO E, 1981, J BIOL CHEM, V256, P592; Couet J, 1996, BIOCHEMISTRY-US, V35, P14800, DOI 10.1021/bi961359w; Delom F, 1999, BIOCHEM BIOPH RES CO, V255, P438, DOI 10.1006/bbrc.1999.0229; Demaurex N, 1998, J BIOL CHEM, V273, P2044, DOI 10.1074/jbc.273.4.2044; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; DORNER AJ, 1990, J BIOL CHEM, V265, P22029; DUMONT JE, 1989, METABOLIC BASIS INHE, P1843; EDELHOCH H, 1985, THYROGLOBULIN PROTHY, P1; ERICSON LE, 1981, MOL CELL ENDOCRINOL, V22, P1, DOI 10.1016/0303-7207(81)90098-8; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Hotchkiss KA, 1996, BIOCHEMISTRY-US, V35, P9761, DOI 10.1021/bi9603938; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; KIM PS, 1992, J CELL BIOL, V118, P541, DOI 10.1083/jcb.118.3.541; KOMFELD R, 1985, ANNU REV BIOCHEM, V54, P631; KRONING H, 1994, SCAND J IMMUNOL, V39, P346, DOI 10.1111/j.1365-3083.1994.tb03384.x; KUZNETSOV G, 1994, J BIOL CHEM, V269, P22990; Kuznetsov G, 1997, J BIOL CHEM, V272, P3057, DOI 10.1074/jbc.272.5.3057; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MANDEL R, 1993, P NATL ACAD SCI USA, V91, P4559; Marino M, 1999, J BIOL CHEM, V274, P12898, DOI 10.1074/jbc.274.18.12898; MAXFIELD FR, 1989, METHOD ENZYMOL, V173, P745; Mezgrhani H, 1997, J BIOL CHEM, V272, P23340, DOI 10.1074/jbc.272.37.23340; MIQUELIS R, 1987, J BIOL CHEM, V262, P15291; MOLINA F, 1996, EUR J BIOCHEM, V240, P225; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; Mziaut H, 1996, ENDOCRINOLOGY, V137, P1370, DOI 10.1210/en.137.4.1370; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; NOIVA R, 1992, J BIOL CHEM, V267, P3553; OKHUMA S, 1978, P NATL ACAD SCI USA, V75, P3327; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; PARMA J, 1987, J MOL BIOL, V196, P769, DOI 10.1016/0022-2836(87)90403-7; RAO ASMK, 1993, P NATL ACAD SCI USA, V90, P2950, DOI 10.1073/pnas.90.7.2950; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; Tager M, 1997, EXP HEMATOL, V25, P601; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; THIBAULT V, 1993, ENDOCRINOLOGY, V132, P468, DOI 10.1210/en.132.1.468; Thiele C, 1997, CURR BIOL, V7, P496; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P307, DOI 10.1056/NEJM197908093010605; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Zheng G, 1998, ENDOCRINOLOGY, V139, P1462, DOI 10.1210/en.139.3.1462	62	38	39	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1920	1929		10.1074/jbc.275.3.1920	http://dx.doi.org/10.1074/jbc.275.3.1920			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636893	hybrid			2022-12-27	WOS:000084940000056
J	Short, AD; Taylor, CW				Short, AD; Taylor, CW			Parathyroid hormone controls the size of the intracellular Ca2+ stores available to receptors linked to inositol trisphosphate formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PTH/PTHRP RECEPTOR; KIDNEY-CELL LINE; 1,4,5-TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; FUNCTIONAL EXPRESSION; SIGNALING PROPERTIES; OSTEOSARCOMA CELLS; PEPTIDE RECEPTOR; CALCIUM-RELEASE; CLONING	In HEK 293 cells stably expressing type 1 parathyroid (PTH) receptors, PTH stimulated release of intracellular Ca2+ stores in only 27% of cells, whereas 96% of cells responded to carbachol, However, in almost all cells PTH potentiated the response to carbachol by about 3-fold. Responses to carbachol did not desensitize, but only the first challenge in Ca2+-free medium caused an increase in [Ca2+](i), indicating that the carbachol-sensitive Ca2+ stores had been emptied. Subsequent addition of PTH also failed to increase [Ca2+](i), but when it was followed by carbachol there was a substantial increase in [Ca2+](i), A similar potentiation was observed between ATP and PTH but not between carbachol and ATP. Intracellular heparin inhibited responses to carbachol and PTH, and pretreatment with ATP and carbachol abolished responses to PTH, suggesting that the effects of PTH involve inositol trisphosphate (IP3) receptors, PTH neither stimulated detectable IP3 formation nor affected the amount formed in response to ATP or carbachol, PTH stimulated cyclic AMP formation, but this was not the means whereby PTH potentiated Ca2+ signals. We suggest that PTH may regulate Ca2+ mobilization by facilitating translocation of Ca2+ between discrete intracellular stores and that it thereby regulates the size of the Ca2+ pool available to receptors linked to IP3 formation.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	cwt1000@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044				ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; BABICH M, 1991, ENDOCRINOLOGY, V129, P1463, DOI 10.1210/endo-129-3-1463; Behar V, 1996, ENDOCRINOLOGY, V137, P2748, DOI 10.1210/en.137.7.2748; BIRD GS, 1993, J BIOL CHEM, V268, P17917; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; CHABRE O, 1992, MOL ENDOCRINOL, V6, P551, DOI 10.1210/me.6.4.551; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Cullen PJ, 1998, BBA-MOL CELL BIOL L, V1436, P35, DOI 10.1016/S0005-2760(98)00149-0; DAWSON AP, 1989, CELL CALCIUM, V10, P343, DOI 10.1016/0143-4160(89)90060-2; DUNLAY R, 1990, AM J PHYSIOL, V258, pF223, DOI 10.1152/ajprenal.1990.258.2.F223; FUJIMORI A, 1991, ENDOCRINOLOGY, V128, P3032, DOI 10.1210/endo-128-6-3032; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; HAJNOCZKY G, 1994, J BIOL CHEM, V269, P10280; Hansen LH, 1998, AM J PHYSIOL-CELL PH, V274, pC1552, DOI 10.1152/ajpcell.1998.274.6.C1552; HARGREAVES AC, 1994, MOL PHARMACOL, V46, P1120; HARVEY S, 1993, J ENDOCRINOL, V139, P353, DOI 10.1677/joe.0.1390353; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; Jobert AS, 1997, ENDOCRINOLOGY, V138, P5282, DOI 10.1210/en.138.12.5282; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Loomis-Husselbee JW, 1998, BIOCHEM J, V331, P947, DOI 10.1042/bj3310947; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; MASSRY SG, 1995, MINER ELECTROL METAB, V21, P13; MCCUAIG KA, 1994, P NATL ACAD SCI USA, V91, P5051, DOI 10.1073/pnas.91.11.5051; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; PINES M, 1994, ENDOCRINOLOGY, V135, P1713, DOI 10.1210/en.135.4.1713; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; SCHNEIDER H, 1993, EUR J PHARM-MOLEC PH, V246, P149, DOI 10.1016/0922-4106(93)90092-N; SEUWEN K, 1995, BRIT J PHARMACOL, V114, P1613, DOI 10.1111/j.1476-5381.1995.tb14947.x; Tong YH, 1996, J BIOL CHEM, V271, P8183, DOI 10.1074/jbc.271.14.8183; URENA P, 1993, ENDOCRINOLOGY, V133, P617, DOI 10.1210/en.133.2.617; WAYMAN GA, 1995, J BIOL CHEM, V270, P24108, DOI 10.1074/jbc.270.41.24108; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678	37	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1807	1813		10.1074/jbc.275.3.1807	http://dx.doi.org/10.1074/jbc.275.3.1807			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636879	hybrid			2022-12-27	WOS:000084940000042
J	Sun, HY; Squier, TC				Sun, HY; Squier, TC			Ordered and cooperative binding of opposing globular domains of calmodulin to the plasma membrane Ca-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; OXIDE SYNTHASE ACTIVITIES; PEPTIDE COMPLEX; TARGET PROTEINS; ACTIVATION; RECOGNITION; METHIONINE; FRAGMENTS; PHOSPHORYLATION; RESOLUTION	We have investigated the mechanisms of activation of the plasma membrane (PM) Ca-ATPase by calmodulin (CaM), which result in enhanced calcium transport rates and the maintenance of low intracellular calcium levels. We have isolated the amino- or carboxyl-terminal domains of CaM (i.e. CaMN or CaMC), permitting an identification of their relative specificity for binding to sites on either the PM Ca-ATPase or a peptide (C28W) corresponding to the CaM-binding sequence. We find that either CaMN or CaMC alone is capable of productive interactions with the PM Ca-ATPase that induces enzyme activation. There are, however, large differences in the affinity and specificity of binding between CaMN and CaMC and either C28W or the PM Ca-ATPase, The initial binding interaction between CaMC and the PM Ca-ATPase is highly specific, having approximately 10,000-fold greater affinity in comparison with CaMN, However, following the initial association of either CaMC or CaMN, there is a 300-fold enhancement in the affinity of CaMN for the secondary binding site. Thus, while CaMC binds with a high affinity to the two CaM-binding sites within the PM Ca-ATPase in a sequential manner, CaMN binds cooperatively with a lower affinity to both binding sites. These large differences in the binding affinities and specificities of the amino- and carboxyl-terminal domains ensure that CaM binding to the PM Ca-ATPase normally involves the formation of a specific complex in which the initial high affinity association of the carboxyl-terminal domain promotes the association of the amino-terminal domain necessary for enzyme activation.	Univ Kansas, Dept Mol Biosci, Biochem & Biophys Sect, Lawrence, KS 66045 USA	University of Kansas	Squier, TC (corresponding author), Univ Kansas, Dept Mol Biosci, Biochem & Biophys Sect, Lawrence, KS 66045 USA.	TSQUIER@UKANS.EDU			NIA NIH HHS [AG 12993] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG012993] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Barth A, 1998, J BIOL CHEM, V273, P2174, DOI 10.1074/jbc.273.4.2174; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; CHAPMAN ER, 1992, BIOCHEMISTRY-US, V31, P12819, DOI 10.1021/bi00166a016; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 1997, J BIOL CHEM, V272, P31235, DOI 10.1074/jbc.272.50.31235; Chin D, 1997, J BIOL CHEM, V272, P5510, DOI 10.1074/jbc.272.9.5510; Chin D, 1996, J BIOL CHEM, V271, P30465, DOI 10.1074/jbc.271.48.30465; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Edwards RA, 1998, BIOCHEM J, V331, P149, DOI 10.1042/bj3310149; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Gao J, 1998, BIOPHYS J, V74, P1115, DOI 10.1016/S0006-3495(98)77830-0; Gao J, 1998, BIOCHEMISTRY-US, V37, P9536, DOI 10.1021/bi9803877; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GUERINI D, 1984, J BIOL CHEM, V259, P5172; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P17810, DOI 10.1021/bi981656w; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; NEWTON D, 1985, BIOCHIM BIOPHYS ACTA, V845, P533, DOI 10.1016/0167-4889(85)90222-8; NEWTON DL, 1984, J BIOL CHEM, V259, P4419; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; Peersen OB, 1997, PROTEIN SCI, V6, P794; PERSECHINI A, 1994, J BIOL CHEM, V269, P16148; Persechini A, 1996, J BIOL CHEM, V271, P19279, DOI 10.1074/jbc.271.32.19279; PERSECHINI A, 1988, J BIOL CHEM, V263, P12175; Persechini A, 1996, BIOCHEMISTRY-US, V35, P224, DOI 10.1021/bi952383x; PERSECHINI A, 1993, BIOCHIM BIOPHYS ACTA, V1163, P309, DOI 10.1016/0167-4838(93)90167-P; Quadroni M, 1998, BIOCHEMISTRY-US, V37, P6523, DOI 10.1021/bi972930+; Sun HY, 1999, BIOCHEMISTRY-US, V38, P12266, DOI 10.1021/bi9818671; Tjandra N, 1999, CALCIUM AS A CELLULAR REGULATOR, P152; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; Yao YH, 1996, BIOCHEMISTRY-US, V35, P6815, DOI 10.1021/bi960229k; Yao YH, 1996, BIOCHEMISTRY-US, V35, P12015, DOI 10.1021/bi960834n; Yao YH, 1996, BIOCHEMISTRY-US, V35, P2767, DOI 10.1021/bi951712i; Yuan T, 1999, PROTEIN SCI, V8, P113; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; [No title captured]	42	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1731	1738		10.1074/jbc.275.3.1731	http://dx.doi.org/10.1074/jbc.275.3.1731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636869	hybrid			2022-12-27	WOS:000084940000032
J	Wu, YY; Bradshaw, RA				Wu, YY; Bradshaw, RA			Activation of the Stat3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; ACUTE-PHASE RESPONSE; LEUKEMIA INHIBITORY FACTOR; CYTOKINE RECEPTOR GP130; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; NERVOUS-SYSTEM; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; TERMINAL DIFFERENTIATION	The role of signal transducer and activator of transcription (STAT) signaling pathways in the interleukin-6 (IL-6)-induced morphological differentiation of PC12-E2 cells was assessed using wild type and dominant negative mutants of Stat1 and Stat3, containing Tyr --> Phe (YF), Ser --> Ala (SA), and the double mutations (DM), respectively. FS3-YF or FS3-DM markedly inhibited the IL-6-induced response, but overexpression of FS3-SA caused only a modest inhibition. Expression of all Stat3 mutants had no effect on NGF-induced neurite outgrowth. Overexpression of wild type Stat1 protein inhibited IL-6 activated DNA binding complexes containing Stat3 homodimers, which may explain the partial negative effect of Stat1 on IL-6-induced neurite outgrowth. Specificity of these STAT constructs was confirmed using luciferase reporter gene assays, which showed that IL-6-activated transcription was blocked by expression of FS3-YF and FS3-DM and that FS1 enhanced the interferon gamma-activated transcription. Thus, in PC12-E2 cells, Stat3 homodimers are preferentially activated by IL-6, indicating a role for Stat3 in the regulation of cellular differentiation. Furthermore, IL-6 induced robust neurite outgrowth in PC12-E2 cells expressing dominant negative forms of RAS or SHC or in cells pretreated with the mitogen-activated protein kinase mitogen-activated protein kinase kinase inhibitor, PD98059, Thus, activation of the Stat3 signaling pathway, but not RAS/ERK dependent pathways, is essential for differentiation of PC12-E2 cells by IL-6.	Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Bradshaw, RA (corresponding author), Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	rablab@uci.edu	Bradshaw, Ralph A/K-1515-2013		NIA NIH HHS [AG09735] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009735] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BOLIN LM, 1995, J NEUROCHEM, V64, P850; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; BOULTON TG, 1995, P NATL ACAD SCI USA, V92, P6915, DOI 10.1073/pnas.92.15.6915; Candotti F, 1997, BLOOD, V90, P3996, DOI 10.1182/blood.V90.10.3996; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen EH, 1998, IMMUNOL TODAY, V19, P338, DOI 10.1016/S0167-5699(98)01295-X; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; DAEIPOUR M, 1993, J IMMUNOL, V150, P4743; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Darnell JE, 1996, P NATL ACAD SCI USA, V93, P6221, DOI 10.1073/pnas.93.13.6221; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; EILERS A, 1995, MOL CELL BIOL, V15, P3579; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Giordano V, 1997, J IMMUNOL, V158, P4097; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hemmann U, 1996, J BIOL CHEM, V271, P12999, DOI 10.1074/jbc.271.22.12999; Hirano T, 1998, Int Rev Immunol, V16, P249; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Ihara S, 1997, EMBO J, V16, P5345, DOI 10.1093/emboj/16.17.5345; Ihara S, 1996, J BIOCHEM, V120, P865; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; IP NY, 1994, NEURON, V13, P443, DOI 10.1016/0896-6273(94)90359-X; Ip NY, 1996, ANNU REV NEUROSCI, V19, P491; Kaplan DR, 1998, PROG BRAIN RES, V117, P35; Kaptein A, 1996, J BIOL CHEM, V271, P5961, DOI 10.1074/jbc.271.11.5961; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; Kim HK, 1997, J BIOL CHEM, V272, P14571, DOI 10.1074/jbc.272.23.14571; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUSHIMA Y, 1992, NEUROSCI RES, V13, P267, DOI 10.1016/0168-0102(92)90039-F; Lai CF, 1999, J BIOL CHEM, V274, P7793, DOI 10.1074/jbc.274.12.7793; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LOTAN M, 1994, FASEB J, V8, P1026, DOI 10.1096/fasebj.8.13.7926367; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Marz P, 1996, BRAIN RES, V706, P71, DOI 10.1016/0006-8993(95)01210-9; Marz P, 1997, EUR J NEUROSCI, V9, P2765, DOI 10.1111/j.1460-9568.1997.tb01705.x; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; Murphy PG, 1999, J NEUROSCI, V19, P3791; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Ng J, 1997, J BIOL CHEM, V272, P24542, DOI 10.1074/jbc.272.39.24542; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PATTERSON PH, 1994, P NATL ACAD SCI USA, V91, P7833, DOI 10.1073/pnas.91.17.7833; PATTERSON PH, 1993, CELL, V72, P123, DOI 10.1016/S0092-8674(05)80032-7; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PENG X, 1995, NEURON, V15, P395, DOI 10.1016/0896-6273(95)90043-8; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; Schindler C, 1998, TRENDS CELL BIOL, V8, P97, DOI 10.1016/S0962-8924(98)01233-1; Sterneck E, 1996, J NEUROCHEM, V67, P1365; SZEBERENYI J, 1990, MOL CELL BIOL, V10, P5324, DOI 10.1128/MCB.10.10.5324; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Thomas D, 1997, J BIOL CHEM, V272, P22293, DOI 10.1074/jbc.272.35.22293; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; WILDER RL, 1995, ANNU REV IMMUNOL, V13, P307; WU YY, 1995, J CELL PHYSIOL, V164, P522, DOI 10.1002/jcp.1041640310; Wu YY, 1996, J BIOL CHEM, V271, P13033, DOI 10.1074/jbc.271.22.13033; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; YAMADA M, 1994, BRAIN RES, V643, P173, DOI 10.1016/0006-8993(94)90023-X; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhong J, 1999, J NEUROSCI, V19, P4305; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu XJ, 1997, MOL CELL BIOL, V17, P6618, DOI 10.1128/MCB.17.11.6618	79	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2147	2156		10.1074/jbc.275.3.2147	http://dx.doi.org/10.1074/jbc.275.3.2147			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636920	hybrid			2022-12-27	WOS:000084940000083
J	Floyd, H; Ni, J; Cornish, AL; Zeng, ZZ; Liu, D; Carter, KC; Steel, J; Crocker, PR				Floyd, H; Ni, J; Cornish, AL; Zeng, ZZ; Liu, D; Carter, KC; Steel, J; Crocker, PR			Siglec-8 - A novel eosinophil-specific member of the immunoglobulin superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BINDING-SITE; MYELIN-ASSOCIATED GLYCOPROTEIN; MOLECULAR-CLONING; CD22; SIALOADHESIN; ANTIGEN; CD33; EXPRESSION; RECEPTOR; LOCALIZATION	We describe the characterization of siglec-8, a novel sialic acid-binding immunoglobulin-like lectin that is expressed specifically by eosinophils. A full-length cDNA encoding siglec-8 was isolated from a human eosinophil cDNA library. Siglec-8 is predicted to contain three extracellular immunoglobulin-like domains, a transmembrane region, and a cytoplasmic tail of 47 amino acids. The siglec-8 gene mapped on chromosome 19q13.33-41, closely linked to genes encoding CD33 (siglec-3), siglec-5, siglec-6, and siglec-7. When siglec-8 was expressed on COS cells or as a recombinant protein fused to the Fc region of human IgG(1), it was able to mediate sialic acid-dependent binding to human erythrocytes and to soluble sialoglycoconjugates. Using specific monoclonal antibodies, siglec-8 could be detected only on eosinophils and hence appears to be the first example of an eosinophil-specific transmembrane receptor.	Univ Dundee, Dept Biochem, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Human Genome Sci Inc, Rockville, MD 20852 USA; Imperial Canc Res Fund, London WC1, England	University of Dundee; GlaxoSmithKline; Human Genome Sciences Inc	Crocker, PR (corresponding author), Univ Dundee, Dept Biochem, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	p.r.crocker@dundee.ac.uk		Crocker, Paul/0000-0001-6230-0293				Boyce JA, 1997, ALLERGY ASTHMA PROC, V18, P293, DOI 10.2500/108854197778590489; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker P R, 1998, Glycobiology, V8, pv; CROCKER PR, 1994, EMBO J, V13, P4490, DOI 10.1002/j.1460-2075.1994.tb06771.x; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; Cyster JG, 1997, IMMUNITY, V6, P509, DOI 10.1016/S1074-7613(00)80339-8; DORKEN B, 1986, J IMMUNOL, V136, P4470; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; FREEMAN SD, 1995, BLOOD, V85, P2005, DOI 10.1182/blood.V85.8.2005.bloodjournal8582005; Gergely J, 1999, IMMUNOL LETT, V68, P3, DOI 10.1016/S0165-2478(99)00024-3; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; HASLETT C, 1997, WEIRS HDB EXPT IMMUN, V4; KANTOR AB, 1997, WEIRS HDB EXPT IMMUN, V2; KELM S, 1994, CURR BIOL, V4, P965, DOI 10.1016/S0960-9822(00)00220-7; KIMURA I, 1973, Clinical Allergy, V3, P195, DOI 10.1111/j.1365-2222.1973.tb01321.x; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; NATH D, 1995, J BIOL CHEM, V270, P26184, DOI 10.1074/jbc.270.44.26184; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; PEIPER SC, 1988, BLOOD, V72, P314; PEIPER SC, 1989, LEUCOCYTE TYPING 4 W, P814; SGROI D, 1993, J BIOL CHEM, V268, P7011; SGROI D, 1995, P NATL ACAD SCI USA, V92, P4026, DOI 10.1073/pnas.92.9.4026; Takei Y, 1997, CYTOGENET CELL GENET, V78, P295, DOI 10.1159/000134676; Tang S, 1997, J CELL BIOL, V138, P1355, DOI 10.1083/jcb.138.6.1355; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; vanderMerwe PA, 1996, J BIOL CHEM, V271, P9273, DOI 10.1074/jbc.271.16.9273	28	160	171	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					861	866		10.1074/jbc.275.2.861	http://dx.doi.org/10.1074/jbc.275.2.861			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625619	hybrid			2022-12-27	WOS:000084836600023
J	Lee, SY; Wang, RG; Soderhall, K				Lee, SY; Wang, RG; Soderhall, K			A lipopolysaccharide- and beta-1,3-glucan-binding protein from hemocytes of the freshwater crayfish Pacifastacus leniusculus - Purification, characterization, and cDNA cloning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; BINDING-PROTEIN; MOLECULAR-CLONING; INNATE IMMUNITY; SERINE-PROTEASE; BOMBYX-MORI; PERIPLANETA-AMERICANA; GLUCAN-BINDING; BLOOD-CELLS; CRAB	A lipopolysaccharide- and beta-1,3-glucan-binding protein (LGBP) was isolated and characterized from blood cells (hemocytes) of the freshwater crayfish Pacifastacus leniusculus. The LGBP was purified by chromatography on Blue-Sepharose and phenyl-Sepharose, followed by Sephacryl S-200. The LGBP has a molecular mass of 36 kDa and 40 kDa on 10% SDS-polyacrylamide gel electrophoresis under reducing and nonreducing conditions, respectively. The calculated mass of LGBP is 39,492 Da, which corresponds to the native size of LGBP; the estimated pi of the mature LGBP is 5.80. LGBP has binding activity to lipopolysaccharides as well as to beta-1,3-glucans such as laminarin and curdlan, but peptidoglycan could not bind to LGBP. Cloning and sequencing of LGBP showed significant homology with several putative Gram-negative bacteria-binding proteins and beta-1,3-glucanases. Interestingly, LGBP also has a structure and functions similar to those of the coelomic cytolytic factor-1, a lipopolysaccharide- and glucan-binding protein from the earthworm Eisenia foetida. To evaluate the involvement of LGBP in the prophenoloxidase (proPO) activating system, a polyclonal antibody against LGBP was made and used for the inhibition of phenoloxidase (PO) activity triggered by the beta-1,3-glucan laminarin in the hemocyte lysate of crayfish. The PO activity was blocked completely by the anti-LGBP antibody. Moreover, the PO activity could be recovered by the addition of purified LGBP. These results suggest that the 36-kDa LGBP plays a role in the activation of the proPO activating system in crayfish and thus seems to play an important role in the innate immune system of crayfish.	Uppsala Univ, Evolutionary Biol Ctr, Dept Comparat Physiol, S-75236 Uppsala, Sweden	Uppsala University	Soderhall, K (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Comparat Physiol, Norbyvagen 18A, S-75236 Uppsala, Sweden.			Lee, So Young/0000-0003-3130-785X				Asgari S, 1998, P NATL ACAD SCI USA, V95, P3690, DOI 10.1073/pnas.95.7.3690; ASPAN A, 1991, INSECT BIOCHEM, V21, P363, DOI 10.1016/0020-1790(91)90002-V; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Bachman ES, 1996, P NATL ACAD SCI USA, V93, P6808, DOI 10.1073/pnas.93.13.6808; BARRACCO MA, 1991, CELL TISSUE RES, V266, P491, DOI 10.1007/BF00318590; Beschin A, 1998, J BIOL CHEM, V273, P24948, DOI 10.1074/jbc.273.38.24948; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; CERENIUS L, 1994, J BIOL CHEM, V269, P29462; Cho MY, 1999, EUR J BIOCHEM, V262, P737, DOI 10.1046/j.1432-1327.1999.00416.x; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; DUVIC B, 1992, EUR J BIOCHEM, V207, P223, DOI 10.1111/j.1432-1033.1992.tb17041.x; DUVIC B, 1990, J BIOL CHEM, V265, P9327; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Foukas LC, 1998, J BIOL CHEM, V273, P14813, DOI 10.1074/jbc.273.24.14813; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; Iwanaga S, 1998, J BIOCHEM, V123, P1; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Johansson MW, 1999, J CELL SCI, V112, P917; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; JOMORI T, 1991, J BIOL CHEM, V266, P13318; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kawabata S, 1999, DEV COMP IMMUNOL, V23, P391, DOI 10.1016/S0145-305X(99)00019-1; KAWANO K, 1990, J BIOL CHEM, V265, P15365; KOBAYASHI M, 1990, CELL TISSUE RES, V260, P13, DOI 10.1007/BF00297485; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Koizumi N, 1997, EUR J BIOCHEM, V248, P217, DOI 10.1111/j.1432-1033.1997.t01-1-00217.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIFOOK J, 1966, J INSECT PHYSIOL, V12, P195, DOI 10.1016/0022-1910(66)90136-3; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; LEONARD C, 1985, INSECT BIOCHEM, V15, P803, DOI 10.1016/0020-1790(85)90109-X; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mendoza HL, 1999, DEV COMP IMMUNOL, V23, P359, DOI 10.1016/S0145-305X(99)00017-8; MUTA T, 1991, J BIOL CHEM, V266, P6554; MUTA T, 1995, J BIOL CHEM, V270, P892, DOI 10.1074/jbc.270.2.892; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Parrillo J E, 1993, N Engl J Med, V328, P1471; RIETSCHEL ET, 1992, SCI AM, V267, P54, DOI 10.1038/scientificamerican0892-54; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schnapp D, 1996, EUR J BIOCHEM, V240, P532, DOI 10.1111/j.1432-1033.1996.0532h.x; SEKI N, 1994, J BIOL CHEM, V269, P1370; Shin SW, 1998, INSECT BIOCHEM MOLEC, V28, P827, DOI 10.1016/S0965-1748(98)00077-0; SMITH VJ, 1986, IMMUNE MECH INVERTEB, P59; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; SUGUMARAN M, 1991, FEBS LETT, V295, P233, DOI 10.1016/0014-5793(91)81431-7; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; Vasta GR, 1999, DEV COMP IMMUNOL, V23, P401, DOI 10.1016/S0145-305X(99)00020-8; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; YAHATA N, 1990, GENE, V86, P113, DOI 10.1016/0378-1119(90)90122-8; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	58	250	267	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1337	1343		10.1074/jbc.275.2.1337	http://dx.doi.org/10.1074/jbc.275.2.1337			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625682	hybrid, Green Submitted			2022-12-27	WOS:000084836600086
J	Jakymiw, A; Raharjo, E; Rattner, JB; Eystathioy, T; Chan, EKL; Fujita, DJ				Jakymiw, A; Raharjo, E; Rattner, JB; Eystathioy, T; Chan, EKL; Fujita, DJ			Identification and characterization of a novel Golgi protein, golgin-67	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN; COILED COILS; TRANSMEMBRANE DOMAINS; FUSION PROTEINS; VESICLE DOCKING; MESSENGER-RNAS; SEQUENCES; MITOSIS; BINDING; GM130	In the course of screening a lambda gt11 human leukemic T-cell cDNA expression library with an antibody specific to the mitotic target of Src, Sam68, we identified and cloned a cDNA encoding a novel protein with a predicted molecular mass of 51.4 kDa. Polyclonal antibodies raised to a His(6)-tagged construct of this protein, detected a -67-kDa protein in immunoprecipitation experiments, and cytological studies showed that this protein localized to the Golgi complex, through colocalization experiments with specific Golgis markers. Therefore, we designated this protein golgin-67, Sequence analysis revealed that golgin-67 is a highly coiled-coil protein, with potential Cdc2 and Src kinase phosphorylation motifs. It has sequence homologies to other Golgi proteins, in eluding the coatamer complex I vesicle docking protein, GM130. Structurally, golgin-67 resembles, golgin-84, an integral membrane Golgi protein with an N-terminal coiled coil domain and a single C-terminal transmembrane domain. The C-terminal region of golgin-67, which contains a predicted transmembrane domain, was demonstrated to be essential for its Golgi localization.	Univ Calgary, Ctr Med, Dept Biochem & Mol Biol, Canc Biol Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Ctr Med, Dept Biochem & Mol Biol, Joint Injury & Arthrit Res Grp, Calgary, AB T2N 4N1, Canada; Scripps Res Inst, Dept Mol & Expt Med, Wm Keck Autoimmune Dis Ctr, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, DNA Core Lab Struct Anal, La Jolla, CA 92037 USA	University of Calgary; University of Calgary; Scripps Research Institute; Scripps Research Institute	Chan, EKL (corresponding author), Univ Calgary, Ctr Med, Dept Biochem & Mol Biol, Canc Biol Res Grp, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503; Jakymiw, Andrew/0000-0001-6431-8753	NIAID NIH HHS [AI-39645] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039645] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Bascom RA, 1999, J BIOL CHEM, V274, P2953, DOI 10.1074/jbc.274.5.2953; Bastos R, 1997, J CELL BIOL, V137, P989, DOI 10.1083/jcb.137.5.989; Biscardi JS, 1999, ADV CANCER RES, V76, P61; DAVIDPFEUTY T, 1990, J CELL BIOL, V111, P3097, DOI 10.1083/jcb.111.6.3097; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FRITZLER MJ, 1993, J EXP MED, V178, P49, DOI 10.1084/jem.178.1.49; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; GOBLET C, 1989, NUCLEIC ACIDS RES, V17, P2144, DOI 10.1093/nar/17.5.2144; HARLOW E, 1988, ANTIBODIES LABORATOR, P313; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOFFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; KOWAL R, 1980, ANAL BIOCHEM, V102, P72, DOI 10.1016/0003-2697(80)90319-X; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lowe M, 1998, TRENDS CELL BIOL, V8, P40, DOI 10.1016/S0962-8924(97)01189-6; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; McBride AE, 1996, P NATL ACAD SCI USA, V93, P2296, DOI 10.1073/pnas.93.6.2296; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1995, BIOCHEM SOC T, V23, P527, DOI 10.1042/bst0230527; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Nagase T, 1998, DNA Res, V5, P355, DOI 10.1093/dnares/5.6.355; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; OAS TG, 1994, TRENDS BIOCHEM SCI, V19, P51, DOI 10.1016/0968-0004(94)90030-2; Pfeffer SR, 1996, ANNU REV CELL DEV BI, V12, P441, DOI 10.1146/annurev.cellbio.12.1.441; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; VOGEL LB, 1995, J BIOL CHEM, V270, P2506, DOI 10.1074/jbc.270.6.2506; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L; Zhou Songyang, 1995, Nature (London), V373, P536	44	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4137	4144		10.1074/jbc.275.6.4137	http://dx.doi.org/10.1074/jbc.275.6.4137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660574	hybrid			2022-12-27	WOS:000085288800058
J	Selmer, T; Kahnt, J; Goubeaud, M; Shima, S; Grabarse, W; Ermler, U; Thauer, RK				Selmer, T; Kahnt, J; Goubeaud, M; Shima, S; Grabarse, W; Ermler, U; Thauer, RK			The biosynthesis of methylated amino acids in the active site region of methyl-coenzyme M reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOGENIC BACTERIA; METHANOBACTERIUM-THERMOAUTOTROPHICUM; S-ADENOSYLMETHIONINE; CATALYTIC MECHANISM; METHYLTRANSFERASE; IDENTIFICATION; SEQUENCE; PROTEIN; F430; FACTOR-F430	The global production of the greenhouse gas methane by methanogenic archaea reaches 1 billion tons per annum. The final reaction releasing methane is catalyzed by the enzyme methyl-coenzyme M reductase, The crystal structure of methyl-coenzyme RI reductase from Methanobacterium thermoautotrophicum revealed the presence of five modified amino acids within the alpha-sub-unit and near the active site region. Four of these modifications were C-, N-, and S-methylations, two of which, 2-(S)-methylglutamine and 5-(S)-methylarginine, have never been encountered before. We have now confirmed these modifications by mass spectrometry of chymotryptic peptides, With methyl-coenzyme M reductase purified from cells grown in the presence of L-[methyl-D-3]methionine, it was shown that the methyl groups of the modified amino acids are derived from the methyl group of methionine rather than from methyl-coenzyme RI, an intermediate in methane formation. The D-3 labeling pattern was found to be qualitatively and quantitatively the same as in the two methyl groups of the methanogenic coenzyme F-430, which are known to be introduced via S-adenosylmethionine. From the results, it is concluded that the methyl groups of the modified amino acids in methyl-coenzyme RI reductase are biosynthetically introduced by an S-adenosylmethionine-dependent post-translational modification. A mechanism for the methylation of glutamine at C-2 and of arginine at C-5 is discussed.	Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany; Univ Marburg, Fachbereich Biol, Mikrobiol Lab, D-35032 Marburg, Germany; Max Planck Inst Biophys, D-60528 Frankfurt, Germany	Max Planck Society; Philipps University Marburg; Max Planck Society	Thauer, RK (corresponding author), Max Planck Inst Terr Mikrobiol, Karl Von Frisch Str, D-35043 Marburg, Germany.							Appleyard MVCL, 1998, J BIOL CHEM, V273, P14869, DOI 10.1074/jbc.273.24.14869; Atkinson D., 1977, CELLULAR ENERGY META, P75; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; DOOLITTLE LR, 1977, ANAL BIOCHEM, V78, P491, DOI 10.1016/0003-2697(77)90109-9; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; FARBER G, 1991, HELV CHIM ACTA, V74, P697, DOI 10.1002/hlca.19910740404; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Gu QM, 1997, J PEPT RES, V49, P484; JAENCHEN R, 1981, FEBS LETT, V130, P133, DOI 10.1016/0014-5793(81)80681-3; JOHNSON AW, 1966, YLID CHEM, P251; KATOH Y, 1990, AGR BIOL CHEM TOKYO, V54, P3117, DOI 10.1080/00021369.1990.10870466; Kim S, 1998, AMINO ACIDS, V15, P291, DOI 10.1007/BF01320895; Kim SD, 1998, J BIOL CHEM, V273, P27374, DOI 10.1074/jbc.273.42.27374; LU RC, 1977, BIOCHEMISTRY-US, V16, P5801, DOI 10.1021/bi00645a025; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Musker W. K., 1970, TOP CURR CHEM, V14, P295; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Nolling J, 1996, INT J SYST BACTERIOL, V46, P1170, DOI 10.1099/00207713-46-4-1170; PAIK WK, 1990, PROTEIN METHYLATION; PATE JS, 1995, AUST J BOT, V543, P73; PFALTZ A, 1985, HELV CHIM ACTA, V68, P1338, DOI 10.1002/hlca.19850680527; PFALTZ A, 1987, EUR J BIOCHEM, V170, P459, DOI 10.1111/j.1432-1033.1987.tb13722.x; PFALTZ A, 1982, HELV CHIM ACTA, V65, P828, DOI 10.1002/hlca.19820650320; Porse BT, 1998, J MOL BIOL, V276, P391, DOI 10.1006/jmbi.1997.1541; Raftery MJ, 1996, BIOCHEM J, V316, P285, DOI 10.1042/bj3160285; Roehm PC, 1998, J AM CHEM SOC, V120, P13083, DOI 10.1021/ja982546f; Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711; SCHONHEIT P, 1980, ARCH MICROBIOL, V127, P59, DOI 10.1007/BF00414356; Selmer T, 1999, J BIOL CHEM, V274, P20772, DOI 10.1074/jbc.274.30.20772; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; SPRINGER E, 1995, INT J SYST BACTERIOL, V45, P554, DOI 10.1099/00207713-45-3-554; TAKUSAGAWA F, 1998, COMPREHENSIVE BIOL C, V1, P1; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; UY R, 1977, SCIENCE, V198, P890, DOI 10.1126/science.337487; WOLFE RS, 1991, ANNU REV MICROBIOL, V45, P1, DOI 10.1146/annurev.mi.45.100191.000245; WU JC, 1987, J BIOL CHEM, V262, P4778; YUN BS, 1995, BIOSCI BIOTECH BIOCH, V59, P876, DOI 10.1271/bbb.59.876; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	39	60	68	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3755	3760		10.1074/jbc.275.6.3755	http://dx.doi.org/10.1074/jbc.275.6.3755			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660523	hybrid			2022-12-27	WOS:000085288800007
J	Urquhart, AJ; Kennedy, D; Gould, SJ; Crane, DI				Urquhart, AJ; Kennedy, D; Gould, SJ; Crane, DI			Interaction of Pex5p, the type 1 peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pex14p and Pex13p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PICHIA-PASTORIS; SACCHAROMYCES-CEREVISIAE; PTS1 RECEPTOR; 3-KETOACYL-COA THIOLASE; SH3 DOMAIN; IMPORT; IDENTIFICATION; GENE; SEQUENCE; BINDING	Pexp5p, a receptor for peroxisomal matrix proteins with a type 1 peroxisome targeting signal (PTS1), has been proposed to cycle from the cytoplasm to the peroxisomal membrane where it docks with Pex14p and Pex13p, the latter an SH3 domain-containing protein. Using in vitro binding assays we have demonstrated that binding of Pex5p to Pex14p is enhanced when Pex5p is loaded with a PTS1-containing peptide. In contrast, Pex5p binding to Pex13p, which involves only the SH3 domain, occurs at 20-40-fold lower levels and is reduced when Pex5p is preloaded with a PTS1 peptide, Pex14p was also shown to bind weakly to the Pex13p SH3 domain. Site-directed mutagenesis of the Pex13p SH3 domain attenuated binding to Pex5p and Pex14p, consistent with both of these proteins being binding partners for this domain. The SH3 binding site in Pex5p was determined to lie within a 114-residue peptide (Trp(100)-Glu(213)) in the amino-terminal region of the protein. The interaction between this peptide and the SH3 domain was competitively inhibited by Pex14p, We interpret these data as suggesting that docking of the Pex5p-PTS1 protein complex at the peroxisome membrane occurs at Pex14p and that the Pex13p SH3 domain functions as an associated component possibly involved in sequestering Pex5p after relinquishment of the PTS1 protein cargo to components of the translocation machinery.	Griffith Univ, Sch Biomol & Biomed Sci, Nathan, Qld 4111, Australia; Univ Queensland, Ctr Cellular & Mol Biol, St Lucia, Qld 4072, Australia; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Griffith University; University of Queensland; Johns Hopkins University	Crane, DI (corresponding author), Griffith Univ, Sch Biomol & Biomed Sci, Nathan, Qld 4111, Australia.		Crane, Denis I/A-7887-2011; Kennedy, Hendrick/A-7635-2010	Crane, Denis I/0000-0002-5696-1906; Kennedy, Hendrick/0000-0001-7937-3069				ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; CHOTHIA C, 1986, SCIENCE, V233, P755, DOI 10.1126/science.3090684; Colombo P, 1998, J IMMUNOL, V160, P2780; CRANE DI, 1994, J BIOL CHEM, V269, P21835; CRANE DI, 1994, CURR GENET, V26, P443, DOI 10.1007/BF00309932; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Elgersma Y, 1998, J CELL BIOL, V140, P807, DOI 10.1083/jcb.140.4.807; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Huhse B, 1998, J CELL BIOL, V140, P49, DOI 10.1083/jcb.140.1.49; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; LUTHY R, 1991, PROTEINS, V10, P229, DOI 10.1002/prot.340100307; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsushita M, 1998, BIOCHEM BIOPH RES CO, V245, P337, DOI 10.1006/bbrc.1998.8420; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; SARASTE M, 1994, NAT STRUCT BIOL, V1, P835, DOI 10.1038/nsb1294-835; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TERLECKY SR, 1995, EMBO J, V14, P3627, DOI 10.1002/j.1460-2075.1995.tb00032.x; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	35	112	112	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4127	4136		10.1074/jbc.275.6.4127	http://dx.doi.org/10.1074/jbc.275.6.4127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660573	hybrid			2022-12-27	WOS:000085288800057
J	Geerlings, A; Ibanez, MML; Memelink, J; van der Heijden, R; Verpoorte, R				Geerlings, A; Ibanez, MML; Memelink, J; van der Heijden, R; Verpoorte, R			Molecular cloning and analysis of strictosidine beta-d-glucosidase, an enzyme in terpenoid indole alkaloid biosynthesis in Catharanthus roseus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSPENSION-CULTURED CELLS; ENDOPLASMIC-RETICULUM; LOCALIZATION; SYNTHASE; PLANTS; EXPRESSION; RETENTION; CINCHONA; PROTEINS; VECTORS	Strictosidine beta-D-glucosidase (SGD) is an enzyme involved in the biosynthesis of terpenoid indole alkaloids (TLAs) by converting strictosidine to cathenamine, The biosynthetic pathway toward strictosidine is thought to be similar in all TIA-producing plants. Somewhere downstream of strictosidine formation, however, the biosynthesis diverges to give rise to the different TIAs found, SGD may play a role in creating this biosynthetic diversity. We have studied SGD at both the molecular and enzymatic levels. Based on the homology between different plant beta-glucosidases, degenerate polymerase chain reaction primers were designed and used to isolate a cDNA clone from a Catharanthus roseus cDNA library. A full-length clone gave rise to SGD activity when expressed in Saccharomyces cerevisiae, SGD shows similar to 60% homology at the amino acid level to other beta-glucosidases from plants and is encoded by a single-copy gene. Sgd expression is induced by methyl jasmonate with kinetics similar to those of two other genes acting prior to Sgd in TLA biosynthesis. These results show that coordinate induction of the biosynthetic genes forms at least part of the mechanism for the methyl jasmonate-induced increase in TIA production. Using a novel in vivo staining method, subcellular localization studies of SGD were performed, This showed that SGD is most likely associated with the endoplasmic reticulum, which is in accordance with the presence of a putative signal sequence, but in contrast to previous localization studies. This new insight in SGD localization has significant implications for our understanding of the complex intracellular trafficking of metabolic intermediates during TIA biosynthesis.	Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Pharmacognosy, NL-2300 RA Leiden, Netherlands; Leiden Univ, Clusius Lab, Inst Mol Plant Sci, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Verpoorte, R (corresponding author), Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Pharmacognosy, POB 9502, NL-2300 RA Leiden, Netherlands.		van der Heijden, Rob/D-1403-2013; Verpoorte, Robert/Y-4363-2019	Memelink, Johan/0000-0002-4767-506X; Verpoorte, Robert/0000-0001-6180-1424				AERTS RJ, 1994, PLANT J, V5, P635, DOI 10.1111/j.1365-313X.1994.00635.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BOLLER T, 1979, PLANT PHYSIOL, V63, P1123, DOI 10.1104/pp.63.6.1123; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDEL V, 1992, P NATL ACAD SCI USA, V89, P2002; BRUNELLI JP, 1993, YEAST, V9, P1309, DOI 10.1002/yea.320091204; Contin A, 1998, FEBS LETT, V434, P413, DOI 10.1016/S0014-5793(98)01022-9; DAVIS LG, 1986, BASIC METHODS MOL BI, P315; Gantet P, 1998, PLANT CELL PHYSIOL, V39, P220, DOI 10.1093/oxfordjournals.pcp.a029360; GEERLINGS A, 1999, IN PRESS PLNAT CELL; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; HEMSCHEIDT T, 1980, FEBS LETT, V110, P187, DOI 10.1016/0014-5793(80)80069-X; HOLTMAN WL, 1994, PLANT SCI, V99, P43, DOI 10.1016/0168-9452(94)90119-8; HUGHES MA, 1992, ACS SYM SER, V533, P151; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; Luijendijk TJC, 1996, J CHEM ECOL, V22, P1355, DOI 10.1007/BF02027718; Luijendijk TJC, 1996, PHYTOCHEM ANALYSIS, V7, P16, DOI 10.1002/(SICI)1099-1565(199601)7:1<16::AID-PCA280>3.0.CO;2-H; Luijendijk TJC, 1998, PLANT PHYSIOL BIOCH, V36, P419, DOI 10.1016/S0981-9428(98)80205-2; MCKNIGHT TD, 1991, PLANTA, V185, P148, DOI 10.1007/BF00194055; MEIJER AH, 1993, J PLANT RES, P145; Memelink J, 1994, PLANT MOL BIOL MANUA, pF1; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Menke FLH, 1999, PLANT PHYSIOL, V119, P1289, DOI 10.1104/pp.119.4.1289; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; OLSEN LJ, 1995, ANNU REV PLANT PHYS, V46, P123, DOI 10.1146/annurev.pp.46.060195.001011; PFITZNER U, 1982, PLANTA MED, V46, P10, DOI 10.1055/s-2007-970008; RENAUDIN JP, 1986, PHYSIOL PLANTARUM, V68, P695, DOI 10.1111/j.1399-3054.1986.tb03420.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; Saito T, 1999, PLANT CELL PHYSIOL, V40, P77, DOI 10.1093/oxfordjournals.pcp.a029477; SIKORSKI RS, 1989, GENETICS, V122, P19; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; STEVENS LH, 1992, PLANT PHYSIOL BIOCH, V30, P675; STEVENS LH, 1993, PLANT CELL REP, V12, P573, DOI 10.1007/BF00233063; Stevens LH, 1994, THESIS LEIDEN U LEID, DOI 10.1007/s11101-006-9047-8; VRPOORTE R, 1998, ALKALOIDS, V50, P453	37	119	143	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3051	3056		10.1074/jbc.275.5.3051	http://dx.doi.org/10.1074/jbc.275.5.3051			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652285	hybrid			2022-12-27	WOS:000085146500007
J	Kimberly, WT; Xia, WM; Rahmati, T; Wolfe, MS; Selkoe, DJ				Kimberly, WT; Xia, WM; Rahmati, T; Wolfe, MS; Selkoe, DJ			The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED PRESENILIN-1; FAMILIAL ALZHEIMERS-DISEASE; IN-VIVO; PRECURSOR PROTEIN; MUTANT PRESENILIN-1; TRANSFECTED CELLS; TRANSGENIC MICE; DEGRADATION; DEPOSITION; ENDOPROTEOLYSIS	The discovery that a deficiency of presenilin 1 (PS1) decreases the production of amyloid beta-protein (A beta) identified the presenilins as important mediators of the gamma-secretase cleavage of beta-amyloid precursor protein (APP). Recently, we found that two conserved transmembrane (TM) aspartates in PS1 are critical for AP production, providing evidence that PS1 either functions as a required diaspartyl cofactor for gamma-secretase or is itself gamma-secretase. Presenilin 2 (PS2) shares substantial sequence and possibly functional homology with PS1. Here, we show that the two TM aspartates in PS2 are also critical for gamma-secretase activity, providing further evidence that PS2 is functionally homologous to PS1. Cells stably co-expressing TM Asp -> Ala mutations in both PS1 and PS2 show further accumulation of the APP-derived gamma-secretase substrates, C83 and C99. The production of A beta is reduced to undetectable levels in the conditioned media of these cells. Furthermore, endoproteolysis of the exogenous Asp mutant PS2 is absent, and endogenous PS1 C-terminal fragments are diminished to undetectable levels. Therefore, the co-expression of PS1 and PS2 TM Asp -> Ala mutants suppresses the formation of any detectable PS1 or PS2 heterodimeric fragments and essentially abolishes the production of A beta. These results explain the residual A beta production seen in PS1-deficient cells and demonstrate the absolute requirement of functional presenilins for A beta generation. We conclude that presenilins, and their TM aspartates in particular, are attractive targets for lowering A beta therapeutically to prevent Alzheimer's disease.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Selkoe, DJ (corresponding author), Harvard Univ, Inst Med, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.		xia, weiming/E-5465-2016	xia, weiming/0000-0002-7463-3295	NIA NIH HHS [AG06173, AG15379] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [RF1AG006173, P01AG015379, R37AG006173, R01AG006173] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kim TW, 1997, J BIOL CHEM, V272, P11006; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tjernberg LO, 1997, J BIOL CHEM, V272, P1870, DOI 10.1074/jbc.272.3.1870; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Walter J, 1997, P NATL ACAD SCI USA, V94, P5349, DOI 10.1073/pnas.94.10.5349; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; XIA W, 1999, SOC NEUR ABSTR; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	33	216	234	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3173	3178		10.1074/jbc.275.5.3173	http://dx.doi.org/10.1074/jbc.275.5.3173			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652302	hybrid			2022-12-27	WOS:000085146500024
J	Goldstein, LA; Chen, WT				Goldstein, LA; Chen, WT			Identification of an alternatively spliced seprase mRNA that encodes a novel intracellular isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; S-ADENOSYLMETHIONINE DECARBOXYLASE; FIBROBLAST-ACTIVATION PROTEIN; DIPEPTIDYL-PEPTIDASE-IV; INTEGRAL MEMBRANE PROTEASE; VERTEBRATE MESSENGER-RNAS; MALIGNANT MELANOMA-CELLS; TRANSLATIONAL CONTROL; EPITHELIAL CANCERS; MOLECULAR-CLONING	Seprase is a homodimeric 170-kDa integral membrane gelatinase that is related to the ectoenzyme dipeptidyl peptidase IV. We have identified an alternatively spliced seprase messenger from the human melanoma cell line LOX that encodes a novel truncated isoform, seprase-s. The splice variant mRNA is generated by an out-of-frame deletion of a 1223-base pair exonic region that encodes part of the cytoplasmic tail, transmembrane, and the membrane progimal-central regions of the extracellular domain (Val(5) through Ser(412)) of the seprase 97-kDa subunit (seprase-l). The seprase-s mRNA has an elongated 5' leader (548 nucleotides) that harbors at least two upstream open reading frames that inhibit seprase-s expression from a downstream major open reading frame. Deletion mutagenesis of the wild type splice variant cDNA confirms that initiation of the seprase-s coding sequence begins with an ATG codon that corresponds to Met(522) Of seprase-l, The seprase-s open reading frame encodes a 239-amino acid polypeptide with an M-r similar to 27,000 that precisely overlaps the carboxyl-terminal catalytic region of seprase-l.	SUNY Stony Brook, Dept Med, Div Med Oncol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chen, WT (corresponding author), SUNY Stony Brook, Dept Med, Div Med Oncol, HSC T-17,Rm 080, Stony Brook, NY 11794 USA.				NATIONAL CANCER INSTITUTE [R01CA039077] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-39077] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; ABBOTT CA, 1995, IMMUNOGENETICS, V42, P76; ABBOTT CA, 1994, IMMUNOGENETICS, V40, P331, DOI 10.1007/BF01246674; AOYAMA A, 1990, P NATL ACAD SCI USA, V87, P8296, DOI 10.1073/pnas.87.21.8296; Bergamini G, 1998, J VIROL, V72, P8425, DOI 10.1128/JVI.72.10.8425-8429.1998; BERGENHEM NCH, 1992, P NATL ACAD SCI USA, V89, P8798, DOI 10.1073/pnas.89.18.8798; BERGQUIN IM, 1996, INTRACELLULAR PROTEI, P281; Bermpohl F, 1998, FEBS LETT, V428, P152, DOI 10.1016/S0014-5793(98)00515-8; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Chen WT, 1996, ENZYME PROTEIN, V49, P59, DOI 10.1159/000468616; DAMIANI RD, 1993, P NATL ACAD SCI USA, V90, P8244, DOI 10.1073/pnas.90.17.8244; DELBECQ P, 1994, MOL CELL BIOL, V14, P2378, DOI 10.1128/MCB.14.4.2378; Dietrich JM, 1996, J BIOL CHEM, V271, P2271, DOI 10.1074/jbc.271.4.2271; DIRKSEN WP, 1994, J BIOL CHEM, V269, P6431; DONZE O, 1995, NUCLEIC ACIDS RES, V23, P861, DOI 10.1093/nar/23.5.861; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; GARNIER G, 1995, J IMMUNOL, V154, P3275; Goldstein LA, 1997, BBA-MOL BASIS DIS, V1361, P11, DOI 10.1016/S0925-4439(97)00032-X; HAN ST, 1993, EMBO J, V12, P2449, DOI 10.1002/j.1460-2075.1993.tb05899.x; Harigai M, 1996, ONCOGENE, V12, P1369; HILL JR, 1992, J BIOL CHEM, V267, P21886; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFMANN MA, 1993, P NATL ACAD SCI USA, V90, P11733, DOI 10.1073/pnas.90.24.11733; JASCUR T, 1991, BIOCHEMISTRY-US, V30, P1908, DOI 10.1021/bi00221a025; Kelly T, 1998, MODERN PATHOL, V11, P855; KELLY T, 1994, J CELL PHYSIOL, V158, P299, DOI 10.1002/jcp.1041580212; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1994, BIOCHIMIE, V76, P815, DOI 10.1016/0300-9084(94)90182-1; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Luo ZL, 1996, J BACTERIOL, V178, P2172, DOI 10.1128/jb.178.8.2172-2177.1996; McGraw DW, 1998, J CLIN INVEST, V102, P1927, DOI 10.1172/JCI4862; Mehtani S, 1998, J BIOL CHEM, V273, P13236, DOI 10.1074/jbc.273.21.13236; Mize GJ, 1998, J BIOL CHEM, V273, P32500, DOI 10.1074/jbc.273.49.32500; MONSKY WL, 1994, CANCER RES, V54, P5702; Mori Y, 1996, HYPERTENSION, V28, P810, DOI 10.1161/01.HYP.28.5.810; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Niedermeyer J, 1998, EUR J BIOCHEM, V254, P650, DOI 10.1046/j.1432-1327.1998.2540650.x; Niedermeyer J, 1997, INT J CANCER, V71, P383, DOI 10.1002/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H; OHSHIMA Y, 1987, J MOL BIOL, V195, P247, DOI 10.1016/0022-2836(87)90647-4; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; RAMCHATESINGH J, 1995, MOL CELL BIOL, V15, P4898; Rescheleit DK, 1996, FEBS LETT, V394, P345, DOI 10.1016/0014-5793(96)00986-6; Reynolds K, 1996, J CELL BIOL, V134, P827, DOI 10.1083/jcb.134.4.827; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Shofuda K, 1997, J BIOL CHEM, V272, P9749; Van den Oord JJ, 1998, BRIT J DERMATOL, V138, P615; WALBORG EF, 1985, EXP CELL RES, V158, P509, DOI 10.1016/0014-4827(85)90474-4; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; Yeakley JM, 1996, P NATL ACAD SCI USA, V93, P7582, DOI 10.1073/pnas.93.15.7582; ZIMMER A, 1994, J CELL BIOL, V127, P1111, DOI 10.1083/jcb.127.4.1111	60	28	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2554	2559		10.1074/jbc.275.4.2554	http://dx.doi.org/10.1074/jbc.275.4.2554			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644713	hybrid			2022-12-27	WOS:000085128000045
J	Jeong, W; Cha, MK; Kim, IH				Jeong, W; Cha, MK; Kim, IH			Thioredoxin-dependent hydroperoxide peroxidase activity of bacterioferritin comigratory protein (BCP) as a new member of the thiol-specific antioxidant protein (TSA)/alkyl hydroperoxide peroxidase C (AhpC) family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-CATALYZED OXIDATION; GLUTATHIONE-PEROXIDASE; ESCHERICHIA-COLI; REDUCTASE; PURIFICATION; EXISTENCE; CYSTEINE; YEAST; CELL; ACID	Escherichia coli bacterioferritin comigratory protein (BCP), a putative bacterial member of the TSA/AhpC family, was characterized as a thiol peroxidase, BCP showed a thioredoxin-dependent thiol peroxidase activity, BCP preferentially reduced linoleic: acid hydroperoxide rather than H2O2 and t-butyl hydroperoxide with the use of thioredoxin as an in vivo immediate electron donor. The value of V-max/K-m of BCP for Linoleic acid hydroperoxide was calculated to be 5-fold higher than that for H2O2, implying that ECP has a selective capability to reduce linoleic acid hydroperoxide. Replacement of Cys-45 with serine resulted in the complete loss of thiol peroxidase activity; suggesting that BCP is a new bacterial member of TSA/AhpC family having a conserved cysteine as the primary site of catalysis, BCP exists as a monomer, and its functional Cys-45 appeared to exist as cysteine sulfenic acid. The expression level of BCP gradually elevated during exponential growth until mid-log phase growth, beyond which the expression level was decreased. BCP was induced 3-fold by the oxidative stress given by changing the growth conditions from the anaerobic to aerobic culture. Bcp null mutant grew more slowly than its wild type in aerobic culture and showed the hypersensitivity toward various oxidants such as H2O2, t-butyl hgdroperoxide, and linoleic acid hydroperoxide. The peroxide hypersensitivity of the null mutant could be complemented by the expression of bcp gene. Taken together, these data suggest that BCP is a new member of thioredoxin-dependent TSA/AhpC family, acting as a general hydroperoxide peroxidase.	PaiChai Univ, Dept Biochem, Natl Creat Res Ctr Antioxidant Prot, Taejon 302735, South Korea	Pai Chai University	Kim, IH (corresponding author), PaiChai Univ, Dept Biochem, Natl Creat Res Ctr Antioxidant Prot, Taejon 302735, South Korea.	ihkim@woonam.paichai.ac.kr	Kim, Il-Han/W-1401-2019					Cha MK, 1996, J BACTERIOL, V178, P5610, DOI 10.1128/jb.178.19.5610-5614.1996; Cha MK, 1995, BIOCHEM BIOPH RES CO, V217, P900, DOI 10.1006/bbrc.1995.2856; CHA MK, 1995, J BIOL CHEM, V270, P28635, DOI 10.1074/jbc.270.48.28635; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; CHAE HZ, 1994, BIOFACTORS, V4, P177; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; FORSTROM JW, 1979, ARCH BIOCHEM BIOPHYS, V193, P51, DOI 10.1016/0003-9861(79)90007-9; HALLIWELL B, 1989, FREE RACICAL BIOL ME; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Kim HK, 1996, BIOCHEM BIOPH RES CO, V221, P641, DOI 10.1006/bbrc.1996.0649; KIM IH, 1989, P NATL ACAD SCI USA, V86, P6018, DOI 10.1073/pnas.86.16.6018; KIM KW, 1988, J BIOL CHEM, V263, P4704; KWON SJ, 1994, BIOCHEM BIOPH RES CO, V201, P8, DOI 10.1006/bbrc.1994.1662; LADENSTEIN R, 1979, J MOL BIOL, V134, P199, DOI 10.1016/0022-2836(79)90032-9; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V1, P55; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MOSIALOU E, 1993, FEBS LETT, V315, P77, DOI 10.1016/0014-5793(93)81137-O; PARSONAGE D, 1993, J BIOL CHEM, V268, P3161; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182	26	171	182	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2924	2930		10.1074/jbc.275.4.2924	http://dx.doi.org/10.1074/jbc.275.4.2924			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644761	hybrid			2022-12-27	WOS:000085128000093
J	Luongo, CL; Reinisch, KM; Harrison, SC; Nibert, ML				Luongo, CL; Reinisch, KM; Harrison, SC; Nibert, ML			Identification of the guanylyltransferase region and active site in reovirus mRNA capping protein lambda 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA GUANYLYLTRANSFERASE; VACCINIA VIRUS; SACCHAROMYCES-CEREVISIAE; DIRECTED MUTAGENESIS; ENZYME; SUBUNIT; DNA; LOCALIZATION; CORES; GENE	The 144-kDa lambda 2 protein of mammalian reovirus catalyzes a number of enzymatic activities in the capping of reovirus mRNA, including the transfer of GMP from GTP to the 5' end of the 5'-diphosphorylated nascent transcript, This reaction proceeds through a covalently autoguanylylated lambda 2-GMP intermediate. The smaller size of RNA capping guanylyltransferases from other organisms suggested that the lambda 2-associated guanylyltransferase would be only a part of this protein. Limited proteinase K digestion of baculovirus-expressed lambda 2 was used to generate an amino-terminal M-r 42,000 fragment that appears to be both necessary and sufficient for guanylyltransferase activity. Although lysine 226 was identified by previous biochemical studies as the active-site residue that forms a phosphoamide bond with GMP in autoguanylylated lambda 2, mutation of lysine 226 to alanine caused only a partial reduction in guanylyltransferase activity at the autoguanylylation step. Alanine substitution for other lysines within the amino-terminal region of lambda 2 identified lysine 190 as necessary for autoguanylylation and lysine 171 as an important contributor to autoguanylylation. A novel active-site motif is proposed for the RNA guanylyltransferases of mammalian reoviruses and other Reoviridae members.	Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Howard Hughes Medical Institute; Harvard University	Nibert, ML (corresponding author), Univ Wisconsin, Inst Mol Virol, 1525 Linden Dr, Madison, WI 53706 USA.				NATIONAL CANCER INSTITUTE [R01CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI039533] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA13202] Funding Source: Medline; NIAID NIH HHS [R29-AI39533] Funding Source: Medline; NIGMS NIH HHS [GM18409A] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARLETT NM, 1974, J VIROL, V167, P315; Bisaillon M, 1997, VIROLOGY, V236, P1, DOI 10.1006/viro.1997.8698; Bisaillon M, 1997, J BIOL CHEM, V272, P18298, DOI 10.1074/jbc.272.29.18298; Bisaillon M, 1997, J BIOL CHEM, V272, P29954, DOI 10.1074/jbc.272.47.29954; BORNSTEIN P, 1977, METHOD ENZYMOL, V11, P189; BRUENN JA, 1991, NUCLEIC ACIDS RES, V19, P217, DOI 10.1093/nar/19.2.217; CASHDOLLAR LW, 1984, VIROLOGY, V133, P191, DOI 10.1016/0042-6822(84)90438-0; CLEVELAND DR, 1986, J VIROL, V60, P307, DOI 10.1128/JVI.60.1.307-311.1986; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CONG PJ, 1993, J BIOL CHEM, V268, P7256; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; FAUSNAUGH J, 1990, J BIOL CHEM, V265, P7669; FRESCO LD, 1994, P NATL ACAD SCI USA, V91, P6624, DOI 10.1073/pnas.91.14.6624; FURUICHI Y, 1976, J BIOL CHEM, V251, P5043; Hakansson K, 1998, P NATL ACAD SCI USA, V95, P1505, DOI 10.1073/pnas.95.4.1505; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; HIGMAN MA, 1992, J BIOL CHEM, V267, P16430; Ho CK, 1996, J VIROL, V70, P6658, DOI 10.1128/JVI.70.10.6658-6664.1996; ITOH N, 1987, J BIOL CHEM, V262, P1989; Jin JP, 1998, J VIROL, V72, P10011, DOI 10.1128/JVI.72.12.10011-10019.1998; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Luongo CL, 1998, J BIOL CHEM, V273, P23773, DOI 10.1074/jbc.273.37.23773; Luongo CL, 1997, J VIROL, V71, P8035, DOI 10.1128/JVI.71.10.8035-8040.1997; MAO ZX, 1991, VIROLOGY, V185, P377, DOI 10.1016/0042-6822(91)90785-A; MARTIN SA, 1975, J BIOL CHEM, V250, P9322; MORGAN JR, 1984, J VIROL, V52, P206, DOI 10.1128/JVI.52.1.206-214.1984; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; NILES EG, 1993, J BIOL CHEM, V268, P24986; NILES EG, 1989, VIROLOGY, V172, P513, DOI 10.1016/0042-6822(89)90194-3; Noble S, 1997, J VIROL, V71, P2182, DOI 10.1128/JVI.71.3.2182-2191.1997; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; PETT DM, 1973, VIROLOGY, V52, P174, DOI 10.1016/0042-6822(73)90407-8; SCHWER B, 1994, P NATL ACAD SCI USA, V91, P4328, DOI 10.1073/pnas.91.10.4328; SELIGER LS, 1987, J BIOL CHEM, V262, P16289; SHATKIN AJ, 1983, DOUBLE STRANDED RNA, P43; SHIBAGAKI Y, 1992, J BIOL CHEM, V267, P9521; SHUMAN S, 1989, J BIOL CHEM, V264, P9690; STARNES MC, 1993, VIROLOGY, V193, P356, DOI 10.1006/viro.1993.1132; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; VIRGIN HW, 1991, J VIROL, V65, P6772, DOI 10.1128/JVI.65.12.6772-6781.1991; Wang SP, 1997, P NATL ACAD SCI USA, V94, P9573, DOI 10.1073/pnas.94.18.9573; WONG F, 1995, BIOTECHNIQUES, V18, P1034; YEAGER M, 1996, BIOPHYS J, V70, P116	44	55	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2804	2810		10.1074/jbc.275.4.2804	http://dx.doi.org/10.1074/jbc.275.4.2804			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644745	hybrid			2022-12-27	WOS:000085128000077
J	Nyitrai, M; Hild, G; Lukacs, A; Bodis, E; Somogyi, B				Nyitrai, M; Hild, G; Lukacs, A; Bodis, E; Somogyi, B			Conformational distributions and proximity relationships in the rigor complex of actin and myosin subfragment-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE ENERGY-TRANSFER; RABBIT SKELETAL-MUSCLE; REGULATORY LIGHT-CHAIN; F-ACTIN; TRANSFER SPECTROSCOPY; 3-DIMENSIONAL STRUCTURE; RADIAL COORDINATE; BINDING-SITES; HEAVY-CHAIN; CONTRACTION	Cyclic conformational changes in the myosin head are considered essential for muscle contraction. We hereby show that the extension of the fluorescence resonance energy transfer method described originally by Taylor et al. (Taylor, D, L., Reidler, J., Spudich, J. A, and Stryer, L, (1981) J Cell Biol, 89, 362-367) allows determination of the position of a labeled point outside the actin filament in supramolecular complexes and also characterization of the conformational heterogeneity of an actin-binding protein while considering donor-acceptor distance distributions. Using this method we analyzed proximity relationships between two labeled points of S1 and the actin filament in the acto-S1 rigor complex. The donor (N-[[(iodoacetyl)amino]ethyl]-5-naphthylamine mine-1- sulfonate) was attached to either the catalytic domain (Cys-707) or the essential light chain (Cys-177) of S1, whereas the acceptor (5-(iodoacetamido)fluorescein) was attached to the actin filament (Cys-374), In contrast to the narrow positional distribution (assumed as being Gaussian) of Cys-707 (5 +/- 3 Angstrom), the positional distribution of Cys-177 was found to be broad (102 +/- 4 Angstrom). Such a broad positional distribution of the label on the essential light chain of S1 may be important in accommodating the helically arranged acto-myosin binding relative to the filament axis.	Univ Pecs, Sch Med, Res Grp, Hungarian Acad Sci, H-7601 Pecs, Hungary; Univ Pecs, Sch Med, Dept Biophys, H-7601 Pecs, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of Pecs; University of Pecs	Somogyi, B (corresponding author), Univ Pecs, Sch Med, Res Grp, Hungarian Acad Sci, H-7601 Pecs, Hungary.			Nyitrai, Miklos/0000-0002-6229-4337; Lukacs, Andras/0000-0001-8841-9823				Adhikari B, 1997, P NATL ACAD SCI USA, V94, P9643, DOI 10.1073/pnas.94.18.9643; AMIR D, 1986, BIOPOLYMERS, V25, P235, DOI 10.1002/bip.360250205; Baker JE, 1998, P NATL ACAD SCI USA, V95, P2944, DOI 10.1073/pnas.95.6.2944; BAY Z, 1963, P NATL ACAD SCI USA, V50, P1071, DOI 10.1073/pnas.50.6.1071; BHANDARI DG, 1985, FEBS LETT, V187, P160, DOI 10.1016/0014-5793(85)81234-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burghardt TP, 1997, P NATL ACAD SCI USA, V94, P9631, DOI 10.1073/pnas.94.18.9631; COOKE R, 1986, CRIT REV BIOCHEM MOL, V21, P53, DOI 10.3109/10409238609113609; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; ELOFSSON A, 1991, BIOCHEMISTRY-US, V30, P9648, DOI 10.1021/bi00104a012; Feuer G., 1948, HUNGARICA ACTA PHYSIOL, V1, P150; FISHE CH, 1925, J BIOL CHEM, V66, P375; GENNIS RB, 1972, BIOCHEMISTRY-US, V11, P2509, DOI 10.1021/bi00763a020; HENRY GD, 1985, BIOCHIM BIOPHYS ACTA, V830, P233, DOI 10.1016/0167-4838(85)90279-1; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOLMES KC, 1997, CURR BIOL, V7, P112; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Ishiwata S, 1997, BIOPHYS J, V73, P895, DOI 10.1016/S0006-3495(97)78122-0; JONTES JD, 1995, J STRUCT BIOL, V115, P119, DOI 10.1006/jsbi.1995.1037; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KASPRZAK AA, 1988, BIOCHEMISTRY-US, V27, P4512, DOI 10.1021/bi00412a044; KASPRZAK AA, 1989, BIOCHEMISTRY-US, V28, P9230, DOI 10.1021/bi00449a040; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P43; Lillo MP, 1997, BIOCHEMISTRY-US, V36, P11261, DOI 10.1021/bi9707887; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MIKI M, 1986, BIOCHIM BIOPHYS ACTA, V871, P137, DOI 10.1016/0167-4838(86)90166-4; MIKI M, 1986, BIOCHEM INT, V12, P725; MIKI M, 1984, BIOCHIM BIOPHYS ACTA, V790, P275, DOI 10.1016/0167-4838(84)90032-3; MIKI M, 1986, BIOCHIM BIOPHYS ACTA, V872, P76, DOI 10.1016/0167-4838(86)90149-4; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; Moens PDJ, 1997, BIOCHEMISTRY-US, V36, P7353, DOI 10.1021/bi962588l; MOENS PDJ, 1994, BIOCHEMISTRY-US, V33, P13102, DOI 10.1021/bi00248a020; Nyitrai M, 1999, J BIOL CHEM, V274, P12996, DOI 10.1074/jbc.274.19.12996; PARK HS, 1991, BIOCHEMISTRY-US, V30, P3189, DOI 10.1021/bi00227a005; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Roopnarine O, 1998, BIOCHEMISTRY-US, V37, P14428, DOI 10.1021/bi9808363; SELVE N, 1986, J MOL BIOL, V187, P627, DOI 10.1016/0022-2836(86)90341-4; Smyczynski C, 1997, BIOCHEMISTRY-US, V36, P13201, DOI 10.1021/bi970746i; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; TAKASHI R, 1979, BIOCHEMISTRY-US, V18, P5164, DOI 10.1021/bi00590a021; TAKASHI R, 1987, BIOCHEMISTRY-US, V26, P7471, DOI 10.1021/bi00397a041; TAYLOR DL, 1981, J CELL BIOL, V89, P362, DOI 10.1083/jcb.89.2.362; TRAYER HR, 1983, EUR J BIOCHEM, V135, P47, DOI 10.1111/j.1432-1033.1983.tb07616.x; WAGNER PD, 1977, J MOL BIOL, V109, P455, DOI 10.1016/S0022-2836(77)80023-5; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; XING J, 1995, BIOCHEMISTRY-US, V34, P6475, DOI 10.1021/bi00019a029; YAMAMOTO K, 1983, J BIOCHEM-TOKYO, V94, P2075, DOI 10.1093/oxfordjournals.jbchem.a134565; ZAAGER S, 1988, J BIOL CHEM, V263, P1513	54	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2404	2409		10.1074/jbc.275.4.2404	http://dx.doi.org/10.1074/jbc.275.4.2404			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644692	hybrid			2022-12-27	WOS:000085128000024
J	Andersen, MD; Busk, PK; Svendsen, I; Moller, BL				Andersen, MD; Busk, PK; Svendsen, I; Moller, BL			Cytochromes P-450 from cassava (Manihot esculenta Crantz) catalyzing the first steps in the biosynthesis of the cyanogenic glucosides linamarin and lotaustralin - Cloning, functional expression in Pichia pastoris, and substrate specificity of the isolated recombinant enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICOLOR L MOENCH; P-HYDROXYPHENYLACETALDEHYDE OXIME; HIGH-LEVEL EXPRESSION; SORGHUM-BICOLOR; IN-VITRO; ESCHERICHIA-COLI; GLUCOSINOLATE BIOSYNTHESIS; METHYLOTROPHIC YEAST; MEMBRANE-PROTEINS; PHASE-SEPARATION	The first committed steps in the biosynthesis of the two cyanogenic glucosides linamarin and lotaustralin in cassava are the conversion of L-valine and L-isoleucine, respectively, to the corresponding oximes, Two full-length cDNA clones that encode cytochromes P-450 catalyzing these reactions have been isolated, The two cassava cytochromes P-450 are 85% identical, share 54% sequence identity to CYP79A1 from sorghum, and have been assigned CYP79D1 and CYP79D2. Functional expression has been achieved using the methylotrophic yeast, Pichia pastoris, The amount of CYP79D1 isolated from 1 liter of P. pastoris culture exceeds the amounts that putatively could be isolated from 22,000 grown-up cassava plants. Each cytochrome P-450 metabolizes L-valine as well as L-isoleucine consistent with the cooccurrence of linamarin and lotaustralin in cassava. CYP79D1 was isolated from P, pastoris, Reconstitution in lipid micelles showed that CYP79D1 has a higher k(c) value with L-valine as substrate than with L-isoleucine, which is consistent with linamarin being the major cyanogenic glucoside in cassava, Both CYP79D1 and CYP79D2 are present in the genome of cassava cultivar MCol22 in agreement with cassava being allotetraploid, CYP79D1 and CYP79D2 are actively transcribed, and production of acyanogenic cassava plants would therefore require down-regulation of both genes.	Royal Vet & Agr Univ, Plant Biochem Lab, Dept Plant Biol, DK-1871 Frederiksberg C, Denmark; Royal Vet & Agr Univ, Ctr Mol Plant Physiol PlaCe, DK-1871 Frederiksberg C, Denmark; Carlsberg Lab, Dept Chem, DK-2500 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Moller, BL (corresponding author), Royal Vet & Agr Univ, Plant Biochem Lab, Dept Plant Biol, 40 Thorvaldsensvej, DK-1871 Frederiksberg C, Denmark.	blm@kvl.dk	Busk, Peter/Q-8145-2016; Møller, Birger Lindberg/H-2657-2014; Møller, Birger Lindberg/GQI-1792-2022	Busk, Peter/0000-0003-1920-636X; Møller, Birger Lindberg/0000-0002-3252-3119; Møller, Birger Lindberg/0000-0002-3252-3119				ANDERSEN MD, 1988, PROTEIN EXPRES PURIF, V13, P355; Bak S, 1998, PLANT MOL BIOL, V38, P725, DOI 10.1023/A:1006064202774; Bak S, 1998, PLANT MOL BIOL, V36, P393, DOI 10.1023/A:1005915507497; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; BENNETT R, 1995, PLANTA, V196, P239, DOI 10.1007/BF00201380; Bennett RN, 1996, PLANT CELL ENVIRON, V19, P801, DOI 10.1111/j.1365-3040.1996.tb00417.x; Bennett RN, 1997, PLANT PHYSIOL, V114, P1283, DOI 10.1104/pp.114.4.1283; BENVENISTE I, 1986, BIOCHEM J, V235, P365, DOI 10.1042/bj2350365; BOKANGA M, 1994, ACTA HORTIC, V375, P1; BOKANGA M, 1992, P CBN CALI, P418; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Boyle SM, 1998, MAR ENVIRON RES, V46, P25, DOI 10.1016/S0141-1136(97)00102-5; CHEN J, 1994, MAIZE HDB; CLARE JJ, 1991, BIO-TECHNOL, V9, P455, DOI 10.1038/nbt0591-455; Cliff J, 1997, TROP MED INT HEALTH, V2, P1068, DOI 10.1046/j.1365-3156.1997.d01-178.x; COCK JH, 1982, SCIENCE, V218, P755, DOI 10.1126/science.7134971; COLBY HD, 1995, BIOCHEM PHARMACOL, V49, P1057, DOI 10.1016/0006-2952(95)98501-Y; COLLINGE DB, 1982, J EXP BOT, V33, P154, DOI 10.1093/jxb/33.1.154; COLLINGE DB, 1982, ARCH BIOCHEM BIOPHYS, V218, P38, DOI 10.1016/0003-9861(82)90318-6; CONN EE, 1980, ANNU REV PLANT PHYS, V31, P433, DOI 10.1146/annurev.pp.31.060180.002245; CREGG JM, 1993, BIO-TECHNOL, V11, P905, DOI 10.1038/nbt0893-905; CREGG JM, 1987, BIO-TECHNOL, V5, P479, DOI 10.1038/nbt0587-479; Du LC, 1995, P NATL ACAD SCI USA, V92, P12505, DOI 10.1073/pnas.92.26.12505; DU LC, 1995, PHYTOCHEMISTRY, V39, P323, DOI 10.1016/0031-9422(94)00878-W; Durst Francis, 1995, Drug Metabolism and Drug Interactions, V12, P189; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Fregene M, 1997, THEOR APPL GENET, V95, P431, DOI 10.1007/s001220050580; GONZALEZ FJ, 1995, ANNU REV PHARMACOL, V35, P369, DOI 10.1146/annurev.pa.35.040195.002101; GOTOH O, 1992, J BIOL CHEM, V267, P83; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; HALKIER BA, 1989, PLANT PHYSIOL, V90, P1552, DOI 10.1104/pp.90.4.1552; HALKIER BA, 1995, ARCH BIOCHEM BIOPHYS, V322, P369, DOI 10.1006/abbi.1995.1477; HALKIER BA, 1991, PLANT PHYSIOL, V96, P10, DOI 10.1104/pp.96.1.10; Jefcoate C R, 1978, Methods Enzymol, V52, P258; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Kahn RA, 1997, PLANT PHYSIOL, V115, P1661, DOI 10.1104/pp.115.4.1661; Kahn RA, 1996, J BIOL CHEM, V271, P32944, DOI 10.1074/jbc.271.51.32944; KOCH B, 1992, ARCH BIOCHEM BIOPHYS, V292, P141, DOI 10.1016/0003-9861(92)90062-2; KOCH BM, 1995, ARCH BIOCHEM BIOPHYS, V323, P177; Li HQ, 1996, NAT BIOTECHNOL, V14, P736, DOI 10.1038/nbt0696-736; MCFARLANE IJ, 1975, J BIOL CHEM, V250, P4708; Moller BL, 1999, BOOK SOIL P, P563; MOLLER BL, 1979, J BIOL CHEM, V254, P8575; NARTEY F, 1968, PHYTOCHEMISTRY, V7, P1307, DOI 10.1016/S0031-9422(00)85629-0; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2370; OSUNTOKUN BO, 1981, WORLD REV NUT DIET, V26, P141; PETROWITZ HF, 1967, DUNNSCHICHT CHROMATO, P626; POULOS TL, 1985, J BIOL CHEM, V260, P6122; ROMANOS MA, 1991, VACCINE, V9, P901, DOI 10.1016/0264-410X(91)90011-T; Sambrook J., 1989, MOL CLONING LAB MANU, V1; SCHUNCK WH, 1987, ARCH MICROBIOL, V147, P245, DOI 10.1007/BF00463483; SHIMOZAWA O, 1993, J BIOL CHEM, V268, P21399; SIBBESEN O, 1995, J BIOL CHEM, V270, P3506, DOI 10.1074/jbc.270.8.3506; SIBBESEN O, 1994, P NATL ACAD SCI USA, V91, P9740, DOI 10.1073/pnas.91.21.9740; Trant JM, 1996, ARCH BIOCHEM BIOPHYS, V326, P8, DOI 10.1006/abbi.1996.0040; TYLLESKAR T, 1995, INT J EPIDEMIOL, V24, P949, DOI 10.1093/ije/24.5.949; TYLLESKAR T, 1992, LANCET, V339, P208, DOI 10.1016/0140-6736(92)90006-O; Wallsgrove RM, 1999, BOOK SOIL P, P523; WERCKREICHHART D, 1993, PLANT PHYSIOL, V102, P1291, DOI 10.1104/pp.102.4.1291; WERCKREICHHART D, 1991, ANAL BIOCHEM, V197, P125, DOI 10.1016/0003-2697(91)90367-3; XU D, 1994, BIOCHEM PHARMACOL, V48, P1421, DOI 10.1016/0006-2952(94)90566-5; FAOSTAT NUTR DATA FO	63	139	156	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1966	1975		10.1074/jbc.275.3.1966	http://dx.doi.org/10.1074/jbc.275.3.1966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636899	hybrid			2022-12-27	WOS:000084940000062
J	Keularts, IMLW; van Gorp, RMA; Feijge, MAH; Vuist, WMJ; Heemskerk, JWM				Keularts, IMLW; van Gorp, RMA; Feijge, MAH; Vuist, WMJ; Heemskerk, JWM			alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PHOSPHOLIPASE-C; CYCLIC-AMP; ADENYLATE-CYCLASE; ALPHA-2-ADRENERGIC RECEPTOR; TYROSINE PHOSPHORYLATION; NA+/H+ EXCHANGE; INTACT-CELLS; EPINEPHRINE; ACTIVATION	alpha(2A)-Adrenergic receptor-mediated Ca2+ signaling and integrin alpha(IIb)beta(3) exposure were investigated in human platelets under conditions where indirect, thromboxane- or ADP-mediated effects were absent. The alpha(2)-adrenergic receptor agonists, UK14304 and epinephrine (EPI), were unable to raise cytosolic levels of inositol 1,4,5-trisphosphate (InsP(3)) or Ca2+ but potentiated the [Ca2+](i) rises evoked by other agonists that act through stimulation of phospholipase C (thrombin or platelet-activating factor) or stimulation of Ca2+-induced Ca2+ release (CICR) in the absence of InsP(3) generation (thimerosal or thapsigargin), In addition, alpha(2)-adrenergic stimulation resulted in a 20% lowering in the cytosolic cAMP level. In platelets treated with G(s alpha)-stimulating prostaglandin E-1, EPI increased the Ca2+ signal evoked by either phospholipase C- or CICR-stimulating agonists mainly through modulation of the cAMP level. The stimulating effects of UK14304 and EPI on platelet Ca2+ responses, and also on integrin alpha(IIb)beta(3) exposure and platelet aggregation, were abolished by pharmacological stimulation of cAMP-dependent protein kinase, and these effects were mimicked by inhibition of this activity. In permeabilized platelets, UK14304 and EPI potentiated InsP(3)-induced, CICR-mediated mobilization of Ca2+ from internal stores in a similar way as did inhibition of cAMP-dependent protein kinase, In summary, a G(i alpha)-mediated decrease in cAMP level appears to play a major role in the platelet-activating effects of alpha(2A)-adrenergic receptor stimulation. Thus, in platelets, unlike other cell types, occupation of the G(i alpha)-coupled alpha(2A)-adrenergic receptors does not result in phospholipase C activation but rather in modulation of the Ca2+ response by relieving cAMP-mediated suppression of InsP(3)-dependent CICR.	Univ Limburg, Dept Human Biol, NL-6200 MD Maastricht, Netherlands; Univ Limburg, Dept Biochem, NL-6200 MD Maastricht, Netherlands	Hasselt University; Maastricht University; Hasselt University; Maastricht University	Heemskerk, JWM (corresponding author), Univ Limburg, Dept Human Biol, POB 616, NL-6200 MD Maastricht, Netherlands.		Heemskerk, Johan/AAM-8323-2021	Heemskerk, Johan/0000-0002-2848-5121				AKTORIES K, 1981, FEBS LETT, V130, P235, DOI 10.1016/0014-5793(81)81128-3; BANGA HS, 1986, P NATL ACAD SCI USA, V83, P9197, DOI 10.1073/pnas.83.23.9197; Banno Y, 1998, THROMB HAEMOSTASIS, V79, P1008; BRASS LF, 1988, J BIOL CHEM, V263, P5348; BYLUND DB, 1988, J PHARMACOL EXP THER, V245, P600; Cavallini L, 1996, J BIOL CHEM, V271, P5545, DOI 10.1074/jbc.271.10.5545; CHABRE O, 1994, J BIOL CHEM, V269, P5730; COBB CE, 1987, J BIOL CHEM, V262, P16566; CROUCH MF, 1988, J BIOL CHEM, V263, P3363; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dorn GW, 1997, BIOCHEMISTRY-US, V36, P6415, DOI 10.1021/bi970080s; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; GALITZKY J, 1990, BRIT J PHARMACOL, V100, P862, DOI 10.1111/j.1476-5381.1990.tb14105.x; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; HALBRUGGE M, 1993, PROTEIN KINASES BLOO, P245; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; Haslam R J, 1978, Adv Cyclic Nucleotide Res, V9, P533; HASLAM RJ, 1971, BIOCHEM J, V125, P377, DOI 10.1042/bj1250377; HASLAM RJ, 1978, BIOCHEM J, V176, P83, DOI 10.1042/bj1760083; HEEMSKERK JWM, 1993, J BIOL CHEM, V268, P356; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473; JOHANSSON JS, 1992, BIOCHIM BIOPHYS ACTA, V1105, P19, DOI 10.1016/0005-2736(92)90158-I; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; MARTI KB, 1992, P NATL ACAD SCI USA, V89, P2784, DOI 10.1073/pnas.89.7.2784; MICHEL MC, 1989, J BIOL CHEM, V264, P4986; NIEUWLAND R, 1993, BIOCHIM BIOPHYS ACTA, V1148, P185, DOI 10.1016/0005-2736(93)90128-M; Paul BZS, 1998, BRIT J HAEMATOL, V102, P1204; PEERSCHKE EI, 1982, BLOOD, V60, P71; REGAN JW, 1986, J BIOL CHEM, V261, P3894; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Ryningen A, 1998, BBA-LIPID LIPID MET, V1394, P235, DOI 10.1016/S0005-2760(98)00106-4; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHATTIL SJ, 1989, BLOOD, V73, P150; SIESS W, 1984, J BIOL CHEM, V259, P8286; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; STEEN VM, 1988, BIOCHEM J, V253, P581, DOI 10.1042/bj2530581; SWEATT JD, 1986, J BIOL CHEM, V261, P8660; Tertyshnikova S, 1998, P NATL ACAD SCI USA, V95, P1613, DOI 10.1073/pnas.95.4.1613; THOMAS DP, 1967, NATURE, V215, P298, DOI 10.1038/215298a0; THOMPSON NT, 1986, EUR J BIOCHEM, V161, P399, DOI 10.1111/j.1432-1033.1986.tb10459.x; VUIST WMJ, 1994, BLOOD, V83, P899; WARE JA, 1986, J CLIN INVEST, V77, P878, DOI 10.1172/JCI112385; ZAVOICO GB, 1984, BIOCHEM BIOPH RES CO, V120, P579, DOI 10.1016/0006-291X(84)91294-4	47	73	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1763	1772		10.1074/jbc.275.3.1763	http://dx.doi.org/10.1074/jbc.275.3.1763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636873	hybrid			2022-12-27	WOS:000084940000036
J	Flugel, RS; Hwangbo, Y; Lambalot, RH; Cronan, JE; Walsh, CT				Flugel, RS; Hwangbo, Y; Lambalot, RH; Cronan, JE; Walsh, CT			Holo-(acyl carrier protein) synthase and phosphopantetheinyl transfer in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; 3-DIMENSIONAL STRUCTURE; DISTANCE GEOMETRY; ACID BIOSYNTHESIS; PDXJ OPERON; COENZYME-A; CLONING; STREPTOMYCES; POLYKETIDE; EXPRESSION	Holo-(acyl carrier protein) synthase (AcpS) posttranslationally modifies apoacyl carrier protein (apoACP) via transfer of 4'-phosphopantetheine from coenzyme A (CoA) to the conserved serine 36 gamma-OH of apoACP, The resulting holo-acyl carrier protein (holoACP) is then active as the central coenzyme of fatty acid biosynthesis, The acpS gene has previously been identified and shown to be essential for Escherichia coli growth, Earlier mutagenic studies isolated the E, coli MP4 strain, whose elevated growth requirement for CoA was ascribed to a deficiency in holoACP synthesis. Sequencing of the acpS gene from the E. coli MP4 strain (denoted acpS1) showed that the AcpS1 protein contains a G4D mutation. AcpS1 exhibited a similar to 5-fold reduction in its catalytic efficiency when compared with wild type AcpS, accounting for the E. coli MP4 strain phenotype, It is shown that a conditional acpS mutant accumulates apoACP in vivo under nonpermissive conditions in a manner similar to the E, coli MP4 strain. In addition, it is demonstrated that the gene product, YhhU, of a previously identified E. coli open reading frame can completely suppress the acpS conditional, lethal phenotype upon overexpression of the protein, suggesting that YhhU may be involved in an alternative pathway for phosphopantetheinyl transfer and holoACP synthesis in E. coli.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Harvard University; Harvard Medical School; Harvard University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	walsh@walsh.med.harvard.edu	Cronan, John/V-6626-2019	Hwangbo, Yon/0000-0001-8380-0641	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011, R37GM020011, T32GM008313] Funding Source: NIH RePORTER; NIAID NIH HHS [AI15650] Funding Source: Medline; NIGMS NIH HHS [5T32-GM08313-07, GM20011] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cleland W. W, 1970, ENZYMES, V2, P1; Cronan Jr. J.E., 1987, ESCHERICHIA COLI SAL, P474; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Debabov DV, 1996, J BACTERIOL, V178, P3869, DOI 10.1128/jb.178.13.3869-3876.1996; Earhart C.F., 1996, ESCHERICHIA COLI SAL, V2nd ed., P1075; ELOVSON J, 1968, J BIOL CHEM, V243, P3603; Gehring AM, 1997, CHEM BIOL, V4, P17, DOI 10.1016/S1074-5521(97)90233-7; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Ghose R, 1996, FEBS LETT, V388, P66, DOI 10.1016/0014-5793(96)00512-1; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HILL RB, 1995, PROTEIN EXPRES PURIF, V6, P394, DOI 10.1006/prep.1995.1052; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P6135, DOI 10.1021/bi00416a046; HOLAK TA, 1988, EUR J BIOCHEM, V175, P9, DOI 10.1111/j.1432-1033.1988.tb14159.x; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Keating DH, 1996, J BACTERIOL, V178, P2662, DOI 10.1128/jb.178.9.2662-2667.1996; KEATING DH, 1995, J BIOL CHEM, V270, P22229, DOI 10.1074/jbc.270.38.22229; LAM HM, 1992, J BACTERIOL, V174, P1554, DOI 10.1128/jb.174.5.1554-1567.1992; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Miller J.H., 1992, SHORT COURSE BACTERI, P150; POLACCO ML, 1981, J BIOL CHEM, V256, P5750; PRIDMORE RD, 1987, GENE, V56, P309, DOI 10.1016/0378-1119(87)90149-1; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULZ H, 1969, J BIOL CHEM, V244, P6577; SCHULZ H, 1975, J BIOL CHEM, V250, P2299; TAKIFF HE, 1992, J BACTERIOL, V174, P1544, DOI 10.1128/jb.174.5.1544-1553.1992; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1	29	105	114	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					959	968		10.1074/jbc.275.2.959	http://dx.doi.org/10.1074/jbc.275.2.959			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625633	hybrid			2022-12-27	WOS:000084836600037
J	Kishi, H; Mikawa, T; Seto, M; Sasaki, Y; Kanayasu-Toyoda, T; Yamaguchi, T; Imamura, M; Ito, M; Karaki, H; Bao, JJ; Nakamura, A; Ishikawa, R; Kohama, K				Kishi, H; Mikawa, T; Seto, M; Sasaki, Y; Kanayasu-Toyoda, T; Yamaguchi, T; Imamura, M; Ito, M; Karaki, H; Bao, JJ; Nakamura, A; Ishikawa, R; Kohama, K			Stable transfectants of smooth muscle cell line lacking the expression of myosin light chain kinase and their characterization with respect to the actomyosin system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT INTERACTION; ACTIN-BINDING DOMAIN; GROWTH-FACTOR; CULTURED-CELLS; PROTEIN; PHOSPHORYLATION; LOCALIZATION; RECEPTOR; ACTIVATION; MIGRATION	We constructed a plasmid vector having a 1.4-kilobase pair insert of myosin light chain kinase (MLCK) cDNA in an antisense direction to express antisense mRNA The construct was then transfected to SM3, a cell line from vascular smooth muscle cells, producing a few stable transfectants. The down-regulation of MLCK expression in the transfectants was confirmed by both Northern and Western blots. The control SM3 showed chemotaxic motility to platelet-derived growth factor-BB, which was supported by lamellipodia. However, the transfectants showed neither chemotaxic motility nor developed lamellipodia, indicating the essential role of MLCK in the motility. The specificity for the targeting was assessed by a few tests including the rescue experiment. Despite this importance of MLCK, platelet-derived growth factor-BB failed to induce MLC20 phosphorylation in not only the transfectants but also in SM3. The mode in which MLCK was involved in the development of membrane ruffling is discussed with special reference to the novel property of MLCK that stimulates the ATPase activity of smooth muscle myosin without phosphorylating its light chain.	Gunma Univ, Sch Med, Dept Pharmacol, Maebashi, Gumma 3718511, Japan; Gunma Univ, Sch Med, Dept Internal Med 1, Maebashi, Gumma 3718511, Japan; Cornell Univ, Coll Med, Dept Cell Biol, New York, NY 10021 USA; Asahi Chem Ind Co Ltd, Shizuoka 4160934, Japan; Natl Inst Hlth Sci, Tokyo 1588501, Japan; Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan; Mie Univ, Sch Med, Dept Internal Med 1, Tsu, Mie 5148507, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, Tokyo 1138657, Japan	Gunma University; Gunma University; Cornell University; National Institute of Health Sciences - Japan; National Center for Neurology & Psychiatry - Japan; Mie University; University of Tokyo	Kohama, K (corresponding author), Gunma Univ, Sch Med, Dept Pharmacol, Maebashi, Gumma 3718511, Japan.		Kishi, Hiroko/AAR-9148-2021	Kishi, Hiroko/0000-0003-2896-7355	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056987, R01HL054128, R01HL062175] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62175, HL54128, HL56987] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKASU T, 1993, NEURON, V11, P1133, DOI 10.1016/0896-6273(93)90226-H; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLMAN A, 1990, J CELL SCI, V97, P399; DABROWSKA R, 1982, BIOCHEM BIOPH RES CO, V107, P1524, DOI 10.1016/S0006-291X(82)80172-1; DELANEROLLE P, 1993, J BIOL CHEM, V268, P16883; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; GALLAGHER PJ, 1995, J BIOL CHEM, V270, P29090, DOI 10.1074/jbc.270.49.29090; Gallagher PJ, 1997, MOL CELL BIOCHEM, V173, P51, DOI 10.1023/A:1006876318155; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUERRIERO V, 1981, CELL, V27, P449, DOI 10.1016/0092-8674(81)90386-X; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; Hayakawa K, 1999, BBA-MOL CELL RES, V1450, P12, DOI 10.1016/S0167-4889(99)00034-8; HAYAKAWA K, 1994, BIOCHEM BIOPH RES CO, V199, P786, DOI 10.1006/bbrc.1994.1298; ITO M, 1991, BIOCHEMISTRY-US, V30, P3498, DOI 10.1021/bi00228a021; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KOHAMA K, 1992, BIOCHEM BIOPH RES CO, V184, P1204, DOI 10.1016/S0006-291X(05)80010-5; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; MARSTON S, 1995, INT J BIOCHEM CELL B, V27, P97, DOI 10.1016/1357-2725(94)00080-U; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; MELLSTROM K, 1983, J MUSCLE RES CELL M, V4, P589, DOI 10.1007/BF00712117; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sakurada K, 1998, AM J PHYSIOL-CELL PH, V274, pC1563, DOI 10.1152/ajpcell.1998.274.6.C1563; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SASAKI Y, 1989, J BIOCHEM-TOKYO, V106, P1009, DOI 10.1093/oxfordjournals.jbchem.a122956; SATO M, 1995, J BIOCHEM, V118, P1; SELLERS JR, 1984, J BIOL CHEM, V259, P7740; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Seto M, 1996, PFLUG ARCH EUR J PHY, V432, P7, DOI 10.1007/s004240050099; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; SHRINSKY VP, 1993, J BIOL CHEM, V268, P16578; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; WESTERMARK B, 1990, P NATL ACAD SCI USA, V87, P128, DOI 10.1073/pnas.87.1.128; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; YE LH, 1994, J BIOCHEM, V116, P1377, DOI 10.1093/oxfordjournals.jbchem.a124690; Ye LH, 1997, J BIOL CHEM, V272, P32182, DOI 10.1074/jbc.272.51.32182; Ye LH, 1999, P NATL ACAD SCI USA, V96, P6666, DOI 10.1073/pnas.96.12.6666	43	35	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1414	1420		10.1074/jbc.275.2.1414	http://dx.doi.org/10.1074/jbc.275.2.1414			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625693	hybrid			2022-12-27	WOS:000084836600097
J	Rauer, H; Lanigan, MD; Pennington, MW; Aiyar, J; Ghanshani, S; Cahalan, MD; Norton, RS; Chandy, KG				Rauer, H; Lanigan, MD; Pennington, MW; Aiyar, J; Ghanshani, S; Cahalan, MD; Norton, RS; Chandy, KG			Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca2+-activated over voltage-gated K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; HUMAN T-LYMPHOCYTES; MUTANT CYCLES; IN-VIVO; CLOTRIMAZOLE; BLOCKADE; MEMBER; KV1.3; CONSERVATION; EXPRESSION	We have used a structure-based design strategy to transform the polypeptide toxin charybdotoxin, which blocks several voltage-gated and Ca2+-activated KC channels, into a selective inhibitor. As a model system, we chose two channels in T-lymphocytes, the voltage-gated channel Kv1.3 and the Ca2+-activated channel IKCa1, Homology models of both channels were generated based on the crystal structure of the bacterial channel KcsA. Initial docking of charybdotoxin was undertaken with both models, and the accuracy of these docking configurations was tested by mutant cycle analyses, establishing that charybdotoxin has a similar docking configuration in the external vestibules of IKCa1 and Kv1.3. Comparison of the refined models revealed a unique cluster of negatively charged residues in the turret of Kv1.3, not present in IKCa1, To exploit this difference, three novel charybdotoxin analogs were designed by introducing negatively charged residues in place of charybdotoxin Lys(32), which lies in close proximity to this cluster. These analogs block IKCa1 with similar to 20-fold higher affinity than Kv1.3, The other charybdotoxin-sensitive Kv channels, Kv1.2 and Rv1.6, contain the negative cluster and are predictably insensitive to the charybdotoxin position 32 analogs, whereas the maxi-K-Ca, channel, hSlo, lacking the cluster, is sensitive to the analogs. This provides strong evidence for topological similarity of the external vestibules of diverse K+ channels and demonstrates the feasibility of using structure-based strategies to design selective inhibitors for mammalian K+ channels. The availability of potent and selective inhibitors of IKCa1 will help to elucidate the role of this channel in T-lymphocytes during the immune response as well as in erythrocytes and colonic epithelia.	Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92697 USA; Biomol Res Inst, Parkville, Vic 3052, Australia; Bachem Biosci Inc, King Of Prussia, PA 19406 USA; AstraZeneca Pharmaceut, Target Discovery Dept, Wilmington, DE 19850 USA	University of California System; University of California Irvine; AstraZeneca	Chandy, KG (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Rm 291,Joan Irvine Smith Hall, Irvine, CA 92697 USA.			Norton, Raymond/0000-0001-8893-0584; pennington, michael/0000-0001-5446-3447	NIGMS NIH HHS [GM54221] Funding Source: Medline; NIMH NIH HHS [MH59222] Funding Source: Medline; NINDS NIH HHS [NS14609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609, R56NS014609, R01NS014609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIYAR J, 1995, NEURON, V15, P1169, DOI 10.1016/0896-6273(95)90104-3; Aiyar J, 1996, J BIOL CHEM, V271, P31013, DOI 10.1074/jbc.271.49.31013; BRUGNARA C, 1995, J PHARMACOL EXP THER, V273, P266; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Brugnara C, 1995, Curr Opin Hematol, V2, P132; Brugnara C, 1995, Ann N Y Acad Sci, V763, P262, DOI 10.1111/j.1749-6632.1995.tb32411.x; Cahalan MD, 1997, CURR OPIN BIOTECH, V8, P749, DOI 10.1016/S0958-1669(97)80130-9; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; GARCIA ML, 1995, AM J PHYSIOL-CELL PH, V269, pC1, DOI 10.1152/ajpcell.1995.269.1.C1; GARDOS G, 1958, BIOCHIM BIOPHYS ACTA, V30, P653, DOI 10.1016/0006-3002(58)90124-0; GODLSTEIN SA, 1994, NEURON, V12, P1377; GRISSMER S, 1992, J GEN PHYSIOL, V99, P63, DOI 10.1085/jgp.99.1.63; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; Hanson DC, 1999, BRIT J PHARMACOL, V126, P1707, DOI 10.1038/sj.bjp.0702480; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jensen BS, 1998, AM J PHYSIOL-CELL PH, V275, pC848, DOI 10.1152/ajpcell.1998.275.3.C848; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; KIRSCH GE, 1991, FEBS LETT, V278, P55, DOI 10.1016/0014-5793(91)80082-E; Koo GC, 1997, J IMMUNOL, V158, P5120; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; MUNUJOS P, 1995, BIOCHEMISTRY-US, V34, P10771, DOI 10.1021/bi00034a009; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Rauer H, 1999, BRIT J PHARMACOL, V127, P1065, DOI 10.1038/sj.bjp.0702599; Rauer H, 1996, MOL PHARMACOL, V50, P1625; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542	39	96	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1201	1208		10.1074/jbc.275.2.1201	http://dx.doi.org/10.1074/jbc.275.2.1201			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625664	hybrid			2022-12-27	WOS:000084836600068
J	Contestabile, R; Angelaccio, S; Maytum, R; Bossa, F; John, RA				Contestabile, R; Angelaccio, S; Maytum, R; Bossa, F; John, RA			The contribution of a conformationally mobile, active site loop to the reaction catalyzed by glutamate semialdehyde aminomutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE KINETIC-ANALYSIS; 1-SEMIALDEHYDE AMINOTRANSFERASE; AMINOLEVULINATE; SYNECHOCOCCUS; INTERMEDIATE	The behavior of glutamate semialdehyde amino-mutase, the enzyme that produces 4-aminolevulinate for tetrapyrrole synthesis in plants and bacteria, is markedly affected by the extent to which the central intermediate in the reaction, 4,5-diaminovalerate, is allowed to dissociate. The kinetic properties of the wild-type enzyme are compared with those of a mutant form in which a flexible loop, that reversibly plugs the entrance to the active site, has been deleted by site-directed mutagenesis. The deletion has three effects. The dissociation constant for diaminovalerate is increased approximately 100-fold. The catalytic efficiency of the enzyme, measured as k(cat)/K-m in the presence of saturating concentrations of diaminovalerate, is lowered 30-fold to 2.1 mM(-1) s(-1). During the course of the reaction, which begins with the enzyme in its pyridoxamine form, the mutant enzyme undergoes absorbance changes not seen with the wild-type enzyme under the same conditions. These are proposed to be due to abortive complex formation between the pyridoxal form of the enzyme (formed by dissociation of diaminovalerate) and glutamate semialdehyde itself.	Univ Wales, Cardiff Sch Biosci, Cardiff CF1 3US, S Glam, Wales; Univ Rome La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; Univ Rome La Sapienza, CNR, Ctr Mol Biol, I-00185 Rome, Italy	Cardiff University; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	John, RA (corresponding author), Univ Wales, Cardiff Sch Biosci, POB 911, Cardiff CF1 3US, S Glam, Wales.		Angelaccio, Sebastiana/D-2842-2011; Contestabile, Roberto/J-3467-2019	Contestabile, Roberto/0000-0002-5235-9993; Maytum, Robin/0000-0003-0395-403X				CLARKE AR, 1986, NATURE, V324, P699, DOI 10.1038/324699a0; ECCLESTON JF, 1980, ANAL BIOCHEM, V106, P73, DOI 10.1016/0003-2697(80)90120-7; GRIMM B, 1991, J BIOL CHEM, V266, P12495; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; KALLEN RG, 1985, TRANSAMINASES, P37; KANNANGARA CG, 1988, TRENDS BIOCHEM SCI, V13, P139; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; POGSON CI, 1972, BIOCHEM BIOPH RES CO, V46, P1043; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; PUGH CE, 1992, J BIOL CHEM, V267, P1584; PUGH CE, 1991, ANAL BIOCHEM, V198, P43, DOI 10.1016/0003-2697(91)90503-L; Shen BW, 1998, J MOL BIOL, V277, P81, DOI 10.1006/jmbi.1997.1583; SMITH MA, 1991, EUR J BIOCHEM, V202, P749, DOI 10.1111/j.1432-1033.1991.tb16429.x; Smith MA, 1998, BIOCHEMISTRY-US, V37, P319, DOI 10.1021/bi9717587; TYACKE RJ, 1993, BIOCHEM J, V293, P697, DOI 10.1042/bj2930697; TYACKE RJ, 1995, BIOCHEM J, V309, P307, DOI 10.1042/bj3090307	18	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3879	3886		10.1074/jbc.275.6.3879	http://dx.doi.org/10.1074/jbc.275.6.3879			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660540	hybrid			2022-12-27	WOS:000085288800024
J	De Cristofaro, R; De Candia, E; Rutella, S; Weitz, JI				De Cristofaro, R; De Candia, E; Rutella, S; Weitz, JI			The Asp(272)-Glu(282) region of platelet glycoprotein Ib alpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; PROTHROMBIN FRAGMENT-2; VONWILLEBRAND-FACTOR; IX COMPLEX; IDENTIFICATION; RECEPTOR; RESIDUES; DOMAIN; LOCALIZATION; GPIB	Platelet glycoprotein Ib (GpIb) mediates interaction with both von Willebrand factor and thrombin. Thrombin binds to GpIb via its heparin-binding site (HBS) (De Candia, E., De Cristofaro, R., De Marco, L., Mazzucato, M., Picozzi, M., and Landolfi, R. (1997) Thromb. Haemostasis 77,735-740; De Cristofaro, R., De Candia, E., Croce, G., Morosetti, R., and Landolfi, R, (1998) Biochem. J. 332, 643-650). To identify the thrombin-binding domain on GpIb alpha, we examined the effect of GpIb alpha(1-282), a GpIb alpha fragment released by the cobra venom mocarhagin on the heparin-catalyzed rate of thrombin inhibition by antithrombin III (AT). GpIb alpha(1-282) inhibited the reaction in a dose-dependent and competitive fashion. In contrast, the GpIb alpha(1-271) fragment, produced by exposing QpI alpha(1-282) to carboxypeptidase Y, had no effect on thrombin inhibition by the heparin-AT complex. Measurements of the apparent equilibrium constant of the GpIb alpha(1-282) binding to thrombin as a function of different salts (NaCl and tetramethyl-ammonium chloride) concentration (0.1-0.2 M) indicated a large salt dependence (Gamma(+/-) = -4.5), similar to that pertaining to the heparin binding to thrombin. The importance of thrombin HBS in its interaction with GpIb alpha was confirmed using DNA aptamers, which specifically bind to either HBS (HD22) or the fibrinogen recognition site of thrombin (HD1). HD22, but not HD1, inhibited thrombin binding to GpIb alpha(1-282). Furthermore, the proteolytic derivative gamma(T)-thrombin, which lacks the fibrinogen recognition site, binds to GpIb alpha via its intact HBS in a reaction that is inhibited by HD22. Neither alpha- nor gamma(T)-thrombin bound to GpIb alpha(1-271), suggesting that the Asp(272)-Glu(282) region of GpIb alpha may act as a "heparin-like" ligand for the thrombin DBS, thereby inhibiting heparin binding to thrombin. It was also demonstrated that intact platelets may dose-dependently inhibit the heparin-catalyzed thrombin inhibition by AT at enzyme concentrations <5 nM. Altogether, these findings show that thrombin HBS binds to the region of GpIb alpha involving the Asp(272)-GlU(282) segment, protecting the enzyme from the inactivation by the heparin-AT system.	Univ Cattolica Sacro Cuore, Haemostasis Res Ctr, Sch Med, I-00168 Rome, Italy; Univ Cattolica Sacro Cuore, Ctr Flow Cytometr Study Blood Cells, Sch Med, I-00168 Rome, Italy; McMaster Univ, Hamilton, ON L8V 1C3, Canada; Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; McMaster University; McMaster University	De Cristofaro, R (corresponding author), Univ Cattolica Sacro Cuore, Ist Semeiot Med, Ctr Ric Fisiopatol Emostasi, Largo F Vito 1, I-00168 Rome, Italy.		Rutella, Sergio/AAF-9187-2020; De Candia, Erica/K-9632-2016; De Cristofaro, Raimondo/K-3942-2018; Rutella, Sergio/AAF-9210-2020; Weitz, Jeffrey/AAD-1929-2019	De Candia, Erica/0000-0003-0942-2819; De Cristofaro, Raimondo/0000-0002-8066-8849; Rutella, Sergio/0000-0003-1970-7375; Weitz, Jeffrey/0000-0002-1092-7550				ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; BODE W, 1992, PROTEIN SCI, V1, P426; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; CHA S, 1976, BIOCHEM PHARMACOL, V25, P2695, DOI 10.1016/0006-2952(76)90259-8; CLEMETSON KJ, 1995, SEMIN THROMB HEMOST, V21, P130, DOI 10.1055/s-2007-1000387; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; De Candia E, 1999, CIRCULATION, V99, P3308, DOI 10.1161/01.CIR.99.25.3308; de Cristofaro R, 1998, BIOCHEM J, V332, P643, DOI 10.1042/bj3320643; DeCandia E, 1997, THROMB HAEMOSTASIS, V77, P735; DECRISTOFARO R, 1993, BIOCHEM J, V289, P475, DOI 10.1042/bj2890475; DECRISTOFARO R, 1995, J MOL BIOL, V245, P447; DEMARCO L, 1994, J BIOL CHEM, V269, P6478; DONG JF, 1994, BIOCHEMISTRY-US, V33, P13946, DOI 10.1021/bi00250a050; EDSALL JT, 1958, BIOPHYSICAL CHEM, P151; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; GAN ZR, 1994, J BIOL CHEM, V269, P1301; GRALNICK HR, 1994, P NATL ACAD SCI USA, V91, P6334, DOI 10.1073/pnas.91.14.6334; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P915, DOI 10.1021/bi951504q; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P906, DOI 10.1021/bi951503y; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; HESS D, 1991, EUR J BIOCHEM, V199, P389, DOI 10.1111/j.1432-1033.1991.tb16135.x; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Jandrot-Perrus M, 1999, THROMB HAEMOSTASIS, V81, P316; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; LEVINA NB, 1984, J CHROMATOGR, V286, P207, DOI 10.1016/S0021-9673(01)99187-3; LI CQ, 1997, BLOOD S, V90, P430; Liaw PCY, 1998, J BIOL CHEM, V273, P8932, DOI 10.1074/jbc.273.15.8932; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P97; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; NORDENMAN B, 1978, BIOCHEMISTRY-US, V17, P3339, DOI 10.1021/bi00609a026; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1995, BIOPHYS J, V68, P786, DOI 10.1016/S0006-3495(95)80254-7; RYDEL TJ, 1994, J BIOL CHEM, V269, P22000; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; SOBEL M, 1991, J CLIN INVEST, V87, P1787, DOI 10.1172/JCI115198; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; WU QY, 1992, J BIOL CHEM, V267, P24408	50	53	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3887	3895		10.1074/jbc.275.6.3887	http://dx.doi.org/10.1074/jbc.275.6.3887			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660541	Green Accepted, hybrid			2022-12-27	WOS:000085288800025
J	Nurse, P; Bahng, S; Mossessova, E; Marians, KJ				Nurse, P; Bahng, S; Mossessova, E; Marians, KJ			Mutational analysis of Escherichia coli topoisomerase IV. ATPase negative mutants of ParE induce hyper-DNA cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; DEPENDENT REACTIONS; NALIDIXIC-ACID; GYRASE; MECHANISM; PURIFICATION; REPLICATION; TRANSPORT; RESIDUE; SUBUNIT	ParE is the ATP-binding subunit of topoisomerase TV (Topo TV). During topoisomerization, the ATP-binding and hydrolysis cycle must be coordinated with the cycle of DNA cleavage and religation. We have isolated three dominant-negative mutant alleles of parE that encode ParE proteins that fail to hydrolyze ATP when reconstituted with ParC to form Topo IV. ParE G110S Topo IV and ParE S123L Topo IV failed to bind ATP at all, whereas ParE T201A could bind ATP. All three mutant Topo TV proteins exhibited an elevated level of spontaneous DNA cleavage that could be associated with a decreased rate of DNA resealing. In ParE T201A Topo TV, this defect appeared to result from an increased likelihood that the tetrameric enzyme would fall apart after DNA cleavage. Thus, while ATP is not required for DNA cleavage, the properties of these mutant enzymes suggests that ATP-hydrolysis informs DNA religation.	Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Mol Biol Grad Program, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Nurse, P (corresponding author), Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34558] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benedetti P, 1997, J BIOL CHEM, V272, P12132, DOI 10.1074/jbc.272.18.12132; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Caron PR, 1999, METH MOL B, V94, P279; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; Hu T, 1998, J BIOL CHEM, V273, P9586, DOI 10.1074/jbc.273.16.9586; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; LINDSLEY JE, 1993, NATURE, V361, P749, DOI 10.1038/361749a0; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; LYNN R, 1986, SCIENCE, V233, P647, DOI 10.1126/science.3014661; Marians KJ, 1997, J BIOL CHEM, V272, P9401; Morris SNK, 1999, J BIOL CHEM, V274, P3446, DOI 10.1074/jbc.274.6.3446; Mossessova E, 2000, J BIOL CHEM, V275, P4099, DOI 10.1074/jbc.275.6.4099; ODea MH, 1996, J BIOL CHEM, V271, P9723, DOI 10.1074/jbc.271.16.9723; PENG H, 1993, J BIOL CHEM, V268, P24481; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Schultz P, 1996, P NATL ACAD SCI USA, V93, P5936, DOI 10.1073/pnas.93.12.5936; Smith CV, 1998, BIOCHEMISTRY-US, V37, P9658, DOI 10.1021/bi9801309; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Ullsperger C, 1996, J BIOL CHEM, V271, P31549, DOI 10.1074/jbc.271.49.31549; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223	25	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4104	4111		10.1074/jbc.275.6.4104	http://dx.doi.org/10.1074/jbc.275.6.4104			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660570	hybrid			2022-12-27	WOS:000085288800054
J	Rubino, M; Miaczynska, M; Lippe, R; Zerial, M				Rubino, M; Miaczynska, M; Lippe, R; Zerial, M			Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; RAB PROTEINS; PHOSPHATIDYLINOSITOL 3-KINASE; ENDOCYTIC VESICLES; AUTOANTIGEN EEA1; FUSION INVITRO; COMPLEX; DOCKING; CELLS	The molecular mechanisms ensuring directionality of endocytic membrane trafficking between transport vesicles and target organelles still remain poorly characterized. We have been investigating the function of the small GTPase Rab5 in early endocytic transport. In vitro studies have demonstrated a role of Rab5 in two membrane fusion events: the heterotypic fusion between plasma membrane-derived clathrin-coated vesicles (CCVs) and early endosomes and in the homotypic fusion between early endosomes. Several Rab5 effecters are required in homotypic endosome fusion, including EEA1, which mediates endosome membrane docking, a's well as Rabaptin-5.Rabex-5 complex and phosphatidylinositol 3-kinase hVPS34. In this study we have examined the localization and function of Rab5 and its effecters in heterotypic fusion in vitro. We report that the presence of active Rab5 is necessary on both CCVs and early endosomes for a heterotypic fusion event to occur. This process requires EEA1 in addition to the Rabaptin-5 complex. However, whereas Rab5 and Rabaptin-5 are symmetrically distributed between CCVs and early endosomes, EEA1 is recruited selectively onto the membrane of early endosomes. Our results suggest that EEA1 is a tethering molecule that provides directionality to vesicular transport from the plasma membrane to the early endosomes.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Zerial, M (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	zerial@embl-heidelberg.de		Lippe, Roger/0000-0001-5066-3070; Miaczynska, Marta/0000-0003-0031-5267				ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; ARAKI S, 1990, J BIOL CHEM, V265, P13007; Barbieri MA, 1998, J BIOL CHEM, V273, P25850, DOI 10.1074/jbc.273.40.25850; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1994, P NATL ACAD SCI USA, V91, P5061, DOI 10.1073/pnas.91.11.5061; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; GOODY RS, 1972, BIOCHIM BIOPHYS ACTA, V276, P155, DOI 10.1016/0005-2744(72)90016-2; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Murphy R F, 1991, Trends Cell Biol, V1, P77, DOI 10.1016/0962-8924(91)90022-2; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Panaretou C, 1997, J BIOL CHEM, V272, P2477; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steel GJ, 1996, EMBO J, V15, P745, DOI 10.1002/j.1460-2075.1996.tb00410.x; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Tang BL, 1998, J BIOL CHEM, V273, P6944, DOI 10.1074/jbc.273.12.6944; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; ULLRICH O, 1995, METHOD ENZYMOL, V257, P243; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEIJLAND A, 1993, SCIENCE, V259, P1311, DOI 10.1126/science.8446899; WOODMAN PG, 1991, J CELL BIOL, V112, P1133, DOI 10.1083/jcb.112.6.1133; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	48	125	130	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3745	3748		10.1074/jbc.275.6.3745	http://dx.doi.org/10.1074/jbc.275.6.3745			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660521	hybrid			2022-12-27	WOS:000085288800005
J	Lawe, DC; Patki, V; Heller-Harrison, R; Lambright, D; Corvera, S				Lawe, DC; Patki, V; Heller-Harrison, R; Lambright, D; Corvera, S			The FYVE domain of early endosome antigen 1 is required for both phosphatidylinositol 3-phosphate and Rab5 binding - Critical role of this dual interaction for endosomal localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC PATHWAY; PHOSPHOINOSITIDE 3-KINASE; AUTOANTIGEN EEA1; MEMBRANE-FUSION; WORTMANNIN; TRAFFICKING; INHIBITOR; RECEPTOR; FINGERS; PROTEIN	Early endosome antigen 1 (EEA1) is 170-kDa polypeptide required for endosome fusion. EEA1 binds to both phosphtidylinositol 3-phosphate (PtdIns3P) and to Rab5-GTP in vitro, but the functional role of this dual interaction at the endosomal membrane is unclear. Here we have determined the structural features in EEA1 required for binding to these ligands, We have found that the FYVE domain is critical for both PtdIns3P and Rab5 binding, Whereas PtdIns3P binding only required the FYVE domain, Rab5 binding additionally required a 30-amino acid region directly adjacent to the FYVE domain. Microinjection of glutathione S-transferase fusion constructs into Cos cells revealed that the FYVE domain alone is insufficient for localization to cellular membranes; the upstream 30-amino acid region required for Rab5 binding must also be present for endosomal binding. The importance of Rab5 in membrane binding of EEA1 is underscored by the finding that the increased expression of wild-type Rab5 increases endosomal binding of EEA1 and decreases its dependence on PtdIns3P, Thus, the levels of Rab5 are rate-limiting for the recruitment of EEA1 to endosome membranes. PtdIns3P may play a role in modulating the Rab5 EEA1 interaction.	Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 373 Plantat St, Worcester, MA 01605 USA.				NIDDK NIH HHS [DK54479] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054479] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burd CG, 1998, SEMIN CELL DEV BIOL, V9, P527, DOI 10.1006/scdb.1998.0255; Callaghan J, 1999, BIOCHEM J, V338, P539, DOI 10.1042/0264-6021:3380539; Chao DS, 1999, J CELL BIOL, V144, P869, DOI 10.1083/jcb.144.5.869; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HANSEN SH, 1995, J BIOL CHEM, V270, P28425; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; Kundra A, 1998, J BIOL CHEM, V273, P3848, DOI 10.1074/jbc.273.7.3848; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Li GP, 1996, BIOCELL, V20, P325; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Reaves BJ, 1996, J CELL SCI, V109, P749; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Sollner TH, 1996, EXPERIENTIA, V52, P1021; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9	30	163	168	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3699	3705		10.1074/jbc.275.5.3699	http://dx.doi.org/10.1074/jbc.275.5.3699			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652369	hybrid			2022-12-27	WOS:000085146500091
J	Tani, M; Okino, N; Mitsutake, S; Tanigawa, T; Izu, H; Ito, M				Tani, M; Okino, N; Mitsutake, S; Tanigawa, T; Izu, H; Ito, M			Purification and characterization of a neutral ceramidase from mouse liver - A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ACID CERAMIDASE; ENZYMATIC-SYNTHESIS; N-DEACYLASE; GLYCOSPHINGOLIPIDS; IDENTIFICATION; BIOSYNTHESIS; CLONING; DISEASE; SKIN	report here a novel ceramidase that was purified more than 150,000-fold from the membrane fraction of mouse liver. The enzyme was a monomeric polypeptide having a molecular mass of 94 kDa and was highly glycosylated with N-glycans, The amino acid sequence of a fragment obtained from the purified enzyme was homologous to those deduced from the genes encoding an alkaline ceramidase of Pseudomonas aeruginosa and a hypotheical protein of the slime mold Dictyostelium discoideum. However, no significant sequence similarities were found in other known functional proteins including acid ceramidases of humans and mice. The enzyme hydrolyzed various N-acylsphingosines but not galactosylceramide, sulfatide, GM1a, or sphingomyelin. The enzyme exhibited the highest activity around pH 7.5 and was thus identified as a type of neutral ceramidase, The apparent K-m and V-max values for C12-4-nitrobenzo-2-oxa-1,3-diazole-ceramide and C16-C-14-ceramide were 22.3 mu M and 29.1 mu mol/min/mg and 72.4 mu M and 3.6 mu mol/ min/mg, respectively. This study also clearly demonstrated that the purified 94-kDa ceramidase catalyzed the condensation of fatty acid to sphingosine to generate ceramide, but did not catalyze acyl-CoA-dependent acyl-transfer reaction.	Kyushu Univ, Dept Biosci & Biotechnol, Dept Bioresource & Bioenvironm Sci, Grad Sch,Higashi Ku, Fukuoka 8128581, Japan; Takara Shuzo Co Ltd, Biotechnol Res Labs, Otsu, Shiga 5202134, Japan	Kyushu University; Takara Holdings Inc.	Ito, M (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Dept Bioresource & Bioenvironm Sci, Grad Sch,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.		Okino, Nozomu/AAY-2635-2021; Mitsutake, Susumu/A-4082-2012; Ito, Makoto/Q-6164-2019; Tanigawa, Tetsuya/J-6131-2019	Tanigawa, Tetsuya/0000-0002-9305-1637; ito, Makoto/0000-0003-3159-7818; Tani, Motohiro/0000-0003-4316-8260				AL BJM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P245, DOI 10.1016/0005-2760(89)90274-9; BENDALL DS, 1960, BIOCHEM J, V74, P444, DOI 10.1042/bj0740444; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; CHEN WW, 1981, ARCH BIOCHEM BIOPHYS, V208, P444, DOI 10.1016/0003-9861(81)90531-2; CORONEOS E, 1995, J BIOL CHEM, V270, P23305, DOI 10.1074/jbc.270.40.23305; GATT S, 1963, J BIOL CHEM, V238, P3131; HANNUN YA, 1993, ADV LIPID RES, V25, P43; HASSLER DF, 1993, ADV LIPID RES, V26, P49; ITO M, 1995, J BIOL CHEM, V270, P24370, DOI 10.1074/jbc.270.41.24370; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CM, 1998, GENOMICS, V50, P267, DOI 10.1006/geno.1998.5334; Li Y.-T., 1972, METHOD ENZYMOL, V28, P702; Mitsutake S, 1998, J BIOCHEM-TOKYO, V123, P859; Mitsutake S, 1997, ANAL BIOCHEM, V247, P52, DOI 10.1006/abio.1997.2022; MOORE GL, 1969, ANAL BIOCHEM, V32, P122, DOI 10.1016/0003-2697(69)90111-0; MORELL P, 1972, J LIPID RES, V13, P203; NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339, DOI 10.1016/0005-2760(69)90192-1; OHSAWA K, 1983, ANAL BIOCHEM, V135, P409, DOI 10.1016/0003-2697(83)90703-0; Okino N, 1998, J BIOL CHEM, V273, P14368, DOI 10.1074/jbc.273.23.14368; Okino N, 1999, J BIOL CHEM, V274, P36616, DOI 10.1074/jbc.274.51.36616; ROSENGREN B, 1987, J NEUROCHEM, V49, P834, DOI 10.1111/j.1471-4159.1987.tb00969.x; SUGITA M, 1975, BIOCHIM BIOPHYS ACTA, V398, P125, DOI 10.1016/0005-2760(75)90176-9; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Tani M, 1998, ANAL BIOCHEM, V263, P183, DOI 10.1006/abio.1998.2781; WANG E, 1991, J BIOL CHEM, V266, P14486; YADA Y, 1995, J BIOL CHEM, V270, P12677, DOI 10.1074/jbc.270.21.12677; YAVIN E, 1969, BIOCHEMISTRY-US, V8, P1692, DOI 10.1021/bi00832a052	29	71	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3462	3468		10.1074/jbc.275.5.3462	http://dx.doi.org/10.1074/jbc.275.5.3462			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652340	hybrid			2022-12-27	WOS:000085146500062
J	Aizencang, GI; Bishop, DF; Forrest, D; Astrin, KH; Desnick, RJ				Aizencang, GI; Bishop, DF; Forrest, D; Astrin, KH; Desnick, RJ			Uroporphyrinogen III synthase - An alternative promoter controls erythroid-specific expression in the murine gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; PORPHOBILINOGEN DEAMINASE GENE; MOUSE ERYTHROLEUKEMIA-CELLS; TRANSCRIPTION FACTOR GATA-1; HUMAN FERROCHELATASE GENE; FULL-LENGTH CDNA; NUCLEOTIDE-SEQUENCE; 5-AMINOLEVULINATE SYNTHASE; COPROPORPHYRINOGEN OXIDASE	Uroporphyrinogen III synthase (URO-synthase, EC 4.2.1.75) is the fourth enzyme of the heme biosynthetic pathway and is the defective enzyme in congenital erythropoietic porphyria. To investigate the erythroid-specific expression of murine URO-synthase, the cDNA and similar to 24-kilobase genomic sequences were isolated and characterized. Three alternative transcripts were identified containing different 5'-untranslated regions (5'-UTRs), but identical coding exons 2B through 10. Transcripts with 5'-UTR exon IA alone or fused to exon 1B were ubiquitously expressed (housekeeping), whereas transcripts with 5'-UTR exon 2A were only present in erythroid cells (erythroid-specific). Analysis of the TATA-less housekeeping promoter upstream of exon 1A revealed binding sites for ubiquitously expressed transcription factors Spl, NF1, AP1, Oct1, and NRF2. The TATA-less erythroid-specific promoter upstream of exon 2A had nine putative GATA1 erythroid enhancer binding sites. Luciferase promoter/reporter constructs transfected into NIH 3T3 and mouse erythroleukemia cells indicated that the housekeeping promoter was active in both cell lines, while the erythroid promoter was active only in erythroid cells. Site-specific mutagenesis of the first GATA1 binding site markedly reduced luciferase activity in K562 cells (<5% of wild type). Thus, housekeeping and erythroid-specific transcripts are expressed from alternative promoters of a single mouse URO-synthase gene.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Desnick, RJ (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, 5th Ave & 100th St, New York, NY 10029 USA.	rjdesnick@msvax.mssm.edu	Bishop, David F./X-4102-2019		NCRR NIH HHS [5 MO1 RR00071] Funding Source: Medline; NIDDK NIH HHS [2 RO1 DK40895, 5 RO1 DK26824] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026824, R01DK040895] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aizencang GI, 1999, AM J HUM GENET, V65, pA280; ALWAN AF, 1989, BIOCHEM J, V264, P397, DOI 10.1042/bj2640397; ASTRIN KH, 1991, HUM GENET, V87, P18, DOI 10.1007/BF01213085; BATTERSBY AR, 1982, J CHEM SOC PERK T 1, P2413, DOI 10.1039/p19820002413; BATTERSBY AR, 1982, J CHEM SOC PERK T 1, P2427, DOI 10.1039/p19820002427; BEAUMONT C, 1989, J BIOL CHEM, V264, P14829; BISHOP DF, 1990, NUCLEIC ACIDS RES, V18, P7187, DOI 10.1093/nar/18.23.7187; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BISHOP TR, 1991, AM J HUM GENET, V49, P425; Bishop TR, 1996, NUCLEIC ACIDS RES, V24, P2511, DOI 10.1093/nar/24.13.2511; BOGORAD L, 1958, J BIOL CHEM, V233, P510; BOULECHFAR S, 1992, HUM GENET, V88, P320, DOI 10.1007/BF00197267; BRAIDOTTI G, 1993, J BIOL CHEM, V268, P1109; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHAPMAN VM, 1994, MAMM GENOME, V5, P741, DOI 10.1007/BF00426087; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; CONBOY JG, 1992, J BIOL CHEM, V267, P18753; DELFAULARUE MH, 1994, HUM MOL GENET, V3, P1325, DOI 10.1093/hmg/3.8.1325; Desnick RJ, 1998, SEMIN LIVER DIS, V18, P77, DOI 10.1055/s-2007-1007143; DIEKS P, 1990, BIOSYNTHESIS HEME CH, P201; Dittmer J, 1997, J BIOL CHEM, V272, P4953, DOI 10.1074/jbc.272.8.4953; DUPRIEZ VJ, 1993, P NATL ACAD SCI USA, V90, P8224, DOI 10.1073/pnas.90.17.8224; Furukawa T, 1997, BIOCHEM MOL BIOL INT, V41, P1161; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; Gong QH, 1996, MOL CELL BIOL, V16, P6055; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; HART GJ, 1985, BIOCHEM J, V232, P151, DOI 10.1042/bj2320151; Hegde SP, 1998, MOL CELL BIOL, V18, P2729, DOI 10.1128/MCB.18.5.2729; Hromas R, 1996, CURR TOP MICROBIOL, V211, P159; JAVAHERY R, 1994, MOL CELL BIOL, V14, P116, DOI 10.1128/MCB.14.1.116; Kappas A., 1995, METABOLIC MOL BASES, V2, P2103; KAYA AH, 1994, GENOMICS, V19, P242, DOI 10.1006/geno.1994.1054; KOHASHI M, 1984, BIOCHEM J, V220, P755, DOI 10.1042/bj2200755; LEVIN EY, 1968, SCIENCE, V161, P907, DOI 10.1126/science.161.3844.907; Lin HH, 1996, CURR TOP MICROBIOL, V211, P79; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Minta JO, 1998, GENE, V208, P17, DOI 10.1016/S0378-1119(97)00632-X; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; MoranJimenez MJ, 1996, AM J HUM GENET, V58, P712; Mu WT, 1999, MOL BRAIN RES, V67, P137, DOI 10.1016/S0169-328X(99)00049-2; PEVNY L, 1995, DEVELOPMENT, V121, P163; PORCHER C, 1995, J BIOL CHEM, V270, P17368, DOI 10.1074/jbc.270.29.17368; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; ROMANA M, 1987, NUCLEIC ACIDS RES, V15, P7343, DOI 10.1093/nar/15.18.7343; ROMEO G, 1970, Biochemical Genetics, V4, P659, DOI 10.1007/BF00486379; ROMEO G, 1969, P NATL ACAD SCI USA, V63, P856, DOI 10.1073/pnas.63.3.856; SHIVDASANI RA, 1995, P NATL ACAD SCI USA, V92, P8690, DOI 10.1073/pnas.92.19.8690; SHOOLINGINJORDAN PM, 1995, J BIOENERG BIOMEMBR, V27, P181, DOI 10.1007/BF02110033; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; SMYTHE E, 1988, BIOCHEM J, V253, P275, DOI 10.1042/bj2530275; Takahashi S, 1998, BLOOD, V92, P3436, DOI 10.1182/blood.V92.9.3436.421k13_3436_3444; TAKETANI S, 1992, EUR J BIOCHEM, V205, P217, DOI 10.1111/j.1432-1033.1992.tb16771.x; TAKETANI S, 1995, GENOMICS, V29, P698, DOI 10.1006/geno.1995.9949; Tanabe A, 1997, BIOCHEM BIOPH RES CO, V233, P729, DOI 10.1006/bbrc.1997.6532; Teerawatanasuk N, 1998, MOL BRAIN RES, V55, P61, DOI 10.1016/S0169-328X(97)00364-1; TSAI SF, 1987, J BIOL CHEM, V262, P1268; TSAI SF, 1988, P NATL ACAD SCI USA, V85, P7049, DOI 10.1073/pnas.85.19.7049; TUGORES A, 1994, J BIOL CHEM, V269, P30789; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARNER CA, 1992, J CLIN INVEST, V89, P693, DOI 10.1172/JCI115637; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; XU WM, 1995, GENOMICS, V26, P556, DOI 10.1016/0888-7543(95)80175-L; XU WM, 1995, J CLIN INVEST, V95, P905, DOI 10.1172/JCI117742; YOO HW, 1993, GENOMICS, V15, P21, DOI 10.1006/geno.1993.1005	67	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2295	2304		10.1074/jbc.275.4.2295	http://dx.doi.org/10.1074/jbc.275.4.2295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644678	hybrid			2022-12-27	WOS:000085128000010
J	Wynn, RM; Song, JL; Chuang, DT				Wynn, RM; Song, JL; Chuang, DT			GroEL/GroES promote dissociation/reassociation cycles of a heterodimeric intermediate during alpha(2)beta(2) protein assembly - Iterative annealing at the quaternary structure level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETOACID DEHYDROGENASE COMPLEX; CHAPERONIN ATPASE CYCLE; CRYSTAL-STRUCTURE; FOLDING INTERMEDIATE; ESCHERICHIA-COLI; GROEL; BINDING; MECHANISM; ALPHA-2-BETA-2; IDENTIFICATION	Whereas the mechanism of GroEL/GroES-mediated protein folding has been extensively studied, the role of these chaperonins in oligomeric protein assembly remains poorly understood. In the present study, we investigated the interaction of the chaperonins with an alpha beta heterodimeric intermediate during the alpha(2)beta(2) assembly of human mitochondrial branched-chain alpha-ketoacid dehydrogenase/decarboxylase (BCKD), Incubation of the recombinant His(6)-tagged BCKD in 400 mM KSCN for 45 min at 23 degrees C caused a complete dissociation of the alpha(2)beta(2) heterotetramers into inactive alpha beta heterodimers. Dilution of the denaturant resulted in a rapid recovery of BCKD independent of the chaperonins GroEL/GroES, Prolonged incubation of BCKD in 400 mM KSCN resulted in the generation of nonproductive or "bad" heterodimers, which were unable to undergo spontaneous reactivation but capable of binding to GroEL to form a stable GroEL-alpha beta complex. incubation of this complex with GroES and Mg-ATP led to the slow reactivation of BCKD with a second-order rate constant k = 480 m(-1) s(-1). mixing experiments with radiolabeled and unlabeled protein substrates provided direct evidence that GroEL/GroES promote dissociation and subunit exchange between bad heterodimers. This was accompanied by the transformation of bad heterodimers to their "good" or productive counterparts. The good heterodimers were capable of spontaneous dimerization to initially form an inactive heterotetrameric species, followed by conversion to active heterotetramers, However, a large fraction of bad heterodimers were regenerated and rebound to GroEL, The cycle was perpetuated until tbe reconstitution of active BCKD was complete. Our data support the thesis that chaperonins GroEL/GroES mediate iterative annealing of nonproductive assembly intermediates at the quaternary structure level. This step is essential for an efficient subsequent higher order oligomerization.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	chuang01@utsw.swmed.edu		Wynn, Richard/0000-0002-1879-2136	NIDDK NIH HHS [DK-26758] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; CHUANG DT, 1995, METABOLIC MOL BASES, P1239; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; DAVIE JR, 1992, J BIOL CHEM, V267, P16601; Fedorov AN, 1997, J MOL BIOL, V268, P712, DOI 10.1006/jmbi.1997.1007; GEORGOPOULOS CP, 1978, P NATL ACAD SCI USA, V75, P131, DOI 10.1073/pnas.75.1.131; Goldberg MS, 1997, P NATL ACAD SCI USA, V94, P1080, DOI 10.1073/pnas.94.4.1080; Grallert H, 1998, J BIOL CHEM, V273, P33305, DOI 10.1074/jbc.273.50.33305; GRAY TE, 1993, J MOL BIOL, V232, P1197, DOI 10.1006/jmbi.1993.1471; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Huang YS, 1999, J BIOL CHEM, V274, P10405, DOI 10.1074/jbc.274.15.10405; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; JAENICKE R, 1981, EUR J BIOCHEM, V114, P525, DOI 10.1111/j.1432-1033.1981.tb05176.x; KOCHAN J, 1983, VIROLOGY, V131, P100, DOI 10.1016/0042-6822(83)90537-8; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LAU KS, 1990, BIOCHIM BIOPHYS ACTA, V1038, P360, DOI 10.1016/0167-4838(90)90249-F; LEBRAS G, 1989, BIOCHEMISTRY-US, V28, P6836, DOI 10.1021/bi00443a009; Li J, 1999, J BIOL CHEM, V274, P10790, DOI 10.1074/jbc.274.16.10790; LILIE H, 1995, P NATL ACAD SCI USA, V92, P8100, DOI 10.1073/pnas.92.18.8100; MacColl R, 1998, BIOCHEMISTRY-US, V37, P417, DOI 10.1021/bi971453s; Mande SC, 1996, SCIENCE, V271, P1655; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; NiebaAxmann SE, 1997, J MOL BIOL, V271, P803, DOI 10.1006/jmbi.1997.1192; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Tanford C., 1961, PHYS CHEM MACROMOLEC, P356; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; WYNN RM, 1992, J BIOL CHEM, V267, P12400; Wynn RM, 1998, J BIOL CHEM, V273, P13110, DOI 10.1074/jbc.273.21.13110; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZAHN R, 1994, NATURE, V368, P261, DOI 10.1038/368261a0; ZHENG XX, 1993, J BIOL CHEM, V268, P7489	40	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2786	2794		10.1074/jbc.275.4.2786	http://dx.doi.org/10.1074/jbc.275.4.2786			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644743	hybrid			2022-12-27	WOS:000085128000075
J	Evanko, DS; Thiyagarajan, MM; Wedegaertner, PB				Evanko, DS; Thiyagarajan, MM; Wedegaertner, PB			Interaction with G beta gamma is required for membrane targeting and palmitoylation of G alpha(s), and G alpha(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-ALPHA-SUBUNIT; GTP-BINDING PROTEIN; PLASMA-MEMBRANE; ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; HORMONE RECEPTOR; PHOSPHOLIPASE-C; FATTY ACYLATION; AMINO-TERMINUS; RAS PROTEINS	Peripheral membrane proteins utilize a variety of mechanisms to attach tightly, and often reversibly, to cellular membranes. The covalent lipid modifications, myristoylation and palmitoylation, are critical for plasma membrane localization of heterotrimeric G protein alpha subunits, For alpha(s) and alpha(q), two subunits that are palmitoylated but not myristoylated, we examined the importance of interacting with the G protein beta gamma dimer for their proper plasma membrane localization and palmitoylation. Conserved alpha subunit N-terminal amino acids predicted to mediate binding to beta gamma were mutated to create a series of beta gamma binding region mutants expressed in HEK293 cells. These alpha(s) and alpha(q) mutants were found in soluble rather than particulate fractions, and they no longer localized to plasma membranes as demonstrated by immunofluorescence microscopy, The mutations also inhibited incorporation of radiolabeled palmitate into the proteins and abrogated their signaling ability. Additional alpha(q) mutants, which contain these mutations but are modified by both myristate and palmitate, retained their localization to plasma membranes and ability to undergo palmitoylation, These findings identify binding to beta gamma as a critical membrane attachment signal for alpha(s) and alpha(q) and as a prerequisite for their palmitoylation, while myristoylation can restore membrane localization and palmitoylation of beta gamma binding-deficient alpha(s) subunits.	Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Inst, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Wedegaertner, PB (corresponding author), Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, 233 S 10th St,839 BLSB, Philadelphia, PA 19107 USA.	p_wedegaertner@lac.jci.tju.edu			NIGMS NIH HHS [GM56444] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM056444, R56GM056444, R01GM056444] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAND L, 1994, J BIOL CHEM, V269, P16701; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; Bhamre S, 1998, J PHARMACOL EXP THER, V286, P1482; Booden MA, 1999, J BIOL CHEM, V274, P1423, DOI 10.1074/jbc.274.3.1423; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Busconi L, 1997, BIOCHEM J, V328, P23, DOI 10.1042/bj3280023; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; DENKER BM, 1992, J BIOL CHEM, V267, P6272; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; FUNG BKK, 1983, J BIOL CHEM, V258, P503; GALBIATI F, 1994, BIOCHEM J, V303, P697, DOI 10.1042/bj3030697; GARCIA PD, 1995, EMBO J, V14, P4460, DOI 10.1002/j.1460-2075.1995.tb00125.x; Gillen KM, 1998, J CELL SCI, V111, P3235; GRAF R, 1992, J BIOL CHEM, V267, P24307; GRASSIE MA, 1994, BIOCHEM J, V302, P913, DOI 10.1042/bj3020913; Grishina G, 1997, J BIOL CHEM, V272, P20619, DOI 10.1074/jbc.272.33.20619; HALLAK H, 1994, J BIOL CHEM, V269, P4571; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hepler JR, 1996, J BIOL CHEM, V271, P496, DOI 10.1074/jbc.271.1.496; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; Huang CF, 1999, P NATL ACAD SCI USA, V96, P412, DOI 10.1073/pnas.96.2.412; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Jones TLZ, 1998, BIOCHEMISTRY-US, V37, P3196, DOI 10.1021/bi972253j; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; Kleuss C, 1997, P NATL ACAD SCI USA, V94, P6116, DOI 10.1073/pnas.94.12.6116; KOEGEL M, 1994, BIOCHEM J, V303, P349; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; MAZZONI MR, 1989, BIOCHEMISTRY-US, V28, P9873, DOI 10.1021/bi00451a047; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Morales J, 1998, MOL BIOL CELL, V9, P1, DOI 10.1091/mbc.9.1.1; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; PARENTI M, 1993, BIOCHEM J, V291, P349, DOI 10.1042/bj2910349; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Schroeder H, 1996, J CELL BIOL, V134, P647, DOI 10.1083/jcb.134.3.647; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; Stanislaus D, 1998, BIOL REPROD, V59, P579, DOI 10.1095/biolreprod59.3.579; Stanislaus D, 1997, MOL ENDOCRINOL, V11, P738, DOI 10.1210/me.11.6.738; STERNWEIS PC, 1986, J BIOL CHEM, V261, P631; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wedegaertner PB, 1998, BIOL SIGNAL RECEPT, V7, P125; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WEDEGAERTNER PB, 1999, CRC METH SIG TRANS, P153; WILSON PT, 1995, J BIOL CHEM, V270, P9667, DOI 10.1074/jbc.270.16.9667; Wise A, 1997, FEBS LETT, V407, P257, DOI 10.1016/S0014-5793(97)00300-1; Wolven A, 1997, MOL BIOL CELL, V8, P1159, DOI 10.1091/mbc.8.6.1159; Zlatkine P, 1997, J CELL SCI, V110, P673	65	95	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1327	1336		10.1074/jbc.275.2.1327	http://dx.doi.org/10.1074/jbc.275.2.1327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625681	hybrid			2022-12-27	WOS:000084836600085
J	Nathanson, L; Gromet-Elhanan, Z				Nathanson, L; Gromet-Elhanan, Z			Mutations in the beta-subunit Thr(159) and Glu(184) of the Rhodospirillum rubrum F0F1 ATP synthase reveal differences in ligands for the coupled Mg2+- and decoupled Ca2+-dependent F0F1 activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; CORE COMPLEX; F1-ATPASE; BINDING; PROTEIN; MUTANTS; PURIFICATION; RESOLUTION; EXTRACTION	In the crystal structure of the mitochondrial F(1)ATPase, the beta-Thr(163) residue was identified as a ligand to Mg2+ and the beta-Glu(188) as directly involved in catalysis. We replaced the equivalent beta-Thr(159) Of the chromatophore F0F1 ATP synthase of Rhodospirillum rubrum with Ser, Ala, or Val and the Glu(184) with Gin or Lys. The mutant beta subunits were isolated and tested for their capacity to assemble into a beta-less chromatophore F0F1 and restore its lost activities. All of them were found to bind into the beta-less enzyme with the same efficiency as the wild type beta subunit, but only the beta-Thr(159) --> Ser mutant restored the activity of the assembled enzyme. These results indicate that both Thr(159) and Glu(184) not required for assembly and that Glu(184) is indeed essential for all the membrane-bound chromatophore F0F1 activities. A detailed comparison between the wild type and the beta-Thr(159), Ser mutant revealed a rather surprising difference. Although this mutant restored the wild type levels and all specific properties of this F0F1 proton-coupled ATP synthesis as well as Mg- and Mn-dependent ATP hydrolysis, it did not restore at all the proton-decoupled CaATPase activity. This clear difference between the ligands for Mg2+ and Mn2+, where threonine can be replaced by serine, and Ca2+, where only threonine is active, suggests that the beta-subunit catalytic site has different conformational states when occupied by Ca2+ as compared with Mg2+ These different states might result in different interactions between the beta and gamma subunits, which are involved in linking F-1 catalysis with F-0 proton-translocation and can thus explain the complete absence of Ca-dependent proton-coupled F0F1 catalytic activity.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Gromet-Elhanan, Z (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		Nathanson, Lubov/ABC-2642-2021	Nathanson, Lubov/0000-0003-1038-9083				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; ANDVALOJC PJ, 1993, BIOCHIM BIOPHYS ACTA, V1143, P51; AVITAL S, 1991, J BIOL CHEM, V266, P7067; AVNI A, 1991, J BIOL CHEM, V266, P7317; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Clayton R. K., 1963, BACTERIAL PHOTOSYNTH, P495; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; Du ZY, 1999, EUR J BIOCHEM, V263, P430, DOI 10.1046/j.1432-1327.1999.00512.x; Du ZY, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL III, P27; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; GERSHONI JM, 1988, METHOD BIOCHEM ANAL, V33, P1; Gromet-Elhanan Z., 1995, ANOXYGENIC PHOTOSYNT, P807; GROMETELHANAN Z, 1989, BIOCHEMISTRY-US, V28, P3645, DOI 10.1021/bi00435a004; GrometElhanan Z, 1995, PHOTOSYNTH RES, V46, P79, DOI 10.1007/BF00020418; GROMETELHANAN Z, 1986, METHOD ENZYMOL, V126, P528; GROMETELHANAN Z, 1984, BIOCHEMISTRY-US, V23, P1022, DOI 10.1021/bi00300a034; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOCHMAN Y, 1976, FEBS LETT, V178, P10; Hu DL, 1998, FEBS LETT, V421, P65, DOI 10.1016/S0014-5793(97)01531-7; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; JENSEN PR, 1992, J BACTERIOL, V174, P7635, DOI 10.1128/JB.174.23.7635-7641.1992; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCARTY RE, 1996, OXYGENIC PHOTOSYNTHE, P439; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MUELLER DM, 1989, J BIOL CHEM, V264, P16552; Nathanson L, 1998, J BIOL CHEM, V273, P10933, DOI 10.1074/jbc.273.18.10933; Nathanson L, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL III, P51; OMOTE H, 1992, J BIOL CHEM, V267, P20571; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; OREN R, 1979, BIOCHIM BIOPHYS ACTA, V548, P106, DOI 10.1016/0005-2728(79)90191-9; PARK MY, 1994, J BIOCHEM-TOKYO, V116, P1139, DOI 10.1093/oxfordjournals.jbchem.a124640; PENEFSKY HS, 1991, ADV ENZYMOL RAMB, V64, P173; PHILOSOPH S, 1977, J BIOL CHEM, V252, P8747; RICHTER ML, 1996, OXYGENIC PHOTOSYNTHE, P453; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sokolov M, 1996, BIOCHEMISTRY-US, V35, P1242, DOI 10.1021/bi9511189; Sokolov M, 1999, J BIOL CHEM, V274, P13824, DOI 10.1074/jbc.274.20.13824; Strotmann H., 1998, MOL BIOL CHLOROPLAST, P477; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; Tucker WC, 2000, J BIOL CHEM, V275, P906, DOI 10.1074/jbc.275.2.906; VIK SB, 1994, J BIOL CHEM, V269, P30364; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WEBSTER GD, 1977, FEBS LETT, V76, P29, DOI 10.1016/0014-5793(77)80114-2	50	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					901	905		10.1074/jbc.275.2.901	http://dx.doi.org/10.1074/jbc.275.2.901			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625625	hybrid			2022-12-27	WOS:000084836600029
J	Ozoline, ON; Fujita, N; Ishihama, A				Ozoline, ON; Fujita, N; Ishihama, A			Transcription activation mediated by the carboxyl-terminal domain of the RNA polymerase alpha-subunit - Multipoint monitoring using a fluorescent probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RECEPTOR PROTEIN; ESCHERICHIA-COLI; FUNCTIONAL MAP; PROMOTER DNA; CONTACT SITE; BINDING; ELEMENT; CRP; IDENTIFICATION; MUTATIONS	Conformational changes within the carboxyl-terminal domain of the Escherichia coli RNA polymerase alpha-subunit (alpha-CTD) upon interaction with the DNA UP element or the transcription factor cAMP receptor protein (CRP) were studied by monitoring the spectral parameters of a fluorescent dye, fluorescein mercuric acetate, conjugated to various positions of alpha-CTD. When fluorescein mercuric acetate was conjugated to Cys located on helix I and the loop between helices III and TV, the spectral changes typical for DNA interaction were observed for the RNA polymerase-promoter binary complex with UP element-dependent rrnBP1 and the ternary complex with the CRP-dependent uxuAB promoter in the presence of cAMP/CRP. Likewise, the chemical nuclease iron-(p-bromoacetamidobenzyl)-EDTA conjugated to Cys-269 or Cys-272 introduced CRP-dependent cleavage of the uxuAB promoter, as in the case of rrnBP1 (Murakami, K., Owens, J. T., Belyaeva, T, A, Meares, C. F., Busby, S. J. W., and Ishihama, A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11274-11278), indicating that CRP rearranges the topology of the DNA contact surface in alpha-CTD. Conformational changes in alpha-CTD were also observed upon formation of a binary complex with the uxuAB (in the absence of CRP) and factor-independent T7D promoters. The spectral changes suggested that helix TV of alpha-CTD approaches the negatively charged phosphate moiety of DNA, In agreement with this prediction, iron-(p-bromoacetamidobenzyl)-EDTA conjugated to Cys-309 induced extensive DNA cleavage upstream from the uxuAB promoter -35 element, We propose that helix IV of alpha-CTD is involved in direct interaction with some promoters.	Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; Russian Acad Sci, Inst Cell Biophys, Pushchino 142292, Moscow Region, Russia	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS	Ishihama, A (corresponding author), Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan.							AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; ATTEY A, 1994, NUCLEIC ACIDS RES, V22, P4375, DOI 10.1093/nar/22.21.4375; BUSBY S, 1995, REGULATION GENE EXPR, P255; Caslake LF, 1997, J BACTERIOL, V179, P1787, DOI 10.1128/jb.179.5.1787-1795.1997; CHEN Y, 1994, SCIENCE, V265, P90, DOI 10.1126/science.8016656; Colland F, 1999, EMBO J, V18, P4049, DOI 10.1093/emboj/18.14.4049; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HEYDUK E, 1993, CELL MOL BIOL RES, V39, P401; HEYDUK T, 1993, NATURE, V364, P548, DOI 10.1038/364548a0; IGARASHI K, 1991, P NATL ACAD SCI USA, V88, P8958, DOI 10.1073/pnas.88.20.8958; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; Ishihama A., 1997, NUCL ACIDS MOL BIOL, V11, P53; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; Masulis I. S., 1998, Molekulyarnaya Biologiya (Moscow), V32, P598; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami K, 1997, P NATL ACAD SCI USA, V94, P1709, DOI 10.1073/pnas.94.5.1709; Murakami K, 1996, EMBO J, V15, P4358, DOI 10.1002/j.1460-2075.1996.tb00809.x; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Ozoline ON, 1999, J BIOMOL STRUCT DYN, V16, P825, DOI 10.1080/07391102.1999.10508295; Ozoline ON, 1998, EUR J BIOCHEM, V253, P371, DOI 10.1046/j.1432-1327.1998.2530371.x; Ozoline ON, 1997, NUCLEIC ACIDS RES, V25, P4703, DOI 10.1093/nar/25.23.4703; Ozoline ON, 1998, PROTEINS, V30, P183; OZOLINE ON, 1991, BIOCHIM BIOPHYS ACTA, V1076, P387, DOI 10.1016/0167-4838(91)90481-E; OZOLINE ON, 1993, BIOCHIM BIOPHYS ACTA, V1172, P251, DOI 10.1016/0167-4781(93)90211-U; PINKNEY M, 1988, BIOCHEM J, V250, P897, DOI 10.1042/bj2500897; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; USHIDA C, 1990, NUCLEIC ACIDS RES, V18, P6325, DOI 10.1093/nar/18.21.6325; Williams SM, 1997, NUCLEIC ACIDS RES, V25, P4028, DOI 10.1093/nar/25.20.4028; ZOU C, 1992, MOL MICROBIOL, V6, P2599, DOI 10.1111/j.1365-2958.1992.tb01437.x	37	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1119	1127		10.1074/jbc.275.2.1119	http://dx.doi.org/10.1074/jbc.275.2.1119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625654	hybrid			2022-12-27	WOS:000084836600058
J	Ray, R; Chen, G; Vande Velde, C; Cizeau, J; Park, JH; Reed, JC; Gietz, RD; Greenberg, AH				Ray, R; Chen, G; Vande Velde, C; Cizeau, J; Park, JH; Reed, JC; Gietz, RD; Greenberg, AH			BNIP3 heterodimerizes with Bcl-2/Bcl-X-L and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL-PROMOTING PROTEINS; YEAST 2-HYBRID SYSTEM; ENDOPLASMIC-RETICULUM; C-ELEGANS; CAENORHABDITIS-ELEGANS; ACTIVATES APOPTOSIS; FAMILY PROTEINS; CYTOCHROME-C; X-L; INTERACTING PROTEIN	BNIP3 (formerly NIP3) is a pro-apoptotic, mitochondrial protein classified in the Bcl-2 family based on limited sequence homology to the Bcl-2 homology 3 (BH3) domain and COOH-terminal transmembrane (TM) domain. BNIP3 expressed in yeast and mammalian cells interacts with survival promoting proteins Bcl-2, Bcl-X-L, and CED-9. Typically, the BH3 domain of pro-apoptotic Bcl-2 homologues mediates Bcl-2/Bcl-X-L heterodimerization and confers pro-apoptotic activity. Deletion mapping of BNIP3 excluded its BH3-like domain and identified the NH, terminus (residues 1-49) and TM domain as critical for Bcl-2 heterodimerization, and either region was sufficient for Bcl-X-L interaction. Additionally, the removal of the BH3-like domain in BNIP3 did not diminish its killing activity. The TM domain of BNIP3 is critical for homodimerization, pro-apoptotic function, and mitochondrial targeting. Several TM domain mutants were found to disrupt SDS-resistant BNIP3 homodimerization but did not interfere with its killing activity or mitochondrial localization. Substitution of the BNIP3 TM domain with that of cytochrome b(5) directed protein expression to nonmitochondrial sites and still promoted apoptosis and heterodimerization with Bcl-2 and Bcl-X-L. We propose that BNIP3 represents a subfamily of Bcl-2-related proteins that functions without a typical BH3 domain to regulate apoptosis from both mitochondrial and nonmitochondrial sites by selective Bcl-2/Bcl-X-L interactions.	Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; Kyung Hee Univ, Coll Med, Dept Pathol, Seoul 130701, South Korea; Burnham Inst, La Jolla, CA 92037 USA; Univ Manitoba, Fac Med, Dept Biochem & Med Genet, Winnipeg, MB R3E 0W3, Canada	University of Manitoba; Kyung Hee University; Sanford Burnham Prebys Medical Discovery Institute; University of Manitoba	Greenberg, AH (corresponding author), Univ Manitoba, Manitoba Inst Cell Biol, 100 Olivia St, Winnipeg, MB R3E 0V9, Canada.		Vande Velde, Christine/F-2721-2016; Velde, Christine Vande/AAB-8828-2020	Vande Velde, Christine/0000-0001-5926-1529; 				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; AKAO Y, 1994, CANCER RES, V54, P2468; ALNEMRI ES, 1992, P NATL ACAD SCI USA, V89, P7295, DOI 10.1073/pnas.89.16.7295; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; BORNER C, 1994, J CELL BIOL, V126, P1059, DOI 10.1083/jcb.126.4.1059; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; BOYD JM, 1995, ONCOGENE, V11, P1921; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; DIEFFENBACH CW, 1995, PCR PRIMER LAB MANUA, P603; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Elangovan B, 1997, J BIOL CHEM, V272, P24494, DOI 10.1074/jbc.272.39.24494; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Gibson L, 1996, ONCOGENE, V13, P665; Gietz RD, 1997, MOL CELL BIOCHEM, V172, P67, DOI 10.1023/A:1006859319926; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HANADA M, 1995, J BIOL CHEM, V270, P11962, DOI 10.1074/jbc.270.20.11962; He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219; Hegde R, 1998, J BIOL CHEM, V273, P7783, DOI 10.1074/jbc.273.14.7783; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HORVITZ HR, 1994, COLD SPRING HARB SYM, V59, P377, DOI 10.1101/SQB.1994.059.01.042; Hsu SY, 1998, J BIOL CHEM, V273, P30139, DOI 10.1074/jbc.273.46.30139; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P8705, DOI 10.1074/jbc.273.15.8705; Inohara N, 1998, J BIOL CHEM, V273, P32479, DOI 10.1074/jbc.273.49.32479; JANIAK F, 1994, J BIOL CHEM, V269, P9842; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kuo TH, 1998, ONCOGENE, V17, P1903, DOI 10.1038/sj.onc.1202110; Lee ST, 1999, ONCOGENE, V18, P3520, DOI 10.1038/sj.onc.1202716; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Matsushima M, 1998, GENE CHROMOSOME CANC, V21, P230, DOI 10.1002/(SICI)1098-2264(199803)21:3<230::AID-GCC7>3.0.CO;2-0; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; MITOMA JY, 1992, EMBO J, V11, P4197, DOI 10.1002/j.1460-2075.1992.tb05513.x; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Ng FWH, 1998, J BIOL CHEM, V273, P3140, DOI 10.1074/jbc.273.6.3140; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; NGUYEN M, 1994, J BIOL CHEM, V269, P16521; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ohi N, 1999, CELL DEATH DIFFER, V6, P314, DOI 10.1038/sj.cdd.4400493; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reed J C, 1997, Adv Pharmacol, V41, P501, DOI 10.1016/S1054-3589(08)61070-4; Reed JC, 1996, ADV EXP MED BIOL, V406, P99; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; SHIBASAKI F, 1995, J CELL BIOL, V131, P735, DOI 10.1083/jcb.131.3.735; Simonian PL, 1996, J BIOL CHEM, V271, P22764, DOI 10.1074/jbc.271.37.22764; SOLTYS BJ, 1992, BIOCHEM CELL BIOL, V70, P1174, DOI 10.1139/o92-163; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Yasuda M, 1999, CANCER RES, V59, P533; Yasuda M, 1998, ONCOGENE, V17, P2525, DOI 10.1038/sj.onc.1202467; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Zamzami N, 1998, ONCOGENE, V16, P2265, DOI 10.1038/sj.onc.1201989; Zha HB, 1997, J BIOL CHEM, V272, P31482, DOI 10.1074/jbc.272.50.31482; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	89	275	306	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1439	1448		10.1074/jbc.275.2.1439	http://dx.doi.org/10.1074/jbc.275.2.1439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625696	hybrid			2022-12-27	WOS:000084836600100
J	Shen, Y; Lyons, P; Cooley, M; Davidson, D; Veillette, A; Salgia, R; Griffin, JD; Schaller, MD				Shen, Y; Lyons, P; Cooley, M; Davidson, D; Veillette, A; Salgia, R; Griffin, JD; Schaller, MD			The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CELL-MIGRATION; PTP-PEST; LIM DOMAIN; SH3 DOMAIN; IDENTIFICATION; INHIBITION; P130(CAS); BINDING; SRC	The noncatalytic domain of protein-tyrosine phosphatase (PTP)-PEST contains a binding site for the focal adhesion-associated protein paxillin. This binding site has been narrowed to a 52-residue sequence that is composed of two nonoverlapping, weak paxillin binding sites. The PTP-PEST binding site on paxillin has been mapped to the two carboxyl-terminal LIM (lin11, isl-1, and mec-3) domains, Transient expression of PTP-PEST reduced tyrosine phosphorylation of p130(cas), as anticipated. A PTP-PEST mutant defective for binding p130(cas) does not cause a reduction in its tyrosine phosphorylation in vivo, Expression of PTP-PEST also caused a reduction of phosphotyrosine on paxillin. Expression of mutants of PTP-PEST with deletions in the paxillin-binding site did not associate with paxillin in vivo and failed to cause a reduction in the phosphotyrosine content of paxillin, These results demonstrate that paxillin can serve as a PTP-PEST substrate in vivo and support the model that a noncatalytic domain interaction recruits paxillin to PTP-PEST to facilitate its dephosphorylation.	Univ N Carolina, Dept Cell Biol & Anat, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada; Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; McGill University; Harvard University; Dana-Farber Cancer Institute	Schaller, MD (corresponding author), Univ N Carolina, Dept Cell Biol & Anat, Taylor Hall CB 7090, Chapel Hill, NC 27599 USA.			Cooley, Marion A./0000-0002-4286-745X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057943, R29GM053666] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57943, GM53666] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Cary LA, 1996, J CELL SCI, V109, P1787; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; GUTHRIE C, 1991, GUIDE YEAST GENETICS, P186; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Lipsky BP, 1998, J BIOL CHEM, V273, P11709, DOI 10.1074/jbc.273.19.11709; Liu F, 1998, CURR BIOL, V8, P173, DOI 10.1016/S0960-9822(98)70066-1; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Oh ES, 1999, MOL CELL BIOL, V19, P3205; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tamura M, 1999, CANCER RES, V59, P442; Thomas SM, 1999, J CELL SCI, V112, P181; TURNER CE, 1994, J CELL SCI, V107, P1583; Wu RY, 1996, J BIOL CHEM, V271, P15934, DOI 10.1074/jbc.271.27.15934; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997	40	62	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1405	1413		10.1074/jbc.275.2.1405	http://dx.doi.org/10.1074/jbc.275.2.1405			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625692	hybrid, Green Published			2022-12-27	WOS:000084836600096
J	Cruz, JC; Sugii, S; Yu, CJ; Chang, TY				Cruz, JC; Sugii, S; Yu, CJ; Chang, TY			Role of Niemann-Pick type C1 protein in intracellular trafficking of low density lipoprotein-derived cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CULTURED FIBROBLASTS; TRANSPORT; DISEASE; PATHWAY; LDL; HOMEOSTASIS; LYSOSOMES	Niemann-Pick type C (NPC) is a disease that affects intracellular cholesterol-trafficking pathways. By cloning the hamster ortholog of NPC1, we identified the molecular lesions in two independently isolated Chinese hamster ovary cell mutants, CT60 and CT43, Both mutants lead to premature translational terminations of the NPC1 protein. Transfecting hamster NPC1 cDNA complemented the defects of the mutants, Investigation of the CT mutants, their parental cells, and an NPC1-stable transfectant allow us to present evidence that NPC1 is involved in a post-plasma membrane cholesterol-trafficking pathway, We found that the initial movement of low density lipoprotein (LDL)-derived cholesterol to the plasma membrane (PM) did not require NPC1. After reaching the PM and subsequent internalization, however, cholesterol trafficking back to the PM did involve NPC1. Both LDL-derived cholesterol and cholesterol originating from the PM accumulated in a dense, intracellular compartment in the CT mutants. Cholesterol movement from this compartment to the PM or endoplasmic reticulum was defective in the CT mutants, Our results functionally distinguish the dense, intracellular compartment from the early endocytic hydrolytic organelle and imply that NPC1 is involved in sorting cholesterol from the intracellular compartment back to the PM or to the endoplasmic reticulum.	Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Chang, TY (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.		Yu, Chunjiang/E-9419-2012	Chang, Ta-Yuan/0000-0002-3249-0468; Sugii, Shigeki/0000-0002-2537-9534	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036709, R01HL036709] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36709] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRASAEMLE DL, 1990, J LIPID RES, V31, P103; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; CHANG TY, 1980, J BIOL CHEM, V255, P7787; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Christian AE, 1997, J LIPID RES, V38, P2264; COXEY RA, 1993, J LIPID RES, V34, P1165; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Gu JZ, 1997, P NATL ACAD SCI USA, V94, P7378, DOI 10.1073/pnas.94.14.7378; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; JOHNSON WJ, 1990, J BIOL CHEM, V265, P5546; Khelef N, 1998, J BIOL CHEM, V273, P11218, DOI 10.1074/jbc.273.18.11218; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; KUMAGAI H, 1995, J BIOL CHEM, V270, P19107, DOI 10.1074/jbc.270.32.19107; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; LISCUM L, 1989, J CELL BIOL, V108, P1625, DOI 10.1083/jcb.108.5.1625; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Morris JA, 1999, BIOCHEM BIOPH RES CO, V261, P493, DOI 10.1006/bbrc.1999.1070; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; SLISKOVIC DR, 1991, TRENDS PHARMACOL SCI, V12, P194, DOI 10.1016/0165-6147(91)90546-5; SPILLANE DM, 1995, BBA-LIPID LIPID MET, V1254, P283, DOI 10.1016/0005-2760(94)00190-A; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; Watari H, 1999, P NATL ACAD SCI USA, V96, P805, DOI 10.1073/pnas.96.3.805; Watari H, 1999, J BIOL CHEM, V274, P21861, DOI 10.1074/jbc.274.31.21861; Yano T, 1996, P JPN ACAD B-PHYS, V72, P214, DOI 10.2183/pjab.72.214	36	149	154	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4013	4021		10.1074/jbc.275.6.4013	http://dx.doi.org/10.1074/jbc.275.6.4013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660558	hybrid			2022-12-27	WOS:000085288800042
J	Di Venere, A; Rossi, A; De Matteis, F; Rosato, N; Agro, AF; Mei, G				Di Venere, A; Rossi, A; De Matteis, F; Rosato, N; Agro, AF; Mei, G			Opposite effects of Ca2+ and GTP binding on tissue transglutaminase tertiary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLTEN GLOBULE STATE; CROSS-LINKING ENZYMES; ASCORBATE OXIDASE; PROTEINS; FLUORESCENCE; PRESSURE; INTERMEDIATE; IDENTIFICATION; RESOLUTION; COMPLEXES	Tissue transglutaminase (tTG) belongs to a class of enzymes that catalyze a cross-linking reaction between proteins or peptides, The protein activity is known to be finely tuned by Ca2+ and GTP binding. In this study we report the effects of these ligands on the enzyme structure, as revealed by circular dichroism, and steady-state and dynamic fluorescence measurements, We have found that calcium and GTP induced opposite conformational changes at the level of the protein tertiary structure, In particular the metal ions were responsible for a small widening of the protein molecule, as indicated by anisotropy decay measurements and by the binding of a hydrophobic probe such as 1-anilino-8-naphthalenesulfonic acid (ANS), Unlike Ca2+, the nucleotide binding increased the protein dynamics, reducing its rotational correlation lifetime from 32 to 25 ns, preventing also the binding of ANS into the protein matrix. Unfolding of tTG by guanidinium hydrochloride yielded a three-state denaturation mechanism, involving an intermediate species with the characteristics of the so-called "molten globule" state. The effect of GTP binding (but not that of Ca2+) had an important consequence on the stability of tissue transglutaminase, increasing the free energy change from the native to the intermediate species by at least approximate to 0.7 kcal/mol. Also a greater stability of tTG to high hydrostatic pressure was obtained in presence of GTP, These findings suggest that the molecular mechanism by which tTG activity is inhibited by GTP is essentially due to a protein conformational change which, decreasing the accessibility of the protein matrix to the solvent, renders more difficult the exposure of the active site.	Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; Univ Roma Tor Vergata, INFM, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; Osped San Giovanni Calibita Fatebenefratelli, AFaR, CRCCS, Div Neurol, I-00100 Rome, Italy	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Rome Tor Vergata; University of Rome Tor Vergata	Mei, G (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Via Tor Vergata 135, I-00133 Rome, Italy.		De Matteis, Fabio/ABG-1923-2020	De Matteis, Fabio/0000-0001-7860-9754; Di Venere, Almerinda/0000-0002-9493-0270				ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; ACHYUTHAN KE, 1989, MOL CELL BIOCHEM, V85, P57; AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; BEECHEM JM, 1988, P SPIE INT SOC OPT E, V909, P70; BERGAMINI CM, 1988, FEBS LETT, V239, P255, DOI 10.1016/0014-5793(88)80928-1; BERGAMINI CM, 1993, BIOCHEM J, V291, P37, DOI 10.1042/bj2910037; Bismuto E, 1999, PROTEINS, V35, P163, DOI 10.1002/(SICI)1097-0134(19990501)35:2<163::AID-PROT3>3.0.CO;2-8; Bismuto E, 1997, EUR J BIOCHEM, V244, P53, DOI 10.1111/j.1432-1033.1997.00053.x; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P459; CIONI P, 1994, J MOL BIOL, V242, P291, DOI 10.1006/jmbi.1994.1579; Cymes GD, 1996, PROTEIN SCI, V5, P2074, DOI 10.1002/pro.5560051013; Di Venere A, 1998, EUR J BIOCHEM, V257, P337, DOI 10.1046/j.1432-1327.1998.2570337.x; FOLK JE, 1967, J BIOL CHEM, V242, P1838; FOLK JE, 1967, J BIOL CHEM, V242, P2615; GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; GROSS M, 1973, J BIOL CHEM, V248, P1301; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; JOHNSON WC, 1996, CIRCULAR DICHROISM C, P438; KIM SY, 1994, J BIOL CHEM, V269, P27979; Kungl AJ, 1998, BIOCHEMISTRY-US, V37, P2778, DOI 10.1021/bi971654w; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776; Lai TS, 1997, J BIOL CHEM, V272, P16295, DOI 10.1074/jbc.272.26.16295; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P156; Mei G, 1997, BIOCHEMISTRY-US, V36, P10917, DOI 10.1021/bi970614p; Mei G, 1999, EUR J BIOCHEM, V265, P619, DOI 10.1046/j.1432-1327.1999.00751.x; Melino G, 1998, FEBS LETT, V430, P59, DOI 10.1016/S0014-5793(98)00521-3; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; NAKANISHI K, 1991, EUR J BIOCHEM, V202, P15, DOI 10.1111/j.1432-1033.1991.tb16338.x; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B; Strickland E H, 1974, CRC Crit Rev Biochem, V2, P113, DOI 10.3109/10409237409105445; TANFANI F, 1993, EUR J BIOCHEM, V218, P499, DOI 10.1111/j.1432-1033.1993.tb18402.x; Wang CQ, 1998, BIOCHEMISTRY-US, V37, P8457, DOI 10.1021/bi9723010; WARE WR, 1992, PHOTOCHEMISTRY ORG C, P563; WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang YN, 1996, J BIOL CHEM, V271, P8015, DOI 10.1074/jbc.271.14.8015; [No title captured]	44	68	70	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3915	3921		10.1074/jbc.275.6.3915	http://dx.doi.org/10.1074/jbc.275.6.3915			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660544	hybrid			2022-12-27	WOS:000085288800028
J	Tzeng, CM; Kornberg, A				Tzeng, CM; Kornberg, A			The multiple activities of polyphosphate kinase of Escherichia coli and their subunit structure determined by radiation target analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; COMPLETE GENOME SEQUENCE; PROPIONIBACTERIUM-SHERMANII; MYCOBACTERIUM-TUBERCULOSIS; INORGANIC POLYPHOSPHATE; GENE; GLUCOKINASE; PPK; PURIFICATION; MECHANISM	Polyphosphate kinase (PPK), the principal enzyme required for the synthesis of inorganic polyphosphate (polyP) from ATP, also exhibits other enzymatic activities, which differ significantly in their biochemical optima and responses to chemical agents. These several activities include: polyp synthesis (forward reaction), nATP --> polyP(n) + nADP (Equation 1); ATP synthesis from polyP (reverse reaction), ADP + polyp(n) --> ATP + polyp(n - 1) (Equation 2); general nucleoside-diphosphate kinase, GDP + polyP(n) --> GTP + polyP(n - 1) (Equation 3); linear guanosine 5'-tetraphosphate (ppppG) synthesis, GDP + polyP(n) --> ppppG + polyP(n - 2) (Equation 4); and autophosphorylation, PPK + ATP --> PPK-P + ADP (Equation 5), The Mg2+ optima are 5, 2, 1, and 0.2 mM, respectively, for the activities in Equations I, 2, 3, and 4. inorganic pyrophosphate inhibits the activities in Equations 1 and 3 but stimulates that in Equation 4, The kinetics of the activities in Equations 1, 2, and 3 are highly processive, whereas the transfer of a pyrophosphoryl group from polyP to GDP (Equation 4) is distributive and demonstrates a rapid equilibrium, random Bi-Bi catalytic mechanism, Radiation target analysis revealed that the principal functional unit of the homotetrameric PPK is a dimer, Exceptions are a trimer for the synthesis of ppppG (Equation 4) and a tetrameric state for the autophosphorylation of PPK (Equation 5) at low ATP concentrations. Thus, the diverse functions of this enzyme involve different subunit organizations and conformations, The highly conserved homology of PPK among 18 microorganisms was used to determine important residues and conserved regions by alanine substitution, by site-directed mutagenesis, and by deletion mutagenesis, Of 46 single-site mutants, seven exhibit none of the five enzymatic activities; in one mutant, ATP synthesis from polyp is reduced relative to GTP synthesis. Among deletion mutants, some lost all five PPK activities, but others retained partial activity for some reactions but not for others.	Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Kornberg, A (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	akornber@cmgm.stanford.edu			NIGMS NIH HHS [GM07581-38] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM007581, R37GM007581] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN KH, 1990, J BIOL CHEM, V265, P11734; AKIYAMA M, 1992, J BIOL CHEM, V267, P22556; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Cashel M, 1987, ESCHERICHIA COLI SAL, P1410; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DELAROSA A, 1995, BIOESSAYS, V17, P53, DOI 10.1002/bies.950170111; DIAZ MG, 1989, BIOCH INT, V19, P1253; Geissdorfer W, 1998, APPL ENVIRON MICROB, V64, P896; Hsieh PC, 1996, BIOCHEMISTRY-US, V35, P9772, DOI 10.1021/bi9528659; IGNARRO LJ, 1978, BIOCHIM BIOPHYS ACTA, V541, P170, DOI 10.1016/0304-4165(78)90390-2; Ishige K, 1998, DNA Res, V5, P157, DOI 10.1093/dnares/5.3.157; Kaneko T, 1996, DNA Res, V3, P109; KATO J, 1993, GENE, V137, P237, DOI 10.1016/0378-1119(93)90013-S; KEMPNER ES, 1993, TRENDS BIOCHEM SCI, V18, P236, DOI 10.1016/0968-0004(93)90169-N; KULAEV IS, 1979, BIOCH INORGANIC POLY, P11; Kulakovskaya TV, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1051; Kumble KD, 1996, P NATL ACAD SCI USA, V93, P14391, DOI 10.1073/pnas.93.25.14391; Kuroda A, 1997, P NATL ACAD SCI USA, V94, P439, DOI 10.1073/pnas.94.2.439; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lu Q, 1996, P NATL ACAD SCI USA, V93, P5720, DOI 10.1073/pnas.93.12.5720; LU Q, 1995, J MOL BIOL, V254, P337, DOI 10.1006/jmbi.1995.0620; PEPIN CA, 1986, J BIOL CHEM, V261, P4476; PHILLIPS NFB, 1993, ARCH BIOCHEM BIOPHYS, V300, P309, DOI 10.1006/abbi.1993.1043; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; ROBINSON NA, 1986, J BIOL CHEM, V261, P4481; ROBINSON NA, 1987, J BIOL CHEM, V262, P5216; SAEKI T, 1975, J ANTIBIOT, V28, P974, DOI 10.7164/antibiotics.28.974; SEGEL IH, 1975, ENZYME KINETICS, P506; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; TINSLEY CR, 1993, INFECT IMMUN, V61, P3703, DOI 10.1128/IAI.61.9.3703-3710.1993; TINSLEY CR, 1995, INFECT IMMUN, V63, P1624, DOI 10.1128/IAI.63.5.1624-1630.1995; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Tzeng CM, 1998, MOL MICROBIOL, V29, P381, DOI 10.1046/j.1365-2958.1998.00887.x; VOELZ H, 1966, ARCH MIKROBIOL, V53, P371, DOI 10.1007/BF00409874	37	39	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3977	3983		10.1074/jbc.275.6.3977	http://dx.doi.org/10.1074/jbc.275.6.3977			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660553	hybrid			2022-12-27	WOS:000085288800037
J	Fleury, F; Sukhanova, A; Ianoul, A; Devy, J; Kudelina, I; Duval, O; Alix, AJP; Jardillier, JC; Nabiev, I				Fleury, F; Sukhanova, A; Ianoul, A; Devy, J; Kudelina, I; Duval, O; Alix, AJP; Jardillier, JC; Nabiev, I			Molecular determinants of site-specific inhibition of human DNA topoisomerase I by fagaronine and ethoxidine - Relation to DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTILEUKEMIC ALKALOID FAGARONINE; CIRCULAR-DICHROISM; NUCLEIC-ACID; DERIVATIVES; MECHANISM; CELLS; SALTS	DNA topoisomerase (top) I inhibition activity of the natural alkaloid fagaronine (NSC157995) and its new synthetic derivative ethoxidine (12-ethoxy-benzo[c] phenanthridine) has beers correlated with their molecular interactions and sequence specificity within the DNA complexes. Flow linear dichroism shows that ethoxidine exhibits the same inhibition of DNA relaxation as fagaronine at the 10-fold lower concentration. The patterns of DNA cleavage by top I show linear enhancement of CPT-dependent sites at the 0.016-50 mu M concentrations of fagaronine, whereas ethoxidine suppress both top I-specific and CPT-dependent sites. Suppression of top I-mediated cleavage by ethoxidine is found to be specific for the sites, including strand cut between A and T, Fagaronine and ethoxidine are DNA major groove intercalators. Ethoxidine intercalates DNA in A-T sequences and its 12-ethoxy-moiety (absent in fagaronine) extends into the DNA minor groove. These findings may explain specificity of suppression by ethoxidine of the strong top I cleavage sites with the A(+1), T(-l) immediately adjacent to the strand cut. Fagaronine does not show any sequence specificity of DNA intercalation, but its highly electronegative oxygen of hydroxy group (absent in ethoxidine) is shown to be an acceptor of the hydrogen bond with the NH, group of G base of DNA. Ability of fagaronine to stabilize top I-mediated ternary complex is proposed to be determined by interaction of its hydroxy group with the guanine at position (+1) of the DNA cleavage site and of quaternary nitrogen interaction with top I, The model proposed provides a guidance for screening new top I-targeted drugs in terms of identification of molecular determinants responsible for their top I inhibition effects.	Univ Reims, Inst Fed Rech 53 Biomol, UFR Pharm, F-51096 Reims, France	Universite de Reims Champagne-Ardenne	Nabiev, I (corresponding author), Univ Reims, Inst Fed Rech 53 Biomol, UFR Pharm, EA2063,51 Rue Cognacq Jay, F-51096 Reims, France.		ianoul, anatoli/H-8918-2013; Sukhanova, Alyona/P-6540-2014; Nabiev, Igor/A-5077-2014; ianoul, anatoli/C-1247-2015	Sukhanova, Alyona/0000-0003-2796-7898; Nabiev, Igor/0000-0002-8391-040X; 				Bailly Christian, 1992, Journal of Molecular Recognition, V5, P155, DOI 10.1002/jmr.300050406; BARRET Y, 1992, PHYTOTHER RES, V6, P59, DOI 10.1002/ptr.2650060202; Bronstein IB, 1999, ANTICANCER RES, V19, P317; CAPRANICO G, 1994, J MOL BIOL, V235, P1218, DOI 10.1006/jmbi.1994.1075; COMOE L, 1987, LEUKEMIA RES, V11, P445, DOI 10.1016/0145-2126(87)90076-2; COMOE L, 1988, LEUKEMIA RES, V12, P667, DOI 10.1016/0145-2126(88)90101-4; DOSTAL J, 1990, COLLECT CZECH CHEM C, V55, P2841; DOUROS J, 1981, RECENT RES CANCER, V76, P153; FANG SD, 1993, J ORG CHEM, V58, P5025, DOI 10.1021/jo00071a001; Fleury F, 1998, BIOCHEMISTRY-US, V37, P14630, DOI 10.1021/bi9806495; FLEURY F, 1999, P AACR C MOL DET SEN, P12; Ianoul A, 1999, J PHYS CHEM B, V103, P2008, DOI 10.1021/jp984291y; JANIN YL, 1993, J MED CHEM, V36, P3686, DOI 10.1021/jm00075a025; Kerry MA, 1998, J PHARM PHARMACOL, V50, P1307, DOI 10.1111/j.2042-7158.1998.tb03350.x; LARSEN AK, 1993, BIOCHEM PHARMACOL, V46, P1403, DOI 10.1016/0006-2952(93)90105-6; Mackay SP, 1998, ANTI-CANCER DRUG DES, V13, P797; MATSUOKA Y, 1982, BIOPOLYMERS, V21, P2433, DOI 10.1002/bip.360211208; MESSMER WM, 1972, J PHARM SCI-US, V61, P1858, DOI 10.1002/jps.2600611145; MONNOT M, 1992, EUR J BIOCHEM, V204, P1035, DOI 10.1111/j.1432-1033.1992.tb16725.x; Murrell JN, 1963, THEORY ELECT SPECTRA; NABIEV I, 1994, BIOCHEMISTRY-US, V33, P9013, DOI 10.1021/bi00196a020; NORDEN B, 1992, Q REV BIOPHYS, V25, P151; PEZUTTO JM, 1983, CHEM-BIOL INTERACT, V43, P323; Pilch DS, 1997, P NATL ACAD SCI USA, V94, P13565, DOI 10.1073/pnas.94.25.13565; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; RIOU GF, 1978, BIOCHIMIE, V60, P365, DOI 10.1016/S0300-9084(78)80670-1; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIPPER PE, 1980, CHEM PHYS LETT, V70, P17, DOI 10.1016/0009-2614(80)80051-0; SETHI ML, 1984, J MED CHEM, V27, P544; SETHI VS, 1976, CANCER RES, V36, P2390; SETHI VS, 1975, BIOCHEM BIOPH RES CO, V63, P1070; Sukhanova A, 1998, BIOCHEM MOL BIOL INT, V44, P997; TORRES CAC, 1986, BIOCHEM PHARMACOL, V35, P679; WANG LK, 1993, CHEM RES TOXICOL, V6, P813, DOI 10.1021/tx00036a010; WELLS R D, 1970, Journal of Molecular Biology, V54, P465, DOI 10.1016/0022-2836(70)90121-X; ZEECHENG RK, 1975, J MED CHEM, V18, P66, DOI 10.1021/jm00235a015	36	56	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3501	3509		10.1074/jbc.275.5.3501	http://dx.doi.org/10.1074/jbc.275.5.3501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652345	Green Published, hybrid			2022-12-27	WOS:000085146500067
J	Ogasawara, M; Kim, SC; Adamik, R; Togawa, A; Ferrans, VJ; Takeda, K; Kirby, M; Moss, J; Vaughan, M				Ogasawara, M; Kim, SC; Adamik, R; Togawa, A; Ferrans, VJ; Takeda, K; Kirby, M; Moss, J; Vaughan, M			Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; SEC7 DOMAIN; PHOSPHOLIPASE-D; CRYSTAL-STRUCTURE; BOVINE BRAIN; PH DOMAIN; ARF; YEAST; CELL	Activation of ADP-ribosylation factors (ARFs), similar to 20-kDa GTPases that are inactive in the GDP-bound form, depends on guanine nucleotide-exchange proteins (GEPs) to accelerate GTP binding, A novel ARF GEP, designated cytohesin-4, was cloned from a human brain cDNA library. Deduced amino acid sequence of the 47-kDa protein contains the same structural components present in cytohesin -1, -2, and -3, including an similar to 200-amino acid Sec7 domain with an similar to 100-residue pleckstrin homology domain near the C terminus. The Sec7 domain sequence is 77% identical to those of other cytohesins. Structures of the cytohesin-4 and cytohesin-1 genes were remarkably similar, except for an extra 3-base pair (GAG) exon present in cytohesin-1. Two mRNAs with and without the 3-base pair sequence were found in brain in different ratios for cytohesin-1, -2, and -3 but not cytohesin-4, Recombinant cytohesin-4 stimulated guanosine 5'-3-O-(thio)triphosphate binding by human ARF1 and ARF5 but not ARF6. Like other cytohesins and unlike the similar to 200-kDa ARP GEPs, it was not inhibited by brefeldin A A cytohesin-4 mRNA of similar to 3.7 kilobases, abundant in leukocytes, was not detected in most tissues. Among separated populations of blood cells, similar to 90% of CD33(+) (monocytes), 80% of CD2(+) (NK/T), and 10-20% of CD19(+) (B) cells contained cytohesin-4 mRNA by in situ hybridization, Thus, in gene structure and brefeldin A-insensitive GEP activity, cytohesin-4 resembles other cytohesins, but its tissue distribution differs considerably, consistent with a different specific function.	NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Pathol Sect, NIH, Bethesda, MD 20892 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ogasawara, M (corresponding author), NHLBI, Pulm Crit Care Med Branch, NIH, 10 Ctr Dr,MSC 1434,Bldg 10,Rm 5N307, Bethesda, MD 20892 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000627, ZIAHL000627] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Artalejo CR, 1997, EMBO J, V16, P1565, DOI 10.1093/emboj/16.7.1565; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CUKIERMAN E, 1995, SCIENCE, V270, P1994; Ding M, 1996, J BIOL CHEM, V271, P24005, DOI 10.1074/jbc.271.39.24005; DIXON B, 1993, CYTOGENET CELL GENET, V63, P42, DOI 10.1159/000133498; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; Frank S, 1998, J BIOL CHEM, V273, P23, DOI 10.1074/jbc.273.1.23; FRANZUSOFF A, 1989, EMBO J, V8, P2695, DOI 10.1002/j.1460-2075.1989.tb08410.x; HAUN RS, 1993, J BIOL CHEM, V268, P7064; Hayashi T, 1996, AM J PATHOL, V149, P1241; Hemmings BA, 1997, SCIENCE, V275, P1899, DOI 10.1126/science.275.5308.1899; HONG JX, 1994, J BIOL CHEM, V269, P9743; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LIU L, 1992, BIOCHIM BIOPHYS ACTA, V1132, P75, DOI 10.1016/0167-4781(92)90055-5; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Meacci E, 1997, P NATL ACAD SCI USA, V94, P1745, DOI 10.1073/pnas.94.5.1745; Morinaga N, 1999, J BIOL CHEM, V274, P17417, DOI 10.1074/jbc.274.25.17417; Morinaga N, 1997, P NATL ACAD SCI USA, V94, P12926, DOI 10.1073/pnas.94.24.12926; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Pacheco-Rodriguez G, 1998, J BIOL CHEM, V273, P26543, DOI 10.1074/jbc.273.41.26543; PATTON WA, 1997, BACTERIAL TOXINS TOO, P15; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Roth MG, 1997, CURR OPIN CELL BIOL, V9, P519, DOI 10.1016/S0955-0674(97)80028-2; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Telemenakis I, 1997, EUR J CELL BIOL, V74, P143; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; TSAI SC, 1994, P NATL ACAD SCI USA, V91, P3063, DOI 10.1073/pnas.91.8.3063; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	45	69	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3221	3230		10.1074/jbc.275.5.3221	http://dx.doi.org/10.1074/jbc.275.5.3221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652308	hybrid			2022-12-27	WOS:000085146500030
J	Patskovsky, YV; Patskovska, LN; Listowsky, I				Patskovsky, YV; Patskovska, LN; Listowsky, I			The enhanced affinity for thiolate anion and activation of enzyme-bound glutathione is governed by an arginine residue of human Mu class glutathione S-transferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; ACTIVE-SITE; TRANSITION-STATE; COMPLEX; HETEROGENEITY; ISOENZYMES; SUBSTRATE; A1-1	A series of chimeric human Mu class glutathione S-transferases were designed to determine mechanisms by which they activate enzyme-bound glutathione (GSH) for reaction with electrophilic substrates, In view of evidence that the His(107) residue of hGSTM1a-1a is important for catalysis (Patskovsky, Y. V., Patskovska, L. N., and Listowsky, I. (1999) Biochemistry 38, 1193-1202), the cognate Arg(107) residue of the hGSTM2 subunit was replaced (R107N or R107H) and arginine residues were also incorporated into position 107 of hGSTM1 (H107R) and hGSTM4 (S107R) subunits, The major distinguishing kinetic properties invariably associated with enzymes containing an Arg107 residue include an inverse dependence of k(cat) on viscosity and lower K(m)GSH values relative to enzymes with other residues at that position. Moreover, affinities for GSH thiolate anion binding are greater for enzymes containing Arg(107), With K-d values of 20-50 mu M that are consistent with the K(m)GSH values (10-25 mu M) obtained by steady-state kinetic analyses. Both thermodynamic and kinetic and data indicate that the Arg(107) residue is specifically involved in enhancing the binding affinity of GSH thiolate anion relative to that of the protonated form. These enzymes therefore, can be more effective at lower GSH concentrations. Combined mutations indicate that both Arg(107) and Tyr(6) residues are required for thiolate anion formation and stabilization. The three-dimensional structure of ligand-free hGSTM2-2 determined by x-ray crystallography suggests that Arg(107) maintains an electrostatic interaction with the Asp(161) side chain (3 A apart), but is distant from the GSH-binding site. However, an alternative energetically favorable model places the guanidino group 4 Angstrom from the sulfur atom of bound GSH. It is suggested therefore, that in solution, motion of the positively charged arginine into the catalytic pocket could provide a counter ion to promote ionization of the sulfhydryl group of GSH, thereby accounting for the ob served greater affinity of enzymes containing Arg(107) for binding of thiolate anion.	Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Listowsky, I (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL CANCER INSTITUTE [R01CA042448] Funding Source: NIH RePORTER; NCI NIH HHS [CA42448] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALIN P, 1985, FEBS LETT, V179, P267, DOI 10.1016/0014-5793(85)80532-9; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; AWASTHI YC, 1994, INT J BIOCHEM, V26, P195; BJORNESTEDT R, 1995, J MOL BIOL, V247, P765; BOARD P, 1990, PHARMACOL THERAPEUT, V48, P357, DOI 10.1016/0163-7258(90)90054-6; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Caccuri AM, 1997, J BIOL CHEM, V272, P29681, DOI 10.1074/jbc.272.47.29681; CAMBILLAU C, 1987, J MOL GRAPHICS, V5, P174, DOI 10.1016/0263-7855(87)80024-3; Chelvanayagam G, 1997, PROTEINS, V27, P118, DOI 10.1002/(SICI)1097-0134(199701)27:1<118::AID-PROT12>3.0.CO;2-Q; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; COMSTOCK KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P487, DOI 10.1006/abbi.1994.1266; DANIEL V, 1993, CRIT REV BIOCHEM MOL, V28, P173, DOI 10.3109/10409239309086794; Dietze EC, 1996, BIOCHEMISTRY-US, V35, P11938, DOI 10.1021/bi961073r; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; JENSSON H, 1985, METHOD ENZYMOL, V113, P504; JI X, 1993, BIOCHEMISTRY-US, V32, P12949, DOI 10.1021/bi00211a001; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; JOHNSON WW, 1993, J BIOL CHEM, V268, P11508; Ketterer B, 1994, Adv Pharmacol, V27, P37, DOI 10.1016/S1054-3589(08)61029-7; Listowsky Irving, 1993, P397; LIU SX, 1992, J BIOL CHEM, V267, P4296; MANNERVIK B, 1992, BIOCHEM J, V282, P305, DOI 10.1042/bj2820305; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; McCallum SA, 1999, J MOL BIOL, V285, P2119, DOI 10.1006/jmbi.1998.2428; Parsons JF, 1996, J AM CHEM SOC, V118, P2295, DOI 10.1021/ja960022e; PATSKOVSKA L, 1997, ACTA CRYSTALLOGR D, V54, P458; Patskovsky YV, 1999, BIOCHEMISTRY-US, V38, P1193, DOI 10.1021/bi982164m; PEARSON WR, 1993, AM J HUM GENET, V53, P220; Prade L, 1997, STRUCTURE, V5, P1287, DOI 10.1016/S0969-2126(97)00281-5; PRESTERA T, 1995, P NATL ACAD SCI USA, V92, P8965, DOI 10.1073/pnas.92.19.8965; RAGHUNATHAN S, 1994, J MOL BIOL, V238, P815, DOI 10.1006/jmbi.1994.1336; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Rowe JD, 1997, BIOCHEM J, V325, P481, DOI 10.1042/bj3250481; Rowe JD, 1998, J BIOL CHEM, V273, P9593, DOI 10.1074/jbc.273.16.9593; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; SINGHAL SS, 1994, ARCH BIOCHEM BIOPHYS, V311, P242, DOI 10.1006/abbi.1994.1233; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; Thorson JS, 1998, J AM CHEM SOC, V120, P451, DOI 10.1021/ja9731682; TU CPD, 1985, J BIOL CHEM, V260, P9961; WANG RW, 1993, J BIOL CHEM, V268, P23981; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Xiao GY, 1998, J MOL BIOL, V281, P323, DOI 10.1006/jmbi.1998.1935; Xu SJ, 1998, J BIOL CHEM, V273, P3517, DOI 10.1074/jbc.273.6.3517	47	30	30	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3296	3304		10.1074/jbc.275.5.3296	http://dx.doi.org/10.1074/jbc.275.5.3296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652317	hybrid			2022-12-27	WOS:000085146500039
J	Reddy, ST; Wadleigh, DJ; Herschman, HR				Reddy, ST; Wadleigh, DJ; Herschman, HR			Transcriptional regulation of the gyclooxygenase-2 gene in activated mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE-2; FACTOR KAPPA-B; SIGNAL-TRANSDUCTION; NUCLEAR FACTOR; RESPONSE ELEMENT; GRANULOSA-CELLS; PHORBOL ESTER; 3T3 CELLS; EXPRESSION; PHOSPHORYLATION	Activation of mast cells by aggregation of their IgE receptors induces rapid and transient synthesis of cyclooxygenase-2 (COX-2). In this study we investigated (i) the cis-acting response elements and transcription factors active at the COX-2 promoter and (ii) the signal transduction pathways mediating COX-2 induction following aggregation of mast cell IgE receptors. Transient transfection assays with COX-2 promoter/luciferase constructs suggest that a consensus cyclic AMP response element is essential for induced COX-2 expression. Cotransfection studies with plasmids expressing c-Jun, dominant negative Ras, dominant negative c-Jun NH2-terminal kinase, and dominant negative MEKK1 demonstrate that activation of the Ras/MEKK1/c-Jun NH2-terminal kinase/c-Jun pathway is required for COX-2 promoter-mediated luciferase expression. Attenuation of COX-2 promoter activity by dominant negative constructs for Raf-1, ERK1, and ERK2 suggests that the Ras/Raf-1/extracellular signal-regulated kinase pathway is also necessary for COX-2 induction. Although mutating the two NF-IL6 sites individually did not affect COX-2 promoter activity, mutating both NF-IL6 sites substantially inhibits COX-2 promoter activity. Moreover, overexpression of wild type CCAAT/enhancer-binding protein-beta (C/EBP beta) augments COX-2 promoter activity in activated mast cells and cotransfection of a dominant negative C/EBP beta construct completely blocks COX-2 promoter/luciferase expression. Our data suggest that in activated mast cells, a Ras/MEKKl/c-Jun NH,terminal kinase signal transduction pathway activating c-Jun, a Ras/Raf-1/extracellular signal-regulated kinase pathway, and activated C/EBP beta facilitate COX-2 induction via the cyclic AMP response element and NF-IL6 sites of the COX-2 promoter.	Univ Calif Los Angeles, Ctr Hlth Sci, Inst Mol Biol, E Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Dept Biol Chem, E Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Herschman, HR (corresponding author), Univ Calif Los Angeles, Ctr Hlth Sci, Inst Mol Biol, 611 Charles E Young Dr, E Los Angeles, CA 90095 USA.				NIAID NIH HHS [AI34567] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034567, U19AI034567] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CAO Z, 1991, GENE DEV, V5, P1553; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; FRANKLIN CC, 1992, P NATL ACAD SCI USA, V89, P7247, DOI 10.1073/pnas.89.15.7247; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guan ZH, 1998, J BIOL CHEM, V273, P28670, DOI 10.1074/jbc.273.44.28670; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; INOUE H, 1995, J BIOL CHEM, V270, P24965, DOI 10.1074/jbc.270.42.24965; Inoue H, 1998, BIOCHEM BIOPH RES CO, V244, P143, DOI 10.1006/bbrc.1998.8222; JabrilCuenod B, 1996, J BIOL CHEM, V271, P16268, DOI 10.1074/jbc.271.27.16268; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; KAWATA R, 1995, J IMMUNOL, V155, P818; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Morris JK, 1996, J BIOL CHEM, V271, P16633, DOI 10.1074/jbc.271.28.16633; MURAKAMI M, 1995, J IMMUNOL, V155, P4445; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; REDDY ST, 1994, J BIOL CHEM, V269, P15473; ROBERTS LJ, 1979, BIOCHIM BIOPHYS ACTA, V575, P185, DOI 10.1016/0005-2760(79)90020-1; SIROIS J, 1993, J BIOL CHEM, V268, P21931; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; Wadleigh DJ, 1999, BIOCHEM BIOPH RES CO, V264, P865, DOI 10.1006/bbrc.1999.1606; XIE WL, 1994, MOL CELL BIOL, V14, P6531, DOI 10.1128/MCB.14.10.6531; XIE WL, 1995, J BIOL CHEM, V270, P27622, DOI 10.1074/jbc.270.46.27622; Xie WL, 1996, J BIOL CHEM, V271, P31742, DOI 10.1074/jbc.271.49.31742; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315	33	116	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3107	3113		10.1074/jbc.275.5.3107	http://dx.doi.org/10.1074/jbc.275.5.3107			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652293	hybrid			2022-12-27	WOS:000085146500015
J	Shirotani, K; Takahashi, K; Araki, W; Maruyama, K; Tabira, T				Shirotani, K; Takahashi, K; Araki, W; Maruyama, K; Tabira, T			Mutational analysis of intrinsic regions of presenilin 2 that determine its endoproteolytic cleavage and pathological function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID-BETA-PROTEIN; C-TERMINAL FRAGMENTS; TRANSFECTED CELLS; CAENORHABDITIS-ELEGANS; LINKED PRESENILIN-1; MISSENSE MUTATIONS; WILD-TYPE; IN-VIVO; GENE	To investigate the significance of endoproteolytic processing of presenilin 2 (PS2) on its pathological function, we constructed PS2 cDNAs causing amino acid substitutions or deletions around the cleavage site. We found that a PS2 mutant (Del3) with a 20-amino acid deletion was not endoproteolytically processed, while other PS2s with amino acid substitutions and short deletions were cleaved. Overproduction of all the mutant proteins led to a compensatory decrease of endogenous PS1 fragments, but did not affect the amyloid beta peptide X-42/A beta X-40 ratio without the familial Alzheimer's disease mutation. The Del3 mutant did not exhibit significant deficits in gamma-secretase activity. The turnover rate of the Del3 holoprotein was the same as that of full-length PS2. These data suggest that the determinants of the PS2 cleavage site reside within a large region and that the pathological function of PS2 is exerted by familial Alzheimer's disease mutations not related to the cleavage of holoproteins. We also found that PS2 with an 18-amino acid deletion at the C-terminal end was not processed. Its overexpression led neither to diminished accumulation of endogenous PS1 fragments nor to increased production of amyloid beta peptide X-42. The C-terminal end of PS2 seems to possess the signal for entry into the processing pathway.	Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Div Demyelinating Dis & Aging, Kodaira, Tokyo 1878502, Japan; Tokyo Inst Psychiat, Dept Mol Biol, Tokyo 1568585, Japan	National Center for Neurology & Psychiatry - Japan; Tokyo Institute of Psychiatry	Shirotani, K (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kshiro@brain.riken.go.jp	Araki, Wataru/G-7913-2014	Araki, Wataru/0000-0001-8467-6937				ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; Baumeister R, 1997, Genes Funct, V1, P149; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Chui DH, 1998, J NEUROSCI RES, V53, P99; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Grunberg J, 1998, BIOCHEMISTRY-US, V37, P2263, DOI 10.1021/bi972106l; Honda T, 1999, J NEUROCHEM, V72, P255, DOI 10.1046/j.1471-4159.1999.0720255.x; Iwatsubo T., 1998, Society for Neuroscience Abstracts, V24, P6; Kim TW, 1997, J BIOL CHEM, V272, P11006; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Lehmann S, 1997, J BIOL CHEM, V272, P12047, DOI 10.1074/jbc.272.18.12047; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Marambaud P, 1998, MOL MED, V4, P147, DOI 10.1007/BF03401912; MARUYAMA K, 1990, NATURE, V347, P566, DOI 10.1038/347566a0; Mehta ND, 1998, ANN NEUROL, V43, P256, DOI 10.1002/ana.410430217; Mercken M, 1996, FEBS LETT, V389, P297, DOI 10.1016/0014-5793(96)00608-4; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; PerezTur J, 1995, NEUROREPORT, V7, P297; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Ratovitski T, 1997, J BIOL CHEM, V272, P24536, DOI 10.1074/jbc.272.39.24536; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sato S, 1998, HUM MUTAT, pS91; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 1999, NEUROSCI LETT, V262, P37, DOI 10.1016/S0304-3940(99)00037-3; Shirotani K, 1997, BIOCHEM BIOPH RES CO, V240, P728, DOI 10.1006/bbrc.1997.7730; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Sudoh S, 1998, J NEUROCHEM, V71, P1535; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	50	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3681	3686		10.1074/jbc.275.5.3681	http://dx.doi.org/10.1074/jbc.275.5.3681			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652366	hybrid			2022-12-27	WOS:000085146500088
J	Sugiyama, T; Wang, JC; Scott, DK; Granner, DK				Sugiyama, T; Wang, JC; Scott, DK; Granner, DK			Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) - Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTORS; THYROID-HORMONE; POSITIVE REGULATION; ACTIVE REPRESSION; VITAMIN-D; GTP GENE; SUPERFAMILY; ELEMENTS; GRIP1; TRANSACTIVATION	Chicken ovalbumin upstream promoter-transcription factors (COUP-TFs), orphan members of the nuclear receptor superfamily, play a key role in the regulation of organogenesis, neurogenesis, and cellular differentiation during embryogenic development. COUP-TFs are also involved in the regulation of several genes that encode metabolic enzymes. Although COUP-TFs function as potent transcription repressors, there are at least three different molecular mechanisms of activation of gene expression by COUP-TFs, First, as we have previously shown, COUP-TF is required as an accessory factor for the complete induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids, This action is mediated by the binding of COUP-TF to the glucocorticoid accessory factor 1 (gAF1) and 3 (gAF3) elements in the phosphoenolpyruvate carboxykinase gene glucocorticoid response unit. In addition, COUP-TF1 binds to DNA elements in certain genes and transactivates directly. Finally, COUP-TF1 serves as a coactivator through DNA-bound hepatic nuclear factor 4, Here we show that the same region of COUP-TFI, located between amino acids 184 and 423, is involved in these three mechanisms of transactivation by COUP-TFI, Furthermore, we show that GRIP1 and SRC-1 potentiate the activity of COUP-TFI and that COUP-TFI associates with these coactivators in vivo using the same region required for transcription activation. Finally, overexpression of GRIP1 or SRC-1 does not convert COUP-TFI from a transcriptional repressor into a transcriptional activator in HeLa cells.	Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA	Vanderbilt University	Granner, DK (corresponding author), Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, 221 Kirkland Hall, Nashville, TN 37232 USA.		Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886; Sugiyama, Takashi/0000-0002-3715-0075	NIDDK NIH HHS [DK 20593, DK 35107] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035107, P60DK020593, P30DK020593, R37DK035107] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; GRANNER D, 1990, J BIOL CHEM, V265, P10173; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; KADOWAKI Y, 1995, P NATL ACAD SCI USA, V92, P4432, DOI 10.1073/pnas.92.10.4432; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; KIMURA A, 1993, J BIOL CHEM, V268, P11125; Ktistaki E, 1997, MOL CELL BIOL, V17, P2790, DOI 10.1128/MCB.17.5.2790; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Lazennec G, 1997, MOL CELL BIOL, V17, P5053, DOI 10.1128/MCB.17.9.5053; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leng X, 1996, MOL CELL BIOL, V16, P2332; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIU JS, 1991, J BIOL CHEM, V266, P19095; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; OBRIEN RM, 1991, P NATL ACAD SCI USA, V88, P6580, DOI 10.1073/pnas.88.15.6580; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; PETERSEN DD, 1988, MOL CELL BIOL, V8, P96, DOI 10.1128/MCB.8.1.96; Power SC, 1996, MOL CELL BIOL, V16, P778; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Rodriguez JC, 1997, BIOCHEM J, V326, P587, DOI 10.1042/bj3260587; Sawaya BE, 1996, J BIOL CHEM, V271, P23572, DOI 10.1074/jbc.271.38.23572; Scott DK, 1996, J BIOL CHEM, V271, P6260, DOI 10.1074/jbc.271.11.6260; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Stroup D, 1997, J BIOL CHEM, V272, P9833; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Wang JC, 1998, J BIOL CHEM, V273, P30847, DOI 10.1074/jbc.273.47.30847; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; Wang Lee-Ho, 1991, Gene Expression, V1, P207; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; YAMADA K, 1990, J BIOL CHEM, V265, P19885	48	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3446	3454		10.1074/jbc.275.5.3446	http://dx.doi.org/10.1074/jbc.275.5.3446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652338	hybrid			2022-12-27	WOS:000085146500060
J	Ason, B; Bertram, JG; Hingorani, MM; Beechem, JM; O'Donnell, M; Goodman, MF; Bloom, LB				Ason, B; Bertram, JG; Hingorani, MM; Beechem, JM; O'Donnell, M; Goodman, MF; Bloom, LB			A model for Escherichia coli DNA polymerase III holoenzyme assembly at primer/template ends - DNA triggers a change in binding specificity of the gamma complex clamp loader	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION MACHINE; SLIDING CLAMPS; ACCESSORY PROTEINS; ATP-BINDING; SUBUNIT; BETA; PURIFICATION; EXONUCLEASE; MECHANISM; PARTICLE	The gamma complex of the Escherichia coli DNA polymerase III holoenzyme assembles the beta sliding clamp onto DNA in an ATP hydrolysis driven reaction. Interactions between gamma complex and primer/template DNA are investigated using fluorescence depolarization to measure binding of gamma complex to different DNA substrates under steady-state and presteady-state conditions. Surprisingly, gamma complex has a much higher affinity for single-stranded DNA (K-d in the nM range) than for a primed template (K-d in the mu M range) under steady-state conditions. However, when examined on a millisecond time scale, we find that gamma complex initially binds very rapidly and with high affinity to primer/template DNA but is converted subsequently to a much lower affinity DNA binding state. Presteady-state data reveals an effective dissociation constant of 1.5 nM for the initial binding of gamma complex to DNA and a dissociation constant of 5.7 mu M for the low affinity DNA binding state. Experiments using nonhydrolyzable ATP gamma S show that ATP binding con verts gamma complex hom a low affinity "inactive" to high affinity "active" DNA binding state while ATP hydrolysis has the reverse effect, thus allowing cycling between active and inactive DNA binding forms at steady-state. We propose that a DNA-triggered switch between active and inactive states of gamma complex provides a two-tiered mechanism enabling gamma complex to recognize primed template sites and load beta, while preventing gamma complex from competing with DNA polymerase III core for binding a newly loaded beta.DNA complex.	Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ So Calif, Dept Biol Sci, Hedco Mol Biol Labs, Los Angeles, CA 90089 USA; Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA	Arizona State University; Arizona State University-Tempe; University of Southern California; Vanderbilt University; Rockefeller University; Howard Hughes Medical Institute	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.		Bloom, Linda B/F-3684-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055596, R01GM021422, R37GM021422] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055596, GM55596, GM2554, GM21422] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; DIFRANCESCO R, 1984, J BIOL CHEM, V259, P5567; FAY PJ, 1981, J BIOL CHEM, V256, P976; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A., 1992, DNA REPLICATION; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P145; MAKI H, 1985, J BIOL CHEM, V260, P2987; MAKI S, 1988, J BIOL CHEM, V263, P6555; MCHENRY CS, 1991, J BIOL CHEM, V266, P19127; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; ONRUST R, 1993, J BIOL CHEM, V268, P11766; ONRUST R, 1991, J BIOL CHEM, V266, P21681; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; PEREZHOWARD GM, 1995, BIOCHEMISTRY-US, V34, P8005, DOI 10.1021/bi00025a006; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; XIAO H, 1995, J BIOL CHEM, V270, P13378, DOI 10.1074/jbc.270.22.13378; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x	27	51	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					3006	3015		10.1074/jbc.275.4.3006	http://dx.doi.org/10.1074/jbc.275.4.3006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644772	hybrid			2022-12-27	WOS:000085128000104
J	Hallak, H; Seiler, AEM; Green, JS; Ross, BN; Rubin, R				Hallak, H; Seiler, AEM; Green, JS; Ross, BN; Rubin, R			Association of heterotrimeric G(i) with the insulin-like growth factor-I receptor - Release of G(beta gamma) subunits upon receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CEREBELLAR GRANULE NEURONS; SENSITIVE G-PROTEIN; PERMEABLE CATION CHANNEL; PERTUSSIS-TOXIN; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; RAT HEPATOCYTES; GTP-BINDING	The insulin-like growth factor-I receptor (IGF-IR) is a key regulator of cell proliferation and survival. Activation of the IGF-IR induces tyrosine autophosphorylation and the binding of a series of adaptor molecules, thereby leading to the activation of MAPK. It has been demonstrated that pertussis toxin, which inactivates the G(i) class of GTP-binding proteins, inhibits IGF-I-mediated activation of MAPK, and a specific role for G(beta gamma) subunits in IGF-I signaling was shown. In the present study, we have investigated the role of heterotrimeric Gi in IG;F-IR signaling in neuronal cells. Pertussis toxin inhibited IGF-I-induced activation of MAPK in rat cerebellar granule neurons and NG-108 neuronal cells. G(alpha i) and Gp subunits were associated with IGF-IR immunoprecipitates. Similarly, in IGF-IR-null mouse embryo fibroblasts transfected with the human IG;F-IR, Gi was complexed with the IGF-IR. G(alpha s) was not associated with the IGF-IR in any cell type. IGF-I induced the release of the Gp subunits from the IGF-IR but had no effect on the association of G(alpha i). These results demonstrate an association of heterotrimeric Gi with the IGF-IR and identify a discrete pool of G(beta gamma) Subunits available for downstream signaling following stimulation with IGF-I.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Rubin, R (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, 1020 Locust St,Rm 233,Alumni Hall, Philadelphia, PA 19107 USA.	raphael.rubin@mail.tju.edu			NIAAA NIH HHS [AA07186, AA09976] Funding Source: Medline; BHP HRSA HHS [AHA9730028N] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009976, P50AA007186] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BHP HRSA HHS; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler AP, 1996, CELL SIGNAL, V8, P475, DOI 10.1016/S0898-6568(96)00102-7; CHURCH JG, 1988, J BIOL CHEM, V263, P4242; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Curto M, 1997, INT J BIOCHEM CELL B, V29, P1207, DOI 10.1016/S1357-2725(97)00049-6; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; delPeso L, 1997, SCIENCE, V278, P687; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; GAWLER D, 1987, FEBS LETT, V216, P94, DOI 10.1016/0014-5793(87)80763-9; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOREN HJ, 1985, CAN J PHYSIOL PHARM, V63, P1017, DOI 10.1139/y85-167; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HEYWORTH CM, 1986, BIOCHEM J, V235, P145, DOI 10.1042/bj2350145; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; JIN GF, 1993, REGUL PEPTIDES, V49, P125, DOI 10.1016/0167-0115(93)90434-A; Kanzaki M, 1997, J BIOL CHEM, V272, P4964, DOI 10.1074/jbc.272.8.4964; KELLERER M, 1991, BIOCHEM J, V276, P103, DOI 10.1042/bj2760103; KriegerBrauer HI, 1997, J BIOL CHEM, V272, P10135; KRUPINSKI J, 1988, J BIOL CHEM, V263, P12333; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; LANGLOIS D, 1990, ENDOCRINOLOGY, V126, P1867, DOI 10.1210/endo-126-4-1867; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LIANG M, 1991, J BIOL CHEM, V266, P13342; LINDER B, 1994, MOL CELL ENDOCRINOL, V105, P111, DOI 10.1016/0303-7207(94)90042-6; Liu JL, 1997, J BIOL CHEM, V272, P29438, DOI 10.1074/jbc.272.47.29438; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; LUTTRELL L, 1990, J BIOL CHEM, V265, P16873; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Nie L, 1998, ENDOCRINOLOGY, V139, P179, DOI 10.1210/en.139.1.179; OKAMOTO T, 1994, FEBS LETT, V340, P292; Piiper A, 1997, AM J PHYSIOL-GASTR L, V272, pG1276, DOI 10.1152/ajpgi.1997.272.5.G1276; Poiraudeau S, 1997, J CELL BIOCHEM, V64, P414; PYNE NJ, 1989, BIOCHEM BIOPH RES CO, V165, P251, DOI 10.1016/0006-291X(89)91062-0; RAMIREZ I, 1995, CELL SIGNAL, V7, P303, DOI 10.1016/0898-6568(95)00001-6; ROTHENBERG PL, 1988, J BIOL CHEM, V263, P15546; Rozengurt E, 1998, J CELL PHYSIOL, V177, P507, DOI 10.1002/(SICI)1097-4652(199812)177:4<507::AID-JCP2>3.0.CO;2-K; RUBIN R, 1995, LAB INVEST, V73, P311; Sanchez-Margalet V, 1999, CELL MOL LIFE SCI, V55, P142, DOI 10.1007/s000180050279; Sarbassov DD, 1997, MOL ENDOCRINOL, V11, P2038, DOI 10.1210/me.11.13.2038; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Siebler T, 1996, REGUL PEPTIDES, V62, P65, DOI 10.1016/0167-0115(95)00159-X; STRACKE ML, 1988, BIOCHEM BIOPH RES CO, V153, P1076, DOI 10.1016/S0006-291X(88)81338-X; TEBAR F, 1993, J BIOL CHEM, V268, P17199; Uehara T, 1999, EUR J BIOCHEM, V259, P801, DOI 10.1046/j.1432-1327.1999.00100.x; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; VILA MD, 1990, BIOCHEMISTRY-US, V29, P8735, DOI 10.1021/bi00489a033; YAMAUCHI K, 1994, J BIOL CHEM, V269, P31107; YAMAUCHI K, 1994, MOL CELL BIOL, V14, P4427, DOI 10.1128/MCB.14.7.4427; YANG LJ, 1991, J BIOL CHEM, V266, P22451; YANG LJ, 1993, J BIOL CHEM, V268, P3739; Zhang FX, 1998, J NEUROCHEM, V71, P196, DOI 10.1046/j.1471-4159.1998.71010196.x; Zhang FX, 1998, J BIOL CHEM, V273, P26596, DOI 10.1074/jbc.273.41.26596	56	82	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2255	2258		10.1074/jbc.275.4.2255	http://dx.doi.org/10.1074/jbc.275.4.2255			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644671	hybrid			2022-12-27	WOS:000085128000003
J	Hui, D; Morden, C; Zhang, F; Ling, V				Hui, D; Morden, C; Zhang, F; Ling, V			Combinatorial analysis of the structural requirements of the Escherichia coli hemolysin signal sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL SECRETION SIGNAL; AMINO-ACIDS; TRANSPORT SIGNAL; P-GLYCOPROTEIN; HLYA; PROTEIN; MEMBRANE; MUTANTS; SYSTEM; REGION	We have investigated the substrate specificity of the Escherichia coli hemolysin transporter system. Translocation of hemolysin is dependent on a C-terminal signal sequence located within the last 60 amino acids of this protein. Previous comparative studies of the signal sequence have revealed a conserved helix(alpha 1)-linker-helix(alpha 2) motif, suggesting that secondary structure is important for transport. In this study, we generated three random libraries in the alpha 1, linker, and alpha 2 regions, as well as an alpha 1-amphiphilic helical library to identify features buried within the structural motif that contribute to transport, Combinatorial variants were generated by altering the primary sequence of specific regions, and correlation between the genotype and phenotype of the mutant populations allowed us to objectively identify any functional features involved. It was found that the alpha 1-amphiphilic helix and the linker are both important for function. To our surprise, the second helix of the conserved structural motif was not essential for transport. The finding that a predicted amphiphilic helix and hydrophobicity, rather than primary sequence, contribute to transport in the alpha 1 region allows us to speculate on the mechanism of multiple substrate recognition. This may have implications for understanding the broad substrate specificity common among other ATP-binding cassette transporters.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada	University of British Columbia; British Columbia Cancer Agency	Ling, V (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.							CHAN HSL, 1994, HEMATOL ONCOL CLIN N, V8, P383, DOI 10.1016/S0889-8588(18)30178-3; Chervaux C, 1996, J BACTERIOL, V178, P1232, DOI 10.1128/jb.178.4.1232-1236.1996; Childs S, 1994, Important Adv Oncol, P21; DEAN M, 1995, CURR OPIN GENET DEV, V5, P779, DOI 10.1016/0959-437X(95)80011-S; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; HESS J, 1990, MOL GEN GENET, V224, P201, DOI 10.1007/BF00271553; JARCHAU T, 1994, MOL GEN GENET, V245, P53, DOI 10.1007/BF00279750; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; KENNY B, 1994, MOL MICROBIOL, V11, P99, DOI 10.1111/j.1365-2958.1994.tb00293.x; KENNY B, 1992, MOL MICROBIOL, V6, P1477, DOI 10.1111/j.1365-2958.1992.tb00868.x; KORONAKIS V, 1989, EMBO J, V8, P595, DOI 10.1002/j.1460-2075.1989.tb03414.x; MACKMAN N, 1987, EMBO J, V6, P2835, DOI 10.1002/j.1460-2075.1987.tb02580.x; MACKMAN N, 1985, MOL GEN GENET, V201, P282, DOI 10.1007/BF00425672; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1998, EUR J BIOCHEM, V254, P181, DOI 10.1046/j.1432-1327.1998.2540181.x; SHEPS JA, 1995, J BIOL CHEM, V270, P14829, DOI 10.1074/jbc.270.24.14829; SHEPS JA, 1996, MEM PROT TR, V3, P81; STANLEY P, 1991, MOL MICROBIOL, V5, P2391, DOI 10.1111/j.1365-2958.1991.tb02085.x; WOLFF N, 1994, BIOCHEMISTRY-US, V33, P6792, DOI 10.1021/bi00188a007; YIN Y, 1995, FEBS LETT, V366, P1, DOI 10.1016/0014-5793(95)00454-H; ZHANG F, 1995, BIOCHEMISTRY-US, V34, P4193, DOI 10.1021/bi00013a007; ZHANG F, 1993, P NATL ACAD SCI USA, V90, P4211, DOI 10.1073/pnas.90.9.4211; ZHANG F, 1993, J BIOL CHEM, V268, P19889	23	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2713	2720		10.1074/jbc.275.4.2713	http://dx.doi.org/10.1074/jbc.275.4.2713			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644734	hybrid			2022-12-27	WOS:000085128000066
J	Landau, E; Tirosh, R; Pinson, A; Banai, S; Even-Ram, S; Maoz, M; Katzav, S; Bar-Shavit, R				Landau, E; Tirosh, R; Pinson, A; Banai, S; Even-Ram, S; Maoz, M; Katzav, S; Bar-Shavit, R			Protection of thrombin receptor expression under hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY COLLATERAL CIRCULATION; ALPHA-THROMBIN; MYOCARDIAL-ISCHEMIA; MOLECULAR-CLONING; MESSENGER-RNA; DNA-SYNTHESIS; SH2 DOMAIN; ACTIVATION; PROTEIN; GENE	Thrombin receptor (ThR) plays a significant role in myocyte contractility and hypertrophy, Heart myocyte ischemic damage, caused by insufficient blood supply, is the leading cause of heart infarction, Here we demonstrate that when primary myocyte cultures are subjected to hypoxic stress, ThR mRNA levels are reduced markedly. This takes place also in vivo in a model of ischemic pig heart, exhibiting reduced levels of ThR compared with normal heart sections. Prior activation of ThR however, by either thrombin receptor-activating peptide (TRAP) or by alpha-thrombin resulted in full protection of ThR mRNA levels under hypoxia, The effect appeared specific to ThR because the addition of TRAP did not affect the hypoxic damage as shown by the levels of lactic dehydrogenase release and up-regulated GLUT-1, a glucose transporter gene. This protection effect took place not only in primary myocytes but also in NIH3T3 fibroblasts, ThR protection occurs via specific cell signaling events because activation of the receptor by TRAP, following interruption of the signaling cascade by calphostin C, a protein kinase C inhibitor, resulted in loss of ThR mRNA protection. Because Ras and Src are part of the ThR signaling cascade, the introduction of either dominant ras or src oncogenes to NIH3T3 murine fibroblasts gave rise to similar protection of ThR mRNA levels under hypoxic conditions without the exogenous addition of TRAP. Likewise, ThR mRNA protection was obtained after transfection with proto-oncogene vav. The 95-kDa protein Vav undergoes tyrosine phosphorylation after ThR activation, serving thus as part of the receptor machinery cascade. We therefore conclude that the initiation of the signaling cascades either exogenously by TRAP or within the cell via src or ras, as well as via aav oncogene interconnecting G-binding protein to the tyrosine kinase pathway, ultimately results in ThR protection under hypoxia, We present hereby, a novel concept of activated receptors, which under minimal oxygen tension protect their otherwise decaying mRNA Maintaining the level of ThR that plays an active role in normal myocyte function may provide a significant repair mechanism in ischemic tissue, assisting in the regaining of normal myocyte functions.	Hadassah Univ Hosp, Dept Oncol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Med, Dept Oncol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Med, Lab Myocardial Res, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Med, Dept Cardiol, Bikur Cholim Hosp, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Med, Dept Expt Med, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Bar-Shavit, R (corresponding author), Hadassah Univ Hosp, Dept Oncol, POB 12000, IL-91120 Jerusalem, Israel.			Even-Ram, Sharona/0000-0002-5540-3822				Albert CJ, 1999, AM J PHYSIOL-HEART C, V276, pH642, DOI 10.1152/ajpheart.1999.276.2.H642; BANAI S, 1994, CARDIOVASC RES, V28, P1176, DOI 10.1093/cvr/28.8.1176; BRAND T, 1992, CIRC RES, V71, P1351, DOI 10.1161/01.RES.71.6.1351; Chen YH, 1996, EMBO J, V15, P1037, DOI 10.1002/j.1460-2075.1996.tb00441.x; CHEN YH, 1994, J BIOL CHEM, V269, P27372; Cichowski K, 1996, J BIOL CHEM, V271, P7544, DOI 10.1074/jbc.271.13.7544; Collins LR, 1997, ONCOGENE, V15, P595, DOI 10.1038/sj.onc.1201220; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; GLEMBOTSKI CC, 1993, J BIOL CHEM, V268, P20646; GOLDBERG MA, 1991, BLOOD, V77, P271; GOLDSTEIN JA, 1994, CIRCULATION, V90, P139, DOI 10.1161/01.CIR.90.1.139; IKMAN WJ, 1992, PHYSIOL REV, V72, P449; IRANI K, 1994, BIOCHEM BIOPH RES CO, V202, P1252, DOI 10.1006/bbrc.1994.2065; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; JAKEMAN LB, 1993, ENDOCRINOLOGY, V133, P848, DOI 10.1210/en.133.2.848; Jiang TR, 1996, CIRC RES, V78, P553, DOI 10.1161/01.RES.78.4.553; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; KATZAV S, 1995, ONCOGENE, V11, P1079; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1993, ONCOGENE, V8, P1757; KONDZIOLKA D, 1988, J NEUROSURG, V69, P494, DOI 10.3171/jns.1988.69.4.0494; LAMORTE VJ, 1992, J BIOL CHEM, V267, P691; Li FZ, 1996, J BIOL CHEM, V271, P26320, DOI 10.1074/jbc.271.42.26320; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; NYSTEDT S, 1995, EUR J BIOCHEM, V232, P84, DOI 10.1111/j.1432-1033.1995.tb20784.x; PINSON A, 1987, HEART CELL CULTURE, V1, P7; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; RUGH BF, 1990, CELL, V61, P1187; RUGH KS, 1987, CARDIOVASC RES, V21, P730, DOI 10.1093/cvr/21.10.730; SABIA PJ, 1992, NEW ENGL J MED, V327, P1825, DOI 10.1056/NEJM199212243272601; SASAYAMA S, 1992, CIRCULATION, V85, P1197, DOI 10.1161/01.CIR.85.3.1197; SCHAPER W, 1971, CIRC RES, V28, P671, DOI 10.1161/01.RES.28.6.671; SHEIKI D, 1992, NATURE, V359, P843; Shock DD, 1997, BIOCHEM J, V321, P525, DOI 10.1042/bj3210525; STEIN I, 1995, MOL CELL BIOL, V15, P5363; STEINBERG SF, 1993, AM J PHYSIOL, V265, pH691, DOI 10.1152/ajpheart.1993.265.2.H691; STENMARK KR, 1988, CHEST, V93, P127; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VEMURI R, 1985, IN VITRO CELL DEV B, V21, P521; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WEBSTER KA, 1993, J BIOL CHEM, V268, P16852; WERTHEIMER E, 1991, P NATL ACAD SCI USA, V88, P2529; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; [No title captured]	46	11	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2281	2287		10.1074/jbc.275.4.2281	http://dx.doi.org/10.1074/jbc.275.4.2281			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644676	hybrid			2022-12-27	WOS:000085128000008
J	Yang, BX; Fukuda, N; van Hoek, A; Matthay, MA; Ma, TH; Verkman, AS				Yang, BX; Fukuda, N; van Hoek, A; Matthay, MA; Ma, TH; Verkman, AS			Carbon dioxide permeability of aquaporin-1 measured in erythrocytes and lung of aquaporin-1 null mice and in reconstituted proteoliposomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHIP28 WATER CHANNELS; KIDNEY COLLECTING DUCT; ION CONDUCTANCE; XENOPUS OOCYTES; EXPRESSION; GLYCEROL; CLONING; MEMBRANES; CELLS; TRANSPORTER	Measurements of CO2 permeability in oocytes and liposomes containing water channel aquaporin-1 (AQP1) have suggested that AQP1 is able to transport both water and CO2. We studied the physiological consequences of CO2 transport by AQP1 by comparing CO2 permeabilities in erythrocytes and intact lung of wild-type and AQP1 null mice. Erythrocytes from wild-type mice strongly expressed AQP1 protein and had 7-fold greater osmotic water permeability than did erythrocytes from null mice. CO2 permeability was measured from the rate of intracellular acidification in response to addition of CO2/HCO3- in a stopped-flow fluorometer using 2',7'-bis-(2-carboxyethyl)-5-(and -6)-carboxyfluorescein (BCECF) as a cytoplasmic pH indicator, In erythrocytes from wild-type mice, acidification was rapid (t(1/2), 7.3 +/- 0.4 ms, S.E., n = 11 mice) and blocked by acetazolamide and increasing external pH (to decrease CO2/HCO3- ratio). Apparent CO2 permeability (P-CO2) was not different in erythrocytes from wild-type (0.012 +/- 0.0008 cm/s) versus null (0.011 +/- 0.001 cm/s) mice. Lung CO2 transport was measured in anesthetized, ventilated mice subjected to a decrease in inspired CO2 content from 5% to 0%, producing an average decrease in arterial blood pCO(2) from 77 +/- 4 to 39 +/- 3 mm Hg (14 mice) with a t(1/2) of 1.4 min. The pCO(2) values and kinetics of decreasing pCO(2) were not different in wild-type versus null mice. Because AQP1 deletion did not affect CO2 transport in erythrocytes and lung we re-examined CO2 permeability in AQP1-reconstituted liposomes containing carbonic anhydrase (CA) and a fluorescent pH indicator. Whereas osmotic water permeability in AQP1-reconstituted liposomes was >100-fold greater than that in control liposomes, apparent P-CO2 (similar to 10(-3) cm/s) did not differ. Measurements using different CA concentrations and HgCl2 indicated that liposome P-CO2 is unstirred layer-limited and that HgCl2 slows acidification because of inhibition of CA rather than AQP1, These results provide direct evidence against physiologically significant AQP1-mediated CO2 transport and establish an upper limit to the CO2 permeability through single AQP1 water channels.	Univ Calif San Francisco, Inst Cardiovasc Res, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Physiol, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Renal Unit, Charlestown, MA 02114 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital	Verkman, AS (corresponding author), Univ Calif San Francisco, Inst Cardiovasc Res, Dept Med, 1246 Hlth sci E Tower, San Francisco, CA 94143 USA.			Ma, Tonghui/0000-0001-9338-1030; Van Hoek, Alfred/0000-0003-2724-6855	NHLBI NIH HHS [HL60288, HL59198] Funding Source: Medline; NIDDK NIH HHS [DK35124] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, P50HL060288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMI L, 1995, PFLUG ARCH EUR J PHY, V430, P447, DOI 10.1007/BF00373921; Agre P, 1997, SCIENCE, V275, P1490, DOI 10.1126/science.275.5305.1490; Bai CX, 1999, J CLIN INVEST, V103, P555, DOI 10.1172/JCI4138; Carter EP, 1996, J GEN PHYSIOL, V108, P133, DOI 10.1085/jgp.108.3.133; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Cooper GJ, 1998, AM J PHYSIOL-CELL PH, V275, pC1481, DOI 10.1152/ajpcell.1998.275.6.C1481; Deen PMT, 1997, SCIENCE, V275, P1491; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; FOLKESSON HG, 1994, P NATL ACAD SCI USA, V91, P4970, DOI 10.1073/pnas.91.11.4970; FOSTER RE, 1998, P NATL ACAD SCI USA, V95, P15815; GUTKNECHT J, 1977, J GEN PHYSIOL, V69, P779; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; MA TH, 1994, J BIOL CHEM, V269, P21845; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; SHI LB, 1994, J BIOL CHEM, V269, P10417; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; VANHOEK AN, 1993, BIOCHEMISTRY-US, V32, P11847, DOI 10.1021/bi00095a013; VANHOEK AN, 1992, J BIOL CHEM, V267, P18267; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; Verkman AS, 1997, SCIENCE, V275, P1491; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; ZHANG RB, 1993, J CELL BIOL, V120, P359, DOI 10.1083/jcb.120.2.359	34	152	156	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2686	2692		10.1074/jbc.275.4.2686	http://dx.doi.org/10.1074/jbc.275.4.2686			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644730	hybrid			2022-12-27	WOS:000085128000062
J	Kaji, T; Yamada, A; Miyajima, S; Yamamoto, C; Fujiwara, Y; Wight, TN; Kinsella, MG				Kaji, T; Yamada, A; Miyajima, S; Yamamoto, C; Fujiwara, Y; Wight, TN; Kinsella, MG			Cell density-dependent regulation of proteoglycan synthesis by transforming growth factor-beta(1) in cultured bovine aortic endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; CHONDROITIN SULFATE PROTEOGLYCAN; SMALL INTERSTITIAL PROTEOGLYCANS; FACTOR-BETA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; ARTERIAL PROTEOGLYCANS; MOLECULAR-WEIGHT; CORE PROTEINS; DNA-SYNTHESIS	The regulation of vascular endothelial cell behavior during angiogenesis and in disease by transforming growth factor-beta(1) (TGF-beta(1)) is complex, but it clearly involves growth factor-induced changes in extracellular matrix synthesis. Proteoglycans (PGs) synthesized by endothelial cells contribute to the formation of the vascular extracellular matrix and also influence cellular proliferation and migration. Since the effects of TGF-beta(1) on vascular smooth muscle cell growth are dependent on cell density, it is possible that TGF-beta(1) also directs different patterns of PG synthesis in endothelial cells at different cell densities. In the present study, dense and sparse cultures of bovine aortic endothelial cells were metabolically labeled with [H-3]glucosamine, [S-35]sulfate, or S-35-labeled amino acids in the presence of TGF-beta(1). The labeled PGs were characterized by DEAE-Sephacel ion exchange chromatography and Sepharose CL-4B molecular sieve chromatography, The glycosaminoglycan M-r and composition were analyzed by Sepharose CL-6B chromatography, and the core protein M-r was analyzed by SDS-polyacrylamide gel electrophoresis, before and after digestion with papain, heparitinase, or chondroitin ABC lyase. These experiments indicate that the effect of TGF-beta(1) on vascular endothelial cell PG synthesis is dependent on cell density. Specifically, TGF-beta(1) induced an accumulation of small chondroitin/dermatan sulfate PGs (CS/DSPGs) with core proteins of similar to 50 kDa in the medium of both dense and sparse cultures, but a cell layer-associated heparan sulfate PG with a core protein size of similar to 400 kDa accumulated only in dense cultures. Moreover, only in the dense cell cultures did TGF-beta(1) cause CS/DSPG hydrodynamic size to increase, which was due to the synthesis of CS/DSPGs with longer glycosaminoglycan chains. The heparan sulfate PG and CS/DSPG core proteins were identified as perlecan and biglycan, respectively, by Western blot analysis. The present data suggest that TGF-beta(1) promotes the synthesis of both perlecan and biglycan when endothelial cell density is high, whereas only biglycan synthesis is stimulated when the cell density is low. Furthermore, glycosaminoglycan chains are elongated only in biglycan synthesized by the cells at a high cell density.	Hokuriku Univ, Fac Pharmaceut Sci, Dept Environm Hlth, Kanazawa, Ishikawa 9201181, Japan; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Hokuriku University; University of Washington; University of Washington Seattle	Kaji, T (corresponding author), Hokuriku Univ, Fac Pharmaceut Sci, Dept Environm Hlth, Ho 3 Kanagawa Machi, Kanazawa, Ishikawa 9201181, Japan.		Fujiwara, Yasuyuki/AAB-8775-2020	Fujiwara, Yasuyuki/0000-0003-0028-0658				ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; ASUNDI V, 1990, EUR J CELL BIOL, V52, P98; AVIEZER D, 1994, J BIOL CHEM, V269, P114; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; BASSOLS A, 1988, J BIOL CHEM, V263, P3039; BERENSON GS, 1984, EXP MOL PATHOL, V41, P267, DOI 10.1016/0014-4800(84)90043-1; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; CAMEJO G, 1980, ATHEROSCLEROSIS, V36, P55, DOI 10.1016/0021-9150(80)90198-7; CAMEJO G, 1982, ADV LIPID RES, V19, P1; CHEN JK, 1987, P NATL ACAD SCI USA, V84, P5287, DOI 10.1073/pnas.84.15.5287; CHEN JK, 1991, IN VITRO CELL DEV B, V27, P6; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; DODGE GR, 1990, J BIOL CHEM, V265, P18023; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FLAUMENHAFT R, 1989, J CELL PHYSIOL, V140, P75, DOI 10.1002/jcp.1041400110; FRATERSCHRODER M, 1986, BIOCHEM BIOPH RES CO, V137, P295, DOI 10.1016/0006-291X(86)91209-X; GILL PJ, 1981, BIOCHEM J, V194, P299, DOI 10.1042/bj1940299; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; GUITERREZ P, 1997, CARDIOVASC PATHOL, V6, P271; HEIMER R, 1995, J MOL CELL CARDIOL, V27, P2191, DOI 10.1016/S0022-2828(95)91479-X; HEINEGARD D, 1985, BIOCHEM J, V230, P181, DOI 10.1042/bj2300181; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; JARVELAINEN HT, 1992, EXP CELL RES, V203, P395, DOI 10.1016/0014-4827(92)90013-X; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; KAPOOR R, 1981, BIOCHEM J, V197, P259, DOI 10.1042/bj1970259; KINSELLA MG, 1986, J CELL BIOL, V102, P679, DOI 10.1083/jcb.102.3.679; KINSELLA MG, 1988, BIOCHEMISTRY-US, V27, P2136, DOI 10.1021/bi00406a048; KISSANE JM, 1958, J BIOL CHEM, V233, P184; KOJIMA T, 1992, J BIOL CHEM, V267, P4859; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAJACK RA, 1987, J CELL BIOL, V105, P465, DOI 10.1083/jcb.105.1.465; MERTENS G, 1992, J BIOL CHEM, V267, P20435; MORITA H, 1990, BIOCHEM J, V265, P61, DOI 10.1042/bj2650061; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; O'Brien KD, 1998, CIRCULATION, V98, P519, DOI 10.1161/01.CIR.98.6.519; REGISTER TC, 1990, CONNECT TISSUE RES, V25, P35, DOI 10.3109/03008209009009811; ROBERTS AB, 1989, AM REV RESPIR DIS, V140, P1126, DOI 10.1164/ajrccm/140.4.1126; ROMARIS M, 1991, BIOCHIM BIOPHYS ACTA, V1093, P229, DOI 10.1016/0167-4889(91)90127-J; ROWE HA, 1985, ARTERIOSCLEROSIS, V5, P101, DOI 10.1161/01.ATV.5.1.101; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SAKU T, 1989, J BIOL CHEM, V264, P3514; SALISBURY BGJ, 1985, AM J PATHOL, V120, P6; SALISBURY BGJ, 1981, J BIOL CHEM, V256, P8050; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; Saxena Uday, 1994, Current Opinion in Lipidology, V5, P316, DOI 10.1097/00041433-199410000-00002; SCHMIDT A, 1982, EUR J BIOCHEM, V125, P95, DOI 10.1111/j.1432-1033.1982.tb06655.x; SCHONHERR E, 1993, ARTERIOSCLER THROMB, V13, P1026, DOI 10.1161/01.ATV.13.7.1026; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schonherr E, 1999, EUR J CELL BIOL, V78, P44, DOI 10.1016/S0171-9335(99)80006-5; SILVERSTEIN JJ, 1987, SEMIN THROMB HEMOST, V13, P504; WAGNER WD, 1983, J BIOL CHEM, V258, P1136; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; Weiser MCM, 1997, MOL BIOL CELL, V8, P999, DOI 10.1091/mbc.8.6.999; Weiser MCM, 1996, MATRIX BIOL, V15, P331, DOI 10.1016/S0945-053X(96)90136-5; Wight T N, 1980, Prog Hemost Thromb, V5, P1; WIGHT TN, 1989, ARTERIOSCLEROSIS, V9, P1, DOI 10.1161/01.ATV.9.1.1; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; YLAHERTTUALA S, 1986, LAB INVEST, V54, P402	63	68	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1463	1470		10.1074/jbc.275.2.1463	http://dx.doi.org/10.1074/jbc.275.2.1463			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625699	hybrid			2022-12-27	WOS:000084836600103
J	Pei, L				Pei, L			Phosphorylation modulates the function of the vasoactive intestinal polypeptide receptor transcriptional repressor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; REPLICATION FACTOR-C; THYROID-HORMONE RECEPTOR; BINDING-PROTEIN; RESPONSIVE ELEMENT; SOMATOSTATIN GENE; MOLECULAR-CLONING; DNA-LIGASE; T-ANTIGEN; EXPRESSION	The transcriptional repressor for rat vasoactive intestinal polypeptide receptor 1 (VIPR-RP) is a recently isolated transcription factor. In this study, we have characterized the functional domains of VIPR-RP and the importance of phosphorylation on VIPR-RP function. Using various regions of VIPR-RP in gel mobility shift assays, we show that the amino acid sequences between positions 367 and 475 play an essential role for VIPR-RP DNA binding. Transient transfection of fusion constructs containing GAL4 DNA binding domain and different parts of VTPR-RP indicated that there are two separate transcriptional repression domains in VIPR-RP, located between amino acids 50 and 101 and between 469 and 527. We demonstrated that VIPR-RP is phosphorylated in vitro by casein kinase II on Ser-69/71 and Thr-110, and by cAMP-dependent kinase on Ser-245/361. Furthermore, by site-directed mutagenesis, we show that phosphorylation of the casein kinase II sites potentiates VIPR-RP transcriptional repression activity by enhancing its nuclear translocation, and that phosphorylation by cAMP-dependent kinase inhibits VIPR-RP transcriptional repression function without affecting its subcellular localization. These observations suggest that phosphorylation plays an important role in regulating VIPR-RP function.	Univ Calif Los Angeles, Cedars Sinai Res Inst, Sch Med, Div Endocrinol & Metab, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pei, L (corresponding author), Cedars Sinai Med Ctr, Div Endocrinol & Metab, 8700 Beverly Blvd,D3066, Los Angeles, CA 90048 USA.				NIDDK NIH HHS [DK-02346] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002346] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANIAHMAD A, 1995, MOL CELL BIOL, V15, P76, DOI 10.1128/MCB.15.1.76; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; BURBELO PD, 1993, P NATL ACAD SCI USA, V90, P11543, DOI 10.1073/pnas.90.24.11543; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FRANKEL AD, 1991, CELL, V65, P717, DOI 10.1016/0092-8674(91)90378-C; GLASS DB, 1986, J BIOL CHEM, V261, P2987; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HIGG EA, 1985, EMBO J, V4, P2801; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; JIN WD, 1994, MOL ENDOCRINOL, V8, P1377, DOI 10.1210/me.8.10.1377; KALDERON D, 1984, NATURE, V311, P109; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; LAUER G, 1991, J BACTERIOL, V173, P5047, DOI 10.1128/jb.173.16.5047-5053.1991; LU Y, 1993, BIOCHEM BIOPH RES CO, V193, P779, DOI 10.1006/bbrc.1993.1693; LUCKOW B, 1994, MOL CELL BIOL, V14, P1626, DOI 10.1128/MCB.14.3.1626; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MCGEHEE RE, 1995, MOL ENDOCRINOL, V9, P487, DOI 10.1210/me.9.4.487; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; MEGGIO F, 1994, CELL MOL BIOL RES, V40, P401; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Pei L, 1997, REGUL PEPTIDES, V71, P153, DOI 10.1016/S0167-0115(97)01012-4; PEI L, 1995, BIOCHEM J, V308, P719, DOI 10.1042/bj3080719; Pei L, 1998, J BIOL CHEM, V273, P19902, DOI 10.1074/jbc.273.31.19902; Pei L, 1996, J BIOL CHEM, V271, P20879; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; RIABOWOL KT, 1988, NATURE, V336, P83, DOI 10.1038/336083a0; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; SCHEIDTMANN KH, 1991, J VIROL, V65, P1479, DOI 10.1128/JVI.65.3.1479-1490.1991; SHARK KB, 1992, FEMS MICROBIOL LETT, V96, P19, DOI 10.1111/j.1574-6968.1992.tb05387.x; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SILVER PA, 1988, GENE DEV, V2, P707, DOI 10.1101/gad.2.6.707; TONE Y, 1994, J BIOL CHEM, V269, P31157; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; USDIN TB, 1994, ENDOCRINOLOGY, V135, P2662, DOI 10.1210/en.135.6.2662	41	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1176	1182		10.1074/jbc.275.2.1176	http://dx.doi.org/10.1074/jbc.275.2.1176			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625661	hybrid			2022-12-27	WOS:000084836600065
J	Namsaraev, EA; Berg, P				Namsaraev, EA; Berg, P			Rad51 uses one mechanism to drive DNA strand exchange in both directions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; RECA PROTEIN; BRANCH MIGRATION; ATP HYDROLYSIS; SACCHAROMYCES-CEREVISIAE; POLARITY; BINDING; REQUIREMENTS; REPLICATION; SEQUENCE	The Rad51 protein of Saccharomyces cerevisiae, like its bacterial counterpart RecA, promotes strand exchange between circular single-stranded DNA (ssDNA) and linear double-stranded DNA (dsDNA) in vitro, However, the two proteins differ in the requirement for initiating joint molecules and in the polarity of branch migration. Whereas RecA initiates joint molecules from any type of ends on the dsDNA and branch migration proceeds exclusively in the 5'- to 3'-direction with respect to the single strand DNA substrate, initiation mediated by Rad51 requires a complementary 3' or 5' overhanging end of the linear dsDNA and branch migration proceeds in either direction. Here we report that the rates of Rad51-mediated branch migration in either the 5'- to 3'- or 3'- to 5'-directions are affected to the same extent by temperature and MgCl2. Furthermore, branch migration in both directions is equally impeded by in sertions of non-homologous sequences in the dsDNA, inserts of 6 base pairs or more being completely inhibitory. We have also found that the preference of strand exchange in the 5'- to 3'-direction does not change if RPA is replaced by Escherichia coli SSB or T4 gene 32 proteins, suggesting that the preference for the direction of strand exchange is intrinsic to Rad51, Based on these results, we conclude that Rad51-promoted branch migration in either direction occurs fundamentally by the same mechanism, quite probably by stabilizing successively formed heteroduplex base pair.	Stanford Univ, Beckman Ctr Mol & Genet Med, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Berg, P (corresponding author), Stanford Univ, Beckman Ctr Mol & Genet Med, Sch Med, Dept Biochem, B062, Stanford, CA 94305 USA.				NIGMS NIH HHS [GM13235] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM013235, R01GM013235] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; BASILE G, 1992, MOL CELL BIOL, V12, P3235, DOI 10.1128/MCB.12.7.3235; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P6018, DOI 10.1073/pnas.78.10.6018; COX MM, 1994, TRENDS BIOCHEM SCI, V19, P217, DOI 10.1016/0968-0004(94)90025-6; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; HALL SD, 1994, P NATL ACAD SCI USA, V91, P3205, DOI 10.1073/pnas.91.8.3205; He ZG, 1996, J BIOL CHEM, V271, P28243, DOI 10.1074/jbc.271.45.28243; JAIN SK, 1994, J BIOL CHEM, V269, P20653; KIM JI, 1992, J BIOL CHEM, V267, P16438; KONFORTI BB, 1992, J MOL BIOL, V227, P38, DOI 10.1016/0022-2836(92)90680-I; Li Z, 1998, J MOL BIOL, V276, P733, DOI 10.1006/jmbi.1997.1572; MacFarland KJ, 1997, J BIOL CHEM, V272, P17675, DOI 10.1074/jbc.272.28.17675; Namsaraev E, 1997, MOL CELL BIOL, V17, P5359, DOI 10.1128/MCB.17.9.5359; Namsaraev EA, 1998, P NATL ACAD SCI USA, V95, P10477, DOI 10.1073/pnas.95.18.10477; Namsaraev EA, 1998, J BIOL CHEM, V273, P6177, DOI 10.1074/jbc.273.11.6177; Namsaraev EA, 1998, BIOCHEMISTRY-US, V37, P11932, DOI 10.1021/bi9810297; Nayak S, 1999, J BIOL CHEM, V274, P25979, DOI 10.1074/jbc.274.37.25979; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; PANYUTIN IG, 1995, EMBO J, V14, P1819, DOI 10.1002/j.1460-2075.1995.tb07170.x; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; WEST SC, 1981, P NATL ACAD SCI-BIOL, V78, P6149, DOI 10.1073/pnas.78.10.6149	30	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3970	3976		10.1074/jbc.275.6.3970	http://dx.doi.org/10.1074/jbc.275.6.3970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660552	hybrid			2022-12-27	WOS:000085288800036
J	Gray, PC; Greenwald, J; Blount, AL; Kunitake, KS; Donaldson, CJ; Choe, S; Vale, W				Gray, PC; Greenwald, J; Blount, AL; Kunitake, KS; Donaldson, CJ; Choe, S; Vale, W			Identification of a binding site on the type II activin receptor for activin and inhibin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PROTEIN; CLONING; RESPONSES; DOMAIN; KINASE; CELLS	Type II activin receptors (ActRII and ActRIIB) are single-transmembrane domain serine/threonine kinase receptors that bind activin to initiate the signaling and cellular responses triggered by this hormone, Inhibin also binds type II activin receptors and antagonizes many activin effects. Here we describe alanine scanning mutagenesis of the ActRII extracellular domain, We identify a cluster of three hydrophobic residues (Phe(42), Trp(60), and phe(83)) that, when individually mutated to alanine in the context of the full-length receptor, cause the disruption of activin and inhibin binding to ActRII, Each of the alanine-substituted ActRII mutants retaining activin binding maintains the ability to form crosslinked complexes with activin and supports activin cross-linking to the type I activin receptor ALK4, Unlike wild-type ActRII, the three mutants unable to bind activin do not cause an increase in activin signaling when transiently expressed in a corticotroph cell line, Together, our results implicate these residues in forming a critical binding surface on ActRII required for functional interactions with both activin and inhibin, This first identification of a transforming growth factor-p family member binding site may provide a general basis for characterizing binding sites for other members of the superfamily.	Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Vale, W (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vale@salk.edu			NICHD NIH HHS [HD-13527] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD013527] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Attisano L, 1996, MOL CELL BIOL, V16, P1066; BILEZIKJIAN LM, 1991, MOL ENDOCRINOL, V5, P1389, DOI 10.1210/mend-5-10-1389; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHILDS SR, 1993, P NATL ACAD SCI USA, V90, P9475, DOI 10.1073/pnas.90.20.9475; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Donaldson CJ, 1999, ENDOCRINOLOGY, V140, P1760, DOI 10.1210/en.140.4.1760; Draper LB, 1998, J BIOL CHEM, V273, P398, DOI 10.1074/jbc.273.1.398; Gilboa L, 1998, J CELL BIOL, V140, P767, DOI 10.1083/jcb.140.4.767; Greenwald J, 1998, BIOCHEMISTRY-US, V37, P16711, DOI 10.1021/bi981939o; Greenwald J, 1999, NAT STRUCT BIOL, V6, P18; Guimond A, 1999, FEBS LETT, V456, P79, DOI 10.1016/S0014-5793(99)00869-8; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; KESSLER DS, 1994, SCIENCE, V266, P596, DOI 10.1126/science.7939714; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; LIU F, 1995, MOL CELL BIOL, V15, P3479; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MATHEWS LS, 1993, J BIOL CHEM, V268, P19013; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Pepin MC, 1996, BIOCHEM BIOPH RES CO, V220, P289, DOI 10.1006/bbrc.1996.0398; REES B, 1993, CHEM RES TOXICOL, V6, P385, DOI 10.1021/tx00034a001; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; TSUCHIDA K, 1995, ENDOCRINOLOGY, V136, P5493, DOI 10.1210/en.136.12.5493; VALE W, 1988, RECENT PROG HORM RES, V44, P1; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; VALE W, 1995, PRINCIPLES PHARM BAS, P883; Vale W., 1990, HDB EXPT PHARM, P211; VAUGHAN JM, 1993, ENDOCRINOLOGY, V132, P2038, DOI 10.1210/en.132.5.2038; Wuytens G, 1999, J BIOL CHEM, V274, P9821, DOI 10.1074/jbc.274.14.9821; XU JM, 1995, J BIOL CHEM, V270, P6308, DOI 10.1074/jbc.270.11.6308; YOUNG L, 1994, PROTEIN SCI, V3, P717	35	87	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3206	3212		10.1074/jbc.275.5.3206	http://dx.doi.org/10.1074/jbc.275.5.3206			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652306	hybrid			2022-12-27	WOS:000085146500028
J	Porter, CM; Havens, MA; Clipstone, NA				Porter, CM; Havens, MA; Clipstone, NA			Identification of amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; TRANSCRIPTION FACTOR NFAT1; KEY SIGNALING ENZYME; NF-AT; NUCLEAR FACTOR; CYCLOSPORINE-A; CALCINEURIN; FAMILY; PHOSPHORYLATION; LYMPHOCYTES	The subcellular localization of the transcription factor NFATc is tightly regulated by the calcium-regulated phosphatase calcineurin, which acts to directly dephosphorylate NFATc, causing its rapid translocation from the cytoplasm to the nucleus. The calcineurin-mediated nuclear localization of NFATc is opposed by poorly defined protein kinases that act either to directly antagonize nuclear import or, alternatively, to promote nuclear export, Here, we provide evidence that the cellular protein kinases JNK, ERK, p38, and CK2 (formerly casein kinase II) are involved in the regulation of NFATc subcellular localization. We show that JNK, ERK, and p38 physically associate with the NFATc N-terminal regulatory domain and can directly phosphorylate functionally important residues involved in regulating NFATc subcellular localization, namely Ser(172) and the conserved NFATc Ser-Pro repeats. Moreover, we found that overexpression of JNK, ERK, or p38 is able to block ionomycin-induced NFATc nuclear translocation, whereas treatment of cells with both PD98059 and SB202190, which inhibit MAPK/SAPK signaling pathways, is sufficient to trigger NFATc nuclear localization. Finally, we show that CK2 also binds the N terminus of NFATc and phosphorylates functionally important amino acid residues, including a conserved amino acid motif located downstream of each of the NFATc Ser-Pro repeats that appears to be important for regulating NFATc nuclear export. Collectively, these studies identify functionally important amino acid residues and protein kinases involved in the regulation of NFATc subcellular localization.	Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University	Clipstone, NA (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	n-clipstone@nwu.edu			NIGMS NIH HHS [GM55292] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM055292] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; CASTIGLI E, 1993, J IMMUNOL, V150, P3284; CHOI MSK, 1994, IMMUNITY, V1, P179, DOI 10.1016/1074-7613(94)90096-5; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.bi.63.070194.005145; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Ho IC, 1998, P NATL ACAD SCI USA, V95, P15537, DOI 10.1073/pnas.95.26.15537; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Klemm JD, 1997, CURR BIOL, V7, P638, DOI 10.1016/S0960-9822(06)00290-9; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Loh C, 1996, MOL CELL BIOL, V16, P3945; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; MartinezMartinez S, 1997, MOL CELL BIOL, V17, P6437, DOI 10.1128/MCB.17.11.6437; Masuda ES, 1997, MOL CELL BIOL, V17, P2066, DOI 10.1128/MCB.17.4.2066; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PRIESCHL EE, 1995, J IMMUNOL, V154, P6112; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; RUFF VA, 1995, J BIOL CHEM, V270, P22602, DOI 10.1074/jbc.270.38.22602; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; VENKATARAMAN L, 1994, IMMUNITY, V1, P189, DOI 10.1016/1074-7613(94)90097-3; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	54	130	135	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3543	3551		10.1074/jbc.275.5.3543	http://dx.doi.org/10.1074/jbc.275.5.3543			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652349	hybrid			2022-12-27	WOS:000085146500071
J	Sester, M; Feuerbach, D; Frank, R; Preckel, T; Gutermann, A; Burgert, HG				Sester, M; Feuerbach, D; Frank, R; Preckel, T; Gutermann, A; Burgert, HG			The amyloid precursor-like protein 2 associates with the major histocompatibility complex class I molecule K-d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ENDOPLASMIC-RETICULUM; ANTIGEN-PRESENTATION; ADENOVIRUS TYPE-2; E3/19K PROTEIN; ALZHEIMERS-DISEASE; CELL-SURFACE; INTRACELLULAR-TRANSPORT; TRANSMEMBRANE PROTEINS; GROWTH-REGULATION	Amyloid precursor-like protein 2 (APLP2) is a member of a protein family related to the amyloid precursor protein, which is implicated in Alzheimer's disease. Little is known about the physiological function of this protein family. The adenovirus E3/19K protein binds to major histocompatibility complex (MHC) class I antigens in the endoplasmic reticulum, thereby preventing their transport to the cell surface. In cells coexpressing E3/19K and the MHC K-d molecule, K-d is associated with E3/19K and two cellular protein species with masses of 100 and 110 kDa, termed p100/110, Interestingly, p100/110 are released from the complex upon the addition of K-d-binding peptides, suggesting a role for these proteins in peptide transfer to MHC molecules. Here we demonstrate by microsequencing, reactivity with APLP2-specific antibodies, and comparison of biochemical parameters that p100/110 is identical to human APLP2, We further show that the APLP2/K-d association does not require the physical presence of E3/19K. Thus, APLP2 exhibits an intrinsic affinity for the MHC K-d molecule. Similar to the binding of MHC molecules to the transporter associated with antigen processing, complex formation between APLP2 and K-d strictly depends upon the presence of beta(2)-microglobulin. Conditions that prolong the residency of K-d in the endoplasmic reticulum lead to a profound increase of the association and a drastic reduction of APLP2 transport. Therefore, this unexpected interplay between these unrelated molecules may have implications for both MHC antigen and APLP2 function.	Max Von Pettenkofer Inst, Dept Virol, Genzentrum, D-81377 Munich, Germany; Ctr Mol Biol, D-69120 Heidelberg, Germany	University of Munich	Burgert, HG (corresponding author), Max Von Pettenkofer Inst, Dept Virol, Genzentrum, Feodor Lynen Str 25, D-81377 Munich, Germany.	burgert@lmb.uni-muenchen.de	Sester, Martina/AAA-3383-2022; Burgert, Hans-Gerhard/AAE-6668-2020	Burgert, Hans-Gerhard/0000-0002-1650-9878; Sester, Martina/0000-0001-5482-0002				ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Bennett EM, 1999, J IMMUNOL, V162, P5049; Burgert HG, 1996, TRENDS MICROBIOL, V4, P107, DOI 10.1016/0966-842X(96)81527-7; BURGERT HG, 1987, P NATL ACAD SCI USA, V84, P1356, DOI 10.1073/pnas.84.5.1356; BURGERT HG, 1987, EMBO J, V6, P2019, DOI 10.1002/j.1460-2075.1987.tb02466.x; BUSH AI, 1994, J BIOL CHEM, V269, P26618; CARRENO BM, 1995, J IMMUNOL, V155, P4726; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; COX JH, 1991, J EXP MED, V174, P1629, DOI 10.1084/jem.174.6.1629; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; DELVAL M, 1992, J EXP MED, V176, P729, DOI 10.1084/jem.176.3.729; Deryckere F, 1996, J VIROL, V70, P2832, DOI 10.1128/JVI.70.5.2832-2841.1996; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Elsing A, 1998, P NATL ACAD SCI USA, V95, P10072, DOI 10.1073/pnas.95.17.10072; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; FEUERBACH D, 1994, J IMMUNOL, V153, P1626; FEUERBACH D, 1993, EMBO J, V12, P3153, DOI 10.1002/j.1460-2075.1993.tb05984.x; Flomenberg P, 1996, J VIROL, V70, P6314, DOI 10.1128/JVI.70.9.6314-6322.1996; GABATHULER R, 1990, J CELL BIOL, V111, P1803, DOI 10.1083/jcb.111.5.1803; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hengel H, 1997, CURR OPIN IMMUNOL, V9, P470, DOI 10.1016/S0952-7915(97)80097-0; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Koopmann JO, 1997, CURR OPIN IMMUNOL, V9, P80, DOI 10.1016/S0952-7915(97)80163-X; KORNER H, 1992, P NATL ACAD SCI USA, V89, P11857, DOI 10.1073/pnas.89.24.11857; Lagaudriere-Gesbert C, 1997, J IMMUNOL, V158, P2790; LAPHAM CK, 1993, J EXP MED, V177, P1633, DOI 10.1084/jem.177.6.1633; Lehner PJ, 1998, CURR BIOL, V8, pR605, DOI 10.1016/S0960-9822(98)70387-2; Lindquist JA, 1998, EMBO J, V17, P2186, DOI 10.1093/emboj/17.8.2186; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LO ACY, 1995, J BIOL CHEM, V270, P12641, DOI 10.1074/jbc.270.21.12641; Marusina K, 1997, BIOCHEMISTRY-US, V36, P856, DOI 10.1021/bi9619738; Neisig A, 1996, J IMMUNOL, V156, P3196; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PAABO S, 1986, EMBO J, V5, P1921, DOI 10.1002/j.1460-2075.1986.tb04445.x; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; PANGALOS MN, 1995, J NEUROCHEM, V65, P762; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Popp GM, 1996, ENDOCRINOLOGY, V137, P1975, DOI 10.1210/en.137.5.1975; Rassoulzadegan M, 1998, EMBO J, V17, P4647, DOI 10.1093/emboj/17.16.4647; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SANDBRINK R, 1994, J BIOL CHEM, V269, P14227; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SESTER M, 1994, J VIROL, V68, P5423, DOI 10.1128/JVI.68.9.5423-5432.1994; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Solheim JC, 1997, J IMMUNOL, V158, P2236; SPRECHER CA, 1993, BIOCHEMISTRY-US, V32, P4481, DOI 10.1021/bi00068a002; SRIVASTAVA PK, 1994, CURR OPIN IMMUNOL, V6, P728, DOI 10.1016/0952-7915(94)90076-0; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; THINAKARAN G, 1995, J NEUROSCI, V15, P6314; THINAKARAN G, 1995, J BIOL CHEM, V270, P16522, DOI 10.1074/jbc.270.28.16522; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; van Endert PM, 1999, CURR OPIN IMMUNOL, V11, P82, DOI 10.1016/S0952-7915(99)80015-6; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; VONDERKAMMER H, 1994, DNA CELL BIOL, V13, P1137, DOI 10.1089/dna.1994.13.1137; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	70	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3645	3654		10.1074/jbc.275.5.3645	http://dx.doi.org/10.1074/jbc.275.5.3645			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652361	hybrid			2022-12-27	WOS:000085146500083
J	Weyand, NJ; Low, DA				Weyand, NJ; Low, DA			Regulation of pap phase variation - Lrp is sufficient for the establishment of the phase off pap DNA methylation pattern and repression of pap transcription in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYELONEPHRITIS-ASSOCIATED PILI; ESCHERICHIA-COLI; RNA-POLYMERASE; EXPRESSION; PROTEIN; OPERON; SEQUENCES; SIGMA; GENE; PROMOTERS	The pyelonephritis-associated pili (pap) operon in Escherichia coli is regulated by an epigenetic mechanism involving the formation of specific DNA methylation patterns characteristic of transcriptionally active (phase ON) and inactive (phase OFF) cells. The formation of pap DNA methylation patterns in vivo was previously shown to require the leucine-responsive regulatory protein (Lrp) and DNA adenine methylase (Dam). To monitor the binding of Lrp to pap DNA, an in vitro methylation protection assay was developed. Binding of Lrp to a Dam target site proximal to the papBA promoter (designated GATC(prox)) blocked methylation of this site and specifically repressed transcription. The DNA methylation pattern and transcription state are identical to those observed in vivo in phase OFF cells. To determine if binding of Lrp at GATC(prox) was necessary for repression of papBA transcription, we analyzed a pnp mutation (pap-13) that reduced the affinity of Lrp for the GATC(prox) region. Binding of Lrp to pap-13 DNA was shifted to a promoter distal Dam target site (designated GATC(dist)). Lrp blocked methylation of GATC(dist) in the pap-13 mutant, but did not repress papBA transcription. Together, these results show that binding of Lrp to the GATC(prox) region is sufficient for the establishment of the phase OFF DNA methylation pattern and repression of papBA transcription.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Low, DA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Rm 3129,Biosci II Bldg, Santa Barbara, CA 93106 USA.	low@lifesci.ucsb.edu			NIAID NIH HHS [AI23348] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023348, R21AI023348] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ausubel FM, 1988, MOL REPROD DEV; Bearson SMD, 1996, J BACTERIOL, V178, P2572, DOI 10.1128/jb.178.9.2572-2579.1996; Beltrametti F, 1999, J BACTERIOL, V181, P3409, DOI 10.1128/JB.181.11.3409-3418.1999; BLYN LB, 1989, EMBO J, V8, P613, DOI 10.1002/j.1460-2075.1989.tb03416.x; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; BRAATEN BA, 1991, J BACTERIOL, V173, P1789, DOI 10.1128/jb.173.5.1789-1800.1991; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; ERNSTING BR, 1993, J BACTERIOL, V175, P7160, DOI 10.1128/JB.175.22.7160-7169.1993; GROSS CA, 1984, J MOL BIOL, V172, P283, DOI 10.1016/S0022-2836(84)80027-3; HALE WB, 1994, J BACTERIOL, V176, P3438, DOI 10.1128/jb.176.11.3438-3441.1994; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HENGGEARONIS R, 1996, ESCHERICHIA COLI SAL, V1, P1497; HU JC, 1983, MOL GEN GENET, V191, P492, DOI 10.1007/BF00425768; HULSMANN KH, 1991, GENE, V98, P83, DOI 10.1016/0378-1119(91)90107-M; HULTGREN SJ, 1993, CELL, V73, P887, DOI 10.1016/0092-8674(93)90269-V; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; KALTENBACH LS, 1995, J BACTERIOL, V177, P6449, DOI 10.1128/jb.177.22.6449-6455.1995; KARLS R, 1989, NUCLEIC ACIDS RES, V17, P3927, DOI 10.1093/nar/17.10.3927; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; LOW D, 1987, MOL MICROBIOL, V1, P335, DOI 10.1111/j.1365-2958.1987.tb01940.x; Marschall C, 1998, J MOL BIOL, V276, P339, DOI 10.1006/jmbi.1997.1533; Mathew E, 1996, J BACTERIOL, V178, P7234, DOI 10.1128/jb.178.24.7234-7240.1996; MULVEY MR, 1988, GENE, V73, P337, DOI 10.1016/0378-1119(88)90498-2; NEWMAN EB, 1992, CELL, V68, P617, DOI 10.1016/0092-8674(92)90135-Y; NOU XW, 1993, MOL MICROBIOL, V7, P545, DOI 10.1111/j.1365-2958.1993.tb01145.x; NOU XW, 1995, EMBO J, V14, P5785, DOI 10.1002/j.1460-2075.1995.tb00267.x; PARKER B, 1988, GENE, V73, P531, DOI 10.1016/0378-1119(88)90517-3; Rhee KY, 1996, J BIOL CHEM, V271, P26499, DOI 10.1074/jbc.271.43.26499; Riggs A.D., 1996, COLD SPRING HARBOR M, V32, P29; SIMONIAN MH, 1995, CURRENT PROTOCOLS PR, V1; Suh SJ, 1999, J BACTERIOL, V181, P3890, DOI 10.1128/JB.181.13.3890-3897.1999; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; van der Woude M, 1998, J BACTERIOL, V180, P5913, DOI 10.1128/JB.180.22.5913-5920.1998; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; VANDERWOUDE MW, 1995, MOL MICROBIOL, V17, P303, DOI 10.1111/j.1365-2958.1995.mmi_17020303.x; VANDERWOUDE MW, 1992, MOL MICROBIOL, V6, P2429; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZHOU YN, 1992, J BACTERIOL, V174, P5005, DOI 10.1128/JB.174.15.5005-5012.1992	45	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3192	3200		10.1074/jbc.275.5.3192	http://dx.doi.org/10.1074/jbc.275.5.3192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652304	hybrid			2022-12-27	WOS:000085146500026
J	Hu, Z; Jin, SK; Scotto, KW				Hu, Z; Jin, SK; Scotto, KW			Transcriptional activation of the MDR1 gene by UV irradiation - Role of NF-Y and Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOX-BINDING-PROTEIN; TRANSPORTING P-GLYCOPROTEINS; MULTIDRUG-RESISTANCE; CLASS-II; DNA-BINDING; PROMOTER ACTIVITY; FACTOR YB-1; EXPRESSION; CELLS; INVOLVEMENT	The MDR1 promoter is subject to control by various internal and external stimuli. We have previously shown that the CCAAT box-binding protein, NF-Y, mediates MDR1 activation by the histone deacetylase inhibitors, trichostatin A and sodium butyrate, through the recruitment of the co-activator, P/CAF. We have now extended our investigation to the activation of MDR1 by genotoxic stress. We show that activation of the MDR1 promoter by UV irradiation is also dependent on the CCAAT box (-82 to -73) as well as on a proximal GC element (-56 to -42). Gel shift and supershift analyses with nuclear extracts prepared from human KB-3-1 cells identified NF-Y as the transcription factor interacting with the CCAAT box, while Spl was the predominant factor binding to the GC element. Mutations that abrogated binding of either of these factors reduced or abolished activation by ultraviolet irradiation; moreover, co-expression of a dominant-negative NF-Y protein (NE-YA29) reduced UV-activated transcription. Interestingly, YB-1, a transcription factor that also recognizes the CCAAT motif and had been reported to mediate induction of the MDR1 promoter by ultraviolet light, was incapable of interacting with the double-stranded MDR1 CCAAT box oligonucleotide in nuclear extracts, although it did interact with a single-stranded oligonucleotide. Furthermore, a mutation that abolished activation of MDR1 by W-irradiation had no effect on YB-1 binding and co-transfection of a YB-1 expression plasmid had a repressive effect on UV-inducible transcription. Taken together, these results indicate a role for both NF-Y and Spl in the transcriptional activation of the MDR1 gene by genotoxic stress, and indicate that YB-1, if involved, is not sufficient to mediate this activation.	Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Scotto, KW (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, 1275 York Ave, New York, NY 10021 USA.	k-scotto@ski.mskcc.org			NCI NIH HHS [R01-CA-57307, P30-CA-08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057307, P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abolhoda A, 1999, CLIN CANCER RES, V5, P3352; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; ASAKUNO K, 1994, BIOCHEM BIOPH RES CO, V199, P1428, DOI 10.1006/bbrc.1994.1390; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Bezombes C, 1998, FASEB J, V12, P101, DOI 10.1096/fasebj.12.1.101; CHARUK JHM, 1995, AM J PHYSIOL-RENAL, V269, pF31, DOI 10.1152/ajprenal.1995.269.1.F31; CHAUDHARY PM, 1993, J NATL CANCER I, V85, P632, DOI 10.1093/jnci/85.8.632; CHIN KV, 1990, J BIOL CHEM, V265, P221; CORNWELL MM, 1993, J BIOL CHEM, V268, P19505; DELMORAI RG, 1909, EXP NEPRHOL, V6, P89; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; Ernest S, 1998, KIDNEY INT, pS11; Fardel O, 1996, GEN PHARMACOL, V27, P1283, DOI 10.1016/S0306-3623(96)00081-X; GOLDSMITH ME, 1993, J BIOL CHEM, V268, P5856; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Haapajarvi T, 1999, EXP CELL RES, V248, P272, DOI 10.1006/excr.1999.4403; Hu XF, 1999, BRIT J CANCER, V79, P831, DOI 10.1038/sj.bjc.6690133; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Johnstone RW, 1999, BLOOD, V93, P1075, DOI 10.1182/blood.V93.3.1075.403k35_1075_1085; KASHANCHI F, 1994, J VIROL, V68, P561, DOI 10.1128/JVI.68.1.561-565.1994; KERR D, 1994, J VIROL, V68, P7637, DOI 10.1128/JVI.68.11.7637-7643.1994; Knutsen T, 1998, GENE CHROMOSOME CANC, V23, P44, DOI 10.1002/(SICI)1098-2264(199809)23:1<44::AID-GCC7>3.0.CO;2-6; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Li WW, 1997, MOL CELL BIOL, V17, P61, DOI 10.1128/MCB.17.1.61; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1992, EMBO J, V11, P3315, DOI 10.1002/j.1460-2075.1992.tb05410.x; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; McCoy C, 1999, CELL GROWTH DIFFER, V10, P377; MCCOY C, 1995, MOL CELL BIOL, V15, P6100; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; Metherall JE, 1996, J BIOL CHEM, V271, P2634, DOI 10.1074/jbc.271.5.2634; MILTENBERGER RJ, 1995, CELL GROWTH DIFFER, V6, P549; Oda Y, 1998, CLIN CANCER RES, V4, P2273; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Ohga T, 1996, CANCER RES, V56, P4224; Pallis M, 1999, LEUKEMIA, V13, P1468, DOI 10.1038/sj.leu.2401498; Raj GV, 1996, J VIROL, V70, P5944, DOI 10.1128/JVI.70.9.5944-5953.1996; Robinson LJ, 1997, BIOCHEMISTRY-US, V36, P11169, DOI 10.1021/bi9627830; Roder K, 1999, GENE, V234, P61, DOI 10.1016/S0378-1119(99)00180-8; Roder K, 1997, J BIOL CHEM, V272, P21616, DOI 10.1074/jbc.272.34.21616; Sawaya BE, 1998, J GEN VIROL, V79, P239, DOI 10.1099/0022-1317-79-2-239; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Scotto KW, 1998, CYTOTECHNOLOGY, V27, P257, DOI 10.1023/A:1008032716628; SHARMA RC, 1992, J BIOL CHEM, V267, P5731; Smyth MJ, 1998, P NATL ACAD SCI USA, V95, P7024, DOI 10.1073/pnas.95.12.7024; Sundseth R, 1997, MOL PHARMACOL, V51, P963, DOI 10.1124/mol.51.6.963; Swamynathan SK, 1998, FASEB J, V12, P515, DOI 10.1096/fasebj.12.7.515; TAFURI SR, 1992, NEW BIOL, V4, P349; Takashima S, 1998, J BIOL CHEM, V273, P7675, DOI 10.1074/jbc.273.13.7675; THAYER S, 1998, THESIS CORNELL U NEW; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; TOFFOLI G, 1995, BIOCHEM PHARMACOL, V50, P1245, DOI 10.1016/0006-2952(95)02003-U; UCHIUMI T, 1993, CELL GROWTH DIFFER, V4, P147; UEDA K, 1992, J BIOL CHEM, V267, P24248; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978; ZWICKER J, 1995, NUCLEIC ACIDS RES, V23, P3822, DOI 10.1093/nar/23.19.3822	65	135	143	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2979	2985		10.1074/jbc.275.4.2979	http://dx.doi.org/10.1074/jbc.275.4.2979			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644769	hybrid			2022-12-27	WOS:000085128000101
J	Morris, SK; Baird, CL; Lindsley, JE				Morris, SK; Baird, CL; Lindsley, JE			Steady-state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL FRAGMENT; GYRASE-B PROTEIN; DNA DOUBLE HELIX; SACCHAROMYCES-CEREVISIAE; BIS(2,6-DIOXOPIPERAZINE) DERIVATIVES; DROSOPHILA-MELANOGASTER; CATALYTIC INHIBITORS; ATP HYDROLYSIS; MECHANISM; CLEAVAGE	DNA topoisomerase II uses a complex, sequential mechanism of ATP hydrolysis to catalyze the transport of one DNA duplex through a transient break in another. ICRF-193 is a catalytic inhibitor of topoisomerase II that is known to trap a closed-clamp intermediate form of the enzyme, Using steady-state and rapid kinetic ATPase and DNA transport assays, we have analyzed how trapping this intermediate by the drug perturbs the topoisomerase II mechanism. The drug has no effect on the rate of the first turnover of decatenation but potently inhibits subsequent turnovers with an IC50 of 6.5 +/- 1 mu w for the Saccharomyces cerevisiae enzyme. This drug inhibits the ATPase activity of topoisomerase II by an unusual, mixed-type mechanism; the drug is not a competitive inhibitor of ATP, and even at saturating concentrations of drug, the enzyme continues to hydrolyze ATP, albeit at a reduced rate. Topoisomerase II that was specifically isolated in the drug-bound, closed-clamp form continues to hydrolyze ATP, indicating that the enzyme clamp does not need to re-open to bind and hydrolyze ATP, When rapid-quench ATPase assays were initiated by the addition of ATP, the drug had no effect on the sequential hydrolysis of either the first or second ATP, By contrast, when the drug was prebound, the enzyme hydrolyzed one labeled ATP at the uninhibited rate but did not hydrolyze a second ATP, These results are interpreted in terms of the catalytic mechanism for topoisomerase II and suggest that ICRF-193 interacts with the enzyme bound to one ADP.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Lindsley, JE (corresponding author), Univ Utah, Sch Med, Dept Biochem, 50 N Med Dr, Salt Lake City, UT 84132 USA.		Baird, Cheryl/AGM-0065-2022; Baird, Cheryl L/F-6569-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051194, T32GM008753] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51194, 5T32GM08753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018; Andoh T, 1998, BBA-GENE STRUCT EXPR, V1400, P155, DOI 10.1016/S0167-4781(98)00133-X; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Chang S, 1998, J BIOL CHEM, V273, P19822, DOI 10.1074/jbc.273.31.19822; Fass D, 1999, NAT STRUCT BIOL, V6, P322; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; GOTO T, 1984, J BIOL CHEM, V259, P422; HALLIGAN BD, 1985, J BIOL CHEM, V260, P2475; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7292, DOI 10.1021/bi9729099; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; HSIEH TS, 1975, BIOCHEMISTRY-US, V14, P527, DOI 10.1021/bi00674a011; ISHIDA R, 1995, CANCER RES, V55, P2299; ISHIDA R, 1991, CANCER RES, V51, P4909; LINDSLEY JE, 1993, NATURE, V361, P749, DOI 10.1038/361749a0; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; LIU L, 1994, DNA TOPOISOMERASES T; LIU LF, 1983, J BIOL CHEM, V258, P5365; Maxwell A, 1999, BIOCHEM SOC T, V27, P48, DOI 10.1042/bst0270048; Morris SK, 1999, J BIOL CHEM, V274, P30690, DOI 10.1074/jbc.274.43.30690; Morris SNK, 1999, J BIOL CHEM, V274, P3446, DOI 10.1074/jbc.274.6.3446; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Olland S, 1999, J BIOL CHEM, V274, P21688, DOI 10.1074/jbc.274.31.21688; OSHEROFF N, 1989, BIOCHEMISTRY-US, V28, P6157, DOI 10.1021/bi00441a005; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; SANDER M, 1983, J BIOL CHEM, V258, P8421; Sato M, 1997, BIOCHEM PHARMACOL, V54, P545, DOI 10.1016/S0006-2952(97)00201-3; SEGEL IH, 1993, ENZYME KINETICS, P390; Sehested M, 1996, BIOCHEM PHARMACOL, V51, P879, DOI 10.1016/0006-2952(95)02241-4; Sehested M, 1998, CANCER RES, V58, P1460; SHELTON ER, 1983, J BIOL CHEM, V258, P9530; SZEDLACSEK SE, 1995, METHOD ENZYMOL, V249, P144; TANABE K, 1991, CANCER RES, V51, P4903; Tennyson RB, 1997, BIOCHEMISTRY-US, V36, P6107, DOI 10.1021/bi970152f; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wessel I, 1999, CANCER RES, V59, P3442	41	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2613	2618		10.1074/jbc.275.4.2613	http://dx.doi.org/10.1074/jbc.275.4.2613			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644721	hybrid			2022-12-27	WOS:000085128000053
J	Morrow, JA; Arnold, KS; Dong, J; Balestra, ME; Innerarity, TL; Weisgraber, KH				Morrow, JA; Arnold, KS; Dong, J; Balestra, ME; Innerarity, TL; Weisgraber, KH			Effect of arginine 172 on the binding of apolipoprotein E to the low density lipoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PROTEIN SECONDARY STRUCTURE; CELL-SURFACE RECEPTORS; HUMAN-E APOPROTEIN; III HYPERLIPOPROTEINEMIA; PLASMA-LIPOPROTEINS; HUMAN-FIBROBLASTS; AQUEOUS-SOLUTION; DOMAIN; SITE	The region of apolipoprotein E (apoE) that interacts directly with the low density lipoprotein (LDL) receptor lies in the vicinity of residues 136-150, where lysine and arginine residues are crucial for full binding activity However, defective binding of carboxyl-terminal truncations of apoE3 has suggested that residues in the vicinity of 170-183 are also important. To characterize and define the role of this region in LDL receptor binding, we created either mutants of apoE in which this region was deleted or in which arginine residues within this region were sequentially changed to alanine, Deletion of residues 167-185 reduced binding activity (15% of apoE3), and elimination of arginines at positions 167, 172, 178, and 180 revealed that only position 172 affected binding activity (2% of apoE3), Substitution of lysine for Arg(172) reduced binding activity to 6%, indicating a specific requirement for arginine at this position. The higher binding activity of the Delta 167-185 mutant relative to the Arg(172) mutant (15% versus 2%) is explained by the fact that arginine residues at positions 189 and 191 are shifted in the deletion mutant into positions equivalent to 170 and 172 in the intact protein. Mutation of these residues and modeling the region around these residues suggested that the influence of Arg(172) On receptor binding activity may be determined by its orientation at a lipid surface. Thus, the association of apoE with phospholipids allows Arg(172) to interact directly with the LDL receptor or with other residues in apoE to promote its receptor-active conformation.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weisgraber, KH (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, POB 419100, San Francisco, CA 94141 USA.				NHLBI NIH HHS [HL41633] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; BRADLEY WA, 1982, BIOCHEM BIOPH RES CO, V109, P1360, DOI 10.1016/0006-291X(82)91927-1; Clayton AHA, 1999, EUR BIOPHYS J BIOPHY, V28, P133, DOI 10.1007/s002490050192; DAS HK, 1985, J BIOL CHEM, V260, P6240; Dong LM, 1996, NAT STRUCT BIOL, V3, P718, DOI 10.1038/nsb0896-718; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; Innerarity T L, 1986, Methods Enzymol, V129, P542; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; INNERARITY TL, 1984, J BIOL CHEM, V259, P7261; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOUNNAS MZ, 1994, ANN NY ACAD SCI, V737, P114, DOI 10.1111/j.1749-6632.1994.tb44305.x; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LALAZAR A, 1989, J BIOL CHEM, V264, P8447; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; PITAS RE, 1987, J BIOL CHEM, V262, P14352; RALL SC, 1982, J BIOL CHEM, V257, P4171; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1994, STRUCTURE, V2, P713, DOI 10.1016/S0969-2126(00)00072-1; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; ZANNIS VI, 1980, J BIOL CHEM, V255, P1759; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059	40	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2576	2580		10.1074/jbc.275.4.2576	http://dx.doi.org/10.1074/jbc.275.4.2576			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644716	hybrid			2022-12-27	WOS:000085128000048
J	Torrents, E; Buist, G; Liu, A; Eliasson, R; Kok, J; Gibert, I; Graslund, A; Reichard, P				Torrents, E; Buist, G; Liu, A; Eliasson, R; Kok, J; Gibert, I; Graslund, A; Reichard, P			The anaerobic (Class III) ribonucleotide reductase from Lactococcus lactis - Catalytic properties and allosteric regulation of the pure enzyme system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CENTER; ESCHERICHIA-COLI; PROTEIN; SEQUENCE; BINDING; TIMES; GENES; SITE	Lactococcus lactis contains an operon with the genes (nrdD and nrdG) for a class III ribonucleotide reductase, Strict anaerobic growth depends on the activity of these genes. Both were sequenced, cloned, and overproduced in Escherichia coli, The corresponding proteins, NrdD and NrdG, were purified close to homogeneity, The amino acid sequences of NrdD (747 residues, 84.1 kDa) and NrdG (199 residues, 23.3 kDa) are 53 and 42% identical with the respective E. coli proteins. Together, they catalyze the reduction of ribonucleoside triphosphates to the corresponding deoxyribonucleotides in the presence of S-adenosylmethionine, reduced flavodoxin or reduced deazaflavin, potassium ions, dithiothreitol, and formate. EPR experiments demonstrated a [4Fe-4S](+) cluster in reduced NrdG and a glycyl radical in activated NrdD, similar to the E, coli NrdD and NrdG proteins. Different from E. coli, the two polypeptides of NrdD and the proteins in the NrdD-NrdG complex were only loosely associated, Also the FeS cluster was easily lost from NrdG, The substrate specificity and overall activity of the L. lactis enzyme was regulated according to the general rules for ribonucleotide reductases. Allosteric effecters bound to two separate sites on NrdD, one binding dATP, dGTP, and dTTP and the other binding dATP and ATP, The two sites showed an unusually high degree of cooperativity with complex interactions between effecters and a fine-tuning of their physiological effects. The results with the L. lactis class III reductase further support the concept of a common origin for all present day ribonucleotide reductases.	Karolinska Inst, Dept Biochem 1, Med Nobel Inst, MBB, S-17177 Stockholm, Sweden; Autonomous Univ Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; Autonomous Univ Barcelona, Inst Biol Fonamental, Bacterial Mol Genet Grp, E-08193 Barcelona, Spain; Univ Groningen, Dept Genet, NL-9641 NN Haren, Netherlands; Stockholm Univ, Dept Biophys, S-10691 Stockholm, Sweden	Karolinska Institutet; Autonomous University of Barcelona; Autonomous University of Barcelona; University of Groningen; Stockholm University	Reichard, P (corresponding author), Karolinska Inst, Dept Biochem 1, Med Nobel Inst, MBB, S-17177 Stockholm, Sweden.	peter.reichard@mbb.ki.se	Torrents, Eduard/C-7184-2008; Kok, Jan/C-9972-2012; Liu, Aimin/C-1572-2017; Gibert, Isidre/L-9834-2014	Torrents, Eduard/0000-0002-3010-1609; Liu, Aimin/0000-0002-4182-8176; Gibert, Isidre/0000-0003-1442-2258				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; CHIARUTTINI C, 1993, J MOL BIOL, V230, P57, DOI 10.1006/jmbi.1993.1126; Eliasson R, 1999, J BIOL CHEM, V274, P7182, DOI 10.1074/jbc.274.11.7182; ELIASSON R, 1994, J BIOL CHEM, V269, P26052; ELIASSON R, 1992, J BIOL CHEM, V267, P25541; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; GASSON MJ, 1983, J BACTERIOL, V154, P1; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Kessler D., 1996, ESCHERICHIA COLI SAL, P199; KING DS, 1995, BIOCHEM BIOPH RES CO, V206, P731, DOI 10.1006/bbrc.1995.1103; KING TE, 1967, METHOD ENZYMOL, V10, P634; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Leenhouts K., 1992, Mededelingen van de Faculteit Landbouwwetenschappen Universiteit Gent, V57, P2031; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Liu A, 1998, BIOCHEMISTRY-US, V37, P16369, DOI 10.1021/bi981471p; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Ollagnier S, 1996, J BIOL CHEM, V271, P9410, DOI 10.1074/jbc.271.16.9410; Ollagnier S, 1999, J AM CHEM SOC, V121, P6344, DOI 10.1021/ja990073m; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; ORMO M, 1990, ANAL BIOCHEM, V189, P138, DOI 10.1016/0003-2697(90)90059-I; Reichard P, 1997, TRENDS BIOCHEM SCI, V22, P81, DOI 10.1016/S0968-0004(97)01003-7; REICHARD P, 1993, J BIOL CHEM, V268, P8383; SAHLIN M, 1986, J MAGN RESON, V67, P135, DOI 10.1016/0022-2364(86)90417-8; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEEGERS JFML, 1994, MICROBIOL-UK, V140, P1291, DOI 10.1099/00221287-140-6-1291; Sjoberg BM, 1997, STRUCT BOND, V88, P139; Stubbe JA, 1995, CHEM BIOL, V2, P793, DOI 10.1016/1074-5521(95)90084-5; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; Tamarit J, 1999, J BIOL CHEM, V274, P31291, DOI 10.1074/jbc.274.44.31291; Teuber M., 1995, GENERA LACTIC ACID B, P173, DOI DOI 10.1007/978-1-4615-5817-0_6; THELANDER L, 1994, MET IONS BIOL SYST, V30, P109; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WAGNER AFV, 1992, P NATL ACAD SCI USA, V89, P996, DOI 10.1073/pnas.89.3.996; Young P, 1996, J BIOL CHEM, V271, P20770, DOI 10.1074/jbc.271.34.20770; YOUNG P, 1994, J BIOL CHEM, V269, P27815	42	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2463	2471		10.1074/jbc.275.4.2463	http://dx.doi.org/10.1074/jbc.275.4.2463			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644700	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000085128000032
J	Liu, QQ; Choe, WC; Campbell, JL				Liu, QQ; Choe, WC; Campbell, JL			Identification of the Xenopus laevis homolog of Saccharomyces cerevisiae DNA2 and its role in DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; CELL-CYCLE REGULATION; CDC6 PROTEIN; YEAST; HELICASE; EXONUCLEASE; ENCODES; GENE; ENDONUCLEASE; BINDING	The DNA2 gene of Saccharomyces cerevisiae is essential for growth and appears to be required for a late stage of chromosomal DNA replication. S. cerevisiae Dna2p (ScDna2p) is a DNA helicase and also a nuclease. We have cloned and sequenced the homologous gene from Xenopus (Xenopus Dnaa), Xenopus Dna2p (XDna2p) is 32% identical to ScDna2p, and the similarity extends over the entire length, including but not limited to the five conserved helicase motifs, XDna2p is even more closely related (60% identical) to a partial human cDNA. The Xenopus Dnaa (XDna2) gene was able to complement an S, cerevisiae dna2-1 mutant strain for growth at the nonpermissive temperature, suggesting that XDna2p is a functional as well as a structural homolog of the yeast protein. Recombinant XDna2p was expressed in insect cells and purified. Like the ScDna2p purified from yeast, it is a single-stranded DNA endonuclease and a DNA-dependent ATPase, suggesting that both of these activities are part of the essential function of Dna2p. However, unlike ScDna2p from yeast, recombinant XDna2p showed no DNA helicase activity. When XDna2 was immunodepleted from interphase egg extracts, chromosomal DNA replication was almost completely inhibited. From the size of the residually synthesized DNA from the XDna2-depleted egg extracts, it seems that initiation of DNA replication may be impaired, This interpretation is also supported by the normal DNA replication of M13 single-stranded DNA in the XDna2-depleted egg extracts.	CALTECH, Braun Lab, Pasadena, CA 91125 USA	California Institute of Technology	Campbell, JL (corresponding author), CALTECH, Braun Lab, Pasadena, CA 91125 USA.				NIGMS NIH HHS [GM25508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; Braguglia D, 1998, J MOL BIOL, V281, P631, DOI 10.1006/jmbi.1998.1973; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1995, METHOD ENZYMOL, V262, P108; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; Elsasser S, 1996, MOL BIOL CELL, V7, P1723, DOI 10.1091/mbc.7.11.1723; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Formosa T, 1999, GENETICS, V151, P1459; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; Gould KL, 1998, GENETICS, V149, P1221; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kornberg A., 1992, DNA REPLICATION; KUO CL, 1983, P NATL ACAD SCI-BIOL, V80, P6465, DOI 10.1073/pnas.80.21.6465; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; MILES J, 1992, P NATL ACAD SCI USA, V89, P1276, DOI 10.1073/pnas.89.4.1276; MILES J, 1992, MOL CELL BIOL, V12, P5274; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; VALLEN EA, 1995, MOL CELL BIOL, V15, P4291; WAGA S, 1994, J BIOL CHEM, V269, P10923; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263	46	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1615	1624		10.1074/jbc.275.3.1615	http://dx.doi.org/10.1074/jbc.275.3.1615			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636853	hybrid			2022-12-27	WOS:000084940000016
J	Xia, Y; McMillin, JB; Lewis, A; Moore, M; Zhu, WG; Williams, RS; Kellems, RE				Xia, Y; McMillin, JB; Lewis, A; Moore, M; Zhu, WG; Williams, RS; Kellems, RE			Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-FACTOR; DEPENDENT TRANSCRIPTIONAL PATHWAY; SPONTANEOUSLY HYPERTENSIVE RATS; MYOCARDIAL-CELL HYPERTROPHY; THYROID-HORMONE; MESSENGER-RNA; ALPHA-ACTIN; VENTRICULAR MYOCYTES; MOLECULAR-CLONING; C-JUN	Electrically stimulated pacing of cultured cardiomyocytes serves as an experimentally convenient and physiologically relevant in vitro model of cardiac hypertrophy, Electrical pacing triggers a signaling cascade that results in the activation of the muscle-specific Adss1 gene and the repression of the nonmuscle Adss2 isoform. Activation of the Adss1 gene involves the calcineurin-mediated dephosphorylation of NFAT3, allowing its translocation to the nucleus, where it can directly participate in Adss1 gene activation. Mutational studies show that an NFAT binding site located in the Adss1 5'-flanking region is essential for this activation. Electrical pacing also results in the increased synthesis of GATA4, another critical cardiac transcription factor required for Adss1 gene expression. MEF2C also produces transactivation of the Adss1 gene reporter in control and paced cardiac myocytes. Using the Adss1 gene as a model, these studies are the first to demonstrate that electrical pacing activates the calcineurin/NFAT3 and GATA4 pathways as a means of regulating cardiac gene expression.	Univ Texas, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Mol Biol Oncol, Dallas, TX 75235 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; Baylor College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kellems, RE (corresponding author), Univ Texas, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin, Houston, TX 77030 USA.	rkellems@bmb.med.uth.tmc.edu			NHLBI NIH HHS [HL38863] Funding Source: Medline; NIAMS NIH HHS [AR40849] Funding Source: Medline; NICHD NIH HHS [HD34130] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034130] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R56HD034130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR040849, R01AR040849] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARAI H, 1988, CIRC RES, V62, P926, DOI 10.1161/01.RES.62.5.926; BISHOPRIC NH, 1991, P NATL ACAD SCI USA, V88, P2132, DOI 10.1073/pnas.88.6.2132; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; BREVET A, 1976, SCIENCE, V193, P1152, DOI 10.1126/science.959833; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; DUBUS I, 1990, CIRC RES, V66, P867, DOI 10.1161/01.RES.66.3.867; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FabreSuver C, 1996, J BIOL CHEM, V271, P4646, DOI 10.1074/jbc.271.9.4646; GUICHERIT OM, 1994, J BIOL CHEM, V269, P4488; GUICHERIT OM, 1991, J BIOL CHEM, V266, P22582; GUSTAFSON TA, 1986, CIRC RES, V59, P194, DOI 10.1161/01.RES.59.2.194; GUTKOWSKA J, 1986, HYPERTENSION, V8, P137; Hogan PG, 1999, NATURE, V398, P200, DOI 10.1038/18327; ITO H, 1991, CIRC RES, V69, P209, DOI 10.1161/01.RES.69.1.209; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.ph.55.030193.000415; LEE HR, 1988, J BIOL CHEM, V263, P7352; Lewis AL, 1996, J BIOL CHEM, V271, P22647, DOI 10.1074/jbc.271.37.22647; Lewis AL, 1999, J BIOL CHEM, V274, P14188, DOI 10.1074/jbc.274.20.14188; Luo ZY, 1998, NAT MED, V4, P1092, DOI 10.1038/2578; McDonough PM, 1997, J BIOL CHEM, V272, P24046, DOI 10.1074/jbc.272.38.24046; MCDONOUGH PM, 1992, J BIOL CHEM, V267, P11665; MCDONOUGH PM, 1994, J BIOL CHEM, V269, P9466; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; NEYSES L, 1991, BIOCHEM BIOPH RES CO, V181, P22, DOI 10.1016/S0006-291X(05)81376-2; Olson EN, 1999, CIRC RES, V84, P623, DOI 10.1161/01.RES.84.6.623; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; Qin WN, 1997, J BIOL CHEM, V272, P25210, DOI 10.1074/jbc.272.40.25210; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SCHWARTZ K, 1981, J MOL CELL CARDIOL, V13, P1071, DOI 10.1016/0022-2828(81)90297-2; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; STARKSEN NF, 1986, P NATL ACAD SCI USA, V83, P8348, DOI 10.1073/pnas.83.21.8348; Sugden PH, 1999, CIRC RES, V84, P633, DOI 10.1161/01.RES.84.6.633; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; WAN B, 1995, J BIOL CHEM, V270, P26433, DOI 10.1074/jbc.270.44.26433; WINEGRAD S, 1990, P NATL ACAD SCI USA, V87, P2456, DOI 10.1073/pnas.87.7.2456; Xia Y, 1998, J BIOL CHEM, V273, P12593, DOI 10.1074/jbc.273.20.12593; Xia Y, 1996, J BIOL CHEM, V271, P12082, DOI 10.1074/jbc.271.20.12082; Xia Y, 1997, P NATL ACAD SCI USA, V94, P11399, DOI 10.1073/pnas.94.21.11399; Zechner D, 1998, J BIOL CHEM, V273, P8232, DOI 10.1074/jbc.273.14.8232	46	91	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1855	1863		10.1074/jbc.275.3.1855	http://dx.doi.org/10.1074/jbc.275.3.1855			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636885	hybrid			2022-12-27	WOS:000084940000048
J	Zhu, T; Lobie, PE				Zhu, T; Lobie, PE			Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone - Resultant transcriptional, activation of ATF-2 and chop, cytoskeletal re-organization and mitogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SIGNAL-TRANSDUCTION PATHWAY; INSULIN-RECEPTOR SUBSTRATE-1; TERNARY COMPLEX FACTORS; JAK2 TYROSINE KINASE; MAP KINASE; C-FOS; PHOSPHATIDYLINOSITOL 3-KINASE; ACTIN REORGANIZATION; DOWNSTREAM MEDIATOR; INDUCED APOPTOSIS	We demonstrate here that p38 mitogen-activated protein (MAP) kinase is activated in response to cellular stimulation by human GH (hGH) in Chinese hamster ovary cells stably transfected with GH receptor cDNA This activation requires the proline-rich box 1 region of the GH receptor required for JAK2 association and is prevented by pretreatment of cells with the JAR2-specific inhibitor AG490. ATF-2 is both phosphorylated and transcriptionally activated by hGH, and its transcriptional activation also requires the proline-rich box 1 region of the GH receptor. Expression of wild type JAK2 can further enhance hGH-induced ATF-2-, CHOP-, and Elk-1-mediated transcriptional activation, whereas pretreatment with AG490 is inhibitory. Use of either specific pharmacological inhibitors or transient transfection of cells with p38 alpha MAP kinase cDNA or a dominant negative variant demonstrated that hGH-stimulated transcriptional activation of ATF-2 and CHOP, but not Elk-1, is regulated by p38 MAP kinase. Both the p38 MAP kinase and p44/42 MAP kinase are critical for hGH-stimulated mitogenesis, whereas only p38 MAP kinase is required for hGH-induced actin cytoskeletal re-organization, p38 MAP kinase is therefore an important regulator in coordinating the pleiotropic effects of GH.	Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 30 Med Dr, Singapore 117609, Singapore.							Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alpert D, 1999, J BIOL CHEM, V274, P22176, DOI 10.1074/jbc.274.32.22176; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BILLESTRUP N, 1995, P NATL ACAD SCI USA, V92, P2725, DOI 10.1073/pnas.92.7.2725; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Brunet A, 1996, SCIENCE, V272, P1652, DOI 10.1126/science.272.5268.1652; CAMPBELL GS, 1992, J BIOL CHEM, V267, P6074; Carter-Su C, 1998, RECENT PROG HORM RES, V53, P61; Clarkson RWE, 1999, MOL ENDOCRINOL, V13, P619, DOI 10.1210/me.13.4.619; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Cuenda A, 1997, EMBO J, V16, P295, DOI 10.1093/emboj/16.2.295; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DERIJARD B, 1995, SCIENCE, V267, P683; DOZA YN, 1995, FEBS LETT, V364, P223, DOI 10.1016/0014-5793(95)00346-B; Duyndam MCA, 1999, ONCOGENE, V18, P2311, DOI 10.1038/sj.onc.1202584; EDEN S, 1982, ENDOCRINOLOGY, V111, P1505, DOI 10.1210/endo-111-5-1505; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Friedman AD, 1996, CANCER RES, V56, P3250; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Goh ELK, 1998, ENDOCRINOLOGY, V139, P4364, DOI 10.1210/en.139.10.4364; Goh ELK, 1997, ENDOCRINOLOGY, V138, P3207, DOI 10.1210/en.138.8.3207; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HARDING PA, 1995, RECEPTOR, V5, P81; Harris KW, 1998, BLOOD, V92, P1219, DOI 10.1182/blood.V92.4.1219.416k07_1219_1224; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hedges JC, 1998, AM J PHYSIOL-CELL PH, V275, pC527, DOI 10.1152/ajpcell.1998.275.2.C527; Hibi M, 1998, Int Rev Immunol, V17, P75, DOI 10.3109/08830189809084488; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Horman S, 1997, CELL PROLIFERAT, V30, P21, DOI 10.1111/j.1365-2184.1997.tb00913.x; Huguier S, 1998, MOL CELL BIOL, V18, P7020, DOI 10.1128/MCB.18.12.7020; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; Kaulsay KK, 1999, EXP CELL RES, V250, P35, DOI 10.1006/excr.1999.4492; Kilgour E, 1996, BIOCHEM J, V315, P517, DOI 10.1042/bj3150517; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Kim SO, 1998, J CELL BIOCHEM, V71, P286, DOI 10.1002/(SICI)1097-4644(19981101)71:2<286::AID-JCB13>3.0.CO;2-J; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Larsen JK, 1997, AM J PHYSIOL-LUNG C, V273, pL930, DOI 10.1152/ajplung.1997.273.5.L930; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Lobie PE, 1996, ENDOCRINOLOGY, V137, P4037, DOI 10.1210/en.137.9.4037; LOBIE PE, 1999, GROWTH HORMONE, P17; Ludwig S, 1996, MOL CELL BIOL, V16, P6687; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Miyazaki T, 1998, GENE DEV, V12, P770, DOI 10.1101/gad.12.6.770; MOLLER C, 1992, J BIOL CHEM, V267, P23403; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; Nagata Y, 1997, BLOOD, V90, P929, DOI 10.1182/blood.V90.3.929.929_929_934; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Rausch O, 1999, J BIOL CHEM, V274, P4096, DOI 10.1074/jbc.274.7.4096; RIDDERSTRALE M, 1995, J BIOL CHEM, V270, P3471, DOI 10.1074/jbc.270.8.3471; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Sambrook J., 2002, MOL CLONING LAB MANU; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; SLOOTWEG MC, 1991, J MOL ENDOCRINOL, V6, P179, DOI 10.1677/jme.0.0060179; Stein B, 1996, J BIOL CHEM, V271, P11427, DOI 10.1074/jbc.271.19.11427; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; VANDERKUUR J, 1995, J BIOL CHEM, V270, P7587, DOI 10.1074/jbc.270.13.7587; Vanderkuur JA, 1997, ENDOCRINOLOGY, V138, P4301, DOI 10.1210/en.138.10.4301; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; Wood TJJ, 1997, MOL CELL ENDOCRINOL, V130, P69, DOI 10.1016/S0303-7207(97)00075-0; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369; Yamauchi T, 1998, J BIOL CHEM, V273, P15719, DOI 10.1074/jbc.273.25.15719; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; ZHAN QM, 1994, CANCER RES, V54, P2755; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhu T, 1998, J BIOL CHEM, V273, P33864, DOI 10.1074/jbc.273.50.33864; Zhu T, 1998, J BIOL CHEM, V273, P10682, DOI 10.1074/jbc.273.17.10682; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	106	78	78	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2103	2114		10.1074/jbc.275.3.2103	http://dx.doi.org/10.1074/jbc.275.3.2103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636915	hybrid			2022-12-27	WOS:000084940000078
J	Casano, LM; Zapata, JM; Martin, M; Sabater, B				Casano, LM; Zapata, JM; Martin, M; Sabater, B			Chlororespiration and poising of cyclic electron transport - Plastoquinone as electron transporter between thylakoid NADH dehydrogenase and peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASTID NDH GENES; COMPLEX-I; SUPEROXIDE-DISMUTASE; CHLOROPLAST GENOME; RESPIRATORY-CHAIN; FLOWERING PLANT; BARLEY; IDENTIFICATION; EXPRESSION; TOBACCO	Polypeptides encoded by plastid ndh genes form a complex (Ndh) which could reduce plastoquinone with NADH, Through a terminal oxidase, reduced plastoquinone would be oxidized in chlororespiration, However, isolated Ndh complex has low activity with plastoquinone and no terminal oxidase has been found in chloroplasts, thus the function of Ndh complex is unknown. Alternatively, thylakoid hydroquinone peroxidase could oxidize reduced plastoquinone with H2O2, By immunoaffinity chromatography, we have purified the plastid Ndh complex of barley (Hordeum vulgare L,) to investigate the electron donor and acceptor specificity. A detergent-containing system was reconstructed with thylakoid Ndh complex and peroxidase which oxidized NADH with H2O2 in a plastoquinone-dependent process. This system and the increases of thylakoid Ndh complex and peroxidase activities under photooxidative stress suggest that the chlororespiratory process consists of the sequence of reactions catalyzed by Ndh complex, peroxidase (acting on reduced plastoquinone), superoxide dismutase, and the non-enzymic one-electron transfer from reduced iron-sulfur protein (FeSP) to O-2, When FeSP is a component of cytochrome b(6).f complex or of the same Ndh complex, O-2 may be reduced with NADH, without requirement of light. Chlororespiration consumes reactive species of oxygen and, eventually, may decrease their production by lowering O-2 concentration in chloroplasts, The common plastoquinone pool with photosynthetic electron transport suggests that chlororespiratory reactions may poise reduced and oxidized forms of the intermediates of cyclic electron transport under highly fluctuating light intensities.	Univ Alcala de Henares, Dept Biol Vegetal, Madrid 28871, Spain	Universidad de Alcala	Sabater, B (corresponding author), Univ Alcala de Henares, Dept Biol Vegetal, Madrid 28871, Spain.	bvsabater@alcala.es	Sabater, Bartolome/B-6039-2008; Casano, Leonardo M. M/H-1036-2015	Sabater, Bartolome/0000-0002-8586-1226; Casano, Leonardo M. M/0000-0002-2304-7317				Ausubel FA, 1990, CURRENT PROTOCOLS MO; BAKER NR, 1984, CHLOROPLAST BIOGENES, P207; BENNOUN P, 1982, P NATL ACAD SCI-BIOL, V79, P4352, DOI 10.1073/pnas.79.14.4352; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; BERGER S, 1993, PLANTA, V190, P25, DOI 10.1007/BF00195671; Biehler K, 1996, PLANT PHYSIOL, V112, P265, DOI 10.1104/pp.112.1.265; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; CASANO LM, 1994, PLANT PHYSIOL, V106, P1033, DOI 10.1104/pp.106.3.1033; Catala R, 1997, PLANT CELL PHYSIOL, V38, P1382, DOI 10.1093/oxfordjournals.pcp.a029133; COHEN AS, 1979, PLANT PHYSIOL, V64, P717, DOI 10.1104/pp.64.5.717; CUELLO J, 1995, PLANT CELL PHYSIOL, V36, P265, DOI 10.1093/oxfordjournals.pcp.a078758; DEPAMPHILIS CW, 1990, NATURE, V348, P337, DOI 10.1038/348337a0; Feild TS, 1998, PLANT PHYSIOL, V116, P1209, DOI 10.1104/pp.116.4.1209; Freyer R, 1995, PLANT MOL BIOL, V29, P679, DOI 10.1007/BF00041158; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; GARAB G, 1989, PLANTA, V179, P349, DOI 10.1007/BF00391080; HABERHAUSEN G, 1994, PLANT MOL BIOL, V24, P217, DOI 10.1007/BF00040588; HEBER U, 1992, PLANT PHYSIOL, V100, P1621, DOI 10.1104/pp.100.4.1621; Kofer W, 1998, MOL GEN GENET, V258, P166, DOI 10.1007/s004380050719; Kubicki A, 1996, PLANTA, V199, P276, DOI 10.1007/BF00196569; KUONEN DR, 1986, ANAL BIOCHEM, V153, P221, DOI 10.1016/0003-2697(86)90084-9; Laloue H, 1997, PLANT PHYSIOL BIOCH, V35, P341; Martin M, 1996, PLANT CELL PHYSIOL, V37, P293, DOI 10.1093/oxfordjournals.pcp.a028945; NEWCOMB EH, 1971, PHOTOSYNTHESIS PHOTO, P173; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; Pearcy RW, 1994, PHOTOINHIBITION PHOT, P255; Quiles MJ, 1996, PLANT CELL PHYSIOL, V37, P1134, DOI 10.1093/oxfordjournals.pcp.a029064; Sazanov LA, 1996, BIOCHEM SOC T, V24, P739, DOI 10.1042/bst0240739; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; UNO T, 1987, J BIOL CHEM, V262, P4549; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; Zapata JM, 1998, PHYTOCHEMISTRY, V48, P1119, DOI 10.1016/S0031-9422(98)00133-2	37	118	129	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					942	948		10.1074/jbc.275.2.942	http://dx.doi.org/10.1074/jbc.275.2.942			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625631	hybrid			2022-12-27	WOS:000084836600035
J	Gerbaud, V; Pignol, D; Loret, E; Bertrand, JA; Berland, Y; Fontecilla-Camps, JC; Canselier, JP; Gabas, N; Verdier, JM				Gerbaud, V; Pignol, D; Loret, E; Bertrand, JA; Berland, Y; Fontecilla-Camps, JC; Canselier, JP; Gabas, N; Verdier, JM			Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC STONE PROTEIN; HUMAN-SERUM-ALBUMIN; ACIDIC MACROMOLECULES; MOLECULAR-DYNAMICS; BIOMINERALIZATION; STEREOCHEMISTRY; CRYSTALLIZATION; SIMULATIONS; NUCLEATION; REFINEMENT	Pancreatic juice is supersaturated with calcium carbonate. Calcite crystals therefore may occur, obstruct pancreatic ducts, and finally cause a lithiasis. Human lithostathine, a protein synthesized by the pancreas, inhibits the growth of calcite crystals by inducing a habit modification: the rhombohedral {10 (1) over bar 4} usual habit is transformed into a needle-like habit through the {11 (2) over bar 0} crystal form. A similar observation was made with the N-terminal undecapeptide (pE(1)R(11)) of lithostathine. We therefore aimed at discovering how peptides inhibit calcium salt crystal growth. We solved the complete x-ray structure of lithostathine, including the flexible N-terminal domain, at 1.3 Angstrom. Docking studies of PE1R11 With the (10 (1) over bar 4) and (11 (2) over bar 0) faces through molecular dynamics simulation resulted in three successive steps. First, the undecapeptide progressively unfolded as it approached the calcite surface. Second, mobile lateral chains of amino acids made hydrogen bonds with the calcite surface. Last, electrostatic bonds between calcium ions and peptide bonds stabilized and anchored pE(1)R(11) on the crystal surface, pE(1)R(11)-calcite interaction was stronger with the (11 (2) over bar 0) face than with the (10 (1) over bar 4) face, confirming earlier experimental observations. Energy contributions showed that the peptide backbone governed the binding more than did the lateral chains. The ability of peptides to inhibit crystal growth is therefore essentially based on backbone flexibility.	Fac Pharm Marseille, UPRESA CNRS 6032, Unite Propre Rech & Enseignement Super, F-13385 Marseille 05, France; Univ Toulouse 3, Inst Natl Polytech Toulouse, Ecole Natl Super Genie Chim, UMR CNRS 5503,Lab Genie Chim, F-31078 Toulouse, France; CEA, CNRS, Inst Biol Struct, Lab Cristallog & Cristallogenese Prot, F-38027 Grenoble, France; UPR CNRS 9027, Lab Ingn Syst Macromol, F-13009 Marseille, France; Hop St Marguerite, Serv Nephrol, F-13385 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Verdier, JM (corresponding author), Fac Pharm Marseille, UPRESA CNRS 6032, Unite Propre Rech & Enseignement Super, 27 Bd Jean Moulin, F-13385 Marseille 05, France.		GERBAUD, Vincent/Q-6864-2019; Gerbaud, Vincent/J-7676-2013	GERBAUD, Vincent/0000-0003-2738-7922; Gerbaud, Vincent/0000-0003-2738-7922; VERDIER, Jean-Michel/0000-0002-7252-1556; PIGNOL, David/0000-0002-8070-0319				ADDADI L, 1986, MOL CRYST LIQ CRYST, V134, P305, DOI 10.1080/00268948608079592; ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; Benson SW, 1996, J AM CHEM SOC, V118, P10645, DOI 10.1021/ja962101w; BERNARD JP, 1992, GASTROENTEROLOGY, V103, P1277, DOI 10.1016/0016-5085(92)91516-7; Bertrand JA, 1996, EMBO J, V15, P2678, DOI 10.1002/j.1460-2075.1996.tb00628.x; Bimmler D, 1997, J BIOL CHEM, V272, P3073, DOI 10.1074/jbc.272.5.3073; BOEK ES, 1992, J CHEM PHYS, V96, P7010, DOI 10.1063/1.462560; Boistelle R, 1986, Adv Nephrol Necker Hosp, V15, P173; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; CATTI M, 1993, PHYS CHEM MINER, V20, P104; Cerini C, 1999, J BIOL CHEM, V274, P22266, DOI 10.1074/jbc.274.32.22266; Cerini C, 1999, KIDNEY INT, V55, P1776, DOI 10.1046/j.1523-1755.1999.00426.x; De Reggi M, 1998, J BIOL CHEM, V273, P4967, DOI 10.1074/jbc.273.9.4967; DECARO AM, 1989, BIOCHIM BIOPHYS ACTA, V994, P281, DOI 10.1016/0167-4838(89)90305-1; DeOliveira DB, 1997, J AM CHEM SOC, V119, P10627, DOI 10.1021/ja972270w; DEREGGI M, 1995, EUR J BIOCHEM, V230, P503; EFFENBERGER H, 1981, Z KRISTALLOGR, V156, P233, DOI 10.1524/zkri.1981.156.3-4.233; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FRANKS F, 1983, WATER, P15; GEFFROY C, 1997, THESIS U FRANCHECOMT; Geider S, 1996, J BIOL CHEM, V271, P26302, DOI 10.1074/jbc.271.42.26302; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; JENKINS HDB, 1976, J INORG NUCL CHEM, V38, P371, DOI 10.1016/0022-1902(76)80265-5; JOHNSON WC, 1985, METHOD BIOCHEM ANAL, V31, P61, DOI 10.1002/9780470110522.ch2; KNIGHT CA, 1993, BIOPHYS J, V64, P252, DOI 10.1016/S0006-3495(93)81361-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lin CH, 1998, J CRYST GROWTH, V191, P791, DOI 10.1016/S0022-0248(98)00130-4; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; MANN S, 1990, J CHEM SOC FARADAY T, V86, P1873, DOI 10.1039/ft9908601873; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pignol D, 1995, PROTEINS, V23, P604, DOI 10.1002/prot.340230418; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; SCHEELE G, 1984, PANCREATITIS CONCEPT, P119; Sheldrick GM, 1997, METHOD ENZYMOL, V276, P628, DOI 10.1016/S0076-6879(97)76083-X; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Tsai FTF, 1997, PROTEINS, V28, P41; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; VERDIER JM, 1993, SCANNING MICROSCOPY, V7, P1017; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; WEISSBUCH I, 1995, ACTA CRYSTALLOGR B, V51, P115, DOI 10.1107/S0108768194012061; WEN DY, 1992, BIOPHYS J, V63, P1659, DOI 10.1016/S0006-3495(92)81750-2; Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858	50	61	62	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1057	1064		10.1074/jbc.275.2.1057	http://dx.doi.org/10.1074/jbc.275.2.1057			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625646	hybrid			2022-12-27	WOS:000084836600050
J	Loussouarn, G; Makhina, EN; Rose, T; Nichols, CG				Loussouarn, G; Makhina, EN; Rose, T; Nichols, CG			Structure and dynamics of the pore of inwardly rectifying K-ATP channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR; SCANNING MUTAGENESIS; SUBUNIT; STOICHIOMETRY; SELECTIVITY; CONDUCTION; MECHANISM; RECTIFICATION; SENSITIVITY	Inwardly rectifying K+ currents are generated by a complex of four Kir (Kir1-6) subunits. Pore properties are conferred by the second transmembrane domain (M2) of each subunit. Using cadmium ions as a cysteine-interacting probe, we examined the accessibility of substituted cysteines in M2 of the Kir6.2 subunit of inwardly rectifying K-ATP channels. The ability of Cd2+ ions to inhibit channels was used as the estimate of accessibility. The distribution of Cd2+ accessibility is consistent with an alpha-helical structure of M2. The apparent surface of reactivity is broad, and the most reactive residues correspond to the solvent-accessible residues in the bacterial KcsA channel crystal structure. In several mutants, single channel measurements indicated that inhibition occurred by a single transition from the open state to a zero-conductance state. Analysis of currents expressed from mixtures of control and L164C mutant subunits indicated that at least three cysteines are required for coordination of the Cd2+ ion. Application of phosphatidylinositol 4,Ei-diphosphate to inside-out membrane patches stabilized the open state of all mutants and also reduced cadmium sensitivity, Moreover, the Cd2+ sensitivity of several mutants was greatly reduced in the presence of inhibitory ATP concentrations. Taken together, these results are consistent with state-dependent accessibility of single Cd2+ ions to coordination sites within a relatively narrow inner vestibule.	Washington Univ, Sch Med, Dept Physiol & Cell Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Physiol & Cell Biol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Loussouarn, Gildas/D-3590-2015; Loussouarn, Gildas/ABH-6043-2020; Nichols, Colin/D-6336-2012	Loussouarn, Gildas/0000-0001-8007-5931; Loussouarn, Gildas/0000-0001-8007-5931; ROSE, Thierry/0000-0001-8863-0207	NHLBI NIH HHS [HL54171] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIYAR J, 1994, BIOPHYS J, V67, P2261, DOI 10.1016/S0006-3495(94)80710-6; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Choe S, 1995, P NATL ACAD SCI USA, V92, P12046, DOI 10.1073/pnas.92.26.12046; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; DEUTSCH N, 1994, J GEN PHYSIOL, V104, P773, DOI 10.1085/jgp.104.4.773; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; HARTMANN HA, 1991, SCIENCE, V251, P942, DOI 10.1126/science.2000495; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KURZ LL, 1995, BIOPHYS J, V68, P900, DOI 10.1016/S0006-3495(95)80266-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; PASCUAL JM, 1995, NEURON, V14, P1055, DOI 10.1016/0896-6273(95)90344-5; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; Trapp S, 1998, J GEN PHYSIOL, V112, P325, DOI 10.1085/jgp.112.3.325; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; YOOL AJ, 1991, NATURE, V349, P700, DOI 10.1038/349700a0	41	82	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1137	1144		10.1074/jbc.275.2.1137	http://dx.doi.org/10.1074/jbc.275.2.1137			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625656	hybrid			2022-12-27	WOS:000084836600060
J	Nemir, M; Bhattacharyya, D; Li, XM; Singh, K; Mukherjee, AB; Mukherjee, BB				Nemir, M; Bhattacharyya, D; Li, XM; Singh, K; Mukherjee, AB; Mukherjee, BB			Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; GENE-EXPRESSION; CELL-ADHESION; BASEMENT-MEMBRANE; GROWTH-FACTOR; IN-VITRO; C-SRC; PROTEIN; INTEGRIN; PROMOTER	Osteopontin (OPN) is a sialic acid-rich, adhesive, extracellular matrix (ECM) protein with Arg-Gly-Asp cell-binding sequence that interacts with several integrins, including alpha(v)beta(3), Since the ECM is a key regulator of mammary gland morphogenesis, and mammary epithelial cells express OPN at elevated levels, we sought to determine whether this protein plays a role in the postnatal mammary gland development. By generating transgenic mice that express OPN antisense-RNA (AS-OPN mice) in the mammary epithelia we achieved suppression of OPN production in this organ. The pregnant AS-OPN mice displayed a lack of mammary alveolar structures, a drastic reduction in the synthesis of beta-casein, whey acidic milk protein, and lactation deficiency. In agreement with these findings, we uncovered that a mammary cell line, NMuMG, which undergoes both structural and functional differentiation on ECM-coated plates, when transfected with an antisense OPN-cDNA construct, failed to undergo such differentiation. Furthermore, the results of gel-invasion assays demonstrated that these cells manifest elevated matrix metalloproteinase (MMP) activity when OPN expression is significantly reduced. The identity of this proteinase as MMP-2 is confirmed by Western blotting, zymography, and inhibition of its activity by a specific inhibitor, TIMP-2. Taken together, our results demonstrate, for the first time, an essential role of OPN in mammary gland differentiation and that the molecular mechanism(s) of its action, at least in part, involves downregulation of MMP-2.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; NICHD, Sect Dev Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mukherjee, BB (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	baridm@bio1.lan.mcgill.ca	Bhattacharyya, Dibyendu/GRS-5261-2022; Bhattacharyya, Dibyendu/AAE-9208-2022	Bhattacharyya, Dibyendu/0000-0003-3252-7440; Bhattacharyya, Dibyendu/0000-0003-3252-7440	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000910] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEHREND EI, 1993, J BIOL CHEM, V268, P11172; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; BROWN LF, 1992, MOL BIOL CELL, V3, P1169, DOI 10.1091/mbc.3.10.1169; BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x; Chackalaparampil I, 1996, ONCOGENE, V12, P1457; Chellaiah M, 1996, ENDOCRINOLOGY, V137, P2432, DOI 10.1210/en.137.6.2432; CHEN LH, 1989, CELL REGUL, V1, P45, DOI 10.1091/mbc.1.1.45; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; CRAIG AM, 1991, GENE, V100, P163, DOI 10.1016/0378-1119(91)90362-F; CRAIG AM, 1989, J BIOL CHEM, V264, P9682; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; FENG ZW, 1995, J CELL BIOL, V131, P1095, DOI 10.1083/jcb.131.4.1095; FET V, 1989, GENOMICS, V5, P375, DOI 10.1016/0888-7543(89)90074-8; GRONER B, 1992, J CELL BIOCHEM, V49, P182; HERRON GS, 1986, J BIOL CHEM, V261, P2814; HWANG S, 1994, J BIOL CHEM, V269, P711; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; LAMPE MA, 1991, J IMMUNOL, V147, P2902; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214; Liaw L, 1998, J CLIN INVEST, V101, P1468; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; MULLER WJ, 1990, EMBO J, V9, P907, DOI 10.1002/j.1460-2075.1990.tb08188.x; NECKERS L, 1993, AM J PHYSIOL, V265, pL1, DOI 10.1152/ajplung.1993.265.1.L1; NEMIR M, 1989, J BIOL CHEM, V264, P18202; OLDBERG A, 1988, J BIOL CHEM, V263, P19433; Panda D, 1997, P NATL ACAD SCI USA, V94, P9308, DOI 10.1073/pnas.94.17.9308; PIERCE DF, 1993, GENE DEV, V7, P2308, DOI 10.1101/gad.7.12a.2308; Rollo EE, 1996, J LEUKOCYTE BIOL, V60, P397, DOI 10.1002/jlb.60.3.397; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; SENGER DR, 1989, BIOCHIM BIOPHYS ACTA, V996, P43, DOI 10.1016/0167-4838(89)90092-7; SINGH K, 1992, J BIOL CHEM, V267, P23847; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; SU LC, 1995, ONCOGENE, V10, P2163; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; SYMPSON CJ, 1994, J CELL BIOL, V125, P681, DOI 10.1083/jcb.125.3.681; TAKAYAMA KM, 1990, CRIT REV BIOCHEM MOL, V25, P155, DOI 10.3109/10409239009090608; TALHOUK RS, 1992, J CELL BIOL, V118, P1271, DOI 10.1083/jcb.118.5.1271; Tezuka KI, 1996, J BIOL CHEM, V271, P22713, DOI 10.1074/jbc.271.37.22713; Uede T, 1997, MICROBIOL IMMUNOL, V41, P641, DOI 10.1111/j.1348-0421.1997.tb01906.x; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Weintraub AS, 1996, AM J PATHOL, V149, P259; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; ZIMOLO Z, 1994, AM J PHYSIOL, V266, P376	47	91	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					969	976		10.1074/jbc.275.2.969	http://dx.doi.org/10.1074/jbc.275.2.969			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625634	hybrid			2022-12-27	WOS:000084836600038
J	Chen, SY; Johnson, BA; Li, Y; Aster, S; McKeever, B; Mosley, R; Moller, DE; Zhou, GC				Chen, SY; Johnson, BA; Li, Y; Aster, S; McKeever, B; Mosley, R; Moller, DE; Zhou, GC			Both coactivator LXXLL motif-dependent and -independent interactions are required for peroxisome proliferator-activated receptor gamma (PPAR gamma) function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-RECEPTOR; LIGAND-BINDING; ASSIGNMENT; PROTEIN; N-15; HETERODIMERS; SPECIFICITY; C-13; PBP	Nuclear receptor activation is dependent on recruitment of coactivators, including CREB-binding protein (GBP/p300) and steroid receptor coactivator-1 (SRC-1), A three-dimensional NMR approach was used to probe the coactivator binding interface in the peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand binding domain (LBD), In the presence of a CBP peptide, peaks corresponding to 20 residues in helices 3, 4, 5, and 12 of the LED were attenuated. Alanine mutants revealed that M301A, V315A, Y320A, L468A, and E471A were required for binding of both CBP and SRC-1 and for cell-based transcription. Several additional amino acids in helix 4 of the PPAR gamma LBD were defective with respect to CBP recruitment, but retained relatively normal SRC-1 recruitment. Thus these amino acid residues may be important determinants of specificity for nuclear receptor LED interactions with discrete coactivator molecules.	Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA; Merck Res Labs, Dept Endocrinol & Chem Biol, Rahway, NJ 07065 USA; Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA; Merck Res Labs, Dept Mol Syst, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Zhou, GC (corresponding author), Merck Res Labs, Dept Metab Disorders, RYSON-31C,126 E Lincoln Ave, Rahway, NJ 07065 USA.							Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Berger J, 1999, J BIOL CHEM, V274, P6718, DOI 10.1074/jbc.274.10.6718; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiRenzo J, 1997, MOL CELL BIOL, V17, P2166, DOI 10.1128/MCB.17.4.2166; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinlein CA, 1999, J BIOL CHEM, V274, P16147, DOI 10.1074/jbc.274.23.16147; Jain S, 1998, AM J PATHOL, V153, P349, DOI 10.1016/S0002-9440(10)65577-0; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Maniatis T., 1989, MOL CLONING LAB MANU; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Mizukami J, 1997, BIOCHEM BIOPH RES CO, V240, P61, DOI 10.1006/bbrc.1997.7602; Mulder FAA, 1996, J BIOMOL NMR, V8, P223, DOI 10.1007/BF00211169; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shan X, 1996, J AM CHEM SOC, V118, P6570, DOI 10.1021/ja960627a; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; VONLANGEN D, 1999, KEYST S MOL CELL BIO; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; YAMAZAKI T, 1995, J AM CHEM SOC, V117, P3556, DOI 10.1021/ja00117a025; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhou GC, 1998, MOL ENDOCRINOL, V12, P1594, DOI 10.1210/me.12.10.1594; Zhu YJ, 1996, GENE EXPRESSION, V6, P185; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	28	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3733	3736		10.1074/jbc.275.6.3733	http://dx.doi.org/10.1074/jbc.275.6.3733			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660518	hybrid			2022-12-27	WOS:000085288800002
J	Inouye, K; Mizutani, S; Koide, H; Kaziro, Y				Inouye, K; Mizutani, S; Koide, H; Kaziro, Y			Formation of the Ras dimer is essential for Raf-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HA-RAS; PLASMA-MEMBRANE; IN-VITRO; KINASE; PROTEINS; EXPRESSION; C-RAF-1; CELLS; ACID; P21(RAS)	Although it is well established that Ras requires membrane localization for activation of its target molecule, Raf-1, the reason for this requirement is not fully understood. in this study, we found that modified Ras, which is purified from Sf9 cells, could activate Raf-1 in a cell-free system, when incorporated into liposome. Using a bifunctional cross-linker and a protein-fragmentation complementation assay, we detected dimer formation of Ras in the liposome and in the intact cells, respectively. These results suggest that dimerization of Ras in the lipid membrane is essential for activation of Raf-1. To support this, we found that, when fused to glutathione S-transferase (GST), unprocessed has expressed in Escherichia coli could bypass the requirement for liposome. A Ras-dependent Raf-1 activator, which we previously reported (Mizutani, S., Koide, H., and Kaziro, Y. (1998) Oncogene 16, 2781-2786), was still required for Raf-1 activation by GST-Ras. Furthermore, an enforced dimerization of unmodified oncogenic Ras mutant in human embryonic kidney (HEK) 293 cells, using a portion of gyrase B or estrogen receptor, also resulted in activation of Raf-1. From these results, we conclude that membrane localization allows has to form a dimer, which is essential, although not sufficient, for Raf-1 activation.	Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Kaziro, Y (corresponding author), Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.		Koide, Hiroshi/E-9000-2011	Koide, Hiroshi/0000-0001-5916-3179				ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; DENT P, 1994, P NATL ACAD SCI USA, V91, P9544, DOI 10.1073/pnas.91.20.9544; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; LOWE PN, 1991, J BIOL CHEM, V266, P1672; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; Mizutani S, 1998, ONCOGENE, V16, P2781, DOI 10.1038/sj.onc.1201806; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rossi F, 1997, P NATL ACAD SCI USA, V94, P8405, DOI 10.1073/pnas.94.16.8405; SHIROUZU M, 1994, ONCOGENE, V9, P2153; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	27	115	117	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3737	3740		10.1074/jbc.275.6.3737	http://dx.doi.org/10.1074/jbc.275.6.3737			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660519	hybrid			2022-12-27	WOS:000085288800003
J	Liao, W; Chan, L				Liao, W; Chan, L			Apolipoprotein B, a paradigm for proteins regulated by intracellular degradation, does not undergo intracellular degradation in CaCo2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEINS; UBIQUITIN-PROTEASOME PATHWAY; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; RAT HEPATOCYTES; OLEIC-ACID; SECRETION; TRANSLOCATION; B100	Studies in different liver-derived cells in culture indicate that apolipoprotein (apo) B-100 production is regulated largely by intracellular degradation and the ubiquitin-proteasome pathway is a major mechanism for the degradation. The proteasomal degradation of apoB-100 was postulated to be an intrinsic property of the protein that occurs even in the presence of optimal amounts of lipids supplied to the cell. We examined apoB-100 and apoB-48 biogenesis in CaCo2, a human colon carcinoma cell line. To our surprise, apoB-100 and apoB-48 were quantitatively secreted by CaCo2 cells; essentially none of the newly synthesized apoB was degraded before secretion in a 2-h period whether the cells were cultured on filter or on plastic. Furthermore, although ubiquitin immunoreactivity was readily detected in the intracellular apoB isolated from HepG2 cells, little or no ubiquitin was detectable in the intracellular apoB from CaCo2 cells. The amounts of free ubiquitin and total and non-apoB ubiquitinated proteins were comparable in HepG2 and CaCo2 cells, indicating that CaCo2 cells have the necessary machinery for tagging ubiquitin chains onto cellular proteins for proteasomal degradation. Incubation in lipoprotein-deficient serum did not induce apoB degradation, but the addition of a microsomal triglyceride transfer protein inhibitor led to apoB degradation in CaCo2 cells. Finally, similar proportions of apoB polypeptide in isolated microsomes from CaCo2 and HepG2 cells were accessible to exogenously added trypsin, indicating that the mere exposure of apoB nascent chains to the cytosolic compartment is insufficient to cause the proteasomal degradation. Therefore, the intracellular degradation of apoB is not an intrinsic property of the protein, and the phenomenon is neither universal nor inevitable. The unconditional use of apoB as a paradigm for intracellular protein degradation is not warranted.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Liao, W (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056668, R37HL016512, R01HL016512] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-16512, HL-56668] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benoist F, 1997, J BIOL CHEM, V272, P20435, DOI 10.1074/jbc.272.33.20435; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOREN J, 1994, J BIOL CHEM, V269, P25879; Cavallo D, 1998, J BIOL CHEM, V273, P33397, DOI 10.1074/jbc.273.50.33397; CHAN L, 1992, J BIOL CHEM, V267, P25621; CHANG BHJ, 1998, MODIFICATION EDITING, P325; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Chen Y, 1998, J BIOL CHEM, V273, P11887, DOI 10.1074/jbc.273.19.11887; DASHTI N, 1990, J LIPID RES, V31, P113; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Du EZ, 1999, J BIOL CHEM, V274, P1856, DOI 10.1074/jbc.274.3.1856; DU EZ, 1994, J BIOL CHEM, V269, P24169; FIELD FJ, 1994, J LIPID RES, V35, P749; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; GINSBERG HN, 1995, CURR OPIN LIPIDOL, V6, P275, DOI 10.1097/00041433-199510000-00006; Gordon DA, 1997, CURR OPIN LIPIDOL, V8, P131, DOI 10.1097/00041433-199706000-00002; Gordon DA, 1996, J BIOL CHEM, V271, P33047, DOI 10.1074/jbc.271.51.33047; Hersberger M, 1998, J BIOL CHEM, V273, P9435, DOI 10.1074/jbc.273.16.9435; JIAO S, 1990, J LIPID RES, V31, P695; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Liang JS, 1998, J BIOL CHEM, V273, P35216, DOI 10.1074/jbc.273.52.35216; Liao W, 1999, BIOCHEMISTRY-US, V38, P7532, DOI 10.1021/bi9904196; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; MOBERLY JB, 1990, BIOCHIM BIOPHYS ACTA, V1042, P70, DOI 10.1016/0005-2760(90)90058-6; MURTHY S, 1992, ARTERIOSCLER THROMB, V12, P691, DOI 10.1161/01.ATV.12.6.691; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; SATO R, 1990, J BIOL CHEM, V265, P11880; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; Tsai HL, 1996, J BIOL CHEM, V271, P3534; VANCE DE, 1984, BIOCHIM BIOPHYS ACTA, V792, P39, DOI 10.1016/0005-2760(84)90280-7; WANG CN, 1995, J BIOL CHEM, V270, P24924, DOI 10.1074/jbc.270.42.24924; Wang S, 1996, J BIOL CHEM, V271, P14124, DOI 10.1074/jbc.271.24.14124; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; WHITE AL, 1992, J BIOL CHEM, V267, P15657; Yao ZM, 1997, J LIPID RES, V38, P1937; Yeung SCJ, 1998, TRENDS CARDIOVAS MED, V8, P8, DOI 10.1016/S1050-1738(97)00120-5; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649	42	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3950	3956		10.1074/jbc.275.6.3950	http://dx.doi.org/10.1074/jbc.275.6.3950			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660549	hybrid			2022-12-27	WOS:000085288800033
J	Jing, N; De Clercq, E; Rando, RF; Pallansch, L; Lackman-Smith, C; Lee, S; Hogan, ME				Jing, N; De Clercq, E; Rando, RF; Pallansch, L; Lackman-Smith, C; Lee, S; Hogan, ME			Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors - A basis for anti-HIV drug design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; AIDS-RELATED COMPLEX; ANTIRETROVIRAL THERAPY; CATALYTIC DOMAIN; HTLV-III/LAV; DNA APTAMER; PHASE-I; INTEGRASE; REPLICATION; BINDING	Recently, we have demonstrated that T30695, a G-tetrad-forming oligonucleotide, is a potent inhibitor of human immunodeficiency virus, type I (HIV-1) integrase and the K+ induced loop folding of T30695 plays a key role in the inhibition of HIV-1 integrase (Jing, N,, and Hogan, M, E, (1998) J, Biol, Chem. 273, 34992-34999), Here we have modified T30695 by introducing a hydrophobic bulky group, propynyl dU, or a positively charged group, 5-amino dU, into the bases of T residues of the loops, and by substitution of the T-Gr loops by T-T loops. Physical measurements have demonstrated that the substitution of propynyl dU or 5-amino dU for T in the T residues of the loops did not alter the structure of T30695, and these derivatives also formed an intramolecular G-quartet structure, which is an essential requirement for anti-HIV activity. Measured IC50 and EC50 values show that these substitutions did not induce an apparent decrease in the ability to inhibit HIV-1 integrase activity and in the inhibition of HIV-1 replication in cell culture. However, the substitution of T-T loops for T-G loops induced a substantial decrease in both thermal stability and anti-MN activity. The data analysis of T30695 and the 21 derivatives shows a significant, functional correlation between thermal stability of the G-tetrad structure and the capacity to inhibit HIV-1 integrase activity and between thermal stability of the G-tetrad structure and the capacity to inhibit HIV-1 replication, as assessed with the virus strains HIV-1 RF, IIIB, and MN in cell culture. This relationship between thermostability and activity provides a basis for improving the efficacy of these compounds to inhibit HIV-1 integrase activity and HIV-1 replication in cell culture.	Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Katholieke Univ Leuven, Inst Med Res, B-3000 Louvain, Belgium; Biochem Pharma, Laval, PQ, Canada; So Res Inst, Frederick, MD 21701 USA	Baylor College of Medicine; KU Leuven	Jing, N (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.			De Clercq, Erik/0000-0002-2985-8890	NATIONAL CANCER INSTITUTE [P01CA074173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060153] Funding Source: NIH RePORTER; NCI NIH HHS [CA74173] Funding Source: Medline; NIGMS NIH HHS [GM60153] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWNE MJ, 1993, J INFECT DIS, V167, P21, DOI 10.1093/infdis/167.1.21; BUSHMAN FD, 1993, P NATL ACAD SCI USA, V90, P3428, DOI 10.1073/pnas.90.8.3428; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; COLLIER AC, 1990, NEW ENGL J MED, V323, P1015, DOI 10.1056/NEJM199010113231502; DECLERCO E, 1992, P NATL ACAD SCI USA, V89, P5286, DOI 10.1073/pnas.89.12.5286; DECLERCQ E, 1995, J MED CHEM, V38, P2491, DOI 10.1021/jm00014a001; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Este JA, 1998, MOL PHARMACOL, V53, P340, DOI 10.1124/mol.53.2.340; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; HICKMAN AB, 1994, J BIOL CHEM, V269, P29279; Jing NJ, 1998, J BIOL CHEM, V273, P34992, DOI 10.1074/jbc.273.52.34992; Jing NJ, 1997, J BIOMOL STRUCT DYN, V15, P573, DOI 10.1080/07391102.1997.10508967; Jing NJ, 1997, BIOCHEMISTRY-US, V36, P12498, DOI 10.1021/bi962798y; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; Katzman M, 1999, ADV VIRUS RES, V52, P371, DOI 10.1016/S0065-3527(08)60307-3; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; LONGFELLOW CE, 1990, BIOCHEMISTRY-US, V29, P278, DOI 10.1021/bi00453a038; Mazumder A, 1996, BIOCHEMISTRY-US, V35, P13762, DOI 10.1021/bi960541u; Mazumder A, 1996, MOL PHARMACOL, V49, P621; MITSUYA H, 1986, P NATL ACAD SCI USA, V83, P1911, DOI 10.1073/pnas.83.6.1911; Pommier Y, 1999, ADV VIRUS RES, V52, P427, DOI 10.1016/S0065-3527(08)60310-3; RANDO RF, 1995, J BIOL CHEM, V270, P1754, DOI 10.1074/jbc.270.4.1754; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; WANG KY, 1993, BIOCHEMISTRY-US, V32, P1899, DOI 10.1021/bi00059a003; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; YARCHOAN R, 1986, LANCET, V1, P575; YARCHOAN R, 1988, LANCET, V1, P76	30	60	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3421	3430		10.1074/jbc.275.5.3421	http://dx.doi.org/10.1074/jbc.275.5.3421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652335	hybrid			2022-12-27	WOS:000085146500057
J	Melia, TJ; Malinski, JA; He, F; Wensel, TG				Melia, TJ; Malinski, JA; He, F; Wensel, TG			Enhancement of phototransduction protein interactions by lipid surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; TRANSDUCIN ALPHA-SUBUNIT; CGMP PHOSPHODIESTERASE ACTIVATION; HETEROTRIMERIC G-PROTEIN; GTP-BINDING PROTEIN; RETINAL RODS; INHIBITORY SUBUNIT; PHOSPHOLIPID-VESICLES; CRYSTAL-STRUCTURE; GAMMA-SUBUNIT	The G protein cascade of vision depends on two peripheral membrane proteins: the Gr protein, transducin (G(t)), and cGMP phosphodiesterase (PDE), Each has covalently attached lipids, and interacts with transduction components on the membrane surface. We have found that their surface interactions are critically dependent on the nature of the lipid. Membranes enhance their protein-protein interactions, especially if electrostatic attraction is introduced with positively charged lipids. These interactions are less enhanced on highly curved surfaces, but are most enhanced by unsaturated or bulky acyl chains. On positively charged membranes, G(t) assembles at a high enough density to form two-dimensional arrays with short-range crystalline order. Cationic membranes also support extremely efficient activation of PDE by the GTP gamma S (guanosine 5'-O-(thio-triphosphate)) form of G alpha(t) (G alpha(t)-GTP gamma S), minimizing functional heterogeneity of transducin and allowing activation with nanomolar G alpha(t)-GTP gamma S. Quantification of PDE activation and of the amount of G alpha(t)-GTP gamma S bound to PDE indicated that G(t) activates PDE maximally when bound in a 1:1 molar ratio. No cooperativity was observed, even at nanomolar concentrations. Thus, under these conditions, the one binding site for G alpha(t)-GTP gamma S on PDE that stimulates catalysis must be of higher affinity than one or more additional sites which are silent with respect to activation of PDE.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA	Baylor College of Medicine	Wensel, TG (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, 1 Baylor Plaza, Houston, TX 77030 USA.			Wensel, Theodore/0000-0003-3518-9352				Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; ANANT JS, 1992, J BIOL CHEM, V267, P687; ANGLESON JK, 1994, J BIOL CHEM, V269, P16290; AvilaSakar AJ, 1996, BIOPHYS J, V70, P57, DOI 10.1016/S0006-3495(96)79597-8; BENNETT N, 1989, BIOCHEMISTRY-US, V28, P7418, DOI 10.1021/bi00444a040; Berger AL, 1999, BIOCHEMISTRY-US, V38, P1293, DOI 10.1021/bi981683m; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCKERT F, 1994, BIOCHEMISTRY-US, V33, P12625, DOI 10.1021/bi00208a013; CHIRUVOLU S, 1994, SCIENCE, V264, P1753, DOI 10.1126/science.8209255; Chiu W, 1999, TRENDS CELL BIOL, V9, P154, DOI 10.1016/S0962-8924(99)01511-1; CLERC A, 1992, J BIOL CHEM, V267, P19948; CLERC A, 1992, J BIOL CHEM, V267, P6620; DAEMEN FJM, 1973, BIOCHIM BIOPHYS ACTA, V300, P255, DOI 10.1016/0304-4157(73)90006-3; DeMar JC, 1996, J BIOL CHEM, V271, P5007; DeMar JC, 1999, PROG LIPID RES, V38, P49, DOI 10.1016/S0163-7827(98)00020-4; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; Fukami A, 1965, J Electron Microsc (Tokyo), V14, P112; FUNG BKK, 1983, J BIOL CHEM, V258, P503; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P532; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; Malinski JA, 1996, J BIOL CHEM, V271, P12919, DOI 10.1074/jbc.271.22.12919; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; Melia TJ, 1999, J STRUCT BIOL, V128, P119, DOI 10.1006/jsbi.1999.4151; MELIA TJ, 1999, THESIS BAYLOR COLL M; MIKI N, 1975, J BIOL CHEM, V250, P6320; MILJANICH GP, 1981, J MEMBRANE BIOL, V60, P249, DOI 10.1007/BF01992562; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Neubert TA, 1998, FEBS LETT, V422, P343, DOI 10.1016/S0014-5793(98)00037-4; OTTOBRUC A, 1993, BIOCHEMISTRY-US, V32, P8636, DOI 10.1021/bi00084a035; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PLAGER DA, 1994, BIOCHEMISTRY-US, V33, P7005, DOI 10.1021/bi00188a033; RAMDAS L, 1991, BIOCHEMISTRY-US, V30, P11637, DOI 10.1021/bi00114a005; REBECCHI M, 1992, BIOCHEMISTRY-US, V31, P12742, DOI 10.1021/bi00166a005; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; SILVERSMITH RE, 1986, BIOCHEMISTRY-US, V25, P7717, DOI 10.1021/bi00371a065; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TSUI FC, 1990, BIOPHYS J, V57, P85, DOI 10.1016/S0006-3495(90)82509-1; TYMINSKI PN, 1984, BIOCHEMISTRY-US, V23, P3986, DOI 10.1021/bi00312a028; UZGIRIS EE, 1983, NATURE, V301, P125, DOI 10.1038/301125a0; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; WENSEL TG, 1999, INTRO SIGNAL TRANSDU, P29; WENSEL TG, 1988, ENZYME DYNAMICS REGU, P102; WHALEN MM, 1989, BIOCHEM J, V259, P13, DOI 10.1042/bj2590013; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; YANG ZH, 1992, J BIOL CHEM, V267, P23197; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	58	35	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3535	3542		10.1074/jbc.275.5.3535	http://dx.doi.org/10.1074/jbc.275.5.3535			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652348	hybrid			2022-12-27	WOS:000085146500070
J	Sanders, CM; Stenlund, A				Sanders, CM; Stenlund, A			Transcription factor-dependent loading of the E1 initiator reveals modular assembly of the papillomavirus origin melting complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA HELICASE ACTIVITIES; LARGE TUMOR-ANTIGEN; BOVINE PAPILLOMAVIRUS; T-ANTIGEN; REPLICATION ORIGIN; E2 PROTEINS; SV40 ORIGIN; STRUCTURAL-CHANGES; BINDING; ATP	Replication of bovine papillomavirus type 1 DNA absolutely requires the viral transcription factor E2 as well as the initiator Fl, although Fl alone has all the activities expected of an initiator protein. El assembles on the DNA in a stepwise fashion and undergoes a transition in activities from site-specific DNA-binding protein to mobile helicase. Complex assembly is assisted by the viral transcription factor E2 at two levels. E2 acts generally as a specificity factor, which through cooperative binding with El generates an initial Fl complex containing three Fl dimers bound to ori on one face of the DNA, El-ori. Furthermore, E2 can promote the transition to an ori melting complex by recruiting additional Fl molecules to ori, effectively reducing the Fl concentration required for ori melting. This reaction is dependent on an Ea-binding site positioned distal to the precursor E1-ori complex. The final origin melting complex has two subunits that each encircle the DNA and function independently to melt ori. The assembly pathway we describe has implication for understanding DNA melting and unwinding reactions, which are generally poorly understood.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stenlund, A (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NCI NIH HHS [CA 13106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berg M, 1997, J VIROL, V71, P3853, DOI 10.1128/JVI.71.5.3853-3863.1997; BOROWIEC JA, 1988, EMBO J, V7, P3149, DOI 10.1002/j.1460-2075.1988.tb03182.x; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Chen G, 1998, J VIROL, V72, P2567, DOI 10.1128/JVI.72.4.2567-2576.1998; DIXON WJ, 1991, METHOD ENZYMOL, V208, P380; DODSON M, 1985, P NATL ACAD SCI USA, V82, P4678, DOI 10.1073/pnas.82.14.4678; Fouts ET, 1999, J BIOL CHEM, V274, P4447, DOI 10.1074/jbc.274.7.4447; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; GILLETTE TG, 1994, P NATL ACAD SCI USA, V91, P8846, DOI 10.1073/pnas.91.19.8846; Gillette TG, 1998, J VIROL, V72, P5735, DOI 10.1128/JVI.72.7.5735-5744.1998; Ito K, 1996, EMBO J, V15, P5636, DOI 10.1002/j.1460-2075.1996.tb00948.x; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Kodadek T, 1998, TRENDS BIOCHEM SCI, V23, P79, DOI 10.1016/S0968-0004(97)01165-1; KOFF A, 1991, J VIROL, V65, P3284, DOI 10.1128/JVI.65.6.3284-3292.1991; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; LUSKY M, 1994, P NATL ACAD SCI USA, V91, P8895, DOI 10.1073/pnas.91.19.8895; MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0; MASTRANGELO IA, 1985, P NATL ACAD SCI USA, V82, P3626, DOI 10.1073/pnas.82.11.3626; PARSONS R, 1990, J VIROL, V64, P509, DOI 10.1128/JVI.64.2.509-518.1990; PARSONS RE, 1991, J VIROL, V65, P2798, DOI 10.1128/JVI.65.6.2798-2806.1991; RAVNAN JB, 1992, J VIROL, V66, P6946, DOI 10.1128/JVI.66.12.6946-6952.1992; Sanders CM, 1998, EMBO J, V17, P7044, DOI 10.1093/emboj/17.23.7044; SASSEDWIGHT S, 1991, METHOD ENZYMOL, V208, P147; SCHNOS M, 1988, CELL, V52, P385, DOI 10.1016/S0092-8674(88)80031-X; Sedman J, 1998, J VIROL, V72, P6893, DOI 10.1128/JVI.72.8.6893-6897.1998; Sedman J, 1996, EMBO J, V15, P5085, DOI 10.1002/j.1460-2075.1996.tb00889.x; Sedman J, 1995, EMBO J, V14, P6218, DOI 10.1002/j.1460-2075.1995.tb00312.x; Sedman T, 1997, J VIROL, V71, P2887, DOI 10.1128/JVI.71.4.2887-2896.1997; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; USTAV E, 1993, P NATL ACAD SCI USA, V90, P898, DOI 10.1073/pnas.90.3.898; USTAV M, 1991, EMBO J, V10, P449, DOI 10.1002/j.1460-2075.1991.tb07967.x; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086; ZAHN K, 1985, EMBO J, V4, P3605, DOI 10.1002/j.1460-2075.1985.tb04124.x	36	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3522	3534		10.1074/jbc.275.5.3522	http://dx.doi.org/10.1074/jbc.275.5.3522			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652347	Green Accepted, hybrid			2022-12-27	WOS:000085146500069
J	Chen, L; Bateman, E				Chen, L; Bateman, E			Linker scanning analysis of TBP promoter binding factor DNA binding, activation, and repression domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR-TFIIB; BASAL TRANSCRIPTION; MUTATIONAL ANALYSIS; TERMINAL DOMAIN; COILED COILS; PROTEIN TBP; TATA-BOX; GENE; INITIATION	The transcription activator TATA box-binding protein promoter-binding factor (TPBF) is both an activator and repressor of TBP gene expression in Acanthamoeba. TPBF bears little similarity to previously characterized families of factors. In order to identify domains that are involved in DNA binding, activation, and repression, we constructed several alanine linker scanning mutants and tested them for their ability to function in a variety of assays. The DNA binding domain comprises a large 100-amino acid domain within the central third of the protein, suggesting that DNA recognition is accomplished by interactions derived from several structural units within this domain. Surprisingly, transcription activation and repression are impaired by mutations within either of two discrete amino acid sequences located on either side of the DNA binding domain. These data suggest that TPBF activation and repression are accomplished by interactions with the same target. Since TATA elements can function bidirectionally, and in solution TBP can bind to TATA elements in either orientation, we propose that TPBF functions in part by orienting TBP or TFIID correctly on the TATA box.	Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Bateman, E (corresponding author), Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.			Chen, Li/0000-0001-9303-4047				Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; BLAIR WS, 1994, MOL CELL BIOL, V14, P7226, DOI 10.1128/MCB.14.11.7226; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLARK AR, 1993, BIOCHEM J, V296, P521, DOI 10.1042/bj2960521; COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; COWELL IG, 1994, TRENDS BIOCHEM SCI, V19, P38, DOI 10.1016/0968-0004(94)90172-4; Cox JM, 1997, P NATL ACAD SCI USA, V94, P13475, DOI 10.1073/pnas.94.25.13475; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HORI R, 1994, CURR OPIN GENET DEV, V4, P236, DOI 10.1016/S0959-437X(05)80050-4; Huang WB, 1996, NUCLEIC ACIDS RES, V24, P1158, DOI 10.1093/nar/24.6.1158; Huang WB, 1997, J BIOL CHEM, V272, P3852, DOI 10.1074/jbc.272.6.3852; HUANG WB, 1995, J BIOL CHEM, V270, P28839, DOI 10.1074/jbc.270.48.28839; IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149; Jackson BM, 1996, MOL CELL BIOL, V16, P5557; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; LATCHMAN DS, 1995, EUKARYOTIC TRANSCRIP; LEWIN B, 1994, GENES, V5; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; LIU F, 1994, J BIOL CHEM, V269, P18541; MULLER CW, 1995, FEBS LETT, V369, P113, DOI 10.1016/0014-5793(95)00541-G; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; PTASHNE M, 1990, NATURE, V346, P329, DOI 10.1038/346329a0; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SEIPEL K, 1993, NUCLEIC ACIDS RES, V21, P5609, DOI 10.1093/nar/21.24.5609; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Struhl K, 1998, CELL, V94, P1, DOI 10.1016/S0092-8674(00)81213-1; Sullivan SM, 1998, NUCLEIC ACIDS RES, V26, P4487, DOI 10.1093/nar/26.19.4487; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; WASYLYK B, 1988, CRC CR REV BIOCH MOL, V23, P77, DOI 10.3109/10409238809088317; WOLBERGER C, 1993, CURR OPIN STRUC BIOL, V3, P3, DOI 10.1016/0959-440X(93)90194-P; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; WONG JM, 1994, NUCLEIC ACIDS RES, V22, P1890, DOI 10.1093/nar/22.10.1890; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2	52	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2771	2776		10.1074/jbc.275.4.2771	http://dx.doi.org/10.1074/jbc.275.4.2771			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644741	hybrid			2022-12-27	WOS:000085128000073
J	Garver, K; Guo, PX				Garver, K; Guo, PX			Mapping the inter-RNA interaction of bacterial virus phi29 packaging RNA by site-specific photoaffinity cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-PHI-29 PROHEAD RNA; PERMUTED TRANSFER-RNAS; PHAGE PHI-29; BACILLUS-SUBTILIS; IN-VITRO; RIBOSOMAL-RNA; SECONDARY STRUCTURE; VIRAL-DNA; PRNA; CONNECTOR	During replication, the lengthy genome of double-stranded DNA viruses is translocated with remarkable velocity into a limited space within the procapsid. The question of how this fascinating task is accomplished has long been a puzzle. Our recent investigation suggests that phi29 DNA packaging is accomplished by a mechanism similar to the driving of a bolt with a hex nut and that six packaging RNAs (pRNAs) form a hexagonal complex to gear the DNA-translocating machine (Chen, C., and Guo, P. (1997) J. Virol. 71, 3864-3871; Zhang, F., Lemieux, S., Wu, X., St.-Arnaud, S., McMurray, C. T., Major, F., and Anderson, D. (1998) Mol. Cell 2, 141-147; Guo, P., Zhang, C., Chen, C., Garver, K., and Trottier, RI., (1998) Mol. Cell 2, 149-155). In the current study, circularly permuted pRNAs were used to position an azido-phenacyl photoreactive cross-linking agent specifically at a strategic site that was predicted to be involved in pRNA-pRNA interaction. Cross-linked pRNA dimers were isolated, and the sites of cross-link were mapped by primer extension. The cross-linked pRNA dimer retained full activity in phi29 procapsid binding and genomic DNA translocation, indicating that the crosslink distance constraints identified in dimer formation reflect the native pRNA complex. Both cross-linked dimers either containing or not containing the interlocking loops for programmed hexamer formation bound procapsid equally well; however, only the one containing the interlocking loops programmed for hexamer formation was active in phi29 DNA packaging. The cross-linked pRNA dimers were also identified as the minimum binding unit necessary for procapsid binding. Primer extension of the purified cross-linked pRNA dimers revealed that base G(82) Was cross-linked to bases G(39), G(40), A(41), C-49, G(62), C-63, and C-64, which contribute to the formation of the three-way junction, suggesting that these bases are proximate in the formation of pRNA tertiary structure. Interestingly, the photoaffinity agent in the left interacting loop did not cross-link directly to the right loop as expected but cross-linked to bases adjacent to the right loop. These data provide a background for future modeling of pRNA tertiary structure.	Purdue Univ, Ctr Canc, Dept Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Guo, PX (corresponding author), Purdue Univ, Ctr Canc, Dept Pathobiol, B-36 Hansen Life Sci Res Bldg, W Lafayette, IN 47907 USA.		Guo, Peixuan/I-7184-2015; Guo, Peixuan/AAE-2573-2022	Guo, Peixuan/0000-0001-5706-2833	NIGMS NIH HHS [GM59944, GM48159] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059944, R01GM048159, R21GM048159] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1990, J BIOL CHEM, V265, P22365; BARTA A, 1984, P NATL ACAD SCI-BIOL, V81, P3607, DOI 10.1073/pnas.81.12.3607; BURGIN AB, 1990, EMBO J, V9, P4111, DOI 10.1002/j.1460-2075.1990.tb07633.x; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CERRITELLI ME, 1996, J MOL BIOL, V285, P29; Chen CP, 1999, RNA, V5, P805, DOI 10.1017/S1355838299990350; Chen CP, 1997, J VIROL, V71, P495, DOI 10.1128/JVI.71.1.495-500.1997; Garver K, 1997, RNA, V3, P1068; GRIMES S, 1989, J MOL BIOL, V209, P91, DOI 10.1016/0022-2836(89)90172-1; Guasch A, 1998, J MOL BIOL, V281, P219, DOI 10.1006/jmbi.1998.1928; GUO PX, 1987, NUCLEIC ACIDS RES, V15, P7081, DOI 10.1093/nar/15.17.7081; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1991, VIROLOGY, V185, P395, DOI 10.1016/0042-6822(91)90787-C; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; GUO PX, 1991, VIROLOGY, V183, P366, DOI 10.1016/0042-6822(91)90149-6; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; HAGENBUCHLE O, 1978, CELL, V13, P551, DOI 10.1016/0092-8674(78)90328-8; HANNA MM, 1983, BIOCHEMISTRY-US, V22, P3547; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hendrix RW, 1998, CELL, V94, P147, DOI 10.1016/S0092-8674(00)81413-0; HERRANZ L, 1986, VIROLOGY, V155, P289, DOI 10.1016/0042-6822(86)90191-1; HIXON SH, 1975, BIOCHEMISTRY-US, V14, P4251; INOUE T, 1985, P NATL ACAD SCI USA, V82, P648, DOI 10.1073/pnas.82.3.648; KOCHAN J, 1984, J MOL BIOL, V174, P433, DOI 10.1016/0022-2836(84)90330-9; LEE CS, 1995, J VIROL, V69, P5024, DOI 10.1128/JVI.69.8.5024-5032.1995; LEE CS, 1995, J VIROL, V69, P5018, DOI 10.1128/JVI.69.8.5018-5023.1995; LEE CS, 1994, VIROLOGY, V202, P1039, DOI 10.1006/viro.1994.1434; Mohammad T, 1999, BIOORG MED CHEM LETT, V9, P1703, DOI 10.1016/S0960-894X(99)00265-6; NOLAN JM, 1993, SCIENCE, V261, P762, DOI 10.1126/science.7688143; PAN T, 1991, SCIENCE, V254, P1361, DOI 10.1126/science.1720569; REID RJD, 1994, J BIOL CHEM, V269, P18656; REID RJD, 1994, J BIOL CHEM, V269, P9084; REID RJD, 1994, J BIOL CHEM, V269, P5157; Rishovd S, 1998, VIROLOGY, V245, P11, DOI 10.1006/viro.1998.9153; Trottier M, 1997, J VIROL, V71, P487, DOI 10.1128/JVI.71.1.487-494.1997; Trottier M, 1996, J VIROL, V70, P55, DOI 10.1128/JVI.70.1.55-61.1996; TURNQUIST S, 1992, P NATL ACAD SCI USA, V89, P10479, DOI 10.1073/pnas.89.21.10479; VALPUESTA JM, 1992, J MOL BIOL, V224, P103, DOI 10.1016/0022-2836(92)90579-9; WICHITWECHKARN J, 1992, J MOL BIOL, V223, P991, DOI 10.1016/0022-2836(92)90257-K; YEO A, 1995, J MOL BIOL, V245, P141, DOI 10.1006/jmbi.1994.0013; YOUVAN DC, 1982, ANAL BIOCHEM, V119, P86, DOI 10.1016/0003-2697(82)90669-8; Zhang CL, 1995, RNA, V1, P1041; ZHANG CL, 1995, VIROLOGY, V207, P442, DOI 10.1006/viro.1995.1103; ZHANG CL, 1994, VIROLOGY, V201, P77, DOI 10.1006/viro.1994.1267; ZHANG CL, 1995, VIROLOGY, V211, P568, DOI 10.1006/viro.1995.1439; Zhang CL, 1997, RNA, V3, P315; Zhang F, 1998, MOL CELL, V2, P141, DOI 10.1016/S1097-2765(00)80123-9	48	31	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2817	2824		10.1074/jbc.275.4.2817	http://dx.doi.org/10.1074/jbc.275.4.2817			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644747	hybrid			2022-12-27	WOS:000085128000079
J	Huang, NW; Miller, WL				Huang, NW; Miller, WL			Cloning of factors related to HIV-inducible LBP proteins that regulate steroidogenic factor-1-independent human placental transcription of the cholesterol side-chain cleavage enzyme, P450scc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULAR-CLONING; GENETIC SELECTION; PROMOTER ACTIVITY; IN-VITRO; EXPRESSION; YEAST; CELLS; BIOSYNTHESIS; ELEMENTS	The cholesterol side-chain cleavage enzyme, cytochrome P450scc, initiates the biosynthesis of all steroid hormones. Adrenal and gonadal strategies for P450scc gene transcription are essentially identical and depend on the orphan nuclear receptor steroidogenic factor-1, but the placental strategy for transcription of P450scc employs cis acting elements different from those used in the adrenal strategy and is independent of steroidogenic factor-1. Because placental expression of P450scc is required for human pregnancy, we sought factors that bind to the -155/-131 region of the human P450scc promoter, which participates in its placental but not adrenal or gonadal transcription. A yeast one-hybrid screen of 2.4 x 10(6) cDNA clones from human placental JEG-3 cells yielded two unique clones; one is the previously described transcription factor LBP-1b, which is induced by HIV type I infection of lymphocytes, and the other is a new factor, termed LBP-9, that shares 83% amino acid sequence identity with LBP-1b. When expressed in transfected yeast, both factors bound specifically to the -155/-131 DNA; antisera to LBP proteins supershifted the LBP-9.DNA complex and inhibited formation of the LBP-1b.DNA complex. Reverse transcriptase-polymerase chain reaction detected LBP-1b in human placental JEG-3, adrenal NCI-H295A, liver HepG2, cervical HeLa, and monkey kidney COS-l cells, but LBP-9 was detected only in JEG-3 cells. When the -155/-131 fragment was linked to a minimal promoter, co-expression of LBP-1b increased transcription 21-fold in a dose-dependent fashion, but addition of LBP-9 suppressed the stimulatory effect of LBP-1b The roles of LBP transcription factors in normal human physiology have been unclear. Their modulation of placental but not adrenal P450scc transcription underscores the distinctiveness of placental strategies for steroidogenic enzyme gene transcription.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Bldg MR-4,Rm 209, San Francisco, CA 94143 USA.		Miller, Walter L/J-3696-2012		NICHD NIH HHS [HD 34449] Funding Source: Medline; NIDDK NIH HHS [DK 42154, DK 37922] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD034449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042154, R01DK037922] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren R, 1999, J BIOL CHEM, V274, P19422, DOI 10.1074/jbc.274.27.19422; Baxter J.D., 1979, GLUCOCORTICOID HORMO; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; CHUNG B, 1986, P NATL ACAD SCI USA, V83, P8962, DOI 10.1073/pnas.83.23.8962; COMPAGNONE N, 1999, 80 ANN M END SOC NEW, P118; Csapo A I, 1978, Obstet Gynecol Surv, V33, P69, DOI 10.1097/00006254-197802000-00001; CSAPO AI, 1973, AM J OBSTET GYNECOL, V115, P759, DOI 10.1016/0002-9378(73)90517-6; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483, DOI 10.1146/annurev.ph.50.030188.002411; DYNLACHT BD, 1989, GENE DEV, V3, P1677, DOI 10.1101/gad.3.11.1677; FARDELLA CE, 1986, ANNU REV NUTR, V16, P443; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARCIA JA, 1987, EMBO J, V6, P3761, DOI 10.1002/j.1460-2075.1987.tb02711.x; GAZDAR AF, 1990, CANCER RES, V50, P5488; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HEERY DM, 1993, P NATL ACAD SCI USA, V90, P4281, DOI 10.1073/pnas.90.9.4281; HONDA S, 1993, J BIOL CHEM, V268, P7494; HUM DW, 1993, CLIN CHEM, V39, P333; HUM DW, 1995, DNA CELL BIOL, V14, P451, DOI 10.1089/dna.1995.14.451; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; KATO H, 1991, SCIENCE, V251, P1476, DOI 10.1126/science.2006421; KEENEY DS, 1995, MOL ENDOCRINOL, V9, P1091, DOI 10.1210/me.9.8.1091; KOHLER PO, 1971, J CLIN ENDOCR METAB, V65, P122; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; LeibMosch C, 1995, VIRUS GENES, V11, P133, DOI 10.1007/BF01728654; LIEBMOSCH C, 1992, LEUKEMIA BALTIMORE S, V6, P72; LIM LC, 1992, MOL CELL BIOL, V12, P828, DOI 10.1128/MCB.12.2.828; Liu Jingdong, 1993, Methods (Orlando), V5, P125, DOI 10.1006/meth.1993.1017; MELLON SH, 1993, BRAIN RES, V629, P283, DOI 10.1016/0006-8993(93)91332-M; Miller WL, 1998, CLIN PERINATOL, V25, P799, DOI 10.1016/S0095-5108(18)30084-8; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; MOORE CCD, 1990, MOL CELL BIOL, V10, P6013, DOI 10.1128/MCB.10.11.6013; MOORE CCD, 1992, MOL ENDOCRINOL, V6, P2045, DOI 10.1210/me.6.12.2045; MOROHASHI K, 1987, J BIOCHEM-TOKYO, V101, P879, DOI 10.1093/oxfordjournals.jbchem.a121955; Morohashi K, 1999, TRENDS ENDOCRIN MET, V10, P169, DOI 10.1016/S1043-2760(98)00142-8; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; Parker KL, 1995, VITAM HORM, V51, P339, DOI 10.1016/S0083-6729(08)61044-4; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; RICHARDS JS, 1988, ANNU REV PHYSIOL, V50, P441; Rodriguez H, 1997, J CLIN ENDOCR METAB, V82, P365, DOI 10.1210/jc.82.2.365; ROSEMD, 1990, METHODS YEAST GENETI; Schneider S, 1996, BIOTECHNIQUES, V20, P960; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; SIMON HA, 1993, ARTIF INTELL ENG, V8, P1; Sjottem E, 1996, J VIROL, V70, P188; SPARKES RS, 1991, DNA CELL BIOL, V10, P359, DOI 10.1089/dna.1991.10.359; STAELS B, 1993, MOL ENDOCRINOL, V7, P423, DOI 10.1210/me.7.3.423; STRAUSS JF, 1985, ENDOCRINOLOGY, P2171; VOUTILAINEN R, 1998, J CLIN ENDOCR METAB, V63, P202; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; WATERMAN MR, 1994, J BIOL CHEM, V269, P27783; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; WU FK, 1988, EMBO J, V7, P2117, DOI 10.1002/j.1460-2075.1988.tb03051.x; YOON JB, 1994, MOL CELL BIOL, V14, P1776, DOI 10.1128/MCB.14.3.1776; Zhang PL, 1997, MOL ENDOCRINOL, V11, P891, DOI 10.1210/me.11.7.891; Zhang PL, 1999, DNA CELL BIOL, V18, P197, DOI 10.1089/104454999315411; ZHANG PL, 1995, MOL ENDOCRINOL, V9, P1571, DOI 10.1210/me.9.11.1571	60	69	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2852	2858		10.1074/jbc.275.4.2852	http://dx.doi.org/10.1074/jbc.275.4.2852			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644752	hybrid			2022-12-27	WOS:000085128000084
J	Kawaide, H; Sassa, T; Kamiya, Y				Kawaide, H; Sassa, T; Kamiya, Y			Functional analysis of the two interacting cyclase domains in ent-kaurene synthase from the fungus Phaeosphaeria sp L487 and a comparison with cyclases from higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; FARNESYL-DIPHOSPHATE SYNTHASE; BIFUNCTIONAL DITERPENE CYCLASE; SQUALENE-HOPENE CYCLASE; RESIN ACID BIOSYNTHESIS; HIGH-LEVEL EXPRESSION; GIBBERELLIN BIOSYNTHESIS; CONSERVED ASPARTATE; ESCHERICHIA-COLI; ISOPRENOID BIOSYNTHESIS	We report here kinetic analysis and identification of the two cyclase domains in a bifunctional diterpene cyclase, Phaeosphaeria ent-kaurene synthase (FCPS/KS). Kinetics of a recombinant FCPS/KS protein indicated that the affinity for copalyl diphosphate is higher than that for geranylgeranyl diphosphate (GGDP), ent-Kaurene production from GGDP by FCPS/KS was enhanced by the addition of a plant ent-kaurene synthase (HS) but not by plant CDP synthase (CPS), suggesting that the rate of ent-kaurene production of FCPS/KS may be limited by the KS activity. Site-directed mutagenesis of aspartate-rich motifs in FCPS/KS indicated that the (DVDD)-D-318 motif near the N terminus and the (DEFFE)-D-656 motif near the C terminus may be part of the active site for the CPS and RS reactions, respectively. The other aspartate-rich (DDVLD)-D-132 motif near the N terminus is thought to be involved in both reactions. Functional analysis of the N- and C-terminal truncated mutants revealed that a N-terminal 59-kDa polypeptide catalyzed the CPS reaction and a C-terminal 66-kDa polypeptide showed RS activity. A 101-kDa polypeptide lacking the first 43 amino acids of the N terminus reduced KS activity severely without CPS activity. These results indicate that there are two separate interacting domains in the 106-kDa polypeptide of FCPS/KS.	RIKEN, Lab Plant Hormone Funct, Frontier Res Program, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Yamagata Univ, Dept Bioresources, Fac Agr, Yamagata 9978555, Japan	RIKEN; Yamagata University	Kawaide, H (corresponding author), RIKEN, Lab Plant Hormone Funct, Frontier Res Program, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan.		Kamiya, Yuji/F-9420-2010; Kawaide, Hiroshi/F-9243-2013	Kamiya, Yuji/0000-0003-4415-520X; Kawaide, Hiroshi/0000-0001-6693-1332				AACH H, 1995, PLANTA, V197, P333, DOI 10.1007/BF00202655; ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; AitAli T, 1997, PLANT J, V11, P443, DOI 10.1046/j.1365-313X.1997.11030443.x; ASHBY MN, 1990, J BIOL CHEM, V265, P13157; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; BEYER P, 1985, METHOD ENZYMOL, V111, P248; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; CANE DE, 1994, BIOCHEMISTRY-US, V33, P5846, DOI 10.1021/bi00185a024; Cane DE, 1996, BIOCHEMISTRY-US, V35, P12369, DOI 10.1021/bi961344y; CHAPPELL J, 1995, ANNU REV PLANT PHYS, V46, P521, DOI 10.1146/annurev.pp.46.060195.002513; Coligan J.E., 1997, CURRENT PROTOCOLS PR; DUNCAN JD, 1981, PLANT PHYSIOL, V68, P1128, DOI 10.1104/pp.68.5.1128; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Feil C, 1996, EUR J BIOCHEM, V242, P51, DOI 10.1111/j.1432-1033.1996.0051r.x; FROST RG, 1977, PLANT PHYSIOL, V59, P22, DOI 10.1104/pp.59.1.22; GROSSELINDEMANN E, 1991, PLANT PHYSIOL, V96, P1099, DOI 10.1104/pp.96.4.1099; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Helliwell CA, 1998, P NATL ACAD SCI USA, V95, P9019, DOI 10.1073/pnas.95.15.9019; Hill AM, 1996, ARCH BIOCHEM BIOPHYS, V336, P283, DOI 10.1006/abbi.1996.0559; Huang EX, 1998, PROTEIN EXPRES PURIF, V13, P90, DOI 10.1006/prep.1998.0870; Huang KX, 1998, ARCH BIOCHEM BIOPHYS, V352, P144, DOI 10.1006/abbi.1998.0578; JOLY A, 1993, J BIOL CHEM, V268, P26983; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; KLEINIG H, 1989, ANNU REV PLANT PHYS, V40, P39, DOI 10.1146/annurev.pp.40.060189.000351; LAFEVER RE, 1994, ARCH BIOCHEM BIOPHYS, V313, P139, DOI 10.1006/abbi.1994.1370; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; MacMillan J, 1997, NAT PROD REP, V14, P221, DOI 10.1039/np9971400221; MACMILLAN J, 1999, COMPREHENSIVE NATURA, V2, P217; MARRERO PF, 1992, J BIOL CHEM, V267, P21873; Murofushi N., 1999, COMPREHENSIVE NATURA, V8, P35; OCHS D, 1992, J BACTERIOL, V174, P298, DOI 10.1128/jb.174.1.298-302.1992; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SAITO T, 1995, PLANT PHYSIOL, V109, P1239, DOI 10.1104/pp.109.4.1239; SHECHTER I, 1969, J BIOL CHEM, V244, P3200; Silverstone AL, 1997, PLANT J, V12, P9, DOI 10.1046/j.1365-313X.1997.12010009.x; Smith MW, 1998, PLANT PHYSIOL, V118, P1411, DOI 10.1104/pp.118.4.1411; SONG LS, 1994, P NATL ACAD SCI USA, V91, P3044, DOI 10.1073/pnas.91.8.3044; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Sun TP, 1997, PHYSIOL PLANTARUM, V101, P701, DOI 10.1111/j.1399-3054.1997.tb01054.x; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; TOYOMASU T, 2000, IN PRESS BIOSCI BIOT, V64; Tudzynski B, 1998, CURR GENET, V34, P234, DOI 10.1007/s002940050392; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wendt KU, 1998, STRUCTURE, V6, P127, DOI 10.1016/S0969-2126(98)00015-X; Wendt KU, 1997, SCIENCE, V277, P1811, DOI 10.1126/science.277.5333.1811; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; Yamaguchi S, 1996, PLANT J, V10, P203, DOI 10.1046/j.1365-313X.1996.10020203.x; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271	48	54	56	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2276	2280		10.1074/jbc.275.4.2276	http://dx.doi.org/10.1074/jbc.275.4.2276			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644675	hybrid			2022-12-27	WOS:000085128000007
J	Munoz-Sanjuan, I; Smallwood, PM; Nathans, J				Munoz-Sanjuan, I; Smallwood, PM; Nathans, J			Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR FGF RECEPTORS; NERVOUS-SYSTEM; GENE ENCODES; TRANSLATION; INITIATION; EXPRESSION; ACTIVATION; POLYPEPTIDES; TRANSCRIPTS; REGIONS	Fibroblast growth factor (FGF) homologous factors-1, -2, -3, and -4 (FHF's 1-4; also referred to as FGFs 11-14) comprise a separate branch of the FGF family and have been implicated in the development of the nervous system and limbs. We report here the characterization of multiple isoforms of FHF-1, -2, -3, and -4 which are generated through the use of alternative start sites of transcription and splicing of one or more of a series of alternative 5'-exons. Several isoforms show different subcellular distributions when expressed in transfected tissue culture cells, and the corresponding differentially spliced transcripts show distinct expression patterns in developing and adult mouse tissues, Together with the evolutionary conservation of the FHF isoforms among human, mouse, and chicken, these data indicate that alternative promoter use and differential splicing are important regulatory processes in controlling the activities of this subfamily of FGFs.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 805 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460				ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; Blunt AG, 1997, J BIOL CHEM, V272, P3733, DOI 10.1074/jbc.272.6.3733; Borja AZM, 1996, DEV BIOL, V180, P680, DOI 10.1006/dbio.1996.0337; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gecz J, 1999, HUM GENET, V104, P56, DOI 10.1007/s004390050910; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; Gospodarowicz D, 1990, Curr Top Dev Biol, V24, P57, DOI 10.1016/S0070-2153(08)60084-8; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lubs HA, 1996, AM J MED GENET, V64, P147, DOI 10.1002/(SICI)1096-8628(19960712)64:1<147::AID-AJMG25>3.0.CO;2-M; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Munoz-Sanjuan I, 1999, DEVELOPMENT, V126, P409; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Prudovsky IA, 1996, J BIOL CHEM, V271, P14198, DOI 10.1074/jbc.271.24.14198; Shin JT, 1996, BBA-MOL CELL RES, V1312, P27, DOI 10.1016/0167-4889(96)00013-4; SHIODA J, 1997, J NEUROSCI RES, V50, P673; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; STIEBER A, 1995, EXP CELL RES, V219, P562, DOI 10.1006/excr.1995.1265; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Szebenyi G, 1999, INT REV CYTOL, V185, P45; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; Yamamoto S, 1998, BBA-GENE STRUCT EXPR, V1398, P38, DOI 10.1016/S0167-4781(98)00050-5	33	73	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2589	2597		10.1074/jbc.275.4.2589	http://dx.doi.org/10.1074/jbc.275.4.2589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644718	hybrid			2022-12-27	WOS:000085128000050
J	Sidobre, S; Nigou, J; Puzo, G; Riviere, M				Sidobre, S; Nigou, J; Puzo, G; Riviere, M			Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria - Critical role of the lipids for lectin-carbohydrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MACROPHAGES; ALVEOLAR MACROPHAGES; ATTENUATED STRAINS; BINDING PROTEIN; II CELLS; TUBERCULOSIS; LIPOARABINOMANNAN; VIRULENT; DOMAINS; LIPOPOLYSACCHARIDES	The human pulmonary surfactant protein A (hSP-A) has been implicated in the early capture and phagocytosis of the pathogenic Mycobacterium tuberculosis by alveolar macrophages. In this report, we examined the interaction of alveolar proteinosis patient hSP-A with Mycobacterium bovis EGG, the vaccinating strain, as a model of pathogenic mycobacteria, and Mycobacterium smegmatis, a nonpathogenic strain. me found that hSP-A binds to the surface of M., bovis BCG;, but also to a slightly lesser extent, to M. smegmatis, indicating that hSP-A does not discriminate between virulent and nonpathogenic strains. Among the various glycoconjugates isolated from the mycobacterial envelope, we found that the best ligands are the two major lipoglycans: the mannosylated lipoarabinomannan (ManLAM) and the lipomannan, In contrast, the mannose-capped arabinomannan, structurally close to the ManLAM, as well as the LAMs from the non pathogenic M. smegmatis are poorly recognized by hSP-A, These results clearly show that the presence of both the terminal mannose residues and the phophatidyl-myo-inositol anchor are necessary to achieve the highest binding affinity. Selective removal of either the terminal mannose or the acyl residues esterifying the glycerol moiety of the ManLAM abrogates the interaction with hSP-A, further supporting the notion that the hSP-A recognition of the carbohydrate epitopes of the lipoglycans is dependent of the presence of the fatty acids.	CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Riviere, M (corresponding author), CNRS, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse, France.		Nigou, Jérôme/D-6802-2019	Nigou, Jérôme/0000-0002-6233-2487				BARNES PF, 1992, INFECT IMMUN, V60, P1441, DOI 10.1128/IAI.60.4.1441-1446.1992; BARNES PF, 1992, J IMMUNOL, V149, P541; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997; DAFFE M, 1993, CARBOHYD RES, V249, P383, DOI 10.1016/0008-6215(93)84102-C; DOWNING JF, 1995, P NATL ACAD SCI USA, V92, P4848, DOI 10.1073/pnas.92.11.4848; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Fenton MJ, 1996, INFECT IMMUN, V64, P683, DOI 10.1128/IAI.64.3.683-690.1996; Ferguson JS, 1999, J IMMUNOL, V163, P312; GAYNOR CD, 1995, J IMMUNOL, V155, P5343; Gilleron M, 1999, J MOL BIOL, V285, P2147, DOI 10.1006/jmbi.1998.2438; Gilleron M, 1997, J BIOL CHEM, V272, P117; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; HAURUM JS, 1993, BIOCHEM J, V293, P873, DOI 10.1042/bj2930873; Hoppe HC, 1997, INFECT IMMUN, V65, P3896, DOI 10.1128/IAI.65.9.3896-3905.1997; Kishore U, 1996, BIOCHEM J, V318, P505, DOI 10.1042/bj3180505; MCCORMACK FX, 1994, J BIOL CHEM, V269, P29801; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Nigou J, 1999, BIOCHEM J, V337, P453, DOI 10.1042/0264-6021:3370453; OGASAWARA Y, 1994, J BIOL CHEM, V269, P29785; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; Pasula R, 1997, AM J RESP CELL MOL, V17, P209, DOI 10.1165/ajrcmb.17.2.2469; Pattanajitvilai S, 1998, J BIOL CHEM, V273, P5702, DOI 10.1074/jbc.273.10.5702; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; RISDALE RA, 1999, BIOCHIM BIOPHYS ACTA, V1453, P23; ROSS GF, 1986, J BIOL CHEM, V261, P14283; Schlesinger LS, 1996, J IMMUNOL, V157, P4568; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Snider GL, 1997, ANN INTERN MED, V126, P237, DOI 10.7326/0003-4819-126-3-199702010-00011; VANIWAARDEN JF, 1994, BIOCHEM J, V303, P407, DOI 10.1042/bj3030407; VENISSE A, 1995, EUR J BIOCHEM, V231, P440, DOI 10.1111/j.1432-1033.1995.tb20717.x; Weikert LF, 1997, AM J PHYSIOL-LUNG C, V272, pL989, DOI 10.1152/ajplung.1997.272.5.L989; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; WRIGHT JR, 1987, J BIOL CHEM, V262, P2888; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; ZIMMERMAN PE, 1992, J CLIN INVEST, V89, P143, DOI 10.1172/JCI115554	40	67	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2415	2422		10.1074/jbc.275.4.2415	http://dx.doi.org/10.1074/jbc.275.4.2415			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644694	hybrid			2022-12-27	WOS:000085128000026
J	Yu, R; Mandlekar, S; Lei, W; Fahl, WE; Tan, TH; Kong, ANT				Yu, R; Mandlekar, S; Lei, W; Fahl, WE; Tan, TH; Kong, ANT			p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; ANTIOXIDANT RESPONSIVE ELEMENT; NAD(P)H-QUINONE OXIDOREDUCTASE GENE; YA-SUBUNIT GENE; MAP KINASE; PHENOLIC ANTIOXIDANTS; INDUCIBLE EXPRESSION; TRANSCRIPTIONAL REGULATION; INFLAMMATORY CYTOKINES; PROTECTIVE ENZYMES	Phase II drug-metabolizing enzymes, such as glutathione S-transferase and quinone reductase, play an important role in the detoxification of chemical carcinogens. The induction of these detoxifying enzymes by a variety of agents occurs at the transcriptional level and is regulated bg a cis-acting element, called the antioxidant response element (ARE) or electrophile-response element. In this study, we identified a signaling kinase pathway that negatively regulates ARE-mediated gene expression. Treatment of human hepatoma HepG2 and murine hepatoma Hepalclc7 cells with tert-butylhydroquinone (tBHQ) stimulated the activity of p38, a member of mitogen-activated protein kinase family. Inhibition of p38 activation by its inhibitor, SB203580, enhanced the induction of quinone reductase activity and the activation of ARE reporter gene by tBHQ. In contrast, SB202474, a negative analog of SB203580, had little effect. Consistent with this result, interfering with the p38 kinase pathway by overexpression of a dominant-negative mutant of p38 or MKK3, an immediate upstream regulator of p38, potentiated the activation of the ARE reporter gene by tBHQ, whereas the wild types of p38 and MKK3 diminished such activation. In addition, inhibition of p38 activity augmented the induction of ARE reporter gene activity by tert-butylhydroxyanisole, sulforaphane, and p-naphthoflavone. Thus, p38 kinase pathway functions as a negative regulator in the ARE-mediated induction of phase II detoxifying enzymes.	Univ Illinois, Dept Pharmaceut & Phamacodynam, Ctr Pharmaceut Biotechnol, Coll Pharm, Chicago, IL 60612 USA; Univ Wisconsin, Mcardle Lab Canc Res, Madison, WI 53706 USA; Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine	Kong, ANT (corresponding author), Univ Illinois, Dept Pharmaceut & Phamacodynam, Ctr Pharmaceut Biotechnol, Coll Pharm, MC870,900 S Ashland Ave,MBRB Rm 3102, Chicago, IL 60607 USA.	KongT@uic.edu	Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021; Kong, Ah-Ng Tony/AAX-2828-2020	Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; 	NCI NIH HHS [R01-CA73647] Funding Source: Medline; NIAID NIH HHS [R01-AI38649, R01-AI42532] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042532, R01AI038649] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ainbinder E, 1997, EUR J BIOCHEM, V243, P49, DOI 10.1111/j.1432-1033.1997.0049a.x; BERGELSON S, 1994, ONCOGENE, V9, P565; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Gerhauser C, 1997, CANCER RES, V57, P272; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN JH, 1993, J BIOL CHEM, V268, P25009; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JAISWAL AK, 1994, PHARMACOGENETICS, V4, P1, DOI 10.1097/00008571-199402000-00001; Kensler TW, 1997, ENVIRON HEALTH PERSP, V105, P965, DOI 10.2307/3433311; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LI Y, 1992, J BIOL CHEM, V267, P15097; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; McLaughlin MM, 1996, J BIOL CHEM, V271, P8488, DOI 10.1074/jbc.271.14.8488; Moriguchi T, 1996, J BIOL CHEM, V271, P26981, DOI 10.1074/jbc.271.43.26981; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; MORSE MA, 1993, CARCINOGENESIS, V14, P1737, DOI 10.1093/carcin/14.9.1737; NAGASE T, 1995, DNA RES, V2, P164; PEZZUTO JM, 1995, RECENT ADV PHYTOCHEM, V29, P19; PRESTERA T, 1993, P NATL ACAD SCI USA, V90, P2965, DOI 10.1073/pnas.90.7.2965; PROCHASKA HJ, 1988, CANCER RES, V48, P4776; PROCHASKA HJ, 1985, P NATL ACAD SCI USA, V82, P8232, DOI 10.1073/pnas.82.23.8232; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; SPORN MB, 1979, FED PROC, V38, P2528; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; WANG B, 1994, BBA-GENE STRUCT EXPR, V1219, P645, DOI 10.1016/0167-4781(94)90223-2; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Wasserman WW, 1997, ARCH BIOCHEM BIOPHYS, V344, P387, DOI 10.1006/abbi.1997.0215; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WATTENBERG LW, 1985, CANCER RES, V45, P1; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Young PR, 1998, CYTOKINE GROWTH F R, V9, P239, DOI 10.1016/S1359-6101(98)00011-2; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Yu R, 1996, CANCER RES, V56, P2954; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Yu R, 1997, J BIOL CHEM, V272, P28962, DOI 10.1074/jbc.272.46.28962; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	54	171	174	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2322	2327		10.1074/jbc.275.4.2322	http://dx.doi.org/10.1074/jbc.275.4.2322			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644681	hybrid			2022-12-27	WOS:000085128000013
J	Busconi, L; Guan, JZ; Denker, BM				Busconi, L; Guan, JZ; Denker, BM			Degradation of heterotrimeric G alpha(o) subunits via the proteosome pathway is induced by the hsp90-specific compound geldanamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TERMINAL BINDING DOMAIN; HETEROPROTEIN COMPLEX; ALPHA-SUBUNIT; PROTEIN; ACTIVATION; RECEPTORS; CELLS; INHIBITION; KINASE	One mechanism utilized by cells to maintain signaling pathways is to regulate the levels of specific signal transduction proteins. The compound geldanamycin (GA) specifically interacts with heat shock protein 90 (hsp90) complexes and has been widely utilized to study the role of hsp90 in modulating the function of signaling proteins, In this study, we used GA to demonstrate that levels of heterotrimeric G alpha subunits can be regulated through interactions with hsp90. In a dose-dependent manner, GA significantly reduced the steady state levels of endogenous G alpha(o) expression in two cell lines (PC12 and GH3) and had a similar effect on G alpha(o), transiently expressed in COS cells. G alpha(o) synthesis and degradation was studied in PC12 cells and in transiently transfected COS cells. S-35 labeling followed by immunoprecipitation demonstrated no effect of GA on the rate of G alpha(o) synthesis, but GA accelerated degradation of G alpha(o) in both PC12 cells and COS cells. The use of inhibitors, including lactacystin (a proteosome-specific inhibitor), suggests that G alpha(o) is predominantly degraded through the proteosome pathway. In vitro translated S-35-labeled G alpha(o) could be detected in hsp90 immunoprecipitates, and this interaction did not require N-terminal myristoylation. Taken together, these results suggest that heterotrimeric G alpha subunits are protected from degradation by interaction with hsp90 and that the interaction of G alpha subunits with heat shock proteins may be a general mechanism for regulating G alpha levels in the cell.	FIBA, INBIOP, RA-7600 Mar Del Plata, Argentina; Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Busconi, L (corresponding author), FIBA, INBIOP, Vieytes 3103, RA-7600 Mar Del Plata, Argentina.							Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Busconi L, 1997, BIOCHEM J, V323, P239, DOI 10.1042/bj3230239; Busconi L, 1997, BIOCHEM J, V328, P23, DOI 10.1042/bj3280023; DENKER BM, 1991, FEBS LETT, V279, P98, DOI 10.1016/0014-5793(91)80260-A; DENKER BM, 1992, J BIOL CHEM, V267, P6272; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; HUFF RM, 1985, J BIOL CHEM, V260, P864; HUNT TW, 1994, J BIOL CHEM, V269, P29565; IANOBE A, 1994, J BIOCHEM-TOKYO, V115, P486; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; MIMNAUGH EG, 1995, J BIOL CHEM, V270, P28654, DOI 10.1074/jbc.270.48.28654; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Nusse O, 1996, J CELL SCI, V109, P221; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; SILBERT S, 1990, J BIOL CHEM, V265, P3102; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Wedegaertner PB, 1998, BIOL SIGNAL RECEPT, V7, P125; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; WISE A, 1995, J BIOL CHEM, V270, P17196, DOI 10.1074/jbc.270.29.17196; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074	27	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1565	1569		10.1074/jbc.275.3.1565	http://dx.doi.org/10.1074/jbc.275.3.1565			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636845	hybrid			2022-12-27	WOS:000084940000008
J	Iyer, RR; Pluciennik, A; Rosche, WA; Sinden, RR; Wells, RD				Iyer, RR; Pluciennik, A; Rosche, WA; Sinden, RR; Wells, RD			DNA polymerase III proofreading mutants enhance the expansion and deletion of triplet repeat sequences in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER-DOT-CAG; HEREDITARY-DISEASE GENES; SYNTHESIS IN-VITRO; MISMATCH REPAIR; TRINUCLEOTIDE REPEATS; CTG REPEATS; MUTATIONAL SPECIFICITY; LEADING-STRAND; MUTATOR MUTD5; REPLICATION	The influence of mutations in the 3' to 5' exonucleolytic proofreading c-subunit of Escherichia coli DNA polymerase III on the genetic instabilities of the CGG.CCG and the CTG.CAG repeats that cause human hereditary neurological diseases was investigated. The dnaQ49(ts) and the mutD5 mutations destabilize the CGG.CCG repeats. The distributions of the deletion products indicate that slipped structures containing a small number of repeats in the loop mediate the deletion process. The CTG.CAG repeats were destabilized by the dnaQ49(ts) mutation by a process mediated by long hairpin loop structures (greater than or equal to 5 repeats). The mutD5 mutator strain stabilized the (CTG.CAG)(175) tract, which contained two interruptions. Since the mutD5 mutator strain has a saturated mismatch repair system, the stabilization is probably an indirect effect of the nonfunctional mismatch repair system in these strains. Shorter uninterrupted tracts expand readily in the mutD5 strain, presumably due to the greater stability of long CTG.CAG tracts (>100 repeats) in this strain. When parallel studies were conducted in minimal medium, where the mutD5 strain is defective in exonucleolytic proofreading but has a functional MMR system, both CTG.CAG and CGG.CCG repeats were destabilized, showing that the proofreading activity is essential for maintaining the integrity of TRS tracts. Thus, we conclude that the expansion and deletion of triplet repeats are enhanced by mutations that reduce the fidelity of replication.	Texas A&M Univ, Texas Med Ctr, Inst Biosci & Technol, Ctr Genome Res,Dept Biochem & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Texas A&M University System	Wells, RD (corresponding author), Texas A&M Univ, Texas Med Ctr, Inst Biosci & Technol, Ctr Genome Res,Dept Biochem & Biophys, 2121 W Holcombe Blvd, Houston, TX 77030 USA.		Sinden, Richard/AAE-3086-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM052982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037554] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES05508] Funding Source: Medline; NIGMS NIH HHS [GM52982] Funding Source: Medline; NINDS NIH HHS [NS37554] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bacolla A, 1997, J BIOL CHEM, V272, P16783, DOI 10.1074/jbc.272.27.16783; Bacolla A, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P467; Bowater RP, 1996, J MOL BIOL, V264, P82, DOI 10.1006/jmbi.1996.0625; Bowater RP, 1997, NUCLEIC ACIDS RES, V25, P2861, DOI 10.1093/nar/25.14.2861; Bzymek M, 1999, J BACTERIOL, V181, P477, DOI 10.1128/JB.181.2.477-482.1999; Chastain PD, 1995, BIOCHEMISTRY-US, V34, P16125, DOI 10.1021/bi00049a027; COX EC, 1983, P NATL ACAD SCI-BIOL, V80, P2295, DOI 10.1073/pnas.80.8.2295; Cox EC, 1997, GENETICS, V146, P443; DAMAGNEZ V, 1989, J BACTERIOL, V171, P4494, DOI 10.1128/JB.171.8.4494-4497.1989; DEGNEN GE, 1974, J BACTERIOL, V117, P477, DOI 10.1128/JB.117.2.477-487.1974; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; ECHOLS H, 1983, P NATL ACAD SCI-BIOL, V80, P2189, DOI 10.1073/pnas.80.8.2189; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; Fijalkowska IJ, 1996, P NATL ACAD SCI USA, V93, P2856, DOI 10.1073/pnas.93.7.2856; Fijalkowska IJ, 1997, J BACTERIOL, V179, P7435, DOI 10.1128/jb.179.23.7435-7445.1997; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; FOWLER RG, 1974, MOL GEN GENET, V133, P179, DOI 10.1007/BF00267667; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gao XL, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P623; Hirst MC, 1998, NUCLEIC ACIDS RES, V26, P2353, DOI 10.1093/nar/26.10.2353; Imbert G, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P27; Iyer RR, 1999, J BIOL CHEM, V274, P3865, DOI 10.1074/jbc.274.6.3865; JAWORSKI A, 1995, P NATL ACAD SCI USA, V92, P11019, DOI 10.1073/pnas.92.24.11019; Jonczyk P, 1998, J BACTERIOL, V180, P1563, DOI 10.1128/JB.180.6.1563-1566.1998; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; Kim S, 1996, J BIOL CHEM, V271, P4315; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Kornberg A., 1992, DNA REPLICATION; Kroutil LC, 1999, NUCLEIC ACIDS RES, V27, P3481, DOI 10.1093/nar/27.17.3481; Kroutil LC, 1996, BIOCHEMISTRY-US, V35, P1046, DOI 10.1021/bi952178h; Kunkel TA, 1997, CELL, V88, P155, DOI 10.1016/S0092-8674(00)81832-2; Mariappan SVS, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P647; MARUYAMA M, 1983, J MOL BIOL, V167, P757, DOI 10.1016/S0022-2836(83)80109-0; Miret JJ, 1997, MOL CELL BIOL, V17, P3382, DOI 10.1128/MCB.17.6.3382; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Ohshima K, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P717; Parniewski P, 1999, NUCLEIC ACIDS RES, V27, P616, DOI 10.1093/nar/27.2.616; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P585; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Rosche WA, 1996, J BACTERIOL, V178, P5042, DOI 10.1128/jb.178.16.5042-5044.1996; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Sambrook J., 2002, MOL CLONING LAB MANU; Sargent RG, 1996, NUCLEIC ACIDS RES, V24, P746; Sarkar PS, 1998, CELL, V95, P531, DOI 10.1016/S0092-8674(00)81620-7; Saveson CJ, 1997, GENETICS, V146, P457; SCHAAPER RM, 1988, P NATL ACAD SCI USA, V85, P8126, DOI 10.1073/pnas.85.21.8126; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; SCHAAPER RM, 1989, GENETICS, V121, P205; SCHAAPER RM, 1989, EMBO J, V8, P3511, DOI 10.1002/j.1460-2075.1989.tb08516.x; Schumacher S, 1998, J MOL BIOL, V279, P1101, DOI 10.1006/jmbi.1998.1827; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; SELICK HE, 1987, DNA REPLICATION RECO, P183; Shimizu M, 1996, J MOL BIOL, V258, P614, DOI 10.1006/jmbi.1996.0273; Strauss BS, 1997, NUCLEIC ACIDS RES, V25, P806, DOI 10.1093/nar/25.4.806; Taft-Benz SA, 1998, NUCLEIC ACIDS RES, V26, P4005, DOI 10.1093/nar/26.17.4005; TAKANO K, 1986, MOL GEN GENET, V205, P9, DOI 10.1007/BF02428026; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wells R.D., 1998, GENETIC INSTABILITIE; Wells RD, 1998, J BIOL CHEM, V273, P19532, DOI 10.1074/jbc.273.31.19532; Wells RD, 1996, J BIOL CHEM, V271, P2875, DOI 10.1074/jbc.271.6.2875	71	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2174	2184		10.1074/jbc.275.3.2174	http://dx.doi.org/10.1074/jbc.275.3.2174			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636923	hybrid			2022-12-27	WOS:000084940000086
J	Ramachandiran, V; Willms, C; Kramer, G; Hardesty, B				Ramachandiran, V; Willms, C; Kramer, G; Hardesty, B			Fluorophores at the N terminus of nascent chloramphenicol acetyltransferase peptides affect translation and movement through the ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA; RHODANESE; RESOLUTION; FLUORESCENCE; ACTIVATION; EXPRESSION; SUBUNIT; RELEASE; PROTEIN; CHAIN	Structurally different fluorescent probes were covalently attached to methionyl-tRNA(f) and tested for their incorporation into nascent peptides and full-length protein using an Escherichia coli cell-free coupled transcription/translation system, Bovine rhodanese and bacterial chloramphenicol acetyltransferase (CAT) were synthesized using derivatives of cascade yellow, eosin, pyrene, or coumarin attached to [S-35]Met-tRNA(f) Al of the probes tested were incorporated into polypeptides, although less efficiently when compared with formyl-methionine. Eosin, the largest of the fluorophores used with estimated dimensions of 20 x Ilk caused the largest reduction in product formed. The rate of initiation was reduced with the fluorophore-Met-tRNA(f),compared with fMet-tRNA(f), with pyrene having the least and eosin the biggest effect. Analysis of the nascent polypeptides showed that the modifications at the N terminus affected the rate at which nascent CAT peptides were elongated causing accumulation of peptides of about 4 kDa, possibly by steric hindrance inside the tunnel within the 50 S ribosomal subunit, Fluorescence measurements indicate that the probe at the N terminus of nascent pyrene-CAT peptides is in a relatively hydrophilic environment. This finding is in agreement with recent data showing crosslinking of the N terminus of nascent peptides to nucleotides of the 23 S ribosomal RNA.	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Hardesty, B (corresponding author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.	b.hardesty@mail.utexas.edu	Rood, Stewart/H-7634-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053152] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 53152] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTON NK, 1979, NATURE, V282, P864, DOI 10.1038/282864a0; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Choi KM, 1998, NUCLEIC ACIDS RES, V26, P887, DOI 10.1093/nar/26.4.887; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Frank J, 1998, J STRUCT BIOL, V124, P142, DOI 10.1006/jsbi.1998.4071; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Hardesty B, 1995, BIOCHEM CELL BIOL, V73, P1199, DOI 10.1139/o95-129; HARDESTY B, 1992, BIOCHIMIE, V74, P391, DOI 10.1016/0300-9084(92)90117-W; Haugland R., 1996, HDB FLUORESCENT PROB; Kramer G, 1999, PRACT APPROACH SER, V202, P201; KUDLICKI W, 1994, J BIOL CHEM, V269, P16549; KUDLICKI W, 1994, J MOL BIOL, V244, P319, DOI 10.1006/jmbi.1994.1732; KUDLICKI W, 1995, J MOL BIOL, V252, P203, DOI 10.1006/jmbi.1995.0488; KUDLICKI W, 1995, J BIOL CHEM, V270, P10650, DOI 10.1074/jbc.270.18.10650; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; MILLER DM, 1991, J BIOL CHEM, V266, P4686; *MOL PROB INC, 1997, BIOPR 25; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; ROBSON B, 1993, NATURE, V361, P506, DOI 10.1038/361506a0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; Tsalkova T, 1998, J MOL BIOL, V278, P713, DOI 10.1006/jmbi.1998.1721; Tsalkova T, 1999, J MOL BIOL, V286, P71, DOI 10.1006/jmbi.1998.2481	26	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1781	1786		10.1074/jbc.275.3.1781	http://dx.doi.org/10.1074/jbc.275.3.1781			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636875	hybrid			2022-12-27	WOS:000084940000038
J	Boguslawski, G; Hale, LV; Yu, XP; Miles, RR; Onyia, JE; Santerre, RF; Chandrasekhar, S				Boguslawski, G; Hale, LV; Yu, XP; Miles, RR; Onyia, JE; Santerre, RF; Chandrasekhar, S			Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; OSTEOBLAST-LIKE CELLS; GROWTH-FACTOR-I; PARATHYROID-HORMONE; GENE-EXPRESSION; CALPHOSTIN-C; BONE; RECEPTOR; PROMOTER; MOUSE	Osteocalcin is a major noncollagenous protein component of bone extracellular matrix, synthesized and secreted exclusively by osteoblastic cells in the late stage of maturation, and is considered indicator of osteoblast differentiation. Osteocalcin expression is modulated by parathyroid hormone (PTH) and a variety of other factors. The cAMP-dependent protein kinase pathway has been shown previously to have an essential role in PTH signaling and regulation of osteocalcin expression. To determine the extent to which other pathways may also participate in osteocalcin expression, we used rat and human osteoblast-like cell lines to generate stably transfected clones in which the osteocalcin promoter was fused to a luciferase reporter gene. These clones were examined for their responsiveness to agents known to activate or interfere with protein kinase A (PKA)- and protein kinase C (PKC)-dependent pathways. We have found that forskolin, cAMP, and PTH, as well as insulin-like growth factor I (IGF-I) and basic fibroblast growth factor, all were effective in activating the osteocalcin promoter. Phorbol 12-myristate 13-acetate (PIMA) was also a strong inducer of the promoter, indicating that PKC plays a role in expression of osteocalcin. In combination with PTH or forskolin, the effect of PMA was additive to synergistic. Calphostin C, a selective inhibitor of PRC, decreased the PMA-, PTH-, and IGF-I-induced luciferase activity in a dose-dependent manner; a PKA inhibitor, H-89, also blocked the induction by PTH and IGF-I but not by PMA. We conclude that regulation of osteocalcin transcription is mediated by both PKA-dependent and PKC-dependent mechanisms and that the respective kinases reside on a linear or convergent pathway.	Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Endocrine Res,Div Endocrine, Indianapolis, IN 46285 USA	Eli Lilly	Chandrasekhar, S (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Endocrine Res,Div Endocrine, Indianapolis, IN 46285 USA.							ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; CELESTE AJ, 1986, EMBO J, V5, P1885, DOI 10.1002/j.1460-2075.1986.tb04440.x; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chorev Michael, 1996, P305; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy Patricia, 1996, P183; Finkelstein Joel S., 1996, P993; Fitzpatrick Lorraine A., 1996, P339; GUO J, 1995, ENDOCRINOLOGY, V136, P3884, DOI 10.1210/en.136.9.3884; HEINRICHS AAJ, 1993, J CELL BIOCHEM, V53, P240, DOI 10.1002/jcb.240530309; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Jobert AS, 1997, ENDOCRINOLOGY, V138, P5282, DOI 10.1210/en.138.12.5282; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Kudo Y, 1998, EUR J ENDOCRINOL, V138, P443, DOI 10.1530/eje.0.1380443; Lian JB, 1997, ENDOCRINOLOGY, V138, P2117, DOI 10.1210/en.138.5.2117; McCarthy TL, 1997, J BIOL CHEM, V272, P18132, DOI 10.1074/jbc.272.29.18132; Newberry EP, 1996, MOL ENDOCRINOL, V10, P1029, DOI 10.1210/me.10.8.1029; NODA M, 1988, J BIOL CHEM, V263, P18574; ONYIA JE, 1995, BONE, V17, P479, DOI 10.1016/8756-3282(95)00332-2; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; PRICE PA, 1981, J BIOL CHEM, V256, P2754; Qu Q, 1998, BONE, V22, P201, DOI 10.1016/S8756-3282(97)00276-7; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; Schwartz Z, 1997, BONE, V21, P249, DOI 10.1016/S8756-3282(97)00123-3; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; STEIN GS, 1998, FRONT BIOSCI, V3, P849; SUNUHARA RK, 1996, ANN REV PHARM TOXICO, V36, P461; TOWLER DA, 1995, ENDOCRINOLOGY, V136, P1089, DOI 10.1210/en.136.3.1089; vanLeeuwen JPTM, 1996, BBA-MOL CELL RES, V1312, P55, DOI 10.1016/0167-4889(96)00016-X; Yang RJ, 1996, J BIOL CHEM, V271, P29839, DOI 10.1074/jbc.271.47.29839; YOON K, 1988, BIOCHEMISTRY-US, V27, P8521, DOI 10.1021/bi00423a003; Yu XP, 1997, ENDOCRINOLOGY, V138, P3085, DOI 10.1210/en.138.8.3085; Zhang R, 1997, J BIOL CHEM, V272, P110, DOI 10.1074/jbc.272.1.110	37	79	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					999	1006		10.1074/jbc.275.2.999	http://dx.doi.org/10.1074/jbc.275.2.999			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625638	hybrid			2022-12-27	WOS:000084836600042
J	Chang, WM; Bohm, RA; Strauss, JC; Kwan, T; Thomas, T; Cowmeadow, RB; Atkinson, NS				Chang, WM; Bohm, RA; Strauss, JC; Kwan, T; Thomas, T; Cowmeadow, RB; Atkinson, NS			Muscle-specific transcriptional regulation of the slowpoke Ca2+-activated K+ channel gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNEL; TISSUE-SPECIFIC EXPRESSION; CALCIUM SPARKS; SMOOTH-MUSCLE; DROSOPHILA; RELAXATION; ELEMENTS; CURRENTS; ISOFORMS; NEURONS	Transcriptional regulation of the Drosophila slowpoke calcium-activated potassium channel gene is complex. To date, five transcriptional promoters have been identified, which are responsible for slowpoke expression in neurons, midgut cells, tracheal cells, and muscle fibers. The slowpoke promoter called Promoter C2 is active in muscles and tracheal cells. To identify sequences that activate Promoter C2 in specific cell types, we introduced small deletions into the slowpoke transcriptional control region. Using transformed flies, we asked how these deletions affected the in situ tissue-specific pattern of expression. Sequence comparisons between evolutionarily divergent species helped guide the placement of these deletions. A section of DNA important for expression in all cell types was subdivided and reintroduced into the mutated control region, a piece at a time, to identify which portion was required for promoter activity. We identified 55-, 214-, and 20-nucleotide sequences that control promoter activity. Different combinations of these elements activate the promoter in adult muscle, larval muscle, and tracheal cells.	Univ Texas, Sch Biol Sci, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas, Sch Biol Sci, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Atkinson, NS (corresponding author), Univ Texas, Sch Biol Sci, Neurobiol Sect, Austin, TX 78712 USA.							Anant S, 1998, DEVELOPMENT, V125, P1361; Atkinson NS, 1998, ANN NY ACAD SCI, V860, P296, DOI 10.1111/j.1749-6632.1998.tb09057.x; Baro DJ, 1997, J NEUROSCI, V17, P6597; BECKER MN, 1995, J NEUROSCI, V15, P6250; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brenner R, 1996, J NEUROSCI, V16, P1827; Brenner R, 1996, DEV BIOL, V177, P536, DOI 10.1006/dbio.1996.0183; CHANG WM, 1998, THESIS U TEXAS AUSTI; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; ELKINS T, 1988, J NEUROSCI, V8, P428; FAY FS, 1995, SCIENCE, V270, P588, DOI 10.1126/science.270.5236.588; FORTINI ME, 1991, MECH DEVELOP, V34, P113, DOI 10.1016/0925-4773(91)90048-B; Hille B., 1992, IONIC CHANNELS EXCIT; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; LUNDELL MJ, 1992, DEV BIOL, V154, P84, DOI 10.1016/0012-1606(92)90050-Q; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; ONEIL MT, 1992, GENETICS, V131, P113; Patterson J. T., 1952, EVOLUTION GENUS DROS; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Postigo AA, 1999, MOL CELL BIOL, V19, P7255; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULER GD, 1995, MULTIPLE ALIGNMENT C; SHEPPARD DN, 1988, J MEMBRANE BIOL, V105, P65, DOI 10.1007/BF01871107; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Thomas Tarita, 1997, Invertebrate Neuroscience, V2, P283, DOI 10.1007/BF02211941; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; TURNHEIM K, 1989, J MEMBRANE BIOL, V112, P247, DOI 10.1007/BF01870955; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5	37	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3991	3998		10.1074/jbc.275.6.3991	http://dx.doi.org/10.1074/jbc.275.6.3991			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660555	hybrid			2022-12-27	WOS:000085288800039
J	Gradia, S; Acharya, S; Fishel, R				Gradia, S; Acharya, S; Fishel, R			The role of mismatched nucleotides in activating the hMSH2-hMSH6 Molecular Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; HMUTS-ALPHA; TRANSLOCATION MECHANISM; HETERODUPLEX REPAIR; TUMOR-CELLS; DNA; ATP; BINDING; HMSH2	We have previously shown that hMSH2-hMSH6 contains an intrinsic ATPase which is activated by mismatch-provoked ADP-->ATP exchange that coordinately induces the formation of a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone (1, 2), These studies suggested that mismatch repair could be propagated by a signaling event transduced via diffusion of ATP-bound hMSH2-hMSH6 molecular switches to the DNA repair machinery. The Molecular Switch model (Fishel, R, (1998) Genes Dev, 12, 2096-2101) is considerably different than the Hydrolysis-Driven Translocation model (Blackwell, L. J., Martik, D., Bjornson, K. P., Bjornson, E. S., and Modrich, P. (1998) J. Biol, Chem. 273, 32055-32062) and makes additional testable predictions beyond the demonstration of hydrolysis-independent diffusion (Gradia, S., Subramanian, D., Wilson, T., Acharya, S., Makhov, A., Griffith, J., and Fishel, R, (1999) Mel. Cell 3, 255-261): (i) individual mismatch-provoked ADP-->ATP exchange should be unique and rate-limiting, and (ii) the k(cat.DNA) for the DNA-stimulated ATPase activity should decrease with increasing chain length. Here we have examined hMSH2-hMSH6 affinity and ATPase stimulatory activity for several DNA substrates containing mispaired nucleotides as well as the chain length dependence of a defined mismatch under physiological conditions. We find that the results are most consistent with the predictions of the Molecular Switch model.	Thomas Jefferson Univ, Dept Microbiol & Immunol, Genet & Mol Biol Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Fishel, R (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Genet & Mol Biol Program, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	rfishel@hendrix.jci.tju.edu			NATIONAL CANCER INSTITUTE [R01CA056542, R01CA067007] Funding Source: NIH RePORTER; NCI NIH HHS [CA67007, CA56542, R01 CA067007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Alani E, 1996, MOL CELL BIOL, V16, P5604; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; ARTHUR PG, 1995, ANAL BIOCHEM, V227, P281, DOI 10.1006/abio.1995.1281; BISHOP DK, 1989, P NATL ACAD SCI USA, V86, P3713, DOI 10.1073/pnas.86.10.3713; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; BOCKER T, 1999, BIOCHIM BIOPHYS ACTA, V31, P1; CHI NW, 1994, J BIOL CHEM, V269, P29984; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; FANG WH, 1993, J BIOL CHEM, V268, P11838; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; FISHEL RA, 1983, UCLA S MOL CELL BIOL, V11, P309; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MATSON SW, 1987, J BIOL CHEM, V262, P2066; Motulsky H., 1999, ANAL DATA GRAPHPAD P; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Sia EA, 1997, MUTAT RES-DNA REPAIR, V383, P61, DOI 10.1016/S0921-8777(96)00046-8; SU SS, 1988, J BIOL CHEM, V263, P6829; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; WERNTGES H, 1986, NUCLEIC ACIDS RES, V14, P3773, DOI 10.1093/nar/14.9.3773; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; YOUNG MC, 1994, J MOL BIOL, V235, P1436, DOI 10.1006/jmbi.1994.1099	40	99	102	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3922	3930		10.1074/jbc.275.6.3922	http://dx.doi.org/10.1074/jbc.275.6.3922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660545	hybrid			2022-12-27	WOS:000085288800029
J	Varoqui, H; Zhu, HM; Yao, DD; Ming, H; Erickson, JD				Varoqui, H; Zhu, HM; Yao, DD; Ming, H; Erickson, JD			Cloning and functional identification of a neuronal glutamine transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; CEREBELLAR GRANULE CELLS; SYNAPTIC VESICLES; EXPRESSION CLONING; ENERGY-DEPENDENCE; CNS TRANSMITTER; RAT-BRAIN; METABOLISM; ASTROCYTES; GENE	Glutamine is the preferred precursor for the neurotransmitter pool of glutamate, the major excitatory transmitter in the mammalian central nervous system. We have isolated a complementary DNA clone (designated GlnT) encoding a plasma membrane glutamine transporter from glutamatergic neurons in culture, and its properties have been examined using the T7 vaccinia system in fibroblasts. When GlnT is transfected into CV-1 cells, L-glutamine is the preferred substrate. Transport is Na+-dependent and inhibited by alpha-methylamino-isobutyric acid, a specific inhibitor of neutral amino acid transport system A. Kinetic analysis of glutamine uptake by GlnT is saturable, with a Michaelis constant (K-m) of 489 +/- 88 mu M at pH 7.4. Glutamine uptake mediated by GlnT is pH-sensitive with a 5-fold greater efficiency of uptake at pH 8.2 than at pH 6.6. Only the maximal velocity of transport increases without a significant change in K-m. The distribution of GlnT mRNA and protein in the central nervous system is widespread and is expressed on neurons that use glutamate as their neurotransmitter. In cultured cerebellar granule cells, GlnT is expressed only on neurons and is absent from astrocytes. GlnT expression increases concomitantly with the morphologic and functional differentiation of these cells in vitro, consistent with its role of supplying glutamatergic neurons with their neurotransmitter precursor, GlnT is the first member of the system A family of neutral amino acid transporters with 11 putative membrane-spanning domains and is a potential target to modulate presynaptic glutamatergic function.	Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Erickson, JD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, 202 Gravier St,Suite D, New Orleans, LA 70112 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036936] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36936] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; BARKER GA, 1990, EXP PHYSIOL, V75, P3, DOI 10.1113/expphysiol.1990.sp003382; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BRADFORD HF, 1976, BRAIN RES, V110, P115, DOI 10.1016/0006-8993(76)90212-2; BRADFORD HF, 1978, J NEUROCHEM, V30, P1453, DOI 10.1111/j.1471-4159.1978.tb10477.x; Broer A, 1999, J NEUROCHEM, V73, P2184; BROOKES N, 1997, GLIA, V21, P4; CHRISTENSEN HN, 1982, PHYSIOL REV, V62, P1193, DOI 10.1152/physrev.1982.62.4.1193; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CHRISTENSEN HN, 1976, TRANSPORT PHENOMENA, P3; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; Erickson JD, 1996, PROG BRAIN RES, V109, P69; FEURST TO, 1986, P NATL ACAD SCI USA, V83, P8122; FISCHER WN, 1995, J BIOL CHEM, V270, P16315, DOI 10.1074/jbc.270.27.16315; FONNUM F, 1993, PROG BIOPHYS MOL BIO, V60, P47, DOI 10.1016/0079-6107(93)90012-9; FROMMER WB, 1993, P NATL ACAD SCI USA, V90, P5944, DOI 10.1073/pnas.90.13.5944; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; GJESSING LR, 1972, J NEUROCHEM, V19, P1807, DOI 10.1111/j.1471-4159.1972.tb06226.x; GUIDOTTI GG, 1978, BIOCHIM BIOPHYS ACTA, V515, P329, DOI 10.1016/0304-4157(78)90009-6; HAMBERGER A, 1979, BRAIN RES, V168, P531, DOI 10.1016/0006-8993(79)90307-X; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; HELL JW, 1990, J BIOL CHEM, V265, P2111; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Hertz L, 1987, MODEL SYSTEMS DEV AG, P19; HSU LC, 1993, P NATL ACAD SCI USA, V90, P7441, DOI 10.1073/pnas.90.16.7441; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kekuda R, 1996, J BIOL CHEM, V271, P18657, DOI 10.1074/jbc.271.31.18657; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LIAO K, 1995, BIOCHEM BIOPH RES CO, V208, P1008, DOI 10.1006/bbrc.1995.1434; Malandro MS, 1996, ANNU REV BIOCHEM, V65, P305; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; Nagaraja TN, 1996, J NEUROCHEM, V66, P1665; NAJLERAHIM A, 1990, MOL BRAIN RES, V7, P317, DOI 10.1016/0169-328X(90)90082-O; NICKLAS WJ, 1983, GLUTAMINE GLUTAMATE, P219; Nissim I, 1999, AM J PHYSIOL-RENAL, V277, pF493, DOI 10.1152/ajprenal.1999.277.4.F493; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; OXENDER DL, 1963, NATURE, V197, P765, DOI 10.1038/197765a0; PENG L, 1993, DEV NEUROSCI-BASEL, V15, P367, DOI 10.1159/000111357; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Prasad PD, 1999, BIOCHEM BIOPH RES CO, V255, P283, DOI 10.1006/bbrc.1999.0206; RAMAHAROBANDRO N, 1982, BRAIN RES, V244, P113, DOI 10.1016/0006-8993(82)90909-X; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; SHANK RP, 1981, LIFE SCI, V28, P837, DOI 10.1016/0024-3205(81)90044-8; Sibson NR, 1997, P NATL ACAD SCI USA, V94, P2699, DOI 10.1073/pnas.94.6.2699; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; Su TZ, 1997, BRAIN RES, V757, P69, DOI 10.1016/S0006-8993(97)00139-X; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; USDIN TB, 1994, NEUROPROTOCOLS, V5, P144; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; WEILER CT, 1982, J NEUROCHEM, V32, P559; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Young III WS, 1992, IN SITU HYBRIDIZATIO, P33	63	242	255	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4049	4054		10.1074/jbc.275.6.4049	http://dx.doi.org/10.1074/jbc.275.6.4049			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660562	hybrid			2022-12-27	WOS:000085288800046
J	Goldstein, S; Czapski, G; Lind, J; Merenyi, G				Goldstein, S; Czapski, G; Lind, J; Merenyi, G			Tyrosine nitration by simultaneous generation of (NO)-N-center dot and O-2(center dot) under physiological conditions - How the radicals do the job	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SOLUTIONS; CARBON-DIOXIDE; BIOLOGICAL-ACTIVITY; HYDROGEN-PEROXIDE; PHENOXYL RADICALS; AQUEOUS-SOLUTIONS; OXIDATIVE DAMAGE; PEROXYNITRITE; MECHANISM; NO	Radiation chemical experiments demonstrate that the reaction of tyrosyl radical (TyrO(.)) with (NO2)-N-. yields 45 +/- 3% 3-nitrotyrosine and that a major product of the reaction of TyrO(.) with (NO)-N-. is 3,3'-dityrosine. Radiolysis was used to generate (NO)-N-. and O-2(-.) in the presence of tyrosine and bicarbonate at pH 7.5 +/- 0.1. The nitration yield was found to be dose rate-dependent, and the yield per radical produced by pulse radiolysis was identical to that obtained with authentic peroxynitrite, The proposed mechanism that accounts for the data is as follows: (i) In the presence of CO2 the reaction of (NO)-N-. with O-2(-.) yields 33% (NO2)-N-. and CO3-. where the latter reacts rapidly with tyrosine to form TyrO; (ii) The formation of 3-nitrotyrosine takes place via the reaction of (NO2)-N-. with TyrO(.), which is the main process at high dose rates; and (iii) Under continuous generation of (NO)-N-. and O-2(-.) the formation of 3-nitrotyrosine is strongly suppressed because of efficient scavenging of NO2, by tyrosine. The proposed model shows that the highest nitration yield is obtained for similar fluxes of (NO)-N-. and O-2(-.) and is completely inhibited upon excess production of O-2(-.) because of efficient scavenging of TyrO(.) by O-2(-.). The biological implications of these findings are discussed.	Hebrew Univ Jerusalem, Dept Phys Chem, IL-91904 Jerusalem, Israel; Royal Inst Technol, Dept Chem Nucl Chem, S-10044 Stockholm 70, Sweden	Hebrew University of Jerusalem; Royal Institute of Technology	Goldstein, S (corresponding author), Hebrew Univ Jerusalem, Dept Phys Chem, IL-91904 Jerusalem, Israel.							Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; ALBERTY RA, 1995, J PHYS CHEM-US, V99, P11028, DOI 10.1021/j100027a051; Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445; BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Berho F, 1998, J PHYS CHEM A, V102, P1, DOI 10.1021/jp972576p; Berlett BS, 1998, P NATL ACAD SCI USA, V95, P2784, DOI 10.1073/pnas.95.6.2784; BUXTON GV, 1995, J CHEM SOC FARADAY T, V91, P279, DOI 10.1039/ft9959100279; Caulfield JL, 1996, J BIOL CHEM, V271, P25859, DOI 10.1074/jbc.271.42.25859; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; EISERICH JP, 1995, BIOCHEM J, V310, P745, DOI 10.1042/bj3100745; Goldstein S, 1997, INORG CHEM, V36, P5113, DOI 10.1021/ic970471v; Goldstein S, 1998, INORG CHEM, V37, P3943, DOI 10.1021/ic980051l; Goldstein S, 1998, J AM CHEM SOC, V120, P3458, DOI 10.1021/ja9733043; Goldstein S, 1996, J AM CHEM SOC, V118, P3419, DOI 10.1021/ja9536680; Goldstein S, 1996, INORG CHEM, V35, P7735, DOI 10.1021/ic960233k; Goldstein S, 1999, CHEM RES TOXICOL, V12, P132, DOI 10.1021/tx9802522; GOLDSTEIN S, 1995, FREE RADICAL BIO MED, V19, P205; Gonzalez-Mancebo S, 1999, J AGR FOOD CHEM, V47, P2235, DOI 10.1021/jf981094n; Goodwin DC, 1998, J BIOL CHEM, V273, P8903, DOI 10.1074/jbc.273.15.8903; Gunther MR, 1997, J BIOL CHEM, V272, P17086, DOI 10.1074/jbc.272.27.17086; HADDAD IY, 1993, AM J PHYSIOL, V265, P555; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; JANZEN EG, 1993, J ORG CHEM, V58, P3597, DOI 10.1021/jo00066a001; JIN FM, 1993, J CHEM SOC PERK T 2, P1583, DOI 10.1039/p29930001583; KAUR H, 1994, FEBS LETT, V350, P9, DOI 10.1016/0014-5793(94)00722-5; Kong SK, 1996, P NATL ACAD SCI USA, V93, P3377, DOI 10.1073/pnas.93.8.3377; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Lymar SV, 1996, BIOCHEMISTRY-US, V35, P7855, DOI 10.1021/bi960331h; Lymar SV, 1998, INORG CHEM, V37, P294, DOI 10.1021/ic970946i; MALLARD WG, 1998, NIST STANDARD REFERE, V40; Merenyi G, 1997, CHEM RES TOXICOL, V10, P1216, DOI 10.1021/tx970101j; Pfeiffer S, 1998, J BIOL CHEM, V273, P27280, DOI 10.1074/jbc.273.42.27280; PIRES M, 1994, INT J CHEM KINET, V26, P1207, DOI 10.1002/kin.550261208; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; PRUTZ WA, 1983, INT J RADIAT BIOL, V44, P183, DOI 10.1080/09553008314550981; Saha A, 1998, FREE RADICAL BIO MED, V24, P653, DOI 10.1016/S0891-5849(97)00365-1; SCHULER RH, 1980, J PHYS CHEM-US, V84, P2088, DOI 10.1021/j100453a020; Szalai VA, 1996, BIOCHEMISTRY-US, V35, P15080, DOI 10.1021/bi961117w; VANDERVLIET A, 1995, ARCH BIOCHEM BIOPHYS, V319, P341, DOI 10.1006/abbi.1995.1303; VONGRAETZEL M, 1969, BER BUNSEN PHYS CHEM, V73, P646; VONGRATZEL M, 1970, BER BUNSEN PHYS CHEM, V74, P488; Williams D. L. H., 1988, NITROSATION, P58; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007	47	177	180	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3031	3036		10.1074/jbc.275.5.3031	http://dx.doi.org/10.1074/jbc.275.5.3031			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652282	hybrid			2022-12-27	WOS:000085146500004
J	Navarro-Antolin, J; Rey-Campos, J; Lamas, S				Navarro-Antolin, J; Rey-Campos, J; Lamas, S			Transcriptional induction of endothelial nitric oxide gene by cyclosporine A - A role for activator protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; SYNTHASE MESSENGER-RNA; A-INDUCED HYPERTENSION; C-FOS EXPRESSION; NF-KAPPA-B; MOLECULAR-CLONING; GROWTH-FACTOR; CHROMOSOMAL LOCALIZATION; CELLS; RATS	We have previously shown that the immunosuppressant cyclosporine A (CsA) increases the activity, the protein level, and the steady-state levels of the mRNA of the endothelial nitric oxide synthase (eNOS) gene in bovine aortic endothelial cells (BAEC). We have now investigated the mechanisms responsible for these effects. Preincubation with an inhibitor of RNA polymerase II abolished CsA-induced eNOS up-regulation. Nuclear run-on experiments demonstrated a 1.6-fold increase in the induction of eNOS gene by CsA In agreement with these results, transient transfections showed that CsA augmented the transactivation of the eNOS promoter. Electrophoretic mobility shift assays showed an increase in the activator protein-1 (AP-1) DNA binding activity in BAEC treated with CsA An increase in the level of c-fos mRNA and in the nuclear content of c-Fos protein was detected in BAEC treated with CsA. Site-directed mutagenesis of the AP-1 cis-regulatory element in the context of the human eNOS promoter resulted in the abrogation of the induction mediated by Csk Hence, upregulation of eNOS mRNA by CsA is a transcriptional phenomenon involving the proximal AP-1 site in the 5'-regulatory region of the human eNOS gene. Furthermore, our data exemplify how immunosuppressive drugs may result in the regulation of specific genes involved in the homeostasis of endothelial function, such as eNOS.	CSIC, Ctr Invest Biol, E-28006 Madrid, Spain; Inst Reina Sofia Invest Nefrol, Madrid 28006, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Lamas, S (corresponding author), CSIC, Ctr Invest Biol, Velazquez 144, E-28006 Madrid, Spain.	slamas@cib.csic.es	Lamas, Santiago/G-7308-2015	Lamas, Santiago/0000-0001-5166-4155				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Alonso J, 1997, MOL CELL BIOL, V17, P5719, DOI 10.1128/MCB.17.10.5719; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; ARNAL JF, 1994, AM J PHYSIOL-CELL PH, V267, pC1381, DOI 10.1152/ajpcell.1994.267.5.C1381; Arnet UA, 1996, J BIOL CHEM, V271, P15069, DOI 10.1074/jbc.271.25.15069; Bartholomeusz B, 1996, HYPERTENSION, V27, P1341, DOI 10.1161/01.HYP.27.6.1341; Bobadilla NA, 1998, AM J PHYSIOL-RENAL, V274, pF791, DOI 10.1152/ajprenal.1998.274.4.F791; Bracht C, 1999, J HYPERTENS, V17, P357, DOI 10.1097/00004872-199917030-00008; BUNCHMAN TE, 1991, J CLIN INVEST, V88, P310, DOI 10.1172/JCI115293; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cieslik K, 1998, J BIOL CHEM, V273, P14885, DOI 10.1074/jbc.273.24.14885; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Cuevas P, 1996, P NATL ACAD SCI USA, V93, P11996, DOI 10.1073/pnas.93.21.11996; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; delArco PG, 1996, J BIOL CHEM, V271, P26335; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DENICOLA L, 1993, J CLIN INVEST, V92, P1859, DOI 10.1172/JCI116777; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Flowers MA, 1995, AM J PHYSIOL-HEART C, V269, pH1988, DOI 10.1152/ajpheart.1995.269.6.H1988; Forstermann U, 1998, FASEB J, V12, P773; GREEMBERG ME, 1997, CURRENT PROTOCOLS MO; Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Hutchinson IV, 1998, CURR OPIN NEPHROL HY, V7, P665, DOI 10.1097/00041552-199811000-00007; INOUE N, 1995, ARTERIOSCL THROM VAS, V15, P1255, DOI 10.1161/01.ATV.15.8.1255; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Kleinert H, 1998, HYPERTENSION, V31, P582, DOI 10.1161/01.HYP.31.2.582; KON V, 1990, KIDNEY INT, V37, P1487, DOI 10.1038/ki.1990.139; KOSTYK SK, 1995, AM J PHYSIOL-HEART C, V269, pH1583, DOI 10.1152/ajpheart.1995.269.5.H1583; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Li HG, 1998, MOL PHARMACOL, V53, P630, DOI 10.1124/mol.53.4.630; LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; LopezOngil S, 1996, AM J PHYSIOL-HEART C, V271, pH1072, DOI 10.1152/ajpheart.1996.271.3.H1072; MARSDEN PA, 1990, AM J PHYSIOL, V258, pF1295, DOI 10.1152/ajprenal.1990.258.5.F1295; MARSDEN PA, 1991, AM J PHYSIOL, V261, pF117, DOI 10.1152/ajprenal.1991.261.1.F117; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; McQuillan Lynda P., 1994, American Journal of Physiology, V267, pH1921; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; MIYAHARA K, 1994, EUR J BIOCHEM, V223, P719, DOI 10.1111/j.1432-1033.1994.tb19045.x; Mosieniak G, 1997, J NEUROCHEM, V68, P1142; NADAUD S, 1994, BIOCHEM BIOPH RES CO, V198, P1027, DOI 10.1006/bbrc.1994.1146; Navarro-Antolin J, 1998, KIDNEY INT, V54, pS20, DOI 10.1046/j.1523-1755.1998.06807.x; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; Oriji GK, 1998, HYPERTENSION, V32, P849, DOI 10.1161/01.HYP.32.5.849; RANJAN V, 1995, AM J PHYSIOL-HEART C, V269, pH550, DOI 10.1152/ajpheart.1995.269.2.H550; REGO A, 1991, J PHARMACOL EXP THER, V259, P905; ROBINSON LJ, 1994, GENOMICS, V19, P350, DOI 10.1006/geno.1994.1068; ROULLET JB, 1994, J CLIN INVEST, V93, P2244, DOI 10.1172/JCI117222; Schaefer A, 1998, BIOCHEM J, V335, P505, DOI 10.1042/bj3350505; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULZEOSTHOFF K, 1995, BIOCHEM PHARMACOL, V50, P735, DOI 10.1016/0006-2952(95)02011-Z; Stroes ESG, 1997, HYPERTENSION, V29, P570, DOI 10.1161/01.HYP.29.2.570; Su QX, 1996, BIOCHEM BIOPH RES CO, V229, P249, DOI 10.1006/bbrc.1996.1788; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205	63	74	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3075	3080		10.1074/jbc.275.5.3075	http://dx.doi.org/10.1074/jbc.275.5.3075			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652288	hybrid, Green Published			2022-12-27	WOS:000085146500010
J	Miller, KE; Sheetz, MP				Miller, KE; Sheetz, MP			Characterization of myosin V binding to brain vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UNCONVENTIONAL MYOSIN; PURKINJE-CELLS; GAMMA-TUBULIN; TRANSPORT; ACTIN; GENE; LOCALIZATION; MEMBRANES; PROTEIN	Myosin II and V are important for the generation and segregation of subcellular compartments. Ne observed that vesicular myosin II and V were associated with the protein scaffolding of a common subset of vesicles by density sedimentation, electron microscopy, and immunofluorescence. Solubilization of either myosin II or V was caused by polyphosphates with the following efficacy at 10 mM: for myosin II ATP-Mg2+ = ATP = AMP-PNP (5'-adenylyl imidodiphosphate) > pyrophosphate = tripolyphosphate much greater than tetrapolyphosphate = ADP > cAMP = Mg2+; and for myosin V pyrophosphate = tripolyphosphate > ATP-Mg2+ = ATP = AMP-PNP much greater than ADP = tetrapolyphosphate > cAMP = Mg2+. Consequently, we suggest solubilization was not an effect of phosphorylation, hydrolysis, or disassociation of myosin from actin filaments. Scatchard analysis of myosin V binding to stripped dense vesicles showed saturable binding with a K-m of 10 nM. Analysis of native vesicles indicates that these sites are fully occupied. Together, these data show there are over 100 myosin Vs/vesicle (100-nm radius). Ne propose that polyphosphate anions bind to myosin Il and V and induce a conformational change that disrupts binding to a receptor.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Sheetz, MP (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.			Miller, Kyle/0000-0003-0401-4736	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023345] Funding Source: NIH RePORTER; NIGMS NIH HHS [1F32-GM-19219-01] Funding Source: Medline; NINDS NIH HHS [NS 23345] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; DekkerOhno K, 1996, BRAIN RES, V714, P226, DOI 10.1016/0006-8993(95)01560-4; Espreafico EM, 1998, P NATL ACAD SCI USA, V95, P8636, DOI 10.1073/pnas.95.15.8636; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Evans LL, 1997, J CELL SCI, V110, P439; Evans LL, 1998, J CELL SCI, V111, P2055; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; GREENE LE, 1980, J BIOL CHEM, V255, P543; HARRINGTON WF, 1972, BIOCHEMISTRY-US, V11, P2945, DOI 10.1021/bi00766a004; Heimann K, 1999, J BIOL CHEM, V274, P10743, DOI 10.1074/jbc.274.16.10743; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; JOSHI HC, 1992, NATURE, V356, P80, DOI 10.1038/356080a0; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Melkonian KA, 1995, BIOCHEMISTRY-US, V34, P16161, DOI 10.1021/bi00049a031; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; OAKLEY CE, 1989, NATURE, V338, P662, DOI 10.1038/338662a0; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Provance DW, 1996, P NATL ACAD SCI USA, V93, P14554, DOI 10.1073/pnas.93.25.14554; Reck-Peterson SL, 1999, MOL BIOL CELL, V10, P1001, DOI 10.1091/mbc.10.4.1001; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stow JL, 1998, TRENDS CELL BIOL, V8, P138, DOI 10.1016/S0962-8924(98)01238-0; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; WAGNER JA, 1978, BIOCHEMISTRY-US, V17, P1199, DOI 10.1021/bi00600a010; Wu XF, 1998, CELL MOTIL CYTOSKEL, V40, P286, DOI 10.1002/(SICI)1097-0169(1998)40:3<286::AID-CM7>3.0.CO;2-B; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899	34	42	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2598	2606		10.1074/jbc.275.4.2598	http://dx.doi.org/10.1074/jbc.275.4.2598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644719	hybrid			2022-12-27	WOS:000085128000051
J	Zhang, Y; Dufau, ML				Zhang, Y; Dufau, ML			Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTOR; COUP-TF; TARGET GENES; SUPERFAMILY; HETERODIMERS; EXPRESSION; PROMOTER; MEMBER; CELLS; IDENTIFICATION	imperfect estrogen receptor half-site response element direct-repeat, located within the TATA-less promoter of the human luteinizing hormone receptor (hLHR), was identified as an inhibitory site for Sp1/Sp3-driven basal transcription. Isolation of proteins recognizing this site by yeast one-hybrid screening of a human placenta cDNA library revealed three nuclear orphan receptors, EARS, EAR3/COUP-TFI, and TR4. Electrophoresis mobility shift assays demonstrated that the in vitro translated nuclear orphan receptors specifically bound the direct-repeat motif of the hLHR promoter. Also, endogenous EARS and EAR3/COUP-TFI from JAR cell and human testis and TR4 from testes bound this motif in electrophoresis mobility shift assays. Functional analyses in CV-1 cells showed that EARS and EAR3/COUP-TFI repressed the hLHR promoter activity by up to 70% in a dose dependent and sequence-specific manner. Conversely, TR4 activated the hLHR promoter activity up to 2.5-fold through binding to the same cis-element. The stimulation was reversed by coexpression of EARS or EARS/COUP-TFI, indicating their competitive binding for this site. Such recognition of a common cognate site by the proteins with antagonistic functions implies that a net regulation of the hLHR gene may result from the relative availability of repressors and activator in a physiological state. This also may contribute to the differential expression of the hLHR gene in gonadal and non-gonadal tissues.	NICHD, Endocrinol & Reprod Res Branch, Sect Mol Endocrinol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), NICHD, Endocrinol & Reprod Res Branch, Sect Mol Endocrinol, NIH, Bldg 49,Rm 6A-36,49 Convent Dr,MSC 4510, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000150] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Catt KJ, 1991, REPROD ENDOCRINOLOGY, P105; CHEN F, 1994, MOL ENDOCRINOL, V8, P1434, DOI 10.1210/me.8.10.1434; Dajee M, 1998, MOL ENDOCRINOL, V12, P1393, DOI 10.1210/me.12.9.1393; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; Geng Y, 1999, BIOCHEM BIOPH RES CO, V263, P366, DOI 10.1006/bbrc.1999.1374; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; HIROSE T, 1994, MOL ENDOCRINOL, V8, P1667, DOI 10.1210/me.8.12.1667; ING NH, 1992, J BIOL CHEM, V267, P17617; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; LEE HJ, 1995, J BIOL CHEM, V270, P30129; Lee YF, 1998, J BIOL CHEM, V273, P13437, DOI 10.1074/jbc.273.22.13437; Lee YF, 1999, J BIOL CHEM, V274, P16198, DOI 10.1074/jbc.274.23.16198; Lee YF, 1997, J BIOL CHEM, V272, P12215, DOI 10.1074/jbc.272.18.12215; Leng X, 1996, MOL CELL BIOL, V16, P2332; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Tsai-Morris C, 1999, HUM HERED, V49, P48, DOI 10.1159/000022840; Tsai-Morris CH, 1998, J CLIN ENDOCR METAB, V83, P288, DOI 10.1210/jc.83.1.288	29	44	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2763	2770		10.1074/jbc.275.4.2763	http://dx.doi.org/10.1074/jbc.275.4.2763			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644740	hybrid			2022-12-27	WOS:000085128000072
J	Horton, JK; Prasad, R; Hou, E; Wilson, SH				Horton, JK; Prasad, R; Hou, E; Wilson, SH			Protection against methylation-induced cytotoxicity by DNA polymerase beta-dependent long patch base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ABASIC SITES; OXYGEN ALKYLATION; MAMMALIAN-CELLS; BOVINE TESTIS; CHO CELLS; PATHWAY; METHOXYAMINE; GLYCOSYLASE; AGENTS	Using a plasmid-based uracil-containing DNA substrate, we found that the long patch base excision repair (BER) activity of a wild-type mouse fibroblast extract was partially inhibited by an antibody to DNA polymerase beta (beta-pol), This suggests that beta-pol participates in long patch BER, in addition to single-nucleotide BER. In single-nucleotide BER, the deoxyribose phosphate (dRP) in the abasic site is removed by the lyase activity of beta-pol. Methoxyamine (MX) can react with the aldehyde of an abasic site, making it refractory to the beta-elimination step of the dRP lyase mechanism, thus blocking single-nucleotide BER. MX exposure sensitizes wildtype, but not beta-pol null mouse embryonic fibroblasts, to the cytotoxic effects of methyl methanesulfonate (MMS) and methylnitrosourea. Expression of beta-pol in the null cells restores the ability of MX to modulate sensitivity to MMS. The beta-pol null cells are known to be hypersensitive to MMS and methylnitrosourea, and in the presence of MX (i.e. under conditions where single-nucleotide BER is blocked) the null cells are still considerably more sensitive than wild-type. The data are consistent with a role of beta-pol in long patch BER, which helps protect cells against methylation damage-induced cytotoxicity.	NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.		Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, Z01ES050159] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Beard WA, 1995, METHOD ENZYMOL, V262, P98; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Calleja F, 1999, MUTAT RES-FUND MOL M, V425, P185, DOI 10.1016/S0027-5107(99)00034-2; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; CHAKRAVARTI D, 1991, J BIOL CHEM, V266, P15710; deVries A, 1996, SEMIN CANCER BIOL, V7, P229, DOI 10.1006/scbi.1996.0031; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; Dianov GL, 1999, J BIOL CHEM, V274, P13741, DOI 10.1074/jbc.274.20.13741; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; FORTINI P, 1992, CARCINOGENESIS, V13, P87, DOI 10.1093/carcin/13.1.87; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; FORTINI P, 1990, MUTAT RES, V236, P129, DOI 10.1016/0921-8777(90)90040-C; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; FROSINA G, 1994, BIOCHEM J, V304, P699, DOI 10.1042/bj3040699; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; LIUZZI M, 1985, J BIOL CHEM, V260, P5252; MATSUMOTO Y, 1994, MOL CELL BIOL, V14, P6187, DOI 10.1128/MCB.14.9.6187; MIRZAYANS R, 1988, CARCINOGENESIS, V9, P2257, DOI 10.1093/carcin/9.12.2257; Nakamura J, 1999, CANCER RES, V59, P2522; Nakamura J, 1998, CANCER RES, V58, P222; Ochs K, 1999, CANCER RES, V59, P1544; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; PRASAD R, 2000, IN PRESS J BIOL CHEM, V275; PRICE A, 1992, FEBS LETT, V300, P101, DOI 10.1016/0014-5793(92)80173-E; ROSA S, 1991, NUCLEIC ACIDS RES, V19, P5569, DOI 10.1093/nar/19.20.5569; Sandigursky M, 1998, NUCLEIC ACIDS RES, V26, P1282, DOI 10.1093/nar/26.5.1282; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; SNOWDEN A, 1990, BIOCHEMISTRY-US, V29, P7251, DOI 10.1021/bi00483a013; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; TALPAERTBORLE M, 1983, BIOCHIM BIOPHYS ACTA, V740, P410, DOI 10.1016/0167-4781(83)90089-1; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; TEO IA, 1983, MUTAT RES, V107, P371, DOI 10.1016/0027-5107(83)90177-X; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	44	130	135	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2211	2218		10.1074/jbc.275.3.2211	http://dx.doi.org/10.1074/jbc.275.3.2211			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636928	hybrid			2022-12-27	WOS:000084940000091
J	Liu, CL; Tsai, CC; Lin, SC; Wang, LI; Hsu, CI; Hwang, MJ; Lin, JY				Liu, CL; Tsai, CC; Lin, SC; Wang, LI; Hsu, CI; Hwang, MJ; Lin, JY			Primary structure and function analysis of the Abrus precatorius agglutinin A chain by site-directed mutagenesis - Pro(199) of amphiphilic alpha-helix H impairs protein synthesis inhibitory activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICIN-A-CHAIN; RIBOSOME-INACTIVATING PROTEINS; AMINO-ACID-RESIDUES; X-RAY-ANALYSIS; ABRIN-A; B-CHAIN; EUKARYOTIC RIBOSOMES; NUCLEOTIDE-SEQUENCE; COMMUNIS AGGLUTININ; ESCHERICHIA-COLI	Abrus agglutinin (AAG), a low-toxicity protein from the plant Abrus precatorius, is less lethal than abrina (ABRa) in mice (LD50 = 5 mg/kg versus 20 mu g/kg of body weight). Nucleotide sequence analysis of a cDNA clone encoding full-length AAG showed an open reading frame with 1641 base pairs, corresponding to a 547-amino acid residue preproprotein containing a signal peptide and a linker region (two amino acid residues) between the AAG-A and AAG-B subunits, AAG had high homology to ABRa (77.8%). The 13 amino acid residues involved in catalytic function, which are highly conserved among abrins and ricins, were also conserved within AAG-A, The protein synthesis inhibitory activity of AAG-A (IC50 = 3.5 nM) was weaker than that of ABRa-A (0.05 nM), Molecular modeling followed by site-directed mutagenesis showed that Pro(199) of AAG-A, located in amphiphilic helix H and corresponding to Asn(200) of ABRa-A, can induce bending of helix H. This bending would presumably affect the binding of AAG-A to its target sequence, GpApGpAp, in the tetraloop structure of the 28 S rRNA subunit and could be one of the major factors contributing to the relatively weak protein synthesis inhibitory activity and toxicity of AAG.	Natl Taiwan Univ, Coll Med, Inst Biochem, Taipei 100, Taiwan; Natl Def Med Ctr, Inst Life Sci, Taipei, Taiwan; Acad Sinica, Inst Biomed, Taipei 115, Taiwan	National Taiwan University; National Defense Medical Center; Academia Sinica - Taiwan	Lin, JY (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem, 9F,1 Sect,1 JenAi Rd, Taipei 100, Taiwan.		Lin, Su-Chang/F-2899-2016; Lin, Jung-Yaw/AGW-9336-2022	Lin, Su-Chang/0000-0003-0687-3139; Lin, Jung-Yaw/0000-0002-6341-1160				BARBIERI L, 1982, CANCER SURV, V1, P489; BOULTER D, 1984, PHILOS T ROY SOC B, V304, P323, DOI 10.1098/rstb.1984.0027; BRINKMANN U, 1991, P NATL ACAD SCI USA, V88, P8616, DOI 10.1073/pnas.88.19.8616; Chen JK, 1997, PROTEIN ENG, V10, P827, DOI 10.1093/protein/10.7.827; CHEN YL, 1992, FEBS LETT, V309, P115, DOI 10.1016/0014-5793(92)81076-X; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; ENDO Y, 1991, J MOL BIOL, V221, P193, DOI 10.1016/0022-2836(91)90814-M; FUNATSU G, 1991, BIOCHIMIE, V73, P1157, DOI 10.1016/0300-9084(91)90160-3; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HUANG QC, 1995, BIOCHEM J, V309, P285, DOI 10.1042/bj3090285; HUNG CH, 1994, EUR J BIOCHEM, V219, P83, DOI 10.1111/j.1432-1033.1994.tb19917.x; HUNG CH, 1992, BIOCHEM BIOPH RES CO, V184, P1524, DOI 10.1016/S0006-291X(05)80056-7; HUNG CH, 1993, J MOL BIOL, V229, P263, DOI 10.1006/jmbi.1993.1029; Kaku H, 1996, J BIOL CHEM, V271, P1480, DOI 10.1074/jbc.271.3.1480; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; Kitaoka Y, 1998, EUR J BIOCHEM, V257, P255, DOI 10.1046/j.1432-1327.1998.2570255.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB FI, 1985, EUR J BIOCHEM, V148, P265, DOI 10.1111/j.1432-1033.1985.tb08834.x; LIN JY, 1981, J NATL CANCER I, V66, P523; LIN JY, 1981, TOXICON, V19, P41; Lin SH, 1996, EUR J BIOCHEM, V240, P564, DOI 10.1111/j.1432-1033.1996.0564h.x; MA XG, 1987, SCI CHINA SER B, V30, P692; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5; NICOLSON GL, 1972, CANCER RES, V35, P144; NIELSEN NC, 1984, PHILOS T ROY SOC B, V304, P287, DOI 10.1098/rstb.1984.0024; OELTMANN TN, 1991, FASEB J, V5, P2334, DOI 10.1096/fasebj.5.10.1676688; OLSNES S, 1982, RECEPTORS RECOGNITIO, V31, P131; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; ROBERTS LM, 1985, J BIOL CHEM, V260, P5682; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; SAMBROOK J, 1989, MOL CLONING LAB MANU, P7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STRIPE F, 1992, BIOTECHNOLOGY, V10, P405; TAHIROV TH, 1995, J MOL BIOL, V250, P354, DOI 10.1006/jmbi.1995.0382; TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6016; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	44	36	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1897	1901		10.1074/jbc.275.3.1897	http://dx.doi.org/10.1074/jbc.275.3.1897			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636890	hybrid			2022-12-27	WOS:000084940000053
J	Asano, K; Mizobuchi, K				Asano, K; Mizobuchi, K			Structural analysis of late intermediate complex formed between plasmid ColIb-P9 Inc RNA and its target RNA - How does a single antisense RNA repress translation of two genes at different rates?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION CONTROL; LEADER PEPTIDE; RIBOSOME-BINDING; REPA SYNTHESIS; R1; PSEUDOKNOT; EXPRESSION; INHIBITION; DUPLEX; COPA	The antisense Inc RNA encoded by the IncI alpha Colib-P9 plasmid replicon controls the translation of repZ encoding the replication initiator and its leader peptide repY at different rates with different mechanisms. The initial loop-loop base pairing between Inc RNA and the target in the repZ mRNA leader inhibits formation of a pseudoknot required for repZ translation. A subsequent base pairing at the 5' leader of Inc RNA blocks repY translation. To delineate the molecular basis for the differential control, we analyzed the intermediate complexes formed between RepZ mRNA and Inc RNA(54), a 5'-truncated Inc RNA derivative. We found that the initial base pairing at the loops transforms into a more stable intermediate complex by its propagation in both directions. The resulting extensive base pairing indicates that the inhibition of the pseudoknot formation is established at this stage. Furthermore, the region of extensive base pairing includes bases different in related plasmids showing different incompatibility. Thus, the observed extensive base pairing is important for determining the incompatibility of the low-copy-number plasmids. We discuss the evolution of replication control systems found in IncI alpha, IncB, and IncFII group plasmids.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan; Univ Electrocommun, Dept Appl Phys & Chem, Chofu, Tokyo 1828585, Japan	University of Tokyo; University of Electro-Communications - Japan	Asano, K (corresponding author), NICHD, Lab Eukaryot Gene Regulat, NIH, Bldg 6A,Rm B1-A13, Bethesda, MD 20892 USA.	kasano@aghmac1.nichd.nih.gov						Asano K, 1998, J BIOL CHEM, V273, P11826, DOI 10.1074/jbc.273.19.11826; ASANO K, 1991, J BIOL CHEM, V266, P3774; Asano K, 1999, J BIOL CHEM, V274, P17924, DOI 10.1074/jbc.274.25.17924; Asano K, 1998, EMBO J, V17, P5201, DOI 10.1093/emboj/17.17.5201; ASANO K, 1991, J BIOL CHEM, V266, P24549; Asano K, 1998, J BIOL CHEM, V273, P11815, DOI 10.1074/jbc.273.19.11815; BLOMBERG P, 1994, MOL MICROBIOL, V12, P49, DOI 10.1111/j.1365-2958.1994.tb00994.x; BLOMBERG P, 1992, EMBO J, V11, P2675, DOI 10.1002/j.1460-2075.1992.tb05333.x; COUTURIER M, 1988, MICROBIOL REV, V52, P375, DOI 10.1128/MMBR.52.3.375-395.1988; EGUCHI Y, 1991, ANNU REV BIOCHEM, V60, P631, DOI 10.1146/annurev.bi.60.070191.003215; HAMA C, 1990, J BACTERIOL, V172, P1983, DOI 10.1128/jb.172.4.1983-1991.1990; HAMA C, 1990, J BIOL CHEM, V265, P10666; HJALT TAH, 1995, NUCLEIC ACIDS RES, V23, P580, DOI 10.1093/nar/23.4.580; Kato A, 1994, DNA Res, V1, P201, DOI 10.1093/dnares/1.5.201; Malmgren C, 1997, J BIOL CHEM, V272, P12508, DOI 10.1074/jbc.272.19.12508; Malmgren C, 1996, RNA, V2, P1022; Miller RV, 1998, SCI AM, V278, P66, DOI 10.1038/scientificamerican0198-66; NIKOLETTI S, 1988, J BACTERIOL, V170, P1311, DOI 10.1128/jb.170.3.1311-1318.1988; NORDSTROM K, 1990, CELL, V63, P1121, DOI 10.1016/0092-8674(90)90405-4; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; PERSSON C, 1990, EMBO J, V9, P3777, DOI 10.1002/j.1460-2075.1990.tb07591.x; PERSSON C, 1990, EMBO J, V9, P3767, DOI 10.1002/j.1460-2075.1990.tb07590.x; SIEMERING KR, 1994, J BACTERIOL, V176, P2677, DOI 10.1128/JB.176.9.2677-2688.1994; TOMIZAWA J, 1985, CELL, V40, P527, DOI 10.1016/0092-8674(85)90201-6; TOMIZAWA J, 1990, J MOL BIOL, V212, P683, DOI 10.1016/0022-2836(90)90230-J; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; WILSON IW, 1993, J BACTERIOL, V175, P6476, DOI 10.1128/jb.175.20.6476-6483.1993; Wilson IW, 1997, J BACTERIOL, V179, P742, DOI 10.1128/jb.179.3.742-753.1997; WILSON IW, 1994, J BACTERIOL, V176, P6497, DOI 10.1128/JB.176.21.6497-6508.1994; WU RP, 1992, J BACTERIOL, V174, P7620, DOI 10.1128/JB.174.23.7620-7628.1992	30	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1269	1274		10.1074/jbc.275.2.1269	http://dx.doi.org/10.1074/jbc.275.2.1269			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625672	hybrid			2022-12-27	WOS:000084836600076
J	Oda, Y; Tu, CL; Chang, WH; Crumrine, D; Komuves, L; Mauro, T; Elias, PM; Bikle, DD				Oda, Y; Tu, CL; Chang, WH; Crumrine, D; Komuves, L; Mauro, T; Elias, PM; Bikle, DD			The calcium sensing receptor and its alternatively spliced form in murine epidermal differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKED ENVELOPE; KERATINOCYTE DIFFERENTIATION; EXTRACELLULAR CALCIUM; CA2+-SENSING RECEPTOR; FUNCTIONAL EXPRESSION; CLONING; CELLS; HYPERPARATHYROIDISM; TRANSGLUTAMINASE; HYPERCALCEMIA	We have recently reported that human keratinocytes express both the full-length calcium sensing receptor (CaR) and an alternatively spliced form lacking exon 5, which were suggested to be involved in calcium induced keratinocyte differentiation. To understand further the role of these CaRs, we analyzed the structure of mouse CaRs, and investigated their role using a mouse model in which only the full-length CaR was disrupted. Our results show that both the full-length and the alternatively spliced variant lacking exon 5 encoding 77 amino acids of the extracellular domain were expressed in mouse epidermis. The deletion of the full-length CaR increased the production of the alternatively spliced form of CaR in mutant mice. The keratinocytes derived from these mutant mice did not respond to extracellular calcium, suggesting that the full-length CaR is required to mediate calcium signaling in the keratinocytes. The loss of the full-length CaR altered the morphologic appearance of the epidermis and resulted in a reduction of the mRNA and protein levels of the keratinocyte differentiation marker, loricrin. These results indicate that CaR is important in epidermal differentiation, and that the alternatively spliced form does not fully compensate for loss of the full-length CaR.	Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med & Dermatol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Endocrinol, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Oda, Y (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med & Dermatol, 4150 Clement St, San Francisco, CA 94121 USA.	y2073@itsa.ucsf.edu		Tu, Chia-Ling/0000-0002-7323-7733	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448, R01AR038386] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR39448, R01-AR38386] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Chattopadhyay N, 1996, ENDOCR REV, V17, P289, DOI 10.1210/er.17.4.289; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; Gibson DFC, 1996, J INVEST DERMATOL, V106, P154, DOI 10.1111/1523-1747.ep12329856; HEBERT SC, 1995, CURR OPIN CELL BIOL, V7, P484, DOI 10.1016/0955-0674(95)80004-2; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; HOHL D, 1991, J INVEST DERMATOL, V96, P414, DOI 10.1111/1523-1747.ep12469779; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Naito T, 1998, P NATL ACAD SCI USA, V95, P5178, DOI 10.1073/pnas.95.9.5178; Nakamura K, 1999, FASEB J, V13, pA1563; Oda Y, 1998, J BIOL CHEM, V273, P23344, DOI 10.1074/jbc.273.36.23344; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; Quarles LD, 1997, J BONE MINER RES, V12, P393, DOI 10.1359/jbmr.1997.12.3.393; RICCARDI D, 1995, P NATL ACAD SCI USA, V92, P131, DOI 10.1073/pnas.92.1.131; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; STEVEN AC, 1990, J STRUCT BIOL, V104, P150, DOI 10.1016/1047-8477(90)90071-J; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; YOUNUS J, 1992, J CELL PHYSIOL, V152, P232, DOI 10.1002/jcp.1041520203	23	94	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1183	1190		10.1074/jbc.275.2.1183	http://dx.doi.org/10.1074/jbc.275.2.1183			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625662	hybrid			2022-12-27	WOS:000084836600066
J	Taylor, JC; Markham, GD				Taylor, JC; Markham, GD			The bifunctional active site of S-adenosylmethionine synthetase - Roles of the basic residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE ADENOSYLTRANSFERASE; TRANSITION-STATE; METHYLATION; MUTAGENESIS; ACTIVATION; MECHANISM; LOOP	S-Adenosylmethionine (AdoMet) synthetase catalyzes a unique two-step enzymatic reaction leading to formation of the primary biological alkylating agent. The crystal structure of Escherichia coli AdoMet synthetase shows that the active site, which lies between two subunits, contains four lysines and one histidine as basic residues. In order to test the proposed charge and hydrogen bonding roles in catalytic function, each lysine has been changed to an uncharged methionine or alanine, and the histidine has been altered to asparagine. The resultant enzyme variants are all tetramers like the wild type enzyme; however, circular dichroism spectra show reductions in helix content for the K245*M and K269M mutants. (The asterisk denotes that the residue is in the second subunit,) Four mutants have k(cat) reductions of similar to 10(3)-10(4)-fold in AdoMet synthesis; however, the k(cat) of K165*M variant is only reduced 2-fold. In each mutant, there is a smaller catalytic impairment in the partial reaction of tripolyphosphate hydrolysis. The K165*A enzyme has a 100-fold greater k(cat) for tripolyphosphate hydrolysis than the wild type enzyme, but this mutant is not activated by AdoMet in contrast to the wild type enzyme. The properties of these mutants require reassessment of the catalytic roles of these residues.	Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Markham, GD (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.				NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031186] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927] Funding Source: Medline; NIGMS NIH HHS [GM31186] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Chamberlin ME, 1997, AM J HUM GENET, V60, P540; Chamberlin ME, 1996, J CLIN INVEST, V98, P1021, DOI 10.1172/JCI118862; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; CHIFFLET S, 1986, ANAL BIOCHEM, V168, P1; Cleland W W, 1979, Methods Enzymol, V63, P103; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; Frey PA, 1998, BIOCHEM SOC T, V26, P304, DOI 10.1042/bst0260304; Fu ZJ, 1996, J BIOMOL STRUCT DYN, V13, P727, DOI 10.1080/07391102.1996.10508887; Hazelwood S, 1998, AM J MED GENET, V75, P395, DOI 10.1002/(SICI)1096-8628(19980203)75:4<395::AID-AJMG9>3.0.CO;2-P; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; LETSINGER RL, 1972, J AM CHEM SOC, V94, P292, DOI 10.1021/ja00756a060; Markham GD, 1999, BIOCHEMISTRY-US, V38, P4433, DOI 10.1021/bi9829579; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; MARKHAM GD, 1987, J BIOL CHEM, V262, P5609; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; MCQUENEY MS, 1995, J BIOL CHEM, V270, P18277, DOI 10.1074/jbc.270.31.18277; Mudd S. H., 1973, ENZYMES, V8, P121; Reczkowski RS, 1998, BIOCHEMISTRY-US, V37, P13499, DOI 10.1021/bi9811011; Reczkowski RS, 1999, BIOCHEMISTRY-US, V38, P9063, DOI 10.1021/bi990528k; RECZKOWSKI RS, 1995, J BIOL CHEM, V270, P18484, DOI 10.1074/jbc.270.31.18484; SOWA T, 1975, B CHEM SOC JPN, V48, P2084, DOI 10.1246/bcsj.48.2084; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1984, ADV ENZYMOL RAMB, V56, P251; Takusagawa F, 1996, J BIOL CHEM, V271, P136, DOI 10.1074/jbc.271.1.136; Takusagawa F, 1996, BIOCHEMISTRY-US, V35, P2586, DOI 10.1021/bi952604z; Taylor JC, 1999, J BIOL CHEM, V274, P32909, DOI 10.1074/jbc.274.46.32909; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; TROWBRIDGE DB, 1972, J AM CHEM SOC, V94, P3816, DOI 10.1021/ja00766a026; USDIN E, 1982, BIOCH S ADENOSYLMETH	31	18	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4060	4065		10.1074/jbc.275.6.4060	http://dx.doi.org/10.1074/jbc.275.6.4060			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660564	hybrid			2022-12-27	WOS:000085288800048
J	Yang, J; Cheng, ZL; Niu, TQ; Liang, XS; Zhao, ZZJ; Zhou, GW				Yang, J; Cheng, ZL; Niu, TQ; Liang, XS; Zhao, ZZJ; Zhou, GW			Structural basis for substrate specificity of protein-tyrosine phosphatase SHP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CRYSTAL-STRUCTURE; SH2 DOMAINS; CATALYTIC DOMAIN; PURIFICATION; DETERMINANTS; RECOGNITION; CELLS; PTP1; 1B	The substrate specificity of the catalytic domain of SHP-1, an important regulator in the proliferation and development of hematopoietic cells, is critical for understanding the physiological functions of SHP-1, Here we report the crystal structures of the catalytic domain of SHP-1 complexed with two peptide substrates derived from SIRP alpha, a member of the signal-regulatory proteins. We show that the variable beta 6-loop-beta 6 motif confers SHP-1 substrate specificity at the P-4 and further N-terminal subpockets. We also observe a novel residue shift at P-2, the highly conserved subpocket in protein-tyrosine phosphatases, Our observations provide new insight into the substrate specificity of SHP-1.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA	University of Massachusetts System; University of Massachusetts Worcester; Vanderbilt University	Zhou, GW (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.		Cheng, Zhiliang/F-3251-2011	Cheng, Zhiliang/0000-0002-9478-957X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057393] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57393] Funding Source: Medline; PHS HHS [AL45858] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adachi T, 1998, J IMMUNOL, V160, P4662; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; BRUNGER AT, 1992, X PLOR MANUAL VERSIO; DECHERT U, 1995, EUR J BIOCHEM, V231, P673, DOI 10.1111/j.1432-1033.1995.0673d.x; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; HOWARD PK, 1994, MOL CELL BIOL, V14, P5154, DOI 10.1128/MCB.14.8.5154; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Liang XS, 1997, J STRUCT BIOL, V120, P201, DOI 10.1006/jsbi.1997.3927; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; O'Reilly AM, 1998, MOL CELL BIOL, V18, P161, DOI 10.1128/MCB.18.1.161; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roussel A, 1990, ACTA CRYSTALLOGR A, V46, pC66; STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; TOWNLEY R, 1993, BIOCHEMISTRY-US, V32, P13414, DOI 10.1021/bi00212a006; Yang J, 1998, J BIOL CHEM, V273, P28199, DOI 10.1074/jbc.273.43.28199; Zhang ZY, 1996, J BIOL CHEM, V271, P5386, DOI 10.1074/jbc.271.10.5386; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816	25	68	72	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4066	4071		10.1074/jbc.275.6.4066	http://dx.doi.org/10.1074/jbc.275.6.4066			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660565	hybrid			2022-12-27	WOS:000085288800049
J	Gong, LM; Millas, S; Maul, GG; Yeh, ETH				Gong, LM; Millas, S; Maul, GG; Yeh, ETH			Differential regulation of sentrinized proteins by a novel sentrin-specific protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE PROTEIN; NUCLEAR-PORE COMPLEX; GTPASE-ACTIVATING PROTEIN; SUMO-1 MODIFICATION; COVALENT MODIFICATION; PML; RANGAP1; CONJUGATION; FAMILY; SMT3P	Sentrin-1, also called SUMO-1, is a protein of 101 residues that is distantly related to ubiquitin and another ubiquitin-like protein, NEDD8, Here we report the cloning of a novel sentrin-specific protease, SENP1, which has no homology to the known de-ubiquitinating enzymes or ubiquitin C-terminal hydrolases. However, SENP1 is distantly related to the yeast Smt3-specific protease, Ulp1. A COS cell expression system was used to demonstrate the activity of SENP1 in vivo. When HA-tagged sentrin-1 was co-expressed with SENP1, the higher molecular weight sentrin-1 conjugates were completely removed. Surprisingly, the major sentrinized band at 90 kDa remained intact. The disappearance of the high molecular weight sentrin-1 conjugates also coincided with an increase in free sentrin-1 monomers. SENP1 is also active against proteins modified by sentrin-2, but not those modified by ubiquitin or NEDD8. In addition, sentrinized PML, a tumor suppressor protein that resides in the nucleus, was selectively affected by SENP1, whereas sentrinized RanGAP1, which is associated with the cytoplasmic fibrils of the nuclear pore complex, remained intact. The inability of SENP1 to process sentrinized RanGAP1 in vivo is most likely due to its nuclear localization because SENP1 is active against sentrinized RanGAP1 in vitro. The identification of a nuclear-localized, sentrin-specific protease will provide a unique tool to study the role of sentrinization in the biological function of PML and in the pathogenesis of acute promyelocytic leukemia.	Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Cardiol, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Res Ctr Cardiovasc Dis, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA; Wistar Inst, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; The Wistar Institute	Yeh, ETH (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Mol Med, 6431 Fannin,Suite 4-200, Houston, TX 77030 USA.				NIGMS NIH HHS [GM-57502] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM057502] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boddy MN, 1996, ONCOGENE, V13, P971; den Dunnen JT, 1999, METHOD ENZYMOL, V303, P100; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ishov AM, 1996, J CELL BIOL, V134, P815, DOI 10.1083/jcb.134.4.815; Ishov AM, 1997, J CELL BIOL, V138, P5, DOI 10.1083/jcb.138.1.5; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Okura T, 1996, J IMMUNOL, V157, P4277; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543	30	234	245	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3355	3359		10.1074/jbc.275.5.3355	http://dx.doi.org/10.1074/jbc.275.5.3355			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652325	hybrid			2022-12-27	WOS:000085146500047
J	Grewal, SS; Horgan, AM; York, RD; Withers, GS; Banker, GA; Stork, PJS				Grewal, SS; Horgan, AM; York, RD; Withers, GS; Banker, GA; Stork, PJS			Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; GENE-EXPRESSION; MAP KINASE; MEMBRANE DEPOLARIZATION; NUCLEAR TRANSLOCATION; HIPPOCAMPAL-NEURONS; BINDING PROTEINS; PC12 CELLS; LATE-PHASE	Activity-dependent regulation of neuronal events such as cell survival and synaptic plasticity is controlled by increases in neuronal calcium levels. These actions often involve stimulation of intracellular kinase signaling pathways. For example, the mitogen-activated protein kinase, or extracellular signal-regulated kinase (ERK), signaling cascade has increasingly been shown to be important for the induction of gene expression and long term potentiation. However, the mechanisms leading to ERK activation by neuronal calcium are still unclear. In the present study, we describe a protein kinase A (PKA)-dependent signaling pathway that may link neuronal calcium influx to ERKs via the small G-protein, Rap1, and the neuronal Raf isoform, B-Raf. Thus, in PC12 cells, depolarization-mediated calcium influx led to the activation of B-Raf, but not Raf-1, via PKA, Furthermore, depolarization also induced the PKA-dependent stimulation of Rap1 and led to the formation of a Rap1/B-Raf signaling complex. In contrast, depolarization did not lead to the association of Ras with B-Raf, The major action of PKA-dependent Rap1/B-Raf signaling in neuronal cells is the activation of ERKs, Thus, we further show that, in both PC12 cells and hippocampal neurons, depolarization-induced calcium influx stimulates ERK activity in a PKA-dependent manner. Given the fact that both Rap1 and B-Raf are highly expressed in the central nervous system, we suggest that this signaling pathway may regulate a number of activity-dependent neuronal functions.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Stork, PJS (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474,SW Sam Jackson Pk Rd, Portland, OR 97201 USA.							Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Agnihotri N, 1997, J NEUROSCI RES, V47, P555, DOI 10.1002/(SICI)1097-4547(19970301)47:5<555::AID-JNR11>3.0.CO;2-X; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Berman DE, 1998, J NEUROSCI, V18, P10037; Bhat RV, 1998, J NEUROCHEM, V70, P558; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Bito H, 1998, CELL CALCIUM, V23, P143, DOI 10.1016/S0143-4160(98)90113-0; Blum S, 1999, J NEUROSCI, V19, P3535; Bos JL, 1998, EMBO J, V17, P6776, DOI 10.1093/emboj/17.23.6776; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Crow T, 1998, J NEUROSCI, V18, P3480; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Egea J, 1999, J BIOL CHEM, V274, P75, DOI 10.1074/jbc.274.1.75; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Fields RD, 1997, J NEUROSCI, V17, P7252; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GADBOIS DM, 1992, P NATL ACAD SCI USA, V89, P8626, DOI 10.1073/pnas.89.18.8626; GALLIN WJ, 1995, CURR OPIN NEUROBIOL, V5, P367, DOI 10.1016/0959-4388(95)80050-6; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Ginty DD, 1997, NEURON, V18, P183, DOI 10.1016/S0896-6273(00)80258-5; GINTY DD, 1991, J BIOL CHEM, V266, P17454; Goslin K., 1991, CULTURING NERVE CELL, P251; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HIDAKA H, 1983, METHOD ENZYMOL, V102, P185; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kawasaki H, 1999, J BIOL CHEM, V274, P13498, DOI 10.1074/jbc.274.19.13498; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KURINO M, 1995, J NEUROCHEM, V65, P1282; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Nguyen PV, 1996, J NEUROSCI, V16, P3189; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Rusanescu G, 1995, NEURON, V15, P1415, DOI 10.1016/0896-6273(95)90019-5; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sgambato V, 1998, J NEUROSCI, V18, P8814; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Xia ZG, 1997, CURR OPIN NEUROBIOL, V7, P391, DOI 10.1016/S0959-4388(97)80068-2; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	65	133	140	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3722	3728		10.1074/jbc.275.5.3722	http://dx.doi.org/10.1074/jbc.275.5.3722			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652372	hybrid			2022-12-27	WOS:000085146500094
J	Lozano, MJF; Remsing, LL; Quiros, LM; Brana, AF; Fernandez, E; Sanchez, C; Mendez, C; Rohr, J; Salas, JA				Lozano, MJF; Remsing, LL; Quiros, LM; Brana, AF; Fernandez, E; Sanchez, C; Mendez, C; Rohr, J; Salas, JA			Characterization of two polyketide methyltransferases involved in the biosynthesis of the antitumor drug mithramycin by Streptomyces argillaceus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREOLIC ACID GROUP; SP STRAIN C5; ESCHERICHIA-COLI; CARMINOMYCIN 4-O-METHYLTRANSFERASE; SACCHAROPOLYSPORA-ERYTHRAEA; NUCLEOTIDE-SEQUENCES; O-METHYLTRANSFERASE; MOLECULAR ANALYSIS; TETRACENOMYCIN-C; GENES	A DNA chromosomal region of Streptomyces argillaceus ATCC 12596, the producer organism of the antitumor polyketide drug mithramycin, was cloned. Sequence analysis of this DNA region, located between four mithramycin glycosyltransferase genes, showed the presence of two genes (mtmMI and mtmMII) whose deduced products resembled S-adenosylmethionine-dependent methyltransferases. By independent insertional inactivation of both genes nonproducing mutants were generated that accumulated different mithramycin biosynthetic intermediates. The M3 Delta MI mutant (mtmMI-minus mutant) accumulated 4-demethylpremithramycinone (4-DPMC) which lacks the methyl groups at carbons 4 and 9, The M3 Delta M2 (mtmMII-minus mutant) accumulated 9-demethylpremithramycin A3 (9-DPMA3), premithramycin Al (PMA1), and 7-demethylmithramycin, all of them containing the O-methyl group at C-4 and C-1', respectively, but lacking the methyl group at the aromatic position. Both genes were expressed in Streptomyces lividans TK21 under the control of the erythromycin resistance promoter (ermEp) of Saccharopolyspora erythraea. Cell-free extracts of these clones were precipitated with ammonium sulfate (90% saturation) and assayed for methylation activity using different mithramycin intermediates as substrates. Extracts of strains MJM1 (expressing the mtmMI gene) and MJM2 (expressing the mtmMII gene) catalyzed efficient transfer of tritium from [H-3]S-adenosylmethionine into 4-DPMC and 9-DPMA3, respectively, being unable to methylate other intermediates at a detectable level. These results demonstrate that the mtmMI and mtmMII genes code for two S-adenosylmethionine-dependent methyltransferases responsible for the 4-O-methylation and 9-C-methylation steps of the biosynthetic precursors 4-DPMC and 9-DPMA3, respectively, of the antitumor drug mithramycin. A pathway is proposed for the last steps in the biosynthesis of mithramycin involving these methylation events.	Univ Oviedo, Dept Biol Func, E-33006 Oviedo, Spain; Univ Oviedo, Inst Univ Oncol, E-33006 Oviedo, Spain; Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA	University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Medical University of South Carolina	Rohr, J (corresponding author), Univ Oviedo, Dept Biol Func, E-33006 Oviedo, Spain.		Rohr, Jurgen/G-5375-2014; Brana, Alfredo/M-1836-2014; Mendez-Fernandez, Carmen/ABE-5745-2020; Quirós, Luis/T-3822-2017; Sánchez, César/E-5937-2010; Fernandez-Brana, Alfredo/O-1488-2019	Rohr, Jurgen/0000-0001-6447-5951; Brana, Alfredo/0000-0002-3277-9085; Mendez-Fernandez, Carmen/0000-0003-2729-841X; Quirós, Luis/0000-0003-3505-3762; Sánchez, César/0000-0001-9891-0843; Fernandez-Brana, Alfredo/0000-0002-3277-9085				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Blanco G, 1996, CHEM BIOL, V3, P193, DOI 10.1016/S1074-5521(96)90262-8; BLANCO G, 1999, IN PRESS MOL GEN GEN; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CONNORS NC, 1993, J GEN MICROBIOL, V139, P1353, DOI 10.1099/00221287-139-6-1353; CONNORS NC, 1990, J GEN MICROBIOL, V136, P1887, DOI 10.1099/00221287-136-9-1887; DAIRI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1099, DOI 10.1271/bbb.59.1099; DECKER H, 1993, J BACTERIOL, V175, P3876, DOI 10.1128/JB.175.12.3876-3886.1993; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEWICK PM, 1997, MED NATURAL PRODUCTS, P85; DICKENS ML, 1995, J BACTERIOL, V177, P536, DOI 10.1128/jb.177.3.536-543.1995; FAWAZ F, 1988, J BIOL CHEM, V263, P4602; Fernandez E, 1998, J BACTERIOL, V180, P4929; Hopwood D.A., 1985, GENETIC MANIPULATION; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; KREUZMAN AJ, 1988, J BIOL CHEM, V263, P15626; KUZUYAMA T, 1992, J ANTIBIOT, V45, P1812, DOI 10.7164/antibiotics.45.1812; LACALLE RA, 1991, GENE, V109, P55, DOI 10.1016/0378-1119(91)90588-3; Lombo F, 1999, J BACTERIOL, V181, P642; Lombo F, 1997, J BACTERIOL, V179, P3354, DOI 10.1128/jb.179.10.3354-3357.1997; Lombo F, 1996, GENE, V172, P87, DOI 10.1016/0378-1119(96)00029-7; MADDURI K, 1993, J BACTERIOL, V175, P3900, DOI 10.1128/JB.175.12.3900-3904.1993; NIEMI J, 1995, J BACTERIOL, V177, P2942, DOI 10.1128/jb.177.10.2942-2945.1995; PAULUS TJ, 1990, J BACTERIOL, V172, P2541, DOI 10.1128/jb.172.5.2541-2546.1990; Prado L, 1999, CHEM BIOL, V6, P19, DOI 10.1016/S1074-5521(99)80017-9; REMERS WA, 1979, CHEM ANTITUMOR ANTIB, V1, P133; Rohr J, 1998, CHEM COMMUN, P437, DOI 10.1039/a707446h; Rohr J, 1999, BIOORG CHEM, V27, P41, DOI 10.1006/bioo.1998.1110; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Skarbek J.D., 1981, ANTITUMOR COMPOUNDS, V1, P191; SUMMERS RG, 1992, J BACTERIOL, V174, P1810, DOI 10.1128/jb.174.6.1810-1820.1992; Tercero JA, 1996, J BIOL CHEM, V271, P1579, DOI 10.1074/jbc.271.3.1579; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989	37	52	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3065	3074		10.1074/jbc.275.5.3065	http://dx.doi.org/10.1074/jbc.275.5.3065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652287	hybrid			2022-12-27	WOS:000085146500009
J	Tuynman, A; Spelberg, JL; Kooter, IM; Schoemaker, HE; Wever, R				Tuynman, A; Spelberg, JL; Kooter, IM; Schoemaker, HE; Wever, R			Enantioselective epoxidation and carbon-carbon bond cleavage catalyzed by Coprinus cinereus peroxidase and myeloperoxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE; CHLOROPEROXIDASE CATALYSIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; LACTOPEROXIDASE; STYRENE; SULFOXIDATION; OXIDATION; MECHANISM; CHLORIDE	We demonstrate that myeloperoxidase (MPO) and Coprinus cinereus peroxidase (CiP) catalyze the enantioselective epoxidation of styrene and a number of substituted derivatives with a reasonable enantiomeric excess (up to 80%) and in a moderate yield. Three major differences with respect to the chloroperoxidase from Caldariomyces fumago (CPO) are observed in the reactivity of MPO and CiP toward styrene derivatives. First, in contrast to CPO, MPO and CiP produced the (S)-isomers of the epoxides in enantiomeric excess. Second, for MPO and CiP the H2O2 had to be added very slowly (10 eq in 16 h) to prevent accumulation of catalytically inactive enzyme intermediates. Under these conditions, CPO hardly showed any epoxidizing activity; only with a high influx of H2O2 (300 eq in 1.6 h) was epoxidation observed. Third, both MPO and CiP formed significant amounts of (substituted) benzaldehydes as side products as a consequence of C-alpha-C-beta bond cleavage of the styrene derivatives, whereas for CPO and cytochrome c peroxidase this activity is not observed. C-alpha-C-beta cleavage was the most prominent reaction catalyzed by CiP, whereas with MPO the relative amount of epoxide formed was higher. This is the first report of peroxidases catalyzing both epoxidation reactions and carbon-carbon bond cleavage. The results are discussed in terms of mechanisms involving ferryl oxygen transfer and electron transfer, respectively.	Univ Amsterdam, BioCentrum, EC Slater Inst, NL-1018 TV Amsterdam, Netherlands; Univ Groningen, Biomol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands; DSM Res, Bioorgan Chem, NL-6160 MD Geleen, Netherlands	University of Amsterdam; University of Groningen; DSM NV	Wever, R (corresponding author), Univ Amsterdam, BioCentrum, EC Slater Inst, Muidergracht 12, NL-1018 TV Amsterdam, Netherlands.		Wever, Ron/AAM-4520-2020					ALLAIN EJ, 1993, J AM CHEM SOC, V115, P4415, DOI 10.1021/ja00063a091; ANDERSEN MB, 1991, ACTA CHEM SCAND, V45, P1080, DOI 10.3891/acta.chem.scand.45-1080; BAKKENIST ARJ, 1978, BIOCHIM BIOPHYS ACTA, V524, P45, DOI 10.1016/0005-2744(78)90101-8; BEERS RF, 1952, J BIOL CHEM, V195, P133; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V788, P1, DOI 10.1016/0167-4838(84)90290-5; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; COLONNA S, 1993, TETRAHEDRON-ASYMMETR, V4, P1325, DOI 10.1016/S0957-4166(00)80243-8; COLONNA S, 1992, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39920000357; Colonna S, 1995, GAZZ CHIM ITAL, V125, P479; COLONNA S, 1990, BIOCHEMISTRY-US, V29, P10465, DOI 10.1021/bi00498a006; CORBETT MD, 1979, BIOCHEM J, V183, P269, DOI 10.1042/bj1830269; CORBETT MD, 1980, BIOCHEM J, V187, P893, DOI 10.1042/bj1870893; DEMONTELLANO PRO, 1987, BIOCHEMISTRY-US, V26, P5310, DOI 10.1021/bi00391a014; DEMONTELLANO PRO, 1987, J BIOL CHEM, V262, P11641; DEMONTELLANO PRO, 1992, ANNU REV PHARMACOL, V32, P89, DOI 10.1146/annurev.pharmtox.32.1.89; DEXTER AF, 1995, J AM CHEM SOC, V117, P6412, DOI 10.1021/ja00128a053; DEXTER AF, 1995, J AM CHEM SOC, V117, P817, DOI 10.1021/ja00107a026; DUESCHER RJ, 1992, J BIOL CHEM, V267, P19859; Finney NS, 1997, ANGEW CHEM INT EDIT, V36, P1720, DOI 10.1002/anie.199717201; GROSS Z, 1995, J AM CHEM SOC, V117, P8021, DOI 10.1021/ja00135a023; GROVES JT, 1986, J AM CHEM SOC, V108, P207; GUENGERICH FP, 1984, ACCOUNTS CHEM RES, V17, P9, DOI 10.1021/ar00097a002; HARVEY PJ, 1985, FEBS LETT, V183, P13, DOI 10.1016/0014-5793(85)80943-1; HOLLENBERG PE, 1970, METHOD ENZYMOL, V52, P521; HOOGLAND H, 1988, BIOCHIM BIOPHYS ACTA, V955, P337, DOI 10.1016/0167-4838(88)90213-0; Hu SH, 1999, J AM CHEM SOC, V121, P872, DOI 10.1021/ja983612g; Hu SH, 1999, TETRAHEDRON LETT, V40, P1641, DOI 10.1016/S0040-4039(99)00056-8; HUWILER M, 1986, EUR J BIOCHEM, V158, P609, DOI 10.1111/j.1432-1033.1986.tb09798.x; JACOBSEN EN, 1993, CATALYTIC ASYMMETRIC, P159; Lakner FJ, 1996, J ORG CHEM, V61, P3923, DOI 10.1021/jo960074m; Lakner FJ, 1997, J AM CHEM SOC, V119, P443, DOI 10.1021/ja962998x; MILLER VP, 1995, ARCH BIOCHEM BIOPHYS, V319, P333, DOI 10.1006/abbi.1995.1302; MILLER VP, 1992, J BIOL CHEM, V267, P8936; NEIDLEMAN SL, 1986, BIOHALOGENATION PRIN, P105; NEWMYER SL, 1995, J BIOL CHEM, V270, P19430, DOI 10.1074/jbc.270.33.19430; OZAKI S, 1995, J AM CHEM SOC, V117, P7056, DOI 10.1021/ja00132a003; PALUCKI M, 1994, J AM CHEM SOC, V116, P9333, DOI 10.1021/ja00099a062; Palucki M, 1998, J AM CHEM SOC, V120, P948, DOI 10.1021/ja973468j; PALUCKI M, 1994, J AM CHEM SOC, V116, P12135, DOI 10.1021/ja00105a099; PAUL KG, 1980, FEBS LETT, V110, P200, DOI 10.1016/0014-5793(80)80072-X; PETERSEN JFW, 1994, FEBS LETT, V339, P291, DOI 10.1016/0014-5793(94)80433-8; PIONTEK K, 1993, FEBS LETT, V315, P119, DOI 10.1016/0014-5793(93)81146-Q; Savenkova MI, 1998, BIOCHEMISTRY-US, V37, P10828, DOI 10.1021/bi9725780; Savenkova MI, 1998, ARCH BIOCHEM BIOPHYS, V351, P286, DOI 10.1006/abbi.1997.0559; SCHOEMAKER HE, 1990, RECL TRAV CHIM PAY B, V109, P255; Spelberg JHL, 1998, TETRAHEDRON-ASYMMETR, V9, P459, DOI 10.1016/S0957-4166(98)00003-2; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Sundaramoorthy M, 1998, CHEM BIOL, V5, P461, DOI 10.1016/S1074-5521(98)90003-5; Tanaka M, 1997, BIOCHEMISTRY-US, V36, P9889, DOI 10.1021/bi970906q; TRAYLOR TG, 1986, J AM CHEM SOC, V108, P2782, DOI 10.1021/ja00270a063; Tuynman A, 1998, EUR J BIOCHEM, V258, P906, DOI 10.1046/j.1432-1327.1998.2580906.x; YAMAZAKI I, 1977, FREE RADICALS BIOL, V3, P183; ZAKS A, 1995, J AM CHEM SOC, V117, P10419, DOI 10.1021/ja00147a001	53	48	49	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3025	3030		10.1074/jbc.275.5.3025	http://dx.doi.org/10.1074/jbc.275.5.3025			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652281	hybrid			2022-12-27	WOS:000085146500003
J	Yang, TB; Poovaiah, BW				Yang, TB; Poovaiah, BW			Molecular and biochemical evidence for the involvement of calcium/calmodulin in auxin action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING DOMAIN; DEPENDENT PROTEIN-KINASE; CYTOSOLIC FREE CALCIUM; GLUTAMATE-DECARBOXYLASE; GENE-EXPRESSION; MESSENGER-RNAS; HIGHER-PLANTS; COLEOPTILES; CLONING; TISSUE	The use of S-35-labeled calmodulin (CaM) to screen a corn root cDNA expression library has led to the isolation of a CaM-binding protein, encoded by a cDNA with sequence similarity to small auxin up RNAs (SAURs), a class of early auxin-responsive genes. The cDNA designated as ZmSAUR1 (Zea mays SAURs) was expressed in Escherichia coli, and the recombinant protein was purified by CaM affinity chromatography. The CaM binding assay revealed that the recombinant protein binds to CaM in a calcium-dependent manner. Deletion analysis revealed that the CaM binding site was located at the NH2-terminal domain. A synthetic peptide of amino acids 20-45, corresponding to the potential CaM binding region, was used for calcium-dependent mobility shift assays. The synthetic peptide formed a stable complex with CaM only in the presence of calcium. The CaM affinity assay indicated that ZmSAUR1 binds to CaM with high affinity (R-d similar to 15 nM) in a calcium-dependent manner, Comparison of the NH,-terminal portions of all of the characterized SAURs revealed that they all contain a stretch of the basic alpha-amphiphilic helix similar to the CaM binding region of ZmSAUR1, CaM binds to the two synthetic peptides from the NH2-terminal regions of Arabidopsis SAUR-AC1 and soybean 10A5, suggesting that this is a general phenomenon for all SAURs, Northern analysis was carried out using the total RNA isolated from auxin-treated corn coleoptile segments, Zm-SAUR1 gene expression began within 10 min, increased rapidly between 10 and 60 min, and peaked around 60 min after 10 mu m alpha-naphthaleneacetic acid treatment. These results indicate that ZmSAUR1 is an early auxin-responsive gene. The CaM antagonist N-(6-aminohexyl) 5-chloro-1-naphthalenesulfonamide hydrochloride inhibited the auxin-induced cell elongation but not the auxin-induced expression of ZmSAUR1. This suggests that calcium/CaM do not regulate ZmSAUR1 at the transcriptional level. CaM binding to ZmSAUR1 in a calcium-dependent manner suggests that calcium/CaM regulate ZmSAUR1 at the post-translational level. Our data provide the first direct evidence for the involvement of calcium/CaM-mediated signaling in auxin-mediated signal transduction.	Washington State Univ, Dept Hort, Lab Plant Mol Biol & Physiol, Pullman, WA 99164 USA	Washington State University	Poovaiah, BW (corresponding author), Washington State Univ, Dept Hort, Lab Plant Mol Biol & Physiol, Pullman, WA 99164 USA.							Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; BRUMMELL DA, 1987, PLANT CELL ENVIRON, V10, P523, DOI 10.1111/1365-3040.ep11603897; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; CLORE GM, 1993, CURR OPIN STRUC BIOL, V3, P838, DOI 10.1016/0959-440X(93)90146-C; COHEN JD, 1976, PLANT PHYSIOL, V57, P347, DOI 10.1104/pp.57.3.347; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DROBAK BK, 1985, BIOCHEM BIOPH RES CO, V145, P1043; ESTRUCH JJ, 1994, P NATL ACAD SCI USA, V91, P8837, DOI 10.1073/pnas.91.19.8837; ETTLINGER C, 1988, NATURE, V331, P176, DOI 10.1038/331176a0; EVANS ML, 1985, CRC CR REV PLANT SCI, V2, P317, DOI 10.1080/07352688509382200; EVANS ML, 1974, ANNU REV PLANT PHYS, V25, P195, DOI 10.1146/annurev.pp.25.060174.001211; FELLE H, 1988, PLANTA, V174, P495, DOI 10.1007/BF00634478; Fromm H, 1992, PLANT MOL BIOL REP, V10, P199, DOI 10.1007/BF02668347; GEE MA, 1991, PLANT CELL, V3, P419, DOI 10.1105/tpc.3.4.419; GEHRING CA, 1990, NATURE, V345, P528, DOI 10.1038/345528a0; GEHRING CA, 1990, P NATL ACAD SCI USA, V87, P9645, DOI 10.1073/pnas.87.24.9645; GIL P, 1994, PLANT PHYSIOL, V104, P777, DOI 10.1104/pp.104.2.777; GONZALEZDAROS F, 1993, PHYSIOL PLANTARUM, V87, P68, DOI 10.1111/j.1399-3054.1993.tb08792.x; GUILFOYLE TJ, 1986, CRIT REV PLANT SCI, V4, P247, DOI 10.1080/07352688609382226; GUILFOYLE TJ, 1992, BIOCHEM SOC T, V20, P97, DOI 10.1042/bst0200097; HARDIN JW, 1972, P NATL ACAD SCI USA, V69, P3146, DOI 10.1073/pnas.69.11.3146; HOBBIE L, 1994, PLANT MOL BIOL, V26, P1499, DOI 10.1007/BF00016487; JENA PK, 1989, P NATL ACAD SCI USA, V86, P3644, DOI 10.1073/pnas.86.10.3644; KEY JL, 1989, BIOESSAYS, V11, P52, DOI 10.1002/bies.950110204; KUBOWICZ BD, 1982, PLANT PHYSIOL, V69, P187, DOI 10.1104/pp.69.1.187; KUDA J, 1999, P NATL ACAD SCI USA, V96, P4718; LI Y, 1994, PLANT PHYSIOL, V106, P37, DOI 10.1104/pp.106.1.37; LI Y, 1991, PLANT CELL, V3, P1167, DOI 10.1105/tpc.3.11.1167; LONGEMANN J, 1987, ANAL BIOCHEM, V163, P16; MCCLURE BA, 1989, PLANT CELL, V1, P229, DOI 10.1105/tpc.1.2.229; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; MCCLURE BA, 1987, PLANT MOL BIOL, V9, P611, DOI 10.1007/BF00020537; MIERNYK JA, 1987, J BIOL CHEM, V262, P15338; Okamoto H, 1995, PLANT CELL PHYSIOL, V36, P1531; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PATIL S, 1995, P NATL ACAD SCI USA, V92, P4897, DOI 10.1073/pnas.92.11.4897; POOVAIAH BW, 1976, PLANT PHYSIOL, V58, P783, DOI 10.1104/pp.58.6.783; POOVAIAH BW, 1993, CRIT REV PLANT SCI, V12, P185, DOI 10.1080/713608046; POOVAIAH BW, 1987, CRC CR REV PLANT SCI, V6, P47, DOI 10.1080/07352688709382247; RAGHOTHAMA KG, 1985, PLANT PHYSIOL, V79, P28, DOI 10.1104/pp.79.1.28; RAIKHEL N, 1992, PLANT PHYSIOL, V100, P1627, DOI 10.1104/pp.100.4.1627; Ramachandiran S, 1997, J BIOCHEM-TOKYO, V121, P984; RAY PM, 1974, RECENT ADV PHYTOCHEM, V7, P93; REDDY ASN, 1988, PLANT CELL PHYSIOL, V29, P1165; ROBERTS DM, 1992, ANNU REV PLANT PHYS, V43, P375, DOI 10.1146/annurev.pp.43.060192.002111; Snedden WA, 1996, J BIOL CHEM, V271, P4148; Snedden WA, 1998, TRENDS PLANT SCI, V3, P299, DOI 10.1016/S1360-1385(98)01284-9; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAGAWA T, 1957, PLANT PHYSIOL, V32, P207, DOI 10.1104/pp.32.3.207; TAKEZAWA D, 1995, PLANT MOL BIOL, V27, P693, DOI 10.1007/BF00020223; Takezawa D, 1996, J BIOL CHEM, V271, P8126, DOI 10.1074/jbc.271.14.8126; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; THEOLOGIS A, 1986, ANNU REV PLANT PHYS, V37, P407, DOI 10.1146/annurev.arplant.37.1.407; TIMPTE C, 1994, GENETICS, V138, P1239; TREWAVAS A, 1999, PLANT PHYSIOL, V120, P428; Trewavas AJ, 1997, PLANT CELL, V9, P1181, DOI 10.1105/tpc.9.7.1181; Vanderhoef L. N., 1980, Plant growth substances 1979 [Skoog, F. (Editor)]., P90; VELUTHAMBI K, 1984, SCIENCE, V223, P167, DOI 10.1126/science.223.4632.167; VELUTHAMBI K, 1984, PLANT PHYSIOL, V76, P359, DOI 10.1104/pp.76.2.359; Watillon B, 1998, PLANT MOL BIOL, V36, P909, DOI 10.1023/A:1005914506110; YAMAMOTO KT, 1992, PLANT CELL PHYSIOL, V33, P93; Yang T, 1998, PLANT MOL BIOL, V37, P109, DOI 10.1023/A:1005902905512; Yang TB, 1996, MOL GEN GENET, V252, P684, DOI 10.1007/BF02173974; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697	67	127	151	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3137	3143		10.1074/jbc.275.5.3137	http://dx.doi.org/10.1074/jbc.275.5.3137			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652297	hybrid			2022-12-27	WOS:000085146500019
J	Cau, J; Faure, S; Vigneron, S; Labbe, JC; Delsert, C; Morin, N				Cau, J; Faure, S; Vigneron, S; Labbe, JC; Delsert, C; Morin, N			Regulation of xenopus p21-activated kinase (X-PAK2) by Cdc42 and maturation-promoting factor controls Xenopus oocyte maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOGEN-ACTIVATED PROTEIN; CELL-CYCLE; MAP KINASE; SACCHAROMYCES-CEREVISIAE; STE20/PAK FAMILY; FOCAL COMPLEXES; MITOTIC EVENTS; ACTIN; RHO; GTPASES	Signal transduction cascades involved in regulation of the cell cycle machinery are poorly understood. In the Xenopus oocyte model, meiotic maturation is triggered by MPF, a complex of p34(cdc2)-cyclin B, which is activated in response to a progesterone signal by largely unknown mechanisms. We have previously shown that the p21-activated kinase (PAK) family negatively regulates the MPF amplification loop. In this study, we identify the endogenous PAK2 as a key enzyme in this regulation and describe the pathways by which PAK2 is regulated. We show that the small GTPase Cdc42 is required for maintenance of active endogenous X-PAK2 in resting stage VI oocytes, whereas Rad is not involved in this regulation. During the process of maturation, X-PAK2 phosphorylation results in its inactivation and allows maturation to proceed to completion Activation of mitogen-activated protein kinase and cyclin B-p34(cdc2) is coincident with X-PAK2 inactivation, and purified active MPF inhibits X-PAK2, demonstrating the existence of a new positive feedback loop. Our results confirm and extend the importance of p21-activated kinases in the control of the G(2)/M transition. We hypothesize that the X-PAK2/Cdc42 pathway could link p34(cdc2) activity to the major cytoskeleton rearrangements leading to spindle migration and anchorage to the animal pole cortex.	CNRS UPR 1086, Ctr Rech Biochim Macromol, F-34293 Montpellier 5, France; IFREMER, F-17390 La Tremblade, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Ifremer	Morin, N (corresponding author), CNRS UPR 1086, Ctr Rech Biochim Macromol, 1919 Route Mende, F-34293 Montpellier 5, France.	morin@crbm.cnrs-mop.fr	labbe, jean-claude/B-2277-2009; FAURE, Sandrine/N-6506-2018	FAURE, Sandrine/0000-0002-8902-8274; Morin, Nathalie/0000-0001-8677-1401; cau, Julien/0000-0001-6045-6737				Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Benton BK, 1997, MOL CELL BIOL, V17, P5067, DOI 10.1128/MCB.17.9.5067; BIRCHMEIER C, 1985, CELL, V43, P615, DOI 10.1016/0092-8674(85)90233-8; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Clayton L, 1999, DEV BIOL, V205, P322, DOI 10.1006/dbio.1998.9117; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Faure S, 1999, J BIOL CHEM, V274, P3573, DOI 10.1074/jbc.274.6.3573; Faure S, 1997, EMBO J, V16, P5550, DOI 10.1093/emboj/16.18.5550; Fisher DL, 1999, DEVELOPMENT, V126, P567; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jessus C, 1998, BIOL CELL, V90, P573, DOI 10.1016/S0248-4900(99)80015-X; LABBE JC, 1991, METHOD ENZYMOL, V200, P291; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Lenormand JL, 1999, EMBO J, V18, P1869, DOI 10.1093/emboj/18.7.1869; MALLER JL, 1977, J BIOL CHEM, V252, P1712; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MORIN N, 1994, EMBO J, V13, P4343, DOI 10.1002/j.1460-2075.1994.tb06754.x; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Richman TJ, 1999, J BIOL CHEM, V274, P16861, DOI 10.1074/jbc.274.24.16861; Ridley AJ, 1996, CURR BIOL, V6, P1256, DOI 10.1016/S0960-9822(02)70711-2; Rime H, 1998, DEV BIOL, V204, P592, DOI 10.1006/dbio.1998.9069; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; SHIBUYA EK, 1992, EMBO J, V11, P3963, DOI 10.1002/j.1460-2075.1992.tb05490.x; Tang Y, 1999, MOL CELL BIOL, V19, P1881; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wu CL, 1998, J BIOL CHEM, V273, P28107, DOI 10.1074/jbc.273.43.28107; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	47	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2367	2375		10.1074/jbc.275.4.2367	http://dx.doi.org/10.1074/jbc.275.4.2367			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644687	hybrid			2022-12-27	WOS:000085128000019
J	Hemming, SA; Edwards, AM				Hemming, SA; Edwards, AM			Yeast RNA polymerase II subunit RPB9 - Mapping of domains required for transcription elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR TFIIS; SACCHAROMYCES-CEREVISIAE; ZINC RIBBON; GENE; MOTIF; DNA; RESOLUTION; CLEAVAGE; SEQUENCE	The RPB9 subunit of RNA polymerase II regulates transcription elongation activity and is required for the action of the transcription elongation factor, TFIIS. RPB9 comprises two zinc ribbon domains joined by a conserved linker region. The C-terminal zinc ribbon is similar in sequence to that found in TFIIS. To elucidate the relationship between the structure and transcription elongation function of RPB9, we initiated a mutagenesis study on the Saccharomyces cerevisiae homologue. The individual zinc ribbon domains, in isolation or in combination could not stimulate transcription by a polymerase lacking RPB9, pol II Delta 9. Mutations in the N-terminal zinc ribbon had little effect on transcription activity. By contrast, mutations in the acidic loop that connects the second and third beta-strands of the C-terminal zinc ribbon were completely inactive for transcription. Interestingly the analogous residues in TFIIS are also critical for elongation activity. A conserved charged stretch in the linker region (residues 89-95, DPTLPR) mediated the interaction with RNA polymerase II.	Univ Toronto, Banting & Best Dept Med Res, Charles H Best Inst, Toronto, ON M5G 1L6, Canada	University of Toronto	Edwards, AM (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Charles H Best Inst, Rm 402,112 Coll St, Toronto, ON M5G 1L6, Canada.			Edwards, Aled/0000-0002-4782-6016				ACKER J, 1993, NUCLEIC ACIDS RES, V21, P5345, DOI 10.1093/nar/21.23.5345; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; CHRISTIE KR, 1994, J BIOL CHEM, V269, P936; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; EREINES D, 1992, P NATL ACAD SCI USA, V88, P4245; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; FURTERGRAVES EM, 1994, NUCLEIC ACIDS RES, V22, P4932, DOI 10.1093/nar/22.23.4932; GU WG, 1993, J BIOL CHEM, V268, P25604; HARRISON DA, 1992, MOL CELL BIOL, V12, P928, DOI 10.1128/MCB.12.3.928; HUBERT JC, 1983, EMBO J, V2, P2071, DOI 10.1002/j.1460-2075.1983.tb01702.x; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; KAINE BP, 1994, P NATL ACAD SCI USA, V91, P3854, DOI 10.1073/pnas.91.9.3854; LANGER D, 1993, NUCLEIC ACIDS RES, V21, P2251, DOI 10.1093/nar/21.9.2251; MCKUNE K, 1995, MOL CELL BIOL, V15, P6895; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; QIAN XQ, 1993, NATURE, V365, P277, DOI 10.1038/365277a0; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; REINES D, 1992, J BIOL CHEM, V267, P3795; Sun ZW, 1996, NUCLEIC ACIDS RES, V24, P2560, DOI 10.1093/nar/24.13.2560; Wang B, 1998, STRUCTURE, V6, P555, DOI 10.1016/S0969-2126(98)00058-6; WOYCHIK NA, 1991, J BIOL CHEM, V266, P19053; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	27	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2288	2294		10.1074/jbc.275.4.2288	http://dx.doi.org/10.1074/jbc.275.4.2288			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644677	hybrid			2022-12-27	WOS:000085128000009
J	Li, L; Otake, LR; Xu, YX; Michaeli, S				Li, L; Otake, LR; Xu, YX; Michaeli, S			The trans-spliceosomal U4 RNA from the monogenetic trypanosomatid Leptomonas collosoma - Cloning and identification of a transcribed tRNA-like element that controls its expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNAS; SMALL NUCLEAR; MODIFIED NUCLEOTIDES; SPLICED LEADER; U6; BRUCEI; GENES; SNRNA; U2; YEAST	U4 small nuclear RNA is essential for tra ns-splicing. Here we report the cloning of U4 snRNA gene from Leptomonas collosoma and analysis of elements controlling its expression. The trypanosome U4 RNA is the smallest known, it carries an Sm-like site, and has the potential for extensive intermolecular base pairing with the U6 RNA. Sequence analysis of the U4 locus indicates the presence of a tRNA-Iike element 86 base pairs upstream of the gene that is divergently transcribed to yield a stable small tRNA-like RNA. Two additional tRNA genes, tRNA(Pro) and tRNA(Gly), were found upstream of this element. By stable expression of a tagged U4 RNA we demonstrate that the tRNA-like gene, but not the upstream tRNA genes, is essential for U4 expression and that the B box but not the A Box of the tRNA-like gene is crucial for expression in vivo, Mapping the 2'-O-methyl groups on U4 and U6 small nuclear RNAs suggests the presence of modifications in canonical positions. However, the number of modified nucleotides is fewer than in mammalian homologues, The U4 genomic organization including both tRNA-Iike and tRNA genes may represent a relic whereby trypanosomatids "hired" tRNA genes to provide extragenic promoter elements, The close proximity of tRNA genes to the tRNA-like molecule in the U4 locus further suggests that the tRNA-like gene may have evolved from a tRNA member of this cluster.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst, New Haven, CT 06536 USA	Weizmann Institute of Science; Bar Ilan University; Howard Hughes Medical Institute; Yale University	Xu, YX (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.		Xu, Yu-Xin/G-4041-2010; Michaeli, Shulamit/AAC-8255-2022	Liu, Li/0000-0002-3733-6961; Xu, Yu-Xin/0000-0002-0200-4633	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026154, R01GM026154] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM26154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; BORDONNE R, 1990, GENE DEV, V4, P1185, DOI 10.1101/gad.4.7.1185; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; CAMPBELL DA, 1984, NATURE, V311, P350, DOI 10.1038/311350a0; Dungan JM, 1996, EMBO J, V15, P4016, DOI 10.1002/j.1460-2075.1996.tb00775.x; ESCHENLAUER JB, 1993, MOL CELL BIOL, V13, P3015, DOI 10.1128/MCB.13.5.3015; FANTONI A, 1994, MOL CELL BIOL, V14, P2021, DOI 10.1128/MCB.14.3.2021; Goldring A, 1996, EXP PARASITOL, V84, P28, DOI 10.1006/expr.1996.0087; GOLDRING A, 1995, GENE, V156, P139, DOI 10.1016/0378-1119(95)00048-B; GOLDRING A, 1995, EXPT PARASITOLOGY, V80, P333; Goncharov I, 1999, J BIOL CHEM, V274, P12217, DOI 10.1074/jbc.274.18.12217; Gu J, 1996, RNA, V2, P909; HARTSHORNE T, 1990, GENE DEV, V4, P2121, DOI 10.1101/gad.4.12a.2121; Hernandez N, 1992, TRANSCRIPTIONAL REGU, P281; HU J, 1995, MOL CELL BIOL, V15, P1274; Jakab G, 1997, BIOCHIMIE, V79, P387, DOI 10.1016/S0300-9084(97)86148-2; KROL A, 1981, NUCLEIC ACIDS RES, V9, P2699, DOI 10.1093/nar/9.12.2699; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Levitan A, 1998, NUCLEIC ACIDS RES, V26, P1775, DOI 10.1093/nar/26.7.1775; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; Massenet S., 1998, MODIFICATION EDITING, P201; MILHAUSEN M, 1984, CELL, V38, P721, DOI 10.1016/0092-8674(84)90267-8; MOTTRAM J, 1989, MOL CELL BIOL, V9, P1212, DOI 10.1128/MCB.9.3.1212; MOTTRAM JC, 1991, J BIOL CHEM, V266, P18313; MYSLINSKI E, 1991, BIOCHIMIE, V73, P17, DOI 10.1016/0300-9084(91)90069-D; NAKAAR V, 1994, MOL CELL BIOL, V14, P6736, DOI 10.1128/MCB.14.10.6736; NAKAAR V, 1995, PARASITOL TODAY, V11, P225, DOI 10.1016/0169-4758(95)80085-9; PALFI Z, 1992, J BIOL CHEM, V267, P20159; PALFI Z, 1991, P NATL ACAD SCI USA, V88, P9097, DOI 10.1073/pnas.88.20.9097; PATZELT E, 1989, MOL CELL BIOL, V9, P4291, DOI 10.1128/MCB.9.10.4291; SILICIANO PG, 1987, CELL, V50, P585, DOI 10.1016/0092-8674(87)90031-6; TSCHUDI C, 1990, GENE, V91, P71, DOI 10.1016/0378-1119(90)90164-M; TSCHUDI C, 1990, CELL, V61, P459, DOI 10.1016/0092-8674(90)90527-L; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; XU GL, 1994, MOL CELL BIOL, V14, P4565, DOI 10.1128/MCB.14.7.4565; Xu YX, 1997, P NATL ACAD SCI USA, V94, P8473, DOI 10.1073/pnas.94.16.8473	37	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2259	2264		10.1074/jbc.275.4.2259	http://dx.doi.org/10.1074/jbc.275.4.2259			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644672	hybrid			2022-12-27	WOS:000085128000004
J	Cavallin, A; Arozenius, H; Kristensson, K; Antonsson, P; Otzen, DE; Bjork, P; Forsberg, G				Cavallin, A; Arozenius, H; Kristensson, K; Antonsson, P; Otzen, DE; Bjork, P; Forsberg, G			The spectral and thermodynamic properties of staphylococcal enterotoxin A, E, and variants suggest that structural modifications are important to control their function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-II; CYTOKINE GENE-EXPRESSION; MHC CLASS-II; ESCHERICHIA-COLI; THERMAL-STABILITY; CRYSTAL-STRUCTURE; BINDING-SITES; BETA-CHAIN; SUPERANTIGEN; RESIDUES	The superantigens staphylococcal enterotoxin A and E (SEA and SEE) can activate a large number of T-cells, SEA and SEE have approximately 80% sequence identity but show some differences in their biological function. Here, the two superantigens and analogues were characterized biophysically. SEE was shown to have a substantially higher thermal stability than SEA. Both SEA and SEE were thermally stabilized by 0.1 mm Zn2+ compared with Zn2+-reduced conditions achieved using 1 1 mm EDTA or specific replacements that affect Zn2+ coordination. The higher stability of SEE was only partly caused by the T-cell receptor (TCR) binding regions, whereas regions in the vicinity of the major histocompatibility complex class II binding sites affected the stability to a greater extent, SEE exhibited a biphasic denaturation between pH 5.0-6.5, influenced by residues in the TCR binding regions. Interestingly, enzyme-linked immunosorbent assay, isoelectric focusing, and circular dichroism analysis indicated that conformational changes had occurred in the SEA/E chimerical constructs relative to SEA and SEE. Thus, it is proposed that the Zn2+ binding site is very important for the stability and potency of SEA and SEE, whereas residues in the TCR binding site have a substantial influence on the molecular conformation to control specificity and function.	Act Biotech Res AB, S-22007 Lund, Sweden; Lund Univ, Ctr Chem & Chem Engn, Dept Biochem, S-22100 Lund, Sweden	Lund University	Forsberg, G (corresponding author), Act Biotech Res AB, Box 724, S-22007 Lund, Sweden.	goran.forsberg@activebiotech.com		Otzen, Daniel/0000-0002-2918-8989				ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Antonsson P, 1997, J IMMUNOL, V158, P4245; Butler JM, 1996, ANAL CHEM, V68, P3283, DOI 10.1021/ac960317a; CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; DRIESSEN C, 1995, IMMUNOLOGY, V84, P272; Fasman G.D., 1996, CIRCULAR DICHROISM C; Forsberg G, 1997, J BIOL CHEM, V272, P12430, DOI 10.1074/jbc.272.19.12430; FRASER JD, 1992, P NATL ACAD SCI USA, V89, P5507, DOI 10.1073/pnas.89.12.5507; Holzer U, 1997, IMMUNOLOGY, V90, P74, DOI 10.1046/j.1365-2567.1997.00141.x; HUDSON KR, 1995, J EXP MED, V182, P711, DOI 10.1084/jem.182.3.711; IRWIN MJ, 1992, NATURE, V359, P841, DOI 10.1038/359841a0; JOHNSON HM, 1992, SCI AM, V266, P92, DOI 10.1038/scientificamerican0492-92; Kanaya S, 1996, J BIOL CHEM, V271, P32729, DOI 10.1074/jbc.271.51.32729; KARP DR, 1992, J EXP MED, V175, P415, DOI 10.1084/jem.175.2.415; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Lando PA, 1996, J IMMUNOL, V157, P2857; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MEHINDATE K, 1995, J EXP MED, V182, P1573, DOI 10.1084/jem.182.5.1573; MOURAD W, 1992, J EXP MED, V175, P613, DOI 10.1084/jem.175.2.613; Munson SH, 1998, INFECT IMMUN, V66, P3337, DOI 10.1128/IAI.66.7.3337-3348.1998; NILSSON B, 1991, METHOD ENZYMOL, V198, P3; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Perrier V, 1998, J BIOL CHEM, V273, P19097, DOI 10.1074/jbc.273.30.19097; Rosendahl A, 1998, INT J CANCER, V76, P274, DOI 10.1002/(SICI)1097-0215(19980413)76:2<274::AID-IJC16>3.0.CO;2-C; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Schad EM, 1997, J MOL BIOL, V269, P270, DOI 10.1006/jmbi.1997.1023; Sundstrom M, 1996, J BIOL CHEM, V271, P32212, DOI 10.1074/jbc.271.50.32212; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Zhang SP, 1998, FEMS MICROBIOL LETT, V168, P227, DOI 10.1111/j.1574-6968.1998.tb13278.x	30	25	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1665	1672		10.1074/jbc.275.3.1665	http://dx.doi.org/10.1074/jbc.275.3.1665			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636860	hybrid			2022-12-27	WOS:000084940000023
J	Chen, NH; Ferrer, JV; Javitch, JA; Justice, JB				Chen, NH; Ferrer, JV; Javitch, JA; Justice, JB			Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NOREPINEPHRINE TRANSPORTER; ETHYLMALEIMIDE-INDUCED REDUCTION; N-ETHYLMALEIMIDE; NEURONAL CARRIER; BINDING DOMAINS; <H-3>WIN-35,428 BINDING; SEROTONIN TRANSPORTER; UPTAKE INHIBITORS; H-3 MAZINDOL; COCAINE	The effect of covalent sulfhydryl modification on dopamine uptake by the human dopamine transporter was determined by rotating disc electrode voltammetry. A transporter construct, X5C, with five mutated cysteines (C90A, C135A, C306A, C319F, and C342A) and the constructs into which the wild-type cysteines were substituted back into X5C, one at a time, all showed nearly normal binding affinity for [H-3]CFT and for cocaine, but they displayed significant reductions in K-m and V-max for DA uptake. Reaction of Cys-90 or Cys-306 with impermeant methanethiosulfonate derivatives enhanced dopamine uptake to a similar extent as the previously observed enhancement of [H-3]CFT binding caused by the same reaction, suggesting that cocaine may bind preferentially to a conformation in the transport cycle. m-Tyramine increased the rate of reaction of (2-amino-ethyl)methanethiosulfonate (MTSEA) with X-A342C, the construct with a cytoplasmic loop residue Cys-342 restored. This m-tyramine-induced increase in reactivity appeared to require the inward transport rather than the outward transport or external binding of m-tyramine, and it was prevented by cocaine. Thus, inward translocation of substrates may involve structural rearrangement of hDAT, which likely exposes Cys-342 to reaction with MTSEA, and Cys-342 may be located on a part of the transporter associated with cytoplasmic gating.	Emory Univ, Dept Chem, Atlanta, GA 30322 USA; Columbia Univ, Coll Mol Recognit, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Emory University; Columbia University; Columbia University; Columbia University	Chen, NH (corresponding author), Univ Illinois, Coll Med, Dept Biomed & Therapeut Sci, POB 1649, Peoria, IL 61656 USA.			Javitch, Jonathan/0000-0001-7395-2967	NATIONAL INSTITUTE ON DRUG ABUSE [R03DA010896] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00179, DA10896, DA1176] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BONNET JJ, 1990, J PHARMACOL EXP THER, V253, P1206; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; Burgess KSD, 1999, J NEUROCHEM, V73, P656, DOI 10.1046/j.1471-4159.1999.0730656.x; Burnette WB, 1996, ANAL CHEM, V68, P2932, DOI 10.1021/ac960022x; CAO CJ, 1989, MEMBRANE BIOCHEM, V8, P207, DOI 10.3109/09687688909026815; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen NH, 1999, J PHARMACOL EXP THER, V290, P940; Chen NH, 1998, J NEUROSCI, V18, P10257; Chen NH, 1998, J NEUROCHEM, V71, P653; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1994, J BIOL CHEM, V269, P15985; GIROS B, 1992, MOL PHARMACOL, V42, P383; HERON C, 1994, EUR J PHARMACOL, V264, P391, DOI 10.1016/0014-2999(94)00502-8; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; JOHNSON KM, 1992, EUR J PHARM-MOLEC PH, V227, P411, DOI 10.1016/0922-4106(92)90159-S; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; MEIERGERD SM, 1994, J NEUROCHEM, V62, P998; Pifl C, 1997, BRIT J PHARMACOL, V121, P205, DOI 10.1038/sj.bjp.0701137; Reith MEA, 1996, BIOCHEM PHARMACOL, V52, P1435, DOI 10.1016/S0006-2952(96)00508-4; REITH MEA, 1992, N-S ARCH PHARMACOL, V345, P309; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; SAADOUNI S, 1994, EUR J PHARM-MOLEC PH, V268, P187, DOI 10.1016/0922-4106(94)90188-0; SCHWERI MM, 1990, NEUROPHARMACOLOGY, V29, P901, DOI 10.1016/0028-3908(90)90140-M; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; Sonders MS, 1997, J NEUROSCI, V17, P960; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; VANDENBERGH DJ, 1992, MOL BRAIN RES, V15, P161, DOI 10.1016/0169-328X(92)90165-8; WANG JB, 1995, J NEUROCHEM, V64, P1416; Xu C, 1997, N-S ARCH PHARMACOL, V355, P64; ZACZEK R, 1991, J PHARMACOL EXP THER, V257, P830	34	50	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1608	1614		10.1074/jbc.275.3.1608	http://dx.doi.org/10.1074/jbc.275.3.1608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636852	hybrid			2022-12-27	WOS:000084940000015
J	Kuhne, MR; Ku, G; Weiss, A				Kuhne, MR; Ku, G; Weiss, A			A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; ANTIGEN RECEPTOR; PROTOONCOGENE PRODUCT; SIGNAL-TRANSDUCTION; FAMILY; REQUIREMENT; KINASES; LACKING; DOMAIN; ZAP-70	T cell antigen receptor (TCR) stimulation induces the tyrosine phosphorylation of several intracellular proteins including the protooncogene Vav1, Vav1 expression is necessary for normal T cell development and activation. We previously showed that overexpression of Vav1 in Jurkat T cells potentiates the activity of the transcription factor nuclear factor of activated T cells (NF-AT), The mechanism by which Vav1 participates in TCR signaling events is not clear. Vav1 contains a guanine nucleotide exchange factor (GEF) domain that has specificity for Rac and other Rho GTPases that have been recently implicated in T cell activation events. Significantly, in vitro tyrosine phosphoryation of Vav1 by Lck activates its exchange activity. This Lck-mediated phosphorylation of Vav1 has been reported to depend upon Tyr-174 in Vav1, a site implicated in Vav1 function by other studies as well. In this report, we demonstrated that Tyr-174 is not required for the TCR-induced phosphorylation of Vav1 in vivo. Moreover, mutation of Tyr-174 augmented the ability of Vav1 to up-regulate NF-AT activation as well as the Vav1 GEF function leading to Rac activation. However, we also showed that the GEF activity of Vav1 was neither sufficient nor necessary for potentiation of NF-AT, and thereby we identify a GEF-independent role of Vav1 in potentiating NF-AT-driven transcription. Oncogenic Vav1 in which the amino-terminal 67 amino acids were deleted had elevated GEF activity but did not potentiate NF-AT when overexpressed in Jurkat cells. We also showed that a GEF mutant form of Vav1 that had impaired GEF function could still potentiate NF-AT, These studies reveal a previously unrecognized negative regulatory function of Tyr-174 in Vav1 and suggest that domains other than the Vav1 GEF domain contribute to TCR signals leading to NF-AT activation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.				NATIONAL CANCER INSTITUTE [R01CA072531] Funding Source: NIH RePORTER; NCI NIH HHS [CA72531] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRUNATI AM, 1995, FEBS LETT, V367, P149, DOI 10.1016/0014-5793(95)00555-N; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HART MJ, 1994, J BIOL CHEM, V269, P62; HOLSINGER LJ, 1995, P NATL ACAD SCI USA, V92, P9810, DOI 10.1073/pnas.92.21.9810; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Michel F, 1998, J BIOL CHEM, V273, P31932, DOI 10.1074/jbc.273.48.31932; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Song JS, 1999, J IMMUNOL, V163, P802; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WU J, 1995, MOL CELL BIOL, V15, P4337; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0	27	95	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2185	2190		10.1074/jbc.275.3.2185	http://dx.doi.org/10.1074/jbc.275.3.2185			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636924	hybrid			2022-12-27	WOS:000084940000087
J	Santoso, B; Ortiz, BD; Winoto, A				Santoso, B; Ortiz, BD; Winoto, A			Control of organ-specific demethylation by an element of the T-cell receptor-alpha locus control region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG-BINDING-PROTEIN; DNA METHYLATION; TRANSGENIC MICE; HISTONE DEACETYLASE; CHROMATIN STRUCTURE; ALPHA/DELTA LOCUS; TARGETED MUTATION; GENE-EXPRESSION; TRANSCRIPTION; BETA	DNA methylation is important for mammalian development and the control of gene expression, Recent data suggest that DNA methylation causes chromatin closure and gene silencing. During development, tissue specifically expressed gene loci become selectively demethylated in the appropriate cell types by poorly understood processes. Locus control regions (LCRs), which are cisacting elements providing stable, tissue-specific expression to linked transgenes in chromatin, may play a role in tissue specific DNA demethylation, We studied the methylation status of the LCR for the mouse T-cell receptor alpha/delta locus using a novel assay for scanning large distances of DNA for methylation sites. Tissue-specific functions of this LCR depend largely on two DNase I-hypersensitive site clusters (HS), HS1 (T-cell receptor cy enhancer) and HS1', We report that these HS induce lymphoid organ-specific DNA demethylation in a region located 3.8 kilobases away with little effect on intervening, methylated DNA. This demethylation is impaired in mice with a germline deletion of the HS1/HS1' clusters. Using 5'-deletion mutants of a transgenic LCR reporter gene construct, we show that HS1' can act in the absence of HS1 to direct this tissue-specific DNA demethylation event. Thus, elements of an LCR can control tissue-specific DNA methylation patterns both in transgenes and inside its native locus.	Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley		winoto@uclink4.berkeley.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031558] Funding Source: NIH RePORTER; NIAID NIH HHS [AI31558] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTEQUERA F, 1989, CELL, V58, P509, DOI 10.1016/0092-8674(89)90431-5; BEDNARIK DP, 1991, NEW BIOL, V3, P969; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bestor TH, 1998, NATURE, V393, P311, DOI 10.1038/30613; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; CHADA K, 1985, NATURE, V314, P377, DOI 10.1038/314377a0; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; Engler P, 1998, P NATL ACAD SCI USA, V95, P10763, DOI 10.1073/pnas.95.18.10763; Foster SA, 1998, MOL CELL BIOL, V18, P1793, DOI 10.1128/MCB.18.4.1793; Fraser P, 1998, CURR OPIN CELL BIOL, V10, P361, DOI 10.1016/S0955-0674(98)80012-4; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; GREAVES DR, 1989, CELL, V56, P979, DOI 10.1016/0092-8674(89)90631-4; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Herman JG, 1996, CANCER RES, V56, P722; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Janeway C., 1994, IMMUNOBIOLOGY IMMUNE; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ortiz BD, 1999, MOL CELL BIOL, V19, P1901; Ortiz BD, 1997, EMBO J, V16, P5037, DOI 10.1093/emboj/16.16.5037; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Selker EU, 1998, P NATL ACAD SCI USA, V95, P9430, DOI 10.1073/pnas.95.16.9430; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Sleckman BP, 1998, J EXP MED, V188, P1465, DOI 10.1084/jem.188.8.1465; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; WENG A, 1995, MOL CELL BIOL, V15, P572, DOI 10.1128/MCB.15.1.572; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; WU C, 1989, METHOD ENZYMOL, V170, P269	48	32	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1952	1958		10.1074/jbc.275.3.1952	http://dx.doi.org/10.1074/jbc.275.3.1952			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636897	hybrid			2022-12-27	WOS:000084940000060
J	Bova, MP; Mchaourab, HS; Han, Y; Fung, BKK				Bova, MP; Mchaourab, HS; Han, Y; Fung, BKK			Subunit exchange of small heat shock proteins - Analysis of oligomer formation of alpha A-crystallin and Hsp27 by fluorescence resonance energy transfer and site-directed truncations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; SMALL STRESS PROTEINS; HUMAN GLIOMA-CELLS; B-CRYSTALLIN; QUATERNARY STRUCTURE; MOLECULAR CHAPERONE; CELLULAR THERMORESISTANCE; ACTIN POLYMERIZATION; CONSERVED DOMAIN; GENE-EXPRESSION	alpha A-Crystallin, a member of the small heat shock protein (sHsp) family, is a large multimeric protein composed of 30-40 identical subunits. Its quaternary structure is highly dynamic, with subunits capable of freely and rapidly exchanging between oligomers. We report here the development of a fluorescence resonance energy transfer method for measuring structural compatibility between alpha A-crystallin and other proteins. We found that Hsp27 and alpha B-crystallin readily exchanged with fluorescence-labeled alpha A-crystallin, but not with other proteins structurally unrelated to sHsps. Truncation of 19 residues from the N terminus or 10 residues from the C terminus of alpha A-crystallin did not significantly change its subunit organization or exchange rate constant. In contrast, removal of the first 56 or more residues converts alpha A-crystallin into a predominantly small multimeric form consisting of three or four subunits, with a concomitant loss of exchange activity. These findings suggest residues 20-56 are essential for the formation of large oligomers and the exchange of subunits. Similar results were obtained with truncated Hsp27 lacking the first 87 residues. We further showed that the exchange rate is independent of alpha A-crystallin concentration, suggesting subunit dissociation may be the rate-limiting step in the exchange reaction. Our findings reveal a quarternary structure of alpha A-crystallin, consisting of small multimers of alpha A-crystallin subunits in a dynamic equilibrium with the oligomeric complex.	Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fung, BKK (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.				NATIONAL EYE INSTITUTE [R01EY005895, R29EY012018, R01EY012018, T32EY007026] Funding Source: NIH RePORTER; NEI NIH HHS [EY05895, EY12018, EY07026] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; ARRIGO AP, 1987, J BIOL CHEM, V262, P15359; ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; AUGUSTEYN RC, 1989, BIOCHIM BIOPHYS ACTA, V999, P293, DOI 10.1016/0167-4838(89)90012-5; BEHLKE J, 1991, FEBS LETT, V288, P119, DOI 10.1016/0014-5793(91)81016-2; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; Berengian AR, 1997, BIOCHEMISTRY-US, V36, P9951, DOI 10.1021/bi9712347; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaufour S, 1996, CELL STRESS CHAPERON, V1, P225, DOI 10.1379/1466-1268(1996)001<0225:TAPACI>2.3.CO;2; CLAUWAERT J, 1989, CURR EYE RES, V8, P397, DOI 10.3109/02713688908996387; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; England P, 1997, BIOCHEMISTRY-US, V36, P164, DOI 10.1021/bi961419y; GERNOLD M, 1993, DEV GENET, V14, P103, DOI 10.1002/dvg.1020140204; Guay J, 1997, J CELL SCI, V110, P357; Guenal I, 1997, ONCOGENE, V15, P347, DOI 10.1038/sj.onc.1201182; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; HEAD MW, 1994, J CELL PHYSIOL, V159, P41, DOI 10.1002/jcp.1041590107; HEAD MW, 1993, AM J PATHOL, V143, P1743; HEIKKILA JJ, 1993, DEV GENET, V14, P87, DOI 10.1002/dvg.1020140202; Hitotsumatsu T, 1996, CANCER, V77, P352, DOI 10.1002/(SICI)1097-0142(19960115)77:2<352::AID-CNCR19>3.0.CO;2-0; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; INAGUMA Y, 1992, BIOCHEM BIOPH RES CO, V182, P844, DOI 10.1016/0006-291X(92)91809-5; INAGUMA Y, 1995, J BIOCHEM-TOKYO, V117, P1238, DOI 10.1093/oxfordjournals.jbchem.a124850; INAGUMA Y, 1993, J BIOCHEM-TOKYO, V114, P378, DOI 10.1093/oxfordjournals.jbchem.a124184; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; IWAKI T, 1994, J CELL BIOL, V125, P1385, DOI 10.1083/jcb.125.6.1385; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; JAFFE NS, 1991, LENS CATARACT; JAKOB U, 1993, J BIOL CHEM, V268, P1517; JAKOB U, 1994, TRENDS BIOCHEM SCI, V19, P205, DOI 10.1016/0968-0004(94)90023-X; Jansson M, 1997, BIOCHEMISTRY-US, V36, P4108, DOI 10.1021/bi961553i; JEDZINIAK JA, 1972, INVEST OPHTH VISUAL, V11, P905; KANTOROW M, 1995, J BIOL CHEM, V270, P17215, DOI 10.1074/jbc.270.29.17215; KATO K, 1993, BIOCHIM BIOPHYS ACTA, V1175, P257, DOI 10.1016/0167-4889(93)90214-A; KATO K, 1993, J BIOCHEM-TOKYO, V114, P640, DOI 10.1093/oxfordjournals.jbchem.a124230; KATO K, 1994, J BIOL CHEM, V269, P11274; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; KATO K, 1992, J BIOL CHEM, V267, P7718; KATO S, 1992, ACTA NEUROPATHOL, V84, P443; KATO S, 1993, NEUROPATH APPL NEURO, V19, P436, DOI 10.1111/j.1365-2990.1993.tb00466.x; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KLEMENZ R, 1993, J CELL BIOL, V120, P639, DOI 10.1083/jcb.120.3.639; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kokke BPA, 1998, FEBS LETT, V433, P228, DOI 10.1016/S0014-5793(98)00917-X; Koteiche HA, 1998, BIOCHEMISTRY-US, V37, P12681, DOI 10.1021/bi9814078; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lutsch G, 1997, CIRCULATION, V96, P3466; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P14627, DOI 10.1021/bi971700s; MEHLEN P, 1995, J CELL BIOCHEM, V58, P248, DOI 10.1002/jcb.240580213; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; MEHLEN P, 1995, J IMMUNOL, V154, P363; MEHLEN P, 1993, EUR J BIOCHEM, V215, P277, DOI 10.1111/j.1432-1033.1993.tb18032.x; MEHLEN P, 1994, EUR J BIOCHEM, V221, P327, DOI 10.1111/j.1432-1033.1994.tb18744.x; MERCK KB, 1992, BIOCHIM BIOPHYS ACTA, V1130, P267, DOI 10.1016/0167-4781(92)90439-7; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MIRON T, 1988, EUR J BIOCHEM, V178, P543, DOI 10.1111/j.1432-1033.1988.tb14481.x; Muchowski PJ, 1998, P NATL ACAD SCI USA, V95, P1004, DOI 10.1073/pnas.95.3.1004; NENE V, 1986, MOL BIOCHEM PARASIT, V21, P179, DOI 10.1016/0166-6851(86)90021-6; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; PERSSON E, 1995, BIOCHEMISTRY-US, V34, P12775, DOI 10.1021/bi00039a038; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Sax C M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P155; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; SIEZEN RJ, 1980, EUR J BIOCHEM, V111, P435, DOI 10.1111/j.1432-1033.1980.tb04958.x; SIEZEN RJ, 1983, BIOCHIM BIOPHYS ACTA, V749, P227, DOI 10.1016/0167-4838(83)90229-7; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; TARDIEU A, 1986, J MOL BIOL, V192, P711, DOI 10.1016/0022-2836(86)90023-9; van de Klundert FAJM, 1998, EUR J CELL BIOL, V75, P38, DOI 10.1016/S0171-9335(98)80044-7; VANDENIJSSEL PRLA, 1994, FEBS LETT, V355, P54, DOI 10.1016/0014-5793(94)01175-3; WANG KY, 1994, J BIOL CHEM, V269, P13601; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; ZANTEMA A, 1992, J BIOL CHEM, V267, P12936; ZANTEMA A, 1989, J VIROL, V63, P3368, DOI 10.1128/JVI.63.8.3368-3375.1989	90	216	219	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1035	1042		10.1074/jbc.275.2.1035	http://dx.doi.org/10.1074/jbc.275.2.1035			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625643	hybrid			2022-12-27	WOS:000084836600047
J	Dell'Angelica, EC; Aguilar, RC; Wolins, N; Hazelwood, S; Gahl, WA; Bonifacino, JS				Dell'Angelica, EC; Aguilar, RC; Wolins, N; Hazelwood, S; Gahl, WA; Bonifacino, JS			Molecular characterization of the protein encoded by the Hermansky-Pudlak syndrome type 1 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AP-3 ADAPTER COMPLEX; PALE EAR EP; VESICLE FORMATION; LOCUS HETEROGENEITY; HPS GENE; CLATHRIN; ENDOCYTOSIS; MUTATION; TRANSPORT; DOMAIN	Hermansky-Pudlak syndrome (HPS) comprises a group of genetic disorders characterized by defective lysosome-related organelles. The most common form of HPS (HPS type 1) is caused by mutations in a gene encoding a protein with no homology to any other known protein. Here we report the identification and biochemical characterization of this gene product, termed HPS1p, Endogenous HPS1p was detected in a wide variety of human cell lines and exhibited an electrophoretic mobility corresponding to a protein of similar to 80 kDa, In contrast to previous theoretical analysis predicting that HPS1p is an integral membrane protein, we found that this protein was predominantly cytosolic, with a small amount being peripherally associated with membranes, The sedimentation coefficient of the soluble form of HPS1p was similar to 6 S as inferred from ultracentrifugation on sucrose gradients. HPS1p-deficient cells derived from patients with HPS type 1 displayed normal distribution and trafficking of the lysosomal membrane proteins, CD63 and Lamp-1. This was in contrast to cells from HPS type 2 patients, having mutations in the beta 3A subunit of the AP-3 adaptor complex, which exhibited increased routing of these lysosomal proteins through the plasma membrane, Similar analyses performed on fibroblasts from 10 different mouse models of HPS revealed that only the AP-3 mutants pearl and mocha display increased trafficking of Lamp-1 through the plasma membrane. Taken together, these observations suggest that the product of the HPS1 gene is a cytosolic protein capable of associating with membranes and involved in the biogenesis and/or function of lysosome-related organelles by a mechanism distinct from that dependent on the AP-3 complex.	NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHD, Cell Biol & Metab Branch, NIH, Bldg 18T,Rm 101, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000131, Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Boissy RE, 1998, LAB INVEST, V78, P1037; Bonifacino J. S., 1998, CURRENT PROTOCOLS CE; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DellAngelica EC, 1997, J BIOL CHEM, V272, P15078, DOI 10.1074/jbc.272.24.15078; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Feng GH, 1997, HUM MOL GENET, V6, P793, DOI 10.1093/hmg/6.5.793; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Harlow E., 1988, ANTIBODIES LAB MANUA; Hazelwood S, 1997, AM J HUM GENET, V61, P1088, DOI 10.1086/301611; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; MANGINI NJ, 1985, J COMP NEUROL, V241, P191, DOI 10.1002/cne.902410207; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Oh J, 1996, NAT GENET, V14, P300, DOI 10.1038/ng1196-300; Oh J, 1998, AM J HUM GENET, V62, P593, DOI 10.1086/301757; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shotelersuk V, 1998, MOL GENET METAB, V65, P85, DOI 10.1006/mgme.1998.2729; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spritz RA, 1999, CLIN GENET, V55, P309, DOI 10.1034/j.1399-0004.1999.550503.x; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Wildenberg SC, 1998, J INVEST DERMATOL, V110, P777, DOI 10.1046/j.1523-1747.1998.00183.x; Witkop C J, 1990, Bol Asoc Med P R, V82, P333; Zhen LJ, 1999, BLOOD, V94, P146, DOI 10.1182/blood.V94.1.146.413k39_146_155	40	84	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1300	1306		10.1074/jbc.275.2.1300	http://dx.doi.org/10.1074/jbc.275.2.1300			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625677	hybrid			2022-12-27	WOS:000084836600081
J	Duranton, J; Boudier, C; Belorgey, D; Mellet, P; Bieth, JG				Duranton, J; Boudier, C; Belorgey, D; Mellet, P; Bieth, JG			DNA strongly impairs the inhibition of cathepsin G by alpha(1)-antichymotrypsin and alpha(1)-proteinase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCUS PROTEINASE-INHIBITOR; NEUTROPHIL ELASTASE; LEUKOCYTE ELASTASE; CRYSTAL-STRUCTURE; HEPARIN; BINDING; MECHANISM; KINETICS; COMPLEX	This paper explores the possibility that neutrophil-derived DNA interferes with the inhibition of neutrophil cathepsin G (cat G) and proteinase 3 by the lung antiproteinases alpha(1)-proteinase inhibitor (alpha(1)PI), alpha(1)-antichy-motrypsin (ACT), and mucus proteinase inhibitor (MPI), A 30-base pair DNA fragment ((30bp)DNA), used as a model of DNA, tightly binds cat G (K-d, 8.5 nm) but does not react with proteinase 3, alpha(1)PI, ACT, and MPI at physiological ionic strength, The polynucleotide is a partial noncompetitive inhibitor of cat G whose Ki is close to K-d. ACT and alpha(1)PI are slow binding inhibitors of the cat G-20(bp)- DNA complex whose second-order rate constants of inhibition are 2300 M-1 s(-1) and 21 M-1 s(-1), respectively, which represents a 195-fold and a 3190-fold rate deceleration. DNA thus renders cat G virtually resistant to inhibition by these irreversible serpins, On the other hand, (30bp)DNA has little or no effect on the reversible inhibition of cat Cf by MPI or chymostatin or on the irreversible inhibition of cat G by carbobenzoxy-Gly-Leu-Phe-chloromethylketone. The polynucleotide neither inhibits proteinase 3 nor affects its rate of inhibition by alpha(1)PI. These findings suggest that cat G may cause lung tissue destruction despite the presence of antiproteinases.	Univ Strasbourg 1, INSERM, U392, Fac Pharm,Lab Enzymol, F-67400 Illkirch, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bieth, JG (corresponding author), Univ Strasbourg 1, INSERM, U392, Fac Pharm,Lab Enzymol, 74 Route Rhin, F-67400 Illkirch, France.		Boudier, Christian/N-3841-2018	Boudier, Christian/0000-0002-5534-6389; Mellet, Philippe/0000-0001-5499-9735				ALBERTY RA, 1958, J PHYS CHEM-US, V62, P154, DOI 10.1021/j150560a005; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Belorgey D, 1998, BIOCHEMISTRY-US, V37, P16416, DOI 10.1021/bi981536o; BELORGEY D, 1995, FEBS LETT, V361, P265, DOI 10.1016/0014-5793(95)00173-7; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BOUDIER C, 1981, J BIOL CHEM, V256, P256; Boudier C, 1999, BIOCHEMISTRY-US, V38, P8451, DOI 10.1021/bi9828526; CADENE M, 1995, J BIOL CHEM, V270, P13204, DOI 10.1074/jbc.270.22.13204; Duranton J, 1998, BIOCHEMISTRY-US, V37, P11239, DOI 10.1021/bi980223q; ERMOLIEFF J, 1994, J BIOL CHEM, V269, P29502; FALLER B, 1993, BIOCHEMISTRY-US, V32, P9230, DOI 10.1021/bi00086a031; Fruh H, 1996, BIOL CHEM, V377, P579, DOI 10.1515/bchm3.1996.377.9.579; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; NAIDOO N, 1995, J BIOL CHEM, V270, P14548, DOI 10.1074/jbc.270.24.14548; POTTER JL, 1969, AM REV RESPIR DIS, V99, P909; RAO NV, 1991, J BIOL CHEM, V266, P9540; Sambrook J., 2002, MOL CLONING LAB MANU; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P2611, DOI 10.1021/bi00383a030; SZEDLACSEK SE, 1988, BIOCHEM J, V254, P311, DOI 10.1042/bj2540311; TEGNER H, 1978, ACTA OTO-LARYNGOL, V85, P282, DOI 10.3109/00016487809111936; Webb J.L., 1963, ENZYMES METABOL INH, P55	25	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3787	3792		10.1074/jbc.275.6.3787	http://dx.doi.org/10.1074/jbc.275.6.3787			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660528	hybrid			2022-12-27	WOS:000085288800012
J	Beck, DC; Na, CL; Whitsett, JA; Weaver, TE				Beck, DC; Na, CL; Whitsett, JA; Weaver, TE			Ablation of a critical surfactant protein B intramolecular disulfide bond in transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; REGULATED SECRETORY PATHWAY; STRUCTURAL REQUIREMENTS; MESSENGER-RNA; SP-C; GRANULES; CELLS; LUNG; IDENTIFICATION; HOMEOSTASIS	The 79-amino acid, mature SP-B peptide contains three intramolecular disulfide bonds shared by all saposin-like proteins. This study tested the hypothesis that the disulfide bond formed between cysteine residues 35 and 46 (residues 235 and 246 of the SP-B proprotein) is essential for proper function of SP-B, To test the role of this bridge in SP-B function in vivo, a construct was generated in which cysteine residues 235 and 246 of the human SP-B proprotein were mutated to serine and cloned under the control of the 3.7-kilobase hSP-C promoter (hSP-B-C235S/C246). In two transgenic mouse lines, expression of the mutant peptide in the wild-type murine SP-B background was invariably lethal in the neonatal period. In four additional lines, survival was inversely related to the level of transgene expression. To test the ability of the mutant peptide to functionally replace the wild type protein, transgenic mice were crossed into the SP-B null background. No animals that expressed hSP-B-C235S/C246S in the murine SP-B-/- background survived the neonatal period. hSP-B-C235S/C246S proprotein accumulated in the endoplasmic reticulum and was not processed to the mature, biologically active peptide, The results of these studies demonstrate that the intramolecular bridge between residues 235 and 246 is critical for intracellular trafficking of SP-B and suggest that overexpression of mutant SP-B in the wild-type background may be lethal.	Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Weaver, TE (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038859, R37HL056285, R01HL056285, R01HL036055, R37HL038859] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38859, HL36055, HL56285] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akinbi HT, 1997, J BIOL CHEM, V272, P9640; CHANAT E, 1994, FEBS LETT, V351, P225, DOI 10.1016/0014-5793(94)00865-5; Chi XY, 1998, AM J RESP CELL MOL, V19, P107, DOI 10.1165/ajrcmb.19.1.2900; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; COOL DR, 1994, BIOCHIMIE, V76, P265, DOI 10.1016/0300-9084(94)90156-2; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; JOHANSSON J, 1991, BIOCHEMISTRY-US, V30, P6917, DOI 10.1021/bi00242a015; Kaether C, 1997, EUR J CELL BIOL, V74, P133; Kunze I, 1999, BBA-BIOENERGETICS, V1410, P287, DOI 10.1016/S0005-2728(99)00006-7; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Lin S, 1999, J BIOL CHEM, V274, P19168, DOI 10.1074/jbc.274.27.19168; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Morin A, 1996, MOL CELL ENDOCRINOL, V117, P59, DOI 10.1016/0303-7207(95)03730-6; Nogee LM, 1998, BBA-MOL BASIS DIS, V1408, P323, DOI 10.1016/S0925-4439(98)00078-7; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Pouli AE, 1998, BIOCHEM J, V331, P669, DOI 10.1042/bj3310669; Pryhuber GS, 1996, AM J PHYSIOL-LUNG C, V270, pL714, DOI 10.1152/ajplung.1996.270.5.L714; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAKAHASHI A, 1990, BIOCHIM BIOPHYS ACTA, V1044, P43, DOI 10.1016/0005-2760(90)90216-K; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; VORBROKER DK, 1995, AM J PHYSIOL, V268, P647; Waring AJ, 1996, PEPTIDE RES, V9, P28; Weaver TE, 1998, BBA-MOL BASIS DIS, V1408, P173, DOI 10.1016/S0925-4439(98)00066-0; WIKENHEISER KA, 1992, AM J PHYSIOL, V262, pL32, DOI 10.1152/ajplung.1992.262.1.L32; YEI SP, 1994, AM J RESP CELL MOL, V11, P329, DOI 10.1165/ajrcmb.11.3.8086169; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	29	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3371	3376		10.1074/jbc.275.5.3371	http://dx.doi.org/10.1074/jbc.275.5.3371			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652328	hybrid			2022-12-27	WOS:000085146500050
J	Lee, YH; Gallant, C; Guo, HQ; Li, YH; Wang, CLA; Morgan, KG				Lee, YH; Gallant, C; Guo, HQ; Li, YH; Wang, CLA; Morgan, KG			Regulation of vascular smooth muscle tone by N-terminal region of caldesmon - Possible role of tethering actin to myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICKEN GIZZARD CALDESMON; PROTEIN-KINASE-C; CALMODULIN-BINDING; ATPASE ACTIVITY; CELLS; FERRET; PHOSPHORYLATION; CONTRACTION; PHENYLEPHRINE; TRANSLOCATION	To assess the functional significance of tethering actin to myosin by caldesmon in the regulation of smooth muscle contraction, we investigated the effects of synthetic peptides, containing the myosin-binding sequences in the N-terminal region of caldesmon, on force directly recorded from single permeabilized smooth muscle cells of ferret portal vein. Two peptides were used, IK29C and MY27C, containing residues from Ile(25) to Lys(53) and from Met(1) to Tyr(27) Of the human and chicken caldesmon sequence, respectively, plus an added cysteine at the C terminus. In cells clamped at pCa 6.7, both peptides increased basal tone. Pretreatment of cells at pCa 6.7 with IK29C or MY27C decreased the amplitude of subsequent phenylephrine-induced contractions but not microcystin-racemic mixture-induced contractions. In all cases the effects of the peptides were concentration-dependent, and IK29C was more potent than MY27C, in agreement with their relative affinity toward myosin, The peptides were ineffective after the phenylephrine contraction was established. MY27C did not further increase the magnitude of contraction caused by a maximally effective concentration of IK29C, consistent with the two peptides having the same mechanism of action. Neither polylysine nor two control peptides containing scrambled sequences of IK29C, which do not bind myosin, had any effect on basal or phenylephrine-induced force. Our results suggest that IK29C and MY27C induce contraction by competing with the myosin-binding domain of endogenous caldesmon, Digital imaging of fluoroisothiocyanate-tagged IK29C confirmed the association of the peptide with intracellular filamentous structures. The results are consistent with a model whereby tethering of actin to myosin by caldesmon may play a role in regulating vascular tone by positioning the C-terminal domain of caldesmon so that it is capable of blocking the actomyosin interaction.	Boston Biomed Res Inst, Signal Transduct Grp, Boston, MA 02114 USA; Boston Biomed Res Inst, Muscle Res Grp, Boston, MA 02114 USA; Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Boston Biomedical Research Institute; Boston Biomedical Research Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Morgan, KG (corresponding author), Boston Biomed Res Inst, Signal Transduct Grp, 20 Staniford St, Boston, MA 02114 USA.			Lee, Young-Ho/0000-0002-5749-1045; Morgan, Kathleen/0000-0003-3300-3630	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL31704] Funding Source: Medline; NIAMS NIH HHS [AR41637] Funding Source: Medline; NICHD NIH HHS [HD42293] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARTEGI A, 1990, J BIOL CHEM, V265, P15231; BROZOVICH FV, 1990, PFLUG ARCH EUR J PHY, V416, P742, DOI 10.1007/BF00370624; BRYAN J, 1989, J BIOL CHEM, V264, P13873; COLLINS EM, 1992, AM J PHYSIOL, V262, pH754, DOI 10.1152/ajpheart.1992.262.3.H754; COLLINS J H, 1991, Protein Sequences and Data Analysis, V4, P29; Dessy C, 1998, AM J PHYSIOL-CELL PH, V275, pC1081, DOI 10.1152/ajpcell.1998.275.4.C1081; Earley JJ, 1998, CIRC RES, V83, P661, DOI 10.1161/01.RES.83.6.661; FUJII T, 1987, J BIOL CHEM, V262, P2757; GERTHOFFER WT, 1987, J PHARMACOL EXP THER, V240, P8; GONG MC, 1992, J BIOL CHEM, V267, P14662; HAYASHI K, 1991, J BIOL CHEM, V266, P355; HAYASHI K, 1989, BIOCHEM BIOPH RES CO, V161, P38, DOI 10.1016/0006-291X(89)91556-8; HEMRIC ME, 1988, J BIOL CHEM, V263, P1878; Horowitz A, 1996, AM J PHYSIOL-CELL PH, V271, pC589, DOI 10.1152/ajpcell.1996.271.2.C589; IKEBE M, 1988, J BIOL CHEM, V263, P3055; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; KATSUYAMA H, 1993, CIRC RES, V72, P651, DOI 10.1161/01.RES.72.3.651; KHALIL RA, 1994, AM J PHYSIOL, V266, pC1544, DOI 10.1152/ajpcell.1994.266.6.C1544; KHALIL RA, 1992, J PHYSIOL-LONDON, V455, P585, DOI 10.1113/jphysiol.1992.sp019317; Malmquist U, 1996, PFLUG ARCH EUR J PHY, V432, P241, DOI 10.1007/s004240050130; MARSTON SB, 1984, BIOCHEM SOC T, V12, P945, DOI 10.1042/bst0120945; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Menice CB, 1997, J BIOL CHEM, V272, P25157, DOI 10.1074/jbc.272.40.25157; MORELAND S, 1987, PFLUG ARCH EUR J PHY, V408, P139, DOI 10.1007/BF00581343; MORGAN JP, 1982, PFLUG ARCH EUR J PHY, V395, P75, DOI 10.1007/BF00584972; NGAI PK, 1984, J BIOL CHEM, V259, P3656; Parker CA, 1998, J PHYSIOL-LONDON, V508, P187, DOI 10.1111/j.1469-7793.1998.187br.x; PFITZER G, 1992, JPN J PHARMACOL, V58, P23; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; SZPACENKO A, 1985, FEBS LETT, V192, P9, DOI 10.1016/0014-5793(85)80032-6; SZYMANSKI PT, 1992, AM J PHYSIOL, V262, pC1446, DOI 10.1152/ajpcell.1992.262.6.C1446; VELAZ L, 1990, J BIOL CHEM, V265, P2929; Vorotnikov AV, 1997, BIOCHEM J, V328, P211; WALSH MP, 1994, CAN J PHYSIOL PHARM, V72, P1392, DOI 10.1139/y94-201; WANG CLA, 1991, J BIOL CHEM, V266, P9166; WANG CLA, 1989, BIOCHEM BIOPH RES CO, V162, P746, DOI 10.1016/0006-291X(89)92373-5; WANG CLA, 1988, BIOCHEM BIOPH RES CO, V156, P1033, DOI 10.1016/S0006-291X(88)80948-3; Wang EZ, 1996, ARCH BIOCHEM BIOPHYS, V329, P156, DOI 10.1006/abbi.1996.0204; WANG Z, 1997, P NATL ACAD SCI USA, V94, P11898; ZHUANG S, 1997, BIOPHYS J, V72, P281; ZHUANG S, 1997, MOL BIOL CELL, V8, P156	42	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3213	3220		10.1074/jbc.275.5.3213	http://dx.doi.org/10.1074/jbc.275.5.3213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652307	hybrid, Green Published			2022-12-27	WOS:000085146500029
J	Miyauchi, A; Notoya, K; Mikuni-Takagaki, Y; Takagi, Y; Goto, M; Miki, Y; Takano-Yamamoto, T; Jinnai, K; Takahashi, K; Kumegawa, M; Chihara, K; Fujita, T				Miyauchi, A; Notoya, K; Mikuni-Takagaki, Y; Takagi, Y; Goto, M; Miki, Y; Takano-Yamamoto, T; Jinnai, K; Takahashi, K; Kumegawa, M; Chihara, K; Fujita, T			Parathyroid hormone-activated volume-sensitive calcium influx pathways in mechanically loaded osteocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOSARCOMA CELLS; HIPPOCAMPAL-NEURONS; BONE-RESORPTION; ION CHANNELS; EXPRESSION; RECEPTOR; STRETCH; DIFFERENTIATION; OSTEOBLASTS; FRAGMENTS	This paper documents for the first time a volume-sensitive Ca2+ influx pathway in osteocytes, which transmits loading-induced signals into bone formation. Stretch loading by swelling rat and chicken osteocytes in hypo-osmotic solution induced a rapid and progressive increase of cytosolic calcium concentration, [Ca2+](i). The influx of extracellular Ca2+ explains the increased [Ca2+](i) that paralleled the increase in the mean cell volume. Gadolinium chloride (Gd3+), an inhibitor of stretch- activated cation channels, blocked the [Ca2+](i) increase caused by hypotonic solutions. Also, the expression of alpha 1C subunit of voltage-operated L-type Ca2+ channels (alpha 1C) is required for the hypotonicity-induced [Ca2+](i) increase judging from the effect of alpha 1C antisense oligodeoxynucleotides. Parathyroid hormone (PTH) specifically potentiated the hypotonicity-induced [Ca2+](i) increase in a dose-dependent manner through the activation of adenyl cyclase, The increases induced by both PTH and hypotonicity were observed primarily in the processes of the osteocytes, In cyclically stretched osteocytes on flexible-bottomed plates, PTH also synergistically elevated the insulin-like growth factor-1 mRNA level. Furthermore, Gd3+ and alpha 1C antisense significantly inhibited the stretch-induced insulin-like growth factor-1 mRNA elevation. The volume-sensitive calcium influx pathways of osteocytes represent a mechanism by which PTH potentiates mechanical responsiveness, an important aspect of bone formation.	Natl Sanatorium Hyogo Chuo Hosp, Sanda, Hyogo 6691515, Japan; Takeda Chem Ind Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan; Kanagawa Dent Coll, Dept Oral Biochem, Yokosuka, Kanagawa 2388580, Japan; Univ Tokushima, Sch Dent, Dept Orthodont, Tokushima 7700042, Japan; Okayama Univ, Sch Dent, Dept Orthodont, Okayama 7008525, Japan; Meikai Univ, Sch Dent, Dept Oral Anat 1, Sakado, Saitama 3500248, Japan; Kobe Univ, Sch Med, Dept Med, Kobe, Hyogo 6500017, Japan; Calcium Res Inst, Kishiwada 5960842, Japan	Takeda Chemical Industries; Kanagawa Dental College; Tokushima University; Okayama University; Meikai University; Kobe University	Miyauchi, A (corresponding author), Natl Sanatorium Hyogo Chuo Hosp, 1314 Ohara, Sanda, Hyogo 6691515, Japan.	miyauchi@hyougotyu.hosp.go.jp						ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; BARRY ELR, 1995, P NATL ACAD SCI USA, V92, P10914, DOI 10.1073/pnas.92.24.10914; CARVALHO RS, 1994, J BONE MINER RES, V9, P999; Chow JWM, 1998, AM J PHYSIOL-ENDOC M, V274, pE146, DOI 10.1152/ajpendo.1998.274.1.E146; DUNCAN RL, 1994, AM J PHYSIOL-RENAL, V267, pF909, DOI 10.1152/ajprenal.1994.267.6.F909; Duncan RL, 1996, P NATL ACAD SCI USA, V93, P1864, DOI 10.1073/pnas.93.5.1864; DUNCAN RL, 1992, FEBS LETT, V307, P219, DOI 10.1016/0014-5793(92)80771-8; ERNEUX C, 1986, BIOCHEM J, V234, P193, DOI 10.1042/bj2340193; FERMOR B, 1995, J BONE MINER RES, V10, P1935; FUJIMORI A, 1991, ENDOCRINOLOGY, V128, P3032, DOI 10.1210/endo-128-6-3032; Hamill OP, 1996, PHARMACOL REV, V48, P231; HAZAMA A, 1988, J PHYSIOL-LONDON, V402, P687, DOI 10.1113/jphysiol.1988.sp017229; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V217, P264, DOI 10.1006/bbrc.1995.2773; Kamata A, 1998, BIOCHEM BIOPH RES CO, V246, P404, DOI 10.1006/bbrc.1998.8632; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; KUDO Y, 1986, BRIT J PHARMACOL, V89, P191, DOI 10.1111/j.1476-5381.1986.tb11135.x; LANGTON PD, 1993, J PHYSIOL-LONDON, V471, P1; LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; LEAN JM, 1995, AM J PHYSIOL-ENDOC M, V268, pE318, DOI 10.1152/ajpendo.1995.268.2.E318; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Ma YF, 1999, J BONE MINER RES, V14, P439, DOI 10.1359/jbmr.1999.14.3.439; MaejimaIkeda A, 1997, BIOCHEM J, V322, P245, DOI 10.1042/bj3220245; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Meszaros JG, 1996, J BIOL CHEM, V271, P32981, DOI 10.1074/jbc.271.51.32981; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; MikuniTakagaki Y, 1996, ENDOCRINOLOGY, V137, P2028, DOI 10.1210/en.137.5.2028; MIYAUCHI A, 1990, J CELL BIOL, V111, P2543, DOI 10.1083/jcb.111.6.2543; MIYAUCHI A, 1991, J BIOL CHEM, V266, P20369; Miyauchi A, 1996, ENDOCRINOLOGY, V137, P3544, DOI 10.1210/en.137.8.3544; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; OGURA A, 1992, NEUROSCI RES, V12, P606, DOI 10.1016/0168-0102(92)90067-M; OKADA Y, 1990, NEUROSCI RES       S, V12, P5; RIXON RH, 1994, J BONE MINER RES, V9, P1179; SCHEINMAN SJ, 1985, MINER ELECTROL METAB, V11, P85; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TANAKA K, 1995, MINER ELECTROL METAB, V21, P189; Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555; VANDERPLAS A, 1992, J BONE MINER RES, V7, P389; YAMAGUCHI DT, 1989, J BIOL CHEM, V264, P4383	43	78	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3335	3342		10.1074/jbc.275.5.3335	http://dx.doi.org/10.1074/jbc.275.5.3335			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652322	hybrid			2022-12-27	WOS:000085146500044
J	Murray, D; Precht, P; Balakir, R; Horton, WE				Murray, D; Precht, P; Balakir, R; Horton, WE			The transcription factor delta EF1 is inversely expressed with type II collagen mRNA and can repress Col2a1 promoter activity in transfected chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIMB CARTILAGE DIFFERENTIATION; TISSUE-SPECIFIC EXPRESSION; BINDING PROTEIN DELTA-EF1; HELIX-LOOP-HELIX; GENE-EXPRESSION; MESSENGER-RNAS; NUCLEAR FACTOR; ZINC-FINGER; 1ST INTRON; ENHANCER	The regulation of Col2a1, which encodes type II collagen, likely results from a balance of both positive and negative proteins. Here we present evidence that the transcription factor delta EF1 participates in the negative regulation of Col2a1 transcription. A deletion analysis suggested that a region between -100 and -307 of the rat Col2a1 gene was required for activity in differentiating chick limb bud mesenchymal cells; however, mutation of a conserved E2 box site in this region actually increased promoter activity. Supershift analysis demonstrated that delta EF1, a known transcriptional repressor, bound to the E2 box in a sequence-dependent manner. Chick limb bud mesenchymal cells, which do not express type II collagen, expressed abundant delta EF1 mRNA, but, following differentiation in micromass culture, delta EF1 mRNA expression was lost. Primary embryonic chick sternal chondrocytes, which express abundant type II collagen, displayed minimal levels of delta EF1 mRNA The inhibition of Col2a1 transcription following treatment of chick sternal chondrocytes with growth factors was accompanied by increased delta EF1 expression. Overexpression of delta EF1 in differentiated chondrocytes resulted in decreased expression of a reporter construct containing a collagen II promoter/enhancer insert; however, this negative regulation was not dependent on the proximal E2 box. This is the first report of a specific transcription factor involved in the negative regulation of Col2a1.	NE Ohio Univ, Coll Med, Dept Anat, Rootstown, OH 44272 USA; NIA, Gerontol Res Ctr, Biol Chem Lab, NIH, Baltimore, MD 21224 USA	Northeast Ohio Medical University (NEOMED); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Horton, WE (corresponding author), NE Ohio Univ, Coll Med, Dept Anat, 4209 State Route 44, Rootstown, OH 44272 USA.							BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; BRADHAM DM, 1994, J CELL PHYSIOL, V158, P61, DOI 10.1002/jcp.1041580109; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dharmavaram RM, 1997, J BIOL CHEM, V272, P26918, DOI 10.1074/jbc.272.43.26918; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; FUNAHASHI J, 1991, NUCLEIC ACIDS RES, V19, P3543, DOI 10.1093/nar/19.13.3543; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON W, 1986, DEV BIOL, V115, P392, DOI 10.1016/0012-1606(86)90258-7; HORTON W, 1987, P NATL ACAD SCI USA, V84, P8864, DOI 10.1073/pnas.84.24.8864; KOSHER RA, 1986, J CELL BIOL, V102, P1151, DOI 10.1083/jcb.102.4.1151; KRAVIS D, 1985, DEV BIOL, V108, P164, DOI 10.1016/0012-1606(85)90018-1; KULYK WM, 1989, DEVELOPMENT, V106, P449; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; LUI VCH, 1995, DEV DYNAM, V203, P198, DOI 10.1002/aja.1002030208; MURRE C, 1991, MOL CELL BIOL, V11, P1156, DOI 10.1128/MCB.11.2.1156; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; NG LJ, 1993, DEV BIOL, V159, P403, DOI 10.1006/dbio.1993.1251; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; REISMAN D, 1993, NUCLEIC ACIDS RES, V21, P345, DOI 10.1093/nar/21.2.345; SAVAGNER P, 1995, DNA CELL BIOL, V14, P501, DOI 10.1089/dna.1995.14.501; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; Sekido R, 1997, GENES CELLS, V2, P771, DOI 10.1046/j.1365-2443.1997.1570355.x; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Takagi T, 1998, DEVELOPMENT, V125, P21; WANG LQ, 1991, J BIOL CHEM, V266, P19878	32	66	69	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3610	3618		10.1074/jbc.275.5.3610	http://dx.doi.org/10.1074/jbc.275.5.3610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652357	hybrid			2022-12-27	WOS:000085146500079
J	Welihinda, AK; Tirasophon, W; Kaufman, RJ				Welihinda, AK; Tirasophon, W; Kaufman, RJ			The transcriptional co-activator ADA5 is required for HAC1 mRNA processing in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN-RESPONSE; TRANSFER-RNA LIGASE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE PROTEIN; IRE1P KINASE; YEAST; COMPLEX; GCN5; INDUCTION	Accumulation of unfolded proteins in the endoplasmic reticulum (ER) activates signaling pathways to induce transcription of a number of genes encoding ER protein chaperones and-folding catalysts. In Saccharomyces cerevisiae this transcriptional induction is mediated by an increase in the synthesis of the transcription factor Hac1p, The transmembrane receptor Ire1p/Em1p containing a Ser/Thr protein kinase and endoribonuclease activity transmits the unfolded protein response (UPR) from the ER to the nucleus. Activation of Ire1p kinase induces its endoribonuclease activity to cleave unspliced HAC1 mRNA and generate exon fragments that are subsequently ligated by tRNA ligase (RLG1). Whereas unspliced HAC1 mRNA is poorly translated, spliced HAC1 mRNA is efficiently translated. Subunits of the yeast transcriptional co-activator complex SAGA also play a role in the UPR. Deletion of GCN5, ADA2, or ADA3 reduces, and deletion of ADA5 completely abolishes, the UPR, Although HAC1 mRNA requires only Ire1p and Rlg1p in vitro, we demonstrate that ADA5 is required for the IRE1/RLG1-dependent splicing reaction of HAC1 mRNA in vivo. In addition, Ada5p interacts with Tre1p. These results suggest that subcomponents of transcriptional co-activator complexes may be involved in RNA processing events.	Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Kaufman, RJ (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	kaufman@umich.edu	Longo, Kenneth A/A-5631-2010	Welihinda, Ajith/0000-0002-0049-0850				Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; CLARK MW, 1987, J CELL BIOL, V105, P1515, DOI 10.1083/jcb.105.4.1515; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Foti DM, 1999, J BIOL CHEM, V274, P30402, DOI 10.1074/jbc.274.43.30402; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Harlow E., 1988, ANTIBODIES LAB MANUA; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marcus GA, 1996, MOL CELL BIOL, V16, P3197; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Mori K, 1998, J BIOL CHEM, V273, P9912, DOI 10.1074/jbc.273.16.9912; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sherman F., 1986, METHODS YEAST GENETI; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Welihinda AA, 1998, MOL CELL BIOL, V18, P1967, DOI 10.1128/MCB.18.4.1967; Welihinda AA, 1997, P NATL ACAD SCI USA, V94, P4289, DOI 10.1073/pnas.94.9.4289; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307	33	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3377	3381		10.1074/jbc.275.5.3377	http://dx.doi.org/10.1074/jbc.275.5.3377			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652329	hybrid			2022-12-27	WOS:000085146500051
J	Li, J; Kim, YN; Bertics, PJ				Li, J; Kim, YN; Bertics, PJ			Platelet-derived growth factor-stimulated migration of murine fibroblasts is associated with epidermal growth factor receptor expression and tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN STRESS FIBERS; SIGNAL-TRANSDUCTION; KINASE-ACTIVITY; CELL-PROLIFERATION; BINDING PROTEIN; BETA-RECEPTOR; EGF RECEPTOR; FACTOR PDGF; 3T3 CELLS; CHEMOTAXIS	Previous studies have shown that epidermal growth factor (EGF) synergizes with various extracellular matrix components in promoting the migration of B82L fibroblasts expressing wild-type EGF receptors and that functional EGF receptors are critical for the conversion of B82L fibroblasts to a migratory cell type (1). In the present study, we examined the effects of platelet-derived growth factor (PDGF) on the motility of B82L fibroblasts using a microchemotaxis chamber. We found that PDGF can enhance fibronectin-induced migration of B82L fibroblasts expressing wild-type EGF receptors (B82L-clone B3), However, B82L cells that lack the EGF receptor (B82L-parental) or that express an EGF receptor that is kinase-inactive (BS2L-K721M) or C-terminally truncated (B82L-c'973) exhibit little PDGF-stimulated migration. In addition, none of these three cell lines exhibit the capacity to migrate to fibronectin alone. These observations indicate that, similar to cell migration toward fibronectin, PDGF-induced cell migration of B82L fibroblasts is augmented by the expression of an intact EGF receptor kinase. The loss of PDGF-stimulated motility in E82L cells that do not express an intact EGF receptor does not appear to result from a gross dysfunction of PDGF receptors, because ligand-stimulated tyrosine phosphorylation of the PDGP-beta receptor and the activation of mitogen-activated protein kinases are readily detectable in these cells. Moreover, an interaction between EGF and PDGF receptor systems is supported by the observation that the EGF receptor exhibits an increase in phosphotyrosine content in a time-dependent fashion upon the addition of PDGF. Altogether, these studies demonstrate that the expression of EGF receptor is critical for PDGF-stimulated migration of murine B82L fibroblasts and suggest a role for the EGF receptor do downstream of PDGF receptor activation in the signaling events that lead to PDGF-stimulated cell motility.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bertics, PJ (corresponding author), Univ Wisconsin, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.							BERTICS PJ, 1985, J BIOL CHEM, V260, P4642; BERTICS PJ, 1985, J CELL BIOCHEM, V29, P195, DOI 10.1002/jcb.240290304; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; COOPER JA, 1982, CELL, V31, P263, DOI 10.1016/0092-8674(82)90426-3; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509; ERIKSSON A, 1992, EMBO J, V11, P545; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; GRONOWSKI AM, 1993, ENDOCRINOLOGY, V133, P2838, DOI 10.1210/en.133.6.2838; GRONOWSKI AM, 1995, ENDOCRINOLOGY, V136, P2198, DOI 10.1210/en.136.5.2198; Habib AA, 1998, J BIOL CHEM, V273, P6885, DOI 10.1074/jbc.273.12.6885; HAYASHI N, 1995, ARCH BIOCHEM BIOPHYS, V322, P423, DOI 10.1006/abbi.1995.1484; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HERMAN B, 1985, J CELL BIOL, V100, P1031, DOI 10.1083/jcb.100.4.1031; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; KNIGHT JB, 1995, J BIOL CHEM, V270, P10199, DOI 10.1074/jbc.270.17.10199; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Li J, 1999, J BIOL CHEM, V274, P11209, DOI 10.1074/jbc.274.16.11209; LIN ML, 1995, J CELL PHYSIOL, V164, P593, DOI 10.1002/jcp.1041640318; Liu PS, 1996, J BIOL CHEM, V271, P10299, DOI 10.1074/jbc.271.17.10299; MAY JV, 1992, ENDOCRINOLOGY, V131, P689, DOI 10.1210/en.131.2.689; MAY JV, 1990, ENDOCRINOLOGY, V126, P2896, DOI 10.1210/endo-126-6-2896; MELLSTROM K, 1988, EXP CELL RES, V177, P347, DOI 10.1016/0014-4827(88)90468-5; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; Miranti CK, 1999, J BIOL CHEM, V274, P10571, DOI 10.1074/jbc.274.15.10571; MIRANTI CK, 1999, FASEB SUMM C PROT KI; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OLASHAW N, 1983, CELL BIOL INT REP, V7, P489, DOI 10.1016/0309-1651(83)90143-1; PIERCE GF, 1989, J CELL BIOL, V109, P429, DOI 10.1083/jcb.109.1.429; PLEDGER WJ, 1978, P NATL ACAD SCI USA, V75, P2839, DOI 10.1073/pnas.75.6.2839; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; Rani CSS, 1997, J BIOL CHEM, V272, P10777; RANKIN S, 1994, J BIOL CHEM, V269, P704; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SENIOR RM, 1983, J CELL BIOL, V96, P382, DOI 10.1083/jcb.96.2.382; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SHRIVER K, 1981, J CELL BIOL, V89, P525, DOI 10.1083/jcb.89.3.525; SIMONSEN CC, 1983, P NATL ACAD SCI USA, V80, P2485; TIDBALL JG, 1993, J CELL BIOL, V123, P627, DOI 10.1083/jcb.123.3.627; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANBERGEN, 1992, EXP CELL RES, V199, P90; WENNSTROM S, 1994, ONCOGENE, V9, P651; WHARTON W, 1982, P NATL ACAD SCI-BIOL, V79, P5567, DOI 10.1073/pnas.79.18.5567; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WRIGHT JD, 1995, J BIOL CHEM, V270, P12085, DOI 10.1074/jbc.270.20.12085	54	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2951	2958		10.1074/jbc.275.4.2951	http://dx.doi.org/10.1074/jbc.275.4.2951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644765	hybrid			2022-12-27	WOS:000085128000097
J	Li, LW; Ljungmann, M; Dixon, JE				Li, LW; Ljungmann, M; Dixon, JE			The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; TRANSCRIPTION FACTOR; GAMMA-RADIATION; CELL-CYCLE; PHOSPHORYLATION; YEAST; CHECKPOINTS; DEGRADATION	The yeast Cdc14 phosphatase has been shown to play an important role in cell cycle regulation by dephosphorylating proteins phosphorylated by the cyclin-dependent kinase Cdc28/clb. We recently cloned two human orthologs of the yeast CDC14, termed hCDC14A and -B, the gene products of which share similar to 80% amino acid sequence identity within their N termini and phosphatase domains. Here we report that the hCdc14A and hCdc14B proteins interact with the tumor suppressor protein p53 both in vitro and in vitro. This interaction is dependent on the N termini of the hCdc14 proteins and the C terminus of p53. Furthermore, the hCdc14 phosphatases were found to dephosphorylate p53 specifically at the p34(Cdc2)/clb phosphorylation site (p53-phosphor-Ser(315)). Our findings that hCdc14 is a cyclin-dependent kinase substrate phosphatase suggest that it may play a role in cell cycle control in human cells. Furthermore, the identification of p53 as a substrate for hCdc14 indicates that hCdc14 may regulate the function of p53.	Wake Forest Univ, Sch Med, Dept Med, Winston Salem, NC 27157 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	Wake Forest University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, LW (corresponding author), Wake Forest Univ, Sch Med, Dept Med, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	lwli@wfubmc.edu		Li, Liwu/0000-0001-8870-5299	NATIONAL CANCER INSTITUTE [T32CA009676] Funding Source: NIH RePORTER; NCI NIH HHS [CA09676] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Barboule N, 1997, ONCOGENE, V15, P2867, DOI 10.1038/sj.onc.1201469; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang THT, 1997, ONCOGENE, V14, P2383, DOI 10.1038/sj.onc.1201196; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; GUILLOUF C, 1995, ONCOGENE, V10, P2263; Hardy CFJ, 1996, MOL CELL BIOL, V16, P1832; Hengstermann A, 1998, ONCOGENE, V17, P2933, DOI 10.1038/sj.onc.1202282; HERRMANN CPE, 1991, ONCOGENE, V6, P877; HUPP TR, 1993, NUCLEIC ACIDS RES, V21, P3167, DOI 10.1093/nar/21.14.3167; JANS DA, 1995, J BIOL CHEM, V270, P17064, DOI 10.1074/jbc.270.29.17064; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lain S, 1999, EXP CELL RES, V248, P457, DOI 10.1006/excr.1999.4433; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Liang SH, 1998, J BIOL CHEM, V273, P19817, DOI 10.1074/jbc.273.31.19817; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; OConnor PM, 1997, CANCER SURV, V29, P151; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Toyn JH, 1997, GENETICS, V145, P85; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	37	86	91	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2410	2414		10.1074/jbc.275.4.2410	http://dx.doi.org/10.1074/jbc.275.4.2410			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644693	hybrid			2022-12-27	WOS:000085128000025
J	Muller, K; Mermod, N				Muller, K; Mermod, N			The histone-interacting domain of nuclear factor I activates simian virus 40 DNA replication in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ACCESS; CTF/NF-I; INVITRO; CHROMATIN; PROMOTER; PROTEIN; MINICHROMOSOMES; EXPRESSION; COMPLEX; ORIGIN	Efficient initiation of SV40 DNA replication requires transcription factors that bind auxiliary sequences Banking the minimally required origin. To evaluate the possibility that transcription factors may activate SV40 replication by acting on the chromatin structure of the origin, we used an in vivo replication system in which we targeted GAL4 fusion proteins to the minimally required origin. We found that the proline-rich transcriptional activation domain of nuclear factor I (NF-I), which has been previously shown to interact with histone H3, specifically activates replication. Evaluation of a series of deletion and point mutants of NF-I indicates that the H3-binding domain and the replication activity coincide perfectly. Assays with other transcription factors, such as Spl, confirmed the correlation between the interaction with H3 and the activation of replication. These findings imply that transcription factors such as NF-I can activate SV40 replication via direct interaction with chromatin components, thereby contributing to the relief of nucleosomal repression at the SV40 origin.	Univ Lausanne, Inst Biol Anim, Lab Mol Biotechnol, CH-1015 Lausanne, Switzerland; Univ Lausanne, Ctr Biotechnol, EPFL, UNIL, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Mermod, N (corresponding author), Swiss Fed Inst Technol, Ctr Biotechnol, UNIL EPFL, Lab Mol Biotechnol,Dept Chem, CH-1015 Lausanne, Switzerland.							Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARMENTERO MT, 1994, P NATL ACAD SCI USA, V91, P11537, DOI 10.1073/pnas.91.24.11537; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; BENNETTCOOK ER, 1991, EMBO J, V10, P959, DOI 10.1002/j.1460-2075.1991.tb08030.x; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; CHENG LH, 1989, CELL, V59, P541, DOI 10.1016/0092-8674(89)90037-8; CHENG LZ, 1992, P NATL ACAD SCI USA, V89, P589, DOI 10.1073/pnas.89.2.589; CREMISI C, 1976, J VIROL, V17, P204, DOI 10.1128/JVI.17.1.204-211.1976; GRUSS C, 1992, BIOESSAYS, V14, P1, DOI 10.1002/bies.950140102; GUO ZS, 1989, MOL CELL BIOL, V9, P3593, DOI 10.1128/MCB.9.9.3593; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KELLY TJ, 1988, J BIOL CHEM, V263, P17889; KELMAN Z, 1994, CURR OPIN GENET DEV, V4, P185, DOI 10.1016/S0959-437X(05)80044-9; LEDNICKY J, 1992, J VIROL, V66, P6379, DOI 10.1128/JVI.66.11.6379-6390.1992; LEECHEN GJ, 1986, MOL CELL BIOL, V6, P3086, DOI 10.1128/MCB.6.9.3086; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; MAJUMDER S, 1993, EMBO J, V12, P1131, DOI 10.1002/j.1460-2075.1993.tb05754.x; MARTINEZ E, 1991, MOL CELL BIOL, V11, P2937, DOI 10.1128/MCB.11.6.2937; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MUL YM, 1992, EMBO J, V11, P751, DOI 10.1002/j.1460-2075.1992.tb05108.x; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; SCHILD C, 1993, EMBO J, V12, P423, DOI 10.1002/j.1460-2075.1993.tb05674.x; SEIPEL K, 1992, EMBO J, V11, P4961, DOI 10.1002/j.1460-2075.1992.tb05603.x; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; WOLFFE AP, 1994, TRENDS BIOCHEM SCI, V19, P240, DOI 10.1016/0968-0004(94)90148-1	29	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1645	1650		10.1074/jbc.275.3.1645	http://dx.doi.org/10.1074/jbc.275.3.1645			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636857	hybrid			2022-12-27	WOS:000084940000020
J	Wright, HM; Clish, CB; Mikami, T; Hauser, S; Yanagi, K; Hiramatsu, R; Serhan, CN; Spiegelman, BM				Wright, HM; Clish, CB; Mikami, T; Hauser, S; Yanagi, K; Hiramatsu, R; Serhan, CN; Spiegelman, BM			A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIGLYCIDYL ETHER BADGE; BISPHENOL-A; GENE-EXPRESSION; LIGAND; J(2)	While searching for natural ligands for the peroxisome proliferator-activated receptor (PPAR) gamma, we identified a synthetic compound that binds to this receptor. Bisphenol A diglycidyl ether (BADGE) is a ligand for PPAR gamma with a K-d(app) of 100 mu M. This compound has no apparent ability to activate the transcriptional activity of PPAR gamma; however, BADGE can antagonize the ability of agonist ligands such as rosiglitazone to activate the transcriptional and adipogenic action of this receptor. BADGE also specifically blocks the ability of natural adipogenic cell lines such as 3T3-L1 and 3T3-F442A cells to undergo hormone-mediated cell differentiation. These results provide the first pharmacological evidence that PPAR gamma activity is required for the hormonally induced differentiation of adipogenic cells.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Anesthesia, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Sumitomo Chem Co Ltd, Biotechnol Lab, Takarazuka, Hyogo 6658555, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Sumitomo Chem Co Ltd	Spiegelman, BM (corresponding author), Dana Farber Canc Inst, 1 Jimmy Fund Way,Smith 958, Boston, MA 02115 USA.		Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038765, R01GM038765, R37GM038765] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38765] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Jonathan N, 1998, TRENDS ENDOCRIN MET, V9, P124, DOI 10.1016/S1043-2760(98)00029-0; COOK KS, 1985, J CELL BIOL, V100, P514, DOI 10.1083/jcb.100.2.514; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Limbird LE, 1998, CELL, V93, P157, DOI 10.1016/S0092-8674(00)81568-8; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; SHARMAN M, 1995, FOOD ADDIT CONTAM, V12, P779, DOI 10.1080/02652039509374370; Steinmetz R, 1998, ENDOCRINOLOGY, V139, P2741, DOI 10.1210/en.139.6.2741; Summerfield W, 1998, FOOD ADDIT CONTAM A, V15, P818; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X	16	326	339	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1873	1877		10.1074/jbc.275.3.1873	http://dx.doi.org/10.1074/jbc.275.3.1873			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636887	Green Published, hybrid			2022-12-27	WOS:000084940000050
J	Yuan, JZ; Slice, L; Walsh, JH; Rozengurt, E				Yuan, JZ; Slice, L; Walsh, JH; Rozengurt, E			Activation of protein kinase D by signaling through the alpha subunit of the heterotrimeric G protein G(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; PHOSPHOLIPASE-C; TRANSDUCTION PATHWAY; MOLECULAR-CLONING; PEPTIDE RECEPTOR; CATALYTIC DOMAIN; PHORBOL ESTERS; INTACT-CELLS; FAMILY; TRANSFORMATION	Protein kinase D (PKD/PKC mu) immunoprecipitated from COS-7 cells transiently transfected with a constitutively active alpha subunit of G(q) (G alpha(q)Q209L) exhibited a marked increase in basal activity, which was not further enhanced by treatment of the cells with phorbol 12,13-dibutyrate, In contrast, transient transfection of COS-7 cells with activated G alpha(12)Q229L or G alpha(13)Q226L neither promoted PKD activation nor interfered with the increase of PKD activity induced by phorbol 12,13-dibutyrate, The addition of aluminum fluoride to cells cotransfected with PKD and wild type G alpha(q) induced a marked increase in PKD activity, which was comparable with that induced by expression of G alpha(q)Q209L. Treatment with the protein kinase C inhibitor GF I or Ro 31-8220 prevented the increase in PKD activity induced by aluminum fluoride. Expression of a COOH-terminal fragment of G alpha(q) that acts in a dominant negative fashion attenuated PKD activation in response to agonist stimulation of bombesin receptor. PKD activation in response to either G alpha(q) or bombesin was completely prevented by mutation of Ser(744) and Ser(748) to Ala in the kinase activation loop of PKD. Our results show that G alpha(q) activation is sufficient to stimulate sustained PKD activation via protein kinase C and indicate that the endogenous G alpha(q) mediates PKD activation in response to acute bombesin receptor stimulation.	Univ Calif Los Angeles, Sch Med, Dept Med, CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, CURE Digest Dis Res Ctr, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			NIDDK NIH HHS [DK 55003, T32 DK07180] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007180] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Althoefer H, 1997, J BIOL CHEM, V272, P24380, DOI 10.1074/jbc.272.39.24380; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DEVIVO M, 1992, J BIOL CHEM, V267, P18263; Dorn GW, 1999, TRENDS CARDIOVAS MED, V9, P26, DOI 10.1016/S1050-1738(99)00004-3; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; EXTON JH, 1990, J BIOL CHEM, V265, P1; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; Needham LK, 1998, J BIOL CHEM, V273, P14626, DOI 10.1074/jbc.273.23.14626; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Paolucci L, 1999, CANCER RES, V59, P572; Plonk SG, 1998, J BIOL CHEM, V273, P4823, DOI 10.1074/jbc.273.9.4823; QIAN NX, 1993, P NATL ACAD SCI USA, V90, P4077, DOI 10.1073/pnas.90.9.4077; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rozengurt E, 1998, J CELL PHYSIOL, V177, P507, DOI 10.1002/(SICI)1097-4652(199812)177:4<507::AID-JCP2>3.0.CO;2-K; Rozengurt E, 1997, BIOCHEM SOC T, V25, P565, DOI 10.1042/bst0250565; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P19772, DOI 10.1074/jbc.273.31.19772; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Wadsworth SJ, 1997, J BIOL CHEM, V272, P28829, DOI 10.1074/jbc.272.46.28829; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; WU DQ, 1992, J BIOL CHEM, V267, P1811; YEO EJ, 1995, J BIOL CHEM, V270, P3980, DOI 10.1074/jbc.270.8.3980; ZACHARY I, 1987, J BIOL CHEM, V262, P3947; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	58	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2157	2164		10.1074/jbc.275.3.2157	http://dx.doi.org/10.1074/jbc.275.3.2157			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636921	hybrid			2022-12-27	WOS:000084940000084
J	Greener, T; Zhao, XH; Nojima, H; Eisenberg, E; Greene, LE				Greener, T; Zhao, XH; Nojima, H; Eisenberg, E; Greene, LE			Role of cyclin G-associated kinase in uncoating clathrin-coated vesicles from non-neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; TUMOR-SUPPRESSOR; GOLGI MEMBRANES; MOLECULAR CHAPERONE; AUXILIN; ATPASE; DNAJ; DISSOCIATION; HOMOLOGS; BINDING	Auxilin is a brain-specific DnaJ homolog that is required for Hsc70 to dissociate clathrin from bovine brain clathrin-coated vesicles. However, Hsc70 is also involved in uncoating clathrin-coated vesicles formed at the plasma membrane of non-neuronal cells suggesting that an auxilin homolog may be required for uncoating in these cells. One candidate is cyclin G-associated kinase (GAK), a 150-kDa protein expressed ubiquitously in various tissues. GAK has a C-terminal domain with high sequence similarity to auxilin; like auxilin this C-terminal domain consists of three subdomains, an N-terminal tensin-like domain, a clathrin-binding domain, and a C-terminal J-domain, Western blot analysis shows that GAK is present in rat liver, bovine testes, and bovine brain clathrin-coated vesicles. More importantly, liver clathrin-coated vesicles, which contain GAK but not auxilin, are uncoated by Hsc70, suggesting that GAK acts as an auxilin homolog in non-neuronal cells. In support of this view, the clathrin-binding domain of GAK alone induces clathrin polymerization into baskets and the combined clathrin-binding domain and J-domain of GAK supports uncoating of AP180-clathrin baskets by Hsc70 at pH 7 and induces Hsc70 binding to clathrin baskets at pH 6, Immunolocalization studies suggest that GAK is a cytosolic protein that is concentrated in the perinuclear region; it appears to be highly associated with the trans-Golgi where the budding of clathrin-coated vesicles occurs. We propose that GAK is a required cofactor for the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells.	NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Osaka Univ, Res Inst Microbial Dis, Dept Mol Genet, Suita, Osaka 5650871, Japan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Osaka University	Greene, LE (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 3,B1-22, Bethesda, MD 20892 USA.	greenel@helix.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000516, ZIAHL000516] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; BUXBAUM E, 1995, J CELL SCI, V108, P1295; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Cheetham ME, 1996, BIOCHEM J, V319, P103, DOI 10.1042/bj3190103; GREENE LE, 1990, J BIOL CHEM, V265, P6682; Haynie DT, 1996, PROTEIN SCI, V5, P2643, DOI 10.1002/pro.5560051227; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Holstein SEH, 1996, J CELL BIOL, V135, P925, DOI 10.1083/jcb.135.4.925; Jiang RF, 1997, J BIOL CHEM, V272, P6141, DOI 10.1074/jbc.272.10.6141; Kanaoka Y, 1997, FEBS LETT, V402, P73, DOI 10.1016/S0014-5793(96)01484-6; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kimura SH, 1997, GENOMICS, V44, P179, DOI 10.1006/geno.1997.4873; King C, 1999, BIOCHEMISTRY-US, V38, P12452, DOI 10.1021/bi9902788; King C, 1997, BIOCHEMISTRY-US, V36, P4067, DOI 10.1021/bi9625307; KING C, 1995, J BIOL CHEM, V270, P22535, DOI 10.1074/jbc.270.38.22535; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lo SH, 1998, MOL BIOL CELL, V9, p412A; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Polishchuk RS, 1999, EUR J CELL BIOL, V78, P170, DOI 10.1016/S0171-9335(99)80096-X; PRASAD K, 1993, J BIOL CHEM, V268, P23758; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SCHRODER S, 1995, EUR J BIOCHEM, V228, P297, DOI 10.1111/j.1432-1033.1995.tb20263.x; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; YE W, 1995, J NEUROSCI RES, V41, P15, DOI 10.1002/jnr.490410104; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	37	125	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1365	1370		10.1074/jbc.275.2.1365	http://dx.doi.org/10.1074/jbc.275.2.1365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625686	hybrid			2022-12-27	WOS:000084836600090
J	Rock, CO; Calder, RB; Karim, MA; Jackowski, S				Rock, CO; Calder, RB; Karim, MA; Jackowski, S			Pantothenate kinase regulation of the intracellular concentration of coenzyme A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RAT-LIVER; A BIOSYNTHESIS; COA; HEART; PURIFICATION; GENE; PEROXISOMES; EXPRESSION; METABOLISM	Pantothenate kinase (PanK) is the key regulatory enzyme in the CoA biosynthetic pathway in bacteria and is thought to play a similar role in mammalian cells. We examined this hypothesis by identifying and characterizing two murine cDNAs that encoded PanK. The two cDNAs were predicted to arise from alternate splicing of the same gene to yield different mRNAs that encode two isoforms (mPanK1 alpha and mPanK1 beta) with distinct amino termini. The predicted protein sequence of mPanK1 was not related to bacterial PanK but exhibited significant similarity to Aspergillus nidulans PanK. mPanK1 alpha was most highly expressed in heart and kidney, whereas mPanK1 beta mRNA was detected primarily in liver and kidney. Pantothenate was the most abundant pathway component (42.8%) in normal cells providing clear evidence that pantothenate phosphorylation was a rate-controlling step in CoA biosynthesis. Enhanced mPanK1 beta expression eliminated the intracellular pantothenate pool and triggered a 13-fold increase in intracellular CoA content. mPanK1 beta activity in vitro was stimulated by CoA and strongly inhibited by acetyl-CoA illustrating that differential modulation of mPanK1 beta activity by pathway end products also contributed to the management of CoA levels. These data support the concept that the expression and/or activity of PanK is a determining factor in the physiological regulation of the intracellular CoA concentration.	St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R01GM045737, R37GM034496] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM45737, GM34496] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abiko Y., 1975, Metabolism of sulphur compounds., P1; ABIKO Y, 1972, BIOCHIM BIOPHYS ACTA, V268, P364, DOI 10.1016/0005-2744(72)90331-2; BHUIYAN AKMJ, 1988, BIOCHEM J, V253, P337, DOI 10.1042/bj2530337; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calder RB, 1999, J BIOL CHEM, V274, P2014, DOI 10.1074/jbc.274.4.2014; Dimroth P, 1997, MOL MICROBIOL, V25, P3, DOI 10.1046/j.1365-2958.1997.4611824.x; DIMROTH P, 1976, EUR J BIOCHEM, V64, P269, DOI 10.1111/j.1432-1033.1976.tb10297.x; FALK KL, 1993, ARCH BIOCHEM BIOPHYS, V301, P424, DOI 10.1006/abbi.1993.1166; FISHER MN, 1985, J BIOL CHEM, V260, P5745; FISHER MN, 1985, FEBS LETT, V190, P293, DOI 10.1016/0014-5793(85)81303-X; FLAMM JA, 1988, GENE, V74, P555, DOI 10.1016/0378-1119(88)90189-8; HALVORSEN O, 1986, SCAND J CLIN LAB INV, V46, P67; HALVORSEN O, 1982, EUR J BIOCHEM, V124, P211, DOI 10.1111/j.1432-1033.1982.tb05927.x; HALVORSEN O, 1983, BIOCHEM PHARMACOL, V32, P1126, DOI 10.1016/0006-2952(83)90638-X; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; JACKOWSKI S, 1990, J BACTERIOL, V172, P3842, DOI 10.1128/jb.172.7.3842-3848.1990; Jackowski S., 1996, ESCHERICHIA COLI SAL, P687; KARASAWA T, 1972, J BIOCHEM-TOKYO, V71, P1065, DOI 10.1093/oxfordjournals.jbchem.a129854; KIRSCHBAUM N, 1990, J NUTR, V120, P1376, DOI 10.1093/jn/120.11.1376; KONDRUP J, 1973, BIOCHEM J, V132, P373, DOI 10.1042/bj1320373; LOPASCHUK GD, 1986, AM J PHYSIOL, V250, pH351, DOI 10.1152/ajpheart.1986.250.3.H351; LUND H, 1986, BIOCHIM BIOPHYS ACTA, V876, P685, DOI 10.1016/0005-2760(86)90058-5; REIBEL DK, 1981, AM J PHYSIOL, V240, pH606, DOI 10.1152/ajpheart.1981.240.4.H606; ROBISHAW JD, 1985, AM J PHYSIOL, V248, pE1, DOI 10.1152/ajpendo.1985.248.1.E1; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; ROBISHAW JD, 1984, AM J PHYSIOL, V246, pH532, DOI 10.1152/ajpheart.1984.246.4.H532; SAVOLAINEN MJ, 1977, BIOCHEM PHARMACOL, V26, P425, DOI 10.1016/0006-2952(77)90202-7; SIEGMUND KD, 1991, BIOCHIM BIOPHYS ACTA, V1076, P123, DOI 10.1016/0167-4838(91)90228-R; SKREDE S, 1983, EUR J BIOCHEM, V131, P57, DOI 10.1111/j.1432-1033.1983.tb07231.x; SKREDE S, 1979, EUR J BIOCHEM, V98, P223, DOI 10.1111/j.1432-1033.1979.tb13180.x; SKREDE S, 1979, BIOCHEM BIOPH RES CO, V91, P1536, DOI 10.1016/0006-291X(79)91239-7; SMITH CM, 1980, BIOCHEM J, V188, P175, DOI 10.1042/bj1880175; SMITH CM, 1978, J NUTR, V108, P854, DOI 10.1093/jn/108.5.854; SONG WJ, 1994, J BIOL CHEM, V269, P27051; SONG WJ, 1992, J BACTERIOL, V174, P1705, DOI 10.1128/jb.174.5.1705-1706.1992; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; TAHILIANI AG, 1987, J BIOL CHEM, V262, P11607; TAHILIANI AG, 1991, BIOCHIM BIOPHYS ACTA, V1067, P29, DOI 10.1016/0005-2736(91)90022-Z; TAHILIANI AG, 1989, J BIOL CHEM, V264, P18426; VAGELOS RP, 1971, CURR TOP CELL REGUL, V4, P119; VALLARI DS, 1985, J BACTERIOL, V162, P1156, DOI 10.1128/JB.162.3.1156-1161.1985; VALLARI DS, 1987, J BACTERIOL, V169, P5795, DOI 10.1128/jb.169.12.5795-5800.1987; VALLARI DS, 1985, J BACTERIOL, V164, P136, DOI 10.1128/JB.164.1.136-142.1985; VALLARI DS, 1988, J BACTERIOL, V170, P3961, DOI 10.1128/jb.170.9.3961-3966.1988; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; VANBROEKHOVEN A, 1981, BIOCHEM BIOPH RES CO, V100, P305, DOI 10.1016/S0006-291X(81)80097-6; VOLTTI H, 1979, BIOCHEM J, V182, P95, DOI 10.1042/bj1820095	48	153	170	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1377	1383		10.1074/jbc.275.2.1377	http://dx.doi.org/10.1074/jbc.275.2.1377			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625688	hybrid			2022-12-27	WOS:000084836600092
J	MacNicol, MC; Muslin, AJ; MacNicol, AM				MacNicol, MC; Muslin, AJ; MacNicol, AM			Disruption of the 14-3-3 binding site within the B-Raf kinase domain uncouples catalytic activity from PC12 cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SIGNALING PROTEINS; MAMMALIAN-CELLS; CYCLE ARREST; IN-VITRO; A-RAF; V-RAF; ACTIVATION; 14-3-3-PROTEINS; IDENTIFICATION	A number of Raf-associated proteins have recently been identified, including members of the 14-3-3 family of phosphoserine-binding proteins. Although both positive and negative regulatory functions have been ascribed for 14-3-3 interactions with Raf-1, the mechanisms by which 14-3-3 binding modulates Raf activity have not been fully established. We report that mutational disruption of 14-3-3 binding to the B-Raf catalytic domain inhibits B-Raf biological activity. Expression of the isolated B-Raf catalytic domain (B-Rafcat) induces PC12 cell differentiation in the absence of nerve growth factor, By contrast, the B-Rafcat 14-3-3 binding mutant, B-Rafcat S728A, was severely compromised for the induction of PC12 cell differentiation. Interestingly, the B-Rafcat 14-3-3 binding mutant retained significant in vitro catalytic activity. In Xenopus oocytes, the analogous full-length B-Raf 14-3-3 binding mutant blocked progesterone-stimulated maturation and the activation of endogenous mitogen-activated protein kinase kinase and mitogen-activated protein kinase. Similarly, the full-length B-Raf 14-3-3 binding mutant inhibited nerve growth factor-stimulated PC12 cell differentiation. We conclude that 14-3-3 interaction with the catalytic domain is not required for kinase activity per se but is essential to couple B-Raf catalytic activity to downstream effector activation.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Chicago; University of Chicago; Washington University (WUSTL)	MacNicol, AM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.				NCI NIH HHS [CA 70846] Funding Source: Medline; NIGMS NIH HHS [GM 54670] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054670] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chang HC, 1997, GENE DEV, V11, P1132, DOI 10.1101/gad.11.9.1132; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Dang A, 1998, J BIOL CHEM, V273, P19909, DOI 10.1074/jbc.273.31.19909; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; EVANS JP, 1991, METHOD CELL BIOL, V36, P133; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FREEMAN RS, 1991, MOL CELL BIOL, V11, P17413; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; GARDNER AM, 1994, METHOD ENZYMOL, V238, P258; Gu MY, 1998, J BIOL CHEM, V273, P33465, DOI 10.1074/jbc.273.50.33465; Howard EL, 1999, MOL CELL BIOL, V19, P1990; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; KAMIYAMA T, 1993, JPN J CANCER RES, V84, P250, DOI 10.1111/j.1349-7006.1993.tb02864.x; Kockel L, 1997, GENE DEV, V11, P1140, DOI 10.1101/gad.11.9.1140; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; LUO ZJ, 1995, J BIOL CHEM, V270, P23681, DOI 10.1074/jbc.270.40.23681; MacNicol MC, 1999, J BIOL CHEM, V274, P13193, DOI 10.1074/jbc.274.19.13193; MacNicol MC, 1997, GENE, V196, P25, DOI 10.1016/S0378-1119(97)00171-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mischak H, 1996, MOL CELL BIOL, V16, P5409; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; MUSLIN AJ, 1993, MOL CELL BIOL, V13, P4197, DOI 10.1128/MCB.13.7.4197; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Papin C, 1996, ONCOGENE, V12, P2213; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; PRITCHARD CA, 1995, MOL CELL BIOL, V15, P6430; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Rommel C, 1996, ONCOGENE, V12, P609; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SUEN KL, 1995, ONCOGENE, V11, P825; Tamada M, 1997, ONCOGENE, V15, P2959, DOI 10.1038/sj.onc.1201582; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; VAN AL, 1993, P NATL ACAD SCI USA, V90, P6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; YAMAMORI B, 1995, J BIOL CHEM, V270, P11723, DOI 10.1074/jbc.270.20.11723	51	37	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3803	3809		10.1074/jbc.275.6.3803	http://dx.doi.org/10.1074/jbc.275.6.3803			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660530	hybrid			2022-12-27	WOS:000085288800014
J	Munsch, D; Watanabe-Fukunaga, R; Bourdon, JC; Nagata, S; May, E; Yonish-Rouach, E; Reisdorf, P				Munsch, D; Watanabe-Fukunaga, R; Bourdon, JC; Nagata, S; May, E; Yonish-Rouach, E; Reisdorf, P			Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; WILD-TYPE P53; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; YEAST GENES; IN-VIVO; BAX; PROTEIN; DAMAGE; CANCER	p53 is a tumor suppressor protein that induces apoptosis at least in part through its ability to act as a sequence-specific transactivator. This work reports that intron 1 of the mouse Fas death receptor gene contains a p53-responsive element (p53RE) that matches the p53 consensus sequence and that is located between nucleotides +1704 and +1723 from the transcription initiation site. This element is specifically bound by p53 and functions as a p53-dependent enhancer in mammalian or in yeast reporter gene assays. Contrary to bax, another known pro-apoptotic p53-target gene, both mouse and human FAS p53REs are still activated by the discriminatory P53 mutants Pro-175 and Ala-143, a class of mutants unable to induce apoptosis. We propose that p53-dependent up-regulation of Fas does not induce apoptosis per se but sensitizes the cell to other pro-apoptotic signal(s). The functional conservation of p53-dependent Fas up-regulation argues strongly in favor of its biological importance and suggests that murine models may be used to study further the in vivo role of Fas in the p53 response.	CEA, Lab Cancerol Mol, Dept Radiobiol & Radiopathol, Direct Sci Vie,CNRS,UMR 217, F-92265 Fontenay Aux Roses, France; Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan	CEA; Centre National de la Recherche Scientifique (CNRS); Osaka University	Reisdorf, P (corresponding author), CEA Saclay, LREG, DSV, DRR, F-91191 Gif Sur Yvette, France.	reisdorf@davidf.cea.fr	Nagata, Shigekazu/AAG-3203-2019; JC, Bourdon/A-4439-2008	Nagata, Shigekazu/0000-0001-9758-8426; JC, Bourdon/0000-0003-4623-9386				Akira S, 1997, INT J BIOCHEM CELL B, V29, P1401, DOI 10.1016/S1357-2725(97)00063-0; Bourdon JC, 1997, ONCOGENE, V14, P85, DOI 10.1038/sj.onc.1200804; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DELPHIN C, 1994, EUR J BIOCHEM, V223, P683, DOI 10.1111/j.1432-1033.1994.tb19041.x; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Flaman JM, 1998, ONCOGENE, V16, P1369, DOI 10.1038/sj.onc.1201889; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Fuchs EJ, 1997, CANCER RES, V57, P2550; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gottlieb TM, 1996, BBA-REV CANCER, V1287, P77, DOI 10.1016/0304-419X(95)00019-C; GREENBLATT MS, 1994, CANCER RES, V54, P4855; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kobayashi T, 1998, CELL DEATH DIFFER, V5, P584, DOI 10.1038/sj.cdd.4400382; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; MAY E, 1989, ONCOGENE, V4, P1037; MAY E, 1992, J VIROL, V66, P3347, DOI 10.1128/JVI.66.6.3347-3354.1992; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; MIYASHITA T, 1995, CELL, V80, P293; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; PRIVES C, 1994, COLD SPRING HARB SYM, V59, P207, DOI 10.1101/SQB.1994.059.01.025; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; Reinke V, 1997, ONCOGENE, V15, P1527, DOI 10.1038/sj.onc.1201316; RESNICKSILVERMA.L, 1998, GENES DEV, V15; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; RUBY SW, 1983, METHOD ENZYMOL, V101, P253; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sheikh MS, 1998, CANCER RES, V58, P1593; Soussi T, 1996, J MOL BIOL, V260, P623, DOI 10.1006/jmbi.1996.0425; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; TSUCHIYA M, 1987, EUR J BIOCHEM, V165, P7, DOI 10.1111/j.1432-1033.1987.tb11187.x; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WADA N, 1995, J BIOL CHEM, V270, P18007, DOI 10.1074/jbc.270.30.18007; WALDMAN T, 1995, CANCER RES, V55, P5187; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	52	110	110	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3867	3872		10.1074/jbc.275.6.3867	http://dx.doi.org/10.1074/jbc.275.6.3867			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660538	hybrid			2022-12-27	WOS:000085288800022
J	Baloh, RH; Tansey, MG; Johnson, EM; Milbrandt, J				Baloh, RH; Tansey, MG; Johnson, EM; Milbrandt, J			Functional mapping of receptor specificity domains of glial cell line-derived neurotrophic factor (GDNF) family ligands and production of GFR alpha 1 RET-specific agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; GROWTH-FACTOR-BETA; CRYSTAL-STRUCTURE; TRANSFORMING GROWTH-FACTOR-BETA-2; ANGSTROM RESOLUTION; TYROSINE KINASE; BINDING SITE; NEURTURIN; ACTIVATION; PROTEIN	The glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) (GDNF, neurturin, artemin, and persephin) are critical regulators of neurodevelopment and support the survival of midbrain dopaminergic and spinal motor neurons in vitro and in animal disease models making them attractive therapeutic candidates for treatment of neurodegenerative diseases. The GFLs signal through a multicomponent receptor complex comprised of a high affinity binding component (GDNF-family receptor alpha-component (GFR alpha 1-GFR alpha 4)) and the receptor tyrosine kinase RET, To bean characterization of GFL receptor specificity at the molecular level, we performed comprehensive homologue-scanning mutagenesis of GDNF, the prototypical member of the GFLs. Replacing short segments of GDNF with the homologous segments from persephin (PSPN) (which cannot bind or activate GFR alpha 1.RET or GFR alpha 2.RET) identified sites along the second finger of GDNF critical for activating the GFR alpha 1.RET and GFR alpha 2.RET receptor complexes. Furthermore, introduction of these regions from GDNF, neurturin, or artemin into PSPN demonstrated that they are sufficient for activating GFR alpha 1.RET, but additional determinants are required for interaction with the other GFR alpha s, This difference in the molecular basis of GFL-GFR alpha specificity allowed the production of GFR alpha 1.RET-specific agonists and provides a foundation for understanding of GFL-GFR alpha.RET signaling at the molecular level.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.	jeff@pathbox.wustl.edu		Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE ON AGING [R01AG013730, R01AG013729] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG13729, R01 AG13730] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Baloh RH, 1997, NEURON, V18, P793, DOI 10.1016/S0896-6273(00)80318-9; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BREWER CB, 1994, METHOD CELL BIOL, V43, P233; Burmester JK, 1998, GROWTH FACTORS, V15, P231, DOI 10.3109/08977199809002119; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Eigenbrot C, 1997, NAT STRUCT BIOL, V4, P435, DOI 10.1038/nsb0697-435; Enokido Y, 1998, CURR BIOL, V8, P1019, DOI 10.1016/S0960-9822(07)00422-8; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Grondin R, 1998, J NEUROL, V245, pP35, DOI 10.1007/PL00007744; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Horger BA, 1998, J NEUROSCI, V18, P4929; Ibanez CF, 1998, TRENDS NEUROSCI, V21, P438, DOI 10.1016/S0166-2236(98)01266-1; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Miller TM, 1996, J NEUROSCI, V16, P7487; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Moulder KL, 1999, J NEUROSCI, V19, P705; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Naveilhan P, 1998, P NATL ACAD SCI USA, V95, P1295, DOI 10.1073/pnas.95.3.1295; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Qian SW, 1996, J BIOL CHEM, V271, P30656, DOI 10.1074/jbc.271.48.30656; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Suvanto P, 1997, HUM MOL GENET, V6, P1267, DOI 10.1093/hmg/6.8.1267; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Worby CA, 1998, J BIOL CHEM, V273, P3502, DOI 10.1074/jbc.273.6.3502; Xu RY, 1998, J NEUROCHEM, V70, P1383, DOI 10.1046/j.1471-4159.1998.70041383.x; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451	38	57	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3412	3420		10.1074/jbc.275.5.3412	http://dx.doi.org/10.1074/jbc.275.5.3412			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652334	hybrid			2022-12-27	WOS:000085146500056
J	Blanton, MP; McCardy, EA; Gallagher, MJ				Blanton, MP; McCardy, EA; Gallagher, MJ			Examining the noncompetitive antagonist-binding site in the ion channel of the nicotinic acetylcholine receptor in the resting state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-3 CHLORPROMAZINE; HYDROPHOBIC PROBE; AMINO-ACIDS; REGIONS; SUBUNIT; M2	3-Trifluoromethyl-3-(m-[I-125]iodophenyl) ([I-125]TID) has been shown to be a potent noncompetitive antagonist (NCA) of the nicotinic acetylcholine receptor (AChR). Amino acids that contribute to the binding site for [I-125]TID in the ion channel have been identified in both the resting and desensitized state of the AChR (White, B. H., and Cohen, J. B. (1992) J. Biol Chem. 267, 15770-15783). To characterize further the structure of the NCA-binding site in the resting state channel, we have employed structural analogs of TLD. The TID analogs were assessed by the following: 1) their ability to inhibit [I-125]TID photoincorporation into the resting state channel; 2) the pattern, agonist sensitivity, and NCA inhibition of [I-125]TID analog photoincorporation into AChR subunits, The addition of a primary alcohol group to TID has no demonstrable effect on the interaction of the compound with the resting state channel. However, conversion of the alcohol function to acetate, isobutyl acetate (TIDBIBA), or to trimethyl acetate leads to rightward shifts in the concentration-response curves for inhibition of [I-125]TID photoincorporation into the AChR channel and a progressive reduction in the agonist sensitivity of [I-125]TID analog photoincorporation into AChR subunits. Inhibition of [I-125]TID analog photoincorporation by NCAs (e.g. tetracaine) as well as identification of the sites of [I-125]TIDBIBA photoincorporation in the delta M2 segment indicate a common binding locus for each TID analog. We conclude that relatively small additions to TID progressively reduce its ability to interact with the NCA site in the resting state channel. A model of the NCA site and resting state channel is presented.	Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol, Lubbock, TX 79430 USA; Texas Tech Univ, Hlth Sci Ctr, Dept Anesthesiol, Lubbock, TX 79430 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Washington University (WUSTL)	Blanton, MP (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol, 3601 4th St, Lubbock, TX 79430 USA.			Gallagher, Martin/0000-0002-3537-4200	NINDS NIH HHS [R29 NS35786] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035786] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arias HR, 1998, BBA-REV BIOMEMBRANES, V1376, P173, DOI 10.1016/S0304-4157(98)00004-5; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Blanton MP, 1998, BIOCHEMISTRY-US, V37, P14545, DOI 10.1021/bi981435q; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COHEN JB, 1985, EFFECTS ANESTHESIA, P53; Eichler J, 1997, EMBO J, V16, P2188, DOI 10.1093/emboj/16.9.2188; Gallagher MJ, 1999, MOL PHARMACOL, V56, P300, DOI 10.1124/mol.56.2.300; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1989, FEBS LETT, V253, P190, DOI 10.1016/0014-5793(89)80957-3; HUCHO F, 1986, EUR J BIOCHEM, V158, P211, DOI 10.1111/j.1432-1033.1986.tb09740.x; Hucho F, 1996, EUR J BIOCHEM, V239, P539, DOI 10.1111/j.1432-1033.1996.0539u.x; Katz EJ, 1997, TOXICOL APPL PHARM, V146, P227, DOI 10.1006/taap.1997.8201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MOORE MA, 1994, BBA-BIOMEMBRANES, V1190, P457, DOI 10.1016/0005-2736(94)90108-2; PEDERSEN SE, 1992, J BIOL CHEM, V267, P10489; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; Smith GR, 1997, BIOPHYS J, V73, P1364, DOI 10.1016/S0006-3495(97)78169-4; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1991, J BIOL CHEM, V266, P21595; WHITE BH, 1992, J BIOL CHEM, V267, P15770; WU G, 1994, BIOCHEMISTRY-US, V33, P15375, DOI 10.1021/bi00255a018	28	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3469	3478		10.1074/jbc.275.5.3469	http://dx.doi.org/10.1074/jbc.275.5.3469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652341	hybrid			2022-12-27	WOS:000085146500063
J	Felts, SJ; Owen, BAL; Nguyen, P; Trepel, J; Donner, DB; Toft, DO				Felts, SJ; Owen, BAL; Nguyen, P; Trepel, J; Donner, DB; Toft, DO			The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGESTERONE-RECEPTOR COMPLEXES; HEAT-SHOCK PROTEINS; ROUS-SARCOMA VIRUS; HSP90 MOLECULAR CHAPERONE; 2 CELLULAR PROTEINS; IN-VIVO; TRANSFORMING PROTEIN; GLUCOCORTICOID RECEPTOR; SIGNALING PATHWAY; TERMINAL DOMAIN	The hsp90 family of molecular chaperones was expanded recently due to the cloning of TRAP1 and hsp75 by yeast two-hybrid screens. Careful analysis of the human TRAP1 and hsp75 sequences revealed that they are identical, and we have cloned a similar protein from Drosophila, Immunofluorescence data show that human TRAP1 is localized to mitochondria. This mitochondrial localization is supported by the existence of mitochondrial localization sequences in the amino termini of both the human and Drosophila proteins. Due to the striking homology of TRAP1 to hsp90, we tested the ability of TRAP1 to function as an hsp90-like chaperone. TRAP1 did not form stable complexes with the classic hsp90 co-chaperones p23 and Hop (p60), Consistent with these observations, TRAP1 had no effect on the hsp90-dependent reconstitution of hormone binding to the progesterone receptor in vitro, nor could it substitute for hsp90 to promote maturation of the receptor to its hormone-binding state. However, TRAP1 is sufficiently conserved with hsp90 such that it bound ATP, and this binding was sensitive to the hsp90 inhibitor geldanamycin, In addition, TRAP1 exhibited ATPase activity that was inhibited by both geldanamycin and radicicol, Thus, TRAP1 has functions that are distinct from those of hsp90.	Mayo Clin & Mayo Grad Sch Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; NCI, Med Branch, NIH, Bethesda, MD 20892 USA; Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute	Felts, SJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, 200 1st St S W, Rochester, MN 55905 USA.	felts.sara@mayo.edu	Owen, Barbara/AAD-2322-2021		NCI NIH HHS [CA67891, CA73023] Funding Source: Medline; NIDDK NIH HHS [DK46249] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073023, R01CA067891, R55CA067891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046249] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALIGUE R, 1994, EMBO J, V13, P6099, DOI 10.1002/j.1460-2075.1994.tb06956.x; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BARDWELL JCA, 1987, P NATL ACAD SCI USA, V84, P5177, DOI 10.1073/pnas.84.15.5177; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen CF, 1996, MOL CELL BIOL, V16, P4691; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; Dittmar KD, 1998, J BIOL CHEM, V273, P7358, DOI 10.1074/jbc.273.13.7358; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; Horton P., 1996, P INT SYST MOL BIOL, V4, P109; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; JOAB I, 1984, NATURE, V308, P850, DOI 10.1038/308850a0; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Johnson J, 1996, J STEROID BIOCHEM, V56, P31, DOI 10.1016/0960-0760(95)00221-9; JOHNSON JL, 1994, MOL CELL BIOL, V14, P1956, DOI 10.1128/MCB.14.3.1956; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OPPERMANN H, 1981, VIROLOGY, V113, P736, DOI 10.1016/0042-6822(81)90202-6; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; PERDEW GH, 1993, EXP CELL RES, V209, P350, DOI 10.1006/excr.1993.1320; Pratt WB, 1998, TRENDS ENDOCRIN MET, V9, P244, DOI 10.1016/S1043-2760(98)00059-9; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; SCHUH S, 1985, J BIOL CHEM, V260, P4292; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulte TW, 1999, MOL ENDOCRINOL, V13, P1435, DOI 10.1210/me.13.9.1435; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Smith DF, 1998, BIOL CHEM, V379, P283; Smith DF, 1998, PHARMACOL REV, V50, P493; SMITH DF, 1995, MOL CELL BIOL, V15, P6804; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Soga S, 1998, J BIOL CHEM, V273, P822, DOI 10.1074/jbc.273.2.822; SONG HY, 1995, J BIOL CHEM, V270, P3574, DOI 10.1074/jbc.270.8.3574; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; SULLIVAN WP, 1986, ENDOCRINOLOGY, V119, P1549, DOI 10.1210/endo-119-4-1549; Toft DO, 1998, TRENDS ENDOCRIN MET, V9, P238, DOI 10.1016/S1043-2760(98)00060-5; vanderStraten A, 1997, EMBO J, V16, P1961, DOI 10.1093/emboj/16.8.1961; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	67	289	304	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3305	3312		10.1074/jbc.275.5.3305	http://dx.doi.org/10.1074/jbc.275.5.3305			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652318	hybrid			2022-12-27	WOS:000085146500040
J	Kimura, A; Ohmichi, M; Tasaka, K; Kanda, Y; Ikegami, H; Hayakawa, J; Hisamoto, K; Morishige, K; Hinuma, S; Kurachi, H; Murata, Y				Kimura, A; Ohmichi, M; Tasaka, K; Kanda, Y; Ikegami, H; Hayakawa, J; Hisamoto, K; Morishige, K; Hinuma, S; Kurachi, H; Murata, Y			Prolactin-releasing peptide activation of the prolactin promoter is differentially mediated by extracellular signal-regulated protein kinase and c-Jun N-terminal protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTERIOR-PITUITARY-CELLS; EPIDERMAL GROWTH-FACTOR; GENE-EXPRESSION; TRANSCRIPTION FACTOR; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; FUNCTIONAL COMPONENTS; RESPONSE ELEMENT; HORMONE ACTION; GH3 CELLS	Regulation of the mitogen-activated protein kinase (MAPK) family by prolactin-releasing peptide (PrRP) in both GH3 rat pituitary tumor cells and primary cultures of rat anterior pituitary cells was investigated. PrRP rapidly and transiently activated extracellular signal-regulated protein kinase (ERK) in both types of cells. Both pertussis toxin, which inactivates G(i)/G(o), proteins, and exogenous expression of a peptide derived from the carboxyl terminus of the beta-adrenergic receptor kinase I, which specifically blocks signaling mediated by the beta gamma subunits of G proteins, completely blocked the PrRP-induced ERK activation, suggesting the involvement of G(i)/G(o) proteins in the PrRP-induced ERK activation, Down-regulation of cellular protein kinase C did not significantly inhibit the PrRP-induced ERK activation, suggesting that a protein kinase C-independent pathway is mainly involved. PrRP-induced ERK activation was not dependent on either extracellular Ca2+ or intracellular Ca2+. However, the ERK cascade was not the only route by which PrRP communicated with the nucleus, JNK was also shown to be significantly activated in response to PrRP, JNK activation in response to PrRP was slower than ERK activation, Moreover, to determine whether a MAPK family cascade regulates rat prolactin (rPRL) promoter activity, we transfected the intact rPRL promoter ligated to the firefly luciferase reporter gene into GH3 cells. PrRP activated the rPRL promoter activity in a time-dependent manner. Co-transfection with a catalytically inactive form of a MAPK construct or a dominant negative JNK, partially but significantly inhibited the induction of the rPRL promoter by PrRP, Furthermore, co-transfection with a dominant negative Ets completely abolished the response of the rPRL promoter to PrRP, These results suggest that PrRP differentially activates ERK and JNK, and both cascades are necessary to elicit rPRL promoter activity in an Ets-dependent mechanism.	Osaka Univ, Sch Med, Dept Obstet & Gynecol, Suita, Osaka 5650871, Japan; Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Discovery Res Labs 1, Tsukuba, Ibaraki 3004293, Japan	Osaka University; Takeda Chemical Industries	Ohmichi, M (corresponding author), Osaka Univ, Sch Med, Dept Obstet & Gynecol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Aperlo C, 1996, MOL CELL BIOL, V16, P6851; BOGOYEVITCH MA, 1993, FEBS LETT, V317, P271, DOI 10.1016/0014-5793(93)81291-7; Bradford AP, 1996, J BIOL CHEM, V271, P24639, DOI 10.1074/jbc.271.40.24639; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Castillo AI, 1998, ONCOGENE, V16, P1981, DOI 10.1038/sj.onc.1200204; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; CHAO TSO, 1992, J BIOL CHEM, V267, P19876; CONRAD KE, 1994, MOL CELL BIOL, V14, P1553, DOI 10.1128/MCB.14.3.1553; CONRAD KE, 1992, ONCOGENE, V7, P1279; DANNIES PS, 1976, NATURE, V261, P707, DOI 10.1038/261707a0; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; FRNTZ AG, 1978, NEW ENGL J MED, V298, P201; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Hayakawa J, 1999, J BIOL CHEM, V274, P31648, DOI 10.1074/jbc.274.44.31648; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; JACKSON SM, 1992, MOL CELL BIOL, V12, P2708, DOI 10.1128/MCB.12.6.2708; JACOB KK, 1995, J BIOL CHEM, V270, P27773, DOI 10.1074/jbc.270.46.27773; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; KANDA Y, 1994, BIOCHEM BIOPH RES CO, V199, P1447, DOI 10.1006/bbrc.1994.1393; KEECH CA, 1991, MOL CELL ENDOCRINOL, V78, P55, DOI 10.1016/0303-7207(91)90185-U; Kimura A, 1999, ENDOCRINOLOGY, V140, P722, DOI 10.1210/en.140.2.722; Kimura A, 1999, CANCER RES, V59, P5133; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; Levi NL, 1998, MOL ENDOCRINOL, V12, P815, DOI 10.1210/me.12.6.815; LOGIN IS, 1991, AM J PHYSIOL, V260, pE553, DOI 10.1152/ajpendo.1991.260.4.E553; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARCHESE A, 1995, GENOMICS, V29, P335, DOI 10.1006/geno.1995.9996; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTIN TFJ, 1983, J BIOL CHEM, V258, P4816; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Newberry EP, 1997, MOL ENDOCRINOL, V11, P1129, DOI 10.1210/me.11.8.1129; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OHMICHI M, 1994, BIOCHEM BIOPH RES CO, V201, P642, DOI 10.1006/bbrc.1994.1749; OHMICHI M, 1994, J BIOL CHEM, V269, P3783; OHMICHI M, 1994, J BIOL CHEM, V269, P1143; OHMICHI M, 1995, ENDOCRINOLOGY, V136, P2082, DOI 10.1210/en.136.5.2082; OHMICHI M, 1990, NEUROENDOCRINOLOGY, V52, P75, DOI 10.1159/000125542; OHMICHI M, 1997, ENDOCRINOLOGY, V138, P3130; PANG L, 1993, BIOCHEM J, V289, P283, DOI 10.1042/bj2890283; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; POTAPOVA O, 1996, CANCER RES, V56, P2800; REBECCHI MJ, 1983, J BIOL CHEM, V258, P227; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; Roberson MS, 1999, ENDOCRINOLOGY, V140, P1310, DOI 10.1210/en.140.3.1310; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROUDBARAKI MM, 1995, AM J PHYSIOL-ENDOC M, V268, pE1215, DOI 10.1152/ajpendo.1995.268.6.E1215; Sawada T, 1997, ENDOCRINOLOGY, V138, P5275, DOI 10.1210/en.138.12.5275; Schweppe RE, 1997, J BIOL CHEM, V272, P30852, DOI 10.1074/jbc.272.49.30852; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shimizu Y, 1997, ENDOCRINOLOGY, V138, P248, DOI 10.1210/en.138.1.248; SIMONSON MS, 1993, J BIOL CHEM, V268, P9347; Sundaresan S, 1996, ENDOCRINOLOGY, V137, P304, DOI 10.1210/en.137.1.304; Toyoshima F, 1997, J CELL BIOL, V139, P1005, DOI 10.1083/jcb.139.4.1005; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; WELCH SK, 1995, BIOCHEM BIOPH RES CO, V209, P606, DOI 10.1006/bbrc.1995.1543; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; YAN GZ, 1991, MOL ENDOCRINOL, V5, P1488, DOI 10.1210/mend-5-10-1488	71	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3667	3674		10.1074/jbc.275.5.3667	http://dx.doi.org/10.1074/jbc.275.5.3667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652364	hybrid			2022-12-27	WOS:000085146500086
J	Klein, S; Carroll, JA; Chen, Y; Henry, MF; Henry, PA; Ortonowski, IE; Pintucci, G; Beavis, RC; Burgess, WH; Rifkin, DB				Klein, S; Carroll, JA; Chen, Y; Henry, MF; Henry, PA; Ortonowski, IE; Pintucci, G; Beavis, RC; Burgess, WH; Rifkin, DB			Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II; ENDOTHELIAL-CELLS; PROTEIN; LOCALIZATION; RNA; NUCLEAR; BINDING; FORMS; BFGF; NG,NG-DIMETHYLARGININE	The post-translational methylation of the N-terminally extended or high molecular weight (HMW) forms of fibroblast growth factor-2 (FGF-2) has been shown to affect the nuclear accumulation of the growth factor. In this study, we determined the extent and position of methyl groups in HMW FGF-2. Using mass spectrometry and amino acid sequence analysis, we have shown that the 22- and 22.5-kDa forms of HMW FGF-2 contain five dimethylated arginines located at positions -22, -24, -26, -36, and -38 using the methionine residue normally used to initiate the 18-kDa form as position 0. The 24-kDa form of HMW FGF-2 contains seven to eight dimethylated arginines located at positions -48, -50, and -52, in addition to positions -22, -24, -26, -36, and -38, In vitro methylation reactions demonstrate that the N-terminal extension of HMW FGF-8 acts as a specific substrate for yeast Hmt1p and human HRMT1L2 arginine methyltransferases. These findings indicate that HMW FGF-8, with the presence of five or more dimethylated Gly-Arg-Gly repeats, contains an RGG box-like domain, which may be important for protein-protein and/or protein-RNA interactions.	NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomed Res, New York, NY 10016 USA; NYU, Dept Chem, New York, NY 10013 USA; Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA; Amer Red Cross, Holland Lab, Dept Tissue Biol, Rockville, MD 20855 USA	New York University; New York University; New York University; New York University; New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center; American Red Cross	Klein, S (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [R01CA034282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058433] Funding Source: NIH RePORTER; NCI NIH HHS [CA237853, CA34282] Funding Source: Medline; NIGMS NIH HHS [R01GM58433] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arese M, 1999, MOL BIOL CELL, V10, P1429, DOI 10.1091/mbc.10.5.1429; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; BIKFALVI A, 1995, J CELL BIOL, V129, P233, DOI 10.1083/jcb.129.1.233; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; BUGLER B, 1991, MOL CELL BIOL, V11, P573, DOI 10.1128/MCB.11.1.573; BURGESS WH, 1991, CELL REGUL, V2, P87, DOI 10.1091/mbc.2.2.87; COUDERC B, 1991, CELL REGUL, V2, P709, DOI 10.1091/mbc.2.9.709; Dealy CN, 1997, DEV BIOL, V184, P343, DOI 10.1006/dbio.1997.8525; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Henry MF, 1996, MOL CELL BIOL, V16, P3668; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; JACKSON A, 1995, J BIOL CHEM, V270, P33, DOI 10.1074/jbc.270.1.33; KANDEL J, 1991, CELL, V66, P1095, DOI 10.1016/0092-8674(91)90033-U; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; KILEDJIAN M, 1994, RNA PROTEIN INTERACT, P127; Klein S, 1996, GROWTH FACTORS, V13, P219, DOI 10.3109/08977199609003223; KLIEN S, 1996, J BIOL CHEM, V37, P22583; Koga C, 1999, BIOCHEM BIOPH RES CO, V261, P756, DOI 10.1006/bbrc.1999.1039; LISCHWE MA, 1985, J BIOL CHEM, V260, P14304; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; LIU Q, 1995, MOL CELL BIOL, V15, P2800; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Pinol-Roma S, 1999, MOL BIOL CELL, V10, P77, DOI 10.1091/mbc.10.1.77; Pintucci G, 1996, MOL BIOL CELL, V7, P1249, DOI 10.1091/mbc.7.8.1249; Piotrowicz RS, 1997, J BIOL CHEM, V272, P7042, DOI 10.1074/jbc.272.11.7042; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; QUARTO N, 1991, J CELL PHYSIOL, V147, P311, DOI 10.1002/jcp.1041470217; RAWAL N, 1995, BBA-PROTEIN STRUCT M, V1248, P11, DOI 10.1016/0167-4838(94)00213-Z; RENKO M, 1990, J CELL PHYSIOL, V144, P108, DOI 10.1002/jcp.1041440114; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Shen B, 1998, BIOCHEM BIOPH RES CO, V252, P524, DOI 10.1006/bbrc.1998.9677; SOMMER A, 1989, BIOCHEM BIOPH RES CO, V160, P1267, DOI 10.1016/S0006-291X(89)80140-8; STACHOWIAK MK, 1994, J CELL BIOL, V127, P203, DOI 10.1083/jcb.127.1.203; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P14001; YU ZX, 1993, EXP CELL RES, V204, P247, DOI 10.1006/excr.1993.1031	43	43	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3150	3157		10.1074/jbc.275.5.3150	http://dx.doi.org/10.1074/jbc.275.5.3150			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652299	hybrid			2022-12-27	WOS:000085146500021
J	Parra, M; Gascard, P; Walensky, LD; Gimm, JA; Blackshaw, S; Chan, N; Takakuwa, Y; Berger, T; Lee, G; Chasis, JA; Snyder, SH; Mohandas, N; Conboy, JG				Parra, M; Gascard, P; Walensky, LD; Gimm, JA; Blackshaw, S; Chan, N; Takakuwa, Y; Berger, T; Lee, G; Chasis, JA; Snyder, SH; Mohandas, N; Conboy, JG			Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; MEMBRANE SKELETAL PROTEIN-4.1; SPECTRIN-ACTIN-BINDING; ERYTHROCYTE PROTEIN-4.1; STRUCTURAL PROTEIN-4.1; 4.1-BINDING SITE; TERNARY COMPLEX; GLYCOPHORIN-C; CELL-BODIES; DOMAIN	Brain-enriched isoforms of skeletal proteins in the spectrin and ankyrin gene families have been described. Here we characterize protein 4.1B, a novel homolog of erythrocyte protein 4.1R that is encoded by a distinct gene. In situ hybridization revealed high level, focal expression of 4.1B mRNA in select neuronal populations within the mouse brain, including Purkinje cells of the cerebellum, pyramidal cells in hippocampal regions CA1-3, thalamic nuclei, and olfactory bulb. Expression was also detected in adrenal gland, kidney, testis, and heart. 4.1B protein exhibits high homology to the membrane binding, spectrin-actin binding, and C-terminal domains of 4.1R, including motifs for interaction with NuMA and FKBP13, cDNA characterization and Western blot analysis revealed multiple spliceoforms of protein 4.1B, with functionally relevant heterogeneity in the spectrin-actin and NuMA binding domains. Regulated alternative splicing events led to expression of unique 4.1B isoforms in brain and muscle; only the latter possessed a functional spectrin-actin binding domain. By immunofluorescence, 4.1B was localized specifically at the plasma membrane in regions of cell-cell contact. Together these results indicate that 4.1B transcription is selectively regulated among neuronal populations and that alternative splicing regulates expression of 4.1B isoforms possessing critical functional domains typical of other protein 4.1 family members.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Tokyo Womens Med Univ, Sch Med, Dept Biochem, Tokyo 162, Japan; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Johns Hopkins University; Tokyo Women's Medical University; University of California System; University of California Davis	Conboy, JG (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, MS 74-174, Berkeley, CA 94720 USA.			Gascard, Philippe/0000-0001-5912-5228	NHLBI NIH HHS [HL45182] Funding Source: Medline; NIDDK NIH HHS [P01 DK032094, DK32094] Funding Source: Medline; NIMH NIH HHS [MH18501] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL045182, R01HL045182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		An XL, 1996, J BIOL CHEM, V271, P33187, DOI 10.1074/jbc.271.52.33187; ANDERSON RA, 1988, J CELL BIOCHEM, V37, P269, DOI 10.1002/jcb.240370303; Baklouti F, 1997, GENOMICS, V39, P289, DOI 10.1006/geno.1996.4512; Baklouti F, 1996, BLOOD, V87, P3934, DOI 10.1182/blood.V87.9.3934.bloodjournal8793934; CHAN W, 1993, J CELL BIOL, V123, P1463, DOI 10.1083/jcb.123.6.1463; CHASIS JA, 1993, J CLIN INVEST, V91, P329, DOI 10.1172/JCI116189; Chasis JA, 1996, BLOOD, V87, P5324, DOI 10.1182/blood.V87.12.5324.bloodjournal87125324; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; CORREAS I, 1991, BIOCHEM J, V279, P581, DOI 10.1042/bj2790581; DeCarcer G, 1995, BIOCHEM J, V312, P871, DOI 10.1042/bj3120871; DISCHER D, 1993, J BIOL CHEM, V268, P7186; DISCHER DE, 1995, J CELL BIOL, V130, P897, DOI 10.1083/jcb.130.4.897; FEHON RG, 1994, DEVELOPMENT, V120, P545; FOWLER V, 1980, J CELL BIOL, V85, P361, DOI 10.1083/jcb.85.2.361; Gascard P, 1999, MOL BIOL CELL, V10, P1783, DOI 10.1091/mbc.10.6.1783; Grabowski PJ, 1998, CELL, V92, P709, DOI 10.1016/S0092-8674(00)81399-9; GRANGER BL, 1984, CELL, V37, P595, DOI 10.1016/0092-8674(84)90390-8; HEMMING NJ, 1994, BIOCHEM J, V299, P191, DOI 10.1042/bj2990191; HORNE WC, 1993, BLOOD, V82, P2558; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; KORDELI E, 1991, J CELL BIOL, V114, P1243, DOI 10.1083/jcb.114.6.1243; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Krauss SW, 1997, P NATL ACAD SCI USA, V94, P7297, DOI 10.1073/pnas.94.14.7297; KREBS KE, 1987, J NEUROSCI, V7, P3907; KREBS KE, 1987, BRAIN RES BULL, V18, P793, DOI 10.1016/0361-9230(87)90218-8; Lallena MJ, 1998, J CELL SCI, V111, P1963; LETO TL, 1984, J BIOL CHEM, V259, P4603; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; Luque CM, 1998, J BIOL CHEM, V273, P11643, DOI 10.1074/jbc.273.19.11643; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Modafferi EF, 1999, RNA, V5, P687, DOI 10.1017/S1355838299990155; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; OTTO E, 1991, J CELL BIOL, V114, P241, DOI 10.1083/jcb.114.2.241; Parra M, 1998, GENOMICS, V49, P298, DOI 10.1006/geno.1998.5265; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; PETERS LL, 1991, J CELL BIOL, V114, P1233, DOI 10.1083/jcb.114.6.1233; Peters LL, 1998, GENOMICS, V54, P348, DOI 10.1006/geno.1998.5537; RALSTON GB, 1976, BIOCHIM BIOPHYS ACTA, V455, P163, DOI 10.1016/0005-2736(76)90161-9; SCHANUS E, 1985, J BIOL CHEM, V260, P3724; Schischmanoff PO, 1997, J BIOL CHEM, V272, P10254, DOI 10.1074/jbc.272.15.10254; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; TANAKA T, 1991, J BIOL CHEM, V266, P1134; Tang CJC, 1998, BLOOD, V92, P1442, DOI 10.1182/blood.V92.4.1442.416k14_1442_1447; TANG TK, 1990, J CELL BIOL, V110, P617, DOI 10.1083/jcb.110.3.617; Tran YK, 1999, CANCER RES, V59, P35; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; Walensky LD, 1998, CURR BIOL, V8, P1269, DOI 10.1016/S0960-9822(07)00536-2; Walensky LD, 1999, J NEUROSCI, V19, P6457; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	56	99	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3247	3255		10.1074/jbc.275.5.3247	http://dx.doi.org/10.1074/jbc.275.5.3247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652311	hybrid			2022-12-27	WOS:000085146500033
J	Tachibanaki, S; Nanda, K; Sasaki, K; Ozaki, K; Kawamura, S				Tachibanaki, S; Nanda, K; Sasaki, K; Ozaki, K; Kawamura, S			Amino acid residues of S-modulin responsible for interaction with rhodopsin kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR LIGHT-ADAPTATION; CYCLIC-GMP PHOSPHODIESTERASE; CALCIUM-BINDING PROTEINS; GUANYLATE-CYCLASE; RETINAL RODS; FROG RODS; RECOVERIN; PHOSPHORYLATION; ACTIVATOR; MECHANISM	S-modulin in frog or its bovine homologue, recoverin, is a 23-kDa EF-hand Ca2+-binding protein found in rod photoreceptors. The Ca2+-bound form of S-modulin binds to rhodopsin kinase (Rk) and inhibits its activity. Through this regulation, S-modulin is thought to modulate the light sensitivity of a rod. In the present study, we tried to identify the interaction site of the Ca2+-bound form of S-modulin to Rk. First, we mapped roughly the interaction regions by using partial peptides of S-modulin, The result suggested that a specific region near the amino terminus is the interaction site of S-modulin. We then identified the essential amino acid residues in this region by using S-modulin mutant proteins: four amino acid residues (Phe(22), Glu(26), Phe(55), and Thr(92)) were suggested to interact with Rk, These residues are located in a small closed pocket in the Ca2+- free, inactive form of S-modulin, but exposed to the surface of the molecule in the Ca2+-bound, active form of S-modulin, Two additional amino acid residues (Tyr(108) and Arg(150)) were found to be crucial for the Ca2+-dependent conformational changes of S-modulin.	Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 5600043, Japan	Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol, Machikane Yama 1-1, Toyonaka, Osaka 5600043, Japan.		Ozaki, Koichi/O-2798-2015	Ozaki, Koichi/0000-0001-7268-5377				AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GORODOVIKOVA EN, 1993, FEBS LETT, V335, P277, DOI 10.1016/0014-5793(93)80746-H; Hisatomi O, 1997, BIOCHEM BIOPH RES CO, V234, P173, DOI 10.1006/bbrc.1997.6609; Johnson WC, 1997, BBA-PROTEIN STRUCT M, V1342, P164, DOI 10.1016/S0167-4838(97)00091-5; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; KAWAMURA S, 1994, NEUROSCI RES, V20, P293, DOI 10.1016/0168-0102(94)90050-7; Kawamura S, 1996, J BIOL CHEM, V271, P21359, DOI 10.1074/jbc.271.35.21359; Kawamura Satoru, 1995, P105; KOBAYASHI M, 1992, BIOCHEM BIOPH RES CO, V189, P511, DOI 10.1016/0006-291X(92)91587-G; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUNO T, 1992, BIOCHEM BIOPH RES CO, V184, P1219, DOI 10.1016/S0006-291X(05)80012-9; LENZ SE, 1992, MOL BRAIN RES, V15, P133, DOI 10.1016/0169-328X(92)90160-D; Matsuda S, 1998, J BIOL CHEM, V273, P20223, DOI 10.1074/jbc.273.32.20223; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; McCarthy ST, 1996, J NEUROPHYSIOL, V76, P1991, DOI 10.1152/jn.1996.76.3.1991; MILLER JL, 1986, BIOCHEMISTRY-US, V25, P4983, DOI 10.1021/bi00366a002; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NEF S, 1995, J RECEPT SIGNAL TR R, V15, P365, DOI 10.3109/10799899509045227; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Sampath AP, 1998, J GEN PHYSIOL, V111, P53, DOI 10.1085/jgp.111.1.53; Sato N, 1997, J BIOCHEM-TOKYO, V122, P1139; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9	37	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3313	3319		10.1074/jbc.275.5.3313	http://dx.doi.org/10.1074/jbc.275.5.3313			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652319	hybrid			2022-12-27	WOS:000085146500041
J	Cosme, J; Johnson, EF				Cosme, J; Johnson, EF			Engineering microsomal cytochrome P4502C5 to be a soluble, monomeric enzyme - Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; RABBIT CYTOCHROME-P-450; ESCHERICHIA-COLI; SUBSTRATE; MODEL; REDUCTASE; P450BM-3; DOMAIN; ACID; 2C3	Deletion of the N-terminal membrane-spanning domain from microsomal P450s 2C5 and 2C3 generates the enzymes, 2C5dH and 2C3dH, that exhibit a salt-dependent association with membranes indicating that they retain a monofacial membrane interaction domain. The two proteins are tetramers and dimers, respectively, in high salt buffers, and only 2C5dh requires phospholipids to reconstitute fully the catalytic activity of the enzyme. Amino acid residues derived from P450 2C3dH between residues 201 and 210 were substituted for the corresponding residues in P450 2C5 to identify those that would diminish the membrane interaction, the phospholipid dependence of catalysis, and aggregation of 2C5dH. Each of four substitutions, N202H, I207L, S209G, and S210T, diminished the aggregation of P450 2C5dH and produced a monomeric enzyme. The N202H and I207L mutations also diminished the stimulation of catalytic activity by phospholipid and reduced the binding of P450 2C5dH to phospholipid vesicles. The modified enzymes exhibit rates of progesterone 21-hydroxylation that are similar to that of P450 2C5dH. These conditionally membrane-bound P450s with improved solubility in high salt buffers are suitable for crystallization and structural determination by x-ray diffraction studies.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Johnson, EF (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 105550 N Torrey Pines Rd,NX-4, La Jolla, CA 92037 USA.	johnson@scripps.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00833] Funding Source: Medline; NIGMS NIH HHS [GM31001] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; Chang YT, 1997, PROTEIN ENG, V10, P119, DOI 10.1093/protein/10.2.119; deGroot MJ, 1996, CHEM RES TOXICOL, V9, P1079, DOI 10.1021/tx960003i; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; GRAHAMLORENCE SE, 1995, PHYSL FUNCTIONS CYTO, P57; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; IKUSHIRO S, 1989, BIOCHIM BIOPHYS ACTA, V984, P50, DOI 10.1016/0005-2736(89)90341-6; INGELMANSUNDBERG M, 1980, BIOCHEMISTRY-US, V19, P4004, DOI 10.1021/bi00558a018; JOHNSON EF, 1979, MOL PHARMACOL, V15, P708; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; Luo Zongshu, 1994, Archives of Biochemistry and Biophysics, V309, P52; Modi S, 1996, BIOCHEMISTRY-US, V35, P4540, DOI 10.1021/bi952742o; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; OMURA T, 1964, J BIOL CHEM, V239, P2379; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; RICHARDSON TH, 1993, ARCH BIOCHEM BIOPHYS, V300, P510, DOI 10.1006/abbi.1993.1069; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SZKLARZ GD, 1994, J BIOMOL STRUCT DYN, V12, P61, DOI 10.1080/07391102.1994.10508088; SZKLARZ GD, 1995, BIOCHEMISTRY-US, V34, P14312, DOI 10.1021/bi00044a008; TANIGUCHI H, 1984, ARCH BIOCHEM BIOPHYS, V232, P585, DOI 10.1016/0003-9861(84)90577-0; TRUDELL JR, 1982, MOL PHARMACOL, V21, P710; Von Wachenfeldt Claes, 1995, P183; vonWachenfeldt C, 1997, ARCH BIOCHEM BIOPHYS, V339, P107, DOI 10.1006/abbi.1996.9859; WILLIAMS PA, 2000, IN PRESS MOL CELL; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; YOSHIDA Y, 1980, J BIOCHEM-TOKYO, V88, P463, DOI 10.1093/oxfordjournals.jbchem.a132993	29	135	142	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2545	2553		10.1074/jbc.275.4.2545	http://dx.doi.org/10.1074/jbc.275.4.2545			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644712	hybrid			2022-12-27	WOS:000085128000044
J	Hu, DL; Crist, M; Duan, XQ; Quiocho, FA; Gimble, FS				Hu, DL; Crist, M; Duan, XQ; Quiocho, FA; Gimble, FS			Probing the structure of the PI-SceI-DNA complex by affinity cleavage and affinity photocross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SPLICING DOMAIN; HOMING ENDONUCLEASE; SACCHAROMYCES-CEREVISIAE; CROSS-LINKING; ADENOSINE-TRIPHOSPHATASE; CRYSTAL-STRUCTURE; RNA-POLYMERASE; I-CREI; BINDING; SITE	The PI-SceI protein is an intein-encoded homing endonuclease that initiates the mobility of its gene by making a double strand break at a single site in the yeast genome. The PI-SceI protein splicing and endonucleolytic active sites are separately located in each of two domains in the PI-SceI structure. To determine the spatial relationship between bases in the PI-SceI recognition sequence and selected PI-SceI amino acids, the PI-SceI-DNA complex was probed by photocross-linking and affinity cleavage methods. Unique solvent-accessible cysteine residues were introduced into the two PI-SceI domains at positions 91, 97, 170, 230, 376, and 378, and the mutant proteins mere modified with either 4-azidophenacyl bromide or iron (S)-1-(p-bromoacetamidobenzyl) -ethylenediaminetetraacetate (FeBABE), The phenyl azide-coupled proteins cross-linked to the PI-SceI target sequence, and the FeBABE-modified proteins cleaved the DNA proximal to the derivatized amino acid. The results suggest that an extended beta-hairpin loop in the endonuclease domain that contains residues 376 and 378 contacts the major groove near the PI-SceI cleavage site. Conversely, residues 91, 97, and 170 in the protein splicing domain are in close proximity to a distant region of the substrate. To interpret our results, we used a new PI-SceI structure that is ordered in regions of the protein that bind DNA. The data strongly support a model of the PI-SceI-DNA complex derived from this structure.	Texas A&M Univ, Ctr Genome Res, Inst Biosci & Technol, Syt Hlth Sci Ctr, Houston, TX 77030 USA; Texas A&M Univ, Dept Med Biochem & Genet, Syst Hlth Sci Ctr, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Verna Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Gimble, FS (corresponding author), Texas A&M Univ, Ctr Genome Res, Inst Biosci & Technol, Syt Hlth Sci Ctr, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	fgimble@ibt.tamu.edu	Wood, David W/B-2992-2012; Meares, Claude F/A-8345-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050815] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50815] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal AK, 1998, CURR OPIN STRUC BIOL, V8, P19, DOI 10.1016/S0959-440X(98)80005-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Carter ES, 1996, COMPUT APPL BIOSCI, V12, P25; CHEN Y, 1993, J MOL BIOL, V230, P453, DOI 10.1006/jmbi.1993.1162; CHRISTOPHER JA, 1998, SPOCK SOFTWARE VERSI; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Derbyshire V, 1997, P NATL ACAD SCI USA, V94, P11466, DOI 10.1073/pnas.94.21.11466; DERVAN PB, 1991, METHOD ENZYMOL, V208, P497; DUAN X, 1998, THESIS BAYLOR COLL M; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; DUMOULIN P, 1993, P NATL ACAD SCI USA, V90, P2030, DOI 10.1073/pnas.90.5.2030; Dumoulin P, 1996, BIOCHEMISTRY-US, V35, P4279, DOI 10.1021/bi9529162; EBRIGHT YW, 1992, BIOCHEMISTRY-US, V31, P10664, DOI 10.1021/bi00159a004; Gimble FS, 1996, J MOL BIOL, V263, P163, DOI 10.1006/jmbi.1996.0567; Gimble FS, 1998, J BIOL CHEM, V273, P30524, DOI 10.1074/jbc.273.46.30524; GIMBLE FS, 1995, J BIOL CHEM, V270, P5849, DOI 10.1074/jbc.270.11.5849; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; GIMBLE FS, 1993, J BIOL CHEM, V268, P21844; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; Grindl W, 1998, NUCLEIC ACIDS RES, V26, P1857, DOI 10.1093/nar/26.8.1857; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; He ZN, 1998, J BIOL CHEM, V273, P4607, DOI 10.1074/jbc.273.8.4607; Heath PJ, 1997, NAT STRUCT BIOL, V4, P468, DOI 10.1038/nsb0697-468; HIRATA R, 1990, J BIOL CHEM, V265, P6726; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu DL, 1999, BIOCHEMISTRY-US, V38, P12621, DOI 10.1021/bi991192h; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami K, 1997, P NATL ACAD SCI USA, V94, P1709, DOI 10.1073/pnas.94.5.1709; OAKLEY MG, 1990, SCIENCE, V248, P847, DOI 10.1126/science.2111578; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Papavassiliou A G, 1994, Methods Mol Biol, V30, P43; Pingoud V, 1999, J BIOL CHEM, V274, P10235, DOI 10.1074/jbc.274.15.10235; Silva GH, 1999, J MOL BIOL, V286, P1123, DOI 10.1006/jmbi.1998.2519; Wende W, 1996, NUCLEIC ACIDS RES, V24, P4123, DOI 10.1093/nar/24.21.4123	42	27	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2705	2712		10.1074/jbc.275.4.2705	http://dx.doi.org/10.1074/jbc.275.4.2705			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644733	hybrid			2022-12-27	WOS:000085128000065
J	Kosalkova, K; Marcos, AT; Fierro, F; Hernando-Rico, V; Gutierrez, S; Martin, JF				Kosalkova, K; Marcos, AT; Fierro, F; Hernando-Rico, V; Gutierrez, S; Martin, JF			A novel heptameric sequence (TTAGTAA) is the binding site for a protein required for high level expression of pcbAB, the first gene of the penicillin biosynthesis in Penicillium chrysogenum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENICILLIN-N SYNTHETASE; AMINOADIPYL-CYSTEINYL-VALINE; ASPERGILLUS-NIDULANS; CATABOLITE REPRESSION; MOLECULAR REGULATION; FILAMENTOUS FUNGI; CLUSTER; TRANSCRIPTION; PROMOTER; AMPLIFICATION	The first two genes pcbAB and pcbC of the penicillin biosynthesis pathway are expressed from a 1.01-kilobase bidirectional promoter region. A series of sequential deletions were made in the pcbAB promoter region, and the constructions with the modified promoters coupled to the lacZ reporter gene were introduced as single copies at the pyrG locus in Penicillium chrysogenum npe10, Three regions, boxes A, B, and C, produced a significant decrease in expression of the reporter gene when deleted. Protein-DNA complexes were observed by using the electrophoretic mobility shift assay with boxes A and B (complexes AGI, BG1, BG2, and BL1) but not with box C, Uracil interference assay showed that a protein in P. chrysogenum cell extracts interacts with the thymines in a palindromic heptanucleotide TTAGTAA. Point mutations and deletion of the entire TTAGTAA sequence supported the involvement of this sequence in the binding of a transcriptional activator named penicillin transcriptional activator 1 (PTA1). In vivo studies using constructions carrying point mutations in the TTAGTAA sequence (or a deletion of the complete heptanucleotide) confirmed that this intact sequence is required for high level expression of the pcbAB gene. The TTAGTAA sequence resembles the target sequence of BASS (PHO2), a factor required for expression of several genes in yeasts.	Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain	Universidad de Leon	Martin, JF (corresponding author), Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain.		Gutiérrez, Santiago/H-6456-2015	Gutiérrez, Santiago/0000-0001-6659-1390; Kosalkova, Katarina/0000-0002-4792-7239; Marcos, Ana Teresa/0000-0002-0263-7473; Fierro, Francisco/0000-0002-2582-5362				ALVAREZ E, 1993, EUR J BIOCHEM, V215, P323, DOI 10.1111/j.1432-1033.1993.tb18038.x; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BARREDO JL, 1989, CURR GENET, V16, P453, DOI 10.1007/BF00340725; Brakhage AA, 1997, FEMS MICROBIOL LETT, V148, P1; BRAKHAGE AA, 1992, J BACTERIOL, V174, P3789, DOI 10.1128/JB.174.11.3789-3799.1992; Brakhage AA, 1998, MICROBIOL MOL BIOL R, V62, P547, DOI 10.1128/MMBR.62.3.547-585.1998; CANTORAL JM, 1993, J BIOL CHEM, V268, P737; CANTORAL JM, 1987, BIO-TECHNOL, V5, P494, DOI 10.1038/nbt0587-494; CHU YW, 1995, CURR GENET, V28, P184, DOI 10.1007/BF00315786; Chu YW, 1997, APPL MICROBIOL BIOT, V47, P250, DOI 10.1007/s002530050922; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; DHAWALE SS, 1993, NUCLEIC ACIDS RES, V21, P5537, DOI 10.1093/nar/21.24.5537; DIEZ B, 1990, J BIOL CHEM, V265, P16358; Favaloro J, 1980, Methods Enzymol, V65, P718; FENG B, 1994, APPL ENVIRON MICROB, V60, P4432, DOI 10.1128/AEM.60.12.4432-4439.1994; FENG B, 1995, CURR GENET, V27, P351, DOI 10.1007/BF00352104; FIERRO F, 1993, MOL GEN GENET, V241, P573, DOI 10.1007/BF00279899; Fierro F, 1996, CURR GENET, V29, P482; Fierro F, 1996, APPL MICROBIOL BIOT, V44, P597; FIERRO F, 1995, P NATL ACAD SCI USA, V92, P6200, DOI 10.1073/pnas.92.13.6200; GUTIERREZ S, 1999, MICROBIOLOGY READ, V145, P315; HAAS H, 1995, CURR GENET, V28, P177, DOI 10.1007/BF00315785; Laich F, 1999, APPL ENVIRON MICROB, V65, P1236; LOPEZNIETO MJ, 1985, APPL MICROBIOL BIOT, V22, P343, DOI 10.1007/BF00582418; MACCABE AP, 1990, EMBO J, V9, P279, DOI 10.1002/j.1460-2075.1990.tb08106.x; Martin JE, 1999, ANTON LEEUW INT J G, V75, P21, DOI 10.1023/A:1001820109140; MARTIN JF, 1997, FUNGAL BIOTECHNOLOGY, P91; Penalva MA, 1998, TRENDS BIOTECHNOL, V16, P483, DOI 10.1016/S0167-7799(98)01229-3; PEREZESTEBAN B, 1993, MOL MICROBIOL, V9, P881, DOI 10.1111/j.1365-2958.1993.tb01746.x; RAMOS FR, 1985, ANTIMICROB AGENTS CH, V27, P380, DOI 10.1128/AAC.27.3.380; SMITH DJ, 1989, MOL GEN GENET, V216, P492, DOI 10.1007/BF00334395; Suarez T, 1996, MOL MICROBIOL, V20, P529, DOI 10.1046/j.1365-2958.1996.5421065.x; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; Vichitsoonthonkul T, 1996, CURR GENET, V30, P447, DOI 10.1007/s002940050155	34	33	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2423	2430		10.1074/jbc.275.4.2423	http://dx.doi.org/10.1074/jbc.275.4.2423			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644695	hybrid			2022-12-27	WOS:000085128000027
J	MacLachlan, TK; Somasundaram, K; Sgagias, M; Shifman, Y; Muschel, RJ; Cowan, KH; El-Deiry, WS				MacLachlan, TK; Somasundaram, K; Sgagias, M; Shifman, Y; Muschel, RJ; Cowan, KH; El-Deiry, WS			BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II HOLOENZYME; TRANSCRIPTIONAL ACTIVATION; DEPENDENT KINASES; CDK INHIBITORS; TNF RECEPTOR-1; GROWTH-ARREST; CANCER-CELLS; P53; PROTEIN; BREAST	The breast and ovarian cancer susceptibility gene product BRCA1 has been reported to be expressed in a cell cycle-dependent manner; possess transcriptional activity; associate with several proteins, including the p53 tumor suppressor; and play an integral role in certain types of DNA repair. We show here that ectopic expression of BRCA1 using an adenovirus vector (Ad-BRCA1) leads to dephosphorylation of the retinoblastoma protein accompanied by a decrease in cyclin-dependent kinase activity. Flow cytometric analysis on Ad-BRCA1-infected cells revealed a G(1) or G(2) phase ac cumulation, High density cDNA array screening of colon, lung and breast cancer cells identified several genes affected by BRCA1 expression in a p53-independent manner, including DNA damage response genes and genes involved in cell cycle control, Notable changes included induction of the GADD45 and GADD153 genes and a reduction in cyclin B1 expression. Therefore, BRCA1 has the potential to modulate the expression of genes and function of proteins involved in cell cycle control and DNA damage response pathways.	Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regual, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA; NCI, Med Branch, NIH, Bethesda, MD 20892 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	El-Deiry, WS (corresponding author), Univ Penn, Sch Med, Lab Mol Oncol & Cell Cycle Regual, Philadelphia, PA 19104 USA.	weldeir@hhmi.upenn.edu	El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266				AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; El-Deiry WS, 1998, CURR TOP MICROBIOL, V227, P121; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; HWANG A, 1995, J BIOL CHEM, V270, P28419; Kao GD, 1997, CANCER RES, V57, P753; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lu KP, 1996, NATURE, V380, P544; MACLACHLAN TK, 1995, CRIT REV EUKAR GENE, V5, P127, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.20; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Patton GW, 1997, TOXICOL APPL PHARM, V147, P126, DOI 10.1006/taap.1997.8227; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Shao NS, 1996, ONCOGENE, V13, P1; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; THOMAS T, 1994, CANCER RES, V54, P1077; Tomlinson GE, 1998, CANCER RES, V58, P3237; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; WALDMAN T, 1995, CANCER RES, V55, P5187; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang Q, 1998, ONCOGENE, V17, P1939, DOI 10.1038/sj.onc.1202403; Wu GS, 1996, CLIN CANCER RES, V2, P623; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; ZHAN QM, 1994, CANCER RES, V54, P2755; ZHAN QM, 1995, INT J ONCOL, V6, P937; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	52	189	200	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2777	2785		10.1074/jbc.275.4.2777	http://dx.doi.org/10.1074/jbc.275.4.2777			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644742	hybrid			2022-12-27	WOS:000085128000074
J	Bruser, T; Selmer, T; Dahl, C				Bruser, T; Selmer, T; Dahl, C			"ADP sulfurylase" from Thiobacillus denitrificans is an adenylylsulfate : phosphate adenylyltransferase and belongs to a new family of nucleotidyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; CHLOROBIUM-VIBRIOFORME; SULFIDE OXIDATION; ATP SULFURYLASE; BINDING-SITE; BACTERIA; YEAST; PURIFICATION; GENERATION	During AMP-dependent sulfite oxidation by some sulfur bacteria, the liberation of sulfate from adenosine-5'-phosphosulfate (APS) is catalyzed by APS:phosphate adenylyltransferase (APAT), Here we report the first biochemical and genetic characterization of APAT, We isolated this enzyme from the chemolithoautotroph Thiobacillus denitrificans and cloned the corresponding gene, The enzyme is homodimeric with 41,387-Da subunits and exhibits a specific activity of 2100 mu mol min(-1) mg(-1). The K-m values are K-m(APS) = 300 mu M and K-m(Pi), = 12 mM. Catalysis occurs by a ping-pong mechanism with a covalently bound AMP as reaction intermediate. The arsenolysis of APS, but not of ADP, CDP, GDP, UDP, or IDP, is also catalyzed, indicating a specific and unidirectional function. The former enzyme name ADP-sulfurylase implies that the reverse reaction is catalyzed; therefore, this name should not be used any longer. Histidine modification of APAT results in complete inactivation that can be suppressed by substrate addition. APAT is highly similar to galactose-1-phosphate uridylyltransferase and also related to Ap(4)A phosphorylase, Active site residues of galactose-1-phosphate uridylyltransferase are conserved in APAT and Ap(4)A phosphorylase, suggesting a histidine as the nucleotide-binding residue in all three enzymes, which together form a new family of nucleotidyltransferases.	Univ Bonn, Inst Mikrobiol & Biotechnol, D-53115 Bonn, Germany; Univ Marburg, Fachbereich Biol Mikrobiol, D-35032 Marburg, Germany	University of Bonn; Philipps University Marburg	Dahl, C (corresponding author), Univ Bonn, Inst Mikrobiol & Biotechnol, Meckenheimer Allee 168, D-53115 Bonn, Germany.		Dahl, Christiane/H-4786-2019	Dahl, Christiane/0000-0001-8288-7546; Bruser, Thomas/0000-0002-5889-8306				ADAMS CA, 1972, BIOCHEM J, V128, P647, DOI 10.1042/bj1280647; ALGUERO M, 1988, Microbiologia (Madrid), V4, P149; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIAS U, 1987, ARCH MICROBIOL, V147, P406, DOI 10.1007/BF00406141; BOWEN TJ, 1966, BIOCHIM BIOPHYS ACTA, V118, P566, DOI 10.1016/S0926-6593(66)80098-X; Brune DC, 1995, ANOXYGENIC PHOTOSYNT, P847, DOI 10.1007/0-306-47954-0_39; CALIGAN JE, 1995, CURRENT PROTOCOLS PR; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; COOPER BP, 1979, Z NATURFORSCH C, V34, P346; DAHL C, 1994, METHOD ENZYMOL, V243, P400; DAHL C, 1989, Z NATURFORSCH C, V44, P137; FARLEY JR, 1979, J BIOL CHEM, V254, P3537; GURANOWSKI A, 1986, J BIOL CHEM, V261, P5943; Hagen KD, 1997, APPL ENVIRON MICROB, V63, P3957, DOI 10.1128/AEM.63.10.3957-3964.1997; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOOPER AB, 1985, MICROBIOL REV, V49, P140, DOI 10.1128/MMBR.49.2.140-157.1985; Kelly DP, 1997, ANTON LEEUW INT J G, V71, P95, DOI 10.1023/A:1000135707181; KHANNA S, 1983, J GEN MICROBIOL, V129, P1365; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN YP, 1994, J BACTERIOL, V176, P44, DOI 10.1128/JB.176.1.44-49.1994; MARCH PE, 1988, ONCOGENE, V2, P539; Marzluf GA, 1997, ANNU REV MICROBIOL, V51, P73, DOI 10.1146/annurev.micro.51.1.73; NICHOLLS RG, 1977, BIOCHEM J, V165, P149, DOI 10.1042/bj1650149; PECK HD, 1960, P NATL ACAD SCI USA, V46, P1053, DOI 10.1073/pnas.46.8.1053; PLATEAU P, 1989, J BACTERIOL, V171, P6437, DOI 10.1128/jb.171.12.6437-6445.1989; Reinartz M, 1998, ARCH MICROBIOL, V170, P59, DOI 10.1007/s002030050615; RENOSTO F, 1991, ARCH BIOCHEM BIOPHYS, V290, P66, DOI 10.1016/0003-9861(91)90592-7; ROBINSON AK, 1991, BIOCHEM J, V279, P135, DOI 10.1042/bj2790135; RUZICKA FJ, 1995, BIOCHEMISTRY-US, V34, P5610, DOI 10.1021/bi00016a036; Sambrook J., 2002, MOL CLONING LAB MANU; SCHEDEL M, 1979, BIOCHIM BIOPHYS ACTA, V568, P454, DOI 10.1016/0005-2744(79)90314-0; SCHEDEL M, 1980, ARCH MICROBIOL, V124, P205, DOI 10.1007/BF00427728; SCHUG A, 1979, THESIS U BONN GERMAN; Schwartz NB, 1998, CHEM-BIOL INTERACT, V109, P143, DOI 10.1016/S0009-2797(97)00129-4; SMITH DW, 1991, VARIATIONS AUTOTROPH, P121; STEINERT PM, 1974, ANAL BIOCHEM, V59, P416, DOI 10.1016/0003-2697(74)90294-2; THIELE HH, 1968, A VAN LEEUW J MICROB, V34, P350, DOI 10.1007/BF02046457; Thoden JB, 1997, BIOCHEMISTRY-US, V36, P1212, DOI 10.1021/bi9626517; WEDEKIND JE, 1995, BIOCHEMISTRY-US, V34, P11049, DOI 10.1021/bi00035a010; Wedekind JE, 1996, BIOCHEMISTRY-US, V35, P11560, DOI 10.1021/bi9612677; Woltjer RL, 1997, BIOCHEMISTRY-US, V36, P9911, DOI 10.1021/bi963007v	41	36	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1691	1698		10.1074/jbc.275.3.1691	http://dx.doi.org/10.1074/jbc.275.3.1691			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636864	hybrid			2022-12-27	WOS:000084940000027
J	Shainskaya, A; Schneeberger, A; Apell, HJ; Karlish, SJD				Shainskaya, A; Schneeberger, A; Apell, HJ; Karlish, SJD			Entrance port for Na+ and K+ ions on Na+,K+-ATPase in the cytoplasmic loop between trans-membrane segments M6 and M7 of the alpha subunit - Proximity of the cytoplasmic segment of the beta subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; CATION OCCLUSION; NA/K-ATPASE; TRANSMEMBRANE SEGMENT-6; INTRACELLULAR-TRANSPORT; EXTRACELLULAR SURFACE; RB+ OCCLUSION; NA,K-ATPASE; DOMAIN	Based on the following observations we propose that the cytoplasmic loop between trans-membrane segments M6 and M7 (L6/7) of the a subunit of Na+,K+-ATPase acts as an entrance port for Na+ and K+ ions. 1) In defined conditions chymotrypsin specifically cleaves L6/7 in the M5/M6 fragment of 19-kDa membranes, produced by extensive proteolysis of Na+,K+-ATPase, and in parallel inactivates Rb+ occlusion, 2) Dissociation of the MB/MB fragment from 19-kDa membranes is prevented either by occluded cations or by competitive antagonists such as Ca2+, Mg2+, La3+,p-xylylene bisguanidinium and m-xylylene bisguanidinium, or 1-bromo-2,4,6-tris (methylisothiouronium)benzene and 1,3-dibromo-2,4,6-tris (methylisothiouronium)benzene (Br-2-TITU3+). 3) Ca2+ ions raise electrophoretic mobility of the M5/M6 fragment but not that of the other fragments of the alpha subunit, It appears that negatively charged residues in L6/7 recognize either Na+ or K+ ions or the competitive cation antagonists. Na+ and K+ ions are then occluded within trans-membrane segments and can be transported, whereas the cation antagonists are not occluded and block transport at the entrance port. The cytoplasmic segment of the beta subunit appears to be close to or contributes to the entrance port, as inferred from the following observations. 1) Specific chymotryptic cleavage of the 16-kDa fragment of the beta subunit to 15-kDa at 20 degrees C (Shainskaya, A., and Karlish, S, J, D, (1996) J, Biol, Chem. 271, 10309-10316) markedly reduces affinity for Br-2-TITU3+ and for Na+ ions, detected by Na+ occlusion assays or electrogenic Na+ binding, whereas Rb+ occlusion is unchanged. 2) Na+ ions specifically protect the 16-kDa fragment against this chymotryptic cleavage.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Univ Konstanz, Dept Biol, D-78434 Constance, Germany	Weizmann Institute of Science; University of Konstanz	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.							Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; Bar Shimon M, 1998, J BIOL CHEM, V273, P34190, DOI 10.1074/jbc.273.51.34190; BLANCO G, 1995, BIOCHEMISTRY-US, V34, P319, DOI 10.1021/bi00001a039; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; CHOW DC, 1995, J EXP BIOL, V198, P1; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; DAVID P, 1991, J BIOL CHEM, V266, P14896; DAVID P, 1992, J BIOL CHEM, V267, P1141; EAKLE KA, 1994, J BIOL CHEM, V269, P6550; EAKLE KA, 1995, J BIOL CHEM, V270, P13937, DOI 10.1074/jbc.270.23.13937; Falson P, 1997, J BIOL CHEM, V272, P17258, DOI 10.1074/jbc.272.28.17258; FAMBROUGH DM, 1994, AM J PHYSIOL, V266, pC579, DOI 10.1152/ajpcell.1994.266.3.C579; FORBUSH B, 1988, J BIOL CHEM, V263, P7970; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; Goldshleger R, 1999, J BIOL CHEM, V274, P16213, DOI 10.1074/jbc.274.23.16213; GROSSMAN Z, 1990, EXP PARASITOL, V70, P62, DOI 10.1016/0014-4894(90)90086-R; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; HEYSE S, 1994, J GEN PHYSIOL, V104, P197, DOI 10.1085/jgp.104.2.197; HOVING S, 1995, J BIOL CHEM, V270, P29788; ISHII T, 1994, P NATL ACAD SCI USA, V91, P6103, DOI 10.1073/pnas.91.13.6103; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; JAUNIN P, 1993, J CELL BIOL, V123, P1751, DOI 10.1083/jcb.123.6.1751; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kuntzweiler TA, 1996, J BIOL CHEM, V271, P29682, DOI 10.1074/jbc.271.47.29682; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; Lutsenko S, 1997, J BIOL CHEM, V272, P5249, DOI 10.1074/jbc.272.8.5249; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Melle-Milovanovic D, 1998, J BIOL CHEM, V273, P11075, DOI 10.1074/jbc.273.18.11075; Menguy T, 1998, J BIOL CHEM, V273, P20134, DOI 10.1074/jbc.273.32.20134; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Nielsen JM, 1998, BIOCHEMISTRY-US, V37, P1961, DOI 10.1021/bi972524q; Or E, 1999, J BIOL CHEM, V274, P2802, DOI 10.1074/jbc.274.5.2802; Or E, 1998, BIOCHEMISTRY-US, V37, P8197, DOI 10.1021/bi9730442; Or E, 1996, J BIOL CHEM, V271, P2470, DOI 10.1074/jbc.271.5.2470; OR E, 1993, J BIOL CHEM, V268, P16929; Palasis M, 1996, J BIOL CHEM, V271, P14176, DOI 10.1074/jbc.271.24.14176; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Rice WJ, 1996, J BIOL CHEM, V271, P31412, DOI 10.1074/jbc.271.49.31412; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schneeberger A, 1999, J MEMBRANE BIOL, V168, P221, DOI 10.1007/s002329900511; SCHULZ S, 1995, EUR BIOPHYS J BIOPHY, V23, P413, DOI 10.1007/BF00196828; SCHWAPPACH B, 1994, J BIOL CHEM, V269, P21620; SHAINSKAYA A, 1994, J BIOL CHEM, V269, P10780; Shainskaya A, 1998, J BIOL CHEM, V273, P7311, DOI 10.1074/jbc.273.13.7311; Shainskaya A, 1996, J BIOL CHEM, V271, P10309, DOI 10.1074/jbc.271.17.10309; SHANI M, 1987, BIOCHIM BIOPHYS ACTA, V904, P13, DOI 10.1016/0005-2736(87)90081-2; SHIN JM, 1994, J BIOL CHEM, V269, P8642; Swarts HGP, 1996, J BIOL CHEM, V271, P29764, DOI 10.1074/jbc.271.47.29764; VASSALO PM, 1986, J BIOL CHEM, V261, P16957; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	54	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2019	2028		10.1074/jbc.275.3.2019	http://dx.doi.org/10.1074/jbc.275.3.2019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636905	hybrid, Green Published			2022-12-27	WOS:000084940000068
J	van Kerkhof, P; Grovers, R; dos Santos, CMA; Strous, GJ				van Kerkhof, P; Grovers, R; dos Santos, CMA; Strous, GJ			Endocytosis and degradation of the growth hormone receptor are proteasome-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN CONJUGATION SYSTEM; FACTOR BETA-RECEPTOR; BINDING-PROTEIN; PLASMA-MEMBRANE; MEDIATED INTERNALIZATION; SACCHAROMYCES-CEREVISIAE; PROTEOLYTIC PATHWAY; ER DEGRADATION; GENE-PRODUCT; IM-9 CELLS	The ubiquitin conjugation system is involved in ligand-induced endocytosis of the growth hormone receptor (GHR) via a cytosolic 10-amino acid ubiquitin-dependent endocytosis motif, Herein, we demonstrate that the proteasome is also involved in growth hormone receptor down-regulation. Ligand-induced degradation was blocked in the presence of specific proteasomal inhibitors. In addition, growth hormone (GH) internalization was inhibited, whereas the transferrin receptor cycle remained unaffected. A truncated GHR entered the cells independent of proteasome action. In addition, we show that GH internalization is independent of the presence of lysine residues in the cytosolic domain of the receptor, whereas its internalization can still be inhibited by proteasomal inhibitors, Thus, GHR internalization requires proteasome action in addition to an active ubiquitin conjugation system, but ubiquitination of the GHR itself seems not to be required.	Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Inst Biomembranes, NL-3584 CX Utrecht, Netherlands	Utrecht University	Strous, GJ (corresponding author), Univ Utrecht, Med Ctr, Dept Cell Biol, Heidelberglaan 100,AZU-G02-525, NL-3584 CX Utrecht, Netherlands.	strous@med.uu.nl	Govers, Roland/O-5782-2016	Govers, Roland/0000-0003-1359-5333; van Kerkhof, Peter/0000-0002-8954-2230				Argetsinger LS, 1996, PHYSIOL REV, V76, P1089, DOI 10.1152/physrev.1996.76.4.1089; BAUMANN G, 1986, J CLIN ENDOCR METAB, V62, P134, DOI 10.1210/jcem-62-1-134; BAXTER RC, 1985, ENDOCRINOLOGY, V117, P650, DOI 10.1210/endo-117-2-650; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Breuer P, 1998, J BIOL CHEM, V273, P33254, DOI 10.1074/jbc.273.50.33254; CAHOREAU C, 1994, FEBS LETT, V350, P230, DOI 10.1016/0014-5793(94)00772-1; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Egner R, 1996, FEBS LETT, V378, P177, DOI 10.1016/0014-5793(95)01450-0; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GalchevaGargova Z, 1995, ONCOGENE, V11, P2649; Goldsmith JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE932, DOI 10.1152/ajpendo.1997.273.5.E932; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GORIN E, 1985, ENDOCRINOLOGY, V116, P1796, DOI 10.1210/endo-116-5-1796; Govers P, 1998, J BIOL CHEM, V273, P16426, DOI 10.1074/jbc.273.26.16426; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Govers R, 1997, EMBO J, V16, P4851, DOI 10.1093/emboj/16.16.4851; Hackett RH, 1997, J BIOL CHEM, V272, P11128; Haft CR, 1998, ENDOCRINOLOGY, V139, P1618, DOI 10.1210/en.139.4.1618; HARRISON SM, 1995, ENDOCRINOLOGY, V136, P651, DOI 10.1210/en.136.2.651; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Horak J, 1997, J BACTERIOL, V179, P1541, DOI 10.1128/jb.179.5.1541-1549.1997; HOU D, 1994, J BIOL CHEM, V269, P14244; ILONDO MM, 1992, ENDOCRINOLOGY, V130, P2037, DOI 10.1210/en.130.4.2037; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; KULKA RG, 1988, J BIOL CHEM, V263, P15726; LESNIAK MA, 1976, J BIOL CHEM, V251, P3730; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; LOBIE PE, 1994, J BIOL CHEM, V269, P31735; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Miura H, 1996, BIOCHEM BIOPH RES CO, V227, P684, DOI 10.1006/bbrc.1996.1569; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; MIYAZAWA K, 1994, BLOOD, V83, P137; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; MORI S, 1995, BIOCHEM BIOPH RES CO, V217, P224, DOI 10.1006/bbrc.1995.2767; MURPHY LJ, 1984, ENDOCRINOLOGY, V115, P1625, DOI 10.1210/endo-115-4-1625; ROUPAS P, 1988, MOL CELL ENDOCRINOL, V57, P93, DOI 10.1016/0303-7207(88)90037-8; SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; SU CC, 1998, RECENT PROG HORM RES, V53, P61; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; YAMADA K, 1987, BIOCHEMISTRY-US, V26, P4438, DOI 10.1021/bi00388a037	51	145	149	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1575	1580		10.1074/jbc.275.3.1575	http://dx.doi.org/10.1074/jbc.275.3.1575			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636847	hybrid			2022-12-27	WOS:000084940000010
J	Kaasch, AJ; Joiner, KA				Kaasch, AJ; Joiner, KA			Targeting and subcellular localization of Toxoplasma gondii catalase - Identification of peroxisomes in an apicomplexan parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; PURIFICATION; SEQUENCE	We sought to identify and characterize peroxisomes in the apicomplexan parasite Toxoplasma gondii, To initiate this process, we first cloned and sequenced the gene for T, gondii catalase (EC 1.11.1.6), a marker enzyme for peroxisomes in eukaryotic cells. The gene predicts a protein of 57.2 kDa and 502 amino acids and has a strong homology to other eukaryotic catalases. A polyclonal antiserum raised against a glutathione S-transferase fusion protein recognized a single band with a molecular mass of 63 kDa by immunoblot, By immunofluorescence T, gondii catalase is present primarily in a punctate staining pattern anterior to the parasite nucleus. This compartment is distinguishable from other parasite organelles, namely micronemes, rhoptries, dense granules, and the apicoplast. Cytochemical visualization of catalase using diaminobenzidine precipitation gives a vesicular staining pattern anterior to the nucleus at the light level and round, vesicular structures with an estimated diameter of 100-300 nm by electron microscopy, T, gondii catalase has a putative C-terminal peroxisomal targeting signal in the last 3 amino acids (-AKM). Expression of T. gondii catalase in mammalian cells results in peroxisomal localization, whereas a construct lacking the targeting signal remains in the cytosol, Furthermore, addition of -AKM to the C terminus of chloramphenicol acetyltransferase is sufficient to target this protein to peroxisomes. These results provide the first evidence for peroxisomes in Apicomplexan parasites.	Yale Univ, Dept Internal Med, Infect Dis Sect, Sch Med, New Haven, CT 06520 USA	Yale University	Joiner, KA (corresponding author), Yale Univ, Dept Internal Med, Infect Dis Sect, Sch Med, 808 LCI,333 Cedar St, New Haven, CT 06520 USA.		Kaasch, Achim J/F-8414-2012; Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X; Kaasch, Achim/0000-0002-6659-6738	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030060] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30060] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ajioka JW, 1998, GENOME RES, V8, P18, DOI 10.1101/gr.8.1.18; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; CHANG HR, 1989, MICROB PATHOGENESIS, V7, P37, DOI 10.1016/0882-4010(89)90109-5; DEIMANN W, 1991, HISTOCHEMISTRY, V3, P573; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GOUET P, 1995, J MOL BIOL, V249, P933, DOI 10.1006/jmbi.1995.0350; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Karsten V, 1997, METHODS, V13, P103, DOI 10.1006/meth.1997.0503; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; Loewen P, 1996, GENE, V179, P39, DOI 10.1016/S0378-1119(96)00321-6; MURRAY HW, 1979, J EXP MED, V150, P938, DOI 10.1084/jem.150.4.938; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SIBLEY LD, 1986, MOL BIOCHEM PARASIT, V19, P83, DOI 10.1016/0166-6851(86)90069-1; Soldati D, 1999, PARASITOL TODAY, V15, P5, DOI 10.1016/S0169-4758(98)01363-5; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANOSSOWSKI I, 1993, J MOL EVOL, V37, P71; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; ZAMOCKY M, 1995, FEBS LETT, V367, P241, DOI 10.1016/0014-5793(95)00568-T	23	42	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1112	1118		10.1074/jbc.275.2.1112	http://dx.doi.org/10.1074/jbc.275.2.1112			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625653	hybrid			2022-12-27	WOS:000084836600057
J	Paine, MJI; Garner, AP; Powell, D; Sibbald, J; Sales, M; Pratt, N; Smith, T; Tew, DG; Wolf, CR				Paine, MJI; Garner, AP; Powell, D; Sibbald, J; Sales, M; Pratt, N; Smith, T; Tew, DG; Wolf, CR			Cloning and characterization of a novel human dual flavin reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P-450 REDUCTASE; FMN-BINDING DOMAIN; NITRIC-OXIDE; METHIONINE SYNTHASE; DELETION (9)(Q34.3); CHROMOSOME 9Q34; NADPH; LIVER; OXIDOREDUCTASE; ACTIVATION	Flavoprotein reductases play a key role in electron transfer in many physiological processes. We have isolated a cDNA with strong sequence similarities to cytochrome P-450 reductase and nitric-oxide synthase. The cDNA encodes a protein of 597 amino acid residues with a predicted molecular mass of 67 kDa. Northern blot analysis identified a predicted transcript of 3.0 kilobase pairs as well as a larger transcript at 6.0 kilobase pairs, and the gene was mapped to chromosome 9q34.3 by fluorescence in situ hybridization analysis. The amino acid sequence of the protein contained distinct FMN-, FAD-, and NADPH-binding domains, and in order to establish whether the protein contained these cofactors, the coding sequence was expressed in insect cells and purified. Recombinant protein bound FMN, FAD, and NADPH cofactors and exhibited a UV-visible spectrum with absorbance maxima at 380, 460, and 626 nm. The purified enzyme reduced cytochrome c, with apparent K-m and k(cat) values of 21 mu M and 1.3 s(-1), respectively, and metabolized the one-electron accepters doxorubicin, menadione, and potassium ferricyanide. Immunoblot analysis of fractionated MCF7 cells with antibodies to recombinant NR1 showed that the enzyme is cytoplasmic and highly expressed in a panel of human cancer cell lines, thus indicating that this novel reductase may play a role in the metabolic activation of bioreductive anticancer drugs and other chemicals activated by one-electron reduction.	Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Imperial Canc Res Fund,Mol Pharmacol Unit, Dundee DD1 9SY, Scotland; SmithKline Beecham Res, King Of Prussia, PA 19406 USA; Univ Dundee, Ninewells Hosp & Med Sch, Dept Cytogenet, Dundee DD1 9SY, Scotland	University of Dundee; GlaxoSmithKline; University of Dundee	Wolf, CR (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Imperial Canc Res Fund,Mol Pharmacol Unit, Dundee DD1 9SY, Scotland.	rooney@dundee.ac.uk	Paine, Mark/D-3360-2013; Paine, Mark John Ingraham/O-7450-2019	Paine, Mark/0000-0003-2061-7713; Paine, Mark John Ingraham/0000-0003-2061-7713				Ayyash H, 1997, J MED GENET, V34, P610, DOI 10.1136/jmg.34.7.610; BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BACKES WL, 1993, CYTOCHROME P450, P35; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Chen ZQ, 1998, J BIOL CHEM, V273, P26248, DOI 10.1074/jbc.273.40.26248; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Cummings J, 1998, BIOCHEM PHARMACOL, V56, P405; DIGNAM JD, 1975, BIOCHEM BIOPH RES CO, V63, P845, DOI 10.1016/0006-291X(75)90644-0; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Garner AP, 1999, CANCER RES, V59, P1929; Gulati S, 1997, J BIOL CHEM, V272, P19171, DOI 10.1074/jbc.272.31.19171; ILAN Z, 1981, J BIOL CHEM, V256, P66; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KEYES SR, 1984, CANCER RES, V44, P5638; Klatt P, 1996, METHOD ENZYMOL, V268, P358; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Makela-Bengs P, 1998, AM J HUM GENET, V63, P506, DOI 10.1086/301968; MASTERS BSS, 1965, J BIOL CHEM, V240, P4081; NARHI LO, 1986, J BIOL CHEM, V261, P7160; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; OSTOWSKI J, 1989, J BIOL CHEM, V264, P15796; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; PORTER TD, 1991, TRENDS BIOCHEM SCI, V16, P154, DOI 10.1016/0968-0004(91)90059-5; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; SCHIMMENTI LA, 1994, AM J MED GENET, V51, P140, DOI 10.1002/ajmg.1320510211; SCHMIDT HHHW, 1992, BIOCHEMISTRY-US, V31, P3243, DOI 10.1021/bi00127a028; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; Shen A. L., 1993, CYTOCHROME P450, P35; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; SPEARMAN ME, 1984, MOL PHARMACOL, V26, P566; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; VERMILION JL, 1981, J BIOL CHEM, V256, P266; VERMILION JL, 1978, J BIOL CHEM, V253, P8812; WALTON MI, 1992, BIOCHEM PHARMACOL, V44, P251, DOI 10.1016/0006-2952(92)90007-6; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Weiler T, 1998, AM J HUM GENET, V63, P140, DOI 10.1086/301925; WILLIAMS CH, 1962, J BIOL CHEM, V237, P587; YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337; Zhao Q, 1999, PROTEIN SCI, V8, P298	49	90	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1471	1478		10.1074/jbc.275.2.1471	http://dx.doi.org/10.1074/jbc.275.2.1471			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625700	hybrid			2022-12-27	WOS:000084836600104
J	Sugiyama, Y; Suzuki, A; Kishikawa, M; Akutsu, R; Hirose, T; Waye, MMY; Tsui, SKW; Yoshida, S; Ohno, S				Sugiyama, Y; Suzuki, A; Kishikawa, M; Akutsu, R; Hirose, T; Waye, MMY; Tsui, SKW; Yoshida, S; Ohno, S			Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; CONFERS RESISTANCE; SKELETAL-MUSCLE; EXPRESSION; GENE; FAMILY; HSP27; KINASE; TISSUE; MEMBER	Previously, we identified a new mammalian sHSP, MKBP, as a myotonic dystrophy protein kinase-binding protein, and suggested its important role in muscle maintenance (Suzuki, A., Sugiyama, Y., Hayashi, Y., Nyu-i, N., Yoshida, M., Nonaka, I., Ishiura, S., Arahata, K., and Ohno, S. (1998) J. Cell Biol. 140, 1113-1124). In this paper, we develop the former work by performing extensive characterization of five of the six sHSPs so far identified, that is, HSP27, alpha B-crystallin, p20, MKBP/HSPB2, and HSPB3, omitting lens-specific alpha A-crystallin. Tissue distribution analysis revealed that although each sHSP shows differential constitutive expression in restricted tissues, tissues that express all five sHSPs are only muscle-related tissues. Especially, the expressions of HSPB3, identified for the first time as a 17-kDa protein in this paper, and MKBP/HSPB2 are distinctly specific to muscles. Moreover, these sHSPs form an oligomeric complex with an apparent molecular mass of 150 kDa that is completely independent of the oligomers formed by HSP27, alpha B-crystallin, and p20. The expressions of MKBP/HSPB2 and HSPB3 are induced during muscle differentiation under the control of MyoD, suggesting that the sHSP oligomer comprising MKBP/HSPB2 and HSPB3 represents an additional system closely related to muscle function. The functional divergence among sHSPs in different oligomers is also demonstrated in several ways: 1) an interaction with myotonic dystrophy protein kinase, which has been suggested to be important for the maintenance of myofibril integrity, was observed only for MKBP/HSPB2; 2) a myotube-specific association with actin bundles was observed for HSP27 and alpha B-crystallin, but not for MKBP/HSPB2; and 3) sHSPs whose mRNAs are induced by heat shock are alpha B-crystallin and HSP27. Taken together, the results suggest that muscle cells develop two kinds of stress response systems composed of diverged sHSP members, and that these systems work independently in muscle maintenance and differentiation.	Yokohama City Univ, Sch Med, Dept Biol Mol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Chinese Univ Hong Kong, Dept Biochem, Shatin, NT, Peoples R China; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan	Yokohama City University; Chinese University of Hong Kong; Kyoto University	Suzuki, A (corresponding author), Yokohama City Univ, Sch Med, Dept Biol Mol, Kanazawa Ku, Yokohama, Kanagawa 236, Japan.	abell@med.yokohama-cu.ac.jp; ohnos@med.yokohama-cu.ac.jp	韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Sugiyama, Yuki/B-2656-2018; Hirose, Tomonori/F-6015-2010; Ohno, Shigeo/B-1768-2010; Tsui, Stephen Kwok-Wing/E-4385-2015; Hirose, Tomonori/M-8872-2019	韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Sugiyama, Yuki/0000-0001-7830-0677; Hirose, Tomonori/0000-0003-2428-0919; Ohno, Shigeo/0000-0002-1294-5269; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Hirose, Tomonori/0000-0003-2428-0919; Yoshida, Shosei/0000-0001-8861-1866				ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; ATOMI Y, 1991, J BIOCHEM-TOKYO, V110, P812, DOI 10.1093/oxfordjournals.jbchem.a123665; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Boelens WC, 1998, BBA-PROTEIN STRUCT M, V1388, P513, DOI 10.1016/S0167-4838(98)00215-5; BROOKE MH, 1969, NEUROLOGY, V19, P221, DOI 10.1212/WNL.19.3.221; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; COKE M, 1990, AM J PHYSIOL, V258, pC723; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DUBIN RA, 1991, MOL CELL BIOL, V11, P4340, DOI 10.1128/MCB.11.9.4340; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOPALSRIVASTAVA R, 1995, MOL CELL BIOL, V15, P7081; HEAD MW, 1994, J CELL PHYSIOL, V159, P41, DOI 10.1002/jcp.1041590107; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; IWAKI T, 1994, J CELL BIOL, V125, P1385, DOI 10.1083/jcb.125.6.1385; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Izumi Y, 1997, J BIOL CHEM, V272, P7381, DOI 10.1074/jbc.272.11.7381; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1074, P201, DOI 10.1016/0304-4165(91)90062-L; KATO K, 1994, J BIOL CHEM, V269, P15302; KATO K, 1992, J BIOL CHEM, V267, P7718; KLEMENZ R, 1993, J CELL BIOL, V120, P639, DOI 10.1083/jcb.120.3.639; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam WY, 1996, BBA-MOL CELL RES, V1314, P120, DOI 10.1016/S0167-4889(96)00121-8; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; LAVOIE JN, 1993, J BIOL CHEM, V268, P3420; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LOCKE M, 1991, AM J PHYSIOL, V261, pC774, DOI 10.1152/ajpcell.1991.261.5.C774; LONGONI S, 1990, MOL CELL BIOCHEM, V97, P121, DOI 10.1007/BF00221053; Lutsch G, 1997, CIRCULATION, V96, P3466; MEHLEN P, 1995, J IMMUNOL, V154, P363; MIRON T, 1991, J CELL BIOL, V114, P255, DOI 10.1083/jcb.114.2.255; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; SUZUKI A, 1995, J CELL BIOL, V128, P373, DOI 10.1083/jcb.128.3.373; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TANGUAY RM, 1993, DEV GENET, V14, P112, DOI 10.1002/dvg.1020140205; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van de Klundert FAJM, 1998, EUR J CELL BIOL, V75, P38, DOI 10.1016/S0171-9335(98)80044-7; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Yoshida N, 1998, J CELL SCI, V111, P769; Yoshida S, 1996, J CELL BIOL, V132, P181, DOI 10.1083/jcb.132.1.181	49	245	261	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1095	1104		10.1074/jbc.275.2.1095	http://dx.doi.org/10.1074/jbc.275.2.1095			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625651	hybrid			2022-12-27	WOS:000084836600055
J	Mossessova, E; Levine, C; Peng, H; Nurse, P; Bahng, S; Marians, KJ				Mossessova, E; Levine, C; Peng, H; Nurse, P; Bahng, S; Marians, KJ			Mutational analysis of Escherichia coli topoisomerase IV. Selection of dominant-negative parE alleles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA GYRASE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PURIFICATION; MECHANISM	In order to define regions of ParE, one of the two subunits of topoisomerase IV, that are involved in catalysis during topoisomerization, we developed a selection procedure to isolate dominant-negative parE alleles. Both wild-type parC and mutagenized parE were expressed from a tightly-regulated lac promoter on a moderate-copy plasmid, Mutated parE alleles were rescued from those plasmids that caused IPTG-dependent cell death, The mutant ParE proteins could be divided into two groups when reconstituted with ParC to form topoisomerase IV, those that elicited hyper-DNA cleavage and those that affected covalent complex formation.	Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, Mol Biol Grad Program, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Mossessova, E (corresponding author), Cornell Univ, Grad Sch Med Sci, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034558] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34558] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bahng S, 2000, J BIOL CHEM, V275, P4112, DOI 10.1074/jbc.275.6.4112; Benedetti P, 1997, J BIOL CHEM, V272, P12132, DOI 10.1074/jbc.272.18.12132; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BIRNBOIM HC, 1970, NUCLEIC ACIDS RES, V24, P1513; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Caron PR, 1999, METH MOL B, V94, P279; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; DIEDERICH L, 1994, BIOTECHNIQUES, V16, P916; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KATO J, 1992, J BIOL CHEM, V267, P25676; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; LYNN R, 1986, SCIENCE, V233, P647, DOI 10.1126/science.3014661; MANIATAS T, 1982, MOL CLONING LAB MANU; Nurse P, 2000, J BIOL CHEM, V275, P4104, DOI 10.1074/jbc.275.6.4104; PENG H, 1993, J BIOL CHEM, V268, P24481; Schultz P, 1996, P NATL ACAD SCI USA, V93, P5936, DOI 10.1073/pnas.93.12.5936; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	21	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4099	4103		10.1074/jbc.275.6.4099	http://dx.doi.org/10.1074/jbc.275.6.4099			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660569	hybrid			2022-12-27	WOS:000085288800053
J	Vennekens, R; Hoenderop, JGJ; Prenen, J; Stuiver, M; Willems, PHGM; Droogmans, G; Nilius, B; Bindels, RJM				Vennekens, R; Hoenderop, JGJ; Prenen, J; Stuiver, M; Willems, PHGM; Droogmans, G; Nilius, B; Bindels, RJM			Permeation and gating properties of the novel epithelial Ca2+ channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR CALCIUM-TRANSPORT; ENDOTHELIAL-CELLS; STORE DEPLETION; ION CHANNELS	The recently cloned epithelial Ca2+ channel (ECaC) constitutes the Ca2+ influx pathway in 1,25-dihydroxyvitamin Ds-responsive epithelia, We have combined patch-clamp analysis and fura-a fluorescence microscopy to functionally characterize ECaC heterologously expressed in HEK293 cells. The intracellular Ca2+ concentration in ECaC-expressing cells was closely correlated with the applied electrochemical Ca2+ gradient, demonstrating the distinctive Ca2+ permeability and constitutive-activation of ECaC, Cells dialyzed with 10 mn 1,2-bis(2-aminoph- enoxy)ethane-N,N,N',N'-tetraacetic acid displayed large inward currents through ECaC in response to voltage ramps. The corresponding current-voltage relationship showed pronounced inward rectification, Currents evoked by voltage steps to potentials below -40 mV partially inactivated with a biexponential timecourse, This inactivation was less pronounced if Ba2+ or Sr2+ replaced Ca2+ and was absent in Ca2+-free solutions, ECaC showed an anomalous mole fraction behavior. The permeability ratio P-CA:P-NA calculated from the reversal potential at 30 mM [Ca2+], was larger than 100, The divalent cation selectivity profile is Ca2+ > Mn2+ > Ba2+ similar to Sr2+. Repetitive stimulation of ECaC-expressing cells induced a decay of the current response, which was greatly reduced if Ca2+ was replaced by Ba2+ and was virtually abolished if [Ca2+], was lowered to 1 nar. In conclusion, ECaC is a Ca2+ selective channel, exhibiting Ca2+-dependent autoregulatory mechanisms, including fast inactivation and slow down-regulation.	Katholieke Univ Leuven, Fysiol Lab, Dept Physiol, B-3000 Louvain, Belgium; Univ Nijmegen, Inst Cellular Signalling, Dept Cell Physiol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Inst Cellular Signalling, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	KU Leuven; Radboud University Nijmegen; Radboud University Nijmegen	Nilius, B (corresponding author), Katholieke Univ Leuven, Fysiol Lab, Dept Physiol, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.		Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013; Vennekens, Rudi/AAQ-1664-2020; Willems, P.H.G.M./L-4759-2015	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; Vennekens, Rudi/0000-0002-2564-5150; Willems, P.H.G.M./0000-0002-0915-1599; Stuiver, Marchel/0000-0003-3437-4468				BINDELS RJM, 1991, J AM SOC NEPHROL, V2, P1122; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; CHAO AC, 1995, J CLIN INVEST, V96, P1794, DOI 10.1172/JCI118225; Fasolato C, 1998, PFLUG ARCH EUR J PHY, V436, P69, DOI 10.1007/s004240050605; FEHER JJ, 1992, AM J PHYSIOL, V262, pC517, DOI 10.1152/ajpcell.1992.262.2.C517; FRIEDMAN PA, 1995, PHYSIOL REV, V75, P429, DOI 10.1152/physrev.1995.75.3.429; Friedman PA, 1998, ANNU REV PHYSIOL, V60, P179, DOI 10.1146/annurev.physiol.60.1.179; Hille B., 1992, IONIC CHANNELS EXCIT, P337, DOI 10.1016/0014-5793(92)81020-M; Hoenderop JGJ, 1999, P NATL ACAD SCI USA, V96, P6084, DOI 10.1073/pnas.96.11.6084; Hoenderop JGJ, 1999, KIDNEY INT, V55, P225, DOI 10.1046/j.1523-1755.1999.00228.x; Hoenderop JGJ, 1999, BIOCHEM BIOPH RES CO, V261, P488, DOI 10.1006/bbrc.1999.1059; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; NILIUS B, 1994, J GEN PHYSIOL, V103, P787, DOI 10.1085/jgp.103.5.787; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Price CJ, 1999, J NEUROCHEM, V72, P634, DOI 10.1046/j.1471-4159.1999.0720634.x; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Trouet D, 1997, PFLUG ARCH EUR J PHY, V434, P632, DOI 10.1007/s004240050445; VANOS CH, 1987, BIOCHIM BIOPHYS ACTA, V906, P195, DOI 10.1016/0304-4157(87)90012-8; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	25	238	249	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3963	3969		10.1074/jbc.275.6.3963	http://dx.doi.org/10.1074/jbc.275.6.3963			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660551	Green Published, hybrid			2022-12-27	WOS:000085288800035
J	Beck, DC; Ikegami, M; Na, CL; Zaltash, S; Johansson, J; Whitsett, JA; Weaver, TE				Beck, DC; Ikegami, M; Na, CL; Zaltash, S; Johansson, J; Whitsett, JA; Weaver, TE			The role of homodimers in surfactant protein B function in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; PULMONARY SURFACTANT; NATURAL SURFACTANT; TRANSGENIC MICE; HOMEOSTASIS	Surfactant protein B (SP-B) is detected in the airways as a sulfhydryl-dependent dimer (M-r similar to 16,000). To test the hypothesis that formation of homodimers is critical for SP-B function, the cysteine residue reported to be involved in SP-B dimerization was mutated to serine (Cys(248) --> Ser) and the mutated protein was targeted to the distal respiratory epithelium of transgenic mice. Transgenic lines which demonstrated appropriate processing, sorting, and secretion of human SP-B monomer were crossed with SP-B +/- mice to achieve expression of human monomer in the absence of endogenous SP B dimer (hSP-B-mon, mSP-B-/-). In two of three transgenic lines, hSP-B-mon, mSP-B-/- mice had normal lung structure, complete processing of SP-C proprotein, well formed lamellar bodies, and normal longevity. Pulmonary function studies revealed an altered hysteresis curve for hSP-B-mon, mSP-B-/- mice relative to wild type mice. Large aggregate surfactant fractions from hSP-B-mon, mSP-B-/- mice resulted in higher minimum surface tension in vitro compared with surfactant from wild type mice. Surfactant lipids supplemented with 2% hSP-B monomer resulted in slower adsorption and higher surface tension than surfactant with 2% hSP-B dimer, Taken together, these data indicate a role for SP-B dimer in surface tension reduction in the alveolus.	Childrens Hosp, Med Ctr, Div Pulm Biol, TCHRF, Cincinnati, OH 45229 USA; Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Cincinnati Children's Hospital Medical Center; Karolinska Institutet	Weaver, TE (corresponding author), Childrens Hosp, Med Ctr, Div Pulm Biol, TCHRF, 3333 Burnet Ave, Cincinnati, OH 45229 USA.			Johansson, Jan/0000-0002-8719-4703	NHLBI NIH HHS [HL56285, HL36055, HL38859] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038859, R01HL056285, R37HL038859, R37HL056285, R01HL036055] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akinbi HT, 1997, J BIOL CHEM, V272, P9640; ALI SA, 1995, BIOTECHNIQUES, V18, P746; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Ikegami M, 1998, AM J PHYSIOL-LUNG C, V275, pL247, DOI 10.1152/ajplung.1998.275.2.L247; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; JOHANSSON J, 1991, BIOCHEMISTRY-US, V30, P6917, DOI 10.1021/bi00242a015; Lin S, 1999, J BIOL CHEM, V274, P19168, DOI 10.1074/jbc.274.27.19168; Lin S, 1996, BBA-MOL CELL RES, V1312, P177, DOI 10.1016/0167-4889(95)00201-4; MIZUNO K, 1995, PEDIATR RES, V37, P271, DOI 10.1203/00006450-199503000-00004; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; RIDER ED, 1993, AM REV RESPIR DIS, V147, P669, DOI 10.1164/ajrccm/147.3.669; Robertson B, 1998, BBA-MOL BASIS DIS, V1408, P346, DOI 10.1016/S0925-4439(98)00080-5; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stark M, 1998, ANAL BIOCHEM, V265, P97, DOI 10.1006/abio.1998.2856; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; VORBROKER DK, 1995, AM J PHYSIOL, V268, P647; Weaver TE, 1998, BBA-MOL BASIS DIS, V1408, P173, DOI 10.1016/S0925-4439(98)00066-0; YEI SP, 1994, AM J RESP CELL MOL, V11, P329, DOI 10.1165/ajrcmb.11.3.8086169; Yusen RD, 1999, AM J RESP CRIT CARE, V159, P411, DOI 10.1164/ajrccm.159.2.9806033; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	29	54	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3365	3370		10.1074/jbc.275.5.3365	http://dx.doi.org/10.1074/jbc.275.5.3365			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652327	hybrid			2022-12-27	WOS:000085146500049
J	Jefferies, CA; O'Neill, LAJ				Jefferies, CA; O'Neill, LAJ			Rad regulates interleukin 1-induced nuclear factor kappa B activation in an inhibitory protein kappa B alpha-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; DEPENDENT TRANSCRIPTION; GTP-BINDING; SIGNAL-TRANSDUCTION; KINASE; PHOSPHORYLATION; RAC1; FAMILY; PATHWAYS; RECEPTOR	We have examined the involvement of Rac1 in nuclear factor kappa B (NF kappa B) activation by interleukin 1 (IL1). IL1 induced a rapid and sustained activation of Rad in the thymoma cell line EL4.NOB-1. Transient transfection with dominant negative RacN17 inhibited IL1-induced kappa B-dependent reporter gene expression but not I kappa B alpha degradation, whereas constitutively active RacV12 po tentiated KB-dependent reporter gene expression in response to IL1 but had no effects on its own. Using porcine aortic endothelial cells stably transfected with RacV12 or RacN17 under the control of an inducible promoter, we confirmed that RacV12 did not affect I kappa B alpha degradation, nor did RacN17 inhibit the nl-induced response. RacV12 was also unable to induce nuclear translocation of NF kappa B. These effects suggested a role for Rad in p65-mediated transactivation of NF kappa B, independent of I kappa B alpha regulation. In support of this we found that IL1 activated a pathway leading to increased p65 transactivation activity and that RacV12 alone could drive this response in both cell systems. Additionally, RacN17 inhibited IL1-driven p65-mediated transactivation. From data using specific inhibitors of p38 and p42/ p44 kinases we propose that both p38 and p42/p44 lie downstream of Rad on the nl pathway leading to enhanced transactivation by p65.	Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Biotechnol, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland.	laoneill@tcd.ie	Jefferies, Caroline/AAI-1543-2021	Jefferies, Caroline/0000-0002-8879-6722; O'Neill, Luke/0000-0002-4333-2748				ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bergmann M, 1998, J BIOL CHEM, V273, P6607, DOI 10.1074/jbc.273.12.6607; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; Bonizzi G, 1999, MOL CELL BIOL, V19, P1950; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN P, 1995, BBA-GENE STRUCT EXPR, V1260, P167, DOI 10.1016/0167-4781(94)00186-7; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Davis W, 1999, BIOCHEM J, V338, P387, DOI 10.1042/0264-6021:3380387; DeBosscher K, 1997, P NATL ACAD SCI USA, V94, P13504, DOI 10.1073/pnas.94.25.13504; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Geijsen N, 1999, BLOOD, V94, P1121, DOI 10.1182/blood.V94.3.1121.415k04_1121_1130; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HOPP TP, 1995, PROTEIN SCI, V4, P1851, DOI 10.1002/pro.5560040920; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; MAHON TM, 1995, J BIOL CHEM, V270, P28557, DOI 10.1074/jbc.270.48.28557; Marmiroli S, 1998, FEBS LETT, V438, P49, DOI 10.1016/S0014-5793(98)01270-8; Matthews JS, 1999, CYTOKINE, V11, P643, DOI 10.1006/cyto.1998.0478; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; ONEILL LAJ, 1990, J BIOL CHEM, V265, P3146; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1994, J CELL SCI, P127; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; SIMMS JE, 1996, EUR CYTOKINE NETW, V7, P119; Singh R, 1999, J CLIN INVEST, V103, P1561, DOI 10.1172/JCI5754; STRICKER K, 1993, EUR J IMMUNOL, V23, P1475, DOI 10.1002/eji.1830230712; Sulciner DJ, 1996, MOL CELL BIOL, V16, P7115; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tang Y, 1999, MOL CELL BIOL, V19, P1881; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	45	74	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3114	3120		10.1074/jbc.275.5.3114	http://dx.doi.org/10.1074/jbc.275.5.3114			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652294	Green Published, hybrid			2022-12-27	WOS:000085146500016
J	Lammers, R; Lerch, MM; Ullrich, A				Lammers, R; Lerch, MM; Ullrich, A			The carboxyl-terminal tyrosine residue of protein-tyrosine phosphatase alpha mediates association with focal adhesion plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; RPTP-ALPHA; PTP-ALPHA; IN-VIVO; RECEPTOR; PHOSPHORYLATION; FAMILY; ADAPTER; DOMAINS; INSULIN	The receptor protein-tyrosine phosphatase alpha (pTP alpha) is involved in the activation of c-Src kinase as well as in down-regulation of the insulin signal. To investigate the role of PTP alpha in activation of the Src kinase in more detail we tried to overexpress this phosphatase in NIH3T3 fibroblasts. Although PTP alpha has been overexpressed in rat embryonic fibroblasts and in embryonic carcinoma cells and should increase mitogenic responses we were not able to achieve a detectable overexpression, In contrast, expression of partially (C442S) or completely inactive (C442S,C732S) PTP alpha or of phosphatase active PTP alpha containing mutation Y781F or Y798F was possible. The level of expression, however, was reduced to background after several passages of lines expressing PTP alpha YC442S,C732S and PTP alpha Y781F. When employed in a focus formation assay, only infection with virus encoding PTP alpha Y798F induced Src-dependent formation of foci. In immunofluorescence studies, PTP alpha C442S and PTP alpha Y781F but not PTP alpha Y798F colocalized with proteins found in focal adhesion plaques. Treatment of PTP alpha YC442S-overexpressing cells with vanadate abolished this colocalization and led to proteolytic processing of the phosphatase. We conclude that tyrosine 798 in PTP alpha is important for localization at focal adhesion plaques. Inhibition of phosphatases by vanadate treatment releases PTP alpha from focal adhesions.	Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Lammers, R (corresponding author), Univ Tubingen, Med Klin 4, Otfried Muller Str 10, D-72076 Tubingen, Germany.		Lerch, Markus M./E-2206-2016	Lerch, Markus M./0000-0002-9643-8263				Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; AUTERO M, 1994, MOL CELL BIOL, V14, P1308, DOI 10.1128/MCB.14.2.1308; BAR SD, 1993, CELL, V74, P83; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; DENHERTOG J, 1995, CELL GROWTH DIFFER, V6, P303; denHertog J, 1996, EMBO J, V15, P3016, DOI 10.1002/j.1460-2075.1996.tb00665.x; FENDLY BM, 1990, CANCER RES, V50, P1550; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Helmke S, 1998, J CELL SCI, V111, P2465; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lammers R, 1998, BIOCHEM BIOPH RES CO, V242, P32, DOI 10.1006/bbrc.1997.7906; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; MOLLER NPH, 1995, J BIOL CHEM, V270, P23126, DOI 10.1074/jbc.270.39.23126; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; SU J, 1994, J BIOL CHEM, V269, P18731; TRACY S, 1995, J BIOL CHEM, V270, P10587, DOI 10.1074/jbc.270.18.10587; TROWBRIDGE IS, 1991, J BIOL CHEM, V266, P23517; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Vecchi M, 1998, J BIOL CHEM, V273, P20589, DOI 10.1074/jbc.273.32.20589; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Wang HY, 1996, ONCOGENE, V12, P2555; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; Weng LP, 1998, CURR BIOL, V8, P247, DOI 10.1016/S0960-9822(98)70106-X; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	34	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3391	3396		10.1074/jbc.275.5.3391	http://dx.doi.org/10.1074/jbc.275.5.3391			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652331	hybrid			2022-12-27	WOS:000085146500053
J	Liu, YH; Witte, S; Liu, YC; Doyle, M; Elly, C; Altman, A				Liu, YH; Witte, S; Liu, YC; Doyle, M; Elly, C; Altman, A			Regulation of protein kinase C theta function during T cell activation by Lck-mediated tyrosine phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; SIGNAL-TRANSDUCTION; PKC-THETA; MOLECULAR-CLONING; ANTIGEN RECEPTOR; GENETIC-EVIDENCE; SKELETAL-MUSCLE; FAMILY KINASES; DELTA; SRC	Protein kinase C theta (PKC theta) is a novel Ca2+-independent PKC isoform, which is selectively expressed in skeletal muscle and hematopoietic cells, especially T cells. In T cells, it colocalizes with the T cell antigen receptor (TCR).CD3 complex in antigen-stimulated T cells and is involved in the transcriptional activation of the interleukin-2 gene. In the present study, we report that PKC theta is tyrosine phosphorylated in Jurkat T cells upon TCR.CD3 activation. The Src family protein-tyrosine kinase, Lck, was critical in TCR-induced tyrosine phosphorylation of PKC theta. Lck phosphorylated and was associated with the regulatory domain of PKC theta both in vitro and in intact cells. This association was constitutive, but it was enhanced by T cell activation, with both Src-homology 2 and Src-homology 3 domains of Lck contributing to it. Tyrosine 90 (Tyr-90) in the regulatory domain of PKC theta was identified as the major phosphorylation site by Lck. A constitutively active mutant of PKC theta (A148E) could enhance proliferation of Jurkat T cells and synergized with ionomycin to induce nuclear factor of T cells activity. However, mutation of Tyr-90 into phenylalanine markedly reduced (or abolished) these activities. These results suggest that Lck plays an important role in tyrosine phosphorylation of PKC theta, which may in turn modulate the physiological functions of PKC theta during TCR-induced T cell activation.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	amnon@liai.org		LIU, YUN-CAI/0000-0002-0996-7109	NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NCI NIH HHS [CA35299] Funding Source: Medline; NIAID NIH HHS [AI09881] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altman A, 1990, Adv Immunol, V48, P227, DOI 10.1016/S0065-2776(08)60756-7; AMREIN KE, 1993, P NATL ACAD SCI USA, V90, P10285, DOI 10.1073/pnas.90.21.10285; BAIER G, 1993, J BIOL CHEM, V268, P4997; BAIER G, 1994, EUR J BIOCHEM, V225, P195, DOI 10.1111/j.1432-1033.1994.00195.x; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Bradford MD, 1998, EUR J MORPHOL, V36, P176; CHANG JD, 1993, J BIOL CHEM, V268, P14208; DENNING MF, 1993, J BIOL CHEM, V268, P26079; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; HALEEMSMITH H, 1995, P NATL ACAD SCI USA, V92, P9112, DOI 10.1073/pnas.92.20.9112; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; Li WQ, 1996, J BIOL CHEM, V271, P26404, DOI 10.1074/jbc.271.42.26404; LIU F, 1994, BIOCHEM BIOPH RES CO, V200, P1570, DOI 10.1006/bbrc.1994.1630; LIU YC, 1993, P NATL ACAD SCI USA, V90, P8957, DOI 10.1073/pnas.90.19.8957; Liu YC, 1997, J BIOL CHEM, V272, P168; Meller N, 1996, MOL CELL BIOL, V16, P5782; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Moussazadeh M, 1998, FEBS LETT, V438, P225, DOI 10.1016/S0014-5793(98)01302-7; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Shanmugam M, 1998, ONCOGENE, V16, P1649, DOI 10.1038/sj.onc.1201684; Song JS, 1998, ONCOGENE, V16, P3357, DOI 10.1038/sj.onc.1201886; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; SZALLASI Z, 1995, BIOCHEM BIOPH RES CO, V214, P888, DOI 10.1006/bbrc.1995.2370; TSUTAKAWA SE, 1995, J BIOL CHEM, V270, P26807, DOI 10.1074/jbc.270.45.26807; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Williams S, 1997, EUR J BIOCHEM, V245, P84, DOI 10.1111/j.1432-1033.1997.00084.x; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698; Zang Q, 1997, J BIOL CHEM, V272, P13275, DOI 10.1074/jbc.272.20.13275; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	44	97	107	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3603	3609		10.1074/jbc.275.5.3603	http://dx.doi.org/10.1074/jbc.275.5.3603			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652356	hybrid			2022-12-27	WOS:000085146500078
J	Segouffin-Cariou, C; Billaud, M				Segouffin-Cariou, C; Billaud, M			Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; NERVE GROWTH-FACTOR; RET PROTOONCOGENE; CELL-SURVIVAL; DOCKING SITE; MEN 2A; PROTEIN; MUTATIONS; DOMAIN; SHC	The RET gene codes for a receptor tyrosine kinase that plays a crucial role during the development of both the enteric nervous system and the kidney. Germ line missense mutations at one of six codons specifying extracytoplasmic cysteines are responsible for two related cancer disorders as follows: multiple endocrine neoplasia type2A (MEN2A) and familial medullary thyroid carcinoma (FMTC).MEN2A and FMTC mutations result in a constitutive catalytic activity and as a consequence convert RET into a dominantly acting transforming gene. Although it has been shown that RET-MEN2 mutants activate several transduction pathways, their respective contribution to the neoplastic phenotype remains poorly understood. Over the past few years, it has become increasingly clear that the transforming ability of several viral and cellular oncoproteins depends on their capacity to activate phosphatidylinositol 3-kinase (PI3K), We now report that RET carrying a representative MEN2A mutation at Cys-634 (termed RET-MENSA) activates PI3K and its downstream effector, the serine/ threonine kinase AKT/protein kinase B. Previous studies have demonstrated that mutation of Tyr-1062, which is the intracellular docking site for Shc and Enigma on RET, abolishes the RET-MENSA transforming activity. We provide evidence that mutation of Tyr-1062 abrogates the binding of the p85 regulatory subunit of PI3K to RET-MENSA and the subsequent stimulation of the PI3K/AKT pathway. Furthermore, infection of rat fibroblasts with a retrovirus expressing a dominant-interfering form of PI3K suppresses RET-MEN2A-dependent transformation, whereas overexpression of AKT enhances the RET-MEN2A oncogenic potential. In summary, these data are consistent with the notion that PET-mediated cell-transforming effect is critically dependent on the activation of the PI3K/AKT pathway.	CNRS, Genet Lab, UMR 5641, F-69373 Lyon 08, France	Centre National de la Recherche Scientifique (CNRS)	Billaud, M (corresponding author), CNRS, Genet Lab, UMR 5641, Domaine Rockefeller,8 Ave Rockefeller, F-69373 Lyon 08, France.	billaud@univ-lyon1.fr	Billaud, Marc N/M-6954-2013					Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Alberti L, 1998, ONCOGENE, V17, P1079, DOI 10.1038/sj.onc.1202046; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Arighi E, 1997, ONCOGENE, V14, P773, DOI 10.1038/sj.onc.1200896; Asai N, 1996, J BIOL CHEM, V271, P17644, DOI 10.1074/jbc.271.30.17644; ASAI N, 1995, MOL CELL BIOL, V15, P1613; Bocciardi R, 1997, ONCOGENE, V15, P2257, DOI 10.1038/sj.onc.1201413; Borrello MG, 1996, MOL CELL BIOL, V16, P2151; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chappuis-Flament S, 1998, ONCOGENE, V17, P2851, DOI 10.1038/sj.onc.1202202; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Chiariello M, 1998, ONCOGENE, V16, P2435, DOI 10.1038/sj.onc.1201778; Coffer PJ, 1998, BIOCHEM J, V335, P1; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Durick K, 1996, J BIOL CHEM, V271, P12691, DOI 10.1074/jbc.271.22.12691; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Iwashita T, 1999, ONCOGENE, V18, P3919, DOI 10.1038/sj.onc.1202742; Iwashita T, 1996, HUM MOL GENET, V5, P1577, DOI 10.1093/hmg/5.10.1577; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Liu X, 1996, J BIOL CHEM, V271, P5309, DOI 10.1074/jbc.271.10.5309; Lorenzo MJ, 1997, ONCOGENE, V14, P763, DOI 10.1038/sj.onc.1200894; Marshall GM, 1997, CANCER RES, V57, P5399; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Melillo RM, 1999, CANCER RES, V59, P1120; Michiels FM, 1997, P NATL ACAD SCI USA, V94, P3330, DOI 10.1073/pnas.94.7.3330; MOTHE I, 1995, EUR J BIOCHEM, V228, P842, DOI 10.1111/j.1432-1033.1995.0842m.x; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; Murakami H, 1999, BIOCHEM BIOPH RES CO, V262, P68, DOI 10.1006/bbrc.1999.1186; Ozes ON, 1999, NATURE, V401, P82; Pandey A, 1996, J BIOL CHEM, V271, P10607, DOI 10.1074/jbc.271.18.10607; Pasini A, 1997, ONCOGENE, V15, P393, DOI 10.1038/sj.onc.1201199; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Ponder BAJ, 1999, CANCER RES, V59, p1736S; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rossel M, 1997, ONCOGENE, V14, P265, DOI 10.1038/sj.onc.1200831; SANTORO M, 1994, MOL CELL BIOL, V14, P663, DOI 10.1128/MCB.14.1.663; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sweetser DA, 1999, ONCOGENE, V18, P877, DOI 10.1038/sj.onc.1202376; TAKAHASHI M, 1988, ONCOGENE, V3, P571; TANIGUCHI M, 1991, BIOCHEM BIOPH RES CO, V181, P416, DOI 10.1016/S0006-291X(05)81435-4; THELEN M, 1994, P NATL ACAD SCI USA, V91, P4960, DOI 10.1073/pnas.91.11.4960; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; vanPuijenbroek AAFL, 1997, ONCOGENE, V14, P1147, DOI 10.1038/sj.onc.1200911; vanWeering DHJ, 1995, ONCOGENE, V11, P2207; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	64	179	182	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3568	3576		10.1074/jbc.275.5.3568	http://dx.doi.org/10.1074/jbc.275.5.3568			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652352	hybrid			2022-12-27	WOS:000085146500074
J	Rochard, P; Rodier, A; Casas, F; Cassar-Malek, I; Marchal-Victorion, S; Daury, L; Wrutniak, C; Cabello, G				Rochard, P; Rodier, A; Casas, F; Cassar-Malek, I; Marchal-Victorion, S; Daury, L; Wrutniak, C; Cabello, G			Mitochondrial activity is involved in the regulation of myoblast differentiation through myogenin expression and activity of myogenic factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CHICK-EMBRYO CELLS; RESPIRATION-DEFICIENT; DOWN-REGULATION; DNA EXPRESSION; PROLIFERATION; INHIBITION; RAS; TRIIODOTHYRONINE; CHLORAMPHENICOL	To characterize the regulatory pathways involved in the inhibition of cell differentiation induced by the impairment of mitochondrial activity, me investigated the relationships occurring between organelle activity and myogenesis using an avian myoblast cell line (QM7). The inhibition of mitochondrial translation by chloramphenicol led to a potent block of myoblast differentiation, Carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone and oligomycin, which affect the organelle at different levels, exerted a similar influence. In addition, we provided evidence that this phenomenon was not the result of an alteration in cell viability. Conversely, overexpression of the mitochondrial T3 receptor (p43) stimulated organelle activity and strongly potentiated myoblast differentiation. The involvement of mitochondrial activity in an actual regulation of myogenesis is further supported by results demonstrating that the muscle regulatory gene myogenin, in contrast to CMD1 (chicken MyoD) and myf5, is a specific transcriptional target of mitochondrial activity. Whereas myogenin mRNA and protein levels were down-regulated by chloramphenicol treatment, they were up-regulated by p43 overexpression, in a positive relationship with the expression level of the transgene, We also found that myogenin or CMD1 overexpression in chloramphenicol-treated myoblasts did not restore differentiation, thus indicating that an alteration in mitochondrial activity interferes with the ability of myogenic factors to induce terminal differentiation.	INRA, Unite Endocrinol Cellulaire, Lab Differenciat Cellulaire & Croissance, F-34060 Montpellier 1, France	INRAE	Cabello, G (corresponding author), INRA, Unite Endocrinol Cellulaire, Lab Differenciat Cellulaire & Croissance, Pl Viala, F-34060 Montpellier 1, France.		, Cassar-Malek/AAW-6386-2020	, Cassar-Malek/0000-0001-7407-1408; Francois, Casas/0000-0002-5535-8195; Daury, Laetitia/0000-0002-1296-7150				ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; BERGMEYER HU, 1963, METHOD ENZYMAT AN, V1, P443; BIGLER J, 1992, MOL CELL BIOL, V12, P2406, DOI 10.1128/MCB.12.5.2406; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; BRUNK CF, 1981, EXP CELL RES, V136, P305, DOI 10.1016/0014-4827(81)90008-2; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Casas F, 1999, MOL CELL BIOL, V19, P7913; CASSARMALEK I, 1994, ONCOGENE, V9, P2197; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; HIRAYAMA E, 1995, CELL STRUCT FUNCT, V20, P377, DOI 10.1247/csf.20.377; KANEKO T, 1988, MOL CELL BIOL, V8, P3311, DOI 10.1128/MCB.8.8.3311; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KONG YF, 1995, MOL CELL BIOL, V15, P5205; KOROHODA W, 1993, FOLIA HISTOCHEM CYTO, V31, P9; LAENG H, 1988, EXP CELL RES, V179, P222, DOI 10.1016/0014-4827(88)90361-8; LEBLONDLAROUCHE L, 1979, J GEN VIROL, V44, P323, DOI 10.1099/0022-1317-44-2-323; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; MARCHAL S, 1995, EXP CELL RES, V220, P1, DOI 10.1006/excr.1995.1285; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; MORAIS R, 1980, BIOCHEM BIOPH RES CO, V94, P71, DOI 10.1016/S0006-291X(80)80189-6; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Orrenius S, 1997, CELL DEATH DIFFER, V4, P427, DOI 10.1038/sj.cdd.4400272; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Ramocki MB, 1997, MOL CELL BIOL, V17, P3547, DOI 10.1128/MCB.17.7.3547; Rochard P, 1996, J CELL PHYSIOL, V168, P239, DOI 10.1002/(SICI)1097-4652(199608)168:2<239::AID-JCP2>3.0.CO;2-Q; Russo S, 1997, ONCOGENE, V14, P63, DOI 10.1038/sj.onc.1200805; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Snedecor G.W., 1961, STAT METHODS; VANDENBOGERT C, 1992, J CELL PHYSIOL, V152, P632, DOI 10.1002/jcp.1041520323; VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763; Wang H, 1997, BBA-GENE STRUCT EXPR, V1352, P325, DOI 10.1016/S0167-4781(97)00035-3; Wang H, 1997, BIOCHEMISTRY-US, V36, P15371, DOI 10.1021/bi971946x; WEBSTER KA, 1990, J CELL PHYSIOL, V142, P566, DOI 10.1002/jcp.1041420316; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wharton DC., 1967, METHOD ENZYMOL, P245; WRUTNIAK C, 1995, J BIOL CHEM, V270, P16347, DOI 10.1074/jbc.270.27.16347; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	40	149	156	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2733	2744		10.1074/jbc.275.4.2733	http://dx.doi.org/10.1074/jbc.275.4.2733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644737	hybrid			2022-12-27	WOS:000085128000069
J	Strovel, ET; Wu, DQ; Sussman, DJ				Strovel, ET; Wu, DQ; Sussman, DJ			Protein phosphatase 2C alpha dephosphorylates axin and activates LEF-1-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; CELL POLARITY; PHOSPHORYLATION; DROSOPHILA; GSK3-BETA; APC; TRANSDUCTION	The Dishevelled (Dvl) gene family encodes cytoplasmic proteins that are necessary for Wnt signal transduction. Utilizing the yeast two-hybrid system, we identified protein phosphatase 2C alpha (PP2C) as a Dvl-PDZ domain-interacting protein. PP2C exists in a complex with Dvl, beta-catenin, and Axin, a negative regulator of Wnt signaling. In a Wnt-responsive LEF-1 reporter gene assay, expression of PP2C activates transcription and also elicits a synergistic response with beta-catenin and Wnt-1. In addition, PP2C expression relieves Axin-mediated repression of LEF-1-dependent transcription. PP2C utilizes Axin as a substrate both in vitro and in vivo and decreases its half-life. These results indicate that PP2C is a positive regulator of Wnt signal transduction and mediates its effects through the dephosphorylation of Axin.	Univ Maryland, Sch Med, Div Human Genet, Baltimore, MD 21201 USA; Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University System of Maryland; University of Maryland Baltimore; University of Rochester	Sussman, DJ (corresponding author), Univ Maryland, Sch Med, Div Human Genet, 655 W Baltimore St, Baltimore, MD 21201 USA.				NATIONAL CANCER INSTITUTE [R01CA063929] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA63929] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Dale TC, 1998, BIOCHEM J, V329, P209; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Steitz SA, 1996, IN VITRO CELL DEV-AN, V32, P441, DOI 10.1007/BF02723007; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; THEISEN H, 1994, DEVELOPMENT, V120, P347; Wagner U, 1996, J CELL SCI, V109, P1537; Wagner U, 1997, FEBS LETT, V411, P369, DOI 10.1016/S0014-5793(97)00733-3; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	39	92	94	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2399	2403		10.1074/jbc.275.4.2399	http://dx.doi.org/10.1074/jbc.275.4.2399			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644691	hybrid			2022-12-27	WOS:000085128000023
J	Worn, A; der Maur, AA; Escher, D; Honegger, A; Barberis, A; Pluckthun, A				Worn, A; der Maur, AA; Escher, D; Honegger, A; Barberis, A; Pluckthun, A			Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN ANTIBODY; LEUCINE-ZIPPER; ESCHERICHIA-COLI; INTRACELLULAR IMMUNIZATION; SACCHAROMYCES-CEREVISIAE; THERMODYNAMIC STABILITY; BINDING PROTEINS; GENE ACTIVATION; SCFV FRAGMENT; LIGHT-CHAIN	A cellular assay system for measuring the activity of cytoplasmically expressed anti-GCN4 scFv fragments directed against the Gcn4p dimerization domain was established in the budding yeast Saccharomyces cerevisiae. The inhibitory potential of different constitutively expressed anti-GCN4 scFv intrabodies was monitored by measuring the activity of beta-galactosidase expressed from a GCN4-dependent reporter gene. The in vivo performance of these scFv intrabodies in specifically decreasing reporter gene activity was related to their in vitro stability, measured by denaturant induced equilibrium unfolding. A framework-engineered stabilized version showed significantly improved activity, while a destabilized point mutant of the anti-GCN4 wild-type showed decreased effects in vivo. These results indicate that stability engineering can result in improved performance of scFv fragments as intrabodies. Increasing the thermodynamic stability appears to be an essential factor for improving the yield of functional scFv in the reducing environment of the cytoplasm, where the conserved intradomain disulfides of antibody fragments cannot form.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; Univ Zurich, ESBATech Inc, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Pluckthun, A (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	plueckthun@biocfebs.unizh.ch	Plückthun, Andreas/C-2746-2009	Plückthun, Andreas/0000-0003-4191-5306; Honegger, Annemarie/0000-0002-3378-3967				Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; BARBERIS A, 1995, CELL, V81, P359, DOI 10.1016/0092-8674(95)90389-5; Berger C, 1998, FEBS LETT, V425, P14, DOI 10.1016/S0014-5793(98)00156-2; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; BIOCCA S, 1995, BIO-TECHNOL, V13, P1110, DOI 10.1038/nbt1095-1110; BIOCCA S, 1994, BIO-TECHNOL, V12, P396, DOI 10.1038/nbt0494-396; BIOCCA S, 1995, TRENDS CELL BIOL, V5, P248, DOI 10.1016/S0962-8924(00)89019-4; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Cardinale A, 1998, FEBS LETT, V439, P197, DOI 10.1016/S0014-5793(98)01369-6; CARLSON JR, 1988, MOL CELL BIOL, V8, P2638, DOI 10.1128/MCB.8.6.2638; Cattaneo A, 1999, TRENDS BIOTECHNOL, V17, P115, DOI 10.1016/S0167-7799(98)01268-2; CHRUNYK BA, 1993, PROTEIN ENG, V6, P733, DOI 10.1093/protein/6.7.733; Cohen PA, 1998, ONCOGENE, V17, P2445, DOI 10.1038/sj.onc.1202190; DUAN LX, 1994, P NATL ACAD SCI USA, V91, P5075, DOI 10.1073/pnas.91.11.5075; Escher D, 1997, MOL GEN GENET, V256, P456, DOI 10.1007/s004380050589; FREUND C, 1993, FEBS LETT, V320, P97, DOI 10.1016/0014-5793(93)80070-B; Frisch C, 1996, FOLD DES, V1, P431, DOI 10.1016/S1359-0278(96)00059-4; Gargano N, 1997, J GEN VIROL, V78, P2591, DOI 10.1099/0022-1317-78-10-2591; Ge L, 1995, ANTIBODY ENG, P229; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; Grim JE, 1998, BIOCHEM BIOPH RES CO, V250, P699, DOI 10.1006/bbrc.1998.9391; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Jung S, 1997, PROTEIN ENG, V10, P959, DOI 10.1093/protein/10.8.959; Kabat E. A., 1991, SEQUENCES PROTEINS I; Kaiser C, 1994, METHODS YEAST GENETI, P169; KNAPPIK A, 1993, BIO-TECHNOL, V11, P77, DOI 10.1038/nbt0193-77; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Leder L, 1995, BIOCHEMISTRY-US, V34, P16509, DOI 10.1021/bi00050a035; Lindner P, 1997, BIOTECHNIQUES, V22, P140, DOI 10.2144/97221rr01; MARASCO WA, 1995, IMMUNOTECHNOLOGY, V1, P1, DOI 10.1016/1380-2933(95)00001-1; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; MHASHILKAR AM, 1995, EMBO J, V14, P1542, DOI 10.1002/j.1460-2075.1995.tb07140.x; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Nieba L, 1997, PROTEIN ENG, V10, P435, DOI 10.1093/protein/10.4.435; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Proba K, 1998, J MOL BIOL, V275, P245, DOI 10.1006/jmbi.1997.1457; Proba K, 1997, J MOL BIOL, V265, P161, DOI 10.1006/jmbi.1996.0726; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tewari D, 1998, J IMMUNOL, V161, P2642; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WENDT H, 1994, J AM CHEM SOC, V116, P6973, DOI 10.1021/ja00094a077; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Worn A, 1998, FEBS LETT, V427, P357, DOI 10.1016/S0014-5793(98)00463-3; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042	56	101	126	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2795	2803		10.1074/jbc.275.4.2795	http://dx.doi.org/10.1074/jbc.275.4.2795			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644744	hybrid			2022-12-27	WOS:000085128000076
J	Brooks, CC; Scherer, PE; Cleveland, K; Whittemore, JL; Lodish, HF; Cheatham, B				Brooks, CC; Scherer, PE; Cleveland, K; Whittemore, JL; Lodish, HF; Cheatham, B			Pantophysin is a phosphoprotein component of adipocyte transport vesicles and associates with GLUT4-containing vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-STIMULATED TRANSLOCATION; SYNAPTOPHYSIN GENE FAMILY; SYNAPTIC VESICLE; 3T3-L1 ADIPOCYTES; MEMBRANE-PROTEIN; SUBCELLULAR-LOCALIZATION; POTENTIAL MECHANISM; GLUCOSE-TRANSPORT; PLASMA-MEMBRANE; RAT ADIPOCYTES	Pantophysin, a protein related to the neuroendocrine-specific synaptophysin, recently has been identified in non-neuronal tissues. In the present study, Northern blots showed that pantophysin mRNA was abundant in adipose tissue and increased during adipogenesis of 3T3-L1 cells. Immunoblot analysis of subcellular fractions showed pantophysin present exclusively in membrane fractions and relatively evenly distributed in the plasma membrane and internal membrane fractions. Sucrose gradient ultracentrifugation demonstrated that pantophysin and GLUT4 exhibited overlapping distribution profiles. Furthermore, immunopurified GLUT4 vesicles contained pantophysin, and both GLUT4 and pantophysin were depleted from this vesicle population following treatment with insulin. Additionally, a subpopulation of immunopurified pantophysin vesicles contained insulin-responsive GLUT4, Consistent with the interaction of synaptophysin with vesicle-associated membrane protein 2 in neuroendocrine tissues, pantophysin associated with vesicle-associated membrane protein 2 in adipocytes, Furthermore, in [P-32]orthophosphate-labeled cells, pantophysin was phosphorylated in the basal state. This phosphorylation was unchanged in response to insulin; however, insulin stimulated the phosphorylation of a 77-kDa protein associated with alpha-pantophysin immunoprecipitates. Although the functional role of pantophysin in vesicle trafficking is unclear, its presence on GLUT4 vesicles is consistent with the emerging role of soluble N-ethylmaleimide-sensitive protein receptor (SNARE) factor complex and related proteins in regulated vesicle transport in adipocytes. In addition, pantophysin may provide a marker for the analysis of other vesicles in adipocytes.	Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute	Cheatham, B (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.		Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392	NICHD NIH HHS [HD07938] Funding Source: Medline; NIDDK NIH HHS [DK47618, DK51668] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051668, R01DK047618, R37DK047618] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asermely KE, 1996, LIFE SCI, V59, P2113, DOI 10.1016/S0024-3205(96)00568-1; BALDINI G, 1995, P NATL ACAD SCI USA, V92, P4284, DOI 10.1073/pnas.92.10.4284; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; BARNEKOW A, 1990, ONCOGENE, V5, P1019; BIXBY JL, 1992, MOL BRAIN RES, V13, P339, DOI 10.1016/0169-328X(92)90217-Y; CAIN CC, 1992, J BIOL CHEM, V267, P11681; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; Cormont M, 1996, MOL CELL BIOL, V16, P6879; CORMONT M, 1991, ENDOCRINOLOGY, V129, P3343, DOI 10.1210/endo-129-6-3343; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DEHERREROS AG, 1989, J BIOL CHEM, V264, P9885; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; ESHKIND LG, 1995, CELL TISSUE RES, V282, P423, DOI 10.1007/s004410050493; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Haass NK, 1996, J CELL BIOL, V134, P731, DOI 10.1083/jcb.134.3.731; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; KANDROR KV, 1995, BIOCHEM J, V307, P383, DOI 10.1042/bj3070383; KITAGAWA K, 1989, BIOCHIM BIOPHYS ACTA, V1014, P83, DOI 10.1016/0167-4889(89)90244-9; LEUBE RE, 1994, J CELL BIOL, V127, P1589, DOI 10.1083/jcb.127.6.1589; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; LEUBE RE, 1994, DIFFERENTIATION, V56, P163, DOI 10.1046/j.1432-0436.1994.5630163.x; LINDSTEDT AD, 1991, J PHYSIOL-LONDON, V85, P90; MASTICK CC, 1994, J BIOL CHEM, V269, P6089; Mastick CC, 1997, ENDOCRINOLOGY, V138, P2391, DOI 10.1210/en.138.6.2391; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; RUBENSTEIN JL, 1993, SYNAPSE, V13, P161, DOI 10.1002/syn.890130207; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1993, CELL, V75, P1; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; Tamori Y, 1996, BIOCHEM BIOPH RES CO, V220, P740, DOI 10.1006/bbrc.1996.0474; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thoidis G, 1998, P NATL ACAD SCI USA, V95, P183, DOI 10.1073/pnas.95.1.183; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; VOLCHUK A, 1995, J BIOL CHEM, V270, P8233, DOI 10.1074/jbc.270.14.8233; WADHWA R, 1993, FEBS LETT, V315, P193, DOI 10.1016/0014-5793(93)81161-R; Wang GY, 1997, J CELL SCI, V110, P505; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Wong PPC, 1997, BIOCHEM BIOPH RES CO, V230, P64, DOI 10.1006/bbrc.1996.5884; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHONG CZ, 1992, BIOCHIM BIOPHYS ACTA, V1129, P235, DOI 10.1016/0167-4781(92)90495-L	56	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2029	2036		10.1074/jbc.275.3.2029	http://dx.doi.org/10.1074/jbc.275.3.2029			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636906	hybrid			2022-12-27	WOS:000084940000069
J	Hoshi, S; Goto, M; Koyama, N; Nomoto, K; Tanaka, H				Hoshi, S; Goto, M; Koyama, N; Nomoto, K; Tanaka, H			Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappa B and its inhibitor, I-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; TISSUE FACTOR EXPRESSION; VEIN ENDOTHELIAL-CELLS; HUMAN MONOCYTIC CELLS; ANTIPLATELET AGENT; MEDIATED TRANSCRIPTION; PLATELET-AGGREGATION; INTIMAL HYPERPLASIA; GROWTH-FACTORS	Proliferation of vascular smooth muscle cells (SMC) is a crucial event in the formation of atherosclerotic tissues and is regulated by nuclear transcriptional factors including nuclear factor-kappa B (NF-kappa B). We constructed a reporter gene assay to measure NF-kappa B-dependent transcriptional activity in SMC. Thrombin receptor-activating peptide (TRAP) and basic fibroblast growth factor (bFGF) stimulated SMC proliferation and rapidly enhanced the NF-kappa B transcriptional activity in a dose-dependent manner. 4-Cyano-5,5-bis-(methoxyphenyl)4-pentenoic acid (E5510) significantly inhibited SMC proliferation and also suppressed NF-kappa B transcription stimulated by TRAP and bFGF. In contrast, although tumor necrosis factor (TNF)-alpha activated NF-kappa B transcription, E5510 had no effect on TNF-alpha-induced activation. NF-kappa B was activated after the stimulation of TRAP, bFGF, and TNF-alpha in electrophoretic mobility shift assay, and E5510 suppressed the NF-kappa B activation induced by TRAP and bFGF but not the activation by TNF-alpha. Western blot analysis of I-kappa B alpha and I-kappa B beta, inhibitors of NF-kappa B, indicated that I-kappa B alpha degradation, rather than I-kappa B beta degradation, was important in NF-kappa B activation after the stimulation of TRAP and bFGF. PD98059, an inhibitor of extracellular signal-regulated kinase (ERK) kinase, suppressed NF-kappa B transcriptional activity and SMC proliferation. The phosphorylation of ERK1/2 was rapidly induced by TRAP and bFGF but not by TNF-alpha. These results indicate that TRAP and bFGF induced I-kappa B degradation and NF-kappa B activation through a distinct pathway from TNF-alpha and that ERK1/2 may play an important role in NF-kappa B activation induced by TRAP and bFGF.	Eisai & Co Ltd, Tsukuba Res Labs, Ibaraki, Osaka 3002635, Japan	Eisai Co Ltd	Hoshi, S (corresponding author), Eisai & Co Ltd, Tsukuba Res Labs, Tokodai 5-1-3, Ibaraki, Osaka 3002635, Japan.			Koyama, Noriyuki/0000-0002-7509-6583				Anrather D, 1997, J IMMUNOL, V159, P5620; AUTIERI MV, 1995, BIOCHEM BIOPH RES CO, V213, P827, DOI 10.1006/bbrc.1995.2204; BELLAS RE, 1995, J CLIN INVEST, V96, P2521, DOI 10.1172/JCI118313; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598; Bretschneider E, 1997, THROMB RES, V87, P493, DOI 10.1016/S0049-3848(97)00164-3; BRINKMAN HJM, 1991, EXP CELL RES, V192, P87, DOI 10.1016/0014-4827(91)90161-M; Cercek B, 1997, ATHEROSCLEROSIS, V131, P59, DOI 10.1016/S0021-9150(96)06767-6; Chaturvedi MM, 1997, J BIOL CHEM, V272, P30129, DOI 10.1074/jbc.272.48.30129; Chen CC, 1996, J CARDIOVASC PHARM, V28, P240, DOI 10.1097/00005344-199608000-00009; Chen G, 1999, LIFE SCI, V64, P1231, DOI 10.1016/S0024-3205(99)00055-7; CLOWES AW, 1991, J VASC SURG, V13, P885; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Deguchi H, 1997, BLOOD, V90, P2345, DOI 10.1182/blood.V90.6.2345.2345_2345_2356; DEISHER TA, 1993, FEBS LETT, V331, P285, DOI 10.1016/0014-5793(93)80354-W; FLORIO C, 1994, AM J PHYSIOL, V266, pL131, DOI 10.1152/ajplung.1994.266.2.L131; FUJIMORI T, 1991, JPN J PHARMACOL, V55, P81, DOI 10.1254/jjp.55.81; Fujioka K, 1996, J CARDIOVASC PHARM, V27, P824, DOI 10.1097/00005344-199606000-00009; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goto M, 1998, J ANTIBIOT, V51, P539, DOI 10.7164/antibiotics.51.539; Goto M, 1999, CYTOKINE, V11, P16, DOI 10.1006/cyto.1998.0390; Goto M, 1996, MOL PHARMACOL, V49, P860; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; Haller H, 1996, ARTERIOSCL THROM VAS, V16, P678, DOI 10.1161/01.ATV.16.5.678; Haller H, 1998, ACTA PHYSIOL SCAND, V164, P599; Harhaj EW, 1997, J BIOL CHEM, V272, P5409, DOI 10.1074/jbc.272.9.5409; Hishikawa K, 1997, CIRC RES, V81, P797; Janosch P, 1996, J BIOL CHEM, V271, P13868, DOI 10.1074/jbc.271.23.13868; KOYAMA N, 1994, CIRC RES, V75, P682, DOI 10.1161/01.RES.75.4.682; KOYAMA N, 1993, J BIOL CHEM, V268, P13301; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Landry DB, 1997, AM J PATHOL, V151, P1085; LAWRENCE R, 1994, J BIOL CHEM, V269, P28913; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Lille S, 1997, J SURG RES, V70, P178, DOI 10.1006/jsre.1997.5114; Mallat A, 1998, J BIOL CHEM, V273, P27300, DOI 10.1074/jbc.273.42.27300; Mattana J, 1997, KIDNEY INT, V52, P1478, DOI 10.1038/ki.1997.478; Mawatari K, 1997, J CARDIOVASC SURG, V38, P359; McGilvray ID, 1997, J BIOL CHEM, V272, P10287; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagakura N, 1996, BIOL PHARM BULL, V19, P828; NAKAJIMA T, 1994, BIOCHEM BIOPH RES CO, V203, P1181, DOI 10.1006/bbrc.1994.2307; NAKAJIMA T, 1994, BIOCHEM BIOPH RES CO, V204, P950, DOI 10.1006/bbrc.1994.2552; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; Natarajan K, 1998, ARCH BIOCHEM BIOPHYS, V352, P59, DOI 10.1006/abbi.1998.0576; NOMOTO K, 1993, JPN J PHARMACOL, V61, P7, DOI 10.1254/jjp.61.7; Obata H, 1996, BIOCHEM BIOPH RES CO, V224, P27, DOI 10.1006/bbrc.1996.0979; OETH P, 1995, BLOOD, V86, P4144, DOI 10.1182/blood.V86.11.4144.bloodjournal86114144; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Parry GCN, 1997, J IMMUNOL, V159, P5450; Pierce JW, 1996, J IMMUNOL, V156, P3961; RITCHIE AJ, 1991, J IMMUNOL, V146, P3056; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Selzman CH, 1999, CIRC RES, V84, P867; Shapiro PS, 1996, J BIOL CHEM, V271, P5750, DOI 10.1074/jbc.271.10.5750; Singh S, 1996, J BIOL CHEM, V271, P31049, DOI 10.1074/jbc.271.49.31049; TAKAHASHI S, 1992, J CARDIOVASC PHARM, V20, P900, DOI 10.1097/00005344-199212000-00009; Tuyt LML, 1999, J IMMUNOL, V162, P4893; Wellner M, 1999, ARTERIOSCL THROM VAS, V19, P178, DOI 10.1161/01.ATV.19.1.178; Yerneni KKV, 1999, DIABETES, V48, P855, DOI 10.2337/diabetes.48.4.855; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	65	88	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					883	889		10.1074/jbc.275.2.883	http://dx.doi.org/10.1074/jbc.275.2.883			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625622	hybrid			2022-12-27	WOS:000084836600026
J	Kazen-Gillespie, KA; Ragsdale, DS; D'Andrea, MR; Mattei, LN; Rogers, KE; Isom, LL				Kazen-Gillespie, KA; Ragsdale, DS; D'Andrea, MR; Mattei, LN; Rogers, KE; Isom, LL			Cloning, localization, and functional expression of sodium channel beta 1A subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN SKELETAL-MUSCLE; LDL RECEPTOR FAMILY; NA+-CHANNEL; MESSENGER-RNA; RAT-BRAIN; SENSORY NEURONS; MOLECULAR DETERMINANTS; XENOPUS OOCYTES; ALPHA-SUBUNITS	Auxiliary beta 1 subunits of voltage-gated sodium channels have been shown to be cell adhesion molecules of the Ig superfamily, Co-expression of alpha and beta 1 subunits modulates channel gating as well as plasma membrane expression levels. We have cloned, sequenced, and expressed a splice variant of beta 1, termed beta 1A, that results from an apparent intron retention event. beta 1 and beta 1A are structurally homologous proteins with type I membrane topology; however, they contain little to no amino acid homology beyond the shared Ig loop region. beta 1A mRNA expression is developmentally regulated in rat brain such that it is complementary to beta 1. beta 1A mRNA is expressed during embryonic development, and then its expression becomes undetectable after birth, concomitant with the onset of beta 1 expression, In contrast, beta 1A mRNA is expressed in adult adrenal gland and heart. Western blot analysis revealed beta 1A protein expression in heart, skeletal muscle, and adrenal gland but not in adult brain or spinal cord. Immunocytochemical analysis of beta 1A expression revealed selective expression in brain and spinal cord neurons, with high expression in heart and all dorsal root ganglia neurons. Co-expression of alpha IIA and beta 1A subunits in Chinese hamster lung 1610 cells results in a 2.5-fold increase in sodium current density compared with cells expressing alpha IIA alone. This increase in current density reflected two effects of beta 1A: 1) an increase in the proportion of cells expressing detectable sodium currents and 2) an increase in the level of functional sodium channels in expressing cells. [H-3]Saxitoxin binding analysis revealed a 4-fold increase in B-max with no change in K-D in cells coexpressing alpha IIA and beta 1A compared with cells expressing alpha IIA alone. beta 1A-expressing cell lines also revealed subtle differences in sodium channel activation and inactivation. These effects of beta 1A subunits on sodium channel function may be physiologically important events in the development of excitable cells.	Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; RW Johnson Pharmaceut Res Inst, Spring House, PA 19477 USA	University of Michigan System; University of Michigan; McGill University; Johnson & Johnson; Johnson & Johnson USA	Isom, LL (corresponding author), Univ Michigan, Dept Pharmacol, 1301 MSRB 3, Ann Arbor, MI 48109 USA.			Isom, Lori/0000-0002-9479-6729	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00042] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ALTIERI DC, 1994, BIOCHEMISTRY-US, V33, P13848, DOI 10.1021/bi00250a039; BENNETT PB, 1993, FEBS LETT, V326, P21, DOI 10.1016/0014-5793(93)81752-L; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CANNON SC, 1993, PFLUG ARCH EUR J PHY, V423, P155, DOI 10.1007/BF00374974; Chen CF, 1995, PFLUG ARCH EUR J PHY, V431, P186, DOI 10.1007/BF00410190; D'Andrea MR, 1998, J HISTOCHEM CYTOCHEM, V46, P157; DELAPENA P, 1992, J BIOL CHEM, V267, P25703; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; DibHajj SD, 1995, FEBS LETT, V377, P485, DOI 10.1016/0014-5793(95)01400-4; Gliemann J, 1998, BIOL CHEM, V379, P951; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAMPSON RK, 1989, MOL CELL BIOL, V9, P1604, DOI 10.1128/MCB.9.4.1604; Higashikawa K, 1996, INT J CANCER, V66, P11, DOI 10.1002/(SICI)1097-0215(19960328)66:1<11::AID-IJC3>3.3.CO;2-L; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; KORENBERG JR, 1994, GENOMICS, V22, P88, DOI 10.1006/geno.1994.1348; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P13070, DOI 10.1074/jbc.270.22.13070; MAKITA N, 1994, GENOMICS, V23, P628, DOI 10.1006/geno.1994.1551; Makita N, 1996, J NEUROSCI, V16, P7117; MAKITA N, 1994, J BIOL CHEM, V269, P7571; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; MCHUGHSUTKOWSKI E, 1990, J BIOL CHEM, V265, P12393; OH YS, 1994, P NATL ACAD SCI USA, V91, P9985, DOI 10.1073/pnas.91.21.9985; PATTON DE, 1994, J BIOL CHEM, V269, P17649; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; SADOT E, 1994, J MOL BIOL, V241, P325, DOI 10.1006/jmbi.1994.1508; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Sashihara S, 1995, MOL BRAIN RES, V34, P239, DOI 10.1016/0169-328X(95)00168-R; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P360, DOI 10.1007/BF00374796; Shah R. M., 1996, Society for Neuroscience Abstracts, V22, P63; Smith MR, 1998, J NEUROSCI, V18, P6093; Smith RD, 1998, J NEUROSCI, V18, P811; Tabiti K, 1996, GENE, V175, P7, DOI 10.1016/0378-1119(96)00113-8; TONG JF, 1993, BIOCHEM BIOPH RES CO, V195, P679, DOI 10.1006/bbrc.1993.2099; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; WALLNER M, 1993, FEBS LETT, V336, P535, DOI 10.1016/0014-5793(93)80871-Q; WEIGT C, 1992, J MOL BIOL, V227, P593, DOI 10.1016/0022-2836(92)90915-7; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; ZHANG JS, 1995, J CELL BIOL, V128, P415, DOI 10.1083/jcb.128.3.415	45	120	124	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1079	1088		10.1074/jbc.275.2.1079	http://dx.doi.org/10.1074/jbc.275.2.1079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625649	hybrid			2022-12-27	WOS:000084836600053
J	Perez-Juste, G; Garcia-Silva, S; Aranda, A				Perez-Juste, G; Garcia-Silva, S; Aranda, A			An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE DEACETYLASE; DOWN-REGULATION; RECEPTOR-ALPHA; NEURO-2A CELLS; PROTEIN; DNA; PROMOTER; CTCF; DIFFERENTIATION	The thyroid hormone (T3) blocks proliferation and induces differentiation of neuroblastoma N2a-beta cells that express the thyroid hormone receptor (TR) beta 1 isoform. c-Myc is required for cell cycle progression, and this study shows that T3-induced neuronal differentiation is preceded by a rapid decrease of c-myc gene expression. A negative T3 responsive element (TRE), arranged as an inverted palindrome spaced by three nucleotides, has been identified within the first exon between nucleotides +237 and +268, The TRE is adjacent to the binding site for the transcriptional repressor CCCTC binding factor and maps precisely within the region of RNA polymerase II pausing and release, suggesting a direct implication of TR on premature termination of transcription. Furthermore, the TRE confers repression by T3 to an heterologous promoter only when inserted downstream of the transcription initiation site. Binding of CCCTC binding factor and TR to their cognate sites in the region of transcriptional attenuation, as well as direct interactions between both factors, could facilitate the formation of a repressor complex and the inhibition of c-myc gene expression. These studies provide insight into mechanisms by which TR mediate transcriptional repression and contribute to the understanding of the important effects bf thyroid hormones on growth and differentiation of neuronal cells.	Inst Invest Biomed, Madrid 28029, Spain; Univ Autonoma Madrid, Madrid 28029, Spain	Autonomous University of Madrid	Aranda, A (corresponding author), Inst Invest Biomed, Arturo Duperier 4, Madrid 28029, Spain.		Garcia-Silva, Susana/AAW-8528-2021; Aranda, Ana/ABG-8820-2020	Garcia-Silva, Susana/0000-0003-1065-0245; Aranda, Ana/0000-0002-8338-9589				Arnold R, 1996, NUCLEIC ACIDS RES, V24, P2640, DOI 10.1093/nar/24.14.2640; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BIGLER J, 1995, EMBO J, V14, P5710, DOI 10.1002/j.1460-2075.1995.tb00258.x; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; FARSETTI A, 1992, J BIOL CHEM, V267, P15784; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; HADZIC E, 1995, MOL CELL BIOL, V15, P4507; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Henriksson M, 1996, ADV CANCER RES, V68, P109, DOI 10.1016/S0065-230X(08)60353-X; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Jimenez-Lara AM, 1999, FASEB J, V13, P1073, DOI 10.1096/fasebj.13.9.1073; Klenova EM, 1997, NUCLEIC ACIDS RES, V25, P466, DOI 10.1093/nar/25.3.466; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; KOHNE AC, 1993, J MOL BIOL, V232, P747, DOI 10.1006/jmbi.1993.1428; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; LAVENU A, 1994, ONCOGENE, V9, P527; LEBEL JM, 1994, P NATL ACAD SCI USA, V91, P2644, DOI 10.1073/pnas.91.7.2644; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MAREU KB, 1992, ANNU REV BIOCHEM, V61, P809; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Perez-Juste G, 1999, J BIOL CHEM, V274, P5026, DOI 10.1074/jbc.274.8.5026; Puymirat J, 1995, J BIOL CHEM, V270, P30651, DOI 10.1074/jbc.270.51.30651; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; SAATCIOGLU F, 1993, CELL, V75, P1095, DOI 10.1016/0092-8674(93)90319-L; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SKERKA C, 1993, ONCOGENE, V8, P2135; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; TINI M, 1994, MOL ENDOCRINOL, V8, P1494, DOI 10.1210/me.8.11.1494; Tolon RM, 1998, J BIOL CHEM, V273, P26652, DOI 10.1074/jbc.273.41.26652; VALCARCEL R, 1994, GENE DEV, V8, P3068, DOI 10.1101/gad.8.24.3068; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WILLIAMS GR, 1994, ENDOCRINOLOGY, V134, P1888, DOI 10.1210/en.134.4.1888; WRIGHT S, 1989, P NATL ACAD SCI USA, V86, P505, DOI 10.1073/pnas.86.2.505; ZHANG WG, 1992, J BIOL CHEM, V267, P15056	40	60	61	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1307	1314		10.1074/jbc.275.2.1307	http://dx.doi.org/10.1074/jbc.275.2.1307			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625678	hybrid			2022-12-27	WOS:000084836600082
J	Baracca, A; Barogi, S; Carelli, V; Lenaz, G; Solaini, G				Baracca, A; Barogi, S; Carelli, V; Lenaz, G; Solaini, G			Catalytic activities of mitochondrial ATP synthase in patients with mitochondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTON TRANSLOCATION; MOLECULAR MACHINE; LEIGHS SYNDROME; DISEASE; MECHANISM; HETEROPLASMY; F1-ATPASE; MTDNA; F1F0-ATPASE	We:investigated the biochemical phenotype of the mtDNA T8993G point mutation in the ATPase 6 gene, associated with neurogenic muscle weakness, ataxia, and retinitis pigmentosa (NARP), in three patients from two unrelated families. All three carried >80% mutant genome in platelets and were manifesting clinically various degrees of the NARP phenotype, Coupled submitochondrial particles prepared from platelets capable of succinate-sustained ATP synthesis were studied using very sensitive and rapid luminometric and fluorescence methods. A sharp decrease (>95%) in the succinate-sustained ATP synthesis rate of the particles was found, but both the ATP hydrolysis rate and ATP-driven proton translocation (when the protons flow from the matrix to the cytosol) were minimally affected. The T8993G mutation changes the highly conserved residue Leu(156) to Arg in the ATPase 6 subunit (subunit a). This subunit, together with subunit c, is thought to cooperatively catalyze proton translocation and rotate, one with respect to the other, during the catalytic cycle of the F1F0 complex. Our results suggest that the T8993G mutation induces a structural defect in human F1F0-ATPase that causes a severe impairment of ATP synthesis. This is possibly due to a defect in either the vectorial proton transport from the cytosol to the mitochondrial matrix or the coupling of proton flow through F-0, to ATP synthesis in F-1, Whatever mechanism is involved, this leads to impaired ATP synthesis. On the other hand, ATP hydrolysis that involves proton flow from the matrix to the cytosol is essentially unaffected.	Univ Perfezionamento S Anna, Scuola Super Studi, Settore Med, I-56127 Pisa, Italy; Univ Bologna, Dipartimento Biochim, I-48026 Bologna, Italy; Univ So Calif, Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	Scuola Superiore Sant'Anna; University of Bologna; University of Southern California	Solaini, G (corresponding author), Univ Perfezionamento S Anna, Scuola Super Studi, Settore Med, Via Carducci 40, I-56127 Pisa, Italy.	gsolaini@sssup.it	Lenaz, Giorgio/B-5751-2013	CARELLI, VALERIO/0000-0003-4923-6404; SOLAINI, GIANCARLO/0000-0001-7825-0446	Telethon [1048] Funding Source: Medline	Telethon(Fondazione Telethon)		Baracca A, 1997, BIOCHEM BIOPH RES CO, V235, P469, DOI 10.1006/bbrc.1997.6807; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Buchanan SK, 1996, BIOCHEM J, V318, P343, DOI 10.1042/bj3180343; CAIN BD, 1988, J BIOL CHEM, V263, P6606; CAIN BD, 1989, J BIOL CHEM, V264, P3292; CAPALDI RA, 1994, TRENDS BIOCHEM SCI, V19, P284, DOI 10.1016/0968-0004(94)90006-X; Carelli V, 1997, NEUROLOGY, V48, P1623, DOI 10.1212/WNL.48.6.1623; Casadio R, 1996, J BIOL INORG CHEM, V1, P284, DOI 10.1007/s007750050055; COX GB, 1986, BIOCHIM BIOPHYS ACTA, V849, P62, DOI 10.1016/0005-2728(86)90096-4; DEVRIES DD, 1993, ANN NEUROL, V34, P410, DOI 10.1002/ana.410340319; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Fillingame RH, 1997, J EXP BIOL, V200, P217; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; Futai M, 1996, J BIOENERG BIOMEMBR, V28, P409, DOI 10.1007/BF02113982; HARTZOG PE, 1993, J BIOL CHEM, V268, P12250; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; HATEFI Y, 1993, EUR J BIOCHEM, V218, P759, DOI 10.1111/j.1432-1033.1993.tb18431.x; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; Howitt SM, 1996, J BIOENERG BIOMEMBR, V28, P415, DOI 10.1007/BF02113983; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KARRASCH S, 1998, EUR BIOENERG C SHORT, V10, P49; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386; MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333; MATSUNOYAGI A, 1986, J BIOL CHEM, V261, P14031; MATTHEWS PM, 1995, HUM GENET, V96, P261; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Papageorgiou S, 1998, J BIOENERG BIOMEMBR, V30, P533, DOI 10.1023/A:1020528432609; PEDERSEN PL, 1993, J BIOL CHEM, V268, P9937; PUDDU P, 1993, BRIT J OPHTHALMOL, V77, P84, DOI 10.1136/bjo.77.2.84; SANTORELLI FM, 1993, ANN NEUROL, V34, P827, DOI 10.1002/ana.410340612; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Tatuch Yuriy, 1994, European Journal of Human Genetics, V2, P35; TROUNCE I, 1994, P NATL ACAD SCI USA, V91, P8334, DOI 10.1073/pnas.91.18.8334; Uziel G, 1997, J NEUROL NEUROSUR PS, V63, P16, DOI 10.1136/jnnp.63.1.16; VazquezMemije ME, 1996, J INHERIT METAB DIS, V19, P43, DOI 10.1007/BF01799347; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wilkens S, 1998, BBA-BIOENERGETICS, V1365, P93, DOI 10.1016/S0005-2728(98)00048-6; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	46	90	92	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4177	4182		10.1074/jbc.275.6.4177	http://dx.doi.org/10.1074/jbc.275.6.4177			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660580	hybrid			2022-12-27	WOS:000085288800064
J	Nakagawa, T; Imanaka, T; Morita, M; Ishiguro, K; Yurimoto, H; Yamashita, A; Kato, N; Sakai, Y				Nakagawa, T; Imanaka, T; Morita, M; Ishiguro, K; Yurimoto, H; Yamashita, A; Kato, N; Sakai, Y			Peroxisomal membrane protein Pmp47 is essential in the metabolism of middle-chain fatty acid in yeast peroxisomes and is associated with peroxisome proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPOROGENOUS METHYLOTROPHIC YEAST; CANDIDA-BOIDINII; SACCHAROMYCES-CEREVISIAE; RAT-LIVER; BETA-OXIDATION; TRANSPORT; COA; EXPRESSION; IMPORT; ENZYME	Pmp47 of the methylotrophic yeast Candida boidinii belongs to a mitochondrial family of solute transporters and is localized in peroxisomal membranes. Its human homolog, Pmp34, is also known. In this study, we characterized the role of Pmp47 in fatty acid metabolism and peroxisome proliferation using the PMP47-deleted strain of C. boidinii (strain pmp47 Delta). The wild-type strain grew well on a middle-chain fatty acid, laureate, as the single carbon source, and mild peroxisome proliferation was observed during its growth. The pmp47 Delta strain could not grow on laureate but could grow on long-chain fatty acids including palmitate, myristate, and oleate, The levels of laureate oxidation activity in intact cells and in semi-permeabilized cells of strain pmp47 Delta were lower than the respective level in the wildtype strain, although the level of laureate oxidation activity in the cell lysate and the level of lauroyl-CoA oxidation in semi-permeabilized cells of strain pmp47 Delta were indistinguishable from the respective level in the wild-type strain. When lauroyl-CoA was provided in the cytosol of strain pmp47 Delta through expression of Saccharomyces cerevisiae Faa2p (lauroyl-CoA synthetase) in which its peroxisome targeting signal was deleted, the growth of strain pmp47 Delta on laureate was recovered to the level of growth of the wild-type strain. Laureate is converted to its CoA form in peroxisomes by the action of lauroyl-CoA synthetase, These results suggested that Pmp47 is involved in the transport of a small molecule (possibly ATP) required in the conversion of laureate to its CoA form in peroxisomes and that the absence of Pmp47 causes impairment of laureate metabolism, which results in the inability of pmp47 Delta cells to grow on laureate. In addition, Pmp47 may be involved in peroxisome proliferation, because the pmp47 Delta strain contained a reduced number of peroxisomes, as judged from the fluorescence analysis of cells expressing green fluorescent protein tagged with the peroxisome targeting signal 1(GFP-AKL).	Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Dept Biol Chem, Sugitani, Toyama 9300194, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Hyg Chem & Nutr, Sagamiko, Kanagawa 1990145, Japan	Kyoto University; University of Toyama; Teikyo University	Sakai, Y (corresponding author), Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.		Yurimoto, Hiroya/N-6538-2018	Yurimoto, Hiroya/0000-0001-7506-6184; Yamashita, Atsushi/0000-0002-2544-2134; Imanaka, Tsuneo/0000-0003-4677-1356; Nakagawa, Tomoyuki/0000-0003-0112-0349				Abumrad N, 1998, J LIPID RES, V39, P2309; BERGMEYER HU, 1955, BIOCHEM Z, V327, P255; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DOODY MC, 1980, BIOCHEMISTRY-US, V19, P108, DOI 10.1021/bi00542a017; GOODMAN JM, 1984, J BIOL CHEM, V259, P8485; GOODMAN JM, 1990, J CELL SCI, V97, P193; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; ICHIHARA K, 1991, J LIPID RES, V32, P1709; Imanaka T, 1999, J BIOL CHEM, V274, P11968, DOI 10.1074/jbc.274.17.11968; Ito K, 1998, J BIOL CHEM, V273, P1684, DOI 10.1074/jbc.273.3.1684; JANK B, 1993, TRENDS BIOCHEM SCI, V18, P427; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; KUNAU WH, 1988, BIOCHEM SOC T, V16, P418, DOI 10.1042/bst0160418; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; Passreiter M, 1998, J CELL BIOL, V141, P373, DOI 10.1083/jcb.141.2.373; SAKAI Y, 1992, J BACTERIOL, V174, P5988, DOI 10.1128/jb.174.18.5988-5993.1992; SAKAI Y, 1991, J BACTERIOL, V173, P7458, DOI 10.1128/jb.173.23.7458-7463.1991; SAKAI Y, 1994, BIO-TECHNOL, V12, P291, DOI 10.1038/nbt0394-291; Sakai Y, 1998, YEAST, V14, P1175, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1175::AID-YEA319>3.3.CO;2-Z; Sakai Y, 1996, J CELL BIOL, V134, P37, DOI 10.1083/jcb.134.1.37; SAKAI Y, 1995, J BACTERIOL, V177, P6773, DOI 10.1128/jb.177.23.6773-6781.1995; SAKAI Y, 2000, IN PRESS CELL BIOCH; Sambrook J., 2002, MOL CLONING LAB MANU; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; SHAFFER JE, 1994, CELL, V79, P427; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Tolbert N E, 1974, Methods Enzymol, V31, P734; VANHOOREN JCT, 1994, INT J BIOCHEM, V26, P1095, DOI 10.1016/0020-711X(94)90131-7; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; VANVELDHOVEN PP, 1987, J BIOL CHEM, V262, P4310; Wylin T, 1998, EUR J BIOCHEM, V258, P332, DOI 10.1046/j.1432-1327.1998.2580332.x; YAMASHITA A, 1995, BIOCHEM J, V312, P301, DOI 10.1042/bj3120301; ZHOU SL, 1994, BIOCHEM J, V297, P315, DOI 10.1042/bj2970315	36	39	40	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3455	3461		10.1074/jbc.275.5.3455	http://dx.doi.org/10.1074/jbc.275.5.3455			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652339	hybrid			2022-12-27	WOS:000085146500061
J	Oyarce, AM; Eipper, BA				Oyarce, AM; Eipper, BA			Cell type-specific storage of dopamine beta-monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMIDATING MONOOXYGENASE; PEPTIDE-PROCESSING ENZYME; GRANULE MEMBRANE-PROTEIN; UNCLEAVED SIGNAL PEPTIDE; SECRETORY GRANULES; ENDOPLASMIC-RETICULUM; ATT-20 CELLS; CHROMAFFIN GRANULES; MESSENGER-RNA; PHEOCHROMOCYTOMA CELLS	Expression of dopamine P-monooxygenase (DBM), the enzyme that converts dopamine into norepinephrine, is limited to adrenal chromaffin cells and a small population of neurons. We studied DBM trafficking to regulated granules by stably expressing rat DBM in AtT-20 corticotrope tumor cells, which contain regulated granules, and in Chinese hamster ovary (CHO) cells, which lack regulated granules. The behavior of exogenous DBM in both cell lines was compared with endogenous DEM in adrenal chromaffin cells. CHO cells secreted active DBM, indicating that production of active enzyme does not require features unique to neuroendocrine cells. Pulse-chase experiments indicated that early steps in DBM maturation followed a similar time course in AtT-20, CHO, and adrenal chromaffin cells. Use of a conformation-sensitive DBM antiserum indicated that acquisition of a folded structure occurred with a similar time course in all three cell types. Cell type-specific differences in DBM trafficking became apparent only when storage in granules was examined. As expected, DBM was stored in secretory granules in chromaffin cells; CHO cells failed to store DBM. Despite the fact that AtT-20 cells have regulated granules, exogenous DBM was not stored in these granules. Thus storage of DBM in secretory granules requires cell type specific factors.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Eipper, BA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, WBSB 907,725 N Wolfe St, Baltimore, MD 21205 USA.				NIDA NIH HHS [DA-11269, DA-00266] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA011269, P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BAEHR W, 1988, FEBS LETT, V238, P253, DOI 10.1016/0014-5793(88)80490-3; BASTIAENSEN E, 1989, FEBS LETT, V244, P477, DOI 10.1016/0014-5793(89)80587-3; BLACKBOROUGH P, 1981, ARCH BIOCHEM BIOPHYS, V669, P33; Boswell JS, 1996, BIOCHEMISTRY-US, V35, P12241, DOI 10.1021/bi960742y; BRAAS KM, 1989, MOL ENDOCRINOL, V3, P1387, DOI 10.1210/mend-3-9-1387; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V16, P112, DOI 10.1016/0968-0004(91)90044-V; BURGESS TL, 1985, J CELL BIOL, V101, P639, DOI 10.1083/jcb.101.2.639; CASTLE AM, 1995, J CELL SCI, V108, P3827; CASTLE AM, 1992, J BIOL CHEM, V267, P13093; COLOMER V, 1994, EMBO J, V13, P3711, DOI 10.1002/j.1460-2075.1994.tb06680.x; Colomer V, 1996, J BIOL CHEM, V271, P48, DOI 10.1074/jbc.271.1.48; CORCORAN JJ, 1990, AM J PHYSIOL, V259, pC161, DOI 10.1152/ajpcell.1990.259.1.C161; Dittie AS, 1997, EMBO J, V16, P4859, DOI 10.1093/emboj/16.16.4859; EIPPER BA, 1992, J BIOL CHEM, V267, P4008; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1993, PROTEIN SCI, V2, P489; FENG ZH, 1992, J BIOL CHEM, V267, P21808; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GIBSON KR, 1993, J BIOL CHEM, V268, P9490; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1978, J NEUROCHEM, V30, P549, DOI 10.1111/j.1471-4159.1978.tb07808.x; Grimmelikhuijzen CJP, 1996, INT REV CYTOL, V167, P37, DOI 10.1016/S0074-7696(08)61345-5; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; HERMAN GA, 1994, P NATL ACAD SCI USA, V91, P12750, DOI 10.1073/pnas.91.26.12750; Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7; HODGES RS, 1988, J BIOL CHEM, V263, P11768; HOFLE G, 1991, REGUL PEPTIDES, V32, P321, DOI 10.1016/0167-0115(91)90025-C; HOUHOU L, 1995, J BIOL CHEM, V270, P12601, DOI 10.1074/jbc.270.21.12601; HUGHES EN, 1981, J BIOL CHEM, V256, P664; HURTLEY SM, 1993, J CELL SCI, V106, P649; JUNG LJ, 1993, J CELL BIOL, V121, P11, DOI 10.1083/jcb.121.1.11; KATOPODIS AG, 1990, BIOCHEMISTRY-US, V29, P6115, DOI 10.1021/bi00478a001; Kolhekar AS, 1997, BIOCHEMISTRY-US, V36, P10901, DOI 10.1021/bi9708747; KULATHILA R, 1994, ARCH BIOCHEM BIOPHYS, V311, P191, DOI 10.1006/abbi.1994.1225; LADURON PM, 1975, FEBS LETT, V52, P132, DOI 10.1016/0014-5793(75)80654-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS EJ, 1992, J BIOL CHEM, V267, P494; Li B, 1996, BIOCHEM J, V313, P57, DOI 10.1042/bj3130057; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; Mains R E, 1980, Ann N Y Acad Sci, V343, P94, DOI 10.1111/j.1749-6632.1980.tb47245.x; MAINS RE, 1990, FRONT NEUROENDOCRIN, V11, P52; MAINS RE, 1990, TRENDS ENDOCRIN MET, V1, P388, DOI 10.1016/1043-2760(90)90097-M; MALTESE JY, 1993, ENDOCRINOLOGY, V133, P2579, DOI 10.1210/en.133.6.2579; MARGOLIS RK, 1984, ARCH BIOCHEM BIOPHYS, V228, P443, DOI 10.1016/0003-9861(84)90009-2; MCMAHON A, 1990, J NEUROSCI RES, V25, P395, DOI 10.1002/jnr.490250317; MERKLER DJ, 1995, FEBS LETT, V366, P165, DOI 10.1016/0014-5793(95)00516-C; Milgram SL, 1996, MOL ENDOCRINOL, V10, P837, DOI 10.1210/me.10.7.837; MILGRAM SL, 1994, J CELL BIOL, V124, P33, DOI 10.1083/jcb.124.1.33; MILGRAM SL, 1992, J CELL BIOL, V117, P717, DOI 10.1083/jcb.117.4.717; Milgram SL, 1997, J CELL SCI, V110, P695; MILGRAM SL, 1993, J CELL BIOL, V121, P23, DOI 10.1083/jcb.121.1.23; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; Muller L, 1999, J BIOL CHEM, V274, P21471, DOI 10.1074/jbc.274.30.21471; Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095; OYARCE AM, 1991, ARCH BIOCHEM BIOPHYS, V290, P503, DOI 10.1016/0003-9861(91)90573-2; OYARCE AM, 1989, J MOL NEUROSCI, V1, P171, DOI 10.1007/BF02918903; OYARCE AM, 1995, J CELL SCI, V108, P287; Partoens P, 1998, J CELL SCI, V111, P681; POTTER LT, 1963, J PHARMACOL EXP THER, V142, P291; ROBERTSON JG, 1994, BIOCHEMISTRY-US, V33, P11563, DOI 10.1021/bi00204a019; Rosenberg JB, 1998, J CLIN INVEST, V101, P613, DOI 10.1172/JCI1250; Rowe J, 1999, J CELL SCI, V112, P1865; SABBAN EL, 1983, J BIOL CHEM, V258, P7812; SABBAN EL, 1989, BIOCHEM INT, V19, P769; SAXENA A, 1983, J BIOL CHEM, V258, P4147; SAXENA A, 1985, J BIOL CHEM, V260, P3386; Slot JW, 1997, J CELL BIOL, V137, P1243, DOI 10.1083/jcb.137.6.1243; SOUTHAN C, 1989, FEBS LETT, V255, P116, DOI 10.1016/0014-5793(89)81072-5; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; TALJANIDISZ J, 1989, BIOCHEMISTRY-US, V28, P10054, DOI 10.1021/bi00452a026; TAYLOR CS, 1989, J BIOL CHEM, V264, P15242; THIELE EA, 1990, ENDOCRINOLOGY, V126, P809, DOI 10.1210/endo-126-2-809; VINDROLA O, 1993, NEUROPEPTIDES, V25, P151, DOI 10.1016/0143-4179(93)90096-S; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; WIMALASENA K, 1991, ANAL BIOCHEM, V197, P353, DOI 10.1016/0003-2697(91)90404-H; WINKLER H, 1993, J ANAT, V183, P237; WONG DL, 1990, NEUROPSYCHOPHARMACOL, V3, P115; ZHOU A, 1994, J BIOL CHEM, V269, P17440; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509	83	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3270	3278		10.1074/jbc.275.5.3270	http://dx.doi.org/10.1074/jbc.275.5.3270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652314	hybrid			2022-12-27	WOS:000085146500036
J	Park, PW; Pier, GB; Preston, MJ; Goldberger, O; Fitzgerald, ML; Bernfield, M				Park, PW; Pier, GB; Preston, MJ; Goldberger, O; Fitzgerald, ML; Bernfield, M			Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; NECROSIS-FACTOR RECEPTOR; CELL-SURFACE; METALLOPROTEASE INHIBITOR; EPITHELIAL-CELLS; FACTOR-ALPHA; L-SELECTIN; BACTERIAL PROTEINASES; BORDETELLA-PERTUSSIS; MAMMALIAN-CELLS	Microbial pathogens frequently take advantage of host systems for their pathogenesis. Shedding of cell surface molecules as soluble extracellular domains (ectodomains) is one of the host responses activated during tissue injury. In this study, we examined whether pathogenic bacteria can modulate shedding of syndecan-1, the predominant syndecan of host epithelia. Our studies found that overnight culture supernatants of Pseudomonas aeruginosa and Staphylococcus aureus enhanced the shedding of syndecan-1 ectodomains, whereas culture supernatants of several other Gramnegative and Gram-positive bacteria had only low levels of activity. Because supernatants from all tested strains of P, aeruginosa (n = 9) enhanced syndecan-1 shedding by more than 4-fold above control levels, we focused our attention on this Gram-negative bacterium. Culture supernatants of P. aeruginosa increased shedding of syndecan-1 in both a concentration- and time-dependent manner, and augmented shedding by various host cells. A 20-kDa shedding enhancer was partially purified from the supernatant through ammonium sulfate precipitation and gel chromatography, and identified by N-terminal sequencing as LasA, a known P. aeruginosa virulence factor. LasA was subsequently determined to be a syndecan-1 shedding enhancer from the findings that (i) immunodepletion of LasA from the partially purified sample resulted in abrogation of its activity to enhance shedding and (ii) purified LasA increased shedding in a concentration-dependent manner. Our results also indicated that LasA enhances syndecan-1 shedding by activation of the host cell's shedding mechanism and not by direct interaction with syndecan-1 ectodomains, Enhanced syndecan-1 shedding may be a means by which pathogenic bacteria take advantage of a host mechanism to promote their pathogenesis.	Harvard Univ, Childrens Hosp, Sch Med, Dept Med,Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bernfield, M (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Med,Div Newborn Med, 300 Longwood Ave,Enders 9, Boston, MA 02115 USA.	bernfield@a1.tch.harvard.edu	Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331; Park, Pyong Woo/0000-0002-7979-4979	NCI NIH HHS [CA28735] Funding Source: Medline; NHLBI NIH HHS [HL569398] Funding Source: Medline; NIAID NIH HHS [AI22535] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA028735] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; BAZIL V, 1991, J IMMUNOL, V147, P1567; Bennett TA, 1996, J IMMUNOL, V156, P3093; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BLACKWOOD LL, 1983, INFECT IMMUN, V39, P198, DOI 10.1128/IAI.39.1.198-201.1983; Blum H, 1996, J IMMUNOL, V157, P1846; BRAKEBUSCH C, 1994, J BIOL CHEM, V269, P32488; Dempsey PJ, 1997, J CELL BIOL, V138, P747, DOI 10.1083/jcb.138.4.747; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Frey M, 1997, J IMMUNOL, V158, P5424; GALLOWAY DR, 1991, MOL MICROBIOL, V5, P2315, DOI 10.1111/j.1365-2958.1991.tb02076.x; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; Grassme H, 1997, CELL, V91, P605, DOI 10.1016/S0092-8674(00)80448-1; Gustin JK, 1996, J BACTERIOL, V178, P6608, DOI 10.1128/jb.178.22.6608-6617.1996; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hayashi J, 1999, INFECT IMMUN, V67, P417, DOI 10.1128/IAI.67.1.417-420.1999; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; KAHN J, 1994, J CELL BIOL, V125, P461, DOI 10.1083/jcb.125.2.461; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kessler E, 1997, J BIOL CHEM, V272, P9884; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; KRIVAN HC, 1988, P NATL ACAD SCI USA, V85, P6157, DOI 10.1073/pnas.85.16.6157; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Manna SK, 1998, J BIOL CHEM, V273, P33333, DOI 10.1074/jbc.273.50.33333; Mattsson E, 1996, INFECT IMMUN, V64, P4351, DOI 10.1128/IAI.64.10.4351-4355.1996; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; MULLBERG J, 1995, J IMMUNOL, V155, P5198; Munk ME, 1999, INFECT IMMUN, V67, P423, DOI 10.1128/IAI.67.1.423-425.1999; Okamoto T, 1997, J BIOL CHEM, V272, P6059, DOI 10.1074/jbc.272.9.6059; Ott VL, 1998, J BIOL CHEM, V273, P35291, DOI 10.1074/jbc.273.52.35291; PANDIELLA A, 1991, J BIOL CHEM, V266, P5769; PETERS JE, 1990, J BACTERIOL, V172, P2236, DOI 10.1128/jb.172.5.2236-2240.1990; Preston MJ, 1997, INFECT IMMUN, V65, P3086, DOI 10.1128/IAI.65.8.3086-3090.1997; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Rostand KS, 1997, INFECT IMMUN, V65, P1; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; SUTER S, 1994, AM J RESP CRIT CARE, V150, pS118, DOI 10.1164/ajrccm/150.6_Pt_2.S118; TRAVIS J, 1995, TRENDS MICROBIOL, V3, P405, DOI 10.1016/S0966-842X(00)88988-X; Vollmer P, 1996, INFECT IMMUN, V64, P3646, DOI 10.1128/IAI.64.9.3646-3651.1996; Walev I, 1996, P NATL ACAD SCI USA, V93, P7882, DOI 10.1073/pnas.93.15.7882; WICK MJ, 1991, CELL, V67, P651; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; WOODS DE, 1982, INFECT IMMUN, V36, P1223, DOI 10.1128/IAI.36.3.1223-1228.1982	59	116	122	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3057	3064		10.1074/jbc.275.5.3057	http://dx.doi.org/10.1074/jbc.275.5.3057			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652286	hybrid			2022-12-27	WOS:000085146500008
J	Lian, JP; Marks, PG; Wang, JY; Falls, DL; Badwey, JA				Lian, JP; Marks, PG; Wang, JY; Falls, DL; Badwey, JA			A protein kinase from neutrophils that specifically recognizes Ser-3 in cofilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-DEPOLYMERIZING FACTOR; NADPH OXIDASE COMPLEX; STIMULATED HUMAN-NEUTROPHILS; RESPIRATORY BURST OXIDASE; P21-ACTIVATED KINASES; RAPID ACTIVATION; PHOSPHORYLATION; DEPHOSPHORYLATION; COMPONENTS; IDENTIFICATION	Cofilin promotes the depolymerization of actin filaments, which is required for a variety of cellular responses such as the formation of lamellipodia and chemotaxis. Phosphorylation of cofilin on serine residue 3 is known to block these activities. We now report that neutrophils contain a protein kinase that selectively catalyzes the phosphorylation of cofilin on serine 3 (greater than or equal to 70%) and a nonspecific kinase that recognizes multiple sites in this protein. The selective serine 3 cofilin kinase binds to a deoxyribonuclease I affinity column, whereas the nonspecific cofilin kinase does not. Deoxyribonuclease I forms a very tight complex with actin, and deoxyribonuclease affinity columns have been utilized to identify a variety of proteins that interact with the cytoskeleton. The serine 3 cofilin kinase did not react with antibodies to LIM kinase 1 or 2, which can catalyze the phosphorylation of cofilin in other cell types. The activity of the serine 3 cofilin kinase was insensitive to a variety of selective antagonists of protein kinases but was blocked by staurosporine. This pattern of inhibition is similar to that observed for the kinase that is active with cofilin in intact neutrophils. Thus, neutrophils contain a protein kinase distinct from LIM kinase-1/2 that selectively recognizes serine 3 in cofilin.	Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Boston Biomed Res Inst, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Emory University; Boston Biomedical Research Institute	Badwey, JA (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Thorn Bldg,Rm 703,75 Francis St, Boston, MA 02115 USA.				NHLBI NIH HHS [K08 HL-03235] Funding Source: Medline; NIAID NIH HHS [AI 23323] Funding Source: Medline; NIDDK NIH HHS [DK 50015] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050015] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Badwey J A, 1986, Methods Enzymol, V132, P365; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; CURNUTTE JT, 1994, J BIOL CHEM, V269, P10813; DING JB, 1993, J BIOL CHEM, V268, P5234; Ding JB, 1996, J BIOL CHEM, V271, P24869, DOI 10.1074/jbc.271.40.24869; Djafarzadeh S, 1997, EXP CELL RES, V236, P427, DOI 10.1006/excr.1997.3731; Edwards DC, 1999, J BIOL CHEM, V274, P11352, DOI 10.1074/jbc.274.16.11352; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; Geijsen N, 1999, BLOOD, V94, P1121, DOI 10.1182/blood.V94.3.1121.415k04_1121_1130; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heyworth PG, 1997, HISTOCHEM CELL BIOL, V108, P221, DOI 10.1007/s004180050162; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Huang RY, 1998, MOL CELL BIOL, V18, P7130, DOI 10.1128/MCB.18.12.7130; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOLBE HVJ, 1985, J BIOL CHEM, V260, P5899; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lian JP, 1997, FEBS LETT, V404, P211, DOI 10.1016/S0014-5793(97)00134-8; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, NATURE, V401, P542, DOI 10.1038/44044; MARKEY F, 1981, CELL, V23, P145, DOI 10.1016/0092-8674(81)90279-8; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; OGAWA K, 1990, NUCLEIC ACIDS RES, V18, P7169, DOI 10.1093/nar/18.23.7169; Okada K, 1996, EXP CELL RES, V227, P116, DOI 10.1006/excr.1996.0256; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; PAPPIN DJC, 1990, ANAL BIOCHEM, V187, P10, DOI 10.1016/0003-2697(90)90410-B; *PIERC CHEM CO, 1996, SUP SUBSTR W BLOTT K; QUINN MT, 1989, BIOCHIM BIOPHYS ACTA, V987, P83, DOI 10.1016/0005-2736(89)90458-6; Ressad F, 1999, J BIOL CHEM, V274, P20970, DOI 10.1074/jbc.274.30.20970; ROBINSON JM, 1995, HISTOCHEM CELL BIOL, V103, P163, DOI 10.1007/BF01454021; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Smertenko AP, 1998, PLANT J, V14, P187, DOI 10.1046/j.1365-313X.1998.00107.x; SULLIVAN S, 1991, ANAL BIOCHEM, V197, P65, DOI 10.1016/0003-2697(91)90356-X; SUZUKI K, 1995, J BIOL CHEM, V270, P19551, DOI 10.1074/jbc.270.33.19551; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Wang JY, 1998, J BIOL CHEM, V273, P20525, DOI 10.1074/jbc.273.32.20525; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042; WYMANN MP, 1989, J BIOL CHEM, V264, P15829; WYMANN MP, 1990, J BIOL CHEM, V265, P619; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	51	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2869	2876		10.1074/jbc.275.4.2869	http://dx.doi.org/10.1074/jbc.275.4.2869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644754	hybrid			2022-12-27	WOS:000085128000086
J	Pari, K; Sundari, CS; Chandani, S; Balasubramanian, D				Pari, K; Sundari, CS; Chandani, S; Balasubramanian, D			beta-Carbolines that accumulate in human tissues may serve a protective role against oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSSIBLE CAUSATIVE SUBSTANCE; CHAPERONE-LIKE ACTIVITY; 1-METHYL-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE-3-CARBOXYLIC ACID; ALPHA-CRYSTALLIN; L-TRYPTOPHAN; EYE LENS; MAILLARD REACTION; ALKALOIDS; IDENTIFICATION; INGESTION	beta-Carbolines are tricyclic nitrogen heterocycles formed in plants and animals as Maillard reaction products between amino acids and reducing sugars or aldehydes. They are being detected increasingly in human tissues, and their physiological roles need to be understood. Two beta-carboline carboxylates have been reported to accumulate in the human eye lens. We report here on the identification of another beta-carboline, namely 1-methyl-1-vinyl -2,3,4 trihydro-beta-caboline-3-carboxylic acid, in the lenses of some cataract patients from India. Analysis of these three lenticular beta-carbolines using photodynamic and antioxidant assays shows all of them to be inert as sensitizers and effective as antioxidants; they quench singlet oxygen, superoxide and hydroxyl radicals and inhibit the oxidative formation of higher molecular weight aggregates of the test protein, eye lens crystallin. Such antioxidative ability of beta-carbolines is of particular relevance to the lens, which faces continual photic and oxidative stress. The beta-carboline diacid TV is also seen to display an unexpected ability of inhibiting the thermal coagulation of gamma-crystallin and the dithiothreitol-induced precipitation of insulin. These results offer experimental support to earlier suggestions that one of the roles that the beta-carbolines have is to offer protection against oxidative stress to the human tissues where they accumulate.	Hyderabad Eye Res Fdn, L V Prasad Eye Inst, Hyderabad 500034, Andhra Pradesh, India; Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	L. V. Prasad Eye Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Balasubramanian, D (corresponding author), Hyderabad Eye Res Fdn, L V Prasad Eye Inst, Rd Number 2, Hyderabad 500034, Andhra Pradesh, India.				NATIONAL EYE INSTITUTE [R01EY010888] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY 10888] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMOVITCH RA, 1964, ADV HETEROCYCL CHEM, V3, P79, DOI 10.1016/S0065-2725(08)60542-5; ADACHI J, 1991, J NUTR, V121, P646, DOI 10.1093/jn/121.5.646; ADACHI J, 1991, ARCH TOXICOL, V65, P505, DOI 10.1007/BF01977365; AIRAKSINEN MM, 1981, MED BIOL, V59, P21; ALLEN JRF, 1980, PHYTOCHEMISTRY, V19, P1573, DOI 10.1016/S0031-9422(00)83773-5; Balon M, 1998, PHOTOCHEM PHOTOBIOL, V67, P414; BROSSI A, 1973, J MED CHEM, V16, P418, DOI 10.1021/jm00262a027; CHAE KH, 1986, B KOR CHEM SOC, V7, P478; CHAKRABARTI B, 1986, J INDIAN CHEM SOC, V63, P131; CHEN RF, 1965, SCIENCE, V150, P1593, DOI 10.1126/science.150.3703.1593; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DIAS A, 1992, J PHYS CHEM-US, V96, P10290, DOI 10.1021/j100204a036; DILLON J, 1976, NATURE, V259, P422, DOI 10.1038/259422a0; EICHNER K, 1981, PROG FOOD NUTR SCI, V5, P441; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Hofmann T, 1998, J AGR FOOD CHEM, V46, P932, DOI 10.1021/jf970732j; HOLMSTEDT B, 1982, JBETA CARBOLINES TET, P3; KAWASHIMA Y, 1995, CHEM PHARM BULL, V43, P783; KOPPENOL WH, 1984, ISR J CHEM, V24, P11; KRALJIC I, 1978, PHOTOCHEM PHOTOBIOL, V28, P577, DOI 10.1111/j.1751-1097.1978.tb06972.x; Krebs HC, 1997, J NAT PROD, V60, P1183, DOI 10.1021/np970283h; KRISHNA CM, 1991, PHOTOCHEM PHOTOBIOL, V54, P51, DOI 10.1111/j.1751-1097.1991.tb01984.x; LARSON RA, 1988, PHOTOCHEM PHOTOBIOL, V48, P665, DOI 10.1111/j.1751-1097.1988.tb02879.x; LINGNERT H, 1983, J AGR FOOD CHEM, V31, P27, DOI 10.1021/jf00115a007; LUTHRA M, 1992, EXP EYE RES, V55, P641, DOI 10.1016/S0014-4835(05)80177-0; LUTHRA M, 1994, FEBS LETT, V349, P39, DOI 10.1016/0014-5793(94)00635-0; Manabe S, 1996, EXP EYE RES, V63, P179, DOI 10.1006/exer.1996.0106; MANDAL K, 1988, PHOTOCHEM PHOTOBIOL, V47, P583, DOI 10.1111/j.1751-1097.1988.tb08848.x; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miller Nicholas J., 1993, Biochemical Society Transactions, V21, p95S; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; NAGAHARA A, 1991, FOOD CHEM TOXICOL, V29, P243, DOI 10.1016/0278-6915(91)90021-X; OGAWA Y, 1993, ARCH TOXICOL, V67, P290, DOI 10.1007/BF01974349; PERIASAMY N, 1988, J CHEM PHYS, V88, P1638, DOI 10.1063/1.454143; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Rommelspacher H, 1985, Prog Drug Res, V29, P415; WAKABAYASHI K, 1983, P NATL ACAD SCI-BIOL, V80, P2912, DOI 10.1073/pnas.80.10.2912; YEN GC, 1995, J AGR FOOD CHEM, V43, P415; ZIGLER JS, 1985, ARCH BIOCHEM BIOPHYS, V241, P163, DOI 10.1016/0003-9861(85)90372-8	40	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2455	2462		10.1074/jbc.275.4.2455	http://dx.doi.org/10.1074/jbc.275.4.2455			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644699	hybrid			2022-12-27	WOS:000085128000031
J	Behrendt, N; Jensen, ON; Engelholm, LH; Mortz, E; Mann, M; Dano, K				Behrendt, N; Jensen, ON; Engelholm, LH; Mortz, E; Mann, M; Dano, K			A urokinase receptor-associated protein with specific collagen binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; SECRETORY PHOSPHOLIPASES A(2); MACROPHAGE MANNOSE RECEPTOR; LINKED IMMUNOSORBENT-ASSAY; MEDIATED CELL-ADHESION; PLASMINOGEN-ACTIVATOR; MEMBRANE-RECEPTOR; V COLLAGEN; STRUCTURAL REQUIREMENTS; CONNECTIVE-TISSUE	The plasminogen activation cascade system, directed by urokinase and the urokinase receptor, plays a key role in extracellular proteolysis during tissue remodeling, To identify molecular interaction partners of these trigger proteins on the cell, we combined covalent protein cross-linking with mass spectrometry based methods for peptide mapping and primary structure analysis of electrophoretically isolated protein conjugates, A specific tri-molecular complex was observed upon addition of pro-urokinase to human U937 cells. This complex included the urokinase receptor, pro-urokinase, and an unknown, high molecular weight urokinase receptor-associated protein. The tryptic peptide mixture derived from a cross-linked complex of pro-urokinase and the latter protein was analyzed by nanoelectrospray tandem mass spectrometric sequencing. This analysis identified the novel protein as the human homologue of a murine membrane-bound lectin with hitherto unknown function, The human cDNA was cloned and sequenced. The protein, designated uPARAP, is a member of the macrophage mannose receptor protein family and contains a putative collagen-binding (fibronectin type II) domain in addition to 8 C-type carbohydrate recognition domains. It proved capable of binding strongly to a single type of collagen, collagen V. This collagen binding reaction at the exact site of plasminogen activation on the cell may lead to adhesive functions as well as a contribution to cellular degradation of collagen matrices.	Rigshosp, Finsen Lab, DK-2100 Copenhagen 0, Denmark; EMBL, Prot & Peptide Grp, Heidelberg, Germany; Odense Univ, Dept Mol Biol, DK-5230 Odense, Denmark	Rigshospitalet; University of Copenhagen; European Molecular Biology Laboratory (EMBL); University of Southern Denmark	Behrendt, N (corresponding author), Rigshosp, Finsen Lab, Strandboulevarden 49,Bldg 7-2, DK-2100 Copenhagen 0, Denmark.		Jensen, Ole N/J-1763-2012; Mann, Matthias/A-3454-2013	Jensen, Ole N/0000-0003-1862-8528; Mann, Matthias/0000-0003-1292-4799; Engelholm, Lars/0000-0002-6616-1232; Behrendt, Niels/0000-0003-1833-3922; Mortz, Ejvind/0000-0002-4381-1546				ADACHI E, 1994, J ELECTRON MICROSC, V43, P264; Adachi E, 1997, INT REV CYTOL, V173, P73; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANCIAN P, 1995, BIOCHEMISTRY-US, V34, P13146, DOI 10.1021/bi00040a028; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; BANYAI L, 1994, BIOCHEM J, V298, P403, DOI 10.1042/bj2980403; BANYAI L, 1990, EUR J BIOCHEM, V193, P801, DOI 10.1111/j.1432-1033.1990.tb19403.x; BEHRENDT N, 1993, METHOD ENZYMOL, V223, P207; Behrendt N, 1996, J BIOL CHEM, V271, P22885, DOI 10.1074/jbc.271.37.22885; Behrendt N, 1998, FIBRINOLYSIS PROTEOL, V12, P191, DOI 10.1016/S0268-9499(98)80013-1; BEHRENDT N, 1990, J BIOL CHEM, V265, P6453; BEHRENDT N, 1993, FEBS LETT, V336, P394, DOI 10.1016/0014-5793(93)80844-K; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; FICHARD A, 1995, MATRIX BIOL, V14, P515, DOI 10.1016/S0945-053X(05)80001-0; GOLDFARB RH, 1986, SEMIN THROMB HEMOST, V12, P294, DOI 10.1055/s-2007-1003570; GRONDAHLHANSEN J, 1988, J LAB CLIN MED, V111, P42; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; ISHIZAKI J, 1994, J BIOL CHEM, V269, P5897; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Jensen ON, 1997, ANAL CHEM, V69, P4741, DOI 10.1021/ac970896z; JENSEN ON, 1997, PROTEIN STRUCTURE PR, P29; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; MUMBY SM, 1984, J CELL BIOL, V98, P646, DOI 10.1083/jcb.98.2.646; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Neels JG, 1998, FIBRINOLYSIS PROTEOL, V12, P219, DOI 10.1016/S0268-9499(98)80016-7; NICOLAS JP, 1995, J BIOL CHEM, V270, P28869, DOI 10.1074/jbc.270.48.28869; NIELSEN LS, 1986, J IMMUNOASSAY, V7, P209, DOI 10.1080/01971528608060467; NIELSEN LS, 1988, J BIOL CHEM, V263, P2358; NIYIBIZI C, 1994, BIOCHEM BIOPH RES CO, V202, P328, DOI 10.1006/bbrc.1994.1931; NIYIBIZI C, 1989, CONNECT TISSUE RES, V20, P247, DOI 10.3109/03008208909023894; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; PLOUG M, 1991, J BIOL CHEM, V266, P1926; POLLANEN J, 1988, J CELL BIOL, V106, P87, DOI 10.1083/jcb.106.1.87; Resnati M, 1996, EMBO J, V15, P1572, DOI 10.1002/j.1460-2075.1996.tb00502.x; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; Ruggiero F, 1996, J CELL SCI, V109, P1865; RUGGIERO F, 1994, EXP CELL RES, V210, P215, DOI 10.1006/excr.1994.1032; SANE DC, 1990, J BIOL CHEM, V265, P3543; Shevchenko A, 1997, J PROTEIN CHEM, V16, P481, DOI 10.1023/A:1026361427575; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185; STEPHENS RW, 1989, J CELL BIOL, V108, P1987, DOI 10.1083/jcb.108.5.1987; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Taylor ME, 1997, GLYCOBIOLOGY, V7, pR5; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323; Zvaritch E, 1996, J BIOL CHEM, V271, P250, DOI 10.1074/jbc.271.1.250	69	124	132	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1993	2002		10.1074/jbc.275.3.1993	http://dx.doi.org/10.1074/jbc.275.3.1993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636902	hybrid			2022-12-27	WOS:000084940000065
J	Christophe, T; Rabiet, MJ; Tardif, M; Milcent, MD; Boulay, F				Christophe, T; Rabiet, MJ; Tardif, M; Milcent, MD; Boulay, F			Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses - Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; MUSCARINIC ACETYLCHOLINE-RECEPTOR; BETA-ARRESTIN; CHEMOATTRACTANT RECEPTORS; KINASE-C; SIGNAL-TRANSDUCTION; HUMAN NEUTROPHILS; INTERNALIZATION; ACTIVATION; DYNAMIN	Upon agonist binding, the anaphylatoxin human complement 5a receptor (C5aR) has previously been found to be phosphorylated on the six serine residues of its carboxyl-terminal tail (Giannini, E., Brouchon, L., and Boulay, F. (1995) J. Biol. Chem. 270, 19166-19172), To evaluate the precise roles that specific phosphorylation sites may play in receptor signaling, a series of mutants were expressed transiently in COS-7 cells and stably in the physiologically relevant myeloid HL-60 cells. Ser(334) was found to be a key residue that controls receptor phosphorylation, Phosphorylation of either of two serine pairs, namely Ser(332) and Ser(334) or Ser(334) and Ser(338), was critical for the phosphorylation of C5aR and its subsequent desensitization. Full phosphorylation and desensitization of C5aR were obtained when these serines were replaced by aspartic acid residues. The mutation S338A had no marked effect on the agonist-mediated phosphorylation of C5aR, but it allowed a sustained C5a-evoked calcium mobilization in HL-60 cells. These findings and the ability of the S314A/S317A/S327A/S532A mutant receptor to undergo desensitization indicate that the phosphorylation of Ser(334) and Ser(338) is critical and sufficient for C5aR desensitization. The lack of phosphorylation was found to result not only in a sustained calcium mobilization and extracellular signal-regulated kinase 2 activity but also in the enhancement of the C5a-mediated respiratory burst in neutrophil-like HL-60 cells. For instance, the nonphosphorylatable S332A/S334A mutant receptor triggered a 1.8-2-fold higher production of superoxide as compared with the wild-type receptor. Interestingly, although the desensitization of this mutant was defective, it was sequestered with the same time course and the same efficiency as the wild-type receptor. Thus, in myeloid HL-60 cells, desensitization and sequestration of C5aR appear to occur through divergent molecular mechanisms.	Commissariat Energy Atom, Grenoble, France; CNRS, Dept Biol Mol & Struct, Lab Biochim & Biophys Syst Integres, Unite Mixte Rech Commissariat Energy Atom 314, F-38054 Grenoble 9, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Boulay, F (corresponding author), Commissariat Energy Atom, Grenoble, France.		Tardif, Marianne/AAA-5357-2019	Tardif, Marianne/0000-0003-4438-8281				Alemany R, 1999, J BIOL CHEM, V274, P3994, DOI 10.1074/jbc.274.7.3994; ALI H, 1993, J BIOL CHEM, V268, P24247; Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Babior B M, 1995, Curr Opin Hematol, V2, P55; Bei L, 1998, BBA-MOL CELL RES, V1404, P475, DOI 10.1016/S0167-4889(98)00081-0; Bock D, 1997, EUR J IMMUNOL, V27, P1522, DOI 10.1002/eji.1830270631; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; BOULAY F, 1991, BIOCHEMISTRY-US, V30, P2993, DOI 10.1021/bi00226a002; BUHL AM, 1995, J BIOL CHEM, V270, P19828, DOI 10.1074/jbc.270.34.19828; BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Diviani D, 1997, J BIOL CHEM, V272, P28712, DOI 10.1074/jbc.272.45.28712; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Dorey M, 1999, BBA-BIOMEMBRANES, V1416, P217, DOI 10.1016/S0005-2736(98)00224-7; ElBenna J, 1996, J BIOL CHEM, V271, P6374; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; EMBER JA, 1994, AM J PATHOL, V144, P393; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FoyouziYoussefi R, 1997, BIOCHEM J, V322, P709, DOI 10.1042/bj3220709; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hsu MH, 1997, J BIOL CHEM, V272, P29426, DOI 10.1074/jbc.272.47.29426; Kim JY, 1997, J BIOL CHEM, V272, P27313, DOI 10.1074/jbc.272.43.27313; KLOS A, 1994, FEBS LETT, V344, P79, DOI 10.1016/0014-5793(94)00350-5; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MERY L, 1994, J BIOL CHEM, V269, P3457; MONTZ H, 1991, IMMUNOLOGY, V74, P373; Murray SR, 1998, J BIOL CHEM, V273, P24987, DOI 10.1074/jbc.273.39.24987; Naik N, 1997, J CELL SCI, V110, P2381; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OKUSAWA S, 1988, J EXP MED, V168, P443, DOI 10.1084/jem.168.1.443; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; SCHOLZ W, 1990, CLIN IMMUNOL IMMUNOP, V57, P297, DOI 10.1016/0090-1229(90)90043-P; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Tardif M, 1998, J IMMUNOL, V161, P6885; TARDIF M, 1993, J IMMUNOL, V150, P3534; TRAPAIDZE N, 1996, J BIOL CHEM, V271, P29273; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; Vogler O, 1999, J BIOL CHEM, V274, P12333, DOI 10.1074/jbc.274.18.12333; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Ye R D, 1997, Adv Pharmacol, V39, P221, DOI 10.1016/S1054-3589(08)60073-3; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	49	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1656	1664		10.1074/jbc.275.3.1656	http://dx.doi.org/10.1074/jbc.275.3.1656			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636859	hybrid			2022-12-27	WOS:000084940000022
J	Han, S; Takahashi, S; Rousseau, DL				Han, S; Takahashi, S; Rousseau, DL			Time dependence of the catalytic intermediates in cytochrome c oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY OXYGEN INTERMEDIATE; RESONANCE RAMAN-SPECTRA; ELECTRON-TRANSFER; HYDROGEN-PEROXIDE; ROOM-TEMPERATURE; 2.8 ANGSTROM; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; AMBIENT-TEMPERATURE; DIOXYGEN REACTION	Cytochrome c oxidase, the terminal enzyme in the electron transfer chain, catalyzes the reduction of oxygen to water in a multiple step process by utilizing four electrons from cytochrome c, To study the reaction mechanism, the resonance Raman spectra of the intermediate states were measured during single turnover of the enzyme after catalytic initiation by photolysis of CO from the fully reduced GO-bound enzyme. By measuring the change in intensity of lines associated with heme a, the electron transfer steps were determined and found to be biphasic with apparent rate constants of similar to 40 x 10(3) s(-1) and similar to 1 x 10(3) s(-1). The time dependence for the oxidation of heme a and for the measured formation and decay of the oxy, the ferryl ("F"), and the hydroxy intermediates could be simulated by a simple reaction scheme. In this scheme, the presence of the "peroxy" ("P") intermediate does not build up a sufficient population to be detected because its decay rate is too fast in buffered H2O at neutral pH. A comparison of the change in the spin equilibrium with the formation of the hydroxy intermediate demonstrates that this intermediate is high spin. We also confirm the presence of an oxygen isotope-sensitive line at 355 cm(-1), detectable in the spectrum from 130 to 980 mu s, coincident with the presence of the F intermediate.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Kyoto Univ, Kyoto 6068501, Japan	Yeshiva University; Albert Einstein College of Medicine; Kyoto University	Rousseau, DL (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Ullmann 313, Bronx, NY 10461 USA.	rousseau@accom.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054806, R01GM054812] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54812, GM54806] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARGADE PV, 1986, BIOPHYS J, V50, P613, DOI 10.1016/S0006-3495(86)83500-7; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BABCOCK GT, 1981, BIOCHEMISTRY-US, V20, P959, DOI 10.1021/bi00507a049; BABCOCK GT, 1979, BIOCHEMISTRY-US, V18, P2493, DOI 10.1021/bi00579a009; BLACKMORE RS, 1991, J BIOL CHEM, V266, P19245; CHING YC, 1985, BIOCHEMISTRY-US, V24, P4938, DOI 10.1021/bi00339a032; Das TK, 1998, BIOCHEMISTRY-US, V37, P14471, DOI 10.1021/bi981500w; FABIAN M, 1995, BIOCHEMISTRY-US, V34, P13802, DOI 10.1021/bi00042a011; Fabian M, 1999, BIOCHEMISTRY-US, V38, P6270, DOI 10.1021/bi982541v; FEIS A, 1994, BIOCHEMISTRY-US, V33, P4577, DOI 10.1021/bi00181a019; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Ghosh A, 1998, J PHYS CHEM B, V102, P10087, DOI 10.1021/jp982232e; GIBSON QH, 1963, BIOCHEM J, V86, P541, DOI 10.1042/bj0860541; GREENWOO.C, 1967, J BIOL CHEM, V242, P1782; HAN S, 1990, P NATL ACAD SCI USA, V87, P8408, DOI 10.1073/pnas.87.21.8408; HAN S, 1989, J BIOL CHEM, V264, P6604; HAN S, 1990, P NATL ACAD SCI USA, V87, P2491, DOI 10.1073/pnas.87.7.2491; HAN SH, 1990, BIOCHEMISTRY-US, V29, P1380, DOI 10.1021/bi00458a006; HAN SH, 1990, J AM CHEM SOC, V112, P9445, DOI 10.1021/ja00182a001; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; HILL BC, 1984, BIOCHEM J, V218, P913, DOI 10.1042/bj2180913; HILL BC, 1994, J BIOL CHEM, V269, P2419; HILL BC, 1986, BIOCHIM BIOPHYS ACTA, V853, P91, DOI 10.1016/0304-4173(86)90006-6; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; MacMillan F, 1999, BIOCHEMISTRY-US, V38, P9179, DOI 10.1021/bi9911987; Mitchell DM, 1996, BIOCHEMISTRY-US, V35, P16782, DOI 10.1021/bi961722z; Mitchell DM, 1996, BIOCHEMISTRY-US, V35, P9446, DOI 10.1021/bi960392f; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; MORGAN JE, 1989, BIOCHEMISTRY-US, V28, P6975, DOI 10.1021/bi00443a030; Musser SM, 1995, ADV ENZYMOL RAMB, V71, P79; OGURA T, 1990, J AM CHEM SOC, V112, P5630, DOI 10.1021/ja00170a032; OGURA T, 1989, BIOCHEMISTRY-US, V28, P8022, DOI 10.1021/bi00446a008; OGURA T, 1991, B CHEM SOC JPN, V64, P2901, DOI 10.1246/bcsj.64.2901; Ogura T, 1996, J AM CHEM SOC, V118, P5443, DOI 10.1021/ja951922i; OGURA T, 1993, J AM CHEM SOC, V115, P8527, DOI 10.1021/ja00072a002; OGURA T, 1990, J BIOL CHEM, V265, P14721; ORII Y, 1984, J BIOL CHEM, V259, P7187; ORII Y, 1988, ANN NY ACAD SCI, V550, P105, DOI 10.1111/j.1749-6632.1988.tb35327.x; ORII Y, 1976, J BIOL CHEM, V251, P7487; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P8580, DOI 10.1021/bi952096t; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P76, DOI 10.1021/bi9511705; PROSHLYAKOV DA, 1994, J BIOL CHEM, V269, P29385; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Rousseau DL, 1999, NATURE, V400, P412, DOI 10.1038/22664; SALMEEN I, 1978, BIOCHEMISTRY-US, V17, P800, DOI 10.1021/bi00598a008; Sucheta A, 1997, BIOCHEMISTRY-US, V36, P554, DOI 10.1021/bi962422k; Sucheta A, 1998, BIOCHEMISTRY-US, V37, P17905, DOI 10.1021/bi981092w; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; VAROTSIS C, 1993, METHOD ENZYMOL, V226, P409; VAROTSIS C, 1995, BBA-BIOENERGETICS, V1231, P111, DOI 10.1016/0005-2728(95)00076-U; VAROTSIS C, 1990, BIOCHEMISTRY-US, V29, P7357, DOI 10.1021/bi00484a001; VAROTSIS C, 1989, J AM CHEM SOC, V111, P6439, DOI 10.1021/ja00198a075; VAROTSIS C, 1990, J AM CHEM SOC, V112, P1297, DOI 10.1021/ja00159a091; VAROTSIS C, 1990, J BIOL CHEM, V265, P11131; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; VYGODINA T, 1987, FEBS LETT, V219, P387, DOI 10.1016/0014-5793(87)80258-2; WANG JL, 1995, BIOCHEMISTRY-US, V34, P9819, DOI 10.1021/bi00031a001; WANG JL, 1995, BIOCHEMISTRY-US, V34, P15504, DOI 10.1021/bi00047a016; WIKSTROM M, 1981, P NATL ACAD SCI-BIOL, V78, P4051, DOI 10.1073/pnas.78.7.4051; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; YONETANI T, 1960, J BIOL CHEM, V235, P845; Yoshikawa S, 1998, J BIOENERG BIOMEMBR, V30, P7, DOI 10.1023/A:1020595108560; YOSHIKAWA S, 1977, J BIOL CHEM, V252, P5498; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	67	97	98	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1910	1919		10.1074/jbc.275.3.1910	http://dx.doi.org/10.1074/jbc.275.3.1910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636892	hybrid			2022-12-27	WOS:000084940000055
J	Reinhardt, DP; Gambee, JE; Ono, RN; Bachinger, HP; Sakai, LY				Reinhardt, DP; Gambee, JE; Ono, RN; Bachinger, HP; Sakai, LY			Initial steps in assembly of microfibrils - Formation of disulfide-cross-linked multimers containing fibrillin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BINDING-PROTEIN; MARFAN-SYNDROME; CALCIUM-BINDING; LATENT; MUTATIONS; COMPONENT; GENE; IDENTIFICATION; ORGANIZATION; SEQUENCE	Fibrillins are the major constituents of extracellular microfibrils, How fibrillin molecules assemble into microfibrils is not known. Sequential extractions and pulse-chase labeling of organ cultures of embryonic chick aortae revealed rapid formation of disulfide-cross-linked aggregates containing fibrillin-1. These results demonstrated that intermolecular disulfide bond formation is an initial step in the assembly process. To identify free cysteine residues available for intermolecular cross-linking, small recombinant peptides of fibrillin-1 harboring candidate cysteine residues were analyzed. Results revealed that the first four cysteine residues in the unique N terminus form intramolecular disulfide bonds. One cysteine residue (Cys(204)) in the first hybrid domain of fibrillin-1 was found to occur as a free thiol and is therefore a good candidate for intermolecular disulfide bonding in initial steps of the assembly process, Furthermore, evidence indicated that the comparable cysteine residue in fibrillin-2 (Cys(233)) also occurs as a free thiol. These free cysteine residues in fibrillins are readily available for intermolecular disulfide bond formation, as determined by reaction with Ellman's reagent. In addition to these major results, the cleavage site of the fibrillin-1 signal peptide and the N-terminal sequence of monomeric authentic fibrillin-1 from conditioned fibroblast medium were determined.	Shriners Hosp Crippled Childrens, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Sakai, LY (corresponding author), Shriners Hosp Crippled Childrens, 3101 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	lys@shcc.org	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872				Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Dzamba BJ, 1998, EXTRACELLULAR MATRIX-CELL INTERACTION, P23; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Liu WO, 1997, GENET TEST, V1, P237, DOI 10.1089/gte.1997.1.237; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MAYER U, 1995, FEBS LETT, V365, P129, DOI 10.1016/0014-5793(95)00438-F; MOREN A, 1994, J BIOL CHEM, V269, P32469; Nakajima Y, 1997, J CELL BIOL, V136, P193, DOI 10.1083/jcb.136.1.193; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Ritty TM, 1999, J BIOL CHEM, V274, P8933, DOI 10.1074/jbc.274.13.8933; ROSS R, 1969, J CELL BIOL, V40, P366, DOI 10.1083/jcb.40.2.366; Saharinen J, 1998, J BIOL CHEM, V273, P18459, DOI 10.1074/jbc.273.29.18459; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SAKAI LY, 1990, ELASTIN CHEM BIOL AS, P213; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; YIN WS, 1995, J BIOL CHEM, V270, P10147, DOI 10.1074/jbc.270.17.10147; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659	29	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2205	2210		10.1074/jbc.275.3.2205	http://dx.doi.org/10.1074/jbc.275.3.2205			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636927	hybrid			2022-12-27	WOS:000084940000090
J	Wilson, TM; Chen, AD; Hsieh, TS				Wilson, TM; Chen, AD; Hsieh, TS			Cloning and characterization of Drosophila topoisomerase III beta - Relaxation of hypernegatively supercoiled DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNERS-SYNDROME GENES; ESCHERICHIA-COLI RECQ; SACCHAROMYCES-CEREVISIAE; HYPER-RECOMBINATION; BLOOMS-SYNDROME; HELICASE; YEAST; SGS1; HOMOLOG; TOP3	We cloned cDNA encoding Drosophila DNA topoisomerase III, The top3 cDNA encodes an 875-amino acid protein, which is nearly 60% identical to mammalian topoisomerase III beta enzymes. Similarity between the Drosophila protein and the topoisomerase III beta s is particularly striking in the carboxyl-terminal region, where all contain eight highly conserved CXXC motifs not found in other topoisomerase III enzymes. We therefore propose the Drosophila protein is a member of the beta-subfamily of topoisomerase III enzymes, The top3 beta gene is a single-copy gene located at 5 E-F on the X chromosome, P-element insertion into the 5'-untranslated region of this gene affects topoisomerase III beta protein levels, but not the overall fertility and viability of the fly. We purified topoisomerase III beta to near homogeneity and observed relaxation activity only with a hypernegatively supercoiled substrate, but not with plasmid DNA directly isolated from bacterial cells. Despite this difference in substrate preference, the degree of relaxation of the hypernegatively supercoiled substrate is comparable to relaxation of plasmid DNA by other type I enzymes. Drosophila topoisomerase III beta forms a covalent linkage to 5' DNA phosphoryl groups, and the DNA cleavage reaction prefers single-stranded substrate over double-stranded, suggesting an affinity of this enzyme for DNA with non-double-helical structure.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	hsieh@biochem.duke.edu	Hsieh, Tao-shih/G-9305-2012; Wu, Wan-lin/G-8937-2012		NIGMS NIH HHS [GM29006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bate M., 1993, DEV DROSOPHILA MELAN, V1; Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Hanai R, 1996, P NATL ACAD SCI USA, V93, P3653, DOI 10.1073/pnas.93.8.3653; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HIASA H, 1994, J BIOL CHEM, V269, P2093; KIM RA, 1992, J BIOL CHEM, V267, P17178; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kusano K, 1999, GENETICS, V151, P1027; LAPEYRE B, 1986, J BIOL CHEM, V261, P9167; LEE MP, 1993, P NATL ACAD SCI USA, V90, P6656, DOI 10.1073/pnas.90.14.6656; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LISCHWE MA, 1985, J BIOL CHEM, V260, P14304; LISCHWE MA, 1985, BIOCHEMISTRY-US, V24, P6025, DOI 10.1021/bi00343a001; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Ng SW, 1999, NUCLEIC ACIDS RES, V27, P993, DOI 10.1093/nar/27.4.993; NOLAN JM, 1986, P NATL ACAD SCI USA, V83, P3664, DOI 10.1073/pnas.83.11.3664; NOLAN JM, 1991, DNA TOPOISOMERASES C, P23; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rothstein R, 1995, GENOME RES, V5, P421, DOI 10.1101/gr.5.5.421; SCHOFIELD MA, 1992, J BACTERIOL, V174, P5168, DOI 10.1128/JB.174.15.5168-5170.1992; Seki T, 1998, J BIOL CHEM, V273, P28553, DOI 10.1074/jbc.273.44.28553; Seki T, 1998, BBA-GENE STRUCT EXPR, V1396, P127, DOI 10.1016/S0167-4781(97)00192-9; Shaiu WL, 1998, MOL CELL BIOL, V18, P4358, DOI 10.1128/MCB.18.7.4358; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TSEDINH YC, 1988, J BIOL CHEM, V263, P15857; TSEDINH YC, 1986, J MOL BIOL, V191, P321, DOI 10.1016/0022-2836(86)90129-4; TSEDINH YC, 1991, J BIOL CHEM, V266, P14317; UMEZU K, 1990, P NATL ACAD SCI USA, V87, P5363, DOI 10.1073/pnas.87.14.5363; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang H, 1996, P NATL ACAD SCI USA, V93, P9477, DOI 10.1073/pnas.93.18.9477; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Watt PM, 1996, GENETICS, V144, P935; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	51	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1533	1540		10.1074/jbc.275.3.1533	http://dx.doi.org/10.1074/jbc.275.3.1533			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636841	hybrid			2022-12-27	WOS:000084940000004
J	Glavy, JS; Wu, SM; Wang, PJ; Orr, GA; Wolkoff, AW				Glavy, JS; Wu, SM; Wang, PJ; Orr, GA; Wolkoff, AW			Down-regulation by extracellular ATP of rat hepatocyte organic anion transport is mediated by serine phosphorylation of oatp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC NA+/TAUROCHOLATE COTRANSPORT; XENOPUS-LAEVIS OOCYTES; MDR1B P-GLYCOPROTEIN; CYCLIC-AMP; DIRECTED KINASES; IDENTIFICATION; EXPRESSION; PROTEIN; MEMBRANE; BRAIN	Recent studies implicate a role in hepatocyte organic anion transport of a plasma membrane protein that has been termed oatp1 (organic anion transport protein 1), Little is known regarding mechanisms by which its transport activity is modulated in vivo, In previous studies (Campbell, C. G., Spray, D, C,, and Wolkoff, A W, (1993) J, BioL Chem. 268, 15399-15404), we demonstrated that hepatocyte uptake of sulfobromophthalein was down-regulated by extracellular ATP, We have now found that extracellular ATP reduces the V-max for transport of sulfobromophthalein by rat hepatocytes; K-m remains unaltered. Reduced transport also results from incubation of hepatocytes with the phosphatase inhibitors okadaic acid and calyculin A. Immunoprecipitation of biotinylated cell surface proteins indicates that oatp1 remains on the cell surface after exposure of cells to ATP or phosphatase inhibitor, suggesting that loss of transport activity is not caused by transporter internalization. Exposure of P-32-loaded hepatocytes to extracellular ATP results in serine phosphorylation of oatp1 with the appearance of a single major tryptic phosphopeptide; oatp1 from control cells is not phosphorylated, This phosphopeptide comigrates with one of four phosphopeptides resulting from incubation of cells with okadaic acid. These studies indicate that the phosphorylation state of oatp1 must be an important consideration when assessing alterations of its functional expression in pathobiological states.	Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Wolkoff, AW (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, 625 Ullmann Bldg,1300 Morris Pk Ave, Bronx, NY 10461 USA.			Glavy, Joseph/0000-0003-3716-3965	NATIONAL CANCER INSTITUTE [R01CA056677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, R01DK023026] Funding Source: NIH RePORTER; NCI NIH HHS [CA-56677] Funding Source: Medline; NIDDK NIH HHS [DK-41296, DK-23026] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395; ABRAMOVITZ M, 1988, J BIOL CHEM, V263, P17627; ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; ANGELETTI R, 1999, AM J PHYSIOL, V275, pC882; Angeletti RH, 1997, P NATL ACAD SCI USA, V94, P283, DOI 10.1073/pnas.94.1.283; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231, DOI 10.1152/ajpgi.1996.271.2.G231; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CAMPBELL CG, 1993, J BIOL CHEM, V268, P15399; Coutinho-Silva R, 1997, AM J PHYSIOL-CELL PH, V273, pC1793, DOI 10.1152/ajpcell.1997.273.6.C1793; DIXON CJ, 1990, BIOCHEM J, V269, P499, DOI 10.1042/bj2690499; Fredholm BB, 1997, TRENDS PHARMACOL SCI, V18, P79, DOI 10.1016/S0165-6147(96)01038-3; Glavy JS, 1997, J BIOL CHEM, V272, P5909, DOI 10.1074/jbc.272.9.5909; Glavy JS, 1998, METHOD ENZYMOL, V292, P342; GRUNE S, 1993, J BIOL CHEM, V268, P17734; Hagenbuch B, 1996, BIOCHEM J, V316, P901, DOI 10.1042/bj3160901; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; JACQUEMIN E, 1991, J CLIN INVEST, V88, P2146, DOI 10.1172/JCI115546; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; KELADA ASM, 1992, J BIOL CHEM, V267, P7021; King BF, 1998, TRENDS PHARMACOL SCI, V19, P506, DOI 10.1016/S0165-6147(98)01271-1; Kupriyanova TA, 1999, J BIOL CHEM, V274, P1458, DOI 10.1074/jbc.274.3.1458; Li DL, 1998, AM J PHYSIOL-RENAL, V275, pF863, DOI 10.1152/ajprenal.1998.275.6.F863; Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184; Logvinenko NS, 1996, P NATL ACAD SCI USA, V93, P9132, DOI 10.1073/pnas.93.17.9132; Lu R, 1996, AM J PHYSIOL-RENAL, V270, pF332, DOI 10.1152/ajprenal.1996.270.2.F332; Masuda S, 1999, MOL PHARMACOL, V55, P743; Masuda S, 1997, FEBS LETT, V407, P127, DOI 10.1016/S0014-5793(97)00314-1; MIN AD, 1991, J CLIN INVEST, V87, P1496, DOI 10.1172/JCI115159; Mukhopadhyay S, 1998, J BIOL CHEM, V273, P30039, DOI 10.1074/jbc.273.45.30039; Mukhopadhyay S, 1998, HEPATOLOGY, V28, P1629, DOI 10.1002/hep.510280624; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Saito H, 1996, J BIOL CHEM, V271, P20719, DOI 10.1074/jbc.271.34.20719; Satlin LM, 1997, J BIOL CHEM, V272, P26340, DOI 10.1074/jbc.272.42.26340; SCHARSCHMIDT BF, 1975, J CLIN INVEST, V56, P1280, DOI 10.1172/JCI108204; SHI XY, 1995, J BIOL CHEM, V270, P25591, DOI 10.1074/jbc.270.43.25591; Simon FR, 1996, AM J PHYSIOL-GASTR L, V271, pG1043, DOI 10.1152/ajpgi.1996.271.6.G1043; Simon FR, 1999, AM J PHYSIOL-GASTR L, V276, pG556, DOI 10.1152/ajpgi.1999.276.2.G556; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Wolkoff AW, 1996, SEMIN LIVER DIS, V16, P121, DOI 10.1055/s-2007-1007225; WOLKOFF AW, 1987, J CLIN INVEST, V79, P1259, DOI 10.1172/JCI112946; [No title captured]	42	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1479	1484		10.1074/jbc.275.2.1479	http://dx.doi.org/10.1074/jbc.275.2.1479			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625701	hybrid			2022-12-27	WOS:000084836600105
J	Owhashi, M; Arita, H; Hayai, N				Owhashi, M; Arita, H; Hayai, N			Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCYSTING ENTAMOEBA-INVADENS; CC-CHEMOKINE RECEPTOR; NH2-TERMINAL RESIDUES; SCHISTOSOMA-JAPONICUM; GRANULOMA-FORMATION; MOLECULAR-CLONING; CELLS; MICE; EXPRESSION; SEQUENCE	A novel eosinophil chemotactic cytokine (ECF-L) was purified from the culture supernatant of splenocytes of mice by a combination of anion-exchange chromatography, Procion red-agarose affinity chromatography, size exclusion high performance liquid chromatography (HPLC), and reverse phase HPLC. The NH2-terminal amino acid sequence was determined by direct protein sequencing. An ECF-L cDNA clone of 1,506 nucleotides was isolated from a cDNA library, and the nucleotide sequence predicted a mature protein of 397 amino acids. A recombinant ECF-L showed a level of eosinophil chemotactic activity comparable with that of natural ECF-L, and the activity was inhibited by a monoclonal antibody to ECF-L. ECF-L also attracted T lymphocytes and bone marrow polymorphonuclear leukocytes in vitro, whereas it caused selective extravasation of eosinophils in vivo. ECF-L mRNA was highly expressed in spleen, bone marrow, lung, and heart. A comprehensive GenBank data base search revealed that ECF-L is a chitinase family protein, ECF-L retains those amino acids highly conserved among chitinase family proteins, but Asp and Glu residues essential for the proton donation in hydrolysis were replaced by Asn and Gin, respectively. Although ECF-L contains a consensus CXC sequence near the NH, terminus akin to chemokine family proteins, the rest of ECF-L shows poor homology with chemokines.	Univ Tokushima, Fac Integrated Arts & Sci, Tokushima 7708502, Japan	Tokushima University	Owhashi, M (corresponding author), Univ Tokushima, Fac Integrated Arts & Sci, Tokushima 7708502, Japan.							ARIAS EB, 1994, BIOL REPROD, V51, P685, DOI 10.1095/biolreprod51.4.685; BASS DA, 1979, J CLIN INVEST, V64, P1415, DOI 10.1172/JCI109599; BOCHNER BS, 1994, J ALLERGY CLIN IMMUN, V94, P427, DOI 10.1016/0091-6749(94)90195-3; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; Coffey MJ, 1997, AM J PHYSIOL-LUNG C, V272, pL1025, DOI 10.1152/ajplung.1997.272.5.L1025; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; DAS S, 1991, BIOCHEM J, V280, P641, DOI 10.1042/bj2800641; FUHRMAN JA, 1992, P NATL ACAD SCI USA, V89, P1548, DOI 10.1073/pnas.89.5.1548; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; HAMANN KJ, 1990, J IMMUNOL, V144, P3166; HART GW, 1979, J BIOL CHEM, V254, P9747; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; IWHASHI M, 1994, CURR TOPICS VET RES, V1, P37; KENIGSBERG RL, 1991, J IMMUNOL METHODS, V136, P247, DOI 10.1016/0022-1759(91)90011-4; KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LITT M, 1963, AM J PATHOL, V42, P529; MARUYAMA H, 1991, EXP HEMATOL, V19, P77; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; MORRISON BW, 1994, ONCOGENE, V9, P3417; Owhashi M, 1996, INT J PARASITOL, V26, P705, DOI 10.1016/0020-7519(96)00054-9; Owhashi M, 1998, PARASITOL RES, V84, P136, DOI 10.1007/s004360050370; OWHASHI M, 1986, INT ARCH ALLER A IMM, V81, P129, DOI 10.1159/000234121; OWHASHI M, 1987, INT ARCH ALLER A IMM, V83, P290, DOI 10.1159/000234310; OWHASHI M, 1982, J IMMUNOL, V129, P226; PAQUETTE Y, 1995, MOL REPROD DEV, V42, P388, DOI 10.1002/mrd.1080420404; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; RAMALHOPINTO FJ, 1978, J EXP MED, V147, P147, DOI 10.1084/jem.147.1.147; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; ROTHENBERG ME, 1995, P NATL ACAD SCI USA, V92, P8960, DOI 10.1073/pnas.92.19.8960; Rotman HL, 1996, EXP PARASITOL, V82, P267, DOI 10.1006/expr.1996.0034; SAMAC DA, 1994, PLANT MOL BIOL, V25, P587, DOI 10.1007/BF00029598; SCHALL TJ, 1992, EUR J IMMUNOL, V22, P1477, DOI 10.1002/eji.1830220621; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; SPINDLER KD, 1990, PARASITOL RES, V76, P283, DOI 10.1007/BF00928180; SPRY CJF, 1971, CELL TISSUE KINET, V4, P351, DOI 10.1111/j.1365-2184.1971.tb01545.x; SPRY CJF, 1971, CELL TISSUE KINET, V4, P365, DOI 10.1111/j.1365-2184.1971.tb01546.x; SUGANE K, 1982, PARASITE IMMUNOL, V4, P307, DOI 10.1111/j.1365-3024.1982.tb00442.x; TODD KS, 1978, LAB ANIM, V12, P51, DOI 10.1258/002367778780953099; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VILLAGOMEZCASTRO JC, 1992, MOL BIOCHEM PARASIT, V52, P53, DOI 10.1016/0166-6851(92)90035-I; WARREN KS, 1975, AM J PATHOL, V80, P279; WATANABE T, 1993, J BIOL CHEM, V268, P18567	51	109	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1279	1286		10.1074/jbc.275.2.1279	http://dx.doi.org/10.1074/jbc.275.2.1279			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625674	hybrid			2022-12-27	WOS:000084836600078
J	Erdman, RA; Shellenberger, KE; Overmeyer, JH; Maltese, WA				Erdman, RA; Shellenberger, KE; Overmeyer, JH; Maltese, WA			Rab24 is an atypical member of the Rab GTPase family - Deficient GTPase activity, GDP dissociation inhibitor interaction, and prenylation of Rab24 expressed in cultured cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYL TRANSFERASE; ESCORT PROTEIN; BINDING PROTEIN; ENDOPLASMIC-RETICULUM; MEMBRANE-FUSION; CDNA CLONING; TRANSPORT; MUTANTS; EXOCYTOSIS; COMPLEX	The function of Rab24 is currently unknown, but other members of the Rab GTPase family are known to participate in various protein trafficking pathways. Rab proteins are thought to cycle on and off vesicle membranes in conjunction with changes in their guanine nucleotide state. The present studies indicate that Rab24 possesses several unusual characteristics that distinguish it from other Rab proteins. 1) Based on [P-32]orthophosphate labeling of protein-bound nucleotide, Rab24 exists predominantly in the GTP state when expressed in cultured cells. The low GTPase activity is related to the presence of serine instead of glutamine at the position cognate to Ras Gln-61. 2) Posttranslational geranylgeranylation of Rab24, determined by metabolic labeling or detergent partitioning assays, is inefficient when compared with other Rabs ending with the common CXC and CC carboxyl-terminal motifs. This is partly due to the presence of two histidines distal to the target cysteines, but also involves other unidentified features. 3) Most of the Rab24 in the cytoplasmic compartment of cultured cells is not associated with Rab GDP dissociation inhibitors. These findings indicate that, if Rab24 functions in vesicular transport processes, it may operate through a novel mechanism that does not depend on GTP hydrolysis or GDP dissociation inhibitor-mediated recycling.	Med Coll Ohio, Dept Biochem & Mol Biol, Toledo, OH 43614 USA; Penn State Univ, Coll Med, Weis Ctr Res, Danville, PA 17822 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Maltese, WA (corresponding author), Med Coll Ohio, Dept Biochem & Mol Biol, 3035 Arlington Ave, Toledo, OH 43614 USA.				NATIONAL CANCER INSTITUTE [R01CA034569] Funding Source: NIH RePORTER; NCI NIH HHS [CA34569] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anant JS, 1998, BIOCHEMISTRY-US, V37, P12559, DOI 10.1021/bi980881a; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARAKI S, 1990, J BIOL CHEM, V265, P13007; ARMSTRONG SA, 1993, J BIOL CHEM, V268, P12221; BERANGER F, 1994, J BIOL CHEM, V269, P13637; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; BRONDYK WH, 1993, J BIOL CHEM, V268, P9410; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CHAVRIER P, 1992, GENE, V112, P261, DOI 10.1016/0378-1119(92)90387-5; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; CHEN YT, 1993, P NATL ACAD SCI USA, V90, P6508, DOI 10.1073/pnas.90.14.6508; COOK DG, 1994, METHOD CELL BIOL, V43, P289; DER CJ, 1988, ONCOGENE, V3, P105; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; DUGAN JM, 1995, J BIOL CHEM, V270, P10982, DOI 10.1074/jbc.270.18.10982; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Foster R, 1996, MOL CELL BIOL, V16, P2689; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; HOFFENBERG S, 1995, J BIOL CHEM, V270, P5048, DOI 10.1074/jbc.270.10.5048; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MALTESE WA, 1984, ANN NEUROL, V16, P250, DOI 10.1002/ana.410160215; MUSHA T, 1992, J BIOL CHEM, V267, P9821; NEWMAN CMH, 1992, J BIOL CHEM, V267, P11329; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; OLKKONEN VM, 1993, J CELL SCI, V106, P249; OVERMEYER JH, 1992, J BIOL CHEM, V267, P22686; Overmeyer JH, 1998, MOL BIOL CELL, V9, P223, DOI 10.1091/mbc.9.1.223; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; Rothman JE, 1997, SCIENCE, V276, P1212, DOI 10.1126/science.276.5316.1212; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Seabra MC, 1996, J BIOL CHEM, V271, P14398, DOI 10.1074/jbc.271.24.14398; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Shen F, 1996, J BIOL CHEM, V271, P3692; Sheridan KM, 1998, J MOL NEUROSCI, V10, P121, DOI 10.1007/BF02737123; SHISHEVA A, 1994, J BIOL CHEM, V269, P23865; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Valencia A, 1995, GUIDEBOOK SMALL GTPA, P12; Valentijn JA, 1996, EUR J CELL BIOL, V71, P129; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; Weber E, 1996, J BIOL CHEM, V271, P6963, DOI 10.1074/jbc.271.12.6963; Wilson AL, 1996, J BIOL CHEM, V271, P10932, DOI 10.1074/jbc.271.18.10932; Wilson AL, 1996, BIOCHEM J, V318, P1007, DOI 10.1042/bj3181007; Wilson AL, 1998, BIOCHEM J, V333, P497, DOI 10.1042/bj3330497; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153	60	44	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3848	3856		10.1074/jbc.275.6.3848	http://dx.doi.org/10.1074/jbc.275.6.3848			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660536	hybrid			2022-12-27	WOS:000085288800020
J	Begg, GE; Harper, SL; Morris, MB; Speicher, DW				Begg, GE; Harper, SL; Morris, MB; Speicher, DW			Initiation of spectrin dimerization involves complementary electrostatic interactions between paired triple-helical bundles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-ASSOCIATION; ERYTHROCYTE SPECTRIN; BETA-SPECTRIN; CRYSTAL-STRUCTURE; IONIC-STRENGTH; ALPHA-SPECTRIN; PROTEIN; BINDING; DOMAIN; SITE	The spectrin heterodimer is formed by the antiparallel lateral association of an alpha and a beta subunit, each of which comprises largely a series of homologous triple-helical motifs. Initiation of dimer assembly involves strong binding between complementary motifs near the actin-binding end of the dimer, In this study, the mechanism of lateral spectrin association at this dimer nucleation site was investigated using the analytical ultracentrifuge to analyze heterodimers formed from recombinant peptides containing two or four homologous motifs from each subunit (alpha 20-21/beta 1-2; alpha 18-21/beta 1-4). Both the two-motif and four-motif dimer associations were weakened substantially with increasing salt concentration, indicating that electrostatic interactions are important for the dimer initiation process. Modeling of the electrostatic potential on the surface of the alpha 20 and beta 2 motifs showed that the side of the motifs comprising the A and B helices is the most favorable for association, with an area of positive electrostatic potential on the AB face of the beta 2 motif opposite negative potential on the AB face of the alpha 20 motif and vise versa. Protease protection analysis of the alpha 20-21/beta 1-2 dimer showed that multiple trypsin and proteinase K sites in the A helices of the beta 2 and alpha 21 motifs become buried upon dimer formation. Together, these data support a model where complementary long range electrostatic interactions on the AB faces of the triple-helical motifs in the dimer nucleation site initiate the correct pairing of motifs, i.e. alpha 21-beta 1 and alpha 20-beta 2. After initial docking of these complementary triple-helical motifs, this association is probably stabilized by subsequent formation of stronger hydrophobic interactions in a complex involving the A helices of both subunits and possibly most of the AB faces. The beta subunit A helix in particular appears to be buried in the dimer interface.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Univ Sydney, Dept Pharm, Sydney, NSW 2006, Australia	The Wistar Institute; University of Sydney	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.upenn.edu	Morris, Michael/AAP-6590-2021	Morris, Michael/0000-0002-1286-4784	NCI NIH HHS [CA10815] Funding Source: Medline; NHLBI NIH HHS [HL38794] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARGOS P, 1988, PROTEIN ENG, V2, P101, DOI 10.1093/protein/2.2.101; BANYARD SH, 1978, NATURE, V271, P282, DOI 10.1038/271282a0; Begg GE, 1997, BIOCHEMISTRY-US, V36, P6977, DOI 10.1021/bi970186n; COLE N, 1992, BIOCHIM BIOPHYS ACTA, V1121, P23, DOI 10.1016/0167-4838(92)90332-8; DeSilva TM, 1997, BIOCHEMISTRY-US, V36, P3991, DOI 10.1021/bi962412j; Fujita T, 1998, BIOCHEMISTRY-US, V37, P264, DOI 10.1021/bi971966z; Gervasoni P, 1998, BIOCHEMISTRY-US, V37, P11660, DOI 10.1021/bi980258q; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; KENNEDY SP, 1994, J BIOL CHEM, V269, P11400; LABRAKE CC, 1993, BIOCHEMISTRY-US, V32, P10296, DOI 10.1021/bi00090a004; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; LUCKOW EA, 1989, BIOCHEMISTRY-US, V28, P2348, DOI 10.1021/bi00431a055; Lusitani D, 1998, BIOCHEMISTRY-US, V37, P16546, DOI 10.1021/bi9811462; MAZDZANOWSKI J, 1992, ELECTROPHORESIS, V13, P59, DOI 10.1002/elps.1150130112; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; SAHR KE, 1990, J BIOL CHEM, V265, P4434; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; SCOTT WG, 1993, J MOL BIOL, V232, P555, DOI 10.1006/jmbi.1993.1411; SETO MH, 1995, PROTEIN SCI, V4, P655; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SPEICHER DW, 1992, J BIOL CHEM, V267, P14775; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; TSE WT, 1990, J CLIN INVEST, V86, P909, DOI 10.1172/JCI114792; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; VIEL A, 1994, P NATL ACAD SCI USA, V91, P10839, DOI 10.1073/pnas.91.23.10839; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WEBER PC, 1980, NATURE, V286, P302, DOI 10.1038/286302a0; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003; ZHONG M, 1995, P NATL ACAD SCI USA, V92, P2111, DOI 10.1073/pnas.92.6.2111	40	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3279	3287		10.1074/jbc.275.5.3279	http://dx.doi.org/10.1074/jbc.275.5.3279			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652315	hybrid			2022-12-27	WOS:000085146500037
J	Ferreira, C; Bucchini, D; Martin, ME; Levi, S; Arosio, P; Grandchamp, B; Beaumont, C				Ferreira, C; Bucchini, D; Martin, ME; Levi, S; Arosio, P; Grandchamp, B; Beaumont, C			Early embryonic lethality of H ferritin gene deletion in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; ERYTHROLEUKEMIA-CELLS; IRON-METABOLISM; L-CHAIN; SUBUNIT; MOUSE; IDENTIFICATION; HETEROPOLYMERS; EXPRESSION; BINDING	Ferritin molecules play an important role in the control of intracellular iron distribution and in the constitution of long term iron stores. In vitro studies on recombinant ferritin subunits have shown that the ferroxidase activity associated with the H subunit is necessary for iron uptake by the ferritin molecule, whereas the L subunit facilitates iron core formation inside the protein shell. However, plant and bacterial ferritins have only a single type of subunit which probably fulfills both functions. To assess the biological significance of the ferroxidase activity associated with the H subunit, we disrupted the H ferritin gene (Fth) in mice by homologous recombination. Fth(+/-) mice are healthy, fertile, and do not differ significantly from their control littermates, However, Fth(-/-) embryos die between 3.5 and 9.5 days of development, suggesting that there is no functional redundancy between the two ferritin subunits and that, in the absence of H subunits, L ferritin homopolymers are not able to maintain iron in a bioavailable and nontoxic form. The pattern of expression of the wild type Fth gene in 9.5-day embryos is suggestive of an important function of the H ferritin gene in the heart.	Fac Xavier Bichat, INSERM, U409, F-75018 Paris, France; Fac Cochin Port Royal, INSERM, U257, F-75014 Paris, France; Hosp San Raffaele, DIBIT, Unit Prot Engn, I-20132 Milan, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Beaumont, C (corresponding author), Fac Xavier Bichat, INSERM, U409, 16 Rue Henri Huchard, F-75018 Paris, France.		arosio, paolo/E-6817-2010; arosio, paolo/S-3272-2019; levi, sonia/A-3161-2015	arosio, paolo/0000-0002-5343-8992; levi, sonia/0000-0002-5092-0847; Ferreira, Chrystophe/0000-0002-1990-278X				BEAUMONT C, 1994, J BIOL CHEM, V269, P20281; BEAUMONT C, 1989, J BIOL CHEM, V264, P7498; Bensidhoum M, 1998, TRANSGENICS, V2, P275; COCCIA EM, 1992, MOL CELL BIOL, V12, P3015, DOI 10.1128/MCB.12.7.3015; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Levi S, 1998, BLOOD, V91, P4180, DOI 10.1182/blood.V91.11.4180.411k38_4180_4187; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1988, J BIOL CHEM, V263, P18086; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Marziali G, 1997, MOL CELL BIOL, V17, P1387, DOI 10.1128/MCB.17.3.1387; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; MUNRO HN, 1978, PHYSIOL REV, V58, P317, DOI 10.1152/physrev.1978.58.2.317; Picard V, 1996, BLOOD, V87, P2057; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Ponka P, 1998, SEMIN HEMATOL, V35, P35; RYAN TP, 1992, CRIT REV TOXICOL, V22, P119, DOI 10.3109/10408449209146308; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Schalinske KL, 1998, J BIOL CHEM, V273, P3740, DOI 10.1074/jbc.273.6.3740; THEIL EC, 1976, BRIT J HAEMATOL, V33, P437, DOI 10.1111/j.1365-2141.1976.tb03561.x; THEIL EC, 1981, DEV BIOL, V84, P481, DOI 10.1016/0012-1606(81)90419-X; Tsuji Y, 1998, J BIOL CHEM, V273, P2984, DOI 10.1074/jbc.273.5.2984; Wai SN, 1996, MOL MICROBIOL, V20, P1127, DOI 10.1111/j.1365-2958.1996.tb02633.x; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676	25	210	220	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3021	3024		10.1074/jbc.275.5.3021	http://dx.doi.org/10.1074/jbc.275.5.3021			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652280	hybrid			2022-12-27	WOS:000085146500002
J	Guy, LG; Delvoye, N; Wall, L				Guy, LG; Delvoye, N; Wall, L			Expression of a human beta-globin transgene in mice with the CACC motif and upstream sequences deleted from the promoter still depends on erythroid Kruppel-like factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; HUMAN GAMMA-GLOBIN; DOMINANT CONTROL REGION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; FACTOR EKLF; CHROMATIN STRUCTURE; BINDING; ELEMENT; THALASSEMIA	Mice in which the erythroid Kruppel-like Factor (EKLF) gene is inactivated die in fetal life due to downregulation of the beta-globin gene. Results have suggested that EKLF functions through the proximal CACC motif of the beta-globin promoter. For example, natural mutations of this element that fail to bind EKLF give reduced gene expression and the ability of EKLF to activate reporter genes in co-transfection assays is dependent on an intact CACC, Here, removal of the CACC motif and upstream promoter sequences from the beta-globin gene resulted in reduced expression in transgenic mice. However, breeding onto an EKLF-/- background demonstrated that a CACC-less beta-globin transgene remains highly dependent on EKLF. Hence, although the beta-globin gene partly depends on the proximal CACC motif for expression, it is unlikely that the major mechanism of gene activation by EKLF is through this element. We also show that a lacZ reporter gene linked to the beta-globin promoter, with or without the CACC box present, is actually expressed higher in EKLF-/- fetuses than in wild type animals, suggesting that EKLF may be able to act as an inhibitor of transcription with certain transgene configurations.	Univ Montreal, Ctr Hosp, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Dept Med, Montreal, PQ H2L 4M1, Canada	Universite de Montreal; Universite de Montreal	Wall, L (corresponding author), Univ Montreal, Ctr Hosp, Inst Canc Montreal, 1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.							ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; ANTONIOU M, 1990, GENE DEV, V4, P1007, DOI 10.1101/gad.4.6.1007; Asano H, 1999, MOL CELL BIOL, V19, P3571; Asano H, 1998, MOL CELL BIOL, V18, P102, DOI 10.1128/MCB.18.1.102; BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Crossley M, 1996, MOL CELL BIOL, V16, P1695; DELVOYE NL, 1993, MOL CELL BIOL, V13, P6969, DOI 10.1128/MCB.13.11.6969; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Donze D, 1996, BLOOD, V88, P4051, DOI 10.1182/blood.V88.10.4051.bloodjournal88104051; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; Epner E, 1998, MOL CELL, V2, P447, DOI 10.1016/S1097-2765(00)80144-6; FELSENFELD G, 1993, GENE, V135, P119, DOI 10.1016/0378-1119(93)90056-9; FENG WC, 1994, J BIOL CHEM, V269, P1493; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Gillemans N, 1998, GENE DEV, V12, P2863, DOI 10.1101/gad.12.18.2863; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guy LG, 1998, BLOOD, V91, P2259, DOI 10.1182/blood.V91.7.2259.2259_2259_2263; Guy LG, 1996, EMBO J, V15, P3713, DOI 10.1002/j.1460-2075.1996.tb00741.x; HANCOMBE O, 1991, GENE DEV, V5, P1387; HARTZOG GA, 1993, MOL CELL BIOL, V13, P44, DOI 10.1128/MCB.13.1.44; Higgs DR, 1998, CELL, V95, P299, DOI 10.1016/S0092-8674(00)81761-4; KULOZIK AE, 1991, BLOOD, V77, P2054; Matsumoto N, 1998, J BIOL CHEM, V273, P28229, DOI 10.1074/jbc.273.43.28229; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; ORKIN SH, 1984, J BIOL CHEM, V259, P8679; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PERKINS AC, 1995, NATURE, V375, P318; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Wijgerde M, 1996, GENE DEV, V10, P2894, DOI 10.1101/gad.10.22.2894	37	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3675	3680		10.1074/jbc.275.5.3675	http://dx.doi.org/10.1074/jbc.275.5.3675			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652365	hybrid			2022-12-27	WOS:000085146500087
J	Pi, M; Garner, SC; Flannery, P; Spurney, RF; Quarles, LD				Pi, M; Garner, SC; Flannery, P; Spurney, RF; Quarles, LD			Sensing of extracellular cations in CasR-deficient osteoblasts - Evidence for a novel cation-sensing mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; CALCIUM (CA-O(2+))-SENSING RECEPTOR; NEONATAL SEVERE HYPERPARATHYROIDISM; CELL-LINE; MC3T3-E1 OSTEOBLASTS; CA2+-SENSING RECEPTOR; EXPRESSION; PROLIFERATION; MUTATIONS; STIMULATION	We isolated osteoblastic cell lines from wild-type (CasR(+/+)) and receptor null (CasR(-/-)) mice to investigate whether CasR is present in osteoblasts and accounts for their responses to extracellular cations, Osteoblasts from both CasR(+/+) and CasR(-/-) mice displayed an initial period of cell replication followed by a culture duration-dependent increase in alkaline phosphatase activity, expression of osteocalcin, and mineralization of extracellular matrix. In addition, a panel of extracellular cations, including aluminum and the CasR agonists gadolinium and calcium, stimulated DNA synthesis, activated a transfected serum response element-luciferase reporter construct, and inhibited agonist-induced cAMP in CasR(-/-) osteoblasts. The functional responses to these cations were identical in CasR(+/+) and CasR(-/-) osteoblasts, Thus, the absence of CasR alters neither the maturational profile of isolated osteoblast cultures nor their in vitro responses to extracellular cations. In addition, CasR transcripts could not be detected by reverse transcription-polymerase chain reaction with mouse specific primers in either CasR(+/+) or CasR(-/-) osteoblasts, and immunoblot analysis with a CasR-specific antibody was negative for CasR protein expression in osteoblasts, The presence of a cation-sensing response in osteoblasts from CasR(-/-) mice indicates the existence of a novel osteoblastic extracellular cation-sensing mechanism.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University	Quarles, LD (corresponding author), Duke Univ, Med Ctr, Dept Med, POB 3036, Durham, NC 27710 USA.			Pi, Min/0000-0002-0319-8003; Quarles, L. Darryl/0000-0002-5082-7896	NIAMS NIH HHS [R01-AR43468, R01-AR37308] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037308, R01AR043468] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bapty BW, 1998, KIDNEY INT, V53, P583, DOI 10.1046/j.1523-1755.1998.00790.x; BROWN EM, 1995, NEW ENGL J MED, V333, P234, DOI 10.1056/NEJM199507273330407; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; DEMAREST KT, 1997, J BONE MINER RES  S1, V12, pS413; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; Emanuel RL, 1996, MOL ENDOCRINOL, V10, P555, DOI 10.1210/me.10.5.555; Goldsmith PK, 1997, J BONE MINER RES, V12, P1780, DOI 10.1359/jbmr.1997.12.11.1780; Hartle JE, 1996, J BONE MINER RES, V11, P789; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; House MG, 1997, J BONE MINER RES, V12, P1959, DOI 10.1359/jbmr.1997.12.12.1959; Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448; KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5; Kovacs CS, 1998, J CLIN INVEST, V101, P2812, DOI 10.1172/JCI2940; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; *NAT RES COUNC, 1985, DHHS PUBL NIH; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; Pi M, 1999, J BONE MINER RES, V14, P1310, DOI 10.1359/jbmr.1999.14.8.1310; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; QUARLES LD, 1992, J BONE MINER RES, V7, P683; QUARLES LD, 1994, J CELL BIOCHEM, V56, P106, DOI 10.1002/jcb.240560115; Quarles LD, 1997, J BONE MINER RES, V12, P393, DOI 10.1359/jbmr.1997.12.3.393; QUARLES LD, 1991, ENDOCRINOLOGY, V128, P3144, DOI 10.1210/endo-128-6-3144; Riccardi D, 1996, AM J PHYSIOL-RENAL, V271, pF951, DOI 10.1152/ajprenal.1996.271.4.F951; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Spurney RF, 1999, KIDNEY INT, V55, P1750, DOI 10.1046/j.1523-1755.1999.00432.x; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; SUGIMOTO TJ, 1993, J BONE MINER RES, V12, P1445; Xiao ZS, 1998, AM J PHYSIOL-ENDOC M, V275, pE700, DOI 10.1152/ajpendo.1998.275.4.E700; Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530; Yamaguchi T, 1998, ENDOCRINOLOGY, V139, P3561, DOI 10.1210/en.139.8.3561; Yamaguchi T, 1998, BIOCHEM BIOPH RES CO, V243, P753, DOI 10.1006/bbrc.1998.8178; YAMAUCHI K, 1993, J BIOL CHEM, V268, P14597	36	77	79	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3256	3263		10.1074/jbc.275.5.3256	http://dx.doi.org/10.1074/jbc.275.5.3256			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652312	hybrid			2022-12-27	WOS:000085146500034
J	Rajamohan, F; Pugmire, MJ; Kurinov, IV; Uckun, FM				Rajamohan, F; Pugmire, MJ; Kurinov, IV; Uckun, FM			Modeling and alanine scanning mutagenesis studies of recombinant pokeweed antiviral protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICIN A-CHAIN; RIBOSOME-INACTIVATING PROTEINS; GENERATE SCHEMATIC DIAGRAMS; SUBSTRATE-ANALOGS; BINDING; PROGRAM; RNA; MECHANISM; SITE	Phytolacca americana-derived naturally occurring ribosome inhibitory protein pokeweed antiviral protein (PAP) is an N-glycosidase that catalytically removes a specific adenine residue from the stem loop of ribosomal RNA. We have employed molecular modeling studies using a novel model of PAP-RNA complexes and site-directed mutagenesis combined with bioassays to evaluate the importance of the residues at the catalytic site and a putative RNA binding active center cleft between the catalytic site and C-terminal domain for the enzymatic deadenylation of ribosomal RNA by PAP, As anticipated, alanine substitutions by site-directed mutagenesis of the PAP active site residues Tyr(72), Tyr(123), Glu(176), and Arg(179) that directly participate in the catalytic deadenylation of RNA resulted in greater than 3 logs of loss in depurinating and ribosome inhibitory activity. Similarly, alanine substitution of the conserved active site residue Trp(208), which results in the loss of stabilizing hydrophobic interactions with the ribose as well as a hydrogen bond to the phosphate backbone of the RNA substrate, caused greater than 3 logs of loss in enzymatic activity, By comparison, alanine substitutions of residues (KD29)-K-28, (FE81)-F-80, (SR112)-S-111, (FL167)-F-166 that are distant from the active site did not significantly reduce the enzymatic activity of PAP. Our modeling studies predicted that the residues of the active center cleft could via electrostatic interactions contribute to both the correct orientation and stable binding of the substrate RNA molecule in the active site pocket. Nota bly, alanine substitutions of the highly conserved, charged, and polar residues of the active site cleft including (48)Ky(49), (RR68)-R-67, (VN70)-V-69, and (FND92)-F-90 substantially reduced the depurinating and ribosome inhibitory activity of PAP, These results provide unprecedented evidence that besides the active site residues of PAP, the conserved, charged, and polar side chains located at its active center cleft also play a critical role in the PAP-mediated depurination of ribosomal RNA.	Parker Hughes Inst, Biotherapy Program, Roseville, MN 55113 USA; Parker Hughes Inst, Dept Prod Engn, Roseville, MN 55113 USA; Parker Hughes Inst, Dept Biol Struct, Roseville, MN 55113 USA; Parker Hughes Inst, Dept Biochem, Roseville, MN 55113 USA; Parker Hughes Inst, Dept Virol, Roseville, MN 55113 USA		Rajamohan, F (corresponding author), Parker Hughes Inst, Biotherapy Program, 2657 Patton Rd, Roseville, MN 55113 USA.			Uckun, Fatih M./0000-0001-9334-183X				AGO H, 1994, EUR J BIOCHEM, V225, P369, DOI 10.1111/j.1432-1033.1994.00369.x; BRAVI G, 1995, J MOL GRAPHICS, V13, P83, DOI 10.1016/0263-7855(94)00014-J; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; DALLAL JA, 1978, FEBS LETT, V89, P257, DOI 10.1016/0014-5793(78)80230-0; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P5908; GESSNER SL, 1980, J BIOL CHEM, V255, P3251; HARDESTY WMB, 1979, METHOD ENZYMOL, V33, P316; HARTLEY MR, 1991, FEBS LETT, V290, P65, DOI 10.1016/0014-5793(91)81227-Y; HUANG QC, 1995, BIOCHEM J, V309, P285, DOI 10.1042/bj3090285; IRVIN JD, 1983, PHARMACOL THERAPEUT, V21, P371, DOI 10.1016/0163-7258(83)90061-X; IRVIN JD, 1975, ARCH BIOCHEM BIOPHYS, V169, P522, DOI 10.1016/0003-9861(75)90195-2; IRVIN JD, 1992, PHARMACOL THERAPEUT, V55, P279, DOI 10.1016/0163-7258(92)90053-3; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurinov IV, 1999, PROTEIN SCI, V8, P1765, DOI 10.1110/ps.8.9.1765; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; MONZINGO AF, 1993, J MOL BIOL, V233, P705, DOI 10.1006/jmbi.1993.1547; MONZINGO AF, 1992, J MOL BIOL, V227, P1136, DOI 10.1016/0022-2836(92)90526-P; *MSI, 1991, INS US GUID; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olson MA, 1997, PROTEINS, V27, P80, DOI 10.1002/(SICI)1097-0134(199701)27:1<80::AID-PROT9>3.0.CO;2-R; Rajamohan F, 1999, PROTEIN EXPRES PURIF, V16, P359, DOI 10.1006/prep.1999.1084; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WELLS JA, 1991, METHOD ENZYMOL, V202, P390	29	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3382	3390		10.1074/jbc.275.5.3382	http://dx.doi.org/10.1074/jbc.275.5.3382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652330	hybrid			2022-12-27	WOS:000085146500052
J	Strom, DK; Nipp, J; Westendorf, JJ; Linggi, B; Lutterbach, B; Downing, JR; Lenny, N; Hiebert, SW				Strom, DK; Nipp, J; Westendorf, JJ; Linggi, B; Lutterbach, B; Downing, JR; Lenny, N; Hiebert, SW			Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; GRANULOCYTE DIFFERENTIATION; TRANSCRIPTIONAL ACTIVATION; FUSION PROTEIN; GENE-PRODUCT; DNA-BINDING; T(8-21); TRANSACTIVATION; PROMOTER	AML-l-encoded transcription factor, AML-1B, regulates numerous hematopoietic-specific genes. Inappropriate expression of AML-1-family proteins is oncogenic in cell culture systems and in mice. To understand the oncogenic functions of AML-1, we established cell lines expressing AML-1B to examine the role of AML-1 in the cell cycle. DNA content analysis and bromodeoxyuridine pulse-chase studies indicated that entry into the S phase of the cell cycle was accelerated by up to 4 h in AML-1B-expressing 32D.3 myeloid progenitor cells as compared with control cells or cells expressing E2F-1. However, AML-1B was not able to induce continued cell cycle progression in the absence of growth factors. The DNA binding and transactivation domains of AML-1B were required for altering the cell cycle. Thus, AML-1B is the first transcription factor that affects the timing of the mammalian cell cycle.	Vanderbilt Univ, Dept Biochem, Ingram Canc Ctr, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Med, Ingram Canc Ctr, Sch Med, Nashville, TN 37232 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	Vanderbilt University; Vanderbilt University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hiebert, SW (corresponding author), Vanderbilt Univ, Dept Biochem, Ingram Canc Ctr, Sch Med, Med Res Bldg 2,Rm 512,23rd & Pierce, Nashville, TN 37232 USA.		Downing, James R./N-8102-2018		NCI NIH HHS [R01-CA77274, R01-CA64140] Funding Source: Medline; NIA NIH HHS [R01 AG13726] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064140, R01CA077274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013726] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aronson BD, 1997, MOL CELL BIOL, V17, P5581, DOI 10.1128/MCB.17.9.5581; ASKEW DS, 1991, ONCOGENE, V6, P1915; BAE SC, 1994, MOL CELL BIOL, V14, P3242, DOI 10.1128/MCB.14.5.3242; Cao WS, 1997, ONCOGENE, V15, P1315, DOI 10.1038/sj.onc.1201305; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; HIEBERT SW, 1993, MOL CELL BIOL, V13, P3384, DOI 10.1128/MCB.13.6.3384; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HIEBERT SW, 1995, MOL CELL BIOL, V15, P6864; Imai Y, 1998, BIOCHEM BIOPH RES CO, V252, P582, DOI 10.1006/bbrc.1998.9705; Jun DY, 1997, MOL CELLS, V7, P537; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Kanno Y, 1998, MOL CELL BIOL, V18, P4252, DOI 10.1128/MCB.18.7.4252; KATO JY, 1993, P NATL ACAD SCI USA, V90, P11513, DOI 10.1073/pnas.90.24.11513; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Kurokawa M, 1996, ONCOGENE, V12, P883; LENNY N, 1995, ONCOGENE, V11, P1761; Lenny N, 1997, MOL BIOL REP, V24, P157, DOI 10.1023/A:1006859700409; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Lutterbach B, 1999, P NATL ACAD SCI USA, V96, P12822, DOI 10.1073/pnas.96.22.12822; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Meyers S, 1996, ONCOGENE, V13, P303; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; ROMANA SP, 1995, BLOOD, V86, P4263, DOI 10.1182/blood.V86.11.4263.bloodjournal86114263; Rubnitz JE, 1997, PEDIATRICS, V100, P101, DOI 10.1542/peds.100.1.101; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Strom DK, 1998, CELL GROWTH DIFFER, V9, P59; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Tanaka Y, 1998, ONCOGENE, V17, P699, DOI 10.1038/sj.onc.1201985; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	45	88	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3438	3445		10.1074/jbc.275.5.3438	http://dx.doi.org/10.1074/jbc.275.5.3438			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652337	hybrid			2022-12-27	WOS:000085146500059
J	Tsai, SC; Pasumarthi, KBS; Pajak, L; Franklin, M; Patton, B; Wang, H; Henzel, WJ; Stults, JT; Field, LJ				Tsai, SC; Pasumarthi, KBS; Pajak, L; Franklin, M; Patton, B; Wang, H; Henzel, WJ; Stults, JT; Field, LJ			Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURVIVAL-PROMOTING PROTEINS; CARDIAC GENE-TRANSCRIPTION; SIMIAN-VIRUS-40 LARGE-T; PROGRAMMED CELL-DEATH; NECROSIS-FACTOR-ALPHA; TRANSGENIC MICE; DNA-SYNTHESIS; DILATED CARDIOMYOPATHY; VENTRICULAR MYOCYTES; ADULT MYOCARDIUM	A 193-kDa SV40 large T antigen (T-Ag)-binding protein, designated p193, was identified and cloned. Inspection of the deduced amino acid sequence revealed the presence of a short motif similar to the Bcl-2 homology (BH) domain 3, suggesting that p193 may be a member of a family of apoptosis promoting proteins containing only BH3 motifs, In support of this, p193 expression promoted apoptosis in NIH-3T3 cells. Deletion of the BH3 motif abolished p193 apoptosis activity, p193-induced apoptosis was antagonized by co-expression of Bcl-X-L. Immune cytologic analysis indicated that p193 is localized to the cytoplasm of transfected cells. p193-induced apoptosis was also antagonized by co-expression of T-Ag, which resulted in the cytoplasmic localization of both proteins. The p193 binding site was mapped to an N-terminal region of T-Ag previously implicated in transforming activity. These results suggest that T-Ag possesses an antiapoptosis activity, independent of p53 sequestration, which is actuated by T-Ag/p193 binding in the cytoplasm.	Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Roche Holding; Genentech	Field, LJ (corresponding author), James Whitcomb Riley Hosp Children, Ctr Pediat Res, 702 Barnhill Dr,Rm 2666, Indianapolis, IN 46202 USA.	ljfield@iupui.edu		Henzel, William/0000-0003-2940-3797; Pasumarthi, Kishore/0000-0001-9317-076X				Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Anversa P, 1998, LAB INVEST, V78, P767; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Bishopric NH, 1997, J BIOL CHEM, V272, P20584, DOI 10.1074/jbc.272.33.20584; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; BOYD JM, 1995, ONCOGENE, V11, P1921; Brown DR, 1998, EMBO J, V17, P2513, DOI 10.1093/emboj/17.9.2513; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Conzen SD, 1997, J VIROL, V71, P4536, DOI 10.1128/JVI.71.6.4536-4543.1997; DAUD AI, 1993, AM J PHYSIOL, V264, pH1693, DOI 10.1152/ajpheart.1993.264.5.H1693; DAVIS D, 1986, EXP CELL RES, V166, P94, DOI 10.1016/0014-4827(86)90510-0; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Ellison KE, 1996, J MOL CELL CARDIOL, V28, P1385, DOI 10.1006/jmcc.1996.0130; ESSER C, 1995, CYTOMETRY, V21, P382, DOI 10.1002/cyto.990210411; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; FARROW SN, 1995, NATURE, V374, P731, DOI 10.1038/374731a0; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; FIELD LJ, 1988, SCIENCE, V239, P1029, DOI 10.1126/science.2964082; Geng YJ, 1999, CIRC RES, V84, P34; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P946, DOI 10.1093/nar/22.6.946; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Hatakeyama M, 1995, Prog Cell Cycle Res, V1, P9; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; Hegde R, 1998, J BIOL CHEM, V273, P7783, DOI 10.1074/jbc.273.14.7783; Henzel William J., 1994, Methods (Orlando), V6, P239, DOI 10.1006/meth.1994.1026; HENZEL WJ, 1987, J CHROMATOGR, V404, P41, DOI 10.1016/S0021-9673(01)86835-7; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; KATZ EB, 1992, AM J PHYSIOL, V262, pH1867, DOI 10.1152/ajpheart.1992.262.6.H1867; KAUFMANN R, 1994, INT J MASS SPECTROM, V131, P355, DOI 10.1016/0168-1176(93)03876-N; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; KIERSTEAD TD, 1993, J VIROL, V67, P1817, DOI 10.1128/JVI.67.4.1817-1829.1993; KIM KK, 1994, J BIOL CHEM, V269, P22607; KIM KK, 1995, GENOMICS, V28, P520, DOI 10.1006/geno.1995.1184; Kim KK, 1996, J BIOL CHEM, V271, P29255, DOI 10.1074/jbc.271.46.29255; KIRSHENBAUM LA, 1995, J BIOL CHEM, V270, P7791, DOI 10.1074/jbc.270.14.7791; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KOHRMAN DC, 1992, J VIROL, V66, P1752, DOI 10.1128/JVI.66.3.1752-1760.1992; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; LaThangue NB, 1996, BIOCHEM SOC T, V24, P54; LI Y, 1993, GENE DEV, V7, P2366, DOI 10.1101/gad.7.12a.2366; Liu Y, 1996, J CELL BIOL, V133, P325, DOI 10.1083/jcb.133.2.325; LUDLOW JW, 1995, VIRUS RES, V35, P113, DOI 10.1016/0168-1702(94)00094-S; MARSILIO E, 1991, J VIROL, V65, P5647, DOI 10.1128/JVI.65.10.5647-5652.1991; MORAN E, 1993, FASEB J, V7, P880, DOI 10.1096/fasebj.7.10.8344487; NEVINS JR, 1992, SCIENCE, V258, P424; Nomura N, 1994, DNA Res, V1, P251, DOI 10.1093/dnares/1.5.251; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SEN A, 1988, J BIOL CHEM, V263, P19132; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Srinivasan A, 1997, MOL CELL BIOL, V17, P4761, DOI 10.1128/MCB.17.8.4761; STENMAN S, 1975, INT J CANCER, V15, P547, DOI 10.1002/ijc.2910150403; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; WHITE E, 1995, CURR TOP MICROBIOL, V199, P33; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; ZHU JY, 1992, J VIROL, V66, P2780, DOI 10.1128/JVI.66.5.2780-2791.1992	72	57	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3239	3246		10.1074/jbc.275.5.3239	http://dx.doi.org/10.1074/jbc.275.5.3239			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652310	hybrid			2022-12-27	WOS:000085146500032
J	Natochin, M; Muradov, KG; McEntaffer, RL; Artemyev, NO				Natochin, M; Muradov, KG; McEntaffer, RL; Artemyev, NO			Rhodopsin recognition by mutant G(s)alpha containing C-terminal residues of transducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT COMPLEX; ALPHA-SUBUNIT; ADP-RIBOSYLATION; BINDING-SITES; RECEPTOR; GTP; ACTIVATION; HYDROLYSIS; MUTATIONS; CHIMERAS	The C-terminal regions of the heterotrimeric Gr protein ru-subunits play key roles in selective activation of G proteins by their cognate receptors, In this study, mutant G(S)alpha proteins with substitutions by C-terminal residues of transducin (G(t)alpha) mere analyzed for their interaction with light-activated rhodopsin (R*) to delineate the critical determinants of the G(t)alpha/R* coupling, In contrast to G(S)alpha, a chimeric G(S)alpha/G(t)alpha protein containing only 11 C-terminal residues from transducin was capable of binding to and being potently activated by R*, Our results suggest that Gys(347) and Gly(348) are absolutely essential, whereas Asp(346) is more modestly involved in the G(t) activation by R*. In addition, the analysis of the intrinsic nucleotide exchange in mutant G(S)alpha indicated an interaction between the C terminus and the switch II region in G(t)alpha.GDP. Mutant G(s)alpha containing the G(t)alpha C terminus and substitutions of Asn(239) and Asp(240) (switch II) by the corresponding C(t)alpha residues, Glu(212) and Gly(213), displayed significant reductions in spontaneous guanosine 5'-O-(3-thiotriphosphate)-binding rates to the levels approaching those in G,cu, Communication between the C terminus and switch II of G(t)alpha does not appear essential for the activational coupling between G, and R*, but may represent one of the mechanisms by which G alpha subunits control intrinsic nucleotide exchange.	Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Artemyev, NO (corresponding author), Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA.			Artemyev, Nikolai/0000-0002-5266-6854	NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NEI NIH HHS [EY-10843] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artemyev NO, 1997, BIOCHEMISTRY-US, V36, P4188, DOI 10.1021/bi963002y; Bae H, 1999, J BIOL CHEM, V274, P14963, DOI 10.1074/jbc.274.21.14963; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; DENKER BM, 1995, BIOCHEMISTRY-US, V34, P5544, DOI 10.1021/bi00016a028; GARCIA PD, 1995, EMBO J, V14, P4460, DOI 10.1002/j.1460-2075.1995.tb00125.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; KISSELEV O, 1995, P NATL ACAD SCI USA, V92, P9102, DOI 10.1073/pnas.92.20.9102; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Osawa S, 1995, J BIOL CHEM, V270, P31052, DOI 10.1074/jbc.270.52.31052; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; VANDOP C, 1984, J BIOL CHEM, V259, P23; WEST RE, 1985, J BIOL CHEM, V260, P4428; Yang CS, 1999, J BIOL CHEM, V274, P2379, DOI 10.1074/jbc.274.4.2379	25	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2669	2675		10.1074/jbc.275.4.2669	http://dx.doi.org/10.1074/jbc.275.4.2669			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644728	hybrid			2022-12-27	WOS:000085128000060
J	Prokhorova, TA; Blow, JJ				Prokhorova, TA; Blow, JJ			Sequential MCM/P1 subcomplex assembly is required to form a heterohexamer with replication licensing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MINICHROMOSOME-MAINTENANCE PROTEINS; ORIGIN RECOGNITION COMPLEX; CELL-CYCLE REGULATION; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; FISSION YEAST; XENOPUS; SYSTEM; INITIATION	Replication licensing factor (RLF) is a multiprotein complex involved in ensuring that chromosomal DNA replicates only once in a single cell cycle. It comprises two components, termed RLF-M and RLF-B. Purified RLF-M consists of a mixture of complexes containing all six members of the MCM/P1 family of minichromosome maintenance proteins. The precise composition of these different complexes and their contribution to RLF-M activity has been unclear. Here we show that in Xenopus extracts, MCM/P1 proteins mainly form heterohexamers containing each of the six proteins. This heterohexamer is readily split into subcomplexes, whose interactions and subunit composition we characterize in detail. We show for the first time an ordered multistep assembly pathway by which the heterohexamer can be reformed from the subcomplexes. Importantly, this novel pathway is essential for DNA replication, since only the full heterohexamer can bind productively to chromatin and provide RLF-M activity.	Univ Dundee, Canc Res Campaign Chromosome Replicat Res Grp, Dept Biochem, Dundee DD1 5EH, Scotland	University of Dundee	Blow, JJ (corresponding author), Univ Dundee, Canc Res Campaign Chromosome Replicat Res Grp, Dept Biochem, Dundee DD1 5EH, Scotland.		Blow, J. Julian/B-3977-2009	Blow, J. Julian/0000-0002-9524-5849; Prokhorova, Tatyana/0000-0001-8768-8298	Cancer Research UK [A2335, A2793] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Adachi Y, 1997, GENES CELLS, V2, P467, DOI 10.1046/j.1365-2443.1997.1350333.x; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; BUCCI E, 1965, J MOL BIOL, V12, P183, DOI 10.1016/S0022-2836(65)80292-3; BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Chong JPJ, 1997, METHOD ENZYMOL, V283, P549; Chong JPJ, 1996, TRENDS BIOCHEM SCI, V21, P102, DOI 10.1016/0968-0004(96)10013-X; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; ISHIMI Y, 1996, J BIOL CHEM, V271, P24111; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kimura H, 1996, GENES CELLS, V1, P977, DOI 10.1046/j.1365-2443.1996.840284.x; KIMURA H, 1994, EMBO J, V13, P4311, DOI 10.1002/j.1460-2075.1994.tb06751.x; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; Krude T, 1996, J CELL SCI, V109, P309; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Kubota Y, 1997, EMBO J, V16, P3320, DOI 10.1093/emboj/16.11.3320; Lei M, 1996, MOL CELL BIOL, V16, P5081; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; MAINE GT, 1984, GENETICS, V106, P365; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; MUSAHL C, 1995, EUR J BIOCHEM, V230, P1096, DOI 10.1111/j.1432-1033.1995.tb20660.x; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; Poddar A, 1999, MOL MICROBIOL, V31, P349, DOI 10.1046/j.1365-2958.1999.01179.x; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Richter A, 1997, EUR J BIOCHEM, V247, P136, DOI 10.1111/j.1432-1033.1997.00136.x; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Rowles A, 1999, J CELL SCI, V112, P2011; Roy N, 1997, CURR GENET, V32, P182, DOI 10.1007/s002940050264; Sanyal K, 1998, MOL GEN GENET, V260, P242, DOI 10.1007/s004380050892; SCHUTZ E, 1996, Z GERMANISTIK, V6, P235; Sherman DA, 1998, NUCLEIC ACIDS RES, V26, P3955, DOI 10.1093/nar/26.17.3955; Sherman DA, 1998, MOL BIOL CELL, V9, P1833, DOI 10.1091/mbc.9.7.1833; Sible JC, 1998, CURR BIOL, V8, P347, DOI 10.1016/S0960-9822(98)70136-8; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Su TT, 1996, MOL BIOL CELL, V7, P319, DOI 10.1091/mbc.7.2.319; Su TT, 1997, J CELL BIOL, V139, P13, DOI 10.1083/jcb.139.1.13; Tada S, 1999, CURR BIOL, V9, P211, DOI 10.1016/S0960-9822(99)80092-X; Tada S, 1998, BIOL CHEM, V379, P941; THOMMES P, 1992, NUCLEIC ACIDS RES, V20, P1069, DOI 10.1093/nar/20.5.1069; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; TODOROV IT, 1995, J CELL BIOL, V129, P1433, DOI 10.1083/jcb.129.6.1433; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149	53	90	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2491	2498		10.1074/jbc.275.4.2491	http://dx.doi.org/10.1074/jbc.275.4.2491			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644704	Green Accepted, hybrid			2022-12-27	WOS:000085128000036
J	Puga, A; Barnes, SJ; Dalton, TP; Chang, CY; Knudsen, ES; Maier, MA				Puga, A; Barnes, SJ; Dalton, TP; Chang, CY; Knudsen, ES; Maier, MA			Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIBENZO-P-DIOXINS; AH-RECEPTOR; LACTATIONAL EXPOSURE; HUMAN KERATINOCYTES; GENE-EXPRESSION; HEPATOMA-CELLS; MALE-RATS; ESTROGEN-RECEPTOR; CANCER MORTALITY; IN-UTERO	Polyhalogenated aromatic hydrocarbons, of which 2,3,7,8-tetrachloro-p-dioxin (TCDD) is the prototype compound, elicit a variety of toxic, teratogenic, and carcinogenic responses in exposed animals and in humans. In cultured cells, TCDD shows marked effects on the regulation of cell cycle progression, including thymocyte apoptosis, induction of keratinocyte proliferation and terminal differentiation, and inhibition of estrogen-dependent proliferation in breast cancer cells, The presence of an LXCXE domain in the dioxin aromatic hydrocarbon receptor (AHR), suggested that the effects of TCDD on cell cycle regulation might be mediated by protein-protein interactions between AHR and the retinoblastoma protein (RB), Using the yeast two-hybrid system, AHR and RE were in fact shown to bind to each other, In vitro pull-down experiments with truncated AHR peptides indicated that at least two separate AHR domains form independent complexes with hypophosphorylated RE. Coimmunoprecipitation of whole cell lysates from human breast carcinoma MCF-7 cells, which express both proteins endogenously, revealed that AHR associates with RE in vivo only after receptor transformation and nuclear translocation. However, the AHR nuclear translocator and transcriptional heterodimerization partner, is not required for (nor is it a part of) the AHR RB complexes detected in vitro. Ectopic expression of AHR and RE in human osteosarcoma SAOS-2 cells, which lack endogenous expression of both proteins, showed that AHR synergizes with RE to repress E2F-dependent transcription and to induce cell cycle arrest. Furthermore, AHR partly blocked T-antigen-mediated reversal of RE-dependent transcriptional repression. These results uncover a potential function for the AHR in cell cycle regulation and suggest that this function may be that of serving as an environmental sensor that signals eel cycle arrest when cells are exposed to certain environmental toxicants.	Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA; Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Med Ctr, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Puga, A (corresponding author), Univ Cincinnati, Med Ctr, Ctr Environm Genet, POB 670056, Cincinnati, OH 45267 USA.	Alvaro.Puga@UC.EDU	Puga, Alvaro/B-7676-2008		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES006273, R01ES006273, P30ES006096] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES06273, P30 ES06096] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbott BD, 1995, TOXICOLOGY, V105, P365, DOI 10.1016/0300-483X(95)03234-7; BERNHARD HP, 1973, DEV BIOL, V35, P83, DOI 10.1016/0012-1606(73)90008-0; BERTAZZI PA, 1991, SCI TOTAL ENVIRON, V106, P5, DOI 10.1016/0048-9697(91)90016-8; BJERKE DL, 1994, TOXICOL APPL PHARM, V127, P241, DOI 10.1006/taap.1994.1158; BJERKE DL, 1994, TOXICOL APPL PHARM, V127, P258, DOI 10.1006/taap.1994.1160; BOWES RC, 1995, ARCH BIOCHEM BIOPHYS, V323, P243, DOI 10.1006/abbi.1995.9968; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Carver LA, 1997, J BIOL CHEM, V272, P11452; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; CHOI EJ, 1991, J BIOL CHEM, V266, P9591; COUMAILLEAU P, 1995, J BIOL CHEM, V270, P25291, DOI 10.1074/jbc.270.42.25291; Cummings AM, 1996, TOXICOL APPL PHARM, V138, P131, DOI 10.1006/taap.1996.0106; DEVITO MJ, 1995, TOXICOLOGY, V102, P115, DOI 10.1016/0300-483X(95)03040-M; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; FINGERHUT MA, 1991, NEW ENGL J MED, V324, P212, DOI 10.1056/NEJM199101243240402; FLESCHJANYS D, 1995, AM J EPIDEMIOL, V142, P1165, DOI 10.1093/oxfordjournals.aje.a117575; FLODSTROM S, 1991, FUND APPL TOXICOL, V16, P375, DOI 10.1016/0272-0590(91)90122-K; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; GAIDO KW, 1992, J BIOL CHEM, V267, P24591; GAIDO KW, 1994, TOXICOL APPL PHARM, V127, P199, DOI 10.1006/taap.1994.1154; Ge NL, 1998, J BIOL CHEM, V273, P22708, DOI 10.1074/jbc.273.35.22708; GOTTLICHER M, 1987, CARCINOGENESIS, V8, P1021, DOI 10.1093/carcin/8.7.1021; Guiney PD, 1997, TOXICOL APPL PHARM, V143, P256, DOI 10.1006/taap.1996.8051; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Herrera RE, 1996, MOL BIOL CELL, V7, P1335, DOI 10.1091/mbc.7.9.1335; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hornug MW, 1999, TOXICOL SCI, V47, P40, DOI 10.1093/toxsci/47.1.40; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kamath AB, 1997, TOXICOL APPL PHARM, V142, P367, DOI 10.1006/taap.1996.8049; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; KERKVLIET NI, 1990, TOXICOL APPL PHARM, V105, P26, DOI 10.1016/0041-008X(90)90356-Y; Kerkvliet NI, 1995, ENVIRON HEALTH PERSP, V103, P47, DOI 10.2307/3432722; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Knudsen ES, 1998, ONCOGENE, V16, P1655, DOI 10.1038/sj.onc.1201682; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; KNUTSON JC, 1982, CELL, V30, P225, DOI 10.1016/0092-8674(82)90028-9; KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Ma Q, 1997, J BIOL CHEM, V272, P8878; Ma Q, 1996, MOL CELL BIOL, V16, P2144; MABLY TA, 1992, TOXICOL APPL PHARM, V114, P118, DOI 10.1016/0041-008X(92)90103-Y; Maier A, 1998, ENVIRON HEALTH PERSP, V106, P421, DOI 10.2307/3434070; MANZ A, 1991, LANCET, V338, P959, DOI 10.1016/0140-6736(91)91835-I; MCCONKEY DJ, 1989, BIOCHEM BIOPH RES CO, V160, P1003, DOI 10.1016/S0006-291X(89)80101-9; MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923; MILSTONE LM, 1984, J INVEST DERMATOL, V82, P532, DOI 10.1111/1523-1747.ep12261149; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Moolgavkar SH, 1996, TOXICOL APPL PHARM, V138, P31, DOI 10.1006/taap.1996.0094; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; OUGHTON JA, 1995, FUND APPL TOXICOL, V25, P60, DOI 10.1006/faat.1995.1040; POLAND A, 1982, NATURE, V300, P271, DOI 10.1038/300271a0; Reiners JJ, 1999, J BIOL CHEM, V274, P2502, DOI 10.1074/jbc.274.4.2502; RININGER J, 1995, P 15 INT S CHLOR DIO, V25, P367; Rorke EA, 1998, INT J ONCOL, V13, P557; Rowlands JC, 1996, MOL PHARMACOL, V50, P538; SAFE SH, 1995, PHARMACOL THERAPEUT, V67, P247, DOI 10.1016/0163-7258(95)00017-B; Strober BE, 1996, MOL CELL BIOL, V16, P1576; SUSKIND RR, 1985, SCAND J WORK ENV HEA, V11, P165, DOI 10.5271/sjweh.2240; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; VANDENHEUVEL JP, 1993, ENVIRON HEALTH PERSP, V100, P189, DOI 10.1289/ehp.93100189; WANG JYJ, 1994, ADV CANCER RES, V64, P25, DOI 10.1016/S0065-230X(08)60834-9; Wang JYJ, 1997, CURR OPIN GENET DEV, V7, P39, DOI 10.1016/S0959-437X(97)80107-4; Wang WL, 1998, ARCH BIOCHEM BIOPHYS, V356, P239, DOI 10.1006/abbi.1998.0782; Weber TJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P227, DOI 10.1006/abbi.1996.0167; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Whitaker LL, 1998, MOL CELL BIOL, V18, P4032, DOI 10.1128/MCB.18.7.4032; WIEBEL FJ, 1991, TOXICOL LETT, V55, P161, DOI 10.1016/0378-4274(91)90130-X; WOLFLE D, 1993, CELL BIOL TOXICOL, V9, P15, DOI 10.1007/BF00755137; Worner W, 1996, CANCER RES, V56, P1272	80	243	260	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2943	2950		10.1074/jbc.275.4.2943	http://dx.doi.org/10.1074/jbc.275.4.2943			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644764	hybrid			2022-12-27	WOS:000085128000096
J	van der Does, C; Swaving, J; van Klompenburg, W; Driessen, AJM				van der Does, C; Swaving, J; van Klompenburg, W; Driessen, AJM			Non-bilayer lipids stimulate the activity of the reconstituted bacterial protein translocase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVELY CHARGED PHOSPHOLIPIDS; COLI PREPROTEIN TRANSLOCASE; ESCHERICHIA-COLI; ANIONIC PHOSPHOLIPIDS; PRECURSOR PROTEIN; SECA PROTEIN; BACILLUS-SUBTILIS; SIGNAL SEQUENCE; ACIDIC PHOSPHOLIPIDS; MEMBRANE-VESICLES	To determine the phospholipid requirement of the preprotein translocase in vitro, the Escherichia coli SecYEG complex was purified in a delipidated form using the detergent dodecyl maltoside, SecYEG was reconstituted into liposomes composed of defined synthetic phospholipids, and proteoliposomes were analyzed for their preprotein translocation and SecA translocation ATPase activity. The activity strictly required the presence of anionic phospholipids, whereas the non-bilayer lipid phosphatidylethanolamine was found stimulatory. The latter effect could also be induced by dioleoylglycerol, a lipid that adopts a non-bilayer conformation, Phosphatidylethanolamine derivatives that prefer the bilayer state were unable to stimulate translocation, In the absence of SecG, activity was reduced, but the phospholipid requirement was unaltered. Remarkably, nonbilayer lipids were found essential for the activity of the Bacillus subtilis SecYEG complex. Optimal activity required a mixture of anionic and non-bilayer Lipids at concentrations that correspond to concentrations found in the natural membrane.	Univ Groningen, Dept Microbiol, NL-9751 NN Haren, Netherlands; Univ Groningen, Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Dept Microbiol, Kerklaan 30, NL-9751 NN Haren, Netherlands.	A.J.M.DRIESSEN@BIOL.RUG.NL	Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104				AKIMARU J, 1991, P NATL ACAD SCI USA, V88, P6545, DOI 10.1073/pnas.88.15.6545; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; BRUNDAGE L, 1992, J BIOL CHEM, V267, P4166; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN CC, 1984, J BIOL CHEM, V259, P150; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; DRIESSEN AJM, 1988, BIOCHEMISTRY-US, V27, P865, DOI 10.1021/bi00403a005; DRIESSEN AJM, 1990, P NATL ACAD SCI USA, V87, P3107, DOI 10.1073/pnas.87.8.3107; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Eichler J, 1997, EMBO J, V16, P2188, DOI 10.1093/emboj/16.9.2188; ELLENS H, 1986, BIOCHEMISTRY-US, V25, P4141, DOI 10.1021/bi00362a023; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KELLER RCA, 1992, BIOCHEMISTRY-US, V31, P1672, DOI 10.1021/bi00121a014; Keller RCA, 1996, BIOCHEMISTRY-US, V35, P3063, DOI 10.1021/bi951870+; KONTINEN VP, 1995, FEBS LETT, V364, P157, DOI 10.1016/0014-5793(95)00378-M; Kontinen VP, 1996, FEBS LETT, V389, P281, DOI 10.1016/0014-5793(96)00602-3; KRULWICH TA, 1987, J BACTERIOL, V169, P4479, DOI 10.1128/jb.169.10.4479-4485.1987; KUSTERS R, 1992, FEBS LETT, V308, P97, DOI 10.1016/0014-5793(92)81060-Y; KUSTERS R, 1991, J BIOL CHEM, V266, P8659; LEENHOUTS JM, 1995, FEBS LETT, V370, P189, DOI 10.1016/0014-5793(95)00823-R; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; Meyer TH, 1999, J MOL BIOL, V285, P1789, DOI 10.1006/jmbi.1998.2413; MULUKUTLA S, 1984, BIOCHEMISTRY-US, V23, P2514, DOI 10.1021/bi00306a030; PHOENIX DA, 1993, J BIOL CHEM, V268, P17069; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; RIETVELD AG, 1993, J BIOL CHEM, V268, P12427; RIETVELD AG, 1994, J BIOL CHEM, V269, P28670; RIETVELD AG, 1995, EMBO J, V14, P5506, DOI 10.1002/j.1460-2075.1995.tb00237.x; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SETOYOUNG D, 1985, J MEMBRANE BIOL, V84, P259, DOI 10.1007/BF01871389; Shimizu H, 1997, MOL MICROBIOL, V26, P1013, DOI 10.1046/j.1365-2958.1997.6392003.x; Suzuki H, 1999, J BIOL CHEM, V274, P31020, DOI 10.1074/jbc.274.43.31020; Swaving J, 1999, J BACTERIOL, V181, P7021, DOI 10.1128/JB.181.22.7021-7027.1999; TOKUDA H, 1990, EUR J BIOCHEM, V192, P583, DOI 10.1111/j.1432-1033.1990.tb19264.x; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; van Klompenburg W, 1998, J MEMBRANE BIOL, V162, P1, DOI 10.1007/s002329900336; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; Van Wely KHM, 1998, EUR J BIOCHEM, V255, P690, DOI 10.1046/j.1432-1327.1998.2550690.x; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; vanRaalte ALJ, 1996, EUR J BIOCHEM, V235, P207; WEIS SJB, 1998, P NATL ACAD SCI USA, V85, P8978; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514	56	94	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2472	2478		10.1074/jbc.275.4.2472	http://dx.doi.org/10.1074/jbc.275.4.2472			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644701	Green Published, hybrid			2022-12-27	WOS:000085128000033
J	Murata, M; Kawanishi, S				Murata, M; Kawanishi, S			Oxidative DNA damage by vitamin A and its derivative via superoxide generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXYL RADICAL FORMATION; OXYGEN PARTIAL-PRESSURE; BETA-CAROTENE; ALPHA-TOCOPHEROL; LUNG-CANCER; PROOXIDANT PROPERTIES; HYDROGEN-PEROXIDE; RETINOL; ANTIOXIDANT; ACID	Recent intervention studies revealed that beta-carotene supplement to smokers resulted in a higher incidence of lung cancer. However, the causal mechanisms remain to be clarified. We reported here that vitamin A (retinol) and its derivative (retinal) caused cellular DNA cleavage detected by pulsed field gel electrophoresis. Retinol and retinal significantly induced 8-oxo-7,8-dihydro-2'-deoxyguanosine formation in HL-60 cells but not in H(2)O(2)-resistant HP100 cells, suggesting the involvement of H(2)O(2) in cellular DNA damage. Experiments using (32)P-labeled isolated DNA demonstrated that retinol and retinal caused Cu(II)-mediated DNA damage, which was inhibited by catalase. W-visible spectroscopic and electron spin resonance-trapping studies revealed the generation of superoxide and carbon-centered radicals, respectively. The superoxide generation during autoxidation of retinoids was significantly correlated with the formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine, although the yield of carbon-centered radicals was not necessarily related to the intensity of DNA damage. These findings suggest that superoxide generated by autoxidation of retinoids was dismutated to H(2)O(2), which was responsible for DNA damage in the presence of endogenous metals. Retinol and retinal have prooxidant abilities, which might lead to carcinogenesis of the supplements of beta-carotene.	Mie Univ, Sch Med, Dept Hyg, Tsu, Mie 5148507, Japan	Mie University	Kawanishi, S (corresponding author), Mie Univ, Sch Med, Dept Hyg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	kawanisi@doc.medic.mie-u.ac.jp						Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Badr FM, 1998, MUTAT RES-GEN TOX EN, V414, P157, DOI 10.1016/S1383-5718(98)00038-2; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Burkitt MJ, 1996, FEBS LETT, V379, P51, DOI 10.1016/0014-5793(95)01481-0; BURKITT MJ, 1994, METHOD ENZYMOL, V234, P66; BURTON GW, 1984, SCIENCE, V224, P569, DOI 10.1126/science.6710156; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CELANDER DW, 1990, BIOCHEMISTRY-US, V29, P1355, DOI 10.1021/bi00458a001; Chen YQ, 1999, CANCER RES, V59, P3985; Collins AR, 1998, CARCINOGENESIS, V19, P2159, DOI 10.1093/carcin/19.12.2159; Duthie SJ, 1997, MUTAT RES-GEN TOX EN, V390, P141, DOI 10.1016/S0165-1218(97)00010-4; Freyaldenhoven MA, 1998, CHEM RES TOXICOL, V11, P102, DOI 10.1021/tx970044u; Giri U, 1996, CARCINOGENESIS, V17, P2023, DOI 10.1093/carcin/17.9.2023; Halliwell B, 1999, MUTAT RES-GEN TOX EN, V443, P37, DOI 10.1016/S1383-5742(99)00009-5; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Herbert V, 1996, J NUTR, V126, pS1197, DOI 10.1093/jn/126.suppl_4.1197S; INOUE S, 1992, CARCINOGENESIS, V13, P1497, DOI 10.1093/carcin/13.9.1497; ITO K, 1992, BIOCHEMISTRY-US, V31, P11606, DOI 10.1021/bi00161a046; ITO K, 1993, J BIOL CHEM, V268, P13221; KASUGAI I, 1992, LEUKEMIA RES, V16, P173, DOI 10.1016/0145-2126(92)90129-U; Kensler T, 1995, Prog Clin Biol Res, V391, P103; KUROKAWA Y, 1985, J NATL CANCER I, V74, P715; Lowe GM, 1999, FREE RADICAL RES, V30, P141, DOI 10.1080/10715769900300151; Maxam A M, 1980, Methods Enzymol, V65, P499; Murata M, 1999, CARCINOGENESIS, V20, P851, DOI 10.1093/carcin/20.5.851; Oikawa S, 1999, CARCINOGENESIS, V20, P1485, DOI 10.1093/carcin/20.8.1485; Olson JA, 1996, J NUTR, V126, pS1208, DOI 10.1093/jn/126.suppl_4.1208S; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Palozza P, 1997, FREE RADICAL BIO MED, V22, P1065, DOI 10.1016/S0891-5849(96)00498-4; Pappalardo G, 1997, EUR J CLIN NUTR, V51, P661, DOI 10.1038/sj.ejcn.1600457; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; PRYOR WA, 1978, BIOCHEM BIOPH RES CO, V81, P498, DOI 10.1016/0006-291X(78)91562-0; Rehman A, 1998, BIOCHEM BIOPH RES CO, V246, P293, DOI 10.1006/bbrc.1998.8592; REID TM, 1993, P NATL ACAD SCI USA, V90, P3904, DOI 10.1073/pnas.90.9.3904; Rodriguez-Burford C, 1999, CARCINOGENESIS, V20, P71, DOI 10.1093/carcin/20.1.71; SLAGA TJ, 1995, ADV EXP MED BIOL, V369, P167; Tada-Oikawa S, 1999, FEBS LETT, V442, P65, DOI 10.1016/S0014-5793(98)01618-4; Tesoriere L, 1997, ARCH BIOCHEM BIOPHYS, V343, P13, DOI 10.1006/abbi.1997.0128; VILE GF, 1988, FEBS LETT, V238, P353, DOI 10.1016/0014-5793(88)80511-8; WILLETT WC, 1984, NEW ENGL J MED, V310, P633, DOI 10.1056/NEJM198403083101006; YAMAMOTO K, 1989, J BIOL CHEM, V264, P15435; Yamashita N, 1998, CHEM RES TOXICOL, V11, P855, DOI 10.1021/tx970129v; Yamashita N, 1999, MUTAT RES-FUND MOL M, V425, P107, DOI 10.1016/S0027-5107(99)00029-9; Yamashita N, 1998, MUTAT RES-FUND MOL M, V397, P191, DOI 10.1016/S0027-5107(97)00210-8; YOUNG IS, 1995, FREE RADICAL BIO MED, V18, P833, DOI 10.1016/0891-5849(94)00202-U	46	156	162	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2003	2008		10.1074/jbc.275.3.2003	http://dx.doi.org/10.1074/jbc.275.3.2003			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636903	hybrid			2022-12-27	WOS:000084940000066
J	Shu, W; Ji, H; Lu, M				Shu, W; Ji, H; Lu, M			Interactions between HIV-1 gp41 core and detergents and their implications for membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; ENVELOPE GLYCOPROTEIN; TRANSMEMBRANE GLYCOPROTEIN; CIRCULAR-DICHROISM; LIPID INTERACTIONS; ATOMIC-STRUCTURE; CONFORMATION; PEPTIDE; MODEL; PH	The gp41 envelope protein mediates entry of human immunodeficiency virus type 1 (HIV-1) into the cell by promoting membrane fusion, The crystal structure of a gp41 ectodomain core in its fusion-active state is a six-helix bundle in which a N-terminal trimeric coiled coil is surrounded by three C-terminal outer helices in an antiparallel orientation. Here we demonstrate that the N34(L6)C28 model of the gp41 core is stabilized by interaction with the ionic detergent sodium dodecyl sulfate (SDS) or the nonionic detergent n-octyl-beta-D-glucopyranoside (beta OG), The high resolution x-ray structures of N34(L6)C28 crystallized from two different detergent micellar media reveal a six-helix bundle conformation very similar to that of the molecule in water. Moreover, N34(L6)C28 adopts a highly alpha-helical conformation in lipid vesicles. Taken together, these results suggest that the six-helix bundle of the gp41 core displays substantial affinity for lipid bilayers rather than unfolding in the membrane environment. This characteristic may be important for formation of the fusion-active gp41 core structure and close apposition of the viral and cellular membranes for fusion.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Lu, M (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	mlu@mail.med.cornell.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042382, R01AI042382, R21AI042382] Funding Source: NIH RePORTER; NIAID NIH HHS [AI42382] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBER J, 1989, NATURE, V340, P601, DOI 10.1038/340601a0; BLUMENTHAL R, 1983, J BIOL CHEM, V258, P3409; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CANTOR C, 1980, BIOPHYSICAL CHEM 3, P1131; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen J, 1995, P NATL ACAD SCI USA, V92, P12205, DOI 10.1073/pnas.92.26.12205; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; GLAESER RM, 1985, BIOCHEMISTRY-US, V24, P6398, DOI 10.1021/bi00344a012; GORDON LM, 1992, BIOCHIM BIOPHYS ACTA, V1139, P257, DOI 10.1016/0925-4439(92)90099-9; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; HOYT DW, 1991, BIOCHEMISTRY-US, V30, P10155, DOI 10.1021/bi00106a012; Hughson FM, 1997, CURR BIOL, V7, pR565, DOI 10.1016/S0960-9822(06)00283-1; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Judice JK, 1997, P NATL ACAD SCI USA, V94, P13426, DOI 10.1073/pnas.94.25.13426; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LI SC, 1994, NAT STRUCT BIOL, V1, P368, DOI 10.1038/nsb0694-368; LI SC, 1993, J BIOL CHEM, V268, P22975; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Luciw PA, 1996, FIELD VIROLOGY, P1881; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiao H, 1998, J CELL BIOL, V141, P1335, DOI 10.1083/jcb.141.6.1335; RABENSTEIN M, 1995, BIOCHEMISTRY-US, V34, P13390, DOI 10.1021/bi00041a016; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; ROTERING BV, 1976, EUR J BIOCHEM, V740, P601; ROTH M, 1989, NATURE, V340, P659, DOI 10.1038/340659a0; Shu W, 1999, BIOCHEMISTRY-US, V38, P5378, DOI 10.1021/bi990199w; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; STEGMANN T, 1991, J BIOL CHEM, V266, P18404; STEGMANN T, 1993, VIRAL FUSION MECHANI, P89; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; TSURUDOME M, 1992, J BIOL CHEM, V267, P20225; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; VANDEVEN FJM, 1993, BIOCHEMISTRY-US, V32, P8322, DOI 10.1021/bi00083a036; WALLACE BA, 1984, ANAL BIOCHEM, V142, P317, DOI 10.1016/0003-2697(84)90471-8; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; YU YG, 1994, SCIENCE, V266, P274, DOI 10.1126/science.7939662	55	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1839	1845		10.1074/jbc.275.3.1839	http://dx.doi.org/10.1074/jbc.275.3.1839			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636883	hybrid			2022-12-27	WOS:000084940000046
J	Gorbea, C; Taillandier, D; Rechsteiner, M				Gorbea, C; Taillandier, D; Rechsteiner, M			Mapping subunit contacts in the regulatory complex of the 26 S proteasome - S2 and S5b form a tetramer with ATPase subunits S4 and S7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; RABBIT RETICULOCYTE LYSATE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; MULTICATALYTIC PROTEASE; PROTEOLYTIC COMPLEX; FUNCTIONAL-ANALYSIS; 20S PROTEASOME; COILED COILS; CDNA CLONING	The 19 S regulatory complex (RC) of the 26 S proteasome is composed of at least 18 different subunits, including six ATPases that form specific pairs S4-S7, S6-S8, and S6'-S10b in vitro, One of the largest regulatory complex subunits, S2, was translated in reticulocyte lysate containing [S-35]methionine and used to probe membranes containing SDS-polyacrylamide gel electrophoresis separated RC subunits, S2 bound to two ATPases, S4 and S7. Association of S2 with regulatory complex subunits was also assayed by co-translation and sedimentation. S2 formed an immunoprecipitable heterotrimer upon co-translation with S4 and S7. The non-ATPase S5b also formed a ternary complex with S4 and S7 and the three proteins assembled into a tetramer with S2, Neither S2 nor S5b formed complexes with S6'-S10b dimers or with S6-S8 oligomers, The use of chimeric ATPases demonstrated that S2 binds the NH2-terminal region of S4 and the COOH-terminal two-thirds of S7, Conversely, S5b binds the COOH-terminal two-thirds of S4 and to S7's NH2-terminal region. The demonstrated association of S2 with ATPases in the mammalian 19 S regulatory complex is consistent with and extends the recent finding that the yeast RC is composed of two subcomplexes, the lid and the base. (Glickman, M. H., Rubin, D. M., Coux, O., Wefes, I., Pfeifer, G., Cejka, Z., Baumeister, W., Fried, V. A., and Finley, D. (1998) Cell 94, 615-623).	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Rechsteiner, M (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA.	rechsteiner@mailman.med.utah.edu		Taillandier, Daniel/0000-0003-4520-0551	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037009] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37009] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beninga J, 1998, UBIQUITIN BIOL CELL, P191; CHEN ZJ, 1998, UBIQUITIN BIOL CELL, P303; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Ferreira PA, 1998, J BIOL CHEM, V273, P24676, DOI 10.1074/jbc.273.38.24676; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; HARLOW E, 1988, ANTIBODIES LABORATOR, P464; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HOFFMAN L, 1994, J BIOL CHEM, V269, P16890; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; HOUGH R, 1986, J BIOL CHEM, V261, P2400; HOUGH R, 1987, J BIOL CHEM, V262, P8303; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MA CP, 1994, J BIOL CHEM, V269, P3539; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Penney M, 1998, J BIOL CHEM, V273, P23938, DOI 10.1074/jbc.273.37.23938; PETERS JM, 1994, J BIOL CHEM, V269, P7709; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RECHSTEINER M, 1998, UBIQUITIN BIOL CELL, P147; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Saito A, 1997, GENE, V203, P241, DOI 10.1016/S0378-1119(97)00524-6; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Tanaka K, 1998, IMMUNOL REV, V163, P161; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsurumi C, 1996, EUR J BIOCHEM, V239, P912, DOI 10.1111/j.1432-1033.1996.0912u.x; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768	59	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					875	882		10.1074/jbc.275.2.875	http://dx.doi.org/10.1074/jbc.275.2.875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625621	Green Published, hybrid			2022-12-27	WOS:000084836600025
J	Cartee, RT; Forsee, WT; Schutzbach, JS; Yother, J				Cartee, RT; Forsee, WT; Schutzbach, JS; Yother, J			Mechanism of type 3 capsular polysaccharide synthesis in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATED TERATOCARCINOMA CELLS; CHITIN SYNTHASE; BIOSYNTHESIS; GENE; HYALURONAN; IDENTIFICATION; SEQUENCE; PROTEIN; LOCUS; SEROTYPE-14	The glycosidic linkages of the type 3 capsular polysaccharide of Streptococcus pneumoniae ([3)-beta-D-GlcUA-(1-->4)-beta-D-Glc-(1-->](n)) are formed by the membrane-associated type 3 synthase (Cps3S), which is capable of synthesizing polymer from UDP sugar precursors. Using membrane preparations of S, pneumoniae in an in vitro assay, we observed type 3 synthase activity in the presence of either Mn2+ or Mg2+ with maximal levels seen with 10-20 mM Mn2+. High molecular weight polymer synthesized in the assay was composed of Glc and glucuronic acid and could be degraded to a low molecular weight product by a type 3-specific depolymerase from Bacillus circulans, Additionally, the polymer bound specifically to an affinity column made with a type 3 polysaccharide-specific monoclonal antibody. The polysaccharide was rapidly synthesized from smaller chains and remained associated with the enzyme-containing membrane fraction throughout its synthesis, indicating a processive mechanism of synthesis. Release of the polysaccharide was observed, however, when the level of one of the substrates became limiting. Finally, addition of sugars to the growing type 3 polysaccharide was shown to occur at the nonreducing end of the polysaccharide chain.	Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Yother, J (corresponding author), Univ Alabama, Dept Microbiol, BBRB 661-12,845 19th St S, Birmingham, AL 35294 USA.				NHLBI NIH HHS [T32HL07553] Funding Source: Medline; NIGMS NIH HHS [GM53017] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053017] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arrecubieta C, 1996, J EXP MED, V184, P449, DOI 10.1084/jem.184.2.449; Arrecubieta C, 1995, GENE, V167, P1, DOI 10.1016/0378-1119(95)00657-5; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; BRILES DE, 1981, NATURE, V294, P88, DOI 10.1038/294088a0; BULAWA CE, 1986, CELL, V46, P213, DOI 10.1016/0092-8674(86)90738-5; Caimano MJ, 1998, MICROB DRUG RESIST, V4, P11, DOI 10.1089/mdr.1998.4.11; CHENWU JL, 1992, MOL MICROBIOL, V6, P497, DOI 10.1111/j.1365-2958.1992.tb01494.x; DeAngelis PL, 1999, J BIOL CHEM, V274, P26557, DOI 10.1074/jbc.274.37.26557; DEANGELIS PL, 1993, J BIOL CHEM, V268, P19181; DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568; DeAngelis PL, 1996, J BIOL CHEM, V271, P23657, DOI 10.1074/jbc.271.39.23657; DEENLEYSIDE WJ, 1997, J BIOL CHEM, V271, P28581; DILLARD JP, 1994, MOL MICROBIOL, V12, P959, DOI 10.1111/j.1365-2958.1994.tb01084.x; DILLARD JP, 1995, J EXP MED, V181, P973, DOI 10.1084/jem.181.3.973; GARDNER KH, 1974, BIOPOLYMERS, V13, P1975, DOI 10.1002/bip.1974.360131005; GEREMIA RA, 1994, P NATL ACAD SCI USA, V91, P2669, DOI 10.1073/pnas.91.7.2669; GUIDOLIN A, 1994, INFECT IMMUN, V62, P5384, DOI 10.1128/IAI.62.12.5384-5396.1994; HEATLEY F, 1988, BIOCHEM J, V254, P489, DOI 10.1042/bj2540489; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; HOPWOOD JJ, 1977, BIOCHEM BIOPH RES CO, V75, P472, DOI 10.1016/0006-291X(77)91066-X; Kolkman MAB, 1997, J BIOL CHEM, V272, P19502, DOI 10.1074/jbc.272.31.19502; Kolkman MAB, 1996, J BACTERIOL, V178, P3736, DOI 10.1128/jb.178.13.3736-3741.1996; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Meyer MF, 1996, P NATL ACAD SCI USA, V93, P4543, DOI 10.1073/pnas.93.10.4543; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Mollerach M, 1998, J EXP MED, V188, P2047, DOI 10.1084/jem.188.11.2047; Munoz R, 1997, MOL MICROBIOL, V25, P79, DOI 10.1046/j.1365-2958.1997.4341801.x; Pigman W.W., 1948, CHEM CARBOHYDRATES; PREHM P, 1983, BIOCHEM J, V211, P181, DOI 10.1042/bj2110181; PREHM P, 1983, BIOCHEM J, V211, P191, DOI 10.1042/bj2110191; Reeves RE, 1941, J BIOL CHEM, V139, P511; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Silakowski B, 1996, J BACTERIOL, V178, P6706, DOI 10.1128/jb.178.23.6706-6713.1996; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SMITH EEB, 1960, J BIOL CHEM, V235, P1876; SPRINGER TA, 1993, CURRENT PROTOCOLS MO; STOOLMILLER AC, 1969, J BIOL CHEM, V244, P236; SUGAHARA K, 1979, J BIOL CHEM, V254, P6252; TORRIANI A, 1962, J BIOL CHEM, V237, P3; TURCO SJ, 1977, J BIOL CHEM, V252, P2918; VANDAM JEG, 1990, ANTON LEEUW INT J G, V58, P1; YOTHER J, 1994, J BACTERIOL, V176, P2976, DOI 10.1128/JB.176.10.2976-2985.1994; ZWEIG G, 1967, PAPER CHROMATOGRAPHY	43	50	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3907	3914		10.1074/jbc.275.6.3907	http://dx.doi.org/10.1074/jbc.275.6.3907			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660543	hybrid			2022-12-27	WOS:000085288800027
J	Cefaratti, C; Romani, A; Scarpa, A				Cefaratti, C; Romani, A; Scarpa, A			Differential localization and operation of distinct Mg2+ transporters in apical and basolateral sides of rat liver plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED BLOOD-CELLS; MAGNESIUM TRANSPORT; STIMULATION; HEPATOCYTES; EXCHANGE; ANTIPORT; MECHANISMS; AMILORIDE; VESICLES; RELEASE	Upon activation of specific cell signaling, hepatocytes rapidly accumulate or release an amount of Mg2+ equivalent to 10% of their total Mg2+ content. Although it is widely accepted that Mg2+ efflux is Na+-dependent, little is known about transporter identity and the overall regulation. Even less is known about the mechanism of cellular Mg2+ uptake. Using sealed and right-sided rat liver plasma membrane vesicles representing either the basolateral (bLPM) or apical (aLPM) domain, it was possible to dissect three different Mg2+ transport mechanisms based upon specific inhibition, localization within the plasma membrane, and directionality, The bLPM: possesses only one Mg2+ transporter, which is strictly Na+-dependent, bi-directional, and not inhibited by amiloride, The aLPM possesses two separate Mg2+ transporters, One, similar to that in the bLPM because it strictly depends on Na+ transport, and it can be differentiated from that of the bLPM because it is unidirectional and fully inhibited by amiloride. The second is a novel Ca2+/Mg2+ exchanger that is unidirectional and inhibited by amiloride and imipramine. Hence, the bLPM transporter may be responsible for the exchange of Mg2+ between hepatocytes and plasma, and vice versa, shown in livers upon specific metabolic stimulation, whereas the aLPM transporters can only extrude Mg2+ into the biliary tract. The dissection of these three distinct pathways and, therefore, the opportunity to study each individually will greatly facilitate further characterization of these transporters and a better understanding of Mg2+ homeostasis.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Scarpa, A (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	axs15@po.cwru.edu		Romani, Andrea/0000-0001-9864-4848	NHLBI NIH HHS [HL 18708] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018708] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BEYENBACH KW, 1990, MAGNESIUM TRACE ELEM, V9, P233; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cefaratti C, 1998, AM J PHYSIOL-CELL PH, V275, pC995, DOI 10.1152/ajpcell.1998.275.4.C995; FERAY JC, 1987, J BIOL CHEM, V262, P5763; FERAY JC, 1988, N-S ARCH PHARMACOL, V338, P332; FLATMAN PW, 1984, J MEMBRANE BIOL, V80, P1, DOI 10.1007/BF01868686; FLATMAN PW, 1991, ANNU REV PHYSIOL, V53, P259, DOI 10.1146/annurev.ph.53.030191.001355; FRENKEL EJ, 1989, J PHYSIOL-LONDON, V414, P385, DOI 10.1113/jphysiol.1989.sp017694; GRUBBS RD, 1987, MAGNESIUM, V6, P113; GUNTHER T, 1985, BIOCHEM BIOPH RES CO, V130, P540, DOI 10.1016/0006-291X(85)90450-4; GUNTHER T, 1992, FEBS LETT, V297, P132, DOI 10.1016/0014-5793(92)80343-F; GUNTHER T, 1993, MINER ELECTROL METAB, V19, P259; Gunzel D, 1996, J PHYSIOL-LONDON, V491, P595, DOI 10.1113/jphysiol.1996.sp021242; ISMAILBEIGI F, 1971, J GEN PHYSIOL, V57, P710, DOI 10.1085/jgp.57.6.710; KANT JA, 1972, NATURE-NEW BIOL, V240, P26, DOI 10.1038/newbio240026a0; KEENAN D, 1995, CIRC RES, V77, P973, DOI 10.1161/01.RES.77.5.973; LUDI H, 1987, J PHYSIOL-LONDON, V390, P367; MAGUIRE ME, 1988, ANN NY ACAD SCI, V551, P201, DOI 10.1111/j.1749-6632.1988.tb22338.x; MOORE EW, 1990, HEPATOLOGY, V12, pS206; MOSELEY RH, 1986, AM J PHYSIOL, V250, pG35, DOI 10.1152/ajpgi.1986.250.1.G35; PRPIC V, 1984, J BIOL CHEM, V259, P1382; RESNICK LM, 1992, J AM SOC NEPHROL, V3, pS78; ROMANI A, 1992, FEBS LETT, V296, P135, DOI 10.1016/0014-5793(92)80364-M; ROMANI A, 1991, J BIOL CHEM, V266, P24376; ROMANI A, 1993, J BIOL CHEM, V268, P15489; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; ROMANI A, 1993, CIRC RES, V72, P1139, DOI 10.1161/01.RES.72.6.1139; ROMANI A, 1990, NATURE, V346, P841, DOI 10.1038/346841a0; SCHELL MJ, 1992, J CELL BIOL, V119, P1173, DOI 10.1083/jcb.119.5.1173; SHIFFMAN ML, 1992, J LAB CLIN MED, V120, P875; STECK TL, 1970, SCIENCE, V168, P255, DOI 10.1126/science.168.3928.255; Sun AQ, 1998, AM J PHYSIOL-GASTR L, V275, pG1045, DOI 10.1152/ajpgi.1998.275.5.G1045; Tessman PA, 1998, AM J PHYSIOL-GASTR L, V275, pG1106, DOI 10.1152/ajpgi.1998.275.5.G1106; WALKER GM, 1986, MAGNESIUM, V5, P9; WEBLING DD, 1966, BIOCHEM J, V100, P652, DOI 10.1042/bj1000652; WOLTERS H, 1991, BIOCHIM BIOPHYS ACTA, V1069, P61, DOI 10.1016/0005-2736(91)90104-G	37	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3772	3780		10.1074/jbc.275.6.3772	http://dx.doi.org/10.1074/jbc.275.6.3772			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660526	hybrid			2022-12-27	WOS:000085288800010
J	Petersen, C; Moller, LB				Petersen, C; Moller, LB			Invariance of the nucleoside triphosphate pools of Escherichia coli with growth rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE ENERGY CHARGE; RIBOSOMAL-RNA; GUANOSINE TETRAPHOSPHATE; PYRIMIDINE STARVATION; MESSENGER-RNA; PROTEIN; TURNOVER; TRANSCRIPTION; BACTERIA; MUTANT	The ATP and GTP pools of Escherichia coli have recently been reported to increase approximately 10-fold with increasing growth rates in the range from 0.4 to 1.4 generations/hour (Gaal, T., Bartlett, M. S., Ross, W., Turnbough, C. L., and Gourse, R. L. (1997) Science 278, 2092-2097), Moreover, it was proposed that this variation of the nucleotide pools, particularly the ATP pool, might be responsible for the well known growth rate-dependent regulation of rRNA synthesis in E. coli, To test this hypothesis we have measured the nucleoside triphosphate pools as a function of growth rate for several E, coli strains. We found that the size of all four RNA precursor pools are essentially invariant with growth rate, in the range from 0.5 to 2.3 generations/hour. Nevertheless we observed the expected growth rate-dependent increase of RNA accumulation in these strains. In light of these results, it seems unlikely that nucleotide pool variations should be responsible for the growth rate-dependent regulation of rRNA synthesis.	Univ Copenhagen, Dept Biol Chem, Inst Mol Biol, DK-1307 Copenhagen K, Denmark; John F Kennedy Inst, DK-2600 Glostrup, Denmark	University of Copenhagen	Petersen, C (corresponding author), Univ Copenhagen, Dept Biol Chem, Inst Mol Biol, Solvgade 83H, DK-1307 Copenhagen K, Denmark.			Moller, Lisbeth/0000-0002-9524-4301				ANDERSEN KB, 1977, J BIOL CHEM, V252, P4151; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BAGNARA AS, 1968, BIOCHEM BIOPH RES CO, V33, P15, DOI 10.1016/0006-291X(68)90247-7; BAGNARA AS, 1973, EUR J BIOCHEM, V36, P422, DOI 10.1111/j.1432-1033.1973.tb02927.x; BECK C, 1973, J MOL BIOL, V78, P117, DOI 10.1016/0022-2836(73)90431-2; Bremer H, 1996, ESCHERICHIA COLI SAL; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chapman A G, 1977, Adv Microb Physiol, V15, P253, DOI 10.1016/S0065-2911(08)60318-5; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; EDLIN G, 1966, J MOL BIOL, V15, P428, DOI 10.1016/S0022-2836(66)80118-3; ERLICH H, 1975, J BIOL CHEM, V250, P3057; FRANZEN JS, 1961, J BIOL CHEM, V236, P515; FRIESEN JD, 1975, J BIOL CHEM, V250, P304; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GALLANT J, 1969, J BIOL CHEM, V244, P3125; GAUSING K, 1977, J MOL BIOL, V115, P335, DOI 10.1016/0022-2836(77)90158-9; GLASER M, 1975, J BACTERIOL, V123, P128, DOI 10.1128/JB.123.1.128-136.1975; GLEMBOTSKI CC, 1981, J BACTERIOL, V145, P1374, DOI 10.1128/JB.145.3.1374-1385.1981; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HOLMS WH, 1972, ARCH MIKROBIOL, V83, P95, DOI 10.1007/BF00425016; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; JINSROBRTSON S, 1987, ESCHERICHIA COLI SAL, V2, P1358; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; LOWRY OH, 1971, J BIOL CHEM, V246, P6511; Maaloe O., 1979, BIOL REGUL DEV, P487; MILLER JH, 1972, EXPT MOL GENETICS, P17; MOSES V, 1972, J GEN MICROBIOL, V71, P181, DOI 10.1099/00221287-71-1-181; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; NAZAR RN, 1972, J BIOL CHEM, V247, P790; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NEUHARD J, 1987, ESCHERICHIA COLI SAL, V1, P445; Petersen C, 1999, J BIOL CHEM, V274, P5348, DOI 10.1074/jbc.274.9.5348; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SADLER WC, 1977, J BIOL CHEM, V252, P8504; SHULTZ J, 1982, CELL, V31, P227, DOI 10.1016/0092-8674(82)90422-6; SMITH RC, 1964, BIOCHIM BIOPHYS ACTA, V86, P229, DOI 10.1016/0304-4165(64)90047-9; SWEDES JS, 1975, J BIOL CHEM, V250, P6930; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; VOGEL U, 1991, J BACTERIOL, V173, P1168, DOI 10.1128/jb.173.3.1168-1174.1991; WINSLOW RM, 1971, J BIOL CHEM, V246, P4872	43	58	58	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3931	3935		10.1074/jbc.275.6.3931	http://dx.doi.org/10.1074/jbc.275.6.3931			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660546	hybrid			2022-12-27	WOS:000085288800030
J	Yu, QT; Lehrer, RI; Tam, JP				Yu, QT; Lehrer, RI; Tam, JP			Engineered salt-insensitive alpha-defensins with end-to-end circularized structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNPROTECTED PEPTIDE SEGMENTS; HUMAN INTESTINAL DEFENSIN-5; ANTIMICROBIAL PEPTIDE; HUMAN BETA-DEFENSIN-1; SECONDARY STRUCTURE; LIGATION STRATEGY; CRYSTAL-STRUCTURE; CYCLIC-PEPTIDES; GROWTH-FACTOR; HOST-DEFENSE	We designed a retro-isomer and seven circularized "beta-tile" peptide analogs of a typical rabbit cu-defensin, NP-1. The analogs retained defensin-like architecture after the characteristic end-to-end, Cys(3,31) (C I:C VI), alpha-defensin disulfide bond was replaced by a backbone peptide bond. The retro-isomer of NP-1 was as active as the parent compound, suggesting that overall topology and amphipathicity governed its antimicrobial activity. A beta-tile design with or without a single cross-bracing disulfide bond sufficed for antimicrobial activity, and some of the analogs retained activity against Escherichia coli and Salmonella typhimurium in NaCl concentrations that rendered NP-I inactive. The new molecules had clustered positive charges resembling those in protegrins and tachyplesins, but were less cytotoxic. Such simplified alpha-defensin analogs minimize problems encountered during the oxidative folding of three-disulfide defensins, In addition, they are readily accessible to a novel thia zip cyclization procedure applicable to large unprotected peptide precursors of 31 amino acids in aqueous solutions. Collectively, these findings provide new and improved methodology to create salt-insensitive defensin-like peptides for application against bacterial diseases.	Vanderbilt Univ, Dept Microbiol & Immunol, Nashville, TN 37232 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA	Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tam, JP (corresponding author), Vanderbilt Univ, Dept Microbiol & Immunol, A5119 MCN, Nashville, TN 37232 USA.		Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X	NATIONAL CANCER INSTITUTE [R01CA036544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022839, R01AI046164, R01AI022839] Funding Source: NIH RePORTER; NCI NIH HHS [CA 36544] Funding Source: Medline; NIAID NIH HHS [AI 22839, AI 46164] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bals R, 1998, INFECT IMMUN, V66, P1225, DOI 10.1128/IAI.66.3.1225-1232.1998; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; BONMATIN JM, 1992, J BIOMOL NMR, V2, P235, DOI 10.1007/BF01875319; Botti P, 1996, J AM CHEM SOC, V118, P10018, DOI 10.1021/ja954278g; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; CHO Y, 1966, INFECT IMMUN, V66, P2791; CHRISTENSEN B, 1988, P NATL ACAD SCI USA, V85, P5072, DOI 10.1073/pnas.85.14.5072; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fahrner RL, 1996, CHEM BIOL, V3, P543, DOI 10.1016/S1074-5521(96)90145-3; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; GRAN L, 1973, ACTA PHARMACOL TOX, V32, P400; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; HOJO H, 1991, B CHEM SOC JPN, V64, P111, DOI 10.1246/bcsj.64.111; Juvvadi P, 1996, J AM CHEM SOC, V118, P8989, DOI 10.1021/ja9542911; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; LIN YZ, 1991, BIOCHEMISTRY-US, V30, P3310, DOI 10.1021/bi00227a020; Liu CF, 1996, J AM CHEM SOC, V118, P307, DOI 10.1021/ja952790w; Liu CF, 1996, TETRAHEDRON LETT, V37, P933, DOI 10.1016/0040-4039(95)02394-1; LIU CF, 1994, P NATL ACAD SCI USA, V91, P6584, DOI 10.1073/pnas.91.14.6584; Meister M, 1997, BIOESSAYS, V19, P1019, DOI 10.1002/bies.950191112; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MERRIFIELD RB, 1995, P NATL ACAD SCI USA, V92, P3449, DOI 10.1073/pnas.92.8.3449; MERRIFIELD RB, 1986, SCIENCE, V57, P1619; NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; PARDI A, 1992, BIOCHEMISTRY-US, V31, P11357, DOI 10.1021/bi00161a013; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Roumestand C, 1998, FEBS LETT, V421, P263, DOI 10.1016/S0014-5793(97)01579-2; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; SHIMODA M, 1995, INFECT IMMUN, V63, P2886, DOI 10.1128/IAI.63.8.2886-2891.1995; Steinbeg Deborah A., 1997, V78, P169; STEWART SM, 1984, SOLID PHASE PEPTIDE, P113; Struthers MD, 1996, SCIENCE, V271, P342, DOI 10.1126/science.271.5247.342; Tam JP, 1995, P NATL ACAD SCI USA, V92, P12485, DOI 10.1073/pnas.92.26.12485; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Tam JP, 1998, BIOPOLYMERS, V46, P319, DOI 10.1002/(SICI)1097-0282(19981015)46:5<319::AID-BIP3>3.0.CO;2-S; Tam JP, 1997, TETRAHEDRON LETT, V38, P5599, DOI 10.1016/S0040-4039(97)01271-9; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; YANG Y, 1994, PROTEIN SCI, V3, P1267, DOI 10.1002/pro.5560030813; Yeh Trai-Ming, 1994, Chinese Journal of Microbiology and Immunology (Taipei), V27, P120; Zhang LS, 1997, TETRAHEDRON LETT, V38, P3, DOI 10.1016/S0040-4039(96)02260-5; Zhang LS, 1997, J AM CHEM SOC, V119, P2363, DOI 10.1021/ja9621105; ZHANG XL, 1992, BIOCHEMISTRY-US, V31, P11348, DOI 10.1021/bi00161a012	57	60	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3943	3949		10.1074/jbc.275.6.3943	http://dx.doi.org/10.1074/jbc.275.6.3943			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660548	hybrid			2022-12-27	WOS:000085288800032
J	Faccio, L; Fusco, C; Chen, A; Martinotti, S; Bonventre, JV; Zervos, AS				Faccio, L; Fusco, C; Chen, A; Martinotti, S; Bonventre, JV; Zervos, AS			Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEINS; GENE; DOMAINS; KINASE; IDENTIFICATION; TEMPERATURES; PRODUCT; GROWTH; DEGP	We report the isolation and characterization of a cDNA encoding the novel mammalian serine protease Omi. Omi protein consists of 458 amino acids and has homology to bacterial HtrA endoprotease, which acts as a chaperone at low temperatures and as a proteolytic enzyme that removes denatured or damaged substrates at elevated temperatures. The carboxyl terminus of Omi has extensive homology to a mammalian protein called L56 (human HtrA), but unlike L56, which is secreted, Omi is localized in the endoplasmic reticulum, Omi has several novel putative protein-protein interaction motifs, as well as a PDZ domain and a Src homology 3-binding domain, Omi mRNA is expressed ubiquitously, and the gene is localized on human chromosome 2p12, Omi interacts with Mxi2, an alternatively spliced form of the p38 stress-activated kinase, Omi protein, when made in a heterologous system, shows proteolytic activity against a nonspecific substrate beta-casein, The proteolytic activity of Omi is markedly up-regulated in the mouse kidney following ischemia/reperfusion.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; Massachusetts Gen Hosp, Renal Unit, Med Serv, Boston, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02129 USA; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of L'Aquila	Zervos, AS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, 149 13th St, Boston, MA 02129 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055734] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK55734-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bao JX, 1996, ONCOGENE, V12, P2171; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; De Silva H, 1998, BIOCHEM BIOPH RES CO, V250, P647, DOI 10.1006/bbrc.1998.9365; Edelstein CL, 1997, KIDNEY INT, V51, P1341, DOI 10.1038/ki.1997.183; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Fusco C, 1999, YEAST, V15, P715, DOI 10.1002/(SICI)1097-0061(19990615)15:8<715::AID-YEA406>3.0.CO;2-K; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; Kaushal GP, 1998, AM J PHYSIOL-RENAL, V274, pF587, DOI 10.1152/ajprenal.1998.274.3.F587; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; LOVIS C, 1994, RENAL FAILURE, V16, P179, DOI 10.3109/08860229409044859; Molitoris BA, 1998, CURR OPIN NEPHROL HY, V7, P405, DOI 10.1097/00041552-199807000-00009; OUELLETTE AJ, 1990, J CLIN INVEST, V85, P766, DOI 10.1172/JCI114502; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Safirstein R, 1997, Adv Ren Replace Ther, V4, P38; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; SHAPIRO DN, 1994, GENOMICS, V23, P282, DOI 10.1006/geno.1994.1496; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; SKORKOGLONEK J, 1995, J BIOL CHEM, V270, P11140, DOI 10.1074/jbc.270.19.11140; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yokota M, 1999, BRAIN RES, V819, P8, DOI 10.1016/S0006-8993(98)01334-1; ZERVOS AS, 1995, P NATL ACAD SCI USA, V92, P10531, DOI 10.1073/pnas.92.23.10531; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	33	179	202	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2581	2588		10.1074/jbc.275.4.2581	http://dx.doi.org/10.1074/jbc.275.4.2581			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644717	hybrid			2022-12-27	WOS:000085128000049
J	Garza, LA; Birnbaum, MJ				Garza, LA; Birnbaum, MJ			Insulin-responsive aminopeptidase trafficking in 3T3-L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER GLUT4; RAT ADIPOSE-CELLS; REGULATED MEMBRANE AMINOPEPTIDASE; HAMSTER OVARY CELLS; PLASMA-MEMBRANE; SUBCELLULAR TRAFFICKING; TRANSFERRIN RECEPTOR; HEXOSE-TRANSPORT; TRANSLOCATION; ENDOCYTOSIS	The insulin-responsive aminopeptidase (IRAP/VP165/gp160) was identified originally in GLUT4-containing vesicles and shown to translocate in response to insulin, much like the glucose transporter 4 (GLUT4), This study characterizes the trafficking and kinetics of IRAP in exocytosis, endocytosis, and recycling to the membrane in 3T3-L1 adipocytes. After exposure of 3T3-L1 adipocytes to insulin, IRAP translocated to the plasma membrane as assessed by either cell fractionation, surface biotinylation, or the plasma membrane sheet assay. The rate of exocytosis closely paralleled that of GLUT4. In the continuous presence of insulin, IRAP was endocytosed with a half-time of about 3-5 min. IRAP endocytosis is inhibited by cytosol acidification, a property of clathrin-mediated endocytosis, but not by the expression of a constitutively active Akt/PKB, Arrival in an LDM fraction derived via subcellular fractionation exhibited a slower time course than disappearance from the cell surface, suggesting additional endocytic intermediates. As assayed by membrane "sheets," GLUT4 and IRAP showed similar internalization rates that are wortmannin-insensitive and occur with a half-time of roughly 5 min. IRAP remaining on the cell surface 10 min following insulin removal was both biotin- and avidin-accessible, implying the absence of thin-necked invaginations, Finally, endocytosed IRAP quickly recycled back to the plasma membrane in a wortmannin-sensitive process. These results demonstrate rapid endocytosis and recycling of IRAP in the presence of insulin and trafficking that matches GLUT4 in rate.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Cox Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	birnbaum@hhmi.upenn.edu		garza, luis/0000-0002-6547-9695; Birnbaum, Morris/0000-0001-9972-8680	NIDDK NIH HHS [DK39615] Funding Source: Medline; NIGMS NIH HHS [5-T32-GM-07170] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; CLANCY BM, 1990, J BIOL CHEM, V265, P12434; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; Filippis A, 1998, BIOCHEM J, V330, P405, DOI 10.1042/bj3300405; FINGAR DC, 1993, J BIOL CHEM, V268, P3005; Garippa RJ, 1996, J BIOL CHEM, V271, P20660, DOI 10.1074/jbc.271.34.20660; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HAUSDORFF SF, 1994, J BIOL CHEM, V269, P21931; Herbst JJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE600, DOI 10.1152/ajpendo.1997.272.4.E600; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; JHUN BH, 1992, J BIOL CHEM, V267, P17710; Johnson AO, 1998, J BIOL CHEM, V273, P17968, DOI 10.1074/jbc.273.28.17968; KANDROR K, 1994, J BIOL CHEM, V269, P138; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Malide D, 1997, FEBS LETT, V409, P461, DOI 10.1016/S0014-5793(97)00563-2; Martin S, 1997, J CELL SCI, V110, P2281; Rao AW, 1998, J BIOL CHEM, V273, P25450, DOI 10.1074/jbc.273.39.25450; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Rogi T, 1996, J BIOL CHEM, V271, P56, DOI 10.1074/jbc.271.1.56; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SATOH S, 1993, J BIOL CHEM, V268, P17820; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sumitani S, 1997, ENDOCRINOLOGY, V138, P1029, DOI 10.1210/en.138.3.1029; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Volchuk A, 1998, J BIOL CHEM, V273, P8169, DOI 10.1074/jbc.273.14.8169; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; WATTS C, 1988, EMBO J, V7, P1937, DOI 10.1002/j.1460-2075.1988.tb03031.x; Wei ML, 1998, J CELL BIOL, V140, P565, DOI 10.1083/jcb.140.3.565; YANG J, 1993, J BIOL CHEM, V268, P4600	39	84	85	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2560	2567		10.1074/jbc.275.4.2560	http://dx.doi.org/10.1074/jbc.275.4.2560			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644714	hybrid			2022-12-27	WOS:000085128000046
J	Krieger-Brauer, HI; Medda, PK; Sattel, B; Kather, H				Krieger-Brauer, HI; Medda, PK; Sattel, B; Kather, H			Inhibitory effect of isoproterenol on NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by beta gamma-subunits derived from G(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; HETEROTRIMERIC G-PROTEINS; GTP-BINDING PROTEIN; ADENYLYL-CYCLASE; SIGNAL-TRANSDUCTION; OXIDASE COMPONENTS; RECEPTOR SIGNAL; ANGIOTENSIN-II; ALPHA-SUBUNITS; ACTIVATION	Previous studies revealed that human fat cell plasma membranes contain a multireceptor-linked H2O2-generating system that is under antagonistic control by hormones and cytokines and is stimulated by insulin via G alpha(12). In this report, it is shown that the inhibitory action of the beta-adrenergic agonist isoproterenol is mediated by G protein beta gamma-subunits, based on observations that its action was specifically reversed by anti-G beta antibodies or a C-terminal beta-adrenergic receptor kinase-1 fragment containing the G beta gamma-binding site of the enzyme, and was mimicked by exogenously supplied G protein beta gamma-subunits. Isoproterenol signals through a prototypical G(s)-coupled receptor. Consistent with these results, direct activation of G(s) by cholera toxin or by an anti-G alpha(s) antibody exhibiting beta-adrenergic receptor-mimetic properties (K-20) resulted in an isoproterenol-like inhibition of NADPH-dependent H2O2 generation. In addition, a peptide corresponding to the target sequence of K-20 blocked the action of the catecholamine, apparently by competition between the peptide and G(s) for activated beta-adrenergic receptors, indicating that the G protein beta gamma-subunits mediating the inhibitory effects of the catecholamine were in fact derived from G(s).	Heidelberg Univ, Klin Inst Herzinfarktforsch & Med, D-69115 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Krieger-Brauer, HI (corresponding author), Heidelberg Univ, Klin Inst Herzinfarktforsch & Med, Bergheimer Str 58, D-69115 Heidelberg, Germany.							Barr AJ, 1997, J BIOL CHEM, V272, P2223; Bayewitch ML, 1998, J BIOL CHEM, V273, P2273, DOI 10.1074/jbc.273.4.2273; Bhunia AK, 1997, J BIOL CHEM, V272, P15642, DOI 10.1074/jbc.272.25.15642; Bokoch GM, 1996, FASEB J, V10, P1290, DOI 10.1096/fasebj.10.11.8836042; BOMSEL M, 1993, J BIOL CHEM, V268, P25824; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Degtiar VE, 1997, J PHYSIOL-LONDON, V502, P321, DOI 10.1111/j.1469-7793.1997.321bk.x; Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Irani K, 1998, BIOCHEM PHARMACOL, V55, P1339; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626, DOI 10.1152/ajpheart.1996.271.4.H1626; KATADA T, 1982, J BIOL CHEM, V257, P3739; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Krieger-Brauer HI, 1999, J BIOL CHEM, V274, P28308, DOI 10.1074/jbc.274.40.28308; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P549, DOI 10.1042/bj3070549; KRIEGERBRAUER HI, 1995, BIOCHEM J, V307, P543, DOI 10.1042/bj3070543; KriegerBrauer HI, 1997, J BIOL CHEM, V272, P10135; Macrez N, 1997, J BIOL CHEM, V272, P23180, DOI 10.1074/jbc.272.37.23180; Marumo T, 1997, CIRCULATION, V96, P2361; MEIER B, 1993, BIOCHEM J, V289, P481, DOI 10.1042/bj2890481; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Moulton PJ, 1998, BIOCHEM J, V329, P449; Murthy KS, 1996, J BIOL CHEM, V271, P23458, DOI 10.1074/jbc.271.38.23458; MURTHY KS, 1994, J BIOL CHEM, V269, P15977; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nielsen MD, 1996, J BIOL CHEM, V271, P33308, DOI 10.1074/jbc.271.52.33308; Pagano PJ, 1997, P NATL ACAD SCI USA, V94, P14483, DOI 10.1073/pnas.94.26.14483; RADEKE HH, 1991, J BIOL CHEM, V266, P21025; RODBELL M, 1964, J BIOL CHEM, V239, P375; SAKAI H, 1994, J BIOL CHEM, V269, P23426; Schandar M, 1998, J BIOL CHEM, V273, P16669, DOI 10.1074/jbc.273.27.16669; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; STEHNOBITTEL L, 1995, J BIOL CHEM, V270, P30068; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; VAUGHAN M, 1978, J SUPRAMOL STR CELL, V8, P473; Wan Y, 1998, J BIOL CHEM, V273, P14533, DOI 10.1074/jbc.273.23.14533; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297	44	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2486	2490		10.1074/jbc.275.4.2486	http://dx.doi.org/10.1074/jbc.275.4.2486			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644703	hybrid			2022-12-27	WOS:000085128000035
J	Terry-Lorenzo, RT; Inoue, M; Connor, JH; Haystead, TAJ; Armbruster, BN; Gupta, RP; Oliver, CJ; Shenolikar, S				Terry-Lorenzo, RT; Inoue, M; Connor, JH; Haystead, TAJ; Armbruster, BN; Gupta, RP; Oliver, CJ; Shenolikar, S			Neurofilament-L is a protein phosphatase-1-binding protein associated with neuronal plasma membrane and post-synaptic density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; FILAMENT-BINDING PROTEIN; LIGHT-CHAIN-PHOSPHATASE; ACID-TREATED NEURONS; MYOSIN PHOSPHATASE; POSTSYNAPTIC DENSITY; SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; DENDRITIC SPINES; TRIPLET PROTEINS	Far Westerns with digoxigenin conjugated protein phosphatase-1 (PP1) catalytic subunit identified PP1-binding proteins in extracts from bovine, rat, and human brain. A major 70-kDa PP1-binding protein was purified from bovine brain cortex plasma membranes, using affinity chromatography on the immobilized phosphatase inhibitor, microcystin-LR. Mixed peptide sequencing following cyanogen bromide digestion identified the 70-kDa membrane-bound PP1-binding protein as bovine neurofilament-1 (NF-L). NF-L was the major PP1-binding protein in purified preparations of bovine spinal cord neurofilaments and the cytoskeletal compartment known as post-synaptic density, purified from rat brain cortex. Bovine neurofilaments, at nanomolar concentrations, inhibited the phosphorylase phosphatase activity of rabbit skeletal muscle PP1 catalytic subunit but not the activity of PP2A, another major serine/ threonine phosphatase. PP1 binding to bovine NF-L was mapped to the head region. This was confirmed by both binding and inhibition of PP1 by recombinant human NF-L fragments. Together, these studies indicate that NF-L fulfills many of the biochemical criteria established for a PP1-targeting subunit and suggest that NF-L may target the functions of PP1 in membranes and cytoskeleton of mammalian neurons.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Duke University; University of Virginia	Shenolikar, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	sheno001@mc.duke.edu		Connor, John/0000-0002-8867-7256	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052054, R01DK052378] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL19242] Funding Source: Medline; NIDDK NIH HHS [DK52378A, DK52054] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Alphey L, 1997, J CELL BIOL, V138, P395, DOI 10.1083/jcb.138.2.395; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Benson DL, 1996, J NEUROCYTOL, V25, P181, DOI 10.1007/BF02284795; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; Campos M, 1996, J BIOL CHEM, V271, P28478, DOI 10.1074/jbc.271.45.28478; Carpenter DA, 1996, J CELL SCI, V109, P2493; Colbran RJ, 1997, J NEUROCHEM, V69, P920; Damer CK, 1998, J BIOL CHEM, V273, P24396, DOI 10.1074/jbc.273.38.24396; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Ehlers MD, 1998, J NEUROSCI, V18, P720; ENDO S, 1995, J NEUROCHEM, V64, P1833; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gailly P, 1996, EUR J BIOCHEM, V239, P326, DOI 10.1111/j.1432-1033.1996.0326u.x; Gardoni F, 1998, J NEUROCHEM, V71, P1733; GEORGES E, 1986, J NEUROCHEM, V47, P477; Giasson BI, 1996, J NEUROCHEM, V66, P1207; Gibb BJM, 1998, J NEUROCHEM, V70, P492; Gibb BJM, 1996, J NEUROCHEM, V66, P1306; Hirokawa N, 1998, J CELL BIOL, V143, P1, DOI 10.1083/jcb.143.1.1; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; JAGIELLO I, 1995, J BIOL CHEM, V270, P17257, DOI 10.1074/jbc.270.29.17257; Johnson D, 1997, EUR J BIOCHEM, V244, P931, DOI 10.1111/j.1432-1033.1997.00931.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Mukai H, 1996, J BIOL CHEM, V271, P9816, DOI 10.1074/jbc.271.16.9816; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nairn A C, 1992, Curr Opin Neurobiol, V2, P296, DOI 10.1016/0959-4388(92)90118-5; Nakai K, 1997, BLOOD, V90, P3936, DOI 10.1182/blood.V90.10.3936; NAKAMURA Y, 1990, BIOCHEM BIOPH RES CO, V169, P744, DOI 10.1016/0006-291X(90)90394-3; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; OZOLS J, 1990, METHOD ENZYMOL, V182, P225; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; SACHER MG, 1994, J BIOL CHEM, V269, P18480; SAITO T, 1995, BIOCHEMISTRY-US, V34, P7376, DOI 10.1021/bi00022a010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; SCOTT D, 1985, J BIOL CHEM, V260, P736; SHENOLIKAR S, 1984, METHOD ENZYMOL, V107, P102; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Snyder GL, 1998, J NEUROSCI, V18, P10297; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1997, MOL BRAIN RES, V49, P15, DOI 10.1016/S0169-328X(97)00117-4; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Streifel TD, 1996, BIOCHEM BIOPH RES CO, V222, P646, DOI 10.1006/bbrc.1996.0797; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Tu JL, 1996, MOL CELL BIOL, V16, P4199; TU JL, 1994, MOL CELL BIOL, V14, P6789, DOI 10.1128/MCB.14.10.6789; TU JL, 1995, EMBO J, V14, P5939, DOI 10.1002/j.1460-2075.1995.tb00282.x; VillaMoruzzi E, 1996, INT J BIOCHEM CELL B, V28, P13, DOI 10.1016/1357-2725(95)00119-0; WALSH MJ, 1992, J NEUROCHEM, V59, P667, DOI 10.1111/j.1471-4159.1992.tb09421.x; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WIBLE BA, 1989, P NATL ACAD SCI USA, V86, P720, DOI 10.1073/pnas.86.2.720; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516; Yoshimura Y, 1999, FEBS LETT, V446, P239, DOI 10.1016/S0014-5793(99)00226-4; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	72	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2439	2446		10.1074/jbc.275.4.2439	http://dx.doi.org/10.1074/jbc.275.4.2439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644697	hybrid			2022-12-27	WOS:000085128000029
J	Bergsdorf, C; Paliga, K; Kreger, S; Masters, CL; Beyreuther, K				Bergsdorf, C; Paliga, K; Kreger, S; Masters, CL; Beyreuther, K			Identification of cis-elements regulating exon 15 splicing of the amyloid precursor protein pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; RNA SECONDARY STRUCTURE; MESSENGER-RNA; ALZHEIMERS-DISEASE; DEFAULT EXON; GENE; SELECTION; INTRON; EXPRESSION; CELLS	Alternative splicing of exon 15 of the amyloid precursor protein (APP) pre-mRNA generates two APP isoform groups App(ex15) (containing exon 15) and L-APP (without exon 15), which show a cell-specific distribution in non-neuronal cells and neurons of rat. Both APP isoforms differ in regard to functional properties like posttranslational modification, APP secretion, and proteolytic production of A beta peptide from APP molecules. Since A beta generation is an important factor in the development of Alzheimer's disease, one could anticipate that these major APP isoforms might contribute differentially to the mechanisms underlying neurodegeneration in Alzheimer's disease, In this study, we established an APP minigene system in a murine cell system to identify cis-acting elements controlling exon 15 recognition. A 12.5-kilobase pair genomic fragment of the murine APP gene contained all cis-regulatory elements to reproduce the splicing pattern of the endogenous APP transcripts. By using this approach, two intronic cis-elements flanking exon 15 were identified that block the inclusion of exon 15 in APP transcripts of non-neuronal cells. Point mutation analysis of these intronic regions indicated that pyrimidine-rich sequences are involved in the splice repressor function. Finally, grafting experiments demonstrated that these regulatory regions cell-specifically enhance the blockage of a chimeric exon in the non-neuronal splicing system.	Univ Heidelberg, Ctr Biol Mol, ZMBH, D-69120 Heidelberg, Germany; Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Ruprecht Karls University Heidelberg; University of Melbourne	Bergsdorf, C (corresponding author), Univ Regensburg, Lehrstuhl Biochem I, Univ Str 31, D-93040 Regensburg, Germany.							Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; BLACK DL, 1992, CELL, V69, P795, DOI 10.1016/0092-8674(92)90291-J; BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; CHAN RC, 1995, MOL CELL BIOL, V15, P6377; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; ESTES PA, 1992, J BIOL CHEM, V267, P14902; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOODING C, 1994, EMBO J, V13, P3861, DOI 10.1002/j.1460-2075.1994.tb06697.x; Gooding C, 1998, RNA, V4, P85; Hartmann T, 1996, J BIOL CHEM, V271, P13208, DOI 10.1074/jbc.271.22.13208; Hattori M, 1997, NUCLEIC ACIDS RES, V25, P1802, DOI 10.1093/nar/25.9.1802; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KONIG G, 1992, J BIOL CHEM, V267, P10804; Lenkkeri U, 1998, HUM GENET, V102, P192, DOI 10.1007/s004390050676; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; LIN CH, 1995, RNA, V1, P234; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; LOU H, 1995, MOL CELL BIOL, V15, P7135; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MIN HS, 1995, GENE DEV, V9, P2659, DOI 10.1101/gad.9.21.2659; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; MULLEN MP, 1991, GENE DEV, V5, P642, DOI 10.1101/gad.5.4.642; OKAMOTO M, 1994, BRAIN RES, V637, P57, DOI 10.1016/0006-8993(94)91217-3; Paliga K, 1997, EUR J BIOCHEM, V250, P354, DOI 10.1111/j.1432-1033.1997.0354a.x; PANGALOS MN, 1995, J NEUROCHEM, V65, P762; PANGALOS MN, 1995, J BIOL CHEM, V270, P10388, DOI 10.1074/jbc.270.18.10388; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; RIO DC, 1993, CURR OPIN GENET DEV, V3, P574, DOI 10.1016/0959-437X(93)90093-5; Ryan KJ, 1996, MOL CELL BIOL, V16, P4014; SAMBROOKJ, 1989, MOL CLONING LAB MANU; SANDBRINK R, 1994, J BIOL CHEM, V269, P1510; Seraphin B, 1996, NUCLEIC ACIDS RES, V24, P3276, DOI 10.1093/nar/24.16.3276; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; SIRANDPUGNET P, 1995, NUCLEIC ACIDS RES, V23, P3501, DOI 10.1093/nar/23.17.3501; SMITH CWJ, 1989, CELL, V56, P749, DOI 10.1016/0092-8674(89)90678-8; STREULI M, 1989, EMBO J, V8, P787, DOI 10.1002/j.1460-2075.1989.tb03439.x; TACKE R, 1991, GENE DEV, V5, P1416, DOI 10.1101/gad.5.8.1416; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; WASCO W, 1993, GENOMICS, V15, P237, DOI 10.1006/geno.1993.1047; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wu AF, 1997, J NEUROSCI, V17, P4987; Zhang L, 1996, RNA, V2, P682	50	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2046	2056		10.1074/jbc.275.3.2046	http://dx.doi.org/10.1074/jbc.275.3.2046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636908	hybrid			2022-12-27	WOS:000084940000071
J	Braud, S; Parry, MAA; Maroun, R; Bon, C; Wisner, A				Braud, S; Parry, MAA; Maroun, R; Bon, C; Wisner, A			The contribution of residues 192 and 193 to the specificity of snake venom serine proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR; TISSUE-TYPE; SUBSTRATE-SPECIFICITY; FACTOR-XA; ENZYME SPECIFICITY; CRYSTAL-STRUCTURE; PROTEASE DOMAIN; THROMBOLYSIS; CHYMOTRYPSIN; TRYPSIN	Snake venom serine proteinases, which belong to the subfamily of trypsin-like serine proteinases, exhibit a high degree of sequence identity (60-66%). Their stringent macromolecular substrate specificity contrasts with that of the less specific enzyme trypsin, One of them, the plasminogen activator from Trimeresurus stejnegeri venom (TSV-PA), which shares 63% sequence identity with batroxobin, a fibrinogen clotting enzyme from Bothrops atrox venom, specifically activates plasminogen to plasmin like tissue-type plasminogen activator (t-PA), even though it exhibits only 23% sequence identity with t-PA This study shows that TSV-PA, t-PA, and batroxobin are quite different in their specificity toward small chromogenic substrates, TSV-PA being less selective than t-PA, and batroxobin not being efficient at all, The specificity of TSV-PA, with respect to t-PA and batroxobin, was investigated further by site directed mutagenesis in the 189-195 segment, which forms the basement of the S-1 pocket of TSV-PA and presents a His at position 192 and a unique Phe at position 193, This study demonstrates that Phe(193) plays a more significant role than His(192) in determining substrate specificity and inhibition resistance. Interestingly, the TSV-PA variant F193G possesses a 8-9-fold increased activity for plasminogen and becomes sensitive to bovine pancreatic trypsin inhibitor.	Inst Pasteur, Unite Venins, F-75724 Paris 15, France; Max Planck Inst Biochem, Dept Struct Res, D-82152 Martinsried, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Max Planck Society	Bon, C (corresponding author), Inst Pasteur, Unite Venins, 25 Rue Docteur Roux, F-75724 Paris 15, France.	cbon@pasteur.fr	Maroun, Rachid C/B-3311-2014; maroun, rachid c/T-1549-2019	Maroun, Rachid C/0000-0002-8124-815X; maroun, rachid c/0000-0002-8124-815X				BERGMANN SR, 1983, SCIENCE, V220, P1181; Bode W, 1983, Adv Exp Med Biol, V156, P289; COLLEN D, 1991, BLOOD, V78, P3114; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; DAVIDOW LS, 1991, PROTEIN ENG, V4, P923, DOI 10.1093/protein/4.8.923; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; IYANIWURA TT, 1991, VET HUM TOXICOL, V33, P475; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Kohnert U, 1996, FIBRINOLYSIS, V10, P93, DOI 10.1016/S0268-9499(96)80084-1; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LIJNEN HR, 1993, METHOD ENZYMOL, V223, P197; MADISON EL, 1995, J BIOL CHEM, V270, P7558, DOI 10.1074/jbc.270.13.7558; Markland FS, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700543-00003; Martin U, 1996, FIBRINOLYSIS, V10, P87, DOI 10.1016/S0268-9499(96)80083-X; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; REZAIE AR, 1993, J BIOL CHEM, V268, P19943; REZAIE AR, 1995, J BIOL CHEM, V270, P16176, DOI 10.1074/jbc.270.27.16176; Rezaie AR, 1996, J BIOL CHEM, V271, P23807, DOI 10.1074/jbc.271.39.23807; RIJKEN DC, 1991, BIOCHEM BIOPH RES CO, V174, P432, DOI 10.1016/0006-291X(91)91434-E; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; ZHANG Y, 1995, J BIOL CHEM, V270, P10246, DOI 10.1074/jbc.270.17.10246; Zhang Y, 1997, J BIOL CHEM, V272, P20531, DOI 10.1074/jbc.272.33.20531; Zhang YL, 1999, J BIOL CHEM, V274, P7153, DOI 10.1074/jbc.274.11.7153	29	32	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1823	1828		10.1074/jbc.275.3.1823	http://dx.doi.org/10.1074/jbc.275.3.1823			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636881	hybrid			2022-12-27	WOS:000084940000044
J	Efimova, T; Eckert, RL				Efimova, T; Eckert, RL			Regulation of human involucrin promoter activity by novel protein kinase C isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER RECEPTOR; SIGNAL-TRANSDUCTION PATHWAY; SERUM RESPONSE ELEMENT; CROSS-LINKED ENVELOPE; HUMAN EPIDERMAL-CELLS; MESSENGER-RNA LEVELS; DELTA PKC-DELTA; TYROSINE PHOSPHORYLATION; HUMAN-SKIN; KERATINOCYTE DIFFERENTIATION	Human involucrin (hINV) mRNA level and promoter activity increase when keratinocytes are treated with the differentiating agent, 12-O-tetradecanoylphorbol-13-acetate (TPA). This response is mediated via a p38 mitogen-activated protein kinase-dependent pathway that targets activator protein 1 (Efimova, T., LaCelle, P. T., Welter, J. F., and Eckert, R. L. (1998) J. Biol, Chem. 273, 24387-24395), In the present study we examine the role of various PKC isoforms in this regulation. Transfection of expression plasmids encoding the novel PKC isoforms delta, epsilon, and eta increase hINV promoter activity. In contrast, neither conventional PKC isoforms (alpha, beta, and gamma) nor the atypical isoform (zeta) regulate promoter activity. Consistent with these observations, promoter activity is inhibited by the PKC delta-selective inhibitor, rottlerin, but not by Go-6976, an inhibitor of conventional PRC isoforms, and novel PKC isoform-dependent promoter activation is inhibited by dominant-negative PKC delta. This regulation appears to be physiologically important, as transfection of keratinocytes with PKC delta, -epsilon, or -eta increases expression of the endogenous hINV gene. Synergistic promoter activation (greater than or equal to 100-fold) is observed when PKC epsilon- or -eta-transfected cells are treated with TPA. In contrast, the PKC delta-dependent response is more complex as either activation or inhibition is observed, depending upon PKC delta concentration.	Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Dermatol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Oncol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Eckert, RL (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Rm E532,2109 Adelbert Rd, Cleveland, OH 44106 USA.			Efimova, Tatiana/0000-0002-9869-1545	NCI NIH HHS [P30 CA134274] Funding Source: Medline; NIAMS NIH HHS [AR39750] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agarwal C, 1999, J BIOL CHEM, V274, P6190, DOI 10.1074/jbc.274.10.6190; ASHENDEL CL, 1985, BIOCHIM BIOPHYS ACTA, V822, P219, DOI 10.1016/0304-4157(85)90009-7; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; DENNING MF, 1993, J BIOL CHEM, V268, P26079; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; DLUGOSZ AA, 1993, J CELL BIOL, V120, P217, DOI 10.1083/jcb.120.1.217; Eckert RL, 1996, CELL DEATH DIFFER, V3, P373; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; Garcia-Paramio P, 1998, BIOCHEM J, V333, P631, DOI 10.1042/bj3330631; GHERZI R, 1992, BIOCHEM BIOPH RES CO, V184, P283, DOI 10.1016/0006-291X(92)91190-2; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; GSCHWENDT M, 1994, FEBS LETT, V347, P85, DOI 10.1016/0014-5793(94)00514-1; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; HALEEMSMITH H, 1995, P NATL ACAD SCI USA, V92, P9112, DOI 10.1073/pnas.92.20.9112; HIRAI S, 1994, EMBO J, V13, P2331, DOI 10.1002/j.1460-2075.1994.tb06517.x; Kadotani M, 1997, J BIOCHEM-TOKYO, V121, P1047; Kampfer S, 1998, EMBO J, V17, P4046, DOI 10.1093/emboj/17.14.4046; KIM SY, 1994, J BIOL CHEM, V269, P27979; KOIZUMI H, 1993, J INVEST DERMATOL, V101, P858, DOI 10.1111/1523-1747.ep12371707; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; LaCelle PT, 1998, SKIN PHARMACOL APPL, V11, P214, DOI 10.1159/000029830; LI WQ, 1995, J BIOL CHEM, V270, P8311, DOI 10.1074/jbc.270.14.8311; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MIZUNO K, 1991, EUR J BIOCHEM, V202, P931, DOI 10.1111/j.1432-1033.1991.tb16453.x; MURPHY GF, 1984, J INVEST DERMATOL, V82, P453, DOI 10.1111/1523-1747.ep12260945; MURTHY S, 1993, J STRUCT BIOL, V111, P68, DOI 10.1006/jsbi.1993.1037; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; OHNO S, 1987, NATURE, V325, P161, DOI 10.1038/325161a0; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; OHNO S, 1988, BIOCHEMISTRY-US, V27, P2083, DOI 10.1021/bi00406a040; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; OSADA S, 1990, J BIOL CHEM, V265, P22434; REYNOLDS NJ, 1994, J INVEST DERMATOL, V103, P364, DOI 10.1111/1523-1747.ep12394957; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Romanova LY, 1998, BIOCHEMISTRY-US, V37, P5558, DOI 10.1021/bi9731807; SHARKEY NA, 1984, P NATL ACAD SCI-BIOL, V81, P607, DOI 10.1073/pnas.81.2.607; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Takahashi H, 1998, J INVEST DERMATOL, V110, P218, DOI 10.1046/j.1523-1747.1998.00110.x; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; Ueda E, 1996, J BIOL CHEM, V271, P9790, DOI 10.1074/jbc.271.16.9790; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; YAAR M, 1993, CLIN RES, V41, pA486, DOI 10.1006/excr.1993.1143; YOUNUS J, 1992, J CELL PHYSIOL, V152, P232, DOI 10.1002/jcp.1041520203	60	79	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1601	1607		10.1074/jbc.275.3.1601	http://dx.doi.org/10.1074/jbc.275.3.1601			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636851	hybrid			2022-12-27	WOS:000084940000014
J	Fasken, MB; Saunders, R; Rosenberg, M; Brighty, DW				Fasken, MB; Saunders, R; Rosenberg, M; Brighty, DW			A leptomycin B-sensitive homologue of human CRM1 promotes nuclear export of nuclear export sequence-containing proteins in Drosophila cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REV TRANS-ACTIVATOR; MESSENGER-RNA; IMPORTIN-ALPHA; NUCLEOCYTOPLASMIC TRANSPORT; RESPONSIVE ELEMENT; GENE-EXPRESSION; TARGET SEQUENCE; PATHWAY; BINDING	The Rev protein of human immunodeficiency virus is a nuclear shuttling protein that promotes nuclear export of mRNAs that encode the viral structural proteins Gag, Pol, and Env, Rev binds to a highly structured RNA motif, the Rev-responsive element (RRE), that is present in all Rev-responsive viral transcripts and facilitates their entry into a nuclear export pathway by recruiting cellular export factors. In mammalian and yeast cells, the principal export receptor engaged by Rev has been identified as the importin/transportin family member CRM1/exportin 1. CRM1 binds directly to a leucine-rich nuclear export sequence (NES) present in Rev, and similar motifs have been identified in a variety of cellular nuclear shuttling proteins. We and our colleagues previously demonstrated that, in transfected Drosophila cells, HIV-l Rev is fully functional and promotes expression of the viral envelope glycoprotein. We now demonstrate that the fundamental mechanism of Rev action in insect cells is identical to that observed in the mammalian systems. In particular, we show that Drosophila cells express a leptomycin B-sensitive homologue of human CRM1 that supports Rev-dependent gene expression and is required for nuclear export of NES-containing proteins in insect cells.	Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Dept Anat & Physiol, Dundee DD1 9SY, Scotland; SmithKline Beecham Pharmaceut, King Of Prussia, PA 19406 USA	University of Dundee; University of Dundee; GlaxoSmithKline	Brighty, DW (corresponding author), Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland.		Fasken, Milo/K-2177-2019	Fasken, Milo/0000-0003-4317-7909				Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; BRIGHTY DW, 1994, P NATL ACAD SCI USA, V91, P8314, DOI 10.1073/pnas.91.18.8314; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Churchill MJ, 1996, J VIROL, V70, P5786, DOI 10.1128/JVI.70.9.5786-5790.1996; CULLEN BR, 1991, ANNU REV MICROBIOL, V45, P219; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fridell RA, 1996, P NATL ACAD SCI USA, V93, P4421, DOI 10.1073/pnas.93.9.4421; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gaits F, 1999, MOL BIOL CELL, V10, P1395, DOI 10.1091/mbc.10.5.1395; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Graves LE, 1999, NATURE, V399, P802, DOI 10.1038/21682; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HANLY SM, 1989, GENE DEV, V3, P1534, DOI 10.1101/gad.3.10.1534; HARLOW E, 1988, ANTIBODIES LABORATOR, P490; HAYNES SR, 1990, MOL CELL BIOL, V10, P316, DOI 10.1128/MCB.10.1.316; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HUANG ZM, 1995, MOL CELL BIOL, V15, P3864; IVEYHOYLE M, 1990, MOL CELL BIOL, V10, P6152, DOI 10.1128/MCB.10.12.6152; Iwasaki T, 1998, FEBS LETT, V428, P259, DOI 10.1016/S0014-5793(98)00540-7; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; MALIM MH, 1991, J VIROL, V65, P4248, DOI 10.1128/JVI.65.8.4248-4254.1991; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; Maniatis T., 1982, MOL CLONING LAB MANU; Matsusaka T, 1998, CURR BIOL, V8, P1031, DOI 10.1016/S0960-9822(07)00425-3; MATUNIS EL, 1992, J CELL BIOL, V116, P257, DOI 10.1083/jcb.116.2.257; Meyer BE, 1996, J VIROL, V70, P2350, DOI 10.1128/JVI.70.4.2350-2359.1996; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; MICHAEL WM, 1995, CELL, V83, P415; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Nicolas FJ, 1997, J CELL SCI, V110, P3019; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; PATERSON T, 1991, NUCLEIC ACIDS RES, V19, P5877, DOI 10.1093/nar/19.21.5877; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; RIMSKY L, 1988, NATURE, V335, P738, DOI 10.1038/335738a0; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131	64	21	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1878	1886		10.1074/jbc.275.3.1878	http://dx.doi.org/10.1074/jbc.275.3.1878			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636888	hybrid			2022-12-27	WOS:000084940000051
J	Sato, AK; Zarutskie, JA; Rushe, MM; Lomakin, A; Natarajan, SK; Sadegh-Nasseri, S; Benedek, GB; Stern, LJ				Sato, AK; Zarutskie, JA; Rushe, MM; Lomakin, A; Natarajan, SK; Sadegh-Nasseri, S; Benedek, GB; Stern, LJ			Determinants of the peptide induced conformational change in the human class II major histocompatibility complex protein HLA-DR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-DERIVED PEPTIDE; HIGH-AFFINITY BINDING; T-CELL RECOGNITION; HLA-DR MOLECULES; MHC CLASS-I; CRYSTAL-STRUCTURE; INVARIANT CHAIN; ANTIGENIC PEPTIDES; BOUND PEPTIDES; BETA-CHAINS	The human class II major histocompatibility complex protein HLA-DR1 has been shown previously to undergo a distinct conformational change from an open to a compact form upon binding peptide, To investigate the role of peptide in triggering the conformational change, the minimal requirements for inducing the compact conformation were determined. Peptides as short as two and four residues, which occupy only a small fraction of the peptide-binding cleft, were able to induce the conformational change. A mutant HLA-DR1 protein with a substitution in the beta subunit designed to fill the P1 pocket from within the protein (Gly(86) to Tyr) adopted to a large extent the compact, peptide-bound conformation. Interactions important in stabilizing the compact conformation are shown to be distinct from those responsible for high affinity binding or for stabilization of the complex against thermal denaturation. The results suggest that occupancy of the P1 pocket is responsible for partial conversion to the compact form but that both side chain and main chain interactions contribute to the full conformational change. The implications of the conformational change to intracellular antigen loading and presentation are discussed.	MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Dept Phys, Cambridge, MA 02139 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Johns Hopkins University	Stern, LJ (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sadegh-Nasseri, Scheherazade/0000-0002-8127-1720	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053549, P01GM056552] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI38996] Funding Source: Medline; NIGMS NIH HHS [P01-GM56552, R01 GM053549, R01-GM53549] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asherie N, 1998, BIOPHYS CHEM, V75, P213, DOI 10.1016/S0301-4622(98)00208-7; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Boniface JJ, 1996, J EXP MED, V183, P119, DOI 10.1084/jem.183.1.119; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; DORNMAIR K, 1989, COLD SPRING HARB SYM, V54, P409; DORNMAIR K, 1990, P NATL ACAD SCI USA, V87, P4134, DOI 10.1073/pnas.87.11.4134; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GRIFFITH IJ, 1988, J EXP MED, V167, P541, DOI 10.1084/jem.167.2.541; HAMMER J, 1994, P NATL ACAD SCI USA, V91, P4456, DOI 10.1073/pnas.91.10.4456; HAMMER J, 1992, J EXP MED, V176, P1007, DOI 10.1084/jem.176.4.1007; HAMMER J, 1994, J EXP MED, V180, P2353, DOI 10.1084/jem.180.6.2353; Harding CV, 1996, CRIT REV IMMUNOL, V16, P13, DOI 10.1615/CritRevImmunol.v16.i1.20; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Jensen PE, 1998, J IMMUNOL METHODS, V215, P71, DOI 10.1016/S0022-1759(98)00062-3; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; LAPAN KE, 1992, HYBRIDOMA, V11, P217, DOI 10.1089/hyb.1992.11.217; LEIGHTON J, 1991, J IMMUNOL, V147, P198; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Murthy VL, 1997, STRUCTURE, V5, P1385, DOI 10.1016/S0969-2126(97)00288-8; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; NELSON CA, 1993, P NATL ACAD SCI USA, V90, P1227, DOI 10.1073/pnas.90.4.1227; NEWTONNASH DK, 1993, J IMMUNOL, V150, P1813; OSULLIVAN D, 1990, J IMMUNOL, V145, P1799; OSULLIVAN D, 1991, J IMMUNOL, V146, P1240; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P193; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Rabinowitz JD, 1997, P NATL ACAD SCI USA, V94, P8702, DOI 10.1073/pnas.94.16.8702; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; Reich Z, 1997, P NATL ACAD SCI USA, V94, P2495, DOI 10.1073/pnas.94.6.2495; ROCHE PA, 1990, J IMMUNOL, V144, P1849; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; SADEGHNASSERI S, 1989, NATURE, V337, P274, DOI 10.1038/337274a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Stebbins CC, 1996, J IMMUNOL, V157, P4892; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Tan LJ, 1997, EUR J IMMUNOL, V27, P1479, DOI 10.1002/eji.1830270626; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wu SH, 1996, J IMMUNOL, V156, P3815; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m	70	74	78	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2165	2173		10.1074/jbc.275.3.2165	http://dx.doi.org/10.1074/jbc.275.3.2165			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636922	hybrid			2022-12-27	WOS:000084940000085
J	Shanmugavelu, M; Baytan, AR; Chesnut, JD; Bonning, BC				Shanmugavelu, M; Baytan, AR; Chesnut, JD; Bonning, BC			A novel protein that binds juvenile hormone esterase in fat body tissue and pericardial cells of the tobacco hornworm Manduca sexta L.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIOTHIS-VIRESCENS; GENE; EXPRESSION; PRODUCTS; DISPLAY; SYSTEM; MIDGUT	Juvenile hormone esterase degrades juvenile hormone, which acts in conjunction with ecdysteroids to control gene expression in insects. Circulating juvenile hormone esterase is removed from insect blood by pericardial cells and degraded in lysosomes, In experiments designed to characterize proteins involved in the degradation of juvenile hormone esterase, a pericardial cell cDNA phage display library derived from the tobacco hornworm moth Manduca sexta L. was constructed and screened for proteins that bind juvenile hormone esterase, A 732-base pair cDNA encoding a novel 29-kDa protein (P29) was isolated. Western and Northern analyses indicated that P29 is present in both pericardial cell and fat body tissues and is expressed in each larval instar, In immunoprecipitation experiments, P29 bound injected recombinant juvenile hormone esterase taken up by pericardial cells and native M. sexta juvenile hormone esterase in fat body tissue, where the enzyme is synthesized. Binding assays showed that P29 bound juvenile hormone esterase more strongly than it did a mutant form of the enzyme with mutations that perturb lysosomal targeting. Based on these data, we propose that P29 functions in pericardial cells to facilitate lysosomal degradation of juvenile hormone esterase.	Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; Iowa State Univ, Genet Program, Ames, IA 50011 USA; Invitrogen, Carlsbad, CA 92008 USA	Iowa State University; Iowa State University; Thermo Fisher Scientific	Bonning, BC (corresponding author), Iowa State Univ, Dept Entomol, 411 Sci 2, Ames, IA 50011 USA.	Bbonning@iastate.edu						ABDELAAL YAI, 1986, SCIENCE, V233, P1073, DOI 10.1126/science.3738525; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bonning BC, 1997, ARCH INSECT BIOCHEM, V34, P275, DOI 10.1002/(SICI)1520-6327(1997)34:3<275::AID-ARCH3>3.3.CO;2-T; Bonning BC, 1997, P NATL ACAD SCI USA, V94, P6007, DOI 10.1073/pnas.94.12.6007; Bonning BC, 1999, J INVERTEBR PATHOL, V73, P234, DOI 10.1006/jipa.1998.4839; BONNING BC, 1992, INSECT BIOCHEM MOLEC, V22, P453, DOI 10.1016/0965-1748(92)90141-Z; BOOTH TF, 1992, TISSUE CELL, V24, P267, DOI 10.1016/0040-8166(92)90100-L; Carcamo J, 1998, P NATL ACAD SCI USA, V95, P11146, DOI 10.1073/pnas.95.19.11146; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRAMERI R, 1994, EUR J BIOCHEM, V226, P53, DOI 10.1111/j.1432-1033.1994.tb20025.x; CRAMERI R, 1993, GENE, V137, P69, DOI 10.1016/0378-1119(93)90253-Y; Crossley A.C., 1985, P487; Hammock B.D., 1985, P431; HAMMOCK BD, 1990, NATURE, V344, P458, DOI 10.1038/344458a0; HAMMOCK BD, 1985, METHOD ENZYMOL, V111, P487; HANZLIK TN, 1989, J BIOL CHEM, V264, P12419; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; ICHINOSE R, 1992, PESTIC BIOCHEM PHYS, V42, P13, DOI 10.1016/0048-3575(92)90069-C; ICHINOSE R, 1992, INSECT BIOCHEM MOLEC, V22, P893, DOI 10.1016/0965-1748(92)90116-V; Locke M, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P687; Luo WP, 1997, BIOTECHNIQUES, V23, P630, DOI 10.2144/97234bm16; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; SNYDER MJ, 1995, INSECT BIOCHEM MOLEC, V25, P455, DOI 10.1016/0965-1748(94)00083-B; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; WROBLEWSKI VJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P461, DOI 10.1016/0003-9861(90)90285-7	27	36	43	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1802	1806		10.1074/jbc.275.3.1802	http://dx.doi.org/10.1074/jbc.275.3.1802			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636878	hybrid			2022-12-27	WOS:000084940000041
J	Bruno, MD; Korfhagen, TR; Liu, C; Morrisey, EE; Whitsett, JA				Bruno, MD; Korfhagen, TR; Liu, C; Morrisey, EE; Whitsett, JA			GATA-6 activates transcription of surfactant protein A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP-A GENE; FACTOR-I; DEFICIENT MICE; DNA-BINDING; B GENE; EXPRESSION; LUNG; PROMOTER; DIFFERENTIATION; INFECTION	Surfactant protein A (SP-A) is a member of the collectin family of innate host defense molecules expressed primarily in respiratory epithelial cells of the lung. SP-A concentrations are influenced by both cell-specific and ubiquitous nuclear proteins that regulate SP-A gene transcription in a cell-selective and temporally regulated manner. In this work, a consensus GATA-binding site (GBS) was identified at positions -69 to -64 of the mouse SP-A gene. The transcriptional activity of wildtype SP-A reporter constructs in HeLa cells was increased 5-10-fold when cotransfected with a GATA-6 expression plasmid, Deletion of the GBS completely blocked transactivation by GATA-6, Transfection of a construct expressing GATA-6-engrailed fusion protein inhibited basal expression of the SP-A/chloramphenicol acetyltransferase construct in MLE-15 cells. Nuclear extract proteins from MLE-15 cells bound to the GBS in the mouse SP-A gene, and a supershifted band was detected with a GATA-6-specific antibody. Transactivation of the wild-type SP-A constructs by GATA-6 increased transcriptional activity 7-10-fold, whereas thyroid transcription factor-1 (TTF-1) increased the activity of these constructs 12-18-fold. The effects of cotransactivating with both GATA-6 and TTF-1 expression constructs were additive. However, mutation of the TTF-1-binding sites alone or in combination decreased GATA-6 transactivation. Likewise, mutation of the GBS blocked TTF-1 activation of the SP-A promoter. In situ hybridization demonstrated GATA-6 mRNA in the peripheral epithelial cells of fetal mouse lung, consistent with the sites of SP-A expression. GATA-6 is expressed in respiratory epithelial cells and binds to a cis-acting element in the SP-A gene promoter, activating the transcriptional activity of the gene.	Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; University of Pennsylvania	Whitsett, JA (corresponding author), Childrens Hosp, Med Ctr, Div Neonatol & Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058795, R01HL028623] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58795, HL28623] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; Bruno MD, 1999, J BIOL CHEM, V274, P27523, DOI 10.1074/jbc.274.39.27523; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Gao EW, 1997, J BIOL CHEM, V272, P23398, DOI 10.1074/jbc.272.37.23398; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; Ikegami M, 1998, AM J PHYSIOL-LUNG C, V275, pL247, DOI 10.1152/ajplung.1998.275.2.L247; Ikegami M, 1997, AM J PHYSIOL-LUNG C, V272, pL479, DOI 10.1152/ajplung.1997.272.3.L479; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; KORFHAGEN TR, 1992, AM J PHYSIOL, V263, pL546, DOI 10.1152/ajplung.1992.263.5.L546; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; LACAZEMASMONTEIL T, 1992, EUR J BIOCHEM, V206, P613, DOI 10.1111/j.1432-1033.1992.tb16966.x; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LeVine AM, 1997, J IMMUNOL, V158, P4336; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; LeVine AM, 1999, J CLIN INVEST, V103, P1015, DOI 10.1172/JCI5849; Li JX, 1998, J BIOL CHEM, V273, P4592, DOI 10.1074/jbc.273.8.4592; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; McCormack FX, 1998, BBA-MOL BASIS DIS, V1408, P109, DOI 10.1016/S0925-4439(98)00062-3; Mendelson CR, 1998, BBA-MOL BASIS DIS, V1408, P132, DOI 10.1016/S0925-4439(98)00063-5; Michael LF, 1996, MOL ENDOCRINOL, V10, P159, DOI 10.1210/me.10.2.159; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Shaw-White JR, 1999, J BIOL CHEM, V274, P2658, DOI 10.1074/jbc.274.5.2658; Shiojima I, 1999, J BIOL CHEM, V274, P8231, DOI 10.1074/jbc.274.12.8231; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; Young PP, 1996, AM J PHYSIOL-LUNG C, V271, pL287, DOI 10.1152/ajplung.1996.271.2.L287; Zhou L, 1996, J HISTOCHEM CYTOCHEM, V44, P1183, DOI 10.1177/44.10.8813084	32	68	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1043	1049		10.1074/jbc.275.2.1043	http://dx.doi.org/10.1074/jbc.275.2.1043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625644	hybrid			2022-12-27	WOS:000084836600048
J	Haeseleer, F; Sokal, I; Verlinde, CLMJ; Erdjument-Bromage, H; Tempst, P; Pronin, AN; Benovic, JL; Fariss, RN; Palczewski, K				Haeseleer, F; Sokal, I; Verlinde, CLMJ; Erdjument-Bromage, H; Tempst, P; Pronin, AN; Benovic, JL; Fariss, RN; Palczewski, K			Five members of a novel Ca2+-binding protein (CABP) subfamily with similarity to calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASES; CALCIUM-BINDING; CONFORMATIONAL-CHANGES; POINT MUTATIONS; SITES; LOCALIZATION; PURIFICATION; RESOLUTION; EXPRESSION; MUTANTS	Five members of a novel Ca2+-binding protein subfamily (CaBP), with 46-58% sequence similarity to calmodulin (CaM), were identified in the vertebrate retina. Important differences between these Ca2+-binding proteins and CaM include alterations within their second EF-hand loop that render these motifs inactive in Ca2+ coordination and the fact that their central alpha-helixes are extended by one alpha-helical turn. CaBP1 and CaBP2 contain a consensus sequence for N-terminal myristoylation, similar to members of the recoverin subfamily and are fatty acid acylated in vitro. The patterns of expression differ for each of the various members. Expression of CaBP5, for example, is restricted to retinal rod and cone bipolar cells. In contrast, CaBP1 has a more widespread pattern of expression. In the brain, CaBP1 is found in the cerebral cortex and hippocampus, and in the retina this protein is found in cone bipolar and amacrine cells. CaBP1 and CaBP2 are expressed as multiple, alternatively spliced variants, and in heterologous expression systems these forms show different patterns of subcellular localization. In reconstitution assays, CaBPs are able to substitute functionally for CaM. These data suggest that these novel CaBPs are an important component of Ca2+-mediated cellular signal transduction in the central nervous system where they may augment or substitute for CaM.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, BioMol Struct Ctr, Seattle, WA 98195 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Immunol, Philadelphia, PA 19107 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Jefferson University; Jefferson University	Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.	palczews@u.washington.edu	Fariss, Robert/ABI-1771-2020; VERLINDE, CHRISTOPHE LMJ/J-5796-2013	VERLINDE, CHRISTOPHE LMJ/0000-0002-7790-3203; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Fariss, Robert/0000-0003-3227-7170	NATIONAL EYE INSTITUTE [F32EY006935, R01EY008061, R29EY008061] Funding Source: NIH RePORTER; NEI NIH HHS [EY08061, EY06935-01, R01 EY008061, F32 EY006935] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BABU YS, 1988, J MOL BIOL, V204, P91; BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; ELICONE C, 1994, J CHROMATOGR A, V676, P121, DOI 10.1016/0021-9673(94)00089-1; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; FORSEN S, 1986, CALCIUM CELL FUNCTIO, V6, P113; GAO ZH, 1993, J BIOL CHEM, V268, P20096; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; HALE IL, 1993, METHOD CELL BIOL, V38, P289; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; KIM CM, 1993, RECEPTOR, V3, P39; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; Lui M, 1996, ANAL BIOCHEM, V241, P156, DOI 10.1006/abio.1996.0393; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; RING CS, 1993, FASEB J, V7, P783, DOI 10.1096/fasebj.7.9.8330685; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; STAROVASNIK MA, 1992, PROTEIN SCI, V1, P245; Surguchov A, 1997, GENOMICS, V39, P312, DOI 10.1006/geno.1996.4513; Tabernero L, 1997, STRUCTURE, V5, P613, DOI 10.1016/S0969-2126(97)00217-7; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wicki R, 1996, CELL CALCIUM, V20, P459, DOI 10.1016/S0143-4160(96)90087-1; Wriggers W, 1998, BIOPHYS J, V74, P1622, DOI 10.1016/S0006-3495(98)77876-2; Yamaguchi K, 1999, J BIOL CHEM, V274, P3610, DOI 10.1074/jbc.274.6.3610; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	50	199	210	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1247	1260		10.1074/jbc.275.2.1247	http://dx.doi.org/10.1074/jbc.275.2.1247			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625670	Green Accepted, hybrid			2022-12-27	WOS:000084836600074
J	Kopriva, S; Koprivova, A; Suss, KH				Kopriva, S; Koprivova, A; Suss, KH			Identification, cloning, and properties of cytosolic D-ribulose-5-phosphate 3-epimerase from higher plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTOSE-PHOSPHATE PATHWAY; RIBULOSE 5-PHOSPHATE 3-EPIMERASE; CALVIN CYCLE; SPINACH-CHLOROPLASTS; ESCHERICHIA-COLI; OXIDATIVE STRESS; TRANSKETOLASE; ENZYME; PURIFICATION; SEQUENCE	Plant cells contain a complete oxidative pentose phosphate pathway in the chloroplasts, but an incomplete pathway was proposed to be present in the cytosol, with cytosolic (cyt) isoforms of ribulose-5-phosphate 3-epimerase (RPEase) and other non-oxidative branch enzymes being undetectable. Here we present for the first time the identification, cloning, and properties of a cyt-RPEase in rice (Oryza sativa) and presence of its homologues in other plant species. Recombinant cyt-RPEase is a homodimer of 24.3-kDa subunits such as in the case of the animal and yeast enzymes, whereas the chloroplast (chl) RPEase is a hexamer. Cytosolic and chloroplastic RPEases cannot be separated by anion exchange chromatography. Since plant cyt-RPEase is more closely related in its primary structure to homologous enzymes in animal and yeast cells than to the chloroplast RPEase, the plant nuclear genes coding for cytosolic and chloroplast RPEases were most likely derived from eubacteria and cyanobacteria, respectively. Accumulation of cyt-RPEase-mRNA and protein is high in root cells, lacking chl-RPEase, and lower in green tissue. These and other observations support the view that green and non-green plant cells possess a complete oxidative pentose phosphate pathway in the cytosol.	Inst Plant Physiol, CH-3013 Bern, Switzerland; Inst Plant Genet & Crop Plant Res, D-06466 Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Kopriva, S (corresponding author), Inst Forstbot & Baumphysiol, Am Flughafen 17, D-79085 Freiburg, Germany.	kopriva@uni-freiburg.de	Kopriva, Stanislav/C-7401-2013	Kopriva, Stanislav/0000-0002-7416-6551				Allona I, 1998, P NATL ACAD SCI USA, V95, P9693, DOI 10.1073/pnas.95.16.9693; BERNACCHIA G, 1995, EMBO J, V14, P610, DOI 10.1002/j.1460-2075.1995.tb07037.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOWSHER CG, 1992, PLANT J, V2, P893, DOI 10.1111/j.1365-313X.1992.00893.x; Chen YR, 1998, PLANT PHYSIOL, V118, P199, DOI 10.1104/pp.118.1.199; DENNIS DT, 1990, PLANT PHYSL BIOCH MO; Favery B, 1998, EMBO J, V17, P6799, DOI 10.1093/emboj/17.23.6799; FEIERABEND J, 1983, Z PFLANZENPHYSIOL, V110, P247, DOI 10.1016/S0044-328X(83)80107-X; Felsenstein J., 1985, EVOLUTION 1985, V39, P783; Flechner A, 1996, PLANT MOL BIOL, V32, P475, DOI 10.1007/BF00019099; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; KARMALI A, 1983, BIOCHEM J, V211, P617, DOI 10.1042/bj2110617; Kopp J, 1999, J MOL BIOL, V287, P761, DOI 10.1006/jmbi.1999.2643; Luttge U, 1994, BOTANIK; LYNGSTADAAS A, 1995, MOL GEN GENET, V247, P546, DOI 10.1007/BF00290345; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; Martin W, 1996, PLANT MOL BIOL, V30, P795, DOI 10.1007/BF00019012; Miosga T, 1996, CURR GENET, V30, P404, DOI 10.1007/s002940050149; Mohr H, 1992, PFLANZENPHYSIOLOGIE; Nowitzki U, 1995, PLANT MOL BIOL, V29, P1279, DOI 10.1007/BF00020468; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHNARRENBERGER C, 1995, PLANT PHYSIOL, V108, P609, DOI 10.1104/pp.108.2.609; SCHNARRENBERGER C, 1973, ARCH BIOCHEM BIOPHYS, V154, P438, DOI 10.1016/0003-9861(73)90077-5; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Sterky F, 1998, P NATL ACAD SCI USA, V95, P13330, DOI 10.1073/pnas.95.22.13330; SUSS KH, 1993, P NATL ACAD SCI USA, V90, P5514, DOI 10.1073/pnas.90.12.5514; Suss KH, 1997, BOOKS SOIL PLANT ENV, P305; Teige M, 1995, FEBS LETT, V377, P349, DOI 10.1016/0014-5793(95)01373-3; Teige M, 1998, EUR J BIOCHEM, V252, P237, DOI 10.1046/j.1432-1327.1998.2520237.x; Teige M, 1996, PLANT PHYSIOL, V112, P1735; Thom E, 1998, PLANTA, V204, P226, DOI 10.1007/s004250050251; VANDEPEER Y, 1993, COMPUT APPL BIOSCI, V9, P177; Weier T.E., 1982, BOT INTRO PLANT BIOL; WILLIAMSON WT, 1966, METHOD ENZYMOL, V9, P605	36	18	19	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1294	1299		10.1074/jbc.275.2.1294	http://dx.doi.org/10.1074/jbc.275.2.1294			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625676	hybrid			2022-12-27	WOS:000084836600080
J	Spahr, H; Beve, J; Larsson, T; Bergstrom, J; Karlsson, KA; Gustafsson, CM				Spahr, H; Beve, J; Larsson, T; Bergstrom, J; Karlsson, KA; Gustafsson, CM			Purification and characterization of RNA polymerase II holoenzyme from Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; HEPTAPEPTIDE REPEAT; YEAST; MEDIATOR; PROTEINS; DOMAIN; COMPLEX; IDENTIFICATION; SIGNAL	We have purified the RNA polymerase II holoenzyme from Schizosaccharomyces pombe to near homogeneity, The Mediator complex is considerably smaller than its counterpart in Saccharomyces cerevisiae, containing only nine polypeptides larger than 19 kDa, Five of these Mediator subunits have been identified as the S, pombe homologs to Rgr1, Srb4, Med7, and Nut2 found in S. cerevisiae and the gene product of a previously uncharacterized open reading frame, PMC2, with no clear homologies to any described protein. The presence of Mediator in a S. pombe RNA polymerase II holoenzyme stimulated phosphorylation of the C-terminal domain by TFIIH purified from S, pombe. This stimulation was species-specific, because S. pombe Mediator could not stimulate TFIIH purified from S. cerevisiae, We suggest that the overall structure and mechanism of the Mediator is evolutionary conserved. The subunit composition, however, has evolved to respond properly to physiological signals.	Gothenburg Univ, Inst Med Biochem, S-40530 Gothenburg, Sweden	University of Gothenburg	Gustafsson, CM (corresponding author), Gothenburg Univ, Inst Med Biochem, POB 440, S-40530 Gothenburg, Sweden.			Gustafsson, Claes/0000-0003-3531-8468				Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Balciunas D, 1999, P NATL ACAD SCI USA, V96, P376, DOI 10.1073/pnas.96.2.376; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gustafsson CM, 1998, J BIOL CHEM, V273, P30851, DOI 10.1074/jbc.273.47.30851; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Lee YC, 1997, MOL CELL BIOL, V17, P4622, DOI 10.1128/MCB.17.8.4622; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; NISHIZAWA M, 1990, P NATL ACAD SCI USA, V87, P5373, DOI 10.1073/pnas.87.14.5373; NONET ML, 1989, GENETICS, V123, P715; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Remacle JE, 1997, EMBO J, V16, P5722, DOI 10.1093/emboj/16.18.5722; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Tabtiang RK, 1998, MOL CELL BIOL, V18, P4707, DOI 10.1128/MCB.18.8.4707; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; Vaughan-Martini Ann, 1998, P391, DOI 10.1016/B978-044481312-1/50052-6	28	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1351	1356		10.1074/jbc.275.2.1351	http://dx.doi.org/10.1074/jbc.275.2.1351			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625684	hybrid			2022-12-27	WOS:000084836600088
J	Tsuchida, M; Manthei, ER; Alam, T; Knechtle, SJ; Hamawy, MM				Tsuchida, M; Manthei, ER; Alam, T; Knechtle, SJ; Hamawy, MM			Regulation of T cell receptor- and CD28-induced tyrosine phosphorylation of the focal adhesion tyrosine kinases Pyk2 and Fak by protein kinase C - A role for protein tyrosine phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-DEPENDENT PHOSPHORYLATION; PHORBOL ESTER; SIGNAL-TRANSDUCTION; LYMPHOCYTES-T; TUMOR PROMOTERS; PHOSPHOLIPASE-C; ACTIVATION; STIMULATION; PP125(FAK); RAFTK	The T cell receptor (TCR)-CD3 complex and the costimulatory molecule CD28 are critical for T cell function. Both receptors utilize protein tyrosine kinases (PTKs) for the phosphorylation of various signaling molecules, a process that is critical for the function of both receptors, The PTKs of the focal adhesion family, Pyk2 and Fak, have been implicated in the signaling of TCR and CD28. We show here evidence for the regulation of TCR- and CD28-induced tyrosine phosphorylation of the focal adhesion PTKs by protein kinase C (PKC). Thus, treating Jurkat T cells with the PKC activator phorbol 12-myristate 13-acetate (PMA) rapidly and strongly reversed receptor-induced tyrosine phosphorylation of the focal adhesion PTKs. In contrast, PMA did not affect TCR-induced tyrosine phosphorylation of CD3 zeta or the PTKs Fyn and Zap-70. However, PMA induced a strong and rapid dephosphorylation of the linker molecule for activation of T cells. PMA failed to induce the dephosphorylation of proteins in PKC-depleted cells or in cells pretreated with the PKC inhibitor Ro-31-8220, confirming the role of PKC in mediating the PMA effect on receptor-induced protein tyrosine phosphorylation, The involvement of protein tyrosine phosphatases (PTPases) in mediating the dephosphorylation of the focal adhesion PTKs was confirmed by the failure of PMA to dephosphorylate Pyk2 in cells pretreated with the PTPase inhibitor orthovanadate, These results implicate PKC in the regulation of receptor-induced tyrosine phosphorylation of the focal adhesion PTKs in T cells. The data also suggest a role for PTPases in the PKC action.	Univ Wisconsin, Dept Surg, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Hamawy, MM (corresponding author), Univ Wisconsin, Dept Surg, H4-749600 Highland Ave, Madison, WI 53792 USA.			Knechtle, Stuart/0000-0002-1625-385X				ABRAHAM RT, 1988, MOL CELL BIOL, V8, P5448, DOI 10.1128/MCB.8.12.5448; Astier A, 1997, J BIOL CHEM, V272, P228; AUTERO M, 1987, EUR J IMMUNOL, V17, P1503, DOI 10.1002/eji.1830171018; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; CANTRELL DA, 1989, J IMMUNOL, V143, P3653; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; CASNELLIE JE, 1986, J BIOL CHEM, V261, P4921; Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; DENHERTOG J, 1995, CELL GROWTH DIFFER, V6, P303; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Elson A, 1995, P NATL ACAD SCI USA, V92, P12235, DOI 10.1073/pnas.92.26.12235; Fechner JH, 1997, TRANSPLANTATION, V63, P1339, DOI 10.1097/00007890-199705150-00023; Felsch JS, 1998, P NATL ACAD SCI USA, V95, P5051, DOI 10.1073/pnas.95.9.5051; FLINT AJ, 1993, EMBO J, V12, P1937, DOI 10.1002/j.1460-2075.1993.tb05843.x; Ganju RK, 1997, J EXP MED, V185, P1055, DOI 10.1084/jem.185.6.1055; Ganju RK, 1998, BLOOD, V91, P791, DOI 10.1182/blood.V91.3.791.791_791_797; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; HAMAWY MM, 1993, J BIOL CHEM, V268, P6851; Hamawy MM, 1997, J BIOL CHEM, V272, P30498, DOI 10.1074/jbc.272.48.30498; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hatch WC, 1998, BLOOD, V91, P3967, DOI 10.1182/blood.V91.10.3967.3967_3967_3973; HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637, DOI 10.1091/mbc.6.6.637; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Hutchcroft JE, 1996, J BIOL CHEM, V271, P13362, DOI 10.1074/jbc.271.23.13362; HUTCHCROFT JE, 1995, P NATL ACAD SCI USA, V92, P8808, DOI 10.1073/pnas.92.19.8808; ISAKOV N, 1987, J IMMUNOL, V138, P3100; LEDBETTER JA, 1990, BLOOD, V75, P1531; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MAGUIRE JE, 1995, J EXP MED, V182, P2079, DOI 10.1084/jem.182.6.2079; MILLS GB, 1989, J IMMUNOL, V142, P1995; Okazaki H, 1997, J BIOL CHEM, V272, P32443, DOI 10.1074/jbc.272.51.32443; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; PARK DJ, 1992, J BIOL CHEM, V267, P1496; PARRY RV, 1997, BIOCHEM SOC T, V25, P305; PURCHIO AF, 1985, SCIENCE, V229, P1393, DOI 10.1126/science.2994221; Qian DP, 1997, CURR OPIN CELL BIOL, V9, P205, DOI 10.1016/S0955-0674(97)80064-6; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; SCHLAEPFER DD, 1994, NATURE, V372, P786; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Tsuchida M, 1999, J BIOL CHEM, V274, P6735, DOI 10.1074/jbc.274.10.6735; Tsuchida M, 1999, EUR J IMMUNOL, V29, P2354, DOI 10.1002/(SICI)1521-4141(199907)29:07<2354::AID-IMMU2354>3.0.CO;2-P; van Seventer GA, 1998, EUR J IMMUNOL, V28, P3867, DOI 10.1002/(SICI)1521-4141(199811)28:11<3867::AID-IMMU3867>3.3.CO;2-B; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; WARD SG, 1990, J IMMUNOL, V144, P3523; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; YAMADA A, 1990, EUR J IMMUNOL, V20, P1655, DOI 10.1002/eji.1830200806; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHAO ZH, 1994, P NATL ACAD SCI USA, V91, P5007, DOI 10.1073/pnas.91.11.5007	55	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1344	1350		10.1074/jbc.275.2.1344	http://dx.doi.org/10.1074/jbc.275.2.1344			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625683	hybrid			2022-12-27	WOS:000084836600087
J	Boisclair, YR; Wang, JR; Shi, JR; Hurst, KR; Ooi, GT				Boisclair, YR; Wang, JR; Shi, JR; Hurst, KR; Ooi, GT			Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1 beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN COMPLEX; MESSENGER-RNA LEVELS; FACTOR-I GENE; PROMOTER ACTIVITY; RAT-LIVER; INSULIN; CIS; EXPRESSION; STIMULATION; ACTIVATION	During catabolic diseases such as sepsis, inflammation, and infection, a state of growth hormone (GH) resistance develops in liver. This has been attributed in part to increased production of the proinflammatory cytokine interleukin-1 beta (IL-1 beta). To determine how IL-1 beta induces GH resistance, we studied the acid-labile subunit (ALS) gene whose hepatic transcription is increased by GH via the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway. IL-1 beta reduced the ability of GH to stimulate ALS mRNA in rat primary hepatocytes and ALS promoter activity in H4-II-E rat hepatoma cells. This inhibition was dependent on ALSGAS1, an element resembling a gamma-interferon activated sequence that mediates the transcriptional effects of GH. Inhibition by IL-1 beta was also associated with a reduction of GH-dependent binding of STATE to this element after chronic (8 and 24 h), but not after acute treatment (15 min). Because these results indicated that the inhibition by IL-1 beta was indirect, expression of the recently discovered suppressors of cytokine action (SOCS) was examined in liver cells. IL-1 beta did not alter the expression of SOCS1, SOCS2, and CIS, indicating that they are not involved. In contrast, IL-1 beta increased SOCS3 mRNA by 8-fold after 24 h of treatment, whereas GH had no effect. Forced expression of SOCS3 was just as effective as IL-1 beta in reducing the GH induction of ALS promoter activity in H4-II-E rat hepatoma cells. Similar results were observed in primary rat hepatocytes. We conclude that the induction of SOCS3 by IL-1 beta contributes to the development of GH resistance in liver, and represents a mechanism by which cytokines such as IL-1 beta cross-talk with cytokines using the JAK-STAT pathway.	Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Cornell University; Prince Henry's Institute of Medical Research	Boisclair, YR (corresponding author), Cornell Univ, Dept Anim Sci, 259 Morrison Hall, Ithaca, NY 14853 USA.	yrb1@cornell.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051624] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-51624] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Auernhammer CJ, 1998, MOL ENDOCRINOL, V12, P954, DOI 10.1210/me.12.7.954; BICHELL DP, 1992, MOL ENDOCRINOL, V6, P1899, DOI 10.1210/me.6.11.1899; Botfield C, 1997, BAILLIERE CLIN ENDOC, V11, P679, DOI 10.1016/S0950-351X(97)80958-5; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cohney SJ, 1999, MOL CELL BIOL, V19, P4980; DAHN MS, 1988, ARCH SURG-CHICAGO, V123, P1409; DAI J, 1992, BIOCHEM BIOPH RES CO, V188, P304, DOI 10.1016/0006-291X(92)92385-B; Defalque D, 1999, AM J PHYSIOL-ENDOC M, V276, pE565, DOI 10.1152/ajpendo.1999.276.3.E565; Delhanty PJD, 1998, BIOCHEM BIOPH RES CO, V243, P269, DOI 10.1006/bbrc.1998.8089; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fan J, 1996, AM J PHYSIOL-REG I, V270, pR621, DOI 10.1152/ajpregu.1996.270.3.R621; FAN J, 1995, AM J PHYSIOL-ENDOC M, V269, pE33, DOI 10.1152/ajpendo.1995.269.1.E33; FAN J, 1995, AM J PHYSIOL-REG I, V269, pR1204, DOI 10.1152/ajpregu.1995.269.5.R1204; Frost R A, 1998, Curr Opin Clin Nutr Metab Care, V1, P195, DOI 10.1097/00075197-199803000-00010; GARGOSKY SE, 1994, ENDOCRINOLOGY, V134, P2267, DOI 10.1210/en.134.5.2267; Helman D, 1998, FEBS LETT, V441, P287, DOI 10.1016/S0014-5793(98)01555-5; Ito S, 1999, BLOOD, V93, P1456, DOI 10.1182/blood.V93.5.1456; Jenkins RC, 1998, BAILLIERE CLIN ENDOC, V12, P315, DOI 10.1016/S0950-351X(98)80025-6; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Losman JA, 1999, J IMMUNOL, V162, P3770; Masuhara M, 1997, BIOCHEM BIOPH RES CO, V239, P439, DOI 10.1006/bbrc.1997.7484; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; MESSINA JL, 1992, J BIOL CHEM, V267, P9223; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ooi GT, 1998, MOL ENDOCRINOL, V12, P675, DOI 10.1210/me.12.5.675; Ooi GT, 1997, MOL ENDOCRINOL, V11, P997, DOI 10.1210/me.11.7.997; RECHLER MM, 1993, VITAM HORM, V47, P1, DOI 10.1016/S0083-6729(08)60444-6; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Starr R, 1999, BIOESSAYS, V21, P47, DOI 10.1002/(SICI)1521-1878(199901)21:1<47::AID-BIES6>3.0.CO;2-N; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; SUH DS, 1994, MOL ENDOCRINOL, V8, P794, DOI 10.1210/me.8.6.794; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; THOMAS MJ, 1995, ENDOCRINOLOGY, V136, P562, DOI 10.1210/en.136.2.562; Twigg SM, 1998, J BIOL CHEM, V273, P6074, DOI 10.1074/jbc.273.11.6074; Venkataraman C, 1999, J IMMUNOL, V162, P4053; WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262; WAXMAN DJ, 1991, P NATL ACAD SCI USA, V88, P6868, DOI 10.1073/pnas.88.15.6868; Wolf M, 1996, EUR J ENDOCRINOL, V135, P729, DOI 10.1530/eje.0.1350729; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yoshimura A, 1998, LEUKEMIA, V12, P1851, DOI 10.1038/sj.leu.2401238; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; ZAPF J, 1986, J CLIN INVEST, V77, P1768, DOI 10.1172/JCI112500; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	55	82	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3841	3847		10.1074/jbc.275.6.3841	http://dx.doi.org/10.1074/jbc.275.6.3841			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660535	hybrid			2022-12-27	WOS:000085288800019
J	Hill, K; Welti, S; Yu, JH; Murray, JT; Yip, SC; Condeelis, JS; Segall, JE; Backer, JM				Hill, K; Welti, S; Yu, JH; Murray, JT; Yip, SC; Condeelis, JS; Segall, JE; Backer, JM			Specific requirement for the p85-p110 alpha phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P85 REGULATORY SUBUNIT; PHOSPHOINOSITIDE 3-KINASE; MAMMARY ADENOCARCINOMA; ACTIVATION; INSULIN; RAC; 3'-KINASE; RHO	We have studied the role of phosphatidylinositol 3-kinases (PI 3-kinases) in the regulation of the actin cytoskeleton in MTLn3 rat adenocarcinoma cells. Stimulation of MTLn3 cells with epidermal growth factor (EGF) induced a rapid increase in actin polymerization, with production of lamellipodia within 3 min. EGF-stimulated lamellipodia were blocked by 100 naa wortmannin, suggesting the involvement of a class Ia PI 3-kinase, MTLn3 cells contain equal amounts of p110 alpha and p110 beta, and do not contain p110 delta. Injection of specific inhibitory antibodies to p110 alpha induced cell rounding and blocked EGF-stimulated lamellipod extension, whereas control or anti-p110 beta antibodies had no effect. In contrast, both antibodies inhibited EGF-stimulated DNA synthesis. An in situ assay for actin nucleation showed that EGF-stimulated formation of new barbed ends was blocked by injection of anti-p110 alpha antibodies. In summary, the p110 alpha isoform of PI 3-kinase is specifically required for EGF-stimulated actin nucleation during lamellipod extension in breast cancer cells.	Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Backer, JM (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Murray, James/AAC-6612-2019	Murray, James/0000-0002-6928-2347	NIGMS NIH HHS [GM55692] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen WE, 1997, J CELL SCI, V110, P707; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; BALTENSPERGER K, 1994, J BIOL CHEM, V269, P28937; Chan AY, 1998, J CELL SCI, V111, P199; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HU P, 1993, MOL CELL BIOL, V13, P7677, DOI 10.1128/MCB.13.12.7677; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; NERI A, 1982, J NATL CANCER I, V68, P507; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; REIF K, 1993, J BIOL CHEM, V268, P10780; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Segall JE, 1996, CLIN EXP METASTAS, V14, P61, DOI 10.1007/BF00157687; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Vanhaesebroeck B, 1999, NAT CELL BIOL, V1, P69, DOI 10.1038/9045; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	28	73	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3741	3744		10.1074/jbc.275.6.3741	http://dx.doi.org/10.1074/jbc.275.6.3741			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660520	hybrid			2022-12-27	WOS:000085288800004
J	Angstrom, J; Backstrom, M; Berntsson, A; Karlsson, N; Holmgren, J; Karlsson, KA; Lebens, M; Teneberg, S				Angstrom, J; Backstrom, M; Berntsson, A; Karlsson, N; Holmgren, J; Karlsson, KA; Lebens, M; Teneberg, S			Novel carbohydrate binding site recognizing blood group A and B determinants in a hybrid of cholera toxin and Escherichia coli heat-labile enterotoxin B-subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING; VIBRIO-CHOLERAE; HUMAN ADENOCARCINOMA; SPECIFICITY; IMMUNOGENICITY; GLYCOLIPIDS; SELECTIN; GLYCOSPHINGOLIPIDS; IDENTIFICATION; ANTIGENS	The B-subunits of cholera toxin (CTB) and Escherichia coli heat-labile enterotoxin (LTB) are structurally and functionally related. However, the carbohydrate binding specificities of the two proteins differ. While both CTB and LTB bind to the GM1 ganglioside, LTB also binds to N-acetyllactosamine-terminated glycoconjugates. The structural basis of the differences in carbohydrate recognition has been investigated by a systematic exchange of amino acids between LTB and CTB. Thereby, a CTB/LTB hybrid with a gain-of-function mutation resulting in recognition of blood group A and B determinants was obtained. Glycosphingolipid binding assays showed a specific binding of this hybrid B-subunit, but not CTB or LTB, to slowly migrating nonacid glycosphingolipids of human and animal small intestinal epithelium. A binding-active glycosphingolipid isolated from cat intestinal epithelium was characterized by mass spectrometry and proton NMR as GalNAc alpha 3(Fuc alpha 2)Gal beta 4(Fuc alpha 3)GlcNAc beta 3Gal beta 4Glc NAc beta 3Gal beta 4Glc beta 1Cer. Comparison with reference glycosphingolipids showed that the minimum binding epitope recognized by the CTB/LTB hybrid was Gal alpha 3(Fuc alpha 2)Gal beta 4(Fuc alpha 3)GlcNAc beta. The blood group A and B determinants bind to a novel carbohydrate binding site located at the top of the B-subunit interfaces, distinct from the GM1 binding site, as found by docking and molecular dynamics simulations.	Univ Gothenburg, Inst Med Biochem, SE-40530 Gothenburg, Sweden; Univ Gothenburg, Dept Med Microbiol & Immunol, SE-41346 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Teneberg, S (corresponding author), Univ Gothenburg, Inst Med Biochem, POB 440, SE-40530 Gothenburg, Sweden.		Karlsson, Niclas/G-5235-2013	Karlsson, Niclas/0000-0002-3045-2628; Lebens, Michael/0000-0001-9458-9474; Holmgren, Jan/0000-0003-1784-5918				ANGSTROM J, 1994, P NATL ACAD SCI USA, V91, P11859, DOI 10.1073/pnas.91.25.11859; Backstrom M, 1997, MOL MICROBIOL, V24, P489, DOI 10.1046/j.1365-2958.1997.3541721.x; BLACK RE, 1985, P 11 NOB C, P23; Blanck O, 1996, J BIOL CHEM, V271, P7289, DOI 10.1074/jbc.271.13.7289; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREIMER ME, 1980, ADV MASS SPECTROM, V8, P1097; CLAUSEN H, 1985, BIOCHEMISTRY-US, V24, P3578, DOI 10.1021/bi00335a028; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; Dickinson Bonny L., 1996, P73, DOI 10.1016/B978-012410580-5/50006-6; DOMENIGHINI M, 1995, MOL MICROBIOL, V15, P1165, DOI 10.1111/j.1365-2958.1995.tb02289.x; Elson Charles O., 1996, P59, DOI 10.1016/B978-012410580-5/50005-4; FUKUTA S, 1988, INFECT IMMUN, V56, P1748, DOI 10.1128/IAI.56.7.1748-1753.1988; Guidry JJ, 1997, INFECT IMMUN, V65, P4943, DOI 10.1128/IAI.65.12.4943-4950.1997; HAKOMORI S, 1984, J BIOL CHEM, V259, P4672; HANSSON GC, 1983, J BIOL CHEM, V258, P4091; HOLMGREN J, 1973, INFECT IMMUN, V8, P851, DOI 10.1128/IAI.8.6.851-859.1973; IMBERTY A, 1995, GLYCOCONJUGATE J, V12, P331, DOI 10.1007/BF00731336; Karlsson K A, 1978, Prog Chem Fats Other Lipids, V16, P207, DOI 10.1016/0079-6832(78)90045-9; Karlsson KA, 1996, BIOORGAN MED CHEM, V4, P1919, DOI 10.1016/S0968-0896(96)00174-5; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; KARLSSON KA, 1979, J BIOL CHEM, V254, P9311; KARLSSON KA, 1974, BIOCHEMISTRY-US, V13, P3643, DOI 10.1021/bi00715a003; KARLSSON KA, 1976, GLYCOLIPID METHODOLO, P97; KOGAN TP, 1995, J BIOL CHEM, V270, P14047, DOI 10.1074/jbc.270.23.14047; LARSON G, 1987, CARBOHYD RES, V161, P281, DOI 10.1016/S0008-6215(00)90085-5; LEBENS M, 1993, BIO-TECHNOL, V11, P1574, DOI 10.1038/nbt1293-1574; Lebens M, 1996, INFECT IMMUN, V64, P2144, DOI 10.1128/IAI.64.6.2144-2150.1996; LEONG J, 1985, INFECT IMMUN, V48, P73, DOI 10.1128/IAI.48.1.73-77.1985; LEVERY SB, 1986, CARBOHYD RES, V151, P311, DOI 10.1016/S0008-6215(00)90351-3; Merritt EA, 1998, J MOL BIOL, V282, P1043, DOI 10.1006/jmbi.1998.2076; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Moreno E, 1997, BIOCHEMISTRY-US, V36, P4429, DOI 10.1021/bi962231h; Nashar TO, 1996, P NATL ACAD SCI USA, V93, P226, DOI 10.1073/pnas.93.1.226; ORLANDI PA, 1994, BIOCHEMISTRY-US, V33, P12886, DOI 10.1021/bi00209a021; Revelle BM, 1996, J BIOL CHEM, V271, P4289; SANCHEZ J, 1989, P NATL ACAD SCI USA, V86, P481, DOI 10.1073/pnas.86.2.481; SIXMA TK, 1992, NATURE, V355, P561, DOI 10.1038/355561a0; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; TENEBERG S, 1994, GLYCOCONJUGATE J, V11, P533, DOI 10.1007/BF00731304; WALDI D, 1962, DUNNSCHICHT CHROMATO, P495	40	33	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3231	3238		10.1074/jbc.275.5.3231	http://dx.doi.org/10.1074/jbc.275.5.3231			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652309	hybrid			2022-12-27	WOS:000085146500031
J	Brodolin, K; Mustaev, A; Severinov, K; Nikiforov, V				Brodolin, K; Mustaev, A; Severinov, K; Nikiforov, V			Identification of RNA polymerase beta ' subunit segment contacting the melted region of the lacUV5 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN COMPLEX-FORMATION; SINGLE-STRANDED-DNA; SIGMA(70) SUBUNIT; CRYSTAL-STRUCTURE; CROSS-LINKING; TEMPERATURE-DEPENDENCE; LAMBDA-EXONUCLEASE; ELONGATION COMPLEX; NONTEMPLATE STRAND; TRANSCRIPTION	Identification of the RNA polymerase functional regions involved in interactions with promoter is a basis for understanding the mechanism of transcription initiation. We have used formaldehyde cross-linking to identify a region of Escherichia coli RNA polymerase beta' subunit contacting lacUV5 promoter in open complex. Treatment of open complex with formaldehyde results in cross-linking of beta' and sigma(70) subunits at positions -5 and -3 on the nontemplate strand of the promoter DNA These cross-links reflect specific interactions between RNA polymerase and promoter established in open complex. The positions of formaldehyde cross-links in the beta' subunit were mapped to the N-terminal segment (Cys(198)-Met(237)), which is contiguous to the evolutionary conserved region B, The proximity of the beta' and sigma crosslinks suggest that the N-terminal region of the beta' subunit, interacting with single-stranded promoter DNA, can cooperate with the sigma subunit in the process of open complex formation.	Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; Publ Hlth Res Inst, New York, NY 10016 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	Russian Academy of Sciences; Rutgers State University New Brunswick	Brodolin, K (corresponding author), Russian Acad Sci, Inst Mol Genet, Kurchatov Sq, Moscow 123182, Russia.		Severinov, Konstantin/C-8545-2016; Brodolin, Konstantin/I-2996-2016; Brodolin, Konstantin/S-5499-2019	Brodolin, Konstantin/0000-0003-3124-7586; Brodolin, Konstantin/0000-0003-3124-7586	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059295, R01GM030717] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30717, R01 GM59295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR SE, 1994, BIOCHEMISTRY-US, V33, P11501, DOI 10.1021/bi00204a012; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; BRODOLIN KL, 1993, NUCLEIC ACIDS RES, V21, P5748, DOI 10.1093/nar/21.24.5748; BUC H, 1985, BIOCHEMISTRY-US, V24, P2712, DOI 10.1021/bi00332a018; BUCKLE M, 1991, NUCLEIC ACIDS RES, V19, P833, DOI 10.1093/nar/19.4.833; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; DEHASETH PL, 1995, MOL MICROBIOL, V16, P817, DOI 10.1111/j.1365-2958.1995.tb02309.x; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; GRAGEROV AI, 1980, MOL GEN GENET, V180, P399, DOI 10.1007/BF00425854; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Heisler LM, 1996, J BIOL CHEM, V271, P14572, DOI 10.1074/jbc.271.24.14572; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; JUANG YL, 1994, J MOL BIOL, V235, P1470, DOI 10.1006/jmbi.1994.1102; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KONTERMANN RE, 1993, PROTEIN SCI, V2, P223; Kovall R, 1997, SCIENCE, V277, P1824, DOI 10.1126/science.277.5333.1824; KUNKEL GR, 1981, MOL CELL BIOCHEM, V34, P3, DOI 10.1007/BF02354846; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; Li XY, 1998, J BIOL CHEM, V273, P23558, DOI 10.1074/jbc.273.36.23558; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; MCGHEE JD, 1975, BIOCHEMISTRY-US, V14, P1281, DOI 10.1021/bi00677a029; MCGHEE JD, 1975, BIOCHEMISTRY-US, V14, P1297, DOI 10.1021/bi00677a030; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Roberts CW, 1996, CELL, V86, P495; ROE JH, 1985, J MOL BIOL, V184, P441, DOI 10.1016/0022-2836(85)90293-1; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; Severinov K, 1997, P NATL ACAD SCI USA, V94, P13481, DOI 10.1073/pnas.94.25.13481; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SIMPSON RB, 1979, CELL, V18, P277, DOI 10.1016/0092-8674(79)90047-3; SRIPRAKASH KS, 1975, J BIOL CHEM, V250, P5438; TULLIUS TD, 1987, METHOD ENZYMOL, V155, P537; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6	46	23	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3661	3666		10.1074/jbc.275.5.3661	http://dx.doi.org/10.1074/jbc.275.5.3661			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652363	hybrid			2022-12-27	WOS:000085146500085
J	Murakami, S; Lefebvre, V; de Crombrugghe, B				Murakami, S; Lefebvre, V; de Crombrugghe, B			Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PRO-ALPHA-1(II) COLLAGEN GENE; CHONDROCYTE-SPECIFIC ENHANCER; HUMAN OSTEOARTHRITIC CARTILAGE; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; II COLLAGEN; RHEUMATOID-ARTHRITIS; CAMPOMELIC DYSPLASIA; INDUCED APOPTOSIS	The inflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) strongly inhibit the expression of genes for cartilage extracellular matrix proteins. We have recently obtained genetic evidence indicating that the high mobility group domain containing transcription factor Sox9 is required for cartilage formation and for expression of chondrocyte-specific genes including the gene for type II collagen (Col2a1). We show here that IL-1 and TNF-alpha cause a marked and rapid decrease in the levels of Sox9 mRNA and/or protein in chondrocytes. A role for the transcription factor NF kappa B in Sox9 down-regulation was suggested by the ability of pyrrolidine dithiocarbamate, an inhibitor of the NF kappa B pathway, to block the effects of IL-1 and TNF-alpha. This role was further supported by the ability of a dominant-negative mutant of I kappa B alpha to block the IL-1 and TNF-alpha inhibition of Sox9-dependent Col2a1 enhancer elements. Furthermore, forced expression of the NF kappa B subunits p65 or p50 also inhibited Sox9-dependent Col2a1 enhancer. Because Sox9 is essential for chondrogenesis, the marked down-regulation of the Sox9 gene by IL-1 and TNF-alpha in chondrocytes is sufficient to account for the inhibition of the chondrocyte phenotype by these cytokines. The down-regulation of Sox9 may have a crucial role in inhibiting expression of the cartilage phenotype in inflammatory joint diseases.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	de Crombrugghe, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042919, R01AR042909] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01 AR42919-02, R01 AR42909] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bolton MC, 1996, BIOCHEM J, V319, P489, DOI 10.1042/bj3190489; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Cameron FJ, 1996, HUM MOL GENET, V5, P1625, DOI 10.1093/hmg/5.10.1625; CHANDRASEKHAR S, 1990, EXP CELL RES, V191, P105, DOI 10.1016/0014-4827(90)90042-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chubinskaya S, 1996, LAB INVEST, V74, P232; CONCA W, 1989, J CLIN INVEST, V83, P1753, DOI 10.1172/JCI114077; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; DUCKETT CS, 1993, MOL CELL BIOL, V13, P1315, DOI 10.1128/MCB.13.3.1315; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FONTANA A, 1982, RHEUMATOL INT, V2, P49, DOI 10.1007/BF00541245; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GOLDRING MB, 1994, J CELL BIOCHEM, V54, P85, DOI 10.1002/jcb.240540110; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Huang JD, 1995, GENE DEV, V9, P3177, DOI 10.1101/gad.9.24.3177; HUSBY G, 1988, J AUTOIMMUN, V1, P363, DOI 10.1016/0896-8411(88)90006-6; IP YT, 1991, CELL, V64, P439; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KIROV N, 1994, MOL CELL BIOL, V14, P713, DOI 10.1128/MCB.14.1.713; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Labow M, 1997, J IMMUNOL, V159, P2452; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1052, P366, DOI 10.1016/0167-4889(90)90145-4; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; Lum ZP, 1996, J CELL PHYSIOL, V166, P351, DOI 10.1002/(SICI)1097-4652(199602)166:2<351::AID-JCP13>3.0.CO;2-E; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; METSARANTA M, 1991, BIOCHIM BIOPHYS ACTA, V1089, P241, DOI 10.1016/0167-4781(91)90014-D; MIOSSEC P, 1986, ARTHRITIS RHEUM, V29, P461, DOI 10.1002/art.1780290402; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Ohta S, 1998, LAB INVEST, V78, P79; OKADA Y, 1992, LAB INVEST, V66, P680; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shornick LP, 1996, J EXP MED, V183, P1427, DOI 10.1084/jem.183.4.1427; SIRUMCONNOLLY K, 1991, NUCLEIC ACIDS RES, V19, P335, DOI 10.1093/nar/19.2.335; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; Sudbeck P, 1996, NAT GENET, V13, P230, DOI 10.1038/ng0696-230; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WOOD DD, 1983, ARTHRITIS RHEUM, V26, P975, DOI 10.1002/art.1780260806; YOCUM DE, 1989, CELL IMMUNOL, V122, P131, DOI 10.1016/0008-8749(89)90154-8; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; ZHOU G, 1995, J CELL SCI, V108, P3677	67	225	244	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3687	3692		10.1074/jbc.275.5.3687	http://dx.doi.org/10.1074/jbc.275.5.3687			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652367	hybrid			2022-12-27	WOS:000085146500089
J	Bertsch, U; Deschermeier, C; Fanick, W; Girkontaite, I; Hillemeier, K; Johnen, H; Weglohner, W; Emmrich, F; Mayr, GW				Bertsch, U; Deschermeier, C; Fanick, W; Girkontaite, I; Hillemeier, K; Johnen, H; Weglohner, W; Emmrich, F; Mayr, GW			The second messenger binding site of inositol 1,4,5-trisphosphate 3-kinase is centered in the catalytic domain and related to the inositol trisphosphate receptor site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; MOLECULAR-CLONING; EXPRESSION; PROTEINS; DNA; 5-PHOSPHATASES; IDENTIFICATION; ACTIVATION; CALMODULIN; RESIDUES	A segment of inositol 1,4,5 trisphosphate 3-kinase responsible for inositol 1,4,5-trisphosphate (InsP(3)) binding was characterized and confirmed by three different approaches employing the fully active expressed catalytic domain of the enzyme. Part of this moiety was protected from limited tryptic proteolysis by InsP(3). Sequencing of two fragments of 16 and 21 kDa, generated in the absence or presence of InsP(3), respectively, identified segment Glu-271 to Arg-305 as being protected. 15 monoclonal antibodies, all binding to epitopes within this region, inhibited enzyme activity and interfered with inositol phosphate binding. Detailed enzyme kinetic parameters of 32 site-directed mutants revealed residues Arg-276 and Lys-303 in this segment and Arg-322, located nearby, as directly involved in and five other closely neighbored residues, all located within a segment of 73 amino acids, as also influencing InsP(3) binding. Part of this region is similar in sequence to an InsP(3) binding segment in InsP(3) receptors, Combined with the finding that mutants influencing only ATP binding all lie outside this region, these data indicate that an InsP(3) binding core domain is inserted between two segments acting together in ATP binding and phosphate transfer.	Univ Hamburg, Krankenhaus Eppendorf, Inst Med Biochem & Mol Biol, D-20246 Hamburg, Germany; Univ Wurzburg, Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Brahms Diagnost, D-12099 Berlin, Germany; Univ Klin Leipzig, Inst Klin Immunol & Transfus Med, D-04103 Leipzig, Germany	University of Hamburg; University of Wurzburg; Thermo Fisher Scientific; Brahms AG; Leipzig University	Mayr, GW (corresponding author), Univ Hamburg, Krankenhaus Eppendorf, Inst Med Biochem & Mol Biol, Martinistr 52, D-20246 Hamburg, Germany.		Girkontaite, Irute/K-9017-2013	Girkontaite, Irute/0000-0002-3659-3202				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bertsch U, 1999, GENE, V228, P61, DOI 10.1016/S0378-1119(99)00018-9; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; COMMUNI D, 1993, BIOCHEM J, V291, P811, DOI 10.1042/bj2910811; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Erneux C, 1998, BBA-MOL CELL BIOL L, V1436, P185, DOI 10.1016/S0005-2760(98)00132-5; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FOSTER PS, 1994, EUR J BIOCHEM, V222, P955, DOI 10.1111/j.1432-1033.1994.tb18946.x; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; MOUREY RJ, 1993, BIOCHEMISTRY-US, V32, P1719, DOI 10.1021/bi00058a004; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; ROSS CA, 1992, P NATL ACAD SCI USA, V89, P4265, DOI 10.1073/pnas.89.10.4265; RYU SH, 1987, FASEB J, V1, P388, DOI 10.1096/fasebj.1.5.2824270; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; SHIN YS, 1995, MOL CELLS, V5, P348; TAKAZAWA K, 1991, BIOCHEM J, V280, P125, DOI 10.1042/bj2800125; TAKAZAWA K, 1990, BIOCHEM J, V272, P107, DOI 10.1042/bj2720107; TAKAZAWA K, 1991, BIOCHEM J, V278, P883, DOI 10.1042/bj2780883; TAKAZAWA K, 1991, BIOCHEM BIOPH RES CO, V174, P529, DOI 10.1016/0006-291X(91)91449-M; THOMAS S, 1994, BBA-MOL CELL RES, V1220, P219, DOI 10.1016/0167-4889(94)90139-2; Togashi S, 1997, BIOCHEM J, V326, P221, DOI 10.1042/bj3260221; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277	37	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1557	1564		10.1074/jbc.275.3.1557	http://dx.doi.org/10.1074/jbc.275.3.1557			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636844	hybrid			2022-12-27	WOS:000084940000007
J	Moffett, S; Brown, DA; Linder, ME				Moffett, S; Brown, DA; Linder, ME			Lipid-dependent targeting of G proteins into rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; GPI-ANCHORED PROTEINS; T-CELL ACTIVATION; SIGNAL-TRANSDUCTION; MEMBRANE-BINDING; ADENYLYL-CYCLASE; TYROSINE KINASES; MODEL MEMBRANES; PLASMA-MEMBRANE; ALPHA-SUBUNITS	Domains rich in sphingolipids and cholesterol, or rafts, may organize signal transduction complexes at the plasma membrane. Raft lipids are believed to exist in a state similar to the liquid-ordered phase. It has been proposed that proteins with a high affinity for an ordered lipid environment will preferentially partition into rafts (Melkonian, K. A., Ostermeyer, A. G., Chen, J. Z., Roth, M. G., and Brown, D. A. (1999) J. Biol. Chem. 274, 3910-3917), We investigated the possibility that lipid-lipid interactions between lipid-modified proteins and raft lipids mediate targeting of proteins to these domains. G protein monomers or trimers were reconstituted in liposomes, engineered to mimic raft domains. Assay for partitioning of G proteins into rafts was based on Triton X-100 insolubility. Myristoylation and palmitoylation of G alpha(i) were necessary and sufficient for association with liposomes and partitioning into rafts. Strikingly, the amount of fatty-acylated G alpha(i) in rafts was significantly reduced when myristoylated G alpha(i) was thioacylated with cis-unsaturated fatty acids instead of saturated fatty acids such as palmitate. Prenylated beta gamma subunits were excluded from rafts, whether reconstituted alone or with fatty-acylated cy subunits, These results suggest that the structural difference between lipids that modify proteins is one basis for the selectivity of protein targeting to rafts.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Linder, ME (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Box 8228, St Louis, MO 63110 USA.		Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466, R01GM047897] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51466, GM47897] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; ANTONNY B, 1993, J BIOL CHEM, V268, P2393; Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478; ARREAZA G, 1995, J BIOL CHEM, V270, P23641, DOI 10.1074/jbc.270.40.23641; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown RE, 1998, J CELL SCI, V111, P1; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Fishburn CS, 1999, J BIOL CHEM, V274, P18793, DOI 10.1074/jbc.274.26.18793; FUNG BKK, 1983, J BIOL CHEM, V258, P503; Galbiati F, 1999, J BIOL CHEM, V274, P5843, DOI 10.1074/jbc.274.9.5843; Ge MT, 1999, BIOPHYS J, V77, P925, DOI 10.1016/S0006-3495(99)76943-2; GENNIS RB, 1989, BIOMEMBRANES MOL STR, P49; HALLAK H, 1994, J BIOL CHEM, V269, P4713; Huang CF, 1999, P NATL ACAD SCI USA, V96, P412, DOI 10.1073/pnas.96.2.412; Huang CF, 1997, MOL BIOL CELL, V8, P2365, DOI 10.1091/mbc.8.12.2365; Iiri T, 1996, P NATL ACAD SCI USA, V93, P14592, DOI 10.1073/pnas.93.25.14592; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; KWONG J, 1995, BIOCHEM BIOPH RES CO, V207, P868, DOI 10.1006/bbrc.1995.1266; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; LINDER ME, 1990, J BIOL CHEM, V265, P8243; MACALA LJ, 1983, J LIPID RES, V24, P1243; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; Morales J, 1998, MOL BIOL CELL, V9, P1, DOI 10.1091/mbc.9.1.1; MUMBY SM, 1994, METHOD ENZYMOL, V237, P254; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Rehm A, 1997, J CELL BIOL, V137, P305, DOI 10.1083/jcb.137.2.305; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; SCHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Song JP, 1996, BIOCHEMISTRY-US, V35, P14806, DOI 10.1021/bi961846b; Song KS, 1997, CELL MOL BIOL, V43, P293; STERNWEIS PC, 1979, J BIOL CHEM, V254, P3333; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	58	345	354	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2191	2198		10.1074/jbc.275.3.2191	http://dx.doi.org/10.1074/jbc.275.3.2191			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636925	hybrid			2022-12-27	WOS:000084940000088
J	Moore, M; Harrison, MS; Peterson, EC; Henry, R				Moore, M; Harrison, MS; Peterson, EC; Henry, R			Chloroplast Oxa1p homolog albino3 is required for post-translational integration off the light harvesting chlorophyll-binding protein into thylakoid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN; N-TERMINI; C-TERMINI; TRANSLOCATION; EXPORT; TRANSPORT; IMPORT; MITOCHONDRIA; INSERTION; PATHWAYS	Multiple sorting pathways operate in chloroplasts to localize proteins to the thylakoid membrane. The signal recognition particle (SRP) pathway in chloroplasts employs the function of a signal recognition particle (cpSRP) to target light harvesting chlorophyll-binding protein (LHCP) to the thylakoid membrane. In assays that reconstitute stroma-dependent LHCP integration in vitro, the stroma is replaceable by the addition of GTP, cpSRP, and an SRP receptor homolog, cpFtsY, Still lacking is an understanding of events that take place at the thylakoid membrane including the identification of membrane proteins that may function at the level of cpFtsY binding or LHCP integration. The identification of Oxalp in mitochondria, an inner membrane translocase component homologous to predicted proteins in bacteria and to the albino3 (ALB3) protein in thylakoids, led us to investigate the potential role of ALB3 in LHGP integration. Antibody raised against a 50-amino acid region of ALB3 (ALB3-50aa) identified a single 45-kDa thylakoid protein. Treatment of thylakoids with antibody to ALB3-50aa inhibited LHCP integration, whereas the same antibody treatment performed in the presence of antigen reversed the inhibition. In contrast, transport by the thylakoid Sec or Delta pH pathways was unaffected. These data support a model whereby a distinct translocase containing ALB3 is used to integrate LHCP into thylakoid membranes.	Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Henry, R (corresponding author), Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA.		Peterson, Eric/I-3082-2013					ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1989, J BIOL CHEM, V264, P14225; CLINE K, 1986, J BIOL CHEM, V261, P4804; Cline K, 1996, ANNU REV CELL DEV BI, V12, P1, DOI 10.1146/annurev.cellbio.12.1.1; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; Dalbey RE, 1999, TRENDS BIOCHEM SCI, V24, P17, DOI 10.1016/S0968-0004(98)01333-4; HARLOW E, 1988, USING ANTIBODIES LAB, P309; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HOFFMAN NE, 1994, PLANT PHYSIOL, V105, P295, DOI 10.1104/pp.105.1.295; HULFORD A, 1994, J BIOL CHEM, V269, P3251; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; LAIDLER V, 1995, J BIOL CHEM, V270, P17664, DOI 10.1074/jbc.270.30.17664; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schuenemann D, 1999, J BIOL CHEM, V274, P12177, DOI 10.1074/jbc.274.17.12177; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; Settles AM, 1998, TRENDS CELL BIOL, V8, P494, DOI 10.1016/S0962-8924(98)01387-7; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514; Zhu YX, 1998, GENE, V208, P1, DOI 10.1016/S0378-1119(97)00613-6	34	186	192	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1529	1532		10.1074/jbc.275.3.1529	http://dx.doi.org/10.1074/jbc.275.3.1529			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636840	hybrid			2022-12-27	WOS:000084940000003
J	Yeh, SR; Couture, M; Ouellet, Y; Guertin, M; Rousseau, DL				Yeh, SR; Couture, M; Ouellet, Y; Guertin, M; Rousseau, DL			A cooperative oxygen finding hemoglobin from Mycobacterium tuberculosis - Stabilization of heme ligands by a distal tyrosine residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ALGA CHLAMYDOMONAS-EUGAMETOS; DIMERIC BACTERIAL HEMOGLOBIN; RESONANCE RAMAN-SCATTERING; SITE-DIRECTED MUTAGENESIS; SPECTROSCOPIC CHARACTERIZATION; ALCALIGENES-EUTROPHUS; ANGSTROM RESOLUTION; INDUCED OXIDATION; PRIMARY SEQUENCE	The homodimeric hemoglobin (HbN) from Mycobacterium tuberculosis displays an extremely high oxygen binding affinity and cooperativity, Sequence alignment with other hemoglobins suggests that the proximal F8 ligand is histidine, the distal E7 residue is leucine, and the B10 position is occupied by tyrosine. To determine how these heme pocket residues regulate the ligand binding affinities and physiological functions of HbN, we have measured the resonance Raman spectra of the O-2, CO, and OH- derivatives of the wild type protein and the B10 Tyr --> Leu and Phe mutants. Taken together these data demonstrate a unique distal environment in which the heme bound ligands strongly interact with the B10 tyrosine residue. The implications of these data on the physiological functions of HbN and another heme-containing protein, cytochrome c oxidase, are considered.	Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Laval, Fac Sci & Engn, Dept Biochem, Quebec City, PQ G1K 7P4, Canada	Yeshiva University; Albert Einstein College of Medicine; Laval University	Yeh, SR (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.		Couture, Manon/F-8326-2015	Couture, Manon/0000-0001-8296-8055; Yeh, Syun-Ru/0000-0002-9858-386X				ANNI H, 1992, MET IONS BIOL SYST, V28, P219; APPLEBY CA, 1984, ANNU REV PLANT PHYS, V35, P443, DOI 10.1146/annurev.pp.35.060184.002303; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; COUTURE M, 1994, MOL GEN GENET, V243, P185, DOI 10.1007/BF00280316; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Couture M, 1996, EUR J BIOCHEM, V242, P779, DOI 10.1111/j.1432-1033.1996.0779r.x; Couture M, 1999, J BIOL CHEM, V274, P6898, DOI 10.1074/jbc.274.11.6898; CRAMM R, 1994, J BIOL CHEM, V269, P7349; Crawford MJ, 1998, J BIOL CHEM, V273, P12543, DOI 10.1074/jbc.273.20.12543; Das TK, 1999, J BIOL CHEM, V274, P2916, DOI 10.1074/jbc.274.5.2916; Das TK, 1998, BIOCHEMISTRY-US, V37, P14471, DOI 10.1021/bi981500w; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; DAS TK, 2000, IN PRESS BIOCHEMISTR; DASGUPTA S, 1989, J BIOL CHEM, V264, P654; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; Dikshit KL, 1998, ARCH BIOCHEM BIOPHYS, V349, P161, DOI 10.1006/abbi.1997.0432; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x; FEIS A, 1994, BIOCHEMISTRY-US, V33, P4577, DOI 10.1021/bi00181a019; GIBSON QH, 1993, J BIOL CHEM, V268, P16993; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; Herold S, 1998, FEBS LETT, V439, P85, DOI 10.1016/S0014-5793(98)01345-3; Hirota S, 1996, J AM CHEM SOC, V118, P7845, DOI 10.1021/ja9608297; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; KITAGAWA T, 1982, NATURE, V298, P869, DOI 10.1038/298869a0; Kushkuley B, 1996, BIOPHYS J, V70, P1214, DOI 10.1016/S0006-3495(96)79680-7; Lee JB, 1998, J AM CHEM SOC, V120, P7493, DOI 10.1021/ja980507y; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; MacMillan F, 1999, BIOCHEMISTRY-US, V38, P9179, DOI 10.1021/bi9911987; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4342, DOI 10.1021/bi00013a024; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; PHILLIPS SEV, 1981, NATURE, V292, P81, DOI 10.1038/292081a0; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; ROUSSEAU DL, 1993, J BIOENERG BIOMEMBR, V25, P165, DOI 10.1007/BF00762858; SASSAROLI M, 1988, BIOCHEMISTRY-US, V27, P2496, DOI 10.1021/bi00407a036; SMULEVICH G, 1988, BIOCHEMISTRY-US, V27, P5486, DOI 10.1021/bi00415a015; SONG SH, 1993, BIOCHEMISTRY-US, V32, P6330, DOI 10.1021/bi00076a005; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; Tarricone C, 1997, STRUCTURE, V5, P497, DOI 10.1016/S0969-2126(97)00206-2; TSAI PS, 1995, BIOTECHNOL PROGR, V11, P288, DOI 10.1021/bp00033a008; Unno M, 1998, J AM CHEM SOC, V120, P2670, DOI 10.1021/ja973293d; VANWART HE, 1985, J BIOL CHEM, V260, P8372; WAKABAYASHI S, 1986, NATURE, V322, P481, DOI 10.1038/322481a0; Wang J., 1996, METHODS NITRIC OXIDE, P427; YANG J, 1995, P NATL ACAD SCI USA, V92, P4224, DOI 10.1073/pnas.92.10.4224; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; YU NT, 1983, BIOCHEMISTRY-US, V22, P4534, DOI 10.1021/bi00288a028; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	50	115	119	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1679	1684		10.1074/jbc.275.3.1679	http://dx.doi.org/10.1074/jbc.275.3.1679			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636862	hybrid			2022-12-27	WOS:000084940000025
J	Tandy, S; Williams, M; Leggett, A; Lopez-Jimenez, M; Dedes, M; Ramesh, B; Srai, SK; Sharp, P				Tandy, S; Williams, M; Leggett, A; Lopez-Jimenez, M; Dedes, M; Ramesh, B; Srai, SK; Sharp, P			Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; BASOLATERAL MEMBRANES; EPITHELIAL-CELLS; ZINC TRANSPORT; LINE CACO-2; MECHANISMS; RAT; ABSORPTION; REDUCTION; MUTATION	The absorption of dietary non-heme iron by intestinal enterocytes is crucial to the maintenance of body iron homeostasis. This process must be tightly regulated since there are no distinct mechanisms for the excretion of excess iron from the body. An insight into the cellular mechanisms has recently been provided by expression cloning of a divalent cation transporter (DCT1) from rat duodenum and positional cloning of its human homologue, Nramp2. Here we demonstrate that Nramp2 is expressed in the apical membrane of the human intestinal epithelial cell line, Caco 2 TC7, and is associated with functional iron transport in these cells with a substrate preference for iron over other divalent cations. Iron transport occurs by a proton-dependent mechanism, exhibiting a concurrent intracellular acidification. Taken together, these data suggest that the expression of the Nramp2 transporter in human enterocytes may play an important role in intestinal iron absorption.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Inst Food Res, Norwich NR4 7UA, Norfolk, England; Royal Free Hosp, Dept Biochem & Mol Biol, London NW3 2PF, England; UCL, Sch Med, London NW3 2PF, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; UCL Medical School	Sharp, P (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	p.a.sharp@uea.ac.uk	Srai, Kaila/AAE-7039-2021; Srai, Surjit K/C-5575-2009					Arredondo M, 1997, AM J PHYSIOL-GASTR L, V273, pG275, DOI 10.1152/ajpgi.1997.273.2.G275; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Carriere V, 1996, AM J PHYSIOL-GASTR L, V270, pG976, DOI 10.1152/ajpgi.1996.270.6.G976; CHANTRET I, 1994, J CELL SCI, V107, P213; COX TM, 1981, BIOCHEM J, V194, P753, DOI 10.1042/bj1940753; COX TM, 1980, Q J MED, V49, P249; FLATMAN R, 1998, J PHYSIOL-LONDON, V511, P26; FLEET JC, 1993, AM J PHYSIOL, V264, pG1037, DOI 10.1152/ajpgi.1993.264.6.G1037; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Glahn RP, 1996, J NUTR, V126, P332, DOI 10.1093/jn/126.1.332; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HALLEUX C, 1991, IN VITRO CELL DEV B, V27, P293; Han O, 1999, J NUTR, V129, P98, DOI 10.1093/jn/129.1.98; HAN O, 1995, J NUTR, V125, P1291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCAS ML, 1978, GUT, V19, P735, DOI 10.1136/gut.19.8.735; MCEWAN GTA, 1988, PROC R SOC SER B-BIO, V234, P219, DOI 10.1098/rspb.1988.0045; Nunez MT, 1996, J NUTR, V126, P2151, DOI 10.1093/jn/126.9.2151; ORiordan DK, 1997, J PHYSIOL-LONDON, V500, P379, DOI 10.1113/jphysiol.1997.sp022028; ORIORDAN DK, 1995, EUR J CLIN INVEST, V25, P722, DOI 10.1111/j.1365-2362.1995.tb01950.x; RAFFANIELLO RD, 1992, J CELL PHYSIOL, V152, P356, DOI 10.1002/jcp.1041520217; RAJA KB, 1992, BIOCHIM BIOPHYS ACTA, V1135, P141, DOI 10.1016/0167-4889(92)90129-Y; SHARP PA, 1994, EXP PHYSIOL, V79, P203, DOI 10.1113/expphysiol.1994.sp003753; SHARP PA, 1998, Z GASTROENTEROL VERH, V36, P342; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; TACNET F, 1993, J PHYSIOL-LONDON, V465, P57, DOI 10.1113/jphysiol.1993.sp019666; WILLIAMS MR, 1992, J MEMBRANE BIOL, V129, P179	28	234	237	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1023	1029		10.1074/jbc.275.2.1023	http://dx.doi.org/10.1074/jbc.275.2.1023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625641	hybrid			2022-12-27	WOS:000084836600045
J	Collette, Y; Arold, S; Picard, C; Janvier, K; Benichou, S; Benarous, R; Olive, D; Dumas, C				Collette, Y; Arold, S; Picard, C; Janvier, K; Benichou, S; Benarous, R; Olive, D; Dumas, C			HIV-2 and SIV Nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY VIRUS NEF; BINDING SURFACE; CRYSTAL-STRUCTURE; RHESUS MACAQUES; DOWN-REGULATION; SERINE KINASE; I MOLECULES; ASSOCIATION; HCK; COMPLEX	The nef gene is required for optimal viral spread of human and simian immunodeficiency viruses. However, the molecular mechanisms underlying the action of the Nef proteins may not be identical for all viral families. Here we investigate the interaction between the Nef protein of human and simian immunodeficiency viruses and SH3 domains from Src family kinases, Using the yeast two-hybrid system and immunoblotting we show that, in contrast to HIV-1 Nef, SN and HIV-2 Nef poorly interact with Hck SH3 but bind to Src and Fyn SH3 domains. The molecular basis of these differences in SH3 targeting was revealed by sequence analysis and homology modeling of the putative SH3-Nef structures. Three amino acids (Trp-113, Thr-117, and Gln-118) that localize in a "hydrophobic pocket" implicated in SH3 binding of HIV-1 Nef, are systematically substituted in SIV/HIV-2 alleles (by Tyr, Glu, and Glu, respectively). We demonstrate that site-directed mutagenesis of these residues in SIVmac239 Nef suffices to restore Hck SH3 binding and co immunoprecipitation with full-length Hck from transfected cells, Our findings identify fundamental mechanistic differences in targeting of Src family kinases by HN and SIV Nef. The herein described mechanism of SH3 selection by Nef via a "pocket" proximal to the canonical proline-rich motif may be a common feature for SH3 recognition by their natural ligands.	Univ Mediterranee, U119 INSERM, F-13009 Marseille, France; Univ Montpellier 1, U414 INSERM, UMR C9955 CNRS, Ctr Biochim Struct,Fac Pharm, F-34060 Montpellier, France; Inst Cochin Genet Mol, EPI INSERM 9923, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Collette, Y (corresponding author), Univ Mediterranee, U119 INSERM, 27 Blvd Lei Roure, F-13009 Marseille, France.		COLLETTE, Yves/F-2270-2013; Janvier, Katy/O-7780-2017; Arold, Stefan/T-2612-2019	COLLETTE, Yves/0000-0001-5359-7099; Janvier, Katy/0000-0002-3105-4736; Benichou, Serge/0000-0003-3602-3530; Arold, Stefan T/0000-0001-5278-0668				Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; DU ZJ, 1995, CELL, V82, P665, DOI 10.1016/0092-8674(95)90038-1; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Greenway AL, 1999, J VIROL, V73, P6152, DOI 10.1128/JVI.73.7.6152-6158.1999; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Karn T, 1998, VIROLOGY, V246, P45, DOI 10.1006/viro.1998.9157; Khan IH, 1998, J VIROL, V72, P5820, DOI 10.1128/JVI.72.7.5820-5830.1998; KORBER B, 1997, HUMAN RETROVIRUS AID; Lang SM, 1997, NAT MED, V3, P860, DOI 10.1038/nm0897-860; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu LX, 1997, J BIOL CHEM, V272, P13779, DOI 10.1074/jbc.272.21.13779; Manninen A, 1998, VIROLOGY, V250, P273, DOI 10.1006/viro.1998.9381; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; TUFFERY P, 1991, J BIOMOL STRUCT DYN, V8, P1267, DOI 10.1080/07391102.1991.10507882; Wiskerchen M, 1996, VIROLOGY, V224, P292, DOI 10.1006/viro.1996.0531	32	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4171	4176		10.1074/jbc.275.6.4171	http://dx.doi.org/10.1074/jbc.275.6.4171			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660579	hybrid			2022-12-27	WOS:000085288800063
J	Dash, PR; Read, ML; Fisher, KD; Howard, KA; Wolfert, M; Oupicky, D; Subr, V; Strohalm, J; Ulbrich, K; Seymour, LW				Dash, PR; Read, ML; Fisher, KD; Howard, KA; Wolfert, M; Oupicky, D; Subr, V; Strohalm, J; Ulbrich, K; Seymour, LW			Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; THERAPY; DNA; FORMULATIONS; COPOLYMERS; COMPLEXES; INJECTION; MELANOMA; LIPOSOME; FUTURE	Binding of serum proteins to polyelectrolyte gene delivery complexes is thought to be an important factor limiting bloodstream circulation and restricting access to target tissues. Protein binding can also inhibit transfection activity in vitro. In this study a multivalent reactive hydrophilic polymer has been used to inhibit protein binding. This polymer is based on poly-[N-(2-hydroxypropyl)methacrylamide] (pHPMA) bearing pendent oligopeptide (Gly-Phe-Leu-Gly) side chains terminated in reactive 4-nitrophenoxy groups (8.6 mol%). The polymer reacts with the primary amino groups of poly(L-lysine) (pLL) and produces a hydrophilic coating on the surface of pLL DNA complexes (as measured by fluorescamine). The resulting pHPMA-coated complexes show a decreased surface charge (from +14 mV for pLL DMA complexes to -25 mV for pHPMA-modified complexes) as measured by zeta potential analysis, The pHPMA-coated complexes also show a slightly increased average diameter (approximately 90 nm compared with 60 nm for pLL DNA complexes) as viewed by atomic force and transmission electron microscopy and around 100 nm as viewed by photon correlation spectroscopy, They are completely resistant to protein interaction, as determined by turbidometry and SDS-polyacrylamide gel electrophoresis analysis of complexes isolated from plasma, and show significantly decreased nonspecific uptake into cells in vitro. Spare reactive ester groups can be used to conjugate targeting ligands (e.g. transferrin) on to the surface of the complex to provide a means of tissue-specific targeting and transfection. The properties of these complexes therefore make them promising candidates for targeted gene delivery, both in vitro and potentially in vivo.	Univ Birmingham, Canc Res Campaign, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England; Acad Sci Czech Republ, Inst Macromol Chem, Prague 6, Czech Republic	University of Birmingham; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences	Seymour, LW (corresponding author), Univ Birmingham, Canc Res Campaign, Inst Canc Studies, Birmingham B15 2TA, W Midlands, England.	L.Seymour@bham.ac.uk	Ulbrich, Karel/G-5145-2014; Šubr, Vladimír/G-3488-2014; Read, Martin/A-3505-2012; Wolfert, Margreet A/J-1726-2016; Oupicky, David/AAR-1655-2021	Read, Martin/0000-0001-8918-4333; Wolfert, Margreet A/0000-0003-4864-0026; Oupicky, David/0000-0003-4710-861X; Subr, Vladimir/0000-0002-1614-6595; Dash, Phil/0000-0002-6029-4560; Howard, Kenneth/0000-0002-9407-278X				Allen TM, 1998, DRUGS, V56, P747, DOI 10.2165/00003495-199856050-00001; Anderson WF, 1998, NATURE, V392, P25; Bonadio J, 1998, ADV DRUG DELIVER REV, V33, P53, DOI 10.1016/S0169-409X(98)00020-9; Chao J, 1999, BIODRUGS, V11, P43, DOI 10.2165/00063030-199911010-00005; Dash PR, 1997, J CONTROL RELEASE, V48, P269, DOI 10.1016/S0168-3659(97)00043-6; Dash PR, 1999, GENE THER, V6, P643, DOI 10.1038/sj.gt.3300843; DeMatteo RP, 1999, ANN SURG ONCOL, V6, P88, DOI 10.1007/s10434-999-0088-2; During MJ, 1998, MOL MED TODAY, V4, P485, DOI 10.1016/S1357-4310(98)01370-7; Efrat S, 1998, DIABETOLOGIA, V41, P1401, DOI 10.1007/s001250051085; Gleich LL, 1998, ARCH OTOLARYNGOL, V124, P1097, DOI 10.1001/archotol.124.10.1097; Gottschalk U, 1998, ARZNEIMITTEL-FORSCH, V48, P1111; Hara T, 1997, ADV DRUG DELIVER REV, V24, P265, DOI 10.1016/S0169-409X(96)00467-X; Hara T, 1997, P NATL ACAD SCI USA, V94, P14547, DOI 10.1073/pnas.94.26.14547; Klatzmann D, 1996, HUM GENE THER, V7, P255, DOI 10.1089/hum.1996.7.2-255; Kong HL, 1998, J NATL CANCER I, V90, P273, DOI 10.1093/jnci/90.4.273; Lasic DD, 1995, CHEM REV, V95, P2601, DOI 10.1021/cr00040a001; Li S, 1997, J LIPOS RES, V7, P207, DOI 10.3109/08982109709035496; Mahato RI, 1997, CRIT REV THER DRUG, V14, P133; Mornex JF, 1998, PRESSE MED, V27, P769; Nomura T, 1997, CANCER RES, V57, P2681; Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900; RIHOVA B, 1989, BIOMATERIALS, V10, P335, DOI 10.1016/0142-9612(89)90075-6; Toncheva V, 1998, BBA-GEN SUBJECTS, V1380, P354, DOI 10.1016/S0304-4165(98)00004-X; Waddill W, 1997, AM J ROENTGENOL, V169, P63, DOI 10.2214/ajr.169.1.9207502; Ward CM, 1999, COLLOID SURFACE B, V16, P253, DOI 10.1016/S0927-7765(99)00076-4; Wolfert MA, 1996, HUM GENE THER, V7, P2123, DOI 10.1089/hum.1996.7.17-2123	26	141	158	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3793	3802		10.1074/jbc.275.6.3793	http://dx.doi.org/10.1074/jbc.275.6.3793			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660529	Green Published, hybrid			2022-12-27	WOS:000085288800013
J	Ying, GG; Proost, P; van Damme, J; Bruschi, M; Introna, M; Golay, J				Ying, GG; Proost, P; van Damme, J; Bruschi, M; Introna, M; Golay, J			Nucleolin, a novel partner for the Myb transcription factor family that regulates their activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; C-MYB; A-MYB; B-MYB; GENE ENCODES; PROTEIN; CELLS; ACTIVATOR; IDENTIFICATION; DIFFERENTIATION	To unravel the mechanisms of action of transcriptional regulation by the Myb family of transcription factors, we have set out to isolate their protein partners. We identify nucleolin as one of the nuclear polypeptides that interact specifically with the A-Myb and c-Myb, but not B-Myb DNA-binding domains. We show unambiguously that this interaction is direct and takes place in vivo, as demonstrated by co-immunoprecipitation of the endogenously and exogenously expressed proteins. The minimal DNA-binding domain containing only the R2R3 c-Myb repeats is sufficient for nucleolin binding. Computer analysis of the R2R3 three-dimensional structure, as well as extensive mutational analysis within this region, reveals that the Arg(161) residue, present in c-Myb and A-Myb, but not B-Myb, is crucial for this interaction. We show that the interaction of nucleolin with Myb is functional because co-transfection of nucleolin downregulates Myb transcriptional activity. Nucleolin is a multifunctional phosphoprotein present in both nucleoplasm and more abundantly in the nucleolus and shows helicase and chromatin decondensing activities. This is the first demonstration of nucleolin binding to a transcription factor.	Ist Ric Farmacol Mario Negri, Dept Immunol & Cell Biol, Lab Mol Immunohematol, I-20157 Milan, Italy; Katholieke Univ Leuven, Rega Inst Med Res, Lab Mol Immunol, B-3000 Louvain, Belgium; Ist Ric Farmacol Mario Negri, Dept Biochem & Mol Pharmacol, I-20157 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; KU Leuven; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Golay, J (corresponding author), Ist Ric Farmacol Mario Negri, Dept Immunol & Cell Biol, Lab Mol Immunohematol, Via Eritrea 62, I-20157 Milan, Italy.	Golay@irfmn.mnegri.it	Proost, Paul/V-3052-2017; Golay, Josee/AAA-4085-2022; Introna, Martino/AAA-5823-2019	Proost, Paul/0000-0002-0133-5545; Golay, Josee/0000-0002-7932-909X; Introna, Martino/0000-0001-6216-0892; BRUSCHI, MAURIZIO/0000-0002-5709-818X				BEUG H, 1984, CELL, V39, P579, DOI 10.1016/0092-8674(84)90465-3; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; BRYS A, 1994, P NATL ACAD SCI USA, V91, P4915, DOI 10.1073/pnas.91.11.4915; CHEN CM, 1991, J BIOL CHEM, V266, P7754; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; Dear TN, 1997, ONCOGENE, V14, P891, DOI 10.1038/sj.onc.1200912; Dempsey LA, 1999, J BIOL CHEM, V274, P1066, DOI 10.1074/jbc.274.2.1066; DeRocco SE, 1997, P NATL ACAD SCI USA, V94, P3240, DOI 10.1073/pnas.94.7.3240; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; Facchinetti V, 1997, BIOCHEM J, V324, P729, DOI 10.1042/bj3240729; FOOS G, 1992, EMBO J, V11, P4619, DOI 10.1002/j.1460-2075.1992.tb05564.x; GABRIELSEN OS, 1991, SCIENCE, V253, P1140, DOI 10.1126/science.1887237; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; GOLAY J, 1994, ONCOGENE, V9, P2469; GOLAY J, 1994, J IMMUNOL, V153, P543; Golay J, 1998, J IMMUNOL, V160, P2786; Golay J, 1997, CELL GROWTH DIFFER, V8, P1305; Hanakahi LA, 1997, P NATL ACAD SCI USA, V94, P3605, DOI 10.1073/pnas.94.8.3605; Hegde SP, 1998, MOL CELL BIOL, V18, P2729, DOI 10.1128/MCB.18.5.2729; INTRONA M, 1994, SEMIN CANCER BIOL, V5, P113; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; JAMIN N, 1993, EUR J BIOCHEM, V216, P147, DOI 10.1111/j.1432-1033.1993.tb18126.x; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KALKBRENNER F, 1990, ONCOGENE, V5, P657; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; MIRANDA GA, 1995, EXP CELL RES, V217, P294, DOI 10.1006/excr.1995.1090; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Oh IH, 1997, J BIOL CHEM, V272, P21432, DOI 10.1074/jbc.272.34.21432; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; Saville MK, 1998, ADV CANCER RES, V72, P109; Schwab MS, 1998, EXP CELL RES, V239, P226, DOI 10.1006/excr.1997.3878; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; TAKAHASHI T, 1995, FEBS LETT, V358, P89, DOI 10.1016/0014-5793(94)01402-M; TASHIRO S, 1995, ONCOGENE, V10, P1699; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; TRAUTH K, 1994, EMBO J, V13, P5994, DOI 10.1002/j.1460-2075.1994.tb06945.x; TUTEJA N, 1995, GENE, V160, P143, DOI 10.1016/0378-1119(95)00207-M; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; WATSON RJ, 1993, NUCLEIC ACIDS RES, V21, P267, DOI 10.1093/nar/21.2.267; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Ying GG, 1997, J BIOL CHEM, V272, P24921, DOI 10.1074/jbc.272.40.24921; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130	59	49	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4152	4158		10.1074/jbc.275.6.4152	http://dx.doi.org/10.1074/jbc.275.6.4152			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660576	hybrid			2022-12-27	WOS:000085288800060
J	Dockal, M; Carter, DC; Ruker, F				Dockal, M; Carter, DC; Ruker, F			Conformational transitions of the three recombinant domains of human serum albumin depending on pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PLASMA-ALBUMIN; N-F TRANSITION; ACID-INDUCED ISOMERIZATION; DRUG-BINDING PROPERTIES; LARGE FRAGMENTS; CIRCULAR-DICHROISM; SULFHYDRYL ENVIRONMENT; DISTANCE MEASUREMENTS; SECONDARY STRUCTURE; BASE TRANSITION	Human serum albumin (HSA) is a protein of 66.5 kDa that is composed of three homologous domains, each of which displays specific structural and functional characteristics. HSA is known to undergo different pH-dependent structural transitions, the N-F and F-E transitions in the acid pH region and the N-B transition at slightly alkaline pH, In order to elucidate the structural behavior of the recombinant HSA domains as stand-alone proteins and to investigate the molecular and structural origins of the pH-induced conformational changes of the intact molecule, we have employed fluorescence and circular dichroic methods. Here we provide evidence that the loosening of the HSA structure in the N-F transition takes place primarily in HSA-DOM III and that HSA-DOM I undergoes a structural rearrangement with only minor changes in secondary structure, whereas HSA-DOM II transforms to a molten globule-like state as the pH is reduced. In the pH region of the N-B transition of HSA, HSA-DOM I and HSA-DOM II experience a tertiary structural isomerization, whereas with HSA-DOM III no alterations in tertiary structure are observed, as judged from near-UV CD and fluorescence measurements.	Univ Agr Sci, Inst Appl Microbiol, A-1190 Vienna, Austria; New Century Pharmaceut Inc, Huntsville, AL 35824 USA	University of Natural Resources & Life Sciences, Vienna	Ruker, F (corresponding author), Univ Agr Sci, Inst Appl Microbiol, Muthgasse 18, A-1190 Vienna, Austria.			Rueker, Florian/0000-0001-7639-2686				BOS OJM, 1988, BIOCHIM BIOPHYS ACTA, V953, P37, DOI 10.1016/0167-4838(88)90007-6; BOS OJM, 1989, J BIOL CHEM, V264, P953; BOS OJM, 1988, BIOCHEM PHARMACOL, V37, P3905, DOI 10.1016/0006-2952(88)90072-X; BRAAM WGM, 1974, INT J PEPT PROT RES, V6, P21; CANN JR, 1958, J AM CHEM SOC, V80, P4263, DOI 10.1021/ja01549a035; CANN JR, 1971, BIOCHEMISTRY-US, V10, P3713, DOI 10.1021/bi00796a012; CANN JR, 1957, J AM CHEM SOC, V79, P4672, DOI 10.1021/ja01574a025; CANN JR, 1971, BIOCHEMISTRY-US, V10, P3707, DOI 10.1021/bi00796a011; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CHEN RF, 1966, BIOCHIM BIOPHYS ACTA, V120, P169, DOI 10.1016/0926-6585(66)90291-3; CORNELL CN, 1978, BIOCHEMISTRY-US, V17, P1755, DOI 10.1021/bi00602a027; CORNELL CN, 1978, BIOCHEMISTRY-US, V17, P1750, DOI 10.1021/bi00602a026; COWGILL RW, 1968, BIOCHIM BIOPHYS ACTA, V168, P431, DOI 10.1016/0005-2795(68)90176-1; COWGILL RW, 1968, BIOCHIM BIOPHYS ACTA, V168, P417, DOI 10.1016/0005-2795(68)90175-X; COWGILL RW, 1966, BIOCHIM BIOPHYS ACTA, V120, P196, DOI 10.1016/0926-6585(66)90339-6; COWGILL RW, 1976, BIOCH FLUORESCENCE, V2, P442; Creighton TE, 1992, PROTEIN FOLDING; Dockal M, 1999, J BIOL CHEM, V274, P29303, DOI 10.1074/jbc.274.41.29303; EDELHOCH H, 1969, ANN NY ACAD SCI, V158, P391, DOI 10.1111/j.1749-6632.1969.tb56233.x; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; ERA S, 1990, INT J PEPT PROT RES, V35, P1; Era S, 1998, J PEPT RES, V52, P431; ERA S, 1983, INT J PEPT PROT RES, V22, P333; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; GEISOW MJ, 1977, BIOCHEM J, V163, P477, DOI 10.1042/bj1630477; GEISOW MJ, 1977, BIOCHEM J, V161, P619, DOI 10.1042/bj1610619; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; HALFMAN CJ, 1971, BIOCHIM BIOPHYS ACTA, V243, P284, DOI 10.1016/0005-2795(71)90085-7; HALFMAN CJ, 1971, BIOCHIM BIOPHYS ACTA, V243, P294, DOI 10.1016/0005-2795(71)90086-9; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; HILAK MC, 1974, INT J PEPT PROT RES, V6, P95; HONORE B, 1989, BIOCHEM J, V258, P199, DOI 10.1042/bj2580199; HORWITZ J, 1970, J AM CHEM SOC, V92, P2119, DOI 10.1021/ja00710a054; HORWITZ J, 1969, J AM CHEM SOC, V91, P184, DOI 10.1021/ja01029a034; KHAN MY, 1984, EUR J BIOCHEM, V141, P473, DOI 10.1111/j.1432-1033.1984.tb08216.x; KHAN MY, 1986, BIOCHEM J, V236, P307, DOI 10.1042/bj2360307; KHAN SM, 1980, BIOCHIM BIOPHYS ACTA, V624, P1, DOI 10.1016/0005-2795(80)90219-6; Kosa T, 1998, PHARMACEUT RES, V15, P449, DOI 10.1023/A:1011932516717; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEE JY, 1992, J BIOL CHEM, V267, P14753; LEONARD WJ, 1961, J BIOL CHEM, V236, P2662; Lund M, 1999, EUR J BIOCHEM, V260, P470, DOI 10.1046/j.1432-1327.1999.00175.x; MOORE WE, 1968, BIOCHEMISTRY-US, V7, P3409, DOI 10.1021/bi00850a015; NOEL JKF, 1972, J BIOL CHEM, V247, P7391; Peters T., 1996, ALL ALBUMIN BIOCH GE; PHELPS RA, 1956, J AM CHEM SOC, V78, P3539, DOI 10.1021/ja01595a075; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; PUNDAK S, 1984, BIOCHEMISTRY-US, V23, P1549, DOI 10.1021/bi00302a032; REED RG, 1975, BIOCHEMISTRY-US, V14, P4578, DOI 10.1021/bi00692a004; SJODIN T, 1977, BIOCHIM BIOPHYS ACTA, V494, P61, DOI 10.1016/0005-2795(77)90135-0; SJOHOLM I, 1973, J BIOL CHEM, V248, P8434; SOGAMI M, 1975, BIOCHIM BIOPHYS ACTA, V393, P446, DOI 10.1016/0005-2795(75)90073-2; SOGAMI M, 1982, INT J PEPT PROT RES, V19, P263; SOGAMI M, 1968, BIOCHEMISTRY-US, V7, P2172, DOI 10.1021/bi00846a020; SOGAMI M, 1969, BIOCHEMISTRY-US, V8, P49, DOI 10.1021/bi00829a008; SOGAMI M, 1971, J BIOCHEM-TOKYO, V69, P819, DOI 10.1093/oxfordjournals.jbchem.a129532; SOGAMI M, 1973, BIOCHIM BIOPHYS ACTA, V310, P118, DOI 10.1016/0005-2795(73)90014-7; STEINER RF, 1963, BIOCHIM BIOPHYS ACTA, V66, P341, DOI 10.1016/0006-3002(63)91203-4; STEINHARDT J, 1971, BIOCHEMISTRY-US, V10, P4005, DOI 10.1021/bi00798a001; STRICKLA.EH, 1969, BIOCHEMISTRY-US, V8, P3205, DOI 10.1021/bi00836a012; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; SUZUKIDA M, 1983, BIOCHEMISTRY-US, V22, P2415, DOI 10.1021/bi00279a017; THART BJ, 1986, BIOCHEM PHARMACOL, V35, P1005, DOI 10.1016/0006-2952(86)90091-2; Uversky VN, 1997, BIOCHEMISTRY-US, V36, P13638, DOI 10.1021/bi970332p; Wang CQ, 1998, BIOCHEMISTRY-US, V37, P8457, DOI 10.1021/bi9723010; WILLIAMS EJ, 1959, J AM CHEM SOC, V81, P865, DOI 10.1021/ja01513a030; WILTING J, 1979, BIOCHIM BIOPHYS ACTA, V579, P469, DOI 10.1016/0005-2795(79)90075-8; Woody RW, 1996, CIRCULAR DICHROISM C, P109	69	406	438	3	87	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3042	3050		10.1074/jbc.275.5.3042	http://dx.doi.org/10.1074/jbc.275.5.3042			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652284	hybrid			2022-12-27	WOS:000085146500006
J	Bonazzi, A; Mastyugin, V; Mieyal, PA; Dunn, MW; Laniado-Schwartzman, M				Bonazzi, A; Mastyugin, V; Mieyal, PA; Dunn, MW; Laniado-Schwartzman, M			Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-ALPHA; NF-KAPPA-B; ENDOTHELIAL-CELLS; INFLAMMATION; ACID; EICOSANOIDS; PRODUCTS; EYE; TRANSCRIPTION; GLUTATHIONE	Hypoxic injury provokes inflammation of many tissues including the ocular surface. In rabbit corneal epithelial cells, both peroxisome proliferator-activated receptor (PPAR)-inducible cytochrome P450 4B1 and cyclooxygenase-2 (COX-2) mRNAs were increased by hypoxia, PPAR alpha and beta but not gamma mRNAs were detected in these cells. The PPAR activator, WY-14,643 increased COX-2 expression. Similarly, non-steroidal anti-inflammatory drugs with the ability to activate PPARs induced COX-2 independently of prostaglandin synthesis inhibition. COX-2 protein overexpression by hypoxia and PPAR activation was not associated with a parallel increase in prostaglandin E-2 accumulation. However, the enzyme regained full catalytic activity when: 1) hypoxic cells were re-exposed to normoxic conditions in the presence of heme and arachidonic acid, and 2) WY-14,643-treated cells were depleted of intracellular GSH. Consistent with previous observations showing that the corneal production of cytochrome P450-derived inflammatory eicosanoids is elevated by hypoxia and inflammation, the current data suggest that hypoxic injury is a model of inflammation in which molecules other than COX-derived arachidonic acid metabolites play a major proinflammatory role. This study also suggests that increased cellular GSH may be the mechanism responsible for the characteristic dissociation of PPAR-induced COX-2 expression and activity. Moreover, we provide new insights into the commonly observed lack of efficacy of classical non-steroidal anti-inflammatory drugs in the treatment of hypoxia-related ocular surface inflammation.	New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA	New York Medical College	Laniado-Schwartzman, M (corresponding author), New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.	michal_schwartzman@nymc.edu		Bonazzi, Albino/0000-0002-7857-5352	NEI NIH HHS [EY05613] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLEN KGD, 1990, ANAL BIOCHEM, V186, P108, DOI 10.1016/0003-2697(90)90581-S; ARAKI K, 1993, INVEST OPHTH VIS SCI, V34, P2665; BAZAN HEP, 1985, CURR EYE RES, V4, P175, DOI 10.3109/02713688509000847; Bazan NG, 1997, SURV OPHTHALMOL, V41, pS23, DOI 10.1016/S0039-6257(97)80004-5; BRUCE AS, 1990, SURV OPHTHALMOL, V35, P25, DOI 10.1016/0039-6257(90)90046-X; CAI YN, 1995, J BIOCHEM TOXICOL, V10, P87, DOI 10.1002/jbt.2570100205; CAPDEVILA JH, 1995, BIOCHEMISTRY-US, V34, P3325, DOI 10.1021/bi00010a023; Chang MS, 1997, CURR EYE RES, V16, P1147, DOI 10.1076/ceyr.16.11.1147.5107; Chida M, 1996, AM J PHYSIOL-LUNG C, V270, pL872, DOI 10.1152/ajplung.1996.270.5.L872; Conners MS, 1997, INVEST OPHTH VIS SCI, V38, P1963; CONNERS MS, 1995, INVEST OPHTH VIS SCI, V36, P828; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; FARBER HW, 1991, CIRC RES, V68, P1446, DOI 10.1161/01.RES.68.5.1446; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GLUUD BS, 1985, ACTA OPHTHALMOL, V63, P375; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF1013, DOI 10.1152/ajprenal.1997.273.6.F1013; HAYNES WL, 1989, INVEST OPHTH VIS SCI, V30, P1588; Hempel SL, 1996, AM J RESP CELL MOL, V14, P170, DOI 10.1165/ajrcmb.14.2.8630267; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kulmacz RJ, 1998, FEBS LETT, V430, P154, DOI 10.1016/S0014-5793(98)00657-7; Ledwith BJ, 1997, J BIOL CHEM, V272, P3707, DOI 10.1074/jbc.272.6.3707; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; MARSHALL PJ, 1987, J BIOL CHEM, V262, P3510; Mastyugin V, 1999, J PHARMACOL EXP THER, V289, P1611; Mates J M, 1999, Front Biosci, V4, pD339; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; MICHELS C, 1993, AM J PHYSIOL, V264, pC866, DOI 10.1152/ajpcell.1993.264.4.C866; MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X; NAPOLI SA, 1990, ANN OPHTHALMOL, V22, P30; SACK RA, 1992, INVEST OPHTH VIS SCI, V33, P626; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Schwartzman ML, 1997, ADVANCES IN OCULAR TOXICOLOGY, P3; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; SMOLIN G, 1989, EYE, V3, P167, DOI 10.1038/eye.1989.24; SRINIVASAN BD, 1980, INVEST OPHTH VIS SCI, V19, P1087; SRINIVASAN BD, 1989, OCULAR EFFECTS PROST, P229; Vafeas C, 1998, J PHARMACOL EXP THER, V287, P903; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; WILLIAMS KI, 1988, J PATHOL, V156, P101, DOI 10.1002/path.1711560204; WILLIAMS RN, 1985, EXP EYE RES, V41, P733, DOI 10.1016/0014-4835(85)90181-2; Willson TM, 1997, CURR OPIN CHEM BIOL, V1, P235, DOI 10.1016/S1367-5931(97)80015-4; ZELDIN DC, 1995, J CLIN INVEST, V95, P2150, DOI 10.1172/JCI117904	44	109	116	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2837	2844		10.1074/jbc.275.4.2837	http://dx.doi.org/10.1074/jbc.275.4.2837			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644750	hybrid			2022-12-27	WOS:000085128000082
J	Kas, K; Finger, E; Grall, F; Gu, XS; Akbarali, Y; Boltax, J; Weiss, A; Oettgen, P; Kapeller, R; Libermann, TA				Kas, K; Finger, E; Grall, F; Gu, XS; Akbarali, Y; Boltax, J; Weiss, A; Oettgen, P; Kapeller, R; Libermann, TA			ESE-3, a novel member of an epithelium-specific Ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GROWTH-FACTOR; SECRETORY PROTEIN; ENDOA ENHANCER; MESSENGER-RNAS; EWINGS-SARCOMA; MAP-KINASE; TEL GENE; EXPRESSION; FAMILY	Most cancers originate as a result of aberrant gene expression in mainly glandular epithelial tissues leading to defects in epithelial cell differentiation. The latter is governed by distinct sets of transcriptional regulators. Here we report the characterization of epithelium-specific Ets factor, family member 3 (ESE-3), a novel member of the ESE subfamily of Ets transcription factors. ESE-3 shows highest homology to two other epithelium restricted Ets factors, ESE-1 and ESE-2. ESE-3, like ESE-1 and ESE-2, is exclusively expressed in a subset of epithelial cells with highest expression in glandular epithelium such as prostate, pancreas, salivary gland, and trachea. A potential role in branching morphogenesis is suggested, since ESE-3 transactivates the c-MET promoter via three high affinity binding sites. Additionally, ESE-3 binding to DNA sequences in the promoters of several glandular epithelium-specific genes suggests a role for ESE-3 in later stages of glandular epithelium differentiation. Although ESE-3 and ESE-1 bind with similar affinity to various Ets binding sites, ESE-3 and ESE-1 differ significantly in their ability to transactivate the promoters containing these sites. Our results support the notion that ESE-1, ESE-2, and ESE-3 represent a unique epithelium-specific subfamily of Ets factors that have critical but distinct functions in epithelial cell differentiation and proliferation.	Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, New England Baptist Bone & Joint Inst,Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Katholieke Univ Leuven, Ctr Human Genet, Mol Oncol Lab, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; New England Baptist Hospital; Harvard University; Harvard Medical School; KU Leuven; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Libermann, TA (corresponding author), Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, New England Baptist Bone & Joint Inst,Dept Med, 4 Blackfan Circle, Boston, MA 02115 USA.	tliberma@caregroup.harvard.edu	Libermann, Towia/F-9866-2010; Oettgen, Peter/AAF-5026-2021	Libermann, Towia/0000-0002-4006-8179	NATIONAL CANCER INSTITUTE [R01CA076323, K08CA071429] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA76323, KO8/CA 71429] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul Stephen F., J MOL BIOL, V215, P403, DOI [10.1016/S0022-2836(05)80360-2, DOI 10.1016/S0022-2836(05)80360-2]; Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; BENNICK A, 1987, J DENT RES, V66, P457, DOI 10.1177/00220345870660021201; Bochert MA, 1998, BIOCHEM BIOPH RES CO, V246, P176, DOI 10.1006/bbrc.1998.8560; BORLES JC, 1995, NATURE, V377, P635; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; BUIJS A, 1995, ONCOGENE, V10, P1511; Chang CH, 1997, ONCOGENE, V14, P1617, DOI 10.1038/sj.onc.1200978; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; Fischer DF, 1999, GENOMICS, V55, P88, DOI 10.1006/geno.1998.5622; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; FLETCHER JC, 1995, DEVELOPMENT, V121, P1411; FUJIMURA Y, 1994, NUCLEIC ACIDS RES, V22, P613, DOI 10.1093/nar/22.4.613; Gambarotta G, 1996, ONCOGENE, V13, P1911; GAWIN B, 1995, GENOMICS, V30, P37, DOI 10.1006/geno.1995.0006; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Golub TR, 1996, MOL CELL BIOL, V16, P4107; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; HART AH, 1995, ONCOGENE, V10, P1423; IDA K, 1995, INT J CANCER, V63, P500, DOI 10.1002/ijc.2910630407; Ishida S, 1998, CYTOGENET CELL GENET, V82, P278, DOI 10.1159/000015119; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; KLOBECK HG, 1989, NUCLEIC ACIDS RES, V17, P3981, DOI 10.1093/nar/17.10.3981; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; LIBERMANN TA, 1987, EMBO J, V6, P1627, DOI 10.1002/j.1460-2075.1987.tb02410.x; LIBERMANN TA, 1993, MOL CELL BIOL, V13, P5957, DOI 10.1128/MCB.13.10.5957; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu YH, 1998, GENE, V215, P159, DOI 10.1016/S0378-1119(98)00264-9; LOPEZ M, 1994, MOL CELL BIOL, V14, P3292, DOI 10.1128/MCB.14.5.3292; Maffe A, 1998, EUR J MORPHOL, V36, P74; MARIN O, 1992, FEBS LETT, V301, P111, DOI 10.1016/0014-5793(92)80221-2; McLean TW, 1996, BLOOD, V88, P4252; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; MURPHY GP, 1998, CANCER, V83, P2559; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; Neve R, 1998, FASEB J, V12, P1541, DOI 10.1096/fasebj.12.14.1541; NOLET S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P247, DOI 10.1016/0167-4781(91)90016-F; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Oettgen P, 1996, MOL CELL BIOL, V16, P5091; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Peeters P, 1997, BLOOD, V90, P2535, DOI 10.1182/blood.V90.7.2535.2535_2535_2540; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; POULSEN K, 1986, EMBO J, V5, P1891, DOI 10.1002/j.1460-2075.1986.tb04441.x; Sark MWJ, 1998, J BIOL CHEM, V273, P24683, DOI 10.1074/jbc.273.38.24683; SAVANTBHONSALE S, 1992, GENE DEV, V6, P1927, DOI 10.1101/gad.6.10.1927; SCHULZ RA, 1993, P NATL ACAD SCI USA, V90, P10076, DOI 10.1073/pnas.90.21.10076; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Seol DW, 1998, BBA-GENE STRUCT EXPR, V1395, P252, DOI 10.1016/S0167-4781(97)00202-9; SETH A, 1994, ONCOGENE, V9, P469; SETH A, 1990, ONCOGENE, V5, P1761; SHIRASUNA K, 1981, CANCER, V48, P745, DOI 10.1002/1097-0142(19810801)48:3<745::AID-CNCR2820480314>3.0.CO;2-7; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WERNERT N, 1992, AM J PATHOL, V140, P119; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	66	93	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2986	2998		10.1074/jbc.275.4.2986	http://dx.doi.org/10.1074/jbc.275.4.2986			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644770	hybrid			2022-12-27	WOS:000085128000102
J	Sampson, DA; Arana, ME; Boehmer, PE				Sampson, DA; Arana, ME; Boehmer, PE			Cysteine 111 affects coupling of single-stranded DNA binding to ATP hydrolysis in the herpes simplex virus type-1 origin-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UL9 GENE; HELICASE ACTIVITY; INSECT CELLS; VIRAL ORIGIN; I ORIGIN; REPLICATION; DOMAIN; ORIS; COMPLEX; MUTANT	Herpes simplex virus type-1 origin-binding protein (UL9 protein) initiates viral replication by unwinding the origins. It possesses sequence specific DNA-binding activity, single-stranded DNA-binding activity, DNA helicase activity, and ATPase activity that is strongly stimulated by single-stranded DNA. We have examined the role of cysteines in its action as a DNA helicase, The DNA helicase and DNA-dependent ATPase activities of UL9 protein were stimulated by reducing agent and specifically inactivated by the sulfhydryl-specific reagent N-ethyhmaleimide, To identify the cysteine responsible for this phenomenon, a conserved cysteine in the vicinity of the ATP-binding site (cysteine 111) was mutagenized to alanine, UL9C111A. protein exhibits defects in its DNA helicase and DNA-dependent ATPase activities and was unable to support origin-specific DNA replication in vivo. A kinetic analysis indicates that these defects are due to the inability of single-stranded DNA to induce high affinity ATP binding in UL9C111A protein. The DNA-dependent ATPase activity of UL9C111A protein is resistant to N-ethylmaleimide, while its DNA helicase activity remains sensitive. Accordingly, sensitivity of UL9 protein to N-ethylmaleimide is due to at least two cysteines, Cysteine 111 is involved in coupling single-stranded DNA binding to ATP-binding and subsequent hydrolysis, while a second cysteine is involved in coupling ATP hydrolysis to DNA unwinding.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Boehmer, PE (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.			Boehmer, Paul/0000-0003-4479-0529	NIAID NIH HHS [AI38335] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038335] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABBOTTS AP, 1995, J GEN VIROL, V76, P3125, DOI 10.1099/0022-1317-76-12-3125; ARBUCKLE MI, 1993, J GEN VIROL, V74, P1349, DOI 10.1099/0022-1317-74-7-1349; Biswas N, 1999, J BIOL CHEM, V274, P8068, DOI 10.1074/jbc.274.12.8068; Boehmer PE, 1998, J BIOL CHEM, V273, P2676, DOI 10.1074/jbc.273.5.2676; BOEHMER PE, 1993, J BIOL CHEM, V268, P1220; BOEHMER PE, 1994, J BIOL CHEM, V269, P29329; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Boehmer PE, 1996, METHOD ENZYMOL, V275, P16; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; BRUCKNER RC, 1991, J BIOL CHEM, V266, P2669; CARMICHAEL EP, 1988, J VIROL, V62, P91, DOI 10.1128/JVI.62.1.91-99.1988; DEB S, 1991, J VIROL, V65, P2829, DOI 10.1128/JVI.65.6.2829-2838.1991; DODSON MS, 1989, J BIOL CHEM, V264, P20835; DODSON MS, 1993, J BIOL CHEM, V268, P1213; EARNSHAW DL, 1994, BIOCHEM BIOPH RES CO, V199, P1333, DOI 10.1006/bbrc.1994.1377; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; ELIAS P, 1992, J BIOL CHEM, V267, P17424; ELIAS P, 1990, J BIOL CHEM, V265, P17167; ELIAS P, 1988, P NATL ACAD SCI USA, V85, P2959, DOI 10.1073/pnas.85.9.2959; FIERER DS, 1992, J VIROL, V66, P3986, DOI 10.1128/JVI.66.7.3986-3995.1992; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; HAZUDA DJ, 1992, J BIOL CHEM, V267, P14309; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee SSK, 1997, P NATL ACAD SCI USA, V94, P2838, DOI 10.1073/pnas.94.7.2838; MALIK AK, 1992, VIROLOGY, V190, P702, DOI 10.1016/0042-6822(92)90908-8; MARTIN DW, 1994, VIROLOGY, V198, P71, DOI 10.1006/viro.1994.1009; MARTINEZ R, 1992, J VIROL, V66, P6735, DOI 10.1128/JVI.66.11.6735-6746.1992; MCGEOCH DJ, 1988, J VIROL, V62, P444, DOI 10.1128/JVI.62.2.444-453.1988; OLIVO PD, 1988, P NATL ACAD SCI USA, V85, P5414, DOI 10.1073/pnas.85.15.5414; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STOW ND, 1992, J GEN VIROL, V73, P313, DOI 10.1099/0022-1317-73-2-313; STOW ND, 1993, VIROLOGY, V196, P413, DOI 10.1006/viro.1993.1496; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WONG SW, 1991, J VIROL, V65, P2601, DOI 10.1128/JVI.65.5.2601-2611.1991; WU CA, 1988, J VIROL, V62, P435, DOI 10.1128/JVI.62.2.435-443.1988; ZAVITZ KH, 1993, J BIOL CHEM, V268, P4337; [No title captured]	43	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2931	2937		10.1074/jbc.275.4.2931	http://dx.doi.org/10.1074/jbc.275.4.2931			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644762	hybrid			2022-12-27	WOS:000085128000094
J	Han, Q; Campbell, RL; Gangloff, A; Huang, YW; Lin, SX				Han, Q; Campbell, RL; Gangloff, A; Huang, YW; Lin, SX			Dehydroepiandrosterone and dihydrotestosterone recognition by human estrogenic 17 beta-hydroxysteroid dehydrogenase - C-18/C-19 steroid discrimination and enzyme-induced strain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BREAST-CANCER; PROTEIN; RECEPTOR; NADP(+); BINDING; INHIBITORS; TISSUES; DESIGN; DHEA	Steroid hormones share a very similar structure, but they behave distinctly. We present structures of human estrogenic 17 beta-hydroxysteroid dehydrogenase(17 beta-HSD1) complexes with dehydroepiandrosterone (DHEA) and dihydrotestosterone (DHT), providing the first pictures to date of DHEA and DHT bound to a protein. Comparisons of these structures with that of the enzyme complexed with the most potent estrogen, estradiol, revealed the structural basis and general model for sex hormone recognition and discrimination. Although the binding cavity is almost entirely composed of hydrophobic residues that can make only nonspecific interactions, the arrangement of residues is highly complementary to that of the estrogenic substrate. Relatively small changes in the shape of the steroid hormone can significantly affect the binding affinity and specificity. The K-m of estrone is more than 1000-fold lower than that of DHEA and the K-m of estradiol is about 10 times lower than that of DHT, The structures suggest that Leu-149 is the primary contributor to the discrimination of C-19 steroids and estrogens by 17 beta-HSD1. The critical role of Leu-149 has been well confirmed by site-directed mutagenesis experiments, as the Leu-149 --> Val variant showed a significantly decreased K-m for C-19 steroids while losing discrimination between estrogens and C-19 steroids. The electron density of DHEA also revealed a distortion of its 17-ketone toward a beta-oriented form, which approaches the transition-state conformation for DHEA reduction.	CHU Laval, Res Ctr, MRC, Grp Mol Endocrinol, St Foy, PQ G1V 4G2, Canada; Univ Laval, St Foy, PQ G1V 4G2, Canada	Laval University; Laval University	Lin, SX (corresponding author), CHU Laval, Res Ctr, MRC, Grp Mol Endocrinol, St Foy, PQ G1V 4G2, Canada.			Lin, Sheng-Xiang/0000-0001-9149-375X; Campbell, Robert/0000-0002-5473-5876				ANDERSSON S, 1995, J ENDOCRINOL, V146, P197, DOI 10.1677/joe.0.1460197; Azzi A, 1996, NAT STRUCT BIOL, V3, P665, DOI 10.1038/nsb0896-665; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETON R, 1994, J STEROID BIOCHEM, V50, P275, DOI 10.1016/0960-0760(94)90132-5; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; Brunger A.T., 1992, X PLOR VERSION 3 1 M; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CAIRA MR, 1995, J CHEM CRYSTALLOGR, V25, P393, DOI 10.1007/BF01665276; Duax WL, 1996, CURR OPIN STRUC BIOL, V6, P813, DOI 10.1016/S0959-440X(96)80012-1; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; GHOSH D, 1995, STRUCTURE, V3, P503, DOI 10.1016/S0969-2126(01)00183-6; GHOSH S, 1988, ANAL BIOCHEM, V169, P227, DOI 10.1016/0003-2697(88)90278-3; Griffiths K, 1997, EUR UROL, V32, P24; *INV CORP, 1997, BAC N BLUE TM TRANSF; JARABAK J, 1966, BIOCHEMISTRY-US, V5, P1269, DOI 10.1021/bi00868a021; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LABRIE C, 1992, CANCER RES, V52, P610; LABRIE F, 1994, BAILLIERE CLIN ENDOC, V8, P451, DOI 10.1016/S0950-351X(05)80261-7; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; LIN SX, 1992, J BIOL CHEM, V267, P16182; LIPPMAN ME, 1986, BREAST CANCER RES TR, V7, P59, DOI 10.1007/BF01806790; LUU-THE V, 1990, Molecular Endocrinology, V4, P268; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Mazza C, 1998, J BIOL CHEM, V273, P8145, DOI 10.1074/jbc.273.14.8145; MILGROM E, 1990, HORMONES MOL DIS, P405; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nokelainen P, 1998, MOL ENDOCRINOL, V12, P1048, DOI 10.1210/me.12.7.1048; OTWINOWSKI Z, 1996, METHODS ENZYMOLOGY P, V76; Peltoketo H, 1996, J ENDOCRINOL, V150, pS21; Penning TM, 1996, ENDOCR-RELAT CANCER, V3, P41, DOI 10.1677/erc.0.0030041; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; SAWETAWAN C, 1994, MOL CELL ENDOCRINOL, V99, P161, DOI 10.1016/0303-7207(94)90004-3; Shealy CN, 1995, INTEGR PHYS BEH SCI, V30, P308, DOI 10.1007/BF02691603; THOMAS DB, 1984, CANCER-AM CANCER SOC, V53, P595, DOI 10.1002/1097-0142(19840201)53:3+<595::AID-CNCR2820531304>3.0.CO;2-Y	35	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1105	1111		10.1074/jbc.275.2.1105	http://dx.doi.org/10.1074/jbc.275.2.1105			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625652	hybrid			2022-12-27	WOS:000084836600056
J	Hjelmsoe, I; Allen, CE; Cohn, MA; Tulchinsky, EM; Wu, LC				Hjelmsoe, I; Allen, CE; Cohn, MA; Tulchinsky, EM; Wu, LC			The kappa B and V(D)J recombination signal sequence binding protein KRC regulates transcription of the mouse metastasis-associated gene S100A4/mts1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MTS1 GENE; TUMOR-CELLS; MOLECULAR-CLONING; CARCINOMA-CELLS; DNA-METHYLATION; ANTISENSE RNA; MESSENGER-RNA; EXPRESSION; P9KA; ELEMENT	A kappa B-like sequence, Sb, is integral to the composite enhancer located in the first intron of the metastasis-associated gene, S100A4/mts1. Oligonucleotides containing this sequence form three specific complexes with nuclear proteins prepared from S100A4/mts1-expressing CSML100 adenocarcinoma cells. Protein studies show the Sb-interacting complexes include NF-kappa B/Rel proteins, p50.p50 and p50.p65 dimers, Additionally, the Sb sequence was bound by an unrelated similar to 200-kDa protein, p200. Site-directed mutagenesis in conjunction with transient transfections indicate that p200, but not the NF-kappa B/Rel proteins, transactivates S100A4/mts1, To identify candidate genes for p200, double-stranded DNA probes containing multiple copies of Sb were used to screen a randomly primed lambda gt11 cDNA expression library made from CSML100 poly(A)(+) RNA. Two clones corresponding to the DNA-binding proteins KRC and Alf1 were identified. KRC encodes a large zinc finger protein that binds to the kappa B motif and to the signal sequences of V(D)J recombination. In vitro DNA binding assays using bacterially expressed KRC fusion proteins, demonstrate specific binding of KRC to the Sb sequence. In addition, introduction of KRC expression vectors into mammalian cells induces expression of S100A4/mts1 and reporter genes driven by S100A4/mts1 gene regulatory sequences. These data indicate that KRC positively regulates transcription of S100A4/mts1.	Ohio State Univ, Dept Internal Med, Davis Med Ctr, Columbus, OH 43210 USA; Danish Canc Soc, Dept Mol Canc Biol, DK-2100 Copenhagen, Denmark; Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem Med, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Virol, Columbus, OH 43210 USA; Ohio State Univ, Dept Immunol, Columbus, OH 43210 USA; Ohio State Univ, Dept Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Danish Cancer Society; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Wu, LC (corresponding author), Ohio State Univ, Dept Internal Med, Davis Med Ctr, Rm S2077,480 W 9th Ave, Columbus, OH 43210 USA.		Tulchinsky, Eugene/ABD-7070-2021; Wu, Lai-Chu/E-4328-2011	Wu, Lai-Chu/0000-0002-1348-269X; Cohn, Martin/0000-0002-2988-3009	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM048798, R55GM048798] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA16058] Funding Source: Medline; NIGMS NIH HHS [GM48798] Funding Source: Medline; PHS HHS [T32] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Albertazzi E, 1998, DNA CELL BIOL, V17, P335, DOI 10.1089/dna.1998.17.335; Albertazzi E, 1998, DNA CELL BIOL, V17, P1003, DOI 10.1089/dna.1998.17.1003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMBARTSUMIAN N, 1995, GENE, V159, P125, DOI 10.1016/0378-1119(94)00778-Q; Ambartsumian NS, 1996, ONCOGENE, V13, P1621; Bachmeyer C, 1999, NUCLEIC ACIDS RES, V27, P643, DOI 10.1093/nar/27.2.643; BARRACLOUGH R, 1987, J MOL BIOL, V198, P13, DOI 10.1016/0022-2836(87)90453-0; Barraclough R, 1998, BBA-MOL CELL RES, V1448, P190, DOI 10.1016/S0167-4889(98)00143-8; BONVEN BJ, 1995, J MOL BIOL, V249, P564, DOI 10.1006/jmbi.1995.0319; BRADY JP, 1995, J BIOL CHEM, V270, P1221, DOI 10.1074/jbc.270.3.1221; Chen DS, 1997, J BIOL CHEM, V272, P20283, DOI 10.1074/jbc.272.32.20283; COLLICK A, 1990, NUCLEIC ACIDS RES, V18, P625, DOI 10.1093/nar/18.3.625; DAVIES BR, 1993, ONCOGENE, V8, P999; Davies MPA, 1996, ONCOGENE, V13, P1631; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorflinger U, 1999, MOL CELL BIOL, V19, P3736; Dukhanina EA, 1997, FEBS LETT, V410, P403, DOI 10.1016/S0014-5793(97)00576-0; EBRALIDZE A, 1989, GENE DEV, V3, P1086, DOI 10.1101/gad.3.7.1086; GOTO K, 1988, J BIOCHEM-TOKYO, V103, P48, DOI 10.1093/oxfordjournals.jbchem.a122237; GRIGORIAN M, 1994, ELECTROPHORESIS, V15, P463, DOI 10.1002/elps.1150150163; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; HARLOW E, 1988, ANTIBODIES LAB MANUA, P92; Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7; JACKSONGRUSBY LL, 1987, NUCLEIC ACIDS RES, V15, P6677, DOI 10.1093/nar/15.16.6677; Ke YQ, 1997, INT J CANCER, V71, P832, DOI 10.1002/(SICI)1097-0215(19970529)71:5<832::AID-IJC22>3.0.CO;2-8; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Lloyd BH, 1998, ONCOGENE, V17, P465, DOI 10.1038/sj.onc.1201948; Maelandsmo GM, 1996, CANCER RES, V56, P5490; Mak CH, 1998, IMMUNOGENETICS, V48, P32, DOI 10.1007/s002510050397; MAK CH, 1994, NUCLEIC ACIDS RES, V22, P383, DOI 10.1093/nar/22.3.383; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Morgenstern B, 1998, BIOINFORMATICS, V14, P290, DOI 10.1093/bioinformatics/14.3.290; Nakamura N, 1998, CLIN EXP METASTAS, V16, P471; NIELSEN AL, 1992, MOL CELL BIOL, V12, P3449, DOI 10.1128/MCB.12.8.3449; Prokhortchouk EB, 1998, J MOL BIOL, V280, P227, DOI 10.1006/jmbi.1998.1857; Ridinger K, 1998, BBA-MOL CELL RES, V1448, P254, DOI 10.1016/S0167-4889(98)00137-2; SAKSELA K, 1993, MOL CELL BIOL, V13, P3698, DOI 10.1128/MCB.13.6.3698; SEELER JS, 1994, J VIROL, V68, P1002, DOI 10.1128/JVI.68.2.1002-1009.1994; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; SUZUKI M, 1989, J MOL BIOL, V207, P61, DOI 10.1016/0022-2836(89)90441-5; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; TAKENAGA K, 1994, J CELL BIOL, V124, P757, DOI 10.1083/jcb.124.5.757; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; TAKENAGA K, 1994, JPN J CANCER RES, V85, P831, DOI 10.1111/j.1349-7006.1994.tb02955.x; Tarabykina S, 1996, GENE, V168, P151, DOI 10.1016/0378-1119(95)00742-3; TULCHINSKY E, 1992, P NATL ACAD SCI USA, V89, P9146, DOI 10.1073/pnas.89.19.9146; TULCHINSKY E, 1993, ONCOGENE, V8, P79; TULCHINSKY E, 1995, BBA-GENE STRUCT EXPR, V1261, P243, DOI 10.1016/0167-4781(95)00013-7; Tulchinsky E, 1997, J BIOL CHEM, V272, P4828, DOI 10.1074/jbc.272.8.4828; Tulchinsky EM, 1996, ONCOGENE, V12, P1737; TULCHINSKY EM, 1990, GENE, V87, P219, DOI 10.1016/0378-1119(90)90305-B; Wahls WP, 1998, SOMAT CELL MOLEC GEN, V24, P41, DOI 10.1007/BF02677494; WATANABE Y, 1992, J BIOL CHEM, V267, P17136; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; WU LC, 1996, GENOMICS, V35, P3415	57	21	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					913	920		10.1074/jbc.275.2.913	http://dx.doi.org/10.1074/jbc.275.2.913			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625627	hybrid			2022-12-27	WOS:000084836600031
J	Mott, JD; Thomas, CL; Rosenbach, MT; Takahara, K; Greenspan, DS; Banda, MJ				Mott, JD; Thomas, CL; Rosenbach, MT; Takahara, K; Greenspan, DS; Banda, MJ			Post-translational proteolytic processing of procollagen C-terminal proteinase enhancer releases a metalloproteinase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE INHIBITOR; BONE MORPHOGENETIC PROTEIN-1; CAPILLARY ENDOTHELIAL-CELLS; ALPHA-1-PROTEINASE INHIBITOR; NEUTROPHIL CHEMOATTRACTANT; MATRIX METALLOPROTEINASES; EXPRESSION; TIMP-1; IDENTIFICATION; GLYCOPROTEIN	Activity of matrix metalloproteinases (MMP) is regulated by a family of proteins called tissue inhibitors of metalloproteinases (TIMP). Four TIMPs have been cloned, and their molecular weights range from 29,000 to 20,000. By reverse zymography, we have observed a metalloproteinase inhibitor with an apparent molecular weight of 16,500 from medium conditioned by human brain tumor cells. Antibodies directed against TIMPs failed to react with the 16,500 molecular weight inhibitor, indicating that it was not a truncated form of a known TIMP. The inhibitor was isolated from conditioned medium using affinity and ion exchange chromatography, N-terminal sequences of the inhibitor matched amino acid sequences within the C-terminal domain of a protein known as procollagen C-terminal proteinase enhancer (PCPE), Thus, the inhibitor was named CT-PCPE. Comparison of the N-terminal domain of TIMP with CT-PCPE revealed that both contained six cysteine residues. As in the case of TIMP, reduction and alkylation abolished the inhibitory activity of CT-PCPE. Purified CT-PCPE inhibited MMP-2 with an IC50 value much greater than that of TIMP-2, This implies that MMPs may not be the physiologic targets for CT-PCPE inhibition. However, these results suggest that CT-PCPE may constitute a new class of metalloproteinase inhibitor.	Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mott, JD (corresponding author), Lawrence Berkeley Nat Lab, Mail Stop 74-157, Berkeley, CA 94720 USA.			Thomas-Virnig, Christina/0000-0002-8179-7749; Greenspan, Daniel/0000-0001-8096-7446	NIAMS NIH HHS [AR43621] Funding Source: Medline; NIEHS NIH HHS [T32-ES07106] Funding Source: Medline; NIGMS NIH HHS [GM46846] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007106] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAR R, 1986, COLLAGEN REL RES, V6, P267; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; APODACA G, 1990, CANCER RES, V50, P2322; APTE SS, 1994, GENOMICS, V19, P86, DOI 10.1006/geno.1994.1016; Arner EC, 1999, J BIOL CHEM, V274, P6594, DOI 10.1074/jbc.274.10.6594; BANDA MJ, 1988, J EXP MED, V167, P1608, DOI 10.1084/jem.167.5.1608; BANDA MJ, 1988, J BIOL CHEM, V263, P4481; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Borland G, 1999, J BIOL CHEM, V274, P2810, DOI 10.1074/jbc.274.5.2810; Caterina NCM, 1997, J BIOL CHEM, V272, P32141, DOI 10.1074/jbc.272.51.32141; CHANG S, 1994, P NATL ACAD SCI USA, V91, P5695; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Greene J, 1996, J BIOL CHEM, V271, P30375, DOI 10.1074/jbc.271.48.30375; HERRON GS, 1986, J BIOL CHEM, V261, P2814; HERRON GS, 1986, J BIOL CHEM, V261, P2810; HOWARD EW, 1991, J BIOL CHEM, V266, P17972; HOWARD EW, 1991, J BIOL CHEM, V266, P13064; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; Hulmes DJS, 1997, MATRIX BIOL, V16, P41, DOI 10.1016/S0945-053X(97)90115-3; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; KESSLER E, 1990, BIOCHEM BIOPH RES CO, V173, P81, DOI 10.1016/S0006-291X(05)81024-1; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; LUI YE, 1997, J BIOL CHEM, V272, P20479; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Matsuzawa K, 1996, J NEUROPATH EXP NEUR, V55, P88, DOI 10.1097/00005072-199601000-00009; MIYAZAKI K, 1993, J BIOL CHEM, V268, P14387; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; NAKANO A, 1995, J NEUROSURG, V83, P298, DOI 10.3171/jns.1995.83.2.0298; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Reddi AH, 1996, SCIENCE, V271, P463, DOI 10.1126/science.271.5248.463; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; STOCKER W, 1995, PROTEIN SCI, V4, P823; TAKAHARA K, 1994, J BIOL CHEM, V269, P32572; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	44	94	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1384	1390		10.1074/jbc.275.2.1384	http://dx.doi.org/10.1074/jbc.275.2.1384			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625689	hybrid			2022-12-27	WOS:000084836600093
J	Nakatani, Y; Tanioka, T; Sunaga, S; Murakami, M; Kudo, I				Nakatani, Y; Tanioka, T; Sunaga, S; Murakami, M; Kudo, I			Identification of a cellular protein that functionally interacts with the C2 domain of cytosolic phospholipase A(2)alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIMENTIN INTERMEDIATE FILAMENTS; ARACHIDONIC-ACID RELEASE; HUMAN SW-13 CELLS; MAST-CELLS; CALCIUM IONOPHORE; STEROID-SYNTHESIS; NUCLEAR-ENVELOPE; BINDING DOMAIN; A(2); KINASE	Cytosolic phospholipase A(2) (cPLA(2)) cu plays critical roles in lipid mediator synthesis. We performed far-Western analysis and identified a 60-kDa protein (P60) that interacted with cPLA(2)alpha in a Ca2+-dependent manner. Peptide microsequencing revealed that purified P60 was identical to vimentin, a major component of the intermediate filament. The interaction occurred between the C2 domain of cPLA(2)alpha and the head domain of vimentin. Immunofluorescence microscopic analysis demonstrated that cPLA(2)alpha and vimentin colocalized around the perinuclear area in cPLA(2)alpha-overexpressing human embryonic kidney 293 cells following A23187 stimulation. Forcible expression of vimentin in vimentin-deficient SW13 cells augmented A23187-induced arachidonate release. Moreover, overexpression of the vimentin head domain in rat fibroblastic 3Y1 cells exerted a dominant inhibitory effect on arachidonate metabolism, significantly reducing A23187-induced arachidonate release and attendant prostanoid generation. These results suggest that vimentin is an adaptor for cPLA(2)alpha to function properly during the eicosanoid-biosynthetic process.	Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 1428555, Japan	Showa University	Kudo, I (corresponding author), Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.							ABDULLAH K, 1995, BBA-GEN SUBJECTS, V1244, P157, DOI 10.1016/0304-4165(94)00218-M; ALMAHBOBI G, 1992, EXP CELL RES, V200, P361, DOI 10.1016/0014-4827(92)90184-A; AMEGADZIE BY, 1993, GENE, V128, P307, DOI 10.1016/0378-1119(93)90580-V; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; Chou YH, 1997, CURR OPIN CELL BIOL, V9, P49, DOI 10.1016/S0955-0674(97)80151-2; CiesielskiTreska J, 1995, EUR J CELL BIOL, V68, P369; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Czar MJ, 1996, EUR J CELL BIOL, V70, P322; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; FRABKE WW, 1987, CELL, V49, P131; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gillard BK, 1998, EXP CELL RES, V242, P561, DOI 10.1006/excr.1998.4126; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Hall PF, 1995, J STEROID BIOCHEM, V55, P601, DOI 10.1016/0960-0760(95)00211-1; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; Huang Z, 1996, BIOCHEMISTRY-US, V35, P3712, DOI 10.1021/bi952541k; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Inagaki N, 1997, J BIOL CHEM, V272, P25195, DOI 10.1074/jbc.272.40.25195; Inagaki N, 1996, NEUROCHEM RES, V21, P795, DOI 10.1007/BF02532302; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LIN LL, 1992, J BIOL CHEM, V267, P23451; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Marshall LA, 1997, J BIOL CHEM, V272, P759, DOI 10.1074/jbc.272.2.759; Meng JJ, 1996, J BIOL CHEM, V271, P1599, DOI 10.1074/jbc.271.3.1599; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225, DOI 10.1615/CritRevImmunol.v17.i3-4.10; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; NAKATANI Y, 1994, J IMMUNOL, V153, P796; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Naraba H, 1998, J IMMUNOL, V160, P2974; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Pouliot M, 1996, EUR J BIOCHEM, V238, P250, DOI 10.1111/j.1432-1033.1996.0250q.x; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Reddy ST, 1997, J BIOL CHEM, V272, P13591, DOI 10.1074/jbc.272.21.13591; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSHAK A, 1994, J BIOL CHEM, V269, P25999; SARRIA AJ, 1994, J CELL SCI, V107, P1593; SARRIA AJ, 1992, J BIOL CHEM, V267, P19455; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHARP JD, 1994, J BIOL CHEM, V269, P23250; Shinohara H, 1999, J BIOL CHEM, V274, P12263, DOI 10.1074/jbc.274.18.12263; Sin WC, 1998, MOL CELL BIOL, V18, P6325, DOI 10.1128/MCB.18.11.6325; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; TREJOSKALLI AV, 1995, P NATL ACAD SCI USA, V92, P8940, DOI 10.1073/pnas.92.19.8940; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; YAMAKI K, 1992, JPN J PHARMACOL, V58, P299, DOI 10.1254/jjp.58.299	69	75	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1161	1168		10.1074/jbc.275.2.1161	http://dx.doi.org/10.1074/jbc.275.2.1161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625659	hybrid			2022-12-27	WOS:000084836600063
J	Ryder, JW; Fahlman, R; Wallberg-Henriksson, H; Alessi, DR; Krook, A; Zierath, JR				Ryder, JW; Fahlman, R; Wallberg-Henriksson, H; Alessi, DR; Krook, A; Zierath, JR			Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle - Involvement of the mitogen- and stress-activated protein kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORT CAPACITY; MAMMALIAN-CELLS; EXERCISE; PATHWAY; MAP; INHIBITOR; P38; INSULIN; INTERLEUKIN-1; MECHANISM	Growing evidence suggests that activation of mitogen-activated protein kinase (MAPK) signal transduction mediates changes in muscle gene expression in response to exercise. Nevertheless, little is known about upstream or downstream regulation of MAPK in response to muscle contraction. Here we show that ex vivo muscle contraction stimulates extracellular signal-regulated kinase 1 and 2 (ERK1/2), and p38(MAPK) phosphorylation. Phosphorylation of ERK1/2 or p38(MAPK) was unaffected by protein kinase C inhibition (GF109203X), suggesting that protein kinase C is not involved in mediating contraction-induced MAPK signaling. Contraction-stimulated phosphorylation of ERK1/2 and p38(MAPK) was completely inhibited by pretreatment with PD98059 (MAPK kinase inhibitor) and SB203580 (p38(MAPK) inhibitor), respectively. Muscle contraction also activated MAPK downstream targets p90 ribosomal S6 kinase (p90(Rsk)), MAPK-activated protein kinase 2 (MAPKAP-K2), and mitogen- and stress-activated protein kinase 1 (MSK1). Use of PD98059 or SB203580 revealed that stimulation of p90(Rsk) and MAPKAP-K2 most closely reflects ERK and p38MAPK stimulation, respectively. Stimulation of MSK1 in contracting skeletal muscle required the activation of both ERK and p38(MAPK). These data demonstrate that muscle contraction, separate from systemic influence, activates MAPK signaling. Furthermore, we are the first to show that contractile activity stimulates MAPKAP-K2 and MSK1.	Karolinska Hosp, Dept Clin Physiol, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17176 Stockholm, Sweden; Univ Dundee, Dept Biochem, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Dundee	Zierath, JR (corresponding author), Karolinska Hosp, Dept Clin Physiol, S-17176 Stockholm, Sweden.		Krook, Anna/K-1192-2015	Krook, Anna/0000-0002-0891-0258; Alessi, Dario/0000-0002-2140-9185; Zierath, Juleen/0000-0001-6891-7497				ALESSI DR, 1989, J BIOL CHEM, V270, P274; Armstrong SC, 1999, J MOL CELL CARDIOL, V31, P555, DOI 10.1006/jmcc.1998.0891; Aronson D, 1997, J BIOL CHEM, V272, P25636, DOI 10.1074/jbc.272.41.25636; Aronson D, 1997, J CLIN INVEST, V99, P1251, DOI 10.1172/JCI119282; Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; BAYAERT R, 1996, EMBO J, V15, P1914; CLELAND PJF, 1989, J BIOL CHEM, V264, P17704; Clerk A, 1998, J CELL BIOL, V142, P523, DOI 10.1083/jcb.142.2.523; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Goodyear LJ, 1996, AM J PHYSIOL-ENDOC M, V271, pE403, DOI 10.1152/ajpendo.1996.271.2.E403; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hjeltnes N, 1998, FASEB J, V12, P1701, DOI 10.1096/fasebj.12.15.1701; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LOWERY OH, 1972, FLEXIBLE SYSTEM ENZY, P189; Price MA, 1996, EMBO J, V15, P6552, DOI 10.1002/j.1460-2075.1996.tb01046.x; RAY LB, 1988, J BIOL CHEM, V263, P12721; REN JM, 1994, J BIOL CHEM, V269, P14396; RICHTER EA, 1987, FEBS LETT, V217, P232, DOI 10.1016/0014-5793(87)80669-5; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Sherwood DJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE870, DOI 10.1152/ajpendo.1999.276.5.E870; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; WALLBERGHENRIKSSON H, 1987, J BIOL CHEM, V262, P7665; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773	34	128	136	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1457	1462		10.1074/jbc.275.2.1457	http://dx.doi.org/10.1074/jbc.275.2.1457			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625698	hybrid			2022-12-27	WOS:000084836600102
J	Braun, KW; Tribley, WA; Griswold, MD; Kim, KH				Braun, KW; Tribley, WA; Griswold, MD; Kim, KH			Follicle-stimulating hormone inhibits all-trans-retinoic acid-induced retinoic acid receptor alpha nuclear localization and transcriptional activation in mouse Sertoli cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; RAT TESTIS; SELECTIVE INHIBITOR; DNA-SYNTHESIS; IN-VIVO; DIFFERENTIATION; EXPRESSION; APOPTOSIS; MICE	The regulation of retinoic acid receptor alpha (RAR alpha) signal transduction has not been well characterized. In this study, we determined whether all-trans-retinoic acid (tRA) and follicle-stimulating hormone (FSH) modulate RAR alpha receptor subcellular localization, leading to changes in its transcriptional activity and protein expression in mouse Sertoli cell lines. We found that tRA induced the nuclear localization of RARa within 30 min and that longer term exposure increased the receptor transcriptional activity and RAR alpha protein expression. Conversely, FSH suppressed the tRA-induced nuclear localization, transcriptional transactivation, and protein expression of RAR alpha, Treatment with two different protein kinase A-selective antagonists reversed the inhibitory actions of FSH on tRA-dependent RAR alpha nuclear localization and transcriptional activity. These results:are consistent with the involvement of protein kinase A in mediating the inhibitory effects of FSH, For the first time, we demonstrate a unique signaling coni vergence between the RAR alpha and the FSH-mediated signaling pathways, which may have significant implications in the testis because both are critical regulators of testis : physiology.	Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Kim, KH (corresponding author), Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA.	khkim@mail.wsu.edu						Akmal KM, 1997, BIOL REPROD, V56, P549, DOI 10.1095/biolreprod56.2.549; Akmal KM, 1998, ENDOCRINOLOGY, V139, P1239, DOI 10.1210/en.139.3.1239; AKNER G, 1995, J STEROID BIOCHEM, V52, P1, DOI 10.1016/0960-0760(94)00155-F; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Chilov D, 1999, J CELL SCI, V112, P1203; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; DE LUCA LM, 1991, FASEB J, V5, P2924; DeFranco DB, 1997, BIOCHEM SOC T, V25, P592, DOI 10.1042/bst0250592; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Dufour JM, 1999, BIOL REPROD, V61, P1300, DOI 10.1095/biolreprod61.5.1300; ESKOLA V, 1993, MOL CELL ENDOCRINOL, V93, P143, DOI 10.1016/0303-7207(93)90117-3; FINDIK D, 1995, J CELL BIOCHEM, V57, P12, DOI 10.1002/jcb.240570103; GEILEN CC, 1992, FEBS LETT, V309, P381, DOI 10.1016/0014-5793(92)80811-T; GRISWOLD MD, 1976, MOL CELL ENDOCRINOL, V4, P139, DOI 10.1016/0303-7207(76)90033-2; GRISWOLD MD, 1977, MOL CELL ENDOCRINOL, V7, P151, DOI 10.1016/0303-7207(77)90064-8; Gudas Lorraine J., 1994, P443; GuiochonMantel A, 1996, J STEROID BIOCHEM, V56, P3, DOI 10.1016/0960-0760(95)00268-5; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; HUGGENVIK JI, 1993, MOL ENDOCRINOL, V7, P543, DOI 10.1210/me.7.4.543; Kumar TR, 1998, ENDOCRINOLOGY, V139, P3289, DOI 10.1210/en.139.7.3289; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; LAROSA GJ, 1988, P NATL ACAD SCI USA, V85, P329, DOI 10.1073/pnas.85.2.329; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; LIU XX, 1994, ENDOCRINOLOGY, V135, P682, DOI 10.1210/en.135.2.682; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Maguire SM, 1997, BIOL REPROD, V56, P1106, DOI 10.1095/biolreprod56.5.1106; MCGUINNESS MP, 1994, BIOL REPROD, V51, P116, DOI 10.1095/biolreprod51.1.116; Mehta K, 1996, CELL GROWTH DIFFER, V7, P179; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; ORTH J, 1997, ENDOCRINOLOGY, V100, P103; PESCHON JJ, 1992, MOL ENDOCRINOL, V6, P1403, DOI 10.1210/me.6.9.1403; ROCHETTEEGLY C, 1995, MOL ENDOCRINOL, V9, P860, DOI 10.1210/me.9.7.860; ROY DY, 1995, MOL CELL BIOL, V15, P6481; RUSSELL LD, 1993, SERTOLI CELL, P493; SCHEIBE RJ, 1991, J CELL BIOL, V113, P1173, DOI 10.1083/jcb.113.5.1173; SSOGAWA K, 1997, BIOCHEMISTRY-US, V122, P1075; TAHAYATO A, 1993, MOL ENDOCRINOL, V7, P1642, DOI 10.1210/me.7.12.1642; Xiao YH, 1996, J CELL PHYSIOL, V167, P413, DOI 10.1002/(SICI)1097-4652(199606)167:3<413::AID-JCP5>3.0.CO;2-S	40	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4145	4151		10.1074/jbc.275.6.4145	http://dx.doi.org/10.1074/jbc.275.6.4145			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660575	hybrid			2022-12-27	WOS:000085288800059
J	Kuai, J; Boman, AL; Arnold, RS; Zhu, XJ; Kahn, RA				Kuai, J; Boman, AL; Arnold, RS; Zhu, XJ; Kahn, RA			Effects of activated ADP-ribosylation factors on Golgi morphology require neither activation of phospholipase D1 nor recruitment of coatomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEIN; ENDOSOME-ENDOSOME FUSION; COATED VESICLES; ENDOPLASMIC-RETICULUM; MEMBRANES REQUIRES; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE EXCHANGE; ARF GTPASE; TRANSPORT; CISTERNAE	Nine mutations in the switch I and switch II regions of human ADP-ribosylation factor 3 (ARF3) were isolated from loss-of-interaction screens, using two-hybrid assays with three different effecters. We then analyzed the ability of the recombinant proteins to (i) bind guanine nucleotides, (ii) activate phospholipase D1 (PLD1), (iii) recruit coatomer (COP-I) to Golgi-enriched membranes, and (iv) expand and vesiculate Golgis in intact cells. Cor relations of activities in these assays were used as a means of testing specific hypotheses of ARF action, including the role of PLD1 activation in COP-I recruitment, the role of COP-I in Golgis vesiculation caused by expression of the dominant activating mutant [Q71L]ARF3, and the need for PLD1 activation in Golgis vesiculation. Because we were able to find at least one example of a protein that has lost each of these activities with retention of the others, we conclude that activation of PLD1, recruitment of COP-I to Golgi, and vesiculation of Golgis in cells are functionally separable processes. The ability of certain mutants of ARF3 to alter Golgi morphology without changes in PLD1 activity or COP-I binding is interpreted as evidence for at least one additional, currently unidentified, effector for ARF action at the Golgi.	Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@bimcore.emory.edu	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601	NATIONAL CANCER INSTITUTE [R01CA046508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055148, R01GM055823] Funding Source: NIH RePORTER; NCI NIH HHS [CA46508] Funding Source: Medline; NIGMS NIH HHS [GM55148, GM55823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; Bai C, 1996, METHOD ENZYMOL, V273, P331; BALCH WE, 1992, J BIOL CHEM, V267, P13053; BECKERS CJM, 1992, METHOD ENZYMOL, V219, P5; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; BOMAN AL, 1992, NATURE, V358, P512, DOI 10.1038/358512a0; BROWN HA, 1995, J BIOL CHEM, V270, P14935, DOI 10.1074/jbc.270.25.14935; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CAVENAGH MM, 1994, J BIOL CHEM, V269, P18937; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Gant TM, 1997, EUR J CELL BIOL, V74, P10; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Happe S, 1998, J CELL BIOL, V140, P511, DOI 10.1083/jcb.140.3.511; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; Ktistakis NT, 1996, J CELL BIOL, V134, P295, DOI 10.1083/jcb.134.2.295; KTISTAKIS NT, 1995, P NATL ACAD SCI USA, V92, P4952, DOI 10.1073/pnas.92.11.4952; LENHARD JM, 1992, J BIOL CHEM, V267, P13047; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; MOODIE SA, 1995, ONCOGENE, V11, P447; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; PALMER DJ, 1993, J BIOL CHEM, V268, P12083; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; ROCQUE WJ, 1993, J BIOL CHEM, V268, P9964; Rudge SA, 1998, MOL BIOL CELL, V9, P2025, DOI 10.1091/mbc.9.8.2025; SERAFINI T, 1992, METHOD ENZYMOL, V219, P286; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; SINGER WD, 1995, J BIOL CHEM, V270, P14944, DOI 10.1074/jbc.270.25.14944; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; SPIRO DJ, 1995, J BIOL CHEM, V270, P13693, DOI 10.1074/jbc.270.23.13693; Stamnes M, 1998, P NATL ACAD SCI USA, V95, P13676, DOI 10.1073/pnas.95.23.13676; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; TAMKUN JW, 1991, P NATL ACAD SCI USA, V88, P3120, DOI 10.1073/pnas.88.8.3120; TAYLOR TC, 1992, CELL, V70, P69, DOI 10.1016/0092-8674(92)90534-J; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Warren G, 1999, CELL, V98, P125, DOI 10.1016/S0092-8674(00)81006-5; West MA, 1997, J CELL BIOL, V138, P1239, DOI 10.1083/jcb.138.6.1239; ZHANG CJ, 1994, J CELL BIOL, V124, P289, DOI 10.1083/jcb.124.3.289; Zhang CJ, 1998, J BIOL CHEM, V273, P19792, DOI 10.1074/jbc.273.31.19792; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	53	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4022	4032		10.1074/jbc.275.6.4022	http://dx.doi.org/10.1074/jbc.275.6.4022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660559	hybrid			2022-12-27	WOS:000085288800043
J	Spurio, R; Brandi, L; Caserta, E; Pon, CL; Gualerzi, CO; Misselwitz, R; Krafft, C; Welfle, K; Welfle, H				Spurio, R; Brandi, L; Caserta, E; Pon, CL; Gualerzi, CO; Misselwitz, R; Krafft, C; Welfle, K; Welfle, H			The C-terminal subdomain (IF2 C-2) contains the entire fMet-tRNA binding site of initiation factor IF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSLATION; ELONGATION; GENE; TU	Previous protein unfolding studies had suggested that IF2 C, the 24.5-kDa fMet-tRNA binding domain of Bacillus stearothermophilus translation initiation factor IF2, may consist of two subdomains, In the present work, the four Phe residues of IF2 C (positions 531, 599, 657, and 721) were replaced with Trp, yielding four variant proteins having intrinsic fluorescence markers in different positions of the molecule. Comparison of the circular dichroism and Trp fluorescence changes induced by increasing concentrations of guanidine hydrochloride demonstrated that LF2 C indeed consists of two subdomains: the more stable N-terminal (IF2 C-l) subdomain containing Trp-599, and the less stable C-terminal (IF2 C-2) subdomain containing Trp-721. Isolated subdomain LF2 C-2, which consists of just 110 amino acids (from Glu-632 to Ala-741), was found to bind fMet-tRNA with the same specificity and affinity as native IF2 or IF2 C-domain, Trimming IF2 C-2 from both N and C termini demonstrated that the minimal fragment still capable of fMet-binding consists of 90 amino acids. LF2 C-2 was further characterized by circular dichroism; by urea-, guanidine hydrochloride-, and temperature-induced unfolding and by differential scanning calorimetry. The results indicate that IF2 C-2 is a globular molecule containing predominantly beta structures (25% antiparallel and 8% parallel beta strands) and turns (19%) whose structural properties are not grossly affected by the presence or absence of the N-terminal subdomain 1F2 C-1.	Univ Camerino, Dept Biol, Genet Lab, I-62032 Camerino, Italy; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; Humboldt Univ, Fac Med Charite, Inst Biochem, D-10117 Berlin, Germany	University of Camerino; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gualerzi, CO (corresponding author), Univ Camerino, Dept Biol, Genet Lab, I-62032 Camerino, Italy.		Krafft, Christoph/A-4595-2009	Krafft, Christoph/0000-0003-1049-0560; Spurio, Roberto/0000-0002-7611-4341				Brock S, 1998, MOL MICROBIOL, V29, P409, DOI 10.1046/j.1365-2958.1998.00893.x; BROMBACH M, 1986, MOL GEN GENET, V205, P97, DOI 10.1007/BF02428037; CENATIEMPO Y, 1987, BIOCHEMISTRY-US, V26, P5070, DOI 10.1021/bi00390a028; CROWL R, 1985, GENE, V38, P31, DOI 10.1016/0378-1119(85)90200-8; Gualerzi CO, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P477; GUALERZI CO, 1991, J BIOL CHEM, V266, P16356; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Krafft C, 1998, BIOPHYS J, V74, P63, DOI 10.1016/S0006-3495(98)77767-7; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MISSELWITZ R, 1995, BBA-PROTEIN STRUCT M, V1250, P9, DOI 10.1016/0167-4838(95)00041-R; Misselwitz R, 1997, BIOCHEMISTRY-US, V36, P3170, DOI 10.1021/bi962613n; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; PETERSEN HU, 1979, BIOCHEM BIOPH RES CO, V91, P1068, DOI 10.1016/0006-291X(79)91989-2; PON CL, 1985, J BIOL CHEM, V260, P8918; Rajbhandary Uttam L., 1995, P511; SPRINZL M, 1994, TRENDS BIOCHEM SCI, V19, P245, DOI 10.1016/0968-0004(94)90149-X; SPURIO R, 1993, TRANSLATIONAL APPARATUS, P241	20	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2447	2454		10.1074/jbc.275.4.2447	http://dx.doi.org/10.1074/jbc.275.4.2447			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644698	hybrid			2022-12-27	WOS:000085128000030
J	Toyoda, H; Kinoshita-Toyoda, A; Selleck, SB				Toyoda, H; Kinoshita-Toyoda, A; Selleck, SB			Structural analysis of glycosaminoglycans in Drosophila and Caenorhabditis elegans and demonstration that tout-velu, a Drosophila gene related to EXT tumor suppressors, affects heparan sulfate in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANES; INDIAN HEDGEHOG; PROTEOGLYCAN; BIOSYNTHESIS; EXPRESSION; GROWTH; INHIBITOR; PROTEIN	We have devised a sensitive method for the isolation and structural analysis of glycosaminoglycans from two genetically tractable model organisms, the fruit fly, Drosophila melanogaster, and the nematode, Caenorhabditis elegans. We detected chondroitin/chondroitin sulfate- and heparan sulfate-derived disaccharides in both organisms. Chondroitinase digestion of glycosaminoglycans from adult Drosophila produced both nonsulfated and 4-O-sulfated unsaturated disaccharides, whereas only unsulfated forms were detected in C. elegans. Heparin lyases released disaccharides bearing N-, 2-O-, and 6-O-sulfated species, including mono-, di-, and trisulfated forms, We observed tissue- and stage-specific differences in both chondroitin sulfate and heparan sulfate composition in Drosophila. We have also applied these methods toward the analysis of tout-velu, an EXT-related gene in Drosophila that controls the tissue distribution of the growth factor Hedgehog. The proteins encoded by the vertebrate tumor suppressor genes EXT1 and 2, show heparan sulfate co-polymerase activity, and it has been proposed that tout-velu affects Hedgehog activity via its role in heparan sulfate biosynthesis. Analysis of total glycosaminoglycans from tout-velu mutant larvae show marked reductions in heparan sulfate but not chondroitin sulfate, consistent with its proposed function as a heparan sulfate co-polymerase.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Chiba Univ, Fac Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan	University of Arizona; Chiba University	Selleck, SB (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, 1007 E Lowell St, Tucson, AZ 85721 USA.	selleck@u.arizona.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054832, R01GM025243] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-25243, GM-54832] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Binari RC, 1997, DEVELOPMENT, V124, P2623; CAMBIAZO V, 1990, COMP BIOCHEM PHYS B, V97, P307, DOI 10.1016/0305-0491(90)90286-3; CAMPBELL AG, 1987, J BIOL CHEM, V262, P17605; Dierick H, 1999, CURR TOP DEV BIOL, V43, P153, DOI 10.1016/S0070-2153(08)60381-6; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; GRANER M, 1994, INSECT BIOCHEM MOLEC, V24, P557, DOI 10.1016/0965-1748(94)90091-4; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Hortsch M, 1998, INT J DEV BIOL, V42, P33; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Kim YS, 1996, J BIOL CHEM, V271, P11750, DOI 10.1074/jbc.271.20.11750; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; MADA A, 1992, ANAL SCI, V8, P793, DOI 10.2116/analsci.8.793; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Moerman DG, 1996, DEV BIOL, V173, P228, DOI 10.1006/dbio.1996.0019; NAKATO H, 1995, DEVELOPMENT, V121, P3687; NELSON GA, 1982, J CELL BIOL, V92, P121, DOI 10.1083/jcb.92.1.121; OCHIAI H, 1988, CHEM PHARM BULL, V36, P3726; Padgett RW, 1998, BIOESSAYS, V20, P382, DOI 10.1002/(SICI)1521-1878(199805)20:5&lt;382::AID-BIES5&gt;3.0.CO;2-Q; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Roth S, 1998, CURR BIOL, V8, pR906, DOI 10.1016/S0960-9822(98)00006-2; Salier JP, 1996, BIOCHEM J, V315, P1, DOI 10.1042/bj3150001; Selleck S, 1998, MATRIX BIOL, V17, P473, DOI 10.1016/S0945-053X(98)90094-4; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Toyoda H, 1999, J CHROMATOGR A, V830, P197, DOI 10.1016/S0021-9673(98)00854-1; TOYODA H, 1993, BIOL PHARM BULL, V16, P945; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613	41	226	239	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2269	2275		10.1074/jbc.275.4.2269	http://dx.doi.org/10.1074/jbc.275.4.2269			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644674	hybrid			2022-12-27	WOS:000085128000006
J	McWhinney, C; Wenham, D; Kanwal, S; Kalman, V; Hansen, C; Robishaw, JD				McWhinney, C; Wenham, D; Kanwal, S; Kalman, V; Hansen, C; Robishaw, JD			Constitutively active mutants of the alpha(1a)- and the alpha(1b)-adrenergic receptor subtypes reveal coupling to different signaling pathways and physiological responses in rat cardiac myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MYOSIN LIGHT CHAIN-2; SMOOTH-MUSCLE CELLS; GENE-EXPRESSION; ALPHA(1)-ADRENERGIC RECEPTOR; ALPHA-1-ADRENERGIC RECEPTOR; TRANSDUCTION PATHWAYS; PHOSPHOLIPASE-C; ALPHA(1C)-ADRENERGIC RECEPTOR; VENTRICULAR CARDIOMYOCYTES	Activation of alpha(1)-adrenergic receptors influences both the contractile activity and the growth potential of cardiac myocytes, However, the signaling pathways linking activation of specific alpha(1)-adrenerse receptor (AR) subtypes to these physiological responses remain controversial. In the present study, a molecular approach was used to identify conclusively the signaling pathways activated in response to the individual alpha(1A)- and alpha(1B)-AR subtypes in cardiac myocytes. For this purpose, a mutant alpha(1a)-AR subtype (alpha(1a)-S-290/293-AR) was constructed based on analogy to the previously described constitutively active mutant alpha(1b)-AR subtype (alpha(1b)-S288-294-AR). The mutant (alpha(1a)-S-290/293-AR subtype displayed constitutive activity based on four criteria. To introduce the constitutively active alpha(1)-AR subtypes into cardiac myocytes, recombinant Sindbis viruses encoding either the alpha(1a)-S-290/293-AR or alpha(1b)-S288-294-R subtype were used to infect the whole cell population with >90%, efficiency, thereby allowing the biochemical activities of the various signaling pathways to be measured. When expressed at comparable levels, the alpha(1a)-S-290/293-AR subtype exhibited a significantly elevated basal level as well as agonist-stimulated level of inositol phosphate accumulation, coincident with activation of atrial natriuretic factor-luciferase gene expression. By contrast, the alpha(1b)-S288-294-AR subtype displayed a markedly increased serum response element luciferase gene expression but no activation of atrial natriuretic factor-luciferase gene expression. Taken together, this study provides the first molecular evidence for coupling of the alpha(1a)-AR and the alpha(1b)-AR subtypes to different signaling pathways in cardiac myocytes.	Penn State Coll Med, Henry Hood Res Program, Weis Ctr Res, Danville, PA 17822 USA; Oklahoma State Univ, Sch Med, Dept Physiol & Pharmacol, Tulsa, OK 74107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Robishaw, JD (corresponding author), Penn State Coll Med, Henry Hood Res Program, Weis Ctr Res, 100 N Acad Ave, Danville, PA 17822 USA.				NHLBI NIH HHS [HL 49278] Funding Source: Medline; NIDDK NIH HHS [DK 45417] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045417] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akhter SA, 1997, J BIOL CHEM, V272, P21253, DOI 10.1074/jbc.272.34.21253; ARDATI A, 1993, EMBO J, V12, P5151; Autelitano DJ, 1998, J MOL CELL CARDIOL, V30, P1515, DOI 10.1006/jmcc.1998.0717; BARKA T, 1987, ONCOGENE, V1, P439; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BOGOYEVITCH MA, 1995, BIOCHEM J, V309, P437, DOI 10.1042/bj3090437; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cornelius T, 1997, HYPERTENSION, V30, P1348, DOI 10.1161/01.HYP.30.6.1348; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DECOCK JBJ, 1994, FEBS LETT, V356, P275, DOI 10.1016/0014-5793(94)01283-0; Deng XF, 1998, J PHARMACOL EXP THER, V286, P489; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Garcia-Sainz JA, 1998, EUR J PHARMACOL, V342, P311, DOI 10.1016/S0014-2999(97)01465-9; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Grupp IL, 1998, AM J PHYSIOL-HEART C, V275, pH1338, DOI 10.1152/ajpheart.1998.275.4.H1338; HAN C, 1987, MOL PHARMACOL, V32, P505; HANINGTON EO, 1995, TRENDS CARDIOVAS MED, V5, P193, DOI 10.1016/1050-1738(95)00058-H; HANSEN CA, 1994, BBA-MOL CELL RES, V1224, P517, DOI 10.1016/0167-4889(94)90289-5; HANSEN CA, 1995, J MOL CELL CARDIOL, V27, P471, DOI 10.1016/S0022-2828(08)80043-0; Harris AN, 1997, J MOL CELL CARDIOL, V29, P515, DOI 10.1006/jmcc.1996.0295; Hefti MA, 1997, J MOL CELL CARDIOL, V29, P2873, DOI 10.1006/jmcc.1997.0523; HIEBLE JP, 1995, PHARMACOL REV, V47, P267; Horban A, 1997, J MOL CELL CARDIOL, V29, P2903, DOI 10.1006/jmcc.1997.0525; Hu ZW, 1999, MOL ENDOCRINOL, V13, P3, DOI 10.1210/me.13.1.3; IKEDA U, 1991, AM J PHYSIOL, V260, pH953, DOI 10.1152/ajpheart.1991.260.3.H953; IWAKI K, 1990, J BIOL CHEM, V265, P13809; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; KARIYA K, 1994, J BIOL CHEM, V269, P3775; KARNS LR, 1995, J BIOL CHEM, V270, P410, DOI 10.1074/jbc.270.1.410; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LAZ TM, 1994, MOL PHARMACOL, V46, P414; LEE HR, 1988, J BIOL CHEM, V263, P7352; Li HT, 1997, CIRC RES, V81, P396, DOI 10.1161/01.RES.81.3.396; LONG CS, 1989, J CLIN INVEST, V83, P1078, DOI 10.1172/JCI113951; MICHEL MC, 1994, N-S ARCH PHARMACOL, V350, P136; MICHEL MC, 1993, N-S ARCH PHARMACOL, V348, P385; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; MINNEMAN KP, 1994, MOL PHARMACOL, V46, P929; MOALIC JM, 1989, J HYPERTENS, V7, P195; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; OKAZAKI M, 1994, J CLIN INVEST, V94, P210, DOI 10.1172/JCI117309; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; PEREZ DM, 1991, MOL PHARMACOL, V40, P876; PEREZ DM, 1993, MOL PHARMACOL, V44, P784; Post GR, 1996, FASEB J, V10, P741, DOI 10.1096/fasebj.10.7.8635691; Ramirez MT, 1997, J BIOL CHEM, V272, P14057, DOI 10.1074/jbc.272.22.14057; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHWINN DA, 1995, J PHARMACOL EXP THER, V272, P134; SCHWINN DA, 1990, J BIOL CHEM, V265, P8183; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; SEI CA, 1991, J BIOL CHEM, V266, P15910; Seternes OM, 1998, BBA-GENE STRUCT EXPR, V1395, P345, DOI 10.1016/S0167-4781(97)00189-9; SHARROCKS AD, 1995, FEBS LETT, V368, P77, DOI 10.1016/0014-5793(95)00604-8; SHUBEITA HE, 1992, P NATL ACAD SCI USA, V89, P1305, DOI 10.1073/pnas.89.4.1305; SIMPSON PC, 1991, MOL CELL BIOCHEM, V104, P35; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Soh JW, 1999, MOL CELL BIOL, V19, P1313; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; STEWART AFR, 1994, CIRC RES, V75, P796, DOI 10.1161/01.RES.75.4.796; SUGDEN PH, 1995, CARDIOVASC RES, V30, P478, DOI 10.1016/S0008-6363(95)00096-8; THORBURN J, 1994, J BIOL CHEM, V269, P30580; THORNBERG H, 1994, J BIOL CHEM, V269, P33179; Thuerauf DJ, 1998, J BIOL CHEM, V273, P20636, DOI 10.1074/jbc.273.32.20636; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Wang YB, 1997, CIRCULATION, V96, P3106; Wenham D, 1997, EUR J PHARMACOL, V339, P77, DOI 10.1016/S0014-2999(97)01359-9; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Xi XP, 1997, FEBS LETT, V417, P283, DOI 10.1016/S0014-5793(97)01303-3	75	31	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2087	2097		10.1074/jbc.275.3.2087	http://dx.doi.org/10.1074/jbc.275.3.2087			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636913	hybrid			2022-12-27	WOS:000084940000076
J	Sirard, C; Kim, S; Mirtsos, C; Tadich, P; Hoodless, PA; Itie, A; Maxson, R; Wrana, JL; Mak, TW				Sirard, C; Kim, S; Mirtsos, C; Tadich, P; Hoodless, PA; Itie, A; Maxson, R; Wrana, JL; Mak, TW			Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR SMAD4/DPC4; DNA-BINDING PROTEIN; TGF-BETA; INDUCED TRANSCRIPTION; MAD PROTEINS; GENE; INHIBITION; DEATH; BMP4; DPC4	The tumor suppressor gene Smad4 has been proposed to be a common mediator of transforming growth factor beta (TGF beta)-related signaling pathways. We investigated the role of Smad4 in TGF beta-related pathways by targeted disruption of its locus in murine cell lines. TGF beta responses, including growth arrest, induction of the endogenous PAI-1 gene, and other extracellular matrix components, were normal in Small-deficient fibroblasts. Assembly of a TGF beta-induced DNA-binding complex on one of two regulatory regions in the human plasminogen activator inhibitor (PAI)-1 promoter did not require Smad4 but was, instead, dependent on a TFE-3 binding site. In contrast, Smad4 was required for activation of the Xenopus Mix.2 promoter in response to TGF beta/activin, Smad4 was also involved in the regulation of the Msx homeobox protein family members in response to bone morphogenetic protein (BMP), Interestingly, the expression of the endogenous Msx-2 was reduced, whereas that of Msx-3 was activated in differentiating Smad4(-/-) ES cells relative to wild-type cells. Moreover, reporter assays of the Msx-2 promoter revealed an absolute requirement for Smad4 in fibroblasts and ES cells for activation, Our results indicate that Smad4 is dispensable for critical TGF beta-induced responses but is required for others in murine fibroblasts. We have identified transcriptional targets for Smad4 in the BMP signaling pathway, which may contribute to the genetic defect observed in the Smad4-deficient embryos.	Amgen Inst Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ So Calif, Sch Med, Dept Biochem, Kenneth R Norris Hosp & Inst, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Biol Mol, Kenneth R Norris Hosp & Inst, Los Angeles, CA 90033 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Southern California; University of Southern California	Mak, TW (corresponding author), Amgen Inst Ontario Canc Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Wrana, Jeffrey/F-8857-2013	Hoodless, Pamela/0000-0003-1371-0725				ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Baldwin RL, 1996, INT J CANCER, V67, P283, DOI 10.1002/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B; Bei M, 1998, DEVELOPMENT, V125, P4325; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen Y, 1996, P NATL ACAD SCI USA, V93, P12992, DOI 10.1073/pnas.93.23.12992; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DAVIDSON D, 1995, TRENDS GENET, V11, P405, DOI 10.1016/S0168-9525(00)89124-6; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; deWinter JP, 1997, ONCOGENE, V14, P1891, DOI 10.1038/sj.onc.1201017; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Goumans MJ, 1999, DEVELOPMENT, V126, P3473; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; LeSuer JA, 1999, DEVELOPMENT, V126, P137; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Marazzi G, 1997, DEV BIOL, V186, P127, DOI 10.1006/dbio.1997.8576; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; Masuyama N, 1999, J BIOL CHEM, V274, P12163, DOI 10.1074/jbc.274.17.12163; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Rodriguez-Leon J, 1999, NAT CELL BIOL, V1, P125, DOI 10.1038/10098; Schwarte-Waldhoff I, 1999, ONCOGENE, V18, P3152, DOI 10.1038/sj.onc.1202641; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; Shimeld SM, 1996, MECH DEVELOP, V55, P201, DOI 10.1016/0925-4773(96)00505-9; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; Suzuki A, 1997, DEVELOPMENT, V124, P3037; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wang WD, 1996, MECH DEVELOP, V58, P203, DOI 10.1016/S0925-4773(96)00562-X; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; Wong C, 1999, MOL CELL BIOL, V19, P1821; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3; Zhou SB, 1998, P NATL ACAD SCI USA, V95, P2412, DOI 10.1073/pnas.95.5.2412; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	58	138	148	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2063	2070		10.1074/jbc.275.3.2063	http://dx.doi.org/10.1074/jbc.275.3.2063			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636910	hybrid			2022-12-27	WOS:000084940000073
J	Oettgen, P; Finger, E; Sun, ZJ; Akbarali, Y; Thamrongsak, U; Boltax, J; Grall, F; Dube, A; Weiss, A; Brown, L; Quinn, G; Kas, K; Endress, G; Kunsch, C; Libermann, TA				Oettgen, P; Finger, E; Sun, ZJ; Akbarali, Y; Thamrongsak, U; Boltax, J; Grall, F; Dube, A; Weiss, A; Brown, L; Quinn, G; Kas, K; Endress, G; Kunsch, C; Libermann, TA			PDEF, a novel prostate epithelium-specific Ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC ORGANIZATION; CELLS; PROTEIN; DOMAIN; CANCER; PROMOTER; UPSTREAM; DISEASE; THERAPY; ELEMENT	Prostate cancer, the most frequent solid cancer in older men, is a leading cause of cancer deaths. Although proliferation and differentiation of normal prostate epithelia and the initial growth of prostate cancer cells are androgen-dependent, prostate cancers ultimately become androgen-independent and refractory to hormone therapy. The prostate-specific antigen (PSA) gene has been widely used as a diagnostic indicator for androgen-dependent and -independent prostate cancer. Androgen-induced and prostate epithelium-specific PSA expression is regulated by a proximal promoter and an upstream enhancer via several androgen receptor binding sites. However, little progress has been made in identifying androgen-independent regulatory elements involved in PSA gene regulation. We report the isolation of a novel, prostate epithelium-specific Ets transcription factor, PDEF (prostate-derived Ets factor), that among the Ets family uniquely prefers binding to a GGAT rather than a GGAA core. PDEF acts as an androgen-independent transcriptional activator of the PSA promoter. PDEF also directly interacts with the DNA binding domain of androgen receptor and enhances androgen-mediated activation of the PSA promoter. Our results, as well. as the critical roles of other Ets factors in cellular differentiation and tumorigenesis, strongly suggest that PDEF is an important regulator of prostate gland and/or prostate cancer development.	Beth Israel Deaconess Med Ctr, Dept Med, New England Baptist Bone & Joint Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Surg & Genet, Stanford, CA 94305 USA; Beth Israel Deaconess Med Ctr, Div Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ York, Dept Biol, York YO1 5YW, N Yorkshire, England; Human Genome Sci Inc, Rockville, MD 20850 USA	Harvard University; Beth Israel Deaconess Medical Center; New England Baptist Hospital; Harvard University; Harvard Medical School; Stanford University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of York - UK; GlaxoSmithKline; Human Genome Sciences Inc	Libermann, TA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, New England Baptist Bone & Joint Inst, 4 Blackfan Circle, Boston, MA 02115 USA.	tliberma@caregroup.harvard.edu	Oettgen, Peter/AAF-5026-2021; Libermann, Towia/F-9866-2010	Libermann, Towia/0000-0002-4006-8179	NATIONAL CANCER INSTITUTE [K08CA071429] Funding Source: NIH RePORTER; NCI NIH HHS [KO8/CA 71429, R29 CA070297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aarnisalo P, 1998, P NATL ACAD SCI USA, V95, P2122, DOI 10.1073/pnas.95.5.2122; Ablin RJ, 1997, J CANCER RES CLIN, V123, P583, DOI 10.1007/s004320050110; Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; BOSSELUT R, 1993, NUCLEIC ACIDS RES, V21, P5184, DOI 10.1093/nar/21.22.5184; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; Bubulya A, 1996, J BIOL CHEM, V271, P24583, DOI 10.1074/jbc.271.40.24583; Chang CH, 1997, ONCOGENE, V14, P1617, DOI 10.1038/sj.onc.1200978; Chen CT, 1998, CANCER RES, V58, P2777; CHEN T, 1992, DEV BIOL, V151, P176, DOI 10.1016/0012-1606(92)90225-6; Chen Y, 1998, ONCOGENE, V16, P1913, DOI 10.1038/sj.onc.1201719; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUNG LW, 1997, J CELL BIOCHEM, V6, P174; CHUNG LWK, 1992, J CELL BIOCHEM, P99; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P148, DOI 10.1210/me.11.2.148; Cleutjens KBJM, 1997, MOL ENDOCRINOL, V11, P1256, DOI 10.1210/me.11.9.1256; Culig Z, 1997, DRUG AGING, V10, P50, DOI 10.2165/00002512-199710010-00005; Dittmer J, 1998, BBA-REV CANCER, V1377, pF1, DOI 10.1016/S0304-419X(97)00039-5; FARR A, 1992, NUCLEIC ACIDS RES, V20, P920, DOI 10.1093/nar/20.4.920; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Koivisto P, 1997, CANCER RES, V57, P314; LIBERMANN TA, 1987, EMBO J, V6, P1627, DOI 10.1002/j.1460-2075.1987.tb02410.x; LIBERMANN TA, 1993, MOL CELL BIOL, V13, P5957, DOI 10.1128/MCB.13.10.5957; LOPEZ M, 1994, MOL CELL BIOL, V14, P3292, DOI 10.1128/MCB.14.5.3292; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Neve R, 1998, FASEB J, V12, P1541, DOI 10.1096/fasebj.12.14.1541; Nupponen N, 1999, EUR UROL, V35, P351, DOI 10.1159/000019907; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, GENOMICS, V55, P358, DOI 10.1006/geno.1998.5681; Oettgen P, 1997, GENOMICS, V45, P456, DOI 10.1006/geno.1997.4974; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Oettgen P, 1996, MOL CELL BIOL, V16, P5091; PAHL HL, 1993, J BIOL CHEM, V268, P5014; RHIM JS, 1994, P NATL ACAD SCI USA, V91, P11874, DOI 10.1073/pnas.91.25.11874; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Small EJ, 2000, CURR OPIN ONCOL, V12, P265, DOI 10.1097/00001622-200005000-00014; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sun ZJ, 1997, NUCLEIC ACIDS RES, V25, P3318, DOI 10.1093/nar/25.16.3318; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Wang XO, 1999, PROSTATE, V39, P182, DOI 10.1002/(SICI)1097-0045(19990515)39:3<182::AID-PROS6>3.0.CO;2-B; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wei Z, 1999, MOL CELL BIOL, V19, P1271; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; Zhang SB, 1997, BIOCHEM BIOPH RES CO, V231, P784, DOI 10.1006/bbrc.1997.6197; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	50	226	257	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1216	1225		10.1074/jbc.275.2.1216	http://dx.doi.org/10.1074/jbc.275.2.1216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625666	hybrid			2022-12-27	WOS:000084836600070
J	Azuma, T; Koths, K; Flanagan, L; Kwiatkowski, D				Azuma, T; Koths, K; Flanagan, L; Kwiatkowski, D			Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and-9 to retard apoptotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C; CELL-DEATH; PROTEASES; EFFECTOR; MOTILITY; PATHWAYS; BCL-2; MICE	Apoptosis, or programmed cell death, occurs because of the activation of a protease cascade amplification circuit that includes the critical effector caspase-3. Previously, we identified the widely expressed actin modulatory protein gelsolin as a prominent substrate of caspase-3 and demonstrated that the N-terminal gelsolin cleavage product promotes apoptosis, Here we show that phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4-bisphosphate in pure micelles or mixed vesicles prevent caspase-3 cleavage of gelsolin. Moreover, phosphatidylinositol 4,5-bisphospfiate-gelsolin strongly inhibits caspase-3 and -9 activity through the formation of a stable phosphatidylinositol 4,6-bisphosphate-gelsolin-caspase complex. In addition, phosphatidylinositol 4,5-bisphosphate-gelsolin prevents apoptotic progression mediated by caspase-3 in a cell-free system, and phosphatidylinositol 4,5-bisphosphategelsolin-caspase-9 and phosphatidylinositol 4,5-bisphosphate-gelsolin-caspase-3 complexes form in mouse embryonic fibroblasts during apoptosis induction when; stimulated with fibronectin, to delay cell death. The results suggest that gelsolin can act as both an effector and an inhibitor of caspase-3, the latter in concert with phosphatidylinositol 4,5-bisphosphate, and other membrane phospholipids to regulate the onset and progression of apoptosis.	Brigham & Womens Hosp, Div Hematol, Genet Lab, Boston, MA 02115 USA; Chiron Corp, Emeryville, CA 94608 USA	Harvard University; Brigham & Women's Hospital; Novartis	Kwiatkowski, D (corresponding author), Brigham & Womens Hosp, Div Hematol, Genet Lab, 221 Longwood Ave,MRC 301, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, R01HL054188] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56949, HL54188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Geng YJ, 1998, EUR J CELL BIOL, V77, P294, DOI 10.1016/S0171-9335(98)80088-5; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; JANMEY PA, 1992, J BIOL CHEM, V267, P11818; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Meerschaert K, 1998, EMBO J, V17, P5923, DOI 10.1093/emboj/17.20.5923; Na SQ, 1996, J BIOL CHEM, V271, P11209, DOI 10.1074/jbc.271.19.11209; Ohtsu M, 1997, EMBO J, V16, P4650, DOI 10.1093/emboj/16.15.4650; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VAUZ DL, 1994, CELL, V76, P777; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0	31	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3761	3766		10.1074/jbc.275.6.3761	http://dx.doi.org/10.1074/jbc.275.6.3761			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660524	hybrid			2022-12-27	WOS:000085288800008
J	Nowling, TK; Johnson, LR; Wiebe, MS; Rizzino, A				Nowling, TK; Johnson, LR; Wiebe, MS; Rizzino, A			Identification of the transactivation domain of the transcription factor Sox-2 and an associated co-activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; FIBROBLAST GROWTH-FACTOR-4 ENHANCER; DNA-BINDING SPECIFICITY; K-FGF PROTOONCOGENE; STEM-CELLS; REGULATORY ELEMENTS; COACTIVATOR P300; GENE-EXPRESSION; GLIAL-CELLS; F9 CELLS	The importance of interactions between Sox and POU transcription factors in the regulation of gene expression is becoming increasingly apparent. Recently, many examples of the involvement of Sox-POU partnerships in transcription have been discovered, including a partnership between Sox-2 and Oct-3, Little is known about the mechanisms by which these factors modulate transcription. To better understand the molecular interactions involved, we mapped the location of the transactivation domain of Sox-2. This was done in the context of its interaction with Oct-3, as well as its ability to trans activate as a fusion protein linked to the DNA-binding domain of Gal4. Both approaches demonstrated that Sox-2 contains a transactivation domain in its C-terminal half, containing a serine-rich region and the C-terminus. We also determined that the viral oncoprotein Ela inhibits the ability of the Ga14/Sox-2 fusion protein to transactivate, as well as the transcriptional activation mediated by the combined action of Sox-a and Oct-3, In contrast, a mutant form of E1a, unable to bind p300, lacks both of these effects. Importantly, we determined that p300 overcomes the inhibitory effects of Ela in both assays. Together, these findings suggest that Sox-2 mediates its effects, at least in part, through the co-activator p300.	Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Nebraska Med Ctr 986805, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Rizzino, A (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Nebraska Med Ctr 986805, Omaha, NE 68198 USA.	arizzino@unmc.edu	Wiebe, Matthew/X-5007-2019; Wiebe, Matt/AAC-4642-2021	Wiebe, Matthew/0000-0001-6337-6556; 	NCI NIH HHS [CA 09476, CA 74771, CA 36727] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009476, R01CA074771, P30CA036727] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM SE, 1993, ONCOGENE, V8, P1639; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chen H, 1997, J BIOL CHEM, V272, P6101, DOI 10.1074/jbc.272.10.6101; CURATOLA AM, 1990, MOL CELL BIOL, V10, P2475, DOI 10.1128/MCB.10.6.2475; DAILEY L, 1994, MOL CELL BIOL, V14, P7758, DOI 10.1128/MCB.14.12.7758; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; Hasegawa K, 1997, J BIOL CHEM, V272, P20049, DOI 10.1074/jbc.272.32.20049; IMAGAWA M, 1991, NUCLEIC ACIDS RES, V19, P4503, DOI 10.1093/nar/19.16.4503; Johnson LR, 1998, MOL REPROD DEV, V50, P377; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; KRAUS VB, 1992, MOL CELL BIOL, V12, P4391, DOI 10.1128/MCB.12.10.4391; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lamb K, 1996, MOL REPROD DEV, V44, P460; MA YG, 1992, DEV BIOL, V154, P45, DOI 10.1016/0012-1606(92)90046-J; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Sang NL, 1997, J CELL BIOCHEM, V66, P277, DOI 10.1002/(SICI)1097-4644(19970901)66:3<277::AID-JCB1>3.0.CO;2-M; SASAKI A, 1991, JPN J CANCER RES, V82, P1191, DOI 10.1111/j.1349-7006.1991.tb01778.x; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Scholtz B, 1996, DEV BIOL, V173, P420, DOI 10.1006/dbio.1996.0037; SCHOORLEMMER J, 1991, MECH DEVELOP, V36, P75, DOI 10.1016/0925-4773(91)90074-G; Shikama N, 1997, TRENDS CELL BIOL, V7, P230, DOI 10.1016/S0962-8924(97)01048-9; Smits PHM, 1996, ONCOGENE, V12, P1529; TIESMAN J, 1989, IN VITRO CELL DEV B, V25, P1193; VANDIJK MA, 1995, MECH DEVELOP, V52, P99, DOI 10.1016/0925-4773(95)00394-G; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VELCICH A, 1989, ONCOGENE RES, V5, P31; Vigano MA, 1996, NUCLEIC ACIDS RES, V24, P2112, DOI 10.1093/nar/24.11.2112; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; YOSHIDA T, 1988, BIOCHEM BIOPH RES CO, V157, P618, DOI 10.1016/S0006-291X(88)80295-X; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; ZANTEMA A, 1995, CURR TOP MICROBIOL, V199, P1	45	73	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3810	3818		10.1074/jbc.275.6.3810	http://dx.doi.org/10.1074/jbc.275.6.3810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660531	Green Published, hybrid			2022-12-27	WOS:000085288800015
J	Kovoor, A; Chen, CK; He, W; Wensel, TG; Simon, MI; Lester, HA				Kovoor, A; Chen, CK; He, W; Wensel, TG; Simon, MI; Lester, HA			Co-expression of G beta 5 enhances the function of two G gamma subunit-like domain-containing regulators of G protein signaling proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC POTASSIUM CHANNEL; RGS PROTEINS; K+ CHANNELS; XENOPUS-OOCYTES; BETA-SUBUNIT; NUCLEOTIDE EXCHANGE; P115 RHOGEF; ACTIVATION; COMPLEX; G-ALPHA(13)	Regulators of G protein signaling (RGS) stimulate the GTPase activity of G protein G alpha subunits and probably play additional roles. Some RGS proteins contain a G gamma subunit-like (GGL) domain, which mediates a specific interaction with G beta 5, The role of such interactions in RGS function is unclear. RGS proteins can accelerate the kinetics of coupling of G protein-coupled receptors to G-protein-gated inwardly rectifying K+ (GIRK) channels. Therefore, we coupled m2-muscarinic acetylcholine receptors to GIRK channels in Xenopus oocytes to evaluate the effect of G beta 5 on RGS function. Co-expression of either RGS7 or RGS9 modestly accelerated GIRK channel kinetics. When G beta 5 was co-expressed with either RGS7 or RGS9, the acceleration of GIRK channel kinetics was strongly increased over that produced by RGS7 or RGS9 alone. RGS function was not enhanced by co-expression of G beta 1, and co-expression of G beta 5 alone had no effect on GIRK channel kinetics. G beta 5 did not modulate the function either of RGS4, an RGS protein that lacks a GGL domain, or of a functional RGS7 construct in which the GGL domain was omitted. Enhancement of RGS7 function by G beta 5 was not a consequence of an increase in the amount of plasma membrane or cytosolic RGS7 protein.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA	California Institute of Technology; Baylor College of Medicine	Lester, HA (corresponding author), CALTECH, Div Biol, MC 156-29, Pasadena, CA 91125 USA.	lester@caltech.edu		Wensel, Theodore/0000-0003-3518-9352				ALBERTS B, 1994, MOL BIOL CELL, P731; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Chuang HH, 1998, P NATL ACAD SCI USA, V95, P11727, DOI 10.1073/pnas.95.20.11727; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Herlitze X, 1999, J PHYSIOL-LONDON, V517, P341, DOI 10.1111/j.1469-7793.1999.0341t.x; HIGGINS JB, 1994, J BIOL CHEM, V269, P9067; Higgins JB, 1996, CELL SIGNAL, V8, P433, DOI 10.1016/S0898-6568(96)00071-X; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Karschin C, 1996, J NEUROSCI, V16, P3559; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; KURACHI Y, 1995, AM J PHYSIOL-CELL PH, V269, pC821, DOI 10.1152/ajpcell.1995.269.4.C821; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; PRONIN AN, 1993, FEBS LETT, V328, P89, DOI 10.1016/0014-5793(93)80971-V; QUICK MW, 1992, BIOTECHNIQUES, V13, P357; Rahman Z, 1999, J NEUROSCI, V19, P2016; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Saitoh O, 1999, J BIOL CHEM, V274, P9899, DOI 10.1074/jbc.274.14.9899; SCHMIDT CJ, 1991, J BIOL CHEM, V266, P4538; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4	38	75	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3397	3402		10.1074/jbc.275.5.3397	http://dx.doi.org/10.1074/jbc.275.5.3397			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652332	hybrid			2022-12-27	WOS:000085146500054
J	McBride, AE; Weiss, VH; Kim, HK; Hogle, JM; Silver, PA				McBride, AE; Weiss, VH; Kim, HK; Hogle, JM; Silver, PA			Analysis of the yeast arginine methyltransferase Hmt1p/Rmt1p and its in vivo function - Cofactor binding and substrate interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; SACCHAROMYCES-CEREVISIAE; S-ADENOSYLMETHIONINE; DEPENDENT METHYLTRANSFERASES; N-METHYLTRANSFERASE; RECOGNITION MOTIF; SHUTTLE VECTORS; NUCLEAR EXPORT; RNA; METHYLATION	Many eukaryotic RNA-binding proteins are modified by methylation of arginine residues. The yeast Saccharomyces cerevisiae contains one major arginine methyltransferase, Hmt1p/Rmt1p, which is not essential for normal cell growth, However, cells missing HIMT1 and also bearing mutations in the mRNA-binding proteins Np13p or Cbp80p can no longer survive, providing genetic backgrounds in which to study Hmt1p function. We now demonstrate that the catalytically active form of Hmt1p is required for its activity in vivo. Amino acid changes in the putative Kmt1p S-adenosyl-L-methionine-binding site were generated and shown to be unable to catalyze methylation of Np13p in vitro and in vivo or to restore growth to strains that require HMT1. In addition these mutations affect nucleocytoplasmic transport of Np13p. A cold-sensitive mutant of Hmt1p was generated and showed reduced methylation of Np13p, but not of other substrates, at 14 degrees C. These results define new aspects of Hmt1 and reveal the importance of its activity in vivo.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Silver, PA (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	psilver@fas.harvard.edu	Hogle, James/HIG-9121-2022	Hogle, James/0000-0002-3655-1504	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019236, R01GM057476] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57476, GM19236] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Ahmad I, 1996, J MOL BIOL, V259, P229, DOI 10.1006/jmbi.1996.0315; BALDWIN GS, 1971, SCIENCE, V171, P579, DOI 10.1126/science.171.3971.579; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CASELLAS P, 1978, BIOCHIM BIOPHYS ACTA, V519, P243, DOI 10.1016/0005-2787(78)90077-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Frankel A, 1999, BIOCHEM BIOPH RES CO, V259, P391, DOI 10.1006/bbrc.1999.0779; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GHOSH SK, 1988, J BIOL CHEM, V263, P19024; Henry M, 1996, GENETICS, V142, P103; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Izaurralde E, 1998, RNA, V4, P351; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Krebber H, 1999, GENE DEV, V13, P1994, DOI 10.1101/gad.13.15.1994; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Lewis JD, 1996, GENE DEV, V10, P1683, DOI 10.1101/gad.10.13.1683; Lewis JD, 1996, NUCLEIC ACIDS RES, V24, P3332, DOI 10.1093/nar/24.17.3332; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; LIU Q, 1995, MOL CELL BIOL, V15, P2800; LOO S, 1995, GENETICS, V141, P889; MIYAKE M, 1975, J NEUROCHEM, V24, P909, DOI 10.1111/j.1471-4159.1975.tb03655.x; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; PAIK WK, 1968, J BIOL CHEM, V243, P2108; RAJPUROHIT R, 1992, BIOCHIM BIOPHYS ACTA, V1122, P183, DOI 10.1016/0167-4838(92)90322-5; RAWAL N, 1994, BIOCHEM J, V300, P483, DOI 10.1042/bj3000483; Rose MD., 1990, METHODS YEAST GENETI; RUSSELL ID, 1992, J CELL BIOL, V119, P737, DOI 10.1083/jcb.119.4.737; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Siebel CW, 1996, P NATL ACAD SCI USA, V93, P13641, DOI 10.1073/pnas.93.24.13641; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGLETON DR, 1995, J CELL SCI, V108, P265; Valentini SR, 1999, RNA, V5, P272, DOI 10.1017/S1355838299981633; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173	44	80	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3128	3136		10.1074/jbc.275.5.3128	http://dx.doi.org/10.1074/jbc.275.5.3128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652296	Green Published, hybrid			2022-12-27	WOS:000085146500018
J	Narumi, O; Mori, S; Boku, S; Tsuji, Y; Hashimoto, N; Nishikawa, S; Yokota, Y				Narumi, O; Mori, S; Boku, S; Tsuji, Y; Hashimoto, N; Nishikawa, S; Yokota, Y			OUT, a novel basic helix-loop-helix transcription factor with an Id-like inhibitory activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING NERVOUS-SYSTEM; E-BOX MOTIF; SKELETAL-MUSCLE; DNA-BINDING; NEGATIVE REGULATOR; MOLECULAR CHARACTERIZATION; MOUSE EMBRYOGENESIS; EXPRESSION PATTERN; CRYSTAL-STRUCTURE; DROSOPHILA-HAIRY	Transcription factors belonging to the basic helix-loop-helix (bHLH) family are involved in various cell differentiation processes. We report the isolation and functional characterization of a novel bHLH factor, termed OUT. OUT, structurally related to capsulin/epicardin/Pod-1 and ABF-1/musculin/MyoR, is expressed mainly in the adult mouse reproductive organs, such as the ovary, uterus, and testis, and is barely detectable in tissues of developing embryos. Physical association of OUT with the E protein was predicted from the primary structure of OUT and confirmed by co-immunoprecipitation, However, unlike other bHLH factors, this novel protein failed to bind E-box or N-box DNA sequences and inhibited DNA binding of homo- and heterodimers consisting of E12 and MyoD in gel mobility shift assays. In luciferase assays, OUT inhibited the induction of E-box-dependent transactivation by MyoD-E12 heterodimers. Deletion studies identified the domain responsible for the inhibitory action of OUT in its bHLH and C-terminal regions. Moreover, terminal differentiation of C2C12 myoblasts was inhibited by exogenous introduction of OUT. These inhibitory functions of OUT closely resemble those of the helix-loop-helix inhibitor Id proteins. Based on these findings, we propose that this novel protein functions as a negative regulator of bHLH factors through the formation of a functionally inactive heterodimeric complex.	Kyoto Univ, Dept Mol Genet, Grad Sch Med, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Dept Neurosurg, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Yokota, Y (corresponding author), Kyoto Univ, Dept Mol Genet, Grad Sch Med, Sakyo Ku, Shogoin Kawahara Cho 53, Kyoto 6068507, Japan.	yyokota@virus.kyoto-u.ac.jp	Boku, Shuken/H-2776-2017					Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; AKIMENKO MA, 1989, NUCLEIC ACIDS RES, V17, P4745, DOI 10.1093/nar/17.12.4745; APONE S, 1995, J BIOL CHEM, V270, P21420, DOI 10.1074/jbc.270.36.21420; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BOTAS J, 1982, EMBO J, V1, P307, DOI 10.1002/j.1460-2075.1982.tb01165.x; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1995, EMBO J, V14, P1176, DOI 10.1002/j.1460-2075.1995.tb07101.x; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; BRODY JR, 1989, AM J ANAT, V186, P1, DOI 10.1002/aja.1001860102; BROWN L, 1994, MOL CELL BIOL, V14, P1245, DOI 10.1128/MCB.14.2.1245; BURGESS R, 1995, DEV BIOL, V168, P296, DOI 10.1006/dbio.1995.1081; Chen BB, 1997, NUCLEIC ACIDS RES, V25, P423, DOI 10.1093/nar/25.2.423; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; CSERJESI P, 1995, DEV BIOL, V170, P664, DOI 10.1006/dbio.1995.1245; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Elnitski L, 1997, J BIOL CHEM, V272, P369; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hidai H, 1998, MECH DEVELOP, V73, P33, DOI 10.1016/S0925-4773(98)00031-8; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; IP YT, 1994, EMBO J, V13, P5826, DOI 10.1002/j.1460-2075.1994.tb06926.x; ISHIBASHI M, 1993, EUR J BIOCHEM, V215, P645, DOI 10.1111/j.1432-1033.1993.tb18075.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; KLEIN ES, 1993, GENE DEV, V7, P55, DOI 10.1101/gad.7.1.55; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE KAW, 1990, METHOD ENZYMOL, V181, P20; Lemercier C, 1997, DEV BIOL, V182, P101, DOI 10.1006/dbio.1996.8454; Lemercier C, 1998, EMBO J, V17, P1412, DOI 10.1093/emboj/17.5.1412; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Massari ME, 1998, MOL CELL BIOL, V18, P3130, DOI 10.1128/MCB.18.6.3130; Mori S, 1999, MOL BRAIN RES, V64, P199, DOI 10.1016/S0169-328X(98)00323-4; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NEUMAN T, 1993, DEV BIOL, V160, P186, DOI 10.1006/dbio.1993.1297; NIELSEN AL, 1992, MOL CELL BIOL, V12, P3449, DOI 10.1128/MCB.12.8.3449; Norton JD, 1998, TRENDS CELL BIOL, V8, P58, DOI 10.1016/S0962-8924(97)01183-5; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OLSON EN, 1994, GENE DEV, V8, P1, DOI 10.1101/gad.8.1.1; Peyton M, 1996, MOL CELL BIOL, V16, P626; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Quaggin SE, 1998, MECH DEVELOP, V71, P37, DOI 10.1016/S0925-4773(97)00201-3; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Robb L, 1998, MECH DEVELOP, V76, P197, DOI 10.1016/S0925-4773(98)00122-1; Robb L, 1998, DEV DYNAM, V213, P105, DOI 10.1002/(SICI)1097-0177(199809)213:1<105::AID-AJA10>3.0.CO;2-1; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Schutte BC, 1997, BIOTECHNIQUES, V22, P40, DOI 10.2144/97221bm06; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SIMPSON P, 1983, GENETICS, V105, P615; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida N, 1998, J CELL SCI, V111, P769; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	88	28	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3510	3521		10.1074/jbc.275.5.3510	http://dx.doi.org/10.1074/jbc.275.5.3510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652346	Green Submitted, hybrid			2022-12-27	WOS:000085146500068
J	LeGros, HL; Halim, AB; Geller, AM; Kotb, M				LeGros, HL; Halim, AB; Geller, AM; Kotb, M			Cloning, expression, and functional characterization of the beta regulatory subunit of human methionine adenosyltransferase (MAT II)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; RAT-LIVER; MOLECULAR MECHANISMS; NUCLEOTIDE-SEQUENCE; HUMAN-ERYTHROCYTES; HUMAN-LYMPHOCYTES; MESSENGER-RNA; ISOZYMES; GENE; FRACTIONATION	MAT II, the extrahepatic form of methionine adeno-syltransferase (MAT), consists of catalytic alpha(2)/alpha(2) subunits and a noncatalytic beta subunit, believed to have a regulatory function. The full-length cDNA that encodes the beta subunit of human MAT II was cloned and found to encode for a 334-amino acid protein with a calculated molecular weight of 37,552. Analysis of sequence homology showed similarity with bacterial enzymes that catalyze the reduction of TDP-linked sugars. The beta subunit cDNA was cloned into the pQE-30 expression vector, and the recombinant His tagged protein, which was expressed in Escherichia cell, was recognized by antibodies to the human MAT II, to synthetic peptides copying the sequence of native beta subunit protein, and to the r beta protein. There is no cross-reactivity between the MAT II alpha(2) or beta subunits. None of the anti-beta subunit antibodies reacted with protein extracts of E. coli host cells, suggesting that these bacteria have no beta subunit protein. Interestingly, the r beta subunit associated with E. coli as well as human MAT a subunits. This association changed the kinetic properties of both enzymes and lowered the K-m of MAT for L-methionine. Together, the data show that we have cloned and expressed the human MAT II beta subunit and confirmed its long suspected regulatory function. This knowledge affords a molecular means by which MAT activity and consequently the levels of AdoMet may be modulated in mammalian cells.	Univ Tennessee, Dept Surg, Memphis, TN 38163 USA; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA; Univ Tennessee, Dept Microbiol & Immunol, Memphis, TN 38163 USA; Vet Affairs Med Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Kotb, M (corresponding author), Univ Tennessee, Dept Surg, 956 Court Ave,Suite A-202, Memphis, TN 38163 USA.				NIGMS NIH HHS [GM-54892-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054892] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALVAREZ L, 1993, BIOCHEM J, V293, P481, DOI 10.1042/bj2930481; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; DELAROSA J, 1992, J BIOL CHEM, V267, P10699; DELAROSA J, 1995, J BIOL CHEM, V270, P21860; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; Gil B, 1996, HEPATOLOGY, V24, P876; HOFFMAN JL, 1983, METHOD ENZYMOL, V94, P223; HORIKAWA S, 1990, J BIOL CHEM, V265, P13683; HORIKAWA S, 1991, BIOCHEM INT, V25, P81; KLAPPER MH, 1977, BIOCHEM BIOPH RES CO, V78, P1018, DOI 10.1016/0006-291X(77)90523-X; KOTB M, 1985, J BIOL CHEM, V260, P3923; KOTB M, 1990, BIOCHIM BIOPHYS ACTA, V1039, P253, DOI 10.1016/0167-4838(90)90193-J; KOTB M, 1990, BIOCHIM BIOPHYS ACTA, V1040, P137, DOI 10.1016/0167-4838(90)90068-Q; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LANGKAMPHENKEN B, 1994, BBA-GEN SUBJECTS, V1201, P397, DOI 10.1016/0304-4165(94)90068-X; LeGros HL, 1997, J BIOL CHEM, V272, P16040, DOI 10.1074/jbc.272.25.16040; LIAU MC, 1979, CANCER RES, V39, P162; Maceratesi P, 1998, MOL GENET METAB, V63, P26, DOI 10.1006/mgme.1997.2645; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; MATO JM, 1994, ADV EXP MED BIOL, V368, P113; Mingorance J, 1997, INT J BIOCHEM CELL B, V29, P485, DOI 10.1016/S1357-2725(96)00151-3; MITSUI KI, 1988, J BIOL CHEM, V263, P11211; MUDD SH, 1973, ADENOSYLTRANSFERASES, P121; MUDD SH, 1995, DISORDERS TRANSSULFU, P1279; ODEN KL, 1983, BIOCHEMISTRY-US, V22, P2978, DOI 10.1021/bi00281a030; OKADA G, 1981, BIOCHEMISTRY-US, V20, P934, DOI 10.1021/bi00507a045; PAJARES MA, 1992, FEBS LETT, V309, P1, DOI 10.1016/0014-5793(92)80726-W; PISSOWOTZKI K, 1991, MOL GEN GENET, V231, P113, DOI 10.1007/BF00293829; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SAKATA SF, 1993, J BIOL CHEM, V268, P13978; SULLIVAN DM, 1983, BIOCHEMISTRY-US, V22, P1636, DOI 10.1021/bi00276a017; SUMA Y, 1986, J BIOCHEM, V100, P67, DOI 10.1093/oxfordjournals.jbchem.a121707; TABOR CW, 1984, ADV ENZYMOL RAMB, V56, P251; UBAGAI T, 1995, J CLIN INVEST, V96, P1943, DOI 10.1172/JCI118240	38	61	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2359	2366		10.1074/jbc.275.4.2359	http://dx.doi.org/10.1074/jbc.275.4.2359			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644686	hybrid			2022-12-27	WOS:000085128000018
J	Swift, S; Sheridan, PJ; Covic, L; Kuliopulos, A				Swift, S; Sheridan, PJ; Covic, L; Kuliopulos, A			PAR1 thrombin receptor-G protein interactions - Separation of binding and coupling determinants in the G alpha subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT CARBOXYLASE; PHEROMONE RESPONSE PATHWAY; BETA-GAMMA-SUBUNITS; SACCHAROMYCES-CEREVISIAE; PLATELET ACTIVATION; MOLECULAR-GENETICS; SYNTHETIC PEPTIDES; MATING SIGNAL; YEAST; IDENTIFICATION	Signal transfer between the protease-activated PAR1 thrombin receptor and membrane-associated heterotrimeric G proteins is mediated by protein-protein interactions. We constructed a yeast signaling system that resolves domain-specific functions of binding from coupling in the G alpha subunit, The endogenous yeast G alpha subunit, Gpa1, does not bind to PAR1 and served as a null structural template. N- and C-terminal portions of mammalian G(i2) and G(16) were substituted back into the Gpa1 template and gain-of-function assessed. The C-terminal third of G(16), but not of G(i2), provides sufficient interactions for coupling to occur with PAR1. The N-terminal two-thirds of G(i2) also contains sufficient determinants to bind and couple to PAR1 and overcome the otherwise negative or missing interactions supplied by the C-terminal third of Gpa1, Replacement of the N-terminal alpha-helix of G(i2), residues 1-34, with those of Opal abolishes coupling but not binding to PAR1 or to beta gamma subunits. These data support a model that the N-terminal alpha N helix of the G alpha subunit is physically interposed between PAR1 and the G beta subunit and directly assists in transferring the signal between agonist-activated receptor and G protein.	Tufts Univ, Sch Med, New England Med Ctr, Div Hematol Oncol,Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Univ, Sch Med, New England Med Ctr, Div Hematol Oncol,Mol Cardiol Res Inst, Boston, MA 02111 USA.	akuliopu@opal.tufts.edu		Swift, Steven/0000-0002-3840-4401	NHLBI NIH HHS [R01HL57905] Funding Source: Medline; NIGMS NIH HHS [R29GM52926] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM052926] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKTORIES K, 1984, EUR J BIOCHEM, V145, P333, DOI 10.1111/j.1432-1033.1984.tb08558.x; Baltensperger H, 1997, J BIOL CHEM, V272, P10151; Barr AJ, 1997, J BIOL CHEM, V272, P2223; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brass Lawrence F., 1995, P1536; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; DeSimone SM, 1998, MOL GEN GENET, V257, P662, DOI 10.1007/s004380050695; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; FENG DM, 1995, J MED CHEM, V38, P4125, DOI 10.1021/jm00020a029; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Harley CA, 1996, J BIOL CHEM, V271, P24625, DOI 10.1074/jbc.271.40.24625; Iniguez-Lluhi Jorge, 1993, Trends in Cell Biology, V3, P230, DOI 10.1016/0962-8924(93)90122-H; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kajkowski EM, 1997, J RECEPT SIGNAL TR R, V17, P293, DOI 10.3109/10799899709036610; Kallal L, 1997, MOL CELL BIOL, V17, P2897, DOI 10.1128/MCB.17.5.2897; KANG YS, 1990, MOL CELL BIOL, V10, P2582, DOI 10.1128/MCB.10.6.2582; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Kostenis E, 1997, BIOCHEMISTRY-US, V36, P1487, DOI 10.1021/bi962554d; KULIOPULOS A, 1992, BIOCHEMISTRY-US, V31, P9436, DOI 10.1021/bi00154a016; KULIOPULOS A, 1994, J BIOL CHEM, V269, P21364; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leibel RL, 1997, J BIOL CHEM, V272, P31937, DOI 10.1074/jbc.272.51.31937; Lindorfer MA, 1998, J BIOL CHEM, V273, P34429, DOI 10.1074/jbc.273.51.34429; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Seiler SM, 1996, MOL PHARMACOL, V49, P190; SLEPAK VZ, 1995, J BIOL CHEM, V270, P4037, DOI 10.1074/jbc.270.8.4037; Stratton HF, 1996, MOL CELL BIOL, V16, P6325; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; Verrall S, 1997, J BIOL CHEM, V272, P6898, DOI 10.1074/jbc.272.11.6898; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; WIELAND T, 1994, METHOD ENZYMOL, V237, P3; WILLIAMS AG, 1990, BLOOD, V76, P721; WU SM, 1991, P NATL ACAD SCI USA, V88, P2236, DOI 10.1073/pnas.88.6.2236; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; ZHAO ZS, 1995, MOL CELL BIOL, V15, P5246	58	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2627	2635		10.1074/jbc.275.4.2627	http://dx.doi.org/10.1074/jbc.275.4.2627			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644723	hybrid			2022-12-27	WOS:000085128000055
J	Vaughn, MW; Huang, KT; Kuo, L; Liao, JC				Vaughn, MW; Huang, KT; Kuo, L; Liao, JC			Erythrocytes possess an intrinsic barrier to nitric oxide consumption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; OXYGEN-UPTAKE; DIFFUSION; HEMOGLOBIN	It has been reported that free hemoglobin (Hb) reacts with NO at an extremely high rate (K-Hb similar to 10(7) M-1 s(-1)) and that the red blood cell (RBC) membrane is highly permeable to NO. RBCs, however, react with NO 500-1000 times slower. This reduction of NO reaction rate by RBCs has been attributed to the extracellular diffusion limitation. To test whether additional Limitations are also important, we designed a competition test, which allows the extracellular diffusion limitation to be distinguished from transmembrane or intracellular resistance. This test exploited the competition between free Hb and RBCs for NO generated in a homogenous phase by an NO donor. If the extracellular diffusion resistance is negligible, then the results would follow a kinetic model that assumes homogenous reaction without extracellular diffusion limitation, In this case, the measured effective reaction rate constant, K-RBC, would remain invariant of the hematocrit, extracellular-free Hb concentration, and NO donor concentration. Results show that the K-RBC approaches a constant only when the hematocrit is greater than 10% suggesting that at higher hematocrit, the extracellular diffusion resistance is negligible. Under such a condition, the NO consumption by RBCs is still 500-1000 times slower than that by free Hb. This result suggests that intrinsic RBC factors, such as transmembrane diffusion limitation or intracellular mechanisms, exist to reduce the NO consumption by RBCs.	Univ Calif Los Angeles, Dept Chem Engn, Los Angeles, CA 90095 USA; Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; Texas A&M Univ, Dept Med Physiol, College Stn, TX 77843 USA	University of California System; University of California Los Angeles; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem Engn, 5531 Boelter Hall, Los Angeles, CA 90095 USA.	liaoj@ucla.edu	Vaughn, Mark w/I-7150-2015	Vaughn, Mark w/0000-0002-2534-4497; Kuo, Lih/0000-0002-4912-6910; Liao, James/0000-0002-4580-7276				BEUTLER MD, 1984, RED CELL METABOLISM; Butler AR, 1998, BBA-GEN SUBJECTS, V1425, P168, DOI 10.1016/S0304-4165(98)00065-8; CARLSEN E, 1958, J GEN PHYSIOL, V42, P83, DOI 10.1085/jgp.42.1.83; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; COIN JT, 1979, J BIOL CHEM, V254, P1178; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V328, P208, DOI 10.1006/abbi.1996.0162; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Gow AJ, 1999, P NATL ACAD SCI USA, V96, P9027, DOI 10.1073/pnas.96.16.9027; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Hartridge H, 1927, J PHYSIOL-LONDON, V52, P232, DOI 10.1113/jphysiol.1927.sp002354; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KREUZER F, 1960, J APPL PHYSIOL, V15, P1117, DOI 10.1152/jappl.1960.15.6.1117; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Lancaster JR, 1996, METHOD ENZYMOL, V268, P31; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; MERCHUK JC, 1983, CHEM ENG SCI, V38, P1315, DOI 10.1016/0009-2509(83)80052-9; MOULINOUX JP, 1984, BIOCHIMIE, V66, P385, DOI 10.1016/0300-9084(84)90022-1; POHL U, 1991, BASIC RES CARDIOL S, V86, P105; RICE SA, 1980, BIOPHYS J, V29, P65, DOI 10.1016/S0006-3495(80)85118-6; Riggs A., 1981, Methods in Enzymology, V76, P5; Schmid-Schonbein H, 1979, QUANTITATIVE CARDIOV, P353; VANDEGRIFF KD, 1984, BIOPHYS J, V45, P825, DOI 10.1016/S0006-3495(84)84226-5; VANDEGRIFF KD, 1984, J BIOL CHEM, V259, P2619; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323	28	185	191	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2342	2348		10.1074/jbc.275.4.2342	http://dx.doi.org/10.1074/jbc.275.4.2342			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644684	hybrid			2022-12-27	WOS:000085128000016
J	Chiou, ST; Chen, YW; Chen, SC; Chao, CF; Liu, TY				Chiou, ST; Chen, YW; Chen, SC; Chao, CF; Liu, TY			Isolation and characterization of proteins that bind to galactose, lipopolysaccharide of Escherichia coli, and protein A of Staphylococcus aureus from the hemolymph of Tachypleus tridentatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; NATURAL ANTI-GAL; LIMULUS-POLYPHEMUS; INNATE IMMUNITY; HORSESHOE-CRAB; SPECIFICITY; SYSTEM; LECTIN; IGG; ALPHA-2-MACROGLOBULIN	In this study, we report the isolation and characterization of three novel hemolymph proteins that are believed to be involved in the innate immune response of horseshoe crabs, Tachypleus tridentatus. They include two closely related proteins, one that binds to the protein A of Staphylococcus aureus (PAP) and another that binds to the lipopolysaccharide of Escherichia coli (LBP). PAP binds specifically to staphylococcal protein A (SpA) with a K-D of 3.86 x 10(-5) M, whereas LBP binds to lipopolysaccharide (LPS) with a K-D of 1.03 x 10(-6) M. Both PAP and LBP are glycoproteins with an apparent molecular mass of about 40 kDa, N-terminal sequences of PAP and LBP showed 61.9 and 72.2% identity, respectively, to tachylectin-3, a lectin isolated from the amebocyte of T. tridentatus, previously characterized by its affinity to the O-antigen of LPS and blood group A antigen (Muta, T., and Iwanaga, S. (1996) Curr. Opin. Immunol. 8, 41-47). The third protein, a galactose-binding protein (GBP), was found to bind tightly to Sepharose CL-4B and could only be eluted from the column matrix with chaotropic agents, such as 4 iu urea or 2 nr guanidine hydrochloride. Further analysis indicated that GBP binds to D(+)-galactose with a K-D of 2.47 x 10(-7) M. N-terminal sequence analysis showed that GBP shared a 50% identity with lectin L-6, identified in the granules of amebocyte of T. tridentatus. (Gokudan, S., Muta, T., Tsuda, R., Koori, K., Kawahara, T., Seki, N., Mizunoe, Y., Wai, S. N,, Iwanaga, S., and Kawabata, S. (1999) Proc. Natl. Acad Sci. U.S.A 96, 10086-10091). Lectin-L6 and tachylectin-3 are nonglycosylated intracellular proteins with about half the molecular mass of PAP, LBP, and GBP. GBP also binds to PAP and LBP with K-D values of 1.25 x 10(-7) and 1.43 x 10(-8) M, respectively, and this binding is enhanced about 10-fold upon the addition of SpA and LPS to form the GBP.PAP SpA and GBP.LBP.LPS complexes, respectively.	Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Academia Sinica - Taiwan	Liu, TY (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.							ARMSTRONG PB, 1993, MOL IMMUNOL, V30, P929, DOI 10.1016/0161-5890(93)90017-6; DAM TK, 1992, MOL CELL BIOCHEM, V117, P1; ENGHILD JJ, 1990, BIOCHEMISTRY-US, V29, P10070, DOI 10.1021/bi00495a009; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; FURGUSON MAJ, 1993, GLYCOBIOLOGY PRACTIC, P349; GALILI U, 1987, J EXP MED, V165, P693, DOI 10.1084/jem.165.3.693; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573; GALILI U, 1993, IMMUNOL TODAY, V14, P480, DOI 10.1016/0167-5699(93)90261-I; GARBER N, 1992, BIOCHIM BIOPHYS ACTA, V1116, P331, DOI 10.1016/0304-4165(92)90048-Y; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Hirabayashi J, 1998, J BIOL CHEM, V273, P14450, DOI 10.1074/jbc.273.23.14450; Hoffmann JA, 1996, CURR OPIN IMMUNOL, V8, P8, DOI 10.1016/S0952-7915(96)80098-7; Inamori K, 1999, J BIOL CHEM, V274, P3272, DOI 10.1074/jbc.274.6.3272; IWANAGA S, 1998, FRONT BIOSCI, V3, pD873; KAPITANY RA, 1973, ANAL BIOCHEM, V56, P361, DOI 10.1016/0003-2697(73)90202-9; Kawabata S, 1999, DEV COMP IMMUNOL, V23, P391, DOI 10.1016/S0145-305X(99)00019-1; LANGONE JJ, 1982, J IMMUNOL METHODS, V55, P277, DOI 10.1016/0022-1759(82)90088-6; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mendoza HL, 1999, DEV COMP IMMUNOL, V23, P359, DOI 10.1016/S0145-305X(99)00017-8; MURER EH, 1975, J CELL PHYSIOL, V86, P533, DOI 10.1002/jcp.1040860310; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; ROBEY FA, 1981, J BIOL CHEM, V256, P969; Saito T, 1997, J BIOL CHEM, V272, P30703, DOI 10.1074/jbc.272.49.30703; SOTTRUPJENSEN L, 1990, COMP BIOCHEM PHYS B, V96, P621, DOI 10.1016/0305-0491(90)90066-3; TANAKA T, 1983, J BIOL CHEM, V258, P3552; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612	29	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1630	1634		10.1074/jbc.275.3.1630	http://dx.doi.org/10.1074/jbc.275.3.1630			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636855	hybrid			2022-12-27	WOS:000084940000018
J	Arcari, P; Masullo, L; Masullo, M; Catanzano, F; Bocchini, V				Arcari, P; Masullo, L; Masullo, M; Catanzano, F; Bocchini, V			A NAD(P)H oxidase isolated from the archaeon Sulfolobus solfataricus is not homologous with another NADH oxidase present in the same microorganism - Biochemical characterization of the enzyme and cloning of the encoding gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL-HYDROPEROXIDE REDUCTASE; FLAVOPROTEIN DISULFIDE OXIDOREDUCTASES; HYDROGEN-PEROXIDE; SALMONELLA-TYPHIMURIUM; THIOREDOXIN REDUCTASE; ESCHERICHIA-COLI; PURIFICATION; SEQUENCE; PROTEINS; BINDING	A NAD(P)H oxidase has been isolated from the archaeon Sulfolobus solfataricus. The enzyme is a homodimer with M-r 38,000 per subunit (SsNOX38) containing 1 FAD molecule/subunit, It oxidizes NADH and, less efficiently, NADPH with the formation of hydrogen peroxide. The enzyme was resistant against chemical and physical denaturating agents, The temperature for its half-denaturation was 93 and 75 degrees C in the absence or presence, respectively, of 8 hr urea, The enzyme did not show any reductase activity. The SsNOX38 encoding gene was cloned and sequenced. It accounted for a product of 36.5 kDa. The translated amino acid sequence was made of 332 residues containing two putative beta alpha beta-fold regions, typical of NAD- and FAD-binding proteins. The primary structure of SsNOX38 did not show any homology with the N-terminal amino acid sequence of a NADH oxidase previously isolated from S. solfataricus (SsNOX35) (Masullo, M,, Raimo, G,, Dello Russo, A, Bocchini, V. and Bannister, J. V. (1996) Biotechnol. Appl. Biochem, 23, 47-54), Conversely, it showed 40% sequence identity with a putative thioredoxin reductase from Bacillus subtilis, but it did not contain cysteines, which are essential for the activity of the reductase.	Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy; Ctr Ingn Genet Biotecnol Avanzate, I-80131 Naples, Italy	University of Naples Federico II	Bocchini, V (corresponding author), Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy.		Masullo, Mariorosario/H-4884-2016	Masullo, Mariorosario/0000-0003-4485-7383				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1982, MOL CLONING LAB MANU; Arcari P, 1999, BIOCHEMISTRY-US, V38, P12288, DOI 10.1021/bi990418d; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; COCCO D, 1988, EUR J BIOCHEM, V174, P267, DOI 10.1111/j.1432-1033.1988.tb14093.x; Dello Russo A, 1997, BBA-PROTEIN STRUCT M, V1343, P23, DOI 10.1016/S0167-4838(97)00105-2; DEROSA M, 1984, BIOCHEM J, V224, P407, DOI 10.1042/bj2240407; DeVendittis E, 1996, GENE, V176, P27, DOI 10.1016/0378-1119(96)00203-X; EGGINK G, 1990, J MOL BIOL, V212, P135, DOI 10.1016/0022-2836(90)90310-I; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HIGUCHI M, 1993, J GEN MICROBIOL, V139, P2343, DOI 10.1099/00221287-139-10-2343; KOIKE K, 1985, J BIOCHEM, V97, P1279, DOI 10.1093/oxfordjournals.jbchem.a135179; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loprasert S, 1997, J BACTERIOL, V179, P3944, DOI 10.1128/jb.179.12.3944-3949.1997; MAEDA K, 1992, BIOCHEM J, V284, P187; Masullo M, 1996, BIOTECHNOL APPL BIOC, V23, P47; MASULLO M, 1996, THESIS CRANFIELD U C; MATSUILEE IS, 1995, J BIOCHEM-TOKYO, V117, P856; NIIMURA Y, 1993, J BACTERIOL, V175, P7945, DOI 10.1128/JB.175.24.7945-7950.1993; NIIMURA Y, 1995, J BIOL CHEM, V270, P25645, DOI 10.1074/jbc.270.43.25645; NIIMURA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P2310, DOI 10.1271/bbb.58.2310; NIIMURA Y, 1989, FEMS MICROBIOL LETT, V61, P79, DOI 10.1016/S0378-1097(98)00072-X; OHNISHI K, 1995, J BIOL CHEM, V270, P5812, DOI 10.1074/jbc.270.11.5812; OHNISHI K, 1994, J BIOL CHEM, V269, P31418; PARK HJ, 1992, EUR J BIOCHEM, V205, P881, DOI 10.1111/j.1432-1033.1992.tb16853.x; RUSSEL M, 1988, J BIOL CHEM, V263, P9015; SAEKI Y, 1985, J BIOCHEM-TOKYO, V98, P1433, DOI 10.1093/oxfordjournals.jbchem.a135411; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; THOMM M, 1988, NUCLEIC ACIDS RES, V16, P151, DOI 10.1093/nar/16.1.151; THURMAN RG, 1972, EUR J BIOCHEM, V25, P420, DOI 10.1111/j.1432-1033.1972.tb01711.x; Toomey D, 1998, EUR J BIOCHEM, V251, P935, DOI 10.1046/j.1432-1327.1998.2510935.x; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2	37	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					895	900		10.1074/jbc.275.2.895	http://dx.doi.org/10.1074/jbc.275.2.895			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625624	hybrid			2022-12-27	WOS:000084836600028
J	Asao, H; Fu, XY				Asao, H; Fu, XY			Interferon-gamma has dual potentials in inhibiting or promoting cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT3 ACTIVATION; GROWTH ARREST; TRANSCRIPTIONAL ACTIVATION; TERMINAL DIFFERENTIATION; CYTOPLASMIC REGION; RECEPTOR; ALPHA; MYC; APOPTOSIS; PROTEIN	Many cytokines have dual functions of promoting or inhibiting cell proliferation; however, the molecular mechanism of the dual functions of cytokines is not well understood. Under normal conditions, interleukin (IL)-3 is required for Ba/FS cell proliferation, whereas interferon (IFN)-gamma inhibits Ba/F3 cell proliferation. It is known that Stat1 play a major role in inhibition of cell growth in response to IFN-gamma, We have examined the possibility of whether IFN-gamma can act as a growth-promoting cytokine if the Stat1 function is selectively blocked. We have established variant Ba/F3 cell lines in which Stat1 function is inhibited by a dominant-negative Stat1 mutant. Intriguingly, once Stat1 function is inhibited, IFN-gamma can replace IL-3 acting as an essential growth factor for cell proliferation. To understand the molecular mechanism of regulation of cell proliferation by the cytokines, the signaling pathways and gene induction by IL-3 and IFN-gamma are further studied. Although IL-3 activates mitogenic-activated protein kinase and Akt kinase, IFN-gamma does not. Interestingly, both IL-3 and IFN-gamma induce expression of the c-Myc gene that is not dependent on the Stat1 activity. Expression of a dominant-negative mutant Myc can block IFN-gamma-mediated Ba/F3 cell proliferation, suggesting that c-Myc gene induction is required for IFN-gamma-mediated cell proliferation. These findings suggest that IFN-gamma intrinsically and simultaneously induces specific and conflicting signaling pathways and transcriptional programs that contribute to the potential dual effects of IFN-gamma in promoting or inhibiting cell proliferation.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University	Fu, XY (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055590] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34522] Funding Source: Medline; NIGMS NIH HHS [GM55590] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARONE MV, 1995, NATURE, V378, P509, DOI 10.1038/378509a0; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Chin H, 1996, BLOOD, V88, P4415, DOI 10.1182/blood.V88.12.4415.bloodjournal88124415; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; GILL GN, 1981, NATURE, V293, P305, DOI 10.1038/293305a0; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Hara T, 1996, STEM CELLS, V14, P605, DOI 10.1002/stem.140605; Hirano Toshio, 1997, Cytokine and Growth Factor Reviews, V8, P241, DOI 10.1016/S1359-6101(98)80005-1; Hunter T, 1996, BIOCHEM SOC T, V24, P307, DOI 10.1042/bst0240307; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumura I, 1997, MOL CELL BIOL, V17, P2933, DOI 10.1128/MCB.17.5.2933; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Mui ALF, 1996, EMBO J, V15, P2425, DOI 10.1002/j.1460-2075.1996.tb00600.x; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Petricoin EF, 1997, NATURE, V390, P629, DOI 10.1038/37648; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; Quelle FW, 1996, MOL CELL BIOL, V16, P1622; ROUSSEL MF, 1991, NATURE, V353, P361, DOI 10.1038/353361a0; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; SAWYERS CL, 1992, CELL, V70, P901, DOI 10.1016/0092-8674(92)90241-4; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; SUGAMURA K, 1985, J EXP MED, V161, P1243, DOI 10.1084/jem.161.5.1243; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; TANIGUCHI T, 1997, BIOCHIM BIOPHYS ACTA, V1333, P9; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Yamanaka Y, 1996, EMBO J, V15, P1557, DOI 10.1002/j.1460-2075.1996.tb00500.x; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555	53	59	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					867	874		10.1074/jbc.275.2.867	http://dx.doi.org/10.1074/jbc.275.2.867			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625620	hybrid			2022-12-27	WOS:000084836600024
J	Fensome, AC; Rodrigues-Lima, F; Josephs, M; Paterson, HF; Katan, M				Fensome, AC; Rodrigues-Lima, F; Josephs, M; Paterson, HF; Katan, M			A neutral magnesium-dependent sphingomyelinase isoform associated with intracellular membranes and reversibly inhibited by reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN ACID SPHINGOMYELINASE; NIEMANN-PICK DISEASE; INDUCED APOPTOSIS; RAT-LIVER; STIMULATED SPHINGOMYELINASE; ENDOPLASMIC-RETICULUM; PHOSPHOLIPASE-C; DEFICIENT MICE; DISTINCT POOL	Activation of neutral sphingomyelinase(s) and subsequent generation of ceramide has been implicated in a wide variety of cellular responses. Although this enzyme(s) has not been purified and cloned from higher organisms, one mammalian cDNA has been previously isolated based on its similarity to the bacterial enzyme. To further elucidate the function of this neutral sphingomyelinase, we studied its relationship with enzymes present in mammalian cells and tissues, its subcellular localization, and properties that could be important for the regulation of its activity. Using specific antibodies, it is suggested that the enzyme could represent one of several forms of neutral sphingomyelinases present in the extract from brain particulate fraction. In PC12 cells, the enzyme is localized in the endoplasmic reticulum and is not present in the plasma membrane. The same result has been obtained in several cell lines transfected or microinjected with plasmids encoding this enzyme. The molecular and enzymatic properties of the cloned neutral magnesium-dependent sphingomyelinase, produced using baculovirus or bacterial expression systems, have been analyzed, demonstrating the expected ion dependence and substrate specificity. The enzyme activity also has a strong requirement for reducing agents and is reversibly inhibited by reactive oxygen species and oxidized glutathione. The studies demonstrate that the cellular localization and some properties of this enzyme are distinct from properties previously associated with neutral magnesium-dependent sphingomyelinases in crude or partially purified preparations.	Chester Beatty Labs, CRC, Ctr Cell & Mol Biol, London SW3 6JB, England	University of London; Institute of Cancer Research - UK	Katan, M (corresponding author), Chester Beatty Labs, CRC, Ctr Cell & Mol Biol, Fulham Rd, London SW3 6JB, England.	matilda@icr.ac.uk						Adam D, 1996, J BIOL CHEM, V271, P14617, DOI 10.1074/jbc.271.24.14617; Adam-Klages S, 1998, J LEUKOCYTE BIOL, V63, P678, DOI 10.1002/jlb.63.6.678; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; ALESSENKO A, 1995, MOL CELL BIOCHEM, V143, P169, DOI 10.1007/BF01816950; Andrieu N, 1996, EUR J BIOCHEM, V236, P738, DOI 10.1111/j.1432-1033.1996.00738.x; BERNERT JT, 1981, BIOCHIM BIOPHYS ACTA, V666, P99, DOI 10.1016/0005-2760(81)90095-3; CIFONE MG, 1995, EMBO J, V14, P5859, DOI 10.1002/j.1460-2075.1995.tb00274.x; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Ferlinz K, 1997, EUR J BIOCHEM, V243, P511, DOI 10.1111/j.1432-1033.1997.511_1a.x; Ghosh N, 1998, MOL CELL BIOCHEM, V189, P161, DOI 10.1023/A:1006910200656; Hampton MB, 1998, TOXICOL LETT, V103, P355, DOI 10.1016/S0378-4274(98)00333-6; Herr I, 1997, EMBO J, V16, P6200, DOI 10.1093/emboj/16.20.6200; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; HOSTETLER KY, 1979, J LIPID RES, V20, P456; Jaffrezou JP, 1996, EMBO J, V15, P2417, DOI 10.1002/j.1460-2075.1996.tb00599.x; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Kaletta K, 1998, FEBS LETT, V434, P377, DOI 10.1016/S0014-5793(98)01013-8; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; Kreder D, 1999, EMBO J, V18, P2472, DOI 10.1093/emboj/18.9.2472; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Li JR, 1999, J BIOL CHEM, V274, P17325, DOI 10.1074/jbc.274.24.17325; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu B, 1998, J BIOL CHEM, V273, P34472, DOI 10.1074/jbc.273.51.34472; Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153; Liu B, 1997, J BIOL CHEM, V272, P16281, DOI 10.1074/jbc.272.26.16281; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Newrzella D, 1996, J BIOL CHEM, V271, P32089, DOI 10.1074/jbc.271.50.32089; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3; QUINN P, 1992, BIOCHIM BIOPHYS ACTA, V1124, P95, DOI 10.1016/0005-2760(92)90131-E; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; ROSS, 1999, ROSSIG L, V274, P6823; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; SPENCE MW, 1982, BIOCHIM BIOPHYS ACTA, V719, P162, DOI 10.1016/0304-4165(82)90321-X; STRUM JC, 1994, J BIOL CHEM, V269, P15493; Takeda Y, 1999, J BIOL CHEM, V274, P10654, DOI 10.1074/jbc.274.15.10654; TAMIYAKOIZUMI K, 1989, J BIOCHEM, V106, P593, DOI 10.1093/oxfordjournals.jbchem.a122901; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; Trombetta ES, 1999, EMBO J, V18, P3282, DOI 10.1093/emboj/18.12.3282; Ueda S, 1998, J IMMUNOL, V161, P6689; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Yoshimura S, 1998, J BIOL CHEM, V273, P6921, DOI 10.1074/jbc.273.12.6921; Zhang P, 1997, J BIOL CHEM, V272, P9609	56	34	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1128	1136		10.1074/jbc.275.2.1128	http://dx.doi.org/10.1074/jbc.275.2.1128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625655	hybrid			2022-12-27	WOS:000084836600059
J	Huang, W; Dolmer, K; Liao, XB; Gettins, PGW				Huang, W; Dolmer, K; Liao, XB; Gettins, PGW			NMR solution structure of the receptor binding domain of human alpha(2)-macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; BETA-AMYLOID PEPTIDE; HIGH-AFFINITY BINDING; HUMAN ALPHA-2-MACROGLOBULIN; ALPHA-MACROGLOBULINS; PROTEIN; ENDOCYTOSIS; CALCIUM; COMPLEX	Human alpha(2)-macroglobulin-proteinase complexes bind to their receptor, the low density lipoprotein receptor-related protein (LRP), through a discrete 138-residue C-terminal receptor binding domain (RBD), which also binds to the beta-amyloid peptide. We have used NMR spectroscopy on recombinantly expressed uniformly C-13/N-15-labeled human RED to determine its three-dimensional structure in solution, Human RED is a sandwich of two antiparallel beta-sheets, one four-strand and one five-strand, and also contains one alpha-helix of 2.5 turns and an additional 1-turn. helical region. The principal alpha-helix contains two lysine residues on the outer face that are known to be essential for receptor binding. A calcium binding site (K-d similar to 11 mM) is present in the loop region at one end of the beta-sandwich, Calcium binding principally affects this loop region and does not significantly perturb the stable core structure of the domain. The structure and NMR. assignments will enable us to examine in solution specific binding of RED to domains of the receptor and to beta-amyloid peptide.	Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA.	pgettins@tigger.uic.edu	Dolmer, Klavs/G-5512-2012	Dolmer, Klavs/0000-0001-7359-360X	NCRR NIH HHS [RR02781, RR02301] Funding Source: Medline; NIGMS NIH HHS [GM54414] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR002781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSEN GR, 1995, J BIOL CHEM, V270, P25133, DOI 10.1074/jbc.270.42.25133; Birkenmeier G, 1997, FEBS LETT, V416, P193, DOI 10.1016/S0014-5793(97)01201-5; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; Cai ML, 1998, PROTEIN SCI, V7, P2669, DOI 10.1002/pro.5560071221; DOLMER K, 1995, FEBS LETT, V372, P93, DOI 10.1016/0014-5793(95)00960-H; Du YS, 1997, J NEUROCHEM, V69, P299; ENGHILD JJ, 1989, BIOCHEMISTRY-US, V28, P1406, DOI 10.1021/bi00429a069; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; GLIEMANN J, 1994, ANN NY ACAD SCI, V737, P20, DOI 10.1111/j.1749-6632.1994.tb44299.x; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HOLTET TL, 1994, FEBS LETT, V344, P242, DOI 10.1016/0014-5793(94)00349-1; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Hughes SR, 1998, P NATL ACAD SCI USA, V95, P3275, DOI 10.1073/pnas.95.6.3275; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Narita M, 1997, J NEUROCHEM, V69, P1904; Qazi U, 1999, J BIOL CHEM, V274, P8137, DOI 10.1074/jbc.274.12.8137; Rodenburg KW, 1998, BIOCHEM J, V329, P55; Sottrup-Jensen L., 1987, PLASMA PROTEINS, V5, P191; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8318; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; VANLEUVEN F, 1986, J BIOL CHEM, V261, P1369; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WEBB DJ, 1994, J BIOL CHEM, V269, P30402; WILLIAMS SE, 1994, ANN NY ACAD SCI, V737, P1, DOI 10.1111/j.1749-6632.1994.tb44297.x; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	31	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1089	1094		10.1074/jbc.275.2.1089	http://dx.doi.org/10.1074/jbc.275.2.1089			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625650	hybrid			2022-12-27	WOS:000084836600054
J	Lackner, CA; Condit, RC				Lackner, CA; Condit, RC			Vaccinia virus gene A18R DNA helicase is a transcript release factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TEMPERATURE-SENSITIVE MUTANTS; PHENOTYPIC CHARACTERIZATION; VIRAL TRANSCRIPTION; TERMINATION FACTOR; ELONGATION-FACTOR; ESCHERICHIA-COLI; INITIATION-FACTOR; DEPENDENT ATPASE; CELLULAR PROTEIN	Prior phenotypic analysis of a vaccinia virus gene A18R mutant, Cts23, showed the synthesis of longer than wild type (Wt) length viral transcripts during the intermediate stage of infection, indicating that the A18R protein may act as a negative transcription elongation factor. The purpose of the work described here was to determine a biochemical activity for the A18R protein. Pulse-labeled transcription complexes established from intermediate virus promoters on bead-bound DNA templates were assayed for transcript release during an elongation step that contained nucleotides and various proteins. Pulse-labeled transcription complexes elongated in the presence of only nucleotides were unable to release nascent RNA. The addition of Wt extract during the elongation phase resulted in release of the nascent transcript, indicating that additional factors present in the Wt extract are capable of inducing transcript release. Extract from Cts23 or mock-infected cells was unable to induce release. The lack of release upon addition of Cts23 extract suggests that A18R is involved in release of nascent RNA. By itself, purified polyhistidine-tagged A18R protein (His-A18R) was unable to induce release; however, release did occur in the presence of purified His-A18R protein plus extract from either Cts23 or mock-infected cells. These data taken together indicate that A18R is necessary but not sufficient for release of nascent transcripts. We have also demonstrated that the combination of A18R protein and mock extract induces transcript release in an ATP-dependent manner, consistent with the fact that the A18R protein is all ATP-dependent helicase. Further analysis revealed that the release activity is not restricted to a vaccinia intermediate promoter but is observed using pulse-labeled transcription complexes initiated from all three viral gene class promoters. Therefore, we conclude that A18R and an as yet unidentified cellular factor(s) are required for the in vitro release of nascent RNA from a vaccinia virus transcription elongation complex.	Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Condit, RC (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.				NIAID NIH HHS [AI18094] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018094] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; BAYLISS CD, 1993, VIROLOGY, V194, P254, DOI 10.1006/viro.1993.1256; BAYLISS CD, 1995, J BIOL CHEM, V270, P1550, DOI 10.1074/jbc.270.4.1550; Beaud G, 1997, J GEN VIROL, V78, P3297, DOI 10.1099/0022-1317-78-12-3297; Black EP, 1996, J VIROL, V70, P47, DOI 10.1128/JVI.70.1.47-54.1996; Black EP, 1998, VIROLOGY, V245, P313, DOI 10.1006/viro.1998.9166; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; CHRISTEN L, 1992, J GEN VIROL, V73, P3155, DOI 10.1099/0022-1317-73-12-3155; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; Condit RC, 1996, VIROLOGY, V218, P169, DOI 10.1006/viro.1996.0177; Condit RC, 1996, VIROLOGY, V220, P10, DOI 10.1006/viro.1996.0280; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Deng L, 1996, J BIOL CHEM, V271, P19556, DOI 10.1074/jbc.271.32.19556; FATHI Z, 1991, VIROLOGY, V181, P273, DOI 10.1016/0042-6822(91)90492-T; Gunasinghe SK, 1998, J BIOL CHEM, V273, P27524, DOI 10.1074/jbc.273.42.27524; Hassett DE, 1997, VIROLOGY, V238, P391, DOI 10.1006/viro.1997.8820; HOODADHINGRA U, 1990, VIROLOGY, V174, P60, DOI 10.1016/0042-6822(90)90054-U; HOODADHINGRA U, 1989, J VIROL, V63, P714, DOI 10.1128/JVI.63.2.714-729.1989; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Kovacs GR, 1996, J VIROL, V70, P6796, DOI 10.1128/JVI.70.10.6796-6802.1996; Liu MY, 1998, J BIOL CHEM, V273, P25541, DOI 10.1074/jbc.273.40.25541; LUO Y, 1991, J BIOL CHEM, V266, P13303; Maraia RJ, 1996, P NATL ACAD SCI USA, V93, P3383, DOI 10.1073/pnas.93.8.3383; Mason SW, 1997, EMBO J, V16, P163, DOI 10.1093/emboj/16.1.163; MOS B, 1996, VIROLOGY, P2637; PACHA RF, 1985, J VIROL, V56, P395, DOI 10.1128/JVI.56.2.395-403.1985; RICHARDSON JP, 1990, BIOCHIM BIOPHYS ACTA, V1048, P127, DOI 10.1016/0167-4781(90)90048-7; ROBERTS JW, 1993, CELL, V72, P653, DOI 10.1016/0092-8674(93)90394-6; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; ROSALES R, 1994, P NATL ACAD SCI USA, V91, P3794, DOI 10.1073/pnas.91.9.3794; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHNIERLE BS, 1992, P NATL ACAD SCI USA, V89, P2897, DOI 10.1073/pnas.89.7.2897; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SIMPSON DA, 1995, J VIROL, V69, P6131, DOI 10.1128/JVI.69.10.6131-6139.1995; SIMPSON DA, 1994, J VIROL, V68, P3642, DOI 10.1128/JVI.68.6.3642-3649.1994; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wang DG, 1997, J BIOL CHEM, V272, P5989, DOI 10.1074/jbc.272.9.5989; Wright CF, 1998, J VIROL, V72, P1446, DOI 10.1128/JVI.72.2.1446-1451.1998; WRIGHT CF, 1989, J VIROL, V63, P4224, DOI 10.1128/JVI.63.10.4224-4233.1989; Xiang Y, 1998, J VIROL, V72, P7012, DOI 10.1128/JVI.72.9.7012-7023.1998; Xie Z, 1997, J BIOL CHEM, V272, P31902, DOI 10.1074/jbc.272.50.31902; Xie Z, 1996, J BIOL CHEM, V271, P11043, DOI 10.1074/jbc.271.19.11043; YARNELL WS, 1992, CELL, V69, P1181, DOI 10.1016/0092-8674(92)90639-T; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhu M, 1998, J VIROL, V72, P3893, DOI 10.1128/JVI.72.5.3893-3899.1998	51	28	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1485	1494		10.1074/jbc.275.2.1485	http://dx.doi.org/10.1074/jbc.275.2.1485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625702	hybrid			2022-12-27	WOS:000084836600106
J	Wang-Gillam, A; Pastuszak, I; Stewart, M; Drake, RR; Elbein, AD				Wang-Gillam, A; Pastuszak, I; Stewart, M; Drake, RR; Elbein, AD			Identification and modification of the uridine-binding site of the UDP-GalNAc (GlcNAc) pyrophosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX VIRUS TYPE-1; GLUCOSE PYROPHOSPHORYLASE; THYMIDINE KINASE; CLONING; COMPLEX	UDP-GaINAc pyrophosphorylase (UDP-GaINAcPP; AGX1) catalyzes the synthesis of UDP-GaINAc from UTP and GaINAc-1-P, The 475-amino acid protein (57 kDa protein) also synthesizes UDP-GIcNAc at about 25% the rate of UDP-GaINAc. The cDNA for this enzyme, termed AGX1, was cloned in Escherichia coli, and expressed as an active enzyme that cross-reacted with antiserum against the original pig liver UDP-HexNAcPP, In the present study, we incubated recombinant AGX1 with N-3-UDP-[P-32]GIcNAc and N-3-UDP-[P-32]GaINAc probes to label the nucleotide-binding site, Proteolytic digestions of the labeled enzyme and analysis of the resulting peptides indicated that both photoprobes cross-linked to one 24-amino acid peptide located between residues Val(216) and GlU(240). Four amino acids in this peptide were found to be highly conserved among closely related enzymes, and each of these was individually modified to alanine, Mutation of Gly(222) to Ala in the peptide almost completely eliminated UDP-GIcNAc and UDP-GaINAc synthesis, while mutation of Gly(224) to Ala, almost completely eliminated UDP-GaINAc synthesis, but UDP-GI-cNAc was only diminished by 50%. Both of these mutations also resulted in almost complete loss of the ability of the mutated proteins to cross-link N-3-UDP-[P-32]GaINAc or N-3-UDP-[P-32]GaINAc. On the other hand, mutations of either pro(220) or Tyr(227) to Ala did not greatly affect enzymatic activity, although there was some reduction in the ability of these proteins to cross-link the photoaffinity probes, We also mutated Gly111 to Ala since this amino acid was reported to be necessary for catalysis (Mio, T., Yabe, T., Arisawa, M., and Yamada-Okabe, H, (1998) J. Biol, Chem. 273, 14392-14397). The Gly(111) to Ala mutant lost all enzymatic activity, but interestingly enough, this mutant protein still cross-linked the radioactive N-3-UDP-GlcNAc although not nearly as well as the wild type. On the other hand, mutation of Arg(115) to Ala had no affect on enzymatic activity although it also reduced the amount of cross-linking of N-3-UDP-[P-32]GIcNAc. These studies help to define essential amino acids at or near the nucleotide-binding site and the catalytic site, as well as peptides involved in binding and catalysis.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Elbein, AD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Slot 516,4301 W Markham, Little Rock, AR 72205 USA.	elbeinaland@exchange.uams.edu	Stewart, Malcolm/AAY-2789-2020	Stewart, Malcolm/0000-0002-5724-9160	NHLBI NIH HHS [HL-17783] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL017783] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROWN DG, 1995, NAT STRUCT BIOL, V2, P876, DOI 10.1038/nsb1095-876; DARAN JM, 1995, EUR J BIOCHEM, V233, P520, DOI 10.1111/j.1432-1033.1995.520_2.x; Di Cera E, 1998, ADV PROTEIN CHEM, V51, P59; DIEKMAN AB, 1994, BIOL REPROD, V50, P1087, DOI 10.1095/biolreprod50.5.1087; Drake RR, 1998, P NATL ACAD SCI USA, V95, P4170, DOI 10.1073/pnas.95.8.4170; DRAKE RR, 1992, GLYCOBIOLOGY, V2, P279, DOI 10.1093/glycob/2.4.279; KONISHI Y, 1993, J BIOCHEM-TOKYO, V114, P61, DOI 10.1093/oxfordjournals.jbchem.a124141; Mio T, 1998, J BIOL CHEM, V273, P14392, DOI 10.1074/jbc.273.23.14392; PATTABIRAMAN T, 1961, BIOCHIM BIOPHYS ACTA, V50, P129, DOI 10.1016/0006-3002(61)91068-X; PENG HL, 1993, FEBS LETT, V329, P153, DOI 10.1016/0014-5793(93)80213-E; Rechtin TM, 1996, ANAL BIOCHEM, V237, P135, DOI 10.1006/abio.1996.0211; STROMINGER JL, 1959, J BIOL CHEM, V234, P1822; Sunthankar P, 1998, ANAL BIOCHEM, V258, P195, DOI 10.1006/abio.1998.2600; Szumilo T, 1996, J BIOL CHEM, V271, P13147, DOI 10.1074/jbc.271.22.13147; Wang-Gillam A, 1998, J BIOL CHEM, V273, P27055, DOI 10.1074/jbc.273.42.27055; Wild K, 1997, PROTEIN SCI, V6, P2097	16	27	29	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1433	1438		10.1074/jbc.275.2.1433	http://dx.doi.org/10.1074/jbc.275.2.1433			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625695	hybrid			2022-12-27	WOS:000084836600099
J	Clark, SF; Molero, JC; James, DE				Clark, SF; Molero, JC; James, DE			Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCOSE-TRANSPORT; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; PHOSPHOTYROSINE PROTEIN; GLYCOGEN-SYNTHASE; RAT ADIPOCYTES; OKADAIC ACID	Insulin receptor substrate (IRS) proteins are major substrates of the insulin receptor (IR), IRS-1 associates with an insoluble multiprotein complex, possibly the cytoskeleton, in adipocytes. This localization may facilitate interaction with the IR at the cell surface. In the present study, we examined the hypothesis that the release of IRS proteins from this location may be a mechanism for insulin desensitization. We show that a second IRS protein, IRS-2, is associated with a multiprotein complex in adipocytes with similar characteristics to the IRS-1 complex. Insulin treatment (15-60 min) caused the release of IRS-1 and IRS-2 from this complex (high speed pellet; HSP) into the cytosol, whereas the level of tyrpsyl-phosphorylated IRS proteins remained constant. Chronic insulin treatment resulted in a dramatic reduction in IRS-1 and IRS-2 in the HSP, eventually (>2 h) leading to IRS protein degradation and decreased levels of tyrosyl-phosphorylated IRS proteins. Okadaic acid, which rapidly induces insulin resistance in adipocytes independently of TR function, caused an almost quantitative release of IRS-1 into the cytosol commensurate with a significant reduction in tyrosyl-phosphorylated IRS proteins. Platelet-derived growth factor, a factor known to compromise insulin signaling, caused a more moderate release of IRS proteins from the HSP. Collectively, these results suggest that the assembly of IRS-1/IRS-2 into a multiprotein complex facilitates coupling to the IR and that the regulated release from this location may represent a novel mechanism of insulin resistance.	Univ Queensland, Dept Physiol & Pharmacol, Ctr Mol & Cellular Biol, Brisbane, Qld 4072, Australia	University of Queensland	James, DE (corresponding author), Univ Queensland, Dept Physiol & Pharmacol, Ctr Mol & Cellular Biol, Brisbane, Qld 4072, Australia.		Clark, Sharon/B-8057-2009	James, David/0000-0001-5946-5257				Anai O, 1998, J BIOL CHEM, V273, P29686, DOI 10.1074/jbc.273.45.29686; BENITO M, 1991, SCIENCE, V253, P565, DOI 10.1126/science.1857988; Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; CHIN JE, 1994, MOL ENDOCRINOL, V8, P51, DOI 10.1210/me.8.1.51; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Craparo A, 1997, J BIOL CHEM, V272, P11663; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; EldarFinkelman H, 1997, P NATL ACAD SCI USA, V94, P9660, DOI 10.1073/pnas.94.18.9660; GUSTAFSON TA, 1995, MOL CELL BIOL, V15, P2500; HELLERHARRISON RA, 1995, J BIOL CHEM, V270, P24442, DOI 10.1074/jbc.270.41.24442; Hill MM, 1997, ELECTROPHORESIS, V18, P2629, DOI 10.1002/elps.1150181419; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Inoue G, 1998, J BIOL CHEM, V273, P11548, DOI 10.1074/jbc.273.19.11548; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JULLIEN D, 1993, J BIOL CHEM, V268, P15246; KELLER SR, 1991, J BIOL CHEM, V266, P12817; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KOTANI K, 1995, BIOCHEM BIOPH RES CO, V209, P343, DOI 10.1006/bbrc.1995.1509; KOZKA IJ, 1991, J BIOL CHEM, V266, P11726; KUBLAOUI B, 1995, J BIOL CHEM, V270, P59, DOI 10.1074/jbc.270.1.59; KURCHALIA T, 1992, J CELL BIOL, V118, P1003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Lavan BE, 1997, J BIOL CHEM, V272, P21403, DOI 10.1074/jbc.272.34.21403; LAVAN BE, 1992, J BIOL CHEM, V267, P11631; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; Li JP, 1999, J BIOL CHEM, V274, P9351, DOI 10.1074/jbc.274.14.9351; Ogawa W, 1998, MOL CELL BIOCHEM, V182, P13, DOI 10.1023/A:1006862807598; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; OKADA T, 1994, J BIOL CHEM, V269, P3568; PEARSE BMF, 1982, P NATL ACAD SCI-BIOL, V79, P451, DOI 10.1073/pnas.79.2.451; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; QUON MJ, 1995, MOL CELL BIOL, V15, P5403; RICE KM, 1993, BIOCHEM BIOPH RES CO, V190, P961, DOI 10.1006/bbrc.1993.1143; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; Ricort JM, 1997, J BIOL CHEM, V272, P19814, DOI 10.1074/jbc.272.32.19814; RICORT JM, 1995, DIABETOLOGIA, V38, P1148, DOI 10.1007/s001250050406; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; Smith LK, 1996, MOL CELL ENDOCRINOL, V122, P81, DOI 10.1016/0303-7207(96)03875-0; Staubs PA, 1998, J BIOL CHEM, V273, P25139, DOI 10.1074/jbc.273.39.25139; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TANTI JF, 1994, J BIOL CHEM, V269, P6051; TANTI JF, 1993, AM J PHYSIOL, V264, pE868, DOI 10.1152/ajpendo.1993.264.6.E868; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; WHITE MF, 1994, J BIOL CHEM, V269, P1; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442; Yenush L, 1996, J BIOL CHEM, V271, P24300, DOI 10.1074/jbc.271.39.24300; Zhou LX, 1997, J BIOL CHEM, V272, P29829, DOI 10.1074/jbc.272.47.29829	57	73	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3819	3826		10.1074/jbc.275.6.3819	http://dx.doi.org/10.1074/jbc.275.6.3819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660532	hybrid			2022-12-27	WOS:000085288800016
J	Lasker, JM; Chen, WB; Wolf, I; Bloswick, BP; Wilson, PD; Powell, PK				Lasker, JM; Chen, WB; Wolf, I; Bloswick, BP; Wilson, PD; Powell, PK			Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney - Role of CYP4F2 and CYP4A11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Proceedings Paper	American-Society-of-Biochemistry-and-Molecular-Biology Annual Meeting	MAY 15-20, 1998	WASHINGTON, D.C.	Amer Soc Biochem & Molec Biol			SPONTANEOUSLY HYPERTENSIVE RATS; HUMAN LIVER-MICROSOMES; ENDOGENOUS EPOXYEICOSATRIENOIC ACIDS; POTENTIAL FUNCTIONAL-SIGNIFICANCE; ARACHIDONIC-ACID; OMEGA-HYDROXYLASE; CYTOCHROME-P450 4A; RENAL-FUNCTION; MOLECULAR-CLONING; CORTEX MICROSOMES	20-Hydroxyeicosatetraenoic acid (20-HETE), an omega-hydroxylated arachidonic acid (AA) metabolite, elicits specific effects on kidney vascular and tubular function that, in turn, influence blood pressure control. The human kidney's capacity to convert AA to SO-METE is unclear, however, as is the underlying P450 catalyst. Microsomes from human kidney cortex were found to convert AA to a single major product, namely 80-HETE, but failed to catalyze AA epoxygenation and midchain hydroxylation. Despite the monophasic nature of renal AA omega-hydroxylation kinetics, immunochemical studies revealed participation of two P450s, CYP4FS and CYP4A11, since antibodies to these enzymes inhibited SO-METE formation by 65.9 +/-17 and 32.5 +/- 14%, respectively. Western blotting confirmed abundant expression of these CYP4 proteins in human kidney and revealed that other AA-oxidizing P450s, including CYP2C8, CYP2C9, and CYP2E1, were not expressed. Immunocytochemistry showed CYP4F2 and CYP4A11 expression in only the S2 and 53 segments of proximal tubules in cortex and outer medulla, Our results demonstrate that CYP4F2 and CYP4A11 underlie conversion of AA to 20-METE, a natriuretic and vasoactive eicosanoid, in human kidney. Considering their proximal tubular localization, these P450 enzymes may partake in pivotal renal functions, including the regulation of salt and water balance, and arterial blood pressure itself.	CUNY Mt Sinai Sch Med, Dept Biochem, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Lasker, JM (corresponding author), CUNY Mt Sinai Sch Med, Dept Biochem, Box 1020,1 Gustave L Levy Pl, New York, NY 10029 USA.	lasker@smtplink.mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092310, R01DK040698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007842] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA07842] Funding Source: Medline; NIDDK NIH HHS [N01 DK92310, DK40698] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amet Y, 1997, BIOCHEM PHARMACOL, V53, P765, DOI 10.1016/S0006-2952(96)00821-0; Amet Y, 1997, BIOCHEM PHARMACOL, V54, P947, DOI 10.1016/S0006-2952(97)00257-8; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; CAPDEVILA JH, 1992, J BIOL CHEM, V267, P21720; Capdevila Jorge H., 1995, P443; CARROLL MA, 1991, J BIOL CHEM, V266, P12306; Carroll MA, 1997, ADV EXP MED BIOL, V407, P255; CUMMINGS B, 1999, TOXICOL SCI S, V48, pS96; Cummings BS, 1999, DRUG METAB DISPOS, V27, P542; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387; ESCALANTE B, 1993, EUR J PHARMACOL, V235, P1, DOI 10.1016/0014-2999(93)90812-V; Feierman DE, 1996, DRUG METAB DISPOS, V24, P932; FERGUSON NL, 1993, DRUG METAB DISPOS, V21, P745; Gibson GG, 1996, ANN NY ACAD SCI, V804, P328; Goasduff T, 1996, ALCOHOL, V13, P301, DOI 10.1016/0741-8329(95)02111-6; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Haehner BD, 1996, MOL PHARMACOL, V50, P52; Harder DR, 1997, J VASC RES, V34, P237, DOI 10.1159/000159228; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; HARDWICK JP, 1991, METHOD ENZYMOL, V206, P273; IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1074, P209, DOI 10.1016/0304-4165(91)90063-M; Imig JD, 1996, AM J PHYSIOL-REG I, V270, pR217, DOI 10.1152/ajpregu.1996.270.1.R217; IMIG JD, 1993, HYPERTENSION, V22, P357, DOI 10.1161/01.HYP.22.3.357; Ito O, 1998, AM J PHYSIOL-RENAL, V274, pF395, DOI 10.1152/ajprenal.1998.274.2.F395; Jin RY, 1998, ARCH BIOCHEM BIOPHYS, V359, P89, DOI 10.1006/abbi.1998.0880; KARARA A, 1989, J BIOL CHEM, V264, P19822; KARARA A, 1990, FEBS LETT, V268, P227, DOI 10.1016/0014-5793(90)81014-F; KARARA A, 1993, J BIOL CHEM, V268, P13565; Kawashima H, 1997, ARCH BIOCHEM BIOPHYS, V347, P148, DOI 10.1006/abbi.1997.0342; LAETHEM RM, 1992, J BIOL CHEM, V267, P5552; LAETHEM RM, 1992, MOL PHARMACOL, V42, P958; Lasker JM, 1998, ARCH BIOCHEM BIOPHYS, V353, P16, DOI 10.1006/abbi.1998.0615; Luo G, 1998, ARCH BIOCHEM BIOPHYS, V357, P45, DOI 10.1006/abbi.1998.0806; MA XL, 1993, HEPATOLOGY, V18, P1247; MA YH, 1993, CIRC RES, V72, P126, DOI 10.1161/01.RES.72.1.126; Makita K, 1996, FASEB J, V10, P1456, DOI 10.1096/fasebj.10.13.8940291; MATSUBARA S, 1987, J BIOL CHEM, V262, P13366; MCGIFF JC, 1993, STEROIDS, V58, P573, DOI 10.1016/0039-128X(93)90098-8; MUERHOFF AS, 1989, J BIOL CHEM, V264, P749; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P902, DOI 10.1111/j.1530-0277.1994.tb00058.x; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nowicki S, 1997, J CLIN INVEST, V99, P1224, DOI 10.1172/JCI119279; OKITA RT, 1979, BIOCHEM PHARMACOL, V28, P3385, DOI 10.1016/0006-2952(79)90077-7; OMATA K, 1992, AM J PHYSIOL, V262, pF591, DOI 10.1152/ajprenal.1992.262.4.F591; PALMER CNA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P161, DOI 10.1016/0167-4781(93)90285-L; Powell PK, 1996, ARCH BIOCHEM BIOPHYS, V335, P219, DOI 10.1006/abbi.1996.0501; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; Powell WS, 1996, J PHARMACOL EXP THER, V276, P728; Rahman M, 1997, AM J HYPERTENS, V10, P356, DOI 10.1016/S0895-7061(96)00381-0; RAUCY JL, 1991, METHOD ENZYMOL, V206, P577; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; ROMAN LJ, 1993, ARCH BIOCHEM BIOPHYS, V307, P57, DOI 10.1006/abbi.1993.1560; Ronis MJJ, 1998, BIOCHEM PHARMACOL, V55, P123, DOI 10.1016/S0006-2952(97)00381-X; SACERDOTI D, 1989, SCIENCE, V243, P388, DOI 10.1126/science.2492116; SACERDOTI D, 1988, BIOCHEM PHARMACOL, V37, P521, DOI 10.1016/0006-2952(88)90223-7; SAWAMURA A, 1993, BIOCHIM BIOPHYS ACTA, V1168, P30; SCHWARTZMAN ML, 1990, KIDNEY INT, V37, P94, DOI 10.1038/ki.1990.13; Schwartzman ML, 1996, NEPHRON, V73, P652; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHIMOJO N, 1993, BIOCHEM PHARMACOL, V46, P621, DOI 10.1016/0006-2952(93)90547-A; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stec DE, 1996, HYPERTENSION, V27, P1329, DOI 10.1161/01.HYP.27.6.1329; Stec DE, 1997, HYPERTENSION, V29, P315, DOI 10.1161/01.HYP.29.1.315; STROMSTEDT M, 1990, DNA CELL BIOL, V9, P569, DOI 10.1089/dna.1990.9.569; SUNDSETH SS, 1992, J BIOL CHEM, V267, P3915; TSUTSUMI M, 1993, ARCH BIOCHEM BIOPHYS, V304, P209, DOI 10.1006/abbi.1993.1341; TSUTSUMI M, 1989, HEPATOLOGY, V10, P437, DOI 10.1002/hep.1840100407; Wang MH, 1999, AM J PHYSIOL-RENAL, V276, pF246, DOI 10.1152/ajprenal.1999.276.2.F246; Wang MH, 1996, ARCH BIOCHEM BIOPHYS, V336, P240, DOI 10.1006/abbi.1996.0554; Wang MH, 1998, J PHARMACOL EXP THER, V284, P966; Wu S, 1996, J BIOL CHEM, V271, P3460; YOSHIMURA R, 1990, J BIOCHEM, V108, P544, DOI 10.1093/oxfordjournals.jbchem.a123239; Zeldin DC, 1996, ARCH BIOCHEM BIOPHYS, V330, P87, DOI 10.1006/abbi.1996.0229; Zeldin DC, 1996, MOL PHARMACOL, V50, P1111; Zeldin DC, 1997, MOL PHARMACOL, V51, P931, DOI 10.1124/mol.51.6.931; Zou AP, 1996, HYPERTENSION, V27, P631, DOI 10.1161/01.HYP.27.3.631; ZOU AP, 1994, AM J PHYSIOL, V266, pF275, DOI 10.1152/ajprenal.1994.266.2.F275; ZOU AP, 1994, J PHARMACOL EXP THER, V268, P474; Zou AP, 1996, AM J PHYSIOL-REG I, V270, pR228, DOI 10.1152/ajpregu.1996.270.1.R228; ZOU AP, 1994, AM J PHYSIOL, V266, pF934, DOI 10.1152/ajprenal.1994.266.6.F934	82	243	255	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4118	4126		10.1074/jbc.275.6.4118	http://dx.doi.org/10.1074/jbc.275.6.4118			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	283RJ	10660572	hybrid			2022-12-27	WOS:000085288800056
J	Yu, WH; Woessner, JF				Yu, WH; Woessner, JF			Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVOLUTING RAT UTERUS; PROGELATINASE-A; CELL-SURFACE; GLYCOSAMINOGLYCAN INTERACTIONS; TISSUE INHIBITORS; BINDING; COLLAGENASE; ACTIVATION; ENZYME; DEGRADATION	Many matrix metalloproteinases (MMPs) are tightly bound to tissues; matrilysin (MMP-7), although the smallest of the MMPs, is one of the most tightly bound. The most likely docking molecules for MMP-7 are heparan sulfate proteoglycans on or around epithelial cells and in the underlying basement membrane. This is established by extraction experiments and confocal microscopy, The enzyme is extracted from homogenates of postpartum rat uterus by heparin/heparan sulfate and by heparinase III treatment. The enzyme is colocalized with heparan sulfate in the apical region of uterine glandular epithelial cells and can be released by heparinase digestion. Heparan sulfate and MMP-7 are expressed at similar stages of the rat estrous cycle. The strength of heparin binding by recombinant rat proMMP-7 was examined by affinity chromatography, affinity coelectrophoresis, and homogeneous enzyme-based binding assay; the K-D, is 5-10 nM. Zymographic measurement of MMP-7 activity is greatly enhanced by heparin, Two putative heparin-binding peptides have been identified near the C- and N-terminal regions of proMMP-7; however, molecular modeling suggests a more extensive binding track or cradle crossing multiple peptide strands. Evidence is also found for the binding of MMP-2, -9, and -13. Binding of MMP-7 and other MMPs to heparan sulfate in the extracellular space could prevent loss of secreted enzyme, provide a reservoir of latent enzyme, and facilitate cellular sensing and regulation of enzyme levels. Binding to the cell surface could position the enzyme for directed proteolytic attack, for activation of or by other MMPs and for regulation of other cell surface proteins. Dislodging MMPs by treatment with compounds such as heparin might be beneficial in attenuating excessive tissue breakdown such as occurs in cancer metastasis, arthritis, and angiogenesis.	Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Woessner, JF (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, R-127,POB 106960, Miami, FL 33101 USA.	fwoessne@med.miami.edu	Yu, Wei Hsuan/AAF-7129-2021	YU, WEI-HSUAN/0000-0002-1782-3738	NIAMS NIH HHS [AR-16940] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR016940, R37AR016940] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABRAMSON SR, 1995, J BIOL CHEM, V270, P16016, DOI 10.1074/jbc.270.27.16016; Anees M, 1996, J ENZYM INHIB, V10, P203, DOI 10.3109/14756369609030314; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Borden P, 1997, CRIT REV EUKAR GENE, V7, P159, DOI 10.1615/CritRevEukarGeneExpr.v7.i1-2.90; BROWNER MF, 1995, BIOCHEMISTRY-US, V34, P6602, DOI 10.1021/bi00020a004; BUSBY TF, 1995, J BIOL CHEM, V270, P18558, DOI 10.1074/jbc.270.31.18558; BUSIEK DF, 1995, J IMMUNOL, V154, P6484; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Cawson T, 1998, MOL MED TODAY, V4, P130, DOI 10.1016/S1357-4310(97)01192-1; Celentano DC, 1997, J CLIN PHARMACOL, V37, P991, DOI 10.1002/j.1552-4604.1997.tb04278.x; Cha J, 1997, BIOCHEMISTRY-US, V36, P16019, DOI 10.1021/bi972223g; Cha JH, 1996, BIOCHEMISTRY-US, V35, P15831, DOI 10.1021/bi962085f; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chen WT, 1996, ENZYME PROTEIN, V49, P59, DOI 10.1159/000468616; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P14419, DOI 10.1021/bi00252a007; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; DEAN DD, 1989, J CLIN INVEST, V84, P678, DOI 10.1172/JCI114215; DEPREZ PN, 1995, BBA-PROTEIN STRUCT M, V1252, P53, DOI 10.1016/0167-4838(95)00109-8; GADHER SJ, 1990, MATRIX, V10, P154, DOI 10.1016/S0934-8832(11)80164-2; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Guo X, 1996, ANAL BIOCHEM, V235, P153, DOI 10.1006/abio.1996.0107; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Jeffrey JJ, 1998, HDB PROTEOLYTIC ENZY, P1167; KAO WWY, 1986, CURR EYE RES, V5, P801; Kolkenbrock H, 1996, BIOL CHEM, V377, P529, DOI 10.1515/bchm3.1996.377.7-8.529; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Mertens G, 1996, J CELL BIOL, V132, P487, DOI 10.1083/jcb.132.3.487; MILSTONE LM, 1994, J CELL SCI, V107, P3183; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nagase H, 1997, BIOL CHEM, V378, P151; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; POTTER SW, 1992, ANAT REC, V234, P383, DOI 10.1002/ar.1092340308; QUINN CO, 1990, J BIOL CHEM, V265, P22342; Rogachefsky R A, 1993, Osteoarthritis Cartilage, V1, P105, DOI 10.1016/S1063-4584(05)80025-1; ROSWIT WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P285, DOI 10.1016/0003-9861(83)90032-2; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; SAKAMOTO S, 1973, CALC TISS RES, V12, P247, DOI 10.1007/BF02013739; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; SELLERS A, 1980, BIOCHEM J, V189, P521, DOI 10.1042/bj1890521; SMITH JW, 1987, ANAL BIOCHEM, V160, P105, DOI 10.1016/0003-2697(87)90619-1; VATER CA, 1978, BIOCHIM BIOPHYS ACTA, V539, P238, DOI 10.1016/0304-4165(78)90010-7; Vyas AA, 1997, J BIOL CHEM, V272, P9661, DOI 10.1074/jbc.272.15.9661; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; WEEKS JG, 1976, BIOCHIM BIOPHYS ACTA, V445, P205, DOI 10.1016/0005-2744(76)90173-X; WELGUS HG, 1980, J BIOL CHEM, V255, P6806; Wilson CL, 1998, BIOL EXTRAC, P149; WIRL G, 1977, CONNECT TISSUE RES, V5, P171, DOI 10.3109/03008207709152268; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; YANG BH, 1993, J BIOL CHEM, V268, P8617	52	196	205	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4183	4191		10.1074/jbc.275.6.4183	http://dx.doi.org/10.1074/jbc.275.6.4183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660581	hybrid			2022-12-27	WOS:000085288800065
J	Benmerah, A; Poupon, V; Cerf-Bensussan, N; Dautry-Varsat, A				Benmerah, A; Poupon, V; Cerf-Bensussan, N; Dautry-Varsat, A			Mapping of Eps15 domains involved in its targeting to clathrin-coated pits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; RECEPTOR-MEDIATED ENDOCYTOSIS; NERVE-TERMINALS; PROTEIN COMPLEX; BINDING DOMAIN; ADAPTER AP-2; SH3 DOMAIN; EH-DOMAIN; DYNAMIN; VESICLES	Clathrin-coated pit (CCP) formation occurs as a result of the targeting and assembly of cytosolic coat proteins, mainly the plasma membrane clathrin-associated protein complex (AP-2) and clathrin, to the intracellular face of the plasma membrane. In the present study, the mechanisms by which Eps15, an AP-a-binding protein, is targeted to CCPs was analyzed by following the intracellular localization of Eps15 mutants fused to the green fluorescent protein. Our previous results indicated that the N-terminal Eps15 homology (EH) domains are required for CCP targeting. We now show that EH domains are, however, not sufficient for targeting to CCPs, Similarly, neither the central coiled-coil nor the C-terminal AP-2 binding domains were able to address green fluorescent protein to CCPs, Thus, targeting of Eps15 to CCPs likely results from the collaboration between EM domains and another domain of the protein. An Eps15 mutant lacking the coiled-coil domain localized to CCPs showing that Eps15 dimerization is not strictly required. In contrast, Eps15 mutants lacking all AP-2 binding sites showed a dramatic decrease in plasma membrane staining, showing that AP-2 binding sites, together with EH domains, play an important role in targeting Eps15 into CCPs, Finally, the effect of the Eps15 mutants on clathrin-dependent endocytosis was tested by both immunofluorescence and flow cytometry, The results obtained showed that inhibition of transferrin uptake was observed only with mutants able to interfere with CCP assembly.	Fac Necker Enfants Malad, INSERM E9925, F-75730 Paris, France; Inst Pasteur, URA CNRS 1960, Unite Biol Interact Cellulaires, F-75724 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Benmerah, A (corresponding author), Fac Necker Enfants Malad, INSERM E9925, 156 Rue de Vaugirard, F-75730 Paris 15, France.		benmerah, alexandre/H-3742-2017; Cerf-Bensussan, nadine/H-9505-2017	benmerah, alexandre/0000-0003-0188-8016; Cerf-Bensussan, nadine/0000-0003-0665-1245				Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Carbone R, 1997, CANCER RES, V57, P5498; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; CHIN DJ, 1989, P NATL ACAD SCI USA, V86, P9289, DOI 10.1073/pnas.86.23.9289; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; Cupers P, 1998, J BIOL CHEM, V273, P1847, DOI 10.1074/jbc.273.4.1847; Cupers P, 1997, J BIOL CHEM, V272, P33430, DOI 10.1074/jbc.272.52.33430; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Durrbach A, 1996, J CELL SCI, V109, P457; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; GAIDAROV I, 1997, MOL BIOL CELL, V8, P92; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Iannolo G, 1997, CANCER RES, V57, P240; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Lee A, 1999, CURR BIOL, V9, P261, DOI 10.1016/S0960-9822(99)80115-8; MAHAFFEY DT, 1989, J CELL BIOL, V108, P1615, DOI 10.1083/jcb.108.5.1615; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PAGE LJ, 1995, J CELL BIOL, V131, P619, DOI 10.1083/jcb.131.3.619; ROBINSON MS, 1993, J CELL BIOL, V123, P67, DOI 10.1083/jcb.123.1.67; ROBINSON MS, 1989, J CELL BIOL, V108, P833, DOI 10.1083/jcb.108.3.833; ROBINSON MS, 1990, J CELL BIOL, V111, P2319, DOI 10.1083/jcb.111.6.2319; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SCHRODER S, 1995, EUR J BIOCHEM, V228, P297, DOI 10.1111/j.1432-1033.1995.tb20263.x; SCHUMACHER C, 1995, J BIOL CHEM, V270, P15341, DOI 10.1074/jbc.270.25.15341; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Tebar F, 1997, J BIOL CHEM, V272, P15413, DOI 10.1074/jbc.272.24.15413; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; TUMA PL, 1995, J BIOL CHEM, V270, P26707, DOI 10.1074/jbc.270.44.26707; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; WONG WT, 1994, ONCOGENE, V9, P1591; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530	56	92	92	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3288	3295		10.1074/jbc.275.5.3288	http://dx.doi.org/10.1074/jbc.275.5.3288			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652316	hybrid			2022-12-27	WOS:000085146500038
J	Bezzine, S; Koduri, RS; Valentin, E; Murakami, M; Kudo, I; Ghomashchi, F; Sadilek, M; Lambeau, G; Gelb, MH				Bezzine, S; Koduri, RS; Valentin, E; Murakami, M; Kudo, I; Ghomashchi, F; Sadilek, M; Lambeau, G; Gelb, MH			Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFACIAL CATALYSIS; ESCHERICHIA-COLI; SCOOTING MODE; VENOM PHOSPHOLIPASE-A2; LYSOPHOSPHATIDIC ACID; BILAYER INTERFACE; PHOSPHATIDIC-ACID; VESICLES; BINDING; EXPRESSION	Mammalian secreted phospholipases A(2) (sPLA2s) comprise a group of at least eight enzymes, including the recently identified group X sPLA2, A bacterial expression system was developed to produce human group X sPLA2 (hGX). Inhibition studies show that the sPLA2 inhibitor LY311727 binds modestly more tightly to human group IIA sPLA2 than to hGX and that a pyrazole-based inhibitor of group IIA sPLA2 is much less active against hGX. The phospholipid head group preference of vesicle-bound hGX was determined, hGX binds tightly to phosphatidylcholine vesicles, which is thought to be required to act efficiently on cells. Tryptophan 67 hGX makes a significant contribution to interfacial binding to zwitterionic vesicles. As little as 10 ng/ml hGX releases arachidonic acid for cyclooxygenase-2-dependent prostaglandin E-2 generation when added exogenously to adherent mammalian cells. In contrast, human group IIA, rat group V, and mouse group IB sPLA2s are virtually inactive at releasing arachidonate when added exogenously to adherent cells. Dislodging cells from the growth surface enhances the ability of all the sPLA2s to release fatty acids. Studies with CHO-K1 cell mutants show that binding of sPLA2s to glycosaminoglycans is not the basis for poor plasma membrane hydrolysis by group IB, IIA, and V sPLA2s.	Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, F-06560 Valbonne, France; Showa Univ, Sch Pharmaceut Sci, Dept Hlth Chem, Shinagawa Ku, Tokyo 142, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Showa University	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Box 351700, Seattle, WA 98195 USA.	gelb@chem.washington.edu	Lambeau, Gerard/GRJ-5624-2022	Lambeau, Gerard/0000-0002-9239-518X; gelb, michael/0000-0001-7000-5219	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL036235, R37HL036235, R01HL036235] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36235] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Baker SF, 1998, BIOCHEMISTRY-US, V37, P13203, DOI 10.1021/bi981223t; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Bayburt T, 1997, BIOCHEMISTRY-US, V36, P3216, DOI 10.1021/bi961659d; BAYBURT T, 1996, THESIS U WASHINGTON; Christie W.W., 2003, LIPID ANAL; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; DEGEUS P, 1987, NUCLEIC ACIDS RES, V15, P3743, DOI 10.1093/nar/15.9.3743; DUDLER T, 1992, BIOCHIM BIOPHYS ACTA, V1165, P201, DOI 10.1016/0005-2760(92)90188-2; ESKO JD, 1986, J BIOL CHEM, V261, P5725; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; FONTEH AN, 1994, J IMMUNOL, V152, P5438; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; GELB MH, 1994, FASEB J, V8, P916, DOI 10.1096/fasebj.8.12.8088457; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; GHOMASHCHI F, 1992, BIOCHEMISTRY-US, V31, P3814, DOI 10.1021/bi00130a012; GHOMASHCHI F, 1991, BIOCHEMISTRY-US, V30, P7318, DOI 10.1021/bi00243a037; Goldberg, 1995, Fold Des, V1, P21; Hack CE, 1997, IMMUNOL TODAY, V18, P111, DOI 10.1016/S0167-5699(97)01002-5; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Han SK, 1997, J BIOL CHEM, V272, P3573, DOI 10.1074/jbc.272.26.16152; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; HARA S, 1991, J BIOCHEM, V110, P163, DOI 10.1093/oxfordjournals.jbchem.a123550; HENDRICKSON HS, 1984, J BIOL CHEM, V259, P5740; HITE GA, Patent No. 846687; JAIN MK, 1991, BIOCHEMISTRY-US, V30, P7330, DOI 10.1021/bi00243a038; JAIN MK, 1982, BIOCHIM BIOPHYS ACTA, V688, P341, DOI 10.1016/0005-2736(82)90345-5; JAIN MK, 1987, BIOCHIM BIOPHYS ACTA, V905, P1, DOI 10.1016/0005-2736(87)90002-2; JAIN MK, 1986, BIOCHIM BIOPHYS ACTA, V860, P435, DOI 10.1016/0005-2736(86)90541-9; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; JAIN MK, 1995, METHOD ENZYMOL, V249, P567; JAIN MK, 1991, METHOD ENZYMOL, V197, P112; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V980, P23, DOI 10.1016/0005-2736(89)90195-8; JAIN MK, 1989, BIOCHEMISTRY-US, V28, P4135, DOI 10.1021/bi00436a002; Janssen MJW, 1999, BBA-MOL CELL BIOL L, V1440, P59, DOI 10.1016/S1388-1981(99)00122-5; JUNG L, IN PRESS J AM CHEM S; KACHEL K, 1995, BIOCHEMISTRY-US, V34, P15475, DOI 10.1021/bi00047a012; KIM HY, 1994, ANAL CHEM, V66, P3977, DOI 10.1021/ac00094a020; KINKAID A, 1991, BIOCHEM J, V278, P843, DOI 10.1042/bj2780843; KINKAID AR, 1995, BIOCHEM J, V308, P507, DOI 10.1042/bj3080507; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; Lin Y, 1998, SCIENCE, V279, P1925, DOI 10.1126/science.279.5358.1925; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Murakami M, 1999, J BIOL CHEM, V274, P29927, DOI 10.1074/jbc.274.42.29927; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Othman R, 1996, BBA-LIPID LIPID MET, V1303, P92, DOI 10.1016/0005-2760(96)00083-5; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PETERS AR, 1992, BIOCHEMISTRY-US, V31, P10024, DOI 10.1021/bi00156a023; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402; Reddy ST, 1996, J BIOL CHEM, V271, P186, DOI 10.1074/jbc.271.1.186; ROBERTS MF, 1977, P NATL ACAD SCI USA, V74, P1950, DOI 10.1073/pnas.74.5.1950; Sartipy P, 1996, J BIOL CHEM, V271, P26307, DOI 10.1074/jbc.271.42.26307; Sartipy P, 1998, ARTERIOSCL THROM VAS, V18, P1934, DOI 10.1161/01.ATV.18.12.1934; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; SCOTT DL, 1994, ADV PROTEIN CHEM, V45, P53; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SIHIZAKI J, 1999, J BIOL CHEM, V274, P24973; Snitko Y, 1999, BIOCHEMISTRY-US, V38, P7803, DOI 10.1021/bi990600e; Snitko Y, 1997, BIOCHEM J, V321, P737, DOI 10.1042/bj3210737; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Valentin E, 1999, J BIOL CHEM, V274, P19152, DOI 10.1074/jbc.274.27.19152; VANCORVEN EJ, 1992, BIOCHEM J, V281, P163, DOI 10.1042/bj2810163; Wilson HA, 1999, J BIOL CHEM, V274, P11494, DOI 10.1074/jbc.274.17.11494; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WORRALL AF, 1991, BIOCHEM J, V278, P365, DOI 10.1042/bj2780365	73	193	195	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3179	3191		10.1074/jbc.275.5.3179	http://dx.doi.org/10.1074/jbc.275.5.3179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652303	hybrid			2022-12-27	WOS:000085146500025
J	Guerini, D; Wang, XQ; Li, L; Genazzani, A; Carafoli, E				Guerini, D; Wang, XQ; Li, L; Genazzani, A; Carafoli, E			Calcineurin controls the expression of isoform 4CII of the plasma membrane Ca2+ pump in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; PROTEIN PHOSPHATASE; GENE-EXPRESSION; CALCIUM-ATPASE; BINDING-PROTEIN; VACCINIA VIRUS; NMDA RECEPTOR; ACTIVATION; DOMAINS; ENZYME	The expression of the CII splice variant of the plasma membrane Ca2+ ATPase 4 (PMCA4) was down-regulated in granule neurons when they were cultured under conditions of partial membrane depolarization (25 mM KCl), which are required for long term in vitro survival of the neurons. These conditions, which cause a chronic increase of the resting free Ca2+ concentration in the neurons, have recently been shown to promote up-regulation of the PMCA2, 3, and 1CII isoforms, Whereas the chronic, i.e. >3 days, Ca2+ increase was necessary for the up-regulation of the PMCA1CII, 2, and 3, the downregulation of the PMCA4CII mRNA was already evident 1-2 h after the start of culturing in 25 mhz KCl, The immunosuppressant calcineurin inhibitor FK506 inhibited the down-regulation of the PMCA4CII at both the protein and the mRNA level but did not affect the changes of the other PMCA pumps, Direct evidence for the involvement of calcineurin in the down-regulation of the PMCA4CII was obtained by overexpressing a truncated, constitutively active, and Ca2+-independent form of calcineurin; under these conditions, depolarization was not required for the down-regulation of the PMCA4CII pump. De novo synthesis of (transcription) factors was required for the down-regulation of the PMCA4CII mRNA Calcineurin, therefore, controls the neuronal transcription of PMCA4CII, a splice variant of the pump isoforms that is found almost exclusively in brain.	Univ Padua, Inst Biochem, Dept Biochem, I-35121 Padua, Italy; Swiss Fed Inst Technol, Inst Biochem, CH-8092 Zurich, Switzerland	University of Padua; Swiss Federal Institutes of Technology Domain; ETH Zurich	Carafoli, E (corresponding author), Univ Padua, Inst Biochem, Dept Biochem, Via Gabelli 65, I-35121 Padua, Italy.		Genazzani, Armando/AAI-8280-2020; Carafoli, Ernesto/K-5192-2016	Carafoli, Ernesto/0000-0002-7826-0094; Genazzani, Armando/0000-0003-1923-7430				Ashiya M, 1997, RNA, V3, P996; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOYLE DB, 1988, GENE, V65, P123, DOI 10.1016/0378-1119(88)90424-6; CARAFOLI E, 1994, J NEUROBIOL, V25, P312, DOI 10.1002/neu.480250311; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; CARAFOLI E, 1993, TRENDS CARDIOVAS MED, V3, P177, DOI 10.1016/1050-1738(93)90003-O; CARMICHAEL J, 1987, CANCER RES, V47, P943; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CLIPSTONE NA, 1994, J BIOL CHEM, V269, P26431; DRILLIEN R, 1983, VIROLOGY, V131, P385, DOI 10.1016/0042-6822(83)90506-8; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FOLETTI D, 1995, FASEB J, V9, P670, DOI 10.1096/fasebj.9.8.7768360; Fresu L, 1999, GLIA, V28, P150, DOI 10.1002/(SICI)1098-1136(199911)28:2<150::AID-GLIA6>3.3.CO;2-Z; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GALLO V, 1987, J NEUROSCI, V7, P2203; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Guerini D, 1999, J BIOL CHEM, V274, P1667, DOI 10.1074/jbc.274.3.1667; Guerini D, 1998, CELL TISSUE RES, V292, P191, DOI 10.1007/s004410051050; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; ITO A, 1989, BIOCHEM BIOPH RES CO, V163, P1492, DOI 10.1016/0006-291X(89)91148-0; KEETON TP, 1995, BIOCHEM J, V306, P779, DOI 10.1042/bj3060779; KEETON TP, 1993, J BIOL CHEM, V268, P2740; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KUO TH, 1991, J BIOL CHEM, V266, P2520; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seiz Preiano Brigitta, 1996, Biochemistry, V35, P7946, DOI 10.1021/bi9527404; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; STAUFFER TP, 1993, J BIOL CHEM, V268, P25993; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; THOMPSON MA, 1995, J BIOL CHEM, V270, P4224, DOI 10.1074/jbc.270.9.4224; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Wang HY, 1998, J CELL BIOL, V140, P737, DOI 10.1083/jcb.140.4.737; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147	46	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3706	3712		10.1074/jbc.275.5.3706	http://dx.doi.org/10.1074/jbc.275.5.3706			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652370	hybrid			2022-12-27	WOS:000085146500092
J	Mikhailov, MV; Ashcroft, SJH				Mikhailov, MV; Ashcroft, SJH			Interactions of the sulfonylurea receptor 1 subunit in the molecular assembly of beta-cell K-ATP channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; NUCLEOTIDE-BINDING FOLD; INSULIN-SECRETION; ANION TRANSPORT; INSECT CELLS; RECONSTITUTION; PROTEIN; COEXPRESSION; FRAGMENTS; MEMBRANE	We have investigated protein interactions involved in pancreatic beta-cell ATP-sensitive potassium channel assembly. These channels, which are of key importance for control of insulin release, are a hetero-oligomeric complex of pore-forming Kir6.2 subunits and sulfonylurea receptor (SUR1) subunits with two nucleotide-binding domains (NBD1 and NBD2), We divided SUR1 into two halves at Pro-1042, Expression of either the individual N- or C-terminal domain in a baculovirus expression system did not lead to glibenclamide binding activity, although studies with green fluorescent protein fusion proteins showed that both half-molecules were inserted into the plasma membrane, However, significant glibenclamide binding activity was observed when the half-molecules were co-expressed (even when NBD2 was deleted from the C-terminal half-molecule). Simultaneous expression of Kir6.2 resulted in enhanced glibenclamide binding activity. We conclude that the glibenclamide-binding site includes amino acid residues from both halves of the molecule, that there is strong interaction between different regions of SUR1, that NBD2 is not essential for glibenclamide binding, and that interactions between Kir6.2 and SUR1 participate in ATP-sensitive potassium channel assembly. Investigation of NBD1-green fluorescent protein fusion protein distribution inside insect cells expressing C-terminal halves of SUR1 demonstrated strong interaction between NBD1 and NBD2. We also expressed and purified NBD1 from Escherichia coli, Purified NBD1 was found to exist as a tetramer indicating strong homomeric attractions and a possible role for NBD1 in SUR1 assembly.	John Radcliffe Hosp, Nuffield Dept Clin Biochem, Oxford OX3 9DU, England	University of Oxford	Mikhailov, MV (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Biochem, Oxford OX3 9DU, England.							AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT SJH, 1989, COLLOQ INSE, V198, P99; ASHCROFT SJH, 1993, ADV EXP MED BIOL, V334, P47; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COPE DL, 1994, BIOCHEM J, V300, P291, DOI 10.1042/bj3000291; DUNNE MJ, 1991, BIOCHIM BIOPHYS ACTA, V1071, P67, DOI 10.1016/0304-4157(91)90012-L; Gao M, 1996, J BIOL CHEM, V271, P27782, DOI 10.1074/jbc.271.44.27782; Giblin JP, 1999, J BIOL CHEM, V274, P22652, DOI 10.1074/jbc.274.32.22652; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; GROVES JD, 1995, J BIOL CHEM, V270, P9097, DOI 10.1074/jbc.270.16.9097; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1995, CELL, V82, P693, DOI 10.1016/0092-8674(95)90465-4; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LOO TW, 1994, J BIOL CHEM, V269, P7750; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; Makhina EN, 1998, J BIOL CHEM, V273, P3369, DOI 10.1074/jbc.273.6.3369; Mikhailov MV, 1998, FEBS LETT, V429, P390, DOI 10.1016/S0014-5793(98)00640-1; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; NIKI I, 1989, PFLUG ARCH EUR J PHY, V415, P47, DOI 10.1007/BF00373140; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Possee RD., 1992, BACULOVIRUS EXPRESSI; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Thomas PM, 1996, AM J HUM GENET, V59, P510; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Tusnady GE, 1997, FEBS LETT, V402, P1, DOI 10.1016/S0014-5793(96)01478-0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang L, 1997, J BIOL CHEM, V272, P10631	35	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3360	3364		10.1074/jbc.275.5.3360	http://dx.doi.org/10.1074/jbc.275.5.3360			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652326	hybrid			2022-12-27	WOS:000085146500048
J	Yam, CH; Siu, WY; Lau, A; Poon, RYC				Yam, CH; Siu, WY; Lau, A; Poon, RYC			Degradation of cyclin a does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; UBIQUITIN-LIGASE COMPLEX; F-BOX PROTEIN; MAMMALIAN-CELLS; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; PROTEASOME PATHWAY; RAPID DEGRADATION; REGULATED BINDING; GENE-EXPRESSION	Many cyclins are degraded by the ubiquitination/proteasome pathways involving the anaphase-promoting complex and SCF complexes. These degradations are frequently dependent on phosphorylation by cyclin-dependent kinases (CDKs), providing a self-limiting mechanism for CDK activity, Here we present evidence from in vitro and in vivo assay systems that the degradation of human cyclin A can be inhibited by kinase-inactive mutants of CDK2 and CDC2, One obvious interpretation of these results is that like other cyclins, CDK-dependent phosphorylation of the cyclin A may be involved in cyclin A degradation. Our data indicated that CDK2 can phosphorylate cyclin A on Ser-154. Site-directed mutagenesis of Ser-154 abolished the phosphorylation by recombinant CDK2 in vitro and the majority of cyclin A phosphorylation in the cell. Activation of CDK2 and binding to SKP2 or p27(KIP1) were not affected by the phosphorylation of Ser-154. Surprising, in marked contrast to cyclin E, where phosphorylation of Thr-380 by CDK2 is required for proteolysis, degradation of cyclin A was not affected by Ser-154 phosphorylation. It is likely that the stabilization of cyclin A by the kinase-inactive CDKs was mainly due to a cell cycle effect. These data suggest an important difference between the regulation of cyclin A and cyclin E.	Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Peoples R China.	bcrandy@ust.hk		Poon, Randy/0000-0001-5571-6231				AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Ausubel FM, 1991, CURRENT PROTOCOLS MO; BARRAL Y, 1995, GENE DEV, V9, P399, DOI 10.1101/gad.9.4.399; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Funakoshi M, 1999, EMBO J, V18, P5009, DOI 10.1093/emboj/18.18.5009; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; KAMPS MP, 1991, METHOD ENZYMOL, V201, P21; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Lanker S, 1996, SCIENCE, V271, P1597, DOI 10.1126/science.271.5255.1597; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Michel JJ, 1998, CELL GROWTH DIFFER, V9, P435; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Poon RYC, 1998, ONCOGENE, V16, P1333, DOI 10.1038/sj.onc.1201897; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Poon RYC, 1997, CANCER RES, V57, P5168; POON RYC, 1996, ENCY CANC, P246; SALAMA SR, 1994, MOL CELL BIOL, V14, P7953, DOI 10.1128/MCB.14.12.7953; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Siu WY, 1999, EXP CELL RES, V250, P131, DOI 10.1006/excr.1999.4551; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; VANDERGEER P, 1994, CELL BIOL LAB HDB, P422; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; Yam CH, 1999, MOL CELL BIOL, V19, P635; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6	55	57	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3158	3167		10.1074/jbc.275.5.3158	http://dx.doi.org/10.1074/jbc.275.5.3158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652300	hybrid			2022-12-27	WOS:000085146500022
J	Park, HS; Park, E; Kim, MS; Ahn, K; Kim, IY; Choi, EJ				Park, HS; Park, E; Kim, MS; Ahn, K; Kim, IY; Choi, EJ			Selenite inhibits the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; CYSTEINE RESIDUES; MAMMALIAN-CELLS; DNA-BINDING; STRESS; TRANSCRIPTION; JNK; APOPTOSIS	Selenium, an essential biological trace element, has been shown to modulate functions of many regulatory proteins involved in signal transduction and to affect a variety of cellular activities including cell growth, survival, and death. The molecular mechanism by which selenium exerts its action on the cellular events, however, remains unclear. In our present study, we observed that selenite suppresses both the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) and the p38 mitogen-activated protein kinase pathway in 293T cells. In contrast, selenite had little effect on the extracellular signal-regulated kinase pathway. Furthermore, selenite directly inhibited JNK/SAPK activity in vitro but not the p38 activity. The in vitro inhibition of JNK/SAPK by selenite was reversed by the addition of reducing agents such as dithiothreitol and beta-mercapto-ethanol. Replacement of cysteine 116 in JNK1 by serine abolished the inhibitory effect of selenite on JNK1 activity both in vitro and in vivo. Selenite also suppressed a c-Jun-dependent luciferase reporter activity stimulated through the JNK signaling pathway. Taken together, our findings strongly suggest that selenite differentially modulates the mammalian mitogen-activated protein kinase pathways and that it can repress the JNK/SAPK signaling pathway by inhibiting JNK/SAPK through a thiol redox mechanism.	Korea Univ, Grad Sch Biotechnol, Sungbuk Ku, Seoul 136701, South Korea; Korea Univ, Natl Creat Res Initiat Ctr Cell Death, Sungbuk Ku, Seoul 136701, South Korea	Korea University; Korea University	Choi, EJ (corresponding author), Korea Univ, Grad Sch Biotechnol, Sungbuk Ku, Seoul 136701, South Korea.							BERGAD PL, 1986, CURR EYE RES, V5, P919, DOI 10.3109/02713688608995172; BOREK C, 1986, P NATL ACAD SCI USA, V83, P1490, DOI 10.1073/pnas.83.5.1490; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DUHE RJ, 1994, J BIOL CHEM, V269, P7290; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; FAKHRUL I, 1991, ARCH BIOCHEM BIOPHYS, V289, P161; Gather H. E., 1968, BIOCHEMISTRY-US, V7, P2898; GATHER HE, 1969, BIOCHEMISTRY-US, V8, P2557; Gopalakrishna R, 1997, ARCH BIOCHEM BIOPHYS, V348, P37, DOI 10.1006/abbi.1997.0335; GREEDER GA, 1980, SCIENCE, V209, P825, DOI 10.1126/science.7406957; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HANDEL ML, 1995, P NATL ACAD SCI USA, V92, P4497, DOI 10.1073/pnas.92.10.4497; HOLBROOK NJ, 1991, NEW BIOL, V3, P825; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Johnson NL, 1996, J BIOL CHEM, V271, P3229, DOI 10.1074/jbc.271.6.3229; Kim H, 1997, BIOCHEMISTRY-US, V36, P13677, DOI 10.1021/bi970837f; Kim IY, 1997, P NATL ACAD SCI USA, V94, P12904, DOI 10.1073/pnas.94.24.12904; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEDINA D, 1984, CANCER RES, V44, P4361; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; MORGAN NJ, 1991, ANNU REV NEUROSCI, V14, P421; Park J, 1997, J BIOL CHEM, V272, P16725, DOI 10.1074/jbc.272.27.16725; PHELPS DC, 1981, BIOCHEMISTRY-US, V20, P453, DOI 10.1021/bi00506a001; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; ROTRUCK JT, 1972, J NUTR, V102, P689, DOI 10.1093/jn/102.5.689; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHAMBERGER RJ, 1985, MUTAT RES, V154, P29, DOI 10.1016/0165-1110(85)90008-9; SHARMA S, 1994, CANCER RES, V54, P5848; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; SPYROU G, 1995, FEBS LETT, V368, P59, DOI 10.1016/0014-5793(95)00599-5; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Stapleton SR, 1997, BBA-MOL CELL RES, V1355, P259, DOI 10.1016/S0167-4889(96)00140-1; TASHIMA Y, 1989, J BIOCHEM-TOKYO, V105, P358, DOI 10.1093/oxfordjournals.jbchem.a122668; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; YAN MH, 1994, NATURE, V372, P798	46	99	102	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2527	2531		10.1074/jbc.275.4.2527	http://dx.doi.org/10.1074/jbc.275.4.2527			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644709	hybrid			2022-12-27	WOS:000085128000041
J	Rui, LY; Archer, SF; Argetsinger, LS; Carter-Su, C				Rui, LY; Archer, SF; Argetsinger, LS; Carter-Su, C			Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTED TYROSYL PHOSPHORYLATION; MESSENGER-RIBONUCLEIC-ACID; ADULT-RAT HEPATOCYTES; GH-BINDING; INSULIN-RECEPTOR; SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; TISSUE DISTRIBUTION; PRIMARY CULTURES; GENE-EXPRESSION	Growth hormone (GH) regulates body growth and metabolism. GH exerts its biological action by stimulating JAK2, a GH receptor (GHR)-associated tyrosine kinase. Activated JAK2 phosphorylates itself and GHR, thus initiating multiple signaling pathways. In this work, we demonstrate that platelet-derived growth factor (PDGF) and lysophosphatidic acid (LPA) down-regulate GH signaling via a protein kinase C (PKC)-dependent pathway. PDGF substantially reduces tyrosyl phosphorylation of JAK2 induced by GH but not interferon-gamma or leukemia inhibitory factor. PDGF, but not epidermal growth factor, decreases tyrosyl phosphorylation of GHR (by approximately 90%) and the amount of both total cellular GHR (by approximately 80%) and GH binding (by approximately 70%). The inhibitory effect of PDGF on GH-induced tyrosyl phosphorylation of JAK2 and GHR is abolished by depletion of 4 beta-phorbol 12-myristate 13-acetate (PMA)-sensitive PKCs with chronic PMA treatment and is severely inhibited by GF109203X, an inhibitor of PKCs. In contrast, extracellular signal-regulated kinases I and 2 and phosphatidylinositol S-kinase appear not to be involved in this inhibitory effect of PDGF. LPA, a known activator of PKC, also inhibits GH-induced tyrosyl phosphorylation of JAK2 and GHR and reduces the number of GHR. We propose that ligands that activate PKC, including PDGF, LPA, and PMA, down-regulate GH signaling by decreasing the number of cell surface GHR through promoting GHR internalization and degradation and/or cleavage of membrane GHR and release of the extracellular domain of GHR.	Univ Michigan, Dept Physiol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Carter-Su, C (corresponding author), Univ Michigan, Dept Physiol, Sch Med, Ann Arbor, MI 48109 USA.	cartersu@umich.edu			NICHD NIH HHS [P30 HD 18258] Funding Source: Medline; NIDDK NIH HHS [R01 DK034171, DK 34171] Funding Source: Medline; NIGMS NIH HHS [GM07315] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD018258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034171, R37DK034171] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht DE, 1997, J BIOL CHEM, V272, P2236; Alele J, 1998, ENDOCRINOLOGY, V139, P1927, DOI 10.1210/en.139.4.1927; ALPERS CE, 1993, KIDNEY INT, V43, P286, DOI 10.1038/ki.1993.45; ARGETSINGER LS, 1995, J BIOL CHEM, V270, P14685, DOI 10.1074/jbc.270.24.14685; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Argetsinger LS, 1996, PHYSIOL REV, V76, P1089, DOI 10.1152/physrev.1996.76.4.1089; Barnard R, 1997, J ENDOCRINOL, V153, P1, DOI 10.1677/joe.0.1530001; BAUMANN G, 1994, J ENDOCRINOL, V141, P1, DOI 10.1677/joe.0.1410001; BAUMANN G, 1988, ENDOCRINOLOGY, V122, P976, DOI 10.1210/endo-122-3-976; BURTON KA, 1992, ENDOCRINOLOGY, V131, P958, DOI 10.1210/en.131.2.958; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; CAMPBELL GS, 1993, J BIOL CHEM, V268, P7427; CAMPBELL GS, 1995, J BIOL CHEM, V270, P3974, DOI 10.1074/jbc.270.8.3974; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; CARTERSU C, 1997, J ANIM S2, V75, P1; CHIN E, 1992, ENDOCRINOLOGY, V131, P3061, DOI 10.1210/en.131.6.3061; ClaessonWelsh L, 1996, INT J BIOCHEM CELL B, V28, P373, DOI 10.1016/1357-2725(95)00156-5; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Clark RG, 1996, ENDOCRINOLOGY, V137, P4308, DOI 10.1210/en.137.10.4308; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; GRONLUND L, 1995, ISSUES SCI TECHNOL, V11, P9; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; GULLER S, 1989, ENDOCRINOLOGY, V125, P2360, DOI 10.1210/endo-125-5-2360; HANSEN BS, 1993, ENDOCRINOLOGY, V133, P2809, DOI 10.1210/en.133.6.2809; HERNDON DN, 1995, ANN SURG, V221, P649, DOI 10.1097/00000658-199506000-00004; HOCK JM, 1994, ENDOCRINOLOGY, V134, P1423, DOI 10.1210/en.134.3.1423; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Hu YH, 1998, MOL BRAIN RES, V53, P251, DOI 10.1016/S0169-328X(97)00306-9; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; Kimura M, 1998, JPN J PHARMACOL, V76, P165, DOI 10.1254/jjp.76.165; Kimura M, 1998, BIOL PHARM BULL, V21, P22; King APJ, 1996, J BIOL CHEM, V271, P18088, DOI 10.1074/jbc.271.30.18088; LIM L, 1990, ENDOCRINOLOGY, V127, P1287, DOI 10.1210/endo-127-3-1287; LINDAHL A, 1987, J ENDOCRINOL, V115, P263, DOI 10.1677/joe.0.1150263; MANNOR DA, 1991, J CLIN ENDOCR METAB, V73, P30, DOI 10.1210/jcem-73-1-30; MAOR G, 1989, ENDOCRINOLOGY, V125, P1239, DOI 10.1210/endo-125-3-1239; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MERTANI HC, 1995, MOL CELL ENDOCRINOL, V109, P47, DOI 10.1016/0303-7207(95)03485-P; MEYER DJ, 1994, J BIOL CHEM, V269, P4701; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; NIXON BT, 1984, P NATL ACAD SCI-BIOL, V81, P3429, DOI 10.1073/pnas.81.11.3429; NIXON T, 1983, J CELL PHYSIOL, V115, P291, DOI 10.1002/jcp.1041150312; Ohlsson C, 1998, EUR J CLIN INVEST, V28, P184; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rui LY, 1998, J BIOL CHEM, V273, P21239, DOI 10.1074/jbc.273.33.21239; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; SADEGHI H, 1990, MOL ENDOCRINOL, V4, P1799, DOI 10.1210/mend-4-12-1799; Seewald S, 1999, AM J HYPERTENS, V12, P532, DOI 10.1016/S0895-7061(98)00269-6; Shoba L, 1999, MOL CELL ENDOCRINOL, V152, P125, DOI 10.1016/S0303-7207(99)00045-3; SILVA CM, 1993, ENDOCRINOLOGY, V133, P2307, DOI 10.1210/en.133.5.2307; SILVA CM, 1993, ENDOCRINOLOGY, V132, P101, DOI 10.1210/en.132.1.101; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; Smit LS, 1997, ENDOCRINOLOGY, V138, P3426, DOI 10.1210/en.138.8.3426; SMITH JC, 1981, P NATL ACAD SCI-BIOL, V78, P4363, DOI 10.1073/pnas.78.7.4363; SOTIROPOULOS A, 1994, ENDOCRINOLOGY, V135, P1292, DOI 10.1210/en.135.4.1292; SOTIROPOULOS A, 1993, ENDOCRINOLOGY, V132, P1863, DOI 10.1210/en.132.4.1863; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; STROBL JS, 1994, PHARMACOL REV, V46, P1; SUZUKI K, 1990, J BIOL CHEM, V265, P11320; TIDBALL JG, 1993, J CELL BIOL, V123, P627, DOI 10.1083/jcb.123.3.627; TIONG TS, 1991, ENDOCRINOLOGY, V129, P1628, DOI 10.1210/endo-129-3-1628; TIONG TS, 1989, BIOCHEM BIOPH RES CO, V158, P141, DOI 10.1016/S0006-291X(89)80189-5; Tritos NA, 1998, AM J MED, V105, P44, DOI 10.1016/S0002-9343(98)00135-1; VANDERKUUR J, 1995, J BIOL CHEM, V270, P7587, DOI 10.1074/jbc.270.13.7587; VANZOELEN EJJ, 1993, GROWTH FACTORS, V9, P329, DOI 10.3109/08977199308991593; Waters MJ., 1999, HDB PHYSL, P397; Windisch PA, 1998, ANN PHARMACOTHER, V32, P437, DOI 10.1345/aph.17255; YABLONKAREUVENI Z, 1990, J CELL BIOL, V111, P1623, DOI 10.1083/jcb.111.4.1623; Yi WS, 1996, MOL ENDOCRINOL, V10, P1425, DOI 10.1210/me.10.11.1425; ZHANG Y, 1999, P 81 ANN M END SOC S, P154	76	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2885	2892		10.1074/jbc.275.4.2885	http://dx.doi.org/10.1074/jbc.275.4.2885			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644756	hybrid			2022-12-27	WOS:000085128000088
J	Glick, E; Leshkowitz, D; Walker, MD				Glick, E; Leshkowitz, D; Walker, MD			Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEIN; PANCREATIC-ISLET CELLS; BINDING PROTEINS; MAMMALIAN-CELLS; HOMEOBOX FACTOR; FACTOR STF-1; EXPRESSION; DNA; MYOD; HOMEODOMAIN	The insulin gene is efficiently expressed only in pancreatic beta cells. Using reverse transcriptase-polymerase chain reaction analysis, we show that insulin mRNA levels are at least 10(5)-fold higher in beta cells than non-beta cells. To examine the underlying mechanisms, we expressed beta cell transcription factors by transfection of non-beta cells. Separate expression of BETA2, E2A or PDX1 led to modest (<10-fold) activation of the insulin promoter, whereas co-expression of the three proteins produced synergistic, high level activation (160-fold), This level of activity is similar to 25% that observed in transfected beta cell lines. Of the three factors studied, BETA2 appears to play a dominant role. Efficient transcription required a C-terminal activation domain of BETA2 and an N-terminal region, which does not function as an independent activation domain, The myogenic basic helix-loop-helix (bHLH) protein MyoD was unable to bind and activate the promoter, even when its DNA binding region was replaced with that of BETA2. Our results demonstrate the central importance of BETA2 in insulin gene transcription and the importance of sequences outside the canonical DNA binding domain in permitting efficient DNA binding and cell-specific activity of the insulin gene promoter.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il						ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; ARONHEIM A, 1991, NUCLEIC ACIDS RES, V19, P3893, DOI 10.1093/nar/19.14.3893; AUSDUBEL FM, 1988, CURRENT PROTOCOLS MO; BESNARD C, 1991, J CELL PHYSIOL, V146, P349, DOI 10.1002/jcp.1041460303; Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; CHAKRABORTY T, 1991, MOL CELL BIOL, V11, P6103, DOI 10.1128/MCB.11.12.6103; CORDLE SR, 1991, MOL CELL BIOL, V11, P1734, DOI 10.1128/MCB.11.3.1734; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DEAN M, 1995, AM J HUM GENET, V57, P1254; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; GERMAN MS, 1992, GENE DEV, V6, P2165, DOI 10.1101/gad.6.11.2165; Huang J, 1998, MOL CELL BIOL, V18, P5478, DOI 10.1128/MCB.18.9.5478; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; LESHKOWITZ D, 1991, MOL CELL BIOL, V11, P1547, DOI 10.1128/MCB.11.3.1547; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; MURRE C, 1994, BIOCHIM BIOPHYS ACTA, V1215, P129; Mutoh H, 1998, GENE DEV, V12, P820, DOI 10.1101/gad.12.6.820; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; PARK CW, 1992, J BIOL CHEM, V267, P15642; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; PEERS B, 1995, MOL CELL BIOL, V15, P7091; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Sander M, 1997, J MOL MED, V75, P327, DOI 10.1007/s001090050118; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Serup P, 1996, P NATL ACAD SCI USA, V93, P9015, DOI 10.1073/pnas.93.17.9015; Sharma A, 1999, MOL CELL BIOL, V19, P704; St-Onge L, 1999, CURR OPIN GENET DEV, V9, P295, DOI 10.1016/S0959-437X(99)80044-6; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Yin DX, 1996, ANAL BIOCHEM, V235, P195, DOI 10.1006/abio.1996.0112	42	100	103	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2199	2204		10.1074/jbc.275.3.2199	http://dx.doi.org/10.1074/jbc.275.3.2199			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636926	hybrid			2022-12-27	WOS:000084940000089
J	Gremer, L; Kellner, S; Dobbek, H; Huber, R; Meyer, O				Gremer, L; Kellner, S; Dobbek, H; Huber, R; Meyer, O			Binding of flavin adenine dinucleotide to molybdenum-containing carbon monoxide dehydrogenase from Oligotropha carboxidovorans - Structural and functional analysis of a carbon monoxide dehydrogenase species in which the native flavoprotein has been replaced by its recombinant counterpart produced in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CENTERS; PSEUDOMONAS-CARBOXYDOVORANS; XANTHINE-OXIDASE; ALDEHYDE OXIDOREDUCTASE; DESULFOVIBRIO-GIGAS; COFACTOR; GENES; QUANTITATION; SPECTROSCOPY; EXPRESSION	The carbon monoxide (CO) dehydrogenase of Oligotropha carboxidovorans is composed of an S-selanylcysteine-containing 88.7-kDa molybdoprotein (L), a 17.8-kDa iron-sulfur protein (S), and a 30.2-kDa flavoprotein (M) in a (LMS)(2) subunit structure. The flavoprotein could be removed from CO dehydrogenase by dissociation with sodium dodecylsulfate, The resulting M(LS)(2)- or (LS)(2)-structured CO dehydrogenase species could be reconstituted with the recombinant apoflavoprotein produced in Escherichia coli, The formation of the heterotrimeric complex composed of the apoflavoprotein, the molybdoprotein, and the iron-sulfur protein involves structural changes that translate into the conversion of the apoflavoprotein from non-FAD binding to FAD binding. Binding of FAD to the reconstituted deflavo (LMS)(2) species occurred with second-order kinetics (k(+1) = 1350 M-1 s(-1)) and high affinity (K-d = 1.0 x 10(-9) M). The structure of the resulting flavo (LMS)(2) species at a 2.8-Angstrom resolution established the same fold and binding of the flavoprotein as in wild-type CO dehydrogenase, whereas the S-selanylcysteine 388 in the active-site loop on the molybdoprotein was disordered. In addition, the structural changes related to heterotrimeric complex formation or FAD binding were transmitted to the iron-sulfur protein and could be monitored by EPR, The type II 2Fe:2S center was identified in the N-terminal domain and the type I center in the C-terminal domain of the iron-sulfur protein.	Univ Bayreuth, Lehrstuhl Mikrobiol, D-95440 Bayreuth, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Bavaria, Germany	University of Bayreuth; Max Planck Society	Meyer, O (corresponding author), Univ Bayreuth, Lehrstuhl Mikrobiol, Univ Str 30, D-95440 Bayreuth, Germany.		Gremer, Lothar/H-9128-2013	Gremer, Lothar/0000-0001-7065-5027				BARATA BAS, 1993, BIOCHEMISTRY-US, V32, P11559, DOI 10.1021/bi00094a012; BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P1648, DOI 10.1021/bi00536a027; BEISENHERZ G, 1953, Z NATURFORSCH B, V8, P555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAY RC, 1991, BIOCHEM J, V280, P817, DOI 10.1042/bj2800817; BRAY RC, 1983, BIOCHEM J, V211, P687, DOI 10.1042/bj2110687; CARDENAS J, 1974, ANAL BIOCHEM, V60, P372, DOI 10.1016/0003-2697(74)90244-9; CYPIONKA H, 1983, J BACTERIOL, V156, P1178, DOI 10.1128/JB.156.3.1178-1187.1983; Dobbek H, 1999, P NATL ACAD SCI USA, V96, P8884, DOI 10.1073/pnas.96.16.8884; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Gremer L, 1996, EUR J BIOCHEM, V238, P862, DOI 10.1111/j.1432-1033.1996.0862w.x; GROSJEAN H, 1982, GENE, V18, P199, DOI 10.1016/0378-1119(82)90157-3; Hanzelmann P, 1999, FEMS MICROBIOL LETT, V176, P139, DOI 10.1111/j.1574-6968.1999.tb13654.x; Hanzelmann P, 1998, EUR J BIOCHEM, V255, P755, DOI 10.1046/j.1432-1327.1998.2550755.x; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Jessee J., 1986, FOCUS, V8, P9; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; KANDA M, 1972, J BIOL CHEM, V247, P765; KIESSLING M, 1982, FEMS MICROBIOL LETT, V13, P333, DOI 10.1016/0378-1097(82)90122-7; KOMAI H, 1969, J BIOL CHEM, V244, P1692; KRAUT M, 1989, ARCH MICROBIOL, V152, P335, DOI 10.1007/BF00425170; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWE DJ, 1978, BIOCHEM J, V169, P471, DOI 10.1042/bj1690471; LOWE DJ, 1972, BIOCHEM J, V130, P239, DOI 10.1042/bj1300239; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MEYER O, 1993, SYST APPL MICROBIOL, V16, P390, DOI 10.1016/S0723-2020(11)80271-7; MEYER O, 1982, J BIOL CHEM, V257, P1333; Meyer Ortwin, 1993, P433; MOURA JJG, 1994, METHOD ENZYMOL, V243, P24; MULLER F, 1990, CHEM BIOCH FLAVINS, V1, P1; MULLER F, 1991, CHEM BIOCH FLAVOENZY, V1, P261; NISHIKIMI M, 1973, J BIOCHEM, V73, P1233, DOI 10.1093/oxfordjournals.jbchem.a130196; Ribbe M, 1997, J BIOL CHEM, V272, P26627, DOI 10.1074/jbc.272.42.26627; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Sambrook J., 2002, MOL CLONING LAB MANU; SCHUBEL U, 1995, J BACTERIOL, V177, P2197, DOI 10.1128/jb.177.8.2197-2203.1995; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; ZANETTI G, 1982, EUR J BIOCHEM, V126, P453, DOI 10.1111/j.1432-1033.1982.tb06801.x	41	44	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1864	1872		10.1074/jbc.275.3.1864	http://dx.doi.org/10.1074/jbc.275.3.1864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636886	hybrid			2022-12-27	WOS:000084940000049
J	Iaccarino, I; Marra, G; Dufner, P; Jiricny, J				Iaccarino, I; Marra, G; Dufner, P; Jiricny, J			Mutation in the magnesium binding site of hMSH6 disables the hMutS alpha sliding clamp from translocating along DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SECA; MUTS-ENCODED PROTEIN; MISMATCH REPAIR; ATPASE; CELLS; IDENTIFICATION; RECOMBINATION; HETERODIMER; MECHANISM; MOTIF	In human cells, binding of base/base mismatches and small insertion/deletion loops is mediated by hMutS alpha, a heterodimer of hMSH2 and hMSH6, In the presence of ATP and magnesium, hMutS alpha dissociates from the mismatch by following the DNA contour in the form of a sliding clamp. This process is enabled by a conformational change of the heterodimer, which is driven by the binding of ATP and magnesium in the Walker type A and B motifs of the polypeptides, respectively. We show that a purified recombinant hMutS alpha variant, hMuts alpha 6DV, which contains an aspartate to valine substitution in the Walker type B motif of the hMSH6 subunit, fails to undergo the conformational change compatible with trans location. Instead, its direct dissociation from the mismatch-containing DNA substrate in the presence of ATP and magnesium precludes the assembly of a functional mismatch repair complex. The "translocation-prone" conformation of wild type hMutS alpha could be observed solely under conditions that favor hydrolysis of the nucleotide and mismatch repair in vitro. Thus, whereas magnesium could be substituted with manganese, ATP could not be replaced with its slowly or nonhydrolyzable homologues ATP-gamma S or AMPPNP, respectively. The finding that ATP induces different conformational changes in hMutS alpha in the presence and in the absence of magnesium helps explain the functional differences between hMutS alpha variants incapable of binding ATP as compared with those unable to bind the metal ion.	Univ Zurich, Inst Med Radiobiol, CH-8008 Zurich, Switzerland; Paul Scherrer Inst, CH-8008 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Jiricny, J (corresponding author), Univ Zurich, Inst Med Radiobiol, August Forel Str 7, CH-8008 Zurich, Switzerland.		Iaccarino, Ingram/B-9086-2015	Iaccarino, Ingram/0000-0001-7324-993X				Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Brosh RM, 1996, J BIOL CHEM, V271, P25360, DOI 10.1074/jbc.271.41.25360; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; GORBALENYA AE, 1990, J MOL BIOL, V213, P583, DOI 10.1016/S0022-2836(05)80243-8; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; HUGHES MJ, 1992, J BIOL CHEM, V267, P23876; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Iaccarino I, 1996, CURR BIOL, V6, P484, DOI 10.1016/S0960-9822(02)00516-X; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; JIRICNY J, 1988, NUCLEIC ACIDS RES, V16, P7843, DOI 10.1093/nar/16.16.7843; JIRICNY J, 1988, P NATL ACAD SCI USA, V85, P8860, DOI 10.1073/pnas.85.23.8860; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Pal E.F., 1989, NATURE, V341, P209; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Sato K, 1996, J BIOL CHEM, V271, P17439, DOI 10.1074/jbc.271.29.17439; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; VANDERWOLK JPW, 1995, J BIOL CHEM, V270, P18975, DOI 10.1074/jbc.270.32.18975	29	64	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2080	2086		10.1074/jbc.275.3.2080	http://dx.doi.org/10.1074/jbc.275.3.2080			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636912	hybrid			2022-12-27	WOS:000084940000075
J	Koziak, K; Kaczmarek, E; Kittel, A; Sevigny, J; Blusztajn, JK; Esch, JSA; Imai, M; Guckelberger, O; Goepfert, C; Qawi, I; Robson, SC				Koziak, K; Kaczmarek, E; Kittel, A; Sevigny, J; Blusztajn, JK; Esch, JSA; Imai, M; Guckelberger, O; Goepfert, C; Qawi, I; Robson, SC			Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FATTY-ACIDS; PLASMALEMMAL CAVEOLAE; SIGNAL-TRANSDUCTION; CELL ACTIVATION; NERVOUS-SYSTEM; CD39; PROTEINS; CLONING; IDENTIFICATION	Ectonucleotidases influence purinergic receptor function by the hydrolysis of extracellular nucleotides, CD39 is an integral membrane protein that is a prototype member of the nucleoside 5'-triphosphate diphosphohydrolase family. The native CD39 protein has two intracytoplasmic and two transmembrane domains. There is a large extracellular domain that undergoes extensive glycosylation and can be post-translationally modified by limited proteolysis, We have identified a potential thioester linkage site for S-acylation within the N-terminal region of CD39 and demonstrate that this region undergoes palmitoylation in a constitutive manner. The covalent lipid modification of this region of the protein appears to be important both in plasma membrane association and in targeting CD39 to caveolae. These specialized plasmalemmal domains are enriched in G protein-coupled receptors and appear to integrate cellular activation events. We suggest that palmitoylation could modulate the function of CD39 in regulating cellular signal transduction pathways.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Ctr Immunobiol, Boston, MA 02215 USA; Hungarian Acad Sci, H-1450 Budapest, Hungary; Boston Univ, Sch Med, Boston, MA 02118 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hungarian Academy of Sciences; Boston University	Robson, SC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Ctr Immunobiol, Rm 370 H,Res N,99 Brookline Ave, Boston, MA 02215 USA.	grobson@caregroup.harvard.edu	Esch, Jan Schulte am/AAL-9904-2021; Robson, Simon C./AAA-8537-2021; Sévigny, Jean/AGH-9323-2022; Sevigny, Jean/E-8039-2012; Koziak, Katarzyna/V-2323-2019	Esch, Jan Schulte am/0000-0002-2101-5012; Sévigny, Jean/0000-0003-2922-1600; Sevigny, Jean/0000-0003-2922-1600; /0000-0001-8438-3122	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL57307] Funding Source: Medline; NIA NIH HHS [P01 AG09525] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BACH R, 1988, BIOCHEMISTRY-US, V27, P4227, DOI 10.1021/bi00412a004; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BIZZOZERO OA, 1994, NEUROCHEM RES, V19, P923, DOI 10.1007/BF00968702; Chadwick BP, 1998, GENOMICS, V50, P357, DOI 10.1006/geno.1998.5317; Chadwick BP, 1997, MAMM GENOME, V8, P668, DOI 10.1007/s003359900534; CHANG WJ, 1992, J CELL BIOL, V118, P63, DOI 10.1083/jcb.118.1.63; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Esch JSA, 1999, BIOCHEMISTRY-US, V38, P2248, DOI 10.1021/bi982426k; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Joseph M, 1997, INDIAN J BIOCHEM BIO, V34, P1; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kittel A, 1999, BIOCHEM BIOPH RES CO, V262, P596, DOI 10.1006/bbrc.1999.1254; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; MARCUS AJ, 1996, ATHEROSCLEROSIS CORO, V1, P607; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Morello JP, 1996, BIOCHEM CELL BIOL, V74, P449, DOI 10.1139/o96-049; Mulero JJ, 1999, J BIOL CHEM, V274, P20064, DOI 10.1074/jbc.274.29.20064; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; PATTERSON SI, 1994, J CELL BIOL, V124, P521, DOI 10.1083/jcb.124.4.521; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Robson SC, 1997, BLOOD COAGUL FIBRIN, V8, P21, DOI 10.1097/00001721-199701000-00005; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang TF, 1998, J BIOL CHEM, V273, P24814, DOI 10.1074/jbc.273.38.24814; Zimmermann H, 1998, NEUROCHEM INT, V32, P421, DOI 10.1016/S0197-0186(97)00126-5; Zimmermann H, 1999, TRENDS PHARMACOL SCI, V20, P231, DOI 10.1016/S0165-6147(99)01293-6	39	78	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2057	2062		10.1074/jbc.275.3.2057	http://dx.doi.org/10.1074/jbc.275.3.2057			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636909	hybrid			2022-12-27	WOS:000084940000072
J	Reardon, AJ; Le Goff, M; Briggs, MD; McLeod, D; Sheehan, JK; Thornton, DJ; Bishop, PN				Reardon, AJ; Le Goff, M; Briggs, MD; McLeod, D; Sheehan, JK; Thornton, DJ; Bishop, PN			Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; COLLAGEN FIBRILLOGENESIS; MONOCLONAL-ANTIBODIES; SKIN FRAGILITY; DECORIN; CORNEAL; BINDING; LUMICAN; BONE; FIBROMODULIN	A prominent 45-kDa component was identified by protein staining following SDS-polyacrylamide gel electrophoresis of a 4 M guanidine hydrochloride extract from bovine vitreous collagen fibrils, Peptide sequences obtained from this component were used as a basis for the cloning (from human retinal cDNA) and sequencing of a novel member of the leucine-rich repeat extracellular matrix protein family that we have named opticin. Opticin mRNA was found by reverse transcription polymerase chain reaction in ligament and skin as well as in retina. An open reading frame containing 332 amino acids was identified, the first 19 amino acids representing a signal peptide. The deduced amino acid sequence of the mature protein encodes a 35-kDa protein with a calculated isoelectric point of 5.4. The central domain of this protein consists of six B-type leucine-rich repeats. This domain is flanked by cysteine clusters including a C-terminal two-cysteine cluster containing an additional leucine-rich repeat. The N-terminal region contains a cluster of potential O-glycosylation sites, and analysis of bovine vitreous opticin demonstrated the presence of sialylated O-linked oligosaccharides substituting the core protein. Opticin shows highest protein sequence identity to epiphycan (42%) and osteoglycin (35%) and belongs to Class III of the leucine-rich repeat extracellular matrix protein family.	Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Manchester Royal Eye Hosp, Sch Med, Res Grp Eye & Vis Sci, Manchester M13 9WH, Lancs, England	University of Manchester; Manchester Royal Eye Hospital; University of Manchester	Bishop, PN (corresponding author), Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Room 2-14,Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.			Thornton, David/0000-0001-7148-1970; Bishop, Paul/0000-0001-7937-7932				BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bishop P, 1996, EYE, V10, P664, DOI 10.1038/eye.1996.159; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; CATERSON B, 1985, FED PROC, V44, P386; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FOOS RY, 1982, OPHTHALMOLOGY, V89, P1502; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; Hocking AM, 1998, MATRIX BIOL, V17, P1; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kresse H, 1997, J BIOL CHEM, V272, P18404, DOI 10.1074/jbc.272.29.18404; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; MCLEOD D, 1977, T OPHTHAL SOC UK, V97, P225; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; Reardon A, 1998, MATRIX BIOL, V17, P325, DOI 10.1016/S0945-053X(98)90085-3; SEBAG J, 1989, INVEST OPHTH VIS SCI, V30, P1867; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snead MP, 1999, J MED GENET, V36, P353; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; Weber IT, 1996, J BIOL CHEM, V271, P31767, DOI 10.1074/jbc.271.50.31767; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; Wilkin DJ, 1998, AM J MED GENET, V80, P121, DOI 10.1002/(SICI)1096-8628(19981102)80:2<121::AID-AJMG6>3.3.CO;2-D	34	83	92	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2123	2129		10.1074/jbc.275.3.2123	http://dx.doi.org/10.1074/jbc.275.3.2123			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636917	hybrid			2022-12-27	WOS:000084940000080
J	Thevenod, F; Friedmann, JM; Katsen, AD; Hauser, IA				Thevenod, F; Friedmann, JM; Katsen, AD; Hauser, IA			Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappa B activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; MAMMALIAN-CELLS; CYCLOSPORINE-A; GENE-PRODUCT; HEAT-SHOCK; MDR1 GENE; EXPRESSION; ALPHA; RATS; INDUCTION	Cadmium-mediated toxicity of cultured proximal tubule (PT) cells is associated with increased production of reactive oxygen species (ROS) and apoptosis, We found that cadmium-dependent apoptosis (Hoechst 33342 and annexin V assays) decreased with prolonged CdCl2 (10 mu M) application (controls: 2.4 +/- 1.6%; 5 h: +5.1 +/- 2.3%, 20 h: +5.7 +/- 2.5%, 48 h: +3.3 +/- 1.0% and 72 h: +2.1 +/- 0.4% above controls), while cell proliferation was not affected. Reduction of apoptosis correlated with a time-dependent up-regulation of the drug efflux pump multidrug resistance P-glycoprotein (mdr1) in cadmium-treated cells ( approximate to 4-fold after 72 h), as determined by immunoblotting with the monoclonal antibody C219 and measurement of intracellular accumulation of the fluorescent probe calcein +/- the mdr1 inhibitor PSC833 (0.5 mu M). When mdr1 inhibitors (PSC833, cyclosporine A, verapamil) were transiently added to cells with mdr1 up-regulation by pretreatment for 72 h with cadmium, cadmium-induced apoptosis increased significantly and to a percentage similar to that obtained in cells with no mdr1 up-regulation (72-h cadmium: 5.2 +/- 0.9% versus 72-h cadmium + 1-h PSC833: 7.2 +/- 1.4%; p less than or equal to 0.001), Cadmium-induced apoptosis and mdr1 up-regulation depended on ROS, since co-incubation with the ROS scavengers N-acetylcysteine (15 mM) or pyrrolidine dithiocarbamate (0.1 mM) abolished both responses. Moreover, cadmium- and ROS-associated mdr1 up-regulation was linked to activation of the transcription factor NF-KB; N-acetylcysteine, pyrrolidine dithiocarbamate, and the I kappa B-alpha kinase inhibitor Bay 11-7082 (20 mu M) prevented both, mdr1 overexpression and degradation of the inhibitory NF-kappa B subunit, I kappa B-alpha, induced by cadmium. The data show that 1) cadmium-mediated apoptosis in PT cells is associated with ROS production, 2) ROS increase mdr1 expression by a process involving NF-kappa B activation, and 3) mdr1 overexpression protects PT cells against cadmium-mediated apoptosis, These data suggest that mdr1 up-regulation, at least in part, provides anti-apoptotic protection for PT cells against cadmium-mediated stress.	Univ Saarlandes, Dept Physiol 2, D-66421 Homburg, Germany; Univ Saarlandes, Dept Expt Surg, D-66421 Homburg, Germany; Univ Frankfurt, Dept Nephrol, Zentrum Innere Med, D-60590 Frankfurt, Germany	Saarland University; Saarland University; Goethe University Frankfurt	Thevenod, F (corresponding author), Univ Saarlandes, Dept Physiol 2, D-66421 Homburg, Germany.							ABRAHAM EH, 1993, P NATL ACAD SCI USA, V90, P312, DOI 10.1073/pnas.90.1.312; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bauerle PA, 1996, CELL, V87, P13; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Bezombes C, 1998, FASEB J, V12, P101, DOI 10.1096/fasebj.12.1.101; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; CHIN KV, 1990, J BIOL CHEM, V265, P221; Dally H, 1997, CARCINOGENESIS, V18, P1021, DOI 10.1093/carcin/18.5.1021; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Endo T, 1999, PHARMACOL TOXICOL, V84, P187, DOI 10.1111/j.1600-0773.1999.tb00898.x; FRIEDMAN PA, 1994, TOXICOL APPL PHARM, V128, P257, DOI 10.1006/taap.1994.1205; Gilbert M, 1997, J CELL PHYSIOL, V171, P299, DOI 10.1002/(SICI)1097-4652(199706)171:3<299::AID-JCP8>3.0.CO;2-J; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hauser IA, 1998, KIDNEY INT, V54, P1139, DOI 10.1046/j.1523-1755.1998.00095.x; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Jakob I, 1998, AM J PHYSIOL-CELL PH, V274, pC182, DOI 10.1152/ajpcell.1998.274.1.C182; Jones G, 1997, BRIT J RHEUMATOL, V36, P95; Katsen AD, 1998, VIRCHOWS ARCH, V433, P75, DOI 10.1007/s004280050219; KIM YK, 1988, PHARMACOL TOXICOL, V63, P342, DOI 10.1111/j.1600-0773.1988.tb00966.x; KIOKA N, 1992, FEBS LETT, V301, P37, DOI 10.1016/0014-5793(92)80205-U; Klaassen CD, 1997, DRUG METAB REV, V29, P79, DOI 10.3109/03602539709037574; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Liu J, 1998, TOXICOL SCI, V46, P197, DOI 10.1093/toxsci/46.1.197; Lotem J, 1996, P NATL ACAD SCI USA, V93, P9166, DOI 10.1073/pnas.93.17.9166; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MATSUOKA M, 1995, KIDNEY INT, V48, P383, DOI 10.1038/ki.1995.306; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; O'Brien P, 1998, ARCH TOXICOL, V72, P690, DOI 10.1007/s002040050562; Ogretmen B, 1999, BIOCHEMISTRY-US, V38, P2189, DOI 10.1021/bi982236+; Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; PISCATOR M, 1986, CADMIUM HDB EXPT PHA, V80, P179; Schaub TP, 1997, J AM SOC NEPHROL, V8, P1213; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SHIMADA H, 1991, J PHARMACOBIO-DYNAM, V14, P555, DOI 10.1248/bpb1978.14.555; Smyth MJ, 1998, P NATL ACAD SCI USA, V95, P7024, DOI 10.1073/pnas.95.12.7024; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; TANIMOTO A, 1993, TOXICOL PATHOL, V21, P341, DOI 10.1177/019262339302100401; Thevenod F, 1999, FASEB J, V13, P1751, DOI 10.1096/fasebj.13.13.1751; Thevenod F., 1997, FASEB Journal, V11, pA460; Thevenod F, 1996, J BIOL CHEM, V271, P3300, DOI 10.1074/jbc.271.6.3300; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; TWENTYMAN PR, 1991, EUR J CANCER, V27, P1639, DOI 10.1016/0277-5379(91)90435-G; VANANTWERP DJ, 1996, SCIENCE, V274, P782; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Vernhet L, 1999, FEBS LETT, V443, P321, DOI 10.1016/S0014-5793(98)01716-5; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wigler PW, 1999, BIOCHEM BIOPH RES CO, V257, P410, DOI 10.1006/bbrc.1999.0475; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295; Zhou G, 1997, J BIOL CHEM, V272, P15174, DOI 10.1074/jbc.272.24.15174	55	268	283	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1887	1896		10.1074/jbc.275.3.1887	http://dx.doi.org/10.1074/jbc.275.3.1887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636889	hybrid			2022-12-27	WOS:000084940000052
J	Callahan, C; Neri-Cortes, D; Deutscher, MP				Callahan, C; Neri-Cortes, D; Deutscher, MP			Purification and characterization of the tRNA-processing enzyme RNase BN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EXORIBONUCLEASES; IDENTIFICATION; PRECURSORS	RNase BN, a tRNA-processing enzyme previously shown to be required for the 3'-maturation of certain bacteriophage T4-encoded tRNAs, was overexpressed and purified to near homogeneity from Escherichia coli. The purified enzyme, which is free of nucleic acid, is an alpha(2)-dimer with a molecular mass of similar to 65 kDa. RNase BN displays a number of unusual catalytic properties compared with the other exoribonucleases of E. coli, The enzyme is most active at PH 6.5 in the presence of Co2+ and high concentrations of monovalent salts. It is highly specific for tRNA substrates containing an incorrect residue within the universal 3'-CCA sequence. Thus, tRNA-CU and tRNA-CA are effective substrates, whereas intact tRNA-CCA, elongated tRNA-CCA-Cn, phosphodiesterase-treated tRNA and the closely related tRNA-CC are essentially inactive as substrates, RNA or DNA oligonucleotides also are not substrates, These data indicate that RNase BN has an extremely narrow substrate specificity. However, since tRNA molecules with incorrect residues within the -CCA sequence are not normally produced in E. coli, the role of RNase BN in uninfected cells remains to be determined.	Univ Miami, Dept Biochem & Mol Biol, Sch Med, Miami, FL 33101 USA; Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA	University of Miami; University of Connecticut	Deutscher, MP (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Sch Med, Miami, FL 33101 USA.				NIGMS NIH HHS [GM16317] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHA PK, 1983, J BACTERIOL, V156, P419, DOI 10.1128/JB.156.1.419-420.1983; ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Callahan C, 1996, J BACTERIOL, V178, P7329, DOI 10.1128/jb.178.24.7329-7332.1996; DEUTSCHER MP, 1978, NUCLEIC ACIDS RES, V5, P3821, DOI 10.1093/nar/5.10.3821; DEUTSCHER MP, 1974, J BIOL CHEM, V249, P6696; DEUTSCHERMP, 1995, TRNA STRUCTURE BIOSY, P51; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; MAISURIAN AN, 1973, MOL GEN GENET, V120, P227, DOI 10.1007/BF00267154; MAISURYAN AN, 1975, GENETIKA+, V11, P114; MCCLAIN WH, 1977, ACCOUNTS CHEM RES, V10, P418, DOI 10.1021/ar50119a006; Miller J. H., 1972, EXPT MOL GENETICS, P431; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2	17	6	6	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1030	1034		10.1074/jbc.275.2.1030	http://dx.doi.org/10.1074/jbc.275.2.1030			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625642	hybrid			2022-12-27	WOS:000084836600046
J	Hains, PG; Sung, KL; Tseng, A; Broady, KW				Hains, PG; Sung, KL; Tseng, A; Broady, KW			Functional characteristics of a phospholipase A(2) inhibitor from Notechis ater serum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; AGKISTRODON-BLOMHOFFII-SINITICUS; CROTALUS-DURISSUS-TERRIFICUS; ARTHRITIC SYNOVIAL-FLUID; BEE-VENOM PHOSPHOLIPASE-A2; OXYURANUS-S-SCUTELLATUS; AUSTRALIAN TIGER SNAKE; BLOOD-PLASMA; TRIMERESURUS-FLAVOVIRIDIS; PRESYNAPTIC NEUROTOXIN	A phospholipase A(2) inhibitor has been purified from the serum of Notechis ater using DEAE-Sephacel chromatography. The inhibitor was found to be composed of two protein subunits (alpha and beta) that form the intact complex of approximately 110 kDa. The alpha-chain is a 30-kDa glycoprotein and the beta-chain a nonglycosylated, 25-kDa protein. N-terminal sequence analysis reveals a high level of homology to other snake phospholipase A(2) inhibitors. The inhibitor was shown to be extremely pH and temperature stable. The inhibitor was tested against a wide variety of phospholipase A(2) enzymes and inhibited the enzymatic activity of all phospholipase A(2) enzymes tested, binding with micromole to nanomole affinity. Furthermore, the inhibitor was compared with the Eli-Lilly compound LY311727 and found to have a higher affinity for human secretory nonpancreatic phospholipase A(2) than this chemical inhibitor. The role of the carbohydrate moiety was investigated and found not to affect the in vitro function of the inhibitor.	Univ Technol, Dept Cell & Mol Biol, Toxin Res Grp, Sydney, NSW 2065, Australia	University of Technology Sydney	Broady, KW (corresponding author), Univ Technol, Dept Cell & Mol Biol, Toxin Res Grp, Westbourne St,Gore Hill, Sydney, NSW 2065, Australia.		Hains, Peter/M-4209-2019; Hains, Peter G/E-6089-2015; Hains, Peter/HIK-2945-2022	Hains, Peter/0000-0002-7276-1760; Hains, Peter G/0000-0002-7276-1760; 				Aitadafoun M, 1996, BIOCHEM PHARMACOL, V51, P737; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; BARRINGTON PL, 1986, TOXICON, V24, P1107, DOI 10.1016/0041-0101(86)90137-6; Binisti C, 1997, J LIPID MEDIAT CELL, V16, P171, DOI 10.1016/S0929-7855(97)00008-4; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BUHL WJ, 1995, BIOCHEM J, V311, P147, DOI 10.1042/bj3110147; CHANG J, 1987, BIOCHEM PHARMACOL, V36, P2429, DOI 10.1016/0006-2952(87)90512-0; Cuellar MJ, 1996, J NAT PROD, V59, P977, DOI 10.1021/np9604339; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; FLEER EAM, 1978, EUR J BIOCHEM, V82, P261, DOI 10.1111/j.1432-1033.1978.tb12019.x; FLOWER RJ, 1976, BIOCHEM PHARMACOL, V25, P285, DOI 10.1016/0006-2952(76)90216-1; FOHLMAN J, 1977, FEBS LETT, V84, P367, DOI 10.1016/0014-5793(77)80726-6; FOHLMAN J, 1976, EUR J BIOCHEM, V68, P457, DOI 10.1111/j.1432-1033.1976.tb10833.x; FORTESDIAS CL, 1991, TOXICON, V29, P997, DOI 10.1016/0041-0101(91)90082-3; FORTESDIAS CL, 1994, J BIOL CHEM, V269, P15646; FUJII S, 1995, BIOCHEM J, V308, P297, DOI 10.1042/bj3080297; GIL B, 1995, LIFE SCI, V57, pPL25, DOI 10.1016/0024-3205(95)00260-D; HALPERT J, 1975, J BIOL CHEM, V250, P6990; HASELBECK A, 1992, TOPICS BIOCH, V10; HASELBECK A, 1988, TOP BIOCH, V8, P1; HYODO S, 1995, TETRAHEDRON, V51, P6717, DOI 10.1016/0040-4020(95)00328-6; Inoue S, 1997, BIOCHEM MOL BIOL INT, V41, P529; INOUE S, 1991, J BIOL CHEM, V266, P1001; JAIN MK, 1995, PHYTOCHEMISTRY, V39, P537, DOI 10.1016/0031-9422(94)00960-2; KARLSSON E, 1972, TOXICON, V10, P405, DOI 10.1016/0041-0101(72)90066-9; KATSUKI H, 1995, PROG NEUROBIOL, V46, P607, DOI 10.1016/0301-0082(95)00016-O; KIHARA H, 1976, J BIOCHEM-TOKYO, V80, P341, DOI 10.1093/oxfordjournals.jbchem.a131282; KOGAKI H, 1989, J BIOCHEM-TOKYO, V106, P966, DOI 10.1093/oxfordjournals.jbchem.a122983; KUCHLER K, 1989, EUR J BIOCHEM, V184, P249, DOI 10.1111/j.1432-1033.1989.tb15014.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIND P, 1982, EUR J BIOCHEM, V124, P441; Lindahl M, 1997, INFLAMMATION, V21, P347, DOI 10.1023/A:1027306118026; Lizano S, 1997, BIOCHEM J, V326, P853, DOI 10.1042/bj3260853; MATSUMOTO K, 1995, J ANTIBIOT, V48, P106, DOI 10.7164/antibiotics.48.106; MICHAELS RM, 1994, CLIN EXP RHEUMATOL, V12, P643; MUKHERJEE AB, 1992, DNA CELL BIOL, V11, P233, DOI 10.1089/dna.1992.11.233; MUKHERJEE AB, 1994, BIOCHEM PHARMACOL, V48, P1, DOI 10.1016/0006-2952(94)90216-X; Nobuhisa I, 1997, EUR J BIOCHEM, V249, P838, DOI 10.1111/j.1432-1033.1997.00838.x; Ohkura N, 1999, J BIOCHEM-TOKYO, V125, P375, DOI 10.1093/oxfordjournals.jbchem.a022297; OHKURA N, 1993, J BIOCHEM-TOKYO, V113, P413, DOI 10.1093/oxfordjournals.jbchem.a124060; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V200, P784, DOI 10.1006/bbrc.1994.1519; Ohkura N, 1997, BIOCHEM J, V325, P527, DOI 10.1042/bj3250527; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V204, P1212, DOI 10.1006/bbrc.1994.2592; Okumura K, 1998, J BIOL CHEM, V273, P19469, DOI 10.1074/jbc.273.31.19469; ORTIZ AR, 1993, J MED CHEM, V36, P1866, DOI 10.1021/jm00065a010; Parks T P, 1990, Adv Exp Med Biol, V275, P55; PERALES J, 1995, EUR J BIOCHEM, V227, P19, DOI 10.1111/j.1432-1033.1995.tb20355.x; PRUZANSKI W, 1991, IMMUNOL TODAY, V12, P143, DOI 10.1016/0167-5699(91)90077-7; PUIJK WC, 1977, BIOCHIM BIOPHYS ACTA, V492, P254, DOI 10.1016/0005-2795(77)90076-9; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; RANDOLPH A, 1982, J BIOL CHEM, V257, P2155; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; SCOTT DL, 1991, SCIENCE, V254, P1007, DOI 10.1126/science.1948070; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; SEILHAMER JJ, 1989, J BIOCHEM, V106, P38, DOI 10.1093/oxfordjournals.jbchem.a122815; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; Settineri C A, 1996, Methods Mol Biol, V61, P255; SOMMERS CD, 1992, EUR J PHARMACOL, V216, P87, DOI 10.1016/0014-2999(92)90213-N; Todhunter J A, 1979, Methods Enzymol, V63, P383; VADAS P, 1993, J LIPID MEDIATOR, V8, P1; VADAS P, 1986, LAB INVEST, V55, P391; VERHEIJ HM, 1983, BIOCHIM BIOPHYS ACTA, V747, P93, DOI 10.1016/0167-4838(83)90126-7; WERY JP, 1991, NATURE, V352, P79, DOI 10.1038/352079a0; WESTERLUND B, 1992, FEBS LETT, V301, P159, DOI 10.1016/0014-5793(92)81238-H	67	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					983	991		10.1074/jbc.275.2.983	http://dx.doi.org/10.1074/jbc.275.2.983			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625636	hybrid			2022-12-27	WOS:000084836600040
J	Mucha, M; Lisowska, K; Goc, A; Filipski, J				Mucha, M; Lisowska, K; Goc, A; Filipski, J			Nuclease-hypersensitive chromatin formed by a CpG island in human DNA cloned as an artificial chromosome in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; GENOME EVOLUTION; CELLS; SITES; GENE; REPLICATION; PROMOTER; MEIOSIS	CPG islands are mostly unmethylated GC-, and CpG-rich chromosomal segments overlapping promoter sequences in all housekeeping and many tissue-specific genes in vertebrates. Typically, these islands show an open chromatin structure, low in histone H1 and rich in acetylated histones. We have previously found that the island-like CGCG-rich sites in human DNA are hypersensitive to DNase I upon cloning in Saccharomyces cerevisiae. Here we studied, with a higher resolution, the chromatin formed in yeast by one such site, the CpG island accompanying the human glucose-6-phosphate dehydrogenase gene. We have found two strong hypersensitive sites and several positioned nucleosomes flanking the island despite the absence in yeast of such chromatin fiber-shaping factors as histone H1, methyltransferase, and the tissue-specific transcription factors. This finding, together with similar observations from our laboratories and others supports the idea that variations in GC and/or CpG content substantially contribute to the DNA sequence features modulating the structure of the chromatin, The composition-dependent fluctuations in the accessibility of DNA in the chromatin may constitute an, evolutionary advantage and may explain the surprising compositional selection that acts in both the coding and non-coding segments of some genes during mammalian evolution.	Univ Paris 06, Lab Mutagenese, Inst Jacques Monod, F-75251 Paris, France; Univ Paris 07, Lab Mutagenese, Inst Jacques Monod, F-75251 Paris, France; Nicholas Copernicus Univ, Genet Lab, PL-87100 Torun, Poland	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Nicolaus Copernicus University	Filipski, J (corresponding author), Univ Paris 06, Lab Mutagenese, Inst Jacques Monod, 2 Pl Jussieu,Tour 43, F-75251 Paris, France.	filipski@ijm.jussieu.fr	Goc, Anna/F-3423-2013; Lisowska, Katarzyna M/G-8295-2011; Goc, Anna/AAM-9436-2021	Goc, Anna/0000-0003-4271-1954; Lisowska, Katarzyna M/0000-0001-9786-3993; Goc, Anna/0000-0003-4271-1954				BERNARDI G, 1986, J MOL EVOL, V24, P1, DOI 10.1007/BF02099946; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; DESCHAVANNE P, 1995, NUCLEIC ACIDS RES, V23, P1350, DOI 10.1093/nar/23.8.1350; DURSO M, 1990, GENOMICS, V7, P531, DOI 10.1016/0888-7543(90)90196-2; Eyre-Walker A, 1999, GENETICS, V152, P675; EYREWALKER A, 1999, P R SOC LOND B, V252, P237; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; FILIPSKI J, 1990, EMBO J, V9, P1319, DOI 10.1002/j.1460-2075.1990.tb08241.x; FILIPSKI J, 1987, FEBS LETT, V217, P184, DOI 10.1016/0014-5793(87)80660-9; Francino HP, 1999, NATURE, V400, P30, DOI 10.1038/21804; Franze A, 1998, FEBS LETT, V437, P313, DOI 10.1016/S0014-5793(98)01259-9; GROMOVA II, 1995, J BIOL CHEM, V270, P18685, DOI 10.1074/jbc.270.31.18685; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HOLMQUIST GP, 1994, TRENDS ECOL EVOL, V9, P65, DOI 10.1016/0169-5347(94)90277-1; Ira G, 1998, NUCLEIC ACIDS RES, V26, P2415, DOI 10.1093/nar/26.10.2415; Klein S, 1996, NAT GENET, V13, P481, DOI 10.1038/ng0896-481; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Ohta K, 1999, NUCLEIC ACIDS RES, V27, P2175, DOI 10.1093/nar/27.10.2175; Patel SA, 1997, MOL CELL BIOL, V17, P5813, DOI 10.1128/MCB.17.10.5813; Patterton HG, 1998, J BIOL CHEM, V273, P7268, DOI 10.1074/jbc.273.13.7268; Sauer F, 1997, CURR OPIN GENET DEV, V7, P176, DOI 10.1016/S0959-437X(97)80126-8; Shimizu TS, 1997, GENE, V205, P103, DOI 10.1016/S0378-1119(97)00542-8; SIMON B, 1994, FEBS LETT, V351, P340, DOI 10.1016/0014-5793(94)00862-0; Svetlova E, 1998, MOL GEN GENET, V257, P292; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Wolffe AP, 1998, PROG NUCLEIC ACID RE, V61, P379, DOI 10.1016/S0079-6603(08)60832-6; WU TC, 1995, GENETICS, V140, P55	35	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1275	1278		10.1074/jbc.275.2.1275	http://dx.doi.org/10.1074/jbc.275.2.1275			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625673	hybrid			2022-12-27	WOS:000084836600077
J	Pereira, CA; Alonso, GD; Paveto, MC; Iribarren, A; Cabanas, ML; Torres, HN; Flawia, MM				Pereira, CA; Alonso, GD; Paveto, MC; Iribarren, A; Cabanas, ML; Torres, HN; Flawia, MM			Trypanosoma cruzi arginine kinase characterization and cloning - A novel energetic pathway in protozoan parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION; SITE; BINDING; SCALLOP; MUSCLE; ACTIN	This work contains the first description of a guanidino kinase in a flagellar unicellular parasite. The enzyme phosphorylates L-arginine and was characterized in preparations from Trypanosoma cruzi, the ethiological agent of Chagas' disease. The activity requires ATP and a divalent cation. Under standard assay conditions (1 mM L-arginine), the presence of B-fold higher concentrations of canavanine or histidine produced a greater than 50% enzyme inhibition, The base sequence of this enzyme revealed an open reading frame of 357 amino acids and a molecular weight of 40,201. The amino acid sequence shows all of the characteristic consensus blocks of the ATP:guanidino phosphotransferase family and a putative "actinin-type" actin-binding domain. The highest amino acid identities of the T. cruzi sequence, about 70%, were with arginine kinases from Arthropoda. Southern and chromosome blots revealed that the kinase is encoded by a single-copy gene. Moreover, Northern blot analysis showed an mRNA subpopulation of about 2.0 kilobases, and Western blotting of T. cruzi-soluble polypeptides revealed a 40-kDa band. The finding in the parasite of a phosphagen and its biosynthetic pathway, which are totally different from those in mammalian host tissues, points out this arginine kinase as a possible chemotherapy target for Chagas' disease.	Univ Buenos Aires, Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Flawia, MM (corresponding author), INGEBI, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.		Pereira, Claudio A/F-5382-2012; Alonso, Guillermo Daniel/AAI-6674-2020; Torres, Héctor/GXG-1780-2022	Pereira, Claudio A/0000-0001-7874-1894; Alonso, Guillermo Daniel/0000-0001-9386-9431; 				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMARGO EP, 1978, EXP PARASITOL, V46, P141, DOI 10.1016/0014-4894(78)90125-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; ENGMAN DM, 1987, MOL BIOCHEM PARASIT, V22, P115, DOI 10.1016/0166-6851(87)90041-7; France RM, 1997, ARCH BIOCHEM BIOPHYS, V345, P73, DOI 10.1006/abbi.1997.0243; Henikoff JG, 1999, NUCLEIC ACIDS RES, V27, P226, DOI 10.1093/nar/27.1.226; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Huennekens F. M., 1960, COMP BIOCHEM, P107; KUHLMAN PA, 1992, FEBS LETT, V304, P201, DOI 10.1016/0014-5793(92)80619-R; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Morrison J. F., 1973, ENZYMES, V8, P457, DOI 10.1016/S1874-6047; PAVETO C, 1995, J BIOL CHEM, V270, P16576, DOI 10.1074/jbc.270.28.16576; Pereira C, 1997, J EUKARYOT MICROBIOL, V44, P155, DOI 10.1111/j.1550-7408.1997.tb05952.x; Pereira CA, 1999, J EUKARYOT MICROBIOL, V46, P566, DOI 10.1111/j.1550-7408.1999.tb05132.x; REDDY SRR, 1992, EUR J BIOCHEM, V206, P251, DOI 10.1111/j.1432-1033.1992.tb16923.x; REDDY SRR, 1991, COMP BIOCHEM PHYS B, V99, P387, DOI 10.1016/0305-0491(91)90059-M; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; ROSENTHAL GA, 1977, J BIOL CHEM, V252, P3679; Strong SJ, 1996, COMP BIOCHEM PHYS B, V113, P809, DOI 10.1016/0305-0491(95)02104-3; YOSHIDA N, 1978, J BACTERIOL, V136, P1184, DOI 10.1128/JB.136.3.1184-1186.1978; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449; Zingales B, 1997, PARASITOL TODAY, V13, P16	22	141	148	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1495	1501		10.1074/jbc.275.2.1495	http://dx.doi.org/10.1074/jbc.275.2.1495			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625703	Green Published, hybrid			2022-12-27	WOS:000084836600107
J	Savelsbergh, A; Mohr, D; Wilden, B; Wintermeyer, W; Rodnina, MV				Savelsbergh, A; Mohr, D; Wilden, B; Wintermeyer, W; Rodnina, MV			Stimulation of the GTPase activity of translation elongation factor G by ribosomal protein L7/12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; AMINOACYL-TRANSFER-RNA; FACTOR EF-G; ESCHERICHIA-COLI; FACTOR-TU; ACTIVATING-PROTEIN; CODON RECOGNITION; HYDROLYSIS; MECHANISM; COMPLEX	Elongation factors (EFs) Tu and G are GTPases that have important functions in protein synthesis. The low intrinsic GTPase activity of both factors is strongly stimulated on the ribosome by unknown mechanisms. Here we report that isolated ribosomal protein L7/12 strongly stimulates GTP hydrolysis by EF-G, but not by EF-Tu, indicating a major contribution of L7/12 to GTPase activation of EF-G on the ribosome. The effect is due to the acceleration of the catalytic step because the rate of GDP-GTP exchange on EF-G, as measured by rapid kinetics, is much faster than the steady-state GTPase rate. The unique, highly conserved arginine residue in the C-terminal domain of L7/12 is not essential for the activation, excluding an "arginine finger"-type mechanism. L7/12 appears to function by stabilizing the GTPase transition state of EF-G.	Univ Witten Herdecke, Inst Mol Biol, D-58448 Witten, Germany	Witten Herdecke University	Rodnina, MV (corresponding author), Univ Witten Herdecke, Inst Mol Biol, D-58448 Witten, Germany.		Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Savelsbergh, Andreas/0000-0002-6136-3230				Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Bocharov EV, 1998, FEBS LETT, V423, P347, DOI 10.1016/S0014-5793(98)00121-5; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; DONNER D, 1978, P NATL ACAD SCI USA, V75, P3192, DOI 10.1073/pnas.75.7.3192; GALE EF, 1981, ANTIBIOTIC INHIBITOR, P402; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; GUDKOV AT, 1995, FEBS LETT, V367, P280, DOI 10.1016/0014-5793(95)00564-P; HAMEL E, 1972, J BIOL CHEM, V247, P6810; Hamman BD, 1996, BIOCHEMISTRY-US, V35, P16672, DOI 10.1021/bi9615001; HILGENFELD R, 1995, NAT STRUCT BIOL, V2, P3, DOI 10.1038/nsb0195-3; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Jagath JR, 1998, BIOCHEMISTRY-US, V37, P15408, DOI 10.1021/bi981523a; KISCHA K, 1971, NATURE-NEW BIOL, V233, P62, DOI 10.1038/newbio233062a0; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Munishkin A, 1997, P NATL ACAD SCI USA, V94, P12280, DOI 10.1073/pnas.94.23.12280; Neuhard J., 1987, ESCHERICHIA COLI SAL; Noel JP, 1997, NAT STRUCT BIOL, V4, P677, DOI 10.1038/nsb0997-677; OLEINIKOV AV, 1993, J BIOL CHEM, V268, P917; PARMEGGIANI A, 1981, MOL CELL BIOCHEM, V35, P129, DOI 10.1007/BF02357085; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; Rodnina MV, 1995, BIOCHEM CELL BIOL, V73, P1221, DOI 10.1139/o95-132; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; SANDER G, 1980, BIOCHEMISTRY-US, V19, P865, DOI 10.1021/bi00546a006; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SOMMER A, 1985, J BIOL CHEM, V260, P6522; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STARK H, 1999, IN PRESS CELL; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; ZEIDLER W, 1995, EUR J BIOCHEM, V229, P596, DOI 10.1111/j.1432-1033.1995.tb20503.x	49	76	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					890	894		10.1074/jbc.275.2.890	http://dx.doi.org/10.1074/jbc.275.2.890			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625623	hybrid, Green Published			2022-12-27	WOS:000084836600027
J	Yao, N; Hurwitz, J; O'Donnell, M				Yao, N; Hurwitz, J; O'Donnell, M			Dynamics of beta and proliferating cell nuclear antigen sliding clamps in traversing DNA secondary structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III HOLOENZYME; CHROMOSOMAL REPLICATION MACHINE; LAGGING-STRAND REPLICATION; ESCHERICHIA-COLI; ACCESSORY PROTEINS; DELTA HOLOENZYME; MISMATCH REPAIR; PCNA; SUBUNIT; MECHANISM	Chromosomal replicases of cellular organisms utilize a ring shaped protein that encircles DNA as a mobile tether for high processivity in DNA synthesis. These "sliding clamps" have sufficiently large linear diameters to encircle duplex DNA and are perhaps even large enough to slide over certain DNA secondary structural elements. This report examines the Escherichia coli beta and human proliferating cell nuclear antigen clamps for their ability to slide over various DNA secondary structures. The results show that these clamps are capable of traversing a 13-nucleotide ssDNA loop, a 4-base pair stem-loop, a 4-nucleotide 5' tail, and a 15-mer bubble within the duplex. However, upon increasing the size of these structures (20-nucleotide loop, 12-base pair stem-loop, 28-nucleotide 5' tail, and 20-nucleotide bubble) the sliding motion of the beta and proliferating cell nuclear antigen over these elements is halted. Studies of the E. coli replicase, DNA polymerase III holoenzyme, in chain elongation with the beta clamp demonstrate that upon encounter with an oligonucleotide annealed in its path, it traverses the duplex and resumes synthesis on the 3' terminus of the oligonucleotide. This sliding and resumption of synthesis occurs even when the oligonucleotide contains a secondary structure element, provided the beta clamp can traverse the structure. However, upon encounter with a downstream oligonucleotide containing a large internal secondary structure, the holoenzyme clears the obstacle by strand displacing the oligonucleotide from the template. Implications of these protein dynamics to DNA transactions are discussed.	Cornell Univ, Joan & Sanford I Weill Grad Sch Med Sci, Dept Microbiol, New York, NY 10021 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, Lab DNA Replicat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Grad Program Mol Biol, New York, NY 10021 USA	Cornell University; Rockefeller University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Yao, N (corresponding author), Cornell Univ, Joan & Sanford I Weill Grad Sch Med Sci, Dept Microbiol, New York, NY 10021 USA.				PHS HHS [38839] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Canceill D, 1996, P NATL ACAD SCI USA, V93, P6647, DOI 10.1073/pnas.93.13.6647; DONG ZM, 1993, J BIOL CHEM, V268, P11758; FAY PJ, 1981, J BIOL CHEM, V256, P976; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; HIASA H, 1989, GENE, V84, P17, DOI 10.1016/0378-1119(89)90134-0; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; KELMAN Z, 1995, GENE, V166, P177, DOI 10.1016/0378-1119(95)00556-7; Kelman Z, 1998, TRENDS BIOCHEM SCI, V23, P236, DOI 10.1016/S0968-0004(98)01223-7; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KORNBERG A, 1992, DNA REPLICATION, P169; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; KURIYAN J, 1993, J MOL BIOL, V234, P915, DOI 10.1006/jmbi.1993.1644; LADUCA RJ, 1986, J BIOL CHEM, V261, P7550; LAMBERT PF, 1986, J VIROL, V58, P450, DOI 10.1128/JVI.58.2.450-458.1986; LEE SH, 1989, P NATL ACAD SCI USA, V86, P7361, DOI 10.1073/pnas.86.19.7361; LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672; LEE SH, 1991, J BIOL CHEM, V266, P594; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu JI, 1999, P NATL ACAD SCI USA, V96, P3552, DOI 10.1073/pnas.96.7.3552; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; MAKI H, 1985, J BIOL CHEM, V260, P2987; MAKI S, 1988, J BIOL CHEM, V263, P6547; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; O'Donnell M, 1999, CURR BIOL, V9, pR545, DOI 10.1016/S0960-9822(99)80348-0; ODONNELL ME, 1985, J BIOL CHEM, V260, P2875; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P5003, DOI 10.1021/bi00015a011; PONTKINGDON G, 1993, EMBO J, V12, P23, DOI 10.1002/j.1460-2075.1993.tb05628.x; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; Stephens KM, 1997, J BIOL CHEM, V272, P28800, DOI 10.1074/jbc.272.45.28800; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; STUDWELLVAUGHAN PS, 1993, J BIOL CHEM, V268, P11785; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; Turner J, 1995, METHOD ENZYMOL, V262, P442; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WANG TSF, 1980, BIOCHEMISTRY-US, V19, P1782, DOI 10.1021/bi00550a009; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; XIAO H, 1993, J BIOL CHEM, V268, P11773; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4; ZECHEL K, 1975, J BIOL CHEM, V250, P4684	65	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1421	1432		10.1074/jbc.275.2.1421	http://dx.doi.org/10.1074/jbc.275.2.1421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625694	hybrid			2022-12-27	WOS:000084836600098
J	Futamura, A; Gettins, PGW				Futamura, A; Gettins, PGW			Serine 380 (P14) -> glutamate mutation activates antithrombin as an inhibitor of factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASED STRUCTURAL FLEXIBILITY; HEPARIN-BINDING SITE; ALPHA(1)-PROTEINASE INHIBITOR; CONFORMATIONAL CHANGE; REACTIVE CENTER; SERPIN; PROTEINASE; MECHANISM; SUBSTRATE; ACCELERATION	Heparin regulates the inhibitory activity of antithrombin. It has been proposed that residues P15 and P14 are expelled from beta-sheet A of antithrombin by heparin binding, permitting better interaction of the reactive center loop with factor Xa. We have made a P14 antithrombin variant (S380E) to create an activated inhibitory form of antithrombin in which P14 is already expelled from beta-sheet A. S380E antithrombin fluorescence is enhanced 35 +/- 5% compared with control antithrombin. There is minimal further increase in antithrombin fluorescence upon heparin binding. The variant has a 5 degrees C lower T-m than control antithrombin. The variant is an inhibitor of proteinases and has a nearly 200-fold increased basal rate of inhibition of factor Xa, after correction for an increased stoichiometry of inhibition. This is comparable to that of antithrombin activated by high affinity heparin pentasaccharide. Full-length high affinity heparin causes only a 7-fold additional increase in rate and a large increase in stoichiometry of inhibition. In contrast, the basal rate of inhibition of thrombin is similar to that of control antithrombin but is increased 300-fold by heparin. These findings suggest that the native state of the S380E variant exists in a loop-expelled conformation that is consequently highly reactive toward factor Xa.	Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049234, R01HL049234] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49234] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; FAN BQ, 1994, BIOCHEMISTRY-US, V33, P14156, DOI 10.1021/bi00251a026; FAN BQ, 1993, J BIOL CHEM, V268, P17588; GETTINS PGW, 1993, BIOCHEMISTRY-US, V32, P8385, DOI 10.1021/bi00084a001; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; KASLIK G, 1995, FEBS LETT, V370, P179, DOI 10.1016/0014-5793(95)00816-R; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; LANCHANTIN GF, 1973, J BIOL CHEM, V248, P5956; Lukacs CM, 1996, NAT STRUCT BIOL, V3, P888, DOI 10.1038/nsb1096-888; MILETICH JP, 1980, ANAL BIOCHEM, V105, P304, DOI 10.1016/0003-2697(80)90462-5; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; Olson S.T., 1993, PERSPECT DRUG DISCOV, V1, P479; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1981, J BIOL CHEM, V256, P1065; OLSON ST, 1985, J BIOL CHEM, V260, P153; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 1997, ARCH BIOCHEM BIOPHYS, V341, P212, DOI 10.1006/abbi.1997.9973; Plotnick MI, 1996, BIOCHEMISTRY-US, V35, P7586, DOI 10.1021/bi960233w; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; Stratikos E, 1998, J BIOL CHEM, V273, P15582, DOI 10.1074/jbc.273.25.15582; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; TURKO IV, 1993, FEBS LETT, V335, P9, DOI 10.1016/0014-5793(93)80429-X; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; Zettlmeissl G, 1988, Behring Inst Mitt, P26	30	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4092	4098		10.1074/jbc.275.6.4092	http://dx.doi.org/10.1074/jbc.275.6.4092			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660568	hybrid			2022-12-27	WOS:000085288800052
J	Zauli, G; Secchiero, P; Rodella, L; Gibellini, D; Mirandola, P; Mazzoni, M; Milani, D; Dowd, DR; Capitani, S; Vitale, M				Zauli, G; Secchiero, P; Rodella, L; Gibellini, D; Mirandola, P; Mazzoni, M; Milani, D; Dowd, DR; Capitani, S; Vitale, M			HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSCRIPTIONAL REPRESSOR ICER; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; RESPONSE ELEMENT; BASIC DOMAIN; T-CELLS; PROTEIN; CAMP; AIDS	lTreatment of dopaminergic rat PC12 cells with human immunodeficiency virus, type 1 (HIV-1) Tat protein or tat cDNA inhibited the expression of tyrosine hydroxylase (TR), the rate limiting enzyme for the dopamine biosynthetic pathway, as well as the production and release of dopamine into the culture medium. Moreover, the: Tat addition to PC12 cells up-regulated the expression of the inducible cAMP early repressor (ICER), a specific member of the cAMP-responsive element modulator transcription factor family, in a cAMP-dependent manner. In turn, ICER overexpression abrogated the transcription activity of the TH promoter in PC12 cells, strongly suggesting ICER involvement in Tat-mediated inhibition of TH gene expression. lit vivo injection of synthetic HIV-1 Tat protein into the striatum of healthy rats induced a subclinical Parkinson's-like disease that became manifested only when the animals were treated with amphetamine. As early as one week postinjection, the histochemical examination of the rat substantia nigra showed a reduced staining of neurons expressing TH followed by a loss of TH+ neurons at later time points. As Tat protein can be locally released into the central nervous system by HIV-1-infected microglial cells, our findings may contribute to the explanation of the pathogenesis of the motorial abnormalities often reported in HIV-1 seropositive individuals.	Univ Ferrara, Dept Morphol & Embryol, Anat Sect, I-44100 Ferrara, Italy; Univ Chieti, Inst Human Morphol Gabriel DAnnunzio, I-66100 Chieti, Italy; Univ Brescia, Dept Biomed Sci & Biotechnol, Human Anat Sect, I-25123 Brescia, Italy; Univ Bologna, Dept Clin & Expt Med, Microbiol Sect, I-40138 Bologna, Italy; St Louis Univ, Hlth Sci Ctr, Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; CNR, Inst Res Codivilla Putti, Inst Normal & Pathol Cytomorphol, I-40136 Bologna, Italy	University of Ferrara; G d'Annunzio University of Chieti-Pescara; University of Brescia; University of Bologna; Saint Louis University; Consiglio Nazionale delle Ricerche (CNR)	Zauli, G (corresponding author), Univ Ferrara, Dept Morphol & Embryol, Anat Sect, Via Fossato Mortara 66, I-44100 Ferrara, Italy.		Milani, Daniela/G-5579-2015; Mirandola, Prisco/L-3137-2015; Zauli, Giorgio/ABE-8001-2020; Rodella, Luigi Fabrizio/F-1079-2010; Gibellini, Davide/K-8725-2016; secchiero, paola/G-9689-2015; Vitale, Marco/O-8751-2015	Milani, Daniela/0000-0002-9540-7801; Mirandola, Prisco/0000-0002-5058-3924; Gibellini, Davide/0000-0003-3688-1252; secchiero, paola/0000-0003-4101-7987; Vitale, Marco/0000-0002-3261-6868; Zauli, Giorgio/0000-0002-3750-8698; Rodella, Luigi Fabrizio/0000-0002-9497-4708; CAPITANI, Silvano/0000-0003-2795-6814				BERGER JR, 1994, AIDS, V8, P67, DOI 10.1097/00002030-199401000-00010; BERGER JR, 1992, SEMIN NEUROL, V12, P1, DOI 10.1055/s-2008-1041151; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cheng J, 1998, NEUROSCIENCE, V82, P97, DOI 10.1016/S0306-4522(97)00174-7; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gallo RC, 1999, P NATL ACAD SCI USA, V96, P8324, DOI 10.1073/pnas.96.15.8324; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gibellini D, 1998, J IMMUNOL, V160, P3891; GOLDSTEIN G, 1996, NAT MED, V1, P960; Gringeri A, 1998, J Hum Virol, V1, P293; HRISO E, 1991, AM J PSYCHIAT, V148, P1558; JEON BS, 1995, NEURODEGENERATION, V4, P131, DOI 10.1006/neur.1995.0016; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; KILBOURNE EJ, 1990, MOL BRAIN RES, V8, P121, DOI 10.1016/0169-328X(90)90056-J; KIM KS, 1993, J BIOL CHEM, V268, P15689; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; KURE K, 1990, ACTA NEUROPATHOL, V80, P393, DOI 10.1007/BF00307693; LAZAROFF M, 1995, J BIOL CHEM, V270, P21579, DOI 10.1074/jbc.270.37.21579; Li CJ, 1997, P NATL ACAD SCI USA, V94, P8116, DOI 10.1073/pnas.94.15.8116; LINDNER MD, 1995, EXP NEUROL, V132, P62, DOI 10.1016/0014-4886(95)90059-4; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Mao DL, 1998, MOL ENDOCRINOL, V12, P492, DOI 10.1210/me.12.4.492; Marzio G, 1998, P NATL ACAD SCI USA, V95, P13519, DOI 10.1073/pnas.95.23.13519; MERRILL JE, 1991, FASEB J, V5, P23921; MILANI D, 1993, J GEN VIROL, V74, P2587, DOI 10.1099/0022-1317-74-12-2587; Milani D, 1998, AIDS, V12, P1275, DOI 10.1097/00002030-199811000-00008; Mirsattari SM, 1998, MOVEMENT DISORD, V13, P684, DOI 10.1002/mds.870130413; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Monaco L, 1997, ONCOGENE, V15, P2493, DOI 10.1038/sj.onc.1201636; NATH A, 1987, NEUROLOGY, V37, P37, DOI 10.1212/WNL.37.1.37; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Orsini MJ, 1996, J NEUROSCI, V16, P2546; PHILIPPON V, 1994, VIROLOGY, V205, P519, DOI 10.1006/viro.1994.1673; REYES MG, 1991, ACTA NEUROPATHOL, V82, P39, DOI 10.1007/BF00310921; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Takai N, 1998, J NEUROSCI RES, V54, P214, DOI 10.1002/(SICI)1097-4547(19981015)54:2<214::AID-JNR9>3.0.CO;2-H; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; UDENFRIE.S, 1966, PHARMACOL REV, V18, P43; WEEKS BS, 1995, J NEUROSCI RES, V42, P34, DOI 10.1002/jnr.490420105; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WONG SC, 1994, J NEUROCHEM, V62, P1691; Yamada M, 1999, P NATL ACAD SCI USA, V96, P4078, DOI 10.1073/pnas.96.7.4078; ZAULI G, 1995, J ACQ IMMUN DEF SYND, V10, P306; ZETTERSTROM T, 1986, BRAIN RES, V376, P1, DOI 10.1016/0006-8993(86)90893-0; Zidovetzki R, 1998, AIDS RES HUM RETROV, V14, P825, DOI 10.1089/aid.1998.14.825; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	52	70	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4159	4165		10.1074/jbc.275.6.4159	http://dx.doi.org/10.1074/jbc.275.6.4159			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660577	hybrid			2022-12-27	WOS:000085288800061
J	Barazzoni, R; Short, KR; Nair, KS				Barazzoni, R; Short, KR; Nair, KS			Effects of aging on mitochondrial DNA copy number and cytochrome c oxidase gene expression in rat skeletal muscle, liver, and heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENESCENT RATS; ENCODED GENES; AGE; TRANSCRIPTION; ADAPTATION; PROTEIN; GROWTH; DAMAGE	Mitochondrial DNA (mtDNA) deletions and mutations have been reported to occur with aging in various tissues. To determine the functional impact of these changes, we measured mtDNA copy number, mitochondria-encoded cytochrome c oxidase (COX) subunit I and III transcript levels, and COX enzyme activity in skeletal muscles (medial and lateral gastrocnemius and soleus), liver, and heart in 6- and 27-month-old rats. Substantial age-related reductions of mtDNA copy number occurred in skeletal muscle groups (-23-40%, p < 0.03) and liver (-50%, p < 0.01) but not in the heart. The decline in mtDNA was not associated with reduced COX transcript levels in tissues with high oxidative capacities such as red soleus muscle or liver, while transcript levels were reduced with aging in the less oxidative mixed fiber gastrocnemius muscle (-17-22%, p < 0.06), Consistent with transcript levels, COX activity also remained unchanged in aging liver and heart but declined with age in the lateral gastrocnemius (-32%, p < 0.05). Thus, the effects of aging on mitochondrial gene expression are tissue-specific. A substantial age-related decline in mtDNA copy number proportional to tissue oxidative capacities is demonstrated in skeletal muscle and liver. mtDNA levels are in contrast preserved in the aging heart muscle, presumably due to its incessant aerobic activity. Reduced mtDNA copy number has no major effects on mitochondrial encoded transcript levels and enzyme activities in various tissues under these baseline study conditions. In contrast, maintenance of mitochondrial transcript levels that may be linked to oxidative metabolism and energy demand appears to be the main determinant of mitochondrial oxidative capacity in aging tissues.	Mayo Clin & Mayo Fdn, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Nair, KS (corresponding author), Mayo Clin & Mayo Fdn, Endocrine Res Unit, Joseph 5-194, Rochester, MN 55905 USA.		Short, Kevin R/AAC-2553-2020	Short, Kevin R/0000-0001-6704-9587	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009531] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 00585] Funding Source: Medline; NIA NIH HHS [R0 AG 09531] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6; ALONI Y, 1971, P NATL ACAD SCI USA, V68, P1757, DOI 10.1073/pnas.68.8.1757; ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647; BOHMAN R, 1985, J EXP ZOOL, V233, P385, DOI 10.1002/jez.1402330307; CASTELLUCCIO C, 1994, MECH AGEING DEV, V76, P73, DOI 10.1016/0047-6374(94)91583-0; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Delp MD, 1998, J APPL PHYSIOL, V85, P1813, DOI 10.1152/jappl.1998.85.5.1813; Dutta C, 1997, MUSCLE NERVE       S, V5, pS5; DUTTA C, 1996, J GERONTOL A-BIOL, V50, P1; Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023; GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x; GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H; GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; HSINCHEN L, 1994, BIOCHIM BIOPHYS ACTA, V1226, P37; JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918; JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; MARINGARCIA J, 1994, J MOL CELL CARDIOL, V26, P1029, DOI 10.1006/jmcc.1994.1123; MEERSON FZ, 1972, J MOL CELL CARDIOL, V4, P571, DOI 10.1016/0022-2828(72)90113-7; MURAKAMI T, 1994, AM J PHYSIOL, V267, pE388, DOI 10.1152/ajpendo.1994.267.3.E388; Newsholme EA, 1973, REGULATION METABOLIS; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; RAJAMANICKAM C, 1979, CIRC RES, V45, P505, DOI 10.1161/01.RES.45.4.505; Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364; Sambrook J., 2002, MOL CLONING LAB MANU; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; SCOTTO AW, 1983, ARCH BIOCHEM BIOPHYS, V222, P150, DOI 10.1016/0003-9861(83)90512-X; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802; TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B; TOMANEK RJ, 1973, J ULTRA MOL STRUCT R, V42, P201, DOI 10.1016/S0022-5320(73)90050-6; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Welle S, 1996, AM J PHYSIOL-ENDOC M, V270, pE224, DOI 10.1152/ajpendo.1996.270.2.E224; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764; WILSON PD, 1975, BIOCHEM SOC T, V3, P126, DOI 10.1042/bst0030126	40	276	287	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3343	3347		10.1074/jbc.275.5.3343	http://dx.doi.org/10.1074/jbc.275.5.3343			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652323	hybrid			2022-12-27	WOS:000085146500045
J	Liu, XB; Wang, WC; Singh, BB; Lockwich, T; Jadlowiec, J; O'Connell, B; Wellner, R; Zhu, MX; Ambudkar, IS				Liu, XB; Wang, WC; Singh, BB; Lockwich, T; Jadlowiec, J; O'Connell, B; Wellner, R; Zhu, MX; Ambudkar, IS			Trp1, a candidate protein for the store-operated Ca2+ influx mechanism in salivary gland cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; FUNCTIONAL EXPRESSION; DROSOPHILA TRP; HUMAN HOMOLOG; ACINAR-CELLS; RAT HOMOLOG; CHANNEL; DEPLETION; CLONING; MEMBRANE	The trp gene family has been proposed to encode the store operated Ca2+ influx (SOC) channel(s). This study examines the role of Trp1 in the SOC mechanism of salivary gland cells. htrp1, htrp3, and Trp1 were detected in the human submandibular gland cell line (HSG), HSG cells stably transfected with htrp1 alpha cDNA displayed (i) a higher level of Trp1, (ii) a 3-5-fold increase in SOC (thapsigargin-stimulated Ca2+ influx), determined by [Ca2+](i) and Ca2+-activated K+ channel current measurements, and (iii) similar basal Ca2+ permeability, and inhibition of SOC by Gd3+ but not by Zn2+, as compared with control cells. importantly, (i) transfection of HSG cells with antisense trp1 alpha cDNA decreased endogenous Trp1 level and significantly attenuated SOC, and (ii) transfection of HSG cells with htrp3 cDNA did not increase SOC, These data demonstrate an association between Trp1 and SOC and strongly suggest that Trp1 is involved in this mechanism in HSG cells, Consistent with this suggestion, Trp1 was detected in the plasma membrane region, the proposed site of SOC, of acinar and ductal cells in intact rat submandibular glands. Based on these aggregate data, we propose Trp1 as a candidate protein for the SOC mechanism in salivary gland cells.	NIDCR, NIH, Secretory Physiol Sect, Gene Therapy & Therapeut Branch, Bethesda, MD 20892 USA; Ohio State Univ, Neurobiotechnol Ctr, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Ohio; Ohio State University	Ambudkar, IS (corresponding author), NIDCR, NIH, Secretory Physiol Sect, Gene Therapy & Therapeut Branch, Bldg 10,Rm 1N-113, Bethesda, MD 20892 USA.			Singh, Brij/0000-0003-0535-5997; O'Connell, Brian/0000-0003-4529-7664	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000438] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AMBUDKAR IS, 2000, IN PRESS CRIT REV OR; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Birnbaumer L, 1996, P NATL ACAD SCI USA, V93, P15195, DOI 10.1073/pnas.93.26.15195; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; He XJ, 1997, PFLUG ARCH EUR J PHY, V433, P260; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liu XB, 1998, J BIOL CHEM, V273, P33295, DOI 10.1074/jbc.273.50.33295; Liu XB, 1998, AM J PHYSIOL-CELL PH, V275, pC571, DOI 10.1152/ajpcell.1998.275.2.C571; Lockwich T, 1995, J MEMBRANE BIOL, V148, P277; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; O'Connell AC, 1999, RADIAT RES, V151, P150, DOI 10.2307/3579765; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PETERSEN OH, 1992, J PHYSIOL-LONDON, V448, P1; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; Sakura H, 1997, DIABETOLOGIA, V40, P528, DOI 10.1007/s001250050711; Sinkins WG, 1998, BIOCHEM J, V331, P331, DOI 10.1042/bj3310331; Tomita Y, 1998, NEUROSCI LETT, V248, P195, DOI 10.1016/S0304-3940(98)00362-0; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC1501, DOI 10.1152/ajpcell.1994.267.5.C1501; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060; Wang WC, 1999, AM J PHYSIOL-CELL PH, V276, pC969, DOI 10.1152/ajpcell.1999.276.4.C969; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Xu XZS, 1997, CELL, V89, P1155, DOI 10.1016/S0092-8674(00)80302-5; Zhu X, 1998, NEWS PHYSIOL SCI, V13, P211; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	36	233	243	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3403	3411		10.1074/jbc.275.5.3403	http://dx.doi.org/10.1074/jbc.275.5.3403			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652333	hybrid			2022-12-27	WOS:000085146500055
J	Bahner, M; Sander, P; Paulsen, R; Huber, A				Bahner, M; Sander, P; Paulsen, R; Huber, A			The visual G protein of fly photoreceptors interacts with the PDZ domain assembled INAD signaling complex via direct binding of activated G alpha(q) to phospholipase C beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRP CA2+ CHANNEL; PHOTOTRANSDUCTION CASCADE; DROSOPHILA-MELANOGASTER; GENETIC DISSECTION; KINASE-C; MEMBRANES; NORPA; PHOSPHORYLATION; LOCALIZATION; DEACTIVATION	Visual transduction in the compound eye of flies is a well-established model system for the study of G protein-coupled transduction pathways. Pivotal components of this signaling pathway, including the principal light-activated Ca2+ channel transient receptor potential, an eye specific protein kinase C, and the norpA-encoded phospholipase C beta, are assembled into a supramolecular signaling complex by the modular PDZ domain protein INAD. We have used immunoprecipitation assays to study the interaction of the heterotrimeric visual G protein with this INAD signaling complex, Light-activated G alpha(q)- guanosine 5'-O-(thiotriphosphate) and Alf(4)(-)-activated G alpha(q), but not G beta gamma, form a stable complex with the INAD signaling complex. This interaction requires the presence of norpA-encoded phospholipase C beta, indicating that phospholipase C beta is the target of activated G alpha(q). Our data establish that the INAD signaling complex is a light-activated target of the phototransduction pathway, with G alpha(q), forming a molecular on-off switch that shuttles the visual signal from activated rhodopsin to INAD-linked phospholipase C beta.	Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, D-76128 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Huber, A (corresponding author), Univ Karlsruhe, Inst Zool, Dept Cell & Neurobiol, Kornblumenstr 13, D-76128 Karlsruhe, Germany.	DC05@rz.uni-karlsruhe.de		Huber, Armin/0000-0003-3977-089X				Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; BENTROP J, 1986, EUR J BIOCHEM, V161, P61, DOI 10.1111/j.1432-1033.1986.tb10124.x; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BLUMENFELD A, 1985, P NATL ACAD SCI USA, V82, P7116, DOI 10.1073/pnas.82.20.7116; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; ELGAMMAL S, 1987, CELL TISSUE RES, V248, P511, DOI 10.1007/BF00216477; GOLDSMITH TH, 1977, J GEN PHYSIOL, V70, P453, DOI 10.1085/jgp.70.4.453; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Huber A, 1998, FEBS LETT, V425, P317, DOI 10.1016/S0014-5793(98)00248-8; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; MCKAY RR, 1995, J BIOL CHEM, V270, P13271, DOI 10.1074/jbc.270.22.13271; MINKE B, 1985, J COMP PHYSIOL A, V156, P339, DOI 10.1007/BF00610727; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; PAK WL, 1970, NATURE, V227, P518, DOI 10.1038/227518b0; PAULSEN R, 1984, J COMP PHYSIOL, V155, P47, DOI 10.1007/BF00610930; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Selinger Z., 1987, Progress in Clinical and Biological Research, V249, P169; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wes PD, 1999, NAT NEUROSCI, V2, P447, DOI 10.1038/8116; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	35	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2901	2904		10.1074/jbc.275.4.2901	http://dx.doi.org/10.1074/jbc.275.4.2901			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644758	hybrid			2022-12-27	WOS:000085128000090
J	Browning, DD; McShane, MP; Marty, C; Ye, RD				Browning, DD; McShane, MP; Marty, C; Ye, RD			Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CYCLIC-GMP; ANCHORING PROTEINS; SIGNAL; GROWTH; TRANSCRIPTION; STIMULATION; IDENTIFICATION; LOCALIZATION; INFLAMMATION	An increase in cellular levels of cyclic nucleotides activates serine/threonine-dependent kinases that lead to diverse physiological effects. Recently we reported the activation of the p38 mitogen-activated protein kinase (MAPK) pathway in neutrophils by a cGMP-dependent mechanism. In this study we demonstrated that exogenously supplied nitric oxide leads to activation of p38 MAPK in 293T fibroblasts. Phosphorylation of p38 corresponded with an increase in ATF-alpha-dependent gene expression. The effect of nitric oxide was mimicked by addition of 8-bromo-cGMP, indicating that activation of soluble guanylyl cyclase was involved. The importance of cGMP-dependent protein kinase in the activation of p38 MAPK by nitric oxide in 293T cells was assessed in a transfection based assay. Overexpression of cGMP-dependent protein kinase-1 alpha caused phosphorylation of p38 in these cells and potentiated the effectiveness of cGMP. Overexpression of a catalytically inactive mutant form of this enzyme (T516A) blocked the ability of both nitric oxide and 8-bromo-cGMP to activate p38 as measured by both p38 phosphorylation and ATF-2 driven gene expression. Together, these data demonstrate that nitric oxide stimulates a novel pathway leading to activation of p38 MAPK that requires activation of cGMP-dependent protein kinase.	Univ Illinois, Dept Pharmacol MC868, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ye, RD (corresponding author), Univ Illinois, Dept Pharmacol MC868, 835 S Wolcott Ave, Chicago, IL 60612 USA.		Ye, Richard/ABF-2413-2020; Ye, Richard/O-5223-2016; MARTY, Caroline/I-1721-2017	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; MARTY, Caroline/0000-0003-4350-2302; Browning, Darren/0000-0003-0497-7620	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040176, R01AI040176, R56AI033503, R01AI033503] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40176, AI33503] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARCHER SL, 1994, P NATL ACAD SCI USA, V91, P7583, DOI 10.1073/pnas.91.16.7583; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bhat NR, 1999, J NEUROCHEM, V72, P472, DOI 10.1046/j.1471-4159.1999.0720472.x; Browning DD, 1999, J BIOL CHEM, V274, P537, DOI 10.1074/jbc.274.1.537; Brune B, 1996, REV PHYSIOL BIOCH P, V127, P1, DOI 10.1007/BFb0048263; BRUNE B, 1994, LIFE SCI, V54, P61, DOI 10.1016/0024-3205(94)00775-6; Callsen D, 1999, BIOCHEMISTRY-US, V38, P2279, DOI 10.1021/bi982292a; Callsen D, 1998, J IMMUNOL, V161, P4852; Chan ED, 1999, J IMMUNOL, V162, P415; Collins SP, 1999, J BIOL CHEM, V274, P8391, DOI 10.1074/jbc.274.13.8391; FEIL R, 1995, BIOCHEMISTRY-US, V34, P13152, DOI 10.1021/bi00040a029; Gudi T, 1996, J BIOL CHEM, V271, P4597; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hobbs AJ, 1997, TRENDS PHARMACOL SCI, V18, P484, DOI 10.1016/S0165-6147(97)01137-1; Hood J, 1998, J BIOL CHEM, V273, P23504, DOI 10.1074/jbc.273.36.23504; Kanterewicz BI, 1998, J NEUROCHEM, V70, P1009; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Lander HM, 1996, J BIOL CHEM, V271, P19705, DOI 10.1074/jbc.271.33.19705; Larsen CM, 1998, J BIOL CHEM, V273, P15294, DOI 10.1074/jbc.273.24.15294; Lincoln T M, 1995, Adv Pharmacol, V34, P305; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MCDONALD LJ, 1994, MOL CELL BIOCHEM, V138, P201, DOI 10.1007/BF00928462; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; MOILANEN E, 1995, ANN MED, V27, P359, DOI 10.3109/07853899509002589; MORRIS BJ, 1995, J BIOL CHEM, V270, P24740; Parenti A, 1998, J BIOL CHEM, V273, P4220, DOI 10.1074/jbc.273.7.4220; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schieke SM, 1999, FEBS LETT, V448, P301, DOI 10.1016/S0014-5793(99)00372-5; Sciorati C, 1997, BRIT J PHARMACOL, V122, P687, DOI 10.1038/sj.bjp.0701413; SEGER R, 1992, J BIOL CHEM, V267, P14373; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Suhasini M, 1998, MOL CELL BIOL, V18, P6983, DOI 10.1128/MCB.18.12.6983; Tamura N, 1996, HYPERTENSION, V27, P552, DOI 10.1161/01.HYP.27.3.552; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Vo NK, 1998, BIOCHEM BIOPH RES CO, V246, P831, DOI 10.1006/bbrc.1998.8722; Wang X, 1997, J NEUROCHEM, V68, P443; Willmott N, 1996, J BIOL CHEM, V271, P3699; Yun HY, 1998, P NATL ACAD SCI USA, V95, P5773, DOI 10.1073/pnas.95.10.5773; ZHUO M, 1994, NATURE, V368, P635, DOI 10.1038/368635a0	44	84	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2811	2816		10.1074/jbc.275.4.2811	http://dx.doi.org/10.1074/jbc.275.4.2811			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644746	hybrid			2022-12-27	WOS:000085128000078
J	Glading, A; Chang, P; Lauffenburger, DA; Wells, A				Glading, A; Chang, P; Lauffenburger, DA; Wells, A			Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFECTED SCHWANN-CELLS; PHOSPHOLIPASE-C; FOCAL ADHESIONS; PROTEASE CALPAIN; MYELIN MCALPAIN; MIGRATION SPEED; TALIN; IMMUNOLOCALIZATION; PHOSPHORYLATION; ATTACHMENT	To become migratory, cells must reorganize their connections to the substratum, and during locomotion they must break rear attachments. The molecular and biochemical mechanisms underlying these biophysical processes are unknown. Recent studies have implicated both extracellular signal-regulated kinase/mitogen-activated protein (ERK/MAP) kinase and calpain (EC 3.4.22.17) in these processes, but it is uncertain whether these are two distinct pathways acting on different modes of motility. We report that cell deadhesion involved in epidermal growth factor (EGF) receptor-mediated fibroblast motility requires activation of M-calpain downstream of ERK/MAP kinase signaling, NR6 fibroblasts expressing full-length mild type epidermal growth factor receptor required both calpain and ERK activation, as demonstrated by pharmacological inhibitors (calpeptin and calpain inhibitor I and PD98059, respectively) for EGF-induced deadhesion and motility. EGF induced rapid activation of calpain that was preventable by molecular inhibition of the Ras-Raf-MEK but not phospholipase C gamma signaling pathway, and calpain was stimulated by transfection of constitutively active MEK. Enhanced calpain activity was not mirrored by increased calpain protein levels or decreased levels of its endogenous inhibitor calpastatin. The link between ERK/MAP kinase signaling and cell motility required the M-isoform of calpain (calpain II), as determined by specific antisense-mediated down-regulation, These data promote a previously undescribed signaling pathway of ERK/MAP kinases activating calpain to destabilize cell-substratum adhesions in response to EGF stimulation.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; MIT, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Massachusetts Institute of Technology (MIT)	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, 713 Scaife, Pittsburgh, PA 15261 USA.		Glading, Angela/AAI-3455-2020	Wells, Alan/0000-0002-1637-8150; Glading, Angela/0000-0002-1830-6601	NATIONAL CANCER INSTITUTE [R01CA069213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054739] Funding Source: NIH RePORTER; NCI NIH HHS [CA69213] Funding Source: Medline; NIGMS NIH HHS [GM54739] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI Y, 1986, BIOCHEM BIOPH RES CO, V136, P1090, DOI 10.1016/0006-291X(86)90445-6; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Chakrabarti AK, 1997, J NEUROSCI RES, V47, P609, DOI 10.1002/(SICI)1097-4547(19970315)47:6<609::AID-JNR6>3.0.CO;2-H; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; COUCHMAN JR, 1985, EUR J CELL BIOL, V36, P182; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Guttmann RP, 1997, J BIOL CHEM, V272, P2005, DOI 10.1074/jbc.272.3.2005; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Johnson GVW, 1997, BIOESSAYS, V19, P1011, DOI 10.1002/bies.950191111; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KUO WN, 1994, MOL CELL BIOCHEM, V136, P157, DOI 10.1007/BF00926076; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Maheshwari G, 1998, MICROSC RES TECHNIQ, V43, P358, DOI 10.1002/(SICI)1097-0029(19981201)43:5<358::AID-JEMT2>3.0.CO;2-D; Maheshwari G, 1999, BIOPHYS J, V76, P2814, DOI 10.1016/S0006-3495(99)77435-7; MUGURUMA M, 1995, J BIOCHEM-TOKYO, V117, P1036, DOI 10.1093/oxfordjournals.jbchem.a124803; Neuberger T, 1997, J NEUROSCI RES, V47, P521, DOI 10.1002/(SICI)1097-4547(19970301)47:5<521::AID-JNR7>3.0.CO;2-J; OSHIMA M, 1989, J BIOL CHEM, V264, P20811; Palecek SP, 1996, J CELL SCI, V109, P941; Palecek SP, 1998, J CELL SCI, V111, P929; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; ROSSER BG, 1993, J BIOL CHEM, V268, P23593; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; Shiraha H, 1999, J CELL BIOL, V146, P243; SHUSTER CB, 1995, J CELL BIOL, V128, P837, DOI 10.1083/jcb.128.5.837; SIEGAL GP, 1993, CANCER LETT, V69, P123, DOI 10.1016/0304-3835(93)90164-5; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; TOMPA P, 1995, ANAL BIOCHEM, V228, P287, DOI 10.1006/abio.1995.1352; TRANQUI L, 1995, EXP CELL RES, V217, P149, DOI 10.1006/excr.1995.1074; VEGA QC, 1992, MOL CELL BIOL, V12, P128, DOI 10.1128/MCB.12.1.128; Ware MF, 1998, J CELL SCI, V111, P2423; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Wells A, 1998, MICROSC RES TECHNIQ, V43, P395, DOI 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T; WELSH JB, 1991, J CELL BIOL, V114, P533, DOI 10.1083/jcb.114.3.533; Xie H, 1998, J CELL SCI, V111, P615; Zhang WL, 1996, J BIOL CHEM, V271, P18825, DOI 10.1074/jbc.271.31.18825	45	222	232	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2390	2398		10.1074/jbc.275.4.2390	http://dx.doi.org/10.1074/jbc.275.4.2390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644690	hybrid			2022-12-27	WOS:000085128000022
J	Noguchi, S; Jianmongkol, S; Bender, AT; Kamada, Y; Demady, DR; Osawa, Y				Noguchi, S; Jianmongkol, S; Bender, AT; Kamada, Y; Demady, DR; Osawa, Y			Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CYTOCHROMES-P450; L-ARGININE; PROTEIN; HEME; 3,5-DICARBETHOXY-2,6-DIMETHYL-4-ETHYL-1,4-DIHYDROPYRIDINE; MECHANISM; ENZYME; BRAIN; LACTACYSTIN; MACROPHAGE	Guanabenz, a metabolism-based irreversible inactivator of neuronal nitric-oxide synthase (nNOS) in vitro, causes the loss of immunodetectable nNOS in vivo. This process is selective in that the slowly reversible inhibitor NG-nitro-L-arginine did not decrease the levels of nNOS in vivo. To better understand the mechanism for the loss of nNOS protein in vivo we have investigated the effects of guanabenz and N-G-nitro-L-arginine in HEB: 293 cells stably transfected with the enzyme. me show here that guanabenz, but not N-G-nitro-L-arginine, caused the inactivation and loss of nNOS protein in the HER 293 cells. in studies with cycloheximide or in pulse-chase experiments with [S-35]methionine, we demonstrate that the loss of nNOS was due in large part to enhanced proteolysis of the protein with the half-life decreasing by one-half from 20 to 10 h. Other metabolism-based irreversible inactivators to nNOS, N-G-methyl-L-arginine, and N-5-(1-iminoethyl)-L-ornithine, but not the reversible inhibitor 7-nitroindazole (7-NI), caused a similar decrease in the half-life of nNOS, Proteasomal inhibitors, lactacystin, Cbz-leucine-leucine-leucinal, and N-acetyl-leucine-leucine-norleucinal, but not the lysosomal protease inhibitor leupeptin, were found to effectively inhibit the proteolytic degradation of nNOS, Thus Fee have shown for the first time that the irreversible inactivators of nNOS, perhaps through covalent alteration of the enzyme, enhance the proteolytic turnover of the enzyme by a mechanism involving the proteasome.	Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.		KAMADA, Yasuhiko/B-2175-2011	KAMADA, Yasuhiko/0000-0003-1271-9082	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES08365] Funding Source: Medline; NIGMS NIH HHS [GM07767] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELES RH, 1983, CHEM ENG NEWS, V61, P48, DOI 10.1021/cen-v061n038.p048; Babu BR, 1998, J BIOL CHEM, V273, P8882, DOI 10.1074/jbc.273.15.8882; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; BORNHEIM LM, 1987, MOL PHARMACOL, V32, P299; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V294, P493, DOI 10.1016/0003-9861(92)90716-A; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; Feelisch M., 1996, METHODS NITRIC OXIDE, P455; FELDMAN PL, 1993, J MED CHEM, V36, P491, DOI 10.1021/jm00056a009; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Hajimohammadreza I, 1997, J NEUROCHEM, V69, P1006; KLATT P, 1994, J BIOL CHEM, V269, P1674; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laine R, 1998, MOL PHARMACOL, V54, P305, DOI 10.1124/mol.54.2.305; LUNETTA JM, 1989, MOL PHARMACOL, V35, P10; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MCMILLAN K, 1992, P NATL ACAD SCI USA, V89, P11141, DOI 10.1073/pnas.89.23.11141; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nakatsuka M, 1998, DRUG METAB DISPOS, V26, P497; NOGUCHI T, 1982, BIOCHEM PHARMACOL, V31, P609, DOI 10.1016/0006-2952(82)90439-7; OLKEN NM, 1994, BIOCHEMISTRY-US, V33, P14784, DOI 10.1021/bi00253a017; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; Reif A, 1999, J BIOL CHEM, V274, P24921, DOI 10.1074/jbc.274.35.24921; REIF DW, 1995, ARCH BIOCHEM BIOPHYS, V320, P170, DOI 10.1006/abbi.1995.1356; RICHARDS MK, 1994, BIOCHEMISTRY-US, V33, P14723, DOI 10.1021/bi00253a010; Roberts BJ, 1997, J BIOL CHEM, V272, P9771; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SCHMIDT HHHW, 1992, MOL PHARMACOL, V41, P615; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; Walker G, 1997, J BIOL CHEM, V272, P16679, DOI 10.1074/jbc.272.26.16679; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; Yang MX, 1997, ARCH BIOCHEM BIOPHYS, V341, P25, DOI 10.1006/abbi.1997.9907	39	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2376	2380		10.1074/jbc.275.4.2376	http://dx.doi.org/10.1074/jbc.275.4.2376			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644688	hybrid			2022-12-27	WOS:000085128000020
J	Oleksiak, MF; Wu, S; Parker, C; Karchner, SI; Stegeman, JJ; Zeldin, DC				Oleksiak, MF; Wu, S; Parker, C; Karchner, SI; Stegeman, JJ; Zeldin, DC			Identification, functional characterization, and regulation of a new cytochrome P450 subfamily, the CYP2Ns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID METABOLISM; PROTEIN-KINASE-C; EPOXYEICOSATRIENOIC ACIDS; MOLECULAR-CLONING; 11,12-EPOXYEICOSATRIENOIC ACID; AMINO-ACID; EPOXYGENASE; EXPRESSION; ENZYMES; SEQUENCES	The screening of liver and heart cDNA libraries from the teleost Fundulus heteroclitus with degenerate oligonucleotide probes to conserved alpha-helical regions in mammalian P450s resulted in the identification of two cDNAs that together represent a novel P450 subfamily, the CYP2Ns. Northern analysis demonstrated that CYP2N1 transcripts are most abundant in liver and intestine, whereas CYP2N2 mRNAs are most abundant in heart and brain. CYP2N1 and CYP2N2 proteins were co-expressed with NADPH cytochrome P450 oxidoreductase in Sf9 insect cells, and their ability to metabolize arachidonic acid and xenobiotic substrates was examined. Both CYP2N1. and CYP2N2 metabolize arachidonic acid to epoxyeicosatrienoic acids. Epoxidation is highly regio- and enantioselective with preferential formation of (8R,9S)-epoxyeicosatrienoic acid (optical purities are 91 and 90% for CYP2N1 and CYP2N2, respectively) and (11R,12S)-epoxyeicosatrienoic acid (optical purities are 92 and 70% for CYP2N1 and CYP2N2, respectively). CYP2N1 and CYP2N2 also catalyze the formation of a variety of hydroxyeicosatetraenoic acids. Both P450s have benzphetamine N-demethylase activities but show minimal alkoxyresorufin O-dealkylase activities. To investigate factors affecting CYP2N expression in vivo, CYP2N transcripts were examined following starvation and/or treatment with 12-O-tetradecanoyl phorbol-13-acetate. Intestinal CYP2N1 mRNAs decrease in starved and/or phorbol ester-treated fish, whereas intestinal CYP2N2 transcripts decrease only following phorbol ester treatment. Interestingly, cardiac CYP2N2 expression decreases following phorbol ester treatment but increases following starvation. These results demonstrate that members of this novel P450 subfamily encode early vertebrate forms of arachidonic acid catalysts that are widely expressed and are regulated by environmental factors. Given the wealth of information on the functional role of P450-derived arachidonate metabolites in mammals, we postulate that CYP2N1 and CYP2N2 products have similar biological functions in early vertebrates. The identity of the mammalian orthologue(s) of the CYP2Ns remains unknown.	NIEHS, Pulm Pathobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Woods Hole Oceanographic Institution	Stegeman, JJ (corresponding author), NIEHS, Pulm Pathobiol Lab, NIH, 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	jstegeman@whoi.edu	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Stegeman, John/0000-0001-8204-5357	CSR NIH HHS [NA46RG0470] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034, Z01ES050106] Funding Source: NIH RePORTER	CSR NIH HHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		CAPDEVILA J, 1983, ENDOCRINOLOGY, V113, P421; CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385; CAPDEVILA JH, 1992, FASEB J, V6, P731, DOI 10.1096/fasebj.6.2.1537463; CAPDEVILA JH, 1986, ARCH BIOCHEM BIOPHYS, V231, P511; CAPDEVILA JH, 1981, P NATL ACAD SCI USA, V78, P7375; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; CINTI DL, 1976, BIOCHEM BIOPH RES CO, V73, P171, DOI 10.1016/0006-291X(76)90512-X; CLARE RA, 1991, J CHROMATOGR-BIOMED, V562, P237, DOI 10.1016/0378-4347(91)80581-V; COREY EJ, 1980, J AM CHEM SOC, V102, P1433, DOI 10.1021/ja00524a043; CRAVEN PA, 1992, DIGEST DIS SCI, V37, P1162, DOI 10.1007/BF01296555; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; DAVANZO C, 1990, ESTUARIES, V13, P20, DOI 10.2307/1351428; FALCK JR, 1990, METHOD ENZYMOL, V187, P357; FALCK JR, 1990, J BIOL CHEM, V265, P10244; FALCK JR, 1982, TETRAHEDRON LETT, V23, P1755, DOI 10.1016/S0040-4039(00)86732-5; Faulkner D. J, 1977, MARINE NATURAL PRODU; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FISCHER SM, 1985, ARACHIDONIC ACID MET; Fitzgerald Lisa M., 1993, Molecular Marine Biology and Biotechnology, V2, P112; FITZPATRICK FA, 1988, PHARMACOL REV, V40, P229; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; Gilday D, 1996, J BIOL CHEM, V271, P33054, DOI 10.1074/jbc.271.51.33054; GOTOH O, 1992, J BIOL CHEM, V267, P83; GRAVES PE, 1990, ARCH BIOCHEM BIOPHYS, V281, P106, DOI 10.1016/0003-9861(90)90419-Y; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HAHN ME, 1993, AQUAT TOXICOL, V26, P185, DOI 10.1016/0166-445X(93)90030-5; HAMMONDS TD, 1989, ANAL BIOCHEM, V182, P300, DOI 10.1016/0003-2697(89)90598-8; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; HARRIS RC, 1990, J CELL PHYSIOL, V144, P429, DOI 10.1002/jcp.1041440310; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; HOBBS AA, 1986, J BIOL CHEM, V261, P9444; Hoebel BG, 1998, EUR J PHARMACOL, V346, P115, DOI 10.1016/S0014-2999(98)00118-6; JUNIER MP, 1990, ENDOCRINOLOGY, V126, P1534, DOI 10.1210/endo-126-3-1534; KARARA A, 1989, J BIOL CHEM, V264, P19822; Kmiec Z, 1996, J ENDOCRINOL INVEST, V19, P304, DOI 10.1007/BF03347867; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; KUTSKY P, 1983, PROSTAGLANDINS, V26, P13, DOI 10.1016/0090-6980(83)90070-9; LAETHEM RM, 1994, BBA-PROTEIN STRUCT M, V1206, P42, DOI 10.1016/0167-4838(94)90070-1; LAETHEM RM, 1992, J PHARMACOL EXP THER, V262, P433; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; LEE CA, 1995, ARCH BIOCHEM BIOPHYS, V319, P157, DOI 10.1006/abbi.1995.1278; LEE PC, 1993, COMP BIOCHEM PHYS C, V106, P649, DOI 10.1016/0742-8413(93)90222-7; MANNA S, 1983, TETRAHEDRON LETT, V24, P33, DOI 10.1016/S0040-4039(00)81319-2; MAURENTE G, 1994, BIOCHIM BIOPHYS ACTA, V1212, P109; MCGIFF JC, 1991, ANNU REV PHARMACOL, V31, P339, DOI 10.1146/annurev.pa.31.040191.002011; MOFFAT MP, 1993, AM J PHYSIOL, V264, pH1154, DOI 10.1152/ajpheart.1993.264.4.H1154; MORRISON AR, 1981, P NATL ACAD SCI-BIOL, V78, P7375, DOI 10.1073/pnas.78.12.7375; MOSSET P, 1986, TETRAHEDRON LETT, V27, P6035, DOI 10.1016/S0040-4039(00)85391-5; MOUSTAKIS CA, 1985, J AM CHEM SOC, V107, P5283, DOI 10.1021/ja00304a048; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; NAVARRO I, 1992, COMP BIOCHEM PHYS A, V102, P401, DOI 10.1016/0300-9629(92)90154-I; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; NISHIMOTO M, 1993, BIOCHEMISTRY-US, V32, P8863, DOI 10.1021/bi00085a018; OLIW EH, 1982, J BIOL CHEM, V257, P3771; OMURA T, 1964, J BIOL CHEM, V239, P2370; PORTER NA, 1979, J ORG CHEM, V44, P3177, DOI 10.1021/jo01332a017; PROCTOR KG, 1989, BLOOD VESSELS, V26, P53; Qu W, 1998, MOL PHARMACOL, V54, P504, DOI 10.1124/mol.54.3.504; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scarborough PE, 1999, DRUG METAB REV, V31, P205, DOI 10.1081/DMR-100101915; Schlezinger JJ, 1998, ARCH BIOCHEM BIOPHYS, V353, P265, DOI 10.1006/abbi.1998.0651; SENGER H, 1997, COMP BIOCH PHYSL, V116, P257; UZUMAKI H, 1986, CARCINOGENESIS, V7, P289, DOI 10.1093/carcin/7.2.289; WAKABAYASHI K, 1961, BIOCHIM BIOPHYS ACTA, V48, P615, DOI 10.1016/0006-3002(61)90069-5; WELLS PG, 1989, TOXICOL APPL PHARM, V97, P398, DOI 10.1016/0041-008X(89)90244-5; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; YOSHIDA S, 1990, ARCH BIOCHEM BIOPHYS, V280, P346, DOI 10.1016/0003-9861(90)90340-5; Zacharewski TR, 1996, AM SOC TEST MATER, V1262, P165, DOI 10.1520/STP15581S; ZELDIN DC, 1995, J CLIN INVEST, V95, P2150, DOI 10.1172/JCI117904	76	47	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2312	2321		10.1074/jbc.275.4.2312	http://dx.doi.org/10.1074/jbc.275.4.2312			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644680	hybrid			2022-12-27	WOS:000085128000012
J	Choi, HI; Hong, JH; Ha, JO; Kang, JY; Kim, SY				Choi, HI; Hong, JH; Ha, JO; Kang, JY; Kim, SY			ABFs, a family of ABA-responsive element binding factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BZIP TRANSCRIPTION FACTORS; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; LOW-TEMPERATURE; LEUCINE-ZIPPER; SPECIFICATION ELEMENTS; FREEZING TOLERANCE; WATER-STRESS; COLD STRESS; G-BOX	Abscisic acid (ABA) plays an important role in environmental stress responses of higher plants during vegetative growth. One of the ABA-mediated responses is the induced expression of a large number of genes, which is mediated by cis-regulatory elements known as abscisic acid-responsive elements (ABREs). Although a number of ABBE binding transcription factors have been known, they are not specifically from vegetative tissues under induced conditions. Considering the tissue specificity of ABA signaling pathways, factors mediating ABA-dependent stress responses during vegetative growth phase may thus have been unidentified so far. Here, we report a family of ABBE binding factors isolated from young Arabidopsis plants under stress conditions. The factors, isolated by a yeast one-hybrid system using a prototypical ABBE and named as ABFs (ABRE binding factors) belong to a distinct subfamily of bZIP proteins. Binding site selection assay performed with one ABF showed that its preferred binding site is the strong ABBE, CACGTGGC. ABFs can transactivate an ABBE-containing reporter gene in yeast. Expression of ABFs is induced by ABA and various stress treatments, whereas their induction patterns are different from one another, Thus, a new family of ABBE binding factors indeed exists that have the potential to activate a large number of ABA/stress-responsive genes in Arabidopsis.	Kumho Life & Environm Sci Lab, Puk Gu, Kwangju 500712, South Korea		Kim, SY (corresponding author), Kumho Life & Environm Sci Lab, Puk Gu, 1 Oryong Dong, Kwangju 500712, South Korea.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Busk PK, 1997, PLANT J, V11, P1285, DOI 10.1046/j.1365-313X.1997.11061285.x; Busk PK, 1998, PLANT MOL BIOL, V37, P425, DOI 10.1023/A:1006058700720; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chung JD, 1996, J MATER PROCESS MANU, V5, P3; deBruxelles GL, 1996, PLANT PHYSIOL, V111, P381, DOI 10.1104/pp.111.2.381; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; Hollung K, 1997, PLANT MOL BIOL, V35, P561, DOI 10.1023/A:1005815017718; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; IZAWA T, 1993, J MOL BIOL, V230, P1131, DOI 10.1006/jmbi.1993.1230; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kim SY, 1998, J PLANT PHYSIOL, V152, P607, DOI 10.1016/S0176-1617(98)80019-9; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; KUSANO T, 1995, MOL GEN GENET, V248, P507, DOI 10.1007/BF02423445; LAM E, 1991, J BIOL CHEM, V266, P17131; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lu GH, 1996, PLANT CELL, V8, P847, DOI 10.1105/tpc.8.5.847; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Meshi T, 1995, PLANT CELL PHYSIOL, V36, P1405; Nakagawa H, 1996, PLANT J, V9, P217, DOI 10.1046/j.1365-313X.1996.09020217.x; OEDA K, 1991, EMBO J, V10, P1793, DOI 10.1002/j.1460-2075.1991.tb07704.x; Ono A, 1996, PLANT PHYSIOL, V112, P483, DOI 10.1104/pp.112.2.483; PLA M, 1993, PLANT MOL BIOL, V21, P259, DOI 10.1007/BF00019942; POLLOCK R, 1990, NUCLEIC ACIDS RES, V18, P6197, DOI 10.1093/nar/18.21.6197; Sambrook J., 2002, MOL CLONING LAB MANU; SCHINDLER U, 1992, EMBO J, V11, P1261, DOI 10.1002/j.1460-2075.1992.tb05170.x; Shinozaki K, 1996, CURR OPIN BIOTECH, V7, P161, DOI 10.1016/S0958-1669(96)80007-3; Thomas T. L., 1997, Signal transduction in plants., P23; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.arplant.39.1.439	41	791	905	17	150	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1723	1730		10.1074/jbc.275.3.1723	http://dx.doi.org/10.1074/jbc.275.3.1723			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636868	hybrid			2022-12-27	WOS:000084940000031
J	Croissant, JD; Carpenter, S; Bader, D				Croissant, JD; Carpenter, S; Bader, D			Identification and genomic cloning of CMHC1 - A unique myosin heavy chain expressed exclusively in the developing chicken heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-I GENE; SKELETAL-MUSCLE; MESSENGER-RNA; CARDIAC-MUSCLE; TRANSCRIPTION; FAMILY	We report the identification and cloning of a unique chick myosin heavy chain (CMHC1) that is expressed exclusively in the heart during embryogenesis. Using primers specific to myosin heavy chains, we used reverse transcriptase-polymerase chain reaction to clone and isolate CMHC1 from embryonic day 10 chicken heart RNA. Sequence analysis indicated that CMHC1 was a novel member of the myosin heavy chain family. Expression of the CMHC1 transcripts was detected in Hamburger Hamilton stage 10 chick embryos in the fusing myocardium, Expression of CMHC1 was maintained at high levels throughout the tubular heart of later stage embryos. Reverse transcriptase-polymerase chain reaction and in situ hybridizations failed to detect CMHC1 transcripts in the developing somites, limb buds, or skeletal musculature at any stage of chick development. Genomic CMHC1 clones have been isolated that contain sequences approximately 5.2 kilobase upstream of the presumptive CMHC1 transcription start site. Portions of the upstream regulatory region induced a al-fold increase in reporter gene expression in primary cardiomyocytes, Because of its unique cardiac-restricted expression, CMHC1 will provide an excellent model system to study the molecular mechanisms required for the early developmental regulation of heart-specific genes.	Vanderbilt Univ, Med Ctr, Gladys P Stahlman Cardiovasc Res Lab, Nashville, TN 37212 USA	Vanderbilt University	Bader, D (corresponding author), Vanderbilt Univ, Med Ctr, Gladys P Stahlman Cardiovasc Res Lab, Nashville, TN 37212 USA.							AUSONI S, 1994, J BIOL CHEM, V269, P339; BISAHA JG, 1991, DEV BIOL, V148, P355, DOI 10.1016/0012-1606(91)90343-2; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; Di Lisi R, 1998, J BIOL CHEM, V273, P25371, DOI 10.1074/jbc.273.39.25371; EPP TA, 1993, GENOMICS, V18, P505, DOI 10.1016/S0888-7543(11)80006-6; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HASTINGS KEM, 1991, J BIOL CHEM, V266, P19659; He CZ, 1997, J BIOL CHEM, V272, P28550, DOI 10.1074/jbc.272.45.28550; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; KENDREW J, 1994, ENCY MOL BIOL, P700; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; Molkentin JD, 1996, J MOL CELL CARDIOL, V28, P1211, DOI 10.1006/jmcc.1996.0112; NAKAYAMA S, 1994, J BIOCHEM-TOKYO, V115, P909, DOI 10.1093/oxfordjournals.jbchem.a124439; NG WA, 1991, CIRC RES, V68, P1742, DOI 10.1161/01.RES.68.6.1742; Nikovits W, 1996, J BIOL CHEM, V271, P17047, DOI 10.1074/jbc.271.29.17047; RADICE GP, 1989, DEV BIOL, V133, P562, DOI 10.1016/0012-1606(89)90058-4; ROBBINS J, 1986, J BIOL CHEM, V261, P6606; RUSHBROOK JI, 1994, J MUSCLE RES CELL M, V15, P505, DOI 10.1007/BF00121157; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; SEIDMAN CE, 1991, MOL BIOL MED, V8, P159; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; STEWART AFR, 1991, J MOL EVOL, V33, P357, DOI 10.1007/BF02102866; Wang GF, 1996, J BIOL CHEM, V271, P19836, DOI 10.1074/jbc.271.33.19836; WANG RX, 1994, J MOL CELL CARDIOL, V26, P1155, DOI 10.1006/jmcc.1994.1134; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Xavier-Neto J, 1999, DEVELOPMENT, V126, P2677; YUTZEY KE, 1994, DEVELOPMENT, V120, P871	30	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1944	1951		10.1074/jbc.275.3.1944	http://dx.doi.org/10.1074/jbc.275.3.1944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636896	hybrid			2022-12-27	WOS:000084940000059
J	de Caestecker, MP; Yahata, T; Wang, D; Parks, WT; Huang, SX; Hill, CS; Shioda, T; Roberts, AB; Lechleider, RJ				de Caestecker, MP; Yahata, T; Wang, D; Parks, WT; Huang, SX; Hill, CS; Shioda, T; Roberts, AB; Lechleider, RJ			The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; TUMOR-SUPPRESSOR; HETERO-OLIGOMERIZATION; BINDING-PROTEIN; DNA-BINDING; COACTIVATOR; CELLS; PHOSPHORYLATION; DOWNSTREAM; RESPONSES	Transforming growth factor-p (TGF-P) family members signal through a unique set of intracellular proteins called Smads, Smad4, previously identified as the tumor suppressor DPC4, is functionally distinct among the Smad family, and is required for the assembly and transcriptional activation of diverse, Smad-DNA complexes. We previously identified a 48-amino acid proline-rich regulatory element within the middle linker domain of this molecule, the Smad4 activation domain (SAD), which is essential for mediating these signaling activities. We now characterize the functional activity of the SAD. Mutants lacking the SAD are still able to form complexes with other Smad family members and associated transcription factors, but cannot activate transcription in these complexes. Furthermore, the SAD itself is able to activate transcription in heterologous reporter assays, identifying it as a proline-rich transcriptional activation domain, and indicating that the SAD is both necessary and sufficient to activate Smad-dependent transcriptional responses. We show that transcriptional activation by the SAD is p300-dependent, and demonstrate that this activity is associated with a physical interaction of the SAD with the amino terminus of p300, These data identify a novel function of the middle linker region of Smad4, and define the role of the SAD as an important locus determining the transcriptional activation of the Smad complex.	NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; Massachusetts Gen Hosp, Ctr Canc, Lab Tumor Biol, Charlestown, MA 02129 USA; Imperial Canc Res Fund, Dev Signaling Lab, London WC2A 3PX, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Cancer Research UK	Lechleider, RJ (corresponding author), NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA.	Robertsa@dce41.nci.nih.gov		Hill, Caroline/0000-0002-8632-0480; Parks, W. Tony/0000-0001-7341-3277				ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; deWinter JP, 1997, ONCOGENE, V14, P1891, DOI 10.1038/sj.onc.1201017; Eckner R, 1996, BIOL CHEM, V377, P685; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; KRAUS VB, 1992, MOL CELL BIOL, V12, P4391, DOI 10.1128/MCB.12.10.4391; KUNZLER M, 1994, EMBO J, V13, P641, DOI 10.1002/j.1460-2075.1994.tb06302.x; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; LEDAI J, 1998, CANCER RES, V58, P4592; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Qin B, 1999, STRUCTURE, V7, P1493, DOI 10.1016/S0969-2126(00)88340-9; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 1997, NATURE, V388, P87, DOI 10.1038/40431; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wu RY, 1997, MOL CELL BIOL, V17, P2521, DOI 10.1128/MCB.17.5.2521; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	38	140	145	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2115	2122		10.1074/jbc.275.3.2115	http://dx.doi.org/10.1074/jbc.275.3.2115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636916	hybrid			2022-12-27	WOS:000084940000079
J	Weisman-Shomer, P; Naot, Y; Fry, M				Weisman-Shomer, P; Naot, Y; Fry, M			Tetrahelical forms of the fragile X syndrome expanded sequence d(CGG)(n) are destabilized by two heterogeneous nuclear ribonucleoprotein-related telomeric DNA-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHESIS IN-VITRO; TRIPLET REPEATS; TRINUCLEOTIDE REPEATS; HAIRPIN STRUCTURES; RAT HEPATOCYTES; METHYLATION; FMR-1; INSTABILITY; EXPRESSION; QUADRUPLEX	Formations of hairpin and tetrahelical structures by the trinucleotide repeat sequence d(CGG)(n) might contribute to its expansion in fragile X syndrome. Here we show that tetraplex structures of d(CGG)(n) are destabilized by two mammalian heterogeneous nuclear ribonucleoprotein-related tetraplex telomeric DNA-binding and -stabilizing proteins, quadruplex telomeric DNA-binding protein 42 (qTBP42) (Sarig, G., Weisman-Shomer, P., Erlitzki, R., and Fry, M. (1997) J. Biol. Chem. 272, 4474-4482) and unimolecular quadruplex telomeric DNA-binding protein 25 (uqTBP25) (Erlitzki, R., and Fry, M. (1997) J. Biol. Chem. 272, 15881-15890). Bluntended and 3'-tailed or 3'- and 8'-tailed bimolecular tetraplex structures of d(CGG)(n) and guanine-sparse 20-/46-mer partial DNA duplex were progressively destabilized by increasing amounts of qTBP42 or uqTBP25 in time-dependent and ATP- or Mg2+-independent reactions. By contrast, tetraplex structures of telomeric and IgG sequences or guanine-rich double-stranded DNA resisted destabilization by qTBP42 or uqTBP25. Increased stability of tetraplex d(CGG)(n) in the presence of K+ or Na+ ions or at lowered reaction temperature diminished the destabilizing activity of uqTBP25. The contrasting stabilization of tetraplex telomeric DNA and destabilization of tetraplex d(CGG)(n) by qTBP42 and uqTBP25 suggested that sequence or structural differences between these tetraplexes might serve as cues for the differential stabilizing/destabilizing activities.	Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Fry, M (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Biochem Unit, POB 9649, IL-31096 Haifa, Israel.							Baran N, 1997, NUCLEIC ACIDS RES, V25, P297, DOI 10.1093/nar/25.2.297; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; CHEN FM, 1995, J BIOL CHEM, V270, P23090, DOI 10.1074/jbc.270.39.23090; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; CVEKI A, 1995, BBA-GENE STRUCT EXPR, V1261, P290, DOI 10.1016/0167-4781(95)00021-8; Darlow JM, 1998, J MOL BIOL, V275, P3, DOI 10.1006/jmbi.1997.1453; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Elliot Brownlee W., 1996, FRAGILE X SYNDROME D, P88; Erlitzki R, 1997, J BIOL CHEM, V272, P15881, DOI 10.1074/jbc.272.25.15881; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; GACY AM, 1995, CELL, V81, P533; GRODENIN DA, 1997, NAT GENET, V16, P116; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; KAMADA S, 1992, GENE, V119, P229, DOI 10.1016/0378-1119(92)90276-U; KANG SM, 1995, J BIOL CHEM, V270, P27014, DOI 10.1074/jbc.270.45.27014; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; KHAN FA, 1991, FEBS LETT, V290, P159, DOI 10.1016/0014-5793(91)81249-8; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUMAR A, 1986, J BIOL CHEM, V261, P1266; LUO S, 1993, SOMAT CELL MOLEC GEN, V9, P393; Mariappan SVS, 1998, J MOL BIOL, V283, P111, DOI 10.1006/jmbi.1998.1990; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; MITAS M, 1995, BIOCHEMISTRY-US, V34, P12803, DOI 10.1021/bi00039a041; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; NADEL Y, 1995, J BIOL CHEM, V270, P28970, DOI 10.1074/jbc.270.48.28970; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PATEL DJ, 1999, OXFORD HDB NUCL ACID, P389; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Sambrook J, 1989, MOL CLONING LAB MANU, VII; Sandberg G, 1997, NUCLEIC ACIDS RES, V25, P2883, DOI 10.1093/nar/25.14.2883; Sarig G, 1997, BIOCHEM BIOPH RES CO, V237, P617, DOI 10.1006/bbrc.1997.7198; Sarig G, 1997, J BIOL CHEM, V272, P4474, DOI 10.1074/jbc.272.7.4474; Shafer RH, 1998, PROG NUCLEIC ACID RE, V59, P55; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Sherman S., 1996, FRAGILE X SYNDROME D, P165; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; Smith SS, 1998, INT J MOL MED, V1, P147; Soulez M, 1996, BIOCHEM BIOPH RES CO, V219, P418, DOI 10.1006/bbrc.1996.0248; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WILLIAMS KR, 1985, P NATL ACAD SCI USA, V82, P5666, DOI 10.1073/pnas.82.17.5666	49	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2231	2238		10.1074/jbc.275.3.2231	http://dx.doi.org/10.1074/jbc.275.3.2231			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636930	hybrid			2022-12-27	WOS:000084940000093
J	Kapyla, J; Ivaska, J; Riikonen, R; Nykvist, P; Pentikainen, O; Johnson, M; Heino, J				Kapyla, J; Ivaska, J; Riikonen, R; Nykvist, P; Pentikainen, O; Johnson, M; Heino, J			Integrin alpha I-2 domain recognizes type I and type IV collagens by different mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA-2-BETA-1 VLA-2; CELL-ADHESION; A-DOMAIN; BINDING; FIBRONECTIN; SEQUENCE; SUBUNIT; SITE; INTEGRIN-ALPHA-2-BETA-1	The collagens are recognized by the alpha I domains of the collagen receptor integrins, A common structural feature in the collagen-binding alpha I domains is the presence of an extra helix, named helix alpha C. However, its participation in collagen binding has not been shown. Here, we have deleted the helix alpha C in the alpha(2)I domain and tested the function of the resultant recombinant protein (Delta alpha C alpha(2)I) by using a real-time biosensor, The Delta alpha C alpha(2)I domain had reduced affinity for type I collagen (430 +/- 90 nM) when compared with wild-type alpha(2)I domain (90 +/- 30 nM), indicating both the importance of helix alpha C in type I collagen binding and that the collagen binding surface in alpha(2)I domain is located near the metal ion-dependent adhesion site. Previous studies have suggested that the charged amino acid residues, surrounding the metal ion-dependent adhesion site but not interacting with Mg2+, may play an important role in the recognition of type I collagen, Direct evidence indicating the participation of these residues in collagen recognition has been missing. To test this idea, we produced a set of recombinant alpha(2)I domains with mutations, namely D219A, D219N, D219R, E256Q, D259N, D292N, and E299Q, Mutations in amino acids Asp(219), Asp(259), Asp(292), and Glu(299) resulted in weakened affinity for type I collagen. When alpha(2) D219N and D292N mutations were introduced separately into alpha(2)beta(1) integrin expressed on Chinese hamster ovary cells, no alterations in the cell spreading on type I collagen were detected. However, Chinese hamster ovary cells expressing double mutated alpha(2) D219N/D292N integrin showed remarkably slower spreading on type I collagen, while spreading on type TV collagen was not affected. The data indicate that alpha(2)I domain binds to type I collagen with a different mechanism than to type IV collagen.	Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40351 Jyvaskyla, Finland; Univ Turku, MediCity Res Lab, FIN-20520 Turku, Finland; Univ Turku, Dept Med Biochem, FIN-20520 Turku, Finland; Abo Akad Univ, Dept Biochem, FIN-20520 Turku, Finland	University of Jyvaskyla; University of Turku; University of Turku; Abo Akademi University; Finland National Institute for Health & Welfare	Kapyla, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, FIN-40351 Jyvaskyla, Finland.		Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Kapyla, Jarmo/0000-0003-3036-713X; Ivaska, Johanna/0000-0002-6295-6556				BERNSTEIN FC, 1977, J MOL BIOL, V233, P716; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Dickeson SK, 1998, BIOCHEMISTRY-US, V37, P11280, DOI 10.1021/bi9727848; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; GERHART J, 1997, CELLS EMBRYOS EVOLUT, P9; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HUGHES AL, 1992, MOL BIOL EVOL, V9, P216; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Ivaska J, 1999, J BIOL CHEM, V274, P3513, DOI 10.1074/jbc.274.6.3513; Johnson MS, 1996, METHOD ENZYMOL, V266, P575; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1994, J BIOL CHEM, V269, P9659; Kern A, 1998, J CELL PHYSIOL, V176, P634, DOI 10.1002/(SICI)1097-4652(199809)176:3<634::AID-JCP20>3.3.CO;2-J; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Messent AJ, 1998, J CELL SCI, V111, P1127; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Pentikainen O, 1999, J BIOL CHEM, V274, P31493, DOI 10.1074/jbc.274.44.31493; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salminen TA, 1999, ACTA CRYSTALLOGR D, V55, P1365, DOI 10.1107/S0907444999006009; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Setty S, 1998, J BIOL CHEM, V273, P12244, DOI 10.1074/jbc.273.20.12244; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735	36	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3348	3354		10.1074/jbc.275.5.3348	http://dx.doi.org/10.1074/jbc.275.5.3348			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652324	hybrid			2022-12-27	WOS:000085146500046
J	Dadgostar, H; Cheng, GH				Dadgostar, H; Cheng, GH			Membrane localization of TRAF 3 enables JNK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE; TERMINAL KINASE; SIGNALING PROTEINS; CELL-DEATH; RECEPTOR; FAMILY; STRESS; CD40; LETHALITY	Members of the tumor necrosis factor receptor family as well as other receptors achieve their diverse biological effects through the activation of intracellular signals including the c-Jun N-terminal kinase (JNK) pathway. Such signals are believed to be delivered through mediators known as TNF receptor-associated factors (TRAFs). Although the N-terminal zinc finger region of TRAFs has been shown to be essential for downstream signaling, there is no indication yet as to the nature of its role or of the factors that distinguish the N terminus of TRAF 3, which does not activate JNK in the systems examined thus far, from those of other TRAFs, which do activate this pathway. In the present study, it is shown that, among the known TRAFs, localization to the insoluble cell pellet fraction consistently correlates with JNK activation and that both characteristics map to the TRAF N terminus. Furthermore, it is demonstrated that forced localization of TRAF 3 to the cell membrane is sufficient to convert this molecule into an activator of JNK. This suggests that one of the roles of the TRAF N terminus may be to participate in interactions that promote the recruitment of TRAFs to the membrane and that this localization effect plays an important role in TRAF-mediated JNK activation.	Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Med Sci Training Program,Grad Program, Los Angeles, CA USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.				NIGMS NIH HHS [GM 08042, R01 GM 57559] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057559, T32GM008042] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Chin AID, 1999, MOL CELL BIOL, V19, P6665; Dadgostar H, 1998, J BIOL CHEM, V273, P24775, DOI 10.1074/jbc.273.38.24775; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Grammer AC, 1998, J IMMUNOL, V161, P1183; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Lee HH, 1999, P NATL ACAD SCI USA, V96, P1421, DOI 10.1073/pnas.96.4.1421; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Min W, 1998, J IMMUNOL, V161, P319; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Shi CS, 1997, J BIOL CHEM, V272, P32102, DOI 10.1074/jbc.272.51.32102; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SONG H, 1997, P NATL ACAD SCI USA, V94, P972; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681	34	36	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2539	2544		10.1074/jbc.275.4.2539	http://dx.doi.org/10.1074/jbc.275.4.2539			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644711	hybrid			2022-12-27	WOS:000085128000043
J	Lin, C; Widjaja, J; Joseph, SK				Lin, C; Widjaja, J; Joseph, SK			The interaction of calmodulin with alternatively spliced isoforms of the type-I inositol trisphosphate receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; 1,4,5-TRISPHOSPHATE RECEPTOR; BINDING DOMAIN; CA2+-INDEPENDENT INHIBITION; RAT-LIVER; PHOSPHORYLATION; CA2+; BRAIN; SEQUENCE; CALCIUM	A 592-amino acid segment of the regulatory domain of the neuronal type-I inositol 1,4,5-trisphosphate receptor (IP3R) isoform (type-I long, amino acids1314-1905) and the corresponding 552-amino acid alternatively spliced form present in peripheral tissues (type-I short, amino acids 1693-1733 deleted) were expressed as glutathione S-transferase fusion proteins. These domains encompass a putative calmodulin (CaM) binding domain and two protein kinase A phosphorylation sites. Both long and short fusion proteins retained the ability to bind CaM in a Ca2+-dependent manner as measured by CaM-Sepharose chromatography or a dansyl-CaM fluorescence assay. Both assays indicated that the short fusion protein bound twice the amount of CaM than the long form at saturating concentrations of CaM. In addition, the binding of the short form to CaM-Sepharose was inhibited by phosphorylation with protein kinase A, whereas the binding of the long form was unaffected. Full-length cDNAs encoding type-I long, type-I short, and type-III IP3R isoforms were expressed in COS cells, and the Ca2+ sensitivity of [H-3]IP, binding to permeabilized cells was measured. The type-I long isoform was more sensitive to Ca2+ inhibition (IC50 = 0.55 mu M) than the type-I short (IC50 = 5.7 mu M) Or the type-III isoform (IC50 = 3 mu M). In agreement with studies on the fusion proteins, the full-length type-I short bound more CaM-Sepharose, and this binding was inhibited to a greater extent by protein kinase A phosphorylation than the type-I long IP3R. Although type-III IP(3)Rs did not bind directly to CaM-Sepharose, hetero-oligomers of type-I/III DP,Rs retained the ability to interact with CaM. We conclude that the deletion of the SII splice site in the type-I IP3R results in the differential regulation of the alternatively spliced isoforms by Ca2+, CaM, and protein kinase A.	Thomas Jefferson Univ, Sch Med, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Joseph, SK (corresponding author), Thomas Jefferson Univ, Sch Med, Dept Pathol & Cell Biol, Romm 230A JAH,1020 Locust St, Philadelphia, PA 19107 USA.	Suresh.Joseph@mail.tju.edu			NIDDK NIH HHS [R01-DK34804] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		APEL ED, 1990, BIOCHEMISTRY-US, V29, P2330, DOI 10.1021/bi00461a017; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; Cardy TJA, 1997, BIOCHEM J, V328, P785, DOI 10.1042/bj3280785; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; FERRIS CD, 1991, BIOCHEM BIOPH RES CO, V175, P192, DOI 10.1016/S0006-291X(05)81219-7; FERRIS CD, 1992, ANNU REV PHYSIOL, V54, P469, DOI 10.1146/annurev.physiol.54.1.469; GUERRINI R, 1995, BIOCHEMISTRY-US, V34, P5120, DOI 10.1021/bi00015a024; HOFMANN F, 1994, J BIOL CHEM, V269, P24298; Islam MO, 1996, BIOCHEM J, V316, P295, DOI 10.1042/bj3160295; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; JOSEPH SK, 1984, J BIOL CHEM, V259, P3077; JOSEPH SK, 1999, METHODS CALCIUM SIGN; KINCAID RL, 1982, J BIOL CHEM, V257, P638; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; MOUREY RJ, 1990, BIOCHEM J, V272, P383, DOI 10.1042/bj2720383; Moyers JS, 1998, BIOCHEM J, V333, P609, DOI 10.1042/bj3330609; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; NUCIFORA FC, 1995, MOL BRAIN RES, V32, P291, DOI 10.1016/0169-328X(95)00089-B; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patel S, 1997, P NATL ACAD SCI USA, V94, P11627, DOI 10.1073/pnas.94.21.11627; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Sipma H, 1999, J BIOL CHEM, V274, P12157, DOI 10.1074/jbc.274.17.12157; Taylor CW, 1998, BBA-MOL CELL BIOL L, V1436, P19, DOI 10.1016/S0005-2760(98)00122-2; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; Yoneshima H, 1997, BIOCHEM J, V322, P591, DOI 10.1042/bj3220591; Zoche M, 1997, BIOL CHEM, V378, P851, DOI 10.1515/bchm.1997.378.8.851; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	49	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2305	2311		10.1074/jbc.275.4.2305	http://dx.doi.org/10.1074/jbc.275.4.2305			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644679	hybrid			2022-12-27	WOS:000085128000011
J	Nemes, Z; Demeny, M; Marekov, LN; Fesus, L; Steiner, PM				Nemes, Z; Demeny, M; Marekov, LN; Fesus, L; Steiner, PM			Cholesterol 3-sulfate interferes with cornified envelope assembly by diverting transglutaminase 1 activity from the formation of cross-links and esters to the hydrolysis of glutamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN STRATUM-CORNEUM; PROTEIN-KINASE-C; CELL-ENVELOPE; KERATINOCYTE TRANSGLUTAMINASE; LAMELLAR ICHTHYOSIS; SUBSTRATE PROPERTIES; STRUCTURAL PROTEINS; ETA-ISOFORM; SULFATE; GENE	The loss of transglutaminase 1 enzyme (TGase 1) activity causes lamellar ichthyosis, Recessive X-linked ichthyosis (XI) results from accumulation of excess cholesterol 3-sulfate (CSO4) in the epidermis but the pathomechanism how elevated epidermal CSO4 causes ichthyosis is largely unknown. Here we provide evidence that III is also a consequence of TGase 1 dysfunction. TGase 1 is a key component of barrier formation in keratinocytes: it participates in the cross-linking of cell envelope (CE) structural proteins, and also forms the lipid bound envelope by esterification of long chain omega-hydroxyceramides onto CE proteins. Using involucrin and an epidermal omega-hydroxyceramide analog as substrates, kinetic analyses revealed that at membrane concentrations above 4 mol %, CSO4 caused a marked and dose-dependent inhibitory effect on isopeptide and ester bond formation. Sequencing of tryptic peptides from TGase 1-reacted involucrin showed a large increase in deamidation of substrate glutamines. me hypothesize that supraphysiological levels of CSO4 in keratinocyte membranes distort the structure of TGase 1 and faoilitate the access of water into its active site causing hydrolysis of substrate glutamine residues. Our findings provide further evidence for the pivotal role of the TGase 1 enzyme in CE formation.	NIAMSD, Skin Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Debrecen, Sch Med, Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Debrecen	Steiner, PM (corresponding author), NIAMS, NIH, Bldg 6,Rm 425, Bethesda, MD 20892 USA.	pemast@helix.nih.gov						Aeschlimann D, 1998, J BIOL CHEM, V273, P3452, DOI 10.1074/jbc.273.6.3452; ANTONLAMPRECHT I, 1992, DIAGNOSTIC ULTRASTRU, P00459; Candi E, 1998, J BIOL CHEM, V273, P13693, DOI 10.1074/jbc.273.22.13693; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; CHIDA K, 1995, CANCER RES, V55, P4865; DeLaurenzi V, 1996, NAT GENET, V12, P52; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; ELIAS PM, 1984, J CLIN INVEST, V74, P1414, DOI 10.1172/JCI111552; EPSTEIN EH, 1984, J AM ACAD DERMATOL, V10, P866, DOI 10.1016/S0190-9622(84)80144-9; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109; GREEN H, 1992, MOL BIOL EVOL, V9, P977; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; GROSS M, 1974, J BIOL CHEM, V249, P3021; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; IKUTA T, 1994, CELL GROWTH DIFFER, V5, P943; Ishida-Yamamoto A, 1998, EXP DERMATOL, V7, P1, DOI 10.1111/j.1600-0625.1998.tb00295.x; Jarnik M, 1998, J CELL SCI, V111, P1051; Kawabe S, 1998, J INVEST DERMATOL, V111, P1098, DOI 10.1046/j.1523-1747.1998.00441.x; KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254; LaCelle PT, 1998, SKIN PHARMACOL APPL, V11, P214, DOI 10.1159/000029830; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LONG SA, 1985, ARCH DERMATOL RES, V277, P284, DOI 10.1007/BF00509081; LYKKESFELDT G, 1983, LANCET, V2, P1336, DOI 10.1016/S0140-6736(83)91093-0; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Nemes Z, 1999, J BIOL CHEM, V274, P11013, DOI 10.1074/jbc.274.16.11013; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; PARAMESWARAN KN, 1981, BIOCHEMISTRY-US, V20, P3703, DOI 10.1021/bi00516a006; Parameswaran KN, 1997, J BIOL CHEM, V272, P10311; POLAKOWSKA RR, 1992, P NATL ACAD SCI USA, V89, P4476, DOI 10.1073/pnas.89.10.4476; RANASINGHE AW, 1986, J INVEST DERMATOL, V86, P187, DOI 10.1111/1523-1747.ep12284246; REHFELD SJ, 1988, J INVEST DERMATOL, V91, P499, DOI 10.1111/1523-1747.ep12476654; REHFELD SJ, 1986, ARCH DERMATOL RES, V278, P259, DOI 10.1007/BF00407734; Rice R.H., 1994, KERATINOCYTE HDB, P259; RICE RH, 1990, BIOCHEM J, V265, P351, DOI 10.1042/bj2650351; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sato J, 1998, J INVEST DERMATOL, V111, P189, DOI 10.1046/j.1523-1747.1998.00244.x; SHAPIRO LJ, 1978, LANCET, V2, P756; Steinberg D., 1978, METABOLIC BASIS INHE, P688; Steinert PM, 1996, J BIOL CHEM, V271, P26242, DOI 10.1074/jbc.271.42.26242; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; Tarcsa E, 1998, J BIOL CHEM, V273, P23297, DOI 10.1074/jbc.273.36.23297; TARCSA E, 1990, ANAL BIOCHEM, V186, P135, DOI 10.1016/0003-2697(90)90586-X; Wertz P W, 1997, EXS, V78, P227; Wertz P. W., 1991, PHYSL BIOCH MOL BIOL, V1, P205; WILLIAMS ML, 1992, SEMIN DERMATOL, V11, P169; WILLIAMS ML, 1991, ADV LIPID RES, V24, P211; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Zettersten E, 1998, J INVEST DERMATOL, V111, P784, DOI 10.1046/j.1523-1747.1998.00386.x	55	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2636	2646		10.1074/jbc.275.4.2636	http://dx.doi.org/10.1074/jbc.275.4.2636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644724	Green Submitted, hybrid			2022-12-27	WOS:000085128000056
J	Rohr, O; Schwartz, C; Hery, C; Aunis, D; Tardieu, M; Schaeffer, E				Rohr, O; Schwartz, C; Hery, C; Aunis, D; Tardieu, M; Schaeffer, E			The nuclear receptor chicken ovalbumin upstream promoter transcription factor interacts with HIV-1 Tat and stimulates viral replication in human microglial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; HUMAN BRAIN-CELLS; GENE-EXPRESSION; TYPE-1 TAT; IN-VITRO; INDEPENDENT ACTIVATION; HORMONE RECEPTOR	Human immunodeficiency virus type 1 (HIV-1) infects the central nervous system and plays a direct role in the pathogenesis of AIDS dementia. However, the molecular mechanisms underlying HIV-1 expression in the central nervous system are poorly understood. We have recently reported that the nuclear receptor chicken ovalbumin upstream promoter transcription factor (COUP-TF), an orphan member of the nuclear receptor superfamily, is an activator of HIV-1 gene transcription. Here, our results show that COUP-TF stimulates HIV-1 transcription in primary cultured human microglial cells, the primary target for HIV-1 infection in brain. Run-on assays indicated that COUP-TF acts on the initiation step of transcription. Results from reverse transcription-polymerase chain reaction and immunocytochemistry analysis further revealed the importance of this factor by demonstrating that overexpression of COUP-TF leads to initiation of viral replication in primary HIV-infected human microglia, In addition, COUP-TF is able to physically interact and cooperate with the viral transactivator Tat, The combination of COUP-TF and Tat leads to NF-kappa B- and Sp1-independent enhanced transcriptional stimulation. In vitro binding studies showed that COUP-TF interacts with Tat through amino acids within the N-terminal DNA-binding domain of COUP-TF. Amino acids 48-72 in the basic and C-terminal regions of Tat are required for the binding of Tat to COUP-TF, These results suggest that COUP-TF is an essential transcription factor involved in HIV-1 expression in microglia and reveal a novel interplay of Tat and COUP-TF during regulation of viral expression.	U338 INSERM, F-67084 Strasbourg, France; Fac Med Paris Sud, Lab Virus Neurone & Immunite, CRI 9612, F-94276 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Schaeffer, E (corresponding author), Gladstone Inst Virol & Immunol, POB 419100, San Francisco, CA 94141 USA.		Dominique, Aunis/W-1419-2019	ROHR, Olivier/0000-0001-8992-2025				ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; CAMPIONI D, 1995, AIDS RES HUM RETROV, V11, P1039, DOI 10.1089/aid.1995.11.1039; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; DESAIYAJNIK V, 1995, J VIROL, V69, P5103, DOI 10.1128/JVI.69.8.5103-5112.1995; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; DUAN LX, 1994, J VIROL, V68, P4302, DOI 10.1128/JVI.68.7.4302-4313.1994; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; GARCIA JA, 1994, PROG NUCLEIC ACID RE, V49, P157; GAYNOR RB, 1995, CURR TOP MICROBIOL, V193, P51; Ghorpade A, 1998, J VIROL, V72, P3340, DOI 10.1128/JVI.72.4.3340-3350.1998; HARRICH D, 1990, EMBO J, V9, P4417, DOI 10.1002/j.1460-2075.1990.tb07892.x; HATCH WC, 1994, AIDS RES HUM RETROV, V10, P1597, DOI 10.1089/aid.1994.10.1597; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; ING NH, 1992, J BIOL CHEM, V267, P17617; Janabi N, 1998, GLIA, V23, P304; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; JEANG KT, 1993, J VIROL, V67, P6224, DOI 10.1128/JVI.67.10.6224-6233.1993; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KAMINE J, 1992, J VIROL, V66, P3932, DOI 10.1128/JVI.66.6.3932-3936.1992; Kashanchi F, 1996, J VIROL, V70, P5503, DOI 10.1128/JVI.70.8.5503-5510.1996; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; LIU JS, 1992, J VIROL, V66, P3883, DOI 10.1128/JVI.66.6.3883-3887.1992; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; NUOVO GJ, 1994, AM J PATHOL, V144, P659; Parada CA, 1996, NATURE, V384, P375, DOI 10.1038/384375a0; PARROTT C, 1991, J VIROL, V65, P1414, DOI 10.1128/JVI.65.3.1414-1419.1991; PERRY VH, 1994, J LEUKOCYTE BIOL, V56, P399, DOI 10.1002/jlb.56.3.399; PEUDENIER S, 1991, ANN NEUROL, V29, P152, DOI 10.1002/ana.410290207; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; RHIM H, 1994, J ACQ IMMUN DEF SYND, V7, P1116; Rohr O, 1999, J CELL BIOCHEM, V75, P404, DOI 10.1002/(SICI)1097-4644(19991201)75:3<404::AID-JCB6>3.0.CO;2-G; Rohr O, 1997, J BIOL CHEM, V272, P31149, DOI 10.1074/jbc.272.49.31149; Sawaya BE, 1996, J BIOL CHEM, V271, P22895, DOI 10.1074/jbc.271.37.22895; Sawaya BE, 1996, J BIOL CHEM, V271, P23572, DOI 10.1074/jbc.271.38.23572; Strizki JM, 1996, J VIROL, V70, P7654, DOI 10.1128/JVI.70.11.7654-7662.1996; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; SUNE C, 1995, J VIROL, V69, P6572; TAYLOR JP, 1992, EMBO J, V11, P3395, DOI 10.1002/j.1460-2075.1992.tb05418.x; TAYLOR JP, 1994, ADV NEUROIMMUNOL, V4, P291, DOI 10.1016/S0960-5428(06)80270-6; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WATKINS BA, 1990, SCIENCE, V249, P549, DOI 10.1126/science.2200125; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089	46	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2654	2660		10.1074/jbc.275.4.2654	http://dx.doi.org/10.1074/jbc.275.4.2654			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644726	Green Published, hybrid			2022-12-27	WOS:000085128000058
J	Saves, I; Ozanne, V; Dietrich, J; Masson, JM				Saves, I; Ozanne, V; Dietrich, J; Masson, JM			Inteins of Thermococcus fumicolans DNA polymerase are endonucleases with distinct enzymatic behaviors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PI-SCEI; ADENOSINE-TRIPHOSPHATASE; GENE; SEQUENCES; CLEAVAGE; MUTATION; DOMAINS; BINDING; SUBUNIT	The DNA polymerase gene of Thermococcus fumicolans harbors two intein genes. Both inteins have been produced in Escherichia coli and purified either as naturally spliced products from the expression of the complete DNA polymerase gene or directly from the cloned inteins genes. Both recombinant inteins exhibit endonuclease activity, with an optimal temperature of 70 degrees C. The Tfu pol-1 intein, which belongs to the Psp KOD pol-1 allelic family, recognizes and cleaves a minimal sequence of 16 base pairs (bp) on supercoiled DNA with either Mn2+ or Mg2+ as cofactor. It cleaves linear DNA only with Mn2+ and requires a 19-bp minimal recognition sequence. The Tfu pol-2 intein, which belongs to the Tli pol-2 allelic family, is a highly active homing endonuclease using Mg2+ as cofactor. Its minimal recognition and cleavage site is 21 bp long either on linear or circular DNA substrate. Its endonuclease activity is strongly inhibited by the 3' digestion product, which remains bound to the enzyme after the cleavage reaction. According to current nomenclature, these endonucleases were named PI-TfuI and PI-TfuII. These two inteins thus exhibit different requirements for metal cofactor and substrate topology as well as different mechanism of action.	CNRS, Inst Pharmacol & Biol Struct, IPBS, F-31077 Toulouse, France; Appligene Oncor, F-67402 Illkirch Graffenstaden, France; IFREMER, Ctr Brest, Biotechnol Lab, F-29280 Plouzane, France; Complexe Sci Rangueil, Inst Natl Sci Appl, F-31077 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse	Masson, JM (corresponding author), Valigene, Tour Neptune, F-92086 Paris, France.	masson@ipbs.fr						BELFORT M, 1995, J BACTERIOL, V177, P3897, DOI 10.1128/jb.177.14.3897-3903.1995; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; Gimble FS, 1996, J MOL BIOL, V263, P163, DOI 10.1006/jmbi.1996.0567; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; Godfroy A, 1996, INT J SYST BACTERIOL, V46, P1113, DOI 10.1099/00207713-46-4-1113; He ZN, 1998, J BIOL CHEM, V273, P4607, DOI 10.1074/jbc.273.8.4607; HIRATA R, 1990, J BIOL CHEM, V265, P6726; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; MUELLER JE, 1993, NUCLEASES, P111; Nishioka M, 1998, NUCLEIC ACIDS RES, V26, P4409, DOI 10.1093/nar/26.19.4409; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; PERLER FB, 1992, P NATL ACAD SCI USA, V89, P5577, DOI 10.1073/pnas.89.12.5577; Pietrokovski S, 1998, CURR BIOL, V8, pR634, DOI 10.1016/S0960-9822(07)00409-5; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shao Y, 1997, CHEM BIOL, V4, P187, DOI 10.1016/S1074-5521(97)90287-8; Vipond IB, 1996, BIOCHEMISTRY-US, V35, P1701, DOI 10.1021/bi952391d; Vipond IB, 1996, BIOCHEMISTRY-US, V35, P1712, DOI 10.1021/bi9523926; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Wende W, 1996, NUCLEIC ACIDS RES, V24, P4123, DOI 10.1093/nar/24.21.4123; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6; XU MQ, 1994, EMBO J, V13, P5517, DOI 10.1002/j.1460-2075.1994.tb06888.x; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	24	19	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2335	2341		10.1074/jbc.275.4.2335	http://dx.doi.org/10.1074/jbc.275.4.2335			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644683	hybrid			2022-12-27	WOS:000085128000015
J	Schulz, A; Grosse, R; Schultz, G; Gudermann, T; Schoneberg, T				Schulz, A; Grosse, R; Schultz, G; Gudermann, T; Schoneberg, T			Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; HORMONE RECEPTOR; MOLECULAR-BASIS; CELL-SURFACE; COEXPRESSION; RHODOPSIN; CYSTEINES; DIMERIZATION	Previous studies have established that G-protein-coupled receptors (GPCRs) are composed of independent folding domains. Based on this findings we attempted to rescue the function of clinically relevant missense mutations (R137H, S167L, and R181C) within the N-terminal domain of the V2 vasopressin receptor (V2-R), by coexpressing mutated full-length (Y280C) and C-terminally truncated (E242X) receptor constructs in COS-7 cells. Coimmunoprecipitation and enzyme-linked immunosorbent assay studies demonstrated a specific association of E242X with full-length V2 Rs even in the presence of missense mutations. Systematic analysis of the structural requirements for the observed receptor/fragment association showed that N-terminal fragments containing at least transmembrane regions 1-3 interact with the full-length V2-R. Despite this specific interaction, no functional reconstitution was achieved for mutant V2-Rs following coexpression with E242X and Y280C, However, functional activity of R137H and R181C upon coexpression with E242X was regained by mutational disruption of the extracellular disulfide bond, which is highly conserved among GPCRs. OUT data with the V2-R are consistent with a structural model in which class I GPCRs form contact oligomers by lateral interaction rather than by a domain-swapping mechanism.	Free Univ Berlin, Inst Pharmakol, Klinikum Benjamin Franklin, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schoneberg, T (corresponding author), Free Univ Berlin, Inst Pharmakol, Thielallee 69-73, D-14195 Berlin, Germany.	schoberg@zedat.fu-berlin.de	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Grosse, Robert/0000-0002-3380-5273				Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Cook JVF, 1996, ENDOCRINOLOGY, V137, P2851, DOI 10.1210/en.137.7.2851; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Gouldson PR, 1998, PROTEIN ENG, V11, P1181, DOI 10.1093/protein/11.12.1181; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; HEBERT TE, 1996, J BIOL CHEM, V271, P18384; Higuchi R., 1989, PCR TECHNOLOGY, P61; HITT M, 1995, VIRAL GENE TECHNIQUE, P13; Jakubik J, 1999, J BIOL CHEM, V274, P1349, DOI 10.1074/jbc.274.3.1349; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KOSUGI S, 1992, BIOCHEM BIOPH RES CO, V189, P1754, DOI 10.1016/0006-291X(92)90281-O; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; Marchese A, 1999, TRENDS PHARMACOL SCI, V20, P370, DOI 10.1016/S0165-6147(99)01366-8; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; PERLMAN JH, 1995, J BIOL CHEM, V270, P24682, DOI 10.1074/jbc.270.42.24682; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Sadeghi HM, 1997, MOL ENDOCRINOL, V11, P706, DOI 10.1210/me.11.6.706; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SAVARESE TM, 1992, J BIOL CHEM, V267, P11439; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schoneberg T, 1996, EMBO J, V15, P1283, DOI 10.1002/j.1460-2075.1996.tb00470.x; Schoneberg T, 1997, J CLIN INVEST, V100, P1547, DOI 10.1172/JCI119678; Schulein R, 1996, J BIOL CHEM, V271, P28844, DOI 10.1074/jbc.271.46.28844; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; Ward DT, 1998, J BIOL CHEM, V273, P14476, DOI 10.1074/jbc.273.23.14476; Wenkert D, 1996, MOL CELL ENDOCRINOL, V124, P43, DOI 10.1016/S0303-7207(96)03926-3; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng FY, 1999, J NEUROCHEM, V72, P2404, DOI 10.1046/j.1471-4159.1999.0722404.x; Zhu XY, 1998, BIOCHEMISTRY-US, V37, P15773, DOI 10.1021/bi981162z	40	80	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2381	2389		10.1074/jbc.275.4.2381	http://dx.doi.org/10.1074/jbc.275.4.2381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644689	hybrid			2022-12-27	WOS:000085128000021
J	Vetter, SW; Keng, YF; Lawrence, DS; Zhang, ZY				Vetter, SW; Keng, YF; Lawrence, DS; Zhang, ZY			Assessment of protein-tyrosine phosphatase 1B substrate specificity using "inverse alanine scanning"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE COMBINATORIAL LIBRARIES; PHOSPHOTYROSINE; RECOGNITION	An "inverse alanine scanning" peptide library approach has been developed to assess the substrate specificity of protein-tyrosine phosphatases (PTPases). In this method each Ala moiety in the parent peptide, Ac-AAAApYAAAA-NH2, is separately and sequentially replaced by the 19 non-Ala amino acids to generate a library of 158 well defined peptides. The relatively small number of peptides allows the acquisition of explicit kinetic data for all library members, thereby furnishing information about the contribution of individual amino acids with respect to substrate properties. The approach was applied to protein-tyrosine phosphatase 1B (PTP1B) as a first example, and the highly potent peptide substrate Ac-ELEFpYMDYE-NH2 (k(cat)/K-m 2.2 +/- 0.05 x 10(7) m(-1) s(-1)) has been identified. More importantly, several heretofore unknown features of the sub strate specificity of PTP1B were revealed. This includes the ability of PTP1B to accommodate acidic, aromatic, and hydrophobic residues at the -1 position, a strong nonpreference for Lys and Arg residues in any position, and the first evidence that residues well beyond the +1 position contribute to substrate efficacy.	Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Lawrence, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.	dlawrenc@aecom.yu.edu; zyzhang@aecom.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055242] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55242] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boutin JA, 1997, MOL DIVERS, V3, P43, DOI 10.1023/A:1009602707067; Chen CL, 1996, METHOD ENZYMOL, V267, P211; Cheung YW, 1997, J AM CHEM SOC, V119, P9568, DOI 10.1021/ja971825k; CHO HJ, 1991, BIOCHEMISTRY-US, V30, P6210, DOI 10.1021/bi00239a019; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; HIPPEN KL, 1993, BIOCHEMISTRY-US, V32, P12405, DOI 10.1021/bi00097a019; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Huyer G, 1998, ANAL BIOCHEM, V258, P19, DOI 10.1006/abio.1997.2541; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Montigiani S, 1996, J MOL BIOL, V258, P6, DOI 10.1006/jmbi.1996.0229; Montserat J, 1996, J BIOL CHEM, V271, P7868, DOI 10.1074/jbc.271.13.7868; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Pellegrini MC, 1998, BIOCHEMISTRY-US, V37, P15598, DOI 10.1021/bi981427+; PINILLA C, 1995, BIOPOLYMERS, V37, P221, DOI 10.1002/bip.360370306; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; RUZZENE M, 1993, EUR J BIOCHEM, V211, P289, DOI 10.1111/j.1432-1033.1993.tb19897.x; Wu L, 1997, J BIOL CHEM, V272, P6994, DOI 10.1074/jbc.272.11.6994; ZHANG ZY, 1995, J BIOL CHEM, V270, P16052; ZHANG ZY, 1993, P NATL ACAD SCI USA, V90, P4446, DOI 10.1073/pnas.90.10.4446; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhang ZY, 1998, CRIT REV BIOCHEM MOL, V33, P1, DOI 10.1080/10409239891204161; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	24	66	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2265	2268		10.1074/jbc.275.4.2265	http://dx.doi.org/10.1074/jbc.275.4.2265			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644673	hybrid			2022-12-27	WOS:000085128000005
J	Baoutina, A; Dean, RT; Jessup, W				Baoutina, A; Dean, RT; Jessup, W			Macrophages can decrease the level of cholesteryl ester hydroperoxides in low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN-DIPLOID FIBROBLASTS; HORMONE-SENSITIVE LIPASE; ALPHA-TOCOPHEROL; LIPID HYDROPEROXIDES; PHOSPHOLIPID HYDROPEROXIDE; MEDIATED OXIDATION; PEROXIDATION; COPPER; LDL	Murine and human macrophages rapidly decreased the level of cholesteryl ester hydroperoxides in low density lipoprotein (LDL) when cultured in media non-permissive for LDL oxidation. This process was proportional to cell number but could not be attributed to the net lipoprotein uptake. Macrophage-mediated loss of lipid hydroperoxides in LDL appears to be metal ion-independent. Degradation of cholesteryl linoleate hydroperoxides was accompanied by accumulation of the corresponding hydroxide as the major product and cholesteryl keto-octadecadienoate as a minor product, although taken together these products could not completely account for the hydroperoxide consumption. Cell-conditioned medium possessed a similar capacity to remove lipid hydroperoxides as seen with cellular monolayers, suggesting that the activity is not an integral component of the cell but is secreted from it. The activity of cell-conditioned medium to lower the level of LDL lipid hydroperoxides is associated with its high molecular weight fraction and is modulated by the availability of free thiol groups. Cell-mediated loss of LDL cholesteryl ester hydroperoxides is facilitated by the presence of alpha-tocopherol in the lipoprotein. Together with our earlier reports on the ability of macrophages to remove peroxides rapidly from oxidized amino acids, peptides, and proteins as well as to clear selectively cholesterol 7-beta-hydroperoxide, results presented in this paper provide evidence of a potential protective activity of the cell against further LDL oxidation by removing reactive peroxide groups in the lipoprotein.	Heart Res Inst, Cell Biol Grp, Camperdown, NSW 2050, Australia	University of Sydney; Heart Research Institute	Baoutina, A (corresponding author), Heart Res Inst, Cell Biol Grp, 145 Missenden Rd, Camperdown, NSW 2050, Australia.	a.baoutina@hri.org.au		Dean, Roger Thornton/0000-0002-8859-8902				BANNAI S, 1980, J CELL PHYSIOL, V104, P215, DOI 10.1002/jcp.1041040211; BANNAI S, 1982, J CELL PHYSIOL, V112, P265, DOI 10.1002/jcp.1041120216; Bao Y, 1997, REDOX REP, V3, P325, DOI 10.1080/13510002.1997.11747130; Baoutina A, 1998, J LIPID RES, V39, P114; Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; BROOKS CJW, 1971, ATHEROSCLEROSIS, V13, P223, DOI 10.1016/0021-9150(71)90025-6; CONTRERAS JA, 1994, ARTERIOSCLER THROMB, V14, P443, DOI 10.1161/01.ATV.14.3.443; Creighton Thomas E., 1992, P301; DEGRAY JA, 1995, BIOTHIOLS HLTH DIS, P65; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; ESTERBAUER H, 1991, AM J CLIN NUTR, V53, pS314, DOI 10.1093/ajcn/53.1.314S; Follmann H, 1995, BIOFACTORS, V5, P147; FU SL, 1995, BIOCHEM J, V311, P821, DOI 10.1042/bj3110821; Garner B, 1997, J BIOL CHEM, V272, P6927, DOI 10.1074/jbc.272.11.6927; GARNER B, 1994, BIOCHEM J, V301, P421, DOI 10.1042/bj3010421; Garner B, 1996, REDOX REP, V2, P97, DOI 10.1080/13510002.1996.11747035; GROSCH W, 1976, Z LEBENSM UNTERS FOR, V160, P371, DOI 10.1007/BF01106327; Hazell LJ, 1997, FEBS LETT, V414, P541, DOI 10.1016/S0014-5793(97)01066-1; Hurst R, 1999, BIOCHEM J, V338, P723, DOI 10.1042/0264-6021:3380723; IWATSUKI M, 1995, FEBS LETT, V360, P271, DOI 10.1016/0014-5793(95)00122-P; JESSUP W, 1990, BIOCHEM J, V265, P399, DOI 10.1042/bj2650399; JOKAY I, 1988, IMMUNOL LETT, V17, P217, DOI 10.1016/0165-2478(88)90032-6; KHOO JC, 1993, J LIPID RES, V34, P1969; KNIGHT BL, 1982, BIOCHEM J, V202, P145, DOI 10.1042/bj2020145; KOHAR I, 1995, FREE RADICAL BIO MED, V19, P197, DOI 10.1016/0891-5849(95)00010-U; KRITHARIDES L, 1993, ANAL BIOCHEM, V213, P79, DOI 10.1006/abio.1993.1389; KRITHARIDES L, 1995, ARCH BIOCHEM BIOPHYS, V323, P127, DOI 10.1006/abbi.1995.0018; Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666; MAIORINO M, 1995, BIOTHIOLS HLTH DIS, P265; Mashima R, 1999, BIOCHEM BIOPH RES CO, V259, P185, DOI 10.1006/bbrc.1999.0739; Neuzil J, 1997, FREE RADICAL BIO MED, V22, P57, DOI 10.1016/S0891-5849(96)00224-9; Niu XW, 1999, ARTERIOSCL THROM VAS, V19, P1708, DOI 10.1161/01.ATV.19.7.1708; NOGUCHI N, 1994, BBA-LIPID LIPID MET, V1213, P176, DOI 10.1016/0005-2760(94)90024-8; OLEARY VJ, 1992, BIOCHEM J, V282, P631, DOI 10.1042/bj2820631; SATTLER W, 1993, BIOCHEM J, V294, P771, DOI 10.1042/bj2940771; SATTLER W, 1994, ARCH BIOCHEM BIOPHYS, V309, P214, DOI 10.1006/abbi.1994.1105; SATTLER W, 1995, FREE RADICAL BIO MED, V18, P421, DOI 10.1016/0891-5849(94)00170-O; SATTLER W, 1994, METHOD ENZYMOL, V233, P469; Smalley DM, 1997, ARTERIOSCL THROM VAS, V17, P3469, DOI 10.1161/01.ATV.17.12.3469; SPARROW CP, 1993, J LIPID RES, V34, P1219; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1990, FREE RADICAL BIO MED, V9, P155, DOI 10.1016/0891-5849(90)90119-4; SUARNA C, 1995, ARTERIOSCL THROM VAS, V15, P1616, DOI 10.1161/01.ATV.15.10.1616; SUZUKAWA M, 1994, ATHEROSCLEROSIS, V110, P77, DOI 10.1016/0021-9150(94)90070-1; THOMAS CE, 1991, J PHARMACOL EXP THER, V256, P1182; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; van Reyk DM, 1999, ARTERIOSCL THROM VAS, V19, P1119, DOI 10.1161/01.ATV.19.4.1119; VANREYK DM, 1995, FREE RADICAL RES, V23, P533, DOI 10.3109/10715769509065274; Witting PK, 1999, METHOD ENZYMOL, V299, P362; Wollman EE, 1997, BIOCHEM BIOPH RES CO, V230, P602, DOI 10.1006/bbrc.1996.6015; YAMAMOTO Y, 1987, ANAL BIOCHEM, V160, P7, DOI 10.1016/0003-2697(87)90606-3	52	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1635	1644		10.1074/jbc.275.3.1635	http://dx.doi.org/10.1074/jbc.275.3.1635			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636856	hybrid			2022-12-27	WOS:000084940000019
J	Bourguignon, LYW; Zhu, HB; Shao, LJ; Chen, YW				Bourguignon, LYW; Zhu, HB; Shao, LJ; Chen, YW			CD44 interaction with Tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HOMING RECEPTOR CD44; MEMBRANE-CYTOSKELETON INTERACTION; PLECKSTRIN HOMOLOGY DOMAIN; ANKYRIN-BINDING DOMAIN; DBL ONCOGENE PRODUCT; ACTIN STRESS FIBERS; PROTEIN-KINASE-C; GROWTH-FACTOR; EPITHELIAL-CELLS	In this study we have explored the interaction between CD44 (the hyaluronic acid (HA)-binding receptor) and Tiam1 (a guanine nucleotide exchange factor) in metastatic breast tumor cells (SP1 cell line). Immunoprecipitation and immunoblot analyses indicate that both the CD44v3 isoform and the Tiam1 protein are expressed in SP1 cells and that these two proteins are physically associated as a complex in vivo. Using an Escherichia coli-derived calmodulin-binding peptide-tagged Tiam1 fragment (i.e. the NH2-terminal pleckstrin homology (PHn) domain and an adjacent protein interaction domain designated as PHn-CC-Ex, amino acids 393-738 of Tiam1) and an in vitro binding assay, we have detected a specific binding interaction between the Tiam1 PHn-CC-Ex domain and CD44. Scatchard plot analysis indicates that there is a single high affinity CD44 binding site in the PHn-CC-Ex domain of Tiam1 with an apparent dissociation constant (K-d) Of 0.2 nM, which is comparable with CD44 binding (K-d = similar to 0.13 nM) to intact Tiam1, These findings suggest that the PHn-CC-Ex domain is the primary Tiam1-binding region for CD44, Most importantly, the binding of HA to CD44v3 of SP1 cells stimulates Tiam1-catalyzed Rad signaling and cytoskeleton-mediated tumor cell migration. Transfection of SP1 cells with Tiam1cDNA promotes Tiam1 association with CD44v3 and up-regulates Rad signaling as well as HA/CD44v3-mediated breast tumor cell migration. Co-transfection of SP1 cells with PHn-CC-Ex cDNA and Tiam1 cDNA effectively inhibits Tiam1 association with CD44 and efficiently blocks tumor behaviors. Taken together, we believe that the linkage between CD44v3 isoform and the PHn-CC-EX domain of Tiam1 is required for HA stimulated Rad signaling and cytoskeleton-mediated tumor cell migration during breast cancer progression.	Univ Miami, Sch Med, Dept Anat & Cell Biol, Miami, FL 33136 USA	University of Miami	Bourguignon, LYW (corresponding author), Univ Miami, Sch Med, Dept Anat & Cell Biol, 1600 NW 10th Ave, Miami, FL 33136 USA.				NCI NIH HHS [CA66163, CA 78633] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Bourguignon L. Y. W., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P196; Bourguignon LYW, 1999, CELL MOTIL CYTOSKEL, V43, P269, DOI 10.1002/(SICI)1097-0169(1999)43:4<269::AID-CM1>3.0.CO;2-5; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Bourguignon LYW, 1996, CURR TOP MEMBR, V43, P293; BOURGUIGNON LYW, 1992, MOL CELL BIOL, V12, P4464, DOI 10.1128/MCB.12.10.4464; Bourguignon LYW, 1995, J NEURO-ONCOL, V26, P201, DOI 10.1007/BF01052623; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; BOURGUIGNON LYW, 1998, FRONT BIOSCI, V3, P637; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DALL P, 1995, INT J CANCER, V60, P471, DOI 10.1002/ijc.2910600408; DICKSON RB, 1995, MOL BASIS CANC, P358; ELLIOTT BE, 1988, CANCER RES, V48, P7237; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HABETS GGM, 1995, ONCOGENE, V10, P1371; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1994, J BIOL CHEM, V269, P62; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HIRAO M, 1996, J CELL BIOL, V135, P36; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; HORST E, 1990, LEUKEMIA, V4, P595; IIDA N, 1995, J CELL PHYSIOL, V162, P127, DOI 10.1002/jcp.1041620115; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; JALKANEN S, 1991, J CLIN INVEST, V87, P1835, DOI 10.1172/JCI115205; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; JIANG WG, 1994, BRIT J SURG, V81, P1576, DOI 10.1002/bjs.1800811107; JOHNSTON CL, 1995, BIOCHEM J, V306, P609, DOI 10.1042/bj3060609; KALISH ED, 1999, FRONT BIOSCI, V4, P1; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; LIAO HX, 1995, J IMMUNOL, V155, P3938; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MUELLER SC, 1991, J CELL SCI, V99, P213; NISHIYAMA T, 1994, MOL CELL BIOL, V14, P2447, DOI 10.1128/MCB.14.4.2447; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; PICKER LJ, 1989, J CELL BIOL, V109, P927, DOI 10.1083/jcb.109.2.927; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P102, DOI 10.1016/S0968-0004(00)88973-2; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; RODRIGUEZ C, 1995, INT J CANCER, V64, P347, DOI 10.1002/ijc.2910640512; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sinn Hans-Peter, 1995, Breast Cancer Research and Treatment, V36, P307, DOI 10.1007/BF00713402; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; UNDERHILL CB, 1987, J BIOL CHEM, V262, P13142; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; ZHANG Y, 1995, METHOD ENZYMOL, V256, P77; Zhu D, 1996, ONCOGENE, V12, P2309; Zhu D, 1998, CELL MOTIL CYTOSKEL, V39, P209, DOI 10.1002/(SICI)1097-0169(1998)39:3<209::AID-CM4>3.0.CO;2-#	68	244	267	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1829	1838		10.1074/jbc.275.3.1829	http://dx.doi.org/10.1074/jbc.275.3.1829			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636882	hybrid			2022-12-27	WOS:000084940000045
J	Kim, YS; Han, SJ; Ryu, JH; Choi, KH; Hong, YS; Chung, YH; Perrot, S; Raibaud, A; Brey, PT; Lee, WJ				Kim, YS; Han, SJ; Ryu, JH; Choi, KH; Hong, YS; Chung, YH; Perrot, S; Raibaud, A; Brey, PT; Lee, WJ			Lipopolysaccharide-activated kinase, an essential component for the induction of the antimicrobial peptide genes in Drosophila melanogaster cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMMUNE-RESPONSE; INSECT IMMUNITY; EMBRYONIC POLARITY; INNATE IMMUNITY; PROTEIN-KINASE; REL PROTEINS; DORSAL; PHOSPHORYLATION; ALPHA	Eukaryotic organisms use a similar Rel/NF-kappa B signaling cascade for the induction of innate immune genes. In Drosophila, lipopolysaccharide (LPS) signal-induced activation of the Rel/NF-kappa B family transcription factors is an essential step in the transcriptional activation of inducible antimicrobial peptide genes. However, the mechanism by which the LPS-induced signaling pathway proceeds remains largely unknown. Here we have cloned a novel Drosophila LPS-activated kinase (DLAK) that is structurally related to mammalian I kappa B kinases, DLAK is expressed and transiently activated in LPS-responsive Drosophila cells following LPS stimulation. Furthermore, DLAK can interact with Cactus, a Drosophila I kappa B and phosphorylate recombinant Cactus, in vitro. Overexpression of dominant-negative mutant DLAK (DLAK(K50A)) blocks LPS induced Cactus degradation. DLAK-bound Cactus can be degraded in a LPS signal-dependent fashion, whereas the DLAK(K50A) mutant-bound Cactus is completely resistant to degradation in the presence of LPS, The DLAK(K50A) mutant also inhibits nuclear kappa B binding activity and kappa B-dependent diptericin reporter gene activity in a dose-dependent manner, but the kappa B-dependent diptericin reporter gene activity can be rescued by overexpression of wild type DLAK. Moreover, mRNA analysis of various kappa B-dependent antimicrobial peptide genes shows that LPS inducibility of these genes is greatly impaired in cells overexpressing DLAK(K50A). These results establish that DLAK is a novel LPS-activated kinase, which is an essential signaling component for the induction of antimicrobial peptide genes following LPS treatment in Drosophila cells.	Yonsei Univ, Coll Med, Immunol Lab, Med Res Ctr, Seoul, South Korea; Hanyang Univ, Dept Microbiol, Coll Med, Seoul 133791, South Korea; Inst Pasteur, Lab Biochim & Biol Mol Insertes, F-75724 Paris, France	Yonsei University; Yonsei University Health System; Hanyang University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lee, WJ (corresponding author), Yonsei Univ, Coll Med, Immunol Lab, Med Res Ctr, CPO Box 8044,Shinchon Dong 134, Seoul, South Korea.		Han, Sung-Jun/B-9547-2012					ASLING B, 1995, INSECT BIOCHEM MOLEC, V25, P511, DOI 10.1016/0965-1748(94)00091-C; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BECKER S, 1991, J IMMUNOL, V147, P4307; BOMAN HG, 1991, CELL, V65, P205, DOI 10.1016/0092-8674(91)90154-Q; Chasan Rebecca, 1993, P387; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Connelly MA, 1995, CELL MOL BIOL RES, V41, P537; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Engstrom Ylva, 1998, P211; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; FYRBERG EA, 1981, CELL, V24, P107, DOI 10.1016/0092-8674(81)90506-7; GRANT PA, 1992, NUCLEIC ACIDS RES, V20, P4401, DOI 10.1093/nar/20.17.4401; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; GROSSHANS J, 1994, NATURE, V372, P563, DOI 10.1038/372563a0; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMANN JA, 1995, CURR OPIN IMMUNOL, V7, P4, DOI 10.1016/0952-7915(95)80022-0; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; IP YT, 1994, CURR OPIN GENET DEV, V4, P672, DOI 10.1016/0959-437X(94)90133-N; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; PARDUE ML, 1986, DROSOPHILA PRACTICAL; PETERSEN UM, 1995, EMBO J, V14, P3146, DOI 10.1002/j.1460-2075.1995.tb07317.x; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Sambrook J., 2002, MOL CLONING LAB MANU; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STJOHNSTON D, 1992, CELL, V68, P201; SUN SC, 1992, EUR J BIOCHEM, V204, P885, DOI 10.1111/j.1432-1033.1992.tb16708.x; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; WAHLEN AM, 1993, J CELL BIOL, V123, P523; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; WICKER C, 1990, J BIOL CHEM, V265, P22493; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611	59	35	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2071	2079		10.1074/jbc.275.3.2071	http://dx.doi.org/10.1074/jbc.275.3.2071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636911	hybrid			2022-12-27	WOS:000084940000074
J	Rodriguez-Gabriel, MA; Remacha, M; Ballesta, JPG				Rodriguez-Gabriel, MA; Remacha, M; Ballesta, JPG			The RNA interacting domain but not the protein interacting domain is highly conserved in ribosomal protein P0	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE VIABILITY; ESCHERICHIA-COLI; ACIDIC PHOSPHOPROTEINS; GTPASE CENTER; BINDING; STALK; SITE; P1; P2; YEAST	Protein P0 interacts with proteins P1 alpha, P1 beta, P2 alpha, and P2 beta, and forms the Saccharomyces cerevisiae ribosomal stalk. The capacity of RPP0 genes from Aspergillus fumigatus, Dictyostelium discoideum, Rattus norvegicus, Homo sapiens, and Leishmania infantum to complement the absence of the homologous gene has been tested. In S. cerevisiae W303dGP0, a strain containing standard amounts of the four P1/P2 protein types, all heterologous genes were functional except the one from L. infantum, some of them inducing an osmosensitive phenotype at 37 degrees C. The polymerizing activity and the elongation factor-dependent functions but not the peptide bond formation capacity is affected in the heterologous P0 containing ribosomes. The heterologous P0 proteins bind to the yeast ribosomes but the composition of the ribosomal stalk is altered. Only proteins P1 alpha and P2 beta are found in ribosomes carrying the A. fumigatus, R. norvegicus, and H. sapiens proteins. When the heterologous genes are expressed in a conditional null-P0 mutant whose ribosomes are totally deprived of P1/P2 proteins, none of the heterologous P0 proteins complemented the conditional phenotype. In contrast, chimeric P0 proteins made of different amino-terminal fragments from mammalian origin and the complementary carboxyl-terminal fragments from yeast allow W303dGP0 and D67dGP0 growth at restrictive conditions, These results indicate that while the P0 protein RNA-binding domain is functionally conserved in eukaryotes, the regions involved in protein-protein interactions with either the other stalk proteins or the elongation factors have notably evolved.	Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; CSIC, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC)	Ballesta, JPG (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, Canto Blanco, E-28049 Madrid, Spain.	jpgballesta@cbm.uam.es	Remacha, Miguel/G-1250-2016; Rodriguez-Gabriel, Miguel/L-2425-2013	Rodriguez-Gabriel, Miguel/0000-0002-6855-5286				Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; BALLESTA JPG, 2000, RIBOSOME STRUCTURE F; BEAUCLERK AAD, 1984, J BIOL CHEM, V259, P6559; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Briones E, 1998, J BIOL CHEM, V273, P31956, DOI 10.1074/jbc.273.48.31956; Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Gomez-Lorenzo MG, 1998, J BIOL CHEM, V273, P25041, DOI 10.1074/jbc.273.39.25041; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HIGHLAND JH, 1975, J BIOL CHEM, V250, P831; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JOSE MP, 1995, BIOCHEMISTRY-US, V34, P7941, DOI 10.1021/bi00024a019; KISCHA K, 1971, NATURE-NEW BIOL, V233, P62, DOI 10.1038/newbio233062a0; LILJAS A, 1991, INT REV CYTOL, V124, P103; MACCONNELL WP, 1980, BIOCHEM BIOPH RES CO, V92, P46, DOI 10.1016/0006-291X(80)91517-X; Moller W., 1986, STRUCTURE FUNCTION G, P309; MONRO RE, 1967, J MOL BIOL, V28, P161, DOI 10.1016/S0022-2836(67)80085-8; MORINAGA Y, 1984, BIO-TECHNOL, V2, P636, DOI 10.1038/nbt0784-636; MUSTERS W, 1991, P NATL ACAD SCI USA, V88, P1469, DOI 10.1073/pnas.88.4.1469; PRIETO J, 1991, NUCLEIC ACIDS RES, V19, P1342, DOI 10.1093/nar/19.6.1342; RAUE HA, 1988, PROG BIOPHYS MOL BIO, V51, P77, DOI 10.1016/0079-6107(88)90011-9; Remacha M, 1995, BIOCHEM CELL BIOL, V73, P959, DOI 10.1139/o95-103; REMACHA M, 1990, MOL CELL BIOL, V10, P2182, DOI 10.1128/MCB.10.5.2182; REMACHA M, 1992, J BIOL CHEM, V267, P12061; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; Rodriguez-Gabriel MA, 1998, BIOCHEMISTRY-US, V37, P16620, DOI 10.1021/bi981396i; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANCHEZMADRID F, 1979, EUR J BIOCHEM, V98, P409, DOI 10.1111/j.1432-1033.1979.tb13200.x; SANTOS C, 1995, J BIOL CHEM, V270, P20608, DOI 10.1074/jbc.270.35.20608; SANTOS C, 1994, J BIOL CHEM, V269, P15689; SHIMMIN LC, 1989, J MOL EVOL, V29, P448, DOI 10.1007/BF02602915; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; THOMPSON J, 1993, EMBO J, V12, P1499, DOI 10.1002/j.1460-2075.1993.tb05793.x; TOWBIN H, 1982, J BIOL CHEM, V257, P2709; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; Uchiumi T, 1997, J BIOL CHEM, V272, P3302, DOI 10.1074/jbc.272.6.3302; Zambrano R, 1997, BIOCHEMISTRY-US, V36, P14439, DOI 10.1021/bi971494o; Zurdo J, 1997, BIOCHEMISTRY-US, V36, P9625, DOI 10.1021/bi9702400	43	48	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2130	2136		10.1074/jbc.275.3.2130	http://dx.doi.org/10.1074/jbc.275.3.2130			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636918	hybrid			2022-12-27	WOS:000084940000081
J	Tsuchiya, K; Yoshizumi, M; Houchi, H; Mason, RP				Tsuchiya, K; Yoshizumi, M; Houchi, H; Mason, RP			Nitric oxide-forming reaction between the iron-N-methyl-D-glucamine dithiocarbamate complex and nitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MICE IN-VIVO; BAND EPR SPECTROSCOPY; SEPTIC-SHOCK MICE; L-ARGININE; RELAXING FACTOR; REPERFUSION INJURY; ANIMAL-TISSUES; RAT; GENERATION	The objective of this study was to elucidate the origin of the nitric oxide-forming reactions from nitrite in the presence of the iron-N-methyl-D-glucamine dithiocarbamate complex ((MGD)(2)Fe2+). The (MGD)(2)Fe2+ complex is commonly used in electron paramagnetic resonance (EPR) spectroscopic detection of NO both in vivo and in vitro. Although it is widely believed that only NO can react with (MGD)(2)Fe2+ complex to form the (MGD)(2)Fe2+. NO complex, a recent article reported that the (MGD)(2)Fe2+ complex can react not only with NO, but also with nitrite to produce the characteristic triplet EPR signal of (MGD)(2)Fe2+. NO (Hiramoto, K., Tomiyama, S., and Kikugawa, K. (1997) Free Radical Res, 27, 505-509). However, no detailed reaction mechanisms were given. Alternatively, nitrite is considered to be a spontaneous NO donor, especially at acidic pH values (Samouilov, A, Kuppusamy, P., and Zweier, J. L. (1998) Arch Biochem, Biophys. 357, 1-7). However, its production of nitric oxide at physiological pH is unclear. In this report, we demonstrate that the (MGD)(2)Fe2+ complex and nitrite reacted to form NO as follows: 1) (MGD)(2)Fe2+. NO complex was produced at pH 7.4; 2) concomitantly, the (MGD)(2)Fe3+ complex, which is the oxidized form of (MGD)Fe-2(2+), was formed; 3) the rate of formation of the (MGD)(2)Fe2+. NO complex was a function of the concentration of [Fe2+](2), [MGD], [H+] and [nitrite].	NIEHS, Free Rad Metabolite Sect, Lab Pharmacol & Chem, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA; Univ Tokushima, Sch Med, Dept Pharmacol, Tokushima 770, Japan; Univ Tokushima, Sch Med, Dept Pharm, Tokushima 770, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tokushima University; Tokushima University	Tsuchiya, K (corresponding author), NIEHS, Free Rad Metabolite Sect, Lab Pharmacol & Chem, Natl Inst Hlth, FO-02, Res Triangle Pk, NC 27709 USA.	tsuchiya@niehs.nih.gov	Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050141] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AKAIKE T, 1993, BIOCHEMISTRY-US, V32, P827, DOI 10.1021/bi00054a013; ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; ARROYO CM, 1991, FREE RADICAL RES COM, V14, P145, DOI 10.3109/10715769109094127; BECHTHOLD PS, 1981, OPT COMMUN, V36, P373, DOI 10.1016/0030-4018(81)90245-5; Beckman JS, 1996, METHODS NITRIC OXIDE, P61; Doi K, 1996, CANCER-AM CANCER SOC, V77, P1598, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1598::AID-CNCR3>3.0.CO;2-A; FORMAN D, 1985, NATURE, V313, P620, DOI 10.1038/313620a0; Fujii H, 1998, PHYS MED BIOL, V43, P1949, DOI 10.1088/0031-9155/43/7/016; Fujii H, 1997, MAGN RESON MED, V38, P565, DOI 10.1002/mrm.1910380410; Fujii S, 1998, AM J PHYSIOL-GASTR L, V274, pG857, DOI 10.1152/ajpgi.1998.274.5.G857; GREENBERG SS, 1990, CIRC RES, V67, P1446, DOI 10.1161/01.RES.67.6.1446; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hiramoto K, 1997, FREE RADICAL RES, V27, P505, DOI 10.3109/10715769709065790; HOLTZMAN JL, 1968, BIOCHEM J, V110, P407, DOI 10.1042/bj1100407; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ishiwata H., 1975, Journal of the Food Hygienic Society of Japan [Shokuhin Eiseigaku Zasshi], V16, P89; James PE, 1998, ADV EXP MED BIOL, V454, P181; Jiang JJ, 1997, MOL PHARMACOL, V52, P1081, DOI 10.1124/mol.52.6.1081; JOSEPH J, 1993, BIOCHEM BIOPH RES CO, V192, P926, DOI 10.1006/bbrc.1993.1504; Kamisaki Y, 1997, BBA-MOL BASIS DIS, V1362, P24, DOI 10.1016/S0925-4439(97)00052-5; KOMAROV A, 1993, BIOCHEM BIOPH RES CO, V195, P1191, DOI 10.1006/bbrc.1993.2170; Komarov AM, 1997, BBA-MOL BASIS DIS, V1361, P229, DOI 10.1016/S0925-4439(97)84636-4; KOMAROV AM, 1995, BBA-MOL BASIS DIS, V1272, P29, DOI 10.1016/0925-4439(95)00061-8; KORTH HG, 1994, J AM CHEM SOC, V116, P2767, DOI 10.1021/ja00086a010; Kotake Y, 1999, NITRIC OXIDE-BIOL CH, V3, P114, DOI 10.1006/niox.1999.0214; KUBRINA LN, 1993, BIOCHIM BIOPHYS ACTA, V1176, P240, DOI 10.1016/0167-4889(93)90050-Y; KUBRINA LN, 1992, BIOCHIM BIOPHYS ACTA, V1099, P233, DOI 10.1016/0304-4173(92)90033-B; KUBRINA LN, 1989, B EXP BIOL MED+, V107, P35, DOI 10.1007/BF00837051; LAI CS, 1994, FEBS LETT, V345, P120, DOI 10.1016/0014-5793(94)00422-6; Laursen JB, 1996, CIRCULATION, V94, P2241, DOI 10.1161/01.CIR.94.9.2241; Lecour S, 1999, J CARDIOVASC PHARM, V33, P78, DOI 10.1097/00005344-199901000-00012; Mikoyan V. D., 1994, Biokhimiya, V59, P732; Mikoyan VD, 1997, BIOFIZIKA+, V42, P490; MIKOYAN VD, 1994, BIOFIZIKA+, V39, P919; MIKOYAN VD, 1994, BIOCHEM MOL BIOL INT, V32, P1157; MIKOYAN VD, 1995, BBA-MOL CELL RES, V1269, P19, DOI 10.1016/0167-4889(95)00092-7; MIKOYAN VD, 1994, BIOFIZIKA+, V39, P915; Mikoyan VD, 1997, BBA-GEN SUBJECTS, V1336, P225, DOI 10.1016/S0304-4165(97)00032-9; Miyajima T, 1997, FREE RADICAL BIO MED, V22, P463, DOI 10.1016/S0891-5849(96)00391-7; MORDVINTCEV P, 1991, ANAL BIOCHEM, V199, P142, DOI 10.1016/0003-2697(91)90282-X; MULSCH A, 1995, BRIT J PHARMACOL, V116, P2743; MULSCH A, 1995, CIRCULATION, V92, P1876, DOI 10.1161/01.CIR.92.7.1876; OBOLENSKAYA MY, 1994, BIOCHEM BIOPH RES CO, V202, P571, DOI 10.1006/bbrc.1994.1966; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Paschenko SV, 1996, BIOCHEM BIOPH RES CO, V225, P577, DOI 10.1006/bbrc.1996.1214; Pou S, 1999, BBA-GEN SUBJECTS, V1427, P216, DOI 10.1016/S0304-4165(99)00014-8; Reinke LA, 1996, ANAL BIOCHEM, V243, P8, DOI 10.1006/abio.1996.0476; Reszka KJ, 1996, J AM CHEM SOC, V118, P8719, DOI 10.1021/ja960922v; Samouilov A, 1998, ARCH BIOCHEM BIOPHYS, V357, P1, DOI 10.1006/abbi.1998.0785; Sasaki T, 1979, J FOOD HYG SOC JPN, V20, P363; SATO S, 1994, BRAIN RES, V647, P91, DOI 10.1016/0006-8993(94)91402-8; Shen JG, 1998, BBA-MOL BASIS DIS, V1406, P228, DOI 10.1016/S0925-4439(98)00007-6; SHINOBU LA, 1984, ACTA PHARMACOL TOX, V54, P189; Shutenko Z, 1999, BIOCHEM PHARMACOL, V57, P199, DOI 10.1016/S0006-2952(98)00296-2; Suzuki Y, 1998, FREE RADICAL RES, V28, P293, DOI 10.3109/10715769809069281; TANNENBAUM SR, 1976, FOOD COSMET TOXICOL, V14, P549, DOI 10.1016/S0015-6264(76)80006-5; TOMINAGA T, 1994, J CEREBR BLOOD F MET, V14, P715, DOI 10.1038/jcbfm.1994.92; Tsuchiya K, 1999, FREE RADICAL BIO MED, V27, P347, DOI 10.1016/S0891-5849(99)00062-3; VANIN AF, 1993, BIOCHIM BIOPHYS ACTA, V1177, P37, DOI 10.1016/0167-4889(93)90154-H; VEDERNIKOV YP, 1992, EUR J PHARMACOL, V212, P125, DOI 10.1016/0014-2999(92)90085-I; VOEVODSKAYA NV, 1992, BIOCHEM BIOPH RES CO, V186, P1423, DOI 10.1016/S0006-291X(05)81565-7; Wallis G, 1996, SHOCK, V6, P274, DOI 10.1097/00024382-199610000-00009; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Williams D. L. H., 1988, NITROSATION; WOLDMAN YY, 1994, BIOCHEM BIOPH RES CO, V202, P195, DOI 10.1006/bbrc.1994.1912; YONETANI T, 1972, J BIOL CHEM, V247, P2447; Yoshimura T, 1996, NAT BIOTECHNOL, V14, P992, DOI 10.1038/nbt0896-992; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304	68	69	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1551	1556		10.1074/jbc.275.3.1551	http://dx.doi.org/10.1074/jbc.275.3.1551			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636843	hybrid			2022-12-27	WOS:000084940000006
J	Ajouz, B; Berrier, C; Besnard, M; Martinac, B; Ghazi, A				Ajouz, B; Berrier, C; Besnard, M; Martinac, B; Ghazi, A			Contributions of the different extramembranous domains of the mechanosensitive ion channel MscL to its response to membrane tension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PATCH-CLAMP; ACTIVATED CHANNELS; PRESSURE; PROTEIN; CELLS	MscL is a mechanosensitive channel that is gated by tension in the membrane bilayer alone. It is a homooligomer of a protein comprising two transmembrane segments connected by an external loop, with the NH(2) and COOH termini located in the cytoplasm, The contributions of the extramembranous domains of the channel to its activity were investigated by specific proteolysis during patch-clamp experiments. Limited proteolysis of the COOH terminus or the NH(2) terminus increased the mechanosensitivity of the channel without changing its conductance. Strikingly, after cleavage of the external loop of each monomer, the channel was still functional, and its mechanosensitivity was increased dramatically, indicating that the loop acts as a spring that resists the opening of the channel and promotes its closure when it is open. These results indicate that the integrity of most of the extramembranous domains is not essential for mechanosensitivity, They suggest that these domains counteract the movement of the transmembrane helices to which they are connected, thus setting the level of sensitivity of the channel to tension.	Univ Paris 11, UMR CNRS 8619, Lab Biomembranes, F-91405 Orsay, France; Univ Western Australia, Dept Pharmacol, Nedlands, WA 6907, Australia	UDICE-French Research Universities; Universite Paris Saclay; University of Western Australia	Ghazi, A (corresponding author), Univ Paris 11, UMR CNRS 8619, Lab Biomembranes, Batiment 430, F-91405 Orsay, France.	alexandre.ghazi@biomemb.u-psud.fr	Martinac, Boris/A-7178-2018	Martinac, Boris/0000-0001-8422-7082				Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; AJOUZ B, 1998, BIOPHYS J, V74, P238; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BERRIER C, 1989, FEBS LETT, V259, P27, DOI 10.1016/0014-5793(89)81486-3; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1996, EMBO J, V15, P4798, DOI 10.1002/j.1460-2075.1996.tb00860.x; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; Hamill OP, 1997, ANNU REV PHYSIOL, V59, P621, DOI 10.1146/annurev.physiol.59.1.621; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hamill OP, 1996, PHARMACOL REV, V48, P231; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Jackson M.B., 1993, THERMODYNAMICS MEMBR, P327; Le Dain AC, 1998, J BIOL CHEM, V273, P12116, DOI 10.1074/jbc.273.20.12116; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; POPOT JL, 1994, METH PHYS S, P41; RIGAUD JL, 1988, BIOCHEMISTRY-US, V27, P2677, DOI 10.1021/bi00408a007; SACHS F, 1992, SOC GEN PHY, V47, P241; SACKIN H, 1995, ANNU REV PHYSIOL, V57, P333, DOI 10.1146/annurev.ph.57.030195.002001; Saint N, 1998, J BIOL CHEM, V273, P14667, DOI 10.1074/jbc.273.24.14667; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; Sukharev SI, 1997, ANNU REV PHYSIOL, V59, P633, DOI 10.1146/annurev.physiol.59.1.633; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659	31	82	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1015	1022		10.1074/jbc.275.2.1015	http://dx.doi.org/10.1074/jbc.275.2.1015			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625640	hybrid			2022-12-27	WOS:000084836600044
J	Kamphaus, GD; Colorado, PC; Panka, DJ; Hopfer, H; Ramchandran, R; Torre, A; Maeshima, Y; Mier, JW; Sukhatme, VP; Kalluri, R				Kamphaus, GD; Colorado, PC; Panka, DJ; Hopfer, H; Ramchandran, R; Torre, A; Maeshima, Y; Mier, JW; Sukhatme, VP; Kalluri, R			Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGEN; BASEMENT-MEMBRANE; IDENTIFICATION; ORGANIZATION; MODULATION; ADHESION; THERAPY; DOMAINS; CELLS	We isolated and identified an endogenous 24-kDa human basement membrane-derived inhibitor of angiogenesis and tumor growth, termed canstatin, Canstatin, a fragment of the alpha 2 chain of type TV collagen, was produced as a recombinant molecule in Escherichia coli and 293 embryonic kidneys cells. Canstatin significantly inhibited human endothelial cell migration and murine endothelial cell tube formation. Additionally, canstatin potently inhibited 10% fetal bovine serum-stimulated endothelial cell proliferation and induced apoptosis, with no inhibition of proliferation or apoptosis observed on non-endothelial cells. Inhibition of endothelial proliferation was not concomitant with a change in extracellular signal-regulated kinase activation. We demonstrate that apoptosis induced by canstatin was associated with a down-regulation of the anti-apoptotic protein, FLIP. Canstatin also suppressed in vivo growth of large and small size tumors in two human xenograft mouse models with histology revealing decreased CD31-positive vasculature. Collectively, these results suggest that canstatin is a powerful therapeutic molecule for suppressing angiogenesis.	Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Ctr Canc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, RW 563A,330 Brookline Ave, Boston, MA 02215 USA.		Hopfer, Helmut/T-5954-2019; Sukhatme, Vikas/W-2776-2019; Kalluri, Raghu/E-2677-2015	Hopfer, Helmut/0000-0003-1755-2170; Kalluri, Raghu/0000-0002-2190-547X	NCI NIH HHS [CA-74401] Funding Source: Medline; NIDDK NIH HHS [DK51711, DK55001] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051711] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Dhanabal M, 1999, CANCER RES, V59, P189; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; GRANT DS, 1994, PATHOL RES PRACT, V190, P854; GUNWAR S, 1991, J BIOL CHEM, V266, P15318; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; HARALABOPOULOS GC, 1994, LAB INVEST, V71, P575; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Madri JA, 1997, TRANSPL IMMUNOL, V5, P179, DOI 10.1016/S0966-3274(97)80035-4; MADRI JA, 1986, J HISTOCHEM CYTOCHEM, V34, P85, DOI 10.1177/34.1.2416801; MARAGOUDAKIS ME, 1993, KIDNEY INT, V43, P147, DOI 10.1038/ki.1993.24; NEILSON EG, 1993, J BIOL CHEM, V268, P8402; OLIVER MH, 1989, J CELL SCI, V92, P513; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; Sata M, 1998, J BIOL CHEM, V273, P33103, DOI 10.1074/jbc.273.50.33103; Setty S, 1998, J BIOL CHEM, V273, P12244, DOI 10.1074/jbc.273.20.12244; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583; ZHANG XM, 1994, DEV BIOL, V164, P10, DOI 10.1006/dbio.1994.1176	28	358	416	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1209	1215		10.1074/jbc.275.2.1209	http://dx.doi.org/10.1074/jbc.275.2.1209			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625665	hybrid			2022-12-27	WOS:000084836600069
J	Rellos, P; Sygusch, J; Cox, TM				Rellos, P; Sygusch, J; Cox, TM			Expression, purification, and characterization of natural mutants of human aldolase B - Role of quaternary structure in catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY FRUCTOSE INTOLERANCE; MUSCLE ALDOLASE; IDENTIFICATION; GENE; MUTATIONS; VARIANT; REGION	Fructaldolases (EC 4.1.2.13) are ancient enzymes of glycolysis that catalyze the reversible cleavage of phosphofructose esters into cognate triose (phosphates). Three vertebrate isozymes of Class I aldolase have arisen by gene duplication and display distinct activity profiles with fructose 1,6-bisphosphate and with fructose l-phosphate, We describe the biochemical and biophysical characterization of seven natural human aldolase B variants, identified in patients suffering from hereditary fructose intolerance and expressed as recombinant proteins in E, call, from which they were purified to homogeneity. The mutant aldolases were all missense variants and could be classified into two principal groups: catalytic mutants, with retained tetrameric structure but altered kinetic properties (W147R, R303W, and A337V), and structural mutants, in which the homotetramers readily dissociate into subunits with greatly impaired enzymatic activity (A149P, A174D, L256P, and N334K), Investigation of these two classes of mutant enzyme suggests that the integrity of the quaternary structure of aldolase B is critical for maintaining its full catalytic function.	Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Montreal, Fac Med, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universite de Montreal	Cox, TM (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Level 5, Cambridge CB2 2QQ, England.			Sygusch, Jurgen/0000-0002-6629-2128				ALI M, 1995, AM J HUM GENET, V56, P1002; ALI M, 1994, HUM MOL GENET, V3, P203; ALI M, 1995, THESIS CAMBRIDGE U C; Beernink PT, 1996, P NATL ACAD SCI USA, V93, P5374, DOI 10.1073/pnas.93.11.5374; BERTHIAUME L, 1993, J BIOL CHEM, V268, P10826; BERTHIAUME L, 1991, J BIOL CHEM, V266, P17099; BLOM N, 1997, NAT STRUCT BIOL, V4, P38; BOESIGER P, 1994, PEDIATR RES, V36, P436, DOI 10.1203/00006450-199410000-00004; CHAMBERS RA, 1956, LANCET, V2, P340; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; COX TM, 1983, J CLIN INVEST, V72, P201, DOI 10.1172/JCI110958; CROSS NCP, 1990, LANCET, V335, P306, DOI 10.1016/0140-6736(90)90603-3; CROSS NCP, 1990, NUCLEIC ACIDS RES, V18, P1925, DOI 10.1093/nar/18.7.1925; CROSS NCP, 1988, CELL, V53, P881, DOI 10.1016/S0092-8674(88)90349-2; GITZELMANN R, 1995, METABOLIC MOL BASES, P905; GURTLER B, 1971, H-S Z PHYSIOL CHEM, V352, P1455, DOI 10.1515/bchm2.1971.352.2.1455; HEALY MJ, 1973, BIOCHEMISTRY-US, V12, P35, DOI 10.1021/bi00725a006; HERS HG, 1953, BIOCHIM BIOPHYS ACTA, V11, P427, DOI 10.1016/0006-3002(53)90062-6; HEYDUK T, 1991, J BIOL CHEM, V266, P15650; James CL, 1996, J MED GENET, V33, P837, DOI 10.1136/jmg.33.10.837; RACKER E, 1947, J BIOL CHEM, V167, P843; Rellos P, 1999, BIOCHEM J, V340, P321, DOI 10.1042/0264-6021:3400321; ROSE IA, 1965, J BIOL CHEM, V240, P1758; Santamaria R, 1996, J MED GENET, V33, P786, DOI 10.1136/jmg.33.9.786; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Sygusch J, 1997, BIOCHEM J, V327, P717, DOI 10.1042/bj3270717; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846	27	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1145	1151		10.1074/jbc.275.2.1145	http://dx.doi.org/10.1074/jbc.275.2.1145			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625657	hybrid			2022-12-27	WOS:000084836600061
J	Wissink, S; Meijer, O; Pearce, D; van der Burg, B; van der Saag, PT				Wissink, S; Meijer, O; Pearce, D; van der Burg, B; van der Saag, PT			Regulation of the rat serotonin-1A receptor gene by corticosteroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GLUCOCORTICOID RECEPTOR; 5-HT1A RECEPTOR; MESSENGER-RNA; MINERALOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR; RETINOIC ACID; CROSS-TALK; BRAIN; BINDING	Dysregulation of the serotonergic system and abnormalities of the hypothalamic-pituitary-adrenal axis function have been implicated to be involved in neuropsychiatric disorders, Serotonin-1A receptors have been shown to be suppressed by corticosteroid hormones in a variety of animal studies. This effect may play a central role in the pathophysiology of depression. However, little is known about the molecular mechanism underlying this suppressive effect of corticosteroids, Here, we show by functional analysis of the promoter region of the rat serotonin-1A receptor gene that two NF-KB elements in the promoter contribute to induced transcription of the rat serotonin-1A receptor gene. Furthermore, we show that corticosteroids repress this NF-KB-mediated induction of transcription. Remarkably, we observed that only the glucocorticoid receptor and not the mineralocorticoid receptor was able to mediate this repressive effect of corticosteroids. We argue that negative crosstalk between the glucocorticoid receptor and NF-KB may provide a basis for the molecular mechanism underlying the negative action of corticosteroids on serotonin signaling in the brain.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, NL-2300 RA Leiden, Netherlands; Univ Calif San Francisco, Div Nephrol, Dept Med, San Francisco, CA 94143 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University - Excl LUMC; University of California System; University of California San Francisco	van der Saag, PT (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.		meijer, onno c/D-8070-2018	meijer, onno c/0000-0002-8394-6859				ALBERT PR, 1990, J BIOL CHEM, V265, P5825; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Buhot MC, 1997, CURR OPIN NEUROBIOL, V7, P243, DOI 10.1016/S0959-4388(97)80013-X; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; CATO ACB, 1996, BIOESSAYS, V18, P317; CHALMERS DT, 1993, J NEUROSCI, V13, P914; CHALMERS DT, 1991, BRAIN RES, V561, P51, DOI 10.1016/0006-8993(91)90748-K; COHN JB, 1985, J CLIN PSYCHIAT, V46, P26; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; EVANS RM, 1989, NEURON, V2, P1105, DOI 10.1016/0896-6273(89)90177-3; FARGIN A, 1989, J BIOL CHEM, V264, P14848; FUXE K, 1985, ENDOCRINOLOGY, V117, P1803, DOI 10.1210/endo-117-5-1803; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HOLSBOER B, 1995, PSYCHOPHARMACOLOGY 4, P957; JULIUS D, 1991, ANNU REV NEUROSCI, V14, P335, DOI 10.1146/annurev.neuro.14.1.335; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; MEIJER OC, 1994, EUR J PHARM-MOLEC PH, V266, P255, DOI 10.1016/0922-4106(94)90134-1; MEIJER OC, 1999, IN PRESS J NEUROENDO; MUMMERY CL, 1987, DEV BIOL, V121, P10, DOI 10.1016/0012-1606(87)90133-3; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Parks CL, 1996, J BIOL CHEM, V271, P4417; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; PFAHL M, 1990, METHOD ENZYMOL, V189, P256; POMPEIANO M, 1992, J NEUROSCI, V12, P440; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; RUPPRECHT R, 1993, MOL ENDOCRINOL, V7, P597, DOI 10.1210/me.7.4.597; SARRIEAU A, 1984, EUR J PHARMACOL, V98, P151, DOI 10.1016/0014-2999(84)90125-0; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; Stokes PE, 1987, PSYCHOPHARMACOLOGY 3, P589; TRABER J, 1987, TRENDS PHARMACOL SCI, V8, P432, DOI 10.1016/0165-6147(87)90231-8; VANDERBURG B, 1988, J CELL PHYSIOL, V134, P101, DOI 10.1002/jcp.1041340112; vanderBurg B, 1997, TRENDS ENDOCRIN MET, V8, P152, DOI 10.1016/S1043-2760(97)00006-4; Wissink S, 1997, IMMUNOBIOLOGY, V198, P50, DOI 10.1016/S0171-2985(97)80026-5	36	63	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1321	1326		10.1074/jbc.275.2.1321	http://dx.doi.org/10.1074/jbc.275.2.1321			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625680	hybrid			2022-12-27	WOS:000084836600084
J	Fu, J; Kreibich, G				Fu, J; Kreibich, G			Retention of subunits of the oligosaccharyltransferase complex in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; MAMMALIAN OLIGOSACCHARYLTRANSFERASE; TRANSMEMBRANE PROTEINS; RIBOSOME BINDING; GOLGI-APPARATUS; RIBOPHORINS-I; ER MEMBRANE; RAT-LIVER; SIGNAL; ROUGH	Membrane proteins of the endoplasmic reticulum (ER) may be localized to this organelle by mechanisms that involve retention, retrieval, or a combination of both. For luminal ER proteins, which contain a KDEL domain, and for type I transmembrane proteins carrying a dilysine motif, specific retrieval mechanisms have been identified. However, most ER membrane proteins do not contain easily identifiable retrieval motifs, ER localization information has been found in cytoplasmic, transmembrane, or luminal domains. In this study, we have identified ER localization domains within the three type I transmembrane proteins, ribophorin I (RI), ribophorin II (RII), and OST48. Together with DAD1, these membrane proteins form an oligomeric complex that has oligosaccharyltransferase (OST) activity. We have previously shown that ER retention information is independently contained within the transmembrane and the cytoplasmic domain of RII, and in the case of RI, a truncated form consisting of the luminal domain was retained in the ER, To determine whether other domains of RI carry additional retention information, we have generated chimeras by exchanging individual domains of the Tac antigen with the corresponding ones of RI, We demonstrate here that only the luminal domain of RI contains ER retention information. We also show that the dilysine motif in OST48 functions as an ER localization motif because OST48 in which the two lysine residues are replaced by serine (OST48ss) is no longer retained in the ER and is found instead also at the plasma membrane. OST48ss is, however, retained in the ER when coexpressed with RI, RII, or chimeras, which by themselves do not exit from the ER, indicating that they may form partial oligomeric complexes by interacting with the luminal domain of OST48. In the case of the Tac chimera containing only the luminal domain of RII, which by itself exits from the ER and is rapidly degraded, it is retained in the ER and becomes stabilized when coexpressed with OST48.	NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University	Kreibich, G (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	kreibg01@mcrcr6.med.nyu.edu						AMARCOSTESEC A, 1984, J CELL BIOL, V99, P2247, DOI 10.1083/jcb.99.6.2247; Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; CRIMAUDO C, 1987, EMBO J, V6, P75, DOI 10.1002/j.1460-2075.1987.tb04721.x; DAHLLOF B, 1991, J BIOL CHEM, V266, P1804; de Virgilio M, 1998, J BIOL CHEM, V273, P9734, DOI 10.1074/jbc.273.16.9734; DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Fu J, 1997, J BIOL CHEM, V272, P29687, DOI 10.1074/jbc.272.47.29687; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; HAAS IG, 1991, CURR TOP MICROBIOL, V167, P71; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HARNIKORT V, 1987, J CELL BIOL, V104, P855, DOI 10.1083/jcb.104.4.855; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HORTSCH M, 1985, EUR J BIOCHEM, V150, P559, DOI 10.1111/j.1432-1033.1985.tb09057.x; IVESSA NE, 1992, J CELL BIOL, V117, P949, DOI 10.1083/jcb.117.5.949; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; Kelleher DJ, 1997, P NATL ACAD SCI USA, V94, P4994, DOI 10.1073/pnas.94.10.4994; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Kolhekar AS, 1998, J BIOL CHEM, V273, P23012, DOI 10.1074/jbc.273.36.23012; KREIBICH G, 1978, J CELL BIOL, V77, P488, DOI 10.1083/jcb.77.2.488; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; LippincottSchwartz J, 1997, CURR OPIN NEUROBIOL, V7, P631, DOI 10.1016/S0959-4388(97)80082-7; MARKS MS, 1995, J BIOL CHEM, V270, P10475, DOI 10.1074/jbc.270.18.10475; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; NILSSON T, 1991, EMBO J, V10, P3567, DOI 10.1002/j.1460-2075.1991.tb04923.x; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; RON D, 1992, BIOTECHNIQUES, V13, P866; ROSENFELD MG, 1984, J CELL BIOL, V99, P1076, DOI 10.1083/jcb.99.3.1076; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; SABATINI DD, 1995, METABOLIC BASIS INHE, P459; Sanjay A, 1998, J BIOL CHEM, V273, P26094, DOI 10.1074/jbc.273.40.26094; SILBERSTEIN S, 1992, J BIOL CHEM, V267, P23658; SITIA R, 1992, MOL BIOL CELL, V3, P1067, DOI 10.1091/mbc.3.10.1067; TANG BL, 1992, J BIOL CHEM, V267, P10122; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; TSAO YS, 1992, J CELL BIOL, V116, P57, DOI 10.1083/jcb.116.1.57; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; YU Y, 1990, J CELL BIOL, V111, P1335, DOI 10.1083/jcb.111.4.1335	53	42	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3984	3990		10.1074/jbc.275.6.3984	http://dx.doi.org/10.1074/jbc.275.6.3984			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660554	hybrid			2022-12-27	WOS:000085288800038
J	Lambrecht, N; Munson, K; Vagin, O; Sachs, G				Lambrecht, N; Munson, K; Vagin, O; Sachs, G			Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPETITIVE PHOTOAFFINITY INHIBITOR; H+/K+-ATPASE; BETA-SUBUNIT; SARCOPLASMIC-RETICULUM; ALPHA-SUBUNIT; MEMBRANE TOPOLOGY; H+,K+-ATPASE; OMEPRAZOLE; PUMP; IDENTIFICATION	The gastric H,K-ATPase is covalently inhibited by substituted pyridyl-methylsulfinyl-benzimidazoles, such as omeprazole, that convert to thiophilic probes of luminally accessible cysteines in the acid space. The K+ competitive inhibitor, SCH28080, prevented inhibition of acid transport by omeprazole. In stably expressing HEK293 cells, the benzimidazole-reactive cysteines, Cys-321 (transmembrane helix (TM) 3), Cys-813 and Cys-822 (TM5/6), and Cys-892 (TM7/8) were mutated to the amino acids found in the SCH28080-resistant Na,K-ATPase and kinetic parameters of H,K-ATPase activity analyzed. Mutations of Cys-822 and Cys-892 had insignificant effects:an the K-i(app), K-m(app) or V-max, but mutations of Cys-813 to threonine and Cys-321 to alanine decreased the affinity for SCH28080, Mutation of Cys-321 to alanine produced mixed kinetics of inhibition, still with higher affinity for the cation-free form of phosphoenzyme. Since the phenylmethoxy ring of the imidazo-pyridine inhibitors binds to TM1/2, as shown by earlier photoaffinity studies, and the mutations in TM6 (Cys-813 --> Thr) as well as the end of TM3 (Cys-321 --> Ala) decrease the affinity for SCH28080, the TM1/2, TM3, and TM6 helices lie within: similar to 16 Angstrom of each other based on the size of the active, extended conformation of SCH28080.	Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sachs, G (corresponding author), Vet Affairs Greater Los Angeles Hlth Care Syst, Bldg 113,Rm 326, Los Angeles, CA 90073 USA.			Lambrecht, Nils/0000-0002-1275-1384	NIDDK NIH HHS [DK40615, DK17294, DK41301] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R37DK017294, R01DK040615, R01DK017294] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asano S, 1996, J BIOL CHEM, V271, P2740, DOI 10.1074/jbc.271.5.2740; Auer M, 1998, NATURE, V392, P840, DOI 10.1038/33967; BAMBERG K, 1992, BIOCHIM BIOPHYS ACTA, V1131, P69, DOI 10.1016/0167-4781(92)90100-E; BESANCON M, 1993, BIOCHEMISTRY-US, V32, P2345, DOI 10.1021/bi00060a028; Besancon M, 1997, J BIOL CHEM, V272, P22438, DOI 10.1074/jbc.272.36.22438; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; DETOMASO AW, 1993, J BIOL CHEM, V268, P1470; EAKLE KA, 1992, P NATL ACAD SCI USA, V89, P2834, DOI 10.1073/pnas.89.7.2834; FENG JN, 1994, BIOCHEMISTRY-US, V33, P4218, DOI 10.1021/bi00180a015; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; HERSEY SJ, 1988, BIOCHIM BIOPHYS ACTA, V956, P49, DOI 10.1016/0167-4838(88)90296-8; KEELING DJ, 1989, J BIOL CHEM, V264, P5545; Lambrecht N, 1998, J BIOL CHEM, V273, P13719, DOI 10.1074/jbc.273.22.13719; LORENTZON P, 1988, J BIOL CHEM, V263, P10705; LORENTZON P, 1987, BIOCHIM BIOPHYS ACTA, V897, P41, DOI 10.1016/0005-2736(87)90313-0; LUTSENKO S, 1992, ANN NY ACAD SCI, V671, P147, DOI 10.1111/j.1749-6632.1992.tb43792.x; MENDLEIN J, 1990, J BIOL CHEM, V265, P5030; MERCIER F, 1993, BIOCHIM BIOPHYS ACTA, V1149, P151, DOI 10.1016/0005-2736(93)90036-Y; MUNSON KB, 1991, J BIOL CHEM, V266, P18976; MUNSON KB, 1988, BIOCHEMISTRY-US, V27, P3932, DOI 10.1021/bi00411a007; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RABON EC, 1990, ANNU REV PHYSIOL, V52, P321; RABON EC, 1988, METHOD ENZYMOL, V157, P649; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; SACHS G, 1992, ANN NY ACAD SCI, V671, P204; SACHS G, 1993, ALIMENT PHARM THER, V7, P4; Segel I.H., 1976, BIOCH CALCULATIONS S; SHIN JM, 1994, J BIOL CHEM, V269, P22533; Shin JM, 1997, ANN NY ACAD SCI, V834, P65, DOI 10.1111/j.1749-6632.1997.tb52226.x; TOH BH, 1990, P NATL ACAD SCI USA, V87, P6418, DOI 10.1073/pnas.87.16.6418; WALLMARK B, 1987, J BIOL CHEM, V262, P2077; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	34	41	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4041	4048		10.1074/jbc.275.6.4041	http://dx.doi.org/10.1074/jbc.275.6.4041			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660561	hybrid			2022-12-27	WOS:000085288800045
J	Meyer, GA; Radsak, KD				Meyer, GA; Radsak, KD			Identification of a novel signal sequence that targets transmembrane proteins to the nuclear envelope inner membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMIN-B-RECEPTOR; VIRUS GLYCOPROTEIN-GB; HUMAN CYTOMEGALOVIRUS; INTRACELLULAR-TRANSPORT; PORE COMPLEX; FUNCTIONAL-ORGANIZATION; DOMAIN; CELLS; SUFFICIENT; BINDING	Herpesvirus maturation requires translocation of glycoprotein B homologue from the endoplasmic reticulum to the inner nuclear membrane. Glycoprotein B of human cytomegalovirus was used in this context as a model protein. To identify a specific signal sequence within human cytomegalovirus glycoprotein B acting in a modular fashion, coding sequences were recombined with reporter proteins. Immunofluorescence and cell fractionation demonstrated that a short sequence element within the cytoplasmic tail of human cytomegalovirus glycoprotein B was sufficient to translocate the membrane protein CD8 to the inner nuclear membrane. This carboxyl-terminal sequence had no detectable nuclear localization signal activity for soluble beta-Galactosidase and could not be substituted by the nuclear localization signal of SV40 T antigen. For glycoprotein B of herpes simplex virus, a carboxyl-terminal element with comparable properties was found. Further experiments showed that the amino acid sequence DRLRHR of human cytomegalovirus glycoprotein B (amino acids 885-890) was sufficient for nuclear envelope translocation. Single residue mutations revealed that the arginine residues in positions 4 and 6 of the DRLRHR sequence were essential for its function. These results support the view that transmembrane protein transport to the inner nuclear membrane is controlled by a mechanism different from that of soluble proteins.	Univ Marburg, Inst Virol, D-35037 Marburg, Germany	Philipps University Marburg	Radsak, KD (corresponding author), Univ Marburg, Inst Virol, Robert Koch Str 17, D-35037 Marburg, Germany.	radsak@mailer.uni-marburg.de						AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6; BERGMANN JE, 1983, J CELL BIOL, V97, P1777, DOI 10.1083/jcb.97.6.1777; Bogner E, 1997, J GEN VIROL, V78, P1647, DOI 10.1099/0022-1317-78-7-1647; Bold S, 1996, J GEN VIROL, V77, P2297, DOI 10.1099/0022-1317-77-9-2297; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; COMPTON T, 1984, J VIROL, V49, P594, DOI 10.1128/JVI.49.2.594-597.1984; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; EISHUBINGER AM, 1991, INTERVIROLOGY, V32, P351, DOI 10.1159/000150219; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Furukawa K, 1998, J BIOL CHEM, V273, P4213, DOI 10.1074/jbc.273.7.4213; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GILBERT R, 1994, J VIROL, V68, P2272, DOI 10.1128/JVI.68.4.2272-2285.1994; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; GONG M, 1990, J VIROL, V64, P1507, DOI 10.1128/JVI.64.4.1507-1516.1990; GRAHAM J, 1984, CENTRIFUGATION PRACT, P219; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; QUALTIERE LF, 1979, INT J CANCER, V23, P808, DOI 10.1002/ijc.2910230612; RADSAK K, 1990, VIROLOGY, V177, P515, DOI 10.1016/0042-6822(90)90516-T; RASILE L, 1993, J VIROL, V67, P4856, DOI 10.1128/JVI.67.8.4856-4866.1993; RAVIPRAKASH K, 1990, J BIOL CHEM, V265, P1777; REIS B, 1993, J GEN VIROL, V74, P1371, DOI 10.1099/0022-1317-74-7-1371; Roizman B, 1996, FIELDS VIROLOGY, P2231; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; SMITH S, 1993, J CELL BIOL, V120, P631, DOI 10.1083/jcb.120.3.631; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; SPAETE RR, 1988, VIROLOGY, V167, P207, DOI 10.1016/0042-6822(88)90071-2; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; WOZNIAK RW, 1992, J CELL BIOL, V119, P1441, DOI 10.1083/jcb.119.6.1441; YE Q, 1994, J BIOL CHEM, V269, P11306	41	35	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3857	3866		10.1074/jbc.275.6.3857	http://dx.doi.org/10.1074/jbc.275.6.3857			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660537	hybrid			2022-12-27	WOS:000085288800021
J	Galvagni, F; Oliviero, S				Galvagni, F; Oliviero, S			Utrophin transcription is activated by an intronic enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MDX MICE; FUNCTIONAL-ANALYSIS; SKELETAL-MUSCLE; EXPRESSION; GENE; PROMOTER; PROTEIN; INDUCTION; MODEL	The utrophin gene codes for a large cytoskeletal protein closely related to dystrophin. Its transcription is driven by a TATA-less promoter. Here we analyzed 40 kilobases of the 5' end region of the utrophin gene searching for new utrophin regulatory elements in muscle cells. By transient transfection of utrophin genomic fragments in front of a reporter gene, we identified a new enhancer that maps downstream of the transcription start site within the second intron and co-localizes with a DNase I-hypersensitive site. By deletion analysis it was mapped to a sequence of 128 base pairs that retains the whole activity. Linker scanning mutagenesis showed that most of the enhancer sequence is essential for its transcriptional activity. Binding analysis with nuclear cell extracts demonstrated that the enhancer regulatory elements, identified by mutagenesis, are protected from DNase I digestion. Because utrophin can functionally substitute dystrophin, the identification and characterization of new regulatory elements provide new targets for possible therapies of Duchenne muscular dystrophy aiming at the up-regulation of the utrophin expression in muscle cells.	Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Siena	Oliviero, S (corresponding author), Univ Siena, Dipartimento Biol Mol, Via Fiorentina 1, I-53100 Siena, Italy.		Galvagni, Federico/F-9186-2013; oliviero, salvatore/R-6657-2019	oliviero, salvatore/0000-0002-3405-765X	Telethon [970] Funding Source: Medline	Telethon(Fondazione Telethon)		Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Dennis CL, 1996, NUCLEIC ACIDS RES, V24, P1646, DOI 10.1093/nar/24.9.1646; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Galvagni F, 1998, J BIOL CHEM, V273, P33708, DOI 10.1074/jbc.273.50.33708; Galvagni F, 1997, MOL CELL BIOL, V17, P1731, DOI 10.1128/MCB.17.3.1731; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Gramolini AO, 1998, J BIOL CHEM, V273, P736, DOI 10.1074/jbc.273.2.736; Gramolini AO, 1997, J BIOL CHEM, V272, P8117, DOI 10.1074/jbc.272.13.8117; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; GRAMOLINI AO, 1999, NUCLEIC ACIDS RES, V98, P1; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; OLIVIERO S, 1987, EMBO J, V6, P1905, DOI 10.1002/j.1460-2075.1987.tb02450.x; PEARCE M, 1993, HUM MOL GENET, V2, P1765, DOI 10.1093/hmg/2.11.1765; SCHOFIELD J, 1993, DEV DYNAM, V198, P254, DOI 10.1002/aja.1001980403; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; TIJAN R, 1994, CELL, V77, P5; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0	24	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3168	3172		10.1074/jbc.275.5.3168	http://dx.doi.org/10.1074/jbc.275.5.3168			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652301	hybrid			2022-12-27	WOS:000085146500023
J	Viriyakosol, S; Mathison, JC; Tobias, PS; Kirkland, TN				Viriyakosol, S; Mathison, JC; Tobias, PS; Kirkland, TN			Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; LPS BINDING-PROTEIN; BACTERIAL LIPOPOLYSACCHARIDE; MEMBRANE CD14; CELLS; ACTIVATION; ENDOTOXIN; IDENTIFICATION; RECOGNITION; COMPLEXES	CD14 is a glycophosphatidylinositol-linked protein expressed by myeloid cells and also circulates as a plasma protein lacking the glycophosphatidylinositol anchor. Both membrane and soluble CD14 function to enhance activation of cells by lipopolysaccharide (LPS), which we refer to as receptor function. We have previously reported the LPS binding and cell activation functions of a group of five deletion mutants of CD14 (Viriyakosol, S., and Kirkland, T.N. (1995) J. Biol. Chem. 270, 361-368). We have now studied the functional impact of these mutations on soluble CD14. We found that some deletions that abrogated LPS binding in membrane CD14 have no effect on LPS binding in soluble CD14. In fact, some of the soluble CD14 deletion mutants bound LPS with an apparent higher affinity than wild-type CD14. Furthermore, we found that all five deletions essentially ablated soluble CD14 LPS receptor function, whereas only two of the deletions completely destroyed membrane CD14 LPS receptor function. Some of the mutants were able to compete with wild-type CD14 in soluble CD14-dependent assays of cellular activation. We concluded that the soluble and membrane forms of CD14 have different structural determinants for LPS receptor function.	Univ Calif San Diego, Sch Med, Vet Affairs San Diego Healthcare Syst, Dept Pathol,Infect Dis Sect, San Diego, CA 92161 USA; Univ Calif San Diego, Sch Med, Vet Affairs San Diego Healthcare Syst, Dept Med, San Diego, CA 92161 USA; Scripps Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Scripps Research Institute	Kirkland, TN (corresponding author), Univ Calif San Diego, Sch Med, Vet Affairs San Diego Healthcare Syst, Dept Pathol,Infect Dis Sect, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.		Kirkland, Theo/ADK-9674-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM037696] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM37696] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; DESCH CE, 1989, LYMPHOKINE RES, V8, P141; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Dziarski R, 1998, J BIOL CHEM, V273, P8680, DOI 10.1074/jbc.273.15.8680; ESPEVIK T, 1993, EUR J IMMUNOL, V23, P255, DOI 10.1002/eji.1830230140; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310; HAZIOT A, 1988, J IMMUNOL, V141, P547; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hogan LH, 1995, J BIOL CHEM, V270, P30725, DOI 10.1074/jbc.270.51.30725; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JUAN TSC, 1995, J BIOL CHEM, V270, P1382, DOI 10.1074/jbc.270.3.1382; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; JUAN TSC, 1995, J BIOL CHEM, V270, P5219, DOI 10.1074/jbc.270.10.5219; KILBOURN RG, 1990, P NATL ACAD SCI USA, V87, P3629, DOI 10.1073/pnas.87.9.3629; KIRIKAE T, 1993, J IMMUNOL, V151, P2742; KIRKLAND TN, 1993, J BIOL CHEM, V268, P24818; KUSUNOKI T, 1995, J EXP MED, V182, P1673, DOI 10.1084/jem.182.6.1673; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; MOORE KL, 1987, J CLIN INVEST, V79, P124, DOI 10.1172/JCI112772; PETERSON PK, 1995, INFECT IMMUN, V63, P1598, DOI 10.1128/IAI.63.4.1598-1602.1995; PUGIN J, 1993, J EXP MED, V178, P2193, DOI 10.1084/jem.178.6.2193; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Shapiro RA, 1997, INFECT IMMUN, V65, P293, DOI 10.1128/IAI.65.1.293-297.1997; SIRIYAKOSOL S, 1995, CLIN INFECT DIS   S2, V21, P190; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Viriyakosol S, 1996, INFECT IMMUN, V64, P653, DOI 10.1128/IAI.64.2.653-656.1996; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wurfel MM, 1997, J IMMUNOL, V158, P3925	36	48	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3144	3149		10.1074/jbc.275.5.3144	http://dx.doi.org/10.1074/jbc.275.5.3144			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652298	hybrid			2022-12-27	WOS:000085146500020
J	Burke, A; Lawson, JA; Meagher, EA; Rokach, J; FitzGerald, GA				Burke, A; Lawson, JA; Meagher, EA; Rokach, J; FitzGerald, GA			Specific analysis in plasma and urine of 2,3-dinor-5,6-dihydro-isoprostane F-2 alpha-III, a metabolite of isoprostane F-2 alpha-III and an oxidation product of gamma-linolenic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCED LIPID-PEROXIDATION; STRESS IN-VIVO; OXIDANT STRESS; 8-ISO-PROSTAGLANDIN F2-ALPHA; CORONARY REPERFUSION; GENERATION; HUMANS; DISEASE; NONCYCLOOXYGENASE; F-2-ISOPROSTANES	F-2-isoprostanes (iPs) are free radical-catalyzed isomers of prostaglandin F-2 alpha. Circulating and urinary iPs have been used as indices of lipid peroxidation in vivo. Utilizing an O-18-labeled homologous internal standard, we developed a gas chromatography/mass spectrometry assay for the 2,3-dinor-5,6 dihydro (dinor-dihydro) metabolite of iPF(2 alpha)-III. Although urinary excretion of iPF(2 alpha)-III reflects systemic lipid peroxidation, the metabolite is more abundant (median of 877 (range of 351-1831) versus 174 (range of 56-321) pg/mg of creatinine; p < 0.01) than the parent iP in urine and can be measured in plasma. Metabolite analysis may be preferable in plasma due to the abundance of arachidonic acid as a source of ex vivo lipid peroxidation. Also, iPF(2 alpha)-III may be formed in blood samples in a cyclooxygenase-dependent manner by platelets ex vivo. By contrast, the metabolite is not formed by aggregated platelets (0.71 +/- 0.08 versus 0.65 +/- 0.09 pg/ml). Although the metabolite/parent ratio is altered in cirrhosis, urinary dinor-dihydro-iPF(2 alpha)-III is elevated and increases further during reperfusion following orthoptic liver transplantation. In addition to its formation as an iPF(2) metabolite, analysis of gamma-linolenic acid autooxidation products and the compound present in freeze-thawed plasma suggests that gamma-linolenic acid may also be an important source of dinor-dihydro-iPF(2 alpha)-III.	Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Florida Inst Technol, Claude Pepper Inst, Melbourne, FL 32901 USA; Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA	University of Pennsylvania; Florida Institute of Technology; Florida Institute of Technology	FitzGerald, GA (corresponding author), Univ Penn, Ctr Expt Therapeut, 816 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	garret@spirit.gcrc.upenn.edu	FitzGerald, Garret A/A-4222-2010	Meagher, Emma/0000-0003-1841-4570; Rokach, Joshu/0000-0003-1814-7505	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000040] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044730] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1 RR00040] Funding Source: Medline; NHLBI NIH HHS [HL 61364] Funding Source: Medline; NIDDK NIH HHS [DK 44730] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleynik SI, 1998, ALCOHOL CLIN EXP RES, V22, P192, DOI 10.1097/00000374-199802000-00026; Basu S, 1998, FEBS LETT, V428, P32, DOI 10.1016/S0014-5793(98)00481-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CATELLA F, 1986, P NATL ACAD SCI USA, V83, P5861, DOI 10.1073/pnas.83.16.5861; Chiabrando C, 1999, J BIOL CHEM, V274, P1313, DOI 10.1074/jbc.274.3.1313; Davi G, 1999, CIRCULATION, V99, P224; Delanty N, 1997, CIRCULATION, V95, P2492, DOI 10.1161/01.CIR.95.11.2492; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3824, DOI 10.1073/pnas.71.10.3824; HARRISON KA, 1995, J BIOL CHEM, V270, P17273, DOI 10.1074/jbc.270.29.17273; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Lawson JA, 1998, J BIOL CHEM, V273, P29295, DOI 10.1074/jbc.273.45.29295; Leo MA, 1997, AM J GASTROENTEROL, V92, P2069; LLOBATESTELLES M, 1989, ANALYST, V114, P597, DOI 10.1039/an9891400597; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; Morrow JD, 1996, J BIOL CHEM, V271, P23185, DOI 10.1074/jbc.271.38.23185; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Morrow JD, 1999, ANAL BIOCHEM, V269, P326, DOI 10.1006/abio.1999.4008; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; Nourooz-Zadeh J, 1999, J NEUROCHEM, V72, P734, DOI 10.1046/j.1471-4159.1999.0720734.x; Parchmann S, 1998, J BIOL CHEM, V273, P32650, DOI 10.1074/jbc.273.49.32650; PICKETT WC, 1981, ANAL BIOCHEM, V111, P115, DOI 10.1016/0003-2697(81)90237-2; Pratico D, 1998, P NATL ACAD SCI USA, V95, P3449, DOI 10.1073/pnas.95.7.3449; Pratico D, 1997, J CLIN INVEST, V100, P2028, DOI 10.1172/JCI119735; Pratico D, 1998, AM J RESP CRIT CARE, V158, P1709, DOI 10.1164/ajrccm.158.6.9709066; Pratico D, 1998, J INVEST MED, V46, P51; PRATICO D, 1995, J BIOL CHEM, V270, P9800, DOI 10.1074/jbc.270.17.9800; Pratico D, 1996, J BIOL CHEM, V271, P8919, DOI 10.1074/jbc.271.15.8919; Pratico D, 1998, FASEB J, V12, P1777, DOI 10.1096/fasebj.12.15.1777; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Reilly MP, 1998, CIRCULATION, V98, P2822, DOI 10.1161/01.CIR.98.25.2822; Reilly MP, 1997, CIRCULATION, V96, P3314; Roberts LJ, 1996, J BIOL CHEM, V271, P20617, DOI 10.1074/jbc.271.34.20617; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P853, DOI 10.1016/S0090-6980(97)00184-6; Rokach J, 1997, PROSTAG OTH LIPID M, V54, P823, DOI 10.1016/S0090-6980(97)00183-4; WANG ZY, 1995, J PHARMACOL EXP THER, V275, P94; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008	37	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2499	2504		10.1074/jbc.275.4.2499	http://dx.doi.org/10.1074/jbc.275.4.2499			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644705	hybrid			2022-12-27	WOS:000085128000037
J	Schumacher, MA; Moff, I; Sudanagunta, SP; Levine, JD				Schumacher, MA; Moff, I; Sudanagunta, SP; Levine, JD			Molecular cloning of an N-terminal splice variant of the capsaicin receptor - Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGEMINAL GANGLION NEURONS; EXPRESS SUBSTANCE-P; RAT SENSORY NEURONS; CATION CHANNEL; ACTIVATED CURRENT; CELLS; DESENSITIZATION; RESINIFERATOXIN; TRANSDUCTION; ELEGANS	Recently a cDNA clone, vanilloid receptor subtype-1 (VR1), was isolated and found to encode an ion channel that is activated by both capsaicin, the pain producing compound in chili peppers, and by noxious thermal stimuli. Subsequently, two related cDNAs have been isolated, a stretch inactivating channel with mechanosensitive properties and a vanilloid receptor-like protein that is responsive to high temperatures (52-53 degrees C). Here, we report the isolation of a vanilloid receptor 5'-splice variant (VR.5'sv) which differs from VR1 by elimination of the majority of the intracellular N-terminal domain and ankyrin repeat elements. Both VR.5'sv and VR1 mRNA were shown to be expressed in tissues reportedly responsive to capsaicin including dorsal root ganglion, brain, and peripheral blood mononuclear cells. Functional expression of VR.5'sv in Xenopus oocytes and mammalian cells showed no sensitivity to capsaicin, the potent vanilloid resiniferatoxin, hydrogen ions (pH 6.2), or noxious thermal stimuli (50 degrees C). Since VR.5'sv is otherwise identical to VR1 throughout its transmembrane spanning domains and C-terminal region, these results support the hypothesis that the N-terminal intracellular domain is essential for the formation of functional receptors activated by vanilloid compounds and noxious thermal stimuli.	Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Oral & Maxillofacial Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schumacher, MA (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021647, R01NS038737] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38737-01, NS21647] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acs G, 1997, J NEUROSCI, V17, P5622; Biro T, 1998, BLOOD, V91, P1332, DOI 10.1182/blood.V91.4.1332; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BUCK SH, 1986, PHARMACOL REV, V38, P179; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Colbert HA, 1997, J NEUROSCI, V17, P8259; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; Ho WZ, 1997, J IMMUNOL, V159, P5654; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; HORI T, 1988, NEUROPHARMACOLOGY, V27, P135, DOI 10.1016/0028-3908(88)90162-1; Jung J, 1999, J NEUROSCI, V19, P529; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Liu L, 1998, NEUROSCIENCE, V84, P569, DOI 10.1016/S0306-4522(97)00523-X; LIU L, 1994, P NATL ACAD SCI USA, V91, P738, DOI 10.1073/pnas.91.2.738; Liu L, 1996, J NEUROPHYSIOL, V75, P1503, DOI 10.1152/jn.1996.75.4.1503; Macica CM, 1998, AM J PHYSIOL-RENAL, V274, pF175, DOI 10.1152/ajprenal.1998.274.1.F175; Morales MJ, 1996, P NATL ACAD SCI USA, V93, P15119, DOI 10.1073/pnas.93.26.15119; Oh U, 1996, J NEUROSCI, V16, P1659; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; Petersen M, 1996, NEUROSCIENCE, V75, P495, DOI 10.1016/0306-4522(96)00259-X; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; VRAY B, 1994, J IMMUNOL METHODS, V174, P53, DOI 10.1016/0022-1759(94)90009-4; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Winter J, 1998, NEUROSCI LETT, V241, P21, DOI 10.1016/S0304-3940(97)00978-6; WOOD JN, 1988, J NEUROSCI, V8, P3208; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	35	110	117	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2756	2762		10.1074/jbc.275.4.2756	http://dx.doi.org/10.1074/jbc.275.4.2756			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644739	hybrid			2022-12-27	WOS:000085128000071
J	Cho, YS; Han, MK; Choi, YB; Yun, Y; Shin, J; Kim, UH				Cho, YS; Han, MK; Choi, YB; Yun, Y; Shin, J; Kim, UH			Direct interaction of the CD38 cytoplasmic tail and the Lck SH2 domain - CD38 transduces T cell activation signals through associated Lck	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; P56(LCK); RECEPTOR; SURFACE; EXPRESSION; MOLECULE; CHAIN; NAD+	CD38 ligation has been shown to induce activation of intracellular signaling cascade in T lymphocytes through a Lck-dependent pathway. However, it is not clear how Lck initiates the CD38-mediated signaling process. In the present study, we showed that CD38 and Lck were physically associated through the cytoplasmic tail and the Src homology 2 domain, respectively. This was evidenced by coimmunoprecipitation of Lck with CD38 and Lck with isolated CD38 cytoplasmic domain from T cell lysate, cell lysate of COS-7 cells cotransfected with cDNAs of Lck and CD38, or a mixture of in vitro translated CD38 and Lck. Because the CD38 cytoplasmic domain does not contain any tyrosine residue, the interaction should be independent of phosphotyrosine. The interaction was further confirmed by in vitro interaction between a purified Lck Src homology 2 domain and a nonphosphosynthetic peptide corresponding to the membrane proximal region of the CD38 cytoplasmic domain. In addition, CD38 ligation resulted in an elevated tyrosine kinase activity of the CD38 associated Lck and ultimate activation of interleukin-a gene transcription. Furthermore, expression of a kinase-deficient Lck mutant suppressed interleukin-a gene activation in a dose-dependent manner. These results strongly suggested that CD38 ligation indeed tranduced signals for T cell activation using its associated Lck.	Chonbuk Natl Univ, Sch Med, Dept Biochem, Chonju 561182, South Korea; Chonbuk Natl Univ, Inst Med Sci, Chonju 561182, South Korea; Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea; Samsung Biomed Res Inst, Suwon 440746, South Korea; Sungkyunkwan Univ, Sch Med, Suwon 440746, South Korea	Jeonbuk National University; Jeonbuk National University; Ewha Womans University; Ewha Womans University; Sungkyunkwan University (SKKU)	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Chonju 561182, South Korea.	uhkim@moak.chonbuk.ac.kr	Choi, Young Bong/J-4317-2019	Choi, Young Bong/0000-0002-2523-1441; Han, Myung-Kwan/0000-0003-1931-8898; /0000-0002-6224-6685; Kim, Uh-Hyun/0000-0003-3304-7190				ANDERSON SJ, 1993, NATURE, V365, P552, DOI 10.1038/365552a0; August A, 1996, J BIOL CHEM, V271, P10054; AUSIELLO CM, 1995, EUR J IMMUNOL, V25, P1477, DOI 10.1002/eji.1830250554; Choi YB, 1999, J IMMUNOL, V163, P5242; CLEGHON V, 1994, J BIOL CHEM, V269, P17749; FUNARO A, 1990, J IMMUNOL, V145, P2390; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GELEZIUNAS R, 1994, FASEB J, V8, P593, DOI 10.1096/fasebj.8.9.8005387; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; HATAKEYAMA M, 1991, SCIENCE, V252, P1523, DOI 10.1126/science.2047859; HE TC, 1995, J BIOL CHEM, V270, P11055, DOI 10.1074/jbc.270.19.11055; Inoue S, 1997, J IMMUNOL, V159, P5226; IZQUIERDO PM, 1995, IMMUNOL TODAY, V16, P159; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; KIKUCHI Y, 1995, P NATL ACAD SCI USA, V92, P11814, DOI 10.1073/pnas.92.25.11814; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kontani K, 1996, J BIOL CHEM, V271, P1534; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; LEE HC, 1989, J BIOL CHEM, V264, P1608; LITVIN DA, 1984, METHOD ENZYMOL, V108, P298; LUND F, 1995, IMMUNOL TODAY, V16, P496; Lund FE, 1998, IMMUNOL REV, V161, P79, DOI 10.1111/j.1600-065X.1998.tb01573.x; Malek SN, 1996, J BIOL CHEM, V271, P6952, DOI 10.1074/jbc.271.12.6952; MALEK SN, 1994, J BIOL CHEM, V269, P33009; Morra M, 1998, FASEB J, V12, P581, DOI 10.1096/fasebj.12.7.581; MULLER AJ, 1992, MOL CELL BIOL, V12, P5087, DOI 10.1128/MCB.12.11.5087; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Raffel GD, 1996, J BIOL CHEM, V271, P4640; RUSINKO N, 1989, J BIOL CHEM, V264, P11725; SANTOSARGUMEDO L, 1993, J IMMUNOL, V151, P3119; Silvennoinen O, 1996, J IMMUNOL, V156, P100; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416; Zubiaur M, 1997, J IMMUNOL, V159, P193	40	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1685	1690		10.1074/jbc.275.3.1685	http://dx.doi.org/10.1074/jbc.275.3.1685			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636863	hybrid			2022-12-27	WOS:000084940000026
J	Guo, N; Faller, DV; Vaziri, C				Guo, N; Faller, DV; Vaziri, C			A novel DNA damage checkpoint involving post-transcriptional regulation of cyclin A expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; RETINOBLASTOMA PROTEIN; ADDUCTS; CANCER; GROWTH; GENE; P53; E2F	The intracellular metabolism of many carcinogenic polycyclic aryl hydrocarbons (PAHs, typified by the ubiquitous pollutant benzo[a]pyrene or B[a]P) generates electrophilic products that react covalently with genomic DNA. Cells that acquire PAM-induced DNA damage undergo growth arrest in a p53-independent manner (Vaziri, C,, and Faller, D. V. (1997) J. Biol. Chem. 272, 2762-2769), In this report we have investigated the molecular basis of PAM-induced cell cycle arrest. Mitogenic signaling events involving cyclins D and E, Rb phosphorylation, and transcriptional activation of E2F-responsive genes (including cyclin E and cyclin A) were unaffected in cells containing PAM-damaged DNA. However, PAM-induced growth arrest was associated with post-transcriptional decreases in cyclin A expression. Mitogen-induced expression of cyclin B, an event that is temporally distal to cyclin A expression, was also inhibited in PAM-treated cells. The PAM-induced cell cycle block was transient, and arrested cells resumed DNA synthesis after a prolonged (similar to 20 h) delay. Resumption of DNA synthesis in PAM-treated cells occurred concomitant with elevated expression of cyclins A and B, PAH-induced cell cycle arrest was overcome by ectopically expressed cyclin A (encoded by a recombinant adenovirus in transiently infected cells). Overall, our results suggest the existence of a DNA damage checkpoint pathway that arrests cell cycle progression via post-transcriptional control of cyclin A expression.	Boston Univ, Sch Med, Ctr Canc Res, Boston, MA 02118 USA	Boston University	Vaziri, C (corresponding author), Boston Univ, Sch Med, Ctr Canc Res, 80 E Concord St, Boston, MA 02118 USA.				NCI NIH HHS [CA50454] Funding Source: Medline; NIEHS NIH HHS [ES09558] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009558, R29ES009558] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BAUM EJ, 1978, POLYCYCLIC HYDROCARB, P45; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; Desdouets C, 1995, Prog Cell Cycle Res, V1, P115; DIPPLE A, 1995, CARCINOGENESIS, V16, P437, DOI 10.1093/carcin/16.3.437; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HEIDELBERGER C, 1975, ANNU REV BIOCHEM, V44, P79, DOI 10.1146/annurev.bi.44.070175.000455; HEMMINKI K, 1993, CARCINOGENESIS, V14, P2007, DOI 10.1093/carcin/14.10.2007; Herwig S, 1997, EUR J BIOCHEM, V246, P581, DOI 10.1111/j.1432-1033.1997.t01-2-00581.x; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DH, 1996, CANCER RES, V56, P287; Mastrangelo G, 1996, ENVIRON HEALTH PERSP, V104, P1166, DOI 10.2307/3432909; Minna John D., 1997, P849; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; PERERA FP, 1995, CANCER EPIDEM BIOMAR, V4, P233; PRUESSSCHWARTZ D, 1988, CARCINOGENESIS, V10, P1863; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Spitkovsky D, 1997, CELL GROWTH DIFFER, V8, P699; Vaziri C, 1997, J BIOL CHEM, V272, P2762, DOI 10.1074/jbc.272.5.2762; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0	29	33	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1715	1722		10.1074/jbc.275.3.1715	http://dx.doi.org/10.1074/jbc.275.3.1715			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636867	hybrid			2022-12-27	WOS:000084940000030
J	Li, SL; Paulsson, KM; Chen, SW; Sjogren, HO; Wang, P				Li, SL; Paulsson, KM; Chen, SW; Sjogren, HO; Wang, P			Tapasin is required for efficient peptide binding to transporter associated with antigen processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; T-CELL RECEPTOR; TAP; COMPLEX; MOLECULES; SITE; MECHANISMS; ABSENCE	The transporter associated with antigen processing (TAP) binds peptides in its cytosolic part and subsequently translocates the peptides into the lumen of the endoplasmic reticulum (ER), where assembly of major histocompatibility complex (MHC) class I and peptide takes place. Tapasin is a subunit of the TAP complex and binds both to TAP1 and MHC class I. In the absence of tapasin, the assembly of MHC class I in the ER is impaired, and the surface expression is reduced. To clarify the function of tapasin in the processing of antigenic peptides, we studied the interaction of peptide and TAP, peptide transport across the membrane of the ER, and association of peptides with MHC class I molecules in the microsomes derived from tapasin mutant cell line 721.220, its sister cell line 721.221 expressing tapasin, and their HLA-A2 transfectants, The binding of peptides to TAP in tapasin mutant 721.220 cells was significantly diminished in comparison with 721.221 cells. Impaired peptide-TAP interaction resulted in a defective peptide transport in tapasin mutant 721.220 cells. Interestingly, despite the diminished peptide binding to TAP, the transport rate of TAP-associated peptides was not significantly altered in 721.220 cells. After transfection of tapasin cDNA into 721.220 cells, efficient peptide-TAP interaction was restored. Thus, we conclude that tapasin is required for efficient peptide-TAP interaction.	Univ Lund, S-22362 Lund, Sweden	Lund University	Li, SL (corresponding author), Univ Lund, Solvegatan 21, S-22362 Lund, Sweden.			Wang, Ping/0000-0001-8992-1233				ANDROLEWICZ MJ, 1994, IMMUNITY, V1, P7, DOI 10.1016/1074-7613(94)90004-3; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI U S, V91, P716; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; GRANDEA AG, 1995, SCIENCE, V270, P105, DOI 10.1126/science.270.5233.105; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; HILL A, 1995, P NATL ACAD SCI USA, V92, P341, DOI 10.1073/pnas.92.2.341; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1998, EUR J IMMUNOL, V28, P3214, DOI 10.1002/(SICI)1521-4141(199810)28:10<3214::AID-IMMU3214>3.3.CO;2-3; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; Li SL, 1999, J BIOL CHEM, V274, P8649, DOI 10.1074/jbc.274.13.8649; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Nijenhuis M, 1996, J IMMUNOL, V157, P5467; Nijenhuis M, 1996, J IMMUNOL, V156, P2186; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; ORTMANN B, 1994, NATURE, V368, P864, DOI 10.1038/368864a0; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; SUH WK, 1994, SCIENCE, V264, P1322, DOI 10.1126/science.8191286; Suh WK, 1999, J IMMUNOL, V162, P1530; Tomazin R, 1996, EMBO J, V15, P3256, DOI 10.1002/j.1460-2075.1996.tb00690.x; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Wang P, 1996, J IMMUNOL, V157, P213; Wang P, 1996, J BIOL CHEM, V271, P24830, DOI 10.1074/jbc.271.40.24830	32	56	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1581	1586		10.1074/jbc.275.3.1581	http://dx.doi.org/10.1074/jbc.275.3.1581			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636848	hybrid			2022-12-27	WOS:000084940000011
J	Oberste-Berghaus, C; Zanger, K; Hashimoto, K; Cohen, RN; Hollenberg, AN; Wondisford, FE				Oberste-Berghaus, C; Zanger, K; Hashimoto, K; Cohen, RN; Hollenberg, AN; Wondisford, FE			Thyroid hormone-independent interaction between the thyroid hormone receptor beta 2 amino terminus and coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-RECEPTOR; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; DEOXYRIBONUCLEIC-ACID; RESPONSE ELEMENT; VARIANT ALPHA-2; CO-REPRESSOR; N-COR; BINDING; IDENTIFICATION	Thyroid hormone receptors (TRs) mediate hormone action by binding to DNA response elements (TREs) and either activating or repressing gene expression in the presence of ligand, T-3. Coactivator recruitment to the AF-2 region of TR in the presence of T-3 is central to this process. The different TR isoforms, TR-beta 1, TR-beta 2, and TR-alpha 1, share strong homology in their DNA- and ligand-binding domains but differ in their amino-terminal domains. Because TR-beta 2 exhibits greater T-3-independent activation on TREs than other TR isoforms, we wanted to determine whether coactivators bound to TR-beta 2 in the absence of ligand, Our results show that TR-beta 2, unlike TR-beta 1 or TR-alpha 1, is able to bind certain coactivators (CBP, SRC-1, and pCIP) in the absence of T-3 through a domain which maps to the amino-terminal half of its A/B domain. This interaction is specific for certain coactivators, as TR-beta 2 does not interact with other co-factors (p120 or the CBP-associated factor (pCAF)) in the absence of T-3, The minimal TR-beta 2 domain for coactivator binding is aa 21-50, although aa 1-50 are required for the full functional response. Thus, isoform specific regulation by TRs may involve T-3-independent coactivator recruitment to the transcription complex via the AF-1 domain.	Beth Israel Deaconess Med Ctr, Thyroid Unit, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Wondisford, FE (corresponding author), Beth Israel Deaconess Med Ctr, Thyroid Unit, Res N,Rm 330C,99 Brookline Ave, Boston, MA 02215 USA.	fwondisf@caregroup.harvard.edu		Grasemann, Corinna/0000-0003-1793-4603				ABEL DE, 1999, IN PRESS J CLIN INVE, V104; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; BANIAHMAD A, 1992, P NATL ACAD SCI USA, V89, P10633, DOI 10.1073/pnas.89.22.10633; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; BREATHNACH R, 1983, NUCLEIC ACIDS RES, V11, P7119, DOI 10.1093/nar/11.20.7119; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cohen RN, 1998, MOL ENDOCRINOL, V12, P1567, DOI 10.1210/me.12.10.1567; DAIMONT BD, 1998, GENE DEV, V12, P3343; DAMM K, 1993, P NATL ACAD SCI USA, V90, P10668, DOI 10.1073/pnas.90.22.10668; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Hadzic E, 1998, J BIOL CHEM, V273, P10270, DOI 10.1074/jbc.273.17.10270; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; HOLLENBERG AN, 1995, MOL ENDOCRINOL, V9, P540, DOI 10.1210/me.9.5.540; HOLLENBERG AN, 1995, J BIOL CHEM, V270, P14274, DOI 10.1074/jbc.270.24.14274; HOLLENBERG AN, 1998, CURR OPIN ENDOCRINOL, V5, P314; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KATZ D, 1993, J BIOL CHEM, V268, P20904; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P893, DOI 10.1210/mend-2-10-893; LECHAN RM, 1994, ENDOCRINOLOGY, V135, P92, DOI 10.1210/en.135.1.92; LIU RT, 1995, MOL ENDOCRINOL, V9, P86, DOI 10.1210/me.9.1.86; Monden T, 1997, J BIOL CHEM, V272, P29834, DOI 10.1074/jbc.272.47.29834; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; ONATE SA, 1995, SCIENCE, V270, P1354; SAKURAI A, 1990, MOL CELL ENDOCRINOL, V71, P83; SAKURAI A, 1989, MOL ENDOCRINOL, V3, P392, DOI 10.1210/mend-3-2-392; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; TomicCanic M, 1996, J BIOL CHEM, V271, P1416, DOI 10.1074/jbc.271.3.1416; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tremblay GB, 1999, MOL CELL BIOL, V19, P1919; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	43	61	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1787	1792		10.1074/jbc.275.3.1787	http://dx.doi.org/10.1074/jbc.275.3.1787			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636876	hybrid			2022-12-27	WOS:000084940000039
J	Ueda, H; Itoh, H; Yamauchi, J; Morishita, R; Kaziro, Y; Kato, K; Asano, T				Ueda, H; Itoh, H; Yamauchi, J; Morishita, R; Kaziro, Y; Kato, K; Asano, T			G protein beta gamma subunits induce stress fiber formation and focal adhesion assembly in a Rho-dependent manner in HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; COUPLED RECEPTORS; SIGNALING PATHWAY; TYROSINE KINASE; JUN KINASE; EXPRESSION; ACTIVATION; 3-KINASE-GAMMA; G-ALPHA(12); STIMULATION	In fibroblasts, the G protein alpha subunits G alpha(12) and G alpha(13) stimulate Rho-dependent stress fiber formation and focal adhesion assembly, whereas G protein beta gamma subunits instead exert a disruptive influence. We show here that the latter can, however, stimulate the formation of stress fibers and focal adhesions in epithelial-like HeLa cells. Transient expression of beta(1) with gamma(2), gamma(5), gamma(7), and gamma(12) in quiescent HeLa cells induced stress fiber formation and focal adhesion assembly as did expression of the constitutively active G alpha(12). Co-expression of beta gamma with G alpha(i2) and the C-terminal fragment of the beta-adrenergic receptor kinase, both of which are known to bind and sequester free beta gamma, blocked beta gamma-induced stress fiber and focal adhesion formation. Inhibition was also noted with co-expression of a dominant negative mutant of Rho. Botulinum C3 exoenzyme, which ADP-ribosylates and inactivates Rho, and a Rho-associated protein kinase inhibitor, Y-27632, similarly inhibited beta gamma-induced stress fiber and focal adhesion assembly. These results indicate that G protein beta gamma subunits regulate Rho-dependent actin polymerization in HeLa cells.	Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Kasugai, Aichi 4800392, Japan; Tokyo Inst Technol, Fac Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Asano, T (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Biochem, Kasugai, Aichi 4800392, Japan.							BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Collins LR, 1996, J BIOL CHEM, V271, P17349, DOI 10.1074/jbc.271.29.17349; Coso OA, 1996, J BIOL CHEM, V271, P3963; EVANS CJ, 1992, SCIENCE, V258, P1952, DOI 10.1126/science.1335167; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lin HC, 1998, P NATL ACAD SCI USA, V95, P5057, DOI 10.1073/pnas.95.9.5057; Lopez-Ilasaca M, 1998, J BIOL CHEM, V273, P2505, DOI 10.1074/jbc.273.5.2505; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; MORISHITA R, 1988, EUR J BIOCHEM, V174, P87, DOI 10.1111/j.1432-1033.1988.tb14066.x; MORISHITA R, 1995, J BIOL CHEM, V270, P29469, DOI 10.1074/jbc.270.49.29469; Nagao M, 1998, J BIOL CHEM, V273, P22892, DOI 10.1074/jbc.273.36.22892; NEMOTO Y, 1991, J BIOL CHEM, V266, P19312; Nern A, 1998, NATURE, V391, P195, DOI 10.1038/34458; NOBES CD, 1995, J CELL SCI, V108, P225; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Ueda H, 1997, J CELL SCI, V110, P1503; Ueda H, 1999, J BIOL CHEM, V274, P12124, DOI 10.1074/jbc.274.17.12124; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Yamauchi J, 1999, J BIOL CHEM, V274, P1957, DOI 10.1074/jbc.274.4.1957; YAMAUCHI J, 1995, BIOCHEM BIOPH RES CO, V214, P694, DOI 10.1006/bbrc.1995.2341; ZHAO ZS, 1995, MOL CELL BIOL, V15, P5246	29	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2098	2102		10.1074/jbc.275.3.2098	http://dx.doi.org/10.1074/jbc.275.3.2098			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636914	hybrid			2022-12-27	WOS:000084940000077
J	Martin, H; Rodriguez-Pachon, JM; Ruiz, C; Nombela, C; Molina, M				Martin, H; Rodriguez-Pachon, JM; Ruiz, C; Nombela, C; Molina, M			Regulatory mechanisms for modulation of signaling through the cell integrity Slt2-mediated pathway in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GTP-BINDING PROTEIN; EXCHANGE FACTOR ROM2; MAP KINASE; TYROSINE PHOSPHATASES; TRANSDUCTION PATHWAY; SHUTTLE VECTORS; STRESS-RESPONSE; WALL INTEGRITY; BUD EMERGENCE	Signal transduction mediated by the mitogen-activated protein kinase (MAPK) Slt2 pathway is essential to maintain the cell wall integrity in Saccharomyces cerevisiae. Stimulation of MAPK pathways results in activation by phosphorylation of conserved threonine and tyrosine residues of MAPKs. We have used an antibody that specifically recognizes dually phosphorylated Slt2 to gain insight into the activation and modulation of signaling through the cell integrity pathway. We show that caffeine and vanadate activate this pathway in the absence of osmotic stabilization. The lack of the putative cell surface sensor Mid2 prevents vanadate- but not caffeine-induced Slt2 phosphorylation. Disruption of the Rhol-GTPase-activating protein genes SAC7 and BEM2 leads to constitutive Slt2 activation, indicating their involvement as negative regulators of the pathway. MAPK kinases also seem to participate in signaling regulation, Mkk1 playing a greater role than Mkk2 in signal transmission to Slt2. Additionally, one of the phosphatases involved in Slt2 dephosphorylation is likely to be the dual specificity phosphatase Msg5, since overexpression of MSG5 in a sac7 Delta mutant eliminates the high Slt2 phosphorylation, and disruption of MSG5 in wild type cells results in increased phosphorylation levels, These data present the first evidence for a negative regulation of the cell integrity pathway.	Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	Complutense University of Madrid	Molina, M (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Plaza Ramon & Cajal S-N, E-28040 Madrid, Spain.	molmifa@eucmax.sim.ucm.es	Nombela Cano, César/H-2565-2015; Brieva, Humberto Martin/E-9254-2016; Ruiz-Romero, Cristina/B-2937-2009; Ruiz-Romero, Cristina/A-8690-2012; Martín, Humberto/Z-3423-2019; Molina, Maria/ABE-7186-2021	Nombela Cano, César/0000-0003-0757-4034; Brieva, Humberto Martin/0000-0002-6736-3602; Ruiz-Romero, Cristina/0000-0001-7649-9803; Martín, Humberto/0000-0002-6736-3602; Molina, Maria/0000-0003-0074-3309				BALLOU L, 1991, P NATL ACAD SCI USA, V88, P3209, DOI 10.1073/pnas.88.8.3209; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Buehrer BM, 1997, MOL CELL BIOL, V17, P6517, DOI 10.1128/MCB.17.11.6517; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COSTIGAN C, 1992, MOL CELL BIOL, V12, P1162, DOI 10.1128/MCB.12.3.1162; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; DUNN TM, 1990, MOL CELL BIOL, V10, P2308, DOI 10.1128/MCB.10.5.2308; ERREDE B, 1993, NATURE, V362, P261, DOI 10.1038/362261a0; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x; HUANG KN, 1995, GENETICS, V141, P1275; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jacoby JJ, 1998, MOL GEN GENET, V258, P148, DOI 10.1007/s004380050717; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; KANIKENNULAT C, 1995, GENETICS, V140, P933; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Lussier M, 1997, GENETICS, V147, P435; Mannazzu I, 1998, MICROBIOL-SGM, V144, P2589, DOI 10.1099/00221287-144-9-2589; Martin H, 1996, CURR GENET, V29, P516; MARTIN H, 1993, MOL GEN GENET, V241, P177, DOI 10.1007/BF00280215; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Nakamura T, 1997, MOL GEN GENET, V256, P481, DOI 10.1007/s004380050592; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629, DOI 10.1128/MCB.7.10.3629; NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; PARSONS WJ, 1988, MOL PHARMACOL, V34, P37; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; SERVOS J, 1993, MOL GEN GENET, V236, P214, DOI 10.1007/BF00277115; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SOLER M, 1995, MOL MICROBIOL, V17, P833, DOI 10.1111/j.1365-2958.1995.mmi_17050833.x; Sugiura R, 1999, NATURE, V399, P479, DOI 10.1038/20951; TAKEUCHI J, 1995, BBA-GENE STRUCT EXPR, V1260, P94, DOI 10.1016/0167-4781(94)00188-9; TORRES L, 1991, MOL MICROBIOL, V5, P2845, DOI 10.1111/j.1365-2958.1991.tb01993.x; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Wilkinson MG, 1998, GENE DEV, V12, P1391, DOI 10.1101/gad.12.10.1391; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	61	292	296	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1511	1519		10.1074/jbc.275.2.1511	http://dx.doi.org/10.1074/jbc.275.2.1511			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625705	hybrid			2022-12-27	WOS:000084836600109
J	Micoli, KJ; Pan, G; Wu, Y; Williams, JP; Cook, WJ; McDonald, JM				Micoli, KJ; Pan, G; Wu, Y; Williams, JP; Cook, WJ; McDonald, JM			Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 TRANSMEMBRANE PROTEIN; LIGHT CHAIN KINASE; T-CELLS; ACID SPHINGOMYELINASE; SIGNAL-TRANSDUCTION; DNA FRAGMENTATION; INFECTED CELLS; UP-REGULATION; EXPRESSION	Accelerated apoptosis is one mechanism proposed for the loss of CD4+ T-lymphocytes in human immunodeficiency virus type 1 (HIV-1) infection. The HIV-1 envelope glycoprotein, gp160, contains two C-terminal calmodulin-binding domains. Expression of gp160 in Jurkat T-cells results in increased sensitivity to FAS- and ceramide-mediated apoptosis, The pro-apoptotic effect of gp160 expression is blocked by two calmodulin antagonists, tamoxifen and trifluoperazine. This enhanced apoptosis in response to FAS antibody or C-2-ceramide is associated with activation of caspase 3, a critical mediator of apoptosis, A point mutation in the C-terminal calmodulin-binding domain of gp160 (alanine 835 to tryptophan, A835W) eliminates gp160-dependent enhanced FAS-mediated apoptosis in transiently transfected cells, as well as in vitro calmodulin binding to a peptide corresponding to the C-terminal calmodulin-binding domain of gp160, Stable Tet-off Jurkat cell lines were developed that inducibly express wild type gp160 or gp160A835W, Increasing expression of wild type gp160, but not gp160A835W, correlates with increased calmodulin levels, increased apoptosis, and caspase 3 activation in response to anti-FAS treatment. The data indicate that gp160-enhanced apoptosis is dependent upon calmodulin up-regulation, involves the activation of caspase 3, and requires calmodulin binding to the C-terminal binding domain of gp160.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Vet Adm Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	McDonald, JM (corresponding author), Univ Alabama, Dept Pathol, 701 19th St S,LHRB 509, Birmingham, AL 35294 USA.				NCI NIH HHS [CA/72823] Funding Source: Medline; NIAID NIH HHS [R01 AI049090] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049090] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON SR, 1986, CALCIUM CELL FUNCTIO, V6, P2; Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; Asada A, 1998, J BIOL CHEM, V273, P28392, DOI 10.1074/jbc.273.43.28392; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Bartz SR, 1999, J VIROL, V73, P1956, DOI 10.1128/JVI.73.3.1956-1963.1999; BLUMENTHAL DK, 1985, P NATL ACAD SCI USA, V82, P3187, DOI 10.1073/pnas.82.10.3187; Boesen-de Cock JGR, 1998, J BIOL CHEM, V273, P7560, DOI 10.1074/jbc.273.13.7560; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cohen O, 1999, J CELL BIOL, V146, P141; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; DUBAY JW, 1992, J VIROL, V66, P6616, DOI 10.1128/JVI.66.11.6616-6625.1992; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gehri R, 1996, AIDS, V10, P9, DOI 10.1097/00002030-199601000-00002; GLYNN JM, 1996, J IMMUNOL, V157, P1754; Granville DJ, 1998, FEBS LETT, V422, P151, DOI 10.1016/S0014-5793(97)01616-5; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; Ishikawa H, 1998, J VIROL, V72, P6574, DOI 10.1128/JVI.72.8.6574-6580.1998; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; Kawai T, 1999, ONCOGENE, V18, P3471, DOI 10.1038/sj.onc.1202701; Khodarev NN, 1996, J IMMUNOL, V156, P922; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Pan G, 1998, IMMUNOPHARMACOLOGY, V40, P91, DOI 10.1016/S0162-3109(98)00018-6; Pan ZG, 1996, AM J PATHOL, V149, P903; PAPP B, 1994, AIDS RES HUM RETROV, V10, P775, DOI 10.1089/aid.1994.10.775; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Prati E, 1997, AIDS RES HUM RETROV, V13, P1501, DOI 10.1089/aid.1997.13.1501; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Sasaki M, 1996, VIROLOGY, V224, P18, DOI 10.1006/viro.1996.0502; Schwandner R, 1998, J BIOL CHEM, V273, P5916, DOI 10.1074/jbc.273.10.5916; Silvestris F, 1996, AIDS, V10, P131, DOI 10.1097/00002030-199602000-00002; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Staunton MJ, 1998, ARCH PATHOL LAB MED, V122, P310; Tencza SB, 1997, AIDS RES HUM RETROV, V13, P263, DOI 10.1089/aid.1997.13.263; TENCZA SB, 1995, J VIROL, V69, P5199, DOI 10.1128/JVI.69.8.5199-5202.1995; VANVELDHOVEN PP, 1992, BIOCHEM BIOPH RES CO, V187, P209, DOI 10.1016/S0006-291X(05)81480-9; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Zhang YJ, 1997, AIDS, V11, P1219, DOI 10.1097/00002030-199710000-00004	51	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1233	1240		10.1074/jbc.275.2.1233	http://dx.doi.org/10.1074/jbc.275.2.1233			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625668				2022-12-27	WOS:000084836600072
J	Petiot, A; Ogier-Denis, E; Blommaart, EFC; Meijer, AJ; Codogno, P				Petiot, A; Ogier-Denis, E; Blommaart, EFC; Meijer, AJ; Codogno, P			Distinct classes of phosphatidylinositol 3 '-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; PROTEIN-KINASE-B; PHOSPHOINOSITIDE 3-KINASE ACTIVITY; CONTROLS AUTOPHAGIC SEQUESTRATION; C2 DOMAIN; AKT PROTOONCOGENE; MOUSE FIBROBLASTS; LATE ENDOSOMES; PI 3-KINASE; LINE HT-29	3-Methyladenine which stops macroautophagy at the sequestration step in mammalian cells also inhibits the phosphoinositide 3-kinase (PI3K) activity raising the possibility that PI3K signaling controls the macroautophagic pathway (Blommaart, E. F. C., Krause, U., Schellens, J. P. M., Vreeling-Sindelarova, H., and Meijer, A. J. (1997) fur. J, Biochem. 243, 240-246). The aim of this study was to identify PI3Ks involved in the control of macroautophagic sequestration in human colon cancer HT-29 cells. An increase of class I PISK products (phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-triphosphate) caused by either feeding cells with synthetic lipids (dipalmitoyl phosphatidylinositol 3,4-bisphosphate and dipalmitoyl phosphatidylinositol 3,4,5-triphosphate) or by stimulating the enzymatic activity by interleukin-13 reduced macroautophagy, In contrast, an increase in the class III PISK product (phosphatidylinositol 3-phosphate), either by feeding cells with a synthetic lipid or by overexpressing the p150 adaptor, stimulates macroautophagy. Transfection of a specific class III PISK antisense oligonucleotide greatly inhibited the rate of macroautophagy. In accordance with a role of class III PISK, wortmannin tan inhibitor of PI3Ks) inhibits macroautophagic sequestration and protein degradation in the low nanomolar range (IC50 5-15 nM), Further in vitro enzymatic assay showed that 3-methyladenine inhibits the class III PISK activity. Dipalmitoyl phosphatidylinositol 3-phosphate supplementation or p150 overexpression rescued the macroautophagic pathway in HT-29 cells overexpressing a GTPase-deficient mutant of the G alpha(i3) protein suggesting that both class III PISK and trimeric G(i3) protein signaling are required in the control macroautophagy in HT-29 cells. In conclusion, our results demonstrate that distinct classes of PI3K control the macroautophagic pathway in opposite directions. The roles of PI3Ks in macroautophagy are discussed in the context of membrane recycling.	INSERM, U504, F-94807 Villejuif, France; Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Amsterdam; Academic Medical Center Amsterdam	Codogno, P (corresponding author), INSERM, U504, 16 Ave Paul Vaillant Couturier, F-94807 Villejuif, France.	codogno@vjf.inserm.fr	Codogno, Patrice/G-1384-2013; Ogier-Denis, Eric/E-5030-2016	Codogno, Patrice/0000-0002-5492-3180; PETIOT, Anne/0000-0001-8038-470X; Ogier-Denis, Eric/0000-0002-0057-7593				Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Codogno P, 1997, CELL SIGNAL, V9, P125, DOI 10.1016/S0898-6568(96)00130-1; Daniele N, 1999, J BIOL CHEM, V274, P3597, DOI 10.1074/jbc.274.6.3597; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Hickinson DM, 1997, CURR BIOL, V7, P987, DOI 10.1016/S0960-9822(06)00418-0; Jones SM, 1997, J CELL BIOL, V139, P339, DOI 10.1083/jcb.139.2.339; KOPITZ J, 1990, J CELL BIOL, V111, P941, DOI 10.1083/jcb.111.3.941; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; MACDOUGLAS LK, 1995, CURR BIOL, V5995, P1404; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Molz L, 1996, J BIOL CHEM, V271, P13892, DOI 10.1074/jbc.271.23.13892; Mortimore G. E., 1994, CELLULAR PROTEOLYTIC, P65; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Panaretou C, 1997, J BIOL CHEM, V272, P2477; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Phung TL, 1997, J BIOL CHEM, V272, P30693, DOI 10.1074/jbc.272.49.30693; PUNNONEN EL, 1994, EUR J CELL BIOL, V65, P14; Reaves BJ, 1996, J CELL SCI, V109, P749; Reif K, 1997, J BIOL CHEM, V272, P14426, DOI 10.1074/jbc.272.22.14426; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Scott SV, 1998, CURR OPIN CELL BIOL, V10, P523, DOI 10.1016/S0955-0674(98)80068-9; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Siddhanta U, 1998, J CELL BIOL, V143, P1647, DOI 10.1083/jcb.143.6.1647; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; Thyberg J, 1998, EUR J CELL BIOL, V76, P33, DOI 10.1016/S0171-9335(98)80015-0; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Virbasius JV, 1996, J BIOL CHEM, V271, P13304, DOI 10.1074/jbc.271.23.13304; VOLINIA S, 1995, EMBO J, V14, P3339, DOI 10.1002/j.1460-2075.1995.tb07340.x; Whiteford CC, 1997, BIOCHEM J, V323, P597, DOI 10.1042/bj3230597; Wright K, 1999, J BIOL CHEM, V274, P17193, DOI 10.1074/jbc.274.24.17193; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	58	996	1049	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					992	998		10.1074/jbc.275.2.992	http://dx.doi.org/10.1074/jbc.275.2.992			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625637	hybrid			2022-12-27	WOS:000084836600041
J	Xiao, HY; Hasegawa, T; Isobe, K				Xiao, HY; Hasegawa, T; Isobe, K			p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; BINDING-PROTEIN; ACETYLTRANSFERASE ACTIVITY; TBP COMPLEXES; TRANSCRIPTION; E1A; DIFFERENTIATION; INDUCTION; WAF1/CIP1; DOMAIN	We have reported that histone acetylation induced by trichostatin A (TSA) promotes p21(waf1/cip1) (p21) expression, the GC-box located just upstream of TATA box was responsible for TSA-induced promoter activation, and both Spl and Sp3 were the working activator of this GC-box, To understand the molecular pathway from histone acetylation to this Spl family factors-mediated promoter activation, we investigated the function of p300, one of the histone acetyltransferase, in the present work. The evidence supporting the linkage between p300 and TSA-induced p21 promoter activation were realized from the following findings: 1) cotransfection of p300 elevated pal promoter activity, and this elevation was dependent on TSA-responsive GC-box; 2) TSA-induced promoter activation was blocked by the introduction of p300 dominant-negative mutant into cells; and 3) Sp1- or Sp3-mediated activation was also suppressed by this p300 dominant-negative mutant. Our data also suggested that p300 collaborates with Spl in a way which is different from that when p300 collaborates with p53 in p21 transcription.	Natl INst Longev Sci, Dept Basic Gerontol, Aichi 4748522, Japan; W China Univ Med Sci, Canc Res Inst, Chengdu 610041, Peoples R China	Sichuan University	Isobe, K (corresponding author), Natl INst Longev Sci, Dept Basic Gerontol, 36-3 Gengo Morioka Cho, Aichi 4748522, Japan.		isobe, ken-ichi/A-6685-2011	isobe, ken-ichi/0000-0002-8150-2496				ABRAHAM SE, 1993, ONCOGENE, V8, P1639; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Billon N, 1996, ONCOGENE, V13, P2047; BOND JA, 1995, CANCER RES, V55, P2404; Dallas PB, 1997, J VIROL, V71, P1726, DOI 10.1128/JVI.71.2.1726-1731.1997; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HARPER JW, 1993, CELL, V75, P806; JIANG HP, 1994, ONCOGENE, V9, P3397; JONSON M, 1994, MOL CARCINOGEN, V11, P59; Mazzarelli JM, 1997, J VIROL, V71, P7978, DOI 10.1128/JVI.71.10.7978-7983.1997; MICHIELI P, 1994, CANCER RES, V54, P3391; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Parks CL, 1996, J BIOL CHEM, V271, P4417; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Sandmoller A, 1996, MOL CELL BIOL, V16, P5846; Shetty S, 1999, BIOCHEM J, V339, P751, DOI 10.1042/0264-6021:3390751; Somasundaram K, 1997, ONCOGENE, V14, P1047, DOI 10.1038/sj.onc.1201002; Sundqvist A, 1998, FEBS LETT, V429, P183, DOI 10.1016/S0014-5793(98)00588-2; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wang LA, 1997, MOL CELL BIOL, V17, P519, DOI 10.1128/MCB.17.1.519; Xiao HY, 1999, J CELL BIOCHEM, V73, P291, DOI 10.1002/(SICI)1097-4644(19990601)73:3<291::AID-JCB1>3.0.CO;2-5; Xiao HY, 1997, BIOCHEM BIOPH RES CO, V237, P457, DOI 10.1006/bbrc.1997.7158; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009	36	154	158	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1371	1376		10.1074/jbc.275.2.1371	http://dx.doi.org/10.1074/jbc.275.2.1371			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625687	hybrid			2022-12-27	WOS:000084836600091
J	Gilbert, M; Brisson, JR; Karwaski, MF; Michniewicz, J; Cunningham, AM; Wu, YY; Young, NM; Wakarchuk, WW				Gilbert, M; Brisson, JR; Karwaski, MF; Michniewicz, J; Cunningham, AM; Wu, YY; Young, NM; Wakarchuk, WW			Biosynthesis of ganglioside mimics in Campylobacter jejuni OH4384 - Identification of the glycosyltransferase genes, enzymatic synthesis of model compounds, and characterization of nanomole amounts by 600-MHz H-1 and C-13 NMR analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUILLAIN-BARRE-SYNDROME; NEISSERIA-MENINGITIDIS; MOLECULAR MIMICRY; HOST STRUCTURES; LIPOPOLYSACCHARIDES; RESIDUES; ALPHA-2,3-SIALYLTRANSFERASE; POLYSACCHARIDE; SEROTYPE-O-19; SEROSTRAIN	We have applied two strategies for the cloning of four genes responsible for the biosynthesis of the GT1a ganglioside mimic in the lipooligosaccharide (LOS) of a bacterial pathogen, Campylobacter jejuni OH4384, which has been associated with Guillain-Barre syndrome. We first cloned a gene encoding an alpha-2,3-sialyltransferase (cst-I) using an activity screening strategy. We then used nucleotide sequence information from the recently completed sequence from C.jejuni NCTC 11168 to amplify a region involved in LOS biosynthesis from C, jejuni OH4384, The LOS biosynthesis locus from C, jejuni OH4384 is 11.47 kilobase pairs and encodes 13 partial or complete open reading frames, while the corresponding locus in C,jejuni NCTC 11168 spans 13.49 kilobase pairs and contains 15 open reading frames, indicating a different organization between these two strains. Potential glycosyltransferase genes were cloned individually, expressed in Escherichia coli, and assayed using synthetic fluorescent oligosaccharides as accepters. We identified genes encoding a beta-1,4-N-acetylgalactosaminyl-transferase (cgtA), a beta-1,3-galactosyltransferase (cgtB), and a bifunctional sialyltransferase (cst-II), which transfers sialic acid to 0-3 of galactose and to 0-8 of a sialic acid that is linked alpha-2,3 to a galactose, The linkage specificity of each identified glycosyltransferase was confirmed by NMR analysis at 600 MHz on nanomole amounts of model compounds synthesized in vitro. Using a gradient inverse broadband nano-NMR probe, sequence information could be obtained by detection of (3)J(C,H) correlations across the glycosidic bond. The role of cgtA and csf-II in the synthesis of the GT1a mimic in C,jejuni OH4384 were confirmed by comparing their sequence and activity with corresponding homologues in two related C,jejuni strains that express shorter ganglioside mimics in their LOS.	Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Wakarchuk, WW (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	warren.wakarchuk@nrc.ca	Wakarchuk, Warren/Q-9514-2017; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Gilbert, Michel/0000-0002-0204-4408				ASPINALL GO, 1992, J BACTERIOL, V174, P1324, DOI 10.1128/jb.174.4.1324-1332.1992; ASPINALL GO, 1994, BIOCHEMISTRY-US, V33, P250, DOI 10.1021/bi00167a033; ASPINALL GO, 1994, INFECT IMMUN, V62, P2122, DOI 10.1128/IAI.62.5.2122-2125.1994; ASPINALL GO, 1994, BIOCHEMISTRY-US, V33, P241, DOI 10.1021/bi00167a032; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Brisson JR, 1997, BIOCHEMISTRY-US, V36, P3278, DOI 10.1021/bi961819l; Chester MA, 1998, EUR J BIOCHEM, V257, P293; Fry BN, 1998, MICROBIOL-SGM, V144, P2049, DOI 10.1099/00221287-144-8-2049; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Gilbert M, 1998, NAT BIOTECHNOL, V16, P769, DOI 10.1038/nbt0898-769; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Klena JD, 1998, GENE, V222, P177, DOI 10.1016/S0378-1119(98)00501-0; KUROKI S, 1993, ANN NEUROL, V33, P243, DOI 10.1002/ana.410330304; MANZI A, 1995, J BIOL CHEM, V270, P9154, DOI 10.1074/jbc.270.16.9154; MICHON F, 1987, BIOCHEMISTRY-US, V26, P8399, DOI 10.1021/bi00399a055; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Moran AP, 1996, J ENDOTOXIN RES, V3, P521, DOI 10.1177/096805199600300611; PARELLA T, 1995, J MAGN RESON SER A, V112, P241, DOI 10.1006/jmra.1995.1038; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; SABESAN S, 1984, CAN J CHEM, V62, P1034, DOI 10.1139/v84-172; SABESAN S, 1986, J AM CHEM SOC, V108, P2068, DOI 10.1021/ja00268a056; Salloway S, 1996, INFECT IMMUN, V64, P2945, DOI 10.1128/IAI.64.8.2945-2949.1996; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wakarchuk W, 1996, J BIOL CHEM, V271, P19166, DOI 10.1074/jbc.271.32.19166; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Wakarchuk WW, 1998, PROTEIN ENG, V11, P295, DOI 10.1093/protein/11.4.295; Wood AC, 1999, MICROBIOL-UK, V145, P379, DOI 10.1099/13500872-145-2-379	31	218	235	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3896	3906		10.1074/jbc.275.6.3896	http://dx.doi.org/10.1074/jbc.275.6.3896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660542	hybrid			2022-12-27	WOS:000085288800026
J	Sharma, KK; Kumar, RS; Kumar, GS; Quinn, PT				Sharma, KK; Kumar, RS; Kumar, GS; Quinn, PT			Synthesis and characterization of a peptide identified as a functional element in alpha A-crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; HEAT-SHOCK-PROTEIN; B-CRYSTALLIN; MOLECULAR CHAPERONE; 1,1'-BI(4-ANILINO)NAPHTHALENE-5,5'-DISULFONIC ACID; TERMINAL DOMAIN; LENS; BINDING; GROEL; TISSUES	Eye lens alpha-crystallin is a member of the small heat shock protein (sHSP) family and forms large multimeric structures. Earlier studies have shown that it can act like a molecular chaperone and form a stable complex with partially unfolded proteins, We have observed that prior binding of the hydrophobic protein melittin to alpha-crystallin diminishes its chaperone-like activity toward denaturing alcohol dehydrogenase, suggesting the presence of mutually exclusive sites for these proteins in alpha-crystallin, To investigate the mechanism of the interaction between alpha-crystallin and substrate proteins, we determined the melittin-binding sites in alpha-crystallin by cross-linking studies. Localization of melittin-binding sites in alpha-crystallin resulted in the identification of RTLGPFYPSR and FVIFLDVKHFSPEDLTVK of alpha A-crystallin and FSVNLDVK of alpha B-crystallin as the chaperone sites. Of these sites, FVIFLDVKHFSPEDLTVK and FSVNLDVK were identified earlier as 1,1'-bi(4-anilino) naphthalene-5,5'-disulfonic acid (bis-ANS)-binding hydrophobic sites. Here we also report the synthesis and characterization of the peptide, KFVIFLDVKHFSPEDLTVK, having the melittin as well as bis-ANS-binding sequence of alpha A-crystallin. We show that this peptide has characteristics similar to that of alpha A-crystallin by in vitro thermal aggregation assay, gel filtration study, CD spectroscopy, and bis-ANS interaction studies. The peptide sequence corresponds to the beta 3 and beta 4 region present in the cu-crystallin domain of sHSP 16.5. We hypothesize that the alpha-crystallin domain in other sHSPs may have a similar function and would likely possess the anti-aggregation property even when separated from the native protein.	Univ Missouri, Dept Ophthalmol, Mason Eye Inst, Columbia, MO 65212 USA; Univ Missouri, Dept Biochem, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sharma, KK (corresponding author), Univ Missouri, Dept Ophthalmol, Mason Eye Inst, Columbia, MO 65212 USA.		Kumar, Dr Suresh/HHZ-2615-2022; KUMAR, P. SURESH/AAT-8951-2020; Kumar, Gopinatha Suresh/W-1461-2019	Kumar, Dr Suresh/0000-0002-2539-6553; KUMAR, P. SURESH/0000-0003-3222-2604; 	NATIONAL EYE INSTITUTE [R01EY011981] Funding Source: NIH RePORTER; NEI NIH HHS [EY11981] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Arrigo AP, 1994, BIOL HEAT SHOCK PROT, P335; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bloemendal M, 1999, BBA-PROTEIN STRUCT M, V1432, P234, DOI 10.1016/S0167-4838(99)00107-7; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brazil BT, 1997, J BIOL CHEM, V272, P5105, DOI 10.1074/jbc.272.8.5105; BYER CF, 1973, NATURE-NEW BIOL, V241, P78; Carver JA, 1996, EXP EYE RES, V63, P639, DOI 10.1006/exer.1996.0158; Clark JI, 1996, P NATL ACAD SCI USA, V93, P15185, DOI 10.1073/pnas.93.26.15185; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GESELOWITZ DA, 1995, BIOCONJUGATE CHEM, V6, P502, DOI 10.1021/bc00034a021; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Leroux MR, 1997, J BIOL CHEM, V272, P12847, DOI 10.1074/jbc.272.19.12847; Lindner RA, 1998, EUR J BIOCHEM, V258, P170, DOI 10.1046/j.1432-1327.1998.2580170.x; Mchaourab HS, 1999, INVEST OPHTH VIS SCI, V40, pS300; MERCK KB, 1993, MOL BIOL REP, V18, P209, DOI 10.1007/BF01674432; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; RAO PV, 1994, J BIOL CHEM, V269, P13266; SEALE JW, 1995, BIOCHEMISTRY-US, V34, P7443, DOI 10.1021/bi00022a018; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; Smith JB, 1996, EXP EYE RES, V63, P125, DOI 10.1006/exer.1996.0100; Smulders RHPH, 1997, FEBS LETT, V409, P101, DOI 10.1016/S0014-5793(97)00498-5; SMULDERS RHPH, 1995, EUR J BIOCHEM, V232, P834, DOI 10.1111/j.1432-1033.1995.834zz.x; TAKEMOTO L, 1993, BIOCHEM J, V294, P435, DOI 10.1042/bj2940435; TAKEMOTO L, 1994, CURR EYE RES, V13, P35, DOI 10.3109/02713689409042396; VANDENIJSSEL PRLA, 1994, FEBS LETT, V355, P54, DOI 10.1016/0014-5793(94)01175-3; WANG KY, 1994, J BIOL CHEM, V269, P13601; YANG JT, 1986, METHOD ENZYMOL, V130, P208	43	195	212	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3767	3771		10.1074/jbc.275.6.3767	http://dx.doi.org/10.1074/jbc.275.6.3767			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660525	hybrid			2022-12-27	WOS:000085288800009
J	Gerrish, K; Grannon, M; Shih, D; Henderson, E; Stoffel, M; Wright, CVE; Stein, R				Gerrish, K; Grannon, M; Shih, D; Henderson, E; Stoffel, M; Wright, CVE; Stein, R			Pancreatic beta cell-specific transcription of the pdx-1 gene - The role of conserved upstream control regions and their hepatic nuclear factor 3 beta sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE; HOMEODOMAIN PROTEIN; HOMEOBOX FACTOR; HYPERSENSITIVE SITES; MOUSE EMBRYO; ISLET CELLS; YOUNG MODY1; EXPRESSION; ACTIVATION; ENDODERM	To identify potential transactivators of pdx-1, we sequenced approximately 4.5 kilobases of the 5' promoter region of the human and chicken homologs, assuming that sequences conserved with the mouse gene would contain critical cis-regulatory elements. The sequences associated with hypersensitive site 1 (HSS1) represented the principal area of homology within which three conserved subdomains were apparent: area I (-2694 to -2561 base pairs (bp)), area II (-2139 to -1958 bp), and area III (-1879 to -1799 bp), The identities between the mouse and chicken/human genes are very high, ranging from 78 to 89%, although only areas I and III are present within this region in chicken. Pancreatic beta cell-selective expression was shown to be controlled by mouse and human area I or area II, but not area III, from an analysis of pdx-1-driven reporter activity in transfected beta- and non-beta cells. Mutational and functional analyses of conserved hepatic nuclear factor 3 (HNF3)-like sites located within area I and area II demonstrated that activation by these regions was mediated by HNF3 beta, To determine if a similar regulatory relationship might exist within the context of the endogenous gene, pdx-1 expression was measured in embryonic stem cells in which one or both alleles of HNF3 beta were inactivated, pdx-1 mRNA levels induced upon differentiation to embryoid bodies were down-regulated in homozygous null HNF3 beta cells. Together, these results suggest that the conserved sequences represented by areas I and II define the binding sites for factors such as HNF3 beta, which control islet beta cell-selective expression of the pdx-1 gene.	Rockefeller Univ, Lab Metabol Dis, New York, NY 10021 USA; Vanderbilt Univ, Med Ctr, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA	Rockefeller University; Vanderbilt University; Vanderbilt University	Stein, R (corresponding author), Rockefeller Univ, Lab Metabol Dis, 1230 York Ave, New York, NY 10021 USA.		Gannon, Maureen A/F-9060-2012	Stoffel, Markus/0000-0003-1304-5817	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050203] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD 28062] Funding Source: Medline; NIDDK NIH HHS [DK 42502, R01 DK50203] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; BrethertonWatt D, 1996, BIOCHEM J, V313, P495, DOI 10.1042/bj3130495; Carty MD, 1997, J BIOL CHEM, V272, P11986, DOI 10.1074/jbc.272.18.11986; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692; Dutta S, 1998, NATURE, V392, P560, DOI 10.1038/33311; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Felsenfeld G, 1996, P NATL ACAD SCI USA, V93, P9384, DOI 10.1073/pnas.93.18.9384; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GUZ Y, 1995, DEVELOPMENT, V121, P11; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Inoue H, 1996, DIABETES, V45, P789, DOI 10.2337/diabetes.45.6.789; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kim SK, 1997, DEVELOPMENT, V124, P4243; Larsson LI, 1996, MECH DEVELOP, V60, P175, DOI 10.1016/S0925-4773(96)00609-0; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; MARTI E, 1995, DEVELOPMENT, V121, P2537; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; OLSON LK, 1995, P NATL ACAD SCI USA, V92, P9127, DOI 10.1073/pnas.92.20.9127; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; Peshavaria M, 1997, MOL CELL BIOL, V17, P3987, DOI 10.1128/MCB.17.7.3987; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Rawdon BB, 1998, MICROSC RES TECHNIQ, V43, P292, DOI 10.1002/(SICI)1097-0029(19981115)43:4<292::AID-JEMT3>3.0.CO;2-X; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; Samadani U, 1996, MOL CELL BIOL, V16, P6273; SERUP P, 1995, BIOCHEM J, V310, P997, DOI 10.1042/bj3100997; Sharma S, 1996, J BIOL CHEM, V271, P2294, DOI 10.1074/jbc.271.4.2294; Sharma S, 1997, MOL CELL BIOL, V17, P2598, DOI 10.1128/MCB.17.5.2598; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang JC, 1996, MOL ENDOCRINOL, V10, P794, DOI 10.1210/me.10.7.794; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; WRIGHT CVE, 1989, DEVELOPMENT, V105, P787; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zaret KS, 1996, ANNU REV PHYSIOL, V58, P231, DOI 10.1146/annurev.physiol.58.1.231	55	127	135	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3485	3492		10.1074/jbc.275.5.3485	http://dx.doi.org/10.1074/jbc.275.5.3485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652343	hybrid			2022-12-27	WOS:000085146500065
J	Kokai-Kun, JF; Melton-Celsa, AR; O'Brien, AD				Kokai-Kun, JF; Melton-Celsa, AR; O'Brien, AD			Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI STRAINS; PROTEOLYTIC ACTIVATION; POLYACRYLAMIDE GELS; BACTERIAL TOXINS; SHIGELLA TOXIN; PROTEINS; MOUSE; IDENTIFICATION; CELLS; GENES	Shiga toxin variant type 2d (Stx2d) produced by some strains of Shiga toxin-producing Escherichia coli is composed of an enzymatically active A subunit and a B (binding) pentamer, The cytotoxicity of Stx2d is increased (activated) 10-1000-fold for Vero cells when the toxin is incubated with mucus obtained from the small intestine of mice. In this study we isolated an Stx2d activator and identified it as a mouse elastase with strong homology to human elastase IIIB, Moreover, commercially available porcine pancreatic elastase preparations also activated Stx2d cytotoxicity although with a lower specific activity than isolated mouse elastase. Elastase directly nicked the Stx2d A subunit to A(1) and A(2), an event that did not correlate with activation. However, elastase also reduced the size and changed the isoelectric point of the A(2) peptide, as determined by SDS-polyacrylamide gel electrophoresis and two-dimensional electrophoresis followed by Western immunoblot analysis. This elastase-mediated size and charge shift in the A(2) peptide of Stx2d occurred concurrently with activation of the toxin, Both the reduction in size of the Stx2d A(2) peptide by incubation with elastase as well as the associated activation of Stx2d cytotoxicity were fully inhibited by elastatinal, an elastase-specific inhibitor.	Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	O'Brien, AD (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bride Rd, Bethesda, MD 20814 USA.				NIAID NIH HHS [AI20148-16] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020148, R22AI020148, R01AI020148] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BALLARD J, 1993, MOL MICROBIOL, V10, P627, DOI 10.1111/j.1365-2958.1993.tb00934.x; DEAN EA, 1990, INFECT IMMUN, V58, P4030, DOI 10.1128/IAI.58.12.4030-4035.1990; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361, DOI 10.1128/JCM.12.3.361-366.1980; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; GRANUM PE, 1981, BIOCHIM BIOPHYS ACTA, V668, P325, DOI 10.1016/0005-2795(81)90165-3; GRANUM PE, 1991, TOXICON, V29, P445; IRVINE JW, 1993, FEMS MICROBIOL LETT, V110, P113, DOI 10.1111/j.1574-6968.1993.tb06304.x; ITO H, 1990, MICROB PATHOGENESIS, V8, P47, DOI 10.1016/0882-4010(90)90007-D; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Kaper J.B, 1998, ESCHERICHIA COLI O15; KokaiKun JF, 1997, INFECT IMMUN, V65, P1014, DOI 10.1128/IAI.65.3.1014-1022.1997; KONGMUANG U, 1988, FEMS MICROBIOL LETT, V56, P105, DOI 10.1016/0378-1097(88)90135-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARGMAN C, 1976, BIOCHEMISTRY-US, V15, P2491, DOI 10.1021/bi00656a036; Lea N, 1999, MICROBIOL-UK, V145, P999, DOI 10.1099/13500872-145-5-999; LINDGREN SW, 1993, INFECT IMMUN, V61, P3832, DOI 10.1128/IAI.61.9.3832-3842.1993; LINDGREN SW, 1994, INFECT IMMUN, V62, P623, DOI 10.1128/IAI.62.2.623-631.1994; LOUIE M, 1994, EPIDEMIOL INFECT, V112, P449, DOI 10.1017/S0950268800051153; MeltonCelsa AR, 1996, INFECT IMMUN, V64, P1569, DOI 10.1128/IAI.64.5.1569-1576.1996; MELTONCELSA AR, 1998, BACTERIAL PROTEIN S, V29, P192; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OGATA M, 1992, J BIOL CHEM, V267, P25396; SCHMITT CK, 1991, INFECT IMMUN, V59, P1065, DOI 10.1128/IAI.59.3.1065-1073.1991; SHEN W, 1987, BIOCHEMISTRY-US, V26, P3447, DOI 10.1021/bi00386a030; Shotton D. M., 1970, METHOD ENZYMOL, V19, P113, DOI 10.1016/0076-6879(70)19009-4; STEVENSON BJ, 1986, NUCLEIC ACIDS RES, V14, P8307, DOI 10.1093/nar/14.21.8307; SZIEGOLEIT A, 1985, EUR J BIOCHEM, V151, P595, DOI 10.1111/j.1432-1033.1985.tb09145.x; TANI T, 1988, J BIOL CHEM, V263, P1231; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Umezawa H, 1976, Methods Enzymol, V45, P678; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P3959, DOI 10.1128/IAI.58.12.3959-3965.1990	36	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3713	3721		10.1074/jbc.275.5.3713	http://dx.doi.org/10.1074/jbc.275.5.3713			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652371	hybrid			2022-12-27	WOS:000085146500093
J	Tasanen, K; Eble, JA; Aumailley, M; Schumann, H; Baetge, J; Tu, H; Bruckner, P; Bruckner-Tuderman, L				Tasanen, K; Eble, JA; Aumailley, M; Schumann, H; Baetge, J; Tu, H; Bruckner, P; Bruckner-Tuderman, L			Collagen XVII is destabilized by a glycine substitution mutation in the cell adhesion domain Col15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BULLOUS PEMPHIGOID ANTIGEN; JUNCTIONAL EPIDERMOLYSIS-BULLOSA; BETA-4 INTEGRIN SUBUNIT; EXTRACELLULAR-MATRIX; DENATURED COLLAGEN; BP180 ECTODOMAIN; TRIPLE-HELIX; AUTOANTIBODIES; KERATINOCYTES; PROCOLLAGEN	Collagen XVII is a hemidesmosomal transmembrane molecule important for epithelial adhesion in the skin. It exists in two forms, as a full-length protein and as a soluble ectodomain that is shed from the keratinocyte surface by furin-mediated proteolysis. To obtain information on the conformation and the functions of this unusual collagen, its largest collagenous domain, Col15, was expressed in a eukaryotic episomal expression system and purified by DEAE and fast protein liquid- Mono S chromatography. The protein was triple-helical (T-m of 26.5 degrees C) when produced in cultures containing ascorbic acid. When the vitamin supply was limited, the 4-hydroxyproline content was reduced from 74 to 9%, which, in turn, resulted in a drastic reduction of the stability of the triple helix. The glycine substitution mutation G627V associated with junctional epidermolysis bullosa, a human blistering shin disease, also had a striking effect on thermal stability of rCol15 causing partial unfolding already at 4 degrees C, Col15 promoted cell adhesion of epithelial and fibroblastic cell lines with a beta 1 integrin-mediated mechanism. In concert with this, in acquired autoimmune blistering skin diseases, circulating IgG and IgA autoantibodies were found to target rCol15r.	Univ Munster, Dept Dermatol, D-48149 Munster, Germany; Univ Munster, Dept Physiol Chem, D-48149 Munster, Germany; Univ Oulu, Dept Dermatol, SF-90220 Oulu, Finland; Univ Oulu, Dept Med Biochem, SF-90220 Oulu, Finland; Univ Cologne, Dept Biochem, D-50931 Cologne, Germany	University of Munster; University of Munster; University of Oulu; University of Oulu; University of Cologne	Bruckner-Tuderman, L (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-48149 Munster, Germany.		Bruckner, Peter/F-4817-2019	Bruckner, Peter/0000-0002-5566-5611; Tasanen, Kaisa/0000-0001-8056-5949				Aho S, 1998, BIOCHEM BIOPH RES CO, V243, P694, DOI 10.1006/bbrc.1998.8162; Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; AUMAILLEY M, 1989, EXP CELL RES, V181, P463, DOI 10.1016/0014-4827(89)90103-1; Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Balding SD, 1997, BIOCHEMISTRY-US, V36, P8821, DOI 10.1021/bi970675n; Balding SD, 1996, J INVEST DERMATOL, V106, P141, DOI 10.1111/1523-1747.ep12329728; Borradori L, 1997, J CELL BIOL, V136, P1333, DOI 10.1083/jcb.136.6.1333; Borradori L, 1998, EXP CELL RES, V239, P463, DOI 10.1006/excr.1997.3923; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNERTUDERMA.L, 2000, CONNECTIVE TISSUE IT; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; Floeth M, 1998, J INVEST DERMATOL, V111, P528, DOI 10.1046/j.1523-1747.1998.00325.x; GAMMON WR, 1992, J AM ACAD DERMATOL, V27, P79; Gatalica B, 1997, AM J HUM GENET, V60, P352; Ghohestani RF, 1997, J INVEST DERMATOL, V108, P854, DOI 10.1111/1523-1747.ep12292581; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; Haase C, 1998, J INVEST DERMATOL, V110, P282, DOI 10.1046/j.1523-1747.1998.00126.x; Hammami-Hauasli N, 1998, J BIOL CHEM, V273, P19228, DOI 10.1074/jbc.273.30.19228; Hirako Y, 1998, J BIOL CHEM, V273, P9711, DOI 10.1074/jbc.273.16.9711; Hirako Y, 1996, J BIOL CHEM, V271, P13739, DOI 10.1074/jbc.271.23.13739; Hopkinson SB, 1998, J INVEST DERMATOL, V111, P1015, DOI 10.1046/j.1523-1747.1998.00452.x; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; McGrath JA, 1996, AM J PATHOL, V148, P1787; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; Nakatani C, 1998, BRIT J DERMATOL, V139, P365; Nie ZX, 1999, J INVEST DERMATOL, V112, P254, DOI 10.1046/j.1523-1747.1999.00501.x; Pas HH, 1997, J INVEST DERMATOL, V108, P423, DOI 10.1111/1523-1747.ep12289703; Perriard J, 1999, J INVEST DERMATOL, V112, P141, DOI 10.1046/j.1523-1747.1999.00497.x; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4129, DOI 10.1021/bi00823a015; PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Pulkkinen L, 1998, EXP DERMATOL, V7, P46, DOI 10.1111/j.1600-0625.1998.tb00304.x; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; RUGGIERO F, 1994, EXP CELL RES, V210, P215, DOI 10.1006/excr.1994.1032; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Schacke H, 1998, J BIOL CHEM, V273, P25937, DOI 10.1074/jbc.273.40.25937; Schumann H, 1997, AM J HUM GENET, V60, P1344, DOI 10.1086/515463; SCHUMANN H, 2000, IN PRESS AM J PATHOL; STANLEY JR, 1995, J EXP MED, V181, P1, DOI 10.1084/jem.181.1.1; TUCKWELL DS, 1994, J CELL SCI, V107, P993; Zafarullah K, 1997, MATRIX BIOL, V16, P245, DOI 10.1016/S0945-053X(97)90013-5; Zillikens D, 1997, J INVEST DERMATOL, V109, P573, DOI 10.1111/1523-1747.ep12337492; Zone JJ, 1998, J INVEST DERMATOL, V110, P207, DOI 10.1046/j.1523-1747.1998.00129.x	51	48	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3093	3099		10.1074/jbc.275.5.3093	http://dx.doi.org/10.1074/jbc.275.5.3093			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652291	hybrid			2022-12-27	WOS:000085146500013
J	Wessler, S; Hocker, M; Fischer, W; Wang, TC; Rosewicz, S; Haas, R; Wiedenmann, B; Meyer, TF; Naumann, M				Wessler, S; Hocker, M; Fischer, W; Wang, TC; Rosewicz, S; Haas, R; Wiedenmann, B; Meyer, TF; Naumann, M			Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCHROMAFFIN-LIKE CELLS; NF-KAPPA-B; PHORBOL 12-MYRISTATE 13-ACETATE; GASTRIC EPITHELIAL-CELLS; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ISCHEMIA-REPERFUSION; HISTAMINE SYNTHESIS; CANCER CELLS; INFECTION	Helicobacter pylori infection of the gastric mucosa is accompanied by an activated histamine metabolism. Histamine plays a central role in the regulation of gastric acid secretion and is involved in the pathogenesis of gastroduodenal ulcerations. Histidine decarboxylase (HDC) is the rate-limiting enzyme for histamine production, and its activity is regulated through transcriptional mechanisms. The present study investigated the effect of H. pylori infection on the transcriptional activity of the human HDC (hHDC) promoter in a gastric epithelial cell line (AGS) and analyzed the underlying molecular mechanisms. Our studies demonstrate that H, pylori infection potently transactivated the hHDC promoter. The H. pylori-responsive element of the hHDC gene was mapped to the sequence +1 to +27 base pairs, which shows no homology to known cis-acting elements and also functions as a gastrin-responsive element. H. pylori regulates the activity of this element via a Raf-1/MEK/ERK pathway, which was activated in a Ras-independent manner. Furthermore, we found that H. pylori-induced transactivation of the hHDC promoter was independent of the cag pathogenicity island and the vacuolating cytotoxin A gene and therefore may be exerted through (a) new virulence factor(s), A better understanding of H. pylori-directed hHDC transcription can provide novel insights into the molecular mechanisms of H, pylori-dependent gene regulation in gastric epithelial cells and may lead to new therapeutic approaches.	Max Planck Inst Infektionsbiol, Mol Biol Abt, D-10117 Berlin, Germany; Humboldt Univ, Klinikum Charite, Med Klink Schwerpunkt Gastroenterol & Hepatol, D-1086 Berlin, Germany; Max Von Pettenkofer Inst Med Mikrobiol & Hyg, Abt Bakteriol, D-80336 Munich, Germany; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Naumann, M (corresponding author), Max Planck Inst Infektionsbiol, Mol Biol Abt, Monbijoustr 2, D-10117 Berlin, Germany.		Wessler, Silja/C-6309-2015; Naumann, Michael/B-5285-2011; Meyer, Thomas F. F/J-2485-2013	Wessler, Silja/0000-0001-7011-6162; Naumann, Michael/0000-0002-8060-2313; Meyer, Thomas F. F/0000-0002-6120-8679; Wiedenmann, Bertram/0000-0002-7890-2552				Aihara M, 1997, INFECT IMMUN, V65, P3218, DOI 10.1128/IAI.65.8.3218-3224.1997; ANDRE F, 1985, GASTROENTEROLOGY, V88, P452, DOI 10.1016/0016-5085(85)90506-2; Asahara M, 1996, GASTROENTEROLOGY, V111, P45, DOI 10.1053/gast.1996.v111.pm8698224; BECHI P, 1996, AM J GASTROENTEROL, V91, P2339; Ben-Hamida A, 1998, INFLAMM RES, V47, P193, DOI 10.1007/s000110050317; Ben-Hamida A, 1998, DIGEST DIS SCI, V43, P126, DOI 10.1023/A:1018888423882; Bodger K, 1998, BRIT MED BULL, V54, P139; BOUCLIER M, 1983, EUR J PHARMACOL, V90, P129, DOI 10.1016/0014-2999(83)90224-8; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chan EC, 1996, FEBS LETT, V399, P127, DOI 10.1016/S0014-5793(96)01304-X; Chang CS, 1999, GASTROENTEROLOGY, V117, P82, DOI 10.1016/S0016-5085(99)70553-6; CHEN D, 1994, GASTROENTEROLOGY, V107, P18, DOI 10.1016/0016-5085(94)90056-6; Covacci A, 1998, CURR OPIN MICROBIOL, V1, P96, DOI 10.1016/S1369-5274(98)80148-3; Cover TL, 1999, GASTROENTEROLOGY, V117, P257, DOI 10.1016/S0016-5085(99)70575-5; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DIMALINE R, 1991, FEBS LETT, V281, P20, DOI 10.1016/0014-5793(91)80348-7; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; FIGURA N, 1987, J CLIN GASTROENTEROL, V25, P149; FUJIMOTO K, 1992, J CLIN INVEST, V89, P126, DOI 10.1172/JCI115552; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; Hocker M, 1997, J BIOL CHEM, V272, P27015, DOI 10.1074/jbc.272.43.27015; Hocker M, 1998, J BIOL CHEM, V273, P23046, DOI 10.1074/jbc.273.36.23046; Hocker M, 1996, AM J PHYSIOL-GASTR L, V270, pG619, DOI 10.1152/ajpgi.1996.270.4.G619; Hocker M, 1996, YALE J BIOL MED, V69, P21; HOLLANDE F, 1994, AM J PHYSIOL, V266, pG395, DOI 10.1152/ajpgi.1994.266.3.G395; KAHLSON G, 1972, EXPERIENTIA, V28, P993, DOI 10.1007/BF01918636; Keates S, 1997, GASTROENTEROLOGY, V113, P1099, DOI 10.1053/gast.1997.v113.pm9322504; Kidd M, 1997, GASTROENTEROLOGY, V113, P1110, DOI 10.1053/gast.1997.v113.pm9322505; KULUSHI S, 1996, GASTROENTEROLOGY, V110, P452; Malfertheiner P, 1997, DIGESTION, V58, P17, DOI 10.1159/000201517; MARAZOVA K, 1993, AGENTS ACTIONS, V38, pC300; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; McGowan CC, 1996, GASTROENTEROLOGY, V110, P926, DOI 10.1053/gast.1996.v110.pm8608904; Megraud F, 1997, J GASTROENTEROL, V32, P278, DOI 10.1007/BF02936383; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Modlin IM, 1996, GASTROENTEROLOGY, V111, P783, DOI 10.1053/gast.1996.v111.agast961110783; Naumann M, 1998, J EXP MED, V188, P1277, DOI 10.1084/jem.188.7.1277; Naumann M, 1999, J BIOL CHEM, V274, P31655, DOI 10.1074/jbc.274.44.31655; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Nedrud JG, 1997, CURR OPIN GASTROEN, V13, P71, DOI 10.1097/00001574-199701000-00013; Pai R, 1998, AM J PATHOL, V152, P1617; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peek RM, 1997, AM J MED, V102, P200, DOI 10.1016/S0002-9343(96)00273-2; PRINZ C, 1993, GASTROENTEROLOGY, V105, P449, DOI 10.1016/0016-5085(93)90719-S; Raychowdhury R, 1999, J BIOL CHEM, V274, P20961, DOI 10.1074/jbc.274.30.20961; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Schubert ML, 1996, CURR OPIN GASTROEN, V12, P493, DOI 10.1097/00001574-199611000-00002; Segal ED, 1997, P NATL ACAD SCI USA, V94, P7595, DOI 10.1073/pnas.94.14.7595; Sharma SA, 1998, J IMMUNOL, V160, P2401; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; TILLY BC, 1990, J CELL BIOL, V110, P1211, DOI 10.1083/jcb.110.4.1211; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TSUNADA S, 1994, GASTROENTEROLOGY, V107, P1297, DOI 10.1016/0016-5085(94)90530-4; Zhang ZS, 1996, J BIOL CHEM, V271, P14188, DOI 10.1074/jbc.271.24.14188	56	64	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3629	3636		10.1074/jbc.275.5.3629	http://dx.doi.org/10.1074/jbc.275.5.3629			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652359	Green Published, hybrid			2022-12-27	WOS:000085146500081
J	Hirao, K; Hata, Y; Yao, I; Deguchi, M; Kawabe, H; Mizoguchi, A; Takai, Y				Hirao, K; Hata, Y; Yao, I; Deguchi, M; Kawabe, H; Mizoguchi, A; Takai, Y			Three isoforms of synaptic scaffolding molecule and their characterization - Multimerization between the isoforms and their interaction with N-methyl-D-aspartate receptors and SAP90/PSD-95-associated protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY; PDZ DOMAIN; RAT-BRAIN; PSD-95; LOCALIZATION; RECOGNITION; FAMILY; SAP90	The synaptic scaffolding molecule (S-SCAM) has been identified as a protein interacting with SAP90/PSD-95-associated protein (SAPAP) (also called guanylate kinase-associated protein/hDLG-associated protein). S-SCAM;I has six PDZ (we have numbered them PDZ-0 to -5), two WV, and one guanylate kinase (GK) domains and interacts with N-methyl-D-aspartate (NMDA) receptor via PDZ-5 and SAPAP via the GIC domain. me have identified here shorter isoforms of S-SCAM that start at the 164th or 224th methionine, and we renamed the original one, S-SCAM alpha, the middle one, S-SCAM beta, and the shortest one, SSCAM-gamma. S-SCAM beta and -gamma have five PDZ (PDZ-1 to -5), two WW, and one GK domains. S-SCAM alpha interacted with S-SCAM beta and -gamma through the region containing PDZ-4 and -5. The region containing both of PDZ-4 and -5 is sufficient for the clustering of NMDA receptors and forms a dimer in gel filtration, suggesting that S-SCAM forms multimers via the interaction between the C-terminal PDZ domains and assembles NMDA receptors into clusters. S-SCAM beta P and -gamma also interacted with SAPAP, suggesting that the N-terminal region of the GH domain is not necessary for the interaction. Finally, we have identified the interaction of the PDZ domains of S-SCAM with the GK domain of PSD-95/SAP90. S-SCAM PSD-95/SAP90, and SAPAP are colocalized at least in some part in brain. Therefore, S-SCAM, PSD-95/SAP90, and SA-PAP may form a complex in vivo.	JCR Pharmaceut Co Ltd, Japan Sci & Technol Corp, ERATO, Takai Biotimer Project,Nishi Ku, Kobe, Hyogo 6512241, Japan; Tokyo Med & Dent Univ, Dept Med Biochem, Bunkyo Ku, Tokyo 1138519, Japan; Osaka Univ, Grad Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan; Kyoto Univ, Grad Sch, Dept Anat & Neurobiol, Kyoto 6068315, Japan	Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Osaka University; Kyoto University	Takai, Y (corresponding author), JCR Pharmaceut Co Ltd, Japan Sci & Technol Corp, ERATO, Takai Biotimer Project,Nishi Ku, 2-2-10 Murotani, Kobe, Hyogo 6512241, Japan.	ytakai@molbio.med.osak-u.ac.jp	Kawabe, Hiroshi/U-7325-2018	Kawabe, Hiroshi/0000-0001-5650-8696				Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1998, J NEUROSCI, V18, P8805; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Deguchi M, 1998, J BIOL CHEM, V273, P26269, DOI 10.1074/jbc.273.41.26269; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Hata Y, 1998, NEUROSCI RES, V32, P1, DOI 10.1016/S0168-0102(98)00069-8; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; SRIVASTAVA S, 1998, NEURON, V22, P179; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463	26	57	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2966	2972		10.1074/jbc.275.4.2966	http://dx.doi.org/10.1074/jbc.275.4.2966			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644767	hybrid			2022-12-27	WOS:000085128000099
J	Jaffe, EK; Volin, M; Bronson-Mullins, CR; Dunbrack, RL; Kervinen, J; Martins, J; Quinlan, JF; Sazinsky, MH; Steinhouse, EM; Yeung, AT				Jaffe, EK; Volin, M; Bronson-Mullins, CR; Dunbrack, RL; Kervinen, J; Martins, J; Quinlan, JF; Sazinsky, MH; Steinhouse, EM; Yeung, AT			An artificial gene for human porphobilinogen synthase allows comparison of an allelic variation implicated in susceptibility to lead poisoning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOLEVULINIC-ACID DEHYDRATASE; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; 5-AMINOLEVULINATE DEHYDRATASE; HUMAN-ERYTHROCYTES; BLOOD LEAD; POLYMORPHISM; ZINC; PURIFICATION; WORKERS	Porphobilinogen synthase (PBGS) is an ancient enzyme essential to tetrapyrrole biosynthesis (e.g. heme, chlorophyll, and vitamin B-12). Two common alleles encoding human PBGS, K59 and N59, have been correlated with differential susceptibility of humans to lead poisoning. However, a model for human PBGS based on homologous crystal structures shows the location of the allelic variation to be distant from the active site with its two Zn(II), Previous microbial expression systems for human PBGS have resulted in a poor yield, Here, an artificial gene encoding human PBGS was constructed by recursive polymerase chain reaction from synthetic oligonucleotides to rectify this problem. The artificial gene was made to resemble the highly expressed homologous Escherichia coli hemB gene and to remove rare codons that can confound heterologous protein expression in E, coli, We have expressed and purified recombinant human PBGS variants K59 and N59 in 100-mg quantities. Both human PBGS proteins purified with eight Zn(II)/octamer; Zn(II) binding was shown to be pH-dependent; and Pb(II) could displace some of the Zn(II), However, there was no differential displacement of Zn(II) by Pb(II) between K59 and N59, and simple Pb(II) inhibition studies revealed no allelic difference.	Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Jaffe, EK (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.		Dunbrack, Roland/ABG-7141-2020; Volin, Michael/U-4115-2019	Dunbrack, Roland/0000-0001-7674-6667	NATIONAL CANCER INSTITUTE [R01CA071426, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003654] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927, CA71426] Funding Source: Medline; NIEHS NIH HHS [ES03654] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANDERSON PM, 1979, J BIOL CHEM, V254, P6924; Bergdahl IA, 1997, PHARMACOL TOXICOL, V81, P153, DOI 10.1111/j.1600-0773.1997.tb02061.x; Bergdahl IA, 1997, ARCH ENVIRON HEALTH, V52, P91, DOI 10.1080/00039899709602870; BEVAN DR, 1980, J BIOL CHEM, V255, P2030; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; DENT AJ, 1990, BIOCHEMISTRY-US, V29, P7822, DOI 10.1021/bi00486a007; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Dunbrack RL, 1999, PROTEINS, P81; Erskine PT, 1997, NAT STRUCT BIOL, V4, P1025, DOI 10.1038/nsb1297-1025; Fleming DEB, 1998, ENVIRON RES, V77, P49, DOI 10.1006/enrs.1997.3818; Forman MD, 1998, PROTEIN SCI, V7, P500; Frankenberg N, 1999, J MOL BIOL, V289, P591, DOI 10.1006/jmbi.1999.2808; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13976, DOI 10.1021/bi9906470; Frankenberg N, 1999, BIOCHEMISTRY-US, V38, P13968, DOI 10.1021/bi9906468; GIBBS PNB, 1985, BIOCHEM J, V230, P25, DOI 10.1042/bj2300025; GRAHAM RW, 1993, NUCLEIC ACIDS RES, V21, P4923, DOI 10.1093/nar/21.21.4923; Gross M, 1999, J BIOL CHEM, V274, P3125, DOI 10.1074/jbc.274.5.3125; GUO GG, 1994, J BIOL CHEM, V269, P12399; Hill AM, 1996, ARCH BIOCHEM BIOPHYS, V336, P283, DOI 10.1006/abbi.1996.0559; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Jaffe E. K., 1993, COMMENTS INORG CHEM, V15, P67; JAFFE EK, 1995, J BIOENERG BIOMEMBR, V27, P169, DOI 10.1007/BF02110032; JAFFE EK, 1984, J BIOL CHEM, V259, P5032; JAFFE EK, 1992, BIOCHEMISTRY-US, V31, P2113, DOI 10.1021/bi00122a032; JAFFE EK, 1991, BIOL TRACE ELEM RES, V28, P223, DOI 10.1007/BF02990469; JORDAN PM, 1986, METHOD ENZYMOL, V123, P427; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; MITCHELL LW, 1993, ARCH BIOCHEM BIOPHYS, V300, P169, DOI 10.1006/abbi.1993.1024; Petrovich RM, 1996, J BIOL CHEM, V271, P8692, DOI 10.1074/jbc.271.15.8692; Petrovich RM, 1997, BIOCHEMISTRY-US, V36, P13421, DOI 10.1021/bi971642a; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; ROESSNER CA, 1995, PROTEIN EXPRES PURIF, V6, P155, DOI 10.1006/prep.1995.1019; SCHAUER WE, 1990, CURR GENET, V17, P1, DOI 10.1007/BF00313241; SCHLOSSER M, 1987, BIOL CHEM H-S, V368, P1469, DOI 10.1515/bchm3.1987.368.2.1469; SCHWARTZ BS, 1995, AM J EPIDEMIOL, V142, P738, DOI 10.1093/oxfordjournals.aje.a117705; Shemin D, 1972, ENZYMES, VVII, P232; SIMONS TJB, 1995, EUR J BIOCHEM, V234, P178, DOI 10.1111/j.1432-1033.1995.178_c.x; SMITH CM, 1995, ENVIRON HEALTH PERSP, V103, P248, DOI 10.2307/3432544; WETMUR JG, 1991, ENVIRON RES, V56, P109, DOI 10.1016/S0013-9351(05)80001-5; WETMUR JG, 1986, P NATL ACAD SCI USA, V83, P7703, DOI 10.1073/pnas.83.20.7703; Yang QH, 1997, PROTEIN EXPRES PURIF, V10, P320, DOI 10.1006/prep.1997.0749; Zimmerman KK, 1998, PROTEIN EXPRES PURIF, V14, P395, DOI 10.1006/prep.1998.0979	43	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2619	2626		10.1074/jbc.275.4.2619	http://dx.doi.org/10.1074/jbc.275.4.2619			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644722	hybrid			2022-12-27	WOS:000085128000054
J	Lei, BF; Wei, CJ; Tu, SC				Lei, BF; Wei, CJ; Tu, SC			Action mechanism of antitubercular isoniazid - Activation mycobacterium tuberculosis KatG, isolation, and characterization of InhA inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALASE-PEROXIDASE GENE; DRUG-RESISTANT TUBERCULOSIS; PURIFICATION; MUTATIONS; TARGET	Activation of the antitubercular isoniazid (INH) by the Mycobacterium tuberculosis KatG produces an inhibitor for enoyl reductase (InhA). The mechanism for INH activation remains poorly understood, and the inhibitor has never been isolated. We have purified the InhA-inhibitor complex generated in the M. tuberculosis KatG-catalyzed INH activation. The complex exhibited a 278-nm absorption peak and a shoulder around 326 nn with a characteristic A(326)/A(278) ratio of 0.16. The complex was devoid of enoyl reductase activity. The inhibitor noncovalently binds to InhA with a K-d < 0.4 nM and can be dissociated from denatured InhA for chromatographic isolation. The free inhibitor showed absorption peaks at 326 (epsilon(326) 6900 M-1 cm(-1)) and 260 nm (epsilon(260) 27,000 M-1 cm(-1)). The inactive complex can be reconstituted from InhA and the isolated inhibitor. The InhA inhibitor from the KatG-catalyzed INH activation was identical to that from a slow, KatG-independent, Mn2+-mediated reaction based on high pressure liquid chromatography analysis and absorption and mass spectral characteristics. By monitoring the formation of the InhA-inhibitor complex, we have found that manganese is not essential to the INH activation by M. tuberculosis KatG. Furthermore, the formation of the InhA inhibitor in the KatG reaction was independent of InhA.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ Houston, Dept Chem, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston	Tu, SC (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.			Lei, Benfang Lei/0000-0001-8133-6021	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025953] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25953] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTAMIRANO M, 1994, J INFECT DIS, V169, P162; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BERNSTEIN J, 1952, AM REV TUBERC PULM, V65, P357; BIFANI P, 1909, JAMA-J AM MED ASSOC, V275, P452; BLOCH AB, 1994, JAMA-J AM MED ASSOC, V271, P665, DOI 10.1001/jama.271.9.665; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Falk J. E., 1964, PORPHYRINS METALLOPO, P804; FASSEL VA, 1974, ANAL CHEM, V46, P1110, DOI 10.1021/ac60349a722; FOX HH, 1952, SCIENCE, V116, P129, DOI 10.1126/science.116.3006.129; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; GOLDMAN P, 1961, J BIOL CHEM, V236, P2620; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; HOLDINESS MR, 1984, CLIN PHARMACOKINET, V9, P511, DOI 10.2165/00003088-198409060-00003; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; LOEWEN PC, 1990, BIOCHEM CELL BIOL, V68, P1037, DOI 10.1139/o90-153; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magliozzo RS, 1997, J BIOL CHEM, V272, P8867; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; Mdluli K, 1996, J INFECT DIS, V174, P1085, DOI 10.1093/infdis/174.5.1085; Mdluli K, 1998, SCIENCE, V280, P1607, DOI 10.1126/science.280.5369.1607; Musser JM, 1996, J INFECT DIS, V173, P196, DOI 10.1093/infdis/173.1.196; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; PANSY F, 1952, AM REV TUBERC PULM, V65, P761; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Wengenack NL, 1998, BIOCHEMISTRY-US, V37, P15825, DOI 10.1021/bi982023k; WINDER F G, 1970, Journal of General Microbiology, V63, P41; Zabinski RF, 1997, J AM CHEM SOC, V119, P2331, DOI 10.1021/ja9639731; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	30	183	188	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2520	2526		10.1074/jbc.275.4.2520	http://dx.doi.org/10.1074/jbc.275.4.2520			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644708	hybrid			2022-12-27	WOS:000085128000040
J	Meagher, JL; Olson, ST; Gettins, PGW				Meagher, JL; Olson, ST; Gettins, PGW			Critical role of the linker region between helix D and strand 2A in heparin activation of antithrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL CHANGE; REACTIVE CENTER; PROTEINASE REACTIONS; BINDING SITE; HINGE REGION; FACTOR-XA; MECHANISM; PENTASACCHARIDE; ACCELERATION; RECOGNITION	The binding of pentasaccharide heparin to antithrombin induces a conformational change that is transmitted to the reactive center loop and increases the rate of inhibition of factor Xa by similar to 300-fold, The mechanism of such transmission is not known. To test the role of residues 134-137, which link helix D to beta-sheet A, in this signal transduction, we created variant antithrombins in which we removed amino acids 134-137 stepwise and cumulatively. Although the deletions did not compromise the fundamental ability of antithrombin to bind to heparin or to inhibit target proteinases thrombin and factor Xa, they did largely decouple conformational changes in the heparin-binding site from conformational activation of the reactive center loop. Because the variant with only Ala(134) removed was as compromised as variants with larger deletions, yet the variant with Ser(137) removed was normal, we concluded that the length of the linker is less important than the precise interrelationship between residues in this region and other residues involved in conformational activation of antithrombin.	Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA; Univ Illinois, Coll Dent, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA.				NHLBI NIH HHS [HL49234, HL39888] Funding Source: Medline; NIDDK NIH HHS [T32 DK07789] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049234, R01HL049234, R37HL039888, R01HL039888, R29HL039888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007789] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOCK PE, 1989, ARCH BIOCHEM BIOPHYS, V273, P375, DOI 10.1016/0003-9861(89)90496-7; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; GETTINS P, 1992, J BIOL CHEM, V267, P21946; GETTINS PGW, 1993, BIOCHEMISTRY-US, V32, P8385, DOI 10.1021/bi00084a001; GETTINS PGW, 1996, SERPINS STRUCTURE FU, P65; HOOD DB, 1994, BIOCHEMISTRY-US, V33, P8538, DOI 10.1021/bi00194a020; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; LANCHANTIN GF, 1973, J BIOL CHEM, V248, P5956; LAWRENCE DA, 1994, J BIOL CHEM, V269, P27657; Lukacs CM, 1996, NAT STRUCT BIOL, V3, P888, DOI 10.1038/nsb1096-888; Meagher JL, 1996, J BIOL CHEM, V271, P29353, DOI 10.1074/jbc.271.46.29353; Meagher JL, 1998, J BIOL CHEM, V273, P23283, DOI 10.1074/jbc.273.36.23283; MILETICH JP, 1980, ANAL BIOCHEM, V105, P304, DOI 10.1016/0003-2697(80)90462-5; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423; Zettlmeissl G, 1988, Behring Inst Mitt, P26	25	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2698	2704		10.1074/jbc.275.4.2698	http://dx.doi.org/10.1074/jbc.275.4.2698			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644732	hybrid			2022-12-27	WOS:000085128000064
J	Swanson, DJ; Adachi, M; Lewis, EJ				Swanson, DJ; Adachi, M; Lewis, EJ			The homeodomain protein Arix promotes protein kinase A-dependent activation of the dopamine beta-hydroxylase promoter through multiple elements and interaction with the coactivator cAMP-response element-binding protein-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER BIOSYNTHETIC GENES; CBP-INDUCED STIMULATION; TRANSCRIPTION FACTOR; TYROSINE-HYDROXYLASE; MAMMALIAN-CELLS; CYCLIC-AMP; EXPRESSION; CREB; PHOX2A; DNA	The differentiation and maintenance of a neurotransmitter phenotype is guided by the interaction of exogenous cues with intrinsic genetic machinery. For the noradrenergic phenotype, these influences combine to activate the expression of the catecholaminergic biosynthetic enzymes tyrosine hydroxylase and dopamine beta-hydroxylase (DBH). in this study, we evaluate the molecular mechanisms by which the transcription factor Arix/Phox2a contributes to DBH gene transcription. We have evaluated the contribution of individual homeodomain binding sites in the rat DBH promoter region and find that all are essential for both basal and cAMP-dependent protein kinase A (PKA)-stimulated transcription. Using mammalian one-hybrid and two-hybrid systems, we demonstrate that recruitment of Arix to the positions of homeodomain core recognition sites 1 and 2 at -153 to -166 of the DBH gene restores complete responsiveness of the promoter to PHA in SHSY-5Y neuroblastoma and HepG2 hepatoma cells. Intracellular Arix-Arix interactions are evident and may contribute to the interdependence of homeodomain binding sites. Analysis of functional domains of Arix reveals an N-terminal activation domain and a C-terminal repression domain. The N terminus of Arix contains an amino acid moth similar to a region in Brachyury and Pax9 transcription factors. The N terminal activation domain of Arix interacts with the transcriptional co-activator, cAMP-response element-binding protein-binding protein, which potentiates transcription from the DBH promoter in a PEA-dependent manner, The present study supports the hypothesis that the paired-like homeodomain protein, Arix, acts as a critical phenotype-specific regulator of the DBH promoter by serving as an integrator of signal-dependent transcription activators within the network of the general transcription machinery.	Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Lewis, EJ (corresponding author), Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, L224, Portland, OR 97201 USA.		Adachi, Megumi/M-7746-2017	Adachi, Megumi/0000-0003-3404-6640	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038696, R01GM038696] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38696] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Ausbel F.M., 1995, CURRENT PROTOCOLS MO; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Bannister AJ, 1995, ONCOGENE, V11, P2509; BISSOTTO S, 1996, J BIOL CHEM, V271, P17746; CAREY M, 1989, J MOL BIOL, V209, P423, DOI 10.1016/0022-2836(89)90007-7; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; ERNSBERGER U, 1995, MECH DEVELOP, V52, P125, DOI 10.1016/0925-4773(95)00396-I; Ghee M, 1998, MOL BRAIN RES, V55, P101, DOI 10.1016/S0169-328X(97)00370-7; Goldman PS, 1997, RECENT PROG HORM RES, V52, P103; Goridis C, 1999, CURR OPIN NEUROBIOL, V9, P47, DOI 10.1016/S0959-4388(99)80006-3; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROVES AK, 1995, DEVELOPMENT, V121, P887; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim HS, 1998, J NEUROSCI, V18, P8247; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; Lo LC, 1998, DEVELOPMENT, V125, P609; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MAURER RA, 1989, J BIOL CHEM, V264, P6870; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; Nornes S, 1996, J BIOL CHEM, V271, P26914, DOI 10.1074/jbc.271.43.26914; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; SHASKUS J, 1992, J BIOL CHEM, V267, P18821; Simon KJ, 1997, MOL CELL BIOL, V17, P6653, DOI 10.1128/MCB.17.11.6653; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Swanson DJ, 1998, J BIOL CHEM, V273, P24065, DOI 10.1074/jbc.273.37.24065; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; TIJAN R, 1994, CELL, V77, P5; Yang CY, 1998, J NEUROCHEM, V71, P1813; Yokoyama M, 1999, GENOMICS, V59, P40, DOI 10.1006/geno.1999.5845; Yokoyama M, 1996, DNA Res, V3, P311, DOI 10.1093/dnares/3.5.311; Zellmer E, 1995, J NEUROSCI, V15, P8109	46	45	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2911	2923		10.1074/jbc.275.4.2911	http://dx.doi.org/10.1074/jbc.275.4.2911			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644760	hybrid			2022-12-27	WOS:000085128000092
J	Thomas, WG; Qian, HW; Chang, CS; Karnik, S				Thomas, WG; Qian, HW; Chang, CS; Karnik, S			Agonist-induced phosphorylation of the angiotensin II (AT(1A)) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CONSTITUTIVE ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; DESENSITIZATION; INTERNALIZATION; BINDING; ENDOCYTOSIS; RHODOPSIN; MUTATION; ASN(111)	G protein coupled receptors are thought to isomerize between distinct inactive and active conformations, an idea supported by receptor mutations that induce constitutive (agonist-independent) activation. The agonist-promoted active state initiates signaling and, presumably, is then phosphorylated and internalized to terminate the signal. In this study, we examined the phosphorylation and internalization of wild type and constitutively active mutants (N111A and N111G) of the type 1 (AT(1A)) angiotensin II receptor. Cells expressing these receptors were stimulated with angiotensin II (Ang-II) and [Sar(1),Ile(4),Ile(8)]AngII, an analog that only activates signaling through the constitutive receptors, Wild type AT(1A) receptors displayed a basal level of phosphorylation, which was stimulated by AngII, Unexpectedly, the constitutively active AT(1A) receptors did not exhibit an increase in basal phosphorylation nor was phosphorylation enhanced by AngII stimulation. Phosphorylation of the constitutively active receptors was unaffected by pretreatment with the non-peptide AT(1A) receptor inverse agonist, EXP3174, and was not stimulated by the selective ligand, [Sar(1),Ile(4),Ile(8)]AngII. Paradoxically, [Sar(1),Ile(4),Ile(8)]AngII produced a robust (similar to 85% of AngII), dose-dependent phosphorylation of the wild type AT(1A) receptor at sites in the carboxyl terminus similar to those phosphorylated by AngII, Moreover, internalization of both wild type and constitutive receptors was induced by AngII, but not [Sar(1),Ile(4),Ile(8)]AngII, providing a differentiation between the phosphorylated and internalized states. These data suggest that the AT(1A) receptor can attain a conformation for phosphorylation without going through the conformation required for inositol phosphate signaling and provide evidence for a transition of the receptor through multiple states, each associated with separate stages of receptor activation and regulation. Separate transition states may be a common paradigm for G protein-coupled receptors.	Baker Med Res Inst, Mol Endocrinol Lab, Melbourne, Vic 8008, Australia; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Baker Heart and Diabetes Institute; Cleveland Clinic Foundation	Thomas, WG (corresponding author), Baker Med Res Inst, Mol Endocrinol Lab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	walter.thomas@baker.edu.au	Karnik, Sadashiva/Y-2477-2019; Thomas, Walter/I-2208-2015	Karnik, Sadashiva/0000-0003-0746-2753; Thomas, Walter/0000-0003-0685-2952	NHLBI NIH HHS [R01 HL057470, HL-5648, R01 HL064845] Funding Source: Medline; PHS HHS [EI 994078] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BOULAY G, 1994, ENDOCRINOLOGY, V135, P2130, DOI 10.1210/en.135.5.2130; CONCHON S, 1994, FEBS LETT, V349, P365, DOI 10.1016/0014-5793(94)00703-9; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; HUNYADY L, 1995, J BIOL CHEM, V270, P16602, DOI 10.1074/jbc.270.28.16602; January B, 1997, J BIOL CHEM, V272, P23871, DOI 10.1074/jbc.272.38.23871; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P256, DOI 10.1016/S0165-6147(00)89037-9; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Leff P, 1997, TRENDS PHARMACOL SCI, V18, P355, DOI 10.1016/S0165-6147(97)90664-7; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leurs R, 1998, TRENDS BIOCHEM SCI, V23, P418, DOI 10.1016/S0968-0004(98)01287-0; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Negishi M, 1996, FEBS LETT, V386, P165, DOI 10.1016/0014-5793(96)00354-7; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Pauwels PJ, 1998, MOL NEUROBIOL, V17, P109, DOI 10.1007/BF02802027; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Perez DM, 1996, MOL PHARMACOL, V49, P112; PIURA S, 1999, J BIOL CHEM, V274, P7103; Prossnitz ER, 1999, BIOCHEMISTRY-US, V38, P2240, DOI 10.1021/bi982274t; Qian HW, 1999, BIOCHEM J, V343, P637, DOI 10.1042/0264-6021:3430637; Quitterer U, 1996, BIOCHEMISTRY-US, V35, P13368, DOI 10.1021/bi961163w; REN Q, 1993, J BIOL CHEM, V268, P16483; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; Scaramellini C, 1998, ANN NY ACAD SCI, V861, P97; Smith RD, 1998, MOL PHARMACOL, V54, P935, DOI 10.1124/mol.54.6.935; Surya A, 1998, TRENDS PHARMACOL SCI, V19, P243; SWILLENS S, 1992, TRENDS PHARMACOL SCI, V13, P430, DOI 10.1016/0165-6147(92)90139-W; Thomas WG, 1998, MOL ENDOCRINOL, V12, P1513, DOI 10.1210/me.12.10.1513; THOMAS WG, 1995, J BIOL CHEM, V270, P207, DOI 10.1074/jbc.270.1.207; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Thomas WG, 1996, CLIN EXP PHARMACOL P, V23, pS74, DOI 10.1111/j.1440-1681.1996.tb02817.x; WESTPHAL RS, 1995, MOL PHARMACOL, V48, P200; Zuscik MJ, 1998, J BIOL CHEM, V273, P3401, DOI 10.1074/jbc.273.6.3401	37	86	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2893	2900		10.1074/jbc.275.4.2893	http://dx.doi.org/10.1074/jbc.275.4.2893			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644757	hybrid			2022-12-27	WOS:000085128000089
J	Ernst, OP; Meyer, CK; Marin, EP; Henklein, P; Fu, WY; Sakmar, TP; Hofmann, KP				Ernst, OP; Meyer, CK; Marin, EP; Henklein, P; Fu, WY; Sakmar, TP; Hofmann, KP			Mutation of the fourth cytoplasmic loop of rhodopsin affects binding of transducin and peptides derived from the carboxyl-terminal sequences of transducin alpha and gamma subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; BOVINE RHODOPSIN; SCHIFF-BASE; METARHODOPSIN-II; SIGNALING STATE; PROTON UPTAKE; ACTIVATION; RECEPTOR; MUTANTS; PALMITOYLATION	The role of the putative fourth cytoplasmic loop of rhodopsin in the binding and catalytic activation of the heterotrimeric G protein, transducin (G(t)), is not well defined. We developed a novel assay to measure the ability of G(t), or G(t)-derived peptides, to inhibit the photoregeneration of rhodopsin from its active metarhodopsin II state. We show that a peptide corresponding to residues 340-350 of the alpha subunit of G(t), or a cysteinyl-thioetherfarnesyl peptide corresponding to residues 50-71 of the gamma subunit of G(t), are able to interact with metarhodopsin II and inhibit its photoconversion to rhodopsin. Alteration of the amino acid sequence of either peptide, or removal of the farnesyl group from the gamma-derived peptide, prevents inhibition. Mutation of the amino-terminal region of the fourth cytoplasmic loop of rhodopsin affects interaction with G(t), (Marin, E, P,, Krishna, A G;., Zvyaga T, A, Isele, J., Siebert, F,, and Sakmar, T. P. (2000) J. Biol Chem. 275, 1930-1936), Here, we provide evidence that this segment of rhodopsin interacts with the carboxyl-terminal peptide of the cu subunit of G(t). We propose that the amino-terminal region of the fourth cytoplasmic loop of rhodopsin is part of the binding site for the carboxyl terminus of the alpha subunit of G(t) and plays a role in the regulation of beta gamma subunit binding.	Rockefeller Univ, Howard Hughes Med Inst, Biochem & Mol Biol Lab, New York, NY 10021 USA; Humboldt Univ, Inst Med Phys & Biophys, Fak Med, D-10098 Berlin, Germany; Humboldt Univ, Inst Biochem, Fak Med, D-10098 Berlin, Germany	Howard Hughes Medical Institute; Rockefeller University; Humboldt University of Berlin; Humboldt University of Berlin	Hofmann, KP (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Biochem & Mol Biol Lab, Box 284,1230 York Ave, New York, NY 10021 USA.	klaus_peter.hofmann@charite.de	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953	NIGMS NIH HHS [GM07739, GM07982] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altenbach C, 1999, BIOCHEMISTRY-US, V38, P7931, DOI 10.1021/bi9900121; ARNIS S, 1995, BIOCHEMISTRY-US, V34, P9333, DOI 10.1021/bi00029a008; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cai KW, 1999, BIOCHEMISTRY-US, V38, P7925, DOI 10.1021/bi9900119; DEGRIP WJ, 1982, METHOD ENZYMOL, V81, P197; EMEIS D, 1981, FEBS LETT, V136, P201, DOI 10.1016/0014-5793(81)80618-7; ERNST OP, 2000, IN PRESS METHODS ENZ; Fahmy K, 1998, BIOPHYS J, V75, P1306, DOI 10.1016/S0006-3495(98)74049-4; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; GARCIA PD, 1995, EMBO J, V14, P4460, DOI 10.1002/j.1460-2075.1995.tb00125.x; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Han M, 1998, BIOCHEMISTRY-US, V37, P538, DOI 10.1021/bi972060w; HECK M, 1993, BIOCHEMISTRY-US, V32, P8220, DOI 10.1021/bi00083a024; Helmreich EJM, 1996, BBA-REV BIOMEMBRANES, V1286, P285, DOI 10.1016/S0304-4157(96)00013-5; HOFMANN KP, 1999, RHODOPSINS PHOTOTRAN, P158; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; KARNIK SS, 1993, P NATL ACAD SCI USA, V90, P40, DOI 10.1073/pnas.90.1.40; Kim JM, 1997, P NATL ACAD SCI USA, V94, P14273, DOI 10.1073/pnas.94.26.14273; KISSELEV O, 1995, P NATL ACAD SCI USA, V92, P9102, DOI 10.1073/pnas.92.20.9102; KISSELEV O, 1995, J BIOL CHEM, V270, P25356, DOI 10.1074/jbc.270.43.25356; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; Kisselev OG, 1999, P NATL ACAD SCI USA, V96, P4898, DOI 10.1073/pnas.96.9.4898; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LONGSTAFF C, 1986, P NATL ACAD SCI USA, V83, P4209, DOI 10.1073/pnas.83.12.4209; Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930; MOENCH SJ, 1994, BIOCHEMISTRY-US, V33, P5791, DOI 10.1021/bi00185a017; Nishimura S, 1998, BIOCHEMISTRY-US, V37, P15816, DOI 10.1021/bi981451n; Osawa S, 1995, J BIOL CHEM, V270, P31052, DOI 10.1074/jbc.270.52.31052; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PAPAC DI, 1992, J BIOL CHEM, V267, P16889; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SCHLEICHER A, 1987, J MEMBRANE BIOL, V95, P271, DOI 10.1007/BF01869489; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501	42	145	151	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1937	1943		10.1074/jbc.275.3.1937	http://dx.doi.org/10.1074/jbc.275.3.1937			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636895	hybrid			2022-12-27	WOS:000084940000058
J	Ballicora, MA; Frueauf, JB; Fu, YB; Schurmann, P; Preiss, J				Ballicora, MA; Frueauf, JB; Fu, YB; Schurmann, P; Preiss, J			Activation of the potato tuber ADP-glucose pyrophosphorylase by thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXINS; ADPGLUCOSE PYROPHOSPHORYLASE; SMALL-SUBUNIT; CHLOROPLAST FRUCTOSE-1,6-BISPHOSPHATASE; PROTEINS; STARCH; MUTAGENESIS; METABOLISM; CELLS; SITE	The potato tuber (Solanum tuberosum L,) ADP-glucose pyrophosphorylase (ADP-GlcPPase) catalyzes the first committed step in starch biosynthesis, The main type of regulation of this enzyme is allosteric, and its activity is controlled by the ratio of activator, 3-phosphoglycerate to inhibitor, P-i. It was reported (Fu, Y,, Ballicora, M, A., Leykam, J, F,, and Preiss, J, (1998) J, Biol, Chem, 273, 25045-25052) that the enzyme was activated by reduction of the Cys(12) disulfide Linkage present in the catalytic subunits, In this study, both reduced thioredoxin f and m from spinach (Spinacia oleracea) leaves reduced and activated the enzyme at low concentrations (10 mu M) of activator (3-phosphoglycerate), Fifty percent activation was at 4.5 and 8.7 mu M for reduced thioredoxin f and m, respectively, and 2 orders of magnitude lower than for dithiothreitol, The activation was reversed by oxidized thioredoxin. Cys(12) is conserved in the ADP-GlcPPases from plant leaves and other tissues except for the monocot endosperm enzymes. We postulate that in photosynthetic tissues, reduction could play a role in the fine regulation of the ADP-GlcPPase mediated by the ferredoxin-thioredoxin system. This is the first time that a covalent mechanism of regulation is postulated in the synthesis of starch.	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Univ Neuchatel, Biochim Lab, CH-2007 Neuchatel, Switzerland	Michigan State University; University of Neuchatel	Preiss, J (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.			Ballicora, Miguel/0000-0002-5324-0724				Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 1999, BIOCHEM BIOPH RES CO, V257, P782, DOI 10.1006/bbrc.1999.0469; BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245; Emes MJ, 1997, J EXP BOT, V48, P1995, DOI 10.1093/jexbot/48.317.1995; Fu YB, 1998, PLANT PHYSIOL, V117, P989, DOI 10.1104/pp.117.3.989; Fu YB, 1998, J BIOL CHEM, V273, P25045, DOI 10.1074/jbc.273.39.25045; GHOSH HP, 1966, J BIOL CHEM, V241, P4491; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; IGLESIAS AA, 1991, PLANT PHYSIOL, V97, P1187, DOI 10.1104/pp.97.3.1187; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; KAISER WM, 1979, PLANT PHYSIOL, V63, P105, DOI 10.1104/pp.63.1.105; KIM WT, 1989, PLANT PHYSIOL, V91, P217, DOI 10.1104/pp.91.1.217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mora-Garcia S, 1998, J BIOL CHEM, V273, P16273, DOI 10.1074/jbc.273.26.16273; MoraGarcia S, 1996, FEBS LETT, V380, P123, DOI 10.1016/0014-5793(96)00022-1; MORELL MK, 1987, PLANT PHYSIOL, V85, P182, DOI 10.1104/pp.85.1.182; NAKATA PA, 1994, J BIOL CHEM, V269, P30798; OKITA TW, 1990, PLANT PHYSIOL, V93, P785, DOI 10.1104/pp.93.2.785; Preiss J, 1998, GENET ENG P, V20, P177; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; PREISS J, 1982, ANNU REV PLANT PHYS, V33, P431, DOI 10.1146/annurev.pp.33.060182.002243; Preiss J., 1997, ENG IMPROVED CARBON, P81; Preiss J., 1988, BIOCH PLANTS, V14., P181; SCHURMANN P, 1995, METHOD ENZYMOL, V252, P272; SIVAK NM, 1998, ADV FOOD NUTR RES, V41, P1; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITHWHITE BJ, 1992, J MOL EVOL, V34, P449, DOI 10.1007/BF00162999; SOWOKINOS JR, 1981, PLANT PHYSIOL, V68, P924, DOI 10.1104/pp.68.4.924; Thorbjornsen T, 1996, BIOCHEM J, V313, P149, DOI 10.1042/bj3130149; WOLOSIUK RA, 1993, FASEB J, V7, P622, DOI 10.1096/fasebj.7.8.8500687	30	128	131	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1315	1320		10.1074/jbc.275.2.1315	http://dx.doi.org/10.1074/jbc.275.2.1315			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625679	hybrid, Green Submitted			2022-12-27	WOS:000084836600083
J	Bourot, S; Sire, O; Trautwetter, A; Touze, T; Wu, LF; Blanco, C; Bernard, T				Bourot, S; Sire, O; Trautwetter, A; Touze, T; Wu, LF; Blanco, C; Bernard, T			Glycine betaine-assisted protein folding in a lysA mutant of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSMOTIC-STRESS; CENTRAL CAVITY; GENE; EXPRESSION; GROEL; FLUORESCENCE; SOLUTES; TRANSCRIPTION; ACCUMULATION; INDUCTION	Osmoprotectants exogenously supplied to a hyperosmotic culture medium are efficiently imported and amassed by stressed cells of Escherichia coli, In addition to their evident role in the recovery and maintenance of osmotic balance, these solutes should play an important role on the behavior of cellular macromolecules, for example in the process of protein folding, Using a random chemical mutagenesis approach, a conditional lysine auxotrophic mutant was obtained. The growth of this mutant was restored by addition of either lysine or osmoprotectants including glycine betaine (GB) in the minimal medium. The growth rate increased proportionally with the augmentation of the intracellular GB concentration. The mutation was located in the lysA gene and resulted in the substitution of the Ser at position 384 by Phe of the diaminopimelate decarboxylase (DAPDC), which catalyzes the conversion of meso-diaminopimelate to L-lysine. We purified both the wild type DAPDC and the mutated DAPDC-sf and demonstrated that GB was capable of activating DAPDC-sf in vitro, thus confirming the in vivo results. Most importantly, we showed that the activation was correlated with a conformational change of DAPDC-sf. Taken together, these results show, for the first time, that GB may actively assist in vivo protein folding in a chaperone-like manner.	Univ Rennes 1, Grp Membranes & Osmoregulat, CNRS UPRESA 6026, F-35042 Rennes, France; Univ Bretagne Sud, Lab Biol & Chim Mol, F-56017 Vannes, France; Inst Biol Struct & Microbiol, UPR 9043 CNRS, Lab Chim Bacterienne, F-13402 Marseille, France	Universite de Rennes; UDICE-French Research Universities; Aix-Marseille Universite	Bernard, T (corresponding author), Univ Rennes 1, Grp Membranes & Osmoregulat, CNRS UPRESA 6026, Batiment 14,Campus Beaulieu, F-35042 Rennes, France.	tbernard@univ-rennes1.fr	Touzé, Thierry/GLT-1308-2022; SIRE, Olivier/A-9807-2016	SIRE, Olivier/0000-0003-1126-8646; Touze, Thierry/0000-0002-2176-6537; Bourot, Stephane/0000-0002-9069-5787				ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978; BROWN AD, 1976, BACTERIOL REV, V40, P803, DOI 10.1128/MMBR.40.4.803-846.1976; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; Csonka L. N., 1996, ESCHERICHIA COLI SAL, P1210; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; ETFINK MR, 1976, J PHYS CHEM-US, V80, P486; FERNANDO T, 1992, BIOCHEMISTRY-US, V31, P3429, DOI 10.1021/bi00128a018; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; HenggeAronis R, 1996, MOL MICROBIOL, V21, P887, DOI 10.1046/j.1365-2958.1996.511405.x; IKUTA S, 1977, J BIOCHEM-TOKYO, V82, P1741, DOI 10.1093/oxfordjournals.jbchem.a131872; JEBBAR M, 1992, J BACTERIOL, V174, P5027, DOI 10.1128/JB.174.15.5027-5035.1992; Kilstrup M, 1997, APPL ENVIRON MICROB, V63, P1826, DOI 10.1128/AEM.63.5.1826-1837.1997; Kojima R, 1996, J BIOL CHEM, V271, P12327, DOI 10.1074/jbc.271.21.12327; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MILLER JH, 1972, EXPT MOL GENETICS, P125; MURATA N, 1992, FEBS LETT, V296, P187, DOI 10.1016/0014-5793(92)80376-R; NILSSON B, 1983, NUCLEIC ACIDS RES, V11, P8019, DOI 10.1093/nar/11.22.8019; PALEG LG, 1981, AUST J PLANT PHYSIOL, V8, P107; PETRONINI PG, 1993, BIOCHEM J, V293, P553, DOI 10.1042/bj2930553; Qu YX, 1998, P NATL ACAD SCI USA, V95, P9268, DOI 10.1073/pnas.95.16.9268; Record MT, 1998, ADV PROTEIN CHEM, V51, P281; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMURA Y, 1966, BIOCHIM BIOPHYS ACTA, V118, P396, DOI 10.1016/S0926-6593(66)80048-6; STRAGIER P, 1983, J MOL BIOL, V168, P333, DOI 10.1016/S0022-2836(83)80022-9; STRAGIER P, 1983, J BACTERIOL, V156, P1198, DOI 10.1128/JB.156.3.1198-1203.1983; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; WARR SRC, 1984, J GEN MICROBIOL, V130, P2169; Zargarian L, 1999, BIOCHEMISTRY-US, V38, P1921, DOI 10.1021/bi981199j; Zhang WT, 1996, BIOCHEMISTRY-US, V35, P10506, DOI 10.1021/bi960795f	43	119	132	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1050	1056		10.1074/jbc.275.2.1050	http://dx.doi.org/10.1074/jbc.275.2.1050			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625645	hybrid			2022-12-27	WOS:000084836600049
J	Leaney, JL; Milligan, G; Tinker, A				Leaney, JL; Milligan, G; Tinker, A			The G protein alpha subunit has a key role in determining the specificity of coupling to, but not the activation of, G protein-gated inwardly rectifying K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; CELL-FREE MEMBRANE; I-KACH; POTASSIUM CHANNEL; BINDING-PROTEINS; XENOPUS OOCYTES; MOLECULAR-PROPERTIES; MUSCARINIC RECEPTOR; STRUCTURAL ELEMENTS; ADENYLYL-CYCLASE	In neuronal and atrial tissue, G protein-gated inwardly rectifying K+ channels (Kir3.x family) are responsible for mediating inhibitory postsynaptic potentials and slowing the heart rate, They are activated by G beta gamma dimers released in response to the stimulation of receptors coupled to inhibitory G proteins of the G(i/o) family but not receptors coupled to the stimulatory G protein G(s), We have used biochemical, electrophysiological, and molecular biology techniques to examine this specificity of channel activation. In this study we have succeeded in reconstituting such specificity in an heterologous expression system stably expressing a cloned counterpart of the neuronal channel (Kir3.1 and Kir3.2A heteromultimers), The use of pertussis toxin-resistant G protein alpha subunits and chimeras between G(il) and G(s) indicate a central role for the G protein alpha subunits in determining receptor specificity of coupling to, but not activation of, G protein-gated inwardly rectifying K+ channels.	UCL, Dept Med, Ctr Clin Pharmacol, Rayne Inst, London WC1E 6JJ, England; Univ Glasgow, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of London; King's College London; University College London; University of Glasgow	Milligan, G (corresponding author), UCL, Dept Med, Ctr Clin Pharmacol, Rayne Inst, 5 Univ St, London WC1E 6JJ, England.	gbca32@udcf.gla.ac.uk; a.tinker@ucl.ac.uk	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519				ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Bahia DS, 1998, BIOCHEMISTRY-US, V37, P11555, DOI 10.1021/bi980284o; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; CHABRE O, 1994, J BIOL CHEM, V269, P5730; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; Corey S, 1998, J BIOL CHEM, V273, P5271, DOI 10.1074/jbc.273.9.5271; COTECCHIA S, 1990, J BIOL CHEM, V265, P63; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DASCAL N, 1995, P NATL ACAD SCI USA, V92, P6758, DOI 10.1073/pnas.92.15.6758; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Delmas P, 1998, EUR J NEUROSCI, V10, P1654, DOI 10.1046/j.1460-9568.1998.00170.x; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Fong CW, 1998, MOL PHARMACOL, V54, P249, DOI 10.1124/mol.54.2.249; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; HUNT TW, 1994, J BIOL CHEM, V269, P29565; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Inanobe A, 1999, J NEUROSCI, V19, P1006; Jeong SW, 1999, J NEUROSCI, V19, P4755; Kennedy ME, 1999, J BIOL CHEM, V274, P2571, DOI 10.1074/jbc.274.4.2571; KLOTZ KN, 1993, N-S ARCH PHARMACOL, V357, P1; Kostenis E, 1997, J BIOL CHEM, V272, P19107, DOI 10.1074/jbc.272.31.19107; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; KURACHI Y, 1986, AM J PHYSIOL, V251, pH681, DOI 10.1152/ajpheart.1986.251.3.H681; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MILLIGAN G, 1988, BIOCHEM J, V255, P1; MURTHY KS, 1994, J BIOL CHEM, V269, P15977; NOMA A, 1978, PFLUG ARCH EUR J PHY, V377, P193, DOI 10.1007/BF00584272; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Ruiz-Velasco V, 1998, J PHYSIOL-LONDON, V513, P761, DOI 10.1111/j.1469-7793.1998.761ba.x; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; Sorota S, 1999, J PHYSIOL-LONDON, V514, P413, DOI 10.1111/j.1469-7793.1999.413ae.x; SREEDHARAN SP, 1994, BIOCHEM BIOPH RES CO, V203, P141, DOI 10.1006/bbrc.1994.2160; Stevens EB, 1997, J PHYSIOL-LONDON, V503, P547, DOI 10.1111/j.1469-7793.1997.547bg.x; Tsu RC, 1997, MOL PHARMACOL, V52, P38, DOI 10.1124/mol.52.1.38; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Xiao RP, 1999, CIRC RES, V84, P43; Yamada M, 1998, PHARMACOL REV, V50, P723; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3	61	72	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					921	929		10.1074/jbc.275.2.921	http://dx.doi.org/10.1074/jbc.275.2.921			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625628	hybrid			2022-12-27	WOS:000084836600032
J	Liu, JS; Kuo, SR; McHugh, MM; Beerman, TA; Melendy, T				Liu, JS; Kuo, SR; McHugh, MM; Beerman, TA; Melendy, T			Adozelesin triggers DNA damage response pathways and arrests SV40 DNA replication through replication protein A inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; SIMIAN VIRUS-40 DNA; RADIATION-INDUCED PHOSPHORYLATION; S-PHASE CHECKPOINT; SIMIAN-VIRUS-40 DNA; BINDING PROTEIN; P34 SUBUNIT; HUMAN-CELLS; ATAXIA-TELANGIECTASIA; BSC-1 CELLS	The cyclopropylpyrroloindole anti-cancer drug, adozelesin, binds to and alkylates DNA. Treatment of human cells with low levels of adozelesin results in potent inhibition of both cellular and simian virus 40 (SV40) DNA replication. Extracts were prepared from adozelesin-treated cells and shown to be deficient in their ability to support SV40 DNA replication in vitro, This effect on in vitro DNA replication was dependent on both the concentration of adozelesin used and the time of treatment but was not due to the presence of adozelesin in the in vitro assay, Adozelesin treatment of cells was shown to result in the following: induction of p53 protein levels, hyperphosphorylation of replication protein A (RPA), and disruption of the p53-RPA complex (but not disruption of the RPA-cdc2 complex), indicating that adozelesin treatment triggers cellular DNA damage response pathways. Interestingly, in vitro DNA replication could be rescued in extracts from adozelesin-treated cells by the addition of exogenous RPA, Therefore, whereas adozelesin and other anti-cancer therapeutics trigger common DNA damage response markers, adozelesin causes DNA replication arrest through a unique mechanism. The S phase checkpoint response triggered by adozelesin acts by inactivating RPA in some function essential for SV40 DNA replication.	SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol, Buffalo, NY 14214 USA; SUNY Buffalo, Sch Med & Biomed Sci, Ctr Microbial Pathogenesis, Buffalo, NY 14214 USA; Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Melendy, T (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol, 138 Farber Hall, Buffalo, NY 14214 USA.	tmelendy@buffalo.edu			NATIONAL CANCER INSTITUTE [P30CA016056, R01CA077491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056406] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16056, CA 77491] Funding Source: Medline; NIGMS NIH HHS [GM 56406] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramova NA, 1997, P NATL ACAD SCI USA, V94, P7186, DOI 10.1073/pnas.94.14.7186; Ball K L, 1997, Prog Cell Cycle Res, V3, P125; BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0; Brush GS, 1995, METHOD ENZYMOL, V262, P522; BRUSH GS, 1994, P NATL ACAD SCI USA, V91, P12520, DOI 10.1073/pnas.91.26.12520; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Burgers PMJ, 1998, CHROMOSOMA, V107, P218, DOI 10.1007/s004120050300; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cheng XB, 1996, RADIOTHER ONCOL, V39, P43, DOI 10.1016/0167-8140(96)01712-4; Cobuzzi RJ, 1996, J BIOL CHEM, V271, P19852, DOI 10.1074/jbc.271.33.19852; Cristofanilli M, 1998, ANTI-CANCER DRUG, V9, P779, DOI 10.1097/00001813-199810000-00006; DOLLARD SC, 1993, J VIROL, V67, P1721, DOI 10.1128/JVI.67.3.1721-1726.1993; EKI T, 1992, J BIOL CHEM, V267, P7284; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; FRIEDMAN PN, 1990, P NATL ACAD SCI USA, V87, P9275, DOI 10.1073/pnas.87.23.9275; Froesch BA, 1999, J BIOL CHEM, V274, P6469, DOI 10.1074/jbc.274.10.6469; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; GRAND RJA, 1995, VIROLOGY, V210, P323, DOI 10.1006/viro.1995.1349; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Henricksen LA, 1996, NUCLEIC ACIDS RES, V24, P3107, DOI 10.1093/nar/24.15.3107; HURLEY LH, 1990, J AM CHEM SOC, V112, P4633, DOI 10.1021/ja00168a003; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; LANFORD RE, 1988, VIROLOGY, V167, P72, DOI 10.1016/0042-6822(88)90055-4; LI JJ, 1984, P NATL ACAD SCI-BIOL, V81, P6973, DOI 10.1073/pnas.81.22.6973; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; MAINE IP, 1992, BIOCHEMISTRY-US, V31, P3968, DOI 10.1021/bi00131a012; McHugh MM, 1999, BIOCHEMISTRY-US, V38, P11508, DOI 10.1021/bi990598r; MELENDY T, 1992, NUCLEIC ACIDS MOL BI, V6, P129; Miller SD, 1997, MOL CELL BIOL, V17, P2194, DOI 10.1128/MCB.17.4.2194; MITCHELL MA, 1991, J AM CHEM SOC, V113, P8994, DOI 10.1021/ja00023a085; MIYAMOTO N, 1990, BIOCHEM BIOPH RES CO, V168, P604, DOI 10.1016/0006-291X(90)92363-5; Morgan SE, 1997, CANCER RES, V57, P3386; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; PAN ZQ, 1995, P NATL ACAD SCI USA, V92, P4636, DOI 10.1073/pnas.92.10.4636; Parry D, 1999, MOL CELL BIOL, V19, P1775; Podust VN, 1997, J BIOL CHEM, V272, P6303, DOI 10.1074/jbc.272.10.6303; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; SUN D, 1992, BIOCHEMISTRY-US, V31, P2822, DOI 10.1021/bi00125a025; SUN DY, 1992, J MED CHEM, V35, P1773, DOI 10.1021/jm00088a012; Treuner K, 1999, NUCLEIC ACIDS RES, V27, P1499, DOI 10.1093/nar/27.6.1499; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; Von Hoff DD, 1998, SEMIN ONCOL, V25, P47; WAGA S, 1994, J BIOL CHEM, V269, P10923; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; Wang Y, 1998, RADIAT RES, V149, P284, DOI 10.2307/3579962; Wang Y, 1999, J BIOL CHEM, V274, P22060, DOI 10.1074/jbc.274.31.22060; Wang Y, 1997, CANCER RES, V57, P1654; Wang Y, 1996, RADIAT RES, V145, P408, DOI 10.2307/3579062; WEINBERG DH, 1990, P NATL ACAD SCI USA, V87, P8692, DOI 10.1073/pnas.87.22.8692; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wood RD, 1997, CARCINOGENESIS, V18, P605, DOI 10.1093/carcin/18.4.605; Woynarowski JM, 1999, BBA-GENE STRUCT EXPR, V1444, P201, DOI 10.1016/S0167-4781(99)00002-0; WOYNAROWSKI JM, 1995, BIOCHEMISTRY-US, V34, P13042, DOI 10.1021/bi00040a015; Woynarowski JM, 1997, BBA-GENE STRUCT EXPR, V1353, P50, DOI 10.1016/S0167-4781(97)00046-8; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896	64	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1391	1397		10.1074/jbc.275.2.1391	http://dx.doi.org/10.1074/jbc.275.2.1391			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625690	hybrid			2022-12-27	WOS:000084836600094
J	Fong, AM; Erickson, HP; Zachariah, JP; Poon, S; Schamberg, NJ; Imai, T; Patel, DD				Fong, AM; Erickson, HP; Zachariah, JP; Poon, S; Schamberg, NJ; Imai, T; Patel, DD			Ultrastructure and function of the fractalkine mucin domain in CX3C chemokine domain presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; EPIDERMAL GROWTH-FACTOR; P-SELECTIN; ADHESION; CX(3)CR1; RECEPTOR; IDENTIFICATION; ENDOTHELIUM; ACTIVATION; LEUKOCYTES	Fractalkine (FKN), a CX3C chemokine/mucin hybrid molecule on endothelium, functions as an adhesion molecule to capture and induce firm adhesion of a subset of leukocytes in a selectin- and integrin-independent manner. We hypothesized that the FKN mucin domain may be important for its function in adhesion, and tested the ability of secreted alkaline phosphatase (SEAP) fusion proteins containing the entire extracellular region (FKN-SEAP), the chemokine domain (CX3C-SEAP), or the mucin domain (mucin-SEAP) to support firm adhesion under now. CX3C-SEAP induced suboptimal firm adhesion of resting peripheral blood mononuclear cells, compared with FKN-SEAP, and mucin-SEAP induced no firm adhesion. CX3C-SEAP and FKN-SEAP bound to CX(3)CR1 with similar affinities. By electron microscopy, fractalkine was 29 nm in length with a long stalk (mucin domain), and a globular head (CX3C). To test the function of the mucin domain, a chimeric protein replacing the mucin domain with a rod-like segment of E-selectin was constructed. This chimeric protein gave the same adhesion of peripheral blood mononuclear cells as intact FKN, both when immobilized on glass and when expressed on the cell surface. This implies that the function of the mucin domain is to provide a stalk, extending the chemokine domain away from the endothelial cell surface to present it to flowing leukocytes.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Kinki Univ, Sch Med, Dept Microbiol, Sayama, Osaka 5898511, Japan	Duke University; Duke University; Kindai University (Kinki University)	Patel, DD (corresponding author), Duke Univ, Med Ctr, Dept Med, 223 Med Sci Res Bldg,Box 3258, Durham, NC 27710 USA.				NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR039162] Funding Source: NIH RePORTER; NCI NIH HHS [CA47056] Funding Source: Medline; NIAMS NIH HHS [AR39162] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chen SH, 1998, J EXP MED, V188, P193, DOI 10.1084/jem.188.1.193; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; FOWLER WE, 1979, J MOL BIOL, V134, P241, DOI 10.1016/0022-2836(79)90034-2; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; HEMMERICH S, 1995, J BIOL CHEM, V270, P12035, DOI 10.1074/jbc.270.20.12035; HONDA S, 1994, J IMMUNOL, V152, P4026; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; LEY K, 1995, J IMMUNOL, V155, P525; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; MCEVER RP, 1997, J CLIN INVEST, V100, P97; Mehta P, 1997, BLOOD, V90, P2381, DOI 10.1182/blood.V90.6.2381.2381_2381_2389; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Tu LL, 1996, J IMMUNOL, V157, P3995; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229	31	71	79	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3781	3786		10.1074/jbc.275.6.3781	http://dx.doi.org/10.1074/jbc.275.6.3781			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660527	hybrid			2022-12-27	WOS:000085288800011
J	Schneider, H; Guerette, B; Guntermann, C; Rudd, CE				Schneider, H; Guerette, B; Guntermann, C; Rudd, CE			Resting lymphocyte kinase (Rlk/Txk) targets lymphoid adaptor SLP-76 in the cooperative activation of interleukin-2 transcription in T-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASES; X-LINKED AGAMMAGLOBULINEMIA; ANTIGEN-RECEPTOR; SRC FAMILY; THYMOCYTE DEVELOPMENT; GENETIC-EVIDENCE; MICE LACKING; PHOSPHORYLATION; ZAP-70; ITK	Blk/Txk is a T-cell-specific member of the Btk/Tec family of tyrosine kinases, whereas SLP-76 is a lymphoid adaptor that is essential for pre-TcR and mature TcR signaling, Although Rlk deficient T-cells show partial defects in T-cell proliferation, Rlk can complement ITK-/- cells with multiple defects in TcR initiated early events and interleukin (IL)-2 production. A key question is the nature of the target of Rlk responsible for bridging the TcR with the activation of IL-2 transcription. In this study, we identify a pathway in which Rlk phosphorylates SLP-76 leading to the phosphorylation of PLC gamma 1, activation of ERKs, and the synergistic up-regulation of TcR-driven IL-2 NFAT/AP-1 transcription, Rlk phosphorylated the N-terminal region of SLP-76, a region that has been previously shown to serve as a target for ZAP-70. Loss of N-terminal YESP/YEPP sites of SLP-76 or the Rlk kinase activity attenuated cooperativity between Rlk and SLP-76. These observations support a model where the TcR can utilize Rlk (as well as ZAP-70) in the phosphorylation of key sites in SLP-76 leading to the up-regulation of Th1 preferred cytokine IL-2.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rudd, CE (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	christopher_rudd@dfci.harvard.edu	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019				Bachmann MF, 1997, J VIROL, V71, P7253, DOI 10.1128/JVI.71.10.7253-7257.1997; Calvo CR, 1997, J EXP MED, V186, P1645, DOI 10.1084/jem.186.10.1645; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; Debnath J, 1999, MOL CELL BIOL, V19, P1498; DESIDERIO S, 1994, CHEM IMMUNOL, V59, P191; Fang N, 1996, J IMMUNOL, V157, P3769; Gibson S, 1996, J IMMUNOL, V156, P2716; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; JACKMAN JK, 1995, J BIOL CHEM, V270, P7029, DOI 10.1074/jbc.270.13.7029; Liao XC, 1997, J EXP MED, V186, P221, DOI 10.1084/jem.186.2.221; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; MUSTELIN T, 1994, IMMUNITY, V1, P351, DOI 10.1016/1074-7613(94)90065-5; Onodera H, 1996, J BIOL CHEM, V271, P22225, DOI 10.1074/jbc.271.36.22225; Peterson EJ, 1998, CURR OPIN IMMUNOL, V10, P337, DOI 10.1016/S0952-7915(98)80173-8; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1994, IMMUNOL TODAY, V15, P225, DOI 10.1016/0167-5699(94)90248-8; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schneider H, 1998, BIOCHEM BIOPH RES CO, V252, P14, DOI 10.1006/bbrc.1998.9559; SILICIANO JD, 1992, P NATL ACAD SCI USA, V89, P11194, DOI 10.1073/pnas.89.23.11194; SOMMERS CL, 1995, ONCOGENE, V11, P245; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; WEISS DR, 1994, CELL, V71, P649; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1	43	50	53	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3835	3840		10.1074/jbc.275.6.3835	http://dx.doi.org/10.1074/jbc.275.6.3835			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660534	hybrid			2022-12-27	WOS:000085288800018
J	Dolmer, K; Huang, W; Gettins, PGW				Dolmer, K; Huang, W; Gettins, PGW			NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein - Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH REPEAT; 3-DIMENSIONAL STRUCTURE; ALPHA-2-MACROGLOBULIN RECEPTOR; SCAVENGER RECEPTORS; APOLIPOPROTEIN-E; CHEMICAL-SHIFTS; COMPLEXES; LRP; MODULE; SITE	We have used NMR methods to determine the structure of the calcium complex of complement-like repeat 3 (CR3) from the low density lipoprotein receptor-related protein (LRP) and to examine its specific interaction with the receptor binding domain of human alpha(2)-macroglobulin. CR3 is one of eight related repeats that constitute a major ligand binding region of LRP. The structure is very similar in overall fold to homologous complement-like repeat CR8 from LRP and complement-like repeats LB1, LB2, and LB5 from the low density lipoprotein receptor and contains a short two-strand antiparallel beta-sheet, a one turn alpha-helix, and a high affinity calcium site with coordination from four carboxyls and two backbone carbonyls, The surface electrostatics and topography are, however, quite distinct from each of these other repeats. Two-dimensional H-1,N-15-heteronuclear single quantum coherence spectra provide evidence for a specific, though relatively weak (K-d similar to 140 mu M), interaction between CR3 and human alpha 2-macroglobulin receptor binding domain that involves a contiguous patch of surface residues in the central region of CR3. This specific interaction is consistent with a mode of LRP binding to ligands that uses contributions from more than one domain to generate a wide array of different binding sites, each with overall high affinity.	Univ Illinois, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Biol, M-C 536,1853 W Polk St, Chicago, IL 60612 USA.		Dolmer, Klavs/G-5512-2012	Dolmer, Klavs/0000-0001-7359-360X	NIGMS NIH HHS [GM54414] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; CASE DA, 1997, AMBER 5; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Dolmer K, 1998, BIOCHEMISTRY-US, V37, P17016, DOI 10.1021/bi982022s; ENGHILD JJ, 1989, BIOCHEMISTRY-US, V28, P1406, DOI 10.1021/bi00429a069; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Huang W, 2000, J BIOL CHEM, V275, P1089, DOI 10.1074/jbc.275.2.1089; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Jenner L, 1998, STRUCTURE, V6, P595, DOI 10.1016/S0969-2126(98)00061-6; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Storm D, 1997, J BIOL CHEM, V272, P31043, DOI 10.1074/jbc.272.49.31043; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	27	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3264	3269		10.1074/jbc.275.5.3264	http://dx.doi.org/10.1074/jbc.275.5.3264			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652313	hybrid			2022-12-27	WOS:000085146500035
J	Vallorosi, CJ; Day, KC; Zhao, X; Rashid, MG; Rubin, MA; Johnson, KR; Wheelock, MJ; Day, ML				Vallorosi, CJ; Day, KC; Zhao, X; Rashid, MG; Rubin, MA; Johnson, KR; Wheelock, MJ; Day, ML			Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELL-ADHESION MOLECULES; RAT VENTRAL PROSTATE; CANCER-CELLS; CYTOPLASMIC DOMAIN; CARCINOMA-CELLS; GROWTH-FACTORS; N-CADHERIN; ACTIVATION; MEMBRANE	A potential target of hormone action during prostate and mammary involution is the intercellular junction of adjacent secretory epithelium. This is supported by the long-standing observation that one of the first visible stages of prostate and mammary involution is the disruption of interepithelial adhesion prior to the onset of apoptosis, In a previous study addressing this aspect of involution, we acquired compelling evidence indicating that the disruption of E-cadherin-dependent adhesion initiates apoptotic programs during prostate and mammary involution. In cultured prostate and mammary epithelial cells, inhibition of E-cadherin-dependent aggregation resulted in cell death following apoptotic stimuli. Loss of cell-cell adhesion in the nonaggregated population appeared to result from the rapid truncation within the cytosolic domain of the mature, 120-kDa species of E-cadherin (E-cad(120)). Immunoprecipitations from cell culture and involuting mammary gland demonstrated that this truncation removed the beta-catenin binding domain from the cytoplasmic tail of E-cadherin, resulting in a non beta-catenin binding, membrane-bound 97-kDa species (E-cad(97)) and a free cytoplasmic 35-kDa form (E-cad(34)) that is bound to beta-catenin, Examination of E-cadherin expression and cellular distribution during prostate and mammary involution revealed a dramatic reduction in junctional membrane staining that correlated with a similar reduction in E-cad(120) and accumulation of E-cad(97) and E-cad(35). The observation that E-cadherin was truncated during involution suggested that hormone depletion activated the same apoptotic pathway in vivo as observed in vitro. Based on these findings, we hypothesize that truncation of E-cadherin results in the loss of beta-catenin binding and cellular dissociation that may signal epithelial apoptosis during prostate and mammary involution, Thus, E-cadherin may be central to homeostatic regulation in these tissues by coordinating adhesion-dependent survival and dissociation-induced apoptosis.	Univ Michigan, Dept Surg, Div Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Toledo, Dept Biol, Toledo, OH 43606 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; University of Toledo	Day, ML (corresponding author), Box 0944,Rm 6219 CGC,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	mday@umich.edu		Rubin, Mark/0000-0002-8321-9950	NATIONAL CANCER INSTITUTE [P50CA069568] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA69568] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Amar LS, 1998, CELL ADHES COMMUN, V5, P1, DOI 10.3109/15419069809005594; Ansonoff MA, 1998, ENDOCRINOLOGY, V139, P3050, DOI 10.1210/en.139.7.3050; BATES RC, 1994, J CELL BIOL, V125, P403, DOI 10.1083/jcb.125.2.403; Cabrera N, 1996, J CELL BIOL, V132, P427, DOI 10.1083/jcb.132.3.427; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CHIANG L, 1982, BIOCHEM INT, V4, P161; Colin IM, 1998, ENDOCRINOLOGY, V139, P3796, DOI 10.1210/en.139.9.3796; Day ML, 1999, J BIOL CHEM, V274, P9656, DOI 10.1074/jbc.274.14.9656; Day ML, 1997, J BIOL CHEM, V272, P8125, DOI 10.1074/jbc.272.13.8125; DAY ML, 1994, CELL GROWTH DIFFER, V5, P735; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P515; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; FABRE M, 1993, J CELL SCI, V106, P513; Fabre S, 1996, MOL CELL ENDOCRINOL, V124, P79, DOI 10.1016/S0303-7207(96)03931-7; Fishman DD, 1998, INT J ONCOL, V12, P181; GEIGER B, 1992, ANNU REV CELL BIOL, V8, P307, DOI 10.1146/annurev.cb.08.110192.001515; GUENETTE RS, 1994, J MOL ENDOCRINOL, V12, P47, DOI 10.1677/jme.0.0120047; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; Ilyas M, 1997, J PATHOL, V182, P128; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; KATAYAMA M, 1994, INT J ONCOL, V5, P1049; LEWIS JE, 1994, J CELL SCI, V107, P3615; Livneh E, 1997, EUR J BIOCHEM, V248, P1, DOI 10.1111/j.1432-1033.1997.t01-4-00001.x; Marino M, 1998, BIOCHEM BIOPH RES CO, V245, P254, DOI 10.1006/bbrc.1998.8413; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; Nieman MT, 1999, J CELL SCI, V112, P1621; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752; Powell CT, 1996, CELL GROWTH DIFFER, V7, P419; RENNIE PS, 1984, BIOCHEM J, V221, P171, DOI 10.1042/bj2210171; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; SHEU HM, 1989, EXP CELL RES, V185, P176, DOI 10.1016/0014-4827(89)90047-5; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SKOUDY A, 1995, FEBS LETT, V374, P415, DOI 10.1016/0014-5793(95)01167-D; St Croix Brad, 1997, Current Opinion in Oncology, V9, P549; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Sylvia VL, 1998, J CELL PHYSIOL, V176, P435, DOI 10.1002/(SICI)1097-4652(199808)176:2<435::AID-JCP22>3.0.CO;2-0; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TALHOUK RS, 1992, J CELL BIOL, V118, P1271, DOI 10.1083/jcb.118.5.1271; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; TENNISWOOD MP, 1992, CANCER METAST REV, V11, P197, DOI 10.1007/BF00048064; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; vanHengel J, 1997, J CELL BIOL, V137, P1103, DOI 10.1083/jcb.137.5.1103; WALKER NI, 1989, AM J ANAT, V185, P19, DOI 10.1002/aja.1001850104; Werb Z, 1996, BRAZ J MED BIOL RES, V29, P1087; WHEELOCK MJ, 1987, J CELL BIOCHEM, V34, P187, DOI 10.1002/jcb.240340305; WILSON MJ, 1995, ARCH ANDROLOGY, V35, P119, DOI 10.3109/01485019508987862; WILSON MJ, 1991, BIOL REPROD, V44, P776, DOI 10.1095/biolreprod44.5.776; WINKEL GK, 1990, DEV BIOL, V138, P1, DOI 10.1016/0012-1606(90)90171-E; Wu JC, 1996, BIOCHEM BIOPH RES CO, V225, P733, DOI 10.1006/bbrc.1996.1243; Zhao X, 1997, J BIOL CHEM, V272, P22751, DOI 10.1074/jbc.272.36.22751	56	82	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3328	3334		10.1074/jbc.275.5.3328	http://dx.doi.org/10.1074/jbc.275.5.3328			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652321	hybrid			2022-12-27	WOS:000085146500043
J	Kawasaki, K; Akashi, S; Shimazu, R; Yoshida, T; Miyake, K; Nishijima, M				Kawasaki, K; Akashi, S; Shimazu, R; Yoshida, T; Miyake, K; Nishijima, M			Mouse toll-like receptor 4 center dot MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MURINE MACROPHAGES; BACTERIAL LIPOPOLYSACCHARIDE; TYROSINE PHOSPHORYLATION; ENDOTOXIN ANTAGONIST; DROSOPHILA TOLL; NITRIC-OXIDE; KAPPA-B; PROTEIN; ACTIVATION	Taxol, an antitumor agent derived from a plant, mimics the action of lipopolysaccharide (LPS) in mice but not in humans, Although Taxol is structurally unrelated to LPS, Taxol and LPS are presumed to share a receptor or signaling molecule, The LPS-mimetic activity of Taxol is not observed in LPS-hyporesponsive C3H/HeJ mice, which possess a point mutation in Toll-like receptor 4 (TLR4); therefore, TLR4 appears to be involved in both Taxol and LPS signaling. In addition, TLR4 was recently shown to physically associate with MD-2, a molecule that confers LPS responsiveness on TLR4. To determine whether TLR4 MD-2 complex mediates a Taxol-induced signal, we constructed transformants of the mouse pro-B cell line, Ba/F3, expressing mouse TLR4 alone, both mouse TLR4 and mouse MD-2, and both mouse MD-2 and mouse TLR4 lacking the cytoplasmic portion, and then examined whether Taxol induced NF kappa B activation in these transfectants, Noticeable NF kappa B activation by Taxol was detected in Ba/F3 expressing mouse TLR4 and mouse MD-2 but not in the other transfectants. Coexpression of human TLR4 and human MD-2 did not confer Taxol responsiveness on Ba/F3 cells, suggesting that the TLR4 MD-2 complex is responsible for the species specificity with respect to Taxol responsiveness. Furthermore, Taxol-induced NF kappa B activation via TLR4 MD-2 was blocked by an LPS antagonist that blocks LPS-induced NF kappa B activation via TLR4 MD-2. These results demonstrated that coexpression of mouse TLR4 and mouse MD-2 is required for Taxol responsiveness and that the TLR4.MD-2 complex is the shared molecule in Taxol and LPS signal transduction in mice.	Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjyuku Ku, Tokyo 1628640, Japan; Saga Med Sch, Dept Immunol, Saga 8498501, Japan	National Institute of Infectious Diseases (NIID); Saga University	Nishijima, M (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjyuku Ku, Toyama 1-23-1, Tokyo 1628640, Japan.							ALLEN JN, 1993, J LAB CLIN MED, V122, P374; Bhat N, 1999, J IMMUNOL, V162, P7335; Byrd CA, 1999, P NATL ACAD SCI USA, V96, P5645, DOI 10.1073/pnas.96.10.5645; CHRIST WJ, 1995, SCIENCE, V268, P80, DOI 10.1126/science.7701344; DING A, 1993, J IMMUNOL, V151, P5596; DING AH, 1990, SCIENCE, V248, P370, DOI 10.1126/science.1970196; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Hoshino K, 1999, J IMMUNOL, V162, P3749; KIRIKAE F, 1995, INFECT IMMUN, V63, P486, DOI 10.1128/IAI.63.2.486-497.1995; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Lee LF, 1996, CANCER RES, V56, P1303; MANTHEY CL, 1992, J IMMUNOL, V149, P2459; MANTHEY CL, 1993, J EXP MED, V178, P695, DOI 10.1084/jem.178.2.695; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MIYAKE K, 1995, J IMMUNOL, V154, P3333; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Perera PY, 1996, INFECT IMMUN, V64, P878, DOI 10.1128/IAI.64.3.878-884.1996; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; QURESHI N, 1991, INFECT IMMUN, V59, P441, DOI 10.1128/IAI.59.1.441-444.1991; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Soejima K, 1996, AM J RESP CRIT CARE, V154, P900, DOI 10.1164/ajrccm.154.4.8887583; WANG SC, 1994, SURGERY, V116, P339; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Yamamoto H, 1997, BIOCHEM J, V325, P223, DOI 10.1042/bj3250223	32	287	307	7	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2251	2254		10.1074/jbc.275.4.2251	http://dx.doi.org/10.1074/jbc.275.4.2251			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644670	hybrid			2022-12-27	WOS:000085128000002
J	Porter, M; Schindler, T; Kuriyan, J; Miller, WT				Porter, M; Schindler, T; Kuriyan, J; Miller, WT			Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416) - Effect of introducing a high affinity intramolecular SH2 ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; C-SRC ACTIVITY; INTERMOLECULAR AUTOPHOSPHORYLATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; NEF PROTEIN; BINDING; FAMILY; ACTIVATION; PEPTIDES	The Src family tyrosine kinase Hck possesses two phosphorylation sites,Tyr(527) and Tyr(416), that affect the catalytic activity in opposite ways. When phosphorylated, Tyr(527) and residues C-terminal to it are involved in an inhibitory intramolecular interaction with the SH2 domain. However, this sequence does not conform to the sequence of the high affinity SH2 ligand, pYEEI, We mutated this sequence to YEEI and show that this mutant form of Hck cannot be activated by exogenous SH2 ligands. The SH3 domain of Hck is also involved in an inhibitory interaction with the catalytic domain. The SH3 ligand Nef binds to and activates YEEI-Hck mutant in a similar manner to wild-type Hck, indicating that disrupting the SH3 interaction overrides the strengthened SH2 interaction. The other phosphorylation site, Tyr(416), is the autophosphorylation site in the activation loop. Phosphorylation of Tyr(416) is required for Hck activation. We mutated this residue to alanine and characterized its catalytic activity. The Y416A mutant shows a higher K-m value for peptide and a lower V-max than autophosphorylated wild-type Hck. We also present evidence for cross-talk between the activation loop and the intramolecular binding of the SH2 and SH3 domains.	SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Miller, WT (corresponding author), SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Basic Sci Tower,T-6, Stony Brook, NY 11794 USA.	miller@physiology.pnb.sunysb.edu			NCI NIH HHS [CA58530] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058530, R29CA058530] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P9083, DOI 10.1021/bi973147k; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; FERRACINI R, 1990, ONCOGENE RES, V5, P205; GARCIA P, 1993, J BIOL CHEM, V268, P25146; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Guappone AC, 1997, MOL CELL BIOCHEM, V175, P243, DOI 10.1023/A:1006840104666; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; LAW DA, 1992, MOL IMMUNOL, V29, P917, DOI 10.1016/0161-5890(92)90130-P; LEE CH, 1995, EMBO J, V14, P5006, DOI 10.1002/j.1460-2075.1995.tb00183.x; LIU XQ, 1993, ONCOGENE, V8, P1119; Mayer BJ, 1997, CURR BIOL, V7, pR295, DOI 10.1016/S0960-9822(06)00141-2; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; MURPHY SM, 1993, MOL CELL BIOL, V13, P5290, DOI 10.1128/MCB.13.9.5290; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nguyen JT, 1997, NAT STRUCT BIOL, V4, P256, DOI 10.1038/nsb0497-256; Onofri F, 1997, P NATL ACAD SCI USA, V94, P12168, DOI 10.1073/pnas.94.22.12168; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Weijland A, 1996, EUR J BIOCHEM, V240, P756, DOI 10.1111/j.1432-1033.1996.0756h.x; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; XU B, 1995, J BIOL CHEM, V270, P29825; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	39	99	101	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2721	2726		10.1074/jbc.275.4.2721	http://dx.doi.org/10.1074/jbc.275.4.2721			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644735	hybrid, Green Submitted			2022-12-27	WOS:000085128000067
J	Villain, M; Jackson, PL; Manion, MK; Dong, WJ; Su, ZC; Fassina, G; Johnson, TM; Sakai, TT; Krishna, NR; Blalock, JE				Villain, M; Jackson, PL; Manion, MK; Dong, WJ; Su, ZC; Fassina, G; Johnson, TM; Sakai, TT; Krishna, NR; Blalock, JE			De novo design of peptides targeted to the EF hands of calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANTI-IDIOTYPIC ANTIBODIES; MONOCLONAL ANTIIDIOTYPIC ANTIBODIES; AUTOIMMUNE MYASTHENIA-GRAVIS; COMPLEMENTARY PEPTIDES; ACETYLCHOLINE-RECEPTOR; PROTEOLYTIC FRAGMENTS; MOLECULAR RECOGNITION; GENETIC ALGORITHM	This report describes the use of the concept of inversion of hyrdropathy patterns to the de novo design of peptides targeted to a predetermined site on a protein. Eight- and la-residue peptides were constructed with the EF hands or Ca2+-coordinating sites of calmodulin as their anticipated points of interaction. These peptides, but not unrelated peptides nor those with the same amino acid composition but a scrambled sequence, interacted with the two carboxyl-terminal Ca2+-binding sites of calmodulin as well as the EF hands of troponin C. The interactions resulted in a conformational change whereby the 8-mer peptide-calmodulin complex could activate phosphodiesterase in the absence of Ca2+. In contrast, the la-mer peptide-calmodulin complex did not activate phosphodiesterase but rather inhibited activation by Ca2+. This inhibition could be overcome by high levels of Ca2+. Thus, it would appear that the afore-mentioned concept can be used to make peptide agonists and antagonists that are targeted to predetermined sites on proteins such as calmodulin.	Univ Alabama Birmingham, Dept Phys & Biophys, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Ctr Canc, Sch Med, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Phys & Biophys, Sch Dent, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Ctr Canc, Birmingham, AL 35294 USA; Tecnogen, I-81015 Piana Di Monte Verna, CE, Italy	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Blalock, JE (corresponding author), Univ Alabama Birmingham, Dept Phys & Biophys, Sch Med, Birmingham, AL 35294 USA.	Blalock@physiology.uab.edu	Fassina, Giorgio/I-7127-2012	Fassina, Giorgio/0000-0003-1845-2657; Blalock, J. Edwin/0000-0001-5303-8123	NCI NIH HHS [CA13148] Funding Source: Medline; NIMH NIH HHS [MH52527] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052527] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSSON A, 1983, BIOCHEMISTRY-US, V22, P2309, DOI 10.1021/bi00279a001; ARAGA S, 1993, P NATL ACAD SCI USA, V90, P8747, DOI 10.1073/pnas.90.18.8747; Araga S, 1996, J IMMUNOL, V157, P386; BARANYI L, 1995, NAT MED, V1, P894, DOI 10.1038/nm0995-894; BLALOCK JE, 1990, TRENDS BIOTECHNOL, V8, P140, DOI 10.1016/0167-7799(90)90159-U; BLALOCK JE, 1995, NAT MED, V1, P876, DOI 10.1038/nm0995-876; BLALOCK JE, 1989, METHOD ENZYMOL, V178, P63; BLALOCK JE, 1981, BIOCHEM BIOPH RES CO, V101, P472, DOI 10.1016/0006-291X(81)91284-5; BLALOCK JE, 1986, BIOCHEM J, V234, P679, DOI 10.1042/bj2340679; Blalock JE, 1999, CELL MOL LIFE SCI, V55, P513, DOI 10.1007/s000180050309; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOQUET D, 1995, MOL IMMUNOL, V32, P303, DOI 10.1016/0161-5890(95)00012-4; BOROVSKY D, 1994, FASEB J, V8, P350, DOI 10.1096/fasebj.8.3.7908271; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; Browne JP, 1997, BIOCHEMISTRY-US, V36, P9550, DOI 10.1021/bi970460d; CADAY CG, 1985, J BIOL CHEM, V260, P5985; CHABBERT M, 1991, BIOCHEMISTRY-US, V30, P7615, DOI 10.1021/bi00244a034; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; DEMAILLE JG, 1982, CALCIUM CELL FUNCTIO, V2, P111; Dery O, 1997, J NEUROIMMUNOL, V76, P1, DOI 10.1016/S0165-5728(97)00026-X; DILL KA, 1995, PROTEIN SCI, V4, P561; DILLON J, 1991, P NATL ACAD SCI USA, V88, P9726, DOI 10.1073/pnas.88.21.9726; Dong WJ, 1997, J BIOL CHEM, V272, P19229, DOI 10.1074/jbc.272.31.19229; Dong WJ, 1997, BIOPHYS J, V72, P850, DOI 10.1016/S0006-3495(97)78719-8; FASSINA G, 1989, J BIOL CHEM, V264, P11252; FASSINA G, 1992, ARCH BIOCHEM BIOPHYS, V296, P137, DOI 10.1016/0003-9861(92)90555-B; GEORGE AJT, 1995, J IMMUNOL METHODS, V183, P51, DOI 10.1016/0022-1759(95)00031-5; GHISO J, 1990, P NATL ACAD SCI USA, V87, P1288, DOI 10.1073/pnas.87.4.1288; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; Henikoff JG, 1999, NUCLEIC ACIDS RES, V27, P226, DOI 10.1093/nar/27.1.226; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; HIRATSUKA T, 1982, J BIOL CHEM, V257, P13354; JANKOV BP, 1994, 23 EUR PEPT S EUR PE, P324; JARPE MA, 1994, PEPTIDES DESIGN SYNT, P165; Johnson H M, 1994, Immunomethods, V5, P167, DOI 10.1006/immu.1994.1051; JOHNSON JD, 1987, ANAL BIOCHEM, V162, P291, DOI 10.1016/0003-2697(87)90039-X; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; KILHOFFER MC, 1992, BIOCHEMISTRY-US, V31, P8098, DOI 10.1021/bi00149a046; KILHOFFER MC, 1988, J BIOL CHEM, V263, P17023; KINCAID RL, 1982, J BIOL CHEM, V257, P638; KINCAID RL, 1986, P NATL ACAD SCI USA, V83, P1193, DOI 10.1073/pnas.83.5.1193; LENTZ TL, 1984, SCIENCE, V226, P847, DOI 10.1126/science.6494916; LI CH, 1982, BIOCHEM ACTION HORM, P1; Maier C C, 1994, Immunomethods, V5, P107, DOI 10.1006/immu.1994.1044; Martins VR, 1997, NAT MED, V3, P1376, DOI 10.1038/nm1297-1376; McGuigan J E, 1994, Immunomethods, V5, P158, DOI 10.1006/immu.1994.1050; Mulchahey JJ, 1999, CELL MOL LIFE SCI, V55, P653, DOI 10.1007/s000180050321; NAGY GM, 1991, 73 ANN END SOC M, P209; OGATA C, 1987, NATURE, V328, P739, DOI 10.1038/328739a0; OMICHINSKI JG, 1988, PROT SOC M SAN DIE S, V321, P58; PALLA E, 1993, J BIOL CHEM, V268, P13486; PASCUAL D W, 1989, Peptide Research, V2, P207; RADDING W, 1992, J AUTONOM NERV SYST, V40, P161, DOI 10.1016/0165-1838(92)90027-E; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; RUIZOPAZO N, 1995, NAT MED, V1, P1074, DOI 10.1038/nm1095-1074; SMITH LR, 1987, J IMMUNOL, V138, P7; THULIN E, 1970, P NATL ACAD SCI USA, V71, P1862; TORRES BA, 1990, J NEUROIMMUNOL, V27, P191, DOI 10.1016/0165-5728(90)90069-Y; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; VOGEL HJ, 1994, CELL BIOL, V72, P357; Weigent D A, 1994, Immunomethods, V5, P91, DOI 10.1006/immu.1994.1042; WHITAKER JN, 1989, J NEUROIMMUNOL, V22, P157, DOI 10.1016/0165-5728(89)90047-7; WOODY WR, 1985, PEPTIDE, P15; Zhou S R, 1994, Immunomethods, V5, P136, DOI 10.1006/immu.1994.1048; ZHOU SR, 1994, J IMMUNOL, V153, P2340; ZHOU SR, 1993, J IMMUNOL, V150, P1629; ZHOU SR, 1994, CLIN IMMUNOL IMMUNOP, V70, P251, DOI 10.1006/clin.1994.1037	70	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2676	2685		10.1074/jbc.275.4.2676	http://dx.doi.org/10.1074/jbc.275.4.2676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644729	hybrid			2022-12-27	WOS:000085128000061
J	Liu, MTW; Wuebbens, MM; Rajagopalan, KV; Schindelin, H				Liu, MTW; Wuebbens, MM; Rajagopalan, KV; Schindelin, H			Crystal structure of the gephyrin-related molybdenum cofactor biosynthesis protein MogA from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTING FACTOR; MOLYBDOPTERIN BIOSYNTHESIS; REFINEMENT; OXIDOREDUCTASE; REPLACEMENT; DEFICIENCY; TUBULIN; OXIDASE; BINDS; TOOL	Molybdenum cofactor (Moco) biosynthesis is an evolutionarily conserved pathway in archaea, eubacteria, and eukaryotes, including humans. Genetic deficiencies of enzymes involved in this biosynthetic pathway trigger an autosomal recessive disease with severe neurological symptoms, which usually leads to death in early childhood. The MogA protein exhibits affinity for molybdopterin, the organic component of Moco, and has been proposed to act as a molybdochelatase incorporating molybdenum into Moco, MogA is related to the protein gephyrin, which, in addition to its role in Moco biosynthesis, is also responsible for anchoring glycinergic receptors to the cytoskeleton at inhibitory synapses. The high resolution crystal structure of the Escherichia coli MogA protein has been determined, and it reveals a trimeric arrangement in which each monomer contains a central, mostly parallel beta-sheet surrounded by cu-helices on either side. Based on structural and biochemical data, a putative active site was identified, including two residues that are essential for the catalytic mechanism.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Duke University	Schindelin, H (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.		Schindelin, Hermann/Q-2697-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054835] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54835] Funding Source: Medline; NIGMS NIH HHS [GM00091] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger AT, 1997, METHOD ENZYMOL, V277, P243, DOI 10.1016/S0076-6879(97)77015-0; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; CHRISTOPHER JA, 1998, J MOL GRAPHICS, V16, P1998; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Hasona A, 1998, J BACTERIOL, V180, P1466, DOI 10.1128/JB.180.6.1466-1472.1998; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; JAMES R, 1993, J DNA SEQUENCING MAP, V3, P327; JOHNSON ME, 1987, J BACTERIOL, V169, P117, DOI 10.1128/jb.169.1.117-125.1987; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joshi MS, 1996, J BACTERIOL, V178, P4310, DOI 10.1128/jb.178.14.4310-4312.1996; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PITTERLE DM, 1993, J BIOL CHEM, V268, P13499; PITTERLE DM, 1989, J BACTERIOL, V171, P3373, DOI 10.1128/jb.171.6.3373-3378.1989; PITTERLE DM, 1993, J BIOL CHEM, V268, P13506; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Rajagopalan KV, 1997, BIOCHEM SOC T, V25, P757, DOI 10.1042/bst0250757; Rajagopalan KV, 1996, ESCHERICHIA COLI SAL, P674; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Reiss J, 1998, HUM GENET, V103, P639, DOI 10.1007/s004390050884; Reiss J, 1999, AM J HUM GENET, V64, P706, DOI 10.1086/302296; Rieder C, 1998, EUR J BIOCHEM, V255, P24, DOI 10.1046/j.1432-1327.1998.2550024.x; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; WUEBBENS MM, 1995, J BIOL CHEM, V270, P1082, DOI 10.1074/jbc.270.3.1082	44	74	76	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1814	1822		10.1074/jbc.275.3.1814	http://dx.doi.org/10.1074/jbc.275.3.1814			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636880	hybrid			2022-12-27	WOS:000084940000043
J	Lukacs, GL; Haggie, P; Seksek, O; Lechardeur, D; Freedman, N; Verkman, AS				Lukacs, GL; Haggie, P; Seksek, O; Lechardeur, D; Freedman, N; Verkman, AS			Size-dependent DNA mobility in cytoplasm and nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ANTISENSE OLIGONUCLEOTIDES; PHOTOBLEACHING RECOVERY; INTRACELLULAR-DISTRIBUTION; TRANSLATIONAL DIFFUSION; CATIONIC LIPIDS; CELL CYTOPLASM; VISCOSITY; STATE; RESOLUTION	The diffusion of DNA in cytoplasm is thought to be an important determinant of the efficacy of gene delivery and antisense therapy. We have measured the translational diffusion of fluorescein-labeled double-stranded DNA fragments (in base pairs (bp): 21, 100, 250, 500, 1000, 2000, 3000, 6000) after microinjection into cytoplasm and nucleus of HeLa cells. Diffusion was measured by spot photobleaching using a focused argon laser spot (488 nm), In aqueous solutions, diffusion coefficients of the DNA fragments in water (D-w) decreased from 53 x 10(-8) to 0.81 x 10(-8) cm(2)/s for sizes of 21-6000 bp; D-w was related empirically to DNA size: D-w = 4.9 x 10(-6) cm(2)/ s.[bp size](-0.72). DNA diffusion coefficients in cytoplasm (D-cyto) were lower than D-w and depended strongly on DNA size. D-cyto/D-w decreased from 0.19 for a 100-bp DNA fragment to 0.06 for a 250-bp DNA fragment and was <0.01 for >2000 bp, Diffusion of microinjected fluorescein isothiocyanate (FITC) dextrans was faster than that of comparably sized DNA fragments of 250 bp and greater. In nucleus, all DNA fragments were nearly immobile, whereas FITC dextrans of molecular size up to 580 kDa were fully mobile. These results suggest that the highly restricted diffusion of DNA fragments in nucleoplasm results from extensive binding to immobile obstacles and that the decreased lateral mobility of DNAs >250 bp in cytoplasm is because of molecular crowding. The diffusion of DNA in cytoplasm may thus be an important rate-limiting barrier in gene delivery utilizing non-viral vectors.	Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Program Cell & Lung Biol, Toronto, ON M5G 1X8, Canada; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.		Freedman, Neal David/B-9741-2015; Seksek, Olivier/AAO-1837-2020	Freedman, Neal David/0000-0003-0074-1098; Seksek, Olivier/0000-0002-3053-3022; Lechardeur, Delphine/0000-0002-5331-4607; Lukacs, Gergely/0000-0003-0900-0675	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK043840, R01DK035124] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60288] Funding Source: Medline; NIDDK NIH HHS [DK35124, DK43840] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BICKNESE S, 1993, BIOPHYS J, V65, P1272, DOI 10.1016/S0006-3495(93)81179-2; Bjorling S, 1998, BIOCHEMISTRY-US, V37, P12971, DOI 10.1021/bi980694c; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Fishman DM, 1996, BIOPOLYMERS, V38, P535, DOI 10.1002/(SICI)1097-0282(199604)38:4<535::AID-BIP9>3.3.CO;2-H; Friend DS, 1996, BBA-BIOMEMBRANES, V1278, P41, DOI 10.1016/0005-2736(95)00219-7; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Ho PTC, 1997, SEMIN ONCOL, V24, P187; Hope MJ, 1998, MOL MEMBR BIOL, V15, P1, DOI 10.3109/09687689809027512; KAO HP, 1993, J CELL BIOL, V120, P175, DOI 10.1083/jcb.120.1.175; Kao HP, 1996, BIOPHYS CHEM, V59, P203; Kashihara N, 1998, EXP NEPHROL, V6, P84; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; LEONETTI JP, 1991, P NATL ACAD SCI USA, V88, P2702, DOI 10.1073/pnas.88.7.2702; LUBYPHELPS K, 1993, BIOPHYS J, V65, P236, DOI 10.1016/S0006-3495(93)81075-0; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Periasamy N, 1996, PHOTOCHEM PHOTOBIOL, V63, P265, DOI 10.1111/j.1751-1097.1996.tb03023.x; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Song LL, 1996, BIOPHYS J, V70, P2959, DOI 10.1016/S0006-3495(96)79866-1; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Swaminathan R, 1996, BIOPHYS J, V71, P1140, DOI 10.1016/S0006-3495(96)79316-5; WROBEL I, 1995, BBA-BIOMEMBRANES, V1235, P296, DOI 10.1016/0005-2736(95)80017-A; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Yarmola E, 1996, ELECTROPHORESIS, V17, P1416, DOI 10.1002/elps.1150170904; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997; Zelphati O, 1996, PHARMACEUT RES, V13, P1367, DOI 10.1023/A:1016026101195	27	571	594	3	105	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1625	1629		10.1074/jbc.275.3.1625	http://dx.doi.org/10.1074/jbc.275.3.1625			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636854	Green Published, hybrid			2022-12-27	WOS:000084940000017
J	Ping, DS; Boekhoudt, G; Zhang, FP; Morris, A; Philipsen, S; Warren, ST; Boss, JM				Ping, DS; Boekhoudt, G; Zhang, FP; Morris, A; Philipsen, S; Warren, ST; Boss, JM			Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MESSENGER-RNA EXPRESSION; TRANSCRIPTION FACTOR SP1; GROWTH-FACTOR; HIV-1 ENHANCER; ALLERGIC INFLAMMATION; FACTOR-ALPHA; IN-VITRO; CHEMOKINES	The monocyte chemoattractant protein-1 gene (MCP-1) is induced by the inflammatory cytokine tumor necrosis factor through the coordinate assembly of an NF-kappa B-dependent distal regulatory region and a proximal region that has been suggested to bind Spl as well as other factors. To provide a genetic correlation for Spl activity in this system, a cell line homozygous for a targeted truncation of the Spl gene was derived and examined. We found that the lack of Spl binding activity resulted in the inability of both the distal and proximal regions to assemble in vivo even though the binding of NF-kappa B to distal region DNA was unaffected in vitro. We also found that Spl and NF-kappa B were the minimal mammalian transcription factors required for efficient activity when transfected into Drosophila Schneider cells. Additionally, Sp3 was able to compensate for Spl in the Drosophila tissue cell system but not in the Sp1(-/-) cell line suggesting that Spl usage is site-specific and is likely to depend on the context of the binding site. Together, these data provide genetic and biochemical proof for Spl in regulating the MCP-I gene.	Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Howard Hughes Med Inst, Atlanta, GA 30322 USA; Erasmus Univ, Dept Cell Biol, Ctr Med Genet, Rotterdam, Netherlands	Emory University; Emory University; Emory University; Howard Hughes Medical Institute; Erasmus University Rotterdam	Boss, JM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	boss@microbio.emory.edu	Warren, Stephen T/A-2498-2012	Morris, Ann/0000-0003-1489-4431	NCI NIH HHS [CA74271] Funding Source: Medline; NIGMS NIH HHS [T32 GM008490] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAGGIOLINI M, 1994, IMMUNOL TODAY, V15, P127, DOI 10.1016/0167-5699(94)90156-2; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Brown Z, 1996, J LEUKOCYTE BIOL, V59, P75, DOI 10.1002/jlb.59.1.75; Charron D, 1990, Adv Immunol, V48, P107, DOI 10.1016/S0065-2776(08)60753-1; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DYNAN WS, 1985, P NATL ACAD SCI USA, V82, P4915, DOI 10.1073/pnas.82.15.4915; Faller DV, 1997, J CELL PHYSIOL, V172, P240, DOI 10.1002/(SICI)1097-4652(199708)172:2<240::AID-JCP11>3.3.CO;2-T; FRAZIERJESSEN MR, 1995, J IMMUNOL, V154, P1838; Freter RR, 1996, J BIOL CHEM, V271, P17417, DOI 10.1074/jbc.271.29.17417; FRETER RR, 1995, MOL CELL BIOL, V15, P315, DOI 10.1128/MCB.15.1.315; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gibran NS, 1997, J SURG RES, V70, P1, DOI 10.1006/jsre.1997.5017; Glabinski AR, 1996, J IMMUNOL, V156, P4363; GORDON HM, 1992, J IMMUNOL, V148, P4021; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HANAZAWA S, 1994, J BIOL CHEM, V269, P21379; Howard OMZ, 1996, TRENDS BIOTECHNOL, V14, P46, DOI 10.1016/0167-7799(96)80920-6; ITO CY, 1994, NUCLEIC ACIDS RES, V22, P3787, DOI 10.1093/nar/22.18.3787; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KAWAHARA RS, 1991, J BIOL CHEM, V266, P13261; Kronke M, 1992, Immunol Ser, V56, P189; Li JM, 1998, NUCLEIC ACIDS RES, V26, P2449, DOI 10.1093/nar/26.10.2449; Lloyd CM, 1997, J LEUKOCYTE BIOL, V62, P676, DOI 10.1002/jlb.62.5.676; Luster AD, 1997, J LEUKOCYTE BIOL, V62, P620, DOI 10.1002/jlb.62.5.620; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Naar AM, 1998, COLD SPRING HARB SYM, V63, P189, DOI 10.1101/sqb.1998.63.189; NEISH AS, 1995, J BIOL CHEM, V270, P28903, DOI 10.1074/jbc.270.48.28903; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1992, P NATL ACAD SCI USA, V89, P1529, DOI 10.1073/pnas.89.5.1529; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Ping DS, 1999, J IMMUNOL, V162, P727; Ping DS, 1996, IMMUNITY, V4, P455, DOI 10.1016/S1074-7613(00)80412-4; Ping DS, 1999, J BIOL CHEM, V274, P31909, DOI 10.1074/jbc.274.45.31909; Ransohoff Richard M., 1996, Cytokine and Growth Factor Reviews, V7, P35, DOI 10.1016/1359-6101(96)00003-2; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; SCHWARTZ CJ, 1991, CLIN CARDIOL, V14, P1, DOI 10.1002/clc.4960141302; Shyy JYJ, 1995, J BIOMECH, V28, P1451, DOI 10.1016/0021-9290(95)00093-3; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Sozzani S, 1997, J LEUKOCYTE BIOL, V62, P30, DOI 10.1002/jlb.62.1.30; Steger DJ, 1997, EMBO J, V16, P2463, DOI 10.1093/emboj/16.9.2463; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; UEDA A, 1994, J IMMUNOL, V153, P2052; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Weiss L, 1997, J INFECT DIS, V176, P1621, DOI 10.1086/517341; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou ZHL, 1998, J IMMUNOL, V160, P3908	56	78	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1708	1714		10.1074/jbc.275.3.1708	http://dx.doi.org/10.1074/jbc.275.3.1708			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636866	hybrid			2022-12-27	WOS:000084940000029
J	Potter, MD; Nicchitta, CV				Potter, MD; Nicchitta, CV			Ribosome-independent regulation of translocon composition and Sec61 alpha conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; PROTEIN TRANSLOCATION; MICROSOMAL-MEMBRANES; ROUGH MICROSOMES; DIFFERENTIAL SOLUBILIZATION; TOPOGENIC SEQUENCE; APOLIPOPROTEIN-B; BINDING-ACTIVITY; BOUND RIBOSOMES	In this study, the contributions of membrane-bound ribosomes to the regulation of endoplasmic reticulum translocon composition and Sec61 alpha conformation were examined. Following solubilization of rough microsomes (RM) with digitonin, ribosomes co-sedimented in complexes containing the translocon proteins Sec61 alpha, ribophorin I, and TRAP alpha, and endoplasmic reticulum phospholipids. Complexes of similar composition were identified in digitonin extracts of ribosome-free membranes, indicating that the ribosome does not define the composition of the digitonin-soluble translocon, Whereas in digitonin solution a highly electrostatic ribosome-translocon junction is observed, no stable interactions between ribosomes and Sec61 alpha, ribophorin I, or TRAP alpha were observed following solubilization of RM with lipid derived detergents at physiological salt concentrations. Sec61 alpha was found to exist in at least two conformational states, as defined by mild proteolysis, A protease-resistant form was observed in RM and detergent-solubilized RM. Removal of peripheral proteins and ribosomes markedly enhanced the sensitivity of Sec61 alpha to proteolysis, yet the readdition of inactive ribosomes to salt-washed membranes yielded only modest reductions in protease sensitivity, Addition of sublytic concentrations of detergents to salt-washed RM markedly decreased the protease sensitivity of Sec61 alpha, indicating that a protease-resistant conformation of Sec61 alpha can be conferred in a ribosome-independent manner.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3709, Durham, NC 27710 USA.				NIDDK NIH HHS [DK47897] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047897] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aveldano MI, 1995, ARCH BIOCHEM BIOPHYS, V324, P331, DOI 10.1006/abbi.1995.0046; BANERJEE P, 1995, CHEM PHYS LIPIDS, V77, P65, DOI 10.1016/0009-3084(95)02455-R; BANERJEE P, 1993, INDIAN J BIOCHEM BIO, V30, P358; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BORGESE N, 1974, J MOL BIOL, V88, P559, DOI 10.1016/0022-2836(74)90408-2; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; CHUCK SL, 1992, CELL, V68, P9, DOI 10.1016/0092-8674(92)90202-N; CHUCK SL, 1990, NATURE, V346, P382, DOI 10.1038/346382a0; COLLINS PG, 1991, J CELL BIOL, V114, P639, DOI 10.1083/jcb.114.4.639; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; GABRIEL NE, 1986, BIOCHEMISTRY-US, V25, P2812, DOI 10.1021/bi00358a012; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HORTSCH M, 1986, J CELL BIOL, V103, P241, DOI 10.1083/jcb.103.1.241; ICHIMURA T, 1992, FEBS LETT, V296, P7, DOI 10.1016/0014-5793(92)80391-S; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KAIHOVAARA P, 1991, BIOCHEMISTRY-US, V30, P8380, DOI 10.1021/bi00098a015; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; KESSI J, 1994, BIOCHEMISTRY-US, V33, P10825, DOI 10.1021/bi00201a033; KIRKPATRICK FH, 1974, BIOCHIM BIOPHYS ACTA, V345, P154, DOI 10.1016/0005-2736(74)90254-5; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; MANS RJ, 1961, ARCH BIOCHEM BIOPHYS, V94, P48, DOI 10.1016/0003-9861(61)90009-1; MARTIN TE, 1969, J MOL BIOL, V43, P135, DOI 10.1016/0022-2836(69)90084-9; MAZER NA, 1980, BIOCHEMISTRY-US, V19, P601, DOI 10.1021/bi00545a001; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Murphy EC, 1997, J CELL BIOL, V136, P1213, DOI 10.1083/jcb.136.6.1213; NICCHITTA CV, 1989, J CELL BIOL, V108, P789, DOI 10.1083/jcb.108.3.789; NUNNARI JM, 1991, NATURE, V352, P638, DOI 10.1038/352638a0; PALADE GE, 1955, J BIOPHYS BIOCHEM CY, V1, P59, DOI 10.1083/jcb.1.1.59; REDMAN CM, 1966, P NATL ACAD SCI USA, V56, P608, DOI 10.1073/pnas.56.2.608; SABATINI DD, 1966, J MOL BIOL, V19, P503, DOI 10.1016/S0022-2836(66)80019-0; SAVITZ AJ, 1993, J CELL BIOL, V120, P853, DOI 10.1083/jcb.120.4.853; SAVITZ AJ, 1990, NATURE, V346, P540, DOI 10.1038/346540a0; Savitz AJ, 1997, J BIOL CHEM, V272, P13140, DOI 10.1074/jbc.272.20.13140; Shivanna BD, 1997, BIOCHEM J, V325, P533, DOI 10.1042/bj3250533; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; SMALL DM, 1969, BIOCHIM BIOPHYS ACTA, V176, P178, DOI 10.1016/0005-2760(69)90086-1; TAZAWA S, 1991, J BIOCHEM-TOKYO, V109, P89; WALTER P, 1983, METHOD ENZYMOL, V96, P84; YU YH, 1989, P NATL ACAD SCI USA, V86, P9931, DOI 10.1073/pnas.86.24.9931	48	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2037	2045		10.1074/jbc.275.3.2037	http://dx.doi.org/10.1074/jbc.275.3.2037			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636907	hybrid			2022-12-27	WOS:000084940000070
J	Courtes, C; Lecointe, N; Le Cam, L; Baudoin, F; Sardet, C; Mathieu-Mahul, D				Courtes, C; Lecointe, N; Le Cam, L; Baudoin, F; Sardet, C; Mathieu-Mahul, D			Erythroid-specific inhibition of the tal-1 intragenic promoter is due to binding of a repressor to a novel silencer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; LOOP-HELIX PROTEINS; SCL GENE-PRODUCT; PRIMITIVE MYELOID CELLS; EPSILON-GLOBIN GENE; ALPHA-BETA-LINEAGE; CENTROMERIC HETEROCHROMATIN; HEMATOPOIETIC LINEAGES; DISTINCT MECHANISMS	The basic helix-loop-helix tal-l gene plays a key role in hematopoiesis, and its expression is tightly controlled through alternative promoters and complex interactions of cis-acting regulatory elements, tal-1 is not expressed in normal T cells, but its transcription is constitutive in a large proportion of human T cell leukemias. We have previously described a downstream initiation of tal-1 transcription specifically associated with a subset of T cell leukemias that leads to the production of NH2-truncated TAL-1 proteins. In this study, we characterize the human promoter (promoter IV), embedded within a GC-rich region in exon TV, responsible for this transcriptional activity. The restriction of promoter IV usage is assured by a novel silencer element in the 3'-unstranslated region of the human gene that represses its activity in erythroid but not in T cells. The silencer activity is mediated through binding of a tissue-specific nuclear factor to a novel protein recognition motif (designated tal-RE) in the silencer. Mutation of a single residue within the tal-RE abolishes both specific protein binding and silencing activity. Altogether, our results demonstrate that the tal-1 promoter IV is actively repressed in cells of the erythro-megakaryocytic lineage and that this repression is released in leukemic T cells, resulting in the expression of the tal-1 truncated transcript.	Inst Mol Genet, UMR 5535, IFR 24, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Mathieu-Mahul, D (corresponding author), Inst Mol Genet, UMR 5535, IFR 24, 1919 Route Mende, F-34293 Montpellier, France.		Le Cam, Laurent/O-1408-2016; Mathieu, Daniele/G-6092-2012	Baudoin, Florence/0000-0002-2300-1490; LE CAM, Laurent/0000-0003-0325-878X				APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; Aplan PD, 1997, EMBO J, V16, P2408, DOI 10.1093/emboj/16.9.2408; APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; BASH RO, 1995, BLOOD, V86, P666, DOI 10.1182/blood.V86.2.666.bloodjournal862666; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; Begley CG, 1999, BLOOD, V93, P2760; BERNARD O, 1990, GENE CHROMOSOME CANC, V1, P194, DOI 10.1002/gcc.2870010303; BERNARD O, 1992, J EXP MED, V176, P919, DOI 10.1084/jem.176.4.919; BERNARD O, 1991, ONCOGENE, V6, P1477; Bockamp EO, 1997, J BIOL CHEM, V272, P8781, DOI 10.1074/jbc.272.13.8781; BOCKAMP EO, 1995, BLOOD, V86, P1502, DOI 10.1182/blood.V86.4.1502.bloodjournal8641502; Bockamp EO, 1998, J BIOL CHEM, V273, P29032, DOI 10.1074/jbc.273.44.29032; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; CHEN Q, 1990, J EXP MED, V172, P1403, DOI 10.1084/jem.172.5.1403; CHENG JT, 1993, MOL CELL BIOL, V13, P801, DOI 10.1128/MCB.13.2.801; CHENG JT, 1993, ONCOGENE, V8, P677; Cohen-Kaminsky S, 1998, EMBO J, V17, P5151, DOI 10.1093/emboj/17.17.5151; Condorelli GL, 1997, MOL CELL BIOL, V17, P2954, DOI 10.1128/MCB.17.5.2954; Condorelli GL, 1996, CANCER RES, V56, P5113; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; Ferrier R, 1999, ONCOGENE, V18, P995, DOI 10.1038/sj.onc.1202374; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Gottgens B, 1997, ONCOGENE, V15, P2419, DOI 10.1038/sj.onc.1201426; GREEN AR, 1992, ONCOGENE, V7, P653; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Hoang T, 1996, BLOOD, V87, P102; HSU HL, 1994, MOL CELL BIOL, V14, P1256, DOI 10.1128/MCB.14.2.1256; HWANG LY, 1993, ONCOGENE, V8, P3043; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Kubo M, 1997, EMBO J, V16, P4007, DOI 10.1093/emboj/16.13.4007; Le Cam L, 1999, BIOTECHNIQUES, V26, P840; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; LECAM A, 1995, EUR J BIOCHEM, V231, P620; LECOINTE N, 1994, ONCOGENE, V9, P2623; LEROYVIARD K, 1995, EMBO J, V14, P2341, DOI 10.1002/j.1460-2075.1995.tb07229.x; LEROYVIARD K, 1994, BLOOD, V84, P3819, DOI 10.1182/blood.V84.11.3819.bloodjournal84113819; Li QL, 1997, P NATL ACAD SCI USA, V94, P2444, DOI 10.1073/pnas.94.6.2444; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; MACINTYRE EA, 1992, BLOOD, V80, P1511; MOUTHON MA, 1993, BLOOD, V81, P647; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Ono Y, 1997, J BIOL CHEM, V272, P4576, DOI 10.1074/jbc.272.7.4576; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; ORKIN SH, 1995, CURR OPIN CELL BIOL, V7, P870, DOI 10.1016/0955-0674(95)80072-7; Park ST, 1998, J BIOL CHEM, V273, P7030, DOI 10.1074/jbc.273.12.7030; PETERS B, 1993, J BIOL CHEM, V268, P3430; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; PULFORD K, 1995, BLOOD, V85, P675, DOI 10.1182/blood.V85.3.675.bloodjournal853675; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Robb L, 1997, BIOESSAYS, V19, P607, DOI 10.1002/bies.950190711; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Sinclair AM, 1999, DEV BIOL, V209, P128, DOI 10.1006/dbio.1999.9236; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; WINOTO A, 1989, CELL, V59, P649, DOI 10.1016/0092-8674(89)90010-X	71	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					949	958		10.1074/jbc.275.2.949	http://dx.doi.org/10.1074/jbc.275.2.949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625632	Green Published, hybrid			2022-12-27	WOS:000084836600036
J	Goto, JJ; Zhu, HN; Sanchez, RJ; Nersissian, A; Gralla, EB; Valentine, JS; Cabelli, DE				Goto, JJ; Zhu, HN; Sanchez, RJ; Nersissian, A; Gralla, EB; Valentine, JS; Cabelli, DE			Loss of in vitro metal ion binding specificity in mutant copper-zinc superoxide dismutases associated with familial amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULSE-RADIOLYSIS; HYDROGEN-PEROXIDE; TYROSINE NITRATION; K-M; ALS; SITE; CHAPERONE; MECHANISM; PEROXYNITRITE; AGGREGATION	The presence of the copper ion at the active site of human wild type copper-zinc superoxide dismutase (CuZnSOD) is essential to its ability to catalyze the disproportionation of superoxide into dioxygen and hydrogen peroxide, Wild type CuZnSOD and several of the mutants associated with familial amyotrophic lateral sclerosis (FALS) (Ala(4) --> Val, Gly(93) --> Ala, and Leu(38) --> Val) were expressed in Saccharomyces cerevisiae, Purified metal-free (apoproteins) and various remetallated derivatives were analyzed by metal titrations monitored by UV-visible spectroscopy, histidine modification studies using diethylpyrocarbonate, and enzymatic activity measurements using pulse radiolysis. From these studies it was concluded that the FALS mutant CuZnSOD apoproteins, in direct contrast to the human wild type apoprotein, have lost their ability to partition and bind copper and zinc ions in their proper locations in vitro, Similar studies of the wild type and FALS mutant CuZnSOD holoenzymes in the "as isolated" metallation state showed abnormally low copper-to-zinc ratios, although all of the copper acquired was located at the native copper binding sites. Thus, the copper ions are properly directed to their native binding sites in vivo, presumably as a result of the action of the yeast copper chaperone Lys7p (yeast CCS), The loss of metal ion binding specificity of FALS mutant CuZnSODs in vitro may be related to their role in ALS.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); Brookhaven National Laboratory	Valentine, JS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 951569, Los Angeles, CA 90095 USA.		Zhu, Haining/A-6076-2008; Valentine, Joan S/B-6665-2008	Zhu, Haining/0000-0001-5498-6694; Valentine, Joan S/0000-0002-7174-925X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028222] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28222] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANNISTER JV, 1973, FEBS LETT, V32, P303, DOI 10.1016/0014-5793(73)80859-2; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BEEM KM, 1974, J BIOL CHEM, V249, P7298; BEEM KM, 1977, BIOCHEMISTRY-US, V16, P1930, DOI 10.1021/bi00628a027; Bertini I, 1998, ADV INORG CHEM, V45, P127, DOI 10.1016/S0898-8838(08)60026-4; BERTINI I, 1985, J AM CHEM SOC, V107, P4391, DOI 10.1021/ja00301a004; Brown RH, 1998, NAT MED, V4, P1362, DOI 10.1038/3945; Bruijn LI, 1997, P NATL ACAD SCI USA, V94, P7606, DOI 10.1073/pnas.94.14.7606; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CABELLI DE, 2000, IN PRESS BIOMIMETIC; CALABRESE L, 1975, FEBS LETT, V59, P29, DOI 10.1016/0014-5793(75)80333-4; CALABRESE L, 1980, CHEM BIOCH ASPECTS S, P265; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Crow JP, 1997, J NEUROCHEM, V69, P1936; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; FEE JA, 1975, BIOCHIM BIOPHYS ACTA, V400, P439, DOI 10.1016/0005-2795(75)90200-7; FIELDEN E M, 1973, Biochemical Society Transactions, V1, P52; FIELDEN EM, 1974, BIOCHEM J, V139, P49, DOI 10.1042/bj1390049; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; KLUG D, 1972, J BIOL CHEM, V247, P4839; KLUGROTH D, 1973, J AM CHEM SOC, V95, P2786, DOI 10.1021/ja00790a007; LIPPARD SJ, 1977, BIOCHEMISTRY-US, V16, P1136, DOI 10.1021/bi00625a017; Lyons TJ, 1996, P NATL ACAD SCI USA, V93, P12240, DOI 10.1073/pnas.93.22.12240; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Lyons TJ, 1999, MET IONS BIOL SYST, V36, P125; MCADAM ME, 1977, BIOCHEM J, V167, P271, DOI 10.1042/bj1670271; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; PANTOLIANO MW, 1982, J AM CHEM SOC, V104, P1717, DOI 10.1021/ja00370a045; PARGE HE, 1986, J BIOL CHEM, V261, P6215; RIGO A, 1977, BIOCHEM J, V161, P31, DOI 10.1042/bj1610031; ROE JA, 1990, J AM CHEM SOC, V102, P1538; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTILIO G, 1972, BIOCHIM BIOPHYS ACTA, V268, P605, DOI 10.1016/0005-2744(72)90359-2; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P4245, DOI 10.1073/pnas.76.9.4245; VALENTINE JS, 1980, CHEM BIOCH ASPECTS S, P254; VALENTINE JS, 1981, COPPER PROTEINS, P292; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709	47	139	140	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1007	1014		10.1074/jbc.275.2.1007	http://dx.doi.org/10.1074/jbc.275.2.1007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625639	hybrid			2022-12-27	WOS:000084836600043
J	Hughes, P; Dennis, E; Whitecross, M; Llewellyn, D; Gage, P				Hughes, P; Dennis, E; Whitecross, M; Llewellyn, D; Gage, P			The cytotoxic plant protein, beta-purothionin, forms ion channels in lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; PYRULARIA THIONIN; ALPHA-THIONIN; RESPONSES; CARDIOTOXIN; RESISTANCE; MELITTIN; BARLEY	Thionins are small cysteine-containing, amphipathic plant proteins found in seeds and vegetative tissues of a number of plant genera, Many of them have been shown to be toxic to microorganisms such as fungi, yeast, and bacteria and also to mammalian cells. It has been suggested that thionins are present in seeds to protect them, and the germinating seedling, from attack by phytopathogenic microorganisms, but the mechanism by which they kill cells remains unclear. Using electrophysiological measurements, we have shown that beta-purothionin from wheat flour can form cation-selective ion channels in artificial lipid bilayer membranes and in the plasmalemma of rat hippocampal neurons. We suggest that the generalized toxicity of thionins is due to their ability to generate ion channels in cell membranes, resulting in the dissipation of ion concentration gradients essential for the maintenance of cellular homeostasis.	CSIRO, Plant Ind, Canberra, ACT 2601, Australia; Australian Natl Univ, Div Bot & Zool, Canberra, ACT 0200, Australia; Australian Natl Univ, John Curtin Sch Med Res, Membrane Biol Program, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Australian National University; John Curtin School of Medical Research	Llewellyn, D (corresponding author), CSIRO, Plant Ind, Clunies Ross St, Canberra, ACT 2601, Australia.		Llewellyn, Danny J/D-5230-2009; Dennis, Elizabeth S/A-6074-2008	Llewellyn, Danny J/0000-0001-9535-8707; Dennis, Elizabeth S/0000-0002-7850-591X				ANGERHOFER CK, 1990, TOXICON, V28, P547, DOI 10.1016/0041-0101(90)90299-M; APEL K, 1990, PHYSIOL PLANTARUM, V80, P315, DOI 10.1111/j.1399-3054.1990.tb04413.x; Balls A, 1940, CEREAL CHEM, V17, P243; BOHLMANN H, 1994, CRIT REV PLANT SCI, V13, P1, DOI 10.1080/713608052; BROKAERT W, 1990, FEMS MICROBIOL LETT, V69, P55; Caaveiro JMM, 1998, PROTEIN SCI, V7, P2567, DOI 10.1002/pro.5560071210; CARMONA MJ, 1993, PLANT J, V3, P457, DOI 10.1046/j.1365-313X.1993.t01-24-00999.x; CURMI JP, 1993, J MEMBRANE BIOL, V136, P273; DALEY LS, 1987, J AGR FOOD CHEM, V35, P680, DOI 10.1021/jf00077a011; DECALEYA RF, 1972, APPL MICROBIOL, V23, P998, DOI 10.1128/AEM.23.5.998-1000.1972; Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509; FLORACK DEA, 1994, PLANT MOL BIOL, V26, P25, DOI 10.1007/BF00039517; FRACKI WS, 1992, TOXICON, V30, P1427, DOI 10.1016/0041-0101(92)90518-A; GARCIA-OLMEDO F, 1968, Anales Instituto Nacional de Investigaciones Agronomicas (Madrid), V17, P433; Garcia-Olmedo F., 1989, OXFORD SURV PLANT MO, V6, P31; GARCIAOLMEDO F, 1994, PLANT MOL BIOL, V26, P11, DOI 10.1007/BF00039515; Kushmerick C, 1998, FEBS LETT, V440, P302, DOI 10.1016/S0014-5793(98)01480-X; MOLINA A, 1993, PLANT SCI, V92, P168; OHTANI S, 1977, J BIOCHEM-TOKYO, V82, P753; OSORIO E, 1989, TOXICON, V27, P511; PAWLAK M, 1994, PROTEIN SCI, V3, P1788, DOI 10.1002/pro.5560031019; Piller SC, 1996, P NATL ACAD SCI USA, V93, P111, DOI 10.1073/pnas.93.1.111; Piller SC, 1998, P NATL ACAD SCI USA, V95, P4595, DOI 10.1073/pnas.95.8.4595; PONZ F, 1983, EMBO J, V2, P1035, DOI 10.1002/j.1460-2075.1983.tb01542.x; REDMAN DG, 1969, J SCI FOOD AGR, V20, P427, DOI 10.1002/jsfa.2740200715; TEETER MM, 1990, PROTEINS, V8, P118, DOI 10.1002/prot.340080203; TERRAS FRG, 1992, PLANT PHYSIOL, V100, P1055, DOI 10.1104/pp.100.2.1055; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; VERNON LP, 1992, J TOXICOL-TOXIN REV, V11, P169, DOI 10.3109/15569549209115819; VERNON LP, 1992, TOXICON, V30, P711, DOI 10.1016/0041-0101(92)90005-P; WADA K, 1982, J BIOCHEM-TOKYO, V91, P257, DOI 10.1093/oxfordjournals.jbchem.a133683; WESTERMEIER R, 1997, ELECTROPHORESIS PRAC, P131	33	76	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					823	827		10.1074/jbc.275.2.823	http://dx.doi.org/10.1074/jbc.275.2.823			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625613	hybrid			2022-12-27	WOS:000084836600017
J	Jugloff, DGM; Khanna, R; Schlichter, LC; Jones, OT				Jugloff, DGM; Khanna, R; Schlichter, LC; Jones, OT			Internalization of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMULTIMERIC K+ CHANNELS; RAT-BRAIN; MEDIATED ENDOCYTOSIS; GUANYLATE KINASES; MOLECULAR-BASIS; MEMBRANE; NEURONS; EXPRESSION; HIPPOCAMPUS; PROTEINS	The contribution of voltage-dependent ion channels to nerve function depends upon their cell-surface distributions. Nevertheless, the mechanisms underlying channel localization are poorly understood. Two phenomena appear particularly important: the clustering of channels by membrane-associated guanylate kinases (MAGUKs), such as PSD-95, and the regional stabilization of cell-surface proteins by differential suppression of endocytosis. Could these phenomena be related? To test this possibility we examined the effect of PSD-95 on the internalization rate of Kv1.4 K+ channels in transfected HEK293 cells using cell-surface biotinylation assays. When expressed alone Kv1.4 was internalized with a half-life of 87 min, but, in the presence of PSD-95, Kv1.4 internalization was completely suppressed. Immunochemistry and electrophysiology showed PSD-95 had little effect on total or cell-surface levels of Kv1.4 or on current amplitude, activation, or inactivation kinetics. Clustering was necessary and sufficient to suppress Kv1.4 internalization since C35S-PSD-95, a mutant reported to bind but not cluster Kv1.4, (confirmed by imaging cells co-expressing a functional, GFP-variant-tagged Kv1.4) restored and, surprisingly, enhanced the rate of Kv1.4 internalization (t(1/2) = 16 min), These data argue PSD-95-mediated clustering suppresses Kv1.4 internalization and suggest a fundamentally new role for PSD-95, and perhaps other MAGUKs, orchestrating the stabilization of channels at the cell-surface.	Univ Toronto, Western Res Inst, Div Cellular & Mol Biol, Hlth Network, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Jones, OT (corresponding author), Univ Toronto, Western Res Inst, Div Cellular & Mol Biol, Hlth Network, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.			Khanna, Rajesh/0000-0002-9066-2969				Aidley D.J., 1996, ION CHANNELS MOL ACT; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Burke NA, 1999, J GEN PHYSIOL, V113, P71, DOI 10.1085/jgp.113.1.71; CASTELLINO RC, 1995, AM J PHYSIOL-HEART C, V269, pH385, DOI 10.1152/ajpheart.1995.269.1.H385; CHANDY KG, 1995, HDB RECEPTORS CHANNE, P1; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Cooper EC, 1998, J NEUROSCI, V18, P965; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DARGENT B, 1995, J NEUROCHEM, V65, P407; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Garcia M L, 1997, Adv Pharmacol, V39, P425, DOI 10.1016/S1054-3589(08)60078-2; Horio Y, 1997, J BIOL CHEM, V272, P12885, DOI 10.1074/jbc.272.20.12885; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Jones OT, 1997, J NEUROSCI, V17, P6152; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KOENIG JA, 1994, J BIOL CHEM, V269, P17174; Kupper J, 1998, EUR J NEUROSCI, V10, P3908; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI M, 1994, CURR BIOL, V4, P110, DOI 10.1016/S0960-9822(94)00026-6; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; LIU J, 1994, MOL PHARMACOL, V45, P1198; London B, 1998, J PHYSIOL-LONDON, V509, P171, DOI 10.1111/j.1469-7793.1998.171bo.x; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILLER C, 1991, SCIENCE, V252, P1092, DOI 10.1126/science.252.5009.1092; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Negulescu D, 1998, J BIOL CHEM, V273, P20109, DOI 10.1074/jbc.273.32.20109; PARTON RG, 1993, J NEUROSCI RES, V36, P1, DOI 10.1002/jnr.490360102; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Perego C, 1999, EMBO J, V18, P2384, DOI 10.1093/emboj/18.9.2384; Phillips WD, 1997, MOL CELL NEUROSCI, V10, P16, DOI 10.1006/mcne.1997.0634; PRINCE LS, 1993, AM J PHYSIOL, V264, pC491, DOI 10.1152/ajpcell.1993.264.2.C491; Rasband M, 1998, J NEUROSCI, V18, P36; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Schlichter LC, 1996, GLIA, V17, P225, DOI 10.1002/(SICI)1098-1136(199607)17:3<225::AID-GLIA5>3.0.CO;2-#; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; Wang ZZ, 1999, J NEUROSCI, V19, P1998; Wickenden AD, 1997, J PHYSIOL-LONDON, V504, P271, DOI 10.1111/j.1469-7793.1997.271be.x	52	94	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1357	1364		10.1074/jbc.275.2.1357	http://dx.doi.org/10.1074/jbc.275.2.1357			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625685	hybrid			2022-12-27	WOS:000084836600089
J	Yang, XL; Ji, XH; Shi, XM; Cao, X				Yang, XL; Ji, XH; Shi, XM; Cao, X			Smad1 domains interacting with hoxc-8 induce osteoblast differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY MEDIATOR SMAD1; GROWTH-FACTOR-BETA; DNA-BINDING; SIGNALING PATHWAYS; HOMEOBOX GENES; CELL-LINE; PROTEIN; TRANSCRIPTION; RECEPTOR; BMP	Bone morphogenetic proteins are potent osteotropic agents that induce osteoblast differentiation and bone formation. The signal transduction of bone morphogenetic proteins has recently been discovered to involve Smad proteins. Smad1 is an essential intracellular component that is specifically phosphorylated by bone morphogenetic protein receptors and translocated into the nucleus upon ligand stimulation. Previously, we have reported that Smad1 activates osteopontin gene expression in response to bone morphogenetic protein simulation through an interaction with a homeodomain transcription factor, Hoxc-8. In the present study, the interaction domains between the two proteins were characterized by deletional analysis in both yeast two-hybrid and gel shift assays. Two regions within the aminoterminal 87 amino acid residues of Smad1 were mapped to interact with Hoxc-8, one of which binds to the homeodomain. Overexpression of recombinant cDNAs encoding the Hoxc-8 interaction domains of Smad1 effectively activated osteopontin gene transcription in transient transfection assays. Furthermore, stable expression of these Smad1 fragments in 2T3 osteoblast precursor cells stimulated osteoblast differentiation-related gene expression and led to mineralized bone matrix formation. Our data suggest that the interaction of amino-terminal Smad1 with Hoxc-8 mimics bone morphogenetic protein signaling and is sufficient to induce osteoblast differentiation and bone cell formation.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Procter & Gamble Co, Pharmaceut, Mason, OH 45040 USA	University of Alabama System; University of Alabama Birmingham; Procter & Gamble	Cao, X (corresponding author), 1670 Univ Blvd,VH G002, Birmingham, AL 35294 USA.				NIDDK NIH HHS [DK53757] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053757] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Cao X, 1996, J BIOL CHEM, V271, P20650, DOI 10.1074/jbc.271.34.20650; CATRON KM, 1995, MOL CELL BIOL, V15, P861; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; LEMOUELLIC H, 1988, GENE DEV, V2, P125, DOI 10.1101/gad.2.1.125; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; MAK A, 1993, GENE DEV, V7, P1862, DOI 10.1101/gad.7.10.1862; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; POLLOCK RA, 1995, P NATL ACAD SCI USA, V92, P4492, DOI 10.1073/pnas.92.10.4492; POLLOCK RA, 1992, CELL, V71, P911, DOI 10.1016/0092-8674(92)90388-S; Schnabel CA, 1996, MOL CELL BIOL, V16, P2678; Sharkey M, 1997, TRENDS GENET, V13, P145, DOI 10.1016/S0168-9525(97)01096-2; Shi XM, 1999, J BIOL CHEM, V274, P13711, DOI 10.1074/jbc.274.19.13711; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shimamoto T, 1999, J EXP ZOOL, V283, P186; SIMEONE A, 1987, P NATL ACAD SCI USA, V84, P4914, DOI 10.1073/pnas.84.14.4914; Sreenath TL, 1996, P NATL ACAD SCI USA, V93, P9636, DOI 10.1073/pnas.93.18.9636; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tiret L, 1998, DEVELOPMENT, V125, P279; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Vigano MA, 1998, MOL CELL BIOL, V18, P6201, DOI 10.1128/MCB.18.11.6201; VIOLETTE SM, 1992, P NATL ACAD SCI USA, V89, P3805, DOI 10.1073/pnas.89.9.3805; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956	50	91	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1065	1072		10.1074/jbc.275.2.1065	http://dx.doi.org/10.1074/jbc.275.2.1065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625647	hybrid			2022-12-27	WOS:000084836600051
J	Graham, DE; Bock, CL; Schalk-Hihi, C; Lu, ZCJ; Markham, GD				Graham, DE; Bock, CL; Schalk-Hihi, C; Lu, ZCJ; Markham, GD			Identification of a highly diverged class of S-adenosylmethionine synthetases in the archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; MASS-SPECTROMETRY; RAT-LIVER; 2 FORMS; PURIFICATION; YEAST; METHYLATION; ACTIVATION; METABOLISM; SEQUENCE	S-Adenosylmethionine is the primary alkylating agent in all known organisms. ATP:L-methionine S-adenosyl-transferase (MAT) catalyzes the only known biosynthetic: route to this central metabolite. Although the amino acid sequence of MAT is strongly conserved among bacteria and eukarya, no homologs have been recognized in the completed genome sequences of any archaea, In this study, MAT has been purified to homogeneity from the archaeon Methanococcus jannaschii, and the gene encoding it has been identified by mass spectrometry. The peptide mass map identifies the gene encoding MAT as MJ1208, a hypothetical open reading frame, The gene was cloned in Escherichia coli, and expressed enzyme has been purified and characterized. This protein has only 22 and 23% sequence identity to the E, coli and human enzymes, respectively, whereas those are 59% identical to each other. The few identical residues include the majority of those constituting the polar active site residues. Each complete archaeal genome sequence contains a homolog of this archaeal-type MAT. Surprisingly, three bacterial genomes encode both the archaeal and eukaryal/bacterial types of MAT. This identification of a second major class of MAT emphasizes the long evolutionary history of the archaeal lineage and the structural diversity found even in crucial metabolic enzymes.	Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	Fox Chase Cancer Center; University of Illinois System; University of Illinois Urbana-Champaign	Graham, DE (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.		Graham, David E/F-8578-2010	Graham, David E/0000-0001-8968-7344	NCI NIH HHS [CA06927] Funding Source: Medline; NIGMS NIH HHS [GM31186] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; CABRERO C, 1987, EUR J BIOCHEM, V170, P299, DOI 10.1111/j.1432-1033.1987.tb13699.x; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; CANTONI GL, 1953, J BIOL CHEM, V204, P403; CHIANG PK, 1977, J BIOL CHEM, V252, P4506; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; CHIFFLET S, 1986, ANAL BIOCHEM, V168, P1; DANIELS L, 1986, APPL ENVIRON MICROB, V51, P703, DOI 10.1128/AEM.51.4.703-709.1986; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; HOFFMAN JL, 1983, METHOD ENZYMOL, V94, P223; HOFFMAN JL, 1986, BIOCHEMISTRY-US, V25, P4444, DOI 10.1021/bi00363a041; Jermiin LS, 1997, MOL BIOL EVOL, V14, P1296, DOI 10.1093/oxfordjournals.molbev.a025739; KOTB M, 1985, J BIOL CHEM, V260, P3923; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; MCQUENEY MS, 1995, J BIOL CHEM, V270, P18277, DOI 10.1074/jbc.270.31.18277; Mudd S. H., 1973, ENZYMES, V8, P121; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P5059; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; PEGG AE, 1988, CANCER RES, V48, P759; PORCELLI M, 1988, EUR J BIOCHEM, V177, P273, DOI 10.1111/j.1432-1033.1988.tb14373.x; RECZKOWSKI RS, 1995, J BIOL CHEM, V270, P18484, DOI 10.1074/jbc.270.31.18484; Schroder G, 1997, PLANT MOL BIOL, V33, P211, DOI 10.1023/A:1005711720930; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1984, ADV ENZYMOL RAMB, V56, P251; Takusagawa F, 1996, J BIOL CHEM, V271, P136, DOI 10.1074/jbc.271.1.136; Taylor JC, 1999, J BIOL CHEM, V274, P32909, DOI 10.1074/jbc.274.46.32909; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; USDIN E, 1982, BIOCH S ADENOSYLMETH; Xu HM, 1999, NAT STRUCT BIOL, V6, P750; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	37	44	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4055	4059		10.1074/jbc.275.6.4055	http://dx.doi.org/10.1074/jbc.275.6.4055			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660563	hybrid			2022-12-27	WOS:000085288800047
J	Pecheur, EI; Martin, I; Bienvenue, A; Ruysschaert, JM; Hoekstra, D				Pecheur, EI; Martin, I; Bienvenue, A; Ruysschaert, JM; Hoekstra, D			Protein-induced fusion can be modulated by target membrane lipids through a structural switch at the level of the fusion peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL EXTREMITY; BIOLOGICAL-MEMBRANES; SECONDARY STRUCTURE; FTIR SPECTROSCOPY; HEMAGGLUTININ; COMPLEX; PHOSPHATIDYLETHANOLAMINE; CONFORMATION; MECHANISMS; BILAYER	Regulatory features of protein-induced membrane fusion are largely unclear, particularly at the level of the fusion peptide. Fusion peptides being part of larger protein complexes, such investigations are met with technical limitations. Here, we show that the fusion activity of influenza virus or Golgi membranes is strongly inhibited by minor amounts of (lyso)lipids when present in the target membrane but not when inserted into the viral or Golgi membrane itself. To investigate the underlying mechanism, we employ a membrane-anchored peptide system and show that fusion is similarly regulated by these lipids when inserted into the target but not when present in the peptide-containing membrane, Peptide-induced fusion is regulated by a reversible switch of secondary structure from a fusion-permissive alpha-helix to a nonfusogenic beta-sheet. The "on/off" activation of this switch is governed by minor amounts of (lyso)-phospholipids in targets, causing a drop in cu-helix and a dramatic increase in beta-sheet contents. Concomitantly, fusion is inhibited, due to impaired peptide insertion into the target membrane. Our observations in biological fusion systems together with the model studies suggest that distinct lipids in target membranes provide a means for regulating membrane fusion by causing a reversible secondary structure switch of the fusion peptides.	Univ Groningen, Dept Physiol Chem, NL-9713 AV Groningen, Netherlands; Free Univ Brussels, Chim Phys Macromol Interfaces Lab, B-1050 Brussels, Belgium; Univ Montpellier 2, UMR 5539, CNRS, Dept Biol Sante, F-34095 Montpellier, France	University of Groningen; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Hoekstra, D (corresponding author), Univ Groningen, Dept Physiol Chem, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.			Pecheur, Eve/0000-0002-8613-862X				Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Canaves JM, 1998, J BIOL CHEM, V273, P34214, DOI 10.1074/jbc.273.51.34214; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; CHERNOMORDIK L, 1995, J VIROL, V69, P3049, DOI 10.1128/JVI.69.5.3049-3058.1995; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 1997, J CELL BIOL, V136, P81, DOI 10.1083/jcb.136.1.81; DEJONGH HHJ, 1995, BIOCHEMISTRY-US, V34, P172, DOI 10.1021/bi00001a021; deJongh HHJ, 1996, ANAL BIOCHEM, V242, P95, DOI 10.1006/abio.1996.0434; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; EPAND RM, 1995, BIOPOLYMERS, V37, P319, DOI 10.1002/bip.360370504; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; GOORMAGHTIGH E, 1997, DETERMINATION SOLUBL, V23, P329; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Hunter GW, 1999, BIOCHEMISTRY-US, V38, P4604, DOI 10.1021/bi982392g; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kiyota T, 1996, BIOCHEMISTRY-US, V35, P13196, DOI 10.1021/bi961289t; Kliger Y, 1997, J BIOL CHEM, V272, P13496, DOI 10.1074/jbc.272.21.13496; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Lindblom G, 1998, CURR OPIN COLLOID IN, V3, P499, DOI 10.1016/S1359-0294(98)80024-1; LUNEBERG J, 1995, J BIOL CHEM, V270, P27606; Martin I, 1998, EUR J BIOCHEM, V258, P150, DOI 10.1046/j.1432-1327.1998.2580150.x; Martin I, 1996, J VIROL, V70, P298, DOI 10.1128/JVI.70.1.298-304.1996; Martin I, 1999, BIOCHEMISTRY-US, V38, P9337, DOI 10.1021/bi9829534; McIntosh TJ, 1999, BIOPHYS J, V76, P2090, DOI 10.1016/S0006-3495(99)77365-0; Myles DG, 1997, BIOL REPROD, V56, P320, DOI 10.1095/biolreprod56.2.320; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; NOVICK SL, 1988, P NATL ACAD SCI USA, V85, P7433, DOI 10.1073/pnas.85.20.7433; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; PAK CC, 1994, J BIOL CHEM, V269, P14614; Pecheur EI, 1997, BIOCHEMISTRY-US, V36, P3773, DOI 10.1021/bi9622128; Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466; Pecheur EI, 1999, BIOCHEMISTRY-US, V38, P364, DOI 10.1021/bi981389u; Pecheur EI, 1998, BIOCHEMISTRY-US, V37, P2361, DOI 10.1021/bi972697f; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; TATULIAN SA, 1995, EMBO J, V14, P5514, DOI 10.1002/j.1460-2075.1995.tb00238.x; VANDEENEN LLM, 1965, PROG CHEM FATS OTHER, V8; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Yun CH, 1997, J BIOL CHEM, V272, P19725, DOI 10.1074/jbc.272.32.19725	41	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3936	3942		10.1074/jbc.275.6.3936	http://dx.doi.org/10.1074/jbc.275.6.3936			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660547	hybrid			2022-12-27	WOS:000085288800031
J	Hauser, M; Donhardt, AM; Barnes, D; Naider, F; Becker, JM				Hauser, M; Donhardt, AM; Barnes, D; Naider, F; Becker, JM			Enkephalins are transported by a novel eukaryotic peptide uptake system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; SACCHAROMYCES-CEREVISIAE; YEAST; <D-PENICILLAMINE(2,5)>ENKEPHALIN; FAMILY; GENE	We have identified an oligopeptide transporter in the yeast Saccharomyces cerevisiae which mediates the uptake of tetra- and pentapeptides, including the endogenous opioids leucine enkephalin (Tyr-Gly-Gly-Phe-Leu) and methionine enkephalin (Tyr-Gly-Gly-Phe-Met). The transporter is encoded by the gene OPT1. Yeast expressing OPT1 can utilize enkephalins to satisfy amino acid auxotrophic requirements for growth. The transport of radiolabeled leucine enkephalin exhibits saturable kinetics, with a K-m of 310 mu M. Transport activity is optimum at acidic pH and sensitive to reagents which uncouple oxidative phosphorylation, suggesting an energy dependence on the proton gradient. Growth, transport, and chromatographic data indicate that leucine enkephalin is not hydrolyzed in the extracellular medium and as such is translocated intact across the cell membrane. The system is specific for tetra- and pentapeptides and can be inhibited by the opioid receptor antagonists naloxone and naltrexone. To date, this is the first example of a eukaryotic transport system which can use enkephalins as a substrate, opening the possibility that a homologue exists in higher eukaryotes.	Univ Tennessee, Dept Microbiol & Biochem Mol & Cellular Biol, Knoxville, TN 37996 USA; CUNY Coll Staten Isl, Dept Chem, Staten Isl, NY 10314 USA	University of Tennessee System; University of Tennessee Knoxville; City University of New York (CUNY) System; College of Staten Island (CUNY)	Becker, JM (corresponding author), Univ Tennessee, Dept Microbiol, M409 Walters Life Sci, Knoxville, TN 37996 USA.	jbecker@utk.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022086, R01GM022087, R56GM022087, R56GM022086] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM22087, GM22086] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANKS WA, 1986, AM J PHYSIOL, V251, pE477, DOI 10.1152/ajpendo.1986.251.4.E477; Banks WA, 1997, ALCOHOL, V14, P237, DOI 10.1016/S0741-8329(96)00148-6; BANKS WA, 1990, AM J PHYSIOL, V259, pE1, DOI 10.1152/ajpendo.1990.259.1.E1; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; BECKER JM, 1977, ARCH BIOCHEM BIOPHYS, V178, P245, DOI 10.1016/0003-9861(77)90189-8; BECKER JM, 1995, PEPTIDE BASED DRUG D, P369; Blakely RD, 1998, BIOL PSYCHIAT, V44, P169, DOI 10.1016/S0006-3223(98)00124-3; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; Brachmann CB, 1998, YEAST, V14, P115; Chen CP, 1997, J PHARMACOL EXP THER, V283, P1151; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Egleton RD, 1999, J PHARM SCI-US, V88, P392, DOI 10.1021/js980410+; Egleton RD, 1998, J PHARM SCI-US, V87, P1433, DOI 10.1021/js980062b; Fei YJ, 1998, PROG NUCLEIC ACID RE, V58, P239; Fiori A, 1997, P NATL ACAD SCI USA, V94, P9469, DOI 10.1073/pnas.94.17.9469; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; HAGTING A, 1994, J BIOL CHEM, V269, P11391; Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x; Lubkowitz MA, 1997, MICROBIOL-UK, V143, P387, DOI 10.1099/00221287-143-2-387; MCNICHOLAS LF, 1984, DRUGS, V27, P81, DOI 10.2165/00003495-198427010-00004; Plotkin SR, 1997, J NEUROSCI RES, V48, P273; Roman G, 1998, AM J PHYSIOL-CELL PH, V275, pC857, DOI 10.1152/ajpcell.1998.275.3.C857; SLOKOVIC BV, 1989, J NEUROCHEM, V53, P1333; STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x; Thomas SA, 1997, J PHARMACOL EXP THER, V280, P1235; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Williams SA, 1996, J NEUROCHEM, V66, P1289	28	66	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3037	3041		10.1074/jbc.275.5.3037	http://dx.doi.org/10.1074/jbc.275.5.3037			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652283	hybrid			2022-12-27	WOS:000085146500005
J	Friedman, SL				Friedman, SL			Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FAT-STORING CELLS; BETA-BINDING-PROTEIN; STELLATE CELLS; LIVER FIBROSIS; CIRRHOTIC LIVER; SPLICE VARIANT; GROWTH-FACTORS; IN-VITRO; EXPRESSION; RAT		CUNY Mt Sinai Sch Med, Dept Med, Div Liver Dis, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Friedman, SL (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, Div Liver Dis, Box 1123,Rm 1170 F,1425 Madison Ave, New York, NY 10029 USA.	frieds02@doc.mssm.edu			NIDDK NIH HHS [DK56621, DK37340] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056621, R56DK056621, R01DK037340] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ankoma-Sey V, 1998, ONCOGENE, V17, P115, DOI 10.1038/sj.onc.1201912; ARTHUR MJP, 1995, J HEPATOL, V22, P43; Bahr MJ, 1999, HEPATOLOGY, V29, P839, DOI 10.1002/hep.510290333; Baroni GS, 1998, HEPATOLOGY, V27, P720; Benyon RC, 1999, HEPATOLOGY, V30, P977, DOI 10.1002/hep.510300431; BRENNER DA, 1993, AM J PHYSIOL, V264, pG589, DOI 10.1152/ajpgi.1993.264.4.G589; Chen AP, 1999, J BIOL CHEM, V274, P158, DOI 10.1074/jbc.274.1.158; Di Sario A, 1999, GASTROENTEROLOGY, V116, P1155, DOI 10.1016/S0016-5085(99)70019-3; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Fibbi G, 1999, HEPATOLOGY, V29, P868, DOI 10.1002/hep.510290343; Friedman SL, 1999, SEMIN LIVER DIS, V19, P129, DOI 10.1055/s-2007-1007105; FRIEDMAN SL, 1998, DIS LIVER, P371; Gong WR, 1998, GASTROENTEROLOGY, V114, P352, DOI 10.1016/S0016-5085(98)70488-3; GRESSNER AM, 1995, J HEPATOL, V22, P28; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Hellerbrand C, 1996, HEPATOLOGY, V24, P670; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Ikeda K, 1998, AM J PATHOL, V153, P1695, DOI 10.1016/S0002-9440(10)65683-0; Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640; INAGAKI Y, 1995, HEPATOLOGY, V22, P573, DOI 10.1016/0270-9139(95)90582-0; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; JARNAGIN WR, 1994, J CELL BIOL, V127, P2037, DOI 10.1083/jcb.127.6.2037; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Knittel T, 1999, AM J PATHOL, V154, P153, DOI 10.1016/S0002-9440(10)65262-5; Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5; Maher JJ, 1999, ALCOHOL CLIN EXP RES, V23, P917, DOI 10.1097/00000374-199905000-00022; Mallat A, 1996, J CLIN INVEST, V98, P2771, DOI 10.1172/JCI119103; Marra F, 1999, HEPATOLOGY, V29, P140, DOI 10.1002/hep.510290107; Marra F, 1998, AM J PATHOL, V152, P423; Marra F, 1997, GASTROENTEROLOGY, V112, P1297, DOI 10.1016/S0016-5085(97)70144-6; Michel K, 1998, HEPATOLOGY, V27, P1592, DOI 10.1002/hep.510270619; Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nakamura T, 1998, P NATL ACAD SCI USA, V95, P5389, DOI 10.1073/pnas.95.9.5389; Nieto N, 1999, HEPATOLOGY, V30, P987, DOI 10.1002/hep.510300433; Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232; Okuno M, 1999, J HEPATOL, V30, P1073, DOI 10.1016/S0168-8278(99)80262-1; Olaso E, 1999, HEPATOLOGY, V30, p413A; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Pinzani M, 1998, LIVER, V18, P2; Pinzani M, 1996, GASTROENTEROLOGY, V110, P534, DOI 10.1053/gast.1996.v110.pm8566602; PINZANI M, 1992, AM J PHYSIOL, V262, pC876, DOI 10.1152/ajpcell.1992.262.4.C876; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1016/0270-9139(95)90378-X; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; Rocky D, 1997, HEPATOLOGY, V25, P2, DOI 10.1002/hep.510250102; Roulot D, 1999, HEPATOLOGY, V29, P1730, DOI 10.1002/hep.510290622; Shao R, 1999, J BIOL CHEM, V274, P3228, DOI 10.1074/jbc.274.5.3228; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Thompson KC, 1998, HEPATOLOGY, V28, P1518, DOI 10.1002/hep.510280611; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Vom Dahl S, 1999, HEPATOLOGY, V29, P195, DOI 10.1002/hep.510290114; Wang SC, 1998, J BIOL CHEM, V273, P302, DOI 10.1074/jbc.273.1.302; Wang XD, 1999, NUTR REV, V57, P51, DOI 10.1111/j.1753-4887.1999.tb01778.x	57	1731	1874	3	160	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2247	2250		10.1074/jbc.275.4.2247	http://dx.doi.org/10.1074/jbc.275.4.2247			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644669	hybrid			2022-12-27	WOS:000085128000001
J	Graff, JR; Gabrielson, E; Fujii, H; Baylin, SB; Herman, JG				Graff, JR; Gabrielson, E; Fujii, H; Baylin, SB; Herman, JG			Methylation patterns of the E-cadherin 5 ' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASION-SUPPRESSOR FUNCTION; CARCINOMA IN-SITU; CANCER CELL-LINES; BREAST-CANCER; CHROMATIN STRUCTURE; DNA METHYLATION; TRANSCRIPTION FACTORS; TUMOR-CELLS; NUDE-MICE; GENE	Metastatic progression of most common epithelial tumors involves a heterogeneous, transient loss of expression of the homotypic cell adhesion protein, E-cadherin, rather than the uniform loss of a functional protein resulting from coding region mutation. Indeed, whereas E-cadherin loss may promote invasion, reexpression may facilitate cell survival within metastatic deposits. The mechanisms underlying such plasticity are unclear. We now show that the heterogeneous loss of E-cadherin expression in primary human breast cancers reflects a heterogeneous pattern of promoter region methylation, which begins early prior to invasion. In cultured human tumor cells, such heterogeneous methylation is dynamic, varying from allele to allele and shifting in relation to the tumor microenvironment. Following invasion in vitro which favors diminished E-cadherin expression, the density of promoter methylation markedly increased. When these cells were cultured as spheroids, which requires homotypic cell adhesion, promoter methylation decreased dramatically, and E-cadherin was reexpressed, These data show that the methylation associated with E-cadherin loss in human breast cancer is heterogeneous and unstable and suggest that such epigenetic plasticity may contribute to the dynamic, phenotypic heterogeneity that drives metastatic progression.	Johns Hopkins Univ, Ctr Comprehens Canc, Baltimore, MD 21231 USA; Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins University	Graff, JR (corresponding author), Eli Lilly & Co, Lilly Res Labs, Lilly Corp Ctr, Drop Code 0546, Indianapolis, IN 46285 USA.	graff_jeremy@lilly.com						Bachman KE, 1999, CANCER RES, V59, P798; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Baylin SB, 1998, ADV CANCER RES, V72, P141; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; BOGHAERT ER, 1991, INT J CANCER, V47, P610, DOI 10.1002/ijc.2910470422; Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; COSTELLO JF, 1994, MOL CELL BIOL, V14, P6515, DOI 10.1128/MCB.14.10.6515; Day ML, 1999, J BIOL CHEM, V274, P9656, DOI 10.1074/jbc.274.14.9656; Fujii H, 1996, CANCER RES, V56, P5260; Graff JR, 1998, CANCER RES, V58, P2063; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; GRAFF JR, 1995, CANCER RES, V55, P5195; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hampson R, 1997, J BIOL CHEM, V272, P28596, DOI 10.1074/jbc.272.45.28596; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; HENNIG G, 1995, ONCOGENE, V11, P475; HEPPNER GH, 1984, CANCER RES, V44, P2259; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ingram M, 1997, IN VITRO CELL DEV-AN, V33, P459; Ji XD, 1997, CELL GROWTH DIFFER, V8, P773; Jones PA, 1996, CANCER RES, V56, P2463; Kanai Y, 1997, INT J CANCER, V71, P355; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Lapidus RG, 1998, CANCER RES, V58, P2515; LING V, 1984, J CELL PHYSIOL, P99; Liteplo R G, 1985, Basic Life Sci, V33, P285; MAREEL M, 1995, CANCER DETECT PREV, V19, P451; MAREEL MM, 1991, INT J CANCER, V47, P922, DOI 10.1002/ijc.2910470623; Matsuo K, 1998, EMBO J, V17, P1446, DOI 10.1093/emboj/17.5.1446; MOLL R, 1993, AM J PATHOL, V143, P1731; NICOLSON GL, 1987, CANCER RES, V47, P1473; OKA H, 1993, CANCER RES, V53, P1696; PASSANITI A, 1992, INT J CANCER, V51, P318, DOI 10.1002/ijc.2910510224; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; Siitonen SM, 1996, AM J CLIN PATHOL, V105, P394; SOMMERS CL, 1991, CELL GROWTH DIFFER, V2, P365; St Croix Brad, 1997, Current Opinion in Oncology, V9, P549; StCroix B, 1996, NAT MED, V2, P1204; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TALMADGE JE, 1982, SCIENCE, V217, P361, DOI 10.1126/science.6953592; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; VANDENBOSSCHE GMR, 1994, INT J CANCER, V57, P73, DOI 10.1002/ijc.2910570114; VandenBroecke C, 1996, CLIN EXP METASTAS, V14, P282, DOI 10.1007/BF00053902; Vermeulen S, 1996, PATHOL RES PRACT, V192, P694, DOI 10.1016/S0344-0338(96)80091-4; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Vos CBJ, 1997, BRIT J CANCER, V76, P1131, DOI 10.1038/bjc.1997.523; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	55	306	321	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2727	2732		10.1074/jbc.275.4.2727	http://dx.doi.org/10.1074/jbc.275.4.2727			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644736	hybrid			2022-12-27	WOS:000085128000068
J	Zhou, TH; Ling, K; Guo, J; Zhou, H; Wu, YL; Jing, Q; Ma, L; Pei, G				Zhou, TH; Ling, K; Guo, J; Zhou, H; Wu, YL; Jing, Q; Ma, L; Pei, G			Identification of a human brain-specific isoform of mammalian STE20-like kinase 3 that is regulated by cAMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL CENTER KINASE; BETA-GAMMA-SUBUNITS; N-TERMINAL KINASE; OPIOID RECEPTOR; MAP KINASE; PATHWAY; ACTIVATION; FAMILY; CLONING; CASCADE	A novel isoform of mammalian STE20-like kinase 3 (MST3) with a different 5' coding region from MST3, termed MST3b, was identified by searching through expressed sequence tag data base and obtained by rapid amplification of cDNA 5'-ends, MST3b was assigned to the long arm of human chromosome 13, D13S159-D13S280, by use of the National Center for Biotechnology Information sequence-tagged sites data base. Reverse transcription-polymerase chain reaction and Northern blot analysis with a probe derived from 5' distinct sequence of MST3b revealed that the expression of MST3b mRNA is restricted to the brain, in contrast to ubiquitous distribution of MST3 transcript. Western analysis confirmed the brain-specific expression of MST3b protein. In situ hybridization of rat brain sections with a MST3b-specific probe indicated that MST3b is widely expressed in different brain regions, with especially high expression in hippocampus and cerebral cortex. When expressed in human embryonic kidney 293 (HEK293) cells, MST3b effectively phosphorylated myelin basic protein, as well as undergoing autophosphorylation, Interestingly, expression of MST3, but not MST3b, in HEK293 cells was able to activate the endogenous p42/44 mitogen-activated protein kinase (MAPK) up to 4-fold, whereas neither isoform activated p38 MAPK under the same conditions. Further experiments demonstrated that MST3b, but not MST3, was effectively phosphorylated by activation of cyclic AMP-dependent protein kinase (PKA) in both in vivo and in vitro assays. The mutation of Thr-18 into Ala in MST3b (T18A), a putative PHA phosphorylation site that is absent in MST3, abolished its phosphorylation by PKA, Consequently, expression of the T18A mutant in HEK293 cells led to partial activation of p42/44 MAPK, indicating that MST3b is under the regulation of PKA, Taken together, our data provide evidence that the two isoforms of STE20-like kinase 3 are differentially distributed and regulated.	Chinese Acad Sci, Shanghai Inst Cell Biol, Shanghai 200031, Peoples R China; Shanghai Med Univ, Natl Lab Med Neurobiol, Shanghai 200032, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	gangpei@sunm.shcnc.ac.cn	zhou, tianhua/K-4908-2013; Ma, Lan/B-9295-2009	zhou, tianhua/0000-0002-1791-2124; Ma, Lan/0000-0001-9034-5472				Allen KM, 1998, NAT GENET, V20, P25, DOI 10.1038/1675; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; BOGUSKI MS, 1994, SCIENCE, V265, P1993, DOI 10.1126/science.8091218; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Cayanis E, 1998, GENOMICS, V47, P26, DOI 10.1006/geno.1997.5087; Cheng ZJ, 1998, J BIOL CHEM, V273, P24328, DOI 10.1074/jbc.273.38.24328; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; FAURE M, 1994, J BIOL CHEM, V269, P7851; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; GRANT AL, 1997, MOL BIOL NEURON, P67; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; HATZ P, 1994, J BIOL CHEM, V269, P16802; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Jing Q, 1999, CIRC RES, V84, P831; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Lou LG, 1999, MOL PHARMACOL, V55, P557; MANSER E, 1995, J BIOL CHEM, V270, P25070, DOI 10.1074/jbc.270.42.25070; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Paul A, 1997, CELL SIGNAL, V9, P403, DOI 10.1016/S0898-6568(97)00042-9; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PEI G, 1995, MOL PHARMACOL, V48, P173; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; RAMER SW, 1993, P NATL ACAD SCI USA, V90, P452, DOI 10.1073/pnas.90.2.452; Ren MD, 1996, P NATL ACAD SCI USA, V93, P5151, DOI 10.1073/pnas.93.10.5151; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tung RM, 1997, ONCOGENE, V14, P653, DOI 10.1038/sj.onc.1200877; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118	51	38	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2513	2519		10.1074/jbc.275.4.2513	http://dx.doi.org/10.1074/jbc.275.4.2513			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644707	hybrid			2022-12-27	WOS:000085128000039
J	Fuglsang, CC; Berka, RM; Wahleithner, JA; Kauppinen, S; Shuster, JR; Rasmussen, G; Halkier, T; Dalboge, H; Henrissat, B				Fuglsang, CC; Berka, RM; Wahleithner, JA; Kauppinen, S; Shuster, JR; Rasmussen, G; Halkier, T; Dalboge, H; Henrissat, B			Biochemical analysis of recombinant fungal mutanases - A new family of alpha 1,3-glucanases with novel carbohydrate-binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BASED CLASSIFICATION; GLYCOSYL HYDROLASES; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-ORYZAE; EXPRESSION; ACID; GENE; CLONING; PURIFICATION; SIMILARITIES	Nucleotide sequence analysis shows that Trichoderma harzianum and Penicillium purpurogenum alpha 1,3-glucanases (mutanases) have homologous primary structures (53% amino acid sequence identity), and are composed of two distinct domains: a NH2-terminal catalytic domain and a putative COOH-terminal polysaccharide-binding domain separated by a O-glycosylated Pro-Ser-Thr-rich linker peptide. Each mutanase was expressed in Aspergillus oryzae host under the transcriptional control of a strong cu-amylase gene promoter. The purified recombinant mutanases show a pH optimum in the range from pH 3.5 to 4.5 and a temperature optimum around 50-55 degrees C at pH 5.5. Also, they exhibit strong binding to insoluble mutan with K-D around 0.11 and 0.13 mu M at pH 7 for the P. purpurogenum and T. harzianum mutanases, respectively. Partial hydrolysis showed that the COOH-terminal domain of the T. harzianum mutanase binds to mutan, The catalytic domains and the binding domains were assigned to a new family of glycoside hydrolases and to a new family of carbohydrate-binding domains, respectively.	Novo Nordisk AS, Novo Allee, DK-2880 Bagsvaerd, Denmark; Novo Nordisk Biotech Inc, Davis, CA 95616 USA; CNRS, INF1, F-13402 Marseille, France	Novo Nordisk; Novo Nordisk; Centre National de la Recherche Scientifique (CNRS)	Fuglsang, CC (corresponding author), Novo Nordisk AS, Novo Allee, DK-2880 Bagsvaerd, Denmark.	ccf@novo.dk	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588				AIZO M, 1992, Patent No. 1992058889; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; Berka RM, 1998, APPL ENVIRON MICROB, V64, P4423; Berka RM, 1997, APPL ENVIRON MICROB, V63, P3151, DOI 10.1128/AEM.63.8.3151-3157.1997; BOEL E, 1984, EMBO J, V3, P1097, DOI 10.1002/j.1460-2075.1984.tb01935.x; BOTHWELL MK, 1995, BIORESOURCE TECHNOL, V53, P21, DOI 10.1016/0960-8524(95)00046-H; BRODY H, 1998, Patent No. 9811203; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISTENSEN T, 1988, BIO-TECHNOL, V6, P1419, DOI 10.1038/nbt1288-1419; COUTINHO PM, 1994, PROTEIN ENG, V7, P393, DOI 10.1093/protein/7.3.393; DALESSIO JM, 1992, FOCUS, V14, P76; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davis R., 1980, ADV BACTERIAL GENETI; Draborg H, 1995, BIOCHEM MOL BIOL INT, V36, P781; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GEBLER J, 1992, J BIOL CHEM, V267, P12559; GIESECKE H, 1992, J VIROL METHODS, V38, P47, DOI 10.1016/0166-0934(92)90168-D; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; GINSBURG I, 1982, MICROBIOLOGY, P292; GUGGENHEIM B, 1972, J DENT RES, V51, P394, DOI 10.1177/00220345720510022701; GUGGENHEIM B, 1970, Helvetica Odontologica Acta, V14, P89; GUGGENHEIM B, 1980, CARIES RES, V14, P128, DOI 10.1159/000260447; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HASEGAWA S, 1969, J BIOL CHEM, V244, P5460; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KELSTRUP J, 1978, SCAND J DENT RES, V86, P93; KOFOD LV, 1994, J BIOL CHEM, V269, P29182; Matsuda S, 1997, J FERMENT BIOENG, V83, P593, DOI 10.1016/S0922-338X(97)81143-9; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; OPPERMANN RV, 1979, SCAND J DENT RES, V87, P302; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SIGGAARDANDERSEN M, 1991, P NATL ACAD SCI USA, V88, P4114, DOI 10.1073/pnas.88.10.4114; Straubinger B., 1992, FUNGAL GENET NEWSLET, V39, P82; TAKEHARA T, 1981, J BACTERIOL, V145, P729, DOI 10.1128/JB.145.2.729-735.1981; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Tsuchiya R, 1998, J DENT RES, V77, P971; VANARSDELL JN, 1987, BIO-TECHNOL, V5, P60, DOI 10.1038/nbt0187-60; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183	46	59	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2009	2018		10.1074/jbc.275.3.2009	http://dx.doi.org/10.1074/jbc.275.3.2009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636904	hybrid			2022-12-27	WOS:000084940000067
J	Hammarsten, O; DeFazio, LG; Chu, G				Hammarsten, O; DeFazio, LG; Chu, G			Activation of DNA-dependent protein kinase by single-stranded DNA ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; KU PROTEIN; SCID MUTATION; V(D)J RECOMBINATION; BREAK REPAIR; BINDING; TRANSCRIPTION; COMPLEX; LYMPHOCYTES; AUTOANTIGEN	DNA-dependent protein kinase (DNA-PK) is involved in joining DNA double-strand breaks induced by ionizing radiation or V(D)J recombination, The kinase is activated by DNA ends and composed of a DNA binding subunit, Ku, and a catalytic subunit, DNA-PKCS. To define the DNA structure required for kinase activation, we synthesized a series of DNA molecules and tested their interactions with purified DNA-PKCS. The addition of unpaired single strands to blunt DNA ends increased binding and activation of the kinase. When single-stranded loops were added to the DNA ends, binding was preserved, but kinase activation was severely reduced. Obstruction of DNA ends by streptavidin reduced both binding and activation of the kinase, Significantly, short single-stranded oligonucleotides of 3-10 bases were capable of activating DNA-PKCS. Taken together, these data indicate that kinase activation involves a specific interaction with free single-stranded DNA ends. The structure of DNA-PKCS, contains an open channel large enough for double-stranded DNA and an adjacent enclosed cavity with the dimensions of single-stranded DNA. The data presented here support a model in which duplex DNA binds to the open channel, and a single-stranded DNA end is inserted into the enclosed cavity to activate the kinase.	Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Chu, G (corresponding author), Stanford Univ, Med Ctr, Dept Med Oncol, M211, Stanford, CA 94305 USA.		Hammarsten, Ola/A-2791-2012	Eli, Lisa/0000-0003-3896-0966	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058120] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM58120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann P, 1998, P NATL ACAD SCI USA, V95, P14066, DOI 10.1073/pnas.95.24.14066; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; BLIER PR, 1993, J BIOL CHEM, V268, P7594; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Cary RB, 1997, P NATL ACAD SCI USA, V94, P4267, DOI 10.1073/pnas.94.9.4267; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chiu CY, 1998, J MOL BIOL, V284, P1075, DOI 10.1006/jmbi.1998.2212; Chu G, 1997, J BIOL CHEM, V272, P24097, DOI 10.1074/jbc.272.39.24097; Danska JS, 1996, MOL CELL BIOL, V16, P5507; DARST SA, 1991, BIOPHYS J, V59, P387, DOI 10.1016/S0006-3495(91)82232-9; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; FALZON M, 1993, J BIOL CHEM, V268, P10546; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; GILFILLAN S, 1993, SCIENCE, V261, P1175, DOI 10.1126/science.8356452; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; MIMORI T, 1986, J BIOL CHEM, V261, P375; MOROZOV VE, 1994, J BIOL CHEM, V269, P16684; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; Smider V, 1998, MOL CELL BIOL, V18, P6853, DOI 10.1128/MCB.18.11.6853; SUWA A, 1994, P NATL ACAD SCI USA, V91, P6904, DOI 10.1073/pnas.91.15.6904; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yavuzer U, 1998, GENE DEV, V12, P2188, DOI 10.1101/gad.12.14.2188	38	74	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1541	1550		10.1074/jbc.275.3.1541	http://dx.doi.org/10.1074/jbc.275.3.1541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636842	hybrid			2022-12-27	WOS:000084940000005
J	Jault, JM; Fieulaine, S; Nessler, S; Gonzalo, P; Di Pietro, A; Deutscher, J; Galinier, A				Jault, JM; Fieulaine, S; Nessler, S; Gonzalo, P; Di Pietro, A; Deutscher, J; Galinier, A			The HPr kinase from Bacillus subtilis is a homo-oligomeric enzyme which exhibits strong positive cooperativity for nucleotide and fructose 1,6-bisphosphate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CARBON CATABOLITE REPRESSION; PHOSPHOTRANSFERASE SYSTEM; MITOCHONDRIAL F1-ATPASE; STREPTOCOCCUS-PYOGENES; PHOSPHOCARRIER PROTEIN; PHOSPHORYLATED-HPR; CRYSTAL-STRUCTURE; CATALYTIC SITE; SERYL RESIDUE	Carbon catabolite repression allows bacteria to rapidly alter the expression of catabolic genes in response to the availability of metabolizable carbon sources. In Bacillus subtilis, this phenomenon is controlled by the Hh kinase (HprK) that catalyzes ATP-dependent phosphorylation of either HPr (histidine containing protein) or Crh (catabolite repression HPr) on residue Ser-46. We report here that B, subtilis HprK forms homo-oligomers constituted most likely of eight subunits, Related to this complex structure, the enzyme displays strong positive cooperativity for the binding of its allosteric activator, fructose 1,6-bisphosphate, as evidenced by either kinetics of its phosphorylation activity or the intrinsic fluorescence properties of its unique tryptophan residue, Trp-235, It is further shown that activation of HPr phosphorylation by fructose 1,6-bisphosphate essentially occurs at low ATP and enzyme concentrations. A positive cooperativity was also detected for the binding of natural nucleotides or their 2'(3')-N-methylanthraniloyl derivatives, in either phosphorylation or fluorescence experiments. Most interestingly, quenching of the HprK tryptophan fluorescence by using either iodide or acrylamide revealed a heterogeneity of tryptophan residues within the population of oligomers, suggesting that the enzyme exists in two different conformations. This result suggests a concerted-symmetry model for the catalytic mechanism of positive cooperativity displayed by HprK.	Inst Biol & Chim Prot, UPR 412 CNRS, F-69367 Lyon 07, France; CNRS, UPR 9063, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; INRA, Lab Genet Microorganismes, F-78850 Thiverval Grignon, France; CNRS ERS 567, F-78850 Thiverval Grignon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Galinier, A (corresponding author), Inst Biol & Chim Prot, UPR 412 CNRS, 7 Passage Vercors, F-69367 Lyon 07, France.		Nessler, Sylvie/R-4296-2016; jault, jean-michel/G-2086-2012	Nessler, Sylvie/0000-0003-4973-9941; jault, jean-michel/0000-0003-1743-2777				Bauer CB, 1997, J MOL BIOL, V274, P394, DOI 10.1006/jmbi.1997.1325; Brochu D, 1999, J BACTERIOL, V181, P709, DOI 10.1128/JB.181.3.709-717.1999; CALHOUN DB, 1983, BIOCHEMISTRY-US, V22, P1533, DOI 10.1021/bi00276a003; CAMERON AD, 1994, J MOL BIOL, V238, P615, DOI 10.1006/jmbi.1994.1318; Christensen DP, 1999, APPL ENVIRON MICROB, V65, P2112; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DEUTSCHER J, 1984, FEMS MICROBIOL LETT, V23, P157; DEUTSCHER J, 1985, J BACTERIOL, V163, P1203, DOI 10.1128/JB.163.3.1203-1209.1985; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; DIVITA G, 1991, BIOCHEMISTRY-US, V30, P3256, DOI 10.1021/bi00227a013; DIVITA G, 1993, J BIOL CHEM, V268, P13178; ECCLESTON JF, 1991, BIOCHEM SOC T, V19, P432, DOI 10.1042/bst0190432; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; ENTIAN KD, 1992, TRENDS BIOCHEM SCI, V17, P506, DOI 10.1016/0968-0004(92)90341-6; FUJITA Y, 1979, J BIOL CHEM, V254, P5340; FUJITA Y, 1995, MOL MICROBIOL, V17, P953, DOI 10.1111/j.1365-2958.1995.mmi_17050953.x; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; GASSNER M, 1977, EUR J BIOCHEM, V75, P287, DOI 10.1111/j.1432-1033.1977.tb11528.x; Gosseringer R, 1997, J MOL BIOL, V266, P665, DOI 10.1006/jmbi.1996.0820; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JAULT JM, 1993, J BIOL CHEM, V268, P20762; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; Kanazawa T, 1995, BIOSCIENCE REP, V15, P317, DOI 10.1007/BF01788364; KANTROWITZ ER, 1990, TRENDS BIOCHEM SCI, V15, P53, DOI 10.1016/0968-0004(90)90176-C; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Martin-Verstraete I, 1999, J BACTERIOL, V181, P2966, DOI 10.1128/JB.181.9.2966-2969.1999; MASON PW, 1981, J BIOL CHEM, V256, P1861; MIMURA CS, 1987, J CELL BIOCHEM, V33, P161, DOI 10.1002/jcb.240330303; MITCHELL WJ, 1993, J BACTERIOL, V175, P2758, DOI 10.1128/JB.175.9.2758-2761.1993; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MURCOTT THL, 1992, EMBO J, V11, P3811, DOI 10.1002/j.1460-2075.1992.tb05472.x; Ormo M, 1998, BIOCHEMISTRY-US, V37, P16565, DOI 10.1021/bi981616s; REIZER J, 1984, J BACTERIOL, V160, P333, DOI 10.1128/JB.160.1.333-340.1984; Reizer J, 1998, MOL MICROBIOL, V27, P1157, DOI 10.1046/j.1365-2958.1998.00747.x; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; Saier MH, 1996, FEMS MICROBIOL LETT, V138, P97; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; THEVENOT T, 1995, J BACTERIOL, V177, P2751, DOI 10.1128/jb.177.10.2751-2759.1995; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; [No title captured]	52	87	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1773	1780		10.1074/jbc.275.3.1773	http://dx.doi.org/10.1074/jbc.275.3.1773			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636874	Green Published, hybrid			2022-12-27	WOS:000084940000037
J	Schwanbeck, R; Manfioletti, G; Wisniewski, JR				Schwanbeck, R; Manfioletti, G; Wisniewski, JR			Architecture of high mobility group protein I-C center dot DNA complex and its perturbation upon phosphorylation by Cdc2 kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-BETA GENE; FACTOR HMGI-C; CONFORMATIONAL-CHANGES; CHROMOSOMAL-PROTEINS; BINDING PROPERTIES; REGIONS FLANKING; VIRUS INDUCTION; RNA-POLYMERASE; BOX DOMAIN; IDENTIFICATION	The high mobility group I-C (HMGI-C) protein is an abundant component of rapidly proliferating undifferentiated cells. High level expression of this protein is characteristic for early embryonic tissue and diverse tumors. HMGI-C can function as an architectural factor enhancing the activity of transcription factor NF-kappa B on the beta-interferon promoter. The protein has three minor groove DNA-binding domains (AT-hooks), Here, we describe the complex of HMGI-C with a fragment of the beta-interferon promoter, We show that the protein binds to NRDI and PRDII elements of the promoter with its first and second AT-hook, respectively. Phosphorylation by Cdc2 kinase leads to a partial derailing of the AT-hooks from the minor groove, affecting mainly the second binding domain. In contrast, binding to long AT stretches of DNA involves contacts with all three AT-hooks and is marginally sensitive to phosphorylation, Our data stress the importance of conformation of the DNA binding site and protein phosphorylation for its function.	Univ Gottingen, Zool Inst 3, D-37073 Gottingen, Germany; Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy	University of Gottingen; University of Trieste	Wisniewski, JR (corresponding author), Univ Gottingen, Zool Inst 3, Humboldtallee 34A, D-37073 Gottingen, Germany.		Schwanbeck, Ralf/A-2648-2008	Schwanbeck, Ralf/0000-0003-0925-929X; MANFIOLETTI, GUIDALBERTO/0000-0001-7913-2601				Arlotta P, 1997, J BIOL CHEM, V272, P29904, DOI 10.1074/jbc.272.47.29904; ASHAR HR, 1995, CELL, V82, P57; Baichoo N, 1997, BIOCHEMISTRY-US, V36, P10830, DOI 10.1021/bi970714v; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; Chin MT, 1998, J BIOL CHEM, V273, P9755, DOI 10.1074/jbc.273.16.9755; CLAUS P, 1994, J BIOL CHEM, V269, P33042; Currie RA, 1997, J BIOL CHEM, V272, P30880, DOI 10.1074/jbc.272.49.30880; DISNEY JE, 1989, J CELL BIOL, V109, P1975, DOI 10.1083/jcb.109.5.1975; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; FERRANTI P, 1992, J BIOL CHEM, V267, P22486; Frank O, 1998, J BIOL CHEM, V273, P20015, DOI 10.1074/jbc.273.32.20015; Ghidelli S, 1997, CHROMOSOMA, V105, P369, DOI 10.1007/BF02529752; GIANCOTTI V, 1991, EUR J BIOCHEM, V198, P211, DOI 10.1111/j.1432-1033.1991.tb16003.x; Goodwin G, 1998, INT J BIOCHEM CELL B, V30, P761, DOI 10.1016/S1357-2725(98)00016-8; HEYDUK E, 1994, BIOCHEMISTRY-US, V33, P9643, DOI 10.1021/bi00198a033; Heyduk E, 1997, J BIOL CHEM, V272, P19763, DOI 10.1074/jbc.272.32.19763; Heyduk T, 1996, P NATL ACAD SCI USA, V93, P10162, DOI 10.1073/pnas.93.19.10162; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; MAHONEY WC, 1981, BIOCHEMISTRY-US, V20, P443, DOI 10.1021/bi00505a033; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; Mantovani F, 1998, NUCLEIC ACIDS RES, V26, P1433, DOI 10.1093/nar/26.6.1433; Maxam A M, 1980, Methods Enzymol, V65, P499; Munteanu MG, 1998, TRENDS BIOCHEM SCI, V23, P341, DOI 10.1016/S0968-0004(98)01265-1; NISSEN MS, 1991, J BIOL CHEM, V266, P19945; PALVIMO J, 1989, FEBS LETT, V257, P101, DOI 10.1016/0014-5793(89)81796-X; PENDERGRAST PS, 1992, P NATL ACAD SCI USA, V89, P10287, DOI 10.1073/pnas.89.21.10287; REEVES R, 1990, J BIOL CHEM, V265, P8573; REEVES R, 1987, P NATL ACAD SCI USA, V84, P6531, DOI 10.1073/pnas.84.18.6531; REEVES R, 1991, P NATL ACAD SCI USA, V88, P1671, DOI 10.1073/pnas.88.5.1671; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Schwanbeck R, 1997, J BIOL CHEM, V272, P27476, DOI 10.1074/jbc.272.43.27476; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; WANG DZ, 1995, J BIOL CHEM, V270, P22924, DOI 10.1074/jbc.270.39.22924; Wisniewski Jacek R., 1998, Zoologica Poloniae, V43, P5; Wisniewski JR, 1999, BBA-GENE STRUCT EXPR, V1447, P25, DOI 10.1016/S0167-4781(99)00123-2; Wisniewski JR, 1999, J BIOL CHEM, V274, P20116; WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P10713; Wisniewski JR, 1997, EUR J BIOCHEM, V243, P151, DOI 10.1111/j.1432-1033.1997.0151a.x; Yie JM, 1999, EMBO J, V18, P3074, DOI 10.1093/emboj/18.11.3074; Yie JM, 1997, MOL CELL BIOL, V17, P3649, DOI 10.1128/MCB.17.7.3649; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	51	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1793	1801		10.1074/jbc.275.3.1793	http://dx.doi.org/10.1074/jbc.275.3.1793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636877	hybrid			2022-12-27	WOS:000084940000040
J	Caldas, T; Laalami, S; Richarme, G				Caldas, T; Laalami, S; Richarme, G			Chaperone properties of bacterial elongation factor EF-G and initiation factor IF2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; BINDING PROTEIN; TRIGGER FACTOR; TRANSFER-RNA; TU; IDENTIFICATION; PURIFICATION; HYDROLYSIS	Elongation factor G(EF-G) and initiation factor 2 (IF2) are involved in the translocation of ribosomes on mRNA and in the binding of initiator tRNA to the 30 S ribosomal subunit, respectively. Here we report that the Escherichia coli EF-G and IF2 interact with unfolded and denatured proteins, as do molecular chaperones that are involved in protein folding and protein renaturation after stress. EF-G and IF2 promote the functional folding of citrate synthase and alpha-glucosidase after urea denaturation. They prevent the aggregation of citrate synthase under heat shock conditions, and they form stable complexes with unfolded proteins such as reduced carboxymethyl alpha-lactalbumin. Furthermore, the EF-G and IF2-dependent renaturations of citrate synthase are stimulated by GTP, and the GTPase activity of EF-G and IF2 is stimulated by the permanently unfolded protein, reduced carboxymethyl alpha-lactalbumin. The concentrations at which these chaperone-like functions occur are lower than the cellular concentrations of EF-G and IF2. These results suggest that EF-G and IF2, in addition to their role in translation, might be implicated in protein folding and protection from stress.	Univ Paris 07, Inst Jacques Monod, F-75005 Paris, France; Univ Poitiers, Inst Biol Mol & Ingn Genet, CNRS, ESA6031, F-86022 Poitiers, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, 2 Pl Jussieu, F-75005 Paris, France.	richarme@ccr.jussieu.fr						ARAI N, 1975, J BIOCHEM-TOKYO, V78, P243; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; BROT N, 1977, MOL MECHANISMS PROTE, P375; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; BURKHOLDER WF, 1994, J MOL BIOL, V242, P374; Caldas TD, 1998, PROTEIN EXPRES PURIF, V14, P65, DOI 10.1006/prep.1998.0922; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; CULL M, 1990, METHOD ENZYMOL, V182, P147; DEVENDITTIS E, 1986, J BIOL CHEM, V261, P4445; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Grunberg-Manago M., 1996, ESCHERICHIA COLI SAL, V1, P1432; Hardesty Boyd, 1999, Current Opinion in Structural Biology, V9, P111, DOI 10.1016/S0959-440X(99)80014-1; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HENDRICK JP, 1993, P NATL ACAD SCI USA, V90, P10216, DOI 10.1073/pnas.90.21.10216; HERSHEY JWB, 1987, ESCHERICHIA COLI SAL, V1, P613; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Krab IM, 1998, BBA-GENE STRUCT EXPR, V1443, P1, DOI 10.1016/S0167-4781(98)00169-9; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Kudlicki W, 1997, J BIOL CHEM, V272, P32206, DOI 10.1074/jbc.272.51.32206; Kurland C., 1996, ESCHERICHIA COLI SAL, V240, P979; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LANGER T, 1992, NATURE, V356, P383; LIBEREK K, 1991, P NATL ACAD SCI USA, V22, P14491; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Miller DL, 1977, MOL MECH PROTEIN BIO, P323; MISSIAKAS D, 1993, J BACTERIOL, V175, P2616; RICHARME G, 1993, J BIOL CHEM, V268, P24074; Richarme G, 1998, BIOCHEM BIOPH RES CO, V252, P156, DOI 10.1006/bbrc.1998.9591; Richarme G, 1997, J BIOL CHEM, V272, P15607, DOI 10.1074/jbc.272.25.15607; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Shibata T, 1996, J BIOL CHEM, V271, P13162, DOI 10.1074/jbc.271.22.13162; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; TRAVERS AA, 1980, BIOCHEMISTRY-US, V19, P1651, DOI 10.1021/bi00549a020; VACHON G, 1993, FEBS LETT, V321, P241, DOI 10.1016/0014-5793(93)80117-D; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; VALENT QA, 1995, EMBO J, V14, P5404; WEIJLAND A, 1992, MOL MICROBIOL, V6, P683, DOI 10.1111/j.1365-2958.1992.tb01516.x; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; ZYLICZ M, 1984, J BIOL CHEM, V259, P8820; [No title captured]	45	122	124	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					855	860		10.1074/jbc.275.2.855	http://dx.doi.org/10.1074/jbc.275.2.855			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625618	hybrid			2022-12-27	WOS:000084836600022
J	Smith, DE; Renshaw, BR; Ketchem, RR; Kubin, M; Garka, KE; Sims, JE				Smith, DE; Renshaw, BR; Ketchem, RR; Kubin, M; Garka, KE; Sims, JE			Four new members expand the interleukin-1 superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-INDUCING FACTOR; HUMAN T-CELLS; IL-1 RECEPTOR; MOLECULAR-CLONING; CONVERTING-ENZYME; EXPRESSION; PROTEIN; SEQUENCE; ANTAGONIST; CYTOKINE	We report here the cloning and characterization of four new members of the interleukin-1 (IL-1) family (FIL1 delta, FIL1 epsilon, FIL1 zeta and FLI1 eta, with FIL1 standing for "Family of IL-1"), The novel genes demonstrate significant sequence similarity to IL-1 alpha, IL-1 beta, IL-1ra, and IL-18, and in addition maintain a conserved exon-intron arrangement that is shared with the previously known members of the family. Protein structure modeling also suggests that the FIL1 genes are related to IL-1 beta and IL-1ra. The novel genes form a cluster with the IL-1s on the long arm of human chromosome 2.	Immunex Corp, Seattle, WA 98101 USA	Immunex Corporation	Sims, JE (corresponding author), Immunex Corp, 51 Univ St, Seattle, WA 98101 USA.	sims@immunex.com	Ketchem, Randal R/K-2258-2017; Ketchem, Randal/AAB-4372-2020	Ketchem, Randal R/0000-0002-7821-2682; Ketchem, Randal/0000-0002-7821-2682; Sims, John/0000-0002-5667-9185				Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Born TL, 1998, J BIOL CHEM, V273, P29445, DOI 10.1074/jbc.273.45.29445; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; Cullinan EB, 1998, J IMMUNOL, V161, P5614; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; Jaroszewski L, 1998, PROTEIN SCI, V7, P1431; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; KUBIN M, 1994, BLOOD, V83, P1847; KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211; Kubin MZ, 1999, EUR J IMMUNOL, V29, P3466, DOI 10.1002/(SICI)1521-4141(199911)29:11<3466::AID-IMMU3466>3.0.CO;2-9; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parnet P, 1996, J BIOL CHEM, V271, P3967; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SIMS JE, 1995, CYTOKINE, V7, P483, DOI 10.1006/cyto.1995.0066; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SIMS JE, 1989, P NATL ACAD SCI USA, V86, P8946, DOI 10.1073/pnas.86.22.8946; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; Thomassen E, 1998, J INTERF CYTOK RES, V18, P1077, DOI 10.1089/jir.1998.18.1077; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Ushio S, 1996, J IMMUNOL, V156, P4274; YOUNG PR, 1998, Patent No. 0879889	41	272	321	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1169	1175		10.1074/jbc.275.2.1169	http://dx.doi.org/10.1074/jbc.275.2.1169			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625660	hybrid			2022-12-27	WOS:000084836600064
J	Jakubowski, H				Jakubowski, H			Calcium-dependent human serum homocysteine thiolactone hydrolase - A protective mechanism against protein N-homocysteinylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; AMINO-ACIDS; PROOFREADING INVIVO; ESCHERICHIA-COLI; PARAOXONASE; PLASMA; LIPOPROTEINS; SELECTION; FAILURE; HEART	Homocysteine thiolactone is formed in all cell types studied thus far as a result of editing reactions of some aminoacyl-tRNA synthetases. Because inadvertent reactions of thiolactone with proteins are potentially harmful, the ability to detoxify homocysteine thiolactone is essential for biological integrity. This work shows that a single specific enzyme, present in mammalian but not in avian sera, hydrolyzes thiolactone to homocysteine. Human serum thiolactonase, a 45-kDa protein component of high density lipoprotein, requires calcium for activity and stability and is inhibited by isoleucine and penicillamine, Substrate specificity studies suggest that homocysteine thiolactone is a likely natural substrate of this enzyme. However, thiolactonase also hydrolyzes nonnatural substrates, such as phenyl acetate, p-nitrophenyl acetate, and the organophospate paraoxon, N-terminal amino acid sequence of pure thiolactonase is identical with that of human paraoxonase. These and other data indicate that paraoxonase, an organophosphate-detoxifying enzyme whose natural substrate and function remained unknown up to now, is in fact homocysteine thiolactonase. By detoxifying homocysteine thiolactone, the thiolactonase/paraoxonase would protect proteins against homocysteinylation, a potential contributing factor to atherosclerosis.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Jakubowski, H (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Microbiol & Mol Genet, 185 S Orange Ave, Newark, NJ 07103 USA.		Jakubowski, Hieronim/AAA-6834-2019; Jakubowski, Hieronim/A-2510-2017	Jakubowski, Hieronim/0000-0001-5845-4409				ANDERSON RF, 1974, INT J RADIAT PHYS CH, V6, P33, DOI 10.1016/0020-7055(74)90033-3; Baernstein HD, 1934, J BIOL CHEM, V106, P451; BURSTEIN M, 1970, J LIPID RES, V11, P583; DONAHUE S, 1974, AM J PATHOL, V77, P167; DUDMAN NPB, 1991, ARTERIOSCLER THROMB, V11, P663, DOI 10.1161/01.ATV.11.3.663; Ferguson E, 1998, J LIPID RES, V39, P925; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1250, DOI 10.1021/bi00574a021; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; Gardemann A, 1999, EUR HEART J, V20, P584, DOI 10.1053/euhj.1998.1340; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; Heinecke JW, 1998, AM J HUM GENET, V62, P20, DOI 10.1086/301691; Jakubowski H, 1996, BIOCHEMISTRY-US, V35, P8252, DOI 10.1021/bi960344v; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 1999, BIOCHEMISTRY-US, V38, P8088, DOI 10.1021/bi990629i; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1995, J BIOL CHEM, V270, P17672, DOI 10.1074/jbc.270.30.17672; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; JAKUBOWSKI H, 1990, P NATL ACAD SCI USA, V87, P4504, DOI 10.1073/pnas.87.12.4504; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Jakubowski H, 1997, BIOCHEMISTRY-US, V36, P11077, DOI 10.1021/bi970589n; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; JAKUBOWSKI H, 2000, HOMOCYSTEINE HLTH DI; JAKUBOWSKI H, 2000, IN PRESS ENCY LIFE S; JAKUBOWSKI H, 1993, FEBS LETT, V317, P593; Liu GM, 1997, J BIOL CHEM, V272, P32370, DOI 10.1074/jbc.272.51.32370; Mackness B, 1998, GEN PHARMACOL-VASC S, V31, P329, DOI 10.1016/S0306-3623(98)00028-7; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; MUDD SH, 1989, RES COMMUN CHEM PATH, V63, P297; Rosenquist TH, 1996, P NATL ACAD SCI USA, V93, P15227, DOI 10.1073/pnas.93.26.15227; RUDEL LL, 1974, BIOCHEM J, V139, P89, DOI 10.1042/bj1390089; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; SKOVBY F, 1984, J BIOL CHEM, V259, P588; STEINER H, 1975, EUR J BIOCHEM, V59, P253, DOI 10.1111/j.1432-1033.1975.tb02449.x; VANAERTES LA, 1993, TOXICOL IN VITRO, V6, P743	36	327	337	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3957	3962		10.1074/jbc.275.6.3957	http://dx.doi.org/10.1074/jbc.275.6.3957			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660550	hybrid			2022-12-27	WOS:000085288800034
J	Nolan, DP; Jackson, DG; Biggs, MJ; Brabazon, ED; Pays, A; Van Laethem, F; Paturiaux-Hanocq, F; Elliot, JF; Voorheis, HP; Pays, E				Nolan, DP; Jackson, DG; Biggs, MJ; Brabazon, ED; Pays, A; Van Laethem, F; Paturiaux-Hanocq, F; Elliot, JF; Voorheis, HP; Pays, E			Characterization of a novel alanine-rich protein located in surface microdomains in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; BLOOD-STREAM FORMS; PHOSPHATIDYLINOSITOL MEMBRANE ANCHOR; ACIDIC REPETITIVE PROTEIN; AFRICAN TRYPANOSOMES; CELL-SURFACE; TRANSFERRIN RECEPTOR; SECONDARY STRUCTURE; PROCYCLIC FORMS; CROSS-LINKING	Heterologous expression in COS cells followed by orientation-specific polymerase chain reaction to select and amplify cDNAs encoding surface proteins in Trypanosoma brucei resulted in the isolation of a cDNA (similar to 1.4 kilobase) which encodes an acidic, alanine-rich polypeptide that is expressed only in bloodstream forms of the parasite and has been termed bloodstream stage alanine-rich protein (BARP). Analysis of the amino acid sequence predicted the presence of a typical NH2-terminal leader sequence as well as a COOH-terminal hydrophobic extension with the potential to be replaced by a glycosylphosphatidylinositol anchor. A search of existing protein sequences revealed partial homology between BARP and the major surface antigen of procyclic forms of Trypanosoma congolense. BARP migrated as a complex, heterogeneous series of bands on Western blots with an apparent molecular mass (similar to 50-70 kDa) significantly higher than predicted from the amino acid sequence (similar to 26 kDa). Confocal microscopy demonstrated that BARP was present in small discrete spots that were distributed over the entire cellular surface. Detergent extraction experiments revealed that BARP was recovered in the detergent-insoluble, glycolipid-enriched fraction. These data suggested that BARP may be sequestered in Lipid rafts.	Free Univ Brussels, Mol Parasitol Lab, Inst Mol Biol & Med, B-6041 Gosselies, Belgium; John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England; Univ Alberta, Dept Med Microbiol & Infect Dis, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Immunol, Edmonton, AB T6G 2H7, Canada; Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland	University of Oxford; University of Alberta; University of Alberta; Trinity College Dublin	Nolan, DP (corresponding author), Free Univ Brussels, Mol Parasitol Lab, Inst Mol Biol & Med, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	dnolan@dbm.ulb.ac.be		, david/0000-0002-4133-9364; Nolan, Derek/0000-0002-3742-4304				BALBER AE, 1990, CRIT REV IMMUNOL, V10, P177; Bastin P, 1996, MOL BIOCHEM PARASIT, V76, P43, DOI 10.1016/0166-6851(95)02537-5; BAYNE RAL, 1993, MOL BIOCHEM PARASIT, V61, P295, DOI 10.1016/0166-6851(93)90075-9; BEECROFT RP, 1993, MOL BIOCHEM PARASIT, V61, P285, DOI 10.1016/0166-6851(93)90074-8; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; BRINGAUD F, 1993, MOL CELL BIOL, V13, P1146, DOI 10.1128/MCB.13.2.1146; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BRUN R, 1979, ACTA TROP, V36, P289; Carrington M, 1996, MOL BIOCHEM PARASIT, V81, P119, DOI 10.1016/0166-6851(96)02706-5; COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753; DANIELSEN EM, 1995, J CELL BIOL, V131, P939, DOI 10.1083/jcb.131.4.939; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FERGUSON MAJ, 1993, BIOCHEM J, V291, P51, DOI 10.1042/bj2910051; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; JACKSON DG, 1993, J BIOL CHEM, V268, P1894; JACKSON DG, 1990, BIOCHEM SOC T, V18, P1032, DOI 10.1042/bst0181032; JACKSON DG, 1993, J BIOL CHEM, V268, P8085; Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0; Kubler E, 1996, J BIOL CHEM, V271, P32975, DOI 10.1074/jbc.271.51.32975; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIGTENBERG MJL, 1994, EMBO J, V13, P2565, DOI 10.1002/j.1460-2075.1994.tb06546.x; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; MORAN P, 1994, J CELL BIOL, V125, P333, DOI 10.1083/jcb.125.2.333; Nolan DP, 1997, J BIOL CHEM, V272, P29212, DOI 10.1074/jbc.272.46.29212; Overath P, 1997, TRENDS CELL BIOL, V7, P27, DOI 10.1016/S0962-8924(97)10046-0; OVERATH P, 1994, PARASITOL TODAY, V10, P53, DOI 10.1016/0169-4758(94)90393-X; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; PaturiauxHanocq F, 1997, BIOCHEM J, V324, P885, DOI 10.1042/bj3240885; Pays E, 1998, MOL BIOCHEM PARASIT, V91, P3, DOI 10.1016/S0166-6851(97)00183-7; PAYS E, 1980, NUCLEIC ACIDS RES, V8, P5965, DOI 10.1093/nar/8.24.5965; PAYS E, 1988, ANNU REV GENET, V22, P107, DOI 10.1146/annurev.ge.22.120188.000543; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; RODITI I, 1990, PARASITOL TODAY, V6, P79, DOI 10.1016/0169-4758(90)90216-Q; ROLIN S, 1990, EXP PARASITOL, V71, P350, DOI 10.1016/0014-4894(90)90041-A; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu M, 1997, J MEMBRANE BIOL, V159, P137, DOI 10.1007/s002329900277; Xiao Z, 1997, MOL BIOL CELL, V8, P855, DOI 10.1091/mbc.8.5.855; ZAMZE SE, 1988, EUR J BIOCHEM, V176, P527, DOI 10.1111/j.1432-1033.1988.tb14310.x; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang XQ, 1997, BIOCHEM J, V323, P197, DOI 10.1042/bj3230197; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10797	59	52	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4072	4080		10.1074/jbc.275.6.4072	http://dx.doi.org/10.1074/jbc.275.6.4072			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660566	hybrid			2022-12-27	WOS:000085288800050
J	Vorobiov, D; Bera, AK; Keren-Raifman, T; Barzilai, R; Dascal, N				Vorobiov, D; Bera, AK; Keren-Raifman, T; Barzilai, R; Dascal, N			Coupling of the muscarinic m2 receptor to G protein-activated K+ channels via G alpha(z) and a Receptor-G alpha(z) fusion protein - Fusion between the receptor and G alpha(z) eliminates catalytic (collision) coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; GUANINE-NUCLEOTIDE-BINDING; SIGNAL-TRANSDUCTION; XENOPUS-OOCYTES; PERTUSSIS-TOXIN; ALPHA-SUBUNIT; POTASSIUM CHANNEL; ACETYLCHOLINE-RECEPTOR; MOLECULAR-PROPERTIES; EXPRESSION	G protein-activated K+ channel (GIRK), which is activated by the Gp, subunit of heterotrimeric G proteins, and muscarinic m2 receptor (m2R) were coexpressed in Xenopus oocytes, Acetylcholine evoked a K+ current, I-ACh, via the endogenous pertussis toxin (PTX)-sensitive G(z), proteins. Activation of I-ACh was accelerated by increasing the expression of m2R, suggesting a collision coupling mechanism in which one receptor catalytically activates several G proteins. Coexpression of the alpha subunit of the PTX-insensitive G protein G(z), G(alpha z), induced a slowly activating PTX-insensitive I-ACh, whose activation kinetics were also compatible with the collision coupling mechanism. When GIRK was coexpressed with an m2R.G alpha(z) fusion protein (tandem), in which the C terminus of m2R was tethered to the N terminus of G(alpha z), part of IACh Was still eliminated by PTX. Thus, the m2R of the tandem activates the tethered Ga, but also the nontethered G(i/o) proteins. After PTX treatment, the speed of activation of the m2R.G alpha(z)-mediated response did not depend on the expression level of m2R.G alpha(z), and was faster than when m2R and Ga, were coexpressed as separate proteins. These results demonstrate that fusing the receptor and the G alpha strengthens their coupling, support the collision-coupling mechanism between m2R and the G proteins, and suggest a noncatalytic (stoichiometric) coupling between the G: protein and GIRK in this model system.	Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.		Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146; Bera, Amal Kanti/0000-0003-0362-5578	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056260] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56260] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEALS CR, 1987, P NATL ACAD SCI USA, V84, P7886, DOI 10.1073/pnas.84.22.7886; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Burt AR, 1998, J BIOL CHEM, V273, P10367, DOI 10.1074/jbc.273.17.10367; Carr IC, 1998, FEBS LETT, V428, P17, DOI 10.1016/S0014-5793(98)00476-1; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Dascal N., 1992, METHODS MOL BIOL VOL, VVolume 13, P205; Dolphin AC, 1998, J PHYSIOL-LONDON, V506, P3, DOI 10.1111/j.1469-7793.1998.003bx.x; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; FU MLX, 1994, RECEPTOR CHANNEL, V2, P121; GARCIA PD, 1995, EMBO J, V14, P4460, DOI 10.1002/j.1460-2075.1995.tb00125.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gudermann T, 1997, ANNU REV NEUROSCI, V20, P399, DOI 10.1146/annurev.neuro.20.1.399; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Ho MKC, 1998, BIOL SIGNAL RECEPT, V7, P80; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Jeong SW, 1998, NEURON, V21, P1201, DOI 10.1016/S0896-6273(00)80636-4; Jing J, 1999, EMBO J, V18, P1245, DOI 10.1093/emboj/18.5.1245; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kostenis E, 1999, LIFE SCI, V64, P355, DOI 10.1016/S0024-3205(98)00574-8; KOVOOR A, 1995, J BIOL CHEM, V270, P589, DOI 10.1074/jbc.270.2.589; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LEVITZKI A, 1993, LIFE SCI, V52, P2093, DOI 10.1016/0024-3205(93)90724-H; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; Medici R, 1997, EMBO J, V16, P7241, DOI 10.1093/emboj/16.24.7241; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Osawa S, 1995, J BIOL CHEM, V270, P31052, DOI 10.1074/jbc.270.52.31052; Sautel M, 1998, FEBS LETT, V436, P46, DOI 10.1016/S0014-5793(98)01094-1; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Silverman SK, 1996, J BIOL CHEM, V271, P30524, DOI 10.1074/jbc.271.48.30524; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sodickson DL, 1998, J NEUROSCI, V18, P8153; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Vorobiov D, 1998, PFLUG ARCH EUR J PHY, V436, P56, DOI 10.1007/s004240050604; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Wise A, 1997, J BIOL CHEM, V272, P24673, DOI 10.1074/jbc.272.39.24673; Yamada M, 1998, PHARMACOL REV, V50, P723	51	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4166	4170		10.1074/jbc.275.6.4166	http://dx.doi.org/10.1074/jbc.275.6.4166			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660578	hybrid			2022-12-27	WOS:000085288800062
J	Bradford, AP; Brodsky, KS; Diamond, SE; Kuhn, LC; Liu, YM; Gutierrez-Hartmann, A				Bradford, AP; Brodsky, KS; Diamond, SE; Kuhn, LC; Liu, YM; Gutierrez-Hartmann, A			The Pit-1 homeodomain and beta-domain interact with Ets-1 and modulate synergistic activation of the rat prolactin promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GHF-1; ANTERIOR-PITUITARY DEVELOPMENT; GROWTH-HORMONE PROMOTER; RETINOIC ACID RECEPTORS; GENE-EXPRESSION; DNA-BINDING; SIGNAL-TRANSDUCTION; RESPONSE ELEMENTS; CELL PHENOTYPES; THYROID-HORMONE	Pit-1/GHF-1 is a pituitary-specific, POU homeodomain transcription factor required for development of somatotroph, lactotroph, and thyrotroph cell lineages and regulation of the temporal and spatial expression of the growth hormone, prolactin (PRL), and thyrotropin-beta genes. Synergistic interaction of Pit-1 with a member of the Ets family of transcription factors, Ets-1, has been shown to be an important mechanism regulating basal and Ras-induced lactotroph-specific rat (r) PRL promoter activity. Pit-1 beta/GHF-2, an alternatively spliced isoform containing a 26-amino acid insert (beta-domain) within its transcription-activation domain, physically interacts with Ets-l but fails to synergize. By using a series of Pit-1 internal-deletion constructs in a transient transfection protocol to reconstitute rPRL promoter activity in HeLa cells, we have determined that the functional and physical interaction of Pit-1 and Ets-1 is mediated via the POU homeodomain, which is common to both Pit-1 and Pit-1 beta. Although the Pit-1 homeodomain is both necessary and sufficient for direct binding to Ets-1 in a DNA-independent manner, an additional interaction surface was mapped to the beta-domain, specific to the Pit-1 beta isoform, Thus, the unique transcriptional properties of Pit-1 and Pit-1 beta on the rPRL promoter may be due to the formation of functionally distinct complexes of these two Pit-1 isoforms with Ets-1.	Univ Colorado, Hlth Sci Ctr, Dept Obstet & Gynecol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Bradford, AP (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Obstet & Gynecol, 4200 E 9th Ave,B-198, Denver, CO 80262 USA.		Gutierrez-Hartmann, Arthur/F-1295-2011		NCI NIH HHS [P30 CA46934] Funding Source: Medline; NIDDK NIH HHS [DK 46868, DK 53496] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053496, R56DK046868, R01DK046868] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN B, 1994, J BIOL CHEM, V269, P29335; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bradford AP, 1996, J BIOL CHEM, V271, P24639, DOI 10.1074/jbc.271.40.24639; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; BRADFORD AP, 1995, MOL CELL BIOL, V15, P2849; CAELLES C, 1995, MOL CELL BIOL, V15, P6694; Castillo AI, 1999, MOL ENDOCRINOL, V13, P1141, DOI 10.1210/me.13.7.1141; Castillo AI, 1998, ONCOGENE, V16, P1981, DOI 10.1038/sj.onc.1200204; Castillo AI, 1997, ENDOCRINOLOGY, V138, P5442, DOI 10.1210/en.138.12.5442; Chang W, 1996, J BIOL CHEM, V271, P17733, DOI 10.1074/jbc.271.30.17733; Chuang FM, 1997, MOL ENDOCRINOL, V11, P1332, DOI 10.1210/me.11.9.1332; CONRAD KE, 1992, ONCOGENE, V7, P1279; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Day RN, 1998, MOL ENDOCRINOL, V12, P1410, DOI 10.1210/me.12.9.1410; de la Hoya M, 1998, CELL MOL LIFE SCI, V54, P1059, DOI 10.1007/s000180050234; Diamond SE, 1999, MOL ENDOCRINOL, V13, P228, DOI 10.1210/me.13.2.228; Diamond SE, 1996, J BIOL CHEM, V271, P28925, DOI 10.1074/jbc.271.46.28925; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; FISCHBERG DJ, 1994, MOL ENDOCRINOL, V8, P1566, DOI 10.1210/me.8.11.1566; Gaiddon C, 1999, MOL ENDOCRINOL, V13, P742, DOI 10.1210/me.13.5.742; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; GUTIERREZHARTMANN A, 1994, MOL ENDOCRINOL, V8, P1447, DOI 10.1210/me.8.11.1447; HAUGEN BR, 1993, J BIOL CHEM, V268, P20818; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HOLLOWAY JM, 1995, GENE DEV, V9, P1992, DOI 10.1101/gad.9.16.1992; HOWARD PW, 1995, J BIOL CHEM, V270, P20930, DOI 10.1074/jbc.270.36.20930; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; JACOB KK, 1995, J BIOL CHEM, V270, P27773, DOI 10.1074/jbc.270.46.27773; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; JANKNECHT R, 1993, BIOCHIM BIOPHYS ACTA, V1155, P346, DOI 10.1016/0304-419X(93)90014-4; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; KAPILOFF MS, 1991, SCIENCE, V253, P786, DOI 10.1126/science.1652153; KEECH CA, 1989, MOL ENDOCRINOL, V3, P832, DOI 10.1210/mend-3-5-832; KONZAK KE, 1992, MOL ENDOCRINOL, V6, P241, DOI 10.1210/me.6.2.241; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; LIANG J, 1995, J BIOL CHEM, V270, P25520, DOI 10.1074/jbc.270.43.25520; LIPKIN SM, 1993, GENE DEV, V7, P1674, DOI 10.1101/gad.7.9.1674; MORRIS AE, 1992, NUCLEIC ACIDS RES, V20, P1355, DOI 10.1093/nar/20.6.1355; NOWAKOWSKI BE, 1994, MOL ENDOCRINOL, V8, P1742, DOI 10.1210/me.8.12.1742; OKIMURA Y, 1994, MOL ENDOCRINOL, V8, P1559, DOI 10.1210/me.8.11.1559; Palomino T, 1998, FASEB J, V12, P1201, DOI 10.1096/fasebj.12.12.1201; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sanchez-Pacheco A, 1998, FEBS LETT, V422, P103, DOI 10.1016/S0014-5793(97)01609-8; Schaufele F, 1996, J BIOL CHEM, V271, P21484, DOI 10.1074/jbc.271.35.21484; Schweppe RE, 1997, J BIOL CHEM, V272, P30852, DOI 10.1074/jbc.272.49.30852; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; THEILL LE, 1992, EMBO J, V11, P2261, DOI 10.1002/j.1460-2075.1992.tb05285.x; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; Tolon RM, 1998, J BIOL CHEM, V273, P26652, DOI 10.1074/jbc.273.41.26652; VOSS JW, 1991, GENE DEV, V5, P1309, DOI 10.1101/gad.5.7.1309; VOSS JW, 1992, CELL, V70, P527, DOI 10.1016/0092-8674(92)90422-9; Wang YH, 1999, MOL ENDOCRINOL, V13, P1094, DOI 10.1210/me.13.7.1094; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WASYLYK B, 1997, TRANSCRIPTION FACTOR, P251; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Yang BS, 1996, MOL CELL BIOL, V16, P538; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Zanger K, 1999, MOL ENDOCRINOL, V13, P268, DOI 10.1210/me.13.2.268	64	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3100	3106		10.1074/jbc.275.5.3100	http://dx.doi.org/10.1074/jbc.275.5.3100			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652292	hybrid			2022-12-27	WOS:000085146500014
J	Choi, J; Liu, RM; Kundu, RK; Sangiorgi, F; Wu, WC; Maxson, R; Forman, HJ				Choi, J; Liu, RM; Kundu, RK; Sangiorgi, F; Wu, WC; Maxson, R; Forman, HJ			Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; NF-KAPPA-B; PERFORMANCE LIQUID-CHROMATOGRAPHY; HIV-INFECTED PATIENTS; EPITHELIAL L2 CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; RAT; ACTIVATION	Human immunodeficiency virus (HIV) progressively depletes GSH content in humans. Although the accumulated evidence suggests a role of decreased GSH in the pathogenesis of HIV, significant controversy remains concerning the mechanism of GSH depletion, especially in regard to envisioning appropriate therapeutic strategies to help compensate for such decreased antioxidant capacity. Tat, a transactivator encoded by HIV, is sufficient to cause GSH depletion in vitro and is implicated in AIDS-associated Kaposi's sarcoma and B cell lymphoma. In this study, we report a decrease in GSH biosynthesis with Tat, using HIV-1 Tat transgenic (Tat+) mice. A significant decline in the total intracellular GSH content in liver and erythrocytes of Tat+ mice was accompanied by decreased gamma-glutamylcysteine synthetase regulatory subunit mRNA and protein content, which resulted in an increased sensitivity of gamma-glutamylcysteine synthetase to feedback inhibition by GSH, Further study revealed a significant reduction in the activity of GSH synthetase in liver of Tat+ mice, which was linearly associated with their GSH content. Therefore, Tat appears to decrease GSH in vivo, at least partially, through modulation of GSH biosynthetic enzymes.	Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; Univ So Calif, Sch Pharm, Dept Mol Pharmacol & Toxicol, Los Angeles, CA 90033 USA; Univ So Calif, Norris Hosp, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Res Inst, Los Angeles, CA 90089 USA; Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90089 USA	University of Alabama System; University of Alabama Birmingham; University of Southern California; University of Southern California; University of Southern California	Forman, HJ (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Environm Hlth Sci, 1665 Univ Blvd,Ryals 317, Birmingham, AL 35294 USA.	hforman@uab.edu		Forman, Henry Jay/0000-0001-5838-2791	NIEHS NIH HHS [ES05511] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES005511, R01ES005511] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749; ANDERSON ME, 1980, BIOCHEM BIOPH RES CO, V96, P848, DOI 10.1016/0006-291X(80)91433-3; Barbaro G, 1996, AM J GASTROENTEROL, V91, P2569; BUHL R, 1989, LANCET, V2, P1294; Chang ML, 1997, MOL CHEM NEUROPATHOL, V30, P187, DOI 10.1007/BF02815097; Chen LH, 1996, CHEM-BIOL INTERACT, V99, P17, DOI 10.1016/0009-2797(95)03657-1; CHEUNG CW, 1989, J BIOL CHEM, V264, P4038; Choi J, 1997, BIOCHEM PHARMACOL, V53, P987, DOI 10.1016/S0006-2952(96)00867-2; DEBIEU D, 1987, CLIN CHIM ACTA, V170, P161, DOI 10.1016/0009-8981(87)90124-0; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; DEQUAY B, 1992, AIDS, V6, P815, DOI 10.1097/00002030-199208000-00008; Dobmeyer TS, 1997, FREE RADICAL BIO MED, V22, P775, DOI 10.1016/S0891-5849(96)00403-0; ECK HP, 1991, LANCET, V338, P346, DOI 10.1016/0140-6736(91)90482-5; ECK HP, 1989, BIOL CHEM H-S, V370, P101, DOI 10.1515/bchm3.1989.370.1.101; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; FAVIER A, 1994, CHEM-BIOL INTERACT, V91, P165, DOI 10.1016/0009-2797(94)90037-X; FLORES SC, 1993, P NATL ACAD SCI USA, V90, P7632, DOI 10.1073/pnas.90.16.7632; Garaci E, 1997, J LEUKOCYTE BIOL, V62, P54, DOI 10.1002/jlb.62.1.54; GAYNOR RB, 1995, CURR TOP MICROBIOL, V193, P51; HAMILOS DL, 1985, J IMMUNOL, V135, P2740; Helbling B, 1996, EUR J CLIN INVEST, V26, P38, DOI 10.1046/j.1365-2362.1996.88237.x; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; ISHII Y, 1992, J CLIN INVEST, V89, P794, DOI 10.1172/JCI115658; Jahoor F, 1999, AM J PHYSIOL-ENDOC M, V276, pE205, DOI 10.1152/ajpendo.1999.276.1.E205; JARSTRAND C, 1994, CHEM-BIOL INTERACT, V91, P141, DOI 10.1016/0009-2797(94)90034-5; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; Kameoka M, 1996, AIDS RES HUM RETROV, V12, P1635, DOI 10.1089/aid.1996.12.1635; Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7; KUMAR S, 1992, BIOCHEM INT, V26, P469; KUMAR S, 1994, FOLIA MICROBIOL, V39, P571, DOI 10.1007/BF02814111; Kundu RK, 1999, BLOOD, V94, P275, DOI 10.1182/blood.V94.1.275.413a30_275_282; LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402; Liu RM, 1998, AM J PHYSIOL-LUNG C, V275, pL861, DOI 10.1152/ajplung.1998.275.5.L861; LOGUERCIO C, 1992, SCAND J CLIN LAB INV, V52, P207, DOI 10.3109/00365519209088787; Luo JL, 1998, AM J PHYSIOL-ENDOC M, V275, pE359, DOI 10.1152/ajpendo.1998.275.2.E359; MARIN E, 1993, ACTA PHYSIOL SCAND, V147, P369, DOI 10.1111/j.1748-1716.1993.tb09513.x; Marmor M, 1997, AIDS, V11, P1389, DOI 10.1097/00002030-199711000-00014; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; NARDI G, 1990, J CHROMATOGR-BIOMED, V530, P122, DOI 10.1016/S0378-4347(00)82310-5; ORLOWSKI M, 1975, EUR J BIOCHEM, V53, P581, DOI 10.1111/j.1432-1033.1975.tb04101.x; PACE GW, 1995, FREE RADICAL BIO MED, V19, P523, DOI 10.1016/0891-5849(95)00047-2; Pacht ER, 1997, CHEST, V112, P785, DOI 10.1378/chest.112.3.785; Palamara AT, 1996, AIDS RES HUM RETROV, V12, P1537, DOI 10.1089/aid.1996.12.1537; Prakash O, 1997, ARCH BIOCHEM BIOPHYS, V343, P173, DOI 10.1006/abbi.1997.0168; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; ROSENBLATT JD, 1995, CURR TOP MICROBIOL, V193, P25; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; SANDSTROM PA, 1993, AIDS RES HUM RETROV, V9, P1107, DOI 10.1089/aid.1993.9.1107; SAPPEY C, 1994, CLIN CHIM ACTA, V230, P35, DOI 10.1016/0009-8981(94)90086-8; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SETHNA SS, 1983, CURR EYE RES, V2, P735, DOI 10.3109/02713688209020005; SHI MM, 1994, J BIOL CHEM, V269, P26512; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Sun Y, 1997, FEBS LETT, V408, P16, DOI 10.1016/S0014-5793(97)00380-3; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; VANDERVEN AJM, 1994, J ANTIMICROB CHEMOTH, V34, P1, DOI 10.1093/jac/34.1.1; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Willmore WG, 1997, AM J PHYSIOL-REG I, V273, pR219, DOI 10.1152/ajpregu.1997.273.1.R219; WITSCHI A, 1995, AIDS RES HUM RETROV, V11, P141, DOI 10.1089/aid.1995.11.141; XIE PY, 1991, OPHTHALMIC RES, V23, P133, DOI 10.1159/000267112; YAN CC, 1995, J CHROMATOGR B, V672, P217, DOI 10.1016/0378-4347(95)00226-9; [No title captured]	68	133	140	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3693	3698		10.1074/jbc.275.5.3693	http://dx.doi.org/10.1074/jbc.275.5.3693			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652368	hybrid			2022-12-27	WOS:000085146500090
J	Glover, BP; McHenry, CS				Glover, BP; McHenry, CS			The DnaX-binding subunits delta ' and psi are bound to gamma and not tau in the DNA polymerase III holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL REPLICATION MACHINE; ESCHERICHIA-COLI; SLIDING CLAMPS; EPSILON-SUBUNIT; LAGGING-STRAND; CROSS-LINKERS; BETA-SUBUNIT; PROTEIN; COMPLEX; IDENTIFICATION	The DnaX complex subassembly of the DNA polymerase III holoenzyme is comprised of the DnaX proteins tau and gamma and the auxiliary subunits delta, delta, chi and Psi,which together load the beta processivity factor onto primed DNA in an ATP-dependent reaction. delta' and Psi bind directly to DnaX whereas delta and chi bind to delta' and Psi, respectively (Onrust, R., Finkelstein, J., Naktinis, V., Turner, J., Fang, L., and O'Donnell, M. (1995) J. Biol. Chem. 270, 13348-13357), Until now, it has been unclear which DnaX protein, tau or gamma, in holoenzyme binds the auxiliary subunits delta, delta' chi,and Psi. Treatment of purified holoenzyme with the homobifunctional cross-linker bis(sulfo-succinimidyl)suberate produces covalently cross-linked gamma-delta' and gamma-Psi complexes identified by Western blot analysis. Immunodetection of cross-linked species with anti-delta' and anti-Psi, antibodies revealed that no tau-delta' or tau-Psi cross-links had formed, suggesting that the delta' and Psi subunits reside only on gamma within holoenzyme.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	McHenry, CS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.				NIGMS NIH HHS [GM 35695] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archibald K, 1998, NEUROPHARMACOLOGY, V37, P1345, DOI 10.1016/S0028-3908(98)00135-X; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; CARTER JR, 1992, J BACTERIOL, V174, P7013, DOI 10.1128/JB.174.21.7013-7025.1992; CARTER JR, 1993, J BACTERIOL, V175, P3812, DOI 10.1128/JB.175.12.3812-3822.1993; Cull MG, 1995, METHOD ENZYMOL, V262, P22; DALLMANN HG, 1995, J BIOL CHEM, V270, P29555, DOI 10.1074/jbc.270.49.29555; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; FAY PJ, 1981, J BIOL CHEM, V256, P976; FLOWER AM, 1991, J MOL BIOL, V220, P649, DOI 10.1016/0022-2836(91)90107-H; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; GEFTER ML, 1971, P NATL ACAD SCI USA, V68, P3150, DOI 10.1073/pnas.68.12.3150; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; HORIUCHI T, 1978, MOL GEN GENET, V163, P277, DOI 10.1007/BF00271956; HURWITZ J, 1974, P NATL ACAD SCI USA, V71, P6, DOI 10.1073/pnas.71.1.6; JENNINGS ML, 1995, BIOCHEMISTRY-US, V34, P3588, DOI 10.1021/bi00011a013; JOHANSON KO, 1986, J BIOL CHEM, V261, P1460; Jordan JA, 1996, BBA-GEN SUBJECTS, V1291, P27, DOI 10.1016/0304-4165(96)00040-2; Kelman Z, 1998, EMBO J, V17, P2436, DOI 10.1093/emboj/17.8.2436; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; LEE SH, 1987, P NATL ACAD SCI USA, V84, P2713, DOI 10.1073/pnas.84.9.2713; MAKI H, 1988, J BIOL CHEM, V263, P6570; MAKI S, 1988, J BIOL CHEM, V263, P6555; McDermott AM, 1996, BIOCHEM J, V317, P119, DOI 10.1042/bj3170119; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MOK M, 1987, J BIOL CHEM, V262, P16644; MULLIN DA, 1983, MOL GEN GENET, V192, P73, DOI 10.1007/BF00327649; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; OLSON MW, 1995, J BIOL CHEM, V270, P29570, DOI 10.1074/jbc.270.49.29570; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; ONRUST R, 1995, J BIOL CHEM, V270, P13348, DOI 10.1074/jbc.270.22.13348; Pritchard AE, 1996, J BIOL CHEM, V271, P10291, DOI 10.1074/jbc.271.17.10291; SCHEUERMANN R, 1983, P NATL ACAD SCI-BIOL, V80, P7085, DOI 10.1073/pnas.80.23.7085; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; TSUCHIHASHI Z, 1990, P NATL ACAD SCI USA, V87, P2516, DOI 10.1073/pnas.87.7.2516; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; XIAO H, 1995, J BIOL CHEM, V270, P13378, DOI 10.1074/jbc.270.22.13378; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	43	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3017	3020		10.1074/jbc.275.5.3017	http://dx.doi.org/10.1074/jbc.275.5.3017			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652279	hybrid			2022-12-27	WOS:000085146500001
J	Rezaie, AR				Rezaie, AR			Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR SUBSTRATE RECOGNITION; BLOOD-COAGULATION FACTOR; PROTEIN-C ACTIVATION; ANTITHROMBIN-III; PROTHROMBINASE COMPLEX; CONFORMATIONAL CHANGE; ENZYME SPECIFICITY; ACTIVE-SITE; THROMBIN; ACCELERATION	recently demonstrated that a template mechanism makes a significant contribution to the heparin-accelerated inactivation of factor Xa (FXa) by antithrombin at physiologic Ca2+, suggesting that FXa has a potential heparin-binding site. Structural data indicate that 7 of the 11 basic residues of the heparin-binding exosite of thrombin are conserved at similar three-dimensional locations in FXa, These residues, Arg(93), Lys(96), Arg(125), Arg(165), Lys(169), Lys(236), and Arg(240) were substituted with Ala in separate constructs in Gla domainless forms. It was found that all derivatives cleave Spectrozyme FXa with similar catalytic efficiencies. Antithrombin inactivated FXa derivatives with a similar second-order association rate constant (k(2)) in both the absence and presence of pentasaccharide, In the presence of heparin, however, k(2) with certain mutants were impaired up to 25-fold. Moreover, these mutants bound to heparin-Sepharose with lower affinities. Heparin concentration dependence of the inactivation revealed that only the template portion of the cofactor effect of heparin was affected by the mutagenesis. The order of importance of these residues for binding heparin was as follows: Arg240 > Lys(236) > Lys(169) > Arg(165) > Lys(96) > Arg(93) greater than or equal to Arg(125). Interestingly, further study suggested that certain basic residues of this site, particularly Arg(165) and Lys(169), play key roles in factor Va and/or prothrombin recognition by FXa in prothrombinase.	St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, 1402 S Grand Blvd, St Louis, MO 63104 USA.				NHLBI NIH HHS [R01 HL 62565] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062565] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; CHATTOPADHYAY A, 1992, J BIOL CHEM, V267, P12323; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; ELLIS V, 1986, BIOCHEM J, V238, P329, DOI 10.1042/bj2380329; ELLIS V, 1986, BIOCHEM J, V233, P161, DOI 10.1042/bj2330161; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; EVANS DL, 1992, BIOCHEMISTRY-US, V31, P12629, DOI 10.1021/bi00165a013; GAN ZR, 1994, J BIOL CHEM, V269, P1301; GRIFFITH MJ, 1982, THROMB RES, V25, P245, DOI 10.1016/0049-3848(82)90244-4; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; JORDAN RE, 1980, J BIOL CHEM, V255, P81; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; LANE DA, 1992, BLOOD COAGUL FIBRIN, V3, P315, DOI 10.1097/00001721-199206000-00012; LEYTUS SP, 1986, BIOCHEMISTRY-US, V25, P5098, DOI 10.1021/bi00366a018; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; OLSON ST, 1992, THROMBIN STRUCTURE F, P159; OWEN BA, 1990, BIOCHEMISTRY-US, V29, P9412, DOI 10.1021/bi00492a015; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PERSSON E, 1991, J BIOL CHEM, V266, P2453; REZAIE AR, 1993, J BIOL CHEM, V268, P8176; REZAIE AR, 1995, J BIOL CHEM, V270, P16176, DOI 10.1074/jbc.270.27.16176; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; Rezaie AR, 1996, J BIOL CHEM, V271, P23807, DOI 10.1074/jbc.271.39.23807; Rezaie AR, 1996, BIOCHEMISTRY-US, V35, P1918, DOI 10.1021/bi952065y; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOEN P, 1989, J BIOL CHEM, V264, P10002; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; SKOGEN WF, 1984, J BIOL CHEM, V259, P2306; YE J, 1994, J BIOL CHEM, V269, P17965	39	104	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3320	3327		10.1074/jbc.275.5.3320	http://dx.doi.org/10.1074/jbc.275.5.3320			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652320	hybrid			2022-12-27	WOS:000085146500042
J	Weixel, KM; Bradbury, NA				Weixel, KM; Bradbury, NA			The carboxyl terminus of the cystic fibrosis transmembrane conductance regulator binds to AP-2 clathrin adaptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN RECEPTOR INTERNALIZATION; DI-LEUCINE MOTIF; CHLORIDE CHANNELS; AMINO-ACID; ENDOCYTOSIS; CFTR; TYROSINE; PROTEIN; SIGNAL; SEQUENCE	The cystic fibrosis transmembrane conductance regulator (CFTR) undergoes rapid and efficient endocytosis. Since functionally active CFTR is found in purified clathrin-coated vesicles isolated from both cultured epithelial cells and intact epithelial tissues, we investigated the molecular mechanisms whereby CFTR could enter such endocytic clathrin-coated vesicles. In vivo cross-linking and in vitro pull-down assays show that full-length CFTR binds to the endocytic adaptor complex AP-2. Fusion proteins containing the carboxyl terminus of CFTR (amino acids 1404-1480) were also able to bind AP-2 but did not bind the Golgi-specific adaptor complex AP-1, Substitution of an alanine residue for tyrosine at position 1424 significantly reduced the ability of AP-2 to bind the carboxyl terminus of CFTR; however, mutation to a phenylalanine residue (an amino acid found at position 1424 in dogfish CFTR) did not perturb AP-2 binding. Secondary structure predictions suggest that Tyr(1424) is present in a beta-turn conformation, a conformation disrupted by alanine but not phenylalanine. Together, these data suggest that the carboxyl terminus of CFTR contains a tyrosine-based internalization signal that interacts with the endocytic adaptor complex AP-2 to facilitate efficient entry of CFTR into clathrin-coated vesicles.	Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Cyst Fibrosis Res Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bradbury, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Cyst Fibrosis Res Ctr, 3500 Terrace St, Pittsburgh, PA 15261 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047850] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47850] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BIWERSI J, 1994, AM J PHYSIOL, V266, pC149, DOI 10.1152/ajpcell.1994.266.1.C149; Boge M, 1998, J BIOL CHEM, V273, P15773, DOI 10.1074/jbc.273.25.15773; BRADBURY NA, 1994, AM J PHYSIOL, V267, pC1, DOI 10.1152/ajpcell.1994.267.1.C1; Bradbury NA, 1999, AM J PHYSIOL-LUNG C, V276, pL659, DOI 10.1152/ajplung.1999.276.4.L659; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; BRADBURY NA, 1994, J BIOL CHEM, V269, P8296; Bradbury NA, 1999, PHYSL REV S, V79, P175, DOI DOI 10.1152/physrev.1999.79.1.S175; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COHN JA, 1994, CYSTIC FIBROSIS CURR, V2, P173; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; Lukacs GL, 1997, BIOCHEM J, V328, P353; MATSUI W, 1990, BIOCHEMISTRY-US, V29, P10791, DOI 10.1021/bi00500a011; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; NESTEROV A, 1995, P NATL ACAD SCI USA, V92, P8719, DOI 10.1073/pnas.92.19.8719; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; PRINCE LS, 1993, AM J PHYSIOL, V264, pC491, DOI 10.1152/ajpcell.1993.264.2.C491; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; ROBINSON M S, 1992, Trends in Cell Biology, V2, P293, DOI 10.1016/0962-8924(92)90118-7; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; WEBSTER P, 1994, AM J PHYSIOL, V267, pC340, DOI 10.1152/ajpcell.1994.267.2.C340	37	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3655	3660		10.1074/jbc.275.5.3655	http://dx.doi.org/10.1074/jbc.275.5.3655			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652362	hybrid			2022-12-27	WOS:000085146500084
J	Bradsher, J; Coin, F; Egly, JM				Bradsher, J; Coin, F; Egly, JM			Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CDK-ACTIVATING KINASE; PIGMENTOSUM GROUP-D; DNA-REPAIR; XERODERMA-PIGMENTOSUM; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; TERMINAL DOMAIN; GENE	To provide an explanation of some clinical features observed within rare xeroderma pigmentosum (XP) patients and to further define the role of XPB, XPD, and cdk7, the three enzymatic subunits of TFIIH, in the transcription reaction, we have examined two defined enzymatic steps: phosphodiester bond formation and promoter escape, me provide evidence that the XPB helicase plays a dominant role in initiation, whereas the XPD helicase plays a minor contributing role in this step. The cyclin-activating kinase subcomplex of TFIIH improves the efficiency of initiation, but this involves only the structural contributions of cyclin-activating kinase rather than enzymatic activity. We demonstrate that XPB patient-derived mutants in TFIIH suffer from defects in initiation. Moreover, mutant analysis shows that in addition to its crucial role in initiation, the XPB helicase plays a critical enzymatic role in the promoter escape, whereas XPD plays an important structural role in the promoter escape process. Finally, using patient-derived mutations in TFIIH, we demonstrate deficiencies in promoter escape for both mutants of the class that suffer from combined xeroderma pigmentosum/Cockayne's syndrome.	ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, CU De Strasbour, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Egly, JM (corresponding author), ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163, F-67404 Illkirch Graffenstaden, CU De Strasbour, France.	egly@igbmc.u-strasbg.fr	Coin, Frédéric/F-5925-2013	Coin, Frédéric/0000-0002-5620-8519	NIGMS NIH HHS [1 F32 GM20174-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020174] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; CONAWAY RC, 1992, J BIOL CHEM, V267, P8464; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Dvir A, 1996, J BIOL CHEM, V271, P23352, DOI 10.1074/jbc.271.38.23352; Dvir A, 1997, J BIOL CHEM, V272, P28175, DOI 10.1074/jbc.272.45.28175; Dvir A, 1996, J BIOL CHEM, V271, P7245, DOI 10.1074/jbc.271.13.7245; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; GERARD M, 1991, J BIOL CHEM, V266, P20940; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; MIYAMOTO NG, 1984, NUCLEIC ACIDS RES, V12, P8779, DOI 10.1093/nar/12.23.8779; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nigg EA, 1996, CURR OPIN CELL BIOL, V8, P312, DOI 10.1016/S0955-0674(96)80003-2; PARVIN JD, 1994, J BIOL CHEM, V269, P18414; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; ROY R, 1994, J BIOL CHEM, V269, P9826; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; TAKAYAMA K, 1995, CANCER RES, V55, P5656; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Weeda G, 1997, AM J HUM GENET, V60, P320; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	38	61	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2532	2538		10.1074/jbc.275.4.2532	http://dx.doi.org/10.1074/jbc.275.4.2532			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644710	hybrid			2022-12-27	WOS:000085128000042
J	Miyamoto, T; Fox, JC				Miyamoto, T; Fox, JC			Autocrine signaling through Ras prevents apoptosis in vascular smooth muscle cells in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR; C-MYC; GENE-TRANSFER; INHIBITION; EFFECTORS; RECEPTOR; TRANSDUCTION; STIMULATION	Vascular smooth muscle cell (SMC) apoptosis contributes to physiological and pathological vascular remodeling, Autocrine fibroblast growth factor (FGF) signaling promotes survival in SMC in vitro. Interruption of autocrine FGF signaling results in apoptosis that can be rescued by other growth factors such as PDGF (platelet-derived growth factor) or EGF (epidermal, growth factor). Such heterologous growth factor rescue is prevented by pharmacological inhibition of MAPK, implicating signaling through Ras in mediating survival. This study was designed to test the hypothesis that signaling through Ras is both necessary and sufficient to mediate SMC survival in vitro. Recombinant adenoviruses encoding dominant-negative (Ras(N17)) and constitutively active (Ras(L61)) mutants of Ras were used. Ras(N17) blocks growth factor-mediated MAPK activation and can itself induce SMC apoptosis. Ras(N17) is synergistic with inhibition of autocrine FGF signaling in triggering apoptosis and prevents heterologous growth factor rescue. Conversely, Ras(L61) prevents apoptosis resulting from inhibition of autocrine FGF signaling. Rescue by Ras(L61) can be partially prevented by pharmacological inhibition of MEK or phosphatidylinositol 3-kinase, two downstream effecters of Ras. These results suggest that Ras signaling is both necessary and sufficient to mediate survival in SMC in vitro. Further work is required to determine how these signaling events are regulated in the context of vascular remodeling in vivo.	Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Fox, JC (corresponding author), SmithKline Beecham Pharmaceut, 51 N 39th St, Philadelphia, PA 19104 USA.				NHLBI NIH HHS [HL02939] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002939] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ai WD, 1999, FEBS LETT, V456, P196, DOI 10.1016/S0014-5793(99)00949-7; Akasaka K, 1996, J BIOL CHEM, V271, P5353, DOI 10.1074/jbc.271.10.5353; ARENDS MJ, 1993, BRIT J CANCER, V68, P1127, DOI 10.1038/bjc.1993.492; CHEN CH, 1994, RADIAT RES, V139, P307, DOI 10.2307/3578828; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Duckworth BC, 1997, J BIOL CHEM, V272, P27665, DOI 10.1074/jbc.272.44.27665; FERNANDEZ A, 1994, ONCOGENE, V9, P2009; FERRARI G, 1994, EMBO J, V13, P5922, DOI 10.1002/j.1460-2075.1994.tb06937.x; Fox JC, 1996, J BIOL CHEM, V271, P12578, DOI 10.1074/jbc.271.21.12578; Gardner AM, 1996, J BIOL CHEM, V271, P14560, DOI 10.1074/jbc.271.24.14560; Hafizi S, 1999, CLIN EXP PHARMACOL P, V26, P511, DOI 10.1046/j.1440-1681.1999.03071.x; Hanna AK, 1997, J VASC SURG, V25, P320, DOI 10.1016/S0741-5214(97)70353-7; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; KINOSHITA T, 1995, ONCOGENE, V10, P2207; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; Miller MJ, 1997, J BIOL CHEM, V272, P5600, DOI 10.1074/jbc.272.9.5600; Miyamoto T, 1998, J CELL PHYSIOL, V177, P58, DOI 10.1002/(SICI)1097-4652(199810)177:1<58::AID-JCP6>3.0.CO;2-D; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; Neschis DG, 1998, J VASC SURG, V27, P126, DOI 10.1016/S0741-5214(98)70299-X; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; RodriguezViciana P, 1996, PHILOS T ROY SOC B, V351, P225, DOI 10.1098/rstb.1996.0020; Rose L, 1998, DEV GROWTH DIFFER, V40, P231; Stang S, 1997, MOL CELL BIOL, V17, P3047, DOI 10.1128/MCB.17.6.3047; Wan Y, 1997, J BIOL CHEM, V272, P17209, DOI 10.1074/jbc.272.27.17209; Wang XHS, 1996, J BIOL CHEM, V271, P31607; YANG YP, 1993, P NATL ACAD SCI USA, V90, P4601, DOI 10.1073/pnas.90.10.4601; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	31	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2825	2830		10.1074/jbc.275.4.2825	http://dx.doi.org/10.1074/jbc.275.4.2825			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644748	hybrid			2022-12-27	WOS:000085128000080
J	Browder, T; Folkman, J; Pirie-Shepherd, S				Browder, T; Folkman, J; Pirie-Shepherd, S			The hemostatic system as a regulator of angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLATELET FACTOR-IV; PLASMINOGEN-ACTIVATOR INHIBITOR; VASCULAR ENDOTHELIAL-CELLS; FIBROBLAST GROWTH-FACTOR; LEWIS-LUNG-CARCINOMA; TUMOR-GROWTH; FACTOR-BETA; ANGIOSTATIN; FIBRIN; RELEASE		Childrens Hosp, Div Surg Res, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Folkman, J (corresponding author), Childrens Hosp, Div Surg Res, Hunnewell 103,300 Longwood Ave, Boston, MA 02115 USA.							Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844; BACHARACH E, 1992, P NATL ACAD SCI USA, V89, P10686, DOI 10.1073/pnas.89.22.10686; BAR RS, 1989, ENDOCRINOLOGY, V124, P1841, DOI 10.1210/endo-124-4-1841; BENEZRA J, 1990, AM J PATHOL, V137, P755; BLEI F, 1993, J CELL PHYSIOL, V155, P568, DOI 10.1002/jcp.1041550315; BRUNNER G, 1993, BLOOD, V81, P631; Cao YH, 1997, J BIOL CHEM, V272, P22924, DOI 10.1074/jbc.272.36.22924; Cao YH, 1996, J BIOL CHEM, V271, P29461, DOI 10.1074/jbc.271.46.29461; Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808; COLLEN D, 1995, BLOOD PRINCIPLES PRA, P1261; Colman RW, 1998, BLOOD, V92, p174A; Colman RW, 1997, J CLIN INVEST, V100, P1481, DOI 10.1172/JCI119669; Date K, 1998, ONCOGENE, V17, P3045, DOI 10.1038/sj.onc.1202231; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Fukao H, 1997, JPN J PHYSIOL, V47, P161, DOI 10.2170/jjphysiol.47.161; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X; HELDIN CH, 1981, BIOCHEM J, V193, P907, DOI 10.1042/bj1930907; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Hill SA, 1996, BLOOD, V87, P5061, DOI 10.1182/blood.V87.12.5061.bloodjournal87125061; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; HWANG DL, 1992, REGUL PEPTIDES, V37, P95, DOI 10.1016/0167-0115(92)90658-H; IRUELAARISPE ML, 1993, DEV DYNAM, V197, P40, DOI 10.1002/aja.1001970105; JAFFE EA, 1982, NATURE, V295, P246, DOI 10.1038/295246a0; KADISH JL, 1979, TISSUE CELL, V11, P99, DOI 10.1016/0040-8166(79)90010-7; KAREY KP, 1989, BLOOD, V74, P1093; KAREY KP, 1989, BLOOD, V74, P1084; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Lijnen HR, 1998, BIOCHEMISTRY-US, V37, P4699, DOI 10.1021/bi9731798; Lind S.E., 1995, BLOOD PRINCIPLES PRA, P949; MAIONE TE, 1991, CANCER RES, V51, P2077; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; NACHMAN RL, 1976, J BIOL CHEM, V251, P4514; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; O'Reilly MS, 1999, SCIENCE, V285, P1926, DOI 10.1126/science.285.5435.1926; O'Reilly MS, 1999, J BIOL CHEM, V274, P29568, DOI 10.1074/jbc.274.41.29568; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Panetti TS, 1999, J BIOL CHEM, V274, P430, DOI 10.1074/jbc.274.1.430; Papapetropoulos A, 1999, LAB INVEST, V79, P213; Patterson BC, 1997, J BIOL CHEM, V272, P28823, DOI 10.1074/jbc.272.46.28823; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; PLOW EF, 1981, BLOOD, V58, P1069; RABBISABILE S, 1996, FIBRINOLYSIS, V7, P237; Rhim TY, 1998, BIOCHEM BIOPH RES CO, V252, P513, DOI 10.1006/bbrc.1998.9682; ROBERTS AB, 1989, AM REV RESPIR DIS, V140, P1126, DOI 10.1164/ajrccm/140.4.1126; Rosen EM, 1997, CIBA F SYMP, V212, P215; Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26775; SHIMA N, 1991, CELL BIOL INT REP, V15, P397, DOI 10.1016/0309-1651(91)90128-6; Stack MS, 1999, BIOCHEM J, V340, P77, DOI 10.1042/0264-6021:3400077; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; TAYLOR S, 1982, NATURE, V297, P307, DOI 10.1038/297307a0; Thiagarajan P, 1996, BIOCHEMISTRY-US, V35, P4169, DOI 10.1021/bi952532b; TSOPANOGLOU NE, 1993, AM J PHYSIOL, V264, pC1302, DOI 10.1152/ajpcell.1993.264.5.C1302; UEKI N, 1992, BIOCHIM BIOPHYS ACTA, V1137, P189; Vailhe B, 1997, IN VITRO CELL DEV-AN, V33, P763; Wartiovaara U, 1998, THROMB HAEMOSTASIS, V80, P171, DOI 10.1055/s-0037-1615158	67	256	275	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1521	1524		10.1074/jbc.275.3.1521	http://dx.doi.org/10.1074/jbc.275.3.1521			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636838	hybrid			2022-12-27	WOS:000084940000001
J	Crambert, G; Hasler, U; Beggah, AT; Yu, CL; Modyanov, NN; Horisberger, JD; Lelievre, L; Geering, K				Crambert, G; Hasler, U; Beggah, AT; Yu, CL; Modyanov, NN; Horisberger, JD; Lelievre, L; Geering, K			Transport and pharmacological properties of nine different human Na,K-ATPase isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; ENZYMATIC-PROPERTIES; XENOPUS-OOCYTES; ALPHA-SUBUNIT; INTRACELLULAR-TRANSPORT; FUNCTIONAL EXPRESSION; ADHESION MOLECULE; SODIUM PUMPS; HUMAN-HEART; ISOFORMS	Na,K-ATPase plays a crucial role in cellular ion homeostasis and is the pharmacological receptor for distalis in man. Nine different human Na,K-ATPase isozymes, composed of 3 alpha and beta isoforms, were expressed in Xenopus oocytes and were analyzed for their transport and pharmacological properties. According to ouabain binding and K+-activated pump current measurements, all human isozymes are functional but differ in their turnover rates depending on the cu isoform, On the other hand, variations in external K+ activation are determined by a cooperative interaction mechanism between alpha and beta isoforms with alpha 2-beta 2 complexes having the lowest apparent K+ affinity, alpha Isoforms influence the apparent internal Na+ affinity in the order alpha 1 > alpha 2 > alpha 3 and the voltage dependence in the order alpha 2 > alpha 1 > alpha 3. All human Na,K-ATPase isozymes have a similar, high affinity for ouabain, However, alpha 2-beta isozymes exhibit more rapid ouabain association as well as dissociation rate constants than alpha 1-beta and alpha 3-beta isozymes, Finally, isoform-specific differences exist in the K+/ouabain antagonism which may protect alpha 1 but not alpha 2 or alpha 3 from digitalis inhibition at physiological K+ levels. In conclusion, our study reveals several new functional characteristics of human Na,K-ATPase isozymes which help to better understand their role in ion homeostasis in different tissues and in digitalis action and toxicity.	Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Univ Paris 07, Lab Pharmacol Transports Ion Membranaires, F-75251 Paris 05, France; Med Coll Ohio, Dept Pharmacol, Toledo, OH 43614 USA	University of Lausanne; UDICE-French Research Universities; Universite Paris Cite	Geering, K (corresponding author), Univ Lausanne, Inst Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.		Horisberger, Jean-Daniel/A-2538-2009	Crambert, Gilles/0000-0001-7065-9124	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM054997] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36573] Funding Source: Medline; NIGMS NIH HHS [GM-54997] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abriel H, 1999, BBA-BIOMEMBRANES, V1418, P85, DOI 10.1016/S0005-2736(99)00025-5; ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; ADAMS RJ, 1982, NATURE, V296, P167, DOI 10.1038/296167a0; AZUMA KK, 1993, AM J PHYSIOL, V265, pC680, DOI 10.1152/ajpcell.1993.265.3.C680; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BRAUGHLER JM, 1977, BIOCHIM BIOPHYS ACTA, V481, P313, DOI 10.1016/0005-2744(77)90265-0; BROWN L, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1314; BURGENERKAIRUZ P, 1991, FEBS LETT, V290, P83, DOI 10.1016/0014-5793(91)81231-V; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Crambert G, 1997, ANN NY ACAD SCI, V834, P97, DOI 10.1111/j.1749-6632.1997.tb52229.x; DEPOVER A, 1979, BIOCHEM PHARMACOL, V28, P3051, DOI 10.1016/0006-2952(79)90612-9; ERDMANN E, 1983, EUR HEART J, V4, P61, DOI 10.1093/eurheartj/4.suppl_A.61; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; Geering K, 1997, CURR OPIN NEPHROL HY, V6, P434, DOI 10.1097/00041552-199709000-00005; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GRIFFITHS NM, 1991, BRIT J PHARMACOL, V104, P419, DOI 10.1111/j.1476-5381.1991.tb12445.x; Hasler U, 1998, J BIOL CHEM, V273, P30826, DOI 10.1074/jbc.273.46.30826; HAUGER R, 1985, J NEUROCHEM, V44, P1704, DOI 10.1111/j.1471-4159.1985.tb07157.x; HORISBERGER J, 1994, NA KATPASE STRUCTURE; HORISBERGER JD, 1991, P NATL ACAD SCI USA, V88, P8397, DOI 10.1073/pnas.88.19.8397; JAISSER F, 1994, J GEN PHYSIOL, V103, P605, DOI 10.1085/jgp.103.4.605; JAUNIN P, 1992, J BIOL CHEM, V267, P577; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; KAWAKAMI K, 1986, NUCLEIC ACIDS RES, V14, P2833, DOI 10.1093/nar/14.7.2833; KAWAKAMI K, 1986, J BIOCHEM-TOKYO, V100, P389, DOI 10.1093/oxfordjournals.jbchem.a121726; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONOUGH AA, 1995, J MOL CELL CARDIOL, V27, P1001; MAIXENT JM, 1987, J BIOL CHEM, V262, P6842; MARTINVASALLO P, 1989, J BIOL CHEM, V264, P4613; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MODYANOV NN, 1995, AM J PHYSIOL-CELL PH, V269, pC992, DOI 10.1152/ajpcell.1995.269.4.C992; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Repke KRH, 1997, DRUG DISCOV TODAY, V2, P110, DOI 10.1016/S1359-6446(97)01001-5; Ruiz A, 1996, GENE, V176, P237, DOI 10.1016/0378-1119(96)00258-2; SCHMALZING G, 1992, J BIOL CHEM, V267, P20212; Schmalzing G, 1997, P NATL ACAD SCI USA, V94, P1136, DOI 10.1073/pnas.94.4.1136; Schmidt TA, 1997, DAN MED BULL, V44, P499; SHAMRAJ OI, 1993, CARDIOVASC RES, V27, P2229, DOI 10.1093/cvr/27.12.2229; SHULL MM, 1989, J BIOL CHEM, V264, P17532; SHYJAN AW, 1990, P NATL ACAD SCI USA, V87, P1178, DOI 10.1073/pnas.87.3.1178; SMITH T W, 1988, New England Journal of Medicine, V318, P358; SVERDLOV ED, 1987, DOKL BIOCH, V297, P426; SWEADNER KJ, 1985, J BIOL CHEM, V260, P1508; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; TUCK ML, 1987, HYPERTENSION, V10, P204, DOI 10.1161/01.HYP.10.2.204; Wang JN, 1996, J CLIN INVEST, V98, P1650, DOI 10.1172/JCI118960; WHITSETT JA, 1980, AM J PHYSIOL, V238, pE38, DOI 10.1152/ajpendo.1980.238.1.E38; Yu CL, 1997, ARCH BIOCHEM BIOPHYS, V345, P143, DOI 10.1006/abbi.1997.0255	51	344	356	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1976	1986		10.1074/jbc.275.3.1976	http://dx.doi.org/10.1074/jbc.275.3.1976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636900	hybrid			2022-12-27	WOS:000084940000063
J	Foster, DB; Shen, LH; Kelly, J; Thibault, P; Van Eyk, JE; Mak, AS				Foster, DB; Shen, LH; Kelly, J; Thibault, P; Van Eyk, JE; Mak, AS			Phosphorylation of caldesmon by p21-activated kinase - Implications for the Ca2+ sensitivity of smooth muscle contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATPASE ACTIVITY; MYOSIN SUBFRAGMENT-1; CALMODULIN-BINDING; HEAVY-MEROMYOSIN; RHO-KINASE; ACTIN; PROTEIN; SITES; ACTIVATION; IDENTIFICATION	We have previously shown that pal-activated kinase, PAK, induces Ca2+-independent contraction of Triton-skinned smooth muscle with concomitant increase in phosphorylation of caldesmon and desmin but not myosin-regulatory light chain (Van Eyk, J, E,, Arrell, D, K,, Foster, D, B., Strauss, J, D,, Heinonen, T, Y,, Furmaniak-Kazmierczak, E,, Cote, G. P,, and Mak, A. S, (1998) J, Biol, Chem. 273, 23433-23439), In this study, we provide biochemical evidence implicating a role for PAK in Ca2+-independent contraction of smooth muscle via phosphorylation of caldesmon, Mass spectroscopy data show that stoichiometric phosphorylation occurs at Ser(657) and Ser(687) abutting the calmodulin-binding sites A and B of chicken gizzard caldesmon, respectively. Phosphorylation of Ser(657) and Ser(687) has an important functional impact on caldesmon, PAK-phosphorylation reduces binding of caldesmon to calmodulin by about 10-fold whereas binding of calmodulin to caldesmon partially inhibits PAK phosphorylation, Phosphorylated caldesmon displays a modest reduction in affinity for actin-tropomyosin but is significantly less effective in inhibiting actin-activated S1 ATPase activity in the presence of tropomyosin, We conclude that PAK-phosphorylation of caldesmon at the calmodulin-binding sites modulates caldesmon inhibition of actin-myosin ATPase activity and may, in concert with the actions of Rho-kinase, contribute to the regulation of Ca2+ sensitivity of smooth muscle contraction.	Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada	Queens University - Canada; Queens University - Canada; National Research Council Canada	Van Eyk, JE (corresponding author), Queens Univ, Dept Physiol, 4th Floor,Botterell Hall, Kingston, ON K7L 3N6, Canada.		Foster, D. Brian/S-9108-2019; Foster, D. Brian/C-6350-2009	Foster, D. Brian/0000-0002-9290-9590; Foster, D. Brian/0000-0002-9290-9590; Thibault, Pierre/0000-0001-5993-0331				ADAM LP, 1993, FEBS LETT, V322, P56, DOI 10.1016/0014-5793(93)81110-L; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; BRETSCHER A, 1984, J BIOL CHEM, V259, P2873; Brzeska H, 1997, P NATL ACAD SCI USA, V94, P1092, DOI 10.1073/pnas.94.4.1092; Chacko S, 1987, Prog Clin Biol Res, V245, P143; CHALOVICH JM, 1987, J BIOL CHEM, V262, P5711; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CHILDS TJ, 1992, J BIOL CHEM, V267, P22853; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Graether SP, 1997, BIOCHEMISTRY-US, V36, P364, DOI 10.1021/bi962008k; GREENE LE, 1983, BIOCHEMISTRY-US, V22, P530, DOI 10.1021/bi00272a002; HEMRIC ME, 1990, J BIOL CHEM, V265, P19672; IKEBE M, 1990, J BIOL CHEM, V265, P17607; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Krymsky MA, 1999, FEBS LETT, V452, P254, DOI 10.1016/S0014-5793(99)00641-9; LASH JA, 1986, J BIOL CHEM, V261, P6155; MANI RS, 1992, BIOCHEMISTRY-US, V31, P11896, DOI 10.1021/bi00162a031; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARSTON SB, 1994, J BIOL CHEM, V269, P8134; MARSTON SB, 1991, BIOCHEM J, V279, P1; MARSTON SB, 1996, BIOCH SMOOTH MUSCLE, P77; NGAI PK, 1984, J BIOL CHEM, V259, P3656; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; Pfitzer G, 1998, ACTA PHYSIOL SCAND, V164, P449, DOI 10.1111/j.1365-201X.1998.tb10698.x; PRITCHARD K, 1989, BIOCHEM J, V257, P839, DOI 10.1042/bj2570839; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SUTHERLAND C, 1994, J MUSCLE RES CELL M, V15, P440, DOI 10.1007/BF00122118; TANAKA T, 1990, EUR J BIOCHEM, V188, P495, DOI 10.1111/j.1432-1033.1990.tb15427.x; Tuazon PT, 1998, BIOCHEMISTRY-US, V37, P17024, DOI 10.1021/bi982103o; Van Eyk JE, 1998, J BIOL CHEM, V273, P23433, DOI 10.1074/jbc.273.36.23433; VanEyk JE, 1997, J BIOL CHEM, V272, P10529; VELAZ L, 1990, J BIOL CHEM, V265, P2929; WANG CLA, 1991, J BIOL CHEM, V266, P9166; WATSON MH, 1990, J BIOL CHEM, V265, P18860; Zhou N, 1997, BIOCHEMISTRY-US, V36, P2817, DOI 10.1021/bi9625713	40	75	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1959	1965		10.1074/jbc.275.3.1959	http://dx.doi.org/10.1074/jbc.275.3.1959			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636898	hybrid			2022-12-27	WOS:000084940000061
J	Seo, B; Choy, EW; Maudsley, S; Miller, WE; Wilson, BA; Luttrell, LM				Seo, B; Choy, EW; Maudsley, S; Miller, WE; Wilson, BA; Luttrell, LM			Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G(q)/(11)-dependent transactivation of the epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; COUPLED RECEPTORS; TYROSINE PHOSPHORYLATION; POTENT MITOGEN; EGF RECEPTOR; DERMONECROTIC TOXIN; DISTINCT PATHWAYS; SIGNALING PATHWAY; ESCHERICHIA-COLI; ION-CHANNEL	The dermatonecrotic toxin produced by Pasteurella multocida is one of the most potent mitogenic substances known for fibroblasts in vitro. Exposure to recombinant P. multocida toxin (rPMT) causes phospholipase C-mediated hydrolysis of inositol phospholipids, calcium mobilization, and activation of protein kinase C via a poorly characterized mechanism involving G(q/11) family heterotrimeric G proteins. To determine whether the regulation of G protein pathways contributes to the mitogenic effects of rPMT, we have examined the mechanism whereby rPMT stimulates the Erk mitogen-activated protein kinase cascade in cultured HEK-293 cells. Treatment with rPMT resulted in a dose and time-dependent increase in Erk 1/2 phosphorylation that paralleled its stimulation of inositol phospholipid hydrolysis. Both rPMT- and alpha-thrombin receptor- stimulated Erk phosphorylation were selectively blocked by cellular expression of two peptide inhibitors of G(q/11) signaling, the dominant negative mutant G protein-coupled receptor kinase, GRK2(K220R), and the G alpha(q) carboxyl-terminal peptide, G alpha(q)-(305359). Like alpha-thrombin receptor-mediated Erk activation, the effect of rPMT was insensitive to the protein kinase C inhibitor GF109203X, but was blocked by the epidermal growth factor receptor-specific tyrphostin, AG1478 and by dominant negative mutants of mSos1 and Ha-Ras, These data indicate that rPMT employs G(q/11) family heterotrimeric G proteins to induce Ras-dependent Erk activation via protein kinase C-independent "transactivation" of the epidermal growth factor receptor.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	Duke University; University of Illinois System; University of Illinois Urbana-Champaign	Luttrell, LM (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3821, Durham, NC 27710 USA.		Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Luttrell, Louis/0000-0003-2805-6949	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038396, R01AI038396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002352, R56DK055524, R01DK055524] Funding Source: NIH RePORTER; NIAID NIH HHS [R29 AI038396, AI38396] Funding Source: Medline; NIDDK NIH HHS [DK02352, DK55524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BUYS WECM, 1990, NUCLEIC ACIDS RES, V18, P2815, DOI 10.1093/nar/18.9.2815; Carter G R, 1967, Adv Vet Sci, V11, P321; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Diviani D, 1996, J BIOL CHEM, V271, P5049; DUDET LI, 1996, INFECT IMMUN, V66, P5636; Eguchi S, 1999, HYPERTENSION, V33, P201, DOI 10.1161/01.HYP.33.1.201; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; FALBO V, 1993, INFECT IMMUN, V61, P4909, DOI 10.1128/IAI.61.11.4909-4914.1993; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; HAWES BE, 1994, J BIOL CHEM, V269, P15776; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; HIGGINS TE, 1992, P NATL ACAD SCI USA, V89, P4240, DOI 10.1073/pnas.89.10.4240; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Lacerda HM, 1996, J BIOL CHEM, V271, P439, DOI 10.1074/jbc.271.1.439; LAX AJ, 1990, FEBS LETT, V277, P59, DOI 10.1016/0014-5793(90)80809-W; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; Luttrell LM, 1997, J BIOL CHEM, V272, P31648, DOI 10.1074/jbc.272.50.31648; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; Mullan PB, 1996, INFECT IMMUN, V64, P959, DOI 10.1128/IAI.64.3.959-965.1996; MURPHY AC, 1992, J BIOL CHEM, V267, P25296; OSWALD E, 1994, P NATL ACAD SCI USA, V91, P3814, DOI 10.1073/pnas.91.9.3814; PETTIT RK, 1993, LAB INVEST, V69, P94; RodriguezFernandez JL, 1996, J BIOL CHEM, V271, P27895, DOI 10.1074/jbc.271.44.27895; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; STADDON JM, 1991, J BIOL CHEM, V266, P4840; STADDON JM, 1990, J BIOL CHEM, V265, P11841; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Wilson BA, 1999, INFECT IMMUN, V67, P80, DOI 10.1128/IAI.67.1.80-87.1999; Wilson BA, 1997, J BIOL CHEM, V272, P1268, DOI 10.1074/jbc.272.20.12961; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767; Zwick E, 1999, J BIOL CHEM, V274, P20989, DOI 10.1074/jbc.274.30.20989	42	74	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2239	2245		10.1074/jbc.275.3.2239	http://dx.doi.org/10.1074/jbc.275.3.2239			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636931	hybrid			2022-12-27	WOS:000084940000094
J	Witte, S; Villalba, M; Bi, K; Liu, YH; Isakov, N; Altman, A				Witte, S; Villalba, M; Bi, K; Liu, YH; Isakov, N; Altman, A			Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappa B pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-THETA; T-CELLS; SIGNAL-TRANSDUCTION; INNATE IMMUNITY; BINDING-PROTEIN; ACTIVATION; FAMILY; AP-1; LYMPHOCYTES; ASSOCIATION	Protein kinase C-theta (PKC theta) is a Ca2+-independent PKC isoform that is selectively expressed in T lymphocytes (and muscle), and is thought to play an important role in T cell receptor-induced activation. To gain a better understanding of the function and regulation of PRC theta, we have employed the yeast two-hybrid system to identify PKC theta-interacting proteins. We report the isolation and characterization of a cDNA encoding a novel 335-amino acid (37.5-kDa) PKC theta-interacting protein termed PICOT (for (P) under bar KC-(i) under bar nteracting (c) under bar ousin (o) under bar f (t) under bar hioredoxin). PICOT is expressed in various tissues, including in T cells, where it colocalizes with PKC theta. PICOT displays an N-terminal thioredoxin homology domain, which is required for the interaction with PKC, Comparison of the unique C-terminal region of PICOT with expressed sequence tag data bases revealed two tandem repeats of a novel domain that is highly conserved from plants to mammals. Transient overexpression of full-length PICOT (but not its N- or C-terminal fragments) in T cells inhibited the activation of c-Jun N-terminal kinase (but not extracellular signal-regulated kinase), and the transcription factors AP-1 or NF-kappa B. These findings suggest that PICOT and its evolutionary conserved homologues may interact with PKC-related kinases in multiple organisms and, second, that it plays a role in regulating the function of the thioredoxin system.	La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA; Ben Gurion Univ Negev, Dept Microbiol, IL-84105 Beer Sheva, Israel	La Jolla Institute for Immunology; Ben Gurion University	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.		ISAKOV, NOAH/F-1659-2012; villalba, martin/N-7123-2017; villalba, martin/AAG-2604-2020	villalba, martin/0000-0002-4385-4888; villalba, martin/0000-0002-4385-4888; Isakov, Noah/0000-0002-1412-0957	NATIONAL CANCER INSTITUTE [R01CA035299] Funding Source: NIH RePORTER; NCI NIH HHS [CA35299] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAIER G, 1993, J BIOL CHEM, V268, P4997; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; DiazMeco MT, 1996, MOL CELL BIOL, V16, P105; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; GOLEMIS EA, 1997, PROTOCOLS MOL BIOL, V3; Hayashi S, 1997, NUCLEIC ACIDS RES, V25, P4035, DOI 10.1093/nar/25.20.4035; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Kang SW, 1998, J BIOL CHEM, V273, P6303, DOI 10.1074/jbc.273.11.6303; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KARIN M, 1997, NEW ENGL J MED, V336, P1066; Kruse M, 1996, J MOL EVOL, V43, P374; Liu YC, 1997, J BIOL CHEM, V272, P168; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meller N, 1998, STEM CELLS, V16, P178, DOI 10.1002/stem.160178; Meller N, 1996, MOL CELL BIOL, V16, P5782; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Muller JM, 1997, METHODS, V11, P301, DOI 10.1006/meth.1996.0424; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; POWIS G, 1994, ONCOL RES, V6, P539; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Sokolova M, 1997, FEBS LETT, V400, P201, DOI 10.1016/S0014-5793(96)01380-4; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Subramaniam R, 1997, PLANT CELL, V9, P653, DOI 10.1105/tpc.9.4.653; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Witte S, 1997, J BIOL CHEM, V272, P22243, DOI 10.1074/jbc.272.35.22243	39	152	164	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1902	1909		10.1074/jbc.275.3.1902	http://dx.doi.org/10.1074/jbc.275.3.1902			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636891	hybrid			2022-12-27	WOS:000084940000054
J	Han, JH; Hajjar, DP; Tauras, JM; Feng, JW; Gotto, AM; Nicholson, AC				Han, JH; Hajjar, DP; Tauras, JM; Feng, JW; Gotto, AM; Nicholson, AC			Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA; GENE-EXPRESSION; OXIDIZED LDL; FACTOR-BETA; HUMAN ATHEROSCLEROSIS; SIGNAL-TRANSDUCTION; MEMBRANE-PROTEIN; SR-BI; BINDING	CD36, the macrophage type B scavenger receptor, binds and internalizes oxidized low density lipoprotein, a hey event in the development of macrophage foam cells within atherosclerotic lesions. Expression of CD36 in monocyte/macrophages is dependent on differentiation status and exposure to soluble mediators. In this study, we investigated the effect of transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 2 on the expression of CD36 in macrophages, Treatment of phorbol ester-differentiated THP-1 macrophages with TGF-beta 1 or TGF-beta 2 significantly decreased expression of CD36 mRNA and surface protein. TGF-beta 1/TGF-beta 2 also inhibited CD36 mRNA expression induced by oxidized low density lipoprotein and 15-deoxy Delta(12,14) prostaglandin J(2), a peroxisome proliferator-activated receptor (PPAR)-gamma ligand, suggesting that the TGF-beta 1/TGF-beta 2 down-regulated CD36 expression by inactivating PPAR-gamma-mediated signaling. TGF-beta 1/TGF-beta 2 increased phosphorylation of both mitogen-activated protein (MAP) kinase and PPAR-gamma, whereas NAP kinase inhibitors reversed suppression of CD36 wand inhibited PPAR-gamma phosphorylation induced by TGF-beta 1/TGF-beta 2. Finally, MAP kinase inhibitors alone increased expression of CD36 mRNA and surface protein but had no effect on PPAR-gamma protein levels, Our data demonstrate for the first time that TGF-beta 1 and TGF-beta 2 decrease expression of CD36 by a mechanism involving phosphorylation of MAP kinase, subsequent MAP kinase phosphorylation of PPAR-gamma, and a decrease in CD36 gene transcription by phosphorylated PPAR-gamma.	Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Ctr Vasc Biol, New York, NY 10021 USA	Cornell University; Cornell University	Nicholson, AC (corresponding author), Cornell Univ, Coll Med, Dept Pathol, A-626,1300 York Ave, New York, NY 10021 USA.	nicholso@mail.med.cornell.edu			NHLBI NIH HHS [P50-HL56987] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056987] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; Atfi A, 1997, J BIOL CHEM, V272, P24731, DOI 10.1074/jbc.272.40.24731; BARNWELL JW, 1985, J IMMUNOL, V135, P3494; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Engel ME, 1998, J CELL BIOCHEM, P111; FOGELMAN AM, 1988, J CELL SCI, P135; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GOWN AM, 1986, AM J PATHOL, V125, P191; GREENWALT DE, 1992, BLOOD, V80, P1105; Han JH, 1999, J LIPID RES, V40, P830; Han JH, 1997, J BIOL CHEM, V272, P21654, DOI 10.1074/jbc.272.34.21654; Hartsough MT, 1996, J BIOL CHEM, V271, P22368, DOI 10.1074/jbc.271.37.22368; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; LEFEBVRE P, 1995, J BIOL CHEM, V270, P10806, DOI 10.1074/jbc.270.18.10806; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LI YS, 1993, MOL CELL BIOCHEM, V126, P61, DOI 10.1007/BF01772208; LIN KH, 1992, P NATL ACAD SCI USA, V89, P7737, DOI 10.1073/pnas.89.16.7737; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakagawa T, 1998, ARTERIOSCL THROM VAS, V18, P1350, DOI 10.1161/01.ATV.18.8.1350; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; RAMPRASAD MP, 1995, P NATL ACAD SCI USA, V92, P9580, DOI 10.1073/pnas.92.21.9580; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; STEINBERG D, 1987, CIRCULATION, V76, P508, DOI 10.1161/01.CIR.76.3.508; TALLE MA, 1983, CELL IMMUNOL, V78, P83, DOI 10.1016/0008-8749(83)90262-9; TANDON NN, 1989, J BIOL CHEM, V264, P7576; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Xue JC, 1996, MOL CELL BIOL, V16, P1567; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yesner LM, 1996, ARTERIOSCL THROM VAS, V16, P1019, DOI 10.1161/01.ATV.16.8.1019	48	154	162	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1241	1246		10.1074/jbc.275.2.1241	http://dx.doi.org/10.1074/jbc.275.2.1241			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625669	hybrid			2022-12-27	WOS:000084836600073
J	LaPointe, CF; Taylor, RK				LaPointe, CF; Taylor, RK			The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR PROTEIN SECRETION; PILIN LEADER PEPTIDASE; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; N-METHYLTRANSFERASE; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; BIFUNCTIONAL ENZYME; CATALYTIC MECHANISM; TOXIN SECRETION	Type 4 prepilins or prepilin-like-proteins are secreted by a wide range of bacterial species and are required for a variety of functions including type 4 pilus formation, toxin and other enzyme secretion, gene transfer, and biofilm formation. A distinctive feature of these proteins is the presence of a specialized leader peptide that is cleaved off by a cognate membrane-bound type 4 prepilin peptidase (TFPP) during the process of secretion. In this report we show that the TFPPs represent a novel family of bilobed aspartate proteases that is unlike any other protease. The active site pairs of aspartic acids of the two TFPPs in Vibrio cholerae are found at positions 125 and 189 of TcpJ and 147 and 212 of VcpD. Corresponding aspartate residues are completely conserved throughout this extensive peptidase family.	Dartmouth Med Sch, Dept Microbiol, Hanover, NH 03755 USA	Dartmouth College	Taylor, RK (corresponding author), Dartmouth Med Sch, Dept Microbiol, Hanover, NH 03755 USA.	ronald.k.taylor@dartmouth.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023096, F31AI009635] Funding Source: NIH RePORTER; NIAID NIH HHS [R0I AI 23096, AI F31-09635] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Dubnau D, 1997, GENE, V192, P191, DOI 10.1016/S0378-1119(96)00804-9; HOARE DG, 1966, J AM CHEM SOC, V88, P2057, DOI 10.1021/ja00961a045; Hu NT, 1995, MOL MICROBIOL, V18, P769, DOI 10.1111/j.1365-2958.1995.mmi_18040769.x; Inagami T., 1981, BIOCH REGULATION BLO, P39; KAUFMAN MR, 1991, GENE DEV, V5, P1834, DOI 10.1101/gad.5.10.1834; Lory S, 1997, GENE, V192, P117, DOI 10.1016/S0378-1119(96)00830-X; Marsh JW, 1998, MOL MICROBIOL, V29, P1481, DOI 10.1046/j.1365-2958.1998.01031.x; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; Oda K, 1998, ADV EXP MED BIOL, V436, P349; Pepe CM, 1996, MOL MICROBIOL, V19, P857, DOI 10.1046/j.1365-2958.1996.431958.x; Pepe JC, 1998, J BIOL CHEM, V273, P19120, DOI 10.1074/jbc.273.30.19120; Pestova EV, 1998, J BACTERIOL, V180, P2701, DOI 10.1128/JB.180.10.2701-2710.1998; Pfau JD, 1998, J BACTERIOL, V180, P4724, DOI 10.1128/JB.180.17.4724-4733.1998; PUGSLEY AP, 1990, MOL MICROBIOL, V4, P365, DOI 10.1111/j.1365-2958.1990.tb00604.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Rawlings ND, 1999, NUCLEIC ACIDS RES, V27, P325, DOI 10.1093/nar/27.1.325; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P105; REEVES PJ, 1994, MOL MICROBIOL, V12, P445, DOI 10.1111/j.1365-2958.1994.tb01033.x; RUSSEL M, 1984, J BACTERIOL, V159, P1034, DOI 10.1128/JB.159.3.1034-1039.1984; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; SANKARAN K, 1995, METHOD ENZYMOL, V248, P169; SHAW CE, 1990, INFECT IMMUN, V58, P3042, DOI 10.1128/IAI.58.9.3042-3049.1990; STROM MS, 1991, J BACTERIOL, V173, P1175, DOI 10.1128/jb.173.3.1175-1180.1991; STROM MS, 1987, J BACTERIOL, V169, P3181, DOI 10.1128/jb.169.7.3181-3188.1987; STROM MS, 1993, J BIOL CHEM, V268, P15788; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Takahashi K, 1998, ADV EXP MED BIOL, V436, P275; TAKAHASHI K, 1991, ADV EXP MED BIOL, V306, P203; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; TSCHANTZ WR, 1993, J BIOL CHEM, V268, P27349; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	37	146	152	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1502	1510		10.1074/jbc.275.2.1502	http://dx.doi.org/10.1074/jbc.275.2.1502			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625704	hybrid			2022-12-27	WOS:000084836600108
J	Pile, LA; Cartwright, IL				Pile, LA; Cartwright, IL			GAGA factor-dependent transcription and establishment of DNase hypersensitivity are independent and unrelated events in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HEAT-SHOCK ELEMENTS; PROMOTER IN-VITRO; PROTEIN INTERACTIONS; HSP70 PROMOTER; DROSOPHILA-MELANOGASTER; (CT)N.(GA)N REPEATS; CHROMATIN STRUCTURE; CELL-CYCLE; GENE	Using a Drosophila transgenic system we investigated the ability of GAGA factor, a putative anti-repressor, to modulate transcription-related events in the absence or presence of a bona fide activator, the Adf-1 transcription factor. In contrast to previous in vitro and in vivo data linking the binding of GAGA factor to the acquisition of DNase hypersensitivity at heat shock promoters, we observed that inserting multiple GAGA binding motifs adjacent to a minimal alcohol dehydrogenase (Adh) promoter led to strongly elevated embryonic transcription without creation of a promoter-associated DNase-hypersensitive (DH) site. Establishment of DNase hypersensitivity required the presence of both GAG;A and Adf-1 binding sites and was accompanied by a further, synergistic increase in transcription. Because Adf-1 is capable neither of establishing a DH site nor of promoting efficient transcription by itself in embryos, it is likely that DH site formation depends on a GAGA factor-mediated binding of Adf-1 to chromatin, perhaps facilitated by a locally remodeled downstream promoter region. More generally we suggest that GAGA factor-binding sequences may operate in a promoter-specific context, with transcriptional activation, polymerase pausing, and/or DH site formation critically dependent on the nature of the sequences (and their binding partners) linked in cis.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Cartwright, IL (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Bethesda Ave, Cincinnati, OH 45267 USA.				NATIONAL CANCER INSTITUTE [T32CA059268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA59268] Funding Source: Medline; NIEHS NIH HHS [P30-ES06096] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agianian B, 1999, J MOL BIOL, V285, P527, DOI 10.1006/jmbi.1998.2355; Benjamin LR, 1998, NUCLEIC ACIDS RES, V26, P1051, DOI 10.1093/nar/26.4.1051; Benyajati C, 1997, NUCLEIC ACIDS RES, V25, P3345, DOI 10.1093/nar/25.16.3345; Bhat KM, 1996, DEVELOPMENT, V122, P1113; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; CARTWRIGHT IL, 1986, MOL CELL BIOL, V6, P779, DOI 10.1128/MCB.6.3.779; Cartwright IL, 1999, METHOD ENZYMOL, V304, P462; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Cutler G, 1998, MOL CELL BIOL, V18, P2252, DOI 10.1128/MCB.18.4.2252; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; ENGLAND BP, 1992, P NATL ACAD SCI USA, V89, P683, DOI 10.1073/pnas.89.2.683; ENGLAND BP, 1990, J BIOL CHEM, V265, P5086; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Gao J, 1998, NUCLEIC ACIDS RES, V26, P5394, DOI 10.1093/nar/26.23.5394; Geyer PK, 1997, CURR OPIN GENET DEV, V7, P242, DOI 10.1016/S0959-437X(97)80134-7; GILMOUR DS, 1989, SCIENCE, V245, P1487, DOI 10.1126/science.2781290; GLASER RL, 1990, J MOL BIOL, V211, P751, DOI 10.1016/0022-2836(90)90075-W; GRANOK H, 1995, CURR BIOL, V5, P238, DOI 10.1016/S0960-9822(95)00048-0; Han W, 1998, MOL CELL BIOL, V18, P3384, DOI 10.1128/MCB.18.6.3384; HEBERLEIN U, 1985, CELL, V41, P965, DOI 10.1016/S0092-8674(85)80077-5; JACKSON JR, 1992, NUCLEIC ACIDS RES, V20, P5413, DOI 10.1093/nar/20.20.5413; JENUWEIN T, 1993, GENE DEV, V7, P2016, DOI 10.1101/gad.7.10.2016; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KERRIGAN LA, 1991, J BIOL CHEM, V266, P574; LANEY JD, 1992, GENE DEV, V6, P1531, DOI 10.1101/gad.6.8.1531; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Li BY, 1996, MOL CELL BIOL, V16, P5433; LU Q, 1992, J MOL BIOL, V225, P985, DOI 10.1016/0022-2836(92)90099-6; LU Q, 1993, MOL CELL BIOL, V13, P2802, DOI 10.1128/MCB.13.5.2802; Mason PB, 1997, J BIOL CHEM, V272, P33227, DOI 10.1074/jbc.272.52.33227; McCall K, 1996, EMBO J, V15, P569, DOI 10.1002/j.1460-2075.1996.tb00389.x; Okada M, 1998, MOL CELL BIOL, V18, P2455, DOI 10.1128/MCB.18.5.2455; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; PEIFER M, 1988, P NATL ACAD SCI USA, V85, P9650, DOI 10.1073/pnas.85.24.9650; Platero JS, 1998, J CELL BIOL, V140, P1297; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RAFF JW, 1994, EMBO J, V13, P5977, DOI 10.1002/j.1460-2075.1994.tb06943.x; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sambrook J., 2002, MOL CLONING LAB MANU; SANDALTZOPOULOS R, 1995, NUCLEIC ACIDS RES, V23, P2479, DOI 10.1093/nar/23.13.2479; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; SOELLER WC, 1993, MOL CELL BIOL, V13, P7961, DOI 10.1128/MCB.13.12.7961; Thummel CS, 1992, DROS INF SERV, V71, P150; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1997, CURR OPIN GENET DEV, V7, P182, DOI 10.1016/S0959-437X(97)80127-X; Vashee S, 1998, CURR BIOL, V8, P452, DOI 10.1016/S0960-9822(98)70179-4; WALL G, 1995, EMBO J, V14, P1727, DOI 10.1002/j.1460-2075.1995.tb07162.x; Weber JA, 1997, MOL CELL BIOL, V17, P3799, DOI 10.1128/MCB.17.7.3799; Wilkins RC, 1998, NUCLEIC ACIDS RES, V26, P2672, DOI 10.1093/nar/26.11.2672; Wilkins RC, 1999, J MOL BIOL, V285, P515, DOI 10.1006/jmbi.1998.2356; Wilkins RC, 1997, NUCLEIC ACIDS RES, V25, P3963, DOI 10.1093/nar/25.20.3963	56	12	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1398	1404		10.1074/jbc.275.2.1398	http://dx.doi.org/10.1074/jbc.275.2.1398			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625691	hybrid			2022-12-27	WOS:000084836600095
J	Ritchie, S; Boyd, FM; Wong, J; Bonham, K				Ritchie, S; Boyd, FM; Wong, J; Bonham, K			Transcription of the human c-Src promoter is dependent on Sp1, a novel pyrimidine binding factor SPy, and can be inhibited by triplex-forming oligonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; PROTEIN-TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; PROTOONCOGENE; GENE; EXPRESSION; ACTIVATION; PP60C-SRC; CELLS; ELEMENT	The tyrosine kinase pp60(C-src) has been implicated in the regulation of numerous normal physiological processes as well the development of several human cancers. However, the mechanisms regulating its expression have not been addressed. In the present study, we report the presence of two Sp1/Sp3 binding sites and three polypurine:polypyrimidine (Pu:Py) tracts in the c-Src promoter that are essential for controlling expression. We demonstrate that Sp1, but not Sp3, is capable of activating the c-Src promoter and that Sp3 is also capable of inhibiting Sp1-mediated transactivation. The presence of multiple Pu:Py tracts conferred S1 sensitivity on plasmids in vitro, suggesting they are capable of adopting non B-DNA conformations. These tracts specifically bind a nuclear factor we named SPy (Src pyrimidine binding factor), which demonstrates both novel double- and single-stranded binding specificities. Mutations eliminating SPy binding compromised Src transcriptional activity, especially in concert with additional mutations affecting Sp1 binding, suggesting the two factors may cooperate in regulating c-Src expression. Finally, we demonstrate that tripler-forming oligonucleotides designed to target both Sp1 and Spy binding sites can down-regulate c-Src expression in vitro, suggesting a potential therapeutic approach to controlling c-Src expression in diseases where aberrant expression or activity has been documented.	Univ Saskatchewan, Div Oncol, Canc Agcy, Saskatoon Canc Ctr Res Unit, Saskatoon, SK S7N 4H4, Canada; Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 4H4, Canada	University of Saskatchewan; University of Saskatchewan	Bonham, K (corresponding author), Univ Saskatchewan, Div Oncol, Canc Agcy, Saskatoon Canc Ctr Res Unit, 20 Campus Dr, Saskatoon, SK S7N 4H4, Canada.	kbonham@scf.sk.ca						AbuAmer Y, 1997, J CLIN INVEST, V100, P1557, DOI 10.1172/JCI119679; AlunniFabbroni M, 1996, BIOCHEMISTRY-US, V35, P16361, DOI 10.1021/bi961750h; Amaldi F, 1995, BIOCHEM CELL BIOL, V73, P969, DOI 10.1139/o95-104; Babnigg G, 1997, J BIOL CHEM, V272, P29434, DOI 10.1074/jbc.272.47.29434; Bayarsaihan D, 1998, BIOCHEM J, V331, P447, DOI 10.1042/bj3310447; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 1999, ADV CANCER RES, V76, P61; BONHAM K, 1993, ONCOGENE, V8, P1973; Brahmachari SK, 1997, GENE, V190, P17, DOI 10.1016/S0378-1119(97)00034-6; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARTWRIGHT CA, 1993, ONCOGENE, V8, P1033; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; COUREY AJ, 1992, TRANSCRIPTIONAL REGU, V2, P743; Dhalla AK, 1998, BIOCHEM J, V336, P373, DOI 10.1042/bj3360373; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; Ko JL, 1998, J BIOL CHEM, V273, P27678, DOI 10.1074/jbc.273.42.27678; Kovacic B, 1998, J BIOL CHEM, V273, P35185; Krasilnikov AS, 1997, NUCLEIC ACIDS RES, V25, P1339, DOI 10.1093/nar/25.7.1339; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LANNIGAN DA, 1989, P NATL ACAD SCI USA, V86, P863, DOI 10.1073/pnas.86.3.863; Lavrovsky Y, 1996, EUR J BIOCHEM, V238, P582, DOI 10.1111/j.1432-1033.1996.0582z.x; LEBEAU JM, 1991, J NEUROSCI RES, V28, P299, DOI 10.1002/jnr.490280217; Lou H, 1999, MOL CELL BIOL, V19, P78; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; MAJELLO B, 1994, NUCLEIC ACIDS RES, V22, P4914, DOI 10.1093/nar/22.23.4914; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MAZURENKO NN, 1992, EUR J CANCER, V28A, P372, DOI 10.1016/S0959-8049(05)80056-5; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; Muller S, 1999, BIOCHEM BIOPH RES CO, V259, P364, DOI 10.1006/bbrc.1999.0677; Olivas WM, 1996, NUCLEIC ACIDS RES, V24, P1758, DOI 10.1093/nar/24.9.1758; Oosterhuis JH, 1999, J BIOL CHEM, V274, P11708, DOI 10.1074/jbc.274.17.11708; Ritchie S, 1998, ANTISENSE NUCLEIC A, V8, P391, DOI 10.1089/oli.1.1998.8.391; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; Sakatsume O, 1996, J BIOL CHEM, V271, P31322, DOI 10.1074/jbc.271.49.31322; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; TANUMA Y, 1995, MOL CELL BIOL, V15, P517, DOI 10.1128/MCB.15.1.517; THOMAS TJ, 1995, NUCLEIC ACIDS RES, V23, P3594, DOI 10.1093/nar/23.17.3594; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Yu M, 1997, J BIOL CHEM, V272, P29060, DOI 10.1074/jbc.272.46.29060	52	68	70	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					847	854		10.1074/jbc.275.2.847	http://dx.doi.org/10.1074/jbc.275.2.847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625617	hybrid			2022-12-27	WOS:000084836600021
J	Webb, RJ; Khan, YM; East, JM; Lee, AG				Webb, RJ; Khan, YM; East, JM; Lee, AG			The importance of carboxyl groups on the lumenal side of the membrane for the function of the Ca2+-ATPase of sarcoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ADENOSINE-TRIPHOSPHATASE; CALCIUM-ATPASE; BINDING-SITES; TRANSPORT; CA2+; (CA2+-MG2+)-ATPASE; CARBODIIMIDE; FLUORESCENCE; MECHANISM; PHOSPHORYLATION	The conventional model for transport of Ca2+ by the Ca2+-ATPase of skeletal muscle sarcoplasmic reticulum (SR) involves a pair of binding sites for Ca2+ that change upon phosphorylation of the ATPase from being high affinity and exposed to the cytoplasm to being low affinity and exposed to the lumen. However, a number of recent experiments suggest that in fact transport involves two separate pairs of binding sites for Ca2+, one pair exposed to the cytoplasmic side and the other pair exposed to the lumenal side. Here we show that the carbodiimide 1-ethyl-3-[3-(dimethylamino)-propyl] carbodiimide (EDC) is membrane-impermeable, and we use EDC to distinguish between cytoplasmic and lumenal sites of reaction. Modification of the Ca2+-ATPase in sealed SR vesicles with EDC leads to loss of ATPase activity without modification of the pair of high affinity Ca2+-binding sites. Modification of the purified ATPase in unsealed membrane fragments was faster than modification in SR vesicles, suggesting the presence of more quickly reacting lumenal sites. This was confirmed in experiments measuring EDC modification of the ATPase reconstituted randomly into sealed lipid vesicles. Modification of sites on the lumenal face of the ATPase led to loss of the Ca2+-induced increase in phosphorylation by P-i. It is concluded that carboxyl groups on the lumenal side of the ATPase are involved in Ca2+ binding to the lumenal side of the ATPase and that modification of these sites leads to loss of ATPase activity, The presence of MgATP or MgADP leads to faster inhibition of the ATPase by EDC in unsealed membrane fragments than in sealed vesicles, suggesting that binding of MgATP or MgADP to the ATPase leads to a conformational change on the lumenal side of the membrane.	Univ Southampton, Sch Biol Sci, Div Biochem & Mol Biol, Southampton SO16 7PX, Hants, England	University of Southampton	Webb, RJ (corresponding author), Univ Southampton, Sch Biol Sci, Div Biochem & Mol Biol, Southampton SO16 7PX, Hants, England.							Andersson P, 1998, MATER HIGH TEMP, V15, P243, DOI 10.1080/09603409.1998.11689607; CHIESI M, 1981, ARCH BIOCHEM BIOPHYS, V208, P586, DOI 10.1016/0003-9861(81)90547-6; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; COAN C, 1993, FEBS LETT, V335, P33, DOI 10.1016/0014-5793(93)80433-U; Dalton KA, 1999, BIOCHEM J, V342, P431, DOI 10.1042/0264-6021:3420431; Dalton KA, 1998, BIOCHEM J, V329, P637; DEANCOS JG, 1988, BIOCHEMISTRY-US, V27, P1793; DEFORESTA B, 1989, BIOCHEMISTRY-US, V28, P2558, DOI 10.1021/bi00432a032; DEMEIS, 1981, LSARCOPLASMIC RETICU; Duggleby RC, 1999, BIOCHEM J, V339, P351, DOI 10.1042/0264-6021:3390351; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; FORGE V, 1995, J BIOL CHEM, V270, P18271, DOI 10.1074/jbc.270.31.18271; Gonzalez DA, 1996, BBA-BIOENERGETICS, V1276, P188, DOI 10.1016/0005-2728(96)00076-X; GUILLAIN F, 1980, J BIOL CHEM, V255, P2072; HENDERSON IMJ, 1994, BIOCHEM J, V297, P615, DOI 10.1042/bj2970615; JENCKS WP, 1993, BIOCHEMISTRY-US, V32, P7030, DOI 10.1021/bi00078a031; Kaback HR, 1997, Q REV BIOPHYS, V30, P333, DOI 10.1017/S0033583597003387; Khan YM, 1997, BIOCHEM J, V321, P671, DOI 10.1042/bj3210671; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LEVY D, 1992, BIOCHIM BIOPHYS ACTA, V1107, P283, DOI 10.1016/0005-2736(92)90415-I; Lundblad RL., 1995, TECHNIQUES PROTEIN M; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Menguy T, 1998, J BIOL CHEM, V273, P20134, DOI 10.1074/jbc.273.32.20134; MUNKONGE F, 1989, BIOCHIM BIOPHYS ACTA, V979, P113, DOI 10.1016/0005-2736(89)90530-0; MYUNG J, 1994, BIOCHEMISTRY-US, V33, P8775, DOI 10.1021/bi00195a020; NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; PICK U, 1985, EUR J BIOCHEM, V152, P83, DOI 10.1111/j.1432-1033.1985.tb09166.x; STARLING AP, 1993, BIOCHEMISTRY-US, V32, P1593, DOI 10.1021/bi00057a025; STEFANOVA HI, 1992, BIOCHEMISTRY-US, V31, P6023, DOI 10.1021/bi00141a010; SUKO J, 1981, EUR J BIOCHEM, V119, P225, DOI 10.1111/j.1432-1033.1981.tb05598.x; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	33	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					977	982		10.1074/jbc.275.2.977	http://dx.doi.org/10.1074/jbc.275.2.977			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625635	hybrid			2022-12-27	WOS:000084836600039
J	Klatt, AR; Nitsche, DP; Kobbe, B; Morgelin, M; Paulsson, M; Wagener, R				Klatt, AR; Nitsche, DP; Kobbe, B; Morgelin, M; Paulsson, M; Wagener, R			Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; CARTILAGE; MODULE; MEMBER; FAMILY	Matrilin-3 is a recently identified member of the superfamily of proteins containing von Willebrand factor Ih-like domains and is able to form hetero-oligomers with matrilin-1 (cartilage matrix protein) via a C-terminal coiled coil domain. Full-length matrilin-3 and a fragment lacking the assembly domain were expressed in 293-EBNA cells, purified, and subjected to biochemical characterization. Recombinantly expressed full-length matrilin-3 occurs as monomers, dimers, trimers, and tetramers, as detected by electron microscopy and SDS-polyacrylamide gel electrophoresis, whereas matrilin-3, purified from fetal calf cartilage, forms homotetramers as well as hetero-oligomers of variable stoichiometry with matrilin-1, In the matrix formed by cultured chondrosarcoma cells, matrilin-3 is found in a filamentous, collagen-dependent network connecting cells and in a collagen-independent pericellular network. Affinity-purified antibodies detect matrilin-3 expression in a variety of mouse cartilaginous tissues, such as sternum, articular, and epiphyseal cartilage, and in the cartilage anlage of developing bones. It is found both inside the lacunae and in the interterritorial matrix of the resting, proliferating, hypertrophic, and calcified cartilage zones, whereas the expression is lower in the superficial articular cartilage. In trachea and in costal cartilage of adult mice, an expression was seen in the perichondrium. Furthermore, matrilin-3 is found in bone, and its expression is, therefore, not restricted to chondroblasts and chondrocytes.	Univ Cologne, Inst Biochem, Fac Med, D-50931 Cologne, Germany; Univ Lund, Dept Cell & Mol Biol, S-22100 Lund, Sweden	University of Cologne; Lund University	Wagener, R (corresponding author), Univ Cologne, Inst Biochem, Fac Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.							Aszodi A, 1996, EUR J BIOCHEM, V236, P970, DOI 10.1111/j.1432-1033.1996.00970.x; Beck K, 1997, EMBO J, V16, P3767, DOI 10.1093/emboj/16.13.3767; Belluoccio D, 1998, GENOMICS, V53, P391, DOI 10.1006/geno.1998.5519; Belluoccio D, 1997, FEBS LETT, V415, P212, DOI 10.1016/S0014-5793(97)01126-5; CHEN Q, 1995, MOL BIOL CELL, V6, P1743, DOI 10.1091/mbc.6.12.1743; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Deak F, 1997, J BIOL CHEM, V272, P9268; DEBLOCK M, 1993, ANAL BIOCHEM, V215, P86, DOI 10.1006/abio.1993.1558; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; HAUSER N, 1994, J BIOL CHEM, V269, P25747; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; PAULSSON M, 1982, BIOCHEM J, V207, P207, DOI 10.1042/bj2070207; PAULSSON M, 1984, BIOCHEM J, V221, P623, DOI 10.1042/bj2210623; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; VORM O, 1994, J AM SOC MASS SPECTR, V5, P955, DOI 10.1016/1044-0305(94)80013-8; Wagener R, 1997, FEBS LETT, V413, P129, DOI 10.1016/S0014-5793(97)00895-8; Wagener R, 1998, FEBS LETT, V436, P123, DOI 10.1016/S0014-5793(98)01111-9; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Wu JJ, 1998, J BIOL CHEM, V273, P17433, DOI 10.1074/jbc.273.28.17433	24	110	113	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3999	4006		10.1074/jbc.275.6.3999	http://dx.doi.org/10.1074/jbc.275.6.3999			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660556	hybrid			2022-12-27	WOS:000085288800040
J	Katayama, A; Fujita, N; Ishihama, A				Katayama, A; Fujita, N; Ishihama, A			Mapping of subunit-subunit contact surfaces on the beta ' subunit of Escherichia coli RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL ASSEMBLY DOMAIN; ALPHA-SUBUNIT; FUNCTIONAL MAP; NUCLEOTIDE-SEQUENCE; ACTIVE-CENTER; BINDING; TRANSCRIPTION; PROTEIN; REGION; BETA'-SUBUNIT	The RNA polymerase core enzyme of Escherichia coli with the catalytic activity of RNA polymerization is assembled sequentially under the order: 2 alpha-->alpha(2)-->alpha(2)beta-->alpha(2)beta beta'. The core enzyme gains the activities of promoter recognition and transcription initiation after binding the sigma subunit, The subunit-subunit contact surfaces of beta' subunit (1407 residues) were analyzed by testing complex formation between various beta' fragments and either the alpha(2)beta complex or the sigma(70) subunit. Results indicate that two regions, one central region between residues 515 and 842 and the other COOH-terminal proximal region downstream from residue 1141, are involved in binding the alpha(2)beta complex; and the NH2-terminal proximal region between residues 201 and 345 plays a major role in binding the sigma(70) subunit. However, both alpha(2)beta binding sites have weak activity of the sigma(70) subunit; likewise, the sigma(70) subunit-contact surface has weak binding activity of the alpha(2)beta complex. The sites involved in the catalytic function of RNA polymerization are all located within two spacer regions sandwiched between these three subunit-subunit contact surfaces.	Grad Univ Adv Studies, Natl Inst Genet, Dept Mol Genet, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Sch Life Sci, Shizuoka 4118540, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Ishihama, A (corresponding author), Grad Univ Adv Studies, Natl Inst Genet, Dept Mol Genet, Shizuoka 4118540, Japan.							Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; AZUMA Y, 1991, NUCLEIC ACIDS RES, V19, P461, DOI 10.1093/nar/19.3.461; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; CLERGET M, 1995, J MOL BIOL, V248, P768, DOI 10.1006/jmbi.1995.0259; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Fujita N, 1996, METHOD ENZYMOL, V273, P121; FUKUDA R, 1974, J MOL BIOL, V87, P523, DOI 10.1016/0022-2836(74)90102-8; GLASS RE, 1986, MOL GEN GENET, V203, P492, DOI 10.1007/BF00422075; Greiner DP, 1996, P NATL ACAD SCI USA, V93, P71, DOI 10.1073/pnas.93.1.71; HAYWARD RS, 1991, J MOL BIOL, V221, P23, DOI 10.1016/0022-2836(91)80197-3; HU J, 1990, P NATL ACAD SCI USA, V87, P1531, DOI 10.1073/pnas.87.4.1531; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; IGLOI GL, 1990, MOL GEN GENET, V221, P379, DOI 10.1007/BF00259403; ISHIHAMA A, 1972, BIOCHEMISTRY-US, V11, P1250, DOI 10.1021/bi00757a021; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1987, PROTEINS, V2, P42, DOI 10.1002/prot.340020106; Ishihama A, 1981, Adv Biophys, V14, P1; Ishihama A., 1997, NUCL ACIDS MOL BIOL, V11, P53; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Jeon YH, 1997, J MOL BIOL, V267, P953, DOI 10.1006/jmbi.1997.0902; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; KIMURA M, 1995, J MOL BIOL, V248, P756, DOI 10.1006/jmbi.1995.0258; KIMURA M, 1994, J MOL BIOL, V242, P107, DOI 10.1006/jmbi.1994.1562; KIMURA M, 1995, J MOL BIOL, V254, P342, DOI 10.1006/jmbi.1995.0621; Kimura M, 1996, GENES CELLS, V1, P517, DOI 10.1046/j.1365-2443.1996.d01-258.x; LUO JY, 1992, J BIOL CHEM, V267, P18175; Luo JY, 1996, GENES CELLS, V1, P819, DOI 10.1046/j.1365-2443.1996.700269.x; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Miller A, 1997, SCIENCE, V275, P1655, DOI 10.1126/science.275.5306.1655; Miyake R, 1998, BIOCHEMISTRY-US, V37, P1344, DOI 10.1021/bi9723313; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; NEGISHI T, 1995, J MOL BIOL, V248, P723, DOI 10.1006/jmbi.1995.0254; Nomura T, 1999, BIOCHEMISTRY-US, V38, P1346, DOI 10.1021/bi982381n; OVCHINNIKOV YA, 1982, NUCLEIC ACIDS RES, V10, P4035, DOI 10.1093/nar/10.13.4035; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; PUHLER G, 1989, NUCLEIC ACIDS RES, V17, P4517, DOI 10.1093/nar/17.12.4517; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; SEVERINOV K, 1995, J BIOL CHEM, V270, P23926, DOI 10.1074/jbc.270.41.23926; SHIMADA H, 1990, MOL GEN GENET, V221, P395, DOI 10.1007/BF00259404; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Wang Y, 1997, J MOL BIOL, V270, P648, DOI 10.1006/jmbi.1997.1139; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Zakharova N, 1998, J BIOL CHEM, V273, P24912, DOI 10.1074/jbc.273.38.24912; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262	46	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3583	3592		10.1074/jbc.275.5.3583	http://dx.doi.org/10.1074/jbc.275.5.3583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652354	hybrid			2022-12-27	WOS:000085146500076
J	Lyman, SD; Escobar, S; Rousseau, AM; Armstrong, A; Fanslow, WC				Lyman, SD; Escobar, S; Rousseau, AM; Armstrong, A; Fanslow, WC			Identification of CD7 as a cognate of the human K12 (SECTM1) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-CELL; COLONY-STIMULATING FACTOR; MOLECULAR-CLONING; MONOCLONAL-ANTIBODIES; EXTRACELLULAR DOMAIN; CELIAC-DISEASE; CROSS-LINKING; GROWTH-FACTOR; ANTIGEN CD7; EXPRESSION	CD7 is a 40-kDa protein found primarily on T, NK, and pre-B cells; the function of the CD7 protein in the immune system is largely unknown. The K12 (SECTM1) protein was originally identified by its location just up-stream of the CD7 locus, The K12 gene encodes a transmembrane protein of unknown function. In order to clone a Kla-binding protein, we generated a soluble version of the human K12 protein by fusing its extracellular domain to the Fc portion of human IgG(1). Flow cytometry experiments showed that the K12-Fc fusion protein bound at high levels to both human T and NK cells. Precipitation experiments using K12-Fc on S-35-radiolabeled NK cells lysates indicated that the K12 cognate was an approximately 40-kDa protein. A human peripheral blood T cell cDNA expression library was screened with the K12-Fc protein, and two independent, positive cDNA clones were identified and sequenced. Both cDNAs encoded the same protein, which was CD7, Thus, K12 and CD7 are cognate proteins that are located next to each other on human chromosome 17q25. Additionally, we have cloned the gene encoding the mouse homologue of K12, shown that it maps near the mouse CD7 gene on chromosome 11, and established that the mouse K12 protein binds to mouse, but not human, CD7. Mouse K12-Fc inhibited in a dose-dependent manner concanavalin A-induced proliferation, but not anti-TcR alpha/beta induced proliferation, of mouse lymph node T cells, Human K12-Fc stimulated the up-regulation of CD25, CD54, and CD69 on human NK cells in vitro.	Immunex Res & Dev Corp, Seattle, WA 98101 USA		Lyman, SD (corresponding author), Immunex Res & Dev Corp, 51 Univ St, Seattle, WA 98101 USA.							ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; ARUFFO A, 1987, EMBO J, V6, P3313, DOI 10.1002/j.1460-2075.1987.tb02651.x; BARCENA A, 1995, LEUKEMIA LYMPHOMA, V17, P1; Baum W, 1996, BRIT J HAEMATOL, V95, P327, DOI 10.1046/j.1365-2141.1996.d01-1900.x; Bonilla FA, 1997, INT IMMUNOL, V9, P1875, DOI 10.1093/intimm/9.12.1875; CARREL S, 1991, EUR J IMMUNOL, V21, P1195, DOI 10.1002/eji.1830210515; CARRERA AC, 1988, J IMMUNOL, V141, P1919; CERRETTI DP, 1988, MOL IMMUNOL, V25, P761, DOI 10.1016/0161-5890(88)90112-5; Eiras P, 1998, CYTOMETRY, V34, P95, DOI 10.1002/(SICI)1097-0320(19980415)34:2<95::AID-CYTO6>3.0.CO;2-B; Flaherty L, 1998, MAMM GENOME, V9, P417, DOI 10.1007/s003359900788; Flavell DJ, 1997, BRIT J CANCER, V75, P1035, DOI 10.1038/bjc.1997.177; Frankel AE, 1997, LEUKEMIA LYMPHOMA, V26, P287, DOI 10.3109/10428199709051778; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; Haynes B F, 1990, Semin Immunol, V2, P67; HAYNES BF, 1981, IMMUNOL REV, V57, P127, DOI 10.1111/j.1600-065X.1981.tb00445.x; HAYNES BF, 1989, IMMUNOL TODAY, V10, P87, DOI 10.1016/0167-5699(89)90232-6; Hou ZC, 1996, BLOOD, V88, P124; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; JUNG LKL, 1986, J CLIN INVEST, V77, P940, DOI 10.1172/JCI112393; JUNG LKL, 1992, CELL IMMUNOL, V141, P189, DOI 10.1016/0008-8749(92)90138-F; LAZAROVITS AI, 1993, J IMMUNOL, V150, P5163; LAZAROVITS AI, 1988, TRANSPLANT P, V20, P1253; Lee DM, 1996, INT IMMUNOL, V8, P1195, DOI 10.1093/intimm/8.8.1195; Lee DM, 1998, J IMMUNOL, V160, P5749; LEE DM, 1994, IMMUNOGENETICS, V39, P289, DOI 10.1007/BF00188794; Leta E, 1996, CELL IMMUNOL, V173, P15, DOI 10.1006/cimm.1996.0247; LETA E, 1995, CELL IMMUNOL, V165, P101, DOI 10.1006/cimm.1995.1192; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; OSADA S, 1988, CYTOGENET CELL GENET, V47, P8, DOI 10.1159/000132494; Pauza ME, 1997, J IMMUNOL, V158, P3259; RABINOWICH H, 1994, J IMMUNOL, V152, P517; RABINOWICH H, 1994, J IMMUNOL, V153, P3504; SATO AI, 1994, J IMMUNOL, V152, P5142; SCHANBERG LE, 1995, J IMMUNOL, V155, P2407; Sempowski GD, 1999, J EXP MED, V189, P1011, DOI 10.1084/jem.189.6.1011; SHIMIZU Y, 1992, J EXP MED, V175, P577, DOI 10.1084/jem.175.2.577; Slentz-Kesler KA, 1998, GENOMICS, V47, P327, DOI 10.1006/geno.1997.5151; SPENCER J, 1989, GUT, V30, P339, DOI 10.1136/gut.30.3.339; YOSHIKAWA K, 1993, IMMUNOGENETICS, V37, P114, DOI 10.1007/BF00216834; YOSHIKAWA K, 1995, IMMUNOGENETICS, V41, P159, DOI 10.1007/BF00182331; YOSHIKAWA K, 1991, IMMUNOGENETICS, V33, P352, DOI 10.1007/BF00216694	45	27	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3431	3437		10.1074/jbc.275.5.3431	http://dx.doi.org/10.1074/jbc.275.5.3431			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652336	hybrid			2022-12-27	WOS:000085146500058
J	Rehling, P; Skaletz-Rorowski, A; Girzalsky, W; Voorn-Brouwer, T; Franse, MM; Distel, B; Veenhuis, M; Kunau, WH; Erdmann, R				Rehling, P; Skaletz-Rorowski, A; Girzalsky, W; Voorn-Brouwer, T; Franse, MM; Distel, B; Veenhuis, M; Kunau, WH; Erdmann, R			Pex8p, an intraperoxisomal peroxin of Saccharomyces cerevisiae required for protein transport into peroxisomes binds the PTS1 receptor Pex5p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI SHUTTLE VECTORS; TARGETING SIGNAL; 3-OXOACYL-COA THIOLASE; HANSENULA-POLYMORPHA; RESTRICTION SITES; PICHIA-PASTORIS; MATRIX PROTEINS; GENE ENCODES; IMPORT; YEAST	We report the characterization of ScPex8p, which is essential for peroxisomal biogenesis in Saccharomyces cerevisiae, Cells lacking Pex8p are characterized by the presence of peroxisomal membrane ghosts and mislocalization of peroxisomal matrix proteins of the PTS1 and PTS2 variety to the cytosol, Pex8p is tightly associated with the lumenal face of the peroxisomal membrane, Consistent with its intraperoxisomal localization, Pex8p contains a peroxisomal targeting signal 1, and it interacts with the PTS1 receptor Pex5p. However, the Pex5p/Pex8p association is also observed upon deletion of the PTS1 of Pex8p, suggesting that Pex8p contains a second binding site for Pex5p. The pex8 Delta mutant phenotype and the observed PTS1-independent interaction with the PTSI receptor suggest that Pex8p is involved in protein import into the peroxisomal matrix. In pex8 Delta cells, the PTS1 and PTS2 receptor still associate with membrane bound components of the protein import machinery, supporting the assumption that the Pex8p function in protein translocation follows the docking event.	Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany; Ruhr Univ Bochum, Inst Physiol Chem, D-44780 Bochum, Germany; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Div Cellular & Mol Medl, La Jolla, CA 92093 USA; Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands; Univ Groningen, Ctr Biol, Electron Microscopy Lab, NL-9751 NN Haren, Netherlands	Free University of Berlin; Ruhr University Bochum; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Erdmann, R (corresponding author), Free Univ Berlin, Inst Biochem, Thielallee 63, D-14195 Berlin, Germany.							Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Ausubel FM, 1992, CURRENT PROTOCOLS MO; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; BUTT TR, 1984, P NATL ACAD SCI-BIOL, V81, P3332, DOI 10.1073/pnas.81.11.3332; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CRANE DI, 1994, J BIOL CHEM, V269, P21835; DEHOOP MJ, 1992, BIOCHEM J, V286, P657, DOI 10.1042/bj2860657; DELAGARZA MM, 1985, EUR J BIOCHEM, V148, P285, DOI 10.1111/j.1432-1033.1985.tb08837.x; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Elgersma Y, 1996, BBA-REV BIOMEMBRANES, V1286, P269, DOI 10.1016/S0304-4157(96)00012-3; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; ERDMANN R, 1994, YEAST, V10, P935, DOI 10.1002/yea.320100708; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Erdmann R, 1997, TRENDS CELL BIOL, V7, P400, DOI 10.1016/S0962-8924(97)01126-4; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Geraghty MT, 1999, P NATL ACAD SCI USA, V96, P2937, DOI 10.1073/pnas.96.6.2937; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; HARLOW E, 1988, ANTIBODIES, P451; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; Huhse B, 1998, J CELL BIOL, V140, P49, DOI 10.1083/jcb.140.1.49; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LIU H, 1995, J BIOL CHEM, V270, P10940, DOI 10.1074/jbc.270.18.10940; Maniatis T., 1982, MOL CLONING LAB MANU; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; McNew JA, 1996, TRENDS BIOCHEM SCI, V21, P54, DOI 10.1016/S0968-0004(96)80181-2; PURDUE PE, 1994, J BIOL CHEM, V269, P30065; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rehling P, 1996, EMBO J, V15, P2901, DOI 10.1002/j.1460-2075.1996.tb00653.x; Rehling P, 1996, ANN NY ACAD SCI, V804, P34, DOI 10.1111/j.1749-6632.1996.tb18606.x; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith JJ, 1997, MOL CELL BIOL, V17, P2511, DOI 10.1128/MCB.17.5.2511; Subramani S, 1996, CURR OPIN CELL BIOL, V8, P513, DOI 10.1016/S0955-0674(96)80029-9; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Subramani S, 1996, J BIOL CHEM, V271, P32483, DOI 10.1074/jbc.271.51.32483; Tabak HF, 1995, COLD SPRING HARB SYM, V60, P649, DOI 10.1101/SQB.1995.060.01.069; vanderKlei IJ, 1996, ANN NY ACAD SCI, V804, P47; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; WATERHAM HR, 1994, J CELL BIOL, V127, P737, DOI 10.1083/jcb.127.3.737	61	69	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3593	3602		10.1074/jbc.275.5.3593	http://dx.doi.org/10.1074/jbc.275.5.3593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652355	Green Published, hybrid			2022-12-27	WOS:000085146500077
J	Romey, MC; Pallares-Ruiz, N; Mange, A; Mettling, C; Peytavi, R; Demaille, J; Claustres, M				Romey, MC; Pallares-Ruiz, N; Mange, A; Mettling, C; Peytavi, R; Demaille, J; Claustres, M			A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; DNA-BINDING ACTIVITY; PROMOTER REGION; 5'-FLANKING REGION; ADENOVIRUS E1A; CFTR GENE; IDENTIFICATION; TRANSCRIPTION; PROTEIN; SITE	We have identified previously a novel complex mutant allele in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in a patient affected with cystic fibrosis (CF), This allele contained a mutation in CFTR exon II known to cause CF (S549R(T>G)), associated with the first alteration described so far in the minimal CFTR promoter region (-102T>A), Studies on genotype-phenotype correlations revealed striking differences between patients carrying mutation (S549R(T>G)) alone, who had a severe disease, and patients carrying the complex allele (-102(T>A) + S549R(T > G)), who exhibited milder forms of CF. We thus postulated that the sequence change (-102T>A) may attenuate the effects of the severe (S549R(T>G)) mutation through regulation of CFTR expression, Analysis of transiently transfected cell lines with wild-type and -102A variant human CFTR-directed luciferase reporter genes demonstrates that constructs containing the -102A variant (which creates a Yin Yang 1 (YY1) core element) increases CFTR expression significantly. Electrophoretic mobility shift. assays indicate that the -102 site is located in a region of multiple DNA-protein interactions and that the -102A allele recruits specifically an additional nuclear protein related to YY1, The finding that the YY1-binding allele causes a significant increase in CFTR expression in vitro may allow a better understanding of the milder phenotype observed in patients who carry a severe CF mutation within the same gene.	Univ Montpellier, Ctr Spitalier, Inst Biol, Mol Genet Lab, F-34060 Montpellier, France; Inst Biol, Virol Lab, F-34060 Montpellier, France; CNRS, Lab Biol Encephalopathies Spongiformes Transmissi, Montpellier 5, France; CNRS, Lab Virol Mol & Transfert Gene, Inst Genet Humaine Unite Propre Rech 1142, Montpellier 5, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Claustres, M (corresponding author), Univ Montpellier, Ctr Spitalier, Inst Biol, Mol Genet Lab, F-34060 Montpellier, France.		Mange, Alain/U-1157-2017; ROMEY-CHATELAIN, Marie-Catherine/A-9623-2008	Mange, Alain/0000-0002-1566-9407; Mettling, Clement/0000-0002-4963-2928				ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BIENVENU T, 1995, HUM GENET, V95, P698; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; CHOU JL, 1991, J BIOL CHEM, V266, P24471; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Furlong EEM, 1996, MOL CELL BIOL, V16, P5933; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; GRUENEBERG DA, 1995, MOL CELL BIOL, V15, P3318; GUALBERTO A, 1992, MOL CELL BIOL, V12, P4209, DOI 10.1128/MCB.12.9.4209; GUO B, 1995, P NATL ACAD SCI USA, V92, P10526, DOI 10.1073/pnas.92.23.10526; HARRIS A, 1991, DEVELOPMENT, V113, P305; HYDEDERUYSCHER RP, 1995, NUCLEIC ACIDS RES, V23, P4457, DOI 10.1093/nar/23.21.4457; Ishiguro H, 1998, J BIOL CHEM, V273, P21941, DOI 10.1074/jbc.273.34.21941; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kim JC, 1998, J BIOL CHEM, V273, P26130, DOI 10.1074/jbc.273.40.26130; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; KOH J, 1993, J BIOL CHEM, V268, P15912; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; Matthews RP, 1996, J BIOL CHEM, V271, P31869, DOI 10.1074/jbc.271.50.31869; NATESAN S, 1993, GENE DEV, V7, P2497, DOI 10.1101/gad.7.12b.2497; NATESAN S, 1995, MOL CELL BIOL, V15, P5975; PITTMAN N, 1995, J BIOL CHEM, V270, P28848, DOI 10.1074/jbc.270.48.28848; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Romey MC, 1999, HUM GENET, V105, P145, DOI 10.1007/s004390051077; Romey MC, 1999, J MED GENET, V36, P263; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rutter JL, 1998, CANCER RES, V58, P5321; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Smith AN, 1996, J BIOL CHEM, V271, P9947, DOI 10.1074/jbc.271.17.9947; SMITH AN, 1995, BIOCHEM BIOPH RES CO, V211, P274, DOI 10.1006/bbrc.1995.1807; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; TREZISE AEO, 1993, HUM MOL GENET, V2, P213, DOI 10.1093/hmg/2.3.213; Usheva A, 1996, P NATL ACAD SCI USA, V93, P13571, DOI 10.1073/pnas.93.24.13571; Verlingue C, 1998, J MED GENET, V35, P137, DOI 10.1136/jmg.35.2.137; Vuillaumier S, 1997, MOL BIOL EVOL, V14, P372, DOI 10.1093/oxfordjournals.molbev.a025773; Vuillaumier S, 1997, BIOCHEM J, V327, P651, DOI 10.1042/bj3270651; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; YOSHIMURA K, 1991, J BIOL CHEM, V266, P9140	53	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3561	3567		10.1074/jbc.275.5.3561	http://dx.doi.org/10.1074/jbc.275.5.3561			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652351	hybrid			2022-12-27	WOS:000085146500073
J	Rosenfeldt, H; Grinnell, F				Rosenfeldt, H; Grinnell, F			Fibroblast quiescence and the disruption of ERK signaling in mechanically unloaded collagen matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; PROTEIN-KINASE-C; MAP-KINASE; IN-VITRO; GROWTH-CONTROL; ACTIVATION; PROLIFERATION; CONTRACTION; PDGF; FOS	Fibroblasts in mechanically unloaded collagen matrices had low levels of DNA synthesis compared with cells in mechanically loaded matrices. Under the former conditions, the cellular ERK signaling pathway appeared to be disrupted. Also, pharmacologic inhibition of ERK signaling blocked DNA synthesis by fibroblasts in mechanically loaded matrices. These results were consistent with the idea that mechanoregulation of fibroblast DNA synthesis in collagen matrices occurs at the level of the ERK signaling pathway.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Grinnell, F (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.				NIAMS NIH HHS [AR41940] Funding Source: Medline; NIGMS NIH HHS [GM31321] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031321, R01GM031321] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Assoian RK, 1997, CURR OPIN CELL BIOL, V9, P93, DOI 10.1016/S0955-0674(97)80157-3; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Desmouliere A, 1996, MOL CELLULAR BIOL WO, P391; EASTWOOD M, 1994, BBA-GEN SUBJECTS, V1201, P186, DOI 10.1016/0304-4165(94)90040-X; Fluck J, 1998, J INVEST DERMATOL, V110, P153, DOI 10.1046/j.1523-1747.1998.00095.x; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440; Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hu YH, 1998, FASEB J, V12, P1135, DOI 10.1096/fasebj.12.12.1135; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Lin TH, 1997, J BIOL CHEM, V272, P8849; LIN YC, 1993, J CELL BIOL, V122, P663, DOI 10.1083/jcb.122.3.663; Lin YC, 1998, EXP CELL RES, V240, P377, DOI 10.1006/excr.1998.4013; MARQUARDT B, 1994, ONCOGENE, V9, P3213; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MELOCHE S, 1992, MOL ENDOCRINOL, V6, P845, DOI 10.1210/me.6.5.845; MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A; NAKAGAWA S, 1989, EXP CELL RES, V182, P572, DOI 10.1016/0014-4827(89)90260-7; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rosenfeldt H, 1998, MOL CELL BIOL, V18, P2659, DOI 10.1128/MCB.18.5.2659; Sambrook J., 2002, MOL CLONING LAB MANU; SARBER R, 1981, MECH AGEING DEV, V17, P107, DOI 10.1016/0047-6374(81)90077-4; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SIEGFRIED Z, 1989, ONCOGENE, V4, P3; SINGER II, 1984, J CELL BIOL, V98, P2091, DOI 10.1083/jcb.98.6.2091; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273; [No title captured]	46	74	77	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3088	3092		10.1074/jbc.275.5.3088	http://dx.doi.org/10.1074/jbc.275.5.3088			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652290	hybrid			2022-12-27	WOS:000085146500012
J	Farrar, JD; Smith, JD; Murphy, TL; Murphy, KM				Farrar, JD; Smith, JD; Murphy, TL; Murphy, KM			Recruitment of Stat4 to the human interferon-alpha/beta receptor requires activated Stat2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; IFN-ALPHA; PHENOTYPE DEVELOPMENT; T-CELLS; GAMMA; IL-12; PROTEIN; CLONING; TH1; LYMPHOCYTES	Stat4 activation is involved in differentiation of type 1 helper (Th1) T cells. Although State is activated by interleukin (IL)-12 in both human and murine T cells, State is activated by interferon (IFN)-alpha only in human, but not murine, CD4+ T cells. This species-specific difference in cytokine activation of State underlies critical differences in Th1 development in response to cytokines and is important to the interpretation of murine models of immunopathogenesis. Here, we sought to determine the mechanism of Stat4 recruitment and activation by the human IFN-alpha receptor. Analysis of phosphopeptide binding analysis suggests that State does not interact directly with tyrosine-phosphorylated amino acid residues within the cytoplasmic domains of either of the subunits of the IFN-alpha receptor complex. Expression of murine State in the Stat1-deficient U3A and the Stat2-deficient U6A cell lines shows that IFN-alpha-induced State phosphorylation requires the presence of activated Stat2 but not Stat1. Thus, in contrast to the direct recruitment of Stat4 by the IL-12 receptor, Stat4 activation by the human IFN-alpha receptor occurs through indirect recruitment by intermediates involving Stat2.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, Ctr Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 S Euclid Ave, St Louis, MO 63110 USA.	murphy@immunology.wustl.edu			NCI NIH HHS [CA09547] Funding Source: Medline; NIAID NIH HHS [AIDK39676] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039676] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; BACON CM, 1995, J EXP MED, V181, P399, DOI 10.1084/jem.181.1.399; BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Cho SS, 1996, J IMMUNOL, V157, P4781; COHEN B, 1995, MOL CELL BIOL, V15, P4208; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; Cook JR, 1996, J BIOL CHEM, V271, P13448, DOI 10.1074/jbc.271.23.13448; Dumler I, 1999, J BIOL CHEM, V274, P24059, DOI 10.1074/jbc.274.34.24059; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; Guler ML, 1997, J IMMUNOL, V159, P1767; HSIEH CS, 1992, P NATL ACAD SCI USA, V89, P6065, DOI 10.1073/pnas.89.13.6065; IMPROTA T, 1994, P NATL ACAD SCI USA, V91, P4776, DOI 10.1073/pnas.91.11.4776; JACOBSON NG, 1995, J EXP MED, V181, P1755, DOI 10.1084/jem.181.5.1755; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim SH, 1997, GENE, V196, P279, DOI 10.1016/S0378-1119(97)00240-0; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naeger LK, 1999, J BIOL CHEM, V274, P1875, DOI 10.1074/jbc.274.4.1875; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Owczarek CM, 1997, J BIOL CHEM, V272, P23865, DOI 10.1074/jbc.272.38.23865; PARRONCHI P, 1992, J IMMUNOL, V149, P2977; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; Ranganath S, 1998, J IMMUNOL, V161, P3822; Rogge L, 1998, J IMMUNOL, V161, P6567; SOH JM, 1994, J BIOL CHEM, V269, P18102; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; Wenner CA, 1996, J IMMUNOL, V156, P1442; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; YAN RQ, 1995, NUCLEIC ACIDS RES, V23, P459, DOI 10.1093/nar/23.3.459	38	81	83	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2693	2697		10.1074/jbc.275.4.2693	http://dx.doi.org/10.1074/jbc.275.4.2693			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644731	hybrid			2022-12-27	WOS:000085128000063
J	Habuchi, H; Tanaka, M; Habuchi, O; Yoshida, K; Suzuki, H; Ban, K; Kimata, K				Habuchi, H; Tanaka, M; Habuchi, O; Yoshida, K; Suzuki, H; Ban, K; Kimata, K			The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HAMSTER OVARY CELLS; MOLECULAR-CLONING; DEACETYLASE/N-SULFOTRANSFERASE; CARCINOMA-CELLS; BINDING SEQUENCE; CDNA CLONING; BIOSYNTHESIS; EXPRESSION; PROTEOGLYCANS	We previously cloned heparan sulfate 6-O-sulfotransferase (HS6ST) (Habuchi, H., Kobayashi, M., and Kimata, K. (1998) J. Biol. Chem. 273, 9208-9213). In this study, we report the cloning and characterization of three mouse isoforms of HS6ST, a mouse homologue to the original human HS6ST (HS6ST-1) and two novel HS6STs (HS6ST-2 and HS6ST-3). The cDNAs have been obtained from mouse brain cDNA library by cross-hybridization with human HS6ST cDNA The three cDNAs contained single open reading frames that predicted type II transmembrane proteins composed of 401, 506, and 470 amino acid residues, respectively. Amino acid sequence of HS6ST-1 was 51 and 57% identical to those of HS6ST-2 and HS6ST-3, respectively. HS6ST-2 and HS6ST-3 had the 50% identity. Overexpression of each isoform in COS-7 cells resulted in about 10-fold increase of HS6ST activity, The three isoforms purified with anti-FLAG antibody affinity column transferred sulfate to heparan sulfate and heparin but not to other glycosaminoglycans. Each isoform showed different specificity toward the isomeric hexuronic acid adjacent to the targeted N-sulfoglucosamine; HS6ST-1 appeared to prefer the iduronosyl N-sulfoglucosamine while HS6ST-2 had a different preference, depending upon the substrate concentrations, and HS6ST-3 acted on either substrate. Northern analysis showed that the expression of each message in various tissues was characteristic to the respective isoform. HS6ST-1 was expressed strongly in liver, and HS6ST-2 was expressed mainly in brain and spleen. In contrast, HS6ST-3 was expressed rather ubiquitously. These results suggest that the expression of these isoforms may be regulated in tissue specific manners and that each isoform may be involved in the synthesis of heparan sulfates with tissue-specific structures and functions.	Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan; Aichi Univ Educ, Dept Life Sci, Kariya, Aichi 4488542, Japan; Seikagaku Corp, Tokyo 1030023, Japan	Aichi Medical University; Aichi University Education; Seikagaku Corporation	Kimata, K (corresponding author), Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan.							Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Bai XM, 1996, J BIOL CHEM, V271, P17711, DOI 10.1074/jbc.271.30.17711; BERNFIELD M, 1992, ANN REV CELL BIOL, V8, P369; Binari RC, 1997, DEVELOPMENT, V124, P2623; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; Brickman YG, 1998, GLYCOBIOLOGY, V8, P463, DOI 10.1093/glycob/8.5.463; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DELFERT DM, 1985, ANAL BIOCHEM, V148, P303, DOI 10.1016/0003-2697(85)90233-7; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; ERIKSSON I, 1994, J BIOL CHEM, V269, P10438; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; FOLKMAN J, 1988, AM J PATHOL, V130, P393; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1997, J BIOL CHEM, V272, P32321, DOI 10.1074/jbc.272.51.32321; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HABUCHI H, 1992, BIOCHEM J, V285, P805, DOI 10.1042/bj2850805; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; HABUCHI H, 1995, J BIOL CHEM, V270, P4172, DOI 10.1074/jbc.270.8.4172; HABUCHI O, 1980, BIOCHIM BIOPHYS ACTA, V616, P208, DOI 10.1016/0005-2744(80)90139-4; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; Inki P, 1996, ANN MED, V28, P63, DOI 10.3109/07853899608999076; ISHIHARA M, 1993, J BIOL CHEM, V268, P20091; ISHIHARA M, 1993, J BIOL CHEM, V268, P4675; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Kobayashi M, 1997, J BIOL CHEM, V272, P13980, DOI 10.1074/jbc.272.21.13980; Kobayashi M, 1996, J BIOL CHEM, V271, P7645, DOI 10.1074/jbc.271.13.7645; KUSCHE M, 1991, J BIOL CHEM, V266, P7400; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; LIND T, 1993, J BIOL CHEM, V268, P20705; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lindahl B, 1997, J BIOL CHEM, V272, P26091, DOI 10.1074/jbc.272.42.26091; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; LINDAHL U, 1984, J BIOL CHEM, V259, P2368; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; LYON M, 1994, J BIOL CHEM, V269, P11216; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; NURCOMBE V, 1993, SCIENCE, V260, P103, DOI 10.1126/science.7682010; ORELLANA A, 1994, J BIOL CHEM, V269, P2270; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Rapraeger AC, 1993, CURR OPIN CELL BIOL, V5, P844, DOI 10.1016/0955-0674(93)90034-N; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Rostand KS, 1997, INFECT IMMUN, V65, P1; Salmivirta M, 1998, GLYCOBIOLOGY, V8, P1029, DOI 10.1093/glycob/8.10.1029; Sen J, 1998, CELL, V95, P471, DOI 10.1016/S0092-8674(00)81615-3; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Shworak NW, 1996, J BIOL CHEM, V271, P27063, DOI 10.1074/jbc.271.43.27063; Stickens D, 1998, NAT GENET, V19, P110, DOI 10.1038/458; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; Zhang LJ, 1998, J BIOL CHEM, V273, P27998, DOI 10.1074/jbc.273.43.27998	77	185	199	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2859	2868		10.1074/jbc.275.4.2859	http://dx.doi.org/10.1074/jbc.275.4.2859			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644753	hybrid			2022-12-27	WOS:000085128000085
J	Hirohashi, T; Suzuki, H; Takikawa, H; Sugiyama, Y				Hirohashi, T; Suzuki, H; Takikawa, H; Sugiyama, Y			ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTER; PRIMARY ACTIVE-TRANSPORT; CONJUGATE EXPORT PUMP; CANALICULAR MEMBRANE; BILIARY-SECRETION; CMOAT MRP2; LIVER; EXPRESSION; ACIDS; GENE	We have previously shown that cloned rat multidrug resistance-associated protein 3 (Mrp3) has the ability to transport organic anions such as 17 beta-estradiol 17-beta-D-glucuronide (E(2)17 beta G) and has a different substrate specificity from MRP1 and MRP2 in that glutathione conjugates are poor substrates for Mrp3 (Hirohashi, T,, Suzuki, H., and Sugiyama, Y, (1999) J, Biol. Chem. 274, 15181-15185). In the present study, the involvement of Mrp3 in the transport of endogenous bile salts was investigated using membrane vesicles from LLC-PK1 cells transfected with rat Mrp3 cDNA The ATP-dependent uptake of [H-3]taurocholate (TC), [C-14]glycocholate (GC), [H-3]taurochenodeoxycholate-3-sulfate (TCDC-S), and [H-3]taurolithocholate-3-sulfate (TLC-S) was markedly stimulated by Mrp3 transfection in LLC-PK1 cells. The extent of Mrp3-mediated transport of bile salts was in the order, TLC-S > TCDC-S > TC > GC. The K-m and V-max values for the uptake of TC and TLC-S were K-m = 15.9 +/- 4.9 mu M and V-max = 50.1 +/- 9.3 pmol/min/mg of protein and K-m = 3.06 +/- 0.57 mu M and V-max = 161.9 +/- 21.7 pmol/min/mg of protein, respectively. At 55 nM [H-3]E(2)17 beta G and 1.2 mu M [H-3]TC, the apparent K-m values for ATP were 1.36 and 0.66 mM, respectively, TC, GC, and TCDC-S inhibited the transport of [H-3]E(2)17 beta G and [H-3]TC to the same extent with an apparent IC50 of similar to 10 mu M. TLC-S inhibited the uptake of [H-3]E(2)17 beta G and [H-3]TC most potently (IC50 of similar to 1 mu M) among the bile salts examined, whereas cholate weakly inhibited the uptake (IC50 similar to 75 mu M). Although TC and GC are transported by bile salt export pump/sister of P-glycoprotein, but not by MRP2, and TCDC-S and TLC-S are transported by MRP2, but not by bile salt export pump/sister of P-glycoprotein, it was found that Mrp3 accepts all these bile salts as substrates, This information, together with the finding that MRP3 is extensively expressed on the basolateral membrane of human cholangiocytes, suggests that MRP3/Mrp3 plays a significant role in the cholehepatic circulation of bile salts.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Teikyo Univ, Sch Med, Dept Med, Itabashi Ku, Tokyo 1730003, Japan	University of Tokyo; Teikyo University	Suzuki, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	suzuki@seizai.f.u-tokyo.ac.jp						Akita H, 1999, HEPATOLOGY, V30, p530A; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cui YH, 1999, MOL PHARMACOL, V55, P929; Deeley RG, 1997, SEMIN CANCER BIOL, V8, P193, DOI 10.1006/scbi.1997.0070; ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215, DOI 10.1016/0304-4157(95)00006-D; Evers R, 1998, J CLIN INVEST, V101, P1310, DOI 10.1172/JCI119886; Gartung C, 1996, GASTROENTEROLOGY, V110, P199, DOI 10.1053/gast.1996.v110.pm8536857; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Hirohashi T, 1998, MOL PHARMACOL, V53, P1068; Hirohashi T, 1999, J BIOL CHEM, V274, P15181, DOI 10.1074/jbc.274.21.15181; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; Ishikawa T, 1997, BIOSCIENCE REP, V17, P189, DOI 10.1023/A:1027385513483; Ito K, 1998, J BIOL CHEM, V273, P1684, DOI 10.1074/jbc.273.3.1684; Jedlitschky G, 1996, CANCER RES, V56, P988; Keppler D, 1997, FASEB J, V11, P509, DOI 10.1096/fasebj.11.7.9212074; Kinoshita S, 1998, PHARMACEUT RES, V15, P1851, DOI 10.1023/A:1011953906065; Kiuchi Y, 1998, FEBS LETT, V433, P149, DOI 10.1016/S0014-5793(98)00899-0; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; Konig J, 1999, HEPATOLOGY, V29, P1156, DOI 10.1002/hep.510290404; Kool M, 1999, P NATL ACAD SCI USA, V96, P6914, DOI 10.1073/pnas.96.12.6914; Kool M, 1997, CANCER RES, V57, P3537; KUIPERS F, 1989, J LIPID RES, V30, P1835; KUIPERS F, 1988, J CLIN INVEST, V81, P1593, DOI 10.1172/JCI113493; Lazaridis KN, 1997, J CLIN INVEST, V100, P2714, DOI 10.1172/JCI119816; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Love MW, 1998, CURR OPIN LIPIDOL, V9, P225, DOI 10.1097/00041433-199806000-00007; Madon J, 1997, FEBS LETT, V406, P75, DOI 10.1016/S0014-5793(97)00245-7; MULLER M, 1991, J BIOL CHEM, V266, P18920; Muller M, 1998, J HEPATOL, V28, P344, DOI 10.1016/0168-8278(88)80024-2; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; MURATA N, 1983, STEROIDS, V42, P575, DOI 10.1016/0039-128X(83)90121-6; Niinuma K, 1997, J PHARMACOL EXP THER, V282, P866; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OGAWA K, 2000, IN PRESS AM J PHYSL; STIEGER B, 1992, BIOCHEM J, V284, P67, DOI 10.1042/bj2840067; Suzuki H, 1998, SEMIN LIVER DIS, V18, P359, DOI 10.1055/s-2007-1007170; TAKIKAWA H, 1991, HEPATOLOGY, V14, P352, DOI 10.1002/hep.1840140223; van Aubel RAMH, 1998, MOL PHARMACOL, V53, P1062; WEINBERG SL, 1986, J CLIN INVEST, V78, P44, DOI 10.1172/JCI112571; YOON YB, 1986, GASTROENTEROLOGY, V90, P837, DOI 10.1016/0016-5085(86)90859-0; Zhang J, 1997, J LABELLED COMPD RAD, V39, P159	41	269	276	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2905	2910		10.1074/jbc.275.4.2905	http://dx.doi.org/10.1074/jbc.275.4.2905			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644759	hybrid			2022-12-27	WOS:000085128000091
J	Ritz, D; Patel, H; Doan, B; Zheng, M; Aring;slund, F; Storz, G; Beckwith, J				Ritz, D; Patel, H; Doan, B; Zheng, M; Aring;slund, F; Storz, G; Beckwith, J			Thioredoxin 2 is involved in the oxidative stress response in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; DISULFIDE BOND FORMATION; SALMONELLA-TYPHIMURIUM; TRANSCRIPTION FACTOR; MUTANT THIOREDOXINS; EXPRESSION; GLUTAREDOXIN; ACTIVATION; CYTOPLASM; SEQUENCE	Two genes encoding thioredoxin are found on the Escherichia coli genome. Both of them are capable of reducing protein disulfide bonds in vivo and in vitro. The catalytic site contains a Cys-X-1-X-2-Cys motif in a so-called thioredoxin fold. Thioredoxin 2 has two additional pairs of cysteines in a non-conserved N-terminal domain. This domain does not appear to be important for the function of thioredoxin 2 in donating electrons to ribonucleotide reductase, 3'-phosphoadenylsulfate-reductase, or the periplasmic disulfide isomerase DsbC. Our results suggests that the two thioredoxins are equivalent for most of the in vivo functions that were tested. On the other hand, transcriptional regulation is different. The expression of trxC is regulated by the transcriptional activator OxyR in response to oxidative stress. Oxidized OxyR binds directly to the trxC promoter and induces its expression in response to elevated hydrogen peroxide levels or the disruption of one or several of the cytoplasmic redox pathways. Mutants lacking thioredoxins 1 and 2 are more resistant to high levels of hydrogen peroxide, whereas they are more sensitive to diamide, a disulfide bond-inducing agent.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; NICHHD, NIH, Cell Biol & Metab Branch, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	Jon_Beckwith@hms.harvard.edu		Storz, Gisela/0000-0001-6698-1241	NIGMS NIH HHS [GM41883] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Aslund F, 1999, J BACTERIOL, V181, P1375; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fetrow JS, 1998, J MOL BIOL, V282, P703, DOI 10.1006/jmbi.1998.2061; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; GUZMAN LM, 1992, J BACTERIOL, V174, P7716, DOI 10.1128/JB.174.23.7717-7728.1992; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUBER HE, 1986, J BIOL CHEM, V261, P5006; Iwata S, 1997, J IMMUNOL, V158, P3108; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miranda-Vizuete A, 1997, J BIOL CHEM, V272, P30841, DOI 10.1074/jbc.272.49.30841; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Mouaheb N, 1998, P NATL ACAD SCI USA, V95, P3312, DOI 10.1073/pnas.95.6.3312; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Poole LB, 1996, BIOCHEMISTRY-US, V35, P65, DOI 10.1021/bi951888k; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; RUSSEL M, 1985, P NATL ACAD SCI USA, V82, P29, DOI 10.1073/pnas.82.1.29; RUSSEL M, 1986, J BIOL CHEM, V261, P4997; RUSSEL M, 1990, J BACTERIOL, V172, P1923, DOI 10.1128/jb.172.4.1923-1929.1990; SCHATZ PJ, 1989, GENE DEV, V3, P1035, DOI 10.1101/gad.3.7.1035; SCHULZEOSTHOFF K, 1995, METHOD ENZYMOL, V252, P253; SINGER M, 1989, MICROBIOL REV, V53, P1; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; STORZ G, 1994, METHOD ENZYMOL, V234, P217; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; TARTAGLIA LA, 1990, J BIOL CHEM, V265, P10535; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999	36	116	124	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2505	2512		10.1074/jbc.275.4.2505	http://dx.doi.org/10.1074/jbc.275.4.2505			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644706	hybrid			2022-12-27	WOS:000085128000038
J	Saika, S; Shiraishi, A; Saika, S; Liu, CY; Funderburgh, JL; Kao, CWC; Converse, RL; Kao, WWY				Saika, S; Shiraishi, A; Saika, S; Liu, CY; Funderburgh, JL; Kao, CWC; Converse, RL; Kao, WWY			Role of lumican in the corneal epithelium during wound healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; COLLAGENASE EXPRESSION; GLYCOPROTEIN-SYNTHESIS; TARGETED DISRUPTION; ENDOTHELIAL-CELLS; SKIN FRAGILITY; SHEET MOVEMENT; MOUSE LUMICAN; SMOOTH-MUSCLE; DECORIN	Lumican regulates collagenous matrix assembly as a keratan sulfate proteoglycan in the cornea and is also present in the connective tissues of other organs and embryonic corneal stroma as a glycoprotein. in normal unwounded cornea, lumican is expressed by stromal keratocytes. Our data show that injured mouse corneal epithelium ectopically and transiently expresses lumican during the early phase of wound healing, suggesting a potential lumican functionality unrelated to regulation of collagen fibrillogenesis, e.g. modulation of epithelial cell adhesion or migration. An anti-lumican antibody was found to retard corneal epithelial wound healing in cultured mouse eyes. Healing of a corneal epithelial injury in Lum(-/-) mice was significantly delayed compared with Lum(+/-) mice. These observations indicate that lumican expressed in injured epithelium may modulate cell behavior such as adhesion or migration, thus contributing to corneal epithelial wound healing.	Univ Cincinnati, Med Ctr, Dept Ophthalmol, Cincinnati, OH 45267 USA; Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15213 USA	University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kao, WWY (corresponding author), Univ Cincinnati, Med Ctr, Dept Ophthalmol, Hlth Profess Bldg,Suite 350,ML0527,Eden & Bethesd, Cincinnati, OH 45267 USA.			Liu, Chia-yang/0000-0002-8398-5516	NATIONAL EYE INSTITUTE [R01EY011845, R01EY009368, R01EY010556] Funding Source: NIH RePORTER; NEI NIH HHS [EY11845, EY10556, R01 EY010556, R01 EY009368-08, EY09368, R01 EY011845, R01 EY009368] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brown DL, 1997, SURGERY, V121, P372, DOI 10.1016/S0039-6060(97)90306-8; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; CORNUET PK, 1994, INVEST OPHTH VIS SCI, V35, P870; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X; Fullwood NJ, 1996, INVEST OPHTH VIS SCI, V37, P1256; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P24773; FUNDERBURGH JL, 1987, J BIOL CHEM, V262, P11634; FUNDERBURGH JL, 1991, J BIOL CHEM, V266, P14226; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; FUNDERBURGH JL, 1995, INVEST OPHTH VIS SCI, V36, P2296; FUNDERBURGH JL, 1990, J BIOL CHEM, V265, P8297; Funderburgh JL, 1998, INVEST OPHTH VIS SCI, V39, P1957; Funderburgh JL, 1997, INVEST OPHTH VIS SCI, V38, P1159; GIPSON IK, 1984, DEV BIOL, V101, P212, DOI 10.1016/0012-1606(84)90131-3; GIPSON IK, 1982, DEV BIOL, V92, P259, DOI 10.1016/0012-1606(82)90170-1; GROVER J, 1995, J BIOL CHEM, V270, P21942, DOI 10.1074/jbc.270.37.21942; INOUE M, 1995, J INVEST DERMATOL, V104, P479, DOI 10.1111/1523-1747.ep12605917; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; ISHIZAKI M, 1993, INVEST OPHTH VIS SCI, V34, P3320; JARVELAINEN HT, 1992, EXP CELL RES, V203, P395, DOI 10.1016/0014-4827(92)90013-X; JARVELAINEN HT, 1991, J BIOL CHEM, V266, P23274; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Kao WWY, 1998, INVEST OPHTH VIS SCI, V39, P502; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Moyer PD, 1996, DIFFERENTIATION, V60, P31, DOI 10.1046/j.1432-0436.1996.6010031.x; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; Saika S, 1998, CURR EYE RES, V17, P1049, DOI 10.1076/ceyr.17.11.1049.5227; SCHRECENGOST PK, 1992, ARCH BIOCHEM BIOPHYS, V292, P54, DOI 10.1016/0003-9861(92)90050-7; Scott JE, 1996, BIOCHEMISTRY-US, V35, P8795, DOI 10.1021/bi960773t; Smith RS, 1996, INVEST OPHTH VIS SCI, V37, P397; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; Wight Thomas N., 1992, Current Opinion in Cell Biology, V4, P793, DOI 10.1016/0955-0674(92)90102-I; Wilson SE, 1997, J REFRACT SURG, V13, P171; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; YU FSX, 1995, INVEST OPHTH VIS SCI, V36, P1997; Yu FSX, 1998, INVEST OPHTH VIS SCI, V39, P710; ZIESKE JD, 1989, J CELL BIOL, V109, P571, DOI 10.1083/jcb.109.2.571	45	202	206	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2607	2612		10.1074/jbc.275.4.2607	http://dx.doi.org/10.1074/jbc.275.4.2607			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644720	Green Accepted, hybrid			2022-12-27	WOS:000085128000052
J	Skovronsky, DM; Moore, DB; Milla, ME; Doms, RW; Lee, VMY				Skovronsky, DM; Moore, DB; Milla, ME; Doms, RW; Lee, VMY			Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-Golgi network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; FAMILIAL ALZHEIMERS-DISEASE; NT2N CELLS; DISINTEGRIN; NEURONS; METALLOPROTEINASE; ACCUMULATION; COMPARTMENT; CATABOLISM; MATURATION	The release of amyloidogenic amyloid-beta peptide (A beta) from amgloid-beta precursor protein (APP) requires cleavage by beta- and gamma-secretases. in contrast, alpha-secretase cleaves APP within the A beta sequence and precludes amyloidogenesis. Regulated and unregulated alpha-secretase activities have been reported, and the fraction of cellular alpha-secretase activity regulated by protein kinase C (PKC) has been attributed to the ADAM (a disintegrin and metalloproaease) family members TACE and ADAM-10. Although unregulated alpha-secretase cleavage of APP has been shown to occur at the cell surface, we sought to identify the intracellular site of PEG-regulated alpha-secretase APP cleavage. To accomplish this, we measured levels of secreted ectodomains and C-terminal fragments of APP generated by alpha-secretase (sAPP alpha) (C83) versus beta-secretase (sAPP beta) (C99) and secreted A beta in cultured cells treated with PEC and inhibitors of TACE/ ADAM-10. We found that PKC stimulation increased sAPP alpha but decreased sAPP beta levels by altering the competition between alpha- versus beta-secretase for APP within the same organelle rather than by perturbing APP trafficking. Moreover, data implicating the trans-Golgi network (TGN) as a major site for beta-secretase activity prompted us to hypothesize that PEG-regulated alpha-secretase(s) also reside in this organelle, To test this hypothesis, we performed studies demonstrating proteolytically mature TACE intracellularly, and we also showed that regulated alpha-secretase APP cleavage occurs in the TGN using an APP mutant construct targeted specifically to the TGN, By detecting regulated alpha-secretase APP cleavage in the TGN by TACE/ADAM-10, we reveal ADAM activity in a novel location. Finally, the competition between TACE/ADAM-10 and beta-secretase for intracellular APP cleavage may represent a novel target for the discovery of new therapeutic agents to treat Alzheimer's disease.	Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), HUP, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Maloney 3, Philadelphia, PA 19104 USA.							Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4; Jolly-Tornetta C, 1998, J BIOL CHEM, V273, P14015, DOI 10.1074/jbc.273.22.14015; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Mills J, 1997, J NEUROSCI, V17, P9415; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Savage MJ, 1998, J NEUROSCI, V18, P1743; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1997, MOL GENETIC BASIS NE, P601; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; SUZUKI N, 1994, AM J PATHOL, V145, P452; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; WOLF BA, 1995, J BIOL CHEM, V270, P4916, DOI 10.1074/jbc.270.9.4916; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	34	282	306	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2568	2575		10.1074/jbc.275.4.2568	http://dx.doi.org/10.1074/jbc.275.4.2568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644715	hybrid			2022-12-27	WOS:000085128000047
J	Tsujimoto, S; Bean, AJ				Tsujimoto, S; Bean, AJ			Distinct protein domains are responsible for the interaction of Hrs-2 with SNAP-25 - The role of Hrs-2 in 7 S complex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE DOCKING; MEMBRANE-FUSION; CLOSTRIDIAL NEUROTOXINS; COILED COILS; SNARE; SYNTAXIN; IDENTIFICATION; SPECIFICITY; EXOCYTOSIS; ACTIVATION	Regulated secretion of neurotransmitter at the synapse is likely to be mediated by dynamic protein interactions involving components of the vesicle (vesicle-associated membrane protein; VAMP) and plasma membrane (syntaxin and synaptosomal associated protein of 25 kDa (SNAP-25)) along with additional molecules that allow for the regulation of this process. Recombinant Hrs-2 interacts with SNAP-25 in a calcium-dependent manner (they dissociate at elevated calcium levels) and inhibits neurotransmitter release. Thus, Hrs-a has been hypothesized to serve a negative regulatory role in secretion through its interaction with SNAP-25. In this report, we show that Hrs-2 and SNAP-25 interact directly through specific coiled-coil domains in each protein. The presence of syntaxin enhances the binding of Hrs-2 to SNAP-25. Moreover, while both Hrs-2 and VAMP can separately bind to SNAP-25, they cannot bind simultaneously. Additionally, the presence of Hrs-2 reduces the incorporation of VAMP into the syntaxin SNAP-25.VAMP (7 S) complex. These findings suggest that Hrs-2 may modulate exocytosis by regulating the assembly of a protein complex implicated in membrane fusion.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA; Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77030 USA	University of Texas System; University of Texas System	Bean, AJ (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, 6431 Fannin St,Rm 7-208, Houston, TX 77030 USA.				NIMH NIH HHS [MH058920] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058920] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Banerjee A, 1996, J BIOL CHEM, V271, P20223, DOI 10.1074/jbc.271.34.20223; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hao JC, 1997, J NEUROSCI, V17, P1596; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Kohn WD, 1997, J BIOL CHEM, V272, P2583, DOI 10.1074/jbc.272.5.2583; KUFFLER SW, 1984, NEURON BRAIN; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tsujimoto S, 1999, EUR J NEUROSCI, V11, P3047, DOI 10.1046/j.1460-9568.1999.00716.x; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	28	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2938	2942		10.1074/jbc.275.4.2938	http://dx.doi.org/10.1074/jbc.275.4.2938			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644763	hybrid			2022-12-27	WOS:000085128000095
J	Garate, MA; Nunez, MT				Garate, MA; Nunez, MT			Overexpression of the ferritin iron-responsive element decreases the labile iron pool and abolishes the regulation of iron absorption by intestinal epithelial (Caco-2) cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; RNA-BINDING; MAMMALIAN-CELLS; MESSENGER-RNA; TRANSFERRIN; HEMOCHROMATOSIS; TRANSPORTER; DEGRADATION; EXPRESSION; ACONITASE	Mammalian cells regulate iron levels tightly through the activity of iron-regulatory proteins (IRPs) that bind to RNA motifs called iron-responsive elements (IREs), When cells become iron-depleted, IRPs bind to IREs present in the mRNAs of ferritin and the transferrin receptor, resulting in diminished translation of the ferritin mRNA and increased translation of the transferrin receptor mRNA. Likewise, intestinal epithelial cells regulate iron absorption by a process that also depends on the intracellular levels of iron. Although intestinal epithelial cells have an active IRE/IRP system, it has not been proven that this system is involved in the regulation of iron absorption in these cells. In this study, we characterized the effect of overexpression of the ferritin IRE on iron absorption by Caco-2 cells, a model of intestinal epithelial cells. Cells overexpressing ferritin IRE had increased levels of ferritin, whereas the levels of the transferrin receptor were decreased. Iron absorption in IRE-transfected cells was deregulated: iron uptake from the apical medium was increased, but the capacity to retain this newly incorporated iron diminished. Cells overexpressing IRE were not able to control iron absorption as a function of intracellular iron, because both iron-deficient cells as well as iron-loaded cells absorbed similarly high levels of iron. The labile iron pool of IRE-transfected cell was extremely low. Likewise, the reduction of the labile iron pool in control cells resulted in cells having increased iron absorption. These results indicate that cells overexpressing IRE do not regulate iron absorption, an effect associated with decreased levels of the regulatory iron pool.	Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; Millennium Inst Advances Studies Cell Biol & Biot, Santiago, Chile	Universidad de Chile	Nunez, MT (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Casilla 653, Santiago, Chile.	mnunez@abello.dic.uchile.cl	Nunez, Marco/H-6348-2014	Nunez, Marco/0000-0002-1967-8570				ALVAREZHERNANDEZ X, 1994, BBA-BIOMEMBRANES, V1192, P215, DOI 10.1016/0005-2736(94)90121-X; Arredondo M, 1997, AM J PHYSIOL-GASTR L, V273, pG275, DOI 10.1152/ajpgi.1997.273.2.G275; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; BOYD D, 1985, J BIOL CHEM, V260, P1755; Cairo G, 1997, BLOOD, V89, P2546, DOI 10.1182/blood.V89.7.2546; DERUSSO PA, 1995, J BIOL CHEM, V270, P15451, DOI 10.1074/jbc.270.26.15451; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; FLANAGAN PR, 1995, HEPATOLOGY, V22, P828, DOI 10.1002/hep.1840220321; FLANAGAN PR, 1990, ACTA PEDIAT SCAND S, V361, P21; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; GAVIN MW, 1994, AM J CLIN NUTR, V59, P1376, DOI 10.1093/ajcn/59.6.1376; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUO B, 1994, J BIOL CHEM, V269, P24252; Gutierrez JA, 1997, J CELL BIOL, V139, P895, DOI 10.1083/jcb.139.4.895; HAN O, 1995, J NUTR, V125, P1291; Harlow E., 1988, ANTIBODIES LAB MANUA, P553; HILLGREN KM, 1995, MED RES REV, V15, P83, DOI 10.1002/med.2610150202; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Lee PL, 1998, BLOOD CELL MOL DIS, V24, P199, DOI 10.1006/bcmd.1998.0186; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; NUNEZ MT, 1994, AM J PHYSIOL-CELL PH, V267, pC1582, DOI 10.1152/ajpcell.1994.267.6.C1582; Nunez MT, 1996, J NUTR, V126, P2151, DOI 10.1093/jn/126.9.2151; PIETRANGELO A, 1992, GASTROENTEROLOGY, V102, P802, DOI 10.1016/0016-5085(92)90161-Q; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Tapia V, 1996, AM J PHYSIOL-GASTR L, V271, pG443, DOI 10.1152/ajpgi.1996.271.3.G443; TOPHAM RW, 1992, BIOCHEM J, V284, P877, DOI 10.1042/bj2840877	31	20	20	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1651	1655		10.1074/jbc.275.3.1651	http://dx.doi.org/10.1074/jbc.275.3.1651			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636858	hybrid			2022-12-27	WOS:000084940000021
J	Jensen, LH; Nitiss, KC; Rose, A; Dong, JW; Zhou, JF; Hu, T; Osheroff, N; Jensen, PB; Sehested, M; Nitiss, JL				Jensen, LH; Nitiss, KC; Rose, A; Dong, JW; Zhou, JF; Hu, T; Osheroff, N; Jensen, PB; Sehested, M; Nitiss, JL			A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA TOPOISOMERASE; SACCHAROMYCES-CEREVISIAE; YEAST-CELLS; CONFERS RESISTANCE; COVALENT COMPLEXES; EUKARYOTIC CELLS; PROTEIN CLAMP; ETOPOSIDE; INHIBITORS; ENZYME	Bisdioxopiperazines are a unique class of topoisomerase II inhibitors that lock topoisomerase II at a point in the enzyme reaction cycle where the enzyme forms a closed clamp around DNA, We examined cell killing by ICRF-187 and ICRF-193 in yeast cells expressing human topoisomerase II alpha (htop-II alpha). Expression of htop-II alpha in yeast cells sensitizes them to both ICRF-187 and ICRF-193, compared with cells expressing yeast topoisomerase II. ICRF 193 is still able to exert growth inhibition in the presence of genes encoding both ICRF-193-resistant and ICRF-193-sensitive htop-II alpha enzymes, indicating that sensitivity to bisdioxopiperazines is dominant. Killing by ICRF-193 occurs more rapidly, than the killing in yeast cells due to a temperature-sensitive yeast topoisomerase II incubated at the non-permissive temperature. These results are reminiscent of a top-II poison such as etoposide, However, the killing caused by ICRF-193 and ICRF-187 is not enhanced by mutations in the RAD52 pathway. The levels of drug-induced DNA cleavage observed with htop-II alpha in vitro is insufficient to explain the sensitivity induced by this enzyme in yeast cells. Finally, arrest of cells in G(1) does not protect cells from ICRF-193 lethality, a result inconsistent with killing mechanisms due to catalytic inhibition of top-II or stabilization of a cleavable complex. We suggest that the observed pattern of cell killing is most consistent with a poisoning of htop-II by ICRF-193 by a novel mechanism. The accumulation of closed clamp conformations of htop-II induced by ICRF-193 that are trapped on DNA might interfere with transcription, or other DNA metabolic processes, resulting in cell death.	St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38018 USA; Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; Duke Univ, Sch Med, Dept Biochem, Durham, NC 27710 USA; Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	St Jude Children's Research Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Duke University; Vanderbilt University; Vanderbilt University	Nitiss, JL (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, 332 N Lauderdale St, Memphis, TN 38018 USA.	john.nitiss@stjude.org	Nitiss, John/E-9974-2010	Nitiss, John/0000-0002-1013-4972	NATIONAL CANCER INSTITUTE [R01CA052814, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765, CA52814] Funding Source: Medline; NIGMS NIH HHS [GM33944] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang S, 1998, J BIOL CHEM, V273, P19822, DOI 10.1074/jbc.273.31.19822; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; CHEN M, 1995, CANCER RES, V55, P1509; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; DRAKE FH, 1989, CANCER RES, V49, P2578; ELSEA SH, 1995, J BIOL CHEM, V270, P1913, DOI 10.1074/jbc.270.4.1913; ELSEA SH, 1992, J BIOL CHEM, V267, P13150; ENG WK, 1988, MOL PHARMACOL, V34, P755; Fortune JM, 1998, J BIOL CHEM, V273, P17643, DOI 10.1074/jbc.273.28.17643; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; Hsiung Y, 1996, CANCER RES, V56, P91; HSIUNG YC, 1995, J BIOL CHEM, V270, P20359, DOI 10.1074/jbc.270.35.20359; HSU SM, 1990, METHOD ENZYMOL, V184, P357; Hu T, 1998, J BIOL CHEM, V273, P9586, DOI 10.1074/jbc.273.16.9586; ISHIDA R, 1995, CANCER RES, V55, P2299; ISHIMI Y, 1995, J MOL BIOL, V247, P835, DOI 10.1006/jmbi.1995.0183; JANNATIPOUR M, 1993, J BIOL CHEM, V268, P18586; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; JENSEN PB, 1991, CANCER RES, V51, P5093; Kingma PS, 1997, BIOCHEMISTRY-US, V36, P5934, DOI 10.1021/bi970507v; LEONG MML, 1990, METHOD ENZYMOL, V184, P442; LINDSLEY JE, 1991, P NATL ACAD SCI USA, V88, P10485, DOI 10.1073/pnas.88.23.10485; LIU YX, 1994, CANCER RES, V54, P2943; Morris SNK, 1999, J BIOL CHEM, V274, P3446, DOI 10.1074/jbc.274.6.3446; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; NITISS J, 1991, DNA TOPOISOMERASES C, P77; Nitiss JL, 1997, CANCER RES, V57, P4564; NITISS JL, 1993, CANCER RES, V53, P89; Nitiss JL, 1998, BBA-GENE STRUCT EXPR, V1400, P63, DOI 10.1016/S0167-4781(98)00128-6; Nitiss JL, 1998, BIOCHEMISTRY-US, V37, P3078, DOI 10.1021/bi9723257; Nitiss JL, 1996, EUR J CANCER, V32A, P958, DOI 10.1016/0959-8049(96)00056-1; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; NITISS JL, 1992, CANCER RES, V52, P4467; OSHEROFF N, 1986, J BIOL CHEM, V261, P9944; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; ROCA J, 1995, TRENDS BIOCHEM SCI, V20, P156, DOI 10.1016/S0968-0004(00)88993-8; Sehested M, 1996, BIOCHEM PHARMACOL, V51, P879, DOI 10.1016/0006-2952(95)02241-4; Sehested M, 1998, CANCER RES, V58, P1460; Snapka RM, 1996, BIOCHEM PHARMACOL, V52, P543, DOI 10.1016/0006-2952(96)00305-X; Tennyson RB, 1997, BIOCHEMISTRY-US, V36, P6107, DOI 10.1021/bi970152f; van Hille B, 1998, CANCER CHEMOTH PHARM, V42, P345, DOI 10.1007/s002800050828; Vassetzky YS, 1996, BRIT J CANCER, V73, P1201, DOI 10.1038/bjc.1996.231; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WASSERMAN RA, 1993, CANCER RES, V53, P3591; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; [No title captured]	51	80	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2137	2146		10.1074/jbc.275.3.2137	http://dx.doi.org/10.1074/jbc.275.3.2137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636919	hybrid			2022-12-27	WOS:000084940000082
J	Kuner, P; Bohrmann, B; Tjernberg, LO; Naslund, J; Huber, G; Celenk, S; Gruninger-Leitch, F; Richards, JG; Jakob-Roetne, R; Kemp, JA; Nordstedt, C				Kuner, P; Bohrmann, B; Tjernberg, LO; Naslund, J; Huber, G; Celenk, S; Gruninger-Leitch, F; Richards, JG; Jakob-Roetne, R; Kemp, JA; Nordstedt, C			Controlling polymerization of beta-amyloid and prion-derived peptides with synthetic small molecule ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; ALZHEIMER-DISEASE; APOLIPOPROTEIN-E; CONGO RED; FIBRIL FORMATION; CYCLOSPORINE-A; PROTEIN; BINDING; COMPLEX; ACCELERATION	The Alzheimer beta-amyloid peptide (A beta) and a fragment of the prion protein have the capacity of forming amyloid-like fibrils when incubated under physiological conditions in vitro, Here we show that a small amyloid ligand, RO-47-1816/001, enhances this process severalfold by binding to amyloid molecules and apparently promote formation of the peptide-to-peptide bonds that join the monomers of the amyloid fibrils. This effect could be antagonized by other ligands, including analogues of RO-47-1816/001, as well as the structurally unrelated ligand Congo red. Analogues of RO-47-1816/001 with low affinity for amyloid did not display any antagonistic effect. In conclusion, these data suggest that synthetic molecules, and possibly also small natural substances present in the brain, may act in a chaperone-like fashion, promoting A beta polymerization and growth of amyloid fibrils in vitro and possibly also in vivo, Furthermore, we demonstrate that small organic molecules can be used to inhibit the action of amyloid-enhancing compounds.	F Hoffmann La Roche & Co Ltd, Div Pharma, Preclin Res, CH-4070 Basel, Switzerland; Karolinska Hosp, Dept Clin Neurosci, Sect Drug Dependence Res, Lab Biochem & Mol Pharmacol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Neurosci Occupat Therapy & Elderly Care, KFC Novum Plan 4, S-14186 Huddinge, Sweden	Roche Holding; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Nordstedt, C (corresponding author), F Hoffmann La Roche & Co Ltd, Div Pharma, Preclin Res, CH-4070 Basel, Switzerland.			Kuner, Pascal/0000-0001-6513-5414				Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Briesewitz R, 1999, P NATL ACAD SCI USA, V96, P1953, DOI 10.1073/pnas.96.5.1953; Brown DR, 1997, EUR J NEUROSCI, V9, P1162, DOI 10.1111/j.1460-9568.1997.tb01470.x; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Esler WP, 1997, NAT BIOTECHNOL, V15, P258, DOI 10.1038/nbt0397-258; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Forloni G, 1996, MOL CHEM NEUROPATHOL, V28, P163, DOI 10.1007/BF02815218; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Hardman J. G., 1996, GOODMAN GILMANS PHAR; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hughes SR, 1996, P NATL ACAD SCI USA, V93, P2065, DOI 10.1073/pnas.93.5.2065; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Klunk WE, 1998, LIFE SCI, V63, P1807, DOI 10.1016/S0024-3205(98)00454-8; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; SOTO C, 1995, FEBS LETT, V371, P110, DOI 10.1016/0014-5793(95)00863-5; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; TAYLOR DL, 1974, J HISTOCHEM CYTOCHEM, V22, P1105, DOI 10.1177/22.12.1105; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Tjernberg LO, 1997, J BIOL CHEM, V272, P12601, DOI 10.1074/jbc.272.19.12601; TURNELL WG, 1992, J MOL BIOL, V227, P1205, DOI 10.1016/0022-2836(92)90532-O; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	42	72	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1673	1678		10.1074/jbc.275.3.1673	http://dx.doi.org/10.1074/jbc.275.3.1673			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636861	hybrid			2022-12-27	WOS:000084940000024
J	Mense, M; Dunbar, LA; Blostein, R; Caplan, MJ				Mense, M; Dunbar, LA; Blostein, R; Caplan, MJ			Residues of the fourth transmembrane segments of the Na,K-ATPase and the gastric H,H-ATPase contribute to cation selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; RAT-KIDNEY NA+,K+-ATPASE; ALPHA-SUBUNIT; FUNCTIONAL CONSEQUENCES; DIRECTED MUTAGENESIS; VANADATE; SITE; DOMAIN; STATE; PUMPS	We have generated protein chimeras to investigate the role of the fourth transmembrane segments (TM4) of the Na,K- and gastric H,K-ATPases in determining the distinct cation selectivities of these two pumps, Based on a helical wheel analysis, three residues of TM4 of the Na,K-ATPase were changed to their H,K-counterparts. A construct carrying three mutations in TM4 (L319F, N326Y, and T340S) and two control constructs were heterologously expressed in Xenopus laevis oocytes and in the pig kidney epithelial cell line LLC-PK1, Biochemical ATPase assays demonstrated a large sodium-independent ATPase activity at pH 6.0 for the pump carrying the TM4 substitutions, whereas the control constructs exhibited little or no activity in the absence of sodium, Furthermore, at pH 6.0 the K-1/2(Na+) shifted to 1.5 mM for the TM4 construct compared with 9.4 and 5.9 mM for the controls. In contrast, at pH 7.5 all three constructs had characteristics similar to wild type Na,K-ATPase, Large increases in K-1/2(K+) were observed for the TM4 construct compared with the control constructs both in two electrode voltage clamp experiments in Xenopus oocytes and in ATPase assays. ATPase assays also revealed a 10-fold shift in vanadate sensitivity for the TM4 construct. Based on these findings, it appears that the three identified TM4 residues play an important role in determining both the specific cation selectivities and the E-1/E-2 conformational equilibria of the Na,K- and H,K-ATPase.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada	Yale University; McGill University; McGill University	Mense, M (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	Martin.Mense@yale.edu		Caplan, Michael/0000-0001-5768-4405	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042136] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42136] Funding Source: Medline; PHS HHS [DR17433] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ambesi A, 1996, J BIOL CHEM, V271, P22999, DOI 10.1074/jbc.271.38.22999; ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; ANNER BM, 1994, MOL MEMBR BIOL, V11, P237, DOI 10.3109/09687689409160433; Blostein R, 1999, J BIOL CHEM, V274, P18374, DOI 10.1074/jbc.274.26.18374; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; CourtoisCoutry N, 1997, CELL, V90, P501, DOI 10.1016/S0092-8674(00)80510-3; DALY SE, 1994, J BIOL CHEM, V269, P23944; Doucet A, 1997, EXP NEPHROL, V5, P271; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Friedrich T, 1996, BIOPHYS J, V71, P2486, DOI 10.1016/S0006-3495(96)79442-0; Fyfe GK, 1998, J GEN PHYSIOL, V112, P423, DOI 10.1085/jgp.112.4.423; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; GRISHIN AV, 1994, FEBS LETT, V349, P144, DOI 10.1016/0014-5793(94)00655-5; HARRIS SL, 1991, J BIOL CHEM, V266, P24439; HORISBERGER JD, 1991, P NATL ACAD SCI USA, V88, P8397, DOI 10.1073/pnas.88.19.8397; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V705, P38, DOI 10.1016/0167-4838(82)90333-8; KRIEG PA, 1987, P NATL ACAD SCI USA, V84, P2331, DOI 10.1073/pnas.84.8.2331; KUNTZWEILER TA, 1995, J BIOL CHEM, V270, P2993, DOI 10.1074/jbc.270.7.2993; MACLENNAN DH, 1992, ANN NY ACAD SCI, V671, P1, DOI 10.1111/j.1749-6632.1992.tb43779.x; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; RAO R, 1993, J BIOL CHEM, V268, P6708; SACHS JR, 1987, J GEN PHYSIOL, V90, P291, DOI 10.1085/jgp.90.2.291; Schneeberger A, 1999, J MEMBRANE BIOL, V168, P221, DOI 10.1007/s002329900511; SERRANO R, 1990, BIOCHIM BIOPHYS ACTA, V1018, P195, DOI 10.1016/0005-2728(90)90247-2; SMITH RL, 1980, J BIOL CHEM, V255, P9852; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; VILSEN B, 1995, FEBS LETT, V363, P179, DOI 10.1016/0014-5793(95)00313-X; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q	28	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1749	1756		10.1074/jbc.275.3.1749	http://dx.doi.org/10.1074/jbc.275.3.1749			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636871	hybrid			2022-12-27	WOS:000084940000034
J	Cvetkovic, B; Yang, B; Williamson, RA; Sigmund, CD				Cvetkovic, B; Yang, B; Williamson, RA; Sigmund, CD			Appropriate tissue- and cell-specific expression of a single copy human angiotensinogen transgene specifically targeted upstream of the HPRT locus by homologous recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; ESSENTIAL-HYPERTENSION; AFRICAN-AMERICANS; BLOOD-PRESSURE; HUMAN RENIN; GENE; MICE; VARIANT; ASSOCIATION; POPULATION	Development of experimental models by genetic manipulation in mice has proven to be very useful in determining the significance of particular genes in the development of or susceptibility to hypertension. Advances in molecular genetics, transgenic mouse technology, and physiological measurements in mice provided an opportunity to go a step further and develop models to analyze the physiological significance of specific gene variants potentially causing hypertension. In this report, we describe the development of a human angiotensinogen transgenic mouse model generated by targeting the human angiotensinogen gene upstream of the mouse HPRT locus by homologous recombination. The main benefit of this transgenic mouse model is that the human angiotensinogen gene is inserted into the mouse genome as a single copy at a predefined locus and in a specific orientation-a process that can be repeated utilizing other variants of this gene. We establish the validity of this approach by showing that the hAGT(hprt) mice have normal tissue- and cell-specific expression of the human angiotensinogen gene and normally produce and process the hAGT protein at physiological levels.	Univ Iowa, Coll Med, Dept Internal Med & Physiol & Biophys, Mol Biol Interdisciplinary Program,Med Lab 2191, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Sigmund, CD (corresponding author), Univ Iowa, Coll Med, Dept Internal Med & Physiol & Biophys, Mol Biol Interdisciplinary Program,Med Lab 2191, Iowa City, IA 52242 USA.		Sigmund, Curt D./W-1611-2019	Sigmund, Curt D./0000-0002-1453-0921	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048058, R37HL048058, P50HL055006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK052617] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL55006, HL48058] Funding Source: Medline; NIDDK NIH HHS [DK52617] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENNETT CL, 1993, BIOCHEM BIOPH RES CO, V197, P833, DOI 10.1006/bbrc.1993.2554; BLOEM LJ, 1995, J CLIN INVEST, V95, P948, DOI 10.1172/JCI117803; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Corvol P, 1999, HYPERTENSION, V33, P1324, DOI 10.1161/01.HYP.33.6.1324; CVETKOVIC B, 2000, IN PRESS KIDNEY INT; Davisson RL, 1997, J CLIN INVEST, V99, P1258, DOI 10.1172/JCI119283; Davisson RL, 1998, CIRC RES, V83, P1047, DOI 10.1161/01.RES.83.10.1047; ELLISON KE, 1989, J CLIN INVEST, V83, P1941, DOI 10.1172/JCI114102; FORNAGE M, 1995, HUM GENET, V96, P295; HATA A, 1994, J CLIN INVEST, V93, P1285, DOI 10.1172/JCI117083; Hatada S, 1999, J BIOL CHEM, V274, P948, DOI 10.1074/jbc.274.2.948; HATAE T, 1994, MOL CELL BIOCHEM, V131, P43, DOI 10.1007/BF01075723; Hingorani AD, 1996, HYPERTENSION, V28, P907, DOI 10.1161/01.HYP.28.5.907; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; ISHIGAMI T, 1995, CIRCULATION, V91, P951, DOI 10.1161/01.CIR.91.4.951; IWAI N, 1995, HYPERTENSION, V25, P688, DOI 10.1161/01.HYP.25.4.688; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Jeunemaitre X, 1999, Curr Hypertens Rep, V1, P31, DOI 10.1007/s11906-999-0071-0; Jeunemaitre X, 1993, J HYPERTENS, V11, P80; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; LIFTON RP, 1993, J HYPERTENS, V11, P231, DOI 10.1097/00004872-199303000-00002; Morgan T, 1997, J CLIN INVEST, V100, P1406, DOI 10.1172/JCI119661; ROTIMI C, 1994, HYPERTENSION, V24, P591, DOI 10.1161/01.HYP.24.5.591; RUTLEDGE DR, 1994, BIOCHEM MOL BIOL INT, V34, P1271; SHAWWHITE JR, 1993, TRANSGENIC RES, V2, P1, DOI 10.1007/BF01977675; Sinn PL, 1999, AM J PHYSIOL-RENAL, V277, pF634, DOI 10.1152/ajprenal.1999.277.4.F634; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; Yang GY, 1998, HYPERTENSION, V31, P734, DOI 10.1161/01.HYP.31.3.734; YANG GY, 1994, J BIOL CHEM, V269, P32497	31	39	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1073	1078		10.1074/jbc.275.2.1073	http://dx.doi.org/10.1074/jbc.275.2.1073			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625648	hybrid			2022-12-27	WOS:000084836600052
J	Kimura, A; Singh, D; Wawrousek, EF; Kikuchi, M; Nakamura, M; Shinohara, T				Kimura, A; Singh, D; Wawrousek, EF; Kikuchi, M; Nakamura, M; Shinohara, T			Both PCE-1/RX and OTX/CRX interactions are necessary for photoreceptor-specific gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING SPECIFICITY; HOMEOBOX GENE; HOMEODOMAIN PROTEINS; BOX GENE; PROMOTER; RETINA; SITE; TRANSCRIPTION; DROSOPHILA; MUTATIONS	RX, a homeodomain-containing protein essential for proper eye development (Mathers, P. H. Grinberg, A., Mahon, K. A., and Jamrich, M. (1997) Nature 387, 603-607), binds to the photoreceptor conserved element-1 (PCE-1/Ret 1) in the photoreceptor cell-specific arrestin promoter and stimulates gene expression. RX is found in many retinal cell types including photoreceptor cells. Another homeodomain-containing protein, CRX, which binds to the OTX element to stimulate promoter activity, is found exclusively in photoreceptor cells (Chen, S., Wang, Q. L., Nie, Z., Sun, H., Lennon, G., Copeland, N. G., Gillbert, D. J. Jenkins, N. A., and Zack, D. J. (1997) Neuron 19, 1017-1030; Furukawa, T., Morrow, E. M., and Cepko, C. L. (1997) Cell 91, 531-541). Binding assay and cell culture studies indicate that both PCE-1 and OTX elements and at least two different regulatory factors RX and CRX are necessary for high level, photoreceptor cell-restricted gene expression. Thus, photoreceptor specificity can be achieved by multiple promoter elements interacting with a combination of both photoreceptor-specific regulatory factors and factors present in closely related cell lineages.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Ophthalmol,Ctr Ophthalm Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Ophthalmol,Cerebrovasc & NeuroSci Res Inst, Boston, MA 02115 USA; NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Shinohara, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Ophthalmol,Ctr Ophthalm Res, Boston, MA 02115 USA.		Wawrousek, Eric/A-4547-2008	Shinohara, Toshimichi/0000-0002-7197-9039	NATIONAL EYE INSTITUTE [Z01EY000285] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Boatright JH, 1997, EXP EYE RES, V64, P269, DOI 10.1006/exer.1996.0222; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; DEJONG R, 1993, NUCLEIC ACIDS RES, V21, P4711, DOI 10.1093/nar/21.20.4711; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Kennedy BN, 1998, J BIOL CHEM, V273, P5591, DOI 10.1074/jbc.273.10.5591; KIKUCHI T, 1993, MOL CELL BIOL, V13, P4400, DOI 10.1128/MCB.13.7.4400; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; LEGENDRE N, 1990, Biotechniques, V9, P788; Martinez JA, 1998, BIOCHEM BIOPH RES CO, V250, P175, DOI 10.1006/bbrc.1998.9261; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; MORABITO MA, 1991, J BIOL CHEM, V266, P9667; OPSTELTEN DJE, 1991, MECH DEVELOP, V34, P29, DOI 10.1016/0925-4773(91)90089-O; Sambrook J., 2002, MOL CLONING LAB MANU; SCHNEITZ K, 1993, GENE DEV, V7, P114, DOI 10.1101/gad.7.1.114; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; STRYER L, 1988, COLD SPRING HARB SYM, V53, P283, DOI 10.1101/SQB.1988.053.01.035; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TREISMAN J, 1989, CELL, V59, P553; WALTHER C, 1991, DEVELOPMENT, V113, P1435; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; Yu X, 1996, J NEUROCHEM, V67, P2494	29	113	118	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1152	1160		10.1074/jbc.275.2.1152	http://dx.doi.org/10.1074/jbc.275.2.1152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625658	hybrid			2022-12-27	WOS:000084836600062
J	Miller, SP; Chen, RD; Karschnia, EJ; Romfo, C; Dean, A; LaPorte, DC				Miller, SP; Chen, RD; Karschnia, EJ; Romfo, C; Dean, A; LaPorte, DC			Locations of the regulatory sites for isocitrate dehydrogenase kinase/phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI ML308; ATP-BINDING-SITE; KINASE PHOSPHATASE; ACTIVE-SITE; PHOSPHORYLATION; INACTIVATION; SENSITIVITY; PROTEINS; CYCLE	Isocitrate dehydrogenase (IDH)(1) of Escherichia coli is regulated by a bifunctional protein, IDH kinase/phosphatase, In this paper, we demonstrate that the effecters controlling these activities belong to two distinct classes that differ in mechanism and in the locations of their binding sites. NADPH and isocitrate are representative members of one of these effector classes. NADPH inhibits both IDH kinase and IDH phosphatase, whereas isocitrate inhibits only IDH kinase, Isocitrate can "activate" IDH phosphatase by reversing product inhibition by dephospho-IDH. Mutations in icd, which encodes IDH, had parallel effects on the binding of these ligands to the IDH active site and on their effects on IDH kinase and phosphatase, indicating that these ligands regulate IDH kinase/phosphatase through the IDH active site. Kinetic analyses suggested that isocitrate and NADPH prevent formation of the complex between IDH kinase/phosphatase and its protein substrate. AMP, 3-phosphoglycerate, and pyruvate represent a class of regulatory ligands that is distinct from that which includes isocitrate and NADPH. These ligands bind directly to IDH kinase/phosphatase, a conclusion which is supported by the observation that they inhibit the IDH-independent ATPase activity of this enzyme. These effector classes can also be distinguished by the observation that mutant derivatives of IDH kinase/phosphatase expressed from aceK3 and aceK4 exhibited dramatic changes in their responses to AMP, 3-phosphoglycerate, and pyruvate but not to NADPH and isocitrate.	Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	LaPorte, DC (corresponding author), Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA.	DAVID-L@LENTI.MED.UMN.EDU			NIDDK NIH HHS [DK40486] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040486] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AXELSON JT, 1981, ANAL BIOCHEM, V116, P357, DOI 10.1016/0003-2697(81)90371-7; BAIS R, 1975, ANAL BIOCHEM, V63, P271, DOI 10.1016/0003-2697(75)90215-8; BENNETT PM, 1975, J GEN MICROBIOL, V87, P37, DOI 10.1099/00221287-87-1-37; BORTHWICK AC, 1984, BIOCHEM J, V222, P797, DOI 10.1042/bj2220797; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Chen RD, 1996, PROTEIN SCI, V5, P287; DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110; DEAN AM, 1989, J BIOL CHEM, V264, P20482; FinerMoore J, 1997, BIOCHEMISTRY-US, V36, P13890, DOI 10.1021/bi9711691; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; GARNAK M, 1979, J BIOL CHEM, V254, P7915; Graves D J, 1980, Methods Enzymol, V64, P325; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; IKEDA T, 1991, J BACTERIOL, V173, P1801, DOI 10.1128/jb.173.5.1801-1806.1991; IKEDA TP, 1992, J BACTERIOL, V174, P1414, DOI 10.1128/jb.174.4.1414-1416.1992; KORNBERG HL, 1957, BIOCHIM BIOPHYS ACTA, V24, P651, DOI 10.1016/0006-3002(57)90268-8; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KOSHLAND DE, 1985, CURR TOP CELL REGUL, V27, P13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; LAPORTE DC, 1985, J BIOL CHEM, V260, P5291; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miller SP, 1996, J BIOL CHEM, V271, P19124, DOI 10.1074/jbc.271.32.19124; NIMMO GA, 1984, EUR J BIOCHEM, V141, P409, DOI 10.1111/j.1432-1033.1984.tb08206.x; STUELAND CS, 1987, J BIOL CHEM, V262, P16095; STUELAND CS, 1989, J BIOL CHEM, V264, P13775; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; VARELA I, 1988, FEBS LETT, V231, P361, DOI 10.1016/0014-5793(88)80850-0	32	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					833	839		10.1074/jbc.275.2.833	http://dx.doi.org/10.1074/jbc.275.2.833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625615	hybrid			2022-12-27	WOS:000084836600019
J	Hall, SK; Armstrong, DL				Hall, SK; Armstrong, DL			Conditional and unconditional inhibition of calcium-activated potassium channels by reversible protein phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNEL; THYROTROPIN-RELEASING-HORMONE; VASOACTIVE INTESTINAL PEPTIDE; KINASE-A; BETA-SUBUNIT; CYCLIC-AMP; DIFFERENTIAL MODULATION; HIPPOCAMPAL-NEURONS; LARGE-CONDUCTANCE; PHOSPHATASE 2A	Large conductance, calcium-activated potassium channels (BKCa or maxi-K) are important determinants of membrane excitability in many cell types. We used patch clamp techniques to study the biochemical regulatiom of native BKCa channel proteins by endogenous Ser/Thr-directed protein kinases and phosphatases in cell-free membrane patches from rat pituitary tumor cells (GE(4)C(1)). When protein kinase activity was blocked by removing ATP, endogenous protein phosphatases slowly increased BKCa channel activity approximately 3-fold. Dephosphorylated channels could be activated fully by physiological increases in cytoplasmic calcium or membrane depolarization. In contrast, endogenous protein kinases inhibited BKCa channel activity at two functionally distinct sites. A closely associated, cAMP-dependent protein kinase rapidly reduced channel activity in a conditional manner that could be overcome completely by increasing cytoplasmic free calcium 3-fold or 20 mV further depolarization. Phosphorylation at a pharmacologically distinct site inhibited channel activity unconditionally by reducing availability to approximately half that of maximum at all physiological calcium and voltages. Conditional versus unconditional inhibition of BKCa channel activity through different protein kinases provides cells with a powerful computational mechanism for regulating membrane excitability.	Cardiff Univ, Cardiff Sch Biosci, Physiol Unit, Cardiff CF10 3US, S Glam, Wales; NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hall, SK (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Physiol Unit, POB 911,Museum Ave, Cardiff CF10 3US, S Glam, Wales.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES080043, ZIAES080043] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; ALKON DL, 1986, BIOCHEM BIOPH RES CO, V134, P1245, DOI 10.1016/0006-291X(86)90384-0; ARMSTRONG DL, 1992, TRENDS NEUROSCI, V15, P403, DOI 10.1016/0166-2236(92)90192-B; ARMSTRONG DL, 1999, ADV 2 MESSENGER PHOS, V33; BARROS F, 1993, FEBS LETT, V336, P433, DOI 10.1016/0014-5793(93)80851-K; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BIELEFELDT K, 1994, J PHYSIOL-LONDON, V475, P241, DOI 10.1113/jphysiol.1994.sp020065; BYERLY L, 1984, J PHYSIOL-LONDON, V352, P637, DOI 10.1113/jphysiol.1984.sp015314; CARL A, 1991, AM J PHYSIOL, V261, pC387, DOI 10.1152/ajpcell.1991.261.2.C387; DORNER D, 1988, J NEUROSCI, V8, P4069; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; LECHLEITER JD, 1988, NEURON, V1, P227, DOI 10.1016/0896-6273(88)90143-2; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MARTY A, 1985, J PHYSIOL-LONDON, V367, P117, DOI 10.1113/jphysiol.1985.sp015817; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; MEERA P, 1995, AM J PHYSIOL-CELL PH, V269, pC312, DOI 10.1152/ajpcell.1995.269.2.C312; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; Pedarzani P, 1995, J NEUROPHYSIOL, V74, P2749, DOI 10.1152/jn.1995.74.6.2749; PEREZ G, 1994, AM J PHYSIOL, V266, pC1459, DOI 10.1152/ajpcell.1994.266.5.C1459; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; REINHART PH, 1991, J NEUROSCI, V11, P1627; REINHART PH, 1995, J NEUROSCI, V15, P4572; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Sakmann B., 1995, SINGLE CHANNEL RECOR; Shipston MJ, 1996, J PHYSIOL-LONDON, V493, P665, DOI 10.1113/jphysiol.1996.sp021413; SIKDAR SK, 1989, BRAIN RES, V496, P113, DOI 10.1016/0006-8993(89)91057-3; SIMASKO SM, 1991, ENDOCRINOLOGY, V128, P2015, DOI 10.1210/endo-128-4-2015; Smith MA, 1998, J PHYSIOL-LONDON, V513, P733, DOI 10.1111/j.1469-7793.1998.733ba.x; Stockand JD, 1996, AM J PHYSIOL-CELL PH, V271, pC1669, DOI 10.1152/ajpcell.1996.271.5.C1669; Tashjian A H Jr, 1979, Methods Enzymol, V58, P527; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; TORRES GE, 1995, MOL PHARMACOL, V47, P191; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0; YAJIMA Y, 1986, J BIOL CHEM, V261, P2684; Zhou XB, 1996, J BIOL CHEM, V271, P19760, DOI 10.1074/jbc.271.33.19760	46	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3749	3754		10.1074/jbc.275.6.3749	http://dx.doi.org/10.1074/jbc.275.6.3749			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660522	hybrid			2022-12-27	WOS:000085288800006
J	Sharma, R; Rensing, C; Rosen, BP; Mitra, B				Sharma, R; Rensing, C; Rosen, BP; Mitra, B			The ATP hydrolytic activity of purified ZntA, a Pb(II)/Cd(II)/Zn(II)-translocating ATPase from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; COPPER-TRANSPORTING ATPASE; WILSON DISEASE GENE; MEMBRANE-VESICLES; ENTEROCOCCUS-HIRAE; MENKES DISEASE; ENCODES; RECONSTITUTION; PURIFICATION; SEQUENCE	ZntA, a soft metal-translocating P1-type ATPase from Escherichia coli, confers resistance to Pb(II), Cd(II), and Zn(II). ZntA was expressed as a histidyl-tagged protein, solubilized from membranes with Triton X-100, and purified to homogeneity, The soft metal-dependent ATP hydrolysis activity of purified ZntA was characterized. The activity was specific for Pb(II), Cd(II), Zn(II), and Hg(II), with the highest activity obtained when the metals were present as thiolate complexes of cysteine or glutathione. The maximal ATPase activity of ZntA was similar to 3 mu mol/(mg.min) obtained with the Pb(II)-thiolate complex. In the absence of thiolates, Cd(II) inhibits ZntA above pH 6, whereas the Cd(II)-thiolate complexes stimulate activity, suggesting that a metal-thiolate complex is the true substrate in vivo. These results are consistent with the physiological role of ZntA as mediator of resistance to toxic concentrations of the divalent soft metals, Pb(PI), Cd(II), and Zn(II), by ATP-dependent efflux. Our results confirm that ZntA is the first Pb(II)-dependent ATPase discovered to date.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Mitra, B (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.		Rensing, Christopher/D-3947-2011; Sharma, Rakesh/F-4859-2012	Rensing, Christopher/0000-0002-5012-7953; Sharma, Rakesh/0000-0003-3320-4491; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054102, R01GM055425, R37GM055425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54102, GM18973, GM55425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; DAWSON RMC, 1969, DATA BIOMEDICAL RES; DiDonato M, 1997, J BIOL CHEM, V272, P33279, DOI 10.1074/jbc.272.52.33279; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Fedosova NU, 1998, BIOCHEMISTRY-US, V37, P13634, DOI 10.1021/bi980703h; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; GE ZM, 1995, MOL MICROBIOL, V15, P97, DOI 10.1111/j.1365-2958.1995.tb02224.x; Gitschier J, 1998, NAT STRUCT BIOL, V5, P47, DOI 10.1038/nsb0198-47; Hunter GW, 1999, BIOCHEMISTRY-US, V38, P4604, DOI 10.1021/bi982392g; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KANAMARU K, 1994, MOL MICROBIOL, V13, P369, DOI 10.1111/j.1365-2958.1994.tb00430.x; Lutsenko S, 1997, J BIOL CHEM, V272, P18939, DOI 10.1074/jbc.272.30.18939; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Morrison J F, 1979, Methods Enzymol, V63, P257; PHUNG LT, 1994, P NATL ACAD SCI USA, V91, P9651, DOI 10.1073/pnas.91.20.9651; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rensing C, 1998, BIOCHEM CELL BIOL, V76, P787, DOI 10.1139/bcb-76-5-787; Rensing C, 1997, P NATL ACAD SCI USA, V94, P14326, DOI 10.1073/pnas.94.26.14326; Rensing C, 1998, J BIOL CHEM, V273, P32614, DOI 10.1074/jbc.273.49.32614; Rensing C, 1999, J BACTERIOL, V181, P5891, DOI 10.1128/JB.181.19.5891-5897.1999; SIGEL H, 1987, EUR J BIOCHEM, V165, P65, DOI 10.1111/j.1432-1033.1987.tb11194.x; Solioz M, 1997, FEBS LETT, V412, P165, DOI 10.1016/S0014-5793(97)00770-9; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; SOLIOZ M, 1995, J BIOL CHEM, V270, P9217, DOI 10.1074/jbc.270.16.9217; Takeda K, 1999, J MEMBRANE BIOL, V170, P13, DOI 10.1007/s002329900533; TSAI KJ, 1992, J BACTERIOL, V174, P116, DOI 10.1128/jb.174.1.116-121.1992; TSAI KJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P267, DOI 10.1006/abbi.1993.1421; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032; Voskoboinik I, 1998, FEBS LETT, V435, P178, DOI 10.1016/S0014-5793(98)01059-X; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WylerDuda P, 1996, FEBS LETT, V399, P143, DOI 10.1016/S0014-5793(96)01306-3	33	177	188	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3873	3878		10.1074/jbc.275.6.3873	http://dx.doi.org/10.1074/jbc.275.6.3873			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660539	hybrid			2022-12-27	WOS:000085288800023
J	Lopez, S; Peiretti, F; Bonardo, B; Juhan-Vague, I; Nalbone, G				Lopez, S; Peiretti, F; Bonardo, B; Juhan-Vague, I; Nalbone, G			Tumor necrosis factor alpha up-regulates in an autocrine manner the synthesis of plasminogen activator inhibitor type-1 during induction of monocytic differentiation of human HL-60 leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED IMMUNOSORBENT-ASSAY; SMOOTH-MUSCLE CELLS; GROWTH-FACTOR-BETA; PROTEIN-KINASE-C; ENDOTHELIAL-CELLS; GENE-EXPRESSION; PHORBOL ESTER; MACROPHAGE DIFFERENTIATION; UROKINASE RECEPTOR; VITRONECTIN	Tumor necrosis factor-alpha (TNF alpha) critically regulates several cellular functions during monocyte/macrophage differentiation. We therefore investigated during the phorbol ester (phorbol 12-myristate 13-acetate (PMA))-nduced monocyte/macrophage differentiation of the human HL-60 leukemia cells, if TNF alpha contributed to plasminogen activator inhibitor type-1 (PAI-1) synthesis that is initiated by a protein kinase CP-extracellular signal-regulated kinase a-dependent pathway (Lopez, S,, Peiretti, F., Morange, P., Laouar, A., Fossat, C., Bonardo, B., Huberman, E., Juhan-Vague, I., and Nalbone, G. (1999) Thromb, Haemostasis 81, 415-422), Following PMA treatment, the level of TNFa mRNA strongly increased and appeared earlier than PAI-1 mRNk. An anti-TNF alpha antibody significantly inhibited the PMAnduced PAI-1NA and protein levels. The recombinant human TNFa, which is inactive on native HL-60 cells in terms of PAI-1 synthesis, optimally potentiates it once HL-60 cells are committed into the differentiation process. The use of 1) the HL-525 cell line, a clone issued from HL-60 cells rendered resistant to PMA-induced differentiation, and 2) the transforming growth factory beta-1/vitamin 113 differentiative mixture confirmed the relationships between the induction of differentiation and the potency of TNF alpha to up-regulate PAI-1 synthesis. In conclusion, we showed that during the induction of monocyte/macrophage differentiation, TNF alpha and PAI-1 gene expressions are activated and that synthesized TNF alpha up-regulates and prolongs, in an autocrine manner, the synthesis of PAI-1.	Fac Med Marseille, Hematol Lab, EPI 9936, INSERM, F-13385 Marseille 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Nalbone, G (corresponding author), Fac Med Marseille, Hematol Lab, EPI 9936, INSERM, 27 Bd Jean Moulin, F-13385 Marseille 5, France.	Gilles.Nalbone@medecine.univ-mrs.fr	LOPEZ, SOPHIE/R-1917-2016; Peiretti, Franck/GLV-3378-2022; peiretti, franck/L-2718-2017	LOPEZ, SOPHIE/0000-0002-5009-5533; Peiretti, Franck/0000-0001-7198-0534; peiretti, franck/0000-0001-7198-0534				AGGARWAL BB, 1987, J BIOL CHEM, V262, P16450; Allaire E, 1998, CIRCULATION, V98, P249, DOI 10.1161/01.CIR.98.3.249; Arts J, 1999, ARTERIOSCL THROM VAS, V19, P39, DOI 10.1161/01.ATV.19.1.39; Bacharach E, 1998, BLOOD, V92, P939, DOI 10.1182/blood.V92.3.939.415k28_939_945; CAMUSSI G, 1991, EUR J BIOCHEM, V202, P3, DOI 10.1111/j.1432-1033.1991.tb16337.x; CAO XM, 1992, J BIOL CHEM, V267, P1345; Carmeliet P, 1997, CIRCULATION, V96, P3180, DOI 10.1161/01.CIR.96.9.3180; CHOMIKI N, 1994, THROMB HAEMOSTASIS, V72, P44; CIAMBRONE GJ, 1990, J CELL BIOL, V111, P2183, DOI 10.1083/jcb.111.5.2183; Colli S, 1999, THROMB HAEMOSTASIS, V81, P576; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DECLERCK PJ, 1988, BLOOD, V71, P220; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Glick D, 1996, FEBS LETT, V394, P237, DOI 10.1016/0014-5793(96)00958-1; GRUNEIRO AJ, 1995, FIBRINOLYSIS, V9, P71, DOI 10.1016/S0268-9499(95)80067-0; HOMMA Y, 1986, P NATL ACAD SCI USA, V83, P7316, DOI 10.1073/pnas.83.19.7316; HORIGUCHI J, 1989, MOL CELL BIOL, V9, P252, DOI 10.1128/MCB.9.1.252; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; JuhanVague I, 1996, CIRCULATION, V94, P2057, DOI 10.1161/01.CIR.94.9.2057; KHARBANDA S, 1994, J BIOL CHEM, V269, P20739; KIM MY, 1991, J BIOL CHEM, V266, P484; Kjoller L, 1997, EXP CELL RES, V232, P420, DOI 10.1006/excr.1997.3540; Kumar A, 1998, ONCOGENE, V17, P913, DOI 10.1038/sj.onc.1201998; Laouar A, 1999, J IMMUNOL, V162, P407; Lee E, 1996, CIRC RES, V78, P44, DOI 10.1161/01.RES.78.1.44; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400; Lopez S, 1999, THROMB HAEMOSTASIS, V81, P415, DOI 10.1055/s-0037-1614488; LUND LR, 1988, MOL CELL ENDOCRINOL, V60, P43, DOI 10.1016/0303-7207(88)90118-9; LUPU F, 1993, ARTERIOSCLER THROMB, V13, P1090, DOI 10.1161/01.ATV.13.7.1090; PADRO T, 1995, ARTERIOSCL THROM VAS, V15, P893, DOI 10.1161/01.ATV.15.7.893; Peiretti F, 1996, BLOOD, V87, P162; RAINES MA, 1993, J BIOL CHEM, V268, P14572; RITCHIE H, 1995, BLOOD, V86, P3428, DOI 10.1182/blood.V86.9.3428.bloodjournal8693428; Robbie LA, 1996, ARTERIOSCL THROM VAS, V16, P539, DOI 10.1161/01.ATV.16.4.539; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; SAWA H, 1993, CIRC RES, V73, P671, DOI 10.1161/01.RES.73.4.671; SAWDEY MS, 1991, J CLIN INVEST, V88, P1346, DOI 10.1172/JCI115440; SCHNEIDERMAN J, 1992, P NATL ACAD SCI USA, V89, P6998, DOI 10.1073/pnas.89.15.6998; SHERMAN ML, 1990, J BIOL CHEM, V265, P3320; Sobel BE, 1998, CIRCULATION, V97, P2213, DOI 10.1161/01.CIR.97.22.2213; Song CZ, 1998, J BIOL CHEM, V273, P29287, DOI 10.1074/jbc.273.45.29287; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; TIPPING PG, 1993, AM J PATHOL, V143, P875; TONETTI DA, 1994, J BIOL CHEM, V269, P23230; VANHINSBERGH VWM, 1988, BLOOD, V72, P1467; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; WALTZ DA, 1993, J CLIN INVEST, V91, P1541, DOI 10.1172/JCI116360; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; WINZEN R, 1992, J IMMUNOL, V148, P3454; WOHLWEND A, 1987, J EXP MED, V165, P320, DOI 10.1084/jem.165.2.320; Xie B, 1998, J BIOL CHEM, V273, P11583, DOI 10.1074/jbc.273.19.11583; YANG KD, 1994, BLOOD, V83, P490	53	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3081	3087		10.1074/jbc.275.5.3081	http://dx.doi.org/10.1074/jbc.275.5.3081			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652289	hybrid			2022-12-27	WOS:000085146500011
J	Ohashi, K; Nagata, K; Maekawa, M; Ishizaki, T; Narumiya, S; Mizuno, K				Ohashi, K; Nagata, K; Maekawa, M; Ishizaki, T; Narumiya, S; Mizuno, K			Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; ACTIN DYNAMICS; ZINC-FINGER; FOCAL ADHESIONS; IDENTIFICATION; REORGANIZATION; CYTOSKELETON; FAMILY; COFILIN; MOTIFS	LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization. LIMK1 is activated by the small GTPase Rho and its downstream protein kinase ROCK. We now report the site of phosphorylation of LIMK1 by ROCK. In vitro kinase reaction revealed that the active forms of ROCK phosphorylated LIMK1 on the threonine residue and markedly increased its cofilin-phosphorylating activity. A LIMK1 mutant (T508A) with replacement of Thr-508 within the activation loop of the kinase domain by alanine was neither phosphorylated nor activated by ROCK. Replacement of Thr-508 by serine changed the ROCK-catalyzed phosphorylation residue from threonine to serine. A LIMK1 mutant with replacement of Thr-508 by two glutamates increased the kinase activity about a-fold but was not further activated by ROCK. In addition, wild-type LIMK1, but not its T508A mutant, was activated by co-expression with ROCK in cultured cells. These results suggest that ROCK activates LIMK1 in vitro and in vivo by phosphorylation at Thr-508. Together with the recent finding that PAI(I, a downstream effector of Rac, also activates LIMK1 by phosphorylation at Thr-508, these results suggest that activation of LIMK1 is one of the common targets for Rho and Rac to reorganize the actin cytoskeleton.	Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan; Kyoto Univ, Fac Med, Dept Pharmacol, Kyoto 6068315, Japan	Tohoku University; Kyoto University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Ohashi, Kazumasa/U-7028-2019; Mizuno, Kensaku/G-8631-2015	Ohashi, Kazumasa/0000-0001-7617-403X; 				AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Carlier MF, 1997, J MOL BIOL, V269, P459, DOI 10.1006/jmbi.1997.1062; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Edwards DC, 1999, J BIOL CHEM, V274, P11352, DOI 10.1074/jbc.274.16.11352; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Leung T, 1996, MOL CELL BIOL, V16, P5313; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MIZUNO K, 1994, ONCOGENE, V9, P1605; Nagata K, 1999, BIOCHEM J, V343, P99, DOI 10.1042/0264-6021:3430099; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; NUNOUE K, 1995, ONCOGENE, V11, P701; OHASHI K, 1994, J BIOCHEM, V116, P636, DOI 10.1093/oxfordjournals.jbchem.a124573; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	30	397	406	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3577	3582		10.1074/jbc.275.5.3577	http://dx.doi.org/10.1074/jbc.275.5.3577			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652353	hybrid			2022-12-27	WOS:000085146500075
J	Himpel, S; Tegge, W; Frank, R; Leder, S; Joost, HG; Becker, W				Himpel, S; Tegge, W; Frank, R; Leder, S; Joost, HG; Becker, W			Specificity determinants of substrate recognition by the protein kinase DYRK1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; SYNDROME CRITICAL REGION; DOWN-SYNDROME; PHOSPHORYLASE-KINASE; HUMAN HOMOLOG; CELLULOSE MEMBRANES; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; SPOT-SYNTHESIS; IDENTIFICATION	DYRK1A is a dual-specificity protein kinase that is thought to be involved in brain development. We identified a single phosphorylated amino acid residue in the DYRK substrate histone H3 (threonine 45) by mass spectrometry, phosphoamino acid analysis, and protein sequencing. Exchange of threonine 45 for alanine abolished phosphorylation of histone H3 by DYRK1A and by the related kinases DYRK1B, DYRK2, and DYRK3 but not by CLK8, In order to define the consensus sequence for the substrate specificity of DYRK1A, a library of 300 peptides was designed in variation of the H3 phosphorylation site. Evaluation of the phosphate incorporation into these peptides identified DYRK1A as a proline-directed kinase with a phosphorylation consensus sequence (RPX(S/T)P) similar to that of ERK2 (PX(S/T)P). A peptide designed after the optimal substrate sequence (DYRKtide) was efficiently phosphorylated by DYRK1A (K-m = 35 mu m) but not by ERK2, Both ERK2 and DYRK1A phosphorylated myelin basic protein, whereas only ERK2, but not DYRK1A phosphorylated the mitogen-activated protein kinase substrate ELK-1, This marked difference in substrate specificity between DYRK1A and ERK2 can be explained by the requirement for an arginine at the P -3 site of DYRK substrates and its presumed interaction with aspartate 247 conserved in all DYRKs.	Rhein Westfal TH Aachen, Fak Med, Inst Pharmakol & Toxikol, D-52057 Aachen, Germany; AG Mol Erkennung, GBF, D-38124 Braunschweig, Germany	RWTH Aachen University; Helmholtz Association; Helmholtz-Center for Infection Research	Becker, W (corresponding author), Rhein Westfal TH Aachen, Fak Med, Inst Pharmakol & Toxikol, Wendlingweg 2, D-52057 Aachen, Germany.	walter.becker@post.rwth-aachen.de	Becker, Walter/B-8889-2008; Joost, Hans-Georg/J-4462-2013	Becker, Walter/0000-0002-0347-4768; Joost, Hans-Georg/0000-0002-5860-606X				Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Becker W, 1996, BBA-MOL CELL RES, V1312, P63, DOI 10.1016/0167-4889(96)00036-5; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Dostmann WRG, 1999, PHARMACOL THERAPEUT, V82, P373, DOI 10.1016/S0163-7258(98)00063-1; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; Frank R, 1996, Methods Mol Biol, V66, P149; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; Gross T, 1997, NUCLEIC ACIDS RES, V25, P1028, DOI 10.1093/nar/25.5.1028; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Himpel S, 1999, ANAL BIOCHEM, V274, P138, DOI 10.1006/abio.1999.4205; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Leder S, 1999, BIOCHEM BIOPH RES CO, V254, P474, DOI 10.1006/bbrc.1998.9967; Lee K, 1996, J BIOL CHEM, V271, P27299, DOI 10.1074/jbc.271.44.27299; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; LUO KX, 1995, P NATL ACAD SCI USA, V92, P11761, DOI 10.1073/pnas.92.25.11761; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; Nigg E A, 1991, Semin Cell Biol, V2, P261; Ohira M, 1997, GENOME RES, V7, P47, DOI 10.1101/gr.7.1.47; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; SANGHERA JS, 1990, FEBS LETT, V273, P223, DOI 10.1016/0014-5793(90)81090-B; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shindoh N, 1996, BIOCHEM BIOPH RES CO, V225, P92, DOI 10.1006/bbrc.1996.1135; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Souza GM, 1998, DEVELOPMENT, V125, P2291; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toomik R, 1996, PEPTIDE RES, V9, P6; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; WANG YH, 1988, ANAL BIOCHEM, V174, P537, DOI 10.1016/0003-2697(88)90053-X; WOODGETT J, 1995, PROTEIN KINASE FACTS, P231; WU JZ, 1994, BIOCHEMISTRY-US, V33, P14825, DOI 10.1021/bi00253a022; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; YUAN CJ, 1993, J BIOL CHEM, V268, P17683; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	177	184	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2431	2438		10.1074/jbc.275.4.2431	http://dx.doi.org/10.1074/jbc.275.4.2431			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644696	hybrid			2022-12-27	WOS:000085128000028
J	Irie, Y; Yamagata, K; Gan, YH; Miyamoto, K; Do, E; Kuo, CH; Taira, E; Miki, N				Irie, Y; Yamagata, K; Gan, YH; Miyamoto, K; Do, E; Kuo, CH; Taira, E; Miki, N			Molecular cloning and characterization of amida, a novel protein which interacts with a neuron-specific immediate early gene product arc, contains novel nuclear localization signals, and causes cell death in cultured cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVITY-REGULATED GENE; SYNAPTIC ACTIVITY; BRAIN NEURONS; GROWTH-FACTOR; APOPTOSIS; EXPRESSION; DENDRITES; ENCODES; LONG	Amida was isolated by the yeast two-hybrid system as a novel protein which associated with Are, a non-transcriptional immediate early gene specific to the brain. Amida was confirmed to be associated with Are in vitro and in vivo. Amida shows no homology to known proteins. Amida is ubiquitously expressed, although it is abundant in the brain. A transfection study revealed that Amida was localized in the nucleus and after 72 h the transfected cells underwent apoptosis, Furthermore, we found two nuclear localization signals and a domain needed for interacting with Are was encompassed by two nuclear localization signals. Co-transfection experiment with Amida and Are suggested that Amida transported Are into the nucleus and negatively regulated Amida-induced cell death. These results indicate that Are together with Amida may modulate cell death in the brain.	Osaka Univ, Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan; Tokyo Metropolitan Inst Neurosci, Dept Mol Neurobiol, Fuchu, Tokyo 1830042, Japan	Osaka University; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Miki, N (corresponding author), Osaka Univ, Sch Med, Dept Pharmacol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DU F, 1995, J NEUROSCI, V15, P6301; FADDIS BT, 1997, J NEUROSCI, V17, P941; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Gould E, 1993, Curr Opin Neurobiol, V3, P676, DOI 10.1016/0959-4388(93)90138-O; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; KOZAK M, 1987, J MOL BIOL, V12, P3919; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; LINK W, 1995, P NATL ACAD SCI USA, V92, P5832; LINZER DIH, 1983, P NATL ACAD SCI-BIOL, V80, P4271, DOI 10.1073/pnas.80.14.4271; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MESNER PW, 1995, J NEUROSCI, V15, P7357; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Pouli AE, 1998, BIOCHEM J, V331, P669, DOI 10.1042/bj3310669; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; WORLEY PF, 1990, COLD SH Q B, V55, P213, DOI 10.1101/SQB.1990.055.01.023; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yamagata K, 1994, Learn Mem, V1, P140; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779	26	39	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2647	2653		10.1074/jbc.275.4.2647	http://dx.doi.org/10.1074/jbc.275.4.2647			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644725	hybrid			2022-12-27	WOS:000085128000057
J	Shenkman, M; Ehrlich, M; Lederkremer, GZ				Shenkman, M; Ehrlich, M; Lederkremer, GZ			Masking of an endoplasmic reticulum retention signal by its presence in the two subunits of the asialoglycoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-GOLGI DEGRADATION; SURFACE EXPRESSION; GENE-TRANSFER; CELL-SURFACE; H2 SUBUNIT; DOMAIN; FATE; ER; DIMERIZATION; ASSOCIATION	Human asialoglycoprotein receptor HI and H2b subunits assemble into a hetero-oligomer that travels to the cell surface. The H2a variant on the other hand is a precursor of a cleaved soluble form that is secreted. Uncleaved H2a precursor molecules cannot exit the endoplasmic reticulum (ER), a lumenal juxtamembrane pentapeptide being responsible for their retention. Insertion of this pentapeptide into H1 (H1i5) causes its complete ER retention but not fast degradation as happens to H2a. Cotransfection of H2a elicited, by heterodimerization, the Golgi processing of H1i5 and its surface expression. This occurred to a much lesser extent by cotransfection of H2b. Likewise, coexpression of H1i5 and not HI stabilized H2a and caused its export to the cell surface. Homodimerization of molecules containing the pentapeptide did not cancel the retention. Thus, only when the pentapeptide is present in both subunits is the ER retention efficiently abrogated. The results show the unexpected finding that identical ER retention signals present in two associated chains can mask and cancel each other's effect. This could have important implications as similar abrogation of ER retention of other proteins could eventually be obtained by engineering and coexpressing an associated protein containing the same retention signal.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Lederkremer, GZ (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.			Lederkremer, Gerardo/0000-0002-9857-7152; Ehrlich, Marcelo/0000-0002-2352-1808				ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; Ayalon-Soffer M, 1999, FEBS LETT, V460, P112, DOI 10.1016/S0014-5793(99)01321-6; Bider MD, 1996, J BIOL CHEM, V271, P31996, DOI 10.1074/jbc.271.50.31996; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Duvet S, 1998, J BIOL CHEM, V273, P32088, DOI 10.1074/jbc.273.48.32088; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; HENNECKE S, 1993, J BIOL CHEM, V268, P26607; KEREM A, 1993, J BIOL CHEM, V268, P180; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; LANKFORD SP, 1993, J BIOL CHEM, V268, P4814; LEDERKREMER GZ, 1991, J BIOL CHEM, V266, P1237; LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971; LODISH HF, 1992, J BIOL CHEM, V267, P12753; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marambaud P, 1998, MOL MED, V4, P147, DOI 10.1007/BF03401912; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Naim HY, 1996, EUR J CELL BIOL, V70, P198; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; PARDI R, 1995, J IMMUNOL, V155, P1252; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; SOLHEIM JC, 1995, EUR J IMMUNOL, V25, P3011, DOI 10.1002/eji.1830251104; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Tolchinsky S, 1996, J BIOL CHEM, V271, P14496, DOI 10.1074/jbc.271.24.14496; WILEMAN T, 1990, J CELL BIOL, V110, P973, DOI 10.1083/jcb.110.4.973; WILEMAN T, 1993, J CELL BIOL, V122, P67, DOI 10.1083/jcb.122.1.67; YUK MH, 1993, J CELL BIOL, V123, P1735, DOI 10.1083/jcb.123.6.1735	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2845	2851		10.1074/jbc.275.4.2845	http://dx.doi.org/10.1074/jbc.275.4.2845			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644751	hybrid			2022-12-27	WOS:000085128000083
J	Vogel, K; Cabaniols, JP; Roche, PA				Vogel, K; Cabaniols, JP; Roche, PA			Targeting of SNAP-25 to membranes is mediated by its association with the target SNARE syntaxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOSOMAL-ASSOCIATED PROTEIN; AXONAL-TRANSPORT; SYNAPTIC VESICLES; PALMITOYLATION; COMPLEX; PALMITOYLTRANSFERASE; MYRISTOYLATION; SYNAPTOBREVIN; INSERTION; MACHINERY	The docking and fusion of synaptic vesicles with the presynaptic plasma membrane require the interaction of the vesicle-associated membrane protein VAMP with the plasma membrane proteins syntaxin and SNAP-25, Both of these proteins behave as integral membrane proteins, although they are unusual in that they insert into membranes post-translationally. Whereas VAMP and syntaxin possess hydrophobic transmembrane domains, SNAP-25 does not, and it is widely believed that SNAP-25 traffics to and inserts into membranes by posttranslational palmitoylation. In pulse-chase biosynthesis studies, we now show that SNAP-25 and syntaxin rapidly bind to each other while still in the cytosol of neuroendocrine and transfected heterologous cells. Cell fractionation studies revealed that cytosolic SNAP-25 .syntaxin complexes then traffic to and insert into membranes. Furthermore, the association of SNAP-25 with membranes is dramatically enhanced by syntaxin, and the transmembrane domain of syntaxin is essential for this effect. Surprisingly, despite the importance of the SNAP-25 palmitoylation domain for membrane anchoring at steady state, removal of this domain did not inhibit the initial association of newly synthesized SNAP-25 with membranes in the presence of syntaxin. These data demonstrate that the initial attachment of newly synthesized SNAP-25 to membranes is a consequence of its association with syntaxin and that it is only after syntaxin-mediated membrane tethering that SNAP-25 is palmitoylated.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.			Roche, Paul/0000-0002-8949-9172				Anderson HA, 1998, J IMMUNOL, V160, P4850; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; HESS DT, 1992, J NEUROSCI, V12, P4634; JANTTI J, 1994, J CELL SCI, V107, P3623; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lane SR, 1997, J NEUROCHEM, V69, P1864; Li JY, 1996, EUR J CELL BIOL, V70, P12; Liu L, 1996, J BIOL CHEM, V271, P23269, DOI 10.1074/jbc.271.38.23269; Low SH, 1998, J BIOL CHEM, V273, P3422, DOI 10.1074/jbc.273.6.3422; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHELLER RH, 1995, NEURON, V14, P893; Shiff G, 1997, J NEUROSCI RES, V48, P313; SOLIMENA M, 1994, J CELL BIOL, V126, P331, DOI 10.1083/jcb.126.2.331; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; SUDHOF TC, 1993, CELL, V75, P1; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Vogel K, 1999, BIOCHEM BIOPH RES CO, V258, P407, DOI 10.1006/bbrc.1999.0652; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119	33	67	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2959	2965		10.1074/jbc.275.4.2959	http://dx.doi.org/10.1074/jbc.275.4.2959			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644766	hybrid			2022-12-27	WOS:000085128000098
J	Zhang, J; Sanguinetti, MC; Kwiecinski, H; Ptacek, LJ				Zhang, J; Sanguinetti, MC; Kwiecinski, H; Ptacek, LJ			Mechanism of inverted activation of ClC-1 channels caused by a novel myotonia congenita mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE CHLORIDE CHANNEL; VARIABLE PENETRANCE; VOLTAGE-DEPENDENCE; THOMSEN DISEASE; DOMINANT; BECKER; GENE; CONDUCTANCE; DELETION; ACIDS	The voltage-gated chloride channel ClC-1 is the major contributor of membrane conductance in skeletal muscle and has been associated with the inherited muscular disorder myotonia congenita. Here, we report a novel mutation identified in a recessive myotonia congenita family, This mutation, Gly-499 to Arg (G499R) is located in the putative transmembrane domain 10 of the ClC-1 protein. In contrast to normal ClC-1 channels that deactivate upon hyperpolarization, functional expression of G499R ClC-1 yielded a hyperpolarization-activated chloride current when measured in the presence of a high (134 mM) intracellular chloride concentration. Current was abolished when measured with a physiological chloride transmembrane gradient. Electrophysiological analysis of other Gly-499 mutants (G499K, G499Q, and G499E) suggests that the positive charge introduced by the G499R mutation may be responsible for this unique gating behavior. To further explore the function of domain 10, we mutated two charged residues near Gly-499 of ClC-1. Functional analyses of R496Q, R496Q/G499R, R496K, and E500Q mutant channels suggest that the charged residues in domain 10 are important for normal channel function. Study of these mutants may shed further light on the structure and voltage-gating of this channel.	Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT 84112 USA; Univ Utah, Program Neurosci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Med Acad Warsaw, Dept Neurol, PL-02097 Warsaw, Poland	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ptacek, LJ (corresponding author), Univ Utah, Howard Hughes Med Inst, Bldg 533,Rm 4420,15N 2030 E, Salt Lake City, UT 84112 USA.	ptacek@genetics.utah.edu	Sanguinetti, Michael/AAN-2615-2020		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR00064] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABDALLA JA, 1992, AM J HUM GENET, V51, P579; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P367, DOI 10.1113/jphysiol.1971.sp009667; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Fahlke C, 1997, J GEN PHYSIOL, V110, P551, DOI 10.1085/jgp.110.5.551; Fahlke C, 1996, BIOPHYS J, V71, P695, DOI 10.1016/S0006-3495(96)79269-X; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; FURMAN RE, 1978, ANN NEUROL, V4, P357, DOI 10.1002/ana.410040411; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEINE R, 1994, HUM MOL GENET, V3, P1123, DOI 10.1093/hmg/3.7.1123; Jentsch T J, 1993, Curr Opin Neurobiol, V3, P316, DOI 10.1016/0959-4388(93)90123-G; JENTSCH TJ, 1993, ANN NY ACAD SCI, V707, P285, DOI 10.1111/j.1749-6632.1993.tb38059.x; KOCH MC, 1993, J MED GENET, V30, P914, DOI 10.1136/jmg.30.11.914; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Koty PP, 1996, NEUROLOGY, V47, P963, DOI 10.1212/WNL.47.4.963; Kubisch C, 1998, HUM MOL GENET, V7, P1753, DOI 10.1093/hmg/7.11.1753; KWIECINSKI H, 1981, CRC CR REV TOXICOL, V8, P279, DOI 10.3109/10408448109089901; KWIECINSKI H, 1988, MUSCLE NERVE, V11, P576, DOI 10.1002/mus.880110609; LEHMANNHORN F, 1995, HUM MOL GENET, V4, P1397, DOI 10.1093/hmg/4.8.1397; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Mailander V, 1996, AM J HUM GENET, V58, P317; MEYERKLEINE C, 1994, HUM MOL GENET, V3, P1015, DOI 10.1093/hmg/3.6.1015; MEYERKLEINE C, 1995, AM J HUM GENET, V57, P1325; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; Plassart-Schiess E, 1998, NEUROLOGY, V50, P1176, DOI 10.1212/WNL.50.4.1176; Pusch M, 1996, J GEN PHYSIOL, V108, P233, DOI 10.1085/jgp.108.4.233; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Pusch M, 1999, J PHYSIOL-LONDON, V515, P341, DOI 10.1111/j.1469-7793.1999.341ac.x; RUDEL R, 1985, PHYSIOL REV, V65, P310, DOI 10.1152/physrev.1985.65.2.310; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Thomsen, 1876, ARCH PSYCHIAT NERVEN, V6, P702, DOI DOI 10.1007/BF02164912; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Zhang J, 1996, NEUROLOGY, V47, P993, DOI 10.1212/WNL.47.4.993	44	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2999	3005		10.1074/jbc.275.4.2999	http://dx.doi.org/10.1074/jbc.275.4.2999			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644771	hybrid			2022-12-27	WOS:000085128000103
J	Abe, JI; Okuda, M; Huang, QH; Yoshizumi, M; Berk, BC				Abe, JI; Okuda, M; Huang, QH; Yoshizumi, M; Berk, BC			Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; H+ EXCHANGER KINASE; PROTEIN-KINASE; HYDROGEN-PEROXIDE; SIGNAL-TRANSDUCTION; ANGIOTENSIN-II; SRC FAMILY; PROTEIN-KINASE-1 BMK1; MEDIATED ACTIVATION; ENDOTHELIAL-CELLS	Reactive oxygen species and growth factors stimulate similar intracellular signal transduction events including activation of Src kinase family members and extracellular signal-regulated kinases (ERK1/2), A potentially important downstream effector of Src and ERK1/2 is p90 ribosomal S6 kinase (p90RSK), which plays an important role in cell growth by activating several transcription factors as well as the Na+/H+ exchanger. In the present study, we determined whether H2O2 activates p90RSK to gain insight into signal transduction mechanisms activated by reactive oxygen species. H2O2 (200 mu M) Stimulated ERK1/2 and p90RSK activity in lymphocytes, endothelial cells, and fibroblasts. The MEK-1 inhibitor, PD98059 (30 mu M), inhibited H2O2-mediated activation of ERK1/2 but not of p90RSK, An essential role for Fyn and Ras in p90RSK activation was suggested by five findings. 1) The tyrosine kinase inhibitor, herbimycin A and the specific Src kinase family inhibitor, PP1, blocked p90RSK activation by H2O2 in a concentration-dependent manner. 2) p90RSK activation by H2O2 was significantly reduced in fibroblasts derived from transgenic mice deficient in Fyn, but not c-Src. 3) H2O2 rapidly activated Ras (peak at 2-5 min), which preceded p90RSK activation (peak at 20 min). 4) Dominant negative Res completely blocked H2O2-induced activation of p90RSK. 5) In Fyn-/- fibroblasts, activation of Ras by H2O2 was significantly attenuated. These results show essential roles for Fyn and Ras in H2O2-mediated activation of p90RSK and establish redox-sensitive regulation of Ras and p90RSK as a new function for Fyn.	Univ Rochester, Sch Med & Dent, Cardiol Unit, Cardiovasc Res Ctr, Rochester, NY 14642 USA; Kobe Univ, Sch Med, Dept Internal Med, Div 1, Kobe, Hyogo 6500017, Japan	University of Rochester; Kobe University	Berk, BC (corresponding author), Univ Rochester, Sch Med & Dent, Cardiol Unit, Cardiovasc Res Ctr, Box 679,601 Elmwood Ave, Rochester, NY 14642 USA.	bradford_berk@urmc.rochester.edu		Berk, Bradford/0000-0002-2767-4115	NHLBI NIH HHS [HL49192, HL44721] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049192, R01HL044721] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe J, 1998, TRENDS CARDIOVAS MED, V8, P59, DOI 10.1016/S1050-1738(97)00133-3; Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; Abe J, 1999, J BIOL CHEM, V274, P21003, DOI 10.1074/jbc.274.30.21003; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; AUCHSCHWELK W, 1992, J CARDIOVASC PHARM, V20, pS62, DOI 10.1097/00005344-199200209-00012; BAAS AS, 1995, CIRC RES, V77, P29, DOI 10.1161/01.RES.77.1.29; BERK BC, 1987, J BIOL CHEM, V262, P5065; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BOYER CS, 1995, BIOCHEM PHARMACOL, V50, P753, DOI 10.1016/0006-2952(95)00195-6; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; CHEN RH, 1991, MOL CELL BIOL, V11, P1861, DOI 10.1128/MCB.11.4.1861; Chen Y, 1998, J BIOL CHEM, V273, P19809, DOI 10.1074/jbc.273.31.19809; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dang A, 1998, J BIOL CHEM, V273, P19909, DOI 10.1074/jbc.273.31.19909; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; DOAN TN, 1994, BIOCHEM J, V297, P209, DOI 10.1042/bj2970209; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Foschi M, 1997, EMBO J, V16, P6439, DOI 10.1093/emboj/16.21.6439; Fukuta Y, 1998, BIOCHEM PHARMACOL, V55, P481, DOI 10.1016/S0006-2952(97)00496-6; GERRITY RG, 1979, AM J PATHOL, V95, P775; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Griffith CE, 1998, J BIOL CHEM, V273, P10771, DOI 10.1074/jbc.273.17.10771; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; HOMANMULLER JWT, 1975, J LAB CLIN MED, V85, P198; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Janssen RAJ, 1998, J BIOL CHEM, V273, P32182, DOI 10.1074/jbc.273.48.32182; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Li HL, 1997, J BIOL CHEM, V272, P18200, DOI 10.1074/jbc.272.29.18200; Liao DF, 1997, J BIOL CHEM, V272, P6146, DOI 10.1074/jbc.272.10.6146; LIBBY P, 1991, LAB INVEST, V64, P5; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; NEGRI M, 1991, CLIN CHIM ACTA, V199, P305, DOI 10.1016/0009-8981(91)90124-U; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Okuda M, 1996, AM J PHYSIOL-HEART C, V271, pH595, DOI 10.1152/ajpheart.1996.271.2.H595; Pende M, 1997, J NEUROSCI, V17, P1291; Phan VN, 1997, HYPERTENSION, V29, P1265, DOI 10.1161/01.HYP.29.6.1265; Puceat M, 1998, J CELL BIOL, V141, P1637, DOI 10.1083/jcb.141.7.1637; RAO GN, 1993, NUCLEIC ACIDS RES, V21, P1259, DOI 10.1093/nar/21.5.1259; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sabri A, 1998, CIRC RES, V82, P1053, DOI 10.1161/01.RES.82.10.1053; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SATOH T, 1992, J BIOL CHEM, V267, P24149; Schiemann WP, 1997, J BIOL CHEM, V272, P16631, DOI 10.1074/jbc.272.26.16631; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; TARDIF JC, 1996, CIRCULATION S1, V94, P91; THOMAS SM, 1995, NATURE, V376, P267, DOI 10.1038/376267a0; TSENG H, 1995, CIRC RES, V77, P869, DOI 10.1161/01.RES.77.5.869; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	65	122	125	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1739	1748		10.1074/jbc.275.3.1739	http://dx.doi.org/10.1074/jbc.275.3.1739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636870	hybrid			2022-12-27	WOS:000084940000033
J	Cheng, AY; Dean, NM; Honkanen, RE				Cheng, AY; Dean, NM; Honkanen, RE			Serine/threonine protein phosphatase type 1 gamma 1 is required for the completion of cytokinesis in human A549 lung carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTISENSE OLIGONUCLEOTIDES; CATALYTIC SUBUNIT; MOLECULAR-CLONING; GROWTH ARREST; OKADAIC ACID; CDNA CLONE; GENE; SEQUENCE; ANAPHASE; MITOSIS	In lower eukaryotic organisms, the loss of serine/threonine protein phosphatase type 1 (PP1) results in growth arrest after the onset of mitosis. In humans, four highly homologous isoforms of PP1 (PP1 alpha, PP1 delta, PP1 gamma 1, and PP1 gamma 2) have been identified. Determining the roles of these phosphatases, however, has proven difficult due to the lack of subtype-specific inhibitors. In this study, we developed chimeric antisense 2'-O-(2-methoxy)ethylphosphothioate oligonucleotides targeting human PP1 gamma 1 that specifically inhibit PP1 gamma 1 gene expression. Two potent antisense oligonucleotides (ISIS 14435 and 14439; IC50 similar to 50 nM) were then employed to elucidate the cellular functions of PP1 gamma 1 during cell cycle progression. In A549 cells, the inhibition of PP1 gamma 1 expression resulted in a dose-dependent inhibition of cellular proliferation, with growth arrest occurring after similar to 36-48 h, when PP1 gamma 1 mRNA expression was inhibited by >85%. Fluorescence-activated cell sorter analysis revealed that ISIS 14435/14439-induced growth arrest was associated with an increase in the number of cells containing 4N DNA. Immunostaining of treated cells revealed that the inhibition of PP1 gamma 1 expression had no apparent effect on the formation of mitotic spindles. However, decreased expression was associated with the failure of cell division in a late stage of cytokinesis and the formation of dikaryons.	Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; ISIS Pharmaceut, Dept Pharmacol, Carlsbad, CA 92008 USA	University of South Alabama; Isis Pharmaceuticals Inc	Honkanen, RE (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, MSB 2198, Mobile, AL 36688 USA.	honkanen@sungcg.usouthal.edu						ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; BALCZON RD, 1987, J CELL BIOL, V105, P855, DOI 10.1083/jcb.105.2.855; BARKER HM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P228, DOI 10.1016/0167-4889(93)90014-G; BARKER HM, 1994, BBA-MOL CELL RES, V1220, P212, DOI 10.1016/0167-4889(94)90138-4; Bastians H, 1996, J CELL SCI, V109, P2865; BECKER W, 1994, J BIOL CHEM, V269, P22586; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; BOOHER R, 1989, CELL, V57, P1009, DOI 10.1016/0092-8674(89)90339-5; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Cheng AY, 1998, CANCER RES, V58, P3611; CHINKERS M, 1994, P NATL ACAD SCI USA, V91, P11075, DOI 10.1073/pnas.91.23.11075; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; CROOKE ST, 1992, ANNU REV PHARMACOL, V32, P329; Dean NM, 1997, ANTISENSE NUCLEIC A, V7, P229, DOI 10.1089/oli.1.1997.7.229; DEAN NM, 1994, J BIOL CHEM, V269, P16416; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; GUERINI D, 1989, DNA-J MOLEC CELL BIO, V8, P675, DOI 10.1089/dna.1.1989.8.675; HISAMOTO N, 1994, MOL CELL BIOL, V14, P3158, DOI 10.1128/MCB.14.5.3158; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Huang XZ, 1997, GENOMICS, V44, P336, DOI 10.1006/geno.1997.4891; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; KINCAID RL, 1988, P NATL ACAD SCI USA, V85, P8983, DOI 10.1073/pnas.85.23.8983; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SILVA EFDE, 1991, BIOCHIM BIOPHYS ACTA, V1089, P269, DOI 10.1016/0167-4781(91)90023-F; SONG Q, 1993, GENE, V129, P291, DOI 10.1016/0378-1119(93)90282-8; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Sugiyama H, 1997, ONCOGENE, V15, P443, DOI 10.1038/sj.onc.1201207; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; VANDOLAH FM, 1992, J CELL PHYSIOL, V152, P190, DOI 10.1002/jcp.1041520124; VANDRE DD, 1984, P NATL ACAD SCI-BIOL, V81, P4439, DOI 10.1073/pnas.81.14.4439; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; WALTER G, 1993, BIOCHIM BIOPHYS ACTA, V1155, P207, DOI 10.1016/0304-419X(93)90005-W; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	47	52	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1846	1854		10.1074/jbc.275.3.1846	http://dx.doi.org/10.1074/jbc.275.3.1846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636884	hybrid			2022-12-27	WOS:000084940000047
J	Griffioen, G; Anghileri, P; Imre, E; Baroni, MD; Ruis, H				Griffioen, G; Anghileri, P; Imre, E; Baroni, MD; Ruis, H			Nutritional control of nucleocytoplasmic localization of cAMP-dependent protein kinase catalytic and regulatory subunits in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; RESPONSE ELEMENT STRE; ADENYLATE-CYCLASE; FRUCTOSE 2,6-BISPHOSPHATE; ESCHERICHIA-COLI; SHUTTLE VECTORS; YEAST; GENES; TRANSCRIPTION; EXPRESSION	In budding yeast, cAMP-dependent protein kinase (PKA) plays a central role in the nutritional control of metabolism, cell cycle, and transcription. This study shows that both the regulatory subunit Bcy1p and the catalytic subunit Tpk1p associated with it are predominantly localized in the nucleus of rapidly growing cells. Activation of nuclear PKA by cAMP leads to fast entry of a significant part of Tpk1p into the cytoplasm, while the regulatory subunit remains nuclear, In contrast to rapidly proliferating cells, both Bcy1p and Tpk1p are distributed over nucleus and cytoplasm in cells growing on a nonfermentable carbon source or in stationary phase cells. These results demonstrate that at least two different mechanisms determine the subcellular localization of PKA; cAMP controls the localization of Tpk1p, and the carbon source determines that of Bcy1p, The N-terminal domain of Bcy1p serves to target it properly during logarithmic and stationary phase. Studies with Bcy1p mutant versions unable to concentrate in the nucleus revealed that cells producing them are less viable in stationary phase than wild type cells, display delayed reproliferation following transfer to fresh growth medium, and, as diploids, exhibit reduced efficiency of sporulation.	Univ Vienna, Inst Biochem & Mol Zellbiol, Vienna Bioctr, A-1030 Vienna, Austria; Ludwig Boltzmann Forschungstelle Biochem, A-1030 Vienna, Austria; Univ Milan, Dipartimento Fisiol & Biochim Gen, Sez Biochim Comparata, I-20133 Milan, Italy	University of Vienna; Vienna Biocenter (VBC); Ludwig Boltzmann Institute; University of Milan	Ruis, H (corresponding author), Univ Vienna, Inst Biochem & Mol Zellbiol, Vienna Bioctr, Waehringer Guertel 18, A-1030 Vienna, Austria.		Baroni, Maurizio David/AAL-8064-2021	Baroni, Maurizio David/0000-0001-6355-9950				BOORSTEIN WR, 1990, EMBO J, V9, P2543, DOI 10.1002/j.1460-2075.1990.tb07435.x; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; ELION A, 1995, TRENDS CELL BIOL, V5, P322; FRANCOIS J, 1984, EUR J BIOCHEM, V145, P187, DOI 10.1111/j.1432-1033.1984.tb08539.x; FRANCOIS J, 1987, EUR J BIOCHEM, V164, P369, DOI 10.1111/j.1432-1033.1987.tb11067.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; GRIFFIOEN G, 1994, FEMS MICROBIOL LETT, V123, P137, DOI 10.1111/j.1574-6968.1994.tb07213.x; Hall DD, 1998, EMBO J, V17, P4370, DOI 10.1093/emboj/17.15.4370; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Jiang Y, 1998, EMBO J, V17, P6942, DOI 10.1093/emboj/17.23.6942; JOHNSON KE, 1987, J BIOL CHEM, V262, P8636; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rose MD., 1990, METHODS YEAST GENETI; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; SIKORSKI RS, 1989, GENETICS, V122, P19; THEVELEIN JM, 1991, MOL MICROBIOL, V5, P1301, DOI 10.1111/j.1365-2958.1991.tb00776.x; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Toone WM, 1998, GENES CELLS, V3, P485, DOI 10.1046/j.1365-2443.1998.00211.x; TORNOW J, 1990, GENE, V90, P79, DOI 10.1016/0378-1119(90)90441-S; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; WERNERWASHBURNE M, 1991, J BIOL CHEM, V266, P19704	40	86	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1449	1456		10.1074/jbc.275.2.1449	http://dx.doi.org/10.1074/jbc.275.2.1449			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625697	hybrid			2022-12-27	WOS:000084836600101
J	Jisaka, M; Kim, RB; Boeglin, WE; Brash, AR				Jisaka, M; Kim, RB; Boeglin, WE; Brash, AR			Identification of amino acid determinants of the positional specificity of mouse 8S-lipoxygenase and human 15S-lipoxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; ACTIVE-SITE; LIPOXYGENASE; EXPRESSION; SKIN; 15-LIPOXYGENASE; MUTAGENESIS; ALIGNMENT	Phorbol ester-inducible mouse 8S-lipoxygenase (8-LOX) and its human homologue, 15S-lipoxygenase-2 (15-LOX-2), share 78% identity in amino acid sequences, yet there is no overlap in their positional specificities. In this study, we investigated the determinants of positional specificity using a random chimeragenesis approach in combination with site-directed mutagenesis, Exchange of the C-terminal one-third of the 8-LOX with the corresponding portion of 15-LOX-2 yielded a chimeric enzyme with exclusively 15S-lipoxygenase activity. The critical region was narrowed down to a cluster of five amino acids by expression of multiple cDNAs obtained by in situ chimeragenesis in Escherichia coli, Finally, a pair of amino acids, Tyr(603) and His(604), was identified as the positional determinant by site-directed mutagenesis, Mutation of both of these amino acids to the corresponding amino acids in 15-LOX-2 (Asp and Val, respectively) converted the positional specificity from 8S to 90% 15S without yielding any other by-products. Mutation of the corresponding residues in 15-LOX-2 to the 8-LOX sequence changed specificity to 50% oxygenation at C-8 for one amino acid substitution and 70% at C-8 for the double mutant. Based on the crystal structure of the reticulocyte 15-LOX, these two amino acids lie opposite the open coordination position of the catalytic iron in a likely site for substrate binding, The change from 8 to 15 specificity entails a switch in the head to tail binding of substrate. Enzymes that react with substrate "head first" (5-LOX and 8-LOX) have a bulky aromatic amino acid and a histidine in these positions, whereas lipoxygenases that accept substrates "tail first" (12-LOX and 15-LOX) have an aliphatic residue with a glutamine or aspartate. Thus, this positional determinant of the 8-LOX and 15-LOX-2 may have significance for other lipoxygenases.	Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Nashville, TN 37232 USA; Shimane Univ, Dept Life Sci & Biotechnol, Matsue, Shimane 6908504, Japan	Vanderbilt University; Shimane University	Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, 23rd Ave Pierce, Nashville, TN 37232 USA.	jisaka@life.shimane-u.ac.jp; alan.brash@mcmail.vanderbilt.edu	Kim, Richard/D-6971-2011	Kim, Richard/0000-0001-8148-1632	NIGMS NIH HHS [GM-53638] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053638] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; Borngraber S, 1996, J MOL BIOL, V264, P1145, DOI 10.1006/jmbi.1996.0702; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; EGMOND MR, 1972, BIOCHEM BIOPH RES CO, V48, P1055, DOI 10.1016/0006-291X(72)90815-7; Gan QF, 1996, J BIOL CHEM, V271, P25412, DOI 10.1074/jbc.271.41.25412; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; Hornung E, 1999, P NATL ACAD SCI USA, V96, P4192, DOI 10.1073/pnas.96.7.4192; HUGHES MA, 1991, BIOCHIM BIOPHYS ACTA, V1081, P347, DOI 10.1016/0005-2760(91)90292-P; Jisaka M, 1997, J BIOL CHEM, V272, P24410, DOI 10.1074/jbc.272.39.24410; Kinzig A, 1999, GENOMICS, V58, P158, DOI 10.1006/geno.1999.5816; Krieg P, 1998, BBA-LIPID LIPID MET, V1391, P7, DOI 10.1016/S0005-2760(97)00214-2; KUHN H, 1990, J BIOL CHEM, V265, P16300; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; MOORE KR, 1994, BIOTECHNIQUES, V17, P130; Prigge ST, 1996, PROTEINS, V24, P275; Schwarz K, 1998, BIOCHEMISTRY-US, V37, P15327, DOI 10.1021/bi9816204; SkrzypczakJankun E, 1997, PROTEINS, V29, P15, DOI [10.1002/(SICI)1097-0134(199709)29:1&lt;15::AID-PROT2&gt;3.0.CO;2-E, 10.1002/(SICI)1097-0134(199709)29:1<15::AID-PROT2>3.3.CO;2-F]; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Sun DX, 1998, J BIOL CHEM, V273, P33540, DOI 10.1074/jbc.273.50.33540	24	89	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1287	1293		10.1074/jbc.275.2.1287	http://dx.doi.org/10.1074/jbc.275.2.1287			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625675	hybrid			2022-12-27	WOS:000084836600079
J	Suter, M; von Ballmoos, P; Kopriva, S; den Camp, RO; Schaller, J; Kuhlemeier, C; Schurmann, P; Brunold, C				Suter, M; von Ballmoos, P; Kopriva, S; den Camp, RO; Schaller, J; Kuhlemeier, C; Schurmann, P; Brunold, C			Adenosine 5 '-phosphosulfate sulfotransferase and adenosine 5 '-phosphosulfate reductase are identical enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERREDOXIN-SULFITE REDUCTASE; LEMNA-MINOR-L; SULFATE ASSIMILATION; PAPS-REDUCTASE; HIGHER-PLANTS; 5'-ADENYLYLSULFATE REDUCTASE; ARABIDOPSIS-THALIANA; APS-SULFOTRANSFERASE; ESCHERICHIA-COLI; SPINACH	Adenosine 5'-phosphosulfate (APS) sulfotransferase and APS reductase have been described as key enzymes of assimilatory sulfate reduction of plants catalyzing the reduction of APS to bound and free sulfite, respectively. APS sulfotransferase was purified to homogeneity from Lemna minor and compared with APS reductase previously obtained by functional complementation of a mutant strain of Escherichia coli with an Arabidopsis thaliana cDNA library. APS sulfotransferase was a homodimer with a monomer M-r of 43,000, Its amino acid sequence was 73% identical with APS reductase. APS sulfotransferase purified from Lemna as well as the recombinant enzyme were yellow proteins, indicating the presence of a cofactor. Like recombinant APS reductase, recombinant APS sulfotransferase used APS (K-m = 6.5 mu M) and not adenosine 3'-phosphate 5'-phosphosulfate as sulfonyl donor. The V-max of recombinant Lemna APS sulfotransferase (40 mu mol min(-1) mg protein(-1)) was about 10 times higher than the previously published V-max of APS reductase. The product of APS sulfotransferase from APS and GSH was almost exclusively SO32-. Bound sulfite in the form of S-sulfoglutathione was only appreciably formed when oxidized glutathione was added to the incubation mixture. Because SO32- was the first reaction product of APS sulfotransferase, this enzyme should be renamed APS reductase.	Univ Bern, Inst Plant Physiol, CH-3013 Bern, Switzerland; Univ Neuchatel, Biochim Lab, CH-2000 Neuchatel, Switzerland; Univ Bern, Dept Biochem & Chem, CH-3012 Bern, Switzerland	University of Bern; University of Neuchatel; University of Bern	Brunold, C (corresponding author), Univ Bern, Inst Plant Physiol, Altenbergrain 21, CH-3013 Bern, Switzerland.	christian.brunold@pfp.unibe.ch	Kopriva, Stanislav/C-7401-2013; von Ballmoos, Peter/B-4123-2008	Kopriva, Stanislav/0000-0002-7416-6551; von Ballmoos, Peter/0000-0001-9649-2289				ABRAMS WR, 1973, ARCH MIKROBIOL, V94, P1, DOI 10.1007/BF00414074; AKETAGAWA J, 1980, AGR BIOL CHEM TOKYO, V44, P2371, DOI 10.1080/00021369.1980.10864341; ARA T, 1996, SULPHUR METABOLISM H, P177; Bick JA, 1998, P NATL ACAD SCI USA, V95, P8404, DOI 10.1073/pnas.95.14.8404; BRUNOLD C, 1984, PLANT PHYSIOL, V76, P579, DOI 10.1104/pp.76.3.579; BRUNOLD C, 1989, PLANTA, V179, P228, DOI 10.1007/BF00393693; BRUNOLD C, 1987, PHYSIOL PLANTARUM, V70, P168, DOI 10.1111/j.1399-3054.1987.tb06127.x; BRUNOLD C, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P61; Brunold C., 1990, METHODS PLANT BIOCH, P339; FANKHAUSER H, 1978, PLANTA, V143, P285, DOI 10.1007/BF00392000; FANKHAUSER H, 1978, EXPERIENTIA, V34, P939; GALLI U, 1993, NEW PHYTOL, V125, P837, DOI 10.1111/j.1469-8137.1993.tb03932.x; GutierrezMarcos JF, 1996, P NATL ACAD SCI USA, V93, P13377, DOI 10.1073/pnas.93.23.13377; Kanno N, 1996, PLANTA, V198, P440, DOI 10.1007/BF00620061; KOPRIVA S, 1999, SULFUR NUTR SULFUR A, P138; KREDICH NM, 1996, ESCHERICHIA COLI SAL, P419; KRUEGER RJ, 1982, BIOCHEMISTRY-US, V21, P2892, DOI 10.1021/bi00541a014; Leustek T, 1996, PHYSIOL PLANTARUM, V97, P411, DOI 10.1034/j.1399-3054.1996.970228.x; LI JY, 1991, BIOCHEM J, V274, P355, DOI 10.1042/bj2740355; MANNERVIK B, 1978, FUNCTIONS GLUTATHION, P148; NEUENSCHWANDER U, 1991, PLANT PHYSIOL, V97, P253, DOI 10.1104/pp.97.1.253; Noctor G, 1998, J EXP BOT, V49, P623, DOI 10.1093/jexbot/49.321.623; Prior A, 1999, BBA-PROTEIN STRUCT M, V1430, P25, DOI 10.1016/S0167-4838(98)00266-0; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2002, MOL CLONING LAB MANU; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; SCHMIDT A, 1992, ANNU REV PLANT PHYS, V43, P325, DOI 10.1146/annurev.pp.43.060192.001545; SCHMIDT A, 1972, Z NATURFORSCH PT B, VB 27, P183; SCHMIDT A, 1973, ARCH MIKROBIOL, V93, P29, DOI 10.1007/BF00666079; SCHMIDT A, 1976, PLANTA, V130, P257, DOI 10.1007/BF00387830; SCHMIDT A, 1972, ARCH MIKROBIOL, V84, P77, DOI 10.1007/BF00408084; SCHWENN JD, 1987, Z NATURFORSCH C, V42, P93; SCHWENN JD, 1989, Z NATURFORSCH C, V44, P504; Setya A, 1996, P NATL ACAD SCI USA, V93, P13383, DOI 10.1073/pnas.93.23.13383; Siegel L.M., 1975, METABOLISM SULFUR CO, P217; Sohndel S, 1996, BIOCHEMISTRY-US, V35, P2357, DOI 10.1021/bi9520949; Takahashi H, 1997, P NATL ACAD SCI USA, V94, P11102, DOI 10.1073/pnas.94.20.11102; THOMAS D, 1992, J GEN MICROBIOL, V138, P2021, DOI 10.1099/00221287-138-10-2021; TSANG MLS, 1971, PLANT PHYSIOL, V47, P20; TSANG MLS, 1976, PLANT CELL PHYSIOL, V17, P1209; VANDEPEER Y, 1993, COMPUT APPL BIOSCI, V9, P177; WALEY SG, 1995, BIOCHEM J, V71, P132; Wray JL, 1998, CHEM-BIOL INTERACT, V109, P153, DOI 10.1016/S0009-2797(97)00130-0	44	72	83	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					930	936		10.1074/jbc.275.2.930	http://dx.doi.org/10.1074/jbc.275.2.930			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625629	Green Submitted, hybrid			2022-12-27	WOS:000084836600033
J	Tucker, WC; Du, ZY; Hein, R; Richter, ML; Gromet-Elhanan, Z				Tucker, WC; Du, ZY; Hein, R; Richter, ML; Gromet-Elhanan, Z			Hybrid Rhodospirillum rubrum F0F1 ATP synthases containing spinach chloroplast F-1 beta or alpha and beta subunits reveal the essential role of the alpha subunit in ATP synthesis and tentoxin sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F1 ADENOSINE-TRIPHOSPHATASE; ESCHERICHIA-COLI F1-ATPASE; CROSS-LINKING; DELTA-SUBUNITS; 2ND STALK; ROTATION; COMPLEX; BINDING; RECONSTITUTION; PURIFICATION	Trace amounts (similar to 55%) of the chloroplast or subunit were found to be absolutely required for effective restoration of catalytic function to LiCl-treated chromatophores of Rhodospirillum rubrum with the chloroplast beta subunit (Avital, S., and Gromet-Elhanan, Z. (1991) J. Biol. Chem. 266, 7067-7072). To clarify the role of the Lu subunit in the rebinding of beta, restoration of catalytic function, and conferral of sensitivity to the chloroplast-specific inhibitor tentoxin, LiCl-treated chromatophores were analyzed by immunoblotting before and after reconstitution with mixtures of R. rubrum and chloroplast alpha and beta subunits. The treated chromatophores were found to have lost, in addition to most of their beta subunits, approximately a third of the alpha subunits, and restoration of catalytic activity required rebinding of both subunits. The hybrid reconstituted with the R. rubrum alpha and chloroplast beta subunits was active in ATP synthesis as well as hydrolysis, and both activities were completely resistant to tentoxin. In contrast, a hybrid reconstituted with both chloroplast or and beta subunits restored only a MgATPase activity, which was fully inhibited by tentoxin, These results indicate that all three copies of the R. rubrum alpha subunit are required for proton-coupled ATP synthesis, whereas for conferral of tentoxin sensitivity at least one copy of the chloroplast alpha subunit is required together with the chloroplast beta subunit. The hybrid system was further used to examine the effects of amino acid substitution at position 83 of the beta subunit on sensitivity to tentoxin.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	Weizmann Institute of Science; University of Kansas	Gromet-Elhanan, Z (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	z.gromet-elhanan@weizmann.ac.il			NIGMS NIH HHS [GM08545] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008545] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ANDRALOJC PJ, 1992, FEBS LETT, V310, P187, DOI 10.1016/0014-5793(92)81326-H; Averboukh L, 1996, BIOTECHNIQUES, V20, P918; AVITAL S, 1991, J BIOL CHEM, V266, P7067; AVNI A, 1991, J BIOL CHEM, V266, P7317; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; AVRON M, 1960, BIOCHIM BIOPHYS ACTA, V40, P257, DOI 10.1016/0006-3002(60)91350-0; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAGG PD, 1986, ARCH BIOCHEM BIOPHYS, V244, P361, DOI 10.1016/0003-9861(86)90125-6; BRAGG PD, 1986, BIOCHIM BIOPHYS ACTA, V851, P385, DOI 10.1016/0005-2728(86)90075-7; CHEN ZG, 1995, J BIOL CHEM, V270, P17124, DOI 10.1074/jbc.270.29.17124; CHEN ZG, 1992, FEBS LETT, V298, P69, DOI 10.1016/0014-5793(92)80024-B; Clayton R. K., 1963, BACTERIAL PHOTOSYNTH, P495; Cross RL, 1996, J BIOENERG BIOMEMBR, V28, P403, DOI 10.1007/BF02113981; DU Z, 1995, PHOTOSYNTHESIS LIGHT, V3, P27; Du ZY, 1999, EUR J BIOCHEM, V263, P430, DOI 10.1046/j.1432-1327.1999.00512.x; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; GAO F, 1995, J BIOL CHEM, V270, P9763, DOI 10.1074/jbc.270.17.9763; GERSHONI JM, 1988, METHOD BIOCHEM ANAL, V33, P1; Gromet-Elhanan Z., 1995, ANOXYGENIC PHOTOSYNT, P807; GROMETELHANAN Z, 1989, BIOCHEMISTRY-US, V28, P3645, DOI 10.1021/bi00435a004; GrometElhanan Z, 1995, PHOTOSYNTH RES, V46, P79, DOI 10.1007/BF00020418; GROMETELHANAN Z, 1992, BIOCHIM BIOPHYS ACTA, V1102, P379, DOI 10.1016/0167-4838(92)90525-I; GROMETELHANAN Z, 1986, METHOD ENZYMOL, V126, P528; Hu DL, 1997, J BIOL CHEM, V272, P5457, DOI 10.1074/jbc.272.9.5457; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCARTY RE, 1996, OXYGENIC PHOTOSYNTHE, P807; Nathanson L, 2000, J BIOL CHEM, V275, P901, DOI 10.1074/jbc.275.2.901; Nathanson L, 1998, J BIOL CHEM, V273, P10933, DOI 10.1074/jbc.273.18.10933; NATHANSON L, 1995, PHOTOSYNTHESIS LIGHT, V3, P51; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ogilvie I, 1997, J BIOL CHEM, V272, P16652, DOI 10.1074/jbc.272.26.16652; PHILOSOPH S, 1977, J BIOL CHEM, V252, P8747; PHILOSOPH S, 1981, EUR J BIOCHEM, V119, P107, DOI 10.1111/j.1432-1033.1981.tb05583.x; RICHTER ML, 1986, J BIOL CHEM, V261, P2109; RICHTER ML, 1996, OXYGENIC PHOTOSYNTHE, P453; Rodgers AJW, 1998, J BIOL CHEM, V273, P29406, DOI 10.1074/jbc.273.45.29406; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SONE N, 1986, BIOCHEM CELL BIOL, V64, P229, DOI 10.1139/o86-033; STEELE JA, 1976, P NATL ACAD SCI USA, V73, P2245, DOI 10.1073/pnas.73.7.2245; Strotmann H., 1998, MOL BIOL CHLOROPLAST, P477; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; TOZER RG, 1986, EUR J BIOCHEM, V161, P513, DOI 10.1111/j.1432-1033.1986.tb10472.x; WEBSTER GD, 1977, FEBS LETT, V76, P29, DOI 10.1016/0014-5793(77)80114-2; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; Zhou YT, 1997, P NATL ACAD SCI USA, V94, P10583, DOI 10.1073/pnas.94.20.10583	51	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					906	912		10.1074/jbc.275.2.906	http://dx.doi.org/10.1074/jbc.275.2.906			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625626	hybrid			2022-12-27	WOS:000084836600030
J	Watson, RT; Pessin, JE				Watson, RT; Pessin, JE			Functional cooperation of two independent targeting domains in syntaxin 6 is required for its efficient localization in the trans-Golgi network of 3T3L1 adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC PROTEIN-TRANSPORT; STIMULATED GLUT4 TRANSLOCATION; CYTOPLASMIC DOMAIN; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; CELL-SURFACE; SYNAPTIC VESICLES; CYTOSOLIC DOMAIN; SNARE PROTEINS; MDCK CELLS	To identify the targeting domains of syntaxin 6 responsible for its localization to the trans-Golgi network (TGN), we examined the subcellular distribution of enhanced green fluorescent protein (EGFP) epitope-tagged syntaxin 6/syntaxin 4 chimerae and syntaxin 6 truncation/deletion mutants in 3T3L1 adipocytes, Expression of EGFP-syntaxin 6 resulted in a perinuclear distribution identical to endogenous syntaxin 6 as determined both by confocal fluorescence microscopy and subcellular fractionation, Furthermore, both the endogenous and the expressed EGFP-syntaxin 6 fusion protein were localized to a brefeldin A-insensitive but okadaic acid-sensitive compartment characteristic of the TGN, In contrast, EGFP-syntaxin 6 constructs lacking the H2 domain were excluded from the TGN and were instead primarily localized to the plasma membrane. Although syntaxin 4 was localized to the plasma membrane, syntaxin 6/syntaxin 4 chimerae and syntaxin 6 truncations containing the H2 domain of syntaxin 6 were predominantly directed to the TGN. Importantly, the syntaxin 6 H2 domain fused to the transmembrane domain of syntaxin 4 was also localized to the TGN, demonstrating that the H2 domain was sufficient to confer TGN localization. In addition to the H2 domain, a tyrosine-based plasma membrane internalization signal (YGRL) was identified between the H1 and H2 domains of syntaxin 6, Deletion of this sequence resulted in the accumulation of the EGFP-syntaxin 6 reporter construct at the plasma membrane. Together, these data demonstrate that syntaxin 6 utilizes two distinct domains to drive its specific subcellular localization to the TGN.	Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Pessin, JE (corresponding author), Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA.	jeffrey-pessin@uiowa.edu			NIDDK NIH HHS [DK25925, DK33823] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033823, R01DK033823] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Banting G, 1997, BBA-MOL CELL RES, V1355, P209, DOI 10.1016/S0167-4889(96)00146-2; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; BOS K, 1993, EMBO J, V12, P2219, DOI 10.1002/j.1460-2075.1993.tb05870.x; Bryant NJ, 1997, J CELL BIOL, V136, P287, DOI 10.1083/jcb.136.2.287; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; DASCHER C, 1994, J BIOL CHEM, V269, P29363; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Eng FJ, 1999, MOL BIOL CELL, V10, P35, DOI 10.1091/mbc.10.1.35; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Gotte M, 1997, FEBS LETT, V411, P48, DOI 10.1016/S0014-5793(97)00575-9; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; HORN M, 1994, BIOCHEM J, V301, P69, DOI 10.1042/bj3010069; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; Keller P, 1997, J CELL SCI, V110, P3001; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; LEBIVIC A, 1991, J CELL BIOL, V115, P607, DOI 10.1083/jcb.115.3.607; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PETERS C, 1990, EMBO J, V9, P3497, DOI 10.1002/j.1460-2075.1990.tb07558.x; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Roquemore EP, 1998, MOL BIOL CELL, V9, P2125, DOI 10.1091/mbc.9.8.2125; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stanley KK, 1996, MOL MEMBR BIOL, V13, P19, DOI 10.3109/09687689609160570; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Subtil A, 1997, J CELL BIOL, V136, P583, DOI 10.1083/jcb.136.3.583; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKAHASHI S, 1995, J BIOL CHEM, V270, P28397; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P345, DOI 10.1006/bbrc.1997.7966; Tang BL, 1998, BIOCHEM BIOPH RES CO, V242, P673, DOI 10.1006/bbrc.1997.8029; Tang BL, 1998, J BIOL CHEM, V273, P6944, DOI 10.1074/jbc.273.12.6944; Tellam JT, 1997, J BIOL CHEM, V272, P6187, DOI 10.1074/jbc.272.10.6187; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; Valdez AC, 1999, J CELL SCI, V112, P845; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; WONG SH, 1993, J BIOL CHEM, V268, P22853; Wong SH, 1998, J BIOL CHEM, V273, P375, DOI 10.1074/jbc.273.1.375; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	65	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1261	1268		10.1074/jbc.275.2.1261	http://dx.doi.org/10.1074/jbc.275.2.1261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625671	hybrid			2022-12-27	WOS:000084836600075
J	Akabas, MH				Akabas, MH			Cystic fibrosis transmembrane conductance regulator - Structure and function of an epithelial chloride channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MEMBRANE-SPANNING SEGMENT; PROTEIN-KINASE-A; LINING RESIDUES; WILD-TYPE; ELECTRON-MICROSCOPY; ANION-SELECTIVITY; P-GLYCOPROTEIN; CL CHANNELS; R-DOMAIN; CFTR		Columbia Univ, Dept Physiol & Cellular Biophys, Ctr Mol Recognit, New York, NY 10032 USA; Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Akabas, MH (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Ctr Mol Recognit, 630 W 168th St, New York, NY 10032 USA.	ma14@columbia.edu		Akabas, Myles/0000-0001-8781-7846	NIDDK NIH HHS [DK51794] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051794] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akabas MH, 1998, BIOCHEMISTRY-US, V37, P12233, DOI 10.1021/bi980969o; AKABAS MH, 1994, J BIOL CHEM, V269, P14865; ALAWQATI Q, 1995, CURR OPIN CELL BIOL, V7, P504, DOI 10.1016/0955-0674(95)80006-9; AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; BERGER HA, 1993, J BIOL CHEM, V268, P2037; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Cheung M, 1997, J GEN PHYSIOL, V109, P289, DOI 10.1085/jgp.109.3.289; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 1999, J GEN PHYSIOL, V114, P49, DOI 10.1085/jgp.114.1.49; CUTHBERT AW, 1994, BRIT J PHARMACOL, V112, P31, DOI 10.1111/j.1476-5381.1994.tb13024.x; Dawson David C., 1999, Physiological Reviews, V79, pS47; De Braekeleer M, 1996, MOL HUM REPROD, V2, P669, DOI 10.1093/molehr/2.9.669; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FIELD M, 1993, ANNU REV PHYSIOL, V55, P631, DOI 10.1146/annurev.ph.55.030193.003215; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GABRIEL SE, 1993, NATURE, V363, P263, DOI 10.1038/363263a0; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Grygorczyk R, 1996, J MEMBRANE BIOL, V151, P139, DOI 10.1007/s002329900065; Guinamard R, 1999, BIOCHEMISTRY-US, V38, P5528, DOI 10.1021/bi990155n; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; HANSEN MB, 1995, PHYSIOL RES, V44, P61; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HWANG TC, 1993, J GEN PHYSIOL, V101, P629, DOI 10.1085/jgp.101.5.629; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Li CH, 1996, J BIOL CHEM, V271, P11623, DOI 10.1074/jbc.271.20.11623; Linsdell P, 1996, AM J PHYSIOL-CELL PH, V271, pC628, DOI 10.1152/ajpcell.1996.271.2.C628; Linsdell P, 1997, J GEN PHYSIOL, V110, P355, DOI 10.1085/jgp.110.4.355; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; MARSHALL J, 1994, J BIOL CHEM, V269, P2987; MCDONOUGH S, 1994, NEURON, V13, P623, DOI 10.1016/0896-6273(94)90030-2; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; Peng SY, 1998, FEBS LETT, V431, P29, DOI 10.1016/S0014-5793(98)00715-7; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; TABCHARANI JA, 1993, NATURE, V366, P79, DOI 10.1038/366079a0; Tabcharani JA, 1997, J GEN PHYSIOL, V110, P341, DOI 10.1085/jgp.110.4.341; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wigley WC, 1998, BIOCHEMISTRY-US, V37, P844, DOI 10.1021/bi972293n; Wilkinson DJ, 1996, J GEN PHYSIOL, V107, P103, DOI 10.1085/jgp.107.1.103; Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Zeltwanger S, 1999, J GEN PHYSIOL, V113, P541, DOI 10.1085/jgp.113.4.541; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zhu T, 1999, J BIOL CHEM, V274, P29102, DOI 10.1074/jbc.274.41.29102	73	99	104	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					3729	3732		10.1074/jbc.275.6.3729	http://dx.doi.org/10.1074/jbc.275.6.3729			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660517	hybrid			2022-12-27	WOS:000085288800001
J	Williams, E; Williams, G; Gour, BJ; Blaschuk, OW; Doherty, P				Williams, E; Williams, G; Gour, BJ; Blaschuk, OW; Doherty, P			A novel family of cyclic peptide antagonists suggests that N-cadherin specificity is determined by amino acids that flank the HAV motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; NEURITE OUTGROWTH; CAM; IDENTIFICATION; LOCALIZATION; MAINTENANCE; NEURONS; CANCER; L1	The classical cadherins (e.g. N-, E-, and P-cadherin) are well established homophilic adhesion molecules; however, the mechanism that governs cadherin specificity remains contentious. The classical cadherins contain an evolutionarily conserved His-Ala-Val (HAV) sequence, and linear peptides harboring this motif are capable of inhibiting a variety of cadherin-dependent processes. We now demonstrate that short cyclic HAV peptides can inhibit N-cadherin function. Interestingly, the nature of the amino acids that flank the HAV motif determine both the activity and specificity of the peptides. For example, when the HAV motif is flanked by a single aspartic acid, which mimics the natural HAVD sequence of N-cadherin, the peptide becomes a much more effective inhibitor of N-cadherin function. In contrast, when the HAV motif is flanked by a single serine, which mimics the natural HAVS sequence of E-cadherin, it loses its ability to inhibit the N-cadherin response. Our results demonstrate that subtle changes in the amino acids that flank the HAV motif can account for cadherin specificity and that small cyclic peptides can inhibit cadherin function. An emerging role for cadherins in a number of pathological processes suggests that the cyclic peptides reported in this study might be developed as therapeutic agents.	Kings Coll London, Mol Neurobiol Grp, Guys Kings & St Thomas Sch Med, London SE1 9RT, England; McGill Univ, Dept Surg, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada	University of London; King's College London; McGill University; McGill University	Doherty, P (corresponding author), Kings Coll London, Mol Neurobiol Grp, Guys Kings & St Thomas Sch Med, 4th Floor,New Hunts House,Guys Campus,London Brid, London SE1 9RT, England.	patrick.doherty@kcl.ac.uk	Doherty, Patrick/A-8752-2008; Williams, Gareth/B-3202-2010	Williams, Gareth/0000-0001-9205-4943; Doherty, Patrick/0000-0002-0407-5689				ALEXANDER JS, 1993, J CELL PHYSIOL, V156, P610, DOI 10.1002/jcp.1041560321; Blaschuk O W, 1994, Can J Oncol, V4, P291; BLASCHUK OW, 1990, DEV BIOL, V139, P227, DOI 10.1016/0012-1606(90)90290-Y; BLASCHUK OW, 1990, J MOL BIOL, V211, P679, DOI 10.1016/0022-2836(90)90065-T; CHEN Z, 1994, ALGEBRA C, V1, P1; CHUAH MI, 1991, DEV BRAIN RES, V60, P123, DOI 10.1016/0165-3806(91)90040-P; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Grunwald GB, 1993, CURR OPIN CELL BIOL, V5, P797, DOI 10.1016/0955-0674(93)90028-O; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; KCH AW, 1999, CURR OPIN STRUC BIOL, V9, P275; MEGE RM, 1992, J CELL SCI, V103, P897; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NEWTON SC, 1993, DEV DYNAM, V197, P1, DOI 10.1002/aja.1001970102; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Peluso JJ, 1996, ENDOCRINOLOGY, V137, P1196, DOI 10.1210/en.137.4.1196; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Rubin Lee L., 1992, Current Opinion in Cell Biology, V4, P830, DOI 10.1016/0955-0674(92)90107-N; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; STEWART JM, 1969, SOLID PHASE PEPTIDE; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; WILLIAMS EJ, 1994, J CELL BIOL, V124, P1029, DOI 10.1083/jcb.124.6.1029; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774	34	131	140	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4007	4012		10.1074/jbc.275.6.4007	http://dx.doi.org/10.1074/jbc.275.6.4007			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660557	hybrid			2022-12-27	WOS:000085288800041
J	Couture, M; Stuehr, DJ; Rousseau, DL				Couture, M; Stuehr, DJ; Rousseau, DL			The ferrous dioxygen complex of the oxygenase domain of neuronal nitric-oxide synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTRA; MACROPHAGE NO SYNTHASE; HYDROXY-L-ARGININE; LOW-TEMPERATURE; BIDOMAIN STRUCTURE; CRYSTAL-STRUCTURE; THIOLATE LIGAND; BINDING DOMAINS; SUBSTRATE; TETRAHYDROBIOPTERIN	The mechanisms by which nitric-oxide synthases (NOSs) bind and activate oxygen at their P450-type heme active site in order to synthesize nitric oxide from the substrate L-arginine are mostly unknown. To obtain information concerning the structure and properties of the first oxygenated intermediate of the enzymatic cycle, we have used a rapid continuous flow mixer and resonance Raman spectroscopy to generate and identify the ferrous dioxygen complex of the oxygenase domain of nNOS (Fe2+O2 nNOSoxy), We detect a line at 1135 cm(-1) in the resonance Raman spectrum of the intermediate formed from 0.6 to 3.0 ms after the rapid mixing of the ferrous enzyme with oxygen that is shifted to 1068 cm(-1) with O-18(2). This line is assigned as the O-O stretching mode (upsilon(O-O)) of the oxygenated complex of nNOSoxy. Rapid mixing experiments performed with nNOSoxy saturated with L-arginine or N-omega-hydroxy-L-arginine, in the presence or absence of (6R)-5,6,7,8-tetrahydro-L-biopterin, reveal that the upsilon(O-O) line is insensitive to the presence of the substrate and the pterin. The optical spectrum of this ferrous dioxygen species, with a Soret band wavelength maximum at 430 nm, confirms the identification of the previously reported oxygenated complexes generated by stopped flow techniques.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Cleveland Clin Fdn, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA	Yeshiva University; Albert Einstein College of Medicine; Cleveland Clinic Foundation	Rousseau, DL (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.		Couture, Manon/F-8326-2015	Couture, Manon/0000-0001-8296-8055	NIGMS NIH HHS [GM51491, GM54812, GM54806] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491, R01GM054806, R01GM054812] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AbuSoud HM, 1997, J BIOL CHEM, V272, P17349, DOI 10.1074/jbc.272.28.17349; ABUSOUD HM, 1995, BIOCHEMISTRY-US, V34, P11167, DOI 10.1021/bi00035a023; ALBEN JO, 1978, FOURIER TRANSFORM IN, P607; BANGCHAROENPAURPONG O, 1986, J BIOL CHEM, V261, P8089; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; BONFILS C, 1979, BIOCHEM BIOPH RES CO, V88, P1301, DOI 10.1016/0006-291X(79)91122-7; BUDYKA MF, 1981, BIOCHEM BIOPH RES CO, V101, P615, DOI 10.1016/0006-291X(81)91303-6; Chen PF, 1996, J BIOL CHEM, V271, P14631, DOI 10.1074/jbc.271.24.14631; CHOTTARD G, 1984, INORG CHEM, V23, P4557, DOI 10.1021/ic00194a030; Clague MJ, 1997, BIOCHEMISTRY-US, V36, P14465, DOI 10.1021/bi971024u; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; EDWARDS SL, 1990, J BIOL CHEM, V265, P2588; EGAWA T, 1991, J BIOL CHEM, V266, P10246; EISENSTEIN L, 1977, BIOCHEM BIOPH RES CO, V77, P1377, DOI 10.1016/S0006-291X(77)80131-9; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; FELDMAN PL, 1993, CHEM ENG NEWS, V71, P26; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; GHOSH DK, 1995, BIOCHEMISTRY-US, V34, P801, DOI 10.1021/bi00003a013; Gorren ACF, 1996, BIOCHEMISTRY-US, V35, P16735, DOI 10.1021/bi961931j; Hirota S, 1996, J AM CHEM SOC, V118, P7845, DOI 10.1021/ja9608297; HU SZ, 1991, J AM CHEM SOC, V113, P4815, DOI 10.1021/ja00013a016; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; KERR EA, 1985, J BIOL CHEM, V260, P8360; KLATT P, 1992, BIOCHEM J, V288, P15, DOI 10.1042/bj2880015; LAMBEIR AM, 1985, EUR J BIOCHEM, V147, P93, DOI 10.1111/j.1432-1033.1985.tb08723.x; LARROQUE C, 1980, FEBS LETT, V115, P175, DOI 10.1016/0014-5793(80)81161-6; Ledbetter AP, 1999, BIOCHEMISTRY-US, V38, P8014, DOI 10.1021/bi990619h; Macdonald IDG, 1999, J AM CHEM SOC, V121, P376, DOI 10.1021/ja9810383; Masters BSS, 1996, FASEB J, V10, P552, DOI 10.1096/fasebj.10.5.8621055; MCMILLAN K, 1995, BIOCHEMISTRY-US, V34, P3686, DOI 10.1021/bi00011a025; MCMILLAN K, 1993, BIOCHEMISTRY-US, V32, P9875, DOI 10.1021/bi00089a001; Migita CT, 1997, BIOCHEMISTRY-US, V36, P10987, DOI 10.1021/bi970823+; NAKAJIMA R, 1985, BIOCHEM BIOPH RES CO, V128, P1, DOI 10.1016/0006-291X(85)91635-3; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; PETERSON JA, 1972, ARCH BIOCHEM BIOPHYS, V149, P197, DOI 10.1016/0003-9861(72)90315-3; PRONIEWICZ LM, 1990, J AM CHEM SOC, V112, P675, DOI 10.1021/ja00158a028; RAAG R, 1989, BIOCHEMISTRY-US, V28, P7586, DOI 10.1021/bi00445a013; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Sato H, 1998, BIOCHEM BIOPH RES CO, V253, P845, DOI 10.1006/bbrc.1998.9851; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SHETA EA, 1994, J BIOL CHEM, V269, P15147; SONO M, 1985, J BIOL CHEM, V260, P5530; STUEHR DJ, 1991, J BIOL CHEM, V266, P6259; STUEHR DJ, 1992, J BIOL CHEM, V267, P20547; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; TUCKEY RC, 1982, J BIOL CHEM, V257, P9309; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; WANG JL, 1995, BIOCHEMISTRY-US, V34, P7080, DOI 10.1021/bi00021a020; Wang JL, 1997, BIOCHEMISTRY-US, V36, P4595, DOI 10.1021/bi962309u; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; XIE QW, 1994, J BIOL CHEM, V269, P28500	54	56	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3201	3205		10.1074/jbc.275.5.3201	http://dx.doi.org/10.1074/jbc.275.5.3201			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652305	hybrid			2022-12-27	WOS:000085146500027
J	Ostrowski, J; Schullery, DS; Denisenko, ON; Higaki, Y; Watts, J; Aebersold, R; Stempka, L; Gschwendt, M; Bomsztyk, K				Ostrowski, J; Schullery, DS; Denisenko, ON; Higaki, Y; Watts, J; Aebersold, R; Stempka, L; Gschwendt, M; Bomsztyk, K			Role of tyrosine phosphorylation in the regulation of the interaction of heterogenous nuclear ribonucleoprotein K protein with its protein and RNA partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-K; T-CELL; MESSENGER-RNA; TRANSCRIPTIONAL REPRESSOR; VAV PROTOONCOGENE; ANTIGEN RECEPTOR; IN-VITRO; KINASE-C; ACTIVATION; IDENTIFICATION	The heterogeneous nuclear ribonucleoprotein K protein recruits a diversity of molecular partners and may act as a docking platform involved in such processes as transcription, RNA processing, and translation. We show that K protein is tyrosine-phosphorylated in vitro by Src and Lck. Treatment with H2O2/Na3VO4, which induces oxidative stress, stimulated tyrosine phosphorylation of K protein in cultured cells and in intact livers. Tyrosine phosphorylation increased binding of Lck and the proto-oncoprotein Vav to K protein in vitro, Oxidative stress increased the association of K protein with Lck and Vav, suggesting that tyrosine phosphorylation regulates the ability of K protein to recruit these effecters in vivo, Translation-based assay showed that K protein is constitutively bound to many mRNAs in vivo. Native immunoprecipitated K protein-mRNA complexes were disrupted by tyrosine phosphorylation, suggesting that the in vine binding of K protein to mRNA may be responsive to the extracellular signals that activate tyrosine kinases, This study shows that tyrosine phosphorylation of K protein regulates K protein-protein and K protein-RNA interactions, These data are consistent with a model in which functional interaction of K protein is responsive to changes in the extracellular environment, Acting as a docking platform, K protein may bridge signal transduction pathways to sites of nucleic acid-dependent process such as transcription, RNA processing, and translation.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; German Canc Res Ctr, D-69120 Heidelberg, Germany; Maria Sklodowska Curie Mem Canc Ctr, Med Ctr Postgrad Educ, Dept Gastroenterol, PL-02781 Warsaw, Poland; Inst Oncol, PL-02781 Warsaw, Poland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Helmholtz Association; German Cancer Research Center (DKFZ); Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Bomsztyk, K (corresponding author), Univ Washington, Dept Med, Box 356521, Seattle, WA 98195 USA.			Ostrowski, Jerzy/0000-0003-1363-3766	NIAID NIH HHS [AI41109] Funding Source: Medline; NIDDK NIH HHS [DK45978] Funding Source: Medline; NIGMS NIH HHS [GM45134] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045978, R01DK045978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045134] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAST A, 1989, PHARM WEEKBLAD, V11, P199, DOI 10.1007/BF01959411; Bijlmakers MJJE, 1999, J CELL BIOL, V145, P457, DOI 10.1083/jcb.145.3.457; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; COOPER JA, 1984, J BIOL CHEM, V259, P7835; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; DEJGAARD K, 1994, J MOL BIOL, V236, P33, DOI 10.1006/jmbi.1994.1116; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Emkey R, 1997, J BIOL CHEM, V272, P31172, DOI 10.1074/jbc.272.49.31172; FEUERBACH D, 1995, J BIOL CHEM, V270, P25949, DOI 10.1074/jbc.270.43.25949; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; HOBERT O, 1994, J BIOL CHEM, V269, P20225; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; MAA MC, 1994, MOL CELL BIOL, V14, P5466, DOI 10.1128/MCB.14.8.5466; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Miau LH, 1998, J BIOL CHEM, V273, P10784, DOI 10.1074/jbc.273.17.10784; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Ostrowski J, 1998, ONCOGENE, V16, P1223, DOI 10.1038/sj.onc.1201624; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; OSTROWSKI J, 1991, J BIOL CHEM, V266, P12722; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; Romero F, 1996, CELL SIGNAL, V8, P545, DOI 10.1016/S0898-6568(96)00118-0; ROSENBERGER U, 1996, EUR J CELL BIOL S42, V69, P288; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TAYLOR SJ, 1995, J BIOL CHEM, V270, P10120, DOI 10.1074/jbc.270.17.10120; VANSEUNINGEN I, 1995, BIOCHEMISTRY-US, V34, P5644, DOI 10.1021/bi00016a040; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; WANG JYJ, 1994, TRENDS BIOCHEM SCI, V19, P373, DOI 10.1016/0968-0004(94)90114-7; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WATTS JD, 1992, J BIOL CHEM, V267, P901; Watts JD, 1996, FEBS LETT, V398, P217, DOI 10.1016/S0014-5793(96)01241-0; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZICK Y, 1990, BIOCHEMISTRY-US, V29, P10240, DOI 10.1021/bi00496a013	53	73	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3619	3628		10.1074/jbc.275.5.3619	http://dx.doi.org/10.1074/jbc.275.5.3619			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652358	hybrid			2022-12-27	WOS:000085146500080
J	Cheng, ZJ; Zhao, J; Sun, Y; Hu, W; Wu, YL; Cen, B; Wu, GX; Pei, G				Cheng, ZJ; Zhao, J; Sun, Y; Hu, W; Wu, YL; Cen, B; Wu, GX; Pei, G			beta-arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between beta-arrestin and CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LEUKOCYTE CHEMOATTRACTANT RECEPTORS; HIV-1 ENTRY; KINASE ACTIVATION; TROPIC HIV-1; DESENSITIZATION; INFECTION; CLONING; LIGAND; SDF-1	The chemokine receptor CXCR4 has recently been shown to be a co-receptor involved in the entry of human immunodeficiency virus type 1 into target cells. This study shows that coexpression of beta-arrestin with CXCR4 in human embryonic kidney 293 cells attenuated chemokine-stimulated G protein activation and inhibition of cAMP production. Truncation of the C-terminal 34 amino acids of CXCR4 (CXCR4-T) abolished the effects of beta-arrestin on CXCR4/G protein signaling, indicating the functional interaction of the receptor C terminus with beta-arrestin. On the other hand, receptor internalization and the subsequent activation of extracellular signal-regulated kinases were significantly promoted by coexpression of beta-arrestin with CXCR4, whereas the C-terminal truncation of CXCR4 did not affect this regulation of beta-arrestin, suggesting that beta-arrestin can functionally interact with CXCR4 with or without the C terminus. Moreover, beta(2)V54D, the dominant inhibitory mutant of beta-arrestin 2, exerted no effects on CXCR4/G protein signaling, but strongly influenced receptor internalization and extracellular signal-regulated kinase activation. Further cross-linking experiments demonstrated that beta-arrestin as well. as beta(2)V54D could physically contact both CXCR4. and CXCR4-T. Glutathione S-transferase pub-down assay showed that beta-arrestin was able to bind efficiently In vitro to both the third intracellular loop and the 34-amino acid C terminus of CXCR4. Taken together, our data clearly establish that beta-arrestin can effectively regulate different functions of CXCR4 and that this is mediated through its distinct interactions with the C terminus and other regions including the third loop of CXCR4.	Chinese Acad Sci, Shanghai Inst Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.		Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BENOVIC JL, 1990, BRIT J CLIN PHARMACO, V30, pS3, DOI 10.1111/j.1365-2125.1990.tb05462.x; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; CHEN CY, 1993, J BIOL CHEM, V268, P7825; Cheng ZJ, 1997, NEUROREPORT, V8, P1913, DOI 10.1097/00001756-199705260-00024; Cheng ZJ, 1998, J BIOL CHEM, V273, P24328, DOI 10.1074/jbc.273.38.24328; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; HAGA K, 1994, J BIOL CHEM, V269, P12594; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; KRUPNICK JG, 1994, J BIOL CHEM, V269, P3226; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Ling K, 1999, P NATL ACAD SCI USA, V96, P7922, DOI 10.1073/pnas.96.14.7922; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MOCHIZUKI M, 1985, INVEST OPHTH VIS SCI, V26, P226; Murakami T, 1997, J EXP MED, V186, P1389, DOI 10.1084/jem.186.8.1389; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PARRUTI G, 1993, J RECEPTOR RES, V13, P95, DOI 10.3109/10799899309073648; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; Power CA, 1996, TRENDS PHARMACOL SCI, V17, P209, DOI 10.1016/0165-6147(96)10019-5; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Ueda H, 1997, J BIOL CHEM, V272, P24966, DOI 10.1074/jbc.272.40.24966; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Zhao J, 1999, J EXP MED, V190, P101, DOI 10.1084/jem.190.1.101	45	172	183	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2479	2485		10.1074/jbc.275.4.2479	http://dx.doi.org/10.1074/jbc.275.4.2479			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644702	hybrid			2022-12-27	WOS:000085128000034
J	Kumar, D; Whiteside, TL; Kasid, U				Kumar, D; Whiteside, TL; Kasid, U			Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SQUAMOUS CARCINOMA; CELL-CARCINOMA; IONIZING-RADIATION; MEDIATED APOPTOSIS; CD95 FAS/APO-1; FLOW-CYTOMETRY; TNF-ALPHA; EXPRESSION; FLICE; RECEPTORS	We report here the isolation and characterization of a novel tumor necrosis factor-alpha (TNF-alpha)-inducible gene, SCC-S2, Based on the nucleotide sequence, the SCC-SP open reading frame contains a sequence in the amino terminus that shows a significant homology to death effector domain II of cell death regulatory protein, Fas-associated death domain-like interleukin-1 beta-converting enzyme-inhibitory protein (FLIP). Unlike FLIP, the SCC-SS open reading frame contains only one death effector domain and lacks the carboxyl-terminal caspase-like homology domain, raising the possibility that SCC-S2 may be a novel member of the FLIP family. SCC-S2 mRNA expression is found in most normal tissues and malignant cells. The steady state level of SCC-S2 mRNA is significantly induced by TNF-a in different tumor cells (TNF-alpha at 20 ng/ml for 3 h: A549, similar to 2-9-fold; SKOV-3, similar to 3-fold; PCI-04A, similar to 3-6-fold), TNF-alpha treatment (100 ng/ml, 4 h) of HeLa cells transiently transfected with FLAG epitope-tagged SCC-S2 cDNA or expression vector alone led to an increase in the number of apoptotic cells as compared with the untreated counterpart. Interestingly, however, SCC-S2 transfectants revealed a significant decrease in the number of apoptotic cells as compared with the vector transfectants (p < 0.001). These data implicate a role of SCC-S2 as a negative mediator of apoptosis in certain cell, types.	Georgetown Univ, Lombardi Canc Ctr, Med Ctr, Dept Radiat Med, Washington, DC 20007 USA; Georgetown Univ, Lombardi Canc Ctr, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20007 USA; Univ Pittsburgh, Sch Med, Pittsburgh Canc Inst, Dept Pathol, Pittsburgh, PA 15261 USA	Georgetown University; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Kasid, U (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Med Ctr, Dept Radiat Med, E208,Res Bldg,3970 Reservoir Rd NW, Washington, DC 20007 USA.	kasidu@gunet.georgetown.edu			NCI NIH HHS [CA74175, CA68322, P30-CA51008] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA068322, P01CA074175, P30CA051008] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bertin J, 1997, P NATL ACAD SCI USA, V94, P1172, DOI 10.1073/pnas.94.4.1172; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Chiou SK, 1998, VIROLOGY, V244, P108, DOI 10.1006/viro.1998.9077; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; EARL PL, 1986, P NATL ACAD SCI USA, V83, P3659, DOI 10.1073/pnas.83.11.3659; Gokhale PC, 1999, ANTISENSE NUCLEIC A, V9, P191, DOI 10.1089/oli.1.1999.9.191; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; Griffith TS, 1998, J IMMUNOL, V161, P2833; HAN SK, 1994, AM J RESP CELL MOL, V11, P270, DOI 10.1165/ajrcmb.11.3.8086165; HEO DS, 1989, CANCER RES, V49, P5167; Horrevoets AJG, 1999, BLOOD, V93, P3418, DOI 10.1182/blood.V93.10.3418.410k23_3418_3431; Hu MC, 1997, VIROLOGY, V227, P295, DOI 10.1006/viro.1996.8349; Hu SM, 1997, J BIOL CHEM, V272, P9621; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; IRMIER M, 1997, NATURE, V388, P190; Kasid U, 1997, MOL CELL BIOCHEM, V173, P193; KASID U, 1989, SCIENCE, V243, P1354, DOI 10.1126/science.2466340; Kasid Usha, 1998, P85; Kataoka T, 1998, J IMMUNOL, V161, P3936; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; MORIMOTO H, 1991, J IMMUNOL, V147, P2609; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; ODA T, 1993, BIOCHEM BIOPH RES CO, V193, P897, DOI 10.1006/bbrc.1993.1710; Patel S, 1998, ACTA ONCOL, V37, P475, DOI 10.1080/028418698430430; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Patel S, 1997, MOL MED, V3, P674, DOI 10.1007/BF03401706; SACCHI M, 1991, ARCH OTOLARYNGOL, V117, P321; Sata M, 1998, J BIOL CHEM, V273, P33103, DOI 10.1074/jbc.273.50.33103; Srinivasula SM, 1997, J BIOL CHEM, V272, P18542, DOI 10.1074/jbc.272.30.18542; TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Troppmair J, 1992, Curr Top Microbiol Immunol, V182, P453; Weiss R A, 1998, J Natl Cancer Inst Monogr, P51; Yeh JH, 1998, J EXP MED, V188, P1795, DOI 10.1084/jem.188.10.1795	43	107	121	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2973	2978		10.1074/jbc.275.4.2973	http://dx.doi.org/10.1074/jbc.275.4.2973			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644768	hybrid			2022-12-27	WOS:000085128000100
J	Lesa, GM; Seemann, J; Shorter, J; Vandekerckhove, J; Warren, G				Lesa, GM; Seemann, J; Shorter, J; Vandekerckhove, J; Warren, G			The amino-terminal domain of the Golgi protein Giantin interacts directly with the vesicle-tethering protein p115	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL MEMBRANE-PROTEIN; CELL-FREE SYSTEM; ENDOPLASMIC-RETICULUM; COATED VESICLES; TRANSPORT VESICLES; HELA-CELLS; CIS-GOLGI; VESICULAR TRANSPORT; MITOTIC CONDITIONS; ENDOSOME FUNCTION	Giantin is thought to form a complex with p115 and Golgi matrix protein 130, which is involved in the reassembly of Golgi cisternae and stacks at the end of mitosis. The complex is involved in the tethering of coat protomer I vesicles to Golgi membranes and the initial stacking of reforming cisternae, Here we show that the NH2-terminal 15% of Giantin suffices to bind p115 in vitro and in vivo and to block cell-free Golgi reassembly. Because Giantin is a long, rod-like protein anchored to the membrane by its extreme COOH terminus, these results support the idea of a long, flexible tether linking vesicles and cisternae.	Imperial Canc Res Fund, Cell Biol Lab, London WC2A 3PX, England; Imperial Canc Res Fund, Mol Neuropathobiol Lab, London WC2A 3PX, England; State Univ Ghent VIB, Dept Biochem, B-9000 Ghent, Belgium; State Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium	Cancer Research UK; Cancer Research UK; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Warren, G (corresponding author), Imperial Canc Res Fund, Cell Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	graham.warren@yale.edu	Shorter, James/ABE-7307-2020; Shorter, James/E-8207-2011	Shorter, James/0000-0001-5269-8533; 				Allen PG, 1999, BIOESSAYS, V21, P451, DOI 10.1002/(SICI)1521-1878(199906)21:6<451::AID-BIES1>3.0.CO;2-B; Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; Barr FA, 1996, SEMIN CELL DEV BIOL, V7, P505, DOI 10.1006/scdb.1996.0063; BARROSO M, 1995, P NATL ACAD SCI USA, V92, P527, DOI 10.1073/pnas.92.2.527; Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Clague MJ, 1999, CURR BIOL, V9, pR258, DOI 10.1016/S0960-9822(99)80158-4; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3; Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747; Dascher C, 1996, J BIOL CHEM, V271, P15866, DOI 10.1074/jbc.271.27.15866; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P203, DOI 10.1006/abio.1995.1031; Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7; Gevaert K, 1998, ELECTROPHORESIS, V19, P909, DOI 10.1002/elps.1150190606; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Griffin PR, 1995, RAPID COMMUN MASS SP, V9, P1546, DOI 10.1002/rcm.1290091515; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0; Hui N, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P46; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kim DW, 1999, MOL BIOL CELL, V10, P3317, DOI 10.1091/mbc.10.10.3317; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazar T, 1997, TRENDS BIOCHEM SCI, V22, P468, DOI 10.1016/S0968-0004(97)01150-X; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; LUCOCQ JM, 1987, EMBO J, V6, P3239, DOI 10.1002/j.1460-2075.1987.tb02641.x; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MISTELI T, 1994, J CELL BIOL, V125, P269, DOI 10.1083/jcb.125.2.269; NAKAJIMA H, 1991, J CELL BIOL, V113, P245, DOI 10.1083/jcb.113.2.245; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; Sohda M, 1998, J BIOL CHEM, V273, P5385, DOI 10.1074/jbc.273.9.5385; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sonnichsen B, 1996, J CELL BIOL, V134, P1411, DOI 10.1083/jcb.134.6.1411; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; WARREN G, 1995, TRENDS CELL BIOL, V5, P413, DOI 10.1016/S0962-8924(00)89094-7; WARREN G, 1985, TRENDS BIOCHEM SCI, V10, P439, DOI 10.1016/0968-0004(85)90027-1; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; WEBER K, 1969, J BIOL CHEM, V244, P4406; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WEIDMAN P, 1993, CELL, V75, P123, DOI 10.1016/S0092-8674(05)80089-3; WHITNEY JA, 1995, CELL, V83, P703; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9; Yamakawa H, 1996, J STRUCT BIOL, V116, P356, DOI 10.1006/jsbi.1996.0053; Yuan L, 1996, EXP CELL RES, V229, P272, DOI 10.1006/excr.1996.0371	71	54	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2831	2836		10.1074/jbc.275.4.2831	http://dx.doi.org/10.1074/jbc.275.4.2831			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644749	Green Submitted, hybrid			2022-12-27	WOS:000085128000081
J	Saas, J; Ziegelbauer, K; von Haeseler, A; Fast, B; Boshart, M				Saas, J; Ziegelbauer, K; von Haeseler, A; Fast, B; Boshart, M			A developmentally regulated aconitase related to iron-regulatory protein-1 is localized in the cytoplasm and in the mitochondrion of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; ELEMENT-BINDING-PROTEIN; ETIOLATED PUMPKIN COTYLEDONS; HIGHER-PLANT CELLS; IN-VITRO IMPORT; SULFUR CLUSTERS; DIHYDROLIPOAMIDE DEHYDROGENASE; AFRICAN TRYPANOSOMES; CYTOSOLIC ACONITASE; MUTATIONAL ANALYSIS	Mitochondrial energy metabolism and Krebs cycle activities are development-ally regulated in the life cycle of the protozoan parasite Typanosoma brucei. Here we report cloning of a T. brucei aconitase gene that is closely related to mammalian iron-regulatory protein 1 (IRP-1) and plant aconitases. Kinetic analysis of purified recombinant TbACO expressed in Escherichia coli resulted in a K-m (isocitrate) of 3 +/- 0.4 mM, similar to aconitases of other organisms. This was unexpected since an arginine conserved in the aconitase protein family and crucial for substrate positioning in the catalytic center and for activity of pig mitochondrial aconitase (Zheng, L., Kennedy, M. C., Beinert, H., and Zalkin, H. (1992) J. Biol. Chem. 267, 7895-7903) is substituted by leucine in the TbACO sequence. Expression of the 98-kDa TbACO was shown to be lowest in the slender bloodstream stage of the parasite, 8-fold elevated in the stumpy stage, and increased a further 4-fold in the procyclic stage. The differential expression of TbACO protein contrasted with only minor changes in TbACO mRNA, indicating translational or post-translational mechanisms of regulation, Whereas animal cells express two distinct compartmentalized aconitases, mitochondrial aconitase and cytoplasmic aconitase/IRP-1, TbACO accounts for total aconitase activity in trypanosomes, By cell fractionation and immunofluorescence microscopy, we show that native as well as a transfected epitope-tagged TbACO localizes in both the mitochondrion (30%) and in the cytoplasm (70%), Together with phylogenetic reconstructions of the aconitase family, this suggests that animal IRPs have evolved from a multicompartmentalized ancestral aconitase, The possible functions of a cytoplasmic aconitase in trypanosomes are discussed.	FU Berlin, Inst Mol Biol & Biochem, AG Mol Zellbiol, D-12203 Berlin, Germany; FU Berlin, Inst Infect Med, D-12203 Berlin, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Max Planck Inst Biol, D-7400 Tubingen, Germany; Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Free University of Berlin; Free University of Berlin; Max Planck Society; Max Planck Society; Max Planck Society	Boshart, M (corresponding author), FU Berlin, Inst Mol Biol & Biochem, AG Mol Zellbiol, Hindenburgdamm 27, D-12203 Berlin, Germany.	boshart@ukbf.fu-berlin.de	Boshart, Michael/A-2700-2011; von Haeseler, Arndt/HCI-9958-2022	Boshart, Michael/0000-0002-5070-2663; von Haeseler, Arndt/0000-0002-3366-4458				Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Anderson SA, 1998, EXP PARASITOL, V89, P63, DOI 10.1006/expr.1998.4260; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; BEINERT H, 1983, P NATL ACAD SCI-BIOL, V80, P393, DOI 10.1073/pnas.80.2.393; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BLUM JJ, 1994, J BIOENERG BIOMEMBR, V26, P147, DOI 10.1007/BF00763063; BOSHART M, 1991, CELL, V66, P849, DOI 10.1016/0092-8674(91)90432-X; BROUQUISSE R, 1987, PLANT PHYSIOL, V84, P1402, DOI 10.1104/pp.84.4.1402; BRUN R, 1979, ACTA TROP, V36, P289; BRUN R, 1981, Z PARASITENKD, V66, P17, DOI 10.1007/BF00941941; CARRUTHERS VB, 1993, NUCLEIC ACIDS RES, V21, P2537, DOI 10.1093/nar/21.10.2537; CLAYTON C, 1992, PROG NUCLEIC ACID RE, V43, P37, DOI 10.1016/S0079-6603(08)61043-0; CLAYTON C, 1995, MICROBIOL REV, V59, P325, DOI 10.1128/MMBR.59.3.325-344.1995; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; COURTOISVERNIQUET F, 1993, BIOCHEM J, V294, P103, DOI 10.1042/bj2940103; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; DANPURE CJ, 1995, TRENDS CELL BIOL, V5, P230, DOI 10.1016/S0962-8924(00)89016-9; DEBELLIS L, 1993, PHYSIOL PLANTARUM, V88, P485, DOI 10.1111/j.1399-3054.1993.tb01363.x; DEBELLIS L, 1995, PLANTA, V195, P464, DOI 10.1007/BF00202606; ELSE AJ, 1994, MOL BIOCHEM PARASIT, V64, P233, DOI 10.1016/0166-6851(93)00016-3; ELSE AJ, 1993, EUR J BIOCHEM, V212, P423, DOI 10.1111/j.1432-1033.1993.tb17678.x; Escher CL, 1997, BIOL CHEM, V378, P803; Fairlamb A. H., 1986, Carbohydrate metabolism in cultured cells., P183; Fast B, 1999, BIOCHEM J, V342, P691, DOI 10.1042/0264-6021:3420691; Frishman D, 1996, EUR J BIOCHEM, V239, P197, DOI 10.1111/j.1432-1033.1996.0197u.x; GALE M, 1994, J BIOL CHEM, V269, P31659; GANGLOFF SP, 1990, MOL CELL BIOL, V10, P3551, DOI 10.1128/MCB.10.7.3551; GLUSKER JP, 1971, ENZYMES, V5, P413; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gruer MJ, 1997, TRENDS BIOCHEM SCI, V22, P3, DOI 10.1016/S0968-0004(96)10069-4; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Hauser R, 1996, J CELL SCI, V109, P517; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Hausler T, 1996, J CELL BIOL, V132, P311, DOI 10.1083/jcb.132.3.311; HAYASHI M, 1995, PLANT CELL PHYSIOL, V36, P669; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HENSON CP, 1967, J BIOL CHEM, V242, P3833; Hentze MW, 1996, TRENDS BIOCHEM SCI, V21, P282, DOI 10.1016/S0968-0004(96)20019-2; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hotz HR, 1997, NUCLEIC ACIDS RES, V25, P3017, DOI 10.1093/nar/25.15.3017; Irvin SD, 1998, J MOL EVOL, V46, P401, DOI 10.1007/PL00006319; JACKMAN SA, 1990, EUR J BIOCHEM, V193, P91, DOI 10.1111/j.1432-1033.1990.tb19308.x; JORDANOV J, 1992, J BIOL CHEM, V267, P16775; KEEGAN FP, 1993, J EUKARYOT MICROBIOL, V40, P730, DOI 10.1111/j.1550-7408.1993.tb04467.x; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KENT TA, 1982, P NATL ACAD SCI-BIOL, V79, P1096, DOI 10.1073/pnas.79.4.1096; KOZAK M, 1983, MICROBIOL REV, V47, P1; KUHN LC, 1992, J INORG BIOCHEM, V47, P183, DOI 10.1016/0162-0134(92)84064-T; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; LAUBLE H, 1995, PROTEINS, V22, P1, DOI 10.1002/prot.340220102; Matthews KR, 1997, J CELL SCI, V110, P2609; MENGAUD JM, 1993, J BACTERIOL, V175, P5666, DOI 10.1128/JB.175.17.5666-5676.1993; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; MIZOBUCHI M, 1992, BIOTECHNIQUES, V12, P350; Murakami K, 1997, BIOCHEM MOL BIOL INT, V41, P481; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; OVERATH P, 1986, EUR J BIOCHEM, V160, P175, DOI 10.1111/j.1432-1033.1986.tb09955.x; PEYRET P, 1995, J BIOL CHEM, V270, P8131, DOI 10.1074/jbc.270.14.8131; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; PRIEST JW, 1994, MOL BIOCHEM PARASIT, V65, P291, DOI 10.1016/0166-6851(94)90080-9; Priest JW, 1996, J BIOL CHEM, V271, P20060, DOI 10.1074/jbc.271.33.20060; PRIEST JW, 1995, BBA-MOL CELL RES, V1269, P201, DOI 10.1016/0167-4889(95)00154-6; PRIEST JW, 1993, BIOCHIM BIOPHYS ACTA, V1144, P229, DOI 10.1016/0005-2728(93)90178-I; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; PURNELLE B, 1994, YEAST, V10, P1235, DOI 10.1002/yea.320100912; Reuner B, 1997, MOL BIOCHEM PARASIT, V90, P269, DOI 10.1016/S0166-6851(97)00160-6; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; ROUAULT TA, 1990, P NATL ACAD SCI USA, V87, P7958, DOI 10.1073/pnas.87.20.7958; ROUAULT TA, 1996, TRANSLATIONAL CONTRO, P335; SCHULZ I, 1990, METHOD ENZYMOL, V192, P280; Schurch N, 1997, MOL BIOCHEM PARASIT, V89, P109, DOI 10.1016/S0166-6851(97)00107-2; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; STEIN I, 1994, MOL CELL BIOL, V14, P4770, DOI 10.1128/MCB.14.7.4770; Steverding D, 1998, PARASITOL RES, V84, P59, DOI 10.1007/s004360050357; Strimmer K, 1997, MOL BIOL EVOL, V14, P210, DOI 10.1093/oxfordjournals.molbev.a025756; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; THEIL EC, 1994, BIOCHEM J, V304, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORRI AF, 1993, MOL BIOCHEM PARASIT, V57, P305, DOI 10.1016/0166-6851(93)90206-D; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tyler KM, 1997, P ROY SOC B-BIOL SCI, V264, P1481, DOI 10.1098/rspb.1997.0205; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; Vassella E, 1996, MOL BIOCHEM PARASIT, V82, P91, DOI 10.1016/0166-6851(96)02727-2; Vassella E, 1997, MOL BIOCHEM PARASIT, V90, P381, DOI 10.1016/S0166-6851(97)00171-0; Vassella E, 1997, J CELL SCI, V110, P2661; VERNIQUET F, 1991, BIOCHEM J, V276, P643, DOI 10.1042/bj2760643; VICKERMAN K, 1965, NATURE, V208, P762, DOI 10.1038/208762a0; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; VILLAREJO MR, 1974, J BACTERIOL, V120, P466, DOI 10.1128/JB.120.1.466-474.1974; WHITE TC, 1986, NUCLEIC ACIDS RES, V14, P9471, DOI 10.1093/nar/14.23.9471; Wirtz E, 1998, NUCLEIC ACIDS RES, V26, P4626, DOI 10.1093/nar/26.20.4626; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; ZHANG JW, 1993, MOL BIOL CELL, V4, P1351, DOI 10.1091/mbc.4.12.1351; ZHENG L, 1992, J BIOL CHEM, V267, P7895; ZHENG LM, 1990, J BIOL CHEM, V265, P2814; ZHOU YH, 1995, PLANT MOL BIOL, V28, P635, DOI 10.1007/BF00021189	108	72	72	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2745	2755		10.1074/jbc.275.4.2745	http://dx.doi.org/10.1074/jbc.275.4.2745			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644738	hybrid, Green Published			2022-12-27	WOS:000085128000070
J	Suzuki, H; Chiba, T; Suzuki, T; Fujita, T; Ikenoue, T; Omata, M; Furuichi, K; Shikama, H; Tanaka, K				Suzuki, H; Chiba, T; Suzuki, T; Fujita, T; Ikenoue, T; Omata, M; Furuichi, K; Shikama, H; Tanaka, K			Homodimer of two F-box proteins beta TrCP1 or beta TrCP2 binds to I kappa B alpha for signal-dependent ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC PHOSPHORYLATION; PROTEASOME PATHWAY; PROTEOLYSIS; DEGRADATION; COMPLEX; ACTIVATION; KINASE; SYSTEM; LIGASE	We found previously that overexpression of an F-box protein beta TrCP1 and the structurally related beta TrCP2 augments ubiquitination of phosphorylated I kappa B alpha (pI kappa B alpha) induced by tumor necrosis factor-alpha (TNF-alpha), but the relationship of the two homologous beta TrCP proteins remains unknown. Herein we reveal that deletion mutants of beta TrCP1 and beta TrCP2 lacking the F-box domain suppressed ubiquitination and destruction of pI kappa B alpha as well as transcriptional activation of NF-kappa B, The ectopically expressed beta TrCP1 and beta TrCP2 formed both homodimer and heterodimer complexes without displaying the trimer complex. Dimerization of beta TrCP1 and/or beta TrCP2 takes place at their conserved NH2-terminal regions, termed a "D-domain" (for dimerization domain), located upstream of the F-box domain. The D-domain was necessary and sufficient for the dimer formation. Intriguingly, the beta TrCP homodimer, but not the heterodimer, was selectively recruited to pI kappa B alpha induced by TNF-alpha. These results indicate that not only beta TrCP1 but also beta TrCP2 participates in the ubiquitination- dependent destruction of I kappa B alpha by forming SCFbeta TrCP1-beta TrCP1 and SCFbeta TrCP2-beta TrCP2 ubiquitin-ligase complexes.	Japan Sci & Technol Corp, Tokyo Metropolitan Inst Med Sci, Core Res Evolut Sci & Technol, Bunkyo Ku, Tokyo 1138613, Japan; Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1138655, Japan	Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute of Medical Science; Astellas Pharmaceuticals; University of Tokyo	Tanaka, K (corresponding author), Japan Sci & Technol Corp, Tokyo Metropolitan Inst Med Sci, Core Res Evolut Sci & Technol, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.			Suzuki, Toshiaki/0000-0002-0650-6251				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; KOMINAMI K, 1975, GENE DEV, V1115, P97; Kroll M, 1999, J BIOL CHEM, V274, P7941, DOI 10.1074/jbc.274.12.7941; Lagna G, 1999, MECH DEVELOP, V80, P101, DOI 10.1016/S0925-4773(98)00208-1; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Maekawa H, 1998, CURR GENET, V33, P29, DOI 10.1007/s002940050305; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Russell A, 1999, ONCOGENE, V18, P1983, DOI 10.1038/sj.onc.1202511; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P121, DOI 10.1006/bbrc.1999.0296; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	47	107	114	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2877	2884		10.1074/jbc.275.4.2877	http://dx.doi.org/10.1074/jbc.275.4.2877			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644755	hybrid			2022-12-27	WOS:000085128000087
J	Toure, BB; Munzer, JS; Basak, A; Benjannet, S; Rochemont, J; Lazure, C; Chretien, M; Seidah, NG				Toure, BB; Munzer, JS; Basak, A; Benjannet, S; Rochemont, J; Lazure, C; Chretien, M; Seidah, NG			Biosynthesis and enzymatic characterization of human SKI-1/S1P and the processing of its inhibitory prosegment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROPROTEIN CONVERTASES; LIVING CELLS; CLEAVAGE; PEPTIDES; INVOLVEMENT; MECHANISM; PROTEINS; BINDING; CALCIUM	Biochemical and enzymatic characterization of the novel human subtilase hSKI-1 was carried out in various cell lines. Within the endoplasmic reticulum of LoVo cells, proSKI-1 is converted to SKI-1 by processing of its prosegment into 26-, 24-, 14-, 10-, and 8-kDa products, some of which remain tightly associated with the enzyme. N-terminal sequencing and mass spectrometric analysis were used to map the cleavage sites of the most abundant fragments, which were confirmed by synthetic peptide processing. To characterize its in vitro enzymatic properties, we generated a secreted form of SKI-1. Our data demonstrate that SKI-1 is a Ca2+-dependent proteinase exhibiting optimal cleavage at pH 6.5. We present evidence that SKI-1 processes peptides mimicking the cleavage sites of the SKI-1 prosegment, pro-brain-derived neurotrophic factor, and the sterol regulatory element-binding protein SREBP-2. Among the candidate peptides encompassing sections of the SKI-1 prosegment, the RSLK137-,and RRLL186-containing peptides were best cleaved by this enzyme. Mutagenesis of the latter peptide allowed us to develop an efficiently processed SKI-I substrate and to assess the importance of several P and P' residues. Finally, we demonstrate that, in vitro, recombinant prosegments of SKI-1 inhibit its activity with apparent inhibitor constants of 100-200 nM.	Clin Res Inst Montreal, Biochem Lab, Montreal, PQ H2W 1R7, Canada; Clin Res Inst Montreal, Lab Mol Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; Clin Res Inst Montreal, Lab Struct & Metab Neuropeptides, Prot Engn Network, Ctr Excellence, Montreal, PQ H2W 1R7, Canada; Univ Ottawa, Prot Chem Ctr, Loeb Hlth Res Inst, Ottawa Hosp, Ottawa, ON K1Y 4K9, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Ottawa; Ottawa Hospital Research Institute	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342				Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Basak A, 1997, J PEPT RES, V49, P596; Basak A, 1995, J Pept Sci, V1, P385, DOI 10.1002/psc.310010606; Benjannet S, 1998, FEBS LETT, V428, P37, DOI 10.1016/S0014-5793(98)00480-3; Boudreault A, 1998, J BIOL CHEM, V273, P31574, DOI 10.1074/jbc.273.47.31574; BURBACH JPH, 1986, EUR J BIOCHEM, V156, P137, DOI 10.1111/j.1432-1033.1986.tb09558.x; Cheng D, 1999, J BIOL CHEM, V274, P22805, DOI 10.1074/jbc.274.32.22805; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; GALLAGHER T, 1995, STRUCTURE, V3, P907, DOI 10.1016/S0969-2126(01)00225-8; GRAM H, 1994, BIO-TECHNOL, V12, P1017, DOI 10.1038/nbt1094-1017; GUPTA SK, 1995, P NATL ACAD SCI USA, V92, P7799, DOI 10.1073/pnas.92.17.7799; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HUDSON P, 1981, NATURE, V291, P127, DOI 10.1038/291127a0; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; JEAN F, 1995, J BIOL CHEM, V270, P19225, DOI 10.1074/jbc.270.33.19225; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Lei YH, 1999, DNA CELL BIOL, V18, P175, DOI 10.1089/104454999315565; LING N, 1976, P NATL ACAD SCI USA, V73, P3042; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; MALIDE D, 1995, J HISTOCHEM CYTOCHEM, V43, P11, DOI 10.1177/43.1.7822759; MIZUNO K, 1989, BIOCHEM BIOPH RES CO, V159, P305, DOI 10.1016/0006-291X(89)92438-8; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nagase T, 1995, DNA Res, V2, P37, DOI 10.1093/dnares/2.1.37; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; RITTENHOUSE J, 1984, ANAL BIOCHEM, V138, P442, DOI 10.1016/0003-2697(84)90836-4; Rovere C, 1999, J BIOL CHEM, V274, P12461, DOI 10.1074/jbc.274.18.12461; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; SEIDAH NG, 1998, MOL B INT U, V2, P49; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	39	76	79	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2000	275	4					2349	2358		10.1074/jbc.275.4.2349	http://dx.doi.org/10.1074/jbc.275.4.2349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280XA	10644685	hybrid			2022-12-27	WOS:000085128000017
J	Arora, A; Rinehart, D; Szabo, G; Tamm, LK				Arora, A; Rinehart, D; Szabo, G; Tamm, LK			Refolded outer membrane protein A of Escherichia coli forms ion channels with two conductance states in planar lipid bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; OMPA PROTEIN; OPRF; LIPOPOLYSACCHARIDE; PERMEATION; MALTOPORIN; RESOLUTION; INSERTION; PORINS; GROWTH	Outer membrane protein A (OmpA), a major structural protein of the outer membrane of Escherichia coli, consists of an N-terminal 8-stranded beta-barrel transmembrane domain and a C-terminal periplasmic domain. OmpA has served as an excellent model for studying the mechanism of insertion, folding, and assembly of constitutive integral membrane proteins in vivo and in vitro. The function of OmpA is currently not well understood. Particularly, the question whether or not OmpA forms an ion channel and/or nonspecific pore for uncharged larger solutes, as some other porins do, has been controversial. We have incorporated detergent-purified OmpA into planar lipid bilayers and studied its permeability to ions by single channel conductance measurements. In 1 M KCI, OmpA formed small (50-80 pS) and large (260-320 pS) channels. These two conductance states were interconvertible, presumably corresponding to two different conformations of OmpA in the membrane. The smaller channels are associated with the N-terminal transmembrane domain, whereas both domains are required to form the larger channels. The two channel activities provide a new functional assay for the refolding in vitro of the two respective domains of OmpA Wild-type and five single tryptophan mutants of urea-denatured OmpA are shown to refold into functional channels in lipid bilayers.	Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Sci Ctr, Ctr Struct Biol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Tamm, LK (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Mol Physiol & Biol Phys, POB 800736, Charlottesville, VA 22908 USA.	lkt2e@virginia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037127, R37HL037127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051329] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37127] Funding Source: Medline; NIGMS NIH HHS [GM51329, R01 GM051329] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Busath D, 1981, NATURE, V294, P371, DOI 10.1038/294371a0; Busath DD, 1998, BIOPHYS J, V75, P2830, DOI 10.1016/S0006-3495(98)77726-4; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DARGENT B, 1987, FEBS LETT, V220, P136, DOI 10.1016/0014-5793(87)80891-8; De E, 1997, MICROBIOL-UK, V143, P1029, DOI 10.1099/00221287-143-3-1029; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; KENNELL WL, 1992, INFECT IMMUN, V60, P380, DOI 10.1128/IAI.60.2.380-384.1992; Ketchem RR, 1997, STRUCTURE, V5, P1655, DOI 10.1016/S0969-2126(97)00312-2; Kleinschmidt JH, 1999, PROTEIN SCI, V8, P2065, DOI 10.1110/ps.8.10.2065; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P4996, DOI 10.1021/bi9824644; Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w; Kleinschmidt JH, 1996, BIOCHEMISTRY-US, V35, P12993, DOI 10.1021/bi961478b; KOEBNIK R, 1995, MOL MICROBIOL, V16, P1269, DOI 10.1111/j.1365-2958.1995.tb02348.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUELLER P, 1962, CIRCULATION, V26, P1167, DOI 10.1161/01.CIR.26.5.1167; Pautsch A, 1999, PROTEINS, V34, P167, DOI 10.1002/(SICI)1097-0134(19990201)34:2<167::AID-PROT2>3.3.CO;2-8; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Phale PS, 1997, P NATL ACAD SCI USA, V94, P6741, DOI 10.1073/pnas.94.13.6741; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; REID G, 1994, MOL GEN GENET, V243, P127; SAINT N, 1993, BIOCHIM BIOPHYS ACTA, V1145, P119, DOI 10.1016/0005-2736(93)90388-G; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schmid B, 1998, PROTEIN SCI, V7, P1603, DOI 10.1002/pro.5560070714; SCHWEIZER M, 1978, EUR J BIOCHEM, V82, P211, DOI 10.1111/j.1432-1033.1978.tb12013.x; Sugawara E., 1997, Biophysical Journal, V72, pA138; SUGAWARA E, 1994, J BIOL CHEM, V269, P17981; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; ULLSTROM CA, 1991, J BACTERIOL, V173, P768, DOI 10.1128/jb.173.2.768-775.1991; WOODRUFF WA, 1986, J BACTERIOL, V167, P473, DOI 10.1128/jb.167.2.473-479.1986	33	132	135	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1594	1600		10.1074/jbc.275.3.1594	http://dx.doi.org/10.1074/jbc.275.3.1594			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636850	hybrid			2022-12-27	WOS:000084940000013
J	Kim, YS; Wall, JS; Meyer, J; Murphy, C; Randolph, TW; Manning, MC; Solomon, A; Carpenter, JF				Kim, YS; Wall, JS; Meyer, J; Murphy, C; Randolph, TW; Manning, MC; Solomon, A; Carpenter, JF			Thermodynamic modulation of light chain amyloid fibril formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; HUMAN INTERFERON-GAMMA; NATIVE-STATE; PROTEIN AGGREGATION; HYDROGEN-EXCHANGE; DEPOSITION; STABILIZATION; STABILITY; PATHOGENESIS; VARIANTS	To obtain further insight into the pathogenesis of amyloidosis and develop therapeutic strategies to inhibit fibril formation we investigated: 1) the relationship between intrinsic physical properties (thermodynamic stability and hydrogen-deuterium (H-D) exchange rates) and the propensity of human immunoglobulin light chains to form amyloid fibrils in vitro; and 2) the effects of extrinsically modulating these properties on fibril formation. An amyloid-associated protein readily formed amyloid fibrils in vitro and had a lower free energy of unfolding than a homologous nonpathological protein, which did not form fibrils in vitro. H-D exchange was much faster for the pathological protein, suggesting it had a greater fraction of partially folded molecules. The thermodynamic stabilizer sucrose completely inhibited fibril formation by the pathological protein and shifted the values for its physical parameters to those measured for the nonpathological protein in buffer alone. Conversely, urea sufficiently destabilized the nonpathological protein such that its measured physical properties were equivalent to those of the pathological protein in buffer, and it formed fibrils. Thus, fibril formation by light chains is predominantly controlled by thermodynamic stability; and a rational strategy to inhibit amyloidosis is to design high affinity ligands that specifically increase the stability of the native protein.	Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA; Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Knoxville, TN 37920 USA; Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Tennessee System; University of Tennessee Health Science Center; University of Colorado System; University of Colorado Boulder	Carpenter, JF (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Box C238,4200 E 9th Ave, Denver, CO 80262 USA.	john.carpenter@uchsc.edu		Kim, Yong-Sung/0000-0003-2673-1509; Wall, Jonathan/0000-0002-5516-8578	NATIONAL CANCER INSTITUTE [R01CA010056] Funding Source: NIH RePORTER; NCI NIH HHS [CA10056] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Chang BS, 1996, BIOPHYS J, V71, P3399, DOI 10.1016/S0006-3495(96)79534-6; Dhodapkar MV, 1997, HEMATOL ONCOL CLIN N, V11, P89, DOI 10.1016/S0889-8588(05)70417-2; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; ENGLANDER SW, 1992, ANNU REV BIOPH BIOM, V21, P243, DOI 10.1146/annurev.biophys.21.1.243; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Freire E, 1998, ADV PROTEIN CHEM, V51, P255; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Gillmore JD, 1997, BRIT J HAEMATOL, V99, P245, DOI 10.1046/j.1365-2141.1997.303194.x; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Helms LR, 1996, J MOL BIOL, V257, P77, DOI 10.1006/jmbi.1996.0148; HIETER PA, 1982, J BIOL CHEM, V257, P1516; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kendrick BS, 1998, P NATL ACAD SCI USA, V95, P14142, DOI 10.1073/pnas.95.24.14142; Kendrick BS, 1997, P NATL ACAD SCI USA, V94, P11917, DOI 10.1073/pnas.94.22.11917; Kendrick BS, 1998, J PHARM SCI, V87, P1069, DOI 10.1021/js9801384; Kreilgaard L, 1998, ARCH BIOCHEM BIOPHYS, V360, P121, DOI 10.1006/abbi.1998.0948; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LEE JC, 1981, J BIOL CHEM, V256, P7193; LIU YF, 1995, BIOCHEMISTRY-US, V34, P12884, DOI 10.1021/bi00039a051; Luque I, 1998, METHOD ENZYMOL, V295, P100; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; MYATT EA, 1994, P NATL ACAD SCI USA, V91, P3034, DOI 10.1073/pnas.91.8.3034; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Peterson SA, 1998, P NATL ACAD SCI USA, V95, P12956, DOI 10.1073/pnas.95.22.12956; Raffen R, 1999, PROTEIN SCI, V8, P509; SCHELLMAN JA, 1990, BIOPOLYMERS, V29, P215, DOI 10.1002/bip.360290126; Solomon A, 1998, P NATL ACAD SCI USA, V95, P9547, DOI 10.1073/pnas.95.16.9547; Solomon A, 1995, AMYLOID, V2, P269, DOI 10.3109/13506129508999010; Timasheff SN, 1998, ADV PROTEIN CHEM, V51, P355; VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Westermark P, 1998, AM J PATHOL, V152, P1125; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8; Wetzel R, 1996, CELL, V86, P699, DOI 10.1016/S0092-8674(00)80143-9	39	114	120	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1570	1574		10.1074/jbc.275.3.1570	http://dx.doi.org/10.1074/jbc.275.3.1570			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636846	hybrid			2022-12-27	WOS:000084940000009
J	Marcus, NY; Perlmutter, DH				Marcus, NY; Perlmutter, DH			Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha 1 antitrypsin Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HUMAN ALPHA(1)-ANTITRYPSIN; SACCHAROMYCES-CEREVISIAE; LIVER-DISEASE; DEGRADATION; CALNEXIN; GLYCOSYLATION; GLYCOPROTEIN; CASTANOSPERMINE; DEFICIENCY	It is now well known that the addition and trimming of oligosaccharide side chains during post-translational modification play an important role in determining the fate of secretory, membrane, and lysosomal glycoproteins, Recent studies have suggested that trimming of oligosaccharide side chains also plays a role in the degradation of misfolded glycoproteins as a part of the quality control mechanism of the endoplasmic reticulum (ER), In this study, we examined the effect of several inhibitors of carbohydrate processing on the fate of the misfolded secretory protein alpha 1 antitrypsin Z. Retention of this misfolded glycoprotein in the ER of liver cells in the classical form of alpha 1 antitrypsin (alpha 1-AT) deficiency is associated with severe liver injury and hepatocellular carcinoma and lack of its secretion is associated with destructive lung disease/emphysema. The results show marked alterations in the fate of alpha 1 antitrypsin Z (alpha 1-ATZ), Indeed, one glucosidase inhibitor, castanospermine (CST), and two mannosidase inhibitors, kifunensine (RIF) and deoxymannojirimycin (DMJ), mediate marked increases in secretion of alpha 1-ATZ by distinct mechanisms. The effects of these inhibitors on secretion have interesting implications for our understanding of the quality control apparatus of the ER, These inhibitors may also constitute models for development of additional drugs for chemoprophylaxis of liver injury and emphysema in patients with alpha 1-AT deficiency.	Washington Univ, St Louis Childrens Hosp, Dept Pediat, Sch Med,Div Gastroenterol & Nutr, St Louis, MO 63110 USA; Washington Univ, St Louis Childrens Hosp, Dept Cell Biol & Physiol, Sch Med,Div Gastroenterol & Nutr, St Louis, MO 63110 USA	St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Perlmutter, DH (corresponding author), Washington Univ, St Louis Childrens Hosp, Dept Pediat, Sch Med,Div Gastroenterol & Nutr, 1 Childrens Pl,Box 8116, St Louis, MO 63110 USA.	perlmutter@kids.wustl.edu			NHLBI NIH HHS [HL37884] Funding Source: Medline; NICHD NIH HHS [T32 HD07409] Funding Source: Medline; NIDDK NIH HHS [DK52526] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007409] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL037884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052526] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BATHURST IC, 1984, FEBS LETT, V177, P179, DOI 10.1016/0014-5793(84)81279-X; BURROWS JAJ, 2000, IN PRESS P NATL ACAD; Campbell EJ, 1999, J CLIN INVEST, V104, P337, DOI 10.1172/JCI6092; GROSS V, 1986, BIOCHEM J, V236, P853, DOI 10.1042/bj2360853; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; JACOB GS, 1995, CURR OPIN STRUC BIOL, V5, P605, DOI 10.1016/0959-440X(95)80051-4; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kang HA, 1998, YEAST, V14, P371, DOI 10.1002/(SICI)1097-0061(19980315)14:4<371::AID-YEA231>3.3.CO;2-T; KANG MS, 1995, GLYCOBIOLOGY, V5, P147, DOI 10.1093/glycob/5.1.147; Karaivanova VK, 1998, GLYCOBIOLOGY, V8, P725, DOI 10.1093/glycob/8.7.725; KEARSE KP, 1994, EMBO J, V13, P3678, DOI 10.1002/j.1460-2075.1994.tb06677.x; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Kwon KS, 1997, BBA-GEN SUBJECTS, V1335, P265, DOI 10.1016/S0304-4165(96)00143-2; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Liu Y, 1997, J BIOL CHEM, V272, P7946, DOI 10.1074/jbc.272.12.7946; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; MOORE SEH, 1993, J BIOL CHEM, V268, P3809; Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Teckman JH, 1996, HEPATOLOGY, V24, P1504, DOI 10.1002/hep.510240635; TECKMAN JH, 1999, IN PRESS AM J PHYSL; Verhoeven AJM, 1999, BIOCHEM J, V337, P133, DOI 10.1042/0264-6021:3370133; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3; Zhang JX, 1997, MOL BIOL CELL, V8, P1943, DOI 10.1091/mbc.8.10.1943	31	55	60	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1987	1992		10.1074/jbc.275.3.1987	http://dx.doi.org/10.1074/jbc.275.3.1987			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636901	hybrid			2022-12-27	WOS:000084940000064
J	Octave, JN; Essalmani, R; Tasiaux, B; Menager, J; Czech, C; Mercken, L				Octave, JN; Essalmani, R; Tasiaux, B; Menager, J; Czech, C; Mercken, L			The role of presenilin-1 in the gamma-secretase cleavage of the amyloid precursor protein of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROTEIN; PEPTIDE; CELLS; EXPRESSION; LOCALIZATION; MEMBRANES; FRAGMENT	Presenilin-1 (PS1) is required for the release of the intracellular domain of Notch from the plasma membrane as well as for the cleavage of the amyloid precursor protein (APP) at the gamma-secretase cleavage site. It remains to be demonstrated whether PS1 acts by facilitating the activity of the protease concerned or is the protease itself. PS1 could have a gamma-secretase activity by itself or could traffic APP and Notch to the appropriate cellular compartment for processing. Human APP 695 and PS1 were coexpressed in Sf9 insect cells, in which endogenous gamma-secretase activity is not detected. In baculovirus-infected Sf9 cells, PS1 undergoes endoproteolysis and interacts with APP. However, PSI does not cleave APP in Sf9 cells. In CHO cells, endocytosis of APP is required for A beta secretion. Deletion of the cytoplasmic sequence of APP (APP Delta C) inhibits both APP endocytosis and A beta production. When APP Delta C and PS1 are coexpressed in CHO cells, A beta is secreted without endocytosis of APP. Taken together, these results conclusively show that, although PS1 does not cleave APP in Sf9 cells, PS1 allows the secretion of A beta without endocytosis of APP by CHO cells.	Catholic Univ Louvain, Lab Pharmacol Expt, B-1200 Brussels, Belgium; Rhone Poulenc Rorer, F-94400 Vitry Sur Seine, France	Universite Catholique Louvain; Sanofi-Aventis	Octave, JN (corresponding author), Catholic Univ Louvain, Lab Pharmacol Expt, FARL 5410,Ave Hippocrate 54, B-1200 Brussels, Belgium.	octave@nchm.ucl.ac.be		Czech, Christian/0000-0001-7746-0134				Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; CURRIE JR, 1991, J NEUROSCI RES, V30, P687, DOI 10.1002/jnr.490300413; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Essalmani R, 1996, FEBS LETT, V389, P157, DOI 10.1016/0014-5793(96)00561-3; Essalmani R, 1996, BIOCHEM BIOPH RES CO, V218, P89, DOI 10.1006/bbrc.1996.0017; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1999, NATURE, V398, P466, DOI 10.1038/18979; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Macq AF, 1998, J BIOL CHEM, V273, P28931, DOI 10.1074/jbc.273.44.28931; Octave JN, 1995, REV NEUROSCIENCE, V6, P287; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; RAMABHADRAN TV, 1993, J BIOL CHEM, V268, P2009; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	29	36	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1525	1528		10.1074/jbc.275.3.1525	http://dx.doi.org/10.1074/jbc.275.3.1525			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636839	hybrid			2022-12-27	WOS:000084940000002
J	Scragg, IG; Kwiatkowski, D; Vidal, V; Reason, A; Paxton, T; Panico, M; Dell, A; Morris, H				Scragg, IG; Kwiatkowski, D; Vidal, V; Reason, A; Paxton, T; Panico, M; Dell, A; Morris, H			Structural characterization of the inflammatory moiety of a variable major lipoprotein of Borrelia recurrentis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; SURFACE PROTEIN-A; FACTOR-KAPPA-B; TREPONEMA-PALLIDUM; BURGDORFERI LIPOPROTEINS; MASS-SPECTROMETRY; ENDOTHELIAL-CELLS; OUTER-MEMBRANE; LIPID MODIFICATION; FACTOR-ALPHA	Louse-borne relapsing fever, caused by Borrelia recurrentis, provides one of the best documented examples of the causative role of tumor necrosis factor (TNF) in the pathology of severe infection in humans, We have identified the principal TNF-inducing factor of B. recurrentis as a variable major lipoprotein (Vmp), Here we report the complete gene sequence of Vmp, including its lipoprotein leader sequence. Using metabolically labeled forms of the native Vmp we confirm that the TNF inducing properties are associated with the lipid portion of the molecule. Quadrupole orthogonal time of flight mass spectrometry unequivocally locates the lipidic moiety at the NH2-terminal cysteine of the native polypeptide, and indicates the existence of three forms which are consistent with the structures C16:0, C16:0, C16:0 glyceryl cysteine; C18:1, C16:0, C16:0 glyceryl cysteine; and C18:0, C16:0, C16:0 glyceryl cysteine, These data provide the first direct evidence that the TNF inducing lipid modification of native Borrelia lipoproteins is a structural homologue of the murein lipoprotein of Escherichia coli.	Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England	University of Oxford	Kwiatkowski, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.			Kwiatkowski, Dominic/0000-0002-5023-0176				AKINS DR, 1993, INFECT IMMUN, V61, P1202, DOI 10.1128/IAI.61.4.1202-1210.1993; ALLAN RJ, 1993, INFECT IMMUN, V61, P4772, DOI 10.1128/IAI.61.11.4772-4776.1993; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BESSLER WG, 1985, J IMMUNOL, V135, P1900; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Bouchon B, 1997, ANAL BIOCHEM, V246, P52, DOI 10.1006/abio.1996.9982; BRANDT ME, 1990, INFECT IMMUN, V58, P983, DOI 10.1128/IAI.58.4.983-991.1990; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Burns MJ, 1997, INFECT IMMUN, V65, P1217, DOI 10.1128/IAI.65.4.1217-1222.1997; Ebnet K, 1997, J IMMUNOL, V158, P3285; Fekade D, 1996, NEW ENGL J MED, V335, P311, DOI 10.1056/NEJM199608013350503; Giambartolomei GH, 1999, INFECT IMMUN, V67, P140, DOI 10.1128/IAI.67.1.140-147.1999; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; LEX A, 1986, J IMMUNOL, V137, P2676; MA Y, 1993, INFECT IMMUN, V61, P3843, DOI 10.1128/IAI.61.9.3843-3853.1993; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; Marietta EV, 1997, J IMMUNOL, V159, P2840; Metzger J W, 1995, J Pept Sci, V1, P184, DOI 10.1002/psc.310010305; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; MORRIS HR, 1998, MASS SPECTROMETRY BI; Morrison TB, 1997, J IMMUNOL, V158, P4838; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Muhlradt PF, 1998, INFECT IMMUN, V66, P4804; NEGUSSIE Y, 1992, J EXP MED, V175, P1207, DOI 10.1084/jem.175.5.1207; PITTENAUER E, 1995, J AM SOC MASS SPECTR, V6, P892, DOI 10.1016/1044-0305(95)00481-R; RADOLF JD, 1991, J IMMUNOL, V147, P1968; RADOLF JD, 1995, J IMMUNOL, V154, P2866; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Sellati TJ, 1998, J IMMUNOL, V160, P5455; TAI KF, 1994, INFECT IMMUN, V62, P520, DOI 10.1128/IAI.62.2.520-528.1994; WEIS JJ, 1994, INFECT IMMUN, V62, P4632, DOI 10.1128/IAI.62.10.4632-4636.1994; WEYER KA, 1987, BIOCHEMISTRY-US, V26, P2909, DOI 10.1021/bi00384a036; Wooten RM, 1996, J IMMUNOL, V157, P4584; Wooten RM, 1998, J IMMUNOL, V160, P5485; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	37	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					937	941		10.1074/jbc.275.2.937	http://dx.doi.org/10.1074/jbc.275.2.937			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625630	hybrid			2022-12-27	WOS:000084836600034
J	Bhaskar, V; Valentine, SA; Courey, AJ				Bhaskar, V; Valentine, SA; Courey, AJ			A functional interaction between dorsal and components of the Smt3 conjugation machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN-LIKE PROTEIN; DROSOPHILA EMBRYO; TRANSCRIPTION FACTORS; DORSOVENTRAL PATTERN; SIGNAL-TRANSDUCTION; NUCLEAR IMPORT; ENZYME; GRADIENT; GENE	To identify proteins that regulate the function of Dorsal, a Drosophila Rel family transcription factor, we employed a yeast two-hybrid screen to search for genes encoding Dorsal-interacting proteins. Six genes were identified, including two that encode previously known Dorsal-interacting proteins (Twist and Cactus), three that encode novel proteins, and one that encodes Drosophila Ubc9 (DmUbc9), a protein thought to conjugate the ubiquitin-like polypeptide Smt3 to protein substrates, We have found that DmUbc9 binds and conjugates Drosophila Smt3 (DmSmt3) to Dorsal. in cultured cells, DmUbc9 was found to relieve inhibition of Dorsal nuclear uptake by Cactus, allowing Dorsal to enter the nucleus and activate transcription. The effect of DmUbc9 on Dorsal activity was potentiated by the overexpression of DmSmt3, We have also identified a DmSmt3-activating enzyme, DmSAE1/DmSAE2 and found that it further potentiates Dorsal-mediated activation.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Courey, AJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90095 USA.				NIGMS NIH HHS [GM07185, GM44522] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 2006, ENZYMATIC MANIPULATI; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; COUREY AJ, 1995, BBA-GENE STRUCT EXPR, V1261, P1, DOI 10.1016/0167-4781(94)00234-T; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Drier EA, 1997, SEMIN CANCER BIOL, V8, P83, DOI 10.1006/scbi.1997.0059; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; Dubnicoff T, 1997, GENE DEV, V11, P2952, DOI 10.1101/gad.11.22.2952; Epps JL, 1998, CURR BIOL, V8, P1277, DOI 10.1016/S0960-9822(07)00538-6; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GIESLER R, 1992, CELL, V71, P613; GOVIND S, 1991, TRENDS GENET, V7, P119, DOI 10.1016/0168-9525(91)90456-Z; Govind S, 1996, MOL CELL BIOL, V16, P1103; Huang HW, 1998, BIOCHEM MOL BIOL INT, V46, P775; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; ISODA K, 1992, GENE DEV, V6, P619, DOI 10.1101/gad.6.4.619; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Joanisse DR, 1998, BIOCHEM BIOPH RES CO, V244, P102, DOI 10.1006/bbrc.1998.8214; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Loveys DA, 1997, GENE, V201, P169, DOI 10.1016/S0378-1119(97)00444-7; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mannen H, 1996, BIOCHEM BIOPH RES CO, V222, P178, DOI 10.1006/bbrc.1996.0717; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; NORRIS JL, 1995, GENE DEV, V9, P358, DOI 10.1101/gad.9.3.358; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Poukka H, 1999, J BIOL CHEM, V274, P19441, DOI 10.1074/jbc.274.27.19441; Qi FX, 1998, VIRUS RES, V57, P1, DOI 10.1016/S0168-1702(98)00073-2; RAY RP, 1991, DEVELOPMENT, V113, P35; Reach M, 1996, DEV BIOL, V180, P353, DOI 10.1006/dbio.1996.0308; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; ROTH S, 1991, DEVELOPMENT, V112, P371; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saltzman A, 1998, FEBS LETT, V425, P431, DOI 10.1016/S0014-5793(98)00287-7; Schwarz SE, 1998, P NATL ACAD SCI USA, V95, P560, DOI 10.1073/pnas.95.2.560; Shirokawa JM, 1997, MOL CELL BIOL, V17, P3345, DOI 10.1128/MCB.17.6.3345; Tashiro K, 1997, P NATL ACAD SCI USA, V94, P7862, DOI 10.1073/pnas.94.15.7862; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Yang J, 1997, P NATL ACAD SCI USA, V94, P14524, DOI 10.1073/pnas.94.26.14524	47	84	89	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 11	2000	275	6					4033	4040		10.1074/jbc.275.6.4033	http://dx.doi.org/10.1074/jbc.275.6.4033			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283RJ	10660560	hybrid			2022-12-27	WOS:000085288800044
J	Ghanouni, P; Schambye, H; Seifert, R; Lee, TW; Rasmussen, SGF; Gether, U; Kobilka, BK				Ghanouni, P; Schambye, H; Seifert, R; Lee, TW; Rasmussen, SGF; Gether, U; Kobilka, BK			The effect of pH on beta(2) adrenoceptor function - Evidence for protonation-dependent activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CARBOXYLIC-ACID GROUP; CONSTITUTIVE ACTIVATION; CONFORMATIONAL-CHANGES; TRANSMEMBRANE HELICES; METARHODOPSIN-II; FUSION PROTEIN; AMINO-ACID; RHODOPSIN; G(S)ALPHA	The transition of rhodopsin from the inactive to the active state is associated with proton uptake at Glu(134) (1), and recent mutagenesis studies suggest that protonation of the homologous amino acid in the alpha(1B) adrenergic receptor (Asp(142)) may be involved in its mechanism of activation (2). To further explore the role of protonation in G protein-coupled receptor activation, we examined the effects of pH on the rate of ligand-induced conformational change and on receptor-mediated G protein activation for the beta(2) adrenergic receptor (beta(2)AR). The rate of agonist-induced change in the fluorescence of NBD-labeled, purified beta(2)AR was 2-fold greater at pH 6.5 than at pH 8, even though agonist affinity was lower at pH 6.5, This biophysical analysis was corroborated by functional studies; basal (agonist-independent) activation of G alpha(8) by the beta(2)AR was greater at pH 6.5 compared with pH 8.0. Taken together, these results provide evidence that protonation increases basal activity by destabilizing the inactive state of the receptor. In addition, we found that the pH sensitivity of beta(2)AR activation is not abrogated by mutation of Asp(130), which is homologous to the highly conserved acidic amino acids that link protonation to activation of rhodopsin (Glu(134)) and the alpha(1B) adrenergic receptor (Asp(142)).	Stanford Univ, Sch Med, Beckman Ctr, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; Univ Copenhagen, Panum Inst, Inst Med Physiol 125, Dept Cellular Physiol, DK-2200 Copenhagen, Denmark	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Copenhagen	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Howard Hughes Med Inst, B-157, Stanford, CA 94305 USA.		Seifert, Roland/G-3189-2013	Gether, Ulrik/0000-0002-0020-3807; Rasmussen, Soren/0000-0002-1853-1841; Kobilka, Brian/0000-0001-5958-3990	NIGMS NIH HHS [5T32GM07365] Funding Source: Medline; NINDS NIH HHS [NS28471] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNIS S, 1994, J BIOL CHEM, V269, P23879; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BERTIN B, 1994, P NATL ACAD SCI USA, V91, P8827, DOI 10.1073/pnas.91.19.8827; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; GETHER U, 1995, J BIOL CHEM, V270, P28268; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kenakin T, 1997, TRENDS PHARMACOL SCI, V18, P416, DOI 10.1016/S0165-6147(97)01127-9; Kim JM, 1997, P NATL ACAD SCI USA, V94, P14273, DOI 10.1073/pnas.94.26.14273; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; Seifert R, 1998, EUR J BIOCHEM, V255, P369, DOI 10.1046/j.1432-1327.1998.2550369.x; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; WEITZ CJ, 1992, NEURON, V8, P465, DOI 10.1016/0896-6273(92)90274-H; Wenzel-Seifert K, 1998, BIOCHEM J, V334, P519, DOI 10.1042/bj3340519; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501	29	89	92	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3121	3127		10.1074/jbc.275.5.3121	http://dx.doi.org/10.1074/jbc.275.5.3121			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652295	Green Submitted, hybrid			2022-12-27	WOS:000085146500017
J	Halbleib, CM; Zhang, YP; Ludden, PW				Halbleib, CM; Zhang, YP; Ludden, PW			Regulation of dinitrogenase reductase ADP-ribosyltransferase and dinitrogenase reductase-activating glycohydrolase by a redox-dependent conformational change of nitrogenase Fe protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM-IRON PROTEIN; AZOTOBACTER-VINELANDII NITROGENASE; BACTERIUM RHODOSPIRILLUM-RUBRUM; KLEBSIELLA-PNEUMONIAE; ELECTRON-TRANSFER; SWITCH-OFF; POSTTRANSLATIONAL REGULATION; AZOSPIRILLUM-BRASILENSE; NUCLEOTIDE-BINDING; METAL CENTERS	The nitrogenase-regulating enzymes dinitrogenase reductase ADP-ribosyltransferase (DRAT) and dinitrogenase reductase-activating glycohydrolase (DRAG), from Rhodospirillum rubrum, were shown to be sensitive to the redox status of the [Fe4S4](1+/2+) cluster of nitrogenase Fe protein from R, rubrum or Azotobacter vinelandii, DRAG had <2% activity with oxidized R. rubrum Fe protein relative to activity with reduced Fe protein, The activity of DRAG with oxygen-denatured Fe protein or a low molecular weight substrate, N-alpha-dansyl-N-omega-(1,N-6-etheno-ADP-ribosyl) arginine methyl ester, was independent of redox potential. The redox midpoint potential of DRAG activation of Fe protein was -430 mV versus standard hydrogen electrode, coinciding with the midpoint potential of the [Fe4S4] cluster from R, rubrum Fe protein. DRAT was found to have a specificity opposite that of DRAG, exhibiting low (<2%) activity with 87% reduced R, rubrum Fe protein relative to activity with fully oxidized Fe protein. A mutant of R. rubrum in which the rate of oxidation of Fe protein was substantially decreased had a markedly slower rate of ADP-ribosylation in vivo in response to 10 mw NH4Cl or darkness stimulus. It is concluded that the redox state of Fe protein plays a significant role in regulation of the activities of DRAT and DRAG in vivo.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Ctr Study Nitrogen Fixat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ludden, PW (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ludden@biochem.wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349, R01GM054910] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 T32 GM08349, GM54910] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RM, 1993, J BIOL CHEM, V268, P23670; ANDERSON GL, 1984, BIOCHEMISTRY-US, V23, P2118, DOI 10.1021/bi00305a002; ASHBY GA, 1987, BIOCHEM J, V246, P455, DOI 10.1042/bj2460455; FITZMAURICE WP, 1989, MOL GEN GENET, V218, P340, DOI 10.1007/BF00331287; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Grunwald SK, 1997, J BACTERIOL, V179, P3277, DOI 10.1128/jb.179.10.3277-3283.1997; GRUNWALD SK, 1995, J BACTERIOL, V177, P628, DOI 10.1128/jb.177.3.628-635.1995; HAGEMAN RV, 1980, BIOCHEMISTRY-US, V19, P2333, DOI 10.1021/bi00552a009; Halbleib CM, 1999, ARCH MICROBIOL, V172, P51, DOI 10.1007/s002030050739; HAUSINGER RP, 1983, J BIOL CHEM, V258, P3486; HAWKES TR, 1984, BIOCHEM J, V217, P317, DOI 10.1042/bj2170317; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Johnson JL, 1996, BIOCHEMISTRY-US, V35, P11336, DOI 10.1021/bi952581o; KANEMOTO RH, 1984, J BACTERIOL, V158, P713, DOI 10.1128/JB.158.2.713-720.1984; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; Lanzilotta WN, 1997, BIOCHEMISTRY-US, V36, P12976, DOI 10.1021/bi9715371; Lanzilotta WN, 1996, BIOCHEMISTRY-US, V35, P7188, DOI 10.1021/bi9603985; Lanzilotta WN, 1998, BIOCHEMISTRY-US, V37, P399, DOI 10.1021/bi971681m; LIANG JH, 1991, J BACTERIOL, V173, P6903, DOI 10.1128/jb.173.21.6903-6909.1991; LJONES T, 1972, BIOCHIM BIOPHYS ACTA, V275, P93, DOI 10.1016/0005-2728(72)90027-8; LOWE DJ, 1993, BIOCHEM J, V292, P93, DOI 10.1042/bj2920093; LOWERY RG, 1986, J BACTERIOL, V166, P513, DOI 10.1128/jb.166.2.513-518.1986; LOWERY RG, 1989, BIOCHEMISTRY-US, V28, P4956, DOI 10.1021/bi00438a008; LOWERY RG, 1988, J BIOL CHEM, V263, P16714; LUDDEN PW, 1989, CURR TOP CELL REGUL, V30, P23; LUDDEN PW, 1989, J BACTERIOL, V171, P5210, DOI 10.1128/jb.171.9.5210-5211.1989; LUDDEN PW, 1978, BIOCHEM J, V175, P251, DOI 10.1042/bj1750251; LUDDEN PW, 1976, SCIENCE, V194, P424, DOI 10.1126/science.824729; Miller RW, 1998, BIOCHEM J, V334, P601, DOI 10.1042/bj3340601; NIELSEN GM, 1994, BIOCHEM J, V302, P801, DOI 10.1042/bj3020801; NORDLUND S, 1984, BIOCHIM BIOPHYS ACTA, V791, P21, DOI 10.1016/0167-4838(84)90276-0; Noren A, 1997, BIOCHEM J, V322, P829, DOI 10.1042/bj3220829; NOREN A, 1994, FEBS LETT, V356, P43, DOI 10.1016/0014-5793(94)01233-4; ORMEROD JG, 1961, ARCH BIOCHEM BIOPHYS, V94, P449, DOI 10.1016/0003-9861(61)90073-X; PAUL TD, 1984, BIOCHEM J, V224, P961, DOI 10.1042/bj2240961; PETERS JW, 1995, J BIOL CHEM, V270, P27007, DOI 10.1074/jbc.270.45.27007; POPE MR, 1985, P NATL ACAD SCI USA, V82, P3173, DOI 10.1073/pnas.82.10.3173; POPE MR, 1986, J BIOL CHEM, V261, P104; POPE MR, 1985, BIOCHEMISTRY-US, V24, P2374, DOI 10.1021/bi00330a037; POPE MR, 1987, ANAL BIOCHEM, V160, P68, DOI 10.1016/0003-2697(87)90615-4; PRESTON GG, 1982, BIOCHEM J, V205, P489, DOI 10.1042/bj2050489; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; SAARI LL, 1984, J BIOL CHEM, V259, P5502; SAARI LL, 1986, J BIOL CHEM, V261, P4973; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; SIMPSON FB, 1984, SCIENCE, V224, P1095, DOI 10.1126/science.6585956; STEPHENS PJ, 1979, P NATL ACAD SCI USA, V76, P2585, DOI 10.1073/pnas.76.6.2585; STEWART WDP, 1967, P NATL ACAD SCI USA, V58, P2071, DOI 10.1073/pnas.58.5.2071; THORNELEY RNF, 1988, BIOCHEM J, V253, P587, DOI 10.1042/bj2530587; THORNELEY RNF, 1983, BIOCHEM J, V215, P393, DOI 10.1042/bj2150393; WATT GD, 1986, BIOCHEMISTRY-US, V25, P8156, DOI 10.1021/bi00373a005; ZHANG YP, 1993, J BACTERIOL, V175, P6781, DOI 10.1128/jb.175.21.6781-6788.1993; ZHANG YP, 1994, J BACTERIOL, V176, P5780, DOI 10.1128/JB.176.18.5780-5787.1994; ZUMFT WG, 1974, EUR J BIOCHEM, V46, P525, DOI 10.1111/j.1432-1033.1974.tb03646.x	55	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3493	3500		10.1074/jbc.275.5.3493	http://dx.doi.org/10.1074/jbc.275.5.3493			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652344	hybrid			2022-12-27	WOS:000085146500066
J	Lam, EWF; Glassford, J; Banerji, L; Thomas, NSB; Sicinski, P; Klaus, GGB				Lam, EWF; Glassford, J; Banerji, L; Thomas, NSB; Sicinski, P; Klaus, GGB			Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; RETINOBLASTOMA PROTEIN; GENE-EXPRESSION; DEPENDENT KINASES; E2F; PROLIFERATION; FAMILY; D1; TRANSCRIPTION; ACCUMULATION	Cyclin D2 is the only D-type cyclin expressed in mature mouse B-lymphocytes, and its expression is associated with retinoblastoma protein (pRB) and pRB-related protein phosphorylation and induction of E2F activity, as B-cells enter the cell cycle following stimulation via surface IgM and/or CD40. Cyclin D-dependent kinase activity is required for cell proliferation, yet cyclin D2(-/-) mice have normal levels of mature B-lymphocytes. Here we show that B-lymphocytes from cyclin D2(-/-) mice can proliferate in response to anti-IgM and anti-CD40, but the time taken to enter S-phase is longer than for the corresponding cyclin D2(+/+) cells. This is due to the compensatory induction of cyclin D3, but not cyclin D1, which causes pRb phosphorylation on CDK4-specific sites. This is the first demonstration that loss of a D-type cyclin causes specific expression and functional compensation by another member of the family in vivo and provides a rationale for the presence of mature B-lymphocytes in cyclin D2(-/-) mice.	Univ London Imperial Coll Sci Technol & Med, Ludwig Inst Canc Res, St Marys, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Sect Virol & Cell Biol, London W2 1PG, England; UCL Royal Free & Univ Coll Med Sch, Dept Haematol, London WC1E 6HX, England; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Natl Inst Med Res, Div Cellular Immunol, London NW7 1AA, England	Imperial College London; Ludwig Institute for Cancer Research; Imperial College London; University of London; University College London; UCL Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; MRC National Institute for Medical Research	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ludwig Inst Canc Res, St Marys Campus,Norfolk Pl, London W2 1PG, England.	eric.lam@ic.ac.uk	Lam, Eric W-F/AAW-8566-2020	Lam, Eric W-F/0000-0003-1274-3576				BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; BEIJERSBERGEN RL, 1995, GENE DEV, V9, P1340, DOI 10.1101/gad.9.11.1340; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Claudio PP, 1996, CANCER RES, V56, P2003; Craxton A, 1998, J IMMUNOL, V161, P3225; DellaRagione F, 1997, BIOCHEM BIOPH RES CO, V231, P73, DOI 10.1006/bbrc.1997.5938; DELMER A, 1995, BLOOD, V85, P2870, DOI 10.1182/blood.V85.10.2870.bloodjournal85102870; Desrivieres S, 1997, J BIOL CHEM, V272, P2470; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; HATAKEYAMA M, 1994, COLD SPRING HARB SYM, V59, P1; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Iida S, 1992, Nihon Rinsho, V50, P1374; JOHNSON DG, 1995, ONCOGENE, V11, P1685; Johnson-Leger C, 1998, J IMMUNOL, V161, P4618; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Klaus G G, 1997, Int Rev Immunol, V15, P5, DOI 10.3109/08830189709068169; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LAM EWF, 1994, CURR OPIN CELL BIOL, V6, P859; Lam EWF, 1999, EUR J IMMUNOL, V29, P3380, DOI 10.1002/(SICI)1521-4141(199910)29:10<3380::AID-IMMU3380>3.0.CO;2-C; Lam EWF, 1998, J BIOL CHEM, V273, P10051, DOI 10.1074/jbc.273.16.10051; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Mulligan G, 1998, TRENDS GENET, V14, P223, DOI 10.1016/S0168-9525(98)01470-X; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; SARDET C, 1997, ONCOGENES TRANSCRIPT, V2, P1; Schilizzi BM, 1997, IMMUNOLOGY, V92, P346, DOI 10.1046/j.1365-2567.1997.d01-2341.x; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Smith EJ, 1998, CELL GROWTH DIFFER, V9, P297; Smith EJ, 1996, MOL CELL BIOL, V16, P6965; Solvason N, 1996, J EXP MED, V184, P407, DOI 10.1084/jem.184.2.407; TAM SW, 1994, ONCOGENE, V9, P2663; Tanguay DA, 1999, J EXP MED, V189, P1685, DOI 10.1084/jem.189.11.1685; van der Sman J, 1999, J BIOL CHEM, V274, P12009, DOI 10.1074/jbc.274.17.12009; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; ZHU LG, 1995, MOL CELL BIOL, V15, P3552	45	106	108	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3479	3484		10.1074/jbc.275.5.3479	http://dx.doi.org/10.1074/jbc.275.5.3479			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652342	hybrid			2022-12-27	WOS:000085146500064
J	Pardali, E; Xie, XQ; Tsapogas, P; Itoh, S; Arvanitidis, K; Heldin, CH; ten Dijke, P; Grundstrom, T; Sideras, P				Pardali, E; Xie, XQ; Tsapogas, P; Itoh, S; Arvanitidis, K; Heldin, CH; ten Dijke, P; Grundstrom, T; Sideras, P			Smad and AML proteins synergistically confer transforming growth factor beta 1 responsiveness to human germ-line IgA genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; HEAVY-CHAIN GENES; HUMAN B-CELLS; CLEIDOCRANIAL DYSPLASIA; INDUCED TRANSCRIPTION; BONE; ACTIVATION; PROMOTER; ENHANCER; CBFA1	Transcription of germ-line immunoglobulin heavy chain genes conditions them to participate in isotype switch recombination, Transforming growth factor-beta 1 (TGF-beta 1) stimulates promoter elements located upstream of the IgA1 and IgA2 switch regions, designated I alpha 1 and I alpha 2, and contributes to the development of IgA responses. We demonstrate that intracellular Smad proteins mediate activation of the I alpha 1 promoter by TGF-beta. TGF-beta type 1 receptor (ALK-5), activin type IB receptor (ALK-4), and the "orphan" ALK-7 trans-activate the I alpha 1 promoter, thus raising the possibility that other members of the TGF-beta superfamily can also modulate IgA synthesis. Smads physically interact with the AML family of transcription factors and cooperate with them to activate the I alpha 1 promoter. The I alpha 1 element provides a canape of interspersed high and low affinity sites for Smad and AML factors, some of which are indispensable for TGF-beta responsiveness. While AML Smad complexes are formed in the cytoplasm of DG75 and K562 cells constitutively, only after TGF-beta receptor activation, novel Smad3.Smad4.AML complexes are detected in nuclear extracts by EMSA with I alpha 1 promoter-derived probes. Considering the wide range of biological phenomena that AMLs and Smads regulate, the physical/ functional interplay between them has implications that extend beyond the regulation of class switching to IgA.	AstraZeneca R&D, Dept Inflammat Pharmacol, S-22100 Lund, Sweden; Umea Univ, Div Tumor Biol, Dept Cell & Mol Biol, S-90187 Umea, Sweden; Biomed Ctr, Ludwig Inst Canc Res, S-75124 Uppsala, Sweden	AstraZeneca; Umea University; Ludwig Institute for Cancer Research	Sideras, P (corresponding author), AstraZeneca R&D, Dept Inflammat Pharmacol, S-22100 Lund, Sweden.	Paschalis.Sideras@cmb.umu.se	Tsapogas, Panagiotis/AAN-2465-2020; Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; Arvanitidis, Konstantinos/0000-0003-0639-2474; Itoh, Susumu/0000-0002-7967-0730; Tsapogas, Panagiotis/0000-0002-9450-2604; Sideras, Paschalis/0000-0003-0701-1258				Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; DEFRANCE T, 1992, J EXP MED, V175, P671, DOI 10.1084/jem.175.3.671; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; Hata A, 1998, MOL MED TODAY, V4, P257, DOI 10.1016/S1357-4310(98)01247-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; KITANI A, 1993, J IMMUNOL, V151, P3478; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LIN YCA, 1992, J IMMUNOL, V149, P2914; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; NILSSON L, 1995, INT IMMUNOL, V7, P1191, DOI 10.1093/intimm/7.8.1191; NILSSON L, 1991, INT IMMUNOL, V3, P1107, DOI 10.1093/intimm/3.11.1107; NILSSON L, 1993, INT IMMUNOL, V5, P271; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rodan GA, 1997, CELL, V89, P677, DOI 10.1016/S0092-8674(00)80249-4; Ryden M, 1996, J BIOL CHEM, V271, P30603, DOI 10.1074/jbc.271.48.30603; Shi MJ, 1998, J IMMUNOL, V161, P6751; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Snapper CM, 1997, IMMUNITY, V6, P217, DOI 10.1016/S1074-7613(00)80324-6; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Stavnezer J, 1996, ADV IMMUNOL, V61, P79, DOI 10.1016/S0065-2776(08)60866-4; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; VANVLASSELAER P, 1992, J IMMUNOL, V148, P2062; Visser JA, 1998, MOL CELL ENDOCRINOL, V146, P7, DOI 10.1016/S0303-7207(98)00198-1; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Wilson PA, 1997, DEVELOPMENT, V124, P3177; Xie XQ, 1999, EUR J IMMUNOL, V29, P488, DOI 10.1002/(SICI)1521-4141(199902)29:02<488::AID-IMMU488>3.0.CO;2-N; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Yingling JM, 1997, MOL CELL BIOL, V17, P7019, DOI 10.1128/MCB.17.12.7019; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	55	131	137	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3552	3560		10.1074/jbc.275.5.3552	http://dx.doi.org/10.1074/jbc.275.5.3552			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652350	hybrid			2022-12-27	WOS:000085146500072
J	Suzuki, E; Nagata, D; Yoshizumi, M; Kakoki, M; Goto, A; Omata, M; Hirata, Y				Suzuki, E; Nagata, D; Yoshizumi, M; Kakoki, M; Goto, A; Omata, M; Hirata, Y			Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor - Possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR-BETA; DEPENDENT KINASES; CDK INHIBITOR; ARRESTED FIBROBLASTS; POTENTIAL MEDIATOR; DOWN-REGULATION; G(1) PHASE; P27(KIP1); EXPRESSION	Vascular endothelial cells are unique in that they exit from the cell cycle when they come into contact with each other. Although the phenomenon is called "contact inhibition," little is known about the cellular mechanisms involved. Here we show that the phosphatase inhibitor sodium orthovanadate (SOV) induced the reentry of contact-inhibited human umbilical vascular endothelial cells (HUVECs) into the cell cycle and that reentry was associated with activation of the extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI 3-K)/Akt pathways. SOV stimulated [H-3]thymidine uptake of contact-inhibited HUVECs in a time- and dose-dependent manner. SOV-induced increase in [SH]thymidine uptake was significantly inhibited by the mitogen-activated protein kinase kinase inhibitor PD98059 and by the PI 3-K inhibitor LY294002, SOV also stimulated the expression of cyclin D1, cyclin E, and cyclin A, and the activity of CDK2 kinase, whereas it decreased the expression of p27(kip1). In marked contrast, growth media alone did not induce these changes. Furthermore, these SOV-induced changes were abolished by pretreatment with PD98059 and LY294002, SOV stimulated phosphorylation of ERK and Akt in contact-inhibited HUVECs, while growth media alone did not. This phosphorylation was associated with inhibition of phosphatase activity in the cells. Finally, overexpression of high cell density-enhanced protein tyrosine phosphatase 1 inhibited c-fos and cyclin A promoter activity. Taken together, our results suggest that in contact-inhibited HUVECs, increased phosphatase activity suppressed the ERK and PI 3-K/Akt pathways, resulting in exit from the cell cycle by down-regulation of cyclin D1, cyclin E, and cyclin A and by upregulation of p27(kip1).	Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Dept Geriatr, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Suzuki, E (corresponding author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.							Aktas H, 1997, MOL CELL BIOL, V17, P3850, DOI 10.1128/MCB.17.7.3850; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DIAZMECO MT, 1994, EMBO J, V13, P2842, DOI 10.1002/j.1460-2075.1994.tb06578.x; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ERIKSON RL, 1991, J BIOL CHEM, V266, P6007; GAITS F, 1995, BIOCHEM J, V311, P97, DOI 10.1042/bj3110097; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Kato A, 1997, J BIOL CHEM, V272, P8065, DOI 10.1074/jbc.272.12.8065; Keane MM, 1996, CANCER RES, V56, P4236; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; Kosaka C, 1996, AM J PHYSIOL-CELL PH, V270, pC170, DOI 10.1152/ajpcell.1996.270.1.C170; Kuramochi S, 1996, FEBS LETT, V378, P7, DOI 10.1016/0014-5793(95)01415-2; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; PALLEN CJ, 1991, P NATL ACAD SCI USA, V88, P6996, DOI 10.1073/pnas.88.16.6996; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; PINES J, 1995, BIOCHEM J, V308, P697, DOI 10.1042/bj3080697; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/0968-0004(96)10016-5; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Suzuki E, 1999, CIRC RES, V84, P611, DOI 10.1161/01.RES.84.5.611; Takeda H, 1999, EMBO J, V18, P386, DOI 10.1093/emboj/18.2.386; Takuwa N, 1997, MOL CELL BIOL, V17, P5348, DOI 10.1128/MCB.17.9.5348; Tang SQ, 1997, J BIOL CHEM, V272, P28704, DOI 10.1074/jbc.272.45.28704; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Winston J, 1996, J BIOL CHEM, V271, P11253, DOI 10.1074/jbc.271.19.11253; YOSHIZUMI M, 1995, MOL CELL BIOL, V15, P3266; ZHOU W, 1993, J BIOL CHEM, V268, P23041	46	65	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 4	2000	275	5					3637	3644		10.1074/jbc.275.5.3637	http://dx.doi.org/10.1074/jbc.275.5.3637			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	281FD	10652360	hybrid			2022-12-27	WOS:000085146500082
J	Bunnell, SC; Diehn, M; Yaffe, MB; Findell, PR; Cantley, LC; Berg, LJ				Bunnell, SC; Diehn, M; Yaffe, MB; Findell, PR; Cantley, LC; Berg, LJ			Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; X-LINKED AGAMMAGLOBULINEMIA; ACTIVATED PROTEIN-KINASE; ENRICHED MEMBRANE DOMAINS; ANTIGEN RECEPTOR; SRC-FAMILY; MEDIATED ACTIVATION; GENETIC-EVIDENCE; SH3 DOMAIN; PHOSPHORYLATION	Itk, a Tec family tyrosine kinase, acts downstream of Lck and phosphatidylinositol S'-kinase to facilitate T cell receptor (TCR)-dependent calcium influxes and increases in extracellular-regulated kinase activity. Here we demonstrate interactions between Itk and crucial components of TCR-dependent signaling pathways. First, the inositide-binding pocket of the Itk pleckstrin homology domain directs the constitutive association of Itk with buoyant membranes that are the primary site of TCR activation and are enriched in both Lck and LAT. This association is required for the transphosphorylation of Itk. Second, the Itk proline-rich region binds to Grb2 and LAT. Third, the Itk Src homology (SH3) 3 and SH2 domains interact cooperatively with Syk-phosphorylated SLP-76. Notably, SLP-76 contains a predicted binding motif for the Itk SH2 domain and binds to full-length Itk In vitro. Finally, we show that kinase-inactive Itk can antagonize the SLP-76-dependent activation of NF-AT. The inhibition of NF-AT activation depends on the Itk pleckstrin homology domain, proline-rich region, and SH2 domain. Together, these observations suggest that multivalent interactions recruit Itk to LAT-nucleated signaling complexes and facilitate the activation of LAT-associated phospholipase C gamma 1 by Itk.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; Harvard Univ, Inst Med, Div Signal Transduct, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Roche Biosci, Palo Alto, CA 94034 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Beth Israel Deaconess Medical Center; Roche Holding	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	Leslie.Berg@umassmed.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Bunnell, Stephen/0000-0001-6887-0828	NHLBI NIH HHS [HL03601] Funding Source: Medline; NIAID NIH HHS [AI32494] Funding Source: Medline; NIGMS NIH HHS [GM56203] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; AOKI Y, 1994, P NATL ACAD SCI USA, V91, P10606, DOI 10.1073/pnas.91.22.10606; Arni S, 1996, BIOCHEM BIOPH RES CO, V225, P801, DOI 10.1006/bbrc.1996.1254; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; Buhl AM, 1997, J EXP MED, V186, P1897, DOI 10.1084/jem.186.11.1897; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Cerny J, 1996, EUR J IMMUNOL, V26, P2335, DOI 10.1002/eji.1830261010; Fang N, 1999, J BIOL CHEM, V274, P16206, DOI 10.1074/jbc.274.23.16206; Fang N, 1996, J IMMUNOL, V157, P3769; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gibson S, 1996, J IMMUNOL, V156, P2716; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; KATZAV S, 1994, J BIOL CHEM, V269, P32579; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Li TJ, 1997, ONCOGENE, V15, P1375, DOI 10.1038/sj.onc.1201308; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; Mano H, 1996, FASEB J, V10, P637, DOI 10.1096/fasebj.10.5.8621063; Marengere LEM, 1997, J IMMUNOL, V159, P3220; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Nisitani S, 1999, P NATL ACAD SCI USA, V96, P2221, DOI 10.1073/pnas.96.5.2221; Pacini S, 1998, J BIOL CHEM, V273, P20487, DOI 10.1074/jbc.273.32.20487; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Rawlings D J, 1995, Semin Immunol, V7, P237, DOI 10.1006/smim.1995.0028; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Shan XC, 1999, J BIOL CHEM, V274, P29323, DOI 10.1074/jbc.274.41.29323; SIDERAS P, 1995, ADV IMMUNOL, V59, P135, DOI 10.1016/S0065-2776(08)60631-8; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; TAMAGNONE L, 1994, ONCOGENE, V9, P3683; Tamir I, 1998, ONCOGENE, V17, P1353, DOI 10.1038/sj.onc.1202187; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Wahl MI, 1997, P NATL ACAD SCI USA, V94, P11526, DOI 10.1073/pnas.94.21.11526; Wan Y, 1997, J BIOL CHEM, V272, P17209, DOI 10.1074/jbc.272.27.17209; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Wu J, 1996, IMMUNITY, V4, P593, DOI 10.1016/S1074-7613(00)80485-9; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; YAFFE MB, 1999, IN PRESS METHODS ENZ; YANG WY, 1995, J BIOL CHEM, V270, P20832, DOI 10.1074/jbc.270.35.20832; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	86	210	217	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					2219	2230		10.1074/jbc.275.3.2219	http://dx.doi.org/10.1074/jbc.275.3.2219			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636929	hybrid			2022-12-27	WOS:000084940000092
J	Drewett, V; Muller, S; Goodall, J; Shaw, PE				Drewett, V; Muller, S; Goodall, J; Shaw, PE			Dimer formation by ternary complex factor ELK-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; SERUM RESPONSE ELEMENT; C-FOS EXPRESSION; ETS-DOMAIN; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; BINDING MOTIF; DNA-BINDING; MAP KINASES; IN-VIVO	Ternary complex factors (TCFs), a subgroup of the ets protein family, bind with a dimer of serum response factor to the c-fos serum response element. Both DNA binding and transcriptional activation by TCFs are regulated by mitogen-activated protein kinases. When activated, mitogen-activated protein kinases form homodimers that translocate to the nucleus, where they interact with TCFs via specific docking sites. Here we show by three different criteria that Elk-l is capable of forming dimers in eukaryotic cells through two distinct interaction domains. These observations are consistent with a dynamic model of TCF-promoter interactions.	Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England; Univ Nottingham, Sch Med, Queens Med Ctr, Inst Cell Signalling, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Shaw, PE (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.			SHAW, Peter/0000-0002-2598-4283				ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; DAI TN, 1995, ONCOGENE, V10, P849; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Elion EA, 1998, SCIENCE, V281, P1625, DOI 10.1126/science.281.5383.1625; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Gille H, 1996, MOL CELL BIOL, V16, P1094; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kortenjann M, 1995, CRIT REV ONCOGENESIS, V6, P99; KORTENJANN M, 1994, MOL CELL BIOL, V14, P4815, DOI 10.1128/MCB.14.7.4815; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; LIANG H, 1994, P NATL ACAD SCI USA, V91, P11655, DOI 10.1073/pnas.91.24.11655; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; May GHW, 1998, CURR BIOL, V8, P117, DOI 10.1016/S0960-9822(98)70043-0; May GHW, 1998, J BIOL CHEM, V273, P33429, DOI 10.1074/jbc.273.50.33429; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; PINGOUD V, 1994, J BIOL CHEM, V269, P23310; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Strahl T, 1996, P NATL ACAD SCI USA, V93, P11563, DOI 10.1073/pnas.93.21.11563; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; WULFING C, 1994, J BIOL CHEM, V269, P2895; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710	37	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1757	1762		10.1074/jbc.275.3.1757	http://dx.doi.org/10.1074/jbc.275.3.1757			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636872	hybrid			2022-12-27	WOS:000084940000035
J	Ganapathy, ME; Huang, W; Rajan, DP; Carter, AL; Sugawara, M; Iseki, K; Leibach, FH; Ganapathy, V				Ganapathy, ME; Huang, W; Rajan, DP; Carter, AL; Sugawara, M; Iseki, K; Leibach, FH; Ganapathy, V			beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER-MEMBRANE; RENAL PEPTIDE TRANSPORTERS; CARNITINE TRANSPORT; CEPHALORIDINE; AFFINITY; KIDNEY; PEPT-2; METABOLISM; VESICLES; CELLS	Therapeutic use of cephaloridine, a beta-lactam antibiotic, in humans is associated with carnitine deficiency. A potential mechanism for the development of carnitine deficiency is competition between cephaloridine and carnitine for the renal reabsorptive process. OCTN2 is an organic cation/carnitine transporter that is responsible for Na+-coupled transport of carnitine in the kidney and other tissues. We investigated the interaction of several beta-lactam antibiotics with OCTN2 using human cell lines that express the transporter constitutively as well as using cloned human and rat OCTN2s expressed heterologously in human cell lines. The beta-lactam antibiotics cephaloridine, cefoselis, cefepime, and cefluprenam were found to inhibit OCTN2-mediated carnitine transport, These antibiotics possess a quaternary nitrogen as does carnitine, Several other beta-lactam antibiotics that do not possess this structural feature did not interact with OCTN2, The interaction of cephaloridine with OCTN2 is competitive with respect to carnitine, Interestingly, many of the beta-lactam antibiotics that were not recognized by OCTN2 were good substrates for the H+-coupled peptide transporters PEPT1 and PEPT2, In contrast, cephaloridine, cefoselis, cefepime, and cefluprenam, which were recognized by OCTN2, did not interact with PEPT1 and PEPT2, The interaction of cephaloridine with OCTN2 was Na+-dependent, whereas the interaction of cefoselis and cefepime with OCTN2 was largely Na+-independent, Furthermore, the Na+-dependent, OCTN2-mediated cellular uptake of cephaloridine could be demonstrated by direct uptake measurements, These studies show that OCTN2 plays a crucial role in the pharmacokinetics and therapeutic efficacy of certain beta-lactam antibiotics such as cephaloridine and that cephaloridine-induced carnitine deficiency is likely to be due to inhibition of carnitine reabsorption in the kidney.	Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido 0608648, Japan	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Hokkaido University	Ganapathy, ME (corresponding author), Med Coll Georgia, Dept Med, Augusta, GA 30912 USA.	mganapat@mail.mcg.edu	Sugawara, Mitsuru/A-5274-2012	Sugawara, Mitsuru/0000-0001-5350-2950	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054412] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 54412] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bretschneider B, 1999, PHARMACEUT RES, V16, P55, DOI 10.1023/A:1018814627484; Burwinkel B, 1999, BIOCHEM BIOPH RES CO, V261, P484, DOI 10.1006/bbrc.1999.1060; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DANIEL H, 1993, J CLIN INVEST, V92, P2215, DOI 10.1172/JCI116824; Ganapathy ME, 1997, BBA-BIOMEMBRANES, V1324, P296, DOI 10.1016/S0005-2736(96)00234-9; GANAPATHY ME, 1995, J BIOL CHEM, V270, P25672, DOI 10.1074/jbc.270.43.25672; Huang W, 1999, BIOCHEM PHARMACOL, V58, P1361, DOI 10.1016/S0006-2952(99)00219-1; Jariyawat S, 1999, J PHARMACOL EXP THER, V290, P672; Kerner J, 1998, ANNU REV NUTR, V18, P179, DOI 10.1146/annurev.nutr.18.1.179; Koepsell H, 1999, J MEMBRANE BIOL, V167, P103, DOI 10.1007/s002329900475; Lamhonwah AM, 1998, BIOCHEM BIOPH RES CO, V252, P396, DOI 10.1006/bbrc.1998.9679; LIU W, 1995, BBA-BIOMEMBRANES, V1235, P461, DOI 10.1016/0005-2736(95)80036-F; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Prasad PD, 1996, BBA-BIOMEMBRANES, V1284, P109, DOI 10.1016/0005-2736(96)00126-5; RAMAMOORTHY S, 1995, BBA-BIOMEMBRANES, V1240, P1, DOI 10.1016/0005-2736(95)00178-7; REBOUCHE CJ, 1984, ARCH BIOCHEM BIOPHYS, V235, P393, DOI 10.1016/0003-9861(84)90212-1; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Roque AS, 1996, BBA-BIOMEMBRANES, V1282, P274, DOI 10.1016/0005-2736(96)00068-5; Stanley C A, 1995, Adv Pediatr, V42, P209; STIEGER B, 1995, BIOCHEM J, V309, P643, DOI 10.1042/bj3090643; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tang NLS, 1999, HUM MOL GENET, V8, P655, DOI 10.1093/hmg/8.4.655; TSUJI A, 1993, J PHARM PHARMACOL, V45, P996, DOI 10.1111/j.2042-7158.1993.tb05645.x; TUNE BM, 1980, KIDNEY INT, V18, P591, DOI 10.1038/ki.1980.177; TUNE BM, 1994, J PHARMACOL EXP THER, V270, P873; TUNE BM, 1995, BIOCHEM PHARMACOL, V50, P562, DOI 10.1016/0006-2952(95)00169-Z; Tune Bruce M., 1993, P257; Wang YH, 1999, P NATL ACAD SCI USA, V96, P2356, DOI 10.1073/pnas.96.5.2356; Wenzel U, 1996, J PHARMACOL EXP THER, V277, P831; WOLD JS, 1977, J CHROMATOGR, V136, P170; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482	32	128	134	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1699	1707		10.1074/jbc.275.3.1699	http://dx.doi.org/10.1074/jbc.275.3.1699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636865	hybrid			2022-12-27	WOS:000084940000028
J	Ravier, MA; Eto, K; Jonkers, FC; Nenquin, M; Kadowaki, T; Henquin, JC				Ravier, MA; Eto, K; Jonkers, FC; Nenquin, M; Kadowaki, T; Henquin, JC			The oscillatory behavior of pancreatic islets from mice with mitochondrial glycerol-3-phosphate dehydrogenase knockout	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL-PHOSPHATE DEHYDROGENASE; STIMULATED INSULIN-SECRETION; MALATE-ASPARTATE SHUTTLE; SENSITIVE K+ CHANNELS; MOUSE B-CELLS; BETA-CELLS; CYTOPLASMIC CA2+; GLYCEROPHOSPHATE DEHYDROGENASE; ADENINE-NUCLEOTIDES; ENERGY-STATE	Glucose stimulation of pancreatic beta cells induces oscillations of the membrane potential, cytosolic Ca2+ ([Ca2+](i)), and insulin secretion. Each of these events depends on glucose metabolism. Both intrinsic oscillations of metabolism and repetitive activation of mitochondrial dehydrogenases by Ca2+ have been suggested to be decisive for this oscillatory behavior. Among these dehydrogenases, mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH), the key enzyme of the glycerol phosphate NADH shuttle, is activated by cytosolic [Ca2+](i),, In the present study, we compared different types of oscillations in beta cells from wild-type and mGPDH(-/-) mice. In clusters of 5-30 islet cells and in intact islets, 15 mM glucose induced an initial drop of [Ca2+](i), followed by am increase in three phases: a marked initial rise, a partial decrease with rapid oscillations and eventually large and slow oscillations. These changes, in particular the frequency of the oscillations and the magnitude of the [Ca2+] rise, were similar in wild-type and mGPDH(-/-) mice. Glucose-induced electrical activity (oscillations of the membrane potential with bursts of action potentials) was not altered in mGPDH(-/-) beta cells. In single islets from either type of mouse, insulin secretion strictly followed the changes in [Ca2+](i) during imposed oscillations induced by pulses of high K+ or glucose and during the biphasic elevation induced by sustained stimulation with glucose. An imposed and controlled rise of [Ca2+](i) in beta cells similarly increased NAD(P)B fluorescence in control and mGDPH(-/-) islets. Inhibition of the malate-aspartate NADH shuttle with aminooxyacetate only had minor effects in control islets but abolished the electrical, [Ca2+](i) and secretory responses in mGPDH(-/-) islets, The results show that the two distinct NADH shuttles play an important but at least partially redundant role in glucose-induced insulin secretion. The oscillatory behavior of beta cells does not depend on the functioning of mGPDH and on metabolic oscillations that would be generated by cyclic activation of this enzyme by Ca2+.	Univ Catholique Louvain, Fac Med, Unite Endocrinol & Metab, B-1200 Brussels, Belgium; Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan	Universite Catholique Louvain; University of Tokyo	Henquin, JC (corresponding author), Univ Catholique Louvain, Fac Med, Unite Endocrinol & Metab, 55-30 Ave Hippocrate 55, B-1200 Brussels, Belgium.		Ravier, Magalie/K-9911-2019; Ravier, Magalie A/N-6934-2017	Ravier, Magalie/0000-0001-6607-6559; Ravier, Magalie A/0000-0001-6607-6559				ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; Barron JT, 1998, J MOL CELL CARDIOL, V30, P1571, DOI 10.1006/jmcc.1998.0722; BERGLUND O, 1980, ACTA ENDOCRINOL-COP, V93, P54, DOI 10.1530/acta.0.0930054; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; BERRY MN, 1994, EUR J BIOCHEM, V225, P557, DOI 10.1111/j.1432-1033.1994.00557.x; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; Cunningham BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE702, DOI 10.1152/ajpendo.1996.271.4.E702; DETIMARY P, 1994, BIOCHEM J, V297, P455, DOI 10.1042/bj2970455; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; DETIMARY P, 1995, J CLIN INVEST, V96, P1738, DOI 10.1172/JCI118219; DUKES ID, 1994, J BIOL CHEM, V269, P10979; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Eto K, 1999, J BIOL CHEM, V274, P25386, DOI 10.1074/jbc.274.36.25386; GARDNER RS, 1974, ANAL BIOCHEM, V59, P272, DOI 10.1016/0003-2697(74)90033-5; GEMBAL M, 1993, J CLIN INVEST, V91, P871, DOI 10.1172/JCI116308; GEMBAL M, 1992, J CLIN INVEST, V89, P1288, DOI 10.1172/JCI115714; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1992, J BIOL CHEM, V267, P20713; HENQUIN JC, 1982, BIOCHEM PHARMACOL, V31, P1407, DOI 10.1016/0006-2952(82)90036-3; IDAHL LA, 1995, BIOCHEM J, V312, P287, DOI 10.1042/bj3120287; Jonas JC, 1998, DIABETES, V47, P1266, DOI 10.2337/diabetes.47.8.1266; Jonkers FC, 1999, J PHYSIOL-LONDON, V520, P839, DOI 10.1111/j.1469-7793.1999.00839.x; Kennedy ED, 1998, DIABETES METAB, V24, P15; LENZEN S, 1979, AM J PHYSIOL, V236, pE391, DOI 10.1152/ajpendo.1979.236.4.E391; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MacDonald MJ, 1997, DIABETES, V46, P1996, DOI 10.2337/diabetes.46.12.1996; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; Malaisse W., 1996, DIABETES REV, P145; MALAISSE WJ, 1982, ENDOCRINOLOGY, V111, P392, DOI 10.1210/endo-111-2-392; MATSCHINSKY FM, 1996, DIABETES REV, V4, P130; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MEISSNER HP, 1990, METHOD ENZYMOL, V192, P235; MISLER S, 1992, DIABETES, V41, P1221, DOI 10.2337/diabetes.41.10.1221; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; RASSCHAERT J, 1991, BIOCHEM J, V278, P335, DOI 10.1042/bj2780335; RUTTER GA, 1992, BIOCHIM BIOPHYS ACTA, V1175, P107, DOI 10.1016/0167-4889(92)90016-5; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; SATO Y, 1992, DIABETES, V41, P438, DOI 10.2337/diabetes.41.4.438; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Tornheim K, 1997, DIABETES, V46, P1375, DOI 10.2337/diabetes.46.9.1375; Ueda K, 1998, DIABETOLOGIA, V41, P649, DOI 10.1007/s001250050963; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914	45	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 21	2000	275	3					1587	1593		10.1074/jbc.275.3.1587	http://dx.doi.org/10.1074/jbc.275.3.1587			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277NQ	10636849	hybrid			2022-12-27	WOS:000084940000012
J	Chin, LS; Nugent, RD; Raynor, MC; Vavalle, JP; Li, L				Chin, LS; Nugent, RD; Raynor, MC; Vavalle, JP; Li, L			SNIP, a novel SNAP-25-interacting protein implicated in regulated exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOSOMAL-ASSOCIATED PROTEIN; MEMBRANE-FUSION COMPLEX; HUMAN GROWTH-HORMONE; PC12 CELLS; SYNAPTIC VESICLES; IN-VITRO; T-SNARE; CA2+-DEPENDENT EXOCYTOSIS; NEUROTRANSMITTER RELEASE; CLOSTRIDIAL NEUROTOXINS	Synaptosome-associated protein of 25 kDa (SNAP-25) is a presynaptic membrane protein that has been clearly implicated in membrane fusion in both developing and mature neurons, although its mechanisms of action are unclear. We have now identified a novel SNAP-BB-interacting protein named SNIP, SNIP is a hydrophilic, 145-kDa protein that comprises two predicted coiled-coil domains, two highly charged regions, and two proline-rich domains with multiple PPXY and PXXP motifs, SNIP is selectively expressed in brain where it codistributes with SNAP-25 in most brain regions. Biochemical studies have revealed that SNIP is tightly associated with the brain cytoskeleton. Subcellular fractionation and immunofluorescence localization studies have demonstrated that SNIP co-localizes with SNAP-25 as well as the cortical actin cytoskeleton, suggesting that SMP serves as a linker protein connecting SNAP-25 to the submembranous cytoskeleton. By using deletion analysis, we have mapped the binding domains of SNIP and SNAP-25, and we have demonstrated that the SNIP-SNAP-25 association is mediated via coiled-coil interactions. Moreover, we have shown that overexpression of SNIP or its SNAP-25-interacting domain inhibits Ca2+-dependent exocytosis from PC12 cells. These results indicate that SNIP is involved in regulation of neurosecretion, perhaps via its interaction with SNAP-25 and the cytoskeleton.	Univ N Carolina, Dept Pharmacol, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Physiol, Sch Med, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Li, L (corresponding author), Univ N Carolina, Dept Pharmacol, Sch Med, Bowles Ctr Alcohol Studies, Rm 1025A Thurston Bowles, Chapel Hill, NC 27599 USA.			Li, Lian/0000-0003-4700-1134; Chin, Lih-Shen/0000-0002-0817-0368	NINDS NIH HHS [NS37939] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037939] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araki S, 1997, BIOCHEM BIOPH RES CO, V234, P257, DOI 10.1006/bbrc.1997.6560; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; Bennett MK, 1997, CURR OPIN NEUROBIOL, V7, P316, DOI 10.1016/S0959-4388(97)80058-X; BINZ T, 1994, J BIOL CHEM, V269, P1617; Bretscher A, 1997, J CELL SCI, V110, P3011; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; CHILCOTE TJ, 1995, J CELL BIOL, V129, P219, DOI 10.1083/jcb.129.1.219; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; Deitcher D. L., 1997, Society for Neuroscience Abstracts, V23, P1170; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Foster LJ, 1999, AM J PHYSIOL-CELL PH, V276, pC1108, DOI 10.1152/ajpcell.1999.276.5.C1108; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GALLI T, 1995, NEUROPHARMACOLOGY, V34, P1351, DOI 10.1016/0028-3908(95)00113-K; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Gotte M, 1998, TRENDS CELL BIOL, V8, P215, DOI 10.1016/S0962-8924(98)01272-0; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; HANNON GJ, 1993, GENE DEV, V7, P2378, DOI 10.1101/gad.7.12a.2378; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; HESS EJ, 1992, J NEUROSCI, V12, P2865; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mains RE, 1999, J BIOL CHEM, V274, P2929, DOI 10.1074/jbc.274.5.2929; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; Mehta PP, 1996, P NATL ACAD SCI USA, V93, P10471, DOI 10.1073/pnas.93.19.10471; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; PFENNINGER KH, 1993, DEV BRAIN RES, V71, P181, DOI 10.1016/0165-3806(93)90170-F; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Raber J, 1997, J NEUROCHEM, V68, P176; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHWEITZER ES, 1985, J CELL BIOL, V101, P667, DOI 10.1083/jcb.101.2.667; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Steffensen SC, 1996, SYNAPSE, V22, P281, DOI 10.1002/(SICI)1098-2396(199603)22:3<281::AID-SYN11>3.3.CO;2-7; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tahara M, 1998, J BIOL CHEM, V273, P33667, DOI 10.1074/jbc.273.50.33667; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wang GY, 1997, J CELL SCI, V110, P505; WANG JKT, 1989, P NATL ACAD SCI USA, V86, P2253, DOI 10.1073/pnas.86.7.2253; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; WICK PF, 1993, J BIOL CHEM, V268, P10983; Williamson LC, 1996, J BIOL CHEM, V271, P7694, DOI 10.1074/jbc.271.13.7694; Wilson MC, 1996, BIOCHEM SOC T, V24, P670, DOI 10.1042/bst0240670; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	83	79	80	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1191	1200		10.1074/jbc.275.2.1191	http://dx.doi.org/10.1074/jbc.275.2.1191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625663	Green Published, hybrid			2022-12-27	WOS:000084836600067
J	Garcia-Ocana, A; Takane, KK; Syed, MA; Philbrick, WM; Vasavada, RC; Stewart, AF				Garcia-Ocana, A; Takane, KK; Syed, MA; Philbrick, WM; Vasavada, RC; Stewart, AF			Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; FETAL PANCREATIC-CELLS; FACTOR SCATTER FACTOR; MOLECULAR-CLONING; EPITHELIAL-CELLS; RAT PANCREAS; EXPRESSION; RECEPTOR; REPLICATION; ACTIVATION	Hepatocyte growth factor (HGF) is produced in pancreatic mesenchyme-derived cells and in islet cells. In vitro, HGF increases the insulin content and proliferation of islets. To study the role of HGF in the islet in vivo, we have developed three lines of transgenic mice overexpressing mHGF using the rat insulin II promoter (RIP). Each RIP-HGF transgenic line displays clear expression of HGF mRNA and protein in the islet. RIP-mHGF mice are relatively hypoglycemic in post-prandial and fasting states compared with their normal littermates. They display inappropriate insulin production, striking overexpression of insulin mRNA in the islet, and a a-fold increase in the insulin content in islet extracts. Importantly, beta cell replication rates in vivo are two to three times higher in RIP-HGF mice. This increase in proliferation results in a 2-3-fold increase in islet mass. Moreover, the islet number per pancreatic area was also increased by approximately 50%. Finally, RIP-mHGF mice show a dramatically attenuated response to the diabetogenic effects of streptozotocin. We conclude that the overexpression of HGF in the islet increases beta cell proliferation, islet number, beta cell mass, and total insulin production in vivo. These combined effects result in mild hypoglycemia and resistance to the diabetogenic effects of streptozotocin.	Univ Pittsburgh, Sch Med, Div Endocrinol, Pittsburgh, PA 15213 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Garcia-Ocana, A (corresponding author), Univ Pittsburgh, Sch Med, Div Endocrinol, BST E-1140,3550 Terrace St, Pittsburgh, PA 15213 USA.				NIDCR NIH HHS [DE 12616] Funding Source: Medline; NIDDK NIH HHS [DK 55023, DK 47168] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047168, R01DK055023] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BONNERWEIR S, 1994, TRENDS ENDOCRIN MET, V5, P60, DOI 10.1016/1043-2760(94)90003-5; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Calvo EL, 1996, BIOCHEM BIOPH RES CO, V229, P257, DOI 10.1006/bbrc.1996.1789; DAVALLI AM, 1995, DIABETES, V44, P104, DOI 10.2337/diabetes.44.1.104; Efrat S, 1996, DIABETES REV, V4, P224; EIZIRIK DL, 1991, BIOCHEM PHARMACOL, V42, P2275, DOI 10.1016/0006-2952(91)90230-3; FURUKAWA T, 1995, AM J PATHOL, V147, P889; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; HOGG J, 1993, J ENDOCRINOL, V138, P401, DOI 10.1677/joe.0.1380401; KORC M, 1993, J CLIN INVEST, V92, P1113, DOI 10.1172/JCI116677; Kosai K, 1998, BIOCHEM BIOPH RES CO, V244, P683, DOI 10.1006/bbrc.1998.8293; Lefebvre VH, 1998, DIABETES, V47, P134, DOI 10.2337/diabetes.47.1.134; Liu YH, 1998, BIOCHEM BIOPH RES CO, V246, P821, DOI 10.1006/bbrc.1998.8676; MARS WM, 1993, AM J PATHOL, V143, P949; Mashima H, 1996, ENDOCRINOLOGY, V137, P3969, DOI 10.1210/en.137.9.3969; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; MIYAURA C, 1991, MOL ENDOCRINOL, V5, P226, DOI 10.1210/mend-5-2-226; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MONTANA E, 1994, J CLIN INVEST, V93, P1577, DOI 10.1172/JCI117137; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; OTONKOSKI T, 1994, DIABETES, V43, P1164, DOI 10.2337/diabetes.43.9.1164; Otonkoski T, 1996, ENDOCRINOLOGY, V137, P3131, DOI 10.1210/en.137.7.3131; OTONKOSKI T, 1994, DIABETES, V43, P947, DOI 10.2337/diabetes.43.7.947; Porter SE, 1998, ENDOCRINOLOGY, V139, P3743, DOI 10.1210/en.139.9.3743; PRAT M, 1991, INT J CANCER, V49, P323, DOI 10.1002/ijc.2910490302; Rafaeloff R, 1997, J CLIN INVEST, V99, P2100, DOI 10.1172/JCI119383; SCAGLIA L, 1995, ENDOCRINOLOGY, V136, P5461, DOI 10.1210/en.136.12.5461; SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257, DOI 10.1111/j.1432-1033.1995.0257l.x; SOIFER NE, 1993, J CLIN INVEST, V92, P2850, DOI 10.1172/JCI116905; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; STEWART AF, 1982, J CLIN ENDOCR METAB, V55, P219, DOI 10.1210/jcem-55-2-219; SWENNE I, 1985, DIABETES, V34, P803, DOI 10.2337/diabetes.34.8.803; TSUDA H, 1992, JPN J CANCER RES, V83, P1262, DOI 10.1111/j.1349-7006.1992.tb02756.x; TURK J, 1993, BIOCHEM BIOPH RES CO, V197, P1458, DOI 10.1006/bbrc.1993.2641; Vasavada RC, 1996, J BIOL CHEM, V271, P1200, DOI 10.1074/jbc.271.2.1200; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; WATANABE T, 1994, P NATL ACAD SCI USA, V91, P3589, DOI 10.1073/pnas.91.9.3589; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; WYSOLMERSKI JJ, 1994, P NATL ACAD SCI USA, V91, P1133, DOI 10.1073/pnas.91.3.1133; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0; ZARNEGAR R, 1990, P NATL ACAD SCI USA, V87, P1252, DOI 10.1073/pnas.87.3.1252; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	47	185	194	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					1226	1232		10.1074/jbc.275.2.1226	http://dx.doi.org/10.1074/jbc.275.2.1226			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625667	hybrid			2022-12-27	WOS:000084836600071
J	Hanley, JG; Jones, EMC; Moss, SJ				Hanley, JG; Jones, EMC; Moss, SJ			GABA receptor rho 1 subunit interacts with a novel splice variant of the glycine transporter, GLYT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGER SALAMANDER RETINA; XENOPUS OOCYTES; AMACRINE CELLS; BIPOLAR CELLS; RAT RETINA; C-RECEPTOR; CLONING; LOCALIZATION; EXPRESSION; BRAIN	Ionotropic gamma-aminobutyric acid (GABA(A) and GABA(C)) receptors mediate fast synaptic inhibition in the central nervous system. GABA(C) receptors are expressed predominantly in the retina on bipolar cell axon terminals, and are thought to mediate feedback inhibition from GABAergic amacrine cells. Utilizing the yeast two-hybrid system, we previously identified MAP1B as a binding partner of the GABA(C) receptor rho 1 subunit, Here we describe the isolation of an additional rho 1 interacting protein: a novel C-terminal variant of the glycine transporter GLYT-1. We show that GLYT-1 exists as four alternatively spliced mRNAs which encode proteins expressing one of two possible intracellullar N- and C-terminal domains. Variants containing the novel C terminus efficiently transport glycine when expressed in COS cells, but with unusual kinetics. We have confirmed the interaction between the novel C terminus and rho 1 subunit and demonstrated binding in heterologous cells. This interaction may be crucial for the integration of GABAergic and glycinergic neurotransmission in the retina.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Pharmacol, London WC1E 6BT, England; Univ Chicago, Comm Neurobiol, Chicago, IL USA	University of London; University College London; University of London; University College London; University of Chicago	Moss, SJ (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	steve.moss@ucl.ac.uk		Hanley, Jonathan/0000-0003-1704-4707				ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; BLONDEL O, 1994, J BIOL CHEM, V269, P27167; Borowsky B, 1998, J BIOL CHEM, V273, P29077, DOI 10.1074/jbc.273.44.29077; BOROWSKY B, 1993, NEURON, V10, P851, DOI 10.1016/0896-6273(93)90201-2; CALVO DJ, 1995, NEUROREPORT, V6, P1118, DOI 10.1097/00001756-199505300-00011; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Enz R, 1996, J NEUROSCI, V16, P4479; Enz R, 1998, VISION RES, V38, P1431, DOI 10.1016/S0042-6989(97)00277-0; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; Hackam AS, 1997, J BIOL CHEM, V272, P13750, DOI 10.1074/jbc.272.21.13750; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; KANNER BI, 1994, J EXP BIOL, V196, P237; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; KIM KM, 1994, MOL PHARMACOL, V45, P608; LIU QR, 1992, FEBS LETT, V305, P110, DOI 10.1016/0014-5793(92)80875-H; Lukasiewicz PD, 1996, MOL NEUROBIOL, V12, P181, DOI 10.1007/BF02755587; LUKASIEWICZ PD, 1994, J NEUROSCI, V14, P1213, DOI 10.1523/JNEUROSCI.14-03-01213.1994; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; OGURUSU T, 1995, J NEUROCHEM, V65, P964; OLIVARES L, 1994, J BIOL CHEM, V269, P28400; PAN ZH, 1995, J NEUROSCI, V15, P2668; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; SHIMADA S, 1992, MOL PHARMACOL, V41, P683; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; THOMSON AM, 1989, TRENDS NEUROSCI, V12, P349, DOI 10.1016/0166-2236(89)90042-8; TROUTT AB, 1992, P NATL ACAD SCI USA, V89, P9823, DOI 10.1073/pnas.89.20.9823; WAESSLE H, 1991, Physiological Reviews, V71, P447; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; WANG TL, 1994, J NEUROSCI, V14, P6524; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; ZHANG DX, 1995, P NATL ACAD SCI USA, V92, P11756, DOI 10.1073/pnas.92.25.11756; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	40	62	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					840	846		10.1074/jbc.275.2.840	http://dx.doi.org/10.1074/jbc.275.2.840			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625616	hybrid			2022-12-27	WOS:000084836600020
J	Zingone, A; Hiraiwa, H; Pan, CJ; Lin, BC; Chen, HW; Ward, JM; Chou, JY				Zingone, A; Hiraiwa, H; Pan, CJ; Lin, BC; Chen, HW; Ward, JM; Chou, JY			Correction of glycogen storage disease type 1a in a mouse model by gene therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT ADENOVIRUSES IMPROVES; GLUCOSE-6-PHOSPHATASE SYSTEM; MURINE GLUCOSE-6-PHOSPHATASE; LIVER; TRANSPLANTATION; TRANSPORT; GLUCOSE; CLONING; VECTORS; E2A	Glycogen storage disease type 1a (GSD-1a), characterized by hypoglycemia, liver and kidney enlargement, growth retardation, hyperlipidemia, and hyperuricemia, is caused by a deficiency in glucose-6-phosphatase (G6Pase), a key enzyme in glucose homeostasis. To evaluate the feasibility of gene replacement therapy for GSD-1a, we have infused adenoviral vector containing the murine G6Pase gene (Ad-mG6Pase) into G6Pase-deficient (G6Pase(-/-)) mice that manifest symptoms characteristic of human GSD-1a. Whereas < 15% of G6Pase(-/-) mice under glucose therapy survived weaning, a 100% survival rate was achieved when G6Pase(-/-) mice were infused with Ad-mG6Pase, 90% of which lived to 3 months of age. Hepatic G6Pase activity in Ad-mG6Pase-infused mice was restored to 19% of that in G6Pase(+/+) mice at 7-14 days post-infusion; the activity persisted for at least 70 days. Ad-mG6Pase infusion also greatly improved growth of G6Pase(-/-) mice and normalized plasma glucose, cholesterol, triglyceride, and uric acid profiles. Furthermore, liver and kidney enlargement was less pronounced with near-normal levels of glycogen depositions in both organs. Our data demonstrate that a single administration of a recombinant adenoviral vector can alleviate the pathological manifestations of GSD-1a in mice, suggesting that this disorder in humans can potentially be corrected by gene therapy.	NICHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Acad Sinica, Inst Biol Chem, Taipei, Taiwan; NCI, Frederick Canc Res & Dev Ctr, Vet & Tumor Pathol Sect,Off Lab Anim Sci, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Academia Sinica - Taiwan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Chou, JY (corresponding author), NICHD, Heritable Disorders Branch, NIH, Bldg 10,Rm 9S241, Bethesda, MD 20892 USA.		Lin, Baochuan/A-8390-2009	Lin, Baochuan/0000-0002-9484-0785	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000912] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000912] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Argaud D, 1997, J BIOL CHEM, V272, P12854, DOI 10.1074/jbc.272.19.12854; ARION WJ, 1980, J BIOL CHEM, V255, P396; Chen Y-T, 1995, METABOLIC MOL BASES, P935; CHEN YT, 1991, J INHERIT METAB DIS, V14, P80, DOI 10.1007/BF01804394; CHEN YT, 1984, NEW ENGL J MED, V310, P171, DOI 10.1056/NEJM198401193100306; EMMETT M, 1978, JAMA-J AM MED ASSOC, V239, P1642, DOI 10.1001/jama.239.16.1642; ENGELHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196, DOI 10.1073/pnas.91.13.6196; Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532; IYNEDJIAN PB, 1987, J BIOL CHEM, V262, P6032; KIRSCHNER BS, 1991, GASTROENTEROLOGY, V101, P238, DOI 10.1016/0016-5085(91)90483-2; KOZARSKY KF, 1993, CURR OPIN GENET DEV, V3, P499, DOI 10.1016/0959-437X(93)90126-A; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin BC, 1998, J BIOL CHEM, V273, P31656, DOI 10.1074/jbc.273.48.31656; MITTEREDER N, 1994, HUM GENE THER, V5, P719; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, V2, P349; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pan CJ, 1998, ARCH BIOCHEM BIOPHYS, V358, P17, DOI 10.1006/abbi.1998.0849; SELBY R, 1993, EUR J PEDIATR, V152, pS71; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; STRATFORDPERRIC.LD, 1991, GENE THERAPEUTICS ME, P345; TEUTSCH HF, 1981, PROGR HISTOCHEMISTRY, V14; TRAPNELL BC, 1993, ADV DRUG DELIVER REV, V12, P185, DOI 10.1016/0169-409X(93)90059-D; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362	23	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 14	2000	275	2					828	832		10.1074/jbc.275.2.828	http://dx.doi.org/10.1074/jbc.275.2.828			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	275TQ	10625614	hybrid			2022-12-27	WOS:000084836600018
